PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dalal, S; Ragheb, DRT; Schubot, FD; Klemba, M				Dalal, Seema; Ragheb, Daniel R. T.; Schubot, Florian D.; Klemba, Michael			A Naturally Variable Residue in the S1 Subsite of M1 Family Aminopeptidases Modulates Catalytic Properties and Promotes Functional Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR HEMOGLOBIN CATABOLISM; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; ACTIVE-SITE; M1-FAMILY AMINOPEPTIDASE; CRYSTAL-STRUCTURE; TRIMS PRECURSORS; STRUCTURAL BASIS; DISTINCT ROLES	M1 family metallo-aminopeptidases fulfill a wide range of critical and in some cases medically relevant roles in humans and human pathogens. The specificity of M1-aminopeptidases is dominated by the interaction of the well defined S1 subsite with the side chain of the first (P1) residue of the substrate and can vary widely. Extensive natural variation occurs at one of the residues that contributes to formation of the cylindrical S1 subsite. We investigated whether this natural variation contributes to diversity in S1 subsite specificity. Effects of 11 substitutions of the S1 subsite residue valine 459 in the Plasmodium falciparum aminopeptidase PfA-M1 and of three substitutions of the homologous residue methionine 260 in Escherichia coli aminopeptidase N were characterized. Many of these substitutions altered steady-state kinetic parameters for dipeptide hydrolysis and remodeled S1 subsite specificity. The most dramatic change in specificity resulted from substitution with proline, which collapsed S1 subsite specificity such that only substrates with P1-Arg, -Lys, or -Met were appreciably hydrolyzed. The structure of PfA-M1 V459P revealed that the proline substitution induced a local conformational change in the polypeptide backbone that resulted in a narrowed S1 subsite. The restricted specificity and active site backbone conformation of PfA-M1 V459P mirrored those of endoplasmic reticulum aminopeptidase 2, a human enzyme with proline in the variable S1 subsite position. Our results provide compelling evidence that changes in the variable residue in the S1 subsite of M1-aminopeptidases have facilitated the evolution of new specificities and ultimately novel functions for this important class of enzymes.	[Dalal, Seema; Ragheb, Daniel R. T.; Klemba, Michael] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Schubot, Florian D.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu		Schubot, Florian/0000-0002-7403-4735	National Institutes of Health [AI077638]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638 (to M.K.).	Addlagatta A, 2008, BIOCHEMISTRY-US, V47, P5303, DOI 10.1021/bi7022333; Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Bhosale M, 2013, MICROBIOL RES, V168, P56, DOI 10.1016/j.micres.2012.06.003; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dalal S, 2012, MOL BIOCHEM PARASIT, V183, P70, DOI 10.1016/j.molbiopara.2012.02.003; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Evnouchidou I, 2009, CURR PHARM DESIGN, V15, P3656, DOI 10.2174/138161209789271816; FERSHT A, 1985, ENZYME STRUCTURE MEC, P311; Flipo M, 2007, J MED CHEM, V50, P1322, DOI 10.1021/jm061169b; Fournie-Zaluski MC, 2009, ACTA CRYSTALLOGR D, V65, P814, DOI 10.1107/S090744490901779X; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Niven GW, 1995, APPL MICROBIOL BIOT, V44, P100, DOI [10.1007/BF00164487, 10.1007/s002530050526]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thompson MW, 2009, PROTEIN PEPTIDE LETT, V16, P1256, DOI 10.2174/092986609789071199; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zervoudi E, 2011, BIOCHEM J, V435, P411, DOI 10.1042/BJ20102049; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	36	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26004	26012		10.1074/jbc.M113.465625	http://dx.doi.org/10.1074/jbc.M113.465625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897806	Green Published, hybrid			2022-12-28	WOS:000330623300031
J	Toei, M; Noji, H				Toei, Masashi; Noji, Hiroyuki			Single-molecule Analysis of F0F1-ATP Synthase Inhibited by N,N-Dicyclohexylcarbodiimide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTIC POWER TRANSMISSION; THERMOPHILIC BACILLUS PS3; AQUEOUS ACCESS PATHWAYS; COLI ATP SYNTHASE; ESCHERICHIA-COLI; SUBUNIT-C; F-1 MOTOR; PROTEOLIPID SUBUNIT; CATALYTIC SITE; RING ROTATION	N,N-Dicyclohexylcarbodiimide (DCCD) is a classical inhibitor of the F0F1-ATP synthase (F0F1), which covalently binds to the highly conserved carboxylic acid of the proteolipid subunit (c subunit) in F-0. Although it is well known that DCCD modification of the c subunit blocks proton translocation in F-0 and the coupled ATP hydrolysis activity of F-1, how DCCD inhibits the rotary dynamics of F0F1 remains elusive. Here, we carried out single-molecule rotation assays to characterize the DCCD inhibition of Escherichia coli F0F1. Upon the injection of DCCD, rotations irreversibly terminated with first order reaction kinetics, suggesting that the incorporation of a single DCCD moiety is sufficient to block the rotary catalysis of the F0F1. Individual molecules terminated at different angles relative to the three catalytic angles of F-1, suggesting that DCCD randomly reacts with one of the 10 c subunits. DCCD-inhibited F0F1 sometimes showed transient activation; molecules abruptly rotated and stopped after one revolution at the original termination angle, suggesting that hindrance by the DCCD moiety is released due to thermal fluctuation. To explore the mechanical activation of DCCD-inhibited molecules, we perturbed inhibited molecules using magnetic tweezers. The probability of transient activation increased upon a forward forcible rotation. Interestingly, during the termination F0F1, showed multiple positional shifts, which implies that F-1 stochastically changes the angular position of its rotor upon a catalytic reaction. This effect could be caused by balancing the angular positions of the F-1 and the F-0 rotors, which are connected via elastic elements.	[Toei, Masashi; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	University of Tokyo	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan;  [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by Grant-in-aid for Scientific Research 18074005 (to H. N.) and by a Special Education and Research Expenses grant (to H. N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GIRVIN ME, 1994, BIOCHEMISTRY-US, V33, P665, DOI 10.1021/bi00169a006; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Nakano T, 2006, J MOL BIOL, V358, P132, DOI 10.1016/j.jmb.2006.01.011; NEGRIN RS, 1980, J BIOL CHEM, V255, P5643; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SEBALD W, 1980, P NATL ACAD SCI-BIOL, V77, P785, DOI 10.1073/pnas.77.2.785; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Sorgen PL, 1999, J BIOL CHEM, V274, P36261, DOI 10.1074/jbc.274.51.36261; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tsunoda SP, 2000, FEBS LETT, V470, P244, DOI 10.1016/S0014-5793(00)01336-3; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Watanabe R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2631; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	47	24	25	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25717	25726		10.1074/jbc.M113.482455	http://dx.doi.org/10.1074/jbc.M113.482455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893417	Green Published, hybrid			2022-12-28	WOS:000330623300005
J	Andrawes, MB; Xu, X; Liu, H; Ficarro, SB; Marto, JA; Aster, JC; Blacklow, SC				Andrawes, Marie Blanke; Xu, Xiang; Liu, Hong; Ficarro, Scott B.; Marto, Jarrod A.; Aster, Jon C.; Blacklow, Stephen C.			Intrinsic Selectivity of Notch 1 for Delta-like 4 Over Delta-like 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIGAND INTERACTIONS; LINKED-N-ACETYLGLUCOSAMINE; INHIBITS TUMOR-GROWTH; LINEAGE COMMITMENT; DROSOPHILA NOTCH; ABRUPTEX DOMAIN; BINDING DOMAIN; O-FUCOSE; B-CELLS; FRINGE	Notch signaling makes critical contributions to cell fate determination in all metazoan organisms, yet remarkably little is known about the binding affinity of the four mammalian Notch receptors for their three Delta-like and two Jagged family ligands. Here, we utilized signaling assays and biochemical studies of purified recombinant ligand and receptor molecules to investigate the differences in signaling behavior and intrinsic affinity between Notch1-Dll1 and Notch1-Dll4 complexes. Systematic deletion mutagenesis of the human Notch1 ectodomain revealed that epidermal growth factor (EGF) repeats 6-15 are sufficient to maintain signaling in a reporter assay at levels comparable with the full-length receptor, and identified important contributions from EGF repeats 8-10 in conveying an activating signal in response to either Dll1 or Dll4. Truncation studies of the Dll1 and Dll4 ectodomains showed that the MNNL-EGF3 region was both necessary and sufficient for full activation. Plate-based and cell binding assays revealed a specific, calcium-dependent interaction between cell-surface and recombinant Notch receptors and ligand molecules. Finally, direct measurement of the binding affinity of Notch1 EGF repeats 6-15 for Dll1 and Dll4 revealed that Dll4 binds with at least an order of magnitude higher affinity than Dll1. Together, these studies give new insights into the features of ligand recognition by Notch1, and highlight how intrinsic differences in the biochemical behavior of receptor-ligand complexes can influence receptor-mediated responses of developmental signaling pathways.	[Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Andrawes, Marie Blanke; Xu, Xiang; Liu, Hong; Ficarro, Scott B.; Marto, Jarrod A.; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02114 USA; [Aster, Jon C.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Blacklow, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Stephen_blacklow@hms.harvard.edu			National Institutes of Health [R01 CA092433, P01 CA119070]; NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA092433 (to S. C. B.) and P01 CA119070.	Abe N, 2010, EUR J IMMUNOL, V40, P2608, DOI 10.1002/eji.200940006; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Askenazi M, 2009, NAT METHODS, V6, P240, DOI 10.1038/nmeth0409-240; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; de Celis JF, 2000, DEVELOPMENT, V127, P1291; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; DECELIS JF, 1994, GENETICS, V136, P183; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; LIEBER T, 1992, NEURON, V9, P847, DOI 10.1016/0896-6273(92)90238-9; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murata A, 2010, J IMMUNOL, V185, P3905, DOI 10.4049/jimmunol.1000195; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Patel NS, 2006, CLIN CANCER RES, V12, P4836, DOI 10.1158/1078-0432.CCR-06-0285; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah DK, 2012, CURR TOP MICROBIOL, V360, P19, DOI 10.1007/82_2012_225; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Van de Walle I, 2013, J EXP MED, V210, P683, DOI 10.1084/jem.20121798; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	67	92	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25477	25489		10.1074/jbc.M113.454850	http://dx.doi.org/10.1074/jbc.M113.454850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839946	hybrid, Green Published			2022-12-28	WOS:000330619000043
J	Franchini, AM; Hunt, D; Melendez, JA; Drake, JR				Franchini, Anthony M.; Hunt, Danielle; Melendez, J. Andres; Drake, James R.			Fc gamma R-driven Release of IL-6 by Macrophages Requires NOX2-dependent Production of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FACTOR-ALPHA SECRETION; NADPH OXIDASE; ACTIVATION; INTERLEUKIN-6; SUPEROXIDE; IGG; P67(PHOX); RECEPTORS; VACCINE	Activation of the Fc gamma R via antigen containing immune complexes can lead to the generation of reactive oxygen species, which are potent signal transducing molecules. However, whether ROS contribute to Fc gamma R signaling has not been studied extensively. We set out to elucidate the role of NADPH oxidase generated ROS in macrophage activation following Fc gamma R engagement using antigen-containing immune complexes. We hypothesized that NOX2 generated ROS is necessary for propagation of downstream Fc gamma R signaling and initiation of the innate immune response. Following exposure of murine bone marrow-derived macrophages (BMDMs) to inactivated Francisella tularensis (iFt)-containing immune complexes, we observed a significant increase in the innate inflammatory cytokine IL-6 at 24 h compared with macrophages treated with Ft LVS-containing immune complexes. Ligation of the Fc gamma R by opsonized Ft also results in significant ROS production. Macrophages lacking the gp91(phox) subunit of NOX2 fail to produce ROS upon Fc gamma R ligation, resulting in decreased Akt phosphorylation and a reduction in the levels of IL-6 compared with wild type macrophages. Similar results were seen following infection of BMDMs with catalase deficient Ft that fail to scavenge hydrogen peroxide. In conclusion, our findings demonstrate that ROS participate in elicitation of an effective innate immune in response to antigen-containing immune complexes through Fc gamma R.	[Franchini, Anthony M.; Hunt, Danielle; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Melendez, J. Andres] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave, Albany, NY 12208 USA.	DrakeJ@mail.amc.edu		Franchini, Anthony/0000-0003-3576-3211; Melendez, Juan/0000-0001-8021-3097	NIAID NIH HHS [P01 AI056320] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON CL, 1986, J BIOL CHEM, V261, P2856; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Huntress EH, 1934, J AM CHEM SOC, V56, P241, DOI 10.1021/ja01316a077; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KIENER PA, 1993, J BIOL CHEM, V268, P24442; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kurtz SL, 2013, INFECT IMMUN, V81, P585, DOI 10.1128/IAI.01249-12; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lim S, 2007, FREE RADICAL BIO MED, V42, P1178, DOI 10.1016/j.freeradbiomed.2007.01.013; Loegering DJ, 2004, INFLAMMATION, V28, P23, DOI 10.1023/B:IFLA.0000014708.87440.45; LUNDQVIST H, 1995, J BIOLUM CHEMILUM, V10, P353, DOI 10.1002/bio.1170100608; Maeda K, 2010, BLOOD, V115, P4699, DOI 10.1182/blood-2009-07-230631; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Okada M., 2011, CLIN DEV IMMUNOL, V2011; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; RYAN TC, 1990, J IMMUNOL METHODS, V130, P223, DOI 10.1016/0022-1759(90)90052-W; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; VANDENDOBBELSTEEN MEA, 1993, KIDNEY INT, V43, P544, DOI 10.1038/ki.1993.81; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x	47	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25098	25108		10.1074/jbc.M113.474106	http://dx.doi.org/10.1074/jbc.M113.474106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857584	hybrid, Green Published			2022-12-28	WOS:000330619000010
J	Su, SF; Minges, JT; Grossman, G; Blackwelder, AJ; Mohler, JL; Wilson, EM				Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Mohler, James L.; Wilson, Elizabeth M.			Proto-oncogene Activity of Melanoma Antigen-A11 (MAGE-A11) Regulates Retinoblastoma-related p107 and E2F1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; RECEPTOR COREGULATOR MAGE-11; ANDROGEN-RECEPTOR; CELL-CYCLE; TRANSCRIPTION FACTOR; PROSTATE-CANCER; ADENOVIRUS E1A; VIRAL ONCOPROTEINS; MOLECULAR-CLONING; TUMOR-SUPPRESSOR	Melanoma antigen-A11 (MAGE-A11) is a low-abundance, primate-specific steroid receptor coregulator in normal tissues of the human reproductive tract that is expressed at higher levels in prostate cancer. Increased expression of MAGE-A11 enhances androgen receptor transcriptional activity and promotes prostate cancer cell growth. Further investigation into the mechanisms of MAGE-A11 function in prostate cancer demonstrated interactions with the retinoblastoma-related protein p107 and Rb tumor suppressor but no interaction with p130 of the Rb family. MAGE-A11 interaction with p107 was associated with transcriptional repression in cells with low MAGE-A11 and transcriptional activation in cells with higher MAGE-A11. Selective interaction of MAGE-A11 with retinoblastoma family members suggested the regulation of E2F transcription factors. MAGE-A11 stabilized p107 by inhibition of ubiquitination and linked p107 to hypophosphorylated E2F1 in association with the stabilization and activation of E2F1. The androgen receptor and MAGE-A11 modulated endogenous expression of the E2F1-regulated cyclin-dependent kinase inhibitor p27(Kip1). The ability of MAGE-A11 to increase E2F1 transcriptional activity was similar to the activity of adenovirus early oncoprotein E1A and depended on MAGE-A11 interactions with p107 and p300. The immunoreactivity of p107 and MAGE-A11 was greater in advanced prostate cancer than in benign prostate, and knockdown with small inhibitory RNA showed that p107 is a transcriptional activator in prostate cancer cells. These results suggest that MAGE-A11 is a proto-oncogene whose increased expression in prostate cancer reverses retinoblastoma-related protein p107 from a transcriptional repressor to a transcriptional activator of the androgen receptor and E2F1.	[Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.] SUNY Buffalo, Dept Urol, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant [HD067721]; NICHD, National Institutes of Health Eunice Kennedy Shriver Grant as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54-HD35041]; National Cancer Institute Grant [P01-CA77739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant; NICHD, National Institutes of Health Eunice Kennedy Shriver Grant as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grant HD16910, by United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant HD067721, and by Cooperative Agreement NICHD, National Institutes of Health Eunice Kennedy Shriver Grant U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by National Cancer Institute Grant P01-CA77739.	Alevizopoulos K, 2000, ONCOGENE, V19, P2067, DOI 10.1038/sj.onc.1203534; Altintas DM, 2012, MOL ENDOCRINOL, V26, P1531, DOI 10.1210/me.2012-1016; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BAGCHI S, 1989, P NATL ACAD SCI USA, V86, P4352, DOI 10.1073/pnas.86.12.4352; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; Bellacchio E, 2013, J CELL PHYSIOL, V228, P285, DOI 10.1002/jcp.24137; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calbo J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cherian MT, 2012, J BIOL CHEM, V287, P23368, DOI 10.1074/jbc.M112.344671; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLAUDIO PP, 1994, CANCER RES, V54, P5556; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; DYSON N, 1993, J VIROL, V67, P7641, DOI 10.1128/JVI.67.12.7641-7647.1993; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; FATTAEY AR, 1993, MOL CELL BIOL, V13, P7267, DOI 10.1128/MCB.13.12.7267; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fera D, 2012, BIOCHEMISTRY-US, V51, P9524, DOI 10.1021/bi3011863; FERGUSON B, 1985, MOL CELL BIOL, V5, P2653, DOI 10.1128/MCB.5.10.2653; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Gregory CW, 2001, CANCER RES, V61, P2892; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Hodul PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052526; Hofman K, 2001, BIOCHEM BIOPH RES CO, V283, P97, DOI 10.1006/bbrc.2001.4738; Hsia EYC, 2010, MOL CANCER RES, V8, P183, DOI 10.1158/1541-7786.MCR-09-0095; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; James SR, 2013, EPIGENETICS-US, V8, P849, DOI 10.4161/epi.25500; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kondo T, 2001, J BIOL CHEM, V276, P17559, DOI 10.1074/jbc.M009911200; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI Y, 1994, CANCER RES, V54, P6078; Li YR, 2012, MOL CELL BIOL, V32, P2454, DOI 10.1128/MCB.06663-11; Lin WC, 2001, GENE DEV, V15, P1833; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Lu JM, 1998, J BIOL CHEM, V273, P31528, DOI 10.1074/jbc.273.47.31528; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mallik I, 2008, BBA-MOL CELL RES, V1783, P1737, DOI 10.1016/j.bbamcr.2008.05.006; Minges JT, 2013, J BIOL CHEM, V288, P1939, DOI 10.1074/jbc.M112.428409; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Puri PL, 1998, CANCER RES, V58, P1325; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Takahashi Y, 2000, GENE DEV, V14, P804; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsihlias J, 1998, CANCER RES, V58, P542; Tsihlias J, 2000, ONCOGENE, V19, P670, DOI 10.1038/sj.onc.1203369; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5; Yang XH, 1997, BIOCHEM BIOPH RES CO, V232, P336, DOI 10.1006/bbrc.1997.6284; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	118	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24809	24824		10.1074/jbc.M113.468579	http://dx.doi.org/10.1074/jbc.M113.468579			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853093	hybrid, Green Published			2022-12-28	WOS:000330612300046
J	Fagan, RL; Cryderman, DE; Kopelovich, L; Wallrath, LL; Brenner, C				Fagan, Rebecca L.; Cryderman, Diane E.; Kopelovich, Levy; Wallrath, Lori L.; Brenner, Charles			Laccaic Acid A Is a Direct, DNA-competitive Inhibitor of DNA Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TUMOR-SUPPRESSOR GENES; TRANSCRIPTIONAL REGULATION; EPIGENETIC REGULATION; ENZYMATIC-PROPERTIES; PPAR-GAMMA; METHYLATION; DNMT1; MOUSE; EXPRESSION	Methylation of cytosines in CpG dinucleotides is the predominant epigenetic mark on vertebrate DNA. DNA methylation is associated with transcriptional repression. The pattern of DNA methylation changes during development and with disease. Human DNA methyltransferase 1 (Dnmt1), a 1616-amino acid multidomain enzyme, is essential for maintenance of DNA methylation in proliferating cells and is considered an important cancer drug target. Using a fluorogenic, endonuclease-coupled DNA methylation assay with an activated form of Dnmt1 engineered to lack the replication foci targeting sequence domain, we discovered that laccaic acid A (LCA), a highly substituted anthraquinone natural product, is a direct inhibitor with a 310 nM K-i. LCA is competitive with the DNA substrate in in vitro methylation assays and alters the expression of methylated genes in MCF-7 breast cancer cells synergistically with 5-aza-2'-deoxycytidine. LCA represents a novel class of Dnmt-targeted molecular probes, with biochemical properties that allow it to distinguish between non DNA-bound and DNA-bound Dnmt1.	[Fagan, Rebecca L.; Cryderman, Diane E.; Wallrath, Lori L.; Brenner, Charles] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Kopelovich, Levy] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brenner, C (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Wallrath, Lori/0000-0002-4391-7199; Switzer, Rebecca/0000-0003-0591-2538	National Institutes of Health [R01CA075954]; National Cancer Institute [HHSN261200433000C]; Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center; American Cancer Society postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center; American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA075954, Contract HHSN261200433000C from the National Cancer Institute and a generous gift from the Roy J. Carver Charitable Trust (to C. B.). This work was also supported by Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center (to C. B. and L. L. W.), and an American Cancer Society postdoctoral fellowship (to R. L. F.).	Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Ceccaldi A, 2011, CHEMBIOCHEM, V12, P1337, DOI 10.1002/cbic.201100130; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Eads CA, 2002, CANCER RES, V62, P1296; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Huang J, 2013, ONCOGENE IN PRESS; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Khan SI, 2012, CHEM RES TOXICOL, V25, P61, DOI 10.1021/tx200378c; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Norwood LE, 2004, GENE, V336, P37, DOI 10.1016/j.gene.2004.04.003; Ohno M, 2012, J BIOCHEM MOL TOXIC, V26, P16, DOI 10.1002/jbt.20408; Oleaga C, 2012, EUR J NUTR, V51, P465, DOI 10.1007/s00394-011-0231-2; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Paluszczak J, 2010, TOXICOL LETT, V192, P119, DOI 10.1016/j.toxlet.2009.10.010; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Rao CN, 2003, INT J ONCOL, V22, P843; Rivenbark AG, 2006, EPIGENETICS-US, V1, P32, DOI 10.4161/epi.1.1.2358; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tanaka T, 1997, FOOD ADDIT CONTAM, V14, P373, DOI 10.1080/02652039709374540; Tao YG, 2011, NUCLEIC ACIDS RES, V39, P9508, DOI 10.1093/nar/gkr611; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wiechec E, 2008, GENE CHROMOSOME CANC, V47, P766, DOI 10.1002/gcc.20578; Wood RJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq047; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	59	45	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23858	23867		10.1074/jbc.M113.480517	http://dx.doi.org/10.1074/jbc.M113.480517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839987	Green Published, hybrid			2022-12-28	WOS:000330611400025
J	Leroux, AE; Haanstra, JR; Bakker, BM; Krauth-Siegel, RL				Leroux, Alejandro E.; Haanstra, Jurgen R.; Bakker, Barbara M.; Krauth-Siegel, R. Luise			Dissecting the Catalytic Mechanism of Trypanosoma brucei Trypanothione Synthetase by Kinetic Analysis and Computational Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; ESCHERICHIA-COLI; IN-VIVO; AFRICAN TRYPANOSOMES; METABOLITE CONCENTRATIONS; CRITHIDIA-FASCICULATA; PARASITIC PROTOZOA; LEISHMANIA-MAJOR	In pathogenic trypanosomes, trypanothione synthetase (TryS) catalyzes the synthesis of both glutathionylspermidine (Gsp) and trypanothione (bis(glutathionyl) spermidine (T(SH)(2))). Here we present a thorough kinetic analysis of Trypanosoma brucei TryS in a newly developed phosphate buffer system at pH 7.0 and 37 degrees C, mimicking the physiological environment of the enzyme in the cytosol of bloodstream parasites. Under these conditions, TryS displays K-m values for GSH, ATP, spermidine, and Gsp of 34, 18, 687, and 32 mu M, respectively, as well as K-i values for GSH and T(SH) 2 of 1 mM and 360 mu M, respectively. As Gsp hydrolysis has a K-m value of 5.6 mM, the in vivo amidase activity is probably negligible. To obtain deeper insight in the molecular mechanism of TryS, we have formulated alternative kinetic models, with elementary reaction steps represented by linear kinetic equations. The model parameters were fitted to the extensive matrix of steady-state data obtained for different substrate/product combinations under the in vivo-like conditions. The best model describes the full kinetic profile and is able to predict time course data that were not used for fitting. This system's biology approach to enzyme kinetics led us to conclude that (i) TryS follows a ter-reactant mechanism, (ii) the intermediate Gsp dissociates from the enzyme between the two catalytic steps, and (iii) T(SH)(2) inhibits the enzyme by remaining bound at its product site and, as does the inhibitory GSH, by binding to the activated enzyme complex. The newly detected concerted substrate and product inhibition suggests that TryS activity is tightly regulated.	[Leroux, Alejandro E.; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Haanstra, Jurgen R.; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands; [Haanstra, Jurgen R.; Bakker, Barbara M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; University of Groningen; Vrije Universiteit Amsterdam	Bakker, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, CA84,Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	b.m.bakker01@umcg.nl; luise.krauth-siegel@bzh.uni-heidelberg.de	Leroux, Alejandro E./W-3153-2019	Leroux, Alejandro E./0000-0001-6149-3572; Haanstra, Jurgen/0000-0001-9652-0219; Bakker, Barbara/0000-0001-6274-3633	Bundesministerium fur Bildung und Forschung (BMBF), Germany; Netherlands Organization for Scientific Research (NWO), The Netherlands; SysMo2; European Union; University of Groningen	Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Netherlands Organization for Scientific Research (NWO), The Netherlands; SysMo2; European Union(European Commission); University of Groningen	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF), Germany, and the Netherlands Organization for Scientific Research (NWO), The Netherlands, within the framework of the SysMo2-funded SilicoTryp project of the European Union (work packages 4 (to B. M. B.) and 6 (to R.L.K.-S.).; Recipient of a Rosalind Franklin Fellowship from the University of Groningen. To whom correspondence may be addressed: Dept. of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University of Groningen, University Medical Centre Groningen CA84, Hanzeplein 1, NL-9713 GZ Groningen, The Netherlands. Tel.: 31-50-3080407; Fax: 31-50-361-1746; E-mail: b.m.bakker01@umcg.nl.	Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; BUCHLI R, 1994, MAGN RESON MED, V32, P453, DOI 10.1002/mrm.1910320405; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; DAVIS TME, 1993, T ROY SOC TROP MED H, V87, P49, DOI 10.1016/0035-9203(93)90416-N; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; DUBIN DT, 1959, BIOCHEM BIOPH RES CO, V1, P262, DOI 10.1016/0006-291X(59)90034-8; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Fuad FAA, 2011, METALLOMICS, V3, P1310, DOI 10.1039/c1mt00119a; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Haldane J. B. S., 1930, ENZYMES, P84; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; KIMBERLY MM, 1981, ANAL CHEM, V53, P789, DOI 10.1021/ac00229a011; Koch O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056788; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lin CH, 1997, BIOCHEMISTRY-US, V36, P14930, DOI 10.1021/bi9714464; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Mouat MF, 1998, COMP HAEMATOL INT, V8, P58, DOI 10.1007/BF02628107; Nolan DP, 2000, EUR J BIOCHEM, V267, P4601, DOI 10.1046/j.1432-1327.2000.01476.x; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; NOLAN DP, 1990, BIOCHEM SOC T, V18, P735, DOI 10.1042/bst0180735; Olin-Sandoval V, 2012, FEBS J, V279, P1811, DOI 10.1111/j.1742-4658.2012.08557.x; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, BIOCHEM J, V364, P679, DOI 10.1042/BJ20011370; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; RUBEN L, 1991, J BIOL CHEM, V266, P24351; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Shahi SK, 2002, MOL MICROBIOL, V43, P1129, DOI 10.1046/j.1365-2958.2002.02831.x; TABOR H, 1975, J BIOL CHEM, V250, P2648; THISSEN JA, 1991, EXP PARASITOL, V72, P243, DOI 10.1016/0014-4894(91)90143-K; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van Eunen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002483; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	55	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23751	23764		10.1074/jbc.M113.483289	http://dx.doi.org/10.1074/jbc.M113.483289			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814051	hybrid, Green Published			2022-12-28	WOS:000330611400015
J	Giladi, M; Hiller, R; Hirsch, JA; Khananshvili, D				Giladi, Moshe; Hiller, Reuben; Hirsch, Joel A.; Khananshvili, Daniel			Population Shift Underlies Ca2+-induced Regulatory Transitions in the Sodium-Calcium Exchanger (NCX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND CA2+-BINDING DOMAIN; SMALL-ANGLE SCATTERING; CA2+ BINDING DOMAINS; NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; SENSOR; FEATURES; VIEW	In eukaryotic Na+/Ca2+ exchangers (NCX) the Ca2+ binding CBD1 and CBD2 domains form a two-domain regulatory tandem (CBD12). An allosteric Ca2+ sensor (Ca3-Ca4 sites) is located on CBD1, whereas CBD2 contains a splice-variant segment. Recently, a Ca2+-driven interdomain switch has been described, albeit how it couples Ca2+ binding with signal propagation remains unclear. To resolve the dynamic features of Ca2+-induced conformational transitions we analyze here distinct splice variants and mutants of isolated CBD12 at varying temperatures by using small angle x-ray scattering (SAXS) and equilibrium Ca-45(2+) binding assays. The ensemble optimization method SAXS analysis demonstrates that the apo and Mg2+-bound forms of CBD12 are highly flexible, whereas Ca2+ binding to the Ca3-Ca4 sites results in a population shift of conformational landscape to more rigidified states. Population shift occurs even under conditions in which no effect of Ca2+ is observed on the globally derived D-max (maximal interatomic distance), although under comparable conditions a normal [Ca2+]-dependent allosteric regulation occurs. Low affinity sites (Ca1-Ca2) of CBD1 do not contribute to Ca2+-induced population shift, but the occupancy of these sites by 1 mM Mg2+ shifts the Ca2+ affinity (K-d) at the neighboring Ca3-Ca4 sites from similar to 50 nM to similar to 200 nM and thus, keeps the primary Ca2+ sensor (Ca3-Ca4 sites) within a physiological range. Thus, Ca2+ binding to the Ca3-Ca4 sites results in a population shift, where more constraint conformational states become highly populated at dynamic equilibrium in the absence of global conformational transitions in CBD alignment.	[Giladi, Moshe; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Hirsch, Joel A.] Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Hirsch, JA (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel.	jhirsch@post.tau.ac.il; dhanan@post.tau.ac.il	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Khananshvili, Daniel/0000-0002-4202-9966; Giladi, Moshe/0000-0002-8589-6920	Israeli Ministry of Health [2010-3-6266]; United States-Israel Binational Foundation [2009-334]; Israel Science Foundation [23/10]; Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft; Bernstein Foundation; Clore Israel Foundation	Israeli Ministry of Health; United States-Israel Binational Foundation; Israel Science Foundation(Israel Science Foundation); Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bernstein Foundation; Clore Israel Foundation	This work was partially funded by Israeli Ministry of Health Grant 2010-3-6266, United States-Israel Binational Foundation Research Grant 2009-334, Israel Science Foundation Grant 23/10 (to D. K.), a Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft grant (to J. A. H.), and the Bernstein Foundation.; Supported by a Ph.D. fellowship from the Clore Scholars Program of the Clore Israel Foundation.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado Pau, 2012, Methods Mol Biol, V896, P107, DOI 10.1007/978-1-4614-3704-8_7; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2011, BIOCHEMISTRY-US, V50, P8804, DOI 10.1021/bi201134u; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Giladi M, 2012, BIOCHEMISTRY-US, V51, P7313, DOI 10.1021/bi300739z; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Giladi M, 2012, CELL CALCIUM, V51, P478, DOI 10.1016/j.ceca.2012.04.007; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	30	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23141	23149		10.1074/jbc.M113.471698	http://dx.doi.org/10.1074/jbc.M113.471698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798674	Green Published, hybrid			2022-12-28	WOS:000330598200021
J	Parsaud, L; Li, LJ; Jung, CH; Park, S; Saw, NMN; Park, S; Kim, MY; Sugita, S				Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Park, Sanghyun; Kim, Moo Yup; Sugita, Shuzo			Calcium-dependent Activator Protein for Secretion 1 (CAPS1) Binds to Syntaxin-1 in a Distinct Mode from Munc13-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLE; PLASMA-MEMBRANE; SNARE COMPLEX; CA2+-DEPENDENT EXOCYTOSIS; SYNAPTIC-TRANSMISSION; NEUROTROPHIN RELEASE; PC12 CELLS; FUSION; MUNC18-1; EXPRESSION	Calcium-dependent activator protein for secretion 1 (CAPS1) is a multidomain protein containing a Munc13 homology domain 1 (MHD1). Although CAPS1 and Munc13-1 play crucial roles in the priming stage of secretion, their functions are non-redundant. Similar to Munc13-1, CAPS1 binds to syntaxin-1, a key t-SNARE protein in neurosecretion. However, whether CAPS1 interacts with syntaxin-1 in a similar mode to Munc13-1 remains unclear. Here, using yeast two-hybrid assays followed by biochemical binding experiments, we show that the region in CAPS1 consisting of the C-terminal half of the MHD1 with the corresponding C-terminal region can bind to syntaxin-1. Importantly, the binding mode of CAPS1 to syntaxin-1 is distinct from that of Munc13-1; CAPS1 binds to the full-length of cytoplasmic syntaxin-1 with preference to its "open" conformation, whereas Munc13-1 binds to the first 80 N-terminal residues of syntaxin-1. Unexpectedly, the majority of the MHD1 of CAPS1 is dispensable, whereas the C-terminal 69 residues are crucial for the binding to syntaxin-1. Functionally, a C-terminal truncation of 69 or 134 residues in CAPS1 abolishes its ability to reconstitute secretion in permeabilized PC12 cells. Our results reveal a novel mode of binding between CAPS1 and syntaxin-1, which play a crucial role in neurosecretion. We suggest that the distinct binding modes between CAPS1 and Munc13-1 can account for their non-redundant functions in neurosecretion. We also propose that the preferential binding of CAPS1 to open syntaxin-1 can contribute to the stabilization of the open state of syntaxin-1 during its transition from "closed" state to the SNARE complex formation.	[Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Park, Sanghyun; Kim, Moo Yup; Sugita, Shuzo] Univ Hlth Network, Div Fundamental Neurobiol, Toronto, ON M5T 2S8, Canada; [Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Sugita, Shuzo] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sugita, S (corresponding author), Univ Hlth Network, Toronto Western Res Inst, 399 Bathurst St,MP11-304, Toronto, ON M5T 2S8, Canada.	ssugita@uhnres.utoronto.ca		Sugita, Shuzo/0000-0002-9182-873X	Canada Research Chair program; Heart and Stroke Foundation [NA6217, T6700]; Natural Sciences and Engineering Research Council of Canada [456042]; Canadian Institute of Health Research [MOP-93665]	Canada Research Chair program(Canada Research Chairs); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canada Research Chair program, Heart and Stroke Foundation Grants NA6217 and T6700, Natural Sciences and Engineering Research Council of Canada Grant 456042, and Canadian Institute of Health Research Grant MOP-93665.	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Li G, 2005, J NEUROSCI, V25, P10188, DOI 10.1523/JNEUROSCI.3560-05.2005; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Liu YY, 2010, J CELL BIOL, V190, P1067, DOI 10.1083/jcb.201001164; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Matos MF, 2003, NEUROPHARMACOLOGY, V45, P777, DOI 10.1016/S0028-3908(03)00318-6; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-25; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sassa T, 1999, J NEUROSCI, V19, P4772; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Speidel D, 2008, CELL METAB, V7, P57, DOI 10.1016/j.cmet.2007.11.009; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang L, 2005, J BIOL CHEM, V280, P16522, DOI 10.1074/jbc.M413263200; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200	46	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23050	23063		10.1074/jbc.M113.494088	http://dx.doi.org/10.1074/jbc.M113.494088			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801330	Green Published, hybrid			2022-12-28	WOS:000330598200014
J	Srinivasan, S; Meyer, RD; Lugo, R; Rahimi, N				Srinivasan, Srimathi; Meyer, Rosana D.; Lugo, Ricardo; Rahimi, Nader			Identification of PDCL3 as a Novel Chaperone Protein Involved in the Generation of Functional VEGF Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; BETA-GAMMA; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; CARBOXYL-TERMINUS; QUALITY CONTROL; GROWTH; ACTIVATION; ANGIOGENESIS; REGULATOR	Angiogenesis, a hallmark step in tumor metastasis and ocular neovascularization, is driven primarily by the function of VEGF ligand on one of its receptors, VEGF receptor 2 (VEGFR-2). Central to the proliferation and ensuing angiogenesis of endothelial cells, the abundance of VEGFR-2 on the surface of endothelial cells is essential for VEGF to recognize and activate VEGFR-2. We have identified phosducin-like 3 (PDCL3, also known as PhLP2A), through a yeast two-hybrid system, as a novel protein involved in the stabilization of VEGFR-2 by serving as a chaperone. PDCL3 binds to the juxtamembrane domain of VEGFR-2 and controls the abundance of VEGFR-2 by inhibiting its ubiquitination and degradation. PDCL3 increases VEGF-induced tyrosine phosphorylation and is required for VEGFR-2-dependent endothelial capillary tube formation and proliferation. Taken together, our data provide strong evidence for the role of PDCL3 in angiogenesis and establishes the molecular mechanism by which it regulates VEGFR-2 expression and function.	Boston Univ, Dept Pathol, Sch Med, Boston, MA 02118 USA; Boston Univ, Dept Ophthalmol, Sch Med, Boston, MA 02118 USA	Boston University; Boston University	Rahimi, N (corresponding author), Boston Univ, Dept Pathol, Med Campus,670 Albany St,Rm 510, Boston, MA 02118 USA.	nrahimi@bu.edu		Rahimi, Nader/0000-0002-6745-1725	NEI, National Institutes of Health; Department of Pathology, Boston University; Massachusetts Lions Foundation; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Pathology, Boston University; Massachusetts Lions Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by grants from the NEI, National Institutes of Health (to N. R.). This work was also supported by a grant from the Department of Pathology, Boston University and by a grant from the Massachusetts Lions Foundation (to the Department of Ophthalmology, Boston University).	Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Humrich J, 2003, J BIOL CHEM, V278, P4474, DOI 10.1074/jbc.M206347200; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Meyer RD, 2011, ONCOGENE, V30, P2198, DOI 10.1038/onc.2010.597; Meyer RD, 2004, J BIOL CHEM, V279, P735, DOI 10.1074/jbc.M305575200; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Rahimi N, 2012, MOL BIOL CELL, V23, P1646, DOI 10.1091/mbc.E11-11-0934; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Schroder S, 1996, P NATL ACAD SCI USA, V93, P2100, DOI 10.1073/pnas.93.5.2100; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; YAFFE MB, 1992, J BIOL CHEM, V267, P12233	38	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23171	23181		10.1074/jbc.M113.473173	http://dx.doi.org/10.1074/jbc.M113.473173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792958	hybrid, Green Published			2022-12-28	WOS:000330598200024
J	Bao, Y; Chen, Y; Ledderose, C; Li, LL; Junger, WG				Bao, Yi; Chen, Yu; Ledderose, Carola; Li, Linglin; Junger, Wolfgang G.			Pannexin 1 Channels Link Chemoattractant Receptor Signaling to Local Excitation and Global Inhibition Responses at the Front and Back of Polarized Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE RECEPTORS; STERILE INFLAMMATION; CELL-MIGRATION; CHEMOTAXIS; ACTIVATION; GTPASES; RHO; RECRUITMENT; INTEGRINS; AGONISTS	Neutrophil chemotaxis requires excitatory signals at the front and inhibitory signals at the back of cells, which regulate cell migration in a chemotactic gradient field. We have previously shown that ATP release via pannexin 1 (PANX1) channels and autocrine stimulation of P2Y(2) receptors contribute to the excitatory signals at the front. Here we show that PANX1 also contributes to the inhibitory signals at the back, namely by providing the ligand for A(2A) adenosine receptors. In resting neutrophils, we found that A(2A) receptors are uniformly distributed across the cell surface. In polarized cells, A(2A) receptors redistributed to the back where their stimulation triggered intracellular cAMP accumulation and protein kinase A (PKA) activation, which blocked chemoattractant receptor signaling. Inhibition of PANX1 blocked A(2A) receptor stimulation and cAMP accumulation in response to formyl peptide receptor stimulation. Treatments that blocked endogenous A(2A) receptor signaling impaired the polarization and migration of neutrophils in a chemotactic gradient field and resulted in enhanced ERK and p38 MAPK signaling in response to formyl peptide receptor stimulation. These findings suggest that chemoattractant receptors require PANX1 to trigger excitatory and inhibitory signals that synergize to fine-tune chemotactic responses at the front and back of neutrophils. PANX1 channels thus link local excitatory signals to the global inhibitory signals that orchestrate chemotaxis of neutrophils in gradient fields.	[Bao, Yi; Chen, Yu; Ledderose, Carola; Li, Linglin; Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Boltzmann Institute	Junger, WG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Bao, Yi/J-5418-2013	Junger, Wolfgang G/0000-0003-3350-8452; Bao, Yi/0000-0003-0748-1575	National Institutes of Health [GM-51477, GM-60475, AI-072287, AI-080582]; Congressionally Directed Medical Research Program [PR043034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080582, R01AI072287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060475, R01GM051477, R29GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-51477, GM-60475, AI-072287, and AI-080582 (to W. J.). This work was also supported by the Congressionally Directed Medical Research Program PR043034 (to W. J.).	Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Olah ME, 1997, J BIOL CHEM, V272, P337; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Peng GE, 2011, MOL BIOL CELL, V22, P3986, DOI 10.1091/mbc.E11-04-0379; Pillinger MH, 1996, J BIOL CHEM, V271, P12049, DOI 10.1074/jbc.271.20.12049; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751, DOI 10.1152/ajpheart.2000.278.6.H1751; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Thibault N, 2002, J LEUKOCYTE BIOL, V71, P367; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Verghese MW, 1996, J BIOL CHEM, V271, P15597, DOI 10.1074/jbc.271.26.15597; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	42	72	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22650	22657		10.1074/jbc.M113.476283	http://dx.doi.org/10.1074/jbc.M113.476283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798685	Green Published, hybrid			2022-12-28	WOS:000330596300044
J	Cui, Z; Zhang, ST				Cui, Zhi; Zhang, Shetuan			Regulation of the Human Ether-a-go-go-related Gene (hERG) Channel by Rab4 Protein through Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Cell Biology; Gene Expression; HERG; Patch Clamp; Potassium Channels; Protein Degradation; Rab; Trafficking; Ubiquitin Ligase	E3 UBIQUITIN LIGASES; LONG QT SYNDROME; POTASSIUM CHANNEL; I-KR; EXTRACELLULAR K+; C2 DOMAIN; RECEPTOR; TRANSPORT; GTPASES; PROLONGATION	The human ether-a-go-go-related gene (hERG) encodes the pore-forming -subunit of the rapidly activating delayed rectifier K+ channel in the heart, which plays a critical role in cardiac action potential repolarization. Dysfunction of I-Kr causes long QT syndrome, a cardiac electrical disorder that predisposes affected individuals to fatal arrhythmias and sudden death. The homeostasis of hERG channels in the plasma membrane depends on a balance between protein synthesis and degradation. Our recent data indicate that hERG channels undergo enhanced endocytic degradation under low potassium (hypokalemia) conditions. The GTPase Rab4 is known to mediate rapid recycling of various internalized proteins to the plasma membrane. In the present study, we investigated the effect of Rab4 on the expression level of hERG channels. Our data revealed that overexpression of Rab4 decreases the expression level of hERG in the plasma membrane. Rab4 does not affect the expression level of the Kv1.5 or EAG K+ channels. Mechanistically, our data demonstrate that overexpression of Rab4 increases the expression level of endogenous Nedd4-2, a ubiquitin ligase that targets hERG but not Kv1.5 or EAG channels for ubiquitination and degradation. Nedd4-2 undergoes self- ubiquitination and degradation. Rab4 interferes with Nedd4-2 degradation, resulting in an increased expression level of Nedd4-2, which targets hERG. In summary, the present study demonstrates a novel pathway for hERG regulation; Rab4 decreases the hERG density at the plasma membrane by increasing the endogenous Nedd4-2 expression.	[Cui, Zhi; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research Grant [MOP 72911]; Heart and Stroke Foundation of Ontario Grant [T 6612]; Canadian Institutes of Health Research new investigator award	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Grant; Canadian Institutes of Health Research new investigator award(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research Grant MOP 72911 and the Heart and Stroke Foundation of Ontario Grant T 6612 (to S. Z.).; Recipient of a Canadian Institutes of Health Research new investigator award.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Etzion S, 2010, J MOL CELL CARDIOL, V49, P931, DOI 10.1016/j.yjmcc.2010.08.011; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Johnson JN, 2011, EUR HEART J, V32, P1114, DOI 10.1093/eurheartj/ehr021; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Madias C, 2011, HEART RHYTHM, V8, P555, DOI 10.1016/j.hrthm.2010.12.012; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Marban E, 1999, J CARDIOVASC ELECTR, V10, P1425, DOI 10.1111/j.1540-8167.1999.tb00199.x; MARTIN AB, 1994, AM HEART J, V127, P64, DOI 10.1016/0002-8703(94)90510-X; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V341, P184, DOI 10.1016/j.bbrc.2005.12.170; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V340, P726, DOI 10.1016/j.bbrc.2005.12.036; Shallow H, 2011, BIOPHYS J, V100, P102; Strous GJ, 1999, J CELL SCI, V112, P1417; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	56	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21876	10.1074/jbc.M113.461715	http://dx.doi.org/10.1074/jbc.M113.461715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23792956	hybrid, Green Published			2022-12-28	WOS:000328841900036
J	Wendel, AA; Cooper, DE; Ilkayeva, OR; Muoio, DM; Coleman, RA				Wendel, Angela A.; Cooper, Daniel E.; Ilkayeva, Olga R.; Muoio, Deborah M.; Coleman, Rosalind A.			Glycerol-3-phosphate Acyltransferase (GPAT)-1, but Not GPAT4, Incorporates Newly Synthesized Fatty Acids into Triacylglycerol and Diminishes Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; INSULIN-RESISTANCE; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEFICIENT MICE; PURIFICATION; METABOLISM; EXPRESSION; IDENTIFICATION; GLYCEROL; ENZYMES	Four glycerol-3-phosphate acyltransferase (GPAT) isoforms, each encoded by a separate gene, catalyze the initial step in glycerolipid synthesis; in liver, the major isoforms are GPAT1 and GPAT4. To determine whether each of these hepatic isoforms performs a unique function in the metabolism of fatty acid, we measured the incorporation of de novo synthesized fatty acid or exogenous fatty acid into complex lipids in primary mouse hepatocytes from control, Gpat1(-/-), and Gpat4(-/-) mice. Although hepatocytes from each genotype incorporated a similar amount of exogenous fatty acid into triacylglycerol (TAG), only control and Gpat4(-/-) hepatocytes were able to incorporate de novo synthesized fatty acid into TAG. When compared with controls, Gpat1(-/-) hepatocytes oxidized twice as much exogenous fatty acid. To confirm these findings and to assess hepatic beta-oxidation metabolites, we measured acylcarnitines in liver from mice after a 24-h fast and after a 24-h fast followed by 48 h of refeeding with a high sucrose diet to promote lipogenesis. Confirming the in vitro findings, the hepatic content of long-chain acylcarnitine in fasted Gpat1(-/-) mice was 3-fold higher than in controls. When compared with control and Gpat4(-/-) mice, after the fasting-refeeding protocol, Gpat1(-/-) hepatic TAG was depleted, and long-chain acylcarnitine content was 3.5-fold higher. Taken together, these data demonstrate that GPAT1, but not GPAT4, is required to incorporate de novo synthesized fatty acids into TAG and to divert them away from oxidation.	[Wendel, Angela A.; Cooper, Daniel E.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Dept Med & Pharmacol, Durham, NC 27704 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC 27704 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, CB 7461, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health [DK56598, DK089312, DK083157, T32HD057824]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312, F32DK083157, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56598 (to R.A.C.), DK089312 (to D.M.M.), DK083157 (to A.A.W.), and T32HD057824 (to D.E.C.).	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BREMER J, 1976, MOL CELL BIOCHEM, V12, P113, DOI 10.1007/BF01731557; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Hammond LE, 2007, EXP MOL PATHOL, V82, P210, DOI 10.1016/j.yexmp.2006.12.004; Harada N, 2007, MOL CELL BIOCHEM, V297, P41, DOI 10.1007/s11010-006-9321-5; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; KELKER HC, 1979, J BIOL CHEM, V254, P5364; Lewin TM, 2008, BBA-MOL CELL BIOL L, V1781, P352, DOI 10.1016/j.bbalip.2008.05.001; Lu BA, 2010, J LIPID RES, V51, P3207, DOI 10.1194/jlr.M007054; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; MONROY G, 1973, J BIOL CHEM, V248, P2845; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Timlin MT, 2005, DIABETES, V54, P2694, DOI 10.2337/diabetes.54.9.2694; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	31	62	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27299	27306		10.1074/jbc.M113.485219	http://dx.doi.org/10.1074/jbc.M113.485219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908354	Green Published, hybrid			2022-12-28	WOS:000330597300026
J	Gould, N; Doulias, PT; Tenopoulou, M; Raju, K; Ischiropoulos, H				Gould, Neal; Doulias, Paschalis-Thomas; Tenopoulou, Margarita; Raju, Karthik; Ischiropoulos, Harry			Regulation of Protein Function and Signaling by Reversible Cysteine S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE SYNTHASE; ISOCITRATE DEHYDROGENASE; NITROSOTHIOL FORMATION; REDOX; MECHANISMS; GLUTATHIOLATION; PALMITOYLATION; IDENTIFICATION; NITROSATION; RESIDUES	NO is a versatile free radical that mediates numerous biological functions within every major organ system. A molecular pathway by which NO accomplishes functional diversity is the selective modification of protein cysteine residues to form S-nitrosocysteine. This post-translational modification, S-nitrosylation, impacts protein function, stability, and location. Despite considerable advances with individual proteins, the in vivo biological chemistry, the structural elements that govern the selective S-nitrosylation of cysteine residues, and the potential overlap with other redox modifications are unknown. In this minireview, we explore the functional features of S-nitrosylation at the proteome level and the structural diversity of endogenously modified residues, and we discuss the potential overlap and complementation that may exist with other cysteine modifications.	[Ischiropoulos, Harry] Univ Penn, Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ischiropoulos, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	DeltaOmicronUpsilonLambdaIotaAlphaSigma, PiAlphaSigmaChiAlphaLambdaEtaSigma-ThetaOmegaMuAlphaSigma/AAY-1665-2020	Doulias, Paschalis-Thomas/0000-0001-7891-3131	National Institutes of Health [HL054926, AG13966, T32AG000255]; NIEHS Center of Excellence in Environmental Toxicology [ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255, R01AG013966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center of Excellence in Environmental Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL054926 and AG13966 and NIEHS Center of Excellence in Environmental Toxicology Grant ES013508 and by National Institutes of Health Training Grant T32AG000255 (to K. R.). This is the second article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Go Young-Mi, 2011, J Proteomics Bioinform, V4, P196; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Held JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.013037; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; Jones DP, 2011, CURR OPIN CHEM BIOL, V15, P103, DOI 10.1016/j.cbpa.2010.12.014; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Lopez-Sanchez LM, 2009, PROTEOMICS, V9, P808, DOI 10.1002/pmic.200800546; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Moncada S, 1997, PHARMACOL REV, V49, P137; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Murphy E, 2012, J MOL CELL CARDIOL, V52, P568, DOI 10.1016/j.yjmcc.2011.08.021; Murray CI, 2012, CIRC-CARDIOVASC GENE, V5, pO1, DOI 10.1161/CIRCGENETICS.111.961425; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Raju K, 2012, BBA-GEN SUBJECTS, V1820, P684, DOI 10.1016/j.bbagen.2011.05.009; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Shin SW, 2009, FREE RADICAL RES, V43, P409, DOI 10.1080/10715760902801525; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Smith BC, 2012, CURR OPIN CHEM BIOL, V16, P498, DOI 10.1016/j.cbpa.2012.10.016; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Sun JH, 2008, BIOCHEMISTRY-US, V47, P13985, DOI 10.1021/bi8012627; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4; Yang ZY, 2010, J IMMUNOL, V185, P6664, DOI 10.4049/jimmunol.1000080; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	68	209	215	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26473	26479		10.1074/jbc.R113.460261	http://dx.doi.org/10.1074/jbc.R113.460261			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861393	Green Published, hybrid			2022-12-28	WOS:000330594500013
J	Grek, CL; Zhang, J; Manevich, Y; Townsend, DM; Tew, KD				Grek, Christina L.; Zhang, Jie; Manevich, Yefim; Townsend, Danyelle M.; Tew, Kenneth D.			Causes and Consequences of Cysteine S-Glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN; MOLECULAR-MECHANISMS; REDOX REGULATION; BONE-MARROW; STEM-CELLS; TRANSFERASE; THIOL; PROTEINS	Post-translational S-glutathionylation occurs through the reversible addition of a proximal donor of glutathione to thiolate anions of cysteines in target proteins, where the modification alters molecular mass, charge, and structure/function and/or prevents degradation from sulfhydryl overoxidation or proteolysis. Catalysis of both the forward (glutathione S-transferase P) and reverse (glutaredoxin) reactions creates a functional cycle that can also regulate certain protein functional clusters, including those involved in redox-dependent cell signaling events. For translational application, S-glutathionylated serum proteins may be useful as biomarkers in individuals (who may also have polymorphic expression of glutathione S-transferase P) exposed to agents that cause oxidative or nitrosative stress.	[Grek, Christina L.; Zhang, Jie; Manevich, Yefim; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Tew, KD (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	tewk@musc.edu	Zhang, Jie/F-1540-2011	Zhang, Jie/0000-0002-0466-2955	National Institutes of Health [CA08660, CA117259]; National Center for Research Resources (NCRR) [P20 RR024485-COBRE]; South Carolina Centers of Excellence Program; Drug Metabolism and Clinical Pharmacology Shared Resource of Hollings Cancer Center of the Medical University of South Carolina; Swedish Research Council [524-2011-6998]; National Institutes of Health from the NCRR Extramural Research Facilities Program [C06 RR015455]; NATIONAL CANCER INSTITUTE [R01CA085660, R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, P20RR024485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); South Carolina Centers of Excellence Program; Drug Metabolism and Clinical Pharmacology Shared Resource of Hollings Cancer Center of the Medical University of South Carolina; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health from the NCRR Extramural Research Facilities Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA08660 and CA117259 and National Center for Research Resources (NCRR) Grant P20 RR024485-COBRE in Oxidants, Redox Balance, and Stress Signaling. This work was also supported by the South Carolina Centers of Excellence Program, by the Drug Metabolism and Clinical Pharmacology Shared Resource of Hollings Cancer Center of the Medical University of South Carolina, and by Swedish Research Council Grant 524-2011-6998 (to J. Z.). This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the NCRR Extramural Research Facilities Program. This is the fifth article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	Abdelsaid MA, 2012, J CELL SCI, V125, P4751, DOI 10.1242/jcs.103481; Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Anathy V, 2012, MOL CELL BIOL, V32, P3464, DOI 10.1128/MCB.00125-12; Anathy V, 2009, J CELL BIOL, V184, P241, DOI 10.1083/jcb.200807019; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bowers RR, 2012, BIOCHEMISTRY-US, V51, P7740, DOI 10.1021/bi301006w; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Cabiscol E, 1996, P NATL ACAD SCI USA, V93, P4170, DOI 10.1073/pnas.93.9.4170; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Coles SJ, 2009, BIOCHEMISTRY-US, V48, P645, DOI 10.1021/bi801805h; Feig C, 2007, EUR J IMMUNOL, V37, pS61, DOI 10.1002/eji.200737462; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Gao XH, 2009, MOL PLANT, V2, P218, DOI 10.1093/mp/ssn072; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Go Young-Mi, 2008, V464, P303; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; Grek CL, 2012, CANCER RES, V72, P2383, DOI 10.1158/0008-5472.CAN-11-4088; Grek CL, 2011, PHARMACOL THERAPEUT, V129, P172, DOI 10.1016/j.pharmthera.2010.09.008; Griffiths SW, 2002, J BIOL CHEM, V277, P25486, DOI 10.1074/jbc.M203089200; Hamnell-Pamment Y, 2005, BIOCHEM BIOPH RES CO, V332, P362, DOI 10.1016/j.bbrc.2005.04.130; Harris MJ, 1998, PHARMACOGENETICS, V8, P27, DOI 10.1097/00008571-199802000-00004; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hobbs GA, 2013, FREE RADICAL BIO MED, V57, P221, DOI 10.1016/j.freeradbiomed.2012.10.531; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jin X, 2012, J PHYSIOL-LONDON, V590, P5335, DOI 10.1113/jphysiol.2012.236885; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kehr S, 2011, ANTIOXID REDOX SIGN, V15, P2855, DOI 10.1089/ars.2011.4029; Kil IS, 2012, BIOCHEM BIOPH RES CO, V425, P892, DOI 10.1016/j.bbrc.2012.07.169; Kim HS, 2012, P NATL ACAD SCI USA, V109, pE2803, DOI 10.1073/pnas.1212596109; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kubo M, 2007, AM J PHYSIOL-HEART C, V292, pH2582, DOI 10.1152/ajpheart.00786.2006; Landino LM, 2004, BIOCHEM BIOPH RES CO, V314, P555, DOI 10.1016/j.bbrc.2003.12.126; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Manevich Y, 2013, FREE RADICAL BIO MED, V54, P62, DOI 10.1016/j.freeradbiomed.2012.10.556; Manevich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014151; Martinez MC, 2009, ANTIOXID REDOX SIGN, V11, P669, DOI 10.1089/ars.2007.1993; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Nauser T, 2006, BIOCHEMISTRY-US, V45, P6038, DOI 10.1021/bi0602260; Nauser T, 2012, AMINO ACIDS, V42, P39, DOI 10.1007/s00726-010-0602-7; Niwa T, 2000, CLIN CHEM, V46, P82; Padmaja S, 1998, ARCH BIOCHEM BIOPHYS, V349, P1, DOI 10.1006/abbi.1997.0407; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Petrushanko IY, 2012, J BIOL CHEM, V287, P32195, DOI 10.1074/jbc.M112.391094; Pizarro GO, 2009, BIOCHEMISTRY-US, V48, P7533, DOI 10.1021/bi900669m; Przygodzka P, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-30; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Sarma BK, 2005, J AM CHEM SOC, V127, P11477, DOI 10.1021/ja052794t; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sun CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055512; Sun R, 2012, J BIOL CHEM, V287, P24304, DOI 10.1074/jbc.M112.381996; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; Takayama F, 2001, KIDNEY INT, V59, pS155, DOI 10.1046/j.1523-1755.2001.59780155.x; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; van Pel M, 2006, P NATL ACAD SCI USA, V103, P1469, DOI 10.1073/pnas.0510192103; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; WINTERBOURN CC, 1995, METHOD ENZYMOL, V251, P81, DOI 10.1016/0076-6879(95)51112-1; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; Xiong Y., 2012, INT J CELL BIOL, V2012, P273549, DOI 10.1155/2012/273549; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578; Zaffagnini M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014142; Zhang C, 2011, ANAL BIOANAL CHEM, V401, P2165, DOI 10.1007/s00216-011-5311-x; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	99	224	227	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26497	26504		10.1074/jbc.R113.461368	http://dx.doi.org/10.1074/jbc.R113.461368			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861399	Green Published, hybrid			2022-12-28	WOS:000330594500016
J	Ridley, CM; Thur, KE; Shanahan, J; Thillaiappan, NB; Shen, A; Uhl, K; Walden, CM; Rahim, AA; Waddington, SN; Platt, FM; van der Spoel, AC				Ridley, Christina M.; Thur, Karen E.; Shanahan, Jessica; Thillaiappan, Nagendra Babu; Shen, Ann; Uhl, Karly; Walden, Charlotte M.; Rahim, Ahad A.; Waddington, Simon N.; Platt, Frances M.; van der Spoel, Aarnoud C.			beta-Glucosidase 2 (GBA2) Activity and Imino Sugar Pharmacology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDURITOL-B-EPOXIDE; SUBSTRATE REDUCTION THERAPY; SITE-SPECIFIC CHAPERONES; DISEASE TYPE-C; GAUCHER-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; IN-VITRO; NONLYSOSOMAL GLUCOSYLCERAMIDASE; GLUCOCEREBROSIDASE DEFICIENCY; GLYCOSPHINGOLIPID SYNTHESIS	beta-Glucosidase 2 (GBA2) is an enzyme that cleaves the membrane lipid glucosylceramide into glucose and ceramide. The GBA2 gene is mutated in genetic neurological diseases (hereditary spastic paraplegia and cerebellar ataxia). Pharmacologically, GBA2 is reversibly inhibited by alkylated imino sugars that are in clinical use or are being developed for this purpose. We have addressed the ambiguity surrounding one of the defining characteristics of GBA2, which is its sensitivity to inhibition by conduritol B epoxide (CBE). We found that CBE inhibited GBA2, in vitro and in live cells, in a time-dependent fashion, which is typical for mechanism-based enzyme inactivators. Compared with the well characterized impact of CBE on the lysosomal glucosylceramide-degrading enzyme (glucocerebrosidase, GBA), CBE inactivated GBA2 less efficiently, due to a lower affinity for this enzyme (higher K-I) and a lower rate of enzyme inactivation (k(inact)). In contrast to CBE, N-butyldeoxygalactonojirimycin exclusively inhibited GBA2. Accordingly, we propose to redefine GBA2 activity as the beta-glucosidase that is sensitive to inhibition by N-butyldeoxygalactonojirimycin. Revised as such, GBA2 activity 1) was optimal at pH 5.5-6.0; 2) accounted for a much higher proportion of detergent-independent membrane-associated beta-glucosidase activity; 3) was more variable among mouse tissues and neuroblastoma and monocyte cell lines; and 4) was more sensitive to inhibition by N-butyldeoxynojirimycin (miglustat, Zavesca (R)), in comparison with earlier studies. Our evaluation of GBA2 makes it possible to assess its activity more accurately, which will be helpful in analyzing its physiological roles and involvement in disease and in the pharmacological profiling of monosaccharide mimetics.	[Ridley, Christina M.; Thur, Karen E.; Shanahan, Jessica; Shen, Ann; Uhl, Karly; van der Spoel, Aarnoud C.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Ridley, Christina M.; Thur, Karen E.; Shanahan, Jessica; Shen, Ann; Uhl, Karly; van der Spoel, Aarnoud C.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Thillaiappan, Nagendra Babu; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Walden, Charlotte M.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rahim, Ahad A.; Waddington, Simon N.] UCL, Gene Transfer Technol Grp, Inst Womens Hlth, London WC1E 6HX, England	Dalhousie University; Dalhousie University; University of Oxford; University of Oxford; University of London; University College London	van der Spoel, AC (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, POB 15000, Halifax, NS B3H 4R2, Canada.	spoela@dal.ca	rahim, abdul/AAC-6745-2021; Waddington, Simon/G-3778-2011; Thillaiappan, Nagendra Babu/AAR-9619-2020	rahim, abdul/0000-0002-0269-9156; Waddington, Simon/0000-0003-4970-4730; Thillaiappan, Nagendra Babu/0000-0001-5641-4067; Platt, Frances/0000-0001-7614-0403; Ridley, Christina M/0000-0003-4632-8055	National Institutes of Health from NICHD [U01 HD45861]; IWK Health Centre, Halifax, Nova Scotia, Canada [0152]; Natural Sciences and Engineering Research Council of Canada; Department of Pediatrics; Faculty of Medicine of Dalhousie University; MRC [G1000709] Funding Source: UKRI; Medical Research Council [G1000709] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045861] Funding Source: NIH RePORTER	National Institutes of Health from NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IWK Health Centre, Halifax, Nova Scotia, Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Pediatrics; Faculty of Medicine of Dalhousie University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health U01 HD45861 from NICHD (to A. C. V. and F. M. P.). This work was also supported by Project 0152 from the IWK Health Centre, Halifax, Nova Scotia, Canada (to A. C. V.), an undergraduate student research award from Natural Sciences and Engineering Research Council of Canada (to J. S.), and the Department of Pediatrics and the Faculty of Medicine of Dalhousie University (to A. C. V.).	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7; Amory JK, 2007, HUM REPROD, V22, P702, DOI 10.1093/humrep/del414; Andersson U, 2004, NEUROBIOL DIS, V16, P506, DOI 10.1016/j.nbd.2004.04.012; Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Ardes-Guisot N, 2011, ORG BIOMOL CHEM, V9, P5373, DOI 10.1039/c1ob05119a; Asano N, 2009, CELL MOL LIFE SCI, V66, P1479, DOI 10.1007/s00018-008-8522-3; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Burke D. G., 2012, J INHERIT M IN PRESS; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DANIELS LB, 1981, CLIN CHIM ACTA, V115, P369, DOI 10.1016/0009-8981(81)90251-5; De Palma C, 2012, CLIN LIPIDOL, V7, P111, DOI 10.2217/CLP.11.71; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Fantur K, 2010, MOL GENET METAB, V100, P262, DOI 10.1016/j.ymgme.2010.03.019; FINK JK, 1990, P NATL ACAD SCI USA, V87, P2334, DOI 10.1073/pnas.87.6.2334; Gatt S, 2012, CHEM PHYS LIPIDS, V165, P462, DOI 10.1016/j.chemphyslip.2012.02.006; Gee KR, 1999, ANAL BIOCHEM, V273, P41, DOI 10.1006/abio.1999.4202; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Germain DP, 2009, INT J CLIN PHARM TH, V47, pS111; Ghisaidoobe A, 2011, ACS MED CHEM LETT, V2, P119, DOI 10.1021/ml100192b; Goddard-Borger ED, 2012, J MED CHEM, V55, P2737, DOI 10.1021/jm201633y; Gouaze-Andersson V, 2011, ANTI-CANCER AGENT ME, V11, P891, DOI 10.2174/187152011797655069; Grabowski G. A., 2000, METABOLIC MOL BASES; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; Hakomori S.-I., 2006, GLYCOLIPIDS ANIMALS; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Hein LK, 2007, MOL GENET METAB, V92, P336, DOI 10.1016/j.ymgme.2007.08.001; Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; KOK JW, 1989, P NATL ACAD SCI USA, V86, P9896, DOI 10.1073/pnas.86.24.9896; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Krippendorff B, 2009, J BIOMOL SCREEN, V14, P913, DOI 10.1177/1087057109336751; Lee JC, 2012, J ORG CHEM, V77, P3082, DOI 10.1021/jo202054g; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Matern H, 1997, J BIOL CHEM, V272, P11261; McDonald A.G., 2012, ENZYMES IRREVERSIBLE; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; MUMFORD RA, 1976, J NEUROCHEM, V27, P943, DOI 10.1111/j.1471-4159.1976.tb05159.x; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; NEWBURG DS, 1988, EXP MOL PATHOL, V48, P317, DOI 10.1016/0014-4800(88)90068-8; Nietupski JB, 2012, MOL GENET METAB, V105, P621, DOI 10.1016/j.ymgme.2012.01.020; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Pastores GM, 2009, CURR MED RES OPIN, V25, P23, DOI 10.1185/03007990802576518 ; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Prence EM, 1996, J NEUROSCI RES, V43, P365, DOI 10.1002/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4; Ron I, 2005, BLOOD CELL MOL DIS, V35, P57, DOI 10.1016/j.bcmd.2005.03.006; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stein VM, 2012, J NEUROPATH EXP NEUR, V71, P434, DOI 10.1097/NEN.0b013e31825414a6; STEPHENS MC, 1978, J NEUROCHEM, V30, P1023, DOI 10.1111/j.1471-4159.1978.tb12395.x; Sugawara K, 2009, MOL GENET METAB, V96, P233, DOI 10.1016/j.ymgme.2008.12.017; Trajkovic-Bodennec S, 2004, BLOOD CELL MOL DIS, V33, P77, DOI 10.1016/j.bcmd.2004.03.001; Trapero A, 2012, J MED CHEM, V55, P4479, DOI 10.1021/jm300342q; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P442, DOI 10.1016/0005-2744(77)90036-5; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; van Meer G, 2003, PHILOS T ROY SOC B, V358, P869, DOI 10.1098/rstb.2003.1266; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Walden CM, 2006, HUM REPROD, V21, P1309, DOI 10.1093/humrep/dei463; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; WENGER DA, 1978, CLIN GENET, V13, P145; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m; Wraith James E, 2009, Ther Clin Risk Manag, V5, P877; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	93	54	54	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26052	26066		10.1074/jbc.M113.463562	http://dx.doi.org/10.1074/jbc.M113.463562			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880767	Green Published, hybrid			2022-12-28	WOS:000330623300035
J	Zhang, CB; Wang, LJ; Thomas, S; Wang, KM; Lin, DH; Rinehart, J; Wang, WH				Zhang, Chengbiao; Wang, Lijun; Thomas, Sherin; Wang, Kemeng; Lin, Dao-Hong; Rinehart, Jesse; Wang, Wen-Hui			Src Family Protein Tyrosine Kinase Regulates the Basolateral K Channel in the Distal Convoluted Tubule (DCT) by Phosphorylation of KCNJ10 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; ANGIOTENSIN-II; ROMK CHANNELS; SENSORINEURAL DEAFNESS; SESAME/EAST SYNDROME; POTASSIUM CHANNELS; DIETARY POTASSIUM; CL COTRANSPORTER; INHIBITION; NEPHRON	The loss of function of the basolateral K channels in the distal nephron causes electrolyte imbalance. The aim of this study is to examine the role of Src family protein tyrosine kinase (SFK) in regulating K channels in the basolateral membrane of the mouse initial distal convoluted tubule (DCT1). Single-channel recordings confirmed that the 40-picosiemen (pS) K channel was the only type of K channel in the basolateral membrane of DCT1. The suppression of SFK reversibly inhibited the basolateral 40-pS K channel activity in cell-attached patches and decreased the Ba2+-sensitive whole-cell K currents in DCT1. Inhibition of SFK also shifted the K reversal potential from -65 to -43 mV, suggesting a role of SFK in determining the membrane potential in DCT1. Western blot analysis showed that KCNJ10 (Kir4.1), a key component of the basolateral 40-pSKchannel in DCT1, was a tyrosine-phosphorylated protein. LC/MS analysis further confirmed that SFK phosphorylated KCNJ10 at Tyr(8) and Tyr(9). The single-channel recording detected the activity of a 19-pS K channel in KCNJ10-transfected HEK293T cells and a 40-pS K channel in the cells transfected with KCNJ10 + KCNJ16 (Kir.5.1) that form a heterotetramer in the basolateral membrane of the DCT. Mutation of Tyr(9) did not alter the channel conductance of the homotetramer and heterotetramer. However, it decreased the whole-cell K currents, the probability of finding K channels, and surface expression of KCNJ10 in comparison to WT KCNJ10. We conclude that SFK stimulates the basolateral K channel activity in DCT1, at least partially, by phosphorylating Tyr(9) on KCNJ10. We speculate that the modulation of tyrosine phosphorylation of KCNJ10 should play a role in regulating membrane transport function in DCT1.	[Zhang, Chengbiao] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Jiangsu, Peoples R China; [Zhang, Chengbiao; Wang, Lijun; Thomas, Sherin; Wang, Kemeng; Lin, Dao-Hong; Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Rinehart, Jesse] Yale Univ, Syst Biol Inst, New Haven, CT 06520 USA	Xuzhou Medical University; New York Medical College; Yale University; Yale University	Wang, WH (corresponding author), New York Med Coll, Dept Pharmacol, 15 Dana Rd, Valhalla, NY 10595 USA.	wenhui_wang@nymc.edu		Thomas, Sherin/0000-0001-5580-1874	National Institutes of Health [DK54983, K01DK089006]; Chinese National Natural Science Foundation [31171109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, K01DK089006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported, in whole or in part, by National Institutes of Health Grants DK54983 (to W. H. W.) and K01DK089006 (to J. R.). This work was also supported by Chinese National Natural Science Foundation Grant 31171109 (to C. Z.).	Bernstein PL, 2011, SEMIN NEPHROL, V31, P475, DOI 10.1016/j.semnephrol.2011.09.002; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Cha SK, 2011, J BIOL CHEM, V286, P1828, DOI 10.1074/jbc.M110.160390; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; Lin DH, 2012, AM J PHYSIOL-RENAL, V303, pF110, DOI 10.1152/ajprenal.00676.2011; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Lin DH, 2002, AM J PHYSIOL-RENAL, V283, pF671, DOI 10.1152/ajprenal.00160.2002; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; Obermuller N, 1995, AM J PHYSIOL-RENAL, V269, pF900, DOI 10.1152/ajprenal.1995.269.6.F900; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; SCHULTZ SG, 1981, AM J PHYSIOL, V241, pF579, DOI 10.1152/ajprenal.1981.241.6.F579; Shifman MA, 2007, J PROTEOME RES, V6, P4019, DOI 10.1021/pr070325f; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Wade JB, 2011, AM J PHYSIOL-RENAL, V300, pF1385, DOI 10.1152/ajprenal.00592.2010; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; WELSH MJ, 1983, AM J PHYSIOL, V244, pF639, DOI 10.1152/ajprenal.1983.244.6.F639; Williams DM, 2010, J AM SOC NEPHROL, V21, P2117, DOI 10.1681/ASN.2009121227; Yue P, 2009, P NATL ACAD SCI USA, V106, P15061, DOI 10.1073/pnas.0907855106	36	40	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26135	26146		10.1074/jbc.M113.478453	http://dx.doi.org/10.1074/jbc.M113.478453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23873931	Green Published, hybrid			2022-12-28	WOS:000330623300042
J	Jiang, K; Yang, ZH; Cheng, L; Wang, SB; Ning, K; Zhou, L; Lin, J; Zhong, H; Wang, LS; Li, Y; Huang, JJ; Zhang, H; Ye, QN				Jiang, Kai; Yang, Zhihong; Cheng, Long; Wang, Shibin; Ning, Kang; Zhou, Lei; Lin, Jing; Zhong, Hui; Wang, Lisheng; Li, Yang; Huang, Junjian; Zhang, Hao; Ye, Qinong			Mediator of ERBB2-driven Cell Motility (MEMO) Promotes Extranuclear Estrogen Receptor Signaling Involving the Growth Factor Receptors IGF1R and ERBB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; REGULATED GENE-EXPRESSION; ACTIVATED PROTEIN-KINASE; FACTOR-I RECEPTOR; ER-ALPHA; INTERACTING PROTEIN; NUCLEAR ACTIONS; MEMBRANE; PHOSPHORYLATION; PATHWAYS	In addition to nuclear estrogen receptor (ER) acting as a transcription factor, extranuclear ER also plays an important role in cancer cell growth regulation through activation of kinase cascades. However, the molecular mechanisms by which extranuclear ER exerts its function are still poorly understood. Here, we report that mediator of ERBB2-driven cell motility (MEMO) regulates extranuclear functions of ER. MEMO physically and functionally interacted with ER. Through its interaction with the growth factor receptors IGF1R and ERBB2, MEMO mediated extranuclear functions of ER, including activation of mitogen-activated protein kinase (MAPK) and protein kinase B/AKT, two important growth regulatory protein kinases, and integration of function with nuclear ER. Activation of MAPK and AKT was responsible for MEMO modulation of ER phosphorylation and estrogen-responsive gene expression. Moreover, MEMO increased anchorage-dependent and -independent growth of ER-positive breast cancer cells in vitro and was required for estrogen-induced breast tumor growth in nude mice. Together, our studies identified MEMO as a new component of extranuclear ER signalosome and suggest an essential role for MEMO in the regulation of ER-positive breast cancer cell growth.	[Jiang, Kai; Yang, Zhihong; Cheng, Long; Ning, Kang; Zhong, Hui; Huang, Junjian; Zhang, Hao; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing 100850, Peoples R China; [Wang, Shibin; Li, Yang] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Gen Surg, Beijing 100037, Peoples R China; [Ning, Kang] Liaoning Ctr Dis Control & Prevent, Liaoning 110005, Peoples R China; [Zhou, Lei] Shijitan Hosp, Dept Tumor, Beijing 100038, Peoples R China; [Lin, Jing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Clin Lab, Beijing 100037, Peoples R China; [Wang, Lisheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 1000850, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Zhang, H (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, 27 Tai Ping Lu Rd, Beijing 100850, Peoples R China.	zhanghal197@hotmail.com; yeqn66@yahoo.com		Jiang, Kai/0000-0002-8507-1945; Cheng, Long/0000-0002-4752-1298	Major State Basic Research Development Program Grants [2011CB504202, 2012CB945100]; National Natural Science Foundation Grants [81072173, 81272913, 30625035]; National Key Technologies R&D Program for New Drugs Grant [2009ZX09301-002]	Major State Basic Research Development Program Grants(National Basic Research Program of China); National Natural Science Foundation Grants(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs Grant	This work was supported by Major State Basic Research Development Program Grants 2011CB504202 and 2012CB945100, National Natural Science Foundation Grants 81072173, 81272913, and 30625035, and National Key Technologies R&D Program for New Drugs Grant 2009ZX09301-002.	Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Boonyaratanakornkit V, 2011, STEROIDS, V76, P877, DOI 10.1016/j.steroids.2011.02.017; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; MANDAL S, 2007, BMC CANCER, V7, P1471; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sun Y, 2006, NUCLEIC ACIDS RES, V34, P6314, DOI 10.1093/nar/gkl914; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Vogel C, 2010, JPN J CLIN ONCOL, V40, P999, DOI 10.1093/jjco/hyq084; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	50	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24590	24599		10.1074/jbc.M113.467837	http://dx.doi.org/10.1074/jbc.M113.467837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861392	Green Published, hybrid			2022-12-28	WOS:000330612300027
J	Milam, SL; Erickson, HP				Milam, Sara L.; Erickson, Harold P.			Rapid in Vitro Assembly of Caulobacter crescentus FtsZ Protein at pH 6.5 and 7.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; BACTERIAL CYTOKINESIS; RINGS; REGULATOR; RIBBONS	FtsZ from most bacteria assembles rapidly in vitro, reaching a steady-state plateau in 5-10 s after addition of GTP. A recent study used a novel dynamic light-scattering technique to assay the assembly of FtsZ from Caulobacter crescentus (CcFtsZ) and reported that assembly required 10 min, similar to 100 times slower than for related bacteria. Previous studies had indicated normal, rapid assembly of CcFtsZ. We have reinvestigated the assembly kinetics using a mutant L72W, where assembly of subunits into protofilaments results in a significant increase in tryptophan fluorescence. Wefound that assembly reached a plateau in 5-10 s and showed no change in the following 10 min. This was confirmed by 90 light scattering and negative-stain electron microscopy. The very slow kinetics in the dynamic light-scattering study may be related to a refractory state induced when the FtsZ protein is stored without nucleotide, a phenomenon that we had observed in a previous study of EcFtsZ. Weconclude that CcFtsZ is not an outlier, but shows rapid assembly kinetics similar to FtsZ from related bacteria.	[Milam, Sara L.; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27701 USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27701 USA	Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu			National Institutes of Health [GM66014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM66014 (to H. P. E.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hou S, 2012, J BIOL CHEM, V287, P23878, DOI 10.1074/jbc.M111.309492; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038	23	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23675	23679		10.1074/jbc.M113.491845	http://dx.doi.org/10.1074/jbc.M113.491845			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824192	Green Published, hybrid			2022-12-28	WOS:000330611400007
J	Pan, X; Siloto, RMP; Wickramarathna, AD; Mietkiewska, E; Weselake, RJ				Pan, Xue; Siloto, Rodrigo M. P.; Wickramarathna, Aruna D.; Mietkiewska, Elzbieta; Weselake, Randall J.			Identification of a Pair of Phospholipid: Diacylglycerol Acyltransferases from Developing Flax (Linum usitatissimum L.) Seed Catalyzing the Selective Production of Trilinolenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; LIPID-SYNTHESIS; GENE; ACCUMULATION; EXPRESSION; CLONING; PATHWAY	The oil from flax (Linum usitatissimum L.) has high amounts of alpha-linolenic acid (ALA; 18:3(cis Delta 9,12,15)) and is one of the richest sources of omega-3 polyunsaturated fatty acids (omega-3-PUFAs). To produce similar to 57% ALA in triacylglycerol (TAG), it is likely that flax contains enzymes that can efficiently transfer ALA to TAG. To test this hypothesis, we conducted a systematic characterization of TAG-synthesizing enzymes from flax. We identified several genes encoding acyl-CoA: diacylglycerol acyltransferases (DGATs) and phospholipid: diacylglycerol acyltransferases (PDATs) from the flax genome database. Due to recent genome duplication, duplicated gene pairs have been identified for all genes except DGAT2-2. Analysis of gene expression indicated that two DGAT1, two DGAT2, and four PDAT genes were preferentially expressed in flax embryos. Yeast functional analysis showed that DGAT1, DGAT2, and two PDAT enzymes restored TAG synthesis when produced recombinantly in yeast H1246 strain. The activity of particular PDAT enzymes (LuPDAT1 and LuPDAT2) was stimulated by the presence of ALA. Further seed-specific expression of flax genes in Arabidopsis thaliana indicated that DGAT1, PDAT1, and PDAT2 had significant effects on seed oil phenotype. Overall, this study indicated the existence of unique PDAT enzymes from flax that are able to preferentially catalyze the synthesis of TAG containing ALA acyl moieties. The identified LuPDATs may have practical applications for increasing the accumulation of ALA and other polyunsaturated fatty acids in oilseeds for food and industrial applications.	[Pan, Xue; Siloto, Rodrigo M. P.; Wickramarathna, Aruna D.; Mietkiewska, Elzbieta; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada	University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	pan, xue/AAE-3374-2019	pan, xue/0000-0001-9415-8316	Genome Alberta/Genome Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Graduate Student Scholarship	Genome Alberta/Genome Canada(Genome Canada); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Graduate Student Scholarship	This work was supported in part by grants from Genome Alberta/Genome Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, the Research Capacity Program of Alberta Enterprise and Advanced Education, AVAC Ltd., Alberta Innovates Bio Solutions, and the Natural Sciences and Engineering Research Council of Canada (to R. J. W.); Recipient of the Alberta Innovates Graduate Student Scholarship.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Ahmad A, 2010, MOL PLANT, V3, P719, DOI 10.1093/mp/ssq026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ciftci ON, 2012, EUR J LIPID SCI TECH, V114, P794, DOI 10.1002/ejlt.201100207; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dahmen JL, 2013, EUKARYOT CELL, V12, P923, DOI 10.1128/EC.00332-12; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GREEN AG, 1986, CAN J PLANT SCI, V66, P499, DOI 10.4141/cjps86-068; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jhala A. J., 2010, Australian Journal of Basic and Applied Sciences, V4, P4304; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lee J, 2011, PLANT BIOTECHNOL J, V9, P359, DOI 10.1111/j.1467-7652.2010.00562.x; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Lock YY, 2009, PHYSIOL PLANTARUM, V137, P61, DOI 10.1111/j.1399-3054.2009.01258.x; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; Mietkiewska E, 2011, FEBS J, V278, P764, DOI 10.1111/j.1742-4658.2010.07995.x; Pereira SL, 2004, BIOCHEM J, V378, P665, DOI 10.1042/BJ20031319; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Rao S, 2008, LIPIDS, V43, P749, DOI 10.1007/s11745-008-3207-0; ROWLAND GG, 1991, CAN J PLANT SCI, V71, P393, DOI 10.4141/cjps91-054; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Ruiz-Lopez N, 2009, PLANT BIOTECHNOL J, V7, P704, DOI 10.1111/j.1467-7652.2009.00436.x; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang JH, 2003, MOL BREEDING, V12, P71, DOI 10.1023/A:1025495000264; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Weigel D., 2002, ARABIDOPSIS LAB MANU; WEISS SB, 1960, J BIOL CHEM, V235, P40; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	58	74	82	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24173	24188		10.1074/jbc.M113.475699	http://dx.doi.org/10.1074/jbc.M113.475699			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824186	hybrid, Green Published			2022-12-28	WOS:000330611400056
J	Rout, AK; Patel, S; Somlata; Shukla, M; Saraswathi, D; Bhattacharya, A; Chary, KVR				Rout, Ashok K.; Patel, Sunita; Somlata; Shukla, Manish; Saraswathi, Deepa; Bhattacharya, Alok; Chary, Kandala V. R.			Functional Manipulation of a Calcium-binding Protein from Entamoeba histolytica Guided by Paramagnetic NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SHIFTS; SENSOR PROTEIN; RESONANCE ASSIGNMENTS; STRUCTURAL BASIS; C-13; CA2+; DOMAINS; SEQUENCE; DYNAMICS; H-1	EhCaBP1, one of the calcium-binding proteins from Entamoeba histolytica, is a two-domain EF-hand protein. The two domains of EhCaBP1 are structurally and functionally different from each other. However, both domains are required for structural stability and a full range of functional diversity. Analysis of sequence and structure of EhCaBP1 and other CaBPs indicates that the C-terminal domain of EhCaBP1 possesses a unique structure compared with other family members. This had been attributed to the absence of a Phe-Phe interaction between highly conserved Phe residues at the -4 position in EF-hand III (F[-4]; Tyr(81)) and at the 13th position in EF-hand IV (F[+13]; Phe(129)) of the C-terminal domain. Against this backdrop, we mutated the Tyr residue at the -4th position of EF III to the Phe residue (Y81F), to bring in the Phe-Phe interaction and understand the nature of structural and functional changes in the protein by NMR spectroscopy, molecular dynamics (MD) simulation, isothermal titration calorimetry (ITC), and biological assays, such as imaging and actin binding. The Y81F mutation in EhCaBP1 resulted in a more compact structure for the C-terminal domain of the mutant as in the case of calmodulin and troponin C. The compact structure is favored by the presence of a pi-pi interaction between Phe(81) and Phe(129) along with several hydrophobic interactions of Phe(81), which are not seen in the wild-type protein. Furthermore, the biological assays reveal preferential membrane localization of the mutant, loss of its colocalization with actin in the phagocytic cups, whereas retaining its ability to bind G- and F-actin.	[Rout, Ashok K.; Patel, Sunita; Shukla, Manish; Saraswathi, Deepa; Chary, Kandala V. R.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Patel, Sunita; Chary, Kandala V. R.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Hyderabad, Andhra Pradesh, India; [Somlata; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Jawaharlal Nehru University, New Delhi	Chary, KVR (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	chary@tifr.res.in		, SOMLATA/0000-0003-1928-5280; Rout, Ashok Kumar/0000-0003-1448-300X	Tata Institute of Fundamental Research (TIFR), Mumbai, India	Tata Institute of Fundamental Research (TIFR), Mumbai, India	This work was supported by the Tata Institute of Fundamental Research (TIFR), Mumbai, India.	Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Atreya HS, 2000, J BIOMOL NMR, V17, P125, DOI 10.1023/A:1008315111278; Atreya HS, 2003, PROTEIN SCI, V12, P412, DOI 10.1110/ps.0225603; Atreya HS, 2001, BIOCHEMISTRY-US, V40, P14392, DOI 10.1021/bi0114978; Barnwal RP, 2008, J BIOMOL NMR, V41, P191, DOI 10.1007/s10858-008-9254-2; Barnwal RP, 2007, J BIOMOL NMR, V39, P259, DOI 10.1007/s10858-007-9200-8; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bunick CG, 2004, J AM CHEM SOC, V126, P5990, DOI 10.1021/ja0397456; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; DeLano W.L, PYMOL MOL GRAPHICS S; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Jain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005269; Keller RLJ, 2004, THESIS ETH ZURICH SW; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mohan PMK, 2008, PROTEINS, V70, P1147, DOI 10.1002/prot.21751; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Mukherjee S., 2006, CALCIUM BIND PROTEIN, V2, P115; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P3835, DOI 10.1021/bi0621260; Mustafi SM, 2004, BIOCHEMISTRY-US, V43, P9320, DOI 10.1021/bi049657d; Mustafi SM, 2009, J BIOL INORG CHEM, V14, P471, DOI 10.1007/s00775-008-0463-7; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Patel S, 2008, J STRUCT BIOL, V164, P60, DOI 10.1016/j.jsb.2008.06.003; Rout AK, 2011, BIOCHEMISTRY-US, V50, P181, DOI 10.1021/bi101411q; Rout AK, 2010, MAGN RESON CHEM, V48, P793, DOI 10.1002/mrc.2664; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Sahu SC, 1999, J BIOMOL NMR, V14, P93, DOI 10.1023/A:1008387531570; Sahu SC, 1999, FEBS LETT, V459, P51, DOI 10.1016/S0014-5793(99)01204-1; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; Somlata, 2012, J BIOL CHEM, V287, P10844, DOI 10.1074/jbc.M111.308874; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; van Gunsteren W. F., 1996, GROMOS96 MANUAL USER, P1; Veeraraghavan S, 2002, J BIOL CHEM, V277, P28564, DOI 10.1074/jbc.M112232200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X	49	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23473	23487		10.1074/jbc.M112.411058	http://dx.doi.org/10.1074/jbc.M112.411058			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782698	hybrid, Green Published			2022-12-28	WOS:000330598200053
J	Riley, LM; Weadge, JT; Baker, P; Robinson, H; Codee, JDC; Tipton, PA; Ohman, DE; Howell, PL				Riley, Laura M.; Weadge, Joel T.; Baker, Perrin; Robinson, Howard; Codee, Jeroen D. C.; Tipton, Peter A.; Ohman, Dennis E.; Howell, P. Lynne			Structural and Functional Characterization of Pseudomonas aeruginosa AlgX ROLE OF AlgX IN ALGINATE ACETYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; BIOFILM FORMATION; EXTRACELLULAR POLYSACCHARIDES; ACETYLPEPTIDOGLYCAN ESTERASE; EVOLUTIONARY CONSERVATION; INDUCED DISPERSION; PROTEIN-STRUCTURE; ACTIVE-SITE; IDENTIFICATION; SEQUENCE	The exopolysaccharide alginate, produced by mucoid Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, undergoes two different chemical modifications as it is synthesized that alter the properties of the polymer and hence the biofilm. One modification, acetylation, causes the cells in the biofilm to adhere better to lung epithelium, form microcolonies, and resist the effects of the host immune system and/or antibiotics. Alginate biosynthesis requires 12 proteins encoded by the algD operon, including AlgX, and although this protein is essential for polymer production, its exact role is unknown. In this study, we present the X-ray crystal structure of AlgX at 2.15 angstrom resolution. The structure reveals that AlgX is a two-domain protein, with an N-terminal domain with structural homology to members of the SGNH hydrolase superfamily and a C-terminal carbohydrate-binding module. A number of residues in the carbohydrate-binding module form a substrate recognition "pinch point" that we propose aids in alginate binding and orientation. Although the topology of the N-terminal domain deviates from canonical SGNH hydrolases, the residues that constitute the Ser-His-Asp catalytic triad characteristic of this family are structurally conserved. In vivo studies reveal that site-specific mutation of these residues results in non-acetylated alginate. This catalytic triad is also required for acetylesterase activity in vitro. Our data suggest that not only does AlgX protect the polymer as it passages through the periplasm but that it also plays a role in alginate acetylation. Our results provide the first structural insight for a wide group of closely related bacterial polysaccharide acetyltransferases.	[Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Tipton, Peter A.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory; Leiden University; Leiden University - Excl LUMC; University of Missouri System; University of Missouri Columbia; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca			United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI019146, R01AI019146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081419] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000477] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Yura Lobsanov, Francis Wolfram, Dustin J. Little, Jason Koo, John C. C. Whitney, and G. David Smith for helpful discussions and Patrick Yip for technical assistance. National Synchrotron Light Source beamline X29 is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Center for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990; CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Codee JDC, 2009, J ORG CHEM, V74, P38, DOI 10.1021/jo8020192; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Damron FH, 2011, J BACTERIOL, V193, P286, DOI 10.1128/JB.01132-10; DARZINS A, 1985, J BACTERIOL, V164, P516, DOI 10.1128/JB.164.2.516-524.1985; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS LR, 1973, J BACTERIOL, V116, P915, DOI 10.1128/JB.116.2.915-924.1973; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Franklin MJ, 2004, J BACTERIOL, V186, P4759, DOI 10.1128/JB.186.14.4759-4773.2004; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Gutsche J, 2006, BIOCHIMIE, V88, P245, DOI 10.1016/j.biochi.2005.06.003; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Hay ID, 2012, APPL MICROBIOL BIOT, V93, P215, DOI 10.1007/s00253-011-3430-0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HESTRIN S, 1949, J BIOL CHEM, V180, P249; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; HOLLOWAY BW, 1969, BACTERIOL REV, V33, P419, DOI 10.1128/MMBR.33.3.419-443.1969; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2003, MOL MICROBIOL, V47, P1123, DOI 10.1046/j.1365-2958.2003.03361.x; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LINKER A, 1966, J BIOL CHEM, V241, P3845; Ma JM, 2011, PROTEINS, V79, P662, DOI 10.1002/prot.22865; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMullen TWP, 2000, PROTEIN ENG, V13, P865, DOI 10.1093/protein/13.12.865; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Pickens LB, 2011, J BIOL CHEM, V286, P41539, DOI 10.1074/jbc.M111.299859; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; ROBERTSON DL, 1994, J BIOL CHEM, V269, P2146; Robles-Price A, 2004, J BACTERIOL, V186, P7369, DOI 10.1128/JB.186.21.7369-7377.2004; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; SHINABARGER D, 1993, MOL MICROBIOL, V9, P1027, DOI 10.1111/j.1365-2958.1993.tb01232.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Suh SJ, 2004, J MICROBIOL METH, V58, P203, DOI 10.1016/j.mimet.2004.03.018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Teutschbein J, 2010, J BIOL CHEM, V285, P38374, DOI 10.1074/jbc.M110.171637; Tielen P, 2005, MICROBIOL RES, V160, P165, DOI 10.1016/j.micres.2004.11.003; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Weadge JT, 2010, ACTA CRYSTALLOGR F, V66, P588, DOI 10.1107/S1744309110011851; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	94	40	43	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22299	22314		10.1074/jbc.M113.484931	http://dx.doi.org/10.1074/jbc.M113.484931			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779107	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330596300012
J	Pinheiro, AR; Paramos-de-Carvalho, D; Certal, M; Costa, MA; Costa, C; Magalhaes-Cardoso, MT; Ferreirinha, F; Sevigny, J; Correia-de-Sa, P				Pinheiro, Ana Rita; Paramos-de-Carvalho, Diogo; Certal, Mariana; Costa, Maria Adelina; Costa, Cristina; Magalhaes-Cardoso, Maria Teresa; Ferreirinha, Fatima; Sevigny, Jean; Correia-de-Sa, Paulo			Histamine Induces ATP Release from Human Subcutaneous Fibroblasts, via Pannexin-1 Hemichannels, Leading to Ca2+ Mobilization and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; LOW-BACK-PAIN; COLLAGEN-SYNTHESIS; OSTEOGENIC DIFFERENTIATION; CARDIAC FIBROBLASTS; CONNECTIVE-TISSUE; EPITHELIAL-CELLS; ADENOSINE; RECEPTORS; CHANNELS	Changes in the regulation of connective tissue ATP-mediated mechano-transduction and remodeling may be an important link to the pathogenesis of chronic pain. It has been demonstrated that mast cell-derived histamine plays an important role in painful fibrotic diseases. Here we analyzed the involvement of ATP in the response of human subcutaneous fibroblasts to histamine. Acute histamine application caused a rise in intracellular Ca2+ ([Ca2+](i)) and ATP release from human subcutaneous fibroblasts via H-1 receptor activation. Histamine-induced [Ca2+](i) rise was partially attenuated by apyrase, an enzyme that inactivates extracellular ATP, and by blocking P2 purinoceptors with pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) tetrasodium salt and reactive blue 2. [Ca2+](i) accumulation caused by histamine was also reduced upon blocking pannexin-1 hemichannels with (10)Panx, probenecid, or carbenoxolone but not when connexin hemichannels were inhibited with mefloquine or 2-octanol. Brefeldin A, an inhibitor of vesicular exocytosis, also did not block histamine-induced [Ca2+](i) mobilization. Prolonged exposure of human subcutaneous fibroblast cultures to histamine favored cell growth and type I collagen synthesis via the activation of H-1 receptor. This effect was mimicked by ATP and its metabolite, ADP, whereas the selective P2Y(1) receptor antagonist, MRS2179, partially attenuated histamine-induced cell growth and type I collagen production. Expression of pannexin-1 and ADP-sensitive P2Y(1) receptor on human subcutaneous fibroblasts was confirmed by immunofluorescence confocal microscopy and Western blot analysis. In conclusion, histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to [Ca2+](i) mobilization and cell growth through the cooperation of H-1 and P2 (probably P2Y(1)) receptors.	[Pinheiro, Ana Rita; Paramos-de-Carvalho, Diogo; Certal, Mariana; Costa, Maria Adelina; Costa, Cristina; Magalhaes-Cardoso, Maria Teresa; Ferreirinha, Fatima; Correia-de-Sa, Paulo] Univ Porto, Lab Farmacol & Neurobiol, Unidade Multidisciplinar Invest Biomed, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal; [Costa, Maria Adelina] Univ Porto, Dept Quim, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal; [Pinheiro, Ana Rita] Inst Politecn Porto, Area Tecn Cient Fisioterapia, Escola Super Tecnol Saude, P-4400330 Vila Nova De Gaia, Portugal; [Sevigny, Jean] Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada	Universidade do Porto; Universidade do Porto; Polytechnic Institute of Porto; Laval University; Laval University	Correia-de-Sa, P (corresponding author), Univ Porto, Lab Farmacol & Neurobiol, Unidade Multidisciplinar Invest Biomed, Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228,Edif 2 Piso 4, P-4050313 Oporto, Portugal.	farmacol@icbas.up.pt	Pinheiro, Ana Rita/B-4018-2017; Ferreirinha, Fatima/K-8752-2014; Correia-de-Sá, Paulo/AAG-5901-2019; Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012; Cardoso, Maria T M M/K-9256-2014; Correia-De-Sá, P./F-1079-2015	Pinheiro, Ana Rita/0000-0003-4310-7652; Ferreirinha, Fatima/0000-0002-0527-1323; Correia-de-Sá, Paulo/0000-0002-6114-9189; Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Cardoso, Maria T M M/0000-0002-5437-3940; Correia-De-Sá, P./0000-0002-6114-9189; Costa, Cristina/0000-0002-8464-3251; Paramos de Carvalho, Diogo/0000-0003-2274-7167; Costa, Maria Adelina Coelho/0000-0001-7664-2075	Fundacao para a Ciencia e a Tecnologia (Fundo Europeu de Desenvolvimento Regional, FEDER) [PTDC/SAU-FCF/108263/2008]; Canadian Institutes of Health Research; Arthritis Society; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/47373/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-FCF/108263/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (Fundo Europeu de Desenvolvimento Regional, FEDER); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Fundo Europeu de Desenvolvimento Regional, FEDER) Grant PTDC/SAU-FCF/108263/2008 and by grants from the Canadian Institutes of Health Research and from the Arthritis Society (to J. S.).; Recipient of Fundacao para a Ciencia e a Tecnologia Ph.D. Scholarship SFRH/BD/47373/2008.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174; Alqallaf SM, 2009, BRIT J PHARMACOL, V156, P1124, DOI 10.1111/j.1476-5381.2009.00119.x; Ansel JC, 1996, J INVEST DERMATOL, V106, P198, DOI 10.1111/1523-1747.ep12330326; Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Corey SM, 2011, CELLS TISSUES ORGANS, V194, P521, DOI 10.1159/000323875; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Cunha RA, 1998, J NEUROSCI, V18, P1987; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Dranoff JA, 2004, J INVEST MED, V52, P475, DOI 10.1136/jim-52-07-42; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Faria M, 2006, J PHARMACOL EXP THER, V319, P405, DOI 10.1124/jpet.106.107821; Fasciani I, 2013, NEUROPHARMACOLOGY, V75, P479, DOI 10.1016/j.neuropharm.2013.03.040; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Garbuzenko E, 2002, CLIN EXP ALLERGY, V32, P237, DOI 10.1046/j.1365-2222.2002.01293.x; Gartner L. P., 2007, COLOR TXB HISTOLOGY; HATAMOCHI A, 1985, ARCH DERMATOL RES, V277, P60; Hedley G., 2008, J BODYW MOV THER, V12, P258; Henriksen Z, 2006, CELL CALCIUM, V39, P435, DOI 10.1016/j.ceca.2006.01.012; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; JORDANA M, 1988, THORAX, V43, P552, DOI 10.1136/thx.43.7.552; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Katayama I, 1997, J DERMATOL SCI, V15, P201, DOI 10.1016/S0923-1811(97)00608-7; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Langevin HM, 2013, J CELL PHYSIOL, V228, P1922, DOI 10.1002/jcp.24356; Langevin HM, 2007, MED HYPOTHESES, V68, P74, DOI 10.1016/j.mehy.2006.06.033; Langevin HM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-151; Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z; Luttikhuizen DT, 2004, CELL TISSUE RES, V317, P289, DOI 10.1007/s00441-004-0939-x; Magalhaes-Cardoso MT, 2003, J PHYSIOL-LONDON, V549, P399, DOI 10.1113/jphysiol.2003.040410; Markenson Joseph A., 1996, American Journal of Medicine, V101, p6S; Mork H, 2003, EUR J PAIN, V7, P145, DOI 10.1016/S1090-3801(02)00096-4; Munkonda MN, 2009, FEBS J, V276, P479, DOI 10.1111/j.1742-4658.2008.06797.x; Noronha-Matos JB, 2012, J CELL PHYSIOL, V227, P2694, DOI 10.1002/jcp.23014; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pleuvry BJ, 1996, PHARMACOL THERAPEUT, V71, P313, DOI 10.1016/S0163-7258(96)00093-9; RIACH RA, 1995, J PHYSIOL-LONDON, V486, P273, DOI 10.1113/jphysiol.1995.sp020810; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	56	66	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27571	27583		10.1074/jbc.M113.460865	http://dx.doi.org/10.1074/jbc.M113.460865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23918924	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000330597300052
J	Wang, J; Ptacek, JB; Kirkegaard, K; Bullitt, E				Wang, Jing; Ptacek, Jennifer B.; Kirkegaard, Karla; Bullitt, Esther			Double-membraned Liposomes Sculpted by Poliovirus 3AB Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION COMPLEX; ENDOPLASMIC-RETICULUM; RNA REPLICATION; POLYMERASE 3D(POL); VIRUS-REPLICATION; VIRAL-PROTEINS; IN-VITRO; ASSOCIATION; ARCHITECTURE; LC3	Infection with many positive-strand RNA viruses dramatically remodels cellular membranes, resulting in the accumulation of double-membraned vesicles that resemble cellular autophagosomes. In this study, a single protein encoded by poliovirus, 3AB, is shown to be sufficient to induce the formation of double-membraned liposomes via the invagination of single-membraned liposomes. Poliovirus 3AB is a 109-amino acid protein with a natively unstructured N-terminal domain. HeLa cells transduced with 3AB protein displayed intracellular membrane disruption; specifically, the formation of cytoplasmic invaginations. The ability of a single viral protein to produce structures of similar topology to cellular autophagosomes should facilitate the understanding of both cellular and viral mechanisms for membrane remodeling.	[Wang, Jing; Bullitt, Esther] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ptacek, Jennifer B.; Kirkegaard, Karla] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94301 USA	Boston University; Stanford University	Kirkegaard, K (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D325, Stanford, CA 94301 USA.	karlak@stanford.edu; bullitt@bu.edu		Bullitt, Esther/0000-0003-2447-6209	National Institutes of Health [GM102474]; American Cancer Society; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award (to K. K.) and National Institutes of Health Grant GM102474 (to E. B.). This work was also supported by the American Cancer Society (to J. B. P.).	Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; DALES S, 1973, BACTERIOL REV, V37, P103, DOI 10.1128/MMBR.37.2.103-135.1973; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996; Ehrlich LS, 2011, J MOL BIOL, V413, P347, DOI 10.1016/j.jmb.2011.08.038; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hoekstra D., 1991, MEMBRANE FUSION, P89; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Khan SH, 2012, MOL BIOSYST, V8, P91, DOI 10.1039/c1mb05265a; LAMA J, 1994, J BIOL CHEM, V269, P66; Lanman J, 2008, J STRUCT BIOL, V161, P439, DOI 10.1016/j.jsb.2007.09.009; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MOLLA A, 1994, J BIOL CHEM, V269, P27015; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042; Pasieka TJ, 2003, J VIROL METHODS, V111, P157, DOI 10.1016/S0166-0934(03)00152-6; Paul AV, 1998, VIROLOGY, V250, P241, DOI 10.1006/viro.1998.9376; PAUL AV, 1994, J BIOL CHEM, V269, P29173; Peker B, 2004, BIOTECHNOL PROGR, V20, P262, DOI 10.1021/bp034182n; PLOTCH SJ, 1995, J VIROL, V69, P7169, DOI 10.1128/JVI.69.11.7169-7179.1995; Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2011, J VIROL, V85, P4284, DOI 10.1128/JVI.02398-10; Thaa B, 2011, BIOCHEM J, V437, P389, DOI 10.1042/BJ20110706; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weill CO, 2008, CYTOTECHNOLOGY, V56, P41, DOI 10.1007/s10616-007-9102-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xiang WK, 1995, RNA, V1, P892; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	66	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27287	27298		10.1074/jbc.M113.498899	http://dx.doi.org/10.1074/jbc.M113.498899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908350	hybrid, Green Published			2022-12-28	WOS:000330597300025
J	Abd Wahab, S; Choi, M; Bianco, PR				Abd Wahab, Syafiq; Choi, Meerim; Bianco, Piero R.			Characterization of the ATPase Activity of RecG and RuvAB Proteins on Model Fork Structures Reveals Insight into Stalled DNA Replication Fork Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RUVA; HOLLIDAY JUNCTION COMPLEX; BRANCH MIGRATION; IN-VITRO; GENETIC-RECOMBINATION; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; STRAND EXCHANGE; BINDING PROTEIN; REVERSAL	RecG and RuvAB are proposed to act at stalled DNA replication forks to facilitate replication restart. To clarify the roles of these proteins in fork regression, we used a coupled spectrophotometric ATPase assay to determine how these helicases act on two groups of model fork substrates: the first group mimics nascent stalled forks, whereas the second mimics regressed fork structures. The results show that RecG is active on the substrates in group 1, whereas these are poor substrates for RuvAB. In addition, in the presence of group 1 forks, the single-stranded DNA-binding protein (SSB) enhances the activity of RecG and enables it to compete with excess RuvA. In contrast, SSB inhibits the activity of RuvAB on these substrates. Results also show that the preferred regressed fork substrate for RuvAB is a Holliday junction, not a forked DNA. The active form of the enzyme on the Holliday junction contains a single RuvA tetramer. In contrast, although the enzyme is active on a regressed fork structure, RuvB loading by a single RuvA tetramer is impaired, and full activity requires the cooperative binding of two forked DNA substrate molecules. Collectively, the data support a model where RecG is responsible for stalled DNA replication fork regression. SSB ensures that if the nascent fork has single-stranded DNA character RuvAB is inhibited, whereas the activity of RecG is preferentially enhanced. Only once the fork has been regressed and the DNA is relaxed can RuvAB bind to a RecG-extruded Holliday junction.	[Abd Wahab, Syafiq; Choi, Meerim; Bianco, Piero R.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Bianco, Piero R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Abd Wahab, Syafiq; Choi, Meerim; Bianco, Piero R.] SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bianco, PR (corresponding author), SUNY Buffalo, Ctr Single Mol Biophys, Dept Microbiol & Immunol, 321 Cary Hall, Buffalo, NY 14214 USA.	pbianco@buffalo.edu		Abd Wahab, Syafiq/0000-0002-3611-2552	National Institutes of Health [GM100156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM100156 (to P. R. B.).	Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Bennett RJ, 1996, P NATL ACAD SCI USA, V93, P12217, DOI 10.1073/pnas.93.22.12217; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; George H, 2000, CURR BIOL, V10, P103, DOI 10.1016/S0960-9822(00)00296-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HIOM K, 1995, NUCLEIC ACIDS RES, V23, P3621, DOI 10.1093/nar/23.18.3621; Hishida T, 1999, J BIOL CHEM, V274, P25335, DOI 10.1074/jbc.274.36.25335; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; IWASAKI H, 1992, GENE DEV, V6, P2214, DOI 10.1101/gad.6.11.2214; IYPE LE, 1994, J BIOL CHEM, V269, P24967; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Liu J, 2011, PROTEIN SCI, V20, P1005, DOI 10.1002/pro.633; LLOYD RG, 1991, J BACTERIOL, V173, P6837, DOI 10.1128/jb.173.21.6837-6843.1991; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Manosas M., 2013, NAT COMMUN IN PRESS; Marians KJ, 2000, CURR OPIN GENET DEV, V10, P151, DOI 10.1016/S0959-437X(00)00059-9; Marians KJ, 2004, PHILOS T ROY SOC B, V359, P71, DOI 10.1098/rstb.2003.1366; Marrione PE, 1996, BIOCHEMISTRY-US, V35, P11228, DOI 10.1021/bi960316c; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2002, MOL CELL, V10, P700, DOI 10.1016/S1097-2765(02)00687-1; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; MULLER B, 1993, J BIOL CHEM, V268, P17185; MULLER B, 1993, J BIOL CHEM, V268, P17179; MULLER B, 1994, EXPERIENTIA, V50, P216; PARSONS CA, 1995, EMBO J, V14, P5736, DOI 10.1002/j.1460-2075.1995.tb00260.x; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Pataleo R., 2010, ATTENTI ALLUOMO BIAN; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Segel IH, 1976, BIOCH CALCULATIONS; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHARPLES GJ, 1990, MOL GEN GENET, V221, P219, DOI 10.1007/BF00261724; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; SHURVINTON CE, 1982, MOL GEN GENET, V185, P352, DOI 10.1007/BF00330811; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; West SC, 1996, J BACTERIOL, V178, P1237, DOI 10.1128/jb.178.5.1237-1241.1996; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yu X, 1997, J MOL BIOL, V266, P217, DOI 10.1006/jmbi.1996.0799	72	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26397	26409		10.1074/jbc.M113.500223	http://dx.doi.org/10.1074/jbc.M113.500223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23893472	Green Published, hybrid			2022-12-28	WOS:000330594500005
J	Deranieh, RM; He, Q; Caruso, JA; Greenberg, ML				Deranieh, Rania M.; He, Quan; Caruso, Joseph A.; Greenberg, Miriam L.			Phosphorylation Regulates myo-Inositol-3-phosphate Synthase A NOVEL REGULATORY MECHANISM OF INOSITOL BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOINOSITOL 1-PHOSPHATE SYNTHASE; YEAST SACCHAROMYCES-CEREVISIAE; INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHOLIPID BIOSYNTHESIS; CRYSTAL-STRUCTURE; L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE; MAJOR SITES; IDENTIFICATION; ENZYME; GENE	myo-Inositol-3-phosphate synthase (MIPS) plays a crucial role in inositol homeostasis. Transcription of the coding gene INO1 is highly regulated. However, regulation of the enzyme is not well defined. We previously showed that MIPS is indirectly inhibited by valproate, suggesting that the enzyme is post-translationally regulated. Using P-32(i) labeling and phosphoamino acid analysis, we show that yeast MIPS is a phosphoprotein. Mass spectrometry analysis identified five phosphosites, three of which are conserved in the human MIPS. Analysis of phosphorylation-deficient and phosphomimetic site mutants indicated that the three conserved sites in yeast (Ser-184, Ser-296, and Ser-374) and humans (Ser-177, Ser-279, and Ser-357) affect MIPS activity. Both S296A and S296D yeast mutants and S177A and S177D human mutants exhibited decreased enzymatic activity, suggesting that a serine residue is critical at that location. The phosphomimetic mutations S184D (human S279D) and S374D (human S357D) but not the phosphodeficient mutations decreased activity, suggesting that phosphorylation of these two sites is inhibitory. The double mutation S184A/S374A caused an increase in MIPS activity, conferred a growth advantage, and partially rescued sensitivity to valproate. Our findings identify a novel mechanism of regulation of inositol synthesis by phosphorylation of MIPS.	[Deranieh, Rania M.; He, Quan; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Caruso, Joseph A.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Caruso, Joseph A./U-8429-2019	Caruso, Joseph A./0000-0003-2900-3996; He, Quan/0000-0001-7706-9960	National Institutes of Health [DK 081367]; Wayne State University Graduate Research Fellowship; Graduate Research Enhancement Funds; National Institutes of Health Center [P30 ES06639, P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University Graduate Research Fellowship; Graduate Research Enhancement Funds; National Institutes of Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 081367 (to M. L. G.). This work was also supported by Wayne State University Graduate Research Fellowship and Graduate Research Enhancement Funds (to R. M. D.). The Wayne State University Proteomics Core Facility is supported by National Institutes of Health Center Grants P30 ES06639 and P30 CA22453.	ADHIKARI J, 1988, INDIAN J BIOCHEM BIO, V25, P408; Azab AN, 2007, MOL MICROBIOL, V63, P1248, DOI 10.1111/j.1365-2958.2007.05591.x; Bachhawat N, 1999, J MOL BIOL, V291, P531, DOI 10.1006/jmbi.1999.2980; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CULBERTSON MR, 1975, GENETICS, V80, P23; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; Deranieh RM, 2012, ORG BIOMOL CHEM, V10, P9601, DOI 10.1039/c2ob26577j; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Geiger James H., 2006, V39, P157; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Jin XS, 2003, ACTA CRYSTALLOGR D, V59, P1154, DOI 10.1107/S0907444903008205; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Kniewel Ryan, 2002, Journal of Structural and Functional Genomics, V2, P129, DOI 10.1023/A:1021293408654; LOEWUS MW, 1971, PLANT PHYSIOL, V48, P255, DOI 10.1104/pp.48.3.255; Lohia A, 1999, MOL BIOCHEM PARASIT, V98, P67, DOI 10.1016/S0166-6851(98)00147-9; MAEDA T, 1980, J BIOL CHEM, V255, P8458; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; Neelon K, 2011, BIOPHYS J, V101, P2816, DOI 10.1016/j.bpj.2011.10.038; Norman RA, 2002, STRUCTURE, V10, P393, DOI 10.1016/S0969-2126(02)00718-9; Nunez Lilia R., 2006, V39, P135; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; WHITE MJ, 1991, J BIOL CHEM, V266, P863	41	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26822	26833		10.1074/jbc.M113.479121	http://dx.doi.org/10.1074/jbc.M113.479121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902760	Green Published, hybrid			2022-12-28	WOS:000330594500048
J	McStay, GP; Su, CH; Thomas, SM; Xu, JT; Tzagoloff, A				McStay, Gavin P.; Su, Chen-Hsien; Thomas, Susan M.; Xu, Jonathan Tong; Tzagoloff, Alexander			Characterization of Assembly Intermediates Containing Subunit 1 of Yeast Cytochrome Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; C-OXIDASE; ATP SYNTHASE; TRANSLATION; GENE; MUTANTS; COX1P; MSS51P	Mitochondrial-encoded Cox1p, one of the three core subunits of yeast cytochrome oxidase (COX), was previously shown to associate with regulatory proteins and nuclear-encoded subunits into five high molecular weight complexes that were proposed to constitute the pathway for biogenesis of the Cox1p assembly module. One of the intermediates (D5) was inferred, but not directly shown to exist. In the present study mitochondria of strains expressing C-terminal-tagged subunits of COX that had not been looked at previously were pulse-labeled and analyzed for the presence of newly translated Cox1p in the immunoprecipitates. These studies revealed that of the eight nuclear-encoded COX subunits, only Cox5ap, Cox6p, and Cox8p are present in the Cox1p module. Both Cox5ap and Cox8p share interfaces with Cox1p in the holoenzyme, whereas Cox6p interacts indirectly through Cox5ap. These results suggest that the subunit contacts in the holoenzyme are probably established during biogenesis of the Cox1p module. To confirm the existence of the largest Cox1p intermediates (D5), which was only inferred previously, radiolabeled Cox1p with a C-terminal tag was expressed in COX-deficient pet111 and pet494 mutants. Pulldown assays confirmed the presence of newly translated Cox1p in D5, which in wild type cannot be demonstrated directly because of its co-migration with COX in the native electrophoresis system used to separate the intermediates. Jointly, the results of these analyses substantiate our previous proposal that COX is assembled from separate assembly modules, each containing one of the mitochondrial-translated core subunits in association with a unique set of nuclear-encoded subunits.	[McStay, Gavin P.; Su, Chen-Hsien; Thomas, Susan M.; Xu, Jonathan Tong; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu	McStay, Gavin/K-9574-2013	McStay, Gavin/0000-0003-1363-8719; Xu, Jonathan/0000-0001-8893-4286	National Institutes of Health [GM 50187]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50187.	Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; COSTANZO MC, 1986, MOL CELL BIOL, V6, P3694, DOI 10.1128/MCB.6.11.3694; DOWNIE JA, 1977, J MOL BIOL, V113, P369, DOI 10.1016/0022-2836(77)90147-4; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POUTRE CG, 1987, GENETICS, V115, P637; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	34	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26546	26556		10.1074/jbc.M113.498592	http://dx.doi.org/10.1074/jbc.M113.498592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897805	Green Published, hybrid			2022-12-28	WOS:000330594500021
J	Gao, XL; Sinha, S; Belcastro, M; Woodard, C; Ramamurthy, V; Stoilov, P; Sokolov, M				Gao, Xueli; Sinha, Satyabrata; Belcastro, Marycharmain; Woodard, Catherine; Ramamurthy, Visvanathan; Stoilov, Peter; Sokolov, Maxim			Splice Isoforms of Phosducin-like Protein Control the Expression of Heterotrimeric G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; CYTOSOLIC CHAPERONIN; CRYSTAL-STRUCTURE; ROD PHOTORECEPTORS; COMPLEX; CCT; REGULATOR; MECHANISM; FAMILY	Heterotrimeric G proteins play an essential role in cellular signaling; however, the mechanism regulating their synthesis and assembly remains poorly understood. A line of evidence indicates that the posttranslational processing of G protein beta subunits begins inside the protein-folding chamber of the chaperonin containing t-complex protein 1. This process is facilitated by the ubiquitously expressed phosducin-like protein (PhLP), which is thought to act as a CCT co-factor. Here we demonstrate that alternative splicing of the PhLP gene gives rise to a transcript encoding a truncated, short protein (PhLPs) that is broadly expressed in human tissues but absent in mice. Seeking to elucidate the function of PhLPs, we expressed this protein in the rod photoreceptors of mice and found that this manipulation caused a dramatic translational and posttranslational suppression of rod heterotrimeric G proteins. The investigation of the underlying mechanism revealed that PhLPs disrupts the folding of G beta and the assembly of G beta and G gamma subunits, events normally assisted by PhLP, by forming a stable and apparently inactive tertiary complex with CCT preloaded with nascent G beta. As a result, the cellular levels of G beta and G gamma, which depends on G beta for stability, decline. In addition, PhLPs evokes a profound and rather specific down-regulation of the G alpha transcript, leading to a complete disappearance of the protein. This study provides the first evidence of a generic mechanism, whereby the splicing of the PhLP gene could potentially and efficiently regulate the cellular levels of heterotrimeric G proteins.	[Gao, Xueli; Sinha, Satyabrata; Belcastro, Marycharmain; Ramamurthy, Visvanathan; Sokolov, Maxim] W Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Woodard, Catherine; Ramamurthy, Visvanathan; Stoilov, Peter; Sokolov, Maxim] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Sokolov, M (corresponding author), W Virginia Univ, Inst Eye, 1 Stadium Dr, Morgantown, WV 26506 USA.	sokolovm@wvuhealthcare.com	Sinha, Satyabrata/K-9095-2016	Sinha, Satyabrata/0000-0003-0514-8613; Ramamurthy, Visvanathan/0000-0003-0289-3685	National Institutes of Health [EY019665, EY017035]; Research to Prevent Blindness; Centers of Biomedical Excellence (CoBRE) [RR031155, RR016440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, P30RR031155] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017035, R01EY019665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Centers of Biomedical Excellence (CoBRE); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019665 (to M. S.) and EY017035 (to V. R.) and an unrestricted Research to Prevent Blindness Grant awarded to the West Virginia University Eye Institute. The Transgenic Animal Core Facility at West Virginia University was supported by Centers of Biomedical Excellence (CoBRE) Grants RR031155 and RR016440.	Belcastro M, 2012, INVEST OPHTH VIS SCI, V53, P3084, DOI 10.1167/iovs.11-8798; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; GARRITSEN A, 1993, P NATL ACAD SCI USA, V90, P7706, DOI 10.1073/pnas.90.16.7706; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gensse M, 2000, FEBS LETT, V480, P184, DOI 10.1016/S0014-5793(00)01926-8; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Humrich J, 2003, J BIOL CHEM, V278, P4474, DOI 10.1074/jbc.M206347200; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; Krispel CM, 2007, J GEN PHYSIOL, V130, P303, DOI 10.1085/jgp.200709812; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; MENDE U, 1995, J BIOL CHEM, V270, P15892, DOI 10.1074/jbc.270.26.15892; MILES MF, 1993, P NATL ACAD SCI USA, V90, P10831, DOI 10.1073/pnas.90.22.10831; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Posokhova E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000570; Schroder S, 2000, N-S ARCH PHARMACOL, V362, P435, DOI 10.1007/s002100000298; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Stirling PC, 2006, J BIOL CHEM, V281, P7012, DOI 10.1074/jbc.M513235200; Stirling PC, 2007, MOL BIOL CELL, V18, P2336, DOI 10.1091/mbc.E07-01-0069; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088	39	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25760	25768		10.1074/jbc.M113.486258	http://dx.doi.org/10.1074/jbc.M113.486258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888055	Green Published, hybrid			2022-12-28	WOS:000330623300009
J	Shepherd, J; Ibba, M				Shepherd, Jennifer; Ibba, Michael			Lipid II-independent trans Editing of Mischarged tRNAs by the Penicillin Resistance Factor MurM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ACCEPTOR IDENTITY; PROTEIN-SYNTHESIS; QUALITY-CONTROL; TRNASCAN-SE; IN-VIVO; SYNTHETASE; MISTRANSLATION; RECOGNITION; MECHANISMS	Streptococcus pneumoniae is a causative agent of nosocomial infections such as pneumonia, meningitis, and septicemia. Penicillin resistance in S. pneumoniae depends in part upon MurM, an aminoacyl-tRNA ligase that attaches L-serine or L-alanine to the stem peptide lysine of Lipid II in cell wall peptidoglycan. To investigate the exact substrates the translation machinery provides MurM, quality control by alanyl-tRNA synthetase (AlaRS) was investigated. AlaRS mischarged serine and glycine to tRNAAla, as observed in other bacteria, and also transferred alanine, serine, and glycine to tRNAPhe. S. pneumoniae tRNAPhe has an unusual U4:C69 mismatch in its acceptor stem that prevents editing by phenylalanyl-tRNA synthetase (PheRS), leading to the accumulation of misaminoacylated tRNAs that could serve as substrates for translation or for MurM. Although the peptidoglycan layer of S. pneumoniae tolerates a combination of both branched and linear muropeptides, deletion of MurM results in a reversion to penicillin sensitivity in strains that were previously resistant. However, because MurM is not required for cell viability, the reason for its functional conservation across all strains of S. pneumoniae has remained elusive. We now show that MurM can directly function in translation quality control by acting as a broad specificity lipid-independent trans editing factor that deacylates tRNA. This activity of MurM does not require the presence of its second substrate, Lipid II, and can functionally substitute for the activity of widely conserved editing domain homologues of AlaRS, termed AlaXPs proteins, which are themselves absent from S. pneumoniae.	[Shepherd, Jennifer; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Science Foundation [MCB-1052344]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1052344.	Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 1997, P NATL ACAD SCI USA, V94, P10150, DOI 10.1073/pnas.94.19.10150; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; Fersht A. R., 1979, TRANSFER RNA STRUCTU, P247; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; Fiser A, 2003, TRENDS MICROBIOL, V11, P547, DOI 10.1016/j.tim.2003.10.003; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Giannouli S, 2009, BIOCHIMIE, V91, P344, DOI 10.1016/j.biochi.2008.10.009; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Ke DB, 2000, J BACTERIOL, V182, P6913, DOI 10.1128/JB.182.24.6913-6920.2000; Ling BD, 1998, ANTIMICROB AGENTS CH, V42, P936, DOI 10.1128/AAC.42.4.936; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Pesakhov S, 2007, BBA-BIOMEMBRANES, V1768, P590, DOI 10.1016/j.bbamem.2006.12.016; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shepherd J, 2011, THESIS U WARWICK COV; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627	37	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25915	25923		10.1074/jbc.M113.479824	http://dx.doi.org/10.1074/jbc.M113.479824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23867453	hybrid, Green Published			2022-12-28	WOS:000330623300022
J	Koenigs, A; Hammerschmidt, C; Jutras, BL; Pogoryelov, D; Barthel, D; Skerka, C; Kugelstadt, D; Wallich, R; Stevenson, B; Zipfel, PF; Kraiczy, P				Koenigs, Arno; Hammerschmidt, Claudia; Jutras, Brandon L.; Pogoryelov, Denys; Barthel, Diana; Skerka, Christine; Kugelstadt, Dominik; Wallich, Reinhard; Stevenson, Brian; Zipfel, Peter F.; Kraiczy, Peter			BBA70 of Borrelia burgdorferi Is a Novel Plasminogen-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRING SURFACE PROTEIN-1; LYME-DISEASE SPIROCHETE; FACTOR H-BINDING; BACTERIAL-CELL SURFACE; TICK INFECTION CYCLE; IMMUNE EVASION; FUNCTIONAL-CHARACTERIZATION; LEPTOSPIRA-INTERROGANS; COMPLEMENT INHIBITOR; EXTRACELLULAR-MATRIX	The Lyme disease spirochete Borrelia burgdorferi lacks endogenous, surface-exposed proteases. In order to efficiently disseminate throughout the host and penetrate tissue barriers, borreliae rely on recruitment of host proteases, such as plasmin(ogen). Here we report the identification of a novel plasminogen-binding protein, BBA70. Binding of plasminogen is dose-dependent and is affected by ionic strength. The BBA70-plasminogen interaction is mediated by lysine residues, primarily located in a putative C-terminal alpha-helix of BBA70. These lysine residues appear to interact with the lysine-binding sites in plasminogen kringle domain 4 because a deletion mutant of plasminogen lacking that domain was unable to bind to BBA70. Bound to BBA70, plasminogen activated by urokinase-type plasminogen activator was able to degrade both a synthetic chromogenic substrate and the natural substrate fibrinogen. Furthermore, BBA70-bound plasmin was able to degrade the central complement proteins C3b and C5 and inhibited the bacteriolytic effects of complement. Consistent with these functional activities, BBA70 is located on the borrelial outer surface. Additionally, serological evidence demonstrated that BBA70 is produced during mammalian infection. Taken together, recruitment and activation of plasminogen could play a beneficial role in dissemination of B. burgdorferi in the human host and may possibly aid the spirochete in escaping the defense mechanisms of innate immunity.	[Koenigs, Arno; Hammerschmidt, Claudia; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, D-60596 Frankfurt, Germany; [Jutras, Brandon L.; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Pogoryelov, Denys] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Barthel, Diana; Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Kugelstadt, Dominik] Sekisui Virotech GmbH, D-65428 Russelsheim, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kentucky; Goethe University Frankfurt; Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	kraiczy@em.uni-frankfurt.de		Jutras, Brandon/0000-0002-7989-1031	Deutsche Forschungsgemeinschaft [Kr3383/1-2]; Collaborative Research Center 807 of the German Research Foundation; Collaborative Research Center 902 of the German Research Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center 807 of the German Research Foundation; Collaborative Research Center 902 of the German Research Foundation	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Kr3383/1-2 (to P. K.).; Supported by Collaborative Research Center 807 and Collaborative Research Center 902 of the German Research Foundation.	ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P353, DOI 10.1016/0009-3084(94)90157-0; [Anonymous], THROMB HAEMOST, V77, P1; BANYAI L, 1984, J BIOL CHEM, V259, P6466; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brissette CA, 2010, CLIN VACCINE IMMUNOL, V17, P274, DOI 10.1128/CVI.00437-09; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Castellino FJ, 1997, CIBA F SYMP, V212, P46; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; GOGUEN JD, 1995, INFECT AGENT DIS, V4, P47; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hammerschmidt C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/349657; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Herzberger P, 2009, INT J MED MICROBIOL, V299, P141, DOI 10.1016/j.ijmm.2008.06.005; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Joshi KK, 2012, BBA-PROTEINS PROTEOM, V1824, P326, DOI 10.1016/j.bbapap.2011.10.010; Jutras Brandon L, 2010, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01e02s19; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kost C, 1996, EUR J BIOCHEM, V236, P682, DOI 10.1111/j.1432-1033.1996.0682d.x; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2006, WIEN KLIN WOCHENSCHR, V118, P669, DOI 10.1007/s00508-006-0691-1; KRAMER MD, 1990, IMMUNOBIOLOGY, V181, P357, DOI 10.1016/S0171-2985(11)80504-8; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; LIJNEN HR, 1995, BAILLIERE CLIN HAEM, V8, P277, DOI 10.1016/S0950-3536(05)80268-9; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PILLEMER L, 1953, J EXP MED, V97, P573, DOI 10.1084/jem.97.4.573; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; SALONEN EM, 1984, FEBS LETT, V172, P29, DOI 10.1016/0014-5793(84)80866-2; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; ULLBERG M, 1989, APMIS, V97, P996, DOI 10.1111/j.1699-0463.1989.tb00508.x; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weisel J W, 1996, Ukr Biokhim Zh (1978), V68, P41; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	87	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25229	25243		10.1074/jbc.M112.413872	http://dx.doi.org/10.1074/jbc.M112.413872			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861404	hybrid, Green Published			2022-12-28	WOS:000330619000022
J	Hedglin, M; Zhang, YR; O'Brien, PJ				Hedglin, Mark; Zhang, Yaru; O'Brien, Patrick J.			Isolating Contributions from Intersegmental Transfer to DNA Searching by Alkyladenine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; RESTRICTION-ENDONUCLEASE; DISORDERED REGIONS; COGNATE SITES; PROTEINS; TRANSLOCATION; MECHANISMS; DIFFUSION; RECOGNITION	Large genomes pose a challenge to DNA repair pathways because rare sites of damage must be efficiently located from among a vast excess of undamaged sites. Human alkyladenine DNA glycosylase (AAG) employs nonspecific DNA binding interactions and facilitated diffusion to conduct a highly redundant search of adjacent sites. This ensures that every site is searched, but could be a detriment if the protein is trapped in a local segment of DNA. Intersegmental transfer between DNA segments that are transiently in close proximity provides an elegant solution that balances global and local searching processes. It has been difficult to detect intersegmental transfer experimentally; therefore, we developed biochemical assays that allowed us to observe and measure the rates of intersegmental transfer by AAG. AAG has a flexible amino terminus that tunes its affinity for nonspecific DNA, but we find that it is not required for intersegmental transfer. As AAG has only a single DNA binding site, this argues against the bridging model for intersegmental transfer. The rates of intersegmental transfer are strongly dependent on the salt concentration, supporting a jumping mechanism that involves microscopic dissociation and capture by a proximal DNA site. As many DNA-binding proteins have only a single binding site, jumping may be a common mechanism for intersegmental transfer.	[O'Brien, Patrick J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu		Hedglin, Mark/0000-0003-2599-1691	National Institutes of Health [RO1 CA122254]; Rackham Graduate School; NATIONAL CANCER INSTITUTE [R01CA122254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA122254 (to P. J. O.). This work was also supported by in part by an International Fellowship and a Barbour Fellowship from the Rackham Graduate School (to Y. Z.).	Baldwin MR, 2012, NUCLEIC ACIDS RES, V40, P11638, DOI 10.1093/nar/gks952; Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; JELTSCH A, 1994, BIOCHEMISTRY-US, V33, P10215, DOI 10.1021/bi00200a001; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Sheinman M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016003; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wentzell LM, 1998, J MOL BIOL, V281, P433, DOI 10.1006/jmbi.1998.1967; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082	42	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24550	24559		10.1074/jbc.M113.477018	http://dx.doi.org/10.1074/jbc.M113.477018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839988	Green Published, hybrid			2022-12-28	WOS:000330612300023
J	Lundqvist, J; Braumann, I; Kurowska, M; Muller, AH; Hansson, M				Lundqvist, Joakim; Braumann, Ilka; Kurowska, Marzena; Mueller, Andre H.; Hansson, Mats			Catalytic Turnover Triggers Exchange of Subunits of the Magnesium Chelatase AAA plus Motor Unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATIVE HEXAMERIC HELICASE; ATPASE ACTIVITY; CHLOROPHYLL BIOSYNTHESIS; PROTOPORPHYRIN CHELATASE; RHODOBACTER-SPHAEROIDES; SYNECHOCYSTIS PCC6803; ESCHERICHIA-COLI; BARLEY MUTANTS; MG-CHELATASE; H-SUBUNIT	The ATP-dependent insertion of Mg2+ into protoporphyrin IX is the first committed step in the chlorophyll biosynthetic pathway. The reaction is catalyzed by magnesium chelatase, which consists of three gene products: BchI, BchD, and BchH. The BchI and BchD subunits belong to the family of AAA+ proteins (ATPases associated with various cellular activities) and form a two-ring complex with six BchI subunits in one layer and six BchD subunits in the other layer. This BchID complex is a two-layered trimer of dimers with the ATP binding site located at the interface between two neighboring BchI subunits. ATP hydrolysis by the BchID motor unit fuels the insertion of Mg2+ into the porphyrin by the BchH subunit. In the present study, we explored mutations that were originally identified in semidominant barley (Hordeum vulgare L.) mutants. The resulting recombinant BchI proteins have marginal ATPase activity and cannot contribute to magnesium chelatase activity although they apparently form structurally correct complexes with BchD. Mixing experiments with modified and wild-type BchI in various combinations showed that an exchange of BchI subunits in magnesium chelatase occurs during the catalytic cycle, which indicates that dissociation of the complex may be part of the reaction mechanism related to product release. Mixing experiments also showed that more than three functional interfaces in the BchI ring structure are required for magnesium chelatase activity.	[Lundqvist, Joakim; Braumann, Ilka; Kurowska, Marzena; Mueller, Andre H.; Hansson, Mats] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Kurowska, Marzena] Silesian Univ, Fac Biol & Environm Protect, Dept Genet, PL-40032 Katowice, Poland; [Mueller, Andre H.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of Silesia in Katowice; Stanford University	Hansson, M (corresponding author), Carlsberg Lab, Gamle Carlsberg Vej 10, DK-1799 Copenhagen V, Denmark.	mats.hansson@carlsberglab.dk		Kurowska, Marzena/0000-0002-9507-6790; Hansson, Mats/0000-0002-0168-9968	Danish Council for Independent Research; Carlsberg Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Danish Council for Independent Research and the Carlsberg Foundation.	Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Hansson A, 1999, P NATL ACAD SCI USA, V96, P1744, DOI 10.1073/pnas.96.4.1744; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lake V, 2004, EUR J BIOCHEM, V271, P2182, DOI 10.1111/j.1432-1033.2004.04143.x; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1994, BIOCHEM J, V299, P277, DOI 10.1042/bj2990277; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24012	24019		10.1074/jbc.M113.480012	http://dx.doi.org/10.1074/jbc.M113.480012			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836887	hybrid, Green Published			2022-12-28	WOS:000330611400039
J	Lund-Katz, S; Lyssenko, NN; Nickel, M; Nguyen, D; Chetty, PS; Weibel, G; Phillips, MC				Lund-Katz, Sissel; Lyssenko, Nicholas N.; Nickel, Margaret; David Nguyen; Chetty, Palaniappan Sevugan; Weibel, Ginny; Phillips, Michael C.			Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; L-ALPHA-DIMYRISTOYLPHOSPHATIDYLCHOLINE; PLASMA-MEMBRANE MICROSOLUBILIZATION; PRE-BETA-HDL; CELLULAR CHOLESTEROL; APOA-I; UNESTERIFIED CHOLESTEROL; SPHINGOLIPID DOMAINS; PHOSPHOLIPID EFFLUX; MICELLAR COMPLEXES	Apolipoprotein (apo) A-I-containing nascent HDL particles produced by the ATP binding cassette transporter A1 have different sizes and compositions. To understand the molecular basis for this heterogeneity, the HDL particles produced by apoA-I-mediated solubilization of phospholipid (PL)/free (unesterified) cholesterol (FC) bilayer membranes in cell and cell-free systems are compared. Incubation of apoA-I with ATP binding cassette transporter A1-expressing baby hamster kidney cells leads to formation of two populations of FC-containing discoidal nascent HDL particles. The larger 11-nm diameter particles are highly FC-enriched (FC/PL = 1.2/1 mol/mol) relative to the smaller 8 nm particles and the cell plasma membrane (FC/PL = 0.4/1). ApoA-I-mediated spontaneous solubilization of either multilamellar or unilamellar vesicles made of a membrane-PL mixture and FC yields discoidal HDL particles with diameters in the range 9-17 nm and, as found with the cell system, the larger particles are relatively enriched in FC despite the fact that all particles are created by solubilization of a common FC/PL membrane domain. The size-dependent distribution of FC among HDL particles is due to varying amounts of PL being sequestered in a boundary layer by interaction with apoA-I at the disc edge. The presence of a relatively large boundary layer in smaller discoidal HDL promotes preferential distribution of phosphatidylserine to such particles. However, phosphatidylcholine and sphingomyelin which are the primary PL constituents of nascent HDL do not exhibit selective incorporation into HDL discs of different sizes. This understanding of the mechanisms responsible for the heterogeneity in lipid composition of nascent HDL particles may provide a basis for selecting subspecies with preferred cardio-protective properties.	[Lund-Katz, Sissel; Lyssenko, Nicholas N.; Nickel, Margaret; David Nguyen; Chetty, Palaniappan Sevugan; Weibel, Ginny; Phillips, Michael C.] Univ Penn, Perelman Sch Med, Lipid Res Grp, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Phillips, MC (corresponding author), Childrens Hosp Philadelphia, Res Inst, 3615 Civ Ctr Blvd,Ste 1102, Philadelphia, PA 19104 USA.	phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; National Research Service Award Postdoctoral Fellowship [HL107065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL107065, P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Program Project Grant HL22633 (to M. C. P.) and National Research Service Award Postdoctoral Fellowship HL107065 (to N. N. L.).	Alexander ET, 2009, J LIPID RES, V50, P1409, DOI 10.1194/jlr.M800578-JLR200; Auton M, 2013, BIOCHEMISTRY-US, V52, P4324, DOI 10.1021/bi4006732; BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; Bielicki JK, 1999, J LIPID RES, V40, P85; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chetty PS, 2013, J LIPID RES, V54, P1589, DOI 10.1194/jlr.M034785; Chetty PS, 2012, P NATL ACAD SCI USA, V109, P11687, DOI 10.1073/pnas.1209305109; COLLINS JJ, 1982, J LIPID RES, V23, P291; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FORTE TM, 1995, J LIPID RES, V36, P148; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gillotte-Taylor K, 2002, J BIOL CHEM, V277, P11811, DOI 10.1074/jbc.M108268200; HARA H, 1991, J BIOL CHEM, V266, P3080; HAUSER H, 1973, J BIOL CHEM, V248, P8585; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; JANIAK MJ, 1979, J BIOL CHEM, V254, P6068; JONAS A, 1978, J BIOL CHEM, V253, P5758; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KADUCE TL, 1983, J LIPID RES, V24, P1398; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lyssenko NN, 2013, FASEB J, V27, P2880, DOI 10.1096/fj.12-216564; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; PHILLIPS MC, 1986, METHOD ENZYMOL, V128, P387; POWNALL HJ, 1979, BIOCHEMISTRY-US, V18, P574, DOI 10.1021/bi00571a004; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saito H, 1997, J LIPID RES, V38, P287; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1980, J BIOL CHEM, V255, P877; TALL AR, 1977, J BIOL CHEM, V252, P4701; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2010, J BIOL CHEM, V285, P31965, DOI 10.1074/jbc.M110.126292; WETTERAU JR, 1983, J BIOL CHEM, V258, P2637; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhang WW, 1998, J LIPID RES, V39, P1601; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	64	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23150	23160		10.1074/jbc.M113.495523	http://dx.doi.org/10.1074/jbc.M113.495523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23836906	Green Published, hybrid			2022-12-28	WOS:000330598200022
J	Yang, HP; Zheng, YH; Li, TWH; Peng, H; Fernandez-Ramos, D; Martinez-Chantar, ML; Rojas, AL; Mato, JM; Lu, SC				Yang, Heping; Zheng, Yuhua; Li, Tony W. H.; Peng, Hui; Fernandez-Ramos, David; Martinez-Chantar, Maria L.; Rojas, Adriana L.; Mato, Jose M.; Lu, Shelly C.			Methionine Adenosyltransferase 2B, HuR, and Sirtuin 1 Protein Cross-talk Impacts on the Effect of Resveratrol on Apoptosis and Growth in Liver Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; HEPATOCELLULAR-CARCINOMA; SPLICING VARIANTS; HEPATOMA-CELLS; IN-VIVO; EXPRESSION; CHEMOPREVENTION; ACTIVATORS; MECHANISM; MICE	Resveratrol is growth-suppressive and pro-apoptotic in liver cancer cells. Methionine adenosyltransferase 2B (MAT2B) encodes for two dominant variants V1 and V2 that positively regulate growth, and V1 is anti-apoptotic when overexpressed. Interestingly, crystal structure analysis of MAT2B protein (MAT beta) protomer revealed two resveratrol binding pockets, which raises the question of the role of MAT2B in resveratrol biological activities. We found that resveratrol induced the expression of MAT2BV1 and V2 in a time-and dose-dependent manner by increasing transcription, mRNA, and protein stabilization. Following resveratrol treatment, HuR expression increased first, followed by SIRT1 and MAT2B. SIRT1 induction contributes to increased MAT2B transcription whereas HuR induction increased MAT2B mRNA stability. MAT beta interacts with HuR and SIRT1, and resveratrol treatment enhanced these interactions while reducing the interaction between MAT beta and MAT alpha 2. Because MAT beta lowers the K-i of MAT alpha 2 for S-adenosylmethionine (AdoMet), this allowed steady-state AdoMet level to rise. Interaction among MAT beta, SIRT1, and HuR increased stability of these proteins. Induction of MAT2B is a compensatory response to resveratrol as knocking down MAT2BV1 potentiated the resveratrol pro-apoptotic and growth-suppressive effects, whereas the opposite occurred with V1 overexpression. The same effect on growth occurred with MAT2BV2. In conclusion, resveratrol induces HuR, SIRT1, and MAT2B expression; the last may represent a compensatory response against apoptosis and growth inhibition. However, MAT beta induction also facilitates SIRT1 activation, as the interaction stabilizes SIRT1. This complex interplay among MAT beta, HuR, and SIRT1 has not been previously reported and suggests that these proteins may regulate each other's signaling.	[Yang, Heping; Li, Tony W. H.; Peng, Hui; Lu, Shelly C.] Univ So Calif, Keck Sch Med, Div Gastroenterol & Liver Dis, Res Ctr Liver Dis,Southern Calif Res Ctr Alcohol, Los Angeles, CA 90033 USA; [Zheng, Yuhua] Childrens Hosp Los Angeles, Dept Pediat Gastroenterol, Los Angeles, CA 90027 USA; [Fernandez-Ramos, David; Martinez-Chantar, Maria L.; Rojas, Adriana L.; Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC BioGUNE, Derio 48160, Bizkaia, Spain	University of Southern California; Children's Hospital Los Angeles; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Univ So Calif, Keck Sch Med, Div Gastroenterol & Liver Dis, HMR 415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Chantar, Maria Luz Martinez/F-5190-2011; Fernández-Ramos, David/S-5231-2016; Fernández-Ramos, David/ABD-1274-2021; MATO, JOSE/A-5187-2011; Rojas, Adriana/G-2403-2011	Chantar, Maria Luz Martinez/0000-0002-6446-9911; Fernández-Ramos, David/0000-0003-4651-195X; Fernández-Ramos, David/0000-0003-4651-195X; MATO, JOSE/0000-0003-1264-3153; Rojas, Adriana/0000-0002-7358-3505	National Institutes of Health [R01DK51719]; Plan Nacional of I + D SAF [2011-29851]; ETORTEK; Sanidad Gobierno Vasco; Educacion Gobierno Vasco [PI2011/29]; Fondo de Investigacion Sanitaria [PI11/01588]; Cell Culture Core of the University of Southern California Research Center for Liver Diseases [P30DK48522]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719, P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I + D SAF; ETORTEK; Sanidad Gobierno Vasco; Educacion Gobierno Vasco; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Cell Culture Core of the University of Southern California Research Center for Liver Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK51719 (to S. C. L., H. Y., and J. M. M.). This work was also supported by Plan Nacional of I + D SAF 2011-29851 (to J. M. M.), ETORTEK-2011, Sanidad Gobierno Vasco 2008, Educacion Gobierno Vasco 2011 (PI2011/29), and Fondo de Investigacion Sanitaria (PI11/01588) (to M. L. M.-C.). Huh7 and HepG2 cells were provided by the Cell Culture Core of the University of Southern California Research Center for Liver Diseases under Grant P30DK48522.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Costa CD, 2011, OBES SURG, V21, P356, DOI 10.1007/s11695-010-0251-7; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Li JP, 2010, AM J PATHOL, V176, P2456, DOI 10.2353/ajpath.2010.090810; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lu SC, 2009, HEPATOLOGY, V50, P462, DOI 10.1002/hep.22990; Mbimba T, 2012, CURR PHARM BIOTECHNO, V13, P229, DOI 10.2174/138920112798868575; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Nordgren KKS, 2011, DRUG METAB DISPOS, V39, P2135, DOI 10.1124/dmd.111.040857; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Ramani Komal, 2011, Cancers (Basel), V3, P1480, DOI 10.3390/cancers3021480; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304; Xia M, 2010, J BIOL CHEM, V285, P20015, DOI 10.1074/jbc.M109.094821; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]	29	30	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23161	23170		10.1074/jbc.M113.487157	http://dx.doi.org/10.1074/jbc.M113.487157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814050	hybrid, Green Published			2022-12-28	WOS:000330598200023
J	Choi, UB; Kazi, R; Stenzoski, N; Wollmuth, LP; Uversky, VN; Bowen, ME				Choi, Ucheor B.; Kazi, Rashek; Stenzoski, Natalie; Wollmuth, Lonnie P.; Uversky, Vladimir N.; Bowen, Mark E.			Modulating the Intrinsic Disorder in the Cytoplasmic Domain Alters the Biological Activity of the N-Methyl-D-aspartate-sensitive Glutamate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; SCAFFOLD PROTEINS; BINDING DOMAIN; NR2 SUBUNITS; PDZ DOMAINS; RECOGNITION; REGIONS; TRAFFICKING; PREDICTION; PROLINE	The NMDA-sensitive glutamate receptor is a ligand-gated ion channel that mediates excitatory synaptic transmission in the nervous system. Extracellular zinc allosterically regulates the NMDA receptor by binding to the extracellular N-terminal domain, which inhibits channel gating. Phosphorylation of the intrinsically disordered intracellular C-terminal domain alleviates inhibition by extracellular zinc. The mechanism for this functional effect is largely unknown. Proline is a hallmark of intrinsic disorder, so we used proline mutagenesis to modulate disorder in the cytoplasmic domain. Proline depletion selectively uncoupled zinc inhibition with little effect on receptor biogenesis, surface trafficking, or ligand-activated gating. Proline depletion also reduced the affinity for a PDZ domain involved in synaptic trafficking and affected small molecule binding. To understand the origin of these phenomena, we used single molecule fluorescence and ensemble biophysical methods to characterize the structural effects of proline mutagenesis. Proline depletion did not eliminate intrinsic disorder, but the underlying conformational dynamics were changed. Thus, we altered the form of intrinsic disorder, which appears sufficient to affect the biological activity. These findings suggest that conformational dynamics within the intrinsically disordered cytoplasmic domain are important for the allosteric regulation of NMDA receptor gating.	[Choi, Ucheor B.; Bowen, Mark E.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Kazi, Rashek; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Stenzoski, Natalie] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of South Florida; Russian Academy of Sciences	Bowen, ME (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, BST 5-121, Stony Brook, NY 11794 USA.	mark.bowen@stonybrook.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health from the National Institute of Mental Health [MH081923]; Hartman Center for Parkinson's Disease; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Mental Health; Hartman Center for Parkinson's Disease; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH081923 from the National Institute of Mental Health (to M. E. B.). This work was also supported by a research award from the Hartman Center for Parkinson's Disease (to L. P. W. and M. E. B.).	BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Choi Ucheor B, 2012, Methods Mol Biol, V896, P3, DOI 10.1007/978-1-4614-3704-8_1; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Williams R M, 2001, Pac Symp Biocomput, P89; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	41	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22506	22515		10.1074/jbc.M113.477810	http://dx.doi.org/10.1074/jbc.M113.477810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782697	Green Published, hybrid			2022-12-28	WOS:000330596300031
J	Ehmann, DE; Jahic, H; Ross, PL; Gu, RF; Hu, J; Durand-Reville, TF; Lahiri, S; Thresher, J; Livchak, S; Gao, N; Palmer, T; Walkup, GK; Fisher, SL				Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Durand-Reville, Thomas F.; Lahiri, Sushmita; Thresher, Jason; Livchak, Stephania; Gao, Ning; Palmer, Tiffany; Walkup, Grant K.; Fisher, Stewart L.			Kinetics of Avibactam Inhibition against Class A, C, and D beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ACTIVITY; PSEUDOMONAS-AERUGINOSA; CEFTAZIDIME-AVIBACTAM; NXL104 COMBINATIONS; ENTEROBACTERIACEAE; ANTIBIOTICS; CHALLENGES; POTENT	Avibactam is a non-beta-lactam beta-lactamase inhibitor with a spectrum of activity that includes beta-lactamase enzymes of classes A, C, and selected D examples. In this work acylation and deacylation rates were measured against the clinically important enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC, OXA-10, and OXA-48. The efficiency of acylation (k(2)/K-i) varied across the enzyme spectrum, from 1.1 x 10(1) M-1 s(-1) for OXA-10 to 1.0 x 10(5) for CTX-M-15. Inhibition of OXA-10 was shown to follow the covalent reversible mechanism, and the acylated OXA-10 displayed the longest residence time for deacylation, with a half-life of greater than 5 days. Across multiple enzymes, acyl enzyme stability was assessed by mass spectrometry. These inhibited enzyme forms were stable to rearrangement or hydrolysis, with the exception of KPC-2. KPC-2 displayed a slow hydrolytic route that involved fragmentation of the acyl-avibactam complex. The identity of released degradation products was investigated, and a possible mechanism for the slow deacylation from KPC-2 is proposed.	[Ehmann, David E.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA 02451 USA; AstraZeneca R&D Boston, Discovery Sci Innovat Med Unit, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca	Ehmann, DE (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	david.ehmann@astrazeneca.com		Gao, Ning/0000-0003-1605-4137				Aktas Z, 2012, INT J ANTIMICROB AG, V39, P86, DOI 10.1016/j.ijantimicag.2011.09.012; Bebrone C, 2010, DRUGS, V70, P651, DOI 10.2165/11318430-000000000-00000; Bethel CR, 2011, ANTIMICROB AGENTS CH, V55, P3465, DOI 10.1128/AAC.00089-11; Bonnefoy A, 2004, J ANTIMICROB CHEMOTH, V54, P410, DOI 10.1093/jac/dkh358; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Bush K, 2012, CURR OPIN PHARMACOL, V12, P527, DOI 10.1016/j.coph.2012.06.003; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Bush K, 2010, EXPERT OPIN THER PAT, V20, P1277, DOI 10.1517/13543776.2010.515588; Coleman K, 2011, CURR OPIN MICROBIOL, V14, P550, DOI 10.1016/j.mib.2011.07.026; De Luca F, 2011, P NATL ACAD SCI USA, V108, P18424, DOI 10.1073/pnas.1110530108; Drawz SM, 2011, PROTEIN SCI, V20, P941, DOI 10.1002/pro.612; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dubreuil J, 2012, INT J ANTIMICROB AG, V39, P500, DOI 10.1016/j.ijantimicag.2012.02.013; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; Fink A. F., 2012, BETA LACTAMASES, P161; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Jencks WP, 1997, ANNU REV BIOCHEM, V66, P1, DOI 10.1146/annurev.biochem.66.1.1; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; Levasseur P, 2012, ANTIMICROB AGENTS CH, V56, P1606, DOI 10.1128/AAC.06064-11; Livermore DM, 2008, J ANTIMICROB CHEMOTH, V62, P1053, DOI 10.1093/jac/dkn320; Livermore DM, 2011, ANTIMICROB AGENTS CH, V55, P390, DOI 10.1128/AAC.00756-10; Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Mushtaq S, 2010, J ANTIMICROB CHEMOTH, V65, P2376, DOI 10.1093/jac/dkq306; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Pratt R., 2012, BETA LACTAMASES, P259; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Shlaes DM, 2013, ANN NY ACAD SCI, V1277, P105, DOI 10.1111/nyas.12010; Stachyra T, 2010, ANTIMICROB AGENTS CH, V54, P5132, DOI 10.1128/AAC.00568-10; Stachyra T, 2009, J ANTIMICROB CHEMOTH, V64, P326, DOI 10.1093/jac/dkp197; Walkty A, 2011, ANTIMICROB AGENTS CH, V55, P2992, DOI 10.1128/AAC.01696-10; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r; Zhanel GG, 2013, DRUGS, V73, P159, DOI 10.1007/s40265-013-0013-7	39	255	264	3	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27960	27971		10.1074/jbc.M113.485979	http://dx.doi.org/10.1074/jbc.M113.485979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913691	hybrid, Green Published			2022-12-28	WOS:000330612800023
J	Yeh, CW; Kao, SH; Cheng, YC; Hsu, LS				Yeh, Chi-Wei; Kao, Shoa-Hsuan; Cheng, Yi-Chuan; Hsu, Li-Sung			Knockdown of Cyclin-dependent Kinase 10 (cdk10) Gene Impairs Neural Progenitor Survival via Modulation of raf1a Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS2 TRANSCRIPTION FACTOR; PROTEIN-KINASE; CELL-CYCLE; CDC2-RELATED KINASE; ZEBRAFISH; DIFFERENTIATION; IDENTIFICATION; APOPTOSIS; NEURONS; CANCER	In this study, we used zebrafish as an animal model to elucidate the developmental function of cdk10 in vertebrates. In situ hybridization analyses demonstrated that cdk10 is expressed throughout development with a relative enrichment in the brain in the late stages. Similar to its mammalian ortholog, cdk10 can interact with the transcription factor ETS2 and exhibit kinase activity by phosphorylating histone H1. Morpholino-based loss of cdk10 expression caused apoptosis in sox2-positive cells and decreased the expression of subsequent neuronal markers. Acetylated tubulin staining revealed a significant reduction in the number of Rohon-Beard sensory neurons in cdk10 morphants. This result is similar to that demonstrated by decreased islet2 expression in the dorsal regions. Moreover, cdk10 morphants exhibited a marked loss of huC-positive neurons in the telencephalon and throughout the spinal cord axis. The population of retinal ganglion cells was also diminished in cdk10 morphants. These phenotypes were rescued by co-injection of cdk10 mRNA. Interestingly, the knockdown of cdk10 significantly elevated raf1a mRNA expression. Meanwhile, an MEK inhibitor (U0126) recovered sox2 and ngn1 transcript levels in cdk10 morphants. Our findings provide the first functional characterization of cdk10 in vertebrate development and reveal its critical function in neurogenesis by modulation of raf1a expression.	[Yeh, Chi-Wei; Kao, Shoa-Hsuan; Hsu, Li-Sung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 40201, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Grad Inst Biomed Sci, Sch Med, Tao Yuan 33302, Taiwan; [Hsu, Li-Sung] Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan	Chung Shan Medical University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsu, LS (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan.	lshsu405@yahoo.com.tw			National Science Council (NSC) [NSC-99-2321-B-001-027, 100-2321-B-400-003]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	We thank the Zebrafish Core in Academia Sinica, Institute of Cellular and Organismic Biology, which is supported by National Science Council (NSC) Grant NSC-99-2321-B-001-027, the Taiwan Zebrafish Core Facility for providing the zebrafish AB strain and Tg (huc:gfp), and the National Health Research Institute, which is supported by NSC Grant 100-2321-B-400-003. Upright fluorescence microscopy was performed in the Instrument Center of Chung Shan Medical University, which is supported by the National Science Council, Ministry of Education, and Chung Shan Medical University.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Bagella L, 2006, J CELL BIOCHEM, V99, P978, DOI 10.1002/jcb.20981; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; BULLRICH F, 1995, CANCER RES, V55, P1199; Chen E, 2004, CURR PHARM BIOTECHNO, V5, P409, DOI 10.2174/1389201043376652; Chen J, 2011, NEUROBIOL DIS, V43, P455, DOI 10.1016/j.nbd.2011.04.019; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Deacon EM, 2002, J CELL SCI, V115, P983; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Hsu LS, 2011, INT J MOL SCI, V12, P3606, DOI 10.3390/ijms12063606; Hsu LS, 2010, DEV DYNAM, V239, P3098, DOI 10.1002/dvdy.22433; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; Illanes O, 2006, TOXICOL PATHOL, V34, P243, DOI 10.1080/01926230600713186; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Kanungo J, 2007, NEUROSCI LETT, V412, P233, DOI 10.1016/j.neulet.2006.11.016; Kanungo J, 2006, J NEUROCHEM, V99, P251, DOI 10.1111/j.1471-4159.2006.04114.x; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Leman ES, 2009, J CELL BIOCHEM, V108, P1274, DOI 10.1002/jcb.22357; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; LI S, 1995, CANCER RES, V55, P3992; Liu QY, 2007, CELL RES, V17, P163, DOI 10.1038/sj.cr.7310144; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossler OG, 2004, J NEUROCHEM, V88, P1240, DOI 10.1046/j.1471-4159.2003.02255.x; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M, 1997, SEMIN CELL DEV BIOL, V8, P477, DOI 10.1006/scdb.1997.0173; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Yu JH, 2012, ONCOL REP, V27, P1266, DOI 10.3892/or.2011.1617; Zhang L, 2011, ECOTOXICOLOGY, V20, P643, DOI 10.1007/s10646-011-0604-6; Zhong XY, 2012, GENE, V498, P68, DOI 10.1016/j.gene.2012.01.022	47	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27927	27939		10.1074/jbc.M112.420265	http://dx.doi.org/10.1074/jbc.M112.420265			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23902762	Green Published, hybrid			2022-12-28	WOS:000330612800020
J	Berrier, C; Pozza, A; de Lavalette, AD; Chardonnet, S; Mesneau, A; Jaxel, C; le Maire, M; Ghazi, A				Berrier, Catherine; Pozza, Alexandre; de lavalette, Agnes de Lacroix; Chardonnet, Solenne; Mesneau, Agnes; Jaxel, Christine; le Maire, Marc; Ghazi, Alexandre			The Purified Mechanosensitive Channel TREK-1 Is Directly Sensitive to Membrane Tension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVATED CHANNELS; DETERGENT BINDING; CRYSTAL-STRUCTURE; ION CHANNELS; PATCH-CLAMP; YEAST; PURIFICATION; PROTEINS; EXPRESSION	Mechanosensitive channels are detected in all cells and are speculated to play a key role in many functions including osmoregulation, growth, hearing, balance, and touch. In prokaryotic cells, a direct gating of mechanosensitive channels by membrane tension was clearly demonstrated because the purified channels could be functionally reconstituted in a lipid bilayer. No such evidence has been presented yet in the case of mechanosensitive channels from animal cells. TREK-1, a two-pore domain K+ channel, was the first animal mechanosensitive channel identified at the molecular level. It is the target of a large variety of agents such as volatile anesthetics, neuroprotective agents, and antidepressants. We have produced the mouse TREK-1 in yeast, purified it, and reconstituted the protein in giant liposomes amenable to patch clamp recording. The protein exhibited the expected electrophysiological properties in terms of kinetics, selectivity, and pharmacology. Negative pressure (suction) applied through the pipette had no effect on the channel, but positive pressure could completely and reversibly close the channel. Our interpretation of these data is that the intrinsic tension in the lipid bilayer is sufficient to maximally activate the channel, which can be closed upon modification of the tension. These results indicate that TREK-1 is directly sensitive to membrane tension.	[Berrier, Catherine; Chardonnet, Solenne; Mesneau, Agnes; Ghazi, Alexandre] Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France; [Pozza, Alexandre; de lavalette, Agnes de Lacroix; Jaxel, Christine; le Maire, Marc] Univ Paris 11, CNRS, UMR 8221, CEA,Inst Biol & Technol Saclay iBitec S, F-91191 Gif Sur Yvette, France; [Pozza, Alexandre; de lavalette, Agnes de Lacroix; Jaxel, Christine; le Maire, Marc] CEA Saclay, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ghazi, A (corresponding author), Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France.	alexandre.ghazi@u-psud.fr		JAXEL, CHRISTINE/0000-0002-1387-4458	Agence nationale de la recherche (ANR) [BLAN06-2_135035]	Agence nationale de la recherche (ANR)(French National Research Agency (ANR))	This work was supported by Agence nationale de la recherche (ANR) Grant BLAN06-2_135035.	Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Cardi D, 2010, METHODS MOL BIOL, V601, P247, DOI 10.1007/978-1-60761-344-2_15; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Di Cera E, 2001, ANN NY ACAD SCI, V936, P133; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ghazi A, 1998, BIOCHIMIE, V80, P357; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hortigon-Vinagre MP, 2011, FREE RADICAL BIO MED, V50, P323, DOI 10.1016/j.freeradbiomed.2010.11.017; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Kloda A, 2001, CELL BIOCHEM BIOPHYS, V34, P349, DOI 10.1385/CBB:34:3:349; Kloda A, 2007, P NATL ACAD SCI USA, V104, P1540, DOI 10.1073/pnas.0609649104; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 2006, NAT REV MOL CELL BIO, V7, P109, DOI 10.1038/nrm1833; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Ursell T, 2011, BIOPHYS J, V101, P1913, DOI 10.1016/j.bpj.2011.08.057; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	47	54	54	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27307	27314		10.1074/jbc.M113.478321	http://dx.doi.org/10.1074/jbc.M113.478321			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23897808	Green Published, hybrid			2022-12-28	WOS:000330597300027
J	Li, YP; Takahashi, M; Stork, PJS				Li, Yanping; Takahashi, Maho; Stork, Philip J. S.			Ras-mutant Cancer Cells Display B-Raf Binding to Ras That Activates Extracellular Signal-regulated Kinase and Is Inhibited by Protein Kinase A Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG-CANCER; ONCOGENIC K-RAS; CYCLIC-AMP; MAP KINASE; DEPENDENT ACTIVATION; TUMOR PROGRESSION; EPITHELIAL-CELLS; RAP1 ACTIVATION; MELANOMA-CELLS; MEK INHIBITOR	The small G protein Ras regulates proliferation through activation of the mitogen-activated protein (MAP) kinase (ERK) cascade. The first step of Ras-dependent activation of ERK signaling is Ras binding to members of the Raf family of MAP kinase kinase kinases, C-Raf and B-Raf. Recently, it has been reported that in melanoma cells harboring oncogenic Ras mutations, B-Raf does not bind to Ras and does not contribute to basal ERK activation. For other types of Ras-mutant tumors, the relative contributions of C-Raf and B-Raf are not known. We examined non-melanoma cancer cell lines containing oncogenic Ras mutations and express both C-Raf and B-Raf isoforms, including the lung cancer cell line H1299 cells. Both B-Raf and C-Raf were constitutively bound to oncogenic Ras and contributed to Ras-dependent ERK activation. Ras binding to B-Raf and C-Raf were both subject to inhibition by the cAMP-dependent protein kinase PKA. cAMP inhibited the growth of H1299 cells and Ras-dependent ERK activation via PKA. PKA inhibited the binding of Ras to both C-Raf and B-Raf through phosphorylations of C-Raf at Ser-259 and B-Raf at Ser-365, respectively. These studies demonstrate that in non-melanocytic Ras-mutant cancer cells, Ras signaling to B-Raf is a significant contributor to ERK activation and that the B-Raf pathway, like that of C-Raf, is a target for inhibition by PKA. We suggest that cAMP and hormones coupled to cAMP may prove useful in dampening the effects of oncogenic Ras in non-melanocytic cancer cells through PKA-dependent actions on B-Raf as well as C-Raf.	[Li, Yanping; Takahashi, Maho; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu	li, yan/GTI-4638-2022		National Institutes of Health [DK090309]; American Association of Cancer Research Grant AACR [11-40-32]; NATIONAL CANCER INSTITUTE [T32CA106195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Cancer Research Grant AACR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK090309 (to P. J. S. S.). This work was also supported by the American Association of Cancer Research Grant AACR 11-40-32 (to Y. L.).	Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; BOS JL, 1989, CANCER RES, V49, P4682; Brose MS, 2002, CANCER RES, V62, P6997; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Calipel A, 2006, J BIOL CHEM, V281, P9238, DOI 10.1074/jbc.M600228200; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cho YJ, 2003, LEUKEMIA RES, V27, P51, DOI 10.1016/S0145-2126(02)00057-7; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dillon TJ, 2013, INT IMMUNOL, V25, P259, DOI 10.1093/intimm/dxs104; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Dumaz Nicolas, 2011, Small GTPases, V2, P289; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; He J, 2007, LUNG CANCER, V56, P51, DOI 10.1016/j.lungcan.2006.11.024; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hmitou I, 2007, MOL CELL BIOL, V27, P31, DOI 10.1128/MCB.01265-06; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Ji ZY, 2012, TRENDS MOL MED, V18, P27, DOI 10.1016/j.molmed.2011.08.001; Kievit P, 2001, MOL ENDOCRINOL, V15, P614, DOI 10.1210/me.15.4.614; Klein PJ, 2006, NEOPLASIA, V8, P1, DOI 10.1593/neo.05373; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Linley AJ, 2012, J BIOL CHEM, V287, P13633, DOI 10.1074/jbc.M111.308973; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Moody TW, 2002, REGUL PEPTIDES, V109, P135, DOI 10.1016/S0167-0115(02)00196-9; PERALDI P, 1995, FEBS LETT, V357, P290, DOI 10.1016/0014-5793(94)01376-C; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sidovar MF, 2000, J BIOL CHEM, V275, P28688, DOI 10.1074/jbc.M909351199; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x	69	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27646	27657		10.1074/jbc.M113.463067	http://dx.doi.org/10.1074/jbc.M113.463067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23893412	Green Published, hybrid			2022-12-28	WOS:000330597300058
J	Maaty, WS; Lord, CI; Gripentrog, JM; Riesselman, M; Keren-Aviram, G; Liu, T; Dratz, EA; Bothner, B; Jesaitis, AJ				Maaty, Walid S.; Lord, Connie I.; Gripentrog, Jeannie M.; Riesselman, Marcia; Keren-Aviram, Gal; Liu, Ting; Dratz, Edward A.; Bothner, Brian; Jesaitis, Algirdas J.			Identification of C-terminal Phosphorylation Sites of N-Formyl Peptide Receptor-1 (FPR1) in Human Blood Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEP IMMUNOAFFINITY PURIFICATION; METHIONYL-LEUCYL-PHENYLALANINE; G-PROTEIN; CHEMOATTRACTANT RECEPTORS; HUMAN-GRANULOCYTES; PLASMA-MEMBRANE; DEPENDENT PHOSPHORYLATION; CYTOSKELETON INTERACTIONS; GUANINE-NUCLEOTIDES; INNATE IMMUNITY	Accumulation, activation, and control of neutrophils at inflammation sites is partly driven by N-formyl peptide chemoattractant receptors (FPRs). Occupancy of these G-protein-coupled receptors by formyl peptides has been shown to induce regulatory phosphorylation of cytoplasmic serine/threonine amino acid residues in heterologously expressed recombinant receptors, but the biochemistry of these modifications in primary human neutrophils remains relatively unstudied. FPR1 and FPR2 were partially immunopurified using antibodies that recognize both receptors (NFPRa) or unphosphorylated FPR1 (NFPRb) in dodecylmaltoside extracts of unstimulated and N-formyl-Met-Leu-Phe (fMLF) + cytochalasin B-stimulated neutrophils or their membrane fractions. After deglycosylation and separation by SDS-PAGE, excised Coomassie Blue-staining bands (similar to 34,000 M-r) were tryptically digested, and FPR1, phospho-FPR1, and FPR2 content was confirmed by peptide mass spectrometry. C-terminal FPR1 peptides (Leu(312)-Arg(322) and Arg(323)-Lys(350)) and extracellular FPR1 peptide (Ile(191)-Arg(201)) as well as three similarly placed FPR2 peptides were identified in unstimulated and fMLF + cytochalasin B-stimulated samples. LC/MS/MS identified seven isoforms of Ala(323)-Lys(350) only in the fMLF + cytochalasin B-stimulated sample. These were individually phosphorylated at Thr(325), Ser(328), Thr(329), Thr(331), Ser(332), Thr(334), and Thr(339). No phospho-FPR2 peptides were detected. Cytochalasin B treatment of neutrophils decreased the sensitivity of fMLF-dependent NFPRb recognition 2-fold, from EC50 = 33 +/- 8 to 74 +/- 21 nM. Our results suggest that 1) partial immunopurification, deglycosylation, and SDS-PAGE separation of FPRs is sufficient to identify C-terminal FPR1 Ser/Thr phosphorylations by LC/MS/MS; 2) kinases/phosphatases activated in fMLF/cytochalasin B-stimulated neutrophils produce multiple C-terminal tail FPR1 Ser/Thr phosphorylations but have little effect on corresponding FPR2 sites; and 3) the extent of FPR1 phosphorylation can be monitored with C-terminal tail FPR1-phosphospecific antibodies.	[Lord, Connie I.; Gripentrog, Jeannie M.; Riesselman, Marcia; Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Maaty, Walid S.; Keren-Aviram, Gal; Liu, Ting; Dratz, Edward A.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Jesaitis, AJ (corresponding author), Montana State Univ, Dept Microbiol, 109 Lewis Hall, Bozeman, MT 59717 USA.	umbaj@montana.edu		Jesaitis, Algirdas/0000-0001-9001-5617	Murdock Charitable Trust [2009084]; National Institutes of Health from the COBRE Program of the National Center for Research Resources [P20RR-020185, 1R42RR-025311, P20GM-103394-05, P20RR-024237]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237, R42RR025311, R42RR021790, P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081961, R01AI064107, R01AI022735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103394] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health from the COBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Emily Kwan and R. Antony Warren for kindly providing the CBM-PNGase F plasmid, which significantly increased yields of deglycosylated FPR1 free of cytokeratin contamination. We are also thankful to Dr. William Nauseef for reading the manuscript and for providing helpful suggestions, especially on early versions. The Montana State University mass spectrometry facility is supported by Murdock Charitable Trust Grant 2009084 and National Institutes of Health Grants P20RR-020185, 1R42RR-025311, P20GM-103394-05 and P20RR-024237 from the COBRE Program of the National Center for Research Resources.	ALI H, 1993, J BIOL CHEM, V268, P24247; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236, DOI 10.1002/jlb.49.3.236; BOMMAKANTI RK, 1992, J BIOL CHEM, V267, P7576; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241; Butcher Adrian J, 2012, Handb Exp Pharmacol, P79, DOI 10.1007/978-3-642-23274-9_5; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; DOLMATCH B, 1983, J BIOL CHEM, V258, P7570; Dratz E. A., 2009, World Patent, Patent No. [2009/005871-A, 2009005871]; Dratz E. A., 2009, United States Patent, Patent No. [8,197,759B2, 8197759]; Dratz E. A., 2004, United States Patent, Patent No. [7,582,260B2, 7582260]; Dratz E. A., 2007, United States Patent, Patent No. [8,197,758B2, 8197758]; Dratz E. A., 2007, United States Patent, Patent No. [7,833,799B2, 7833799]; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Harbecke O, 1997, J LEUKOCYTE BIOL, V61, P753, DOI 10.1002/jlb.61.6.753; HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huber-Lang MS, 2001, FASEB J, V15, P568; JESAITIS AJ, 1984, J CELL BIOL, V98, P1378, DOI 10.1083/jcb.98.4.1378; JESAITIS AJ, 1982, J CELL BIOCHEM, V20, P177, DOI 10.1002/jcb.240200209; JESAITIS AJ, 1986, J BIOL CHEM, V261, P3662; JESAITIS AJ, 1985, J CELL BIOCHEM, V27, P241, DOI 10.1002/jcb.240270306; JESAITIS AJ, 1993, J IMMUNOL, V151, P5653; JESAITIS AJ, 1989, J CELL BIOL, V109, P2783, DOI 10.1083/jcb.109.6.2783; Kang Y, 2000, BIOCHEMISTRY-US, V39, P13551, DOI 10.1021/bi001196i; Key TA, 2005, TRAFFIC, V6, P87, DOI 10.1111/j.1600-0854.2004.00248.x; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; KLOTZ KN, 1994, CELL SIGNAL, V6, P943, DOI 10.1016/0898-6568(94)90027-2; Kobayashi SD, 2013, J INNATE IMMUN, V5, P97, DOI 10.1159/000347135; KOO C, 1983, J CLIN INVEST, V72, P748, DOI 10.1172/JCI111045; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; Kwan EM, 2005, PROTEIN ENG DES SEL, V18, P497, DOI 10.1093/protein/gzi055; Liu L, 1998, J IMMUNOL, V160, P2463; Lord CI, 2008, J IMMUNOL METHODS, V329, P201, DOI 10.1016/j.jim.2007.10.008; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; McDonald B, 2012, TOXICOL PATHOL, V40, P157, DOI 10.1177/0192623311427570; MUKHERJEE G, 1994, J LEUKOCYTE BIOL, V55, P685, DOI 10.1002/jlb.55.6.685; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Pick R, 2013, MOL IMMUNOL, V55, P70, DOI 10.1016/j.molimm.2012.12.008; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Powner DJ, 2007, MOL IMMUNOL, V44, P3211, DOI 10.1016/j.molimm.2007.01.033; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Prevete N, 2011, J BIOL REG HOMEOS AG, V25, P553; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Ramaraj T, 2012, BBA-PROTEINS PROTEOM, V1824, P520, DOI 10.1016/j.bbapap.2011.12.007; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; ROBERTS EC, 1990, J GASTROEN HEPATOL, V5, P38, DOI 10.1111/j.1440-1746.1990.tb01766.x; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1987, J BIOL CHEM, V262, P135; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Suvorova ES, 2009, BBA-MOL CELL RES, V1793, P406, DOI 10.1016/j.bbamcr.2008.09.011; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Taylor RM, 2003, BBA-BIOMEMBRANES, V1612, P65, DOI 10.1016/S0005-2736(03)00086-5; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang MH, 2005, MOL BIOL CELL, V16, P562, DOI 10.1091/mbc.E04-06-0456	85	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27042	27058		10.1074/jbc.M113.484113	http://dx.doi.org/10.1074/jbc.M113.484113			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23873933	Green Published, hybrid			2022-12-28	WOS:000330597300006
J	Ma, SB; Shukla, V; Fang, LL; Gould, KA; Joshi, SS; Lu, RQ				Ma, Shibin; Shukla, Vipul; Fang, Leilei; Gould, Karen A.; Joshi, Shantaram S.; Lu, Runqing			Accelerated Development of Chronic Lymphocytic Leukemia in New Zealand Black Mice Expressing a Low Level of Interferon Regulatory Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; IRF FAMILY; LOCUS; TCL1; DIFFERENTIATION; RECEPTOR; MOUSE; PHOSPHORYLATION	A recent genome-wide SNP association study identified IRF4 as a major susceptibility gene for chronic lymphocytic leukemia (CLL). Moreover, the SNPs located in the 3' UTR of the IRF4 gene have been linked to a down-regulation of IRF4. However, whether a low level of IRF4 is critical for CLL development remains unclear. New Zealand Black (NZB) mice are a naturally occurring, late-onset mouse model of CLL. To examine the role of a reduced level of IRF4 in CLL development, we generated, through breeding, IRF4 heterozygous mutant mice in the NZB background (NZB IRF4(+/-)). Our results show that CLL development is accelerated dramatically in the NZB IRF4(+/-) mice. The average onset of CLL in NZB mice is 12 months, but CLL cells can be detected in NZB IRF4(+/-) mice at 3 months of age. By 5 months of age, 80% of NZB IRF4(+/-) mice developed CLL. CLL cells are derived from B1 cells in mice. Interestingly, NZB IRF4(+/-) B1 cells exhibit prolonged survival, accelerated self-renewal, and defects in differentiation. Although NZB IRF4(+/-) CLL cells are resistant to apoptosis, high levels of IRF4 inhibit their survival. High levels of IRF4 also reduce the survival of MEC-1 human CLL cells. Our analysis further reveals that high levels of IRF4 suppress Akt activity and can do so without the IRF4 DNA binding domain. Thus, our findings reveal a causal relationship between a low level of IRF4 and the development of CLL and establish IRF4 as a novel regulator in the pathogenesis of CLL.	[Ma, Shibin; Shukla, Vipul; Fang, Leilei; Gould, Karen A.; Joshi, Shantaram S.; Lu, Runqing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lu, RQ (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	Rlu@UNMC.edu	Joshi, Sudhanshu/L-2284-2019; Shukla, Vipul/AAM-6310-2020	Joshi, Sudhanshu/0000-0003-4748-5001; 	National Institutes of Health [AI67891]; Nebraska Health and Human Services [LB506]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI67891 (to R. L.). This work was also supported by Nebraska Health and Human Services Grant LB506 (to R. L.).	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Allan JM, 2010, LEUKEMIA, V24, P877, DOI 10.1038/leu.2009.298; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang CC, 2002, BLOOD, V100, P4671, DOI 10.1182/blood-2002-01-0104; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; Enzler T, 2009, BLOOD, V114, P4469, DOI 10.1182/blood-2009-06-230169; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; HANADA M, 1993, BLOOD, V82, P1820; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Havelange V, 2011, BLOOD, V118, P2827, DOI 10.1182/blood-2011-04-350579; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Hofbauer SW, 2010, CANCER RES, V70, P7336, DOI 10.1158/0008-5472.CAN-09-4411; Jo SH, 2012, J BIOL CHEM, V287, P1770, DOI 10.1074/jbc.M111.289728; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lia M, 2012, BLOOD, V119, P2981, DOI 10.1182/blood-2011-09-381814; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michie AM, 2007, BIOCHEM SOC T, V35, P1009, DOI 10.1042/BST0351009; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nordgren TM, 2010, OPEN LEUK J, V3, P69; Pathak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022628; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; PHILLIPS JA, 1992, CANCER RES, V52, P437; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Salerno E, 2009, MOL CANCER THER, V8, P2684, DOI 10.1158/1535-7163.MCT-09-0127; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103	51	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26430	26440		10.1074/jbc.M113.475913	http://dx.doi.org/10.1074/jbc.M113.475913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897826	Green Published, hybrid			2022-12-28	WOS:000330594500008
J	Oliver, MB; van der Linden, MPG; Kuntzel, SA; Saad, JS; Nahm, MH				Oliver, Melissa B.; van der Linden, Mark P. G.; Kuentzel, Sharon A.; Saad, Jamil S.; Nahm, Moon H.			Discovery of Streptococcus pneumoniae Serotype 6 Variants with Glycosyltransferases Synthesizing Two Differing Repeating Units	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; GENETIC-BASIS; AMINO-ACID; VACCINE; SYSTEM; DONOR; BIOSYNTHESIS; SEROGROUP-6; PREDICTION	Streptococcus pneumoniae is a persistent, opportunistic commensal of the human nasopharynx and is the leading cause of community-acquired pneumonia. It expresses an anti-phagocytic capsular polysaccharide (PS). Genetic variation of the capsular PS synthesis (cps) locus is the molecular basis for structural and antigenic heterogeneity of capsule types (serotypes). Serogroup 6 has four known members (6A-6D) with distinct serologic properties, homologous cps loci, and structurally similar PSs. cps of serotypes 6A/6B have wciN alpha, encoding alpha-1,3-galactosyltransferase, whereas serotypes 6C/6D have wciN beta encoding alpha-1,3-glucosyltransferase. Two atypical serogroup 6 isolates (named 6X11 and 6X12) have been discovered recently in Germany. Flow cytometric studies using monoclonal antibodies show that 6X11 has serologic properties of 6B/6D, whereas 6X12 has 6A/6C. NMR studies of their capsular PSs revealed that 6X11 and 6X12 have two different repeating units with a distribution of similar to 40:60 6B:6D and 75:25 6A:6C PS, respectively. Sequencing of the wciN alpha gene in 6X12 and 6X11 revealed single and double nucleotide substitutions, respectively, resulting in the amino acid changes A150T and D38N. Substitution of alanine with threonine at position 150 in a 6A strain was associated with hybrid serologic and chemical profiles like 6X12. The hybrid serotypes represented by 6X12 and 6X11 strains are now named serotypes 6F and 6G. Single amino acid changes in cps genes encoding glycosyltransferases can alter substrate specificities, permit biosynthesis of heterogeneous capsule repeating units, and result in new hybrid capsule types that may differ in their interaction with the immune system of the host.	[Saad, Jamil S.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Oliver, Melissa B.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [van der Linden, Mark P. G.; Kuentzel, Sharon A.] Rhein Westfal TH Aachen, Univ Hosp, German Natl Reference Ctr Streptococci, Dept Med Microbiol, D-52074 Aachen, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; RWTH Aachen University; RWTH Aachen University Hospital	Nahm, MH (corresponding author), Univ Alabama Birmingham, Dept Pathol, BBRB 614,1720 2nd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; Nahm, Moon/0000-0002-6922-1042; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [R01 AI-31473, P30CA013148]; Robert Koch-Institut; Bundesministerium fur Gesundheit Project [1369-235]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Koch-Institut; Bundesministerium fur Gesundheit Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI-31473 (to M. H. N.) and P30CA013148 (to the University of Alabama at Birmingham Comprehensive Cancer Center). This work was also supported by the Robert Koch-Institut and Bundesministerium fur Gesundheit Project 21369-235.	AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Batt SL, 2005, J CLIN MICROBIOL, V43, P2656, DOI 10.1128/JCM.43.6.2656-2661.2005; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; Breton C, 1998, J BIOCHEM, V123, P1000; Cai P, 2012, CARBOHYD RES, V351, P98, DOI 10.1016/j.carres.2012.01.017; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, J BIOL CHEM, V287, P13996, DOI 10.1074/jbc.M112.346924; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Han WQ, 2012, BIOCHEMISTRY-US, V51, P5804, DOI 10.1021/bi300640b; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Lee H, 2009, CLIN VACCINE IMMUNOL, V16, P376, DOI 10.1128/CVI.00344-08; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Sheppard CL, 2010, CLIN VACCINE IMMUNOL, V17, P1820, DOI 10.1128/CVI.00335-10; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Sun Y, 2001, INFECT IMMUN, V69, P336, DOI 10.1128/IAI.69.1.336-344.2001; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Talaga P, 2001, VACCINE, V19, P2987, DOI 10.1016/S0264-410X(00)00535-1; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; Yother J, 2004, PNEUMOCCOCUS, P30; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11; Yuki N, 2007, J NEUROCHEM, V103, P150, DOI 10.1111/j.1471-4159.2007.04707.x	50	57	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25976	25985		10.1074/jbc.M113.480152	http://dx.doi.org/10.1074/jbc.M113.480152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897812	Green Published, hybrid			2022-12-28	WOS:000330623300028
J	Uchida, K; Tominaga, M				Uchida, Kunitoshi; Tominaga, Makoto			Extracellular Zinc Ion Regulates Transient Receptor Potential Melastatin 5 (TRPM5) Channel Activation through Its Interaction with a Pore Loop Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION; INACTIVATION; INHIBITION; SECRETION; RESIDUES; ISLETS; COPPER; BLOCK; CA2+	The transient receptor potential melastatin 5 (TRPM5) channel is a monovalent cation channel activated by intracellular Ca2+. Expression of this channel is restricted to taste cells, the pancreas and brainstem, and is thought to be involved in controlling membrane potentials. Its endogenous ligands are not well characterized. Here, we show that extracellular application of Zn2+ inhibits TRPM5 activity. In whole--cell patch--clamp recordings, extracellular application of ZnCl2 inhibited step-pulse-induced TRPM5 currents with 500 nM free intracellular Ca2+ in a dose-dependent manner (IC50 = 4.3 mu M at -80 mV). ZnSO4 also inhibited TRPM5 activity. Extracellular application of ZnCl2 inhibited TRPM5 activation at several temperatures. Furthermore, inhibition by 30 mu M ZnCl2 was impaired in TRPM5 mutants in which His at 896, and Glu at 926 and/or Glu at 939 in the outer pore loop were replaced with Gln. From these results, we conclude that extracellular Zn2+ inhibits TRPM5 channels, and the residues in the outer pore loop of TRPM5 are critically involved in the inhibition.	[Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Uchida, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	kuchida@nips.ac.jp; tominaga@nips.ac.jp						Alvarez-Collazo J, 2012, PFLUG ARCH EUR J PHY, V464, P459, DOI 10.1007/s00424-012-1162-3; Billeter SR, 2001, J AM CHEM SOC, V123, P11262, DOI 10.1021/ja011384b; Chen JX, 2012, J BIOL CHEM, V287, P35589, DOI 10.1074/jbc.M112.394734; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Enklaar T, 2000, GENOMICS, V67, P179, DOI 10.1006/geno.2000.6234; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Liman E. R., 2007, V179, P287; Lindeman R. D., 2009, HDB CLIN NUTR AGING, P650; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nozaki C, 2011, NAT NEUROSCI, V14, P1017, DOI 10.1038/nn.2844; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Qian WJ, 2004, BIOTECHNIQUES, V37, P922, DOI 10.2144/04376BI01; Shah BP, 2012, AM J PHYSIOL-CELL PH, V302, pC210, DOI 10.1152/ajpcell.00209.2011; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Teisseyre A, 2002, BIOCHEM PHARMACOL, V64, P595, DOI 10.1016/S0006-2952(02)01227-3; Terres-Martos C, 1998, J TRACE ELEM MED BIO, V12, P44, DOI 10.1016/S0946-672X(98)80020-5; Toth B, 2012, P NATL ACAD SCI USA, V109, P13440, DOI 10.1073/pnas.1204702109; Yang W, 2011, J BIOL CHEM, V286, P23789, DOI 10.1074/jbc.M111.247478	30	10	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25950	25955		10.1074/jbc.M113.470138	http://dx.doi.org/10.1074/jbc.M113.470138			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884414	Green Published, hybrid			2022-12-28	WOS:000330623300025
J	Schulman, JJ; Wright, FA; Kaufmann, T; Wojcikiewicz, RJH				Schulman, Jacqualyn J.; Wright, Forrest A.; Kaufmann, Thomas; Wojcikiewicz, Richard J. H.			The Bcl-2 Protein Family Member Bok Binds to the Coupling Domain of Inositol 1,4,5-Trisphosphate Receptors and Protects Them from Proteolytic Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; CALCIUM-RELEASE; CA2+ RELEASE; BH4 DOMAIN; APOPTOSIS; ER; UBIQUITINATION; DEGRADATION; BAK; MODULATION	Bok is a member of the Bcl-2 protein family that controls intrinsic apoptosis. Bok is most closely related to the pro-apoptotic proteins Bak and Bax, but in contrast to Bak and Bax, very little is known about its cellular role. Here we report that Bok binds strongly and constitutively to inositol 1,4,5-trisphosphate receptors (IP(3)Rs), proteins that form tetrameric calcium channels in the endoplasmic reticulum (ER) membrane and govern the release of ER calcium stores. Bok binds most strongly to IP(3)R1 and IP(3)R2, and barely to IP(3)R3, and essentially all cellular Bok is IP3R bound in cells that express substantial amounts of IP(3)Rs. Binding to IP(3)Rs appears to be mediated by the putative BH4 domain of Bok and the docking site localizes to a small region within the coupling domain of IP(3)Rs (amino acids 18951903 of IP(3)R1) that is adjacent to numerous regulatory sites, including sites for proteolysis. With regard to the possible role of Bok-IP3R binding, the following was observed: (i) Bok does not appear to control the ability of IP(3)Rs to release ER calcium stores, (ii) Bok regulates IP3R expression, (iii) persistent activation of inositol 1,4,5-trisphosphate-dependent cell signaling causes Bok degradation by the ubiquitin-proteasome pathway, in a manner that parallels IP3R degradation, and (iv) Bok protects IP(3)Rs from proteolysis, either by chymotrypsin in vitro or by caspase-3 in vivo during apoptosis. Overall, these data show that Bok binds strongly and constitutively to IP(3)Rs and that the most significant consequence of this binding appears to be protection of IP(3)Rs from proteolysis. Thus, Bok may govern IP3R cleavage and activity during apoptosis.	[Schulman, Jacqualyn J.; Wright, Forrest A.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Kaufmann, Thomas] Univ Bern, Fac Med, Inst Pharmacol, CH-3010 Bern, Switzerland	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Bern; University of Geneva	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Kaufmann, Thomas/0000-0001-9906-874X; Schulman, Jacqualyn/0000-0001-6659-3388	National Institutes of Health [DK049194]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194, R01DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part by National Institutes of Health Grant DK049194.	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Elkoreh G, 2012, J CELL BIOCHEM, V113, P2775, DOI 10.1002/jcb.24155; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hsu SY, 1998, J BIOL CHEM, V273, P30139, DOI 10.1074/jbc.273.46.30139; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Ke F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.176; Ke F, 2012, CELL DEATH DIFFER, V19, P915, DOI 10.1038/cdd.2011.210; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2012, BIOCHEM BIOPH RES CO, V428, P31, DOI 10.1016/j.bbrc.2012.10.002; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Pizzo Paola, 2010, Commun Integr Biol, V3, P462, DOI 10.4161/cib.3.5.12473; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wojcikiewicz R.J.H., 2012, WILEY INTERDISCIPL R, V1, P126; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Xu Q, 2004, MOL CANCER THER, V3, P1263; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189; Zhong F, 2011, BLOOD, V117, P2924, DOI 10.1182/blood-2010-09-307405	52	63	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25340	25349		10.1074/jbc.M113.496570	http://dx.doi.org/10.1074/jbc.M113.496570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23884412	Green Published, hybrid			2022-12-28	WOS:000330619000032
J	Taltynov, O; Demeulemeester, J; Christ, F; De Houwer, S; Tsirkone, VG; Gerard, M; Weeks, SD; Strelkov, SV; Debyser, Z				Taltynov, Oliver; Demeulemeester, Jonas; Christ, Frauke; De Houwer, Stephanie; Tsirkone, Vicky G.; Gerard, Melanie; Weeks, Stephen D.; Strelkov, Sergei V.; Debyser, Zeger			Interaction of Transportin-SR2 with Ras-related Nuclear Protein (Ran) GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 INFECTION; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOPORIN NUP153; MOLECULAR SWITCH; BINDING DOMAIN; X-RAY; INTEGRASE; COMPLEX	The human immunodeficiency virus type 1 (HIV-1) and other lentiviruses are capable of infecting non-dividing cells and, therefore, need to be imported into the nucleus before integration into the host cell chromatin. Transportin-SR2 (TRN-SR2, Transportin-3, TNPO3) is a cellular karyopherin implicated in nuclear import of HIV-1. A model in which TRN-SR2 imports the viral preintegration complex into the nucleus is supported by direct interaction between TRN-SR2 and HIV-1 integrase (IN). Residues in the C-terminal domain of HIV-1 IN that mediate binding to TRN-SR2 were recently delineated. As for most nuclear import cargoes, the driving force behind HIV-1 preintegration complex import is likely a gradient of the GDP- and GTP-bound forms of Ran, a small GTPase. In this study we offer biochemical and structural characterization of the interaction between TRN-SR2 and Ran. By size exclusion chromatography we demonstrate stable complex formation of TRN-SR2 and RanGTP in solution. Consistent with the behavior of normal nuclear import cargoes, HIV-1 IN is released from the complex with TRN-SR2 by RanGTP. Although in concentrated solutions TRN-SR2 by itself was predominantly present as a dimer, the TRN-SR2-RanGTP complex was significantly more compact. Further analysis supported a model wherein one monomer of TRN-SR2 is bound to one monomer of RanGTP. Finally, we present a homology model of the TRN-SR2-RanGTP complex that is in excellent agreement with the experimental small angle x-ray scattering data.	[Taltynov, Oliver; Demeulemeester, Jonas; Christ, Frauke; De Houwer, Stephanie; Gerard, Melanie; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium; [Tsirkone, Vicky G.; Weeks, Stephen D.; Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, Kapucijnenvoer 33 VCTB 5 Bus 7001, B-3000 Louvain, Belgium.	zeger.debyser@med.kuleuven.be	Weeks, Stephen/N-4813-2019; Strelkov, Sergei V/G-7425-2014; Weeks, Stephen D/G-6150-2017; Gerard, Melanie/B-6898-2019; Demeulemeester, Jonas/J-6130-2014; Christ, Frauke/H-7513-2018	Weeks, Stephen/0000-0002-1360-0852; Strelkov, Sergei V/0000-0001-7189-4652; Weeks, Stephen D/0000-0002-1360-0852; Gerard, Melanie/0000-0003-0585-6978; Demeulemeester, Jonas/0000-0002-2660-2478; Christ, Frauke/0000-0001-9580-3874	CellCoVir SBO Grant of the Flemish IWT (Innovation by Science and Technology) [60813]; FWO Grant [G.0530.08]; FP7 GrantsTHINC; FP7 Grant CHAARM; Research Fund and the IOF (Industrial Research Fund) Program of the KU Leuven [FU-0T]; Marie Curie Reintegration grant	CellCoVir SBO Grant of the Flemish IWT (Innovation by Science and Technology); FWO Grant(FWO); FP7 GrantsTHINC; FP7 Grant CHAARM; Research Fund and the IOF (Industrial Research Fund) Program of the KU Leuven; Marie Curie Reintegration grant(European Commission)	This work was supported by CellCoVir SBO Grant 60813 of the Flemish IWT (Innovation by Science and Technology), FWO Grant G.0530.08, and FP7 Grants THINC and CHAARM, the Research Fund and the IOF (Industrial Research Fund) Program of the KU Leuven (FU-0T).; Supported by a Marie Curie Reintegration grant.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cribier A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-104; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; De Houwer S, 2012, J BIOL CHEM, V287, P34059, DOI 10.1074/jbc.M112.387944; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Fricke T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-46; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Grunwald M, 2011, EMBO J, V30, P427, DOI 10.1038/emboj.2010.320; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Nevo R, 2003, NAT STRUCT BIOL, V10, P553, DOI 10.1038/nsb940; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Quimby BB, 2000, J BIOL CHEM, V275, P28575, DOI 10.1074/jbc.M005055200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	66	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25603	25613		10.1074/jbc.M113.484345	http://dx.doi.org/10.1074/jbc.M113.484345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23878195	Green Published, hybrid			2022-12-28	WOS:000330619000055
J	Zhu, YW; Dai, JX; Zhang, TC; Li, X; Fang, PF; Wang, HJ; Jiang, YL; Yu, XJ; Xia, T; Niu, LW; Guo, YJ; Teng, MK				Zhu, Yuwei; Dai, Jianxin; Zhang, Tiancheng; Li, Xu; Fang, Pengfei; Wang, Huajing; Jiang, Yongliang; Yu, Xiaojie; Xia, Tian; Niu, Liwen; Guo, Yajun; Teng, Maikun			Structural Insights into the Neutralization Mechanism of Monoclonal Antibody 6C2 against Ricin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; IN-VITRO; A-CHAIN; TOXICITY; SUBUNIT; DEPURINATION; PROTECTION; VACCINE; MICE; INHIBITION	Ricin belongs to the type II ribosome-inactivating proteins that depurinate the universally conserved alpha-sarcin loop of rRNA. The RNA N-glycosidase activity of ricin also largely depends on the ribosomal proteins that play an important role during the process of rRNA depurination. Therefore, the study of the interaction between ricin and the ribosomal elements will be better to understand the catalysis mechanism of ricin. The antibody 6C2 is a mouse monoclonal antibody exhibiting unusually potent neutralizing ability against ricin, but the neutralization mechanism remains unknown. Here, we report the 2.8 angstrom crystal structure of 6C2 Fab in complex with the A-chain of ricin (RTA), which reveals an extensive antigen-antibody interface that contains both hydrogen bonds and van der Waals contacts. The complementarity-determining region loops H1, H2, H3, and L3 form a pocket to accommodate the epitope on the RTA (residues Asp(96)-Thr(116)). ELISA results show that Gln(98), Glu(99), Glu(102), and Thr(105) (RTA) are the key residues that play an important role in recognizing 6C2. With the perturbation of the 6C2 Fab-RTA interface, 6C2 loses its neutralization ability, measured based on the inhibition of protein synthesis in a cell-free system. Finally, we propose that the neutralization mechanism of 6C2 against ricin is that the binding of 6C2 hinders the interaction between RTAand the ribosome and the surface plasmon resonance and pulldown results confirm our hypothesis. In short, our data explain the neutralization mechanism of mAb 6C2 against ricin and provide a structural basis for the development of improved antibody drugs with better specificity and higher affinity.	[Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China; [Dai, Jianxin; Zhang, Tiancheng; Wang, Huajing; Yu, Xiaojie; Xia, Tian; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxin; Zhang, Tiancheng; Wang, Huajing; Yu, Xiaojie; Xia, Tian; Guo, Yajun] State Key Lab Antibody Med & Targeting Therapy, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Naval Medical University	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; mkteng@ustc.edu.cn	yu, xiaojie/GSI-9676-2022; Fang, Pengfei/O-3696-2015	Fang, Pengfei/0000-0002-3448-5494; Li, Xu/0000-0001-5221-0817	Chinese Ministry of Science and Technology [2012CB917200, 2009CB825500]; Chinese National Natural Science Foundation [31270014, 31130018, 31170726, 30900224, 10979039]; Ministry of Science and Technology 973 Project [2010CB833600, 2010CB735605]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 973 Project(National Basic Research Program of China)	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB917200 and 2009CB825500; Chinese National Natural Science Foundation Grants 31270014, 31130018, 31170726, 30900224, and 10979039; and Ministry of Science and Technology 973 Project Grants 2010CB833600 and 2010CB735605.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; CHANH TC, 1993, IMMUNOL INVEST, V22, P63, DOI 10.3109/08820139309066194; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ehrlich P., 1891, UEBER RICIN DEUT MED, V17, P976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 1988, Nucleic Acids Symp Ser, P139; ENDO Y, 1988, J BIOL CHEM, V263, P8735; GODAL A, 1983, INT J CANCER, V32, P515, DOI 10.1002/ijc.2910320420; GRIFFITHS GD, 1995, HUM EXP TOXICOL, V14, P155, DOI 10.1177/096032719501400201; HARLEY SM, 1982, P NATL ACAD SCI-BIOL, V79, P5935, DOI 10.1073/pnas.79.19.5935; Hartley MR, 2004, MINI-REV MED CHEM, V4, P487, DOI 10.2174/1389557043403828; HEWETSON JF, 1993, VACCINE, V11, P743, DOI 10.1016/0264-410X(93)90259-Z; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; HOUSTON LL, 1982, J TOXICOL-CLIN TOXIC, V19, P385, DOI 10.3109/15563658208992492; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Smallshaw JE, 2012, CURR TOP MICROBIOL, V357, P259, DOI 10.1007/82_2011_156; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WILSON IA, 1991, CIBA F SYMP, V159, P13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	39	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25165	25172		10.1074/jbc.M113.480830	http://dx.doi.org/10.1074/jbc.M113.480830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853097	Green Published, hybrid			2022-12-28	WOS:000330619000016
J	Grosely, R; Kopanic, JL; Nabors, S; Kieken, F; Spagnol, G; Al-Mugotir, M; Zach, S; Sorgen, PL				Grosely, Rosslyn; Kopanic, Jennifer L.; Nabors, Sarah; Kieken, Fabien; Spagnol, Gaelle; Al-Mugotir, Mona; Zach, Sydney; Sorgen, Paul L.			Effects of Phosphorylation on the Structure and Backbone Dynamics of the Intrinsically Disordered Connexin43 C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNEL; CIRCULAR-DICHROISM SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; CARBOXYL-TERMINUS; MOLECULAR RECOGNITION; TRANSMEMBRANE DOMAIN; BINDING; COMMUNICATION; EVENT; SRC	Phosphorylation of the connexin43 C-terminal (Cx43CT) domain regulates gap junction intercellular communication. However, an understanding of the mechanisms by which phosphorylation exerts its effects is lacking. Here, we test the hypothesis that phosphorylation regulates Cx43 gap junction intercellular communication by mediating structural changes in the C-terminal domain. Circular dichroism and nuclear magnetic resonance were used to characterize the effects of phosphorylation on the secondary structure and backbone dynamics of soluble and membrane-tethered Cx43CT domains. Cx43CT phospho-mimetic isoforms, which have Asp substitutions at specific Ser/Tyr sites, revealed phosphorylation alters the alpha-helical content of the Cx43CT domain only when attached to the membrane. The changes in secondary structure are due to variations in the conformational preference and backbone flexibility of residues adjacent and distal to the site(s) of modification. In addition to the known direct effects of phosphorylation on molecular partner interactions, the data presented here suggest phosphorylation may also indirectly regulate binding affinity by altering the conformational preference of the Cx43CT domain.	[Grosely, Rosslyn; Kopanic, Jennifer L.; Nabors, Sarah; Kieken, Fabien; Spagnol, Gaelle; Al-Mugotir, Mona; Zach, Sydney; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health Grant from USPHS [GM07263]; Graduate Assistance in Areas of National Need Fellowship; McDonald Fellowship; Regents Tuitions Fellowship; Fred W. Upson grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health Grant from USPHS; Graduate Assistance in Areas of National Need Fellowship; McDonald Fellowship; Regents Tuitions Fellowship; Fred W. Upson grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07263 from USPHS.; Supported by a Graduate Assistance in Areas of National Need Fellowship, McDonald Fellowship, Regents Tuitions Fellowship, and a Fred W. Upson grant.	Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chen JH, 2012, ARCH BIOCHEM BIOPHYS, V524, P123, DOI 10.1016/j.abb.2012.04.024; Cheng A, 2003, CELL COMMUN ADHES, V10, P187, DOI 10.1080/714040425; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; Chung TH, 2007, J CELL BIOCHEM, V100, P653, DOI 10.1002/jcb.21018; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Dobrowolski R, 2009, ANTIOXID REDOX SIGN, V11, P283, DOI 10.1089/ars.2008.2128; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Grosely R., 2012, BIOMOL NMR IN PRESS; Grosely R, 2010, CELL COMMUN ADHES, V17, P23, DOI 10.3109/15419061.2010.487956; Huang RYC, 2011, J PROTEOME RES, V10, P1098, DOI 10.1021/pr1008702; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellezi A, 2008, PROTEIN EXPRES PURIF, V59, P215, DOI 10.1016/j.pep.2008.01.023; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lau A. F., 2005, SCI STKE 2005, V2005, pe33; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Muratore KE, 2007, ACS CHEM BIOL, V2, P454, DOI 10.1021/cb7001285; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Pancsa R, 2012, IUBMB LIFE, V64, P513, DOI 10.1002/iub.1034; Park DJ, 2006, PROTEIN SCI, V15, P2344, DOI 10.1110/ps.062172506; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Severs NJ, 2007, CIRC RES, V101, P1213, DOI 10.1161/CIRCRESAHA.107.165662; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SMITH CL, 1989, J VIROL, V63, P1569, DOI 10.1128/JVI.63.4.1569-1577.1989; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2002, J BIOMOL NMR, V23, P245, DOI 10.1023/A:1019892719979; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Whitmore L, 2010, STRUCTURE, V18, P1267, DOI 10.1016/j.str.2010.08.008; Wikstrom A, 1999, J MOL BIOL, V289, P963, DOI 10.1006/jmbi.1999.2806; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	65	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24857	24870		10.1074/jbc.M113.454389	http://dx.doi.org/10.1074/jbc.M113.454389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828237	hybrid, Green Published			2022-12-28	WOS:000330612300050
J	Hernandez-Rocamora, VM; Garcia-Montanes, C; Reija, B; Monterroso, B; Margolin, W; Alfonso, C; Zorrilla, S; Rivas, G				Hernandez-Rocamora, Victor M.; Garcia-Montanes, Concepcion; Reija, Belen; Monterroso, Begona; Margolin, William; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German			MinC Protein Shortens FtsZ Protofilaments by Preferentially Interacting with GDP-bound Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL DIVISION; TO-POLE OSCILLATION; ASSAY; ULTRACENTRIFUGATION; POLYMERIZATION; CYTOKINESIS; DYNAMICS; SUGGESTS; REVEALS; MONOMER	The interaction of MinC with FtsZ and its effects on FtsZ polymerization were studied under close to physiological conditions by a combination of biophysical methods. The Min system is a widely conserved mechanism in bacteria that ensures the correct placement of the division machinery at midcell. MinC is the component of this system that effectively interacts with FtsZ and inhibits the formation of the Z-ring. Here we report that MinC produces a concentration-dependent reduction in the size of GTP-induced FtsZ protofilaments (FtsZ-GTP) as demonstrated by analytical ultracentrifugation, dynamic light scattering, fluorescence correlation spectroscopy, and electron microscopy. Our experiments show that, despite being shorter, FtsZ protofilaments maintain their narrow distribution in size in the presence of MinC. The protein had the same effect regardless of its addition prior to or after FtsZ polymerization. Fluorescence anisotropy measurements indicated that MinC bound to FtsZ-GDP with a moderate affinity (apparent K-D similar to 10 mu M at 100 mM KCl and pH 7.5) very close to the MinC concentration corresponding to the midpoint of the inhibition of FtsZ assembly. Only marginal binding of MinC to FtsZ-GTP protofilaments was observed by analytical ultracentrifugation and fluorescence correlation spectroscopy. Remarkably, MinC effects on FtsZ-GTP protofilaments and binding affinity to FtsZ-GDP were strongly dependent on ionic strength, being severely reduced at 500 mM KCl compared with 100 mM KCl. Our results support a mechanism in which MinC interacts with FtsZ-GDP, resulting in smaller protofilaments of defined size and having the same effect on both preassembled and growing FtsZ protofilaments.	[Hernandez-Rocamora, Victor M.; Garcia-Montanes, Concepcion; Monterroso, Begona; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Texas System; University of Texas Health Science Center Houston	Zorrilla, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	silvia@cib.csic.es; grivas@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	Human Frontier Science Program Grant [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSICPIE-201020I001, BFU2010-14910, BIO2011-28941-C03]	Human Frontier Science Program Grant(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported in part by Human Frontier Science Program Grant RGP0050/2010 (to G. R. and W. M.), European Commission Contract HEALTH-F3-2009-223431 (to G. R.), and Spanish Government Grants BIO2008-04478-C03 (to G. R.), CSICPIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to G. R. and S. Z.).	Blasios V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060690; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Harry E., 2006, INT REV CYTOL, V253, P27; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Okuno T, 2009, BIOL PHARM BULL, V32, P1473, DOI 10.1248/bpb.32.1473; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; Rosales T, 2008, ANAL BIOCHEM, V381, P270, DOI 10.1016/j.ab.2008.05.056; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yu XC, 1998, J BIOL CHEM, V273, P10216, DOI 10.1074/jbc.273.17.10216	42	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24625	24635		10.1074/jbc.M113.483222	http://dx.doi.org/10.1074/jbc.M113.483222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853099	hybrid, Green Published			2022-12-28	WOS:000330612300030
J	Mikula, M; Bomsztyk, K; Goryca, K; Chojnowski, K; Ostrowski, J				Mikula, Michal; Bomsztyk, Karol; Goryca, Krzysztof; Chojnowski, Krzysztof; Ostrowski, Jerzy			Heterogeneous Nuclear Ribonucleoprotein (HnRNP) K Genome-wide Binding Survey Reveals Its Role in Regulating 3 '-End RNA Processing and Transcription Termination at the Early Growth Response 1 (EGR1) Gene through XRN2 Exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; POLYMERASE-II TRANSCRIPTION; ANDROGEN RECEPTOR; PROMOTER; COMPLEX; ELEMENT; INTERACTOME; ELONGATION; EXPRESSION; RECRUITS	The heterogeneous nuclear ribonucleoprotein K (hnRNPK) is a nucleic acid-binding protein that acts as a docking platform integrating signal transduction pathways to nucleic acid-related processes. Given that hnRNPK could be involved in other steps that compose gene expression the definition of its genome-wide occupancy is important to better understand its role in transcription and co-transcriptional processes. Here, we used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to analyze the genome-wide hnRNPK-DNA interaction in colon cancer cell line HCT116. 9.1/3.6 and 7.0/3.4 million tags were sequenced/mapped, then 1809 and 642 hnRNPK binding sites were detected in quiescent and 30-min serum-stimulated cells, respectively. The inspection of sequencing tracks revealed inducible hnRNPK recruitment along a number of immediate early gene loci, including EGR1 and ZFP36, with the highest densities present at the transcription termination sites. Strikingly, hnRNPK knockdown with siRNA resulted in increased pre-RNA levels transcribed downstream of the EGR1 polyadenylation (A) site suggesting altered 3'-end pre-RNA degradation. Further ChIP survey of hnRNPK knockdown uncovered decreased recruitment of the 5'-3' exonuclease XRN2 along EGR1 and downstream of the poly(A) signal without altering RNA polymerase II density at these sites. Immunoprecipitation of hnRNPK and XRN2 from intact and RNase A-treated nuclear extracts followed by shotgun mass spectrometry revealed the presence of hnRNPK and XRN2 in the same complexes along with other spliceosome-related proteins. Our data suggest that hnRNPK may play a role in recruitment of XRN2 to gene loci thus regulating coupling 3'-end pre-mRNA processing to transcription termination.	[Mikula, Michal; Goryca, Krzysztof; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, PL-02781 Warsaw, Poland; [Mikula, Michal; Goryca, Krzysztof; Ostrowski, Jerzy] Inst Oncol, PL-02781 Warsaw, Poland; [Mikula, Michal; Bomsztyk, Karol] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Chojnowski, Krzysztof] Warsaw Univ Technol, Inst Radioelect, PL-00661 Warsaw, Poland; [Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, PL-01813 Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Washington; University of Washington Seattle; Warsaw University of Technology; Centre of Postgraduate Medical Education - Poland	Mikula, M (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, PL-02781 Warsaw, Poland.	mikula.michal@gmail.com	Mikula, Michal/G-8276-2011	Mikula, Michal/0000-0003-3447-7328; Ostrowski, Jerzy/0000-0003-1363-3766	National Institutes of Health Grants [R01 DK083310, R37 DK45978]; Ministry of Science and Higher Education Grant [IP2010 026770]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083310, R37DK045978] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK083310 and R37 DK45978 (to K. B.) and Ministry of Science and Higher Education Grant IP2010 026770.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Gilmour DS, 2008, J BIOL CHEM, V283, P661, DOI 10.1074/jbc.R700032200; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Mikula M, 2010, DNA RES, V17, P245, DOI 10.1093/dnares/dsq016; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Shi LH, 2008, J BIOL CHEM, V283, P36474, DOI 10.1074/jbc.M805980200; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24788	24798		10.1074/jbc.M113.496679	http://dx.doi.org/10.1074/jbc.M113.496679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23857582	hybrid, Green Published			2022-12-28	WOS:000330612300044
J	Morawski, PA; Mehra, P; Chen, CX; Bhatti, T; Wells, AD				Morawski, Peter A.; Mehra, Parul; Chen, Chunxia; Bhatti, Tricia; Wells, Andrew D.			Foxp3 Protein Stability Is Regulated by Cyclin-dependent Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; CD4(+) T-CELLS; PROMOTER OCCUPANCY; CLONAL EXPANSION; GENE-EXPRESSION; SCID MICE; TGF-BETA; IN-VIVO; CDK2; INHIBITION	Foxp3 is a transcription factor required for the development of regulatory T cells (Treg). Mice and humans with a loss of Foxp3 function suffer from uncontrolled autoimmunity and inflammatory disease. Expression of Foxp3 is necessary for the anti-inflammatory capacity of Treg, but whether Foxp3 activity is further subject to regulation by extracellular signals is unclear. The primary structure of Foxp3 contains four cyclin-dependent kinase (CDK) motifs (Ser/Thr-Pro) within the N-terminal repressor domain, and we show that CDK2 can partner with cyclin E to phosphorylate Foxp3 at these sites. Consistent with our previous demonstration that CDK2 negatively regulates Treg function, we find that mutation of the serine or threonine at each CDK motif to alanine (S/T -> A) results in enhanced Foxp3 protein stability in CD4(+) T cells. T cells expressing the S/T -> A mutant of Foxp3 showed enhanced induction (e. g. CD25) and repression (e. g. IL2) of canonical Foxp3-responsive genes, exhibited an increased capacity to suppress conventional T cell proliferation in vitro, and were highly effective at ameliorating colitis in an in vivo model of inflammatory bowel disease. These results indicate that CDK2 negatively regulates the stability and activity of Foxp3 and implicate CDK-coupled receptor signal transduction in the control of regulatory T cell function and stability.	Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wells, AD (corresponding author), 916F Abramson Res Ctr, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Morawski, Peter/F-2866-2019	Morawski, Peter/0000-0001-9159-4032	National Institutes of Health [R01-AI054643-06]; Goldie Simon Preceptorship Award; Lupus Foundation of America Philadelphia Tri-State Chapter; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldie Simon Preceptorship Award; Lupus Foundation of America Philadelphia Tri-State Chapter; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI054643-06 (to A. D. W.). This work was also supported by the 2011 Goldie Simon Preceptorship Award sponsored by the Lupus Foundation of America Philadelphia Tri-State Chapter and the Pennsylvania Department of Health (to P. A. M.).	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Aranda R, 1997, J IMMUNOL, V158, P3464; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; Conner EM, 1997, J PHARMACOL EXP THER, V282, P1615; COPPOCK DL, 1995, EXP CELL RES, V221, P92, DOI 10.1006/excr.1995.1356; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gallorini M, 2012, BIODRUGS, V26, P377, DOI 10.2165/11634060-000000000-00000; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kamesaki H, 1998, J IMMUNOL, V160, P770; Kasprowicz DJ, 2003, J IMMUNOL, V171, P1216, DOI 10.4049/jimmunol.171.3.1216; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KIM YH, 1992, J IMMUNOL, V149, P17; KIM YH, 1994, J IMMUNOL, V152, P4328; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040896; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li LQ, 2009, CELL CYCLE, V8, P1794, DOI 10.4161/cc.8.11.8738; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	46	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24494	24502		10.1074/jbc.M113.467704	http://dx.doi.org/10.1074/jbc.M113.467704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853094	Green Published, hybrid			2022-12-28	WOS:000330612300018
J	Austin, KM; Nguyen, N; Javid, G; Covic, L; Kuliopulos, A				Austin, Karyn M.; Nga Nguyen; Javid, Golrokh; Covic, Lidija; Kuliopulos, Athan			Noncanonical Matrix Metalloprotease-1-Protease-activated Receptor-1 Signaling Triggers Vascular Smooth Muscle Cell Dedifferentiation and Arterial Stenosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; BREAST-CANCER CELLS; CORONARY ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CONTRACTILE PHENOTYPE; BALLOON ANGIOPLASTY; METALLOPROTEINASES; RESTENOSIS; INHIBITION; EXPRESSION	Vascular injury that results in proliferation and dedifferentiation of vascular smooth muscle cells (SMCs) is an important contributor to restenosis following percutaneous coronary interventions or plaque rupture. Protease-activated receptor-1 (PAR1) has been shown to play a role in vascular repair processes; however, little is known regarding its function or the relative roles of the upstream proteases thrombin and matrix metalloprotease-1 (MMP-1) in triggering PAR1-mediated arterial restenosis. The goal of this study was to determine whether noncanonical MMP-1 signaling through PAR1 would contribute to aberrant vascular repair processes in models of arterial injury. A mouse carotid arterial wire injury model was used for studies of neointima hyperplasia and arterial stenosis. The mice were treated post-injury for 21 days with a small molecule inhibitor of MMP-1 or a direct thrombin inhibitor and compared with vehicle control. Intimal and medial hyperplasia was significantly inhibited by 2.8-fold after daily treatment with the small molecule MMP-1 inhibitor, an effect that was lost in PAR1-deficient mice. Conversely, chronic inhibition of thrombin showed no benefit in suppressing the development of arterial stenosis. Thrombin-PAR1 signaling resulted in a supercontractile, differentiated phenotype in SMCs. Noncanonical MMP-1-PAR1 signaling resulted in the opposite effect and led to a dedifferentiated phenotype via a different G protein pathway. MMP-1-PAR1 significantly stimulated hyperplasia and migration of SMCs, and resulted in down-regulation of SMC contractile genes. These studies provide a new mechanism for the development of vascular intimal hyperplasia and suggest a novel therapeutic strategy to suppress restenosis by targeting noncanonical MMP-1-PAR1 signaling in vascular SMCs.	[Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Hemostasis & Thrombosis Lab, Mol Oncol Res Inst,Tufts Med Ctr,Program Genet,Sa, Boston, MA 02111 USA; [Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Javid, Golrokh] Tufts Univ, Dept Pathol, Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Hemostasis & Thrombosis Lab, Mol Oncol Res Inst,Tufts Med Ctr,Program Genet,Sa, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu			National Institutes of Health [F30 HL108590, P50 HL110789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL108590, P50HL110789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants F30 HL108590 (to K. M. A.) and P50 HL110789 (to A. K.).	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Burchenal JEB, 1998, AM J CARDIOL, V82, P511, DOI 10.1016/S0002-9149(98)00371-3; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; de Smet BJGL, 2000, CIRCULATION, V101, P2962, DOI 10.1161/01.CIR.101.25.2962; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Eckart Robert E, 2004, J Interv Cardiol, V17, P27, DOI 10.1111/j.1540-8183.2004.00289.x; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gaubatz JW, 2010, ARTERIOSCL THROM VAS, V30, P1034, DOI 10.1161/ATVBAHA.109.195370; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Gurbel PA, 2011, EXPERT OPIN INV DRUG, V20, P1445, DOI 10.1517/13543784.2011.606809; Hatziapostolou M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002006; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Jaffre F, 2012, CIRCULATION, V125, P2993, DOI 10.1161/CIRCULATIONAHA.111.066787; Kamath L, 2001, CANCER RES, V61, P5933; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lehrke M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-50; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Navarese EP, 2011, INT J CARDIOL, V152, P387, DOI 10.1016/j.ijcard.2011.08.024; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2008, ARTERIOSCL THROM VAS, V28, P1416, DOI 10.1161/ATVBAHA.108.168930; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Peeters W, 2011, EUR HEART J, V32, P2314, DOI 10.1093/eurheartj/ehq517; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Pfaffen S, 2010, EUR J NUCL MED MOL I, V37, P1559, DOI 10.1007/s00259-010-1446-9; Pfaffen S, 2010, EXP CELL RES, V316, P836, DOI 10.1016/j.yexcr.2009.11.004; Preisack MB, 1997, Z KARDIOL, V86, P581, DOI 10.1007/s003920050097; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Smyth SS, 2002, AM HEART J, V144, P577, DOI 10.1067/mhj.2002.123569; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Wu YW, 2008, J FORMOS MED ASSOC, V107, P93, DOI 10.1016/S0929-6646(08)60015-7; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28; Zhang JS, 2008, CIRCULATION, V118, P1953, DOI 10.1161/CIRCULATIONAHA.108.789743; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918	50	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23105	23115		10.1074/jbc.M113.467019	http://dx.doi.org/10.1074/jbc.M113.467019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814055	Green Published, hybrid			2022-12-28	WOS:000330598200018
J	Steinmann, S; Coulibaly, A; Ohnheiser, J; Jakobs, A; Klempnauer, KH				Steinmann, Simone; Coulibaly, Anna; Ohnheiser, Johanna; Jakobs, Anke; Klempnauer, Karl-Heinz			Interaction and Cooperation of the CCAAT-box Enhancer-binding Protein beta (C/EBP beta) with the Homeodomain-interacting Protein Kinase 2 (Hipk2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; ADIPOCYTE DIFFERENTIATION; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; INHIBITORY PROTEIN; COACTIVATOR P300; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELL; PHOSPHORYLATION	CCAAT box/enhancer-binding protein beta (C/EBP beta) is a bZip transcription factor that plays crucial roles in important cellular processes such as differentiation and proliferation of specific cell types. Previously, we showed that C/EBP beta cooperates with the coactivator p300 through a novel mechanism that involves the C/EBP beta-induced phosphorylation of multiple sites in the carboxyl-terminal domain of p300 by protein kinase Hipk2. We have now examined the interaction and cooperation of C/EBP beta, p300, and Hipk2 in more detail. We show that Hipk2 and C/EBP beta are direct physical binding partners whose interaction is mediated by sequences located in the amino-terminal and central domains of Hipk2 and the amino-terminal part of C/EBP beta. In addition to phosphorylating p300 recruited to C/EBP beta, Hipk2 also phosphorylates C/EBP beta at sites that have previously been shown to plays key roles in the regulation of C/EBP beta activity. Silencing of Hipk2 expression disrupts adipocyte differentiation of 3T3-L1 cells, a physiological C/EBP beta dependent differentiation process indicating that the cooperation of C/EBP beta and Hipk2 is functionally relevant. Finally, we demonstrate that C/EBP beta, a related C/EBP family member whose amino-terminal sequences differ significantly from that of C/EBP beta, is unable to interact and cooperate with Hipk2. Instead, our data suggest that C/EBP beta cooperates with the protein kinase Jnk to induce phosphorylation of p300. Overall, our data identify Hipk2 as a novel regulator of C/EBP beta and implicate different protein kinases in the cooperation of p300 with C/EBP beta and C/EBP beta.	[Steinmann, Simone; Coulibaly, Anna; Ohnheiser, Johanna; Jakobs, Anke; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de		Coulibaly, Anna/0000-0001-5746-4496	Deutsche Forschungsgemeinschaft [KL461/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KL461/12-1.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Raught B, 1996, CANCER RES, V56, P4382; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zahnow CA, 2001, CANCER RES, V61, P261; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang QC, 2007, J PROTEOME RES, V6, P4711, DOI 10.1021/pr700571d	53	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22257	22269		10.1074/jbc.M113.487769	http://dx.doi.org/10.1074/jbc.M113.487769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782693	Green Published, hybrid			2022-12-28	WOS:000330596300008
J	Viarengo, G; Sciara, MI; Salazar, MO; Kieffer, PM; Furlan, RLE; Vescovi, EG				Viarengo, Gaston; Sciara, Mariela I.; Salazar, Mario O.; Kieffer, Pablo M.; Furlan, Ricardo L. E.; Garcia Vescovi, Eleonora			Unsaturated Long Chain Free Fatty Acids Are Input Signals of the Salmonella enterica PhoP/PhoQ Regulatory System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; ENVIRONMENTAL-REGULATION; HISTIDINE KINASE; TRANSCRIPTION; PROTEINS; TARGET; PHOQ; ENVZ	The Salmonella enterica serovar Typhimurium PhoP/PhoQ system has largely been studied as a paradigmatic two-component regulatory system not only to dissect structural and functional aspects of signal transduction in bacteria but also to gain knowledge about the versatile devices that have evolved allowing a pathogenic bacterium to adjust to or counteract environmental stressful conditions along its life cycle. Mg2+ limitation, acidic pH, and the presence of cationic antimicrobial peptides have been identified as cues that the sensor protein PhoQ can monitor to reprogram Salmonella gene expression to cope with extra-or intracellular challenging conditions. In this work, we show for the first time that long chain unsaturated free fatty acids (LCUFAs) present in Salmonella growth medium are signals specifically detected by PhoQ. We demonstrate that LCUFAs inhibit PhoQ autokinase activity, turning off the expression of the PhoP-dependent regulon. We also show that LCUFAs exert their action independently of their cellular uptake and metabolic utilization by means of the beta-oxidative pathway. Our findings put forth the complexity of input signals that can converge to finely tune the activity of the PhoP/PhoQ system. In addition, they provide a new potential biochemical platform for the development of antibacterial strategies to fight against Salmonella infections.	[Viarengo, Gaston; Sciara, Mariela I.; Kieffer, Pablo M.; Garcia Vescovi, Eleonora] Univ Nacl Rosario, Predio CCT CONICET Rosario Ocampo & Esmeralda, Inst Biol Mol & Celular Rosario IBR CONICET, Fac Ciencias Bioquim & Farmaceut,Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina; [Salazar, Mario O.; Furlan, Ricardo L. E.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	Vescovi, EG (corresponding author), Univ Nacl Rosario, Predio CCT CONICET Rosario Ocampo & Esmeralda, Inst Biol Mol & Celular Rosario IBR CONICET, Fac Ciencias Bioquim & Farmaceut,Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina.	garciavescovi@ibr-conicet.gov.ar	Salazar, Mario/AAR-6723-2021; Furlan, Ricardo/AGU-7634-2022; SCIARA, MARIELA/ABE-3753-2021	Garcia Vescovi, Eleonora/0000-0002-4431-8606; Furlan, Ricardo/0000-0001-6136-0980; Salazar, Mario O./0000-0002-0006-7614	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina; CONICET, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work is supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), and Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina (to E. G. V. and R. L. F.).; Recipient of a fellowship from CONICET, Argentina.	Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Antunes LCM, 2012, J BACTERIOL, V194, P2286, DOI 10.1128/JB.00104-12; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; ELY B, 1974, GENETICS, V76, P625; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; GIBSON MM, 1987, MOL GEN GENET, V207, P120, DOI 10.1007/BF00331499; Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004; Goldberg SD, 2010, P NATL ACAD SCI USA, V107, P8141, DOI 10.1073/pnas.1003166107; Groisman EA, 1998, BIOESSAYS, V20, P96, DOI 10.1002/(SICI)1521-1878(199801)20:1<96::AID-BIES13>3.0.CO;2-3; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; LEPAGE G, 1988, J LIPID RES, V29, P227; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Lesley JA, 2003, J BACTERIOL, V185, P2563, DOI 10.1128/JB.185.8.2563-2570.2003; Lippa AM, 2012, J BACTERIOL, V194, P1457, DOI 10.1128/JB.06055-11; Lopez SN, 2007, P NATL ACAD SCI USA, V104, P441, DOI 10.1073/pnas.0608438104; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Maniatis T., 1982, MOL CLONING; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Olveira G, 2006, BRIT J NUTR, V96, P343, DOI 10.1079/BJN20051655; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Audero MEP, 2010, MOL MICROBIOL, V78, P853, DOI 10.1111/j.1365-2958.2010.07370.x; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; RALEIGH JA, 1977, INT J RADIAT BIOL, V31, P203, DOI 10.1080/09553007714550251; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; STOLL LL, 1984, IN VITRO CELL DEV B, V20, P732; Thompson JA, 2011, MICROBIOL-SGM, V157, P2084, DOI 10.1099/mic.0.048926-0; Tsuchiya Y, 2006, CLIN BIOCHEM, V39, P410, DOI 10.1016/j.clinbiochem.2005.11.006; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Visioli Francesco, 2006, Nutrition and Health (Bicester), V18, P127; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; Yoshida T, 2007, METHOD ENZYMOL, V423, P184, DOI 10.1016/S0076-6879(07)23008-3; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zwir I, 2012, MOL MICROBIOL, V84, P463, DOI 10.1111/j.1365-2958.2012.08036.x	67	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22346	22358		10.1074/jbc.M113.472829	http://dx.doi.org/10.1074/jbc.M113.472829			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782700	hybrid, Green Published			2022-12-28	WOS:000330596300016
J	Takeuchi, A; Kobayashi, A; Ironside, JW; Mohri, S; Kitamoto, T				Takeuchi, Atsuko; Kobayashi, Atsushi; Ironside, James W.; Mohri, Shirou; Kitamoto, Tetsuyuki			Characterization of Variant Creutzfeldt-Jakob Disease Prions in Prion Protein-humanized Mice Carrying Distinct Codon 129 Genotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Microbiology; Neurobiology; Prions; Protein Misfolding; Knock-in Mouse; Codon 129 Genotype; Folicular Dendritic Cell; vCJD	GERSTMANN-STRAUSSLER SYNDROME; BLOOD-TRANSFUSION; MOLECULAR PHENOTYPE; TRANSGENIC MICE; TISSUE SAMPLES; TRANSMISSION; VCJD; CJD; INFECTION; SUSCEPTIBILITY	To date, all clinical variant Creutzfeldt-Jakob disease (vCJD) patients are homozygous for methionine at polymorphic codon 129 (129M/M) of the prion protein (PrP) gene. However, the appearance of asymptomatic secondary vCJD infection in individuals with a PRNP codon 129 genotype other than M/M and transmission studies using animal models have raised the concern that all humans might be susceptible to vCJD prions, especially via secondary infection. To reevaluate this possibility and to analyze in detail the transmission properties of vCJD prions to transgenic animals carrying distinct codon 129 genotype, we performed intracerebral inoculation of vCJD prions to humanized knock-in mice carrying all possible codon 129 genotypes (129M/M, 129M/V, or 129V/V). All humanized knock-in mouse lines were susceptible to vCJD infection, although the attack rate gradually decreased from 129M/M to 129M/V and to 129V/V. The amount of PrP deposition including florid/amyloid plaques in the brain also gradually decreased from 129M/M to 129M/V and to 129V/V. The biochemical properties of protease-resistant abnormal PrP in the brain and transmissibility of these humanized mouse-passaged vCJD prions upon subpassage into knock-in mice expressing bovine PrP were not affected by the codon 129 genotype. These results indicate that individuals with the 129V/V genotype may be more susceptible to secondary vCJD infection than expected and may lack the neuropathological characteristics observed in vCJD patients with the 129M/M genotype. Besides the molecular typing of protease-resistant PrP in the brain, transmission studies using knock-in mice carrying bovine PrP may aid the differential diagnosis of secondary vCJD infection, especially in individuals with the 129V/V genotype.	[Takeuchi, Atsuko; Kobayashi, Atsushi; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ironside, James W.] Univ Edinburgh, Western Gen Hosp, Natl Creutzfeldt Jakob Dis Res & Surveillance Uni, Div Pathol,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan	Tohoku University; University of Edinburgh; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Kitamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kitamoto@med.tohoku.ac.jp	Mohri, Shirou/AAK-1281-2020	Ironside, James/0000-0001-5869-2108	National Institute of Biomedical Innovation; Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare, Japan [H23-Shokuhin-lppan-005]; Medical Research Council [G0600953, G0900580] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24650185] Funding Source: KAKEN; MRC [G0600953, G0900580] Funding Source: UKRI	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation (to S. M. and T. K.), grants-in-aid from the Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan (to A. T., S. M., and T. K.), a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (to A. T., A. K., and T. K.), and a grant for TSE research from the Ministry of Health, Labour and Welfare, Japan (H23-Shokuhin-lppan-005) (to T. K.).	Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Head MW, 2001, ANN NEUROL, V50, P258, DOI 10.1002/ana.1100; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Kobayashi A, 2010, J VIROL, V84, P3230, DOI 10.1128/JVI.02387-09; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Lukic A, 2010, ARCH NEUROL-CHICAGO, V67, P1021, DOI 10.1001/archneurol.2010.184; Mead S, 2007, ARCH NEUROL-CHICAGO, V64, P1780, DOI 10.1001/archneur.64.12.1780; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Soldevila Marta, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9157; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 2000, ANN NEUROL, V47, P575; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	34	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21659	21666		10.1074/jbc.M113.470328	http://dx.doi.org/10.1074/jbc.M113.470328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23792955	Green Published, hybrid			2022-12-28	WOS:000328841900018
J	Tinkum, KL; White, LS; Marpegan, L; Herzog, E; Piwnica-Worms, D; Piwnica-Worms, H				Tinkum, Kelsey L.; White, Lynn S.; Marpegan, Luciano; Herzog, Erik; Piwnica-Worms, David; Piwnica-Worms, Helen			Forkhead Box O1 ( FOXO1) Protein, but Not p53, Contributes to Robust Induction of p21 Expression in Fasted Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION; PHOSPHORYLATION; HYPOGLYCEMIA; INSULIN	Reporter mice that enable the activity of the endogenous p21 promoter to be dynamically monitored in real time in vivo and under a variety of experimental conditions revealed ubiquitous p21 expression in mouse organs including the brain. Low light bioluminescence microscopy was employed to localize p21 expression to specific regions of the brain. Interestingly, p21 expression was observed in the paraventricular, arcuate, and dorsomedial nuclei of the hypothalamus, regions that detect nutrient levels in the blood stream and signal metabolic actions throughout the body. These results suggested a link between p21 expression and metabolic regulation. We found that short-term food deprivation (fasting) potently induced p21 expression in tissues involved in metabolic regulation including liver, pancreas and hypothalamic nuclei. Conditional reporter mice were generated that enabled hepatocyte-specific expression of p21 to be monitored in vivo. Bioluminescence imaging demonstrated that fasting induced a 7-fold increase in p21 expression in livers of reporter mice and Western blotting demonstrated an increase in protein levels as well. The ability of fasting to induce p21 expression was found to be independent of p53 but dependent on FOXO1. Finally, occupancy of the endogenous p21 promoter by FOXO1 was observed in the livers of fasted but not fed mice. Thus, fasting promotes loading of FOXO1 onto the p21 promoter to induce p21 expression in hepatocytes.	[Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Marpegan, Luciano; Herzog, Erik] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piwnica-Worms, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Unit 1479, T Boone Pickens Acad Tower,1400 Pressler St, Houston, TX 77030 USA.	dpiwnica-worms@mdanderson.org; hpiwnica-worms@mdanderson.org	Piwnica-Worms, Helen/C-5214-2012	Marpegan, Luciano/0000-0003-3652-9873; Herzog, Erik/0000-0001-7209-5174	NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [P50CA094056, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH063140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jinwu Sun for generating the conditional p21 targeting vector and for screening clones, Catherine Kusmicki for assistance with cloning and Philippe Soriano for providing pBigT plasmid. Anne Brunet is thanked for her generous gift of FOXO1 antibody for ChIP and Ashley Webb is thanked for providing advice on the ChIP protocol. We thank Ron DePinho for providing FOXO1<SUP>f/f</SUP> mice, Shin Imai for providing Albumin-Cre mice, Mike White for performing blastocyst injections, Emily Powell for editorial assistance, Reece Goiffon for statistical assistance, and Clay Semenkovich and Trey Coleman for assistance with metabolic analysis. Finally, we thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital for the use of the Embryonic Stem Cell Core and electroporation services. The Alvin J. Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA91842).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chaya D., 2003, METHOD ENZYMOL, P361; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gross S, 2007, MOL IMAGING, V6, P121, DOI 10.2310/7290.2007.00009; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Marshall BA, 1999, J BIOL CHEM, V274, P27426, DOI 10.1074/jbc.274.39.27426; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paxions G., 2001, MOUSE BRAIN STEREOTA, Vsecond; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Tinkum KL, 2011, MOL CELL BIOL, V31, P3759, DOI 10.1128/MCB.05243-11; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	27	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27999	28008		10.1074/jbc.M113.494328	http://dx.doi.org/10.1074/jbc.M113.494328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23918930	Green Published, hybrid			2022-12-28	WOS:000330612800026
J	Kim, S; Park, S				Kim, Sunmin; Park, SangYoun			Structural Changes during Cysteine Desulfurase CsdA and Sulfur Acceptor CsdE Interactions Provide Insight into the trans-Persulfuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI COUNTERPART; S CLUSTER BIOGENESIS; NIFS-LIKE PROTEIN; CRYSTAL-STRUCTURE; SULFINATE DESULFINASE; SELENOCYSTEINE LYASE; GENE CLONING; ISCU; SUFS; PURIFICATION	In Escherichia coli, three cysteine desulfurases (IscS, SufS, and CsdA) initiate the delivery of sulfur for various biological processes such as the biogenesis of Fe-S clusters. The sulfur generated as persulfide on a cysteine residue of cysteine desulfurases is further transferred to Fe-S scaffolds (e.g. IscU) or to intermediate cysteine-containing sulfur acceptors (e.g. TusA, SufE, and CsdE) prior to its utilization. Here, we report the structures of CsdA and the CsdA-CsdE complex, which provide insight into the sulfur transfer mediated by the trans-persulfuration reaction. Analysis of the structures indicates that the conformational flexibility of the active cysteine loop in CsdE is essential for accepting the persulfide from the cysteine of CsdA. Additionally, CsdA and CsdE invoke a different binding mode than those of previously reported cysteine desulfurase (IscS) and sulfur acceptors (TusA and IscU). Moreover, the conservation of interaction-mediating residues between CsdA/SufS and CsdE/SufE further suggests that the SufS-SufE interface likely resembles that of CsdA and CsdE.	[Kim, Sunmin; Park, SangYoun] Soongsil Univ, Sch Syst Biomed Sci, Seoul 156743, South Korea	Soongsil University	Park, S (corresponding author), Soongsil Univ, Coll Nat Sci, Sch Syst Biomed Sci, 511 Sangdo Dong, Seoul 156743, South Korea.	psy@ssu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea [2013R1A1A2005276]; Ministry of Education, Science and Technology (MEST); MEST; Pohang University of Science and Technology	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology	This work was supported by Basic Science Research Program Grant 2013R1A1A2005276 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST). Experiments performed at the Pohang Light Source were supported in part by MEST and the Pohang University of Science and Technology.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Collins R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030581; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldsmith-Fischman S, 2004, J MOL BIOL, V344, P549, DOI 10.1016/j.jmb.2004.08.074; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Sendra M, 2007, FEBS LETT, V581, P1362, DOI 10.1016/j.febslet.2007.02.058; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	36	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27172	27180		10.1074/jbc.M113.480277	http://dx.doi.org/10.1074/jbc.M113.480277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913692	hybrid, Green Published			2022-12-28	WOS:000330597300016
J	Ma, CL; Hagstrom, D; Polley, SG; Subramani, S				Ma, Changle; Hagstrom, Danielle; Polley, Soumi Guha; Subramani, Suresh			Redox-regulated Cargo Binding and Release by the Peroxisomal Targeting Signal Receptor, Pex5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICHIA-PASTORIS; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; MATRIX; MECHANISM; MEMBRANE; UBIQUITINATION; LOCALIZATION; RECOGNITION; BIOGENESIS	In its role as a mobile receptor for peroxisomal matrix cargo containing a peroxisomal targeting signal called PTS1, the protein Pex5 shuttles between the cytosol and the peroxisome lumen. Pex5 binds PTS1 proteins in the cytosol via its C-terminal tetratricopeptide domains and delivers them to the peroxisome lumen, where the receptor.cargo complex dissociates. The cargo-free receptor is exported to the cytosol for another round of import. How cargo release and receptor recycling are regulated is poorly understood. We found that Pex5 functions as a dimer/oligomer and that its protein interactions with itself (homo-oligomeric) and with Pex8 (hetero-oligomeric) control the binding and release of cargo proteins. These interactions are controlled by a redox-sensitive amino acid, cysteine 10 of Pex5, which is essential for the formation of disulfide bond-linked Pex5 forms, for high affinity cargo binding, and for receptor recycling. Disulfide bond-linked Pex5 showed the highest affinity for PTS1 cargo. Upon reduction of the disulfide bond by dithiothreitol, Pex5 transitioned to a noncovalent dimer, concomitant with the partial release of PTS1 cargo. Additionally, dissipation of the redox balance between the cytosol and the peroxisome lumen caused an import defect. A hetero-oligomeric interaction between the N-terminal domain (amino acids 1-110) of Pex5 and a conserved motif at the C terminus of Pex8 further facilitates cargo release, but only under reducing conditions. This interaction is also important for the release of PTS1 proteins. We suggest a redox-regulated model for Pex5 function during the peroxisomal matrix protein import cycle.	[Ma, Changle; Hagstrom, Danielle; Polley, Soumi Guha; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, Rm 3326 Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu		Ireland, Danielle/0000-0002-9827-1604; Ma, Changle/0000-0003-3360-2799	National Institutes of Health MERIT Award [DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737, R37DK041737, R56DK041737] Funding Source: NIH RePORTER	National Institutes of Health MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award DK41737 (to S. S.).	Aksam EB, 2008, FREE RADICAL BIO MED, V45, P1115, DOI 10.1016/j.freeradbiomed.2008.07.010; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Horiguchi H, 2001, J BIOL CHEM, V276, P14279, DOI 10.1074/jbc.M011661200; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; LIU H, 1995, J BIOL CHEM, V270, P10940, DOI 10.1074/jbc.270.18.10940; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Nashiro C, 2011, TRAFFIC, V12, P774, DOI 10.1111/j.1600-0854.2011.01182.x; Noctor Graham, 2011, Arabidopsis Book, V9, pe0142, DOI 10.1199/tab.0142; Ohdate T, 2012, BBA-MOL CELL BIOL L, V1821, P1295, DOI 10.1016/j.bbalip.2012.05.004; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Pye VE, 2010, J BIOL CHEM, V285, P24078, DOI 10.1074/jbc.M110.106013; Saleem RA, 2006, BBA-MOL CELL RES, V1763, P1541, DOI 10.1016/j.bbamcr.2006.09.005; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Sundaramoorthy R, 2006, J MOL BIOL, V359, P347, DOI 10.1016/j.jmb.2006.03.032; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10; Zhang L, 2006, MOL BIOL CELL, V17, P690, DOI 10.1091/mbc.E05-08-0758	39	59	60	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27220	27231		10.1074/jbc.M113.492694	http://dx.doi.org/10.1074/jbc.M113.492694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902771	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000330597300020
J	Rozeboom, HJ; Yu, SK; Madrid, S; Kalk, KH; Zhang, R; Dijkstra, BW				Rozeboom, Henriette J.; Yu, Shukun; Madrid, Susan; Kalk, Kor H.; Zhang, Ran; Dijkstra, Bauke W.			Crystal Structure of alpha-1,4-Glucan Lyase, a Unique Glycoside Hydrolase Family Member with a Novel Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN DEGRADING ENZYME; ALPHA-GLUCOSIDASE; SULFOLOBUS-SOLFATARICUS; EFFICIENT PURIFICATION; SUBSTRATE-SPECIFICITY; MALTASE-GLUCOAMYLASE; STARCH; 1,5-ANHYDRO-D-FRUCTOSE; CLASSIFICATION; XYLOSIDASE	alpha-1,4-Glucan lyase (EC 4.2.2.13) from the red seaweed Gracilariopsis lemaneiformis cleaves alpha-1,4-glucosidic linkages in glycogen, starch, and malto-oligosaccharides, yielding the keto-monosaccharide 1,5-anhydro-D-fructose. The enzyme belongs to glycoside hydrolase family 31 (GH31) but degrades starch via an elimination reaction instead of hydrolysis. The crystal structure shows that the enzyme, like GH31 hydrolases, contains a (beta/alpha)(8)-barrel catalytic domain with B and B' sub-domains, an N-terminal domain N, and the C-terminal domains C and D. The N-terminal domain N of the lyase was found to bind a trisaccharide. Complexes of the enzyme with acarbose and 1-dexoynojirimycin and two different covalent glycosyl-enzyme intermediates obtained with fluorinated sugar analogues show that, like GH31 hydrolases, the aspartic acid residues Asp(553) and Asp(665) are the catalytic nucleophile and acid, respectively. However, as a unique feature, the catalytic nucleophile is in a position to act also as a base that abstracts a proton from the C2 carbon atom of the covalently bound subsite -1 glucosyl residue, thus explaining the unique lyase activity of the enzyme. One Glu to Val mutation in the active site of the homologous alpha-glucosidase from Sulfolobus solfataricus resulted in a shift from hydrolytic to lyase activity, demonstrating that a subtle amino acid difference can promote lyase activity in a GH31 hydrolase.	[Rozeboom, Henriette J.; Kalk, Kor H.; Dijkstra, Bauke W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [Yu, Shukun; Madrid, Susan] Danisco AS, Danisco Innovat, DK-1001 Copenhagen, Denmark; [Zhang, Ran] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of Groningen; University of British Columbia	Yu, SK (corresponding author), Danisco AS, Genencor, Edwin Rahrs Vej 38, DK-8220 Aarhus, Denmark.	shukun.yu@danisco.com; b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019	Dijkstra, Bauke W./0000-0001-9731-6586; Rozeboom, Henriette/0000-0002-1656-6477				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bojsen K, 1999, BBA-PROTEIN STRUCT M, V1430, P396, DOI 10.1016/S0167-4838(99)00017-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook MW, 2003, FOOD CHEM TOXICOL, V41, P523, DOI 10.1016/S0278-6915(02)00280-6; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2005, BIOLOGIA, V60, P149; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Hirano K, 2000, GLYCOBIOLOGY, V10, P1283, DOI 10.1093/glycob/10.12.1283; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2012, J BIOL CHEM, V287, P43288, DOI 10.1074/jbc.M112.416511; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee SS, 2005, BIOLOGIA, V60, P137; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakai Hiroyuki I.T., 2006, J APPL GLYCOSCI, V53, P137, DOI [10.5458/jag.53.137, DOI 10.5458/JAG.53.137]; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Okuyama M, 2006, FEBS LETT, V580, P2707, DOI 10.1016/j.febslet.2006.04.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; Trincone A, 2001, TETRAHEDRON-ASYMMETR, V12, P2783, DOI 10.1016/S0957-4166(01)00491-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Yoshinaga K, 1999, BBA-GEN SUBJECTS, V1472, P447, DOI 10.1016/S0304-4165(99)00147-6; YU S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P313, DOI 10.1016/0304-4165(93)90049-E; Yu S, 1997, BBA-PROTEIN STRUCT M, V1339, P311, DOI 10.1016/S0167-4838(97)00014-9; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125; Yu SK, 1999, BBA-PROTEIN STRUCT M, V1433, P1, DOI 10.1016/S0167-4838(99)00152-1; YU SK, 1995, BBA-GEN SUBJECTS, V1244, P1, DOI 10.1016/0304-4165(94)00202-9; Yu SK, 1999, ROY SOC CH, P243; Yu SK, 1997, CARBOHYD RES, V305, P73, DOI 10.1016/S0008-6215(97)00226-7	50	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26764	26774		10.1074/jbc.M113.485896	http://dx.doi.org/10.1074/jbc.M113.485896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902768	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000330594500041
J	Carafoli, E				Carafoli, Ernesto			Amarcord: I Remember	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; SKELETAL-MUSCLE MITOCHONDRIA; MEMBRANE CA2+ ATPASE; ACTIVE ACCUMULATION; BIOCHEMICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; PARTIAL-PURIFICATION; ESSENTIAL COMPONENT; HEART-MITOCHONDRIA; CALCIUM-PUMP	I have tried to offer a historical account of a success story, as I saw it develop from the early times when it interested only a few aficionados to the present times when it has pervaded most of cell biochemistry and physiology. It is of course the story of calcium signaling. It became my topic of work when I was a young postdoctoral fellow at The Johns Hopkins University. I entered it through a side door, that of mitochondria, which had been my area of work during my earlier days in Italy. The 1960s and 1970s were glorious times for mitochondrial calcium signaling, but the golden period was not going to last. As I have discussed below, mitochondrial calcium gradually lost appeal, entering a long period of oblivion. Its fading happened as the general area of calcium signaling was instead experiencing a phase of explosive growth, with landmark discoveries at the molecular and cellular levels. These discoveries established that calcium signaling was one of the most important areas of cell biology. However, mitochondria as calcium partners were not dead; they were only dormant. In the 1990s, they were rescued from their state of neglect to the central position of the regulation of cellular calcium signaling, which they had once rightly occupied. Meanwhile, it had also become clear that calcium is an ambivalent messenger. Hardly anything important occurs in cells without the participation of the calcium message, but calcium must be controlled with absolute precision. This is an imperative necessity, which becomes unfortunately impaired in a number of disease conditions that transform calcium into a messenger of death.	Univ Padua, VIMM, I-35129 Padua, Italy	University of Padua; Veneto Institute Molecular Medicine	Carafoli, E (corresponding author), Univ Padua, VIMM, I-35129 Padua, Italy.	ernesto.carafoli@unipd.it	Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094				Adams P. J., 2007, V45, P215; ALOISI M, 1960, J PATHOL BACTERIOL, V80, P33, DOI 10.1002/path.1700800105; AZZONE GF, 1960, EXP CELL RES, V21, P456, DOI 10.1016/0014-4827(60)90279-2; AZZONE GF, 1960, EXP CELL RES, V21, P447, DOI 10.1016/0014-4827(60)90278-0; AZZONE GF, 1958, BIOCHIM BIOPHYS ACTA, V30, P360, DOI 10.1016/0006-3002(58)90061-1; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Brini M., 2007, CALCIUM SIGNALING DI, V45; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CAPLAN AI, 1965, BIOCHIM BIOPHYS ACTA, V104, P317, DOI 10.1016/0304-4165(65)90338-7; CARAFOLI E, 1965, BIOCHIM BIOPHYS ACTA, V97, P88, DOI 10.1016/0304-4165(65)90272-2; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Carafoli E, 2004, TRENDS BIOCHEM SCI, V29, P371, DOI 10.1016/j.tibs.2004.05.006; CARAFOLI E, 1965, BIOCHIM BIOPHYS ACTA, V97, P107, DOI 10.1016/0304-4165(65)90274-6; CARAFOLI E, 1967, J GEN PHYSIOL, V50, P1849, DOI 10.1085/jgp.50.7.1849; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; CARAFOLI E, 1965, BIOCHIM BIOPHYS ACTA, V97, P99, DOI 10.1016/0304-4165(65)90273-4; CARAFOLI E, 1962, NATURE, V196, P1101, DOI 10.1038/1961101a0; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; CARAFOLI ERNESTO, 1964, EXP MOL PATHOL, V3, P171, DOI 10.1016/0014-4800(64)90050-4; CARONI P, 1980, NATURE, V283, P765, DOI 10.1038/283765a0; CHEUNG WY, 1971, J BIOL CHEM, V246, P2859; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; DRAHOTA Z, 1965, J BIOL CHEM, V240, P2712; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Giacomello M, 2011, CELL CALCIUM, V50, P569, DOI 10.1016/j.ceca.2011.09.004; GOPINATH RM, 1977, BIOCHEM BIOPH RES CO, V77, P1203, DOI 10.1016/S0006-291X(77)80107-1; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; Heizmann C. W., 2007, V45, P93; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; JARRETT HW, 1977, BIOCHEM BIOPH RES CO, V77, P1210, DOI 10.1016/S0006-291X(77)80108-3; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PETERSON SW, 1978, ARCH BIOCHEM BIOPHYS, V186, P202, DOI 10.1016/0003-9861(78)90481-2; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; SCHATZMANN HJ, 1966, EXPERIENTIA, V22, P364, DOI 10.1007/BF01901136; SHULL GE, 1988, J BIOL CHEM, V263, P8646; Slater E. C, 1958, REV PURE APPL CHEM, V8, P221; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VORHERR T, 1993, PROTEIN SCI, V2, P339; VORHERR T, 1992, BIOCHEMISTRY-US, V31, P371, DOI 10.1021/bi00117a009; Withers S, 2006, MOL CELL ENDOCRINOL, V250, P93, DOI 10.1016/j.mce.2005.12.028; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109	67	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25668	25682		10.1074/jbc.X113.497966	http://dx.doi.org/10.1074/jbc.X113.497966			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23836917	Green Published, hybrid			2022-12-28	WOS:000330623300001
J	Collier, TS; Diraviyam, K; Monsey, J; Shen, W; Sept, D; Bose, R				Collier, Timothy S.; Diraviyam, Karthikeyan; Monsey, John; Shen, Wei; Sept, David; Bose, Ron			Carboxyl Group Footprinting Mass Spectrometry and Molecular Dynamics Identify Key Interactions in the HER2-HER3 Receptor Tyrosine Kinase Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; STRUCTURAL-ANALYSIS; PROTEIN-STRUCTURE; H/D EXCHANGE; DOMAIN; MECHANISM; ACTIVATION; MUTATIONS; SRC	The HER2 receptor tyrosine kinase is a driver oncogene in many human cancers, including breast and gastric cancer. Under physiologic levels of expression, HER2 heterodimerizes with other members of the EGF receptor/HER/ErbB family, and the HER2-HER3 dimer forms one of the most potent oncogenic receptor pairs. Previous structural biology studies have individually crystallized the kinase domains of HER2 and HER3, but the HER2-HER3 kinase domain heterodimer structure has yet to be solved. Using a reconstituted membrane system to form HER2-HER3 kinase domain heterodimers and carboxyl group foot-printing mass spectrometry, we observed that HER2 and HER3 kinase domains preferentially form asymmetric heterodimers with HER3 and HER2 monomers occupying the donor and acceptor kinase positions, respectively. Conformational changes in the HER2 activation loop, as measured by changes in carboxyl group labeling, required both dimerization and nucleotide binding but did not require activation loop phosphorylation at Tyr-877. Molecular dynamics simulations on HER2-HER3 kinase dimers identify specific inter-and intramolecular interactions and were in good agreement with MS measurements. Specifically, several intermolecular ionic interactions between HER2 Lys-716-HER3 Glu-909, HER2 Glu-717-HER3 Lys-907, and HER2 Asp-871-HER3 Arg-948 were identified by molecular dynamics. We also evaluated the effect of the cancer-associated mutations HER2 D769H/D769Y, HER3 E909G, and HER3 R948K (also numbered HER3 E928G and R967K) on kinase activity in the context of this new structural model. This study provides valuable insights into the EGF receptor/HER/ErbB kinase structure and interactions, which can guide the design of future therapies.	[Collier, Timothy S.; Monsey, John; Shen, Wei; Bose, Ron] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO 63110 USA; [Bose, Ron] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Diraviyam, Karthikeyan; Sept, David] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Diraviyam, Karthikeyan; Sept, David] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bose, R (corresponding author), Washington Univ, Sch Med, Div Oncol, Dept Med, Campus Box 8069,660 S Euclid Ave, St Louis, MO 63110 USA.	rbose@dom.wustl.edu	Mieszkowska, Magdalena/O-6753-2017	Collier, Timothy/0000-0002-1102-8741; Sept, David/0000-0003-3719-2483	National Institutes of Health [R01CA161001, 8P41 GM103422-36]; National Science Foundation [NSF-DBI 0922879]; National Institutes of Health T32 Training [2T32HL007088-36]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health T32 Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA161001 (to R. B.) and 8P41 GM103422-36. This work was also supported by National Science Foundation Grant NSF-DBI 0922879.; Supported by National Institutes of Health T32 Training Grant 2T32HL007088-36.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chitta RK, 2006, J AM SOC MASS SPECTR, V17, P1526, DOI 10.1016/j.jasms.2006.08.004; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gau BC, 2013, BBA-PROTEINS PROTEOM, V1834, P1230, DOI 10.1016/j.bbapap.2013.02.023; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; HOARE DG, 1967, J BIOL CHEM, V242, P2447; HOARE DG, 1968, J AM CHEM SOC, V90, P1638, DOI 10.1021/ja01008a040; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jan AY, 2000, BIOCHEMISTRY-US, V39, P9786, DOI 10.1021/bi9924922; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morgan CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010876; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Roulhac PL, 2004, BIOCHEMISTRY-US, V43, P15767, DOI 10.1021/bi0481848; SEGATTO O, 1990, New Biologist, V2, P187; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Sun GQ, 2002, ARCH BIOCHEM BIOPHYS, V397, P11, DOI 10.1006/abbi.2001.2627; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Williamson AJK, 2008, MOL CELL PROTEOMICS, V7, P459, DOI 10.1074/mcp.M700370-MCP200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]; Zhang HT, 1998, ONCOGENE, V16, P2835, DOI 10.1038/sj.onc.1201820; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	58	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25254	25264		10.1074/jbc.M113.474882	http://dx.doi.org/10.1074/jbc.M113.474882			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23843458	Green Published, hybrid			2022-12-28	WOS:000330619000024
J	Lan, T; Wang, XR; Zeng, QY				Lan, Ting; Wang, Xiao-Ru; Zeng, Qing-Yin			Structural and Functional Evolution of Positively Selected Sites in Pine Glutathione S-Transferase Enzyme Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; DIVERSIFICATION; DIVERGENCE; SYNTHASE; RESIDUES; REVEALS	Phylogenetic analyses have identified positive selection as an important driver of protein evolution, both structural and functional. However, the lack of appropriate combined functional and structural assays has generally hindered attempts to elucidate patterns of positively selected sites and their effects on enzyme activity and substrate specificity. In this study we investigated the evolutionary divergence of the glutathione S-transferase (GST) family in Pinus tabuliformis, a pine that is widely distributed from northern to central China, including cold temperate and drought-stressed regions. GSTs play important roles in plant stress tolerance and detoxification. We cloned 44 GST genes from P. tabuliformis and found that 26 of the 44 belong to the largest (Tau) class of GSTs and are differentially expressed across tissues and developmental stages. Substitution models identified five positively selected sites in the Tau GSTs. To examine the functional significance of these positively selected sites, we applied protein structural modeling and site-directed mutagenesis. We found that four of the five positively selected sites significantly affect the enzyme activity and specificity; thus their variation broadens the GST family substrate spectrum. In addition, positive selection has mainly acted on secondary substrate binding sites or sites close to (but not directly at) the primary substrate binding site; thus their variation enables the acquisition of new catalytic functions without compromising the protein primary biochemical properties. Our study sheds light on selective aspects of the functional and structural divergence of the GST family in pine and other organisms.	[Lan, Ting; Zeng, Qing-Yin] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden	Chinese Academy of Sciences; Institute of Botany, CAS; Umea University	Zeng, QY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	qingyin.zeng@ibcas.ac.cn	Wang, Xiao-Ru/H-6811-2012; Wang, Xiao-Ru/AAC-4444-2020	Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046; Lan, Ting/0000-0001-8491-3365; Zeng, Qing-Yin/0000-0002-5730-3016	National Basic Research Program of China [2009CB119104]; Natural Science Foundation of China [30830010, 91231103]; Vetenskapsradet, Sweden	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vetenskapsradet, Sweden(Swedish Research Council)	This work was supported by National Basic Research Program of China Grant 2009CB119104, Natural Science Foundation of China Grants 30830010 and 91231103), and Vetenskapsradet, Sweden.	Agrawal GK, 2002, PLANT SCI, V163, P1153, DOI 10.1016/S0168-9452(02)00331-X; Axarli I, 2009, J MOL BIOL, V385, P984, DOI 10.1016/j.jmb.2008.10.084; Barkman TJ, 2007, MOL BIOL EVOL, V24, P1320, DOI 10.1093/molbev/msm053; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; HUBER R, 1987, BIOCHEM SOC T, V15, P1009, DOI 10.1042/bst0151009; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Padhi SK, 2010, CHEM BIOL, V17, P863, DOI 10.1016/j.chembiol.2010.06.013; RICCI G, 1994, ANAL BIOCHEM, V218, P463, DOI 10.1006/abio.1994.1209; Sabbagh A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-62; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Williams SG, 2009, MOL BIOL EVOL, V26, P1055, DOI 10.1093/molbev/msp020; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yang X, 2009, PLANT PHYSIOL BIOCH, V47, P1061, DOI 10.1016/j.plaphy.2009.07.003; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zeng QY, 2005, FEBS LETT, V579, P2657, DOI 10.1016/j.febslet.2005.03.086; Zeng QY, 2005, BIOCHIMIE, V87, P445, DOI 10.1016/j.biochi.2005.01.002; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	51	41	43	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24441	24451		10.1074/jbc.M113.456863	http://dx.doi.org/10.1074/jbc.M113.456863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846689	Green Published, hybrid			2022-12-28	WOS:000330612300014
J	Vivona, S; Cipriano, DJ; O'Leary, S; Li, YH; Fenn, TD; Brunger, AT				Vivona, Sandro; Cipriano, Daniel J.; O'Leary, Sean; Li, Ye Henry; Fenn, Timothy D.; Brunger, Axel T.			Disassembly of All SNARE Complexes by N-Ethylmaleimide-sensitive Factor (NSF) Is Initiated by a Conserved 1:1 Interaction between alpha-Soluble NSF Attachment Protein (SNAP) and SNARE Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUSION PROTEIN; TERMINAL DOMAIN; EXOCYTOSIS; PARTICLES; TRANSPORT; SYNTAXIN	Vesicle trafficking in eukaryotic cells is facilitated by SNARE-mediated membrane fusion. The ATPase NSF (N-ethylmaleimide- sensitive factor) and the adaptor protein alpha-SNAP (soluble NSF attachment protein) disassemble all SNARE complexes formed throughout different pathways, but the effect of SNARE sequence and domain variation on the poorly understood disassembly mechanism is unknown. By measuring SNARE-stimulated ATP hydrolysis rates, Michaelis-Menten constants for disassembly, and SNAP-SNARE binding constants for four different ternary SNARE complexes and one binary complex, we found a conserved mechanism, not influenced by N-terminal SNARE domains. alpha-SNAP and the ternary SNARE complex form a 1:1 complex as revealed by multiangle light scattering. We propose a model of NSF-mediated disassembly in which the reaction is initiated by a 1:1 interaction between alpha-SNAP and the ternary SNARE complex, followed by NSF binding. Subsequent additional alpha-SNAP binding events may occur as part of a processive disassembly mechanism.	[Vivona, Sandro; Cipriano, Daniel J.; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Vivona, Sandro; O'Leary, Sean; Li, Ye Henry; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Photon Sci, Stanford, CA 94305 USA; [Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Cipriano, Daniel J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	brunger@stanford.edu		Brunger, Axel/0000-0001-5121-2036	National Institutes of Health [R37-MH63105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-MH63105 (to A. T. B.).	Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swanton E, 2000, J CELL SCI, V113, P1783; Tiwari M, 2008, MOL CELL BIOCHEM, V312, P81, DOI 10.1007/s11010-008-9723-7; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	34	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24984	24991		10.1074/jbc.M113.489807	http://dx.doi.org/10.1074/jbc.M113.489807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836889	Green Published, hybrid			2022-12-28	WOS:000330612300061
J	Matsumoto, Y; Zhang, Q; Akita, K; Nakada, H; Hamamura, K; Tsuchida, A; Okajima, T; Furukawa, K; Urano, T; Furukawa, K				Matsumoto, Yasuyuki; Zhang, Qing; Akita, Kaoru; Nakada, Hiroshi; Hamamura, Kazunori; Tsuchida, Akiko; Okajima, Tetsuya; Furukawa, Keiko; Urano, Takeshi; Furukawa, Koichi			Trimeric Tn Antigen on Syndecan 1 Produced by ppGalNAc-T13 Enhances Cancer Metastasis via a Complex Formation with Integrin alpha 5 beta 1 and Matrix Metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; LEWIS LUNG-CANCER; CELL-GROWTH; O-GLYCOSYLATION; GANGLIOSIDE GM1; IN-VIVO; ADHESION; RECEPTOR; ANTIBODY; MICRODOMAINS	We demonstrated previously that ppGalNAc-T13 (T13), identified as an up-regulated gene with increased metastasis in a DNA microarray, generated trimeric Tn (tTn) antigen (GalNAc alpha 1-Ser/Thr)(3) on Syndecan 1 in highly metastatic sublines of Lewis lung cancer. However, it is not known how tTn antigen regulates cancer metastasis. Here, we analyzed the roles of tTn antigen in cancer properties. tTn antigen on Syndecan 1 increased cell adhesion to fibronectin in an integrin-dependent manner. Furthermore, cell adhesion to fibronectin induced phosphorylation of focal adhesion kinase and paxillin in T13-transfectant cells. In the search of Syndecan 1-interacting molecules, it was demonstrated that tTn antigen-carrying Syndecan 1 interacted with integrin alpha 5 beta 1 and matrix metalloproteinase 9 and that these molecules shifted to a glycolipid-enriched microdomain/rafts along with increased metastatic potential in T13-transfectant cells. We also identified a tTn substitution site on Syndecan 1, demonstrating that tTn on Syndecan 1 is essential for the interaction with integrin alpha 5 beta 1 as well as for the reaction with mAb MLS128. These data suggest that high expression of the ppGalNAc-T13 gene generates tTn antigen on Syndecan 1 under reduced expression of GM1, leading to enhanced invasion and metastasis via the formation of a molecular complex consisting of integrin alpha 5 beta 1, Syndecan 1, and MMP-9 in the glycolipid-enriched microdomain/rafts.	[Matsumoto, Yasuyuki; Zhang, Qing; Hamamura, Kazunori; Tsuchida, Akiko; Okajima, Tetsuya; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan; [Akita, Kaoru; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Tsuchida, Akiko] Noguchi Inst, Itabashi Ku, Tokyo 1730003, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan; [Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane 6938501, Japan	Nagoya University; Kyoto Sangyo University; Chubu University; Shimane University	Furukawa, K (corresponding author), 65 Tsurumai,Showa Ku, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Hamamura, Kazunori/0000-0002-8143-338X	Ministry of Education, Culture, Sports, and Technology of Japan [21390076, 24390078, 23590371, 23110008]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Ministry of Education, Culture, Sports, and Technology of Japan Grants-in-Aid for Scientific Research 21390076, 24390078, and 23590371 and by Ministry of Education, Culture, Sports, and Technology of Japan Grant-in-Aid for Scientific Research on Innovative Areas 23110008.	Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, CLIN CHEM, V52, P1701, DOI 10.1373/clinchem.2006.067975; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; CHEN QM, 1994, J BIOL CHEM, V269, P26602; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GIANCOTTI FG, 1994, BBA-REV CANCER, V1198, P47, DOI 10.1016/0304-419X(94)90005-1; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kannagi R, 2004, GLYCOCONJUGATE J, V20, P353; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; Meng XL, 2012, CANCER METAST REV, V31, P247, DOI 10.1007/s10555-011-9342-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morita N, 2009, BIOSCI TRENDS, V3, P32; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Musselli C, 2002, INT J CANCER, V97, P660, DOI 10.1002/ijc.10081; Noujaim AA, 2001, CANCER BIOTHER RADIO, V16, P187, DOI 10.1089/10849780152389384; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	39	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24264	24276		10.1074/jbc.M113.455006	http://dx.doi.org/10.1074/jbc.M113.455006			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814067	hybrid, Green Published			2022-12-28	WOS:000330611400063
J	Subramanian, P; Locatelli-Hoops, S; Kenealey, J; DesJardin, J; Notari, L; Becerra, SP				Subramanian, Preeti; Locatelli-Hoops, Silvia; Kenealey, Jason; DesJardin, Jacqueline; Notari, Luigi; Becerra, S. Patricia			Pigment Epithelium-derived Factor (PEDF) Prevents Retinal Cell Death via PEDF Receptor (PEDF-R) IDENTIFICATION OF A FUNCTIONAL LIGAND BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; POLYUNSATURATED FATTY-ACIDS; CEREBELLAR GRANULE CELLS; DOCOSAHEXAENOIC ACID; OXIDATIVE STRESS; NEUROPROTECTIN D1; PROSTATE-CANCER; FAMILY-MEMBERS; GENE-TRANSFER; IN-VITRO	The extracellular pigment epithelium-derived factor (PEDF) displays retina survival activity by interacting with receptor proteins on cell surfaces. We have previously reported that PEDF binds and stimulates PEDF receptor (PEDF-R), a transmembrane phospholipase. However, the PEDF binding site of PEDF-R and its involvement in survival activity have not been identified. The purpose of this work is to identify a biologically relevant ligand-binding site on PEDF-R. PEDF bound the PEDF-R ectodomain L4 (Leu(159)-Met(325)) with affinity similar to the full-length PEDF-R (Met(1)-Leu(504)). Binding assays using synthetic peptides spanning L4 showed that PEDF selectively bound E5b (Ile(193)-Leu(232)) and P1 (Thr(210)-Leu(249)) peptides. Recombinant C-terminal truncated PEDF-R4 (Met(1)-Leu(232)) and internally truncated PEDF-R and PEDF-R4 (Delta His(203)-Leu(232)) retained phospholipase activity of the full-length PEDF-R. However, PEDF-R polypeptides without the His(203)-Leu(232) region lost the PEDF affinity that stimulated their enzymatic activity. Cell surface labeling showed that PEDF-R is present in the plasma membranes of retina cells. Using siRNA to selectively knock down PEDF-R in retina cells, we demonstrated that PEDF-R is essential for PEDF-mediated cell survival and antiapoptotic activities. Furthermore, preincubation of PEDF with P1 and E5b peptides blocked the PEDF.PEDF-R-mediated retina cell survival activity, implying that peptide binding to PEDF excluded ligand-receptor interactions on the cell surface. Our findings establish that PEDF-R is required for the survival and antiapoptotic effects of PEDF on retina cells and has determinants for PEDF binding within its L4 ectodomain that are critical for enzymatic stimulation.	[Subramanian, Preeti; Locatelli-Hoops, Silvia; Kenealey, Jason; DesJardin, Jacqueline; Notari, Luigi; Becerra, S. Patricia] NEI, Sect Prot Struct & Funct, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Becerra, SP (corresponding author), NEI, NIH, Bldg 6,Rm 134,6 Ctr Dr, Bethesda, MD 20892 USA.	becerrap@nei.nih.gov		, Preeti/0000-0002-6062-6158; DesJardin, Jacqueline/0000-0002-6632-8995	National Institutes of Health, NEI, Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000306] Funding Source: NIH RePORTER	National Institutes of Health, NEI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Abassi YA, 2004, J IMMUNOL METHODS, V292, P195, DOI 10.1016/j.jim.2004.06.022; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DeCoster MA, 1999, J NEUROSCI RES, V56, P604; Deshpande M, 2012, INT J ONCOL, V41, P219, DOI 10.3892/ijo.2012.1431; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Etschmaier K, 2011, J NEUROCHEM, V119, P1016, DOI 10.1111/j.1471-4159.2011.07498.x; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Goetzl EJ, 2004, J CELL BIOCHEM, V92, P867, DOI 10.1002/jcb.20186; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jimenez-Atienzar M, 2003, LIPIDS, V38, P677, DOI 10.1007/s11745-003-1114-9; Kim HY, 2001, J MOL NEUROSCI, V16, P223, DOI 10.1385/JMN:16:2-3:223; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Ladhani O, 2011, NEOPLASIA, V13, P633, DOI 10.1593/neo.11446; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Miyazaki M, 2011, HUM GENE THER, V22, P559, DOI 10.1089/hum.2010.132; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Notari L, 2005, INVEST OPHTH VIS SCI, V46, P2736, DOI 10.1167/iovs.04-1489; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Ogata N, 2001, CURR EYE RES, V22, P245, DOI 10.1076/ceyr.22.4.245.5506; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Rotstein NP, 1997, J NEUROCHEM, V69, P504; Rotstein NP, 2003, INVEST OPHTH VIS SCI, V44, P2252, DOI 10.1167/iovs.02-0901; Sanchez A, 2012, NEUROSCI RES, V72, P1, DOI 10.1016/j.neures.2011.09.003; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stratikos E, 1996, PROTEIN SCI, V5, P2575, DOI 10.1002/pro.5560051220; Subramanian P, 2010, ADV EXP MED BIOL, V664, P29, DOI 10.1007/978-1-4419-1399-9_4; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; Tanimoto Seiji, 2006, Hiroshima Journal of Medical Sciences, V55, P109; Taniwaki T, 1997, J NEUROCHEM, V68, P26; Unterlauft JD, 2012, NEUROCHEM RES, V37, P1524, DOI 10.1007/s11064-012-0747-8; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	64	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23928	23942		10.1074/jbc.M113.487884	http://dx.doi.org/10.1074/jbc.M113.487884			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818523	Green Published, hybrid			2022-12-28	WOS:000330611400032
J	Yin, T; Cho, SJ; Chen, XB				Yin, Tiffany; Cho, Seong-Jun; Chen, Xinbin			RNPC1, an RNA-binding Protein and a p53 Target, Regulates Macrophage Inhibitory Cytokine-1 (MIC-1) Expression through mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; ACTIVATED GENE NAG-1/GDF15; CELL-GROWTH; CANCER; MEMBER; FAMILY; PATHWAY; SERUM; GDF-15/MIC-1	Macrophage inhibitory cytokine-1 (MIC-1), a secreted cytokine, is a direct target of p53 and known to play a role in cell proliferation, apoptosis, cell metastasis, and angiogenesis through autocrine and paracrine signaling. Previous studies have shown that serum levels of MIC-1 closely parallel cancer progression and are being explored as a diagnostic tool. MIC-1 has also shown potential as a therapeutic agent as it has exhibited several anti-carcinogenic activities. Thus, MIC-1 displays two opposing effects: tumor suppression versus promotion. However, it remains unclear whether MIC-1 is regulated by a mechanism other than transcription and how MIC-1 exerts its tumor suppression. In this study, we show that overexpression of RNA-binding protein RNPC1 can increase, whereas knockdown or knock-out of RNPC1 decreases, MIC-1 transcript and protein levels. Additionally, we demonstrate that RNPC1 can bind to MIC-1 mRNA via an AU-rich element within MIC-1 3'-UTR and then enhances MIC-1 mRNA stability. Finally, to explore the functional significance of MIC-1, we showed that knockdown of MIC-1 can decrease RNPC1-induced cell growth suppression. Altogether, we uncover a novel mechanism by which MIC-1 can be regulated through RNPC1 via mRNA stability.	[Yin, Tiffany; Cho, Seong-Jun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Cho, SJ (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	sjucho@ucdavis.edu; xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		NATIONAL CANCER INSTITUTE [R01CA102188, R01CA121137, R01CA081237] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121137, R01 CA081237, R01 CA102188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cheng JC, 2011, ENDOCRINOLOGY, V152, P2987, DOI 10.1210/en.2011-0059; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Kadowaki M, 2012, INT J CANCER, V130, P267, DOI 10.1002/ijc.26082; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kim IY, 2011, ARCH PHARM RES, V34, P323, DOI 10.1007/s12272-011-0219-8; Kim JS, 2005, MOL CANCER THER, V4, P487; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang H, 2003, MOL CANCER THER, V2, P1023; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	34	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23680	23686		10.1074/jbc.M113.480186	http://dx.doi.org/10.1074/jbc.M113.480186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836903	Green Published, hybrid			2022-12-28	WOS:000330611400008
J	McGettrick, AF; O'Neill, LAJ				McGettrick, Anne F.; O'Neill, Luke A. J.			How Metabolism Generates Signals during Innate Immunity and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTORS; NLRP3 INFLAMMASOME; AEROBIC GLYCOLYSIS; INSULIN-RESISTANCE; GOUTY-ARTHRITIS; FATTY-ACIDS; SIRT1; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS	The interplay between immunity, inflammation, and metabolic changes is a growing field of research. Toll-like receptors and NOD-like receptors are families of innate immune receptors, and their role in the human immune response is well documented. Exciting new evidence is emerging with regard to their role in the regulation of metabolism and the activation of inflammatory pathways during the progression of metabolic disorders such as type 2 diabetes and atherosclerosis. The pro-inflammatory cytokine IL-1 beta appears to play a central role in these disorders. There is also evidence that metabolites such as NAD(+) (acting via deacetylases such as SIRT1 and SIRT2) and succinate (which regulates hypoxia-inducible factor 1 alpha) are signals that regulate innate immunity. In addition, the extracellular overproduction of metabolites such as uric acid and cholesterol crystals acts as a signal sensed by NLRP3, leading to the production of IL-1 beta. These observations cast new light on the role of metabolism during host defense and inflammation.	[McGettrick, Anne F.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	McGettrick, AF (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	mcgettra@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; European Research Council	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Science Foundation Ireland and the European Research Council (to L. A. J. O.).	Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; MOYER CF, 1991, AM J PATHOL, V138, P951; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Schlesinger N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3297; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Violi F, 2009, FUTUR CARDIOL, V5, P83, DOI 10.2217/14796678.5.1.83; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WARBURG O, 1958, Z NATURFORSCH PT B, V13, P515, DOI 10.1515/znb-1958-0806; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	53	156	164	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22893	22898		10.1074/jbc.R113.486464	http://dx.doi.org/10.1074/jbc.R113.486464			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798679	Green Published, hybrid			2022-12-28	WOS:000330598200002
J	Rollenhagen, M; Buettner, FFR; Reismann, M; Jirmo, AC; Grove, M; Behrens, GMN; Gerardy-Schahn, R; Hanisch, FG; Muhlenhoff, M				Rollenhagen, Manuela; Buettner, Falk F. R.; Reismann, Marc; Jirmo, Adan Chari; Grove, Melanie; Behrens, Georg M. N.; Gerardy-Schahn, Rita; Hanisch, Franz-Georg; Muehlenhoff, Martina			Polysialic Acid on Neuropilin-2 Is Exclusively Synthesized by the Polysialyltransferase ST8SiaIV and Attached to Mucin-type O-Glycans Located between the b2 and c Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION-MOLECULE; POSTNATAL MOUSE-BRAIN; HUMAN DENDRITIC CELLS; IN-VIVO; SEMAPHORIN-III; SYNCAM 1; POLYSIALYLATION; NCAM; RECEPTOR; EXPRESSION	Neuropilin-2 (NRP2) is well known as a co-receptor for class 3 semaphorins and vascular endothelial growth factors, involved in axon guidance and angiogenesis. Moreover, NRP2 was shown to promote chemotactic migration of human monocyte-derived dendritic cells (DCs) toward the chemokine CCL21, a function that relies on the presence of polysialic acid (polySia). In vertebrates, this posttranslational modification is predominantly found on the neural cell adhesion molecule (NCAM), where it is synthesized on N-glycans by either of the two polysialyltransferases, ST8SiaII or ST8SiaIV. In contrast to NCAM, little is known on the biosynthesis of polySia on NRP2. Here we identified the polySia attachment sites and demonstrate that NRP2 is recognized only by ST8SiaIV. Although polySia-NRP2 was found on bone marrow-derived DCs from wild-type and St8sia2(-/-) mice, polySia was completely lost in DCs from St8sia4(-/-) mice despite normal NRP2 expression. In COS-7 cells, co-expression of NRP2 with ST8SiaIV but not ST8SiaII resulted in the formation of polySia-NRP2, highlighting distinct acceptor specificities of the two polysialyltransferases. Notably, ST8SiaIV synthesized polySia selectively on a NRP2 glycoform that was characterized by the presence of sialylated core 1 and core 2 O-glycans. Based on a comprehensive site-directed mutagenesis study, we localized the polySia attachment sites to an O-glycan cluster located in the linker region between b2 and c domain. Combined alanine exchange of Thr-607,-613,-614, -615,-619, and -624 efficiently blocked polysialylation. Restoration of single sites only partially rescued polysialylation, suggesting that within this cluster, polySia is attached to more than one site.	[Rollenhagen, Manuela; Buettner, Falk F. R.; Grove, Melanie; Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30623 Hannover, Germany; [Reismann, Marc] Hannover Med Sch, Dept Pediat Surg, D-30623 Hannover, Germany; [Jirmo, Adan Chari; Behrens, Georg M. N.] Hannover Med Sch, Clin Immunol & Rheumatol, D-30623 Hannover, Germany; [Hanisch, Franz-Georg] Univ Cologne, Inst Biochem 2, Fac Med, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Cologne; University of Cologne	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Carl Neuberg Str 1, D-30623 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de	Behrens, Georg MN/Q-4486-2016	Jirmo, Adan Chari/0000-0002-4693-0081; Reismann, Marc/0000-0001-7426-1578	Deutsche Forschungsgemeinschaft [MU 1774/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MU 1774/3 (to M. M.).	Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DENNIS JW, 1993, GLYCOBIOLOGY, V3, P91, DOI 10.1093/glycob/3.2.91; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; HUANG J, 1992, ONCOL RES, V4, P507; HUET G, 1995, J CELL SCI, V108, P1275; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johnson CP, 2005, BIOCHEMISTRY-US, V44, P546, DOI 10.1021/bi048263j; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rollenhagen M, 2012, J BIOL CHEM, V287, P35170, DOI 10.1074/jbc.M112.375642; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schwarz Q, 2010, CELL ADHES MIGR, V4, P61, DOI 10.4161/cam.4.1.10207; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Sozzani S, 2000, J CLIN IMMUNOL, V20, P151, DOI 10.1023/A:1006659211340; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Takashima S, 2002, J BIOL CHEM, V277, P24030, DOI 10.1074/jbc.M112367200; Teintenier-Lelievre M, 2005, BIOCHEM J, V392, P665, DOI 10.1042/BJ20051120; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; ZUBER C, 1992, J BIOL CHEM, V267, P9965	72	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22880	22892		10.1074/jbc.M113.463927	http://dx.doi.org/10.1074/jbc.M113.463927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801331	Green Published, hybrid			2022-12-28	WOS:000330598200001
J	Thomas, F; Lundqvist, LCE; Jam, M; Jeudy, A; Barbeyron, T; Sandstrom, C; Michel, G; Czjzek, M				Thomas, Franois; Lundqvist, Lena C. E.; Jam, Murielle; Jeudy, Alexandra; Barbeyron, Tristan; Sandstrom, Corine; Michel, Gurvan; Czjzek, Mirjam			Comparative Characterization of Two Marine Alginate Lyases from Zobellia galactanivorans Reveals Distinct Modes of Action and Exquisite Adaptation to Their Natural Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; MOLECULAR-IDENTIFICATION; OLIGOALGINATE LYASE; ENZYMATIC FORMATION; ACID METABOLISM; URONIC-ACID; SEQUENCE; OLIGOSACCHARIDES; BACTERIUM	Cell walls of brown algae are complex supramolecular assemblies containing various original, sulfated, and carboxylated polysaccharides. Among these, the major marine polysaccharide component, alginate, represents an important biomass that is successfully turned over by the heterotrophic marine bacteria. In the marine flavobacterium Zobellia galactanivorans, the catabolism and uptake of alginate are encoded by operon structures that resemble the typical Bacteroidetes polysaccharide utilization locus. The genome of Z. galactanivorans contains seven putative alginate lyase genes, five of which are localized within two clusters comprising additional carbohydrate-related genes. This study reports on the detailed biochemical and structural characterization of two of these. We demonstrate here that AlyA1(PL7) is an endolytic guluronate lyase, and AlyA5 cleaves unsaturated units, alpha-L-guluronate or beta-D-manuronate residues, at the nonreducing end of oligo-alginates in an exolytic fashion. Despite a common jelly roll-fold, these striking differences of the mode of action are explained by a distinct active site topology, an open cleft in AlyA1(PL7), whereas AlyA5 displays a pocket topology due to the presence of additional loops partially obstructing the catalytic groove. Finally, in contrast to PL7 alginate lyases from terrestrial bacteria, both enzymes proceed according to a calcium-dependent mechanism suggesting an exquisite adaptation to their natural substrate in the context of brown algal cell walls.	[Thomas, Franois; Jam, Murielle; Barbeyron, Tristan; Michel, Gurvan; Czjzek, Mirjam] Univ Paris 06, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Thomas, Franois; Jam, Murielle; Barbeyron, Tristan; Michel, Gurvan; Czjzek, Mirjam] CNRS, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Lundqvist, Lena C. E.; Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem, SE-75007 Uppsala, Sweden; [Jeudy, Alexandra] Univ Paris 06, FR2424, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Jeudy, Alexandra] CNRS, FR2424, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Swedish University of Agricultural Sciences; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), Univ Paris 06, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France.	czjzek@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; Thomas, Francois/0000-0003-1896-0774	European Community [222628]; Region Bretagne; CNRS	European Community(European Commission); Region Bretagne(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by European Community's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 222628 and by the Region Bretagne and the CNRS.	ABDELAKHER MA, 1951, ARCH BIOCHEM, V30, P407; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; Chavagnat F, 1998, CARBOHYD RES, V308, P409, DOI 10.1016/S0008-6215(98)00095-0; COWMAN MK, 1984, BIOCHEM J, V221, P707, DOI 10.1042/bj2210707; CRAIGIE JS, 1984, CARBOHYD POLYM, V4, P237, DOI 10.1016/0144-8617(84)90001-8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 1998, J BACTERIOL, V180, P3779; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hashimoto Wataru, 2010, Bioeng Bugs, V1, P97, DOI 10.4161/bbug.1.2.10322; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuorelahti S, 2006, MOL MICROBIOL, V61, P1060, DOI 10.1111/j.1365-2958.2006.05294.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; MURATA K, 1993, J FERMENT BIOENG, V76, P427, DOI 10.1016/0922-338X(93)90040-F; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1963, J BIOL CHEM, V238, P1571; PREISS J, 1962, J BIOL CHEM, V237, P317; QUATRANO RS, 1976, PLANT PHYSIOL, V58, P224, DOI 10.1104/pp.58.2.224; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Shimokawa T, 1997, CARBOHYD RES, V304, P125, DOI 10.1016/S0008-6215(97)00230-9; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Skriptsova A, 2004, J APPL PHYCOL, V16, P17, DOI 10.1023/B:JAPH.0000019049.74140.61; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; ZABLACKIS E, 1990, BOT MAR, V33, P273, DOI 10.1515/botm.1990.33.3.273; Zhang ZQ, 2004, CARBOHYD RES, V339, P1475, DOI 10.1016/j.carres.2004.03.010	74	127	134	5	74	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23021	23037		10.1074/jbc.M113.467217	http://dx.doi.org/10.1074/jbc.M113.467217			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782694	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000330598200012
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The X-ray Crystal Structure of Mannose-binding Lectin-associated Serine Proteinase-3 Reveals the Structural Basis for Enzyme Inactivity Associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMBILICAL ANOMALIES; PATHWAY ACTIVATION; ANTERIOR-CHAMBER; DIFFRACTION DATA; SERUM LECTIN; COMPLEMENT; PROTEASE; MUTATIONS; SKELETAL; PTOSIS	The mannose-binding lectin associated-protease-3 (MASP-3) is a member of the lectin pathway of the complement system, a key component of human innate and active immunity. Mutations in MASP-3 have recently been found to be associated with Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome, a severe developmental disorder manifested by cleft palate, intellectual disability, and skeletal abnormalities. However, the molecular basis for MASP-3 function remains to be understood. Here we characterize the substrate specificity of MASP-3 by screening against a combinatorial peptide substrate library. Through this approach, we successfully identified a peptide substrate that was 20-fold more efficiently cleaved than any other identified to date. Furthermore, we demonstrated that mutant forms of the enzyme associated with 3MC syndrome were completely inactive against this substrate. To address the structural basis for this defect, we determined the 2.6-angstrom structure of the zymogen form of the G666E mutant of MASP-3. These data reveal that the mutation disrupts the active site and perturbs the position of the catalytic serine residue. Together, these insights into the function of MASP-3 reveal how a mutation in this enzyme causes it to be inactive and thus contribute to the 3MC syndrome.	[Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Ctr Excellence Struct & Funct Microbia, Clayton, Vic 3800, Australia; [Coetzer, Theresa H.] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, ZA-3209 Scottsville, South Africa	Monash University; Monash University; University of Kwazulu Natal	Pike, RN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	rob.pike@monash.edu; lakshmi.wijeyewickrema@monash.edu	Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019; Wijeyewickrema, Lakshmi/A-9676-2015	Coetzer, Theresa/0000-0003-0706-3808; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Wilmann, Pascal/0000-0002-8376-5150; Whisstock, James/0000-0003-4200-5611	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant from the National Health and Medical Research Council of Australia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Kaissi A, 2007, AM J MED GENET A, V143A, P349, DOI 10.1002/ajmg.a.31610; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; Duncan RC, 2012, J IMMUNOL, V189, P2365, DOI 10.4049/jimmunol.1201085; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endo Y, 1998, J IMMUNOL, V161, P4924; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goldring JPD, 2005, IMMUNOL INVEST, V34, P101, DOI 10.1081/IMM-200049537; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; IKEDA K, 1987, J BIOL CHEM, V262, P7451; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Leal GF, 2008, AM J MED GENET A, V146A, P1059, DOI 10.1002/ajmg.a.32252; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Wijeyewickrema LC, 2013, J BIOL CHEM, V288, P15571, DOI 10.1074/jbc.M113.451757; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	35	20	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22399	22407		10.1074/jbc.M113.483875	http://dx.doi.org/10.1074/jbc.M113.483875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792966	hybrid, Green Published			2022-12-28	WOS:000330596300021
J	Zhang, SF; Zhao, H; Darzynkiewicz, Z; Zhou, PB; Zhang, ZT; Lee, EYC; Lee, MYWT				Zhang, Sufang; Zhao, Hong; Darzynkiewicz, Zbiegniew; Zhou, Pengbo; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			A Novel Function of CRL4(Cdt2) REGULATION OF THE SUBUNIT STRUCTURE OF DNA POLYMERASE delta IN RESPONSE TO DNA DAMAGE AND DURING THE S PHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; OKAZAKI FRAGMENT MATURATION; UBIQUITIN LIGASE; P12 SUBUNIT; PIP BOX; PCNA; DEGRADATION; REPLICATION; P21; REPAIR	DNA polymerase delta (Pol delta 4) is a heterotetrameric enzyme, whose p12 subunit is degraded in response to DNA damage, leaving behind a trimer (Pol delta 3) with altered enzymatic characteristics that participate in gap filling during DNA repair. We demonstrate that CRL4(Cdt2), a key regulator of cell cycle progression that targets replication licensing factors, also targets the p12 subunit of Pol delta 4 in response to DNA damage and on entry into S phase. Evidence for the involvement of CRL4(Cdt2) included demonstration that p12 possesses a proliferating cell nuclear antigen-interacting protein-degron (PIP-degron) and that knockdown of the components of the CRL4(Cdt2) complex inhibited the degradation of p12 in response to DNA damage. Analysis of p12 levels in synchronized cell populations showed that p12 is partially degraded in S phase and that this is affected by knockdowns of CUL4A or CUL4B. Laser scanning cytometry of overexpressed wild type p12 and a mutant resistant to degradation showed that the reduction in p12 levels during S phase was prevented by mutation of p12. Thus, CRL4(Cdt2) also regulates the subunit composition of Pol delta during the cell cycle. These studies reveal a novel function of CRL4(Cdt2), i.e. the direct regulation of DNA polymerase delta, adding to its known functions in the regulation of the licensing of replication origins and expanding the scope of its overall control of DNA replication. The formation of Pol delta 3 in S phase as a normal aspect of cell cycle progression leads to the novel implications that it is involved in DNA replication as well as DNA repair.	[Zhang, Sufang; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Zhao, Hong; Darzynkiewicz, Zbiegniew] New York Med Coll, Dept Pathol, Brander Canc Res Inst, Valhalla, NY 10595 USA; [Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	New York Medical College; New York Medical College; Cornell University	Lee, MYWT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Marietta_lee@NYMC.edu		Zhang, Sufang/0000-0003-3883-023X; Darzynkiewicz, Zbigniew/0000-0002-2040-7081; zhang, zhongtao/0000-0002-1910-4753	National Institutes of Health [GM31973, ES14737, CA028704, CA098210, CA159925]; NATIONAL CANCER INSTITUTE [R56CA098210, R01CA159925, R01CA098210, R01CA028704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31973 and ES14737 (to M. Y. W. T. L.), CA028704 (to Z. D.), and CA098210 and CA159925 (to P. Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Galal WC, 2012, CELL CYCLE, V11, P2771, DOI 10.4161/cc.21258; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gibbs E, 1997, J BIOL CHEM, V272, P2373; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kerzendorfer C, 2011, MECH AGEING DEV, V132, P366, DOI 10.1016/j.mad.2011.02.003; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, DNA REPAIR, V5, P404, DOI 10.1016/j.dnarep.2005.12.005; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li H, 2006, CELL CYCLE, V5, P428, DOI 10.4161/cc.5.4.2425; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Rytkonen AK, 2006, FEBS J, V273, P2984, DOI 10.1111/j.1742-4658.2006.05310.x; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Vaara M, 2012, J BIOL CHEM, V287, P33327, DOI 10.1074/jbc.M112.357996; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P2941, DOI 10.1074/jbc.M112.423392; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhao H, 2012, CYTOM PART A, V81A, P45, DOI 10.1002/cyto.a.21172; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018	80	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29550	29561		10.1074/jbc.M113.490466	http://dx.doi.org/10.1074/jbc.M113.490466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23913683	Green Published, hybrid			2022-12-28	WOS:000330615300031
J	Calderon, RH; Garcia-Cerdan, JG; Malnoe, A; Cook, R; Russell, JJ; Gaw, C; Dent, RM; de Vitry, C; Niyogi, KK				Calderon, Robert H.; Garcia-Cerdan, Jose G.; Malnoe, Alizee; Cook, Ron; Russell, James J.; Gaw, Cynthia; Dent, Rachel M.; de Vitry, Catherine; Niyogi, Krishna K.			A Conserved Rubredoxin Is Necessary for Photosystem II Accumulation in Diverse Oxygenic Photoautotrophs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; SYNECHOCOCCUS SP PCC-7002; ARABIDOPSIS-THALIANA; ELECTRON-TRANSFER; CHLAMYDOMONAS-REINHARDTII; CLOSTRIDIUM-PASTEURIANUM; FUNCTIONAL GENOMICS; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; NIFE HYDROGENASE	In oxygenic photosynthesis, two photosystems work in tandem to harvest light energy and generate NADPH and ATP. Photosystem II (PSII), theprotein-pigmentcomplexthatuseslightenergyto catalyze the splitting of water, is assembled from its component parts in a tightly regulated process that requires a number of assembly factors. The 2pac mutant of the unicellular green alga Chlamydomonas reinhardtii was isolated and found to have no detectable PSII activity, whereas other components of the photosynthetic electron transport chain, including photosystem I, were still functional. PSII activity was fully restored by complementation with the RBD1 gene, which encodes a small iron-sulfur protein known as a rubredoxin. Phylogenetic evidence supports the hypothesis that this rubredoxin and its orthologs are unique to oxygenic phototrophs and distinct from rubredoxins in Archaea and bacteria (excluding cyanobacteria). Knockouts of the rubredoxin orthologs in the cyanobacterium Synechocystis sp. PCC 6803 and the plant Arabidopsis thaliana were also found to be specifically affected in PSII accumulation. Taken together, our data suggest that this rubredoxin is necessary for normal PSII activity in a diverse set of organisms that perform oxygenic photosynthesis.	[Calderon, Robert H.; Garcia-Cerdan, Jose G.; Malnoe, Alizee; Cook, Ron; Russell, James J.; Gaw, Cynthia; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Malnoe, Alizee; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [de Vitry, Catherine] Univ Paris 06, CNRS, Inst Biol Physicochim, Unite Mixte Rech 7141, F-75005 Paris, France	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Niyogi, KK (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@berkeley.edu	Malnoë, Alizée/U-4517-2018	Malnoë, Alizée/0000-0002-8777-3174; Calderon, Robert/0000-0002-7863-9889	Philomathia Foundation; Gordon and Betty Moore Foundation [GBMF3070]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP [449B]	Philomathia Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP	This work was supported in part by the Philomathia Foundation and the Gordon and Betty Moore Foundation (through Grant GBMF3070, to K. K. N.).; Supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP number 449B.	ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; Boehm M, 2011, J BIOL CHEM, V286, P14812, DOI 10.1074/jbc.M110.207944; Cai WH, 2010, PLANT PHYSIOL, V154, P109, DOI 10.1104/pp.110.159558; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Eaton-Rye JJ, 2011, METHODS MOL BIOL, V684, P295, DOI [10.1007/978.1.60761.925.3_22, 10.1007/978-1-60761-925-3_22]; Eriksson Jan, 2000, Molecular Cell Biology Research Communications, V3, P292, DOI 10.1006/mcbr.2000.0227; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fritsch J, 2011, J BACTERIOL, V193, P2487, DOI 10.1128/JB.01427-10; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagelueken G, 2007, P NATL ACAD SCI USA, V104, P12276, DOI 10.1073/pnas.0702919104; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kunert A, 2000, J MICROBIOL METH, V41, P185, DOI 10.1016/S0167-7012(00)00162-7; Kurtz DM, 2004, ACCOUNTS CHEM RES, V37, P902, DOI 10.1021/ar0200091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Martienssen RA, 1998, P NATL ACAD SCI USA, V95, P2021, DOI 10.1073/pnas.95.5.2021; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Tiwari A, 2009, BBA-BIOENERGETICS, V1787, P985, DOI 10.1016/j.bbabio.2009.03.017; Tran PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042196; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Wastl J, 2000, FEBS LETT, V471, P191, DOI 10.1016/S0014-5793(00)01399-5; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417	61	41	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26688	26696		10.1074/jbc.M113.487629	http://dx.doi.org/10.1074/jbc.M113.487629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900844	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330594500034
J	Ismail, IH; McDonald, D; Strickfaden, H; Xu, ZZ; Hendzel, MJ				Ismail, Ismail Hassan; McDonald, Darin; Strickfaden, Hilmar; Xu, Zhizhong; Hendzel, Michael J.			A Small Molecule Inhibitor of Polycomb Repressive Complex 1 Inhibits Ubiquitin Signaling at DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; HISTONE UBIQUITYLATION; REPAIR PROTEINS; H2AX PROTEIN; STEM-CELLS; BMI1; PHOSPHORYLATION; RECRUITMENT; LIGASE; CANCER	Polycomb-repressive complex 1 (PRC1)-mediated histone ubiquitylation plays an important role in aberrant gene silencing in human cancers and is a potential target for cancer therapy. Here we show that 2-pyridine-3-yl-methylene-indan-1,3-dione (PRT4165) is a potent inhibitor of PRC1-mediated H2A ubiquitylation in vivo and in vitro. The drug also inhibits the accumulation of all detectable ubiquitin at sites of DNA double-strand breaks (DSBs), the retention of several DNA damage response proteins in foci that form around DSBs, and the repair of the DSBs. In vitro E3 ubiquitin ligase activity assays revealed that PRT4165 inhibits both RNF2 and RING 1A, which are partially redundant paralogues that together account for the E3 ubiquitin ligase activity found in PRC1 complexes, but not RNF8 nor RNF168. Because ubiquitylation is completely inhibited despite the efficient recruitment of RNF8 to DSBs, our results suggest that PRC1-mediated monoubiquitylation is required for subsequent RNF8- and/or RNF168-mediated polyubiquitylation. Our results demonstrate the unique feature of PRT4165 as a novel chromatin-remodeling compound and provide a new tool for the inhibition of ubiquitylation signaling at DNA double-strand breaks.	[Ismail, Ismail Hassan; McDonald, Darin; Strickfaden, Hilmar; Xu, Zhizhong; Hendzel, Michael J.] Univ Alberta, Cross Canc Inst, Dept Oncol, Fac Med & Dent, Edmonton, AB T6G 1Z2, Canada; [Ismail, Ismail Hassan] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt	University of Alberta; Egyptian Knowledge Bank (EKB); Cairo University	Hendzel, MJ (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Fac Med & Dent, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Hendzel, Michael/C-3391-2009; Strickfaden, Hilmar/AAW-3522-2021	Hendzel, Michael/0000-0002-9603-7945; Ismail, Ismail Hassan/0000-0002-5526-6063	Alberta Cancer Foundation; Canadian Institute of Health Research	Alberta Cancer Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Alberta Cancer Foundation and the Canadian Institute of Health Research.	Alchanati I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008104; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Opeskin K, 1998, J CLIN NEUROSCI, V5, P471, DOI 10.1016/S0967-5868(98)90295-8; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Uhrhammer Nancy, 1998, Cancer Research, V58, P3480; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469	32	58	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26944	26954		10.1074/jbc.M113.461699	http://dx.doi.org/10.1074/jbc.M113.461699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902761	hybrid, Green Published			2022-12-28	WOS:000330594500059
J	Lauffer, BEL; Mintzer, R; Fong, RN; Mukund, S; Tam, C; Zilberleyb, I; Flicke, B; Ritscher, A; Fedorowicz, G; Vallero, R; Ortwine, DF; Gunzner, J; Modrusan, Z; Neumann, L; Koth, CM; Lupardus, PJ; Kaminker, JS; Heise, CE; Steiner, P				Lauffer, Benjamin E. L.; Mintzer, Robert; Fong, Rina; Mukund, Susmith; Tam, Christine; Zilberleyb, Inna; Flicke, Birgit; Ritscher, Allegra; Fedorowicz, Grazyna; Vallero, Roxanne; Ortwine, Daniel F.; Gunzner, Janet; Modrusan, Zora; Neumann, Lars; Koth, Christopher M.; Lupardus, Patrick J.; Kaminker, Joshua S.; Heise, Christopher E.; Steiner, Pascal			Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; ISOFORM SELECTIVITY; EXPRESSION; CANCER; LEUKEMIA; GENE; GENERATION; INDUCTION; APOPTOSIS; PATTERNS	Histone deacetylases (HDACs) are critical in the control of gene expression, and dysregulation of their activity has been implicated in a broad range of diseases, including cancer, cardiovascular, and neurological diseases. HDAC inhibitors (HDACi) employing different zinc chelating functionalities such as hydroxamic acids and benzamides have shown promising results in cancer therapy. Although it has also been suggested that HDACi with increased isozyme selectivity and potency may broaden their clinical utility and minimize side effects, the translation of this idea to the clinic remains to be investigated. Moreover, a detailed understanding of how HDACi with different pharmacological properties affect biological functions in vitro and in vivo is still missing. Here, we show that a panel of benzamide-containing HDACi are slow tight-binding inhibitors with long residence times unlike the hydroxamate-containing HDACi vorinostat and trichostatin-A. Characterization of changes in H2BK5 and H4K14 acetylation following HDACi treatment in the neuroblastoma cell line SH-SY5Y revealed that the timing and magnitude of histone acetylation mirrored both the association and dissociation kinetic rates of the inhibitors. In contrast, cell viability and microarray gene expression analysis indicated that cell death induction and changes in transcriptional regulation do not correlate with the dissociation kinetic rates of the HDACi. Therefore, our study suggests that determining how the selective and kinetic inhibition properties of HDACi affect cell function will help to evaluate their therapeutic utility.	[Lauffer, Benjamin E. L.; Vallero, Roxanne; Steiner, Pascal] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Mintzer, Robert; Heise, Christopher E.] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Fong, Rina; Mukund, Susmith; Tam, Christine; Zilberleyb, Inna; Koth, Christopher M.; Lupardus, Patrick J.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Labs Microarray, San Francisco, CA 94080 USA; [Ortwine, Daniel F.; Gunzner, Janet] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA; [Kaminker, Joshua S.] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Flicke, Birgit; Ritscher, Allegra; Neumann, Lars] Proteros Biostruct GmbH, D-82152 Planegg Martinsfried, Germany; [Fedorowicz, Grazyna] CellScape Corp, Newark, CA 94560 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Heise, CE (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	heise.christopher@gene.com; steiner.pascal@gene.com		Koth, Christopher/0000-0003-3939-8856	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NCRR [P41RR001209]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yvonne Franke and Krista Bowman at Genentech for cloning and expression of HDACs. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy, Office of Science, by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS and Grant P41RR001209 from the NCRR. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bertrand P, 2010, EUR J MED CHEM, V45, P2095, DOI 10.1016/j.ejmech.2010.02.030; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chavan AV, 2010, MINI-REV MED CHEM, V10, P1263; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERICKSON P, 1992, BLOOD, V80, P1825; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guidotti A, 2011, NEUROPHARMACOLOGY, V60, P1007, DOI 10.1016/j.neuropharm.2010.10.021; Halsall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033453; Hanson J., 2013, PLOS ONE IN PRESS; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Janssen C, 2010, J NEUROPATH EXP NEUR, V69, P573, DOI 10.1097/NEN.0b013e3181ddd404; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kattar SD, 2009, BIOORG MED CHEM LETT, V19, P1168, DOI 10.1016/j.bmcl.2008.12.083; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Neumann L, 2011, METHOD ENZYMOL, V493, P299, DOI 10.1016/B978-0-12-381274-2.00012-1; Neumann L, 2009, J COMPUT AID MOL DES, V23, P501, DOI 10.1007/s10822-009-9288-x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Rosato RR, 2003, CANCER RES, V63, P3637; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whitehead L, 2011, BIOORGAN MED CHEM, V19, P4626, DOI 10.1016/j.bmc.2011.06.030; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	57	267	270	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26926	26943		10.1074/jbc.M113.490706	http://dx.doi.org/10.1074/jbc.M113.490706			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897821	hybrid, Green Published			2022-12-28	WOS:000330594500058
J	Xia, HJ; Wang, CY; Chen, WL; Zhang, HL; Chaudhury, L; Zhou, ZM; Liu, R; Chen, CS				Xia, Houjun; Wang, Chunyan; Chen, Wenlin; Zhang, Hailin; Chaudhury, Leena; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi			Kruppel-like Factor 5 Transcription Factor Promotes Microsomal Prostaglandin E-2 Synthase 1 Gene Transcription in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; IN-VIVO; PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; ANGIOTENSIN-II; EXPRESSION; KLF5; PROLIFERATION; TUMORIGENESIS; ACTIVATION	The KLF5 (Kruppel-like factor 5) transcription factor is specifically expressed in a subset of estrogen receptor alpha-negative breast cancers. Although KLF5 promotes breast cancer cell cycle progression, survival, and tumorigenesis, the mechanism by which KLF5 promotes breast cancer is still not entirely understood. Here, we demonstrate that mPGES1, encoding microsomal prostaglandin E-2 synthase 1 (mPGES1), is a KLF5 direct downstream target gene. KLF5 overexpression or knockdown positively altered the levels of mPGES1 mRNA and protein in multiple breast cell lines. 12-O-Tetradecanoylphorbol-13-acetate induced the expression of both KLF5 and mPGES1 in dosage- and time-dependent manners. The induction of KLF5 was essential for 12-O-tetradecanoylphorbol-13-acetate to induce mPGES1 expression. Additionally, KLF5 bound to the mPGES1 gene proximal promoter and activated its transcription. Both KLF5 and mPGES1 promoted prostaglandin E-2 production; regulated p21, p27, and Survivin downstream gene expression; and likewise stimulated cell proliferation. Overexpression of mPGES1 partially rescued the KLF5 knockdown-induced downstream gene expression changes and growth arrest in MCF10A cells. Finally, we demonstrate that the expression of mPGES1 was positively correlated with the estrogen receptor alpha/progesterone receptor/HER2 triple-negative status. These findings suggest that mPGES1 is a target gene of KLF5, making it a new biomarker and a potential therapeutic target for triple-negative breast cancers.	[Xia, Houjun; Wang, Chunyan; Zhang, Hailin; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Xia, Houjun; Wang, Chunyan; Zhang, Hailin; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Wang, Chunyan] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, Chunyan] Kunming Med Univ, Affiliated Hosp 1, Dept Pathol, Kunming 650031, Yunnan, Peoples R China; [Chen, Wenlin] Kunming Med Univ, Canc Hosp, Kunming 650031, Yunnan, Peoples R China; [Chaudhury, Leena] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University; Kunming Medical University; Albany Medical College	Chen, CS (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	chenc@mail.kiz.ac.cn		Xia, Houjun/0000-0003-1045-1465; Chen, Ceshi/0000-0001-6398-3516	Stem Cell and Regenerative Medicine Research Grant from the Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040406]; National Natural Science Foundation of China [81202110, 81272930, U1132605]; Top Talents Program of Yunnan Province, China [2010CI114]; Science and Technological Key Project of Yunnan Province [2012FB185]; "Western Light" Talents Training Program of the Chinese Academy of Sciences	Stem Cell and Regenerative Medicine Research Grant from the Strategic Priority Research Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Talents Program of Yunnan Province, China; Science and Technological Key Project of Yunnan Province; "Western Light" Talents Training Program of the Chinese Academy of Sciences	This work was supported by Stem Cell and Regenerative Medicine Research Grant XDA01040406 from the Strategic Priority Research Program of the Chinese Academy of Sciences; National Natural Science Foundation of China Grants 81202110, 81272930, and U1132605; Grant 2010CI114 from the Top Talents Program of Yunnan Province, China; Grant 2012FB185 from the Science and Technological Key Project of Yunnan Province (to R. L.); and the "Western Light" Talents Training Program of the Chinese Academy of Sciences (to H.X.).	Bafford R, 2006, SURGERY, V140, P289, DOI 10.1016/j.surg.2006.04.004; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chandrasekharan S, 2005, J LIPID RES, V46, P2636, DOI 10.1194/jlr.M500213-JLR200; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CJ, 2012, PATHOL ONCOL RES, V18, P161, DOI 10.1007/s12253-011-9422-7; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Deckmann K, 2010, BIOCHEM PHARMACOL, V80, P1365, DOI 10.1016/j.bcp.2010.07.032; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Diaz-Munoz MD, 2012, BIOCHEM J, V443, P451, DOI 10.1042/BJ20111052; Guerrero MD, 2009, EUR J PHARMACOL, V620, P112, DOI 10.1016/j.ejphar.2009.08.007; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Donnini S, 2012, ONCOGENE, V31, P3457, DOI 10.1038/onc.2011.503; Ekstrom L, 2003, BBA-GENE STRUCT EXPR, V1627, P79, DOI 10.1016/S0167-4781(03)00077-0; Forsberg L, 2000, FEBS LETT, V471, P78, DOI 10.1016/S0014-5793(00)01367-3; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Harris RE, 2000, CANCER RES, V60, P2101; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; Kim HS, 2012, BREAST CANCER RES TR, V132, P51, DOI 10.1007/s10549-011-1521-3; Koeberle A, 2010, J PHARMACOL EXP THER, V332, P840, DOI 10.1124/jpet.109.160663; Kubatka P, 2003, CANCER LETT, V202, P131, DOI 10.1016/j.canlet.2003.08.006; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Lu D, 2012, ONCOGENE, V31, P842, DOI 10.1038/onc.2011.287; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nakanishi M, 2010, BIOCHIMIE, V92, P660, DOI 10.1016/j.biochi.2010.02.006; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Park SY, 2012, J CELL BIOCHEM, V113, P3653, DOI 10.1002/jcb.24238; Rorsch F, 2010, J MED CHEM, V53, P911, DOI 10.1021/jm9012505; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Takagi K, 2012, ENDOCR-RELAT CANCER, V19, P741, DOI 10.1530/ERC-12-0017; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Walters JN, 2012, BIOCHEM J, V443, P561, DOI 10.1042/BJ20111801; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	54	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26731	26740		10.1074/jbc.M113.483958	http://dx.doi.org/10.1074/jbc.M113.483958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913682	Green Published, hybrid			2022-12-28	WOS:000330594500038
J	Kobayashi, M; Debold, EP; Turner, MA; Kobayashi, T				Kobayashi, Minae; Debold, Edward P.; Turner, Matthew A.; Kobayashi, Tomoyoshi			Cardiac Muscle Activation Blunted by a Mutation to the Regulatory Component, Troponin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTOMYOSIN SUBFRAGMENT-1 ATPASE; RABBIT SKELETAL-MUSCLE; THIN-FILAMENT; TROPOMYOSIN-TROPONIN; ACTIN-FILAMENTS; IN-VITRO; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; ALPHA-TROPOMYOSIN; STRIATED-MUSCLE	The striated muscle thin filament comprises actin, tropomyosin, and troponin. The Tn complex consists of three subunits, troponin C (TnC), troponin I (TnI), and troponin T (TnT). TnT may serve as a bridge between the Ca2+ sensor (TnC) and the actin filament. In the short helix preceding the IT-arm region, H1(T2), there are known dilated cardiomyopathy-linked mutations (among them R205L). Thus we hypothesized that there is an element in this short helix that plays an important role in regulating the muscle contraction, especially in Ca2+ activation. We mutated Arg-205 and several other amino acid residues within and near the H1(T2) helix. Utilizing an alanine replacement method to compare the effects of the mutations, the biochemical and mechanical impact on the actomyosin interaction was assessed by solution ATPase activity assay, an in vitro motility assay, and Ca2+ binding measurements. Ca2+ activation was markedly impaired by a point mutation of the highly conserved basic residue R205A, residing in the short helix H1(T2) of cTnT, whereas the mutations to nearby residues exhibited little effect on function. Interestingly, rigor activation was unchanged between the wild type and R205A TnT. In addition to the reduction in Ca2+ sensitivity observed in Ca2+ binding to the thin filament, myosin S1-ADP binding to the thin filament was significantly affected by the same mutation, which was also supported by a series of S1 concentration-dependent ATPase assays. These suggest that the R205A mutation alters function through reduction in the nature of cooperative binding of S1.	[Kobayashi, Minae; Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Debold, Edward P.; Turner, Matthew A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Amherst	Kobayashi, M (corresponding author), 835 S Wolcott Ave M-C 901, Chicago, IL 60612 USA.	minaek@uic.edu			National Institutes of Health [R01 HL082923, T32 HL007692]; American Heart Association [09SDG2100039]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL082923 (to T. K.) and T32 HL007692 (to M. K.). This work was also supported by American Heart Association Grant 09SDG2100039 (to E. P. D.).	AMPHLETT GW, 1976, FEBS LETT, V72, P163, DOI 10.1016/0014-5793(76)80836-8; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; CHONG PCS, 1982, J BIOL CHEM, V257, P9152; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Debold EP, 2012, J APPL PHYSIOL, V113, P1413, DOI 10.1152/japplphysiol.00775.2012; Debold EP, 2011, AM J PHYSIOL-REG I, V300, pR1401, DOI 10.1152/ajpregu.00772.2010; EISENBERG E, 1974, J BIOL CHEM, V249, P4742; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gafurov B, 2004, BIOPHYS J, V87, P1825, DOI 10.1529/biophysj.104.043364; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon AM, 1997, BIOPHYS J, V72, P1295, DOI 10.1016/S0006-3495(97)78776-9; GUTH K, 1987, J BIOL CHEM, V262, P13627; HEELEY DH, 1989, BIOCHEM J, V258, P831, DOI 10.1042/bj2580831; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Homsher E, 2003, BIOPHYS J, V85, P1046, DOI 10.1016/S0006-3495(03)74543-3; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LAMKIN M, 1983, BIOCHEMISTRY-US, V22, P3053, DOI 10.1021/bi00282a005; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Manning EP, 2012, J MOL BIOL, V421, P54, DOI 10.1016/j.jmb.2012.05.008; Manning EP, 2012, J BIOL CHEM, V287, P14515, DOI 10.1074/jbc.M111.257436; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mijailovich SM, 2012, EUR BIOPHYS J BIOPHY, V41, P1015, DOI 10.1007/s00249-012-0859-8; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PAN BS, 1989, J BIOL CHEM, V264, P8495; PAN BS, 1987, J BIOL CHEM, V262, P7839; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pinto JR, 2008, PFLUG ARCH EUR J PHY, V456, P1177, DOI 10.1007/s00424-008-0480-y; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Robinson P, 2007, FASEB J, V21, P896, DOI 10.1096/fj.06-6899com; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Swartz DR, 1997, BIOPHYS J, V73, P293, DOI 10.1016/S0006-3495(97)78070-6; Sykes BD, 2003, NAT STRUCT BIOL, V10, P588, DOI 10.1038/nsb0803-588; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; TAO T, 1986, BIOCHEMISTRY-US, V25, P7633, DOI 10.1021/bi00371a054; TAWADA Y, 1975, J BIOCHEM, V78, P65; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; WALSH TP, 1985, J MOL BIOL, V182, P265, DOI 10.1016/0022-2836(85)90344-4	67	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26335	26349		10.1074/jbc.M113.494096	http://dx.doi.org/10.1074/jbc.M113.494096			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897817	hybrid, Green Published			2022-12-28	WOS:000330623300062
J	Nakashima, A; von Reuss, SH; Tasaka, H; Nomura, M; Mochizuki, S; Iijima, Y; Aoki, K; Shibata, D; Boland, W; Takabayashi, J; Matsui, K				Nakashima, Anna; von Reuss, Stephan H.; Tasaka, Hiroyuki; Nomura, Misaki; Mochizuki, Satoshi; Iijima, Yoko; Aoki, Koh; Shibata, Daisuke; Boland, Wilhelm; Takabayashi, Junji; Matsui, Kenji			Traumatin- and Dinortraumatin-containing Galactolipids in Arabidopsis THEIR FORMATION IN TISSUE-DISRUPTED LEAVES AS COUNTERPARTS OF GREEN LEAF VOLATILES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE LYASE PATHWAY; JASMONIC ACID BIOSYNTHESIS; LIPID-PEROXIDATION; PLANTS; OXYLIPINS; ALDEHYDES; FRAGMENTATION; LIPOXYGENASE; SPECIFICITY; INDUCTION	Green leaf volatiles (GLVs) consisting of six-carbon aldehydes, alcohols, and their esters, are biosynthesized through the action of fatty acid hydroperoxide lyase (HPL), which uses fatty acid hydroperoxides as substrates. GLVs form immediately after disruption of plant leaf tissues by herbivore attacks and mechanical wounding and play a role in defense against attackers that attempt to invade through the wounds. The fates and the physiological significance of the counterparts of the HPL reaction, the 12/10-carbon oxoacids that are formed from 18/16-carbon fatty acid 13-/11-hydroperoxides, respectively, are largely unknown. In this study, we detected monogalactosyl diacylglycerols (MGDGs) containing the 12/10-carbon HPL products in disrupted leaf tissues of Arabidopsis, cabbage, tobacco, tomato, and common bean. They were identified as an MGDG containing 12-oxo-9-hydroxy-(E)-10-dodecenoic acid and 10-oxo-7-hydroxy-(E)-8-decenoic acid and an MGDG containing two 12-oxo-9-hydroxy-(E)-10-dodecenoic acids as their acyl groups. Analyses of Arabidopsis mutants lacking HPL indicated that these MGDGs were formed enzymatically through an active HPL reaction. Thus, our results suggested that in disrupted leaf tissues, MGDG-hydroperoxides were cleaved by HPL to form volatile six-carbon aldehydes and non-volatile 12/10-carbon aldehyde-containing galactolipids. Based on these results, we propose a novel oxylipin pathway that does not require the lipase reaction to form GLVs.	[Nakashima, Anna; Tasaka, Hiroyuki; Nomura, Misaki; Mochizuki, Satoshi; Matsui, Kenji] Yamaguchi Univ, Dept Biol Chem, Fac Agr, Yamaguchi 7538515, Japan; [Nakashima, Anna; Tasaka, Hiroyuki; Nomura, Misaki; Mochizuki, Satoshi; Matsui, Kenji] Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Yamaguchi 7538515, Japan; [von Reuss, Stephan H.; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Iijima, Yoko; Aoki, Koh; Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Iijima, Yoko] Kanagawa Inst Technol, Dept Nutr & Life Sci, Atsugi, Kanagawa 2430292, Japan; [Aoki, Koh] Osaka Prefectural Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Yamaguchi University; Yamaguchi University; Max Planck Society; Kazusa DNA Research Institute; Kanagawa Institute Technology; Osaka Metropolitan University; Kyoto University	Matsui, K (corresponding author), Yamaguchi Univ, Dept Biol Chem, Fac Agr, Yamaguchi 7538515, Japan.	matsui@yamaguchi-u.ac.jp	Boland, Wilhelm/K-7762-2012; Takabayashi, Junji/G-2212-2010	Boland, Wilhelm/0000-0001-6784-2534; Takabayashi, Junji/0000-0002-3575-9952; von Reuss, Stephan/0000-0003-4325-5495	Japan Society for the Promotion of Science (JSPS) [23580151, 20004]; Yamaguchi University Yobimizu Project	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamaguchi University Yobimizu Project	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 23580151 and Core-to-Core Project 20004 and by the Yamaguchi University Yobimizu Project.	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bottcher C, 2007, PLANTA, V226, P629, DOI 10.1007/s00425-007-0511-5; Bonaventure G, 2011, PLANT CELL ENVIRON, V34, P1507, DOI 10.1111/j.1365-3040.2011.02348.x; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chechetkin IR, 2009, FEBS J, V276, P4463, DOI 10.1111/j.1742-4658.2009.07153.x; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; Deng YH, 1998, J ORG CHEM, V63, P7789, DOI 10.1021/jo980861e; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; ESTERBAU.H, 1967, MONATSH CHEM, V98, P1994, DOI 10.1007/BF01167162; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Hammond DG, 2000, J AGR FOOD CHEM, V48, P4410, DOI 10.1021/jf000233+; Hisamatsu Y, 2006, BOT STUD, V47, P45; Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471; Hughes RK, 2006, BIOCHEM SOC T, V34, P1223, DOI 10.1042/BST0341223; Ibrahim A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00095; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kallenbach M, 2011, NEW PHYTOL, V191, P1054, DOI 10.1111/j.1469-8137.2011.03767.x; Kandzia R, 2003, J PLANT PHYSIOL, V160, P803, DOI 10.1078/0176-1617-01026; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; Komisarski M, 2009, ACTA BIOCHIM POL, V56, P189; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050089; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Matsui K, 1996, FEBS LETT, V394, P21, DOI 10.1016/0014-5793(96)00924-6; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Matsui K, 2009, METHODS MOL BIOL, V580, P17, DOI 10.1007/978-1-60761-325-1_2; Mene-Saffrane L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Nakamura S, 2002, J AGR FOOD CHEM, V50, P7639, DOI 10.1021/jf025808c; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Nakashima A, 2011, J PLANT INTERACT, V6, P93, DOI 10.1080/17429145.2010.544767; Nilsson AK, 2012, FEBS LETT, V586, P2483, DOI 10.1016/j.febslet.2012.06.010; Noordermeer MA, 2000, BIOCHEM BIOPH RES CO, V277, P112, DOI 10.1006/bbrc.2000.3641; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Piesik D, 2011, J PLANT PHYSIOL, V168, P1534, DOI 10.1016/j.jplph.2011.01.032; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; SAKAKI T, 1990, PLANT PHYSIOL, V94, P766, DOI 10.1104/pp.94.2.766; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shiojiri K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00378; Sias B, 2004, BIOCHEMISTRY-US, V43, P10138, DOI 10.1021/bi049818d; Stelmach BA, 2001, J BIOL CHEM, V276, P12832, DOI 10.1074/jbc.M010743200; ZIMMERMAN DC, 1979, PLANT PHYSIOL, V63, P536, DOI 10.1104/pp.63.3.536; Zoeller M, 2012, PLANT PHYSIOL, V160, P365, DOI 10.1104/pp.112.202846	52	27	28	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26078	26088		10.1074/jbc.M113.487959	http://dx.doi.org/10.1074/jbc.M113.487959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888054	Green Published, hybrid			2022-12-28	WOS:000330623300037
J	Patenaude, C; Zhang, YQ; Cormack, B; Kohler, J; Rao, R				Patenaude, Cassandra; Zhang, Yongqiang; Cormack, Brendan; Koehler, Julia; Rao, Rajini			Essential Role for Vacuolar Acidification in Candida albicans Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; V-ATPASE; GENE ENCODES; CELLULAR PH; SUBUNIT; DELETION; CALCINEURIN; HOMEOSTASIS; COMPONENTS; ISOFORMS	Fungal infections are on the rise, with mortality above 30% in patients with septic Candida infections. Mutants lacking V-ATPase activity are avirulent and fail to acidify endomembrane compartments, exhibiting pleiotropic defects in secretory, endosomal, and vacuolar pathways. However, the individual contribution of organellar acidification to virulence and its associated traits is not known. To dissect their separate roles in Candida albicans pathogenicity we generated knock-out strains for the V-0 subunit a genes VPH1 and STV1, which target the vacuole and secretory pathway, respectively. While the two subunits were redundant in many vma phenotypes, such as alkaline pH sensitivity, calcium homeostasis, respiratory defects, and cell wall integrity, we observed a unique contribution of VPH1. Specifically, vph1 Delta was defective in acidification of the vacuole and its dependent functions, such as metal ion sequestration as evidenced by hypersensitivity to Zn2+ toxicity, whereas stv1 Delta resembled wild type. In growth conditions that elicit morphogenic switching, vph1 Delta was defective in forming hyphae whereas stv1 Delta was normal or only modestly impaired. Host cell interactions were evaluated in vitro using the Caco-2 model of intestinal epithelial cells, and murine macrophages. Like wild type, stv1 Delta was able to inflict cellular damage in Caco-2 and macrophage cells, as assayed by LDH release, and escape by filamentation. In contrast, vph1 Delta resembled a vma7 Delta mutant, with significant attenuation in host cell damage. Finally, we show that VPH1 is required for fungal virulence in a murine model of systemic infection. Our results suggest that vacuolar acidification has an essential function in the ability of C. albicans to form hyphae and establish infection.	[Patenaude, Cassandra; Zhang, Yongqiang; Rao, Rajini] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cormack, Brendan] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Koehler, Julia] Harvard Univ, Sch Med, Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu			National Institutes of Health [R01AI065983, R01 GM52414, R21 AI064715, 5T32DK007632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064715, R01AI046223, R01AI065983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142, T32GM007445, R01GM052414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI065983 and R01 GM52414 (to R. R.), R21 AI064715 (to J. K.), and Training Grant 5T32DK007632 (to C. P.).	Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; Cornet M, 2009, RES MICROBIOL, V160, P219, DOI 10.1016/j.resmic.2009.02.002; De Bernardis F, 1998, INFECT IMMUN, V66, P3317, DOI 10.1128/IAI.66.7.3317-3325.1998; Dieterich C, 2002, MICROBIOL-SGM, V148, P497, DOI 10.1099/00221287-148-2-497; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; Gamarra S, 2010, ANTIMICROB AGENTS CH, V54, P1753, DOI 10.1128/AAC.01728-09; Ha KC, 1999, ANTIMICROB AGENTS CH, V43, P763, DOI 10.1128/AAC.43.4.763; HEMENWAY CS, 1995, GENETICS, V141, P833; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; NELSON H, 1994, J BIOL CHEM, V269, P24150; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Palmer Glen E, 2011, Commun Integr Biol, V4, P240, DOI 10.4161/cib.4.2.14717; Perzov N, 2002, J EXP BIOL, V205, P1209; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Raines SM, 2013, J BIOL CHEM, V288, P6190, DOI 10.1074/jbc.M112.426197; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhang YQ, 2012, CURR PROTEIN PEPT SC, V13, P134, DOI 10.2174/138920312800493205	39	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26256	26264		10.1074/jbc.M113.494815	http://dx.doi.org/10.1074/jbc.M113.494815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884420	Green Published, hybrid			2022-12-28	WOS:000330623300055
J	Lee, MT; Leung, YK; Chung, I; Tarapore, P; Ho, SM				Lee, Ming-Tsung; Leung, Yuet-Kin; Chung, Irving; Tarapore, Pheruza; Ho, Shuk-Mei			Estrogen Receptor beta (ER beta 1) Transactivation Is Differentially Modulated by the Transcriptional Coregulator Tip60 in a cis-Acting Element-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HISTONE ACETYLTRANSFERASE ACTIVITY; CREB-BINDING PROTEIN; ER-ALPHA; PROSTATE-CANCER; GENE-EXPRESSION; ANDROGEN RECEPTOR; NUCLEAR RECEPTORS; PARTIAL AGONIST; HINGE REGION	Estrogen receptor (ER) beta 1 and ER alpha have overlapping and distinct functions despite their common use of estradiol as the physiological ligand. These attributes are explained in part by their differential utilization of coregulators and ligands. Although Tip60 has been shown to interact with both receptors, its regulatory role in ER beta 1 transactivation has not been defined. In this study, we found that Tip60 enhances transactivation of ER beta 1 at the AP-1 site but suppresses its transcriptional activity at the estrogen-response element (ERE) site in an estradiol-independent manner. However, different estrogenic compounds can modify the Tip60 action. The corepressor activity of Tip60 at the ERE site is abolished by diarylpropionitrile, genistein, equol, and bisphenol A, whereas its coactivation at the AP-1 site is augmented by fulvestrant (ICI 182,780). GRIP1 is an important tethering mediator for ERs at the AP-1 site. We found that coexpression of GRIP1 synergizes the action of Tip60. Although Tip60 is a known acetyltransferase, it is unable to acetylate ER beta 1, and its coregulatory functions are independent of its acetylation activity. In addition, we showed the co-occupancy of ER beta 1 and Tip60 at ERE and AP-1 sites of ER beta 1 target genes. Tip60 differentially regulates the endogenous expression of the target genes by modulating the binding of ER beta 1 to the cis-regulatory regions. Thus, we have identified Tip60 as the first dual-function coregulator of ER beta 1.	[Lee, Ming-Tsung; Leung, Yuet-Kin; Chung, Irving; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Div Environm Genet & Mol Toxicol, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Inst Canc, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Dept Environm Hlth, Rm 130,Kettering Lab Complex,3223 Eden Ave, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Tarapore, Pheruza/A-8876-2013; Leung, Ricky/H-5958-2019	Tarapore, Pheruza/0000-0003-0911-3661; Leung, Ricky/0000-0003-2063-277X	National Institutes of Health from NIEHS [R01CA015776, R01DK061084, R01ES015584, U01ES019480, U01ES020988, P30ES006096]; Veterans Affairs [I01BX000675]; Congressionally Directed Medical Research Program Department of Defense [PC094619, BC094017]; NATIONAL CANCER INSTITUTE [R01CA015776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480, U01ES020988, P30ES006096, R01ES015584] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; Veterans Affairs(US Department of Veterans Affairs); Congressionally Directed Medical Research Program Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA015776, R01DK061084, R01ES015584, U01ES019480, U01ES020988, and P30ES006096 from NIEHS (to S. M. H.). This work was also supported by Veterans Affairs Grant I01BX000675 (to S. M. H.) and Congressionally Directed Medical Research Program Department of Defense Grants PC094619 (to P. T.) and BC094017 (to M. T. L.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bjornstrom Linda, 2004, Nucl Recept, V2, P3, DOI 10.1186/1478-1336-2-3; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Fu MF, 2004, BIOCHEM PHARMACOL, V68, P1199, DOI 10.1016/j.bcp.2004.05.037; Fujimoto N, 2004, J STEROID BIOCHEM, V88, P53, DOI 10.1016/j.jsbmb.2003.10.006; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Harris DM, 2005, EXP BIOL MED, V230, P558, DOI 10.1177/153537020523000807; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ho SM, 2011, ENDOCRIN METAB CLIN, V40, P591, DOI 10.1016/j.ecl.2011.05.002; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Jeong KW, 2012, MOL ENDOCRINOL, V26, P955, DOI 10.1210/me.2012-1066; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jeyakunnar M, 2011, J BIOL CHEM, V286, P12971, DOI 10.1074/jbc.M110.205112; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Nikov GN, 2000, ENVIRON HEALTH PERSP, V108, P867, DOI 10.2307/3434995; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; Sanchez M, 2013, ONCOGENE, V32, P117, DOI 10.1038/onc.2012.19; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shiota M, 2010, PROSTATE, V70, P540, DOI 10.1002/pros.21088; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397; Zwart W, 2010, J CELL SCI, V123, P1253, DOI 10.1242/jcs.061135	71	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25038	25052		10.1074/jbc.M113.476952	http://dx.doi.org/10.1074/jbc.M113.476952			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857583	hybrid, Green Published			2022-12-28	WOS:000330619000005
J	Wang, YT; Murakami, Y; Yasui, T; Wakana, S; Kikutani, H; Kinoshita, T; Maeda, Y				Wang, Yetao; Murakami, Yoshiko; Yasui, Teruhito; Wakana, Shigeharu; Kikutani, Hitoshi; Kinoshita, Taroh; Maeda, Yusuke			Significance of Glycosylphosphatidylinositol-anchored Protein Enrichment in Lipid Rafts for the Control of Autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELLS; T-LYMPHOCYTES; IDENTIFICATION; GENE; CLEARANCE; DELETION; EXPRESSION; RESPONSES; TIM4	Glycosylphosphatidylinositols (GPI) are complex glycolipids that are covalently linked to the C terminus of proteins as a post-translational modification and tether proteins to the plasma membrane. One of the most striking features of GPI-anchored proteins (APs) is their enrichment in lipid rafts. The biosynthesis of GPI and its attachment to proteins occur in the endoplasmic reticulum. In the Golgi, GPI-APs are subjected to fatty acid remodeling, which replaces an unsaturated fatty acid at the sn-2 position of the phosphatidylinositol moiety with a saturated fatty acid. We previously reported that fatty acid remodeling is critical for the enrichment of GPI-APs in lipid rafts. To investigate the biological significance of GPI-AP enrichment in lipid rafts, we generated a PGAP3 knock-out mouse (PGAP3(-/-)) in which fatty acid remodeling of GPI-APs does not occur. Wereport here that a significant number of aged PGAP3(-/-) mice developed autoimmune-like symptoms, such as increased anti-DNA antibodies, spontaneous germinal center formation, and enlarged renal glomeruli with deposition of immune complexes and matrix expansion. A possible cause for this was the impaired engulfment of apoptotic cells by resident peritoneal macrophages in PGAP3(-/-) mice. Mice with conditional targeting of PGAP3 in either B or T cells did not develop such autoimmune-like symptoms. In addition, PGAP3(-/-) mice exhibited the tendency of Th2 polarization. These data demonstrate that PGAP3-dependent fatty acid remodeling of GPI-APs has a significant role in the control of autoimmunity, possibly by the regulation of apoptotic cell clearance and Th1/Th2 balance.	[Wang, Yetao; Murakami, Yoshiko; Kinoshita, Taroh; Maeda, Yusuke] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; [Wang, Yetao; Murakami, Yoshiko; Kinoshita, Taroh; Maeda, Yusuke] Osaka Univ, Lab Immunoglycobiol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yasui, Teruhito; Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; [Yasui, Teruhito; Kikutani, Hitoshi] Osaka Univ, Lab Mol Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Wakana, Shigeharu] RIKEN Bioresource Ctr, Japan Mouse Clin, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan	Osaka University; Osaka University; Osaka University; Osaka University; RIKEN	Maeda, Y (corresponding author), Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ymaeda@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009		Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23370060] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abrami L, 2001, J BIOL CHEM, V276, P30729, DOI 10.1074/jbc.M102039200; Beissert S, 1998, J IMMUNOL, V161, P5296; Gonzalez-Cabrero J, 1999, P NATL ACAD SCI USA, V96, P1019, DOI 10.1073/pnas.96.3.1019; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hazenbos WLW, 2004, J IMMUNOL, V173, P3810, DOI 10.4049/jimmunol.173.6.3810; Hellquist A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008037; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Itoh M, 1998, J IMMUNOL, V161, P3974; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jones DR, 1998, INT J BIOCHEM CELL B, V30, P313, DOI 10.1016/S1357-2725(97)00144-1; Litwack ED, 2004, MOL CELL NEUROSCI, V25, P263, DOI 10.1016/j.mcn.2003.10.016; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Matthes M, 1997, ADV EXP MED BIOL, V419, P271; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Robinson PJ, 1997, ADV EXP MED BIOL, V419, P365; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Seong J, 2013, J LIPID RES, V54, P1077, DOI 10.1194/jlr.M034421; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	35	18	18	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25490	25499		10.1074/jbc.M113.492611	http://dx.doi.org/10.1074/jbc.M113.492611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23864655	Green Published, hybrid			2022-12-28	WOS:000330619000044
J	Yang, Y; Liu, C; Lin, YL; Li, F				Yang, Yang; Liu, Chang; Lin, Yi-Lun; Li, Fang			Structural Insights into Central Hypertension Regulation by Human Aminopeptidase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ENZYMATIC-ACTIVITY; ANGIOTENSIN-II; BLOOD-PRESSURE; INHIBITORS; BRAIN; CALCIUM; RENIN; IDENTIFICATION; VASOPRESSIN	Hypertension is regulated through both the central and systemic renin-angiotensin systems. In the central renin-angiotensin system, zinc-dependent aminopeptidase A (APA) up-regulates blood pressure by specifically cleaving the N-terminal aspartate, but not the adjacent arginine, from angiotensin II, a process facilitated by calcium. Here, we determined the crystal structures of human APA and its complexes with different ligands and identified a calcium-binding site in the S1 pocket of APA. Without calcium, the S1 pocket can bind both acidic and basic residues through formation of salt bridges with the charged side chains. In the presence of calcium, the binding of acidic residues is enhanced as they ligate the cation, whereas the binding of basic residues is no longer favorable due to charge repulsion. Of the peptidomimetic inhibitors of APA, amastatin has higher potency than bestatin by fitting better in the S1 pocket and interacting additionally with the S3' subsite. These results explain the calcium-modulated substrate specificity of APA in central hypertension regulation and can guide the design and development of brain-targeting antihypertensive APA inhibitors.	[Yang, Yang; Liu, Chang; Lin, Yi-Lun; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-121 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu	Yang, Yang/R-7215-2016	Yang, Yang/0000-0001-9061-3828	University of Minnesota	University of Minnesota(University of Minnesota System)	This work was supported the University of Minnesota (to F. L.).	Bakris G, 1997, J HYPERTENS, V15, P545, DOI 10.1097/00004872-199715050-00011; BASSO N, 1981, HYPERTENSION, V3, P14, DOI 10.1161/01.HYP.3.6_Pt_2.II-14; BENAJIBA A, 1980, EUR J BIOCHEM, V107, P381; Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Fournie-Zaluski MC, 2004, P NATL ACAD SCI USA, V101, P7775, DOI 10.1073/pnas.0402312101; GANTEN D, 1983, SCIENCE, V221, P869, DOI 10.1126/science.6879184; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; LI L, 1993, TISSUE ANTIGENS, V42, P488, DOI 10.1111/j.1399-0039.1993.tb02193.x; Marc Y, 2012, HYPERTENSION, V60, P411, DOI 10.1161/HYPERTENSIONAHA.112.190942; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Mizutani S, 2008, HEART FAIL REV, V13, P273, DOI 10.1007/s10741-007-9065-7; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; OPARIL S, 1974, NEW ENGL J MED, V291, P389, DOI 10.1056/NEJM197408222910805; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radevski I, 1999, AM J HYPERTENS, V12, P194, DOI 10.1016/S0895-7061(98)00233-7; Reaux A, 1999, NEUROENDOCRINOLOGY, V69, P370, DOI 10.1159/000054439; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rozenfeld R, 2003, BIOCHEMISTRY-US, V42, P14785, DOI 10.1021/bi034358u; Rozenfeld R, 2002, J BIOL CHEM, V277, P29242, DOI 10.1074/jbc.M204406200; Saine DR, 1996, ANN INTERN MED, V124, P775, DOI 10.7326/0003-4819-124-8-199604150-00015; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; SIELECKI AR, 1989, SCIENCE, V243, P1346, DOI 10.1126/science.2493678; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zini S, 1998, NEUROREPORT, V9, P825, DOI 10.1097/00001756-199803300-00011; Zini S, 1997, NEUROSCIENCE, V78, P1187, DOI 10.1016/S0306-4522(96)00660-4; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	42	28	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25638	25645		10.1074/jbc.M113.494955	http://dx.doi.org/10.1074/jbc.M113.494955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23888046	hybrid, Green Published			2022-12-28	WOS:000330619000058
J	Wang, CM; Liu, XG; Liu, Y; Zhang, Q; Yao, ZY; Huang, B; Zhang, P; Li, N; Cao, XT				Wang, Chunmei; Liu, Xingguang; Liu, Yin; Zhang, Qian; Yao, Zhenyu; Huang, Bo; Zhang, Peng; Li, Nan; Cao, Xuetao			Zinc Finger Protein 64 Promotes Toll-like Receptor-triggered Proinflammatory and Type I Interferon Production in Macrophages by Enhancing p65 Subunit Activation (Publication with Expression of Concern. See vol. 295, pg. 8885, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; IFN-BETA EXPRESSION; INFLAMMATORY RESPONSES; INDUCTION; GFI1; RNA; REGULATOR; CYTOKINE; CELLS	The molecular mechanisms that fine-tune the Toll-like receptor (TLR)-triggered innate immune response need further investigation. As an important transcription factor, zinc finger proteins (ZFPs) play important roles in many cell functions, including development, differentiation, tumorigenesis, and functions of the immune system. However, the role of ZFP members in the innate immune responses remains unclear. Here we showed that the expression of C2H2-type ZFP, ZFP64, was significantly up-regulated in macrophages upon stimulation with TLR ligands, including LPS, CpG oligodeoxynucleotides, or poly(I: C). ZFP64 overexpression promoted TLR-triggered TNF-alpha, IL-6, and IFN-beta production in macrophages. Coincidently, knockdown of ZFP64 expression significantly inhibited the production of the above cytokines. However, activation of MAPK and IRF3 was not responsible for the ZFP64-mediated promotion of cytokine production. Interestingly, ZFP64 significantly up-regulated TLR-induced NF-kappa B activation. ZFP64 could bind to the promoter of the TNF-alpha, IL-6, and IFN-beta genes in macrophages only after TLR ligation. Furthermore, ZFP64 associated with the NF-kappa B p65 subunit upon LPS stimulation, and TLR-ligated macrophages showed a lower level of p65 recruitment to the TNF-alpha, IL-6, and IFN-beta gene promoter in the absence of ZFP64. The data identify ZFP64 as a downstream positive regulator of TLR-initiated innate immune responses by associating with the NF-kappa B p65 subunit, enhancing p65 recruitment to the target gene promoters and increasing p65 activation and, thus, leading to the promotion of TLR-triggered proinflammatory cytokine and type I interferon production. Our findings add mechanistic insight into the efficient activation of the TLR innate response against invading pathogens.	[Wang, Chunmei; Liu, Yin; Zhang, Qian; Yao, Zhenyu; Huang, Bo; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Wang, Chunmei; Liu, Yin; Zhang, Qian; Yao, Zhenyu; Huang, Bo; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Wang, Chunmei; Liu, Xingguang; Zhang, Peng; Li, Nan] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Chunmei; Liu, Xingguang; Zhang, Peng; Li, Nan] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Naval Medical University; Naval Medical University	Li, N (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	linan@immunol.org; caoxt@immunol.org			National High Biotechnology Development Program of China [2012AA020901]; National Key Basic Research Program of China Grant [2013CB530503]; National Natural Science Foundation of China Grants [31070809, 31270931, 31070777]	National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by National High Biotechnology Development Program of China Grant 2012AA020901; by National Key Basic Research Program of China Grant 2013CB530503; and by National Natural Science Foundation of China Grants 31070809, 31270931, and 31070777.	Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jin JM, 2006, EUR J IMMUNOL, V36, P421, DOI 10.1002/eji.200535155; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Mack HG, 1997, GENE, V185, P11, DOI 10.1016/S0378-1119(96)00607-5; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Moroy T, 2008, IMMUNOBIOLOGY, V213, P341, DOI 10.1016/j.imbio.2007.11.004; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Sakamoto K, 2008, J CELL SCI, V121, P1613, DOI 10.1242/jcs.023119; Sharif-Askari E, 2010, MOL CELL BIOL, V30, P3929, DOI 10.1128/MCB.00087-10; Sun RL, 2011, GENET MOL RES, V10, P3712, DOI 10.4238/2011.December.8.6; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamassia N, 2012, J IMMUNOL, V189, P1500, DOI 10.4049/jimmunol.1102985; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283	41	21	25	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24600	24608		10.1074/jbc.M113.473397	http://dx.doi.org/10.1074/jbc.M113.473397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23857586	Green Published, hybrid			2022-12-28	WOS:000330612300028
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			Phosphatidylglycerol Directs Binding and Inhibitory Action of EIIA(Glc) Protein on the Maltose Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PHOSPHOTRANSFERASE SYSTEM; PHOSPHORYL TRANSFER COMPLEX; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CASSETTE TRANSPORTER; INDUCER EXCLUSION; SUGAR-TRANSPORT; GLYCEROL KINASE; ATP; MEMBRANE	The signal-transducing protein EIIA(Glc) belongs to the phosphoenolpyruvate carbohydrate phosphotransferase system. In its dephosphorylated state, EIIA(Glc) is a negative regulator for several permeases, including the maltose transporter MalFGK(2). How EIIA(Glc) is targeted to the membrane, how it interacts with the transporter, and how it inhibits sugar uptake remain obscure. We show here that acidic phospholipids together with the N-terminal tail of EIIA(Glc) are essential for the high affinity binding of the protein to the transporter. Using protein docking prediction and chemical cross-linking, we demonstrate that EIIA(Glc) binds to the MalK dimer, interacting with both the nucleotide-binding and the C-terminal regulatory domains. Dissection of the ATPase cycle reveals that EIIA(Glc) does not affect the binding of ATP but rather inhibits the capacity of MalK to cleave ATP. We propose a mechanism of maltose transport inhibition by this central amphitropic regulatory protein.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Fac Med, Inst Life Sci, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair II award	Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair II award	This work was supported by an infrastructure grant from the Canadian Foundation for Innovation and operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).; The recipient of a Canada Research Chair II award. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Life Sciences Institute, Faculty of Medicine, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T1Z3, Canada. Tel.: 604-822-5975; Fax: 604-822-522; E-mail: fduong@mail.ubc.ca.	Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bluschke B, 2006, J BIOL CHEM, V281, P12833, DOI 10.1074/jbc.M512646200; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DEAN DA, 1990, J BIOL CHEM, V265, P21005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; MISKO TP, 1987, J BIOL CHEM, V262, P16261; NOVOTNY MJ, 1985, J BACTERIOL, V162, P810, DOI 10.1128/JB.162.2.810-816.1985; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Richet E, 2012, MOL MICROBIOL, V85, P632, DOI 10.1111/j.1365-2958.2012.08137.x; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Sondej M, 2000, BIOCHEMISTRY-US, V39, P2931, DOI 10.1021/bi9919596; VANDERVLAG J, 1994, J BACTERIOL, V176, P3518, DOI 10.1128/JB.176.12.3518-3526.1994; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2000, J BIOL CHEM, V275, P39811, DOI 10.1074/jbc.C000709200; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382	31	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23666	23674		10.1074/jbc.M113.489567	http://dx.doi.org/10.1074/jbc.M113.489567			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821551	Green Published, hybrid			2022-12-28	WOS:000330611400006
J	Brun, M; Glubrecht, DD; Baksh, S; Godbout, R				Brun, Miranda; Glubrecht, Darryl D.; Baksh, Shairaz; Godbout, Roseline			Calcineurin Regulates Nuclear Factor I Dephosphorylation and Activity in Malignant Glioma Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; NEURAL STEM-CELLS; TOOTH ROOT DEVELOPMENT; PHOSPHATASE CALCINEURIN; SUBVENTRICULAR ZONE; REACTIVE ASTROCYTES; MOLECULAR-CLONING; PRECURSOR CELLS; GENE-EXPRESSION; CYCLOSPORINE-A	Malignant gliomas (MG), including grades III and IV astrocytomas, are the most common adult brain tumors. These tumors are highly aggressive with a median survival of less than 2 years. Nuclear factor I (NFI) is a family of transcription factors that regulates the expression of glial genes in the developing brain. We have previously shown that regulation of the brain fatty acid-binding protein (B-FABP; FABP7) and glial fibrillary acidic protein (GFAP) genes in MG cells is dependent on the phosphorylation state of NFI, with hypophosphorylation of NFI correlating with GFAP and B-FABP expression. Importantly, NFI phosphorylation is dependent on phosphatase activity that is enriched in GFAP/B-FABP+ve cells. Using chromatin immunoprecipitation, we show that NFI occupies the GFAP and B-FABP promoters in NFI-hypophosphorylated GFAP/BFABP+ve MG cells. NFI occupancy, NFI-dependent transcriptional activity, and NFI phosphorylation are all modulated by the serine/threonine phosphatase calcineurin. Importantly, a cleaved form of calcineurin, associated with increased phosphatase activity, is specifically expressed in NFI-hypophosphorylated GFAP/B-FABP+ve MG cells. Calcineurin in GFAP/BFABP+ve MG cells localizes to the nucleus. In contrast, calcineurin is primarily found in the cytoplasm of GFAP/BFABP-ve cells, suggesting a dual mechanism for calcineurin activation in MG. Finally, our results demonstrate that calcineurin expression is up-regulated in areas of high infiltration/migration in grade IV astrocytoma tumor tissue. Our data suggest a critical role for calcineurin in NFI transcriptional regulation and in the determination of MG infiltrative properties.	[Brun, Miranda; Glubrecht, Darryl D.; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Baksh, Shairaz] Univ Alberta, Cross Canc Inst, Dept Pediat, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016; Baksh, Shairaz/GRX-2106-2022	Godbout, Roseline/0000-0002-4779-9265; 	Alberta Cancer Foundation; Alberta Innovates-Health Solutions; Alberta Innovates [201201237] Funding Source: researchfish	Alberta Cancer Foundation; Alberta Innovates-Health Solutions; Alberta Innovates	This work was supported by a grant from the Alberta Cancer Foundation and a studentship from Alberta Innovates-Health Solutions (to M. B.).	Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Andrin C, 2012, NUCLEUS-PHILA, V3, P384, DOI 10.4161/nucl.21055; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Baumgartel K, 2012, LEARN MEMORY, V19, P375, DOI 10.1101/lm.027201.112; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bleoo S, 2001, MOL BIOL CELL, V12, P3046, DOI 10.1091/mbc.12.10.3046; BOSHER J, 1992, J VIROL, V66, P3140, DOI 10.1128/JVI.66.5.3140-3150.1992; BOSSER R, 1993, J BIOL CHEM, V268, P15477; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DAWSON TM, 1994, NEUROSCIENCE, V62, P569, DOI 10.1016/0306-4522(94)90389-1; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; DONELLADEANA A, 1994, EUR J BIOCHEM, V219, P109, DOI 10.1111/j.1432-1033.1994.tb19920.x; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; ENG LF, 1978, J HISTOCHEM CYTOCHEM, V26, P513, DOI 10.1177/26.7.357640; ENZ A, 1994, ANAL BIOCHEM, V216, P147, DOI 10.1006/abio.1994.1018; FARBER LH, 1987, J NEUROCHEM, V49, P404, DOI 10.1111/j.1471-4159.1987.tb02880.x; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Matsuda T, 1998, J NEUROCHEM, V70, P2004; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; MURAMATSU T, 1992, P NATL ACAD SCI USA, V89, P529, DOI 10.1073/pnas.89.2.529; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; PUJOL MJ, 1993, J NEUROCHEM, V60, P1422, DOI 10.1111/j.1471-4159.1993.tb03304.x; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Santella L, 1997, FASEB J, V11, P1091, DOI 10.1096/fasebj.11.13.9367344; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; Wang MG, 1996, CYTOGENET CELL GENET, V72, P236, DOI 10.1159/000134198; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093	81	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24104	24115		10.1074/jbc.M113.455832	http://dx.doi.org/10.1074/jbc.M113.455832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839947	hybrid, Green Published			2022-12-28	WOS:000330611400046
J	Pacheco, SA; Hsu, FF; Powers, KM; Purdy, GE				Pacheco, Sophia A.; Hsu, Fong-Fu; Powers, Katelyn M.; Purdy, Georgiana E.			MmpL11 Protein Transports Mycolic Acid-containing Lipids to the Mycobacterial Cell Wall and Contributes to Biofilm Formation in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIDING MOTILITY; OUTER-MEMBRANE; DRUG-TOLERANT; TUBERCULOSIS; GROWTH; IDENTIFICATION; BIOSYNTHESIS; BIOGENESIS; VIRULENCE; RESISTANCE	A growing body of evidence indicates that MmpL (mycobacterial membrane protein large) transporters are dedicated to cell wall biosynthesis and transport mycobacterial lipids. How MmpL transporters function and the identities of their substrates have not been fully elucidated. We report the characterization of Mycobacterium smegmatis MmpL11. We showed previously that M. smegmatis lacking MmpL11 has reduced membrane permeability that results in resistance to host antimicrobial peptides. We report herein the further characterization of the M. smegmatis mmpL11 mutant and identification of the MmpL11 substrates. We found that biofilm formation by the M. smegmatis mmpL11 mutant was distinct from that by wildtype M. smegmatis. Analysis of cell wall lipids revealed that the mmpL11 mutant failed to export the mycolic acid-containing lipids monomeromycolyl diacylglycerol and mycolate ester wax to the bacterial surface. In addition, analysis of total lipids indicated that the mycolic acid-containing precursor molecule mycolyl phospholipid accumulated in the mmpL11 mutant compared with wild-type mycobacteria. MmpL11 is encoded at a chromosomal locus that is conserved across pathogenic and nonpathogenic mycobacteria. Phenotypes of the M. smegmatis mmpL11 mutant are complemented by the expression of M. smegmatis or M. tuberculosis MmpL11, suggesting that MmpL11 plays a conserved role in mycobacterial cell wall biogenesis.	[Pacheco, Sophia A.; Powers, Katelyn M.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Mass Spectrometry Resource, Div Endocrinol Diabet Metab & Lipid Res,Dept Inte, St Louis, MO 63110 USA	Oregon Health & Science University; Washington University (WUSTL)	Purdy, GE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd,Mail Code L220, Portland, OR 97239 USA.	purdyg@ohsu.edu		Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [AI079399, AI087840, P41-GM103422, P60-DK20579, P30-DK56341, P01-HL57278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087840, K22AI079399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Awards AI079399 and AI087840 (to G. E. P.). The Washington University Mass Spectrometry Facility is supported by National Institutes of Health Grants P41-GM103422, P60-DK20579, P30-DK56341, and P01-HL57278.	Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Nguyen KT, 2010, J BACTERIOL, V192, P5134, DOI 10.1128/JB.00650-10; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Purdy GE, 2013, ANAL BIOANAL CHEM, V405, P7415, DOI 10.1007/s00216-013-7179-4; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Yamazaki Y, 2006, APPL ENVIRON MICROB, V72, P819, DOI 10.1128/AEM.72.1.819-825.2006	42	66	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24213	24222		10.1074/jbc.M113.473371	http://dx.doi.org/10.1074/jbc.M113.473371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836904	hybrid, Green Published			2022-12-28	WOS:000330611400059
J	Miller, PW; Pokutta, S; Ghosh, A; Almo, SC; Weis, WI; Nelson, WJ; Kwiatkowski, AV				Miller, Phillip W.; Pokutta, Sabine; Ghosh, Agnidipta; Almo, Steven C.; Weis, William I.; Nelson, W. James; Kwiatkowski, Adam V.			Danio rerio alpha E-catenin Is a Monomeric F-actin Binding Protein with Distinct Properties from Mus musculus alpha E-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; BETA-CATENIN; E-CADHERIN; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; COMPLEX; VINCULIN; GROWTH; TISSUE; MORPHOGENESIS	It is unknown whether homologs of the cadherin.catenin complex have conserved structures and functions across the Metazoa. Mammalian alpha E-catenin is an allosterically regulated actin-binding protein that binds the cadherin center dot beta-catenin complex as a monomer and whose dimerization potentiates F-actin association. We tested whether these functional properties are conserved in another vertebrate, the zebrafish Danio rerio. Here we show, despite 90% sequence identity, that Danio rerio and Mus musculus alpha E-catenin have striking functional differences. We demonstrate that D. rerio alpha E-catenin is monomeric by size exclusion chromatography, native PAGE, and small angle x-ray scattering. D. rerio alpha E-catenin binds F-actin in cosedimentation assays as a monomer and as an alpha/beta-catenin heterodimer complex. D. rerio alpha E-catenin also bundles F-actin, as shown by negative stained transmission electron microscopy, and does not inhibit Arp2/3 complex-mediated actin nucleation in bulk polymerization assays. Thus, core properties of alpha-catenin function, F-actin and beta-catenin binding, are conserved between mouse and zebrafish. We speculate that unique regulatory properties have evolved to match specific developmental requirements.	[Miller, Phillip W.; Weis, William I.; Nelson, W. James] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Pokutta, Sabine; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Ghosh, Agnidipta; Almo, Steven C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Nelson, W. James; Kwiatkowski, Adam V.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Dept Biol, James H Clark Ctr E200,318 Campus Dr, Stanford, CA 94305 USA.	wjnelson@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM007276]; National Institutes of Health [GM35527, U01 GM94663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, U01GM094663, R01GM035527, R37GM035527] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM007276 (to P. W. M.), National Institutes of Health Grant GM35527 (to W. J. N.), and National Institutes of Health Grant U01 GM94663 (to W. J. N., W. I. W., and S. A.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dickinson DJ, 2012, BIOESSAYS, V34, P833, DOI 10.1002/bies.201100187; Dickinson DJ, 2011, DEV CELL, V21, P32, DOI 10.1016/j.devcel.2011.06.004; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Larue L, 1996, DEVELOPMENT, V122, P3185; Maiden SL, 2013, J BIOL CHEM, V288, P5694, DOI 10.1074/jbc.M112.438093; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Schepis A, 2012, DEVELOPMENT, V139, P537, DOI 10.1242/dev.073932; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	38	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22324	22332		10.1074/jbc.M113.458406	http://dx.doi.org/10.1074/jbc.M113.458406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788645	Green Published, hybrid			2022-12-28	WOS:000330596300014
J	Probert, F; Whittaker, SBM; Crispin, M; Mitchell, DA; Dixon, AM				Probert, Fay; Whittaker, Sara B. -M.; Crispin, Max; Mitchell, Daniel A.; Dixon, Ann M.			Solution NMR Analyses of the C-type Carbohydrate Recognition Domain of DC-SIGNR Protein Reveal Different Binding Modes for HIV-derived Oligosaccharides and Smaller Glycan Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; STRUCTURAL BASIS; LIGAND-BINDING; SARS CORONAVIRUS; PULSE SEQUENCES; LECTIN; SPECTROSCOPY; N-15; MECHANISM; RECEPTOR	The C-type lectin DC-SIGNR (dendritic cell-specific ICAM-3-grabbing non-integrin-related; also known as L-SIGN or CD299) is a promising drug target due to its ability to promote infection and/or within-host survival of several dangerous pathogens (e.g. HIV and severe acute respiratory syndrome coronavirus (SARS)) via interactions with their surface glycans. Crystallography has provided excellent insight into the mechanism by which DC-SIGNR interacts with small glycans, such as (GlcNAc)(2)Man(3); however, direct observation of complexes with larger, physiological oligosaccharides, such as Man(9)GlcNAc(2), remains elusive. We have utilized solution-state nuclear magnetic resonance spectroscopy to investigate DC-SIGNR binding and herein report the first backbone assignment of its active, calcium-bound carbohydrate recognition domain. Direct interactions with the small sugar fragments Man(3), Man(5), and (GlcNAc)(2)Man(3) were investigated alongside Man(9)GlcNAc derived from recombinant gp120 (present on the HIV viral envelope), providing the first structural data for DC-SIGNR in complex with a virus-associated ligand, and unique binding modes were observed for each glycan. In particular, our data show that DC-SIGNR has a different binding mode for glycans on the HIV viral envelope compared with the smaller glycans previously observed in the crystalline state. This suggests that using the binding mode of Man(9)GlcNAc, instead of those of small glycans, may provide a platform for the design of DC-SIGNR inhibitors selective for high mannose glycans (like those on HIV). N-15 relaxation measurements provided the first information on the dynamics of the carbohydrate recognition domain, demonstrating that it is a highly flexible domain that undergoes ligand-induced conformational and dynamic changes that may explain the ability of DC-SIGNR to accommodate a range of glycans on viral surfaces.	[Probert, Fay] Univ Warwick, Mol Org & Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Mitchell, Daniel A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Whittaker, Sara B. -M.] Univ Birmingham, Sch Canc Sci, Birmingham Canc Res UK Ctr, Henry Wellcome Bldg Biomol NMR Spect, Birmingham B15 2TT, W Midlands, England; [Crispin, Max] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England	University of Warwick; University of Warwick; University of Warwick; University of Birmingham; University of Oxford	Dixon, AM (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	ann.dixon@warwick.ac.uk	Mitchell, Daniel A/A-6580-2009; Crispin, Max/AAG-4098-2020; Dixon, Ann M/I-3696-2012	Mitchell, Daniel A/0000-0003-0936-6212; Crispin, Max/0000-0002-1072-2694; Dixon, Ann M/0000-0002-5261-304X; Probert, Fay/0000-0002-8580-2023	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre; International AIDS Vaccine Initiative; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); International AIDS Vaccine Initiative; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	Recipient of a studentship from the Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre.; Supported by the International AIDS Vaccine Initiative and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery.	Angulo J, 2008, CHEMBIOCHEM, V9, P2225, DOI 10.1002/cbic.200800361; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Chen YX, 2007, J EXP MED, V204, P2529, DOI 10.1084/jem.20070462; Chirife J, 1997, J FOOD ENG, V33, P221, DOI 10.1016/S0260-8774(97)00060-5; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Copie V, 1996, J BIOMOL NMR, V7, P335; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Diehl C, 2010, J AM CHEM SOC, V132, P14577, DOI 10.1021/ja105852y; Drickamer K, 1997, STRUCTURE, V5, P465, DOI 10.1016/S0969-2126(97)00202-5; Drickamer K, 2005, NAT STRUCT MOL BIOL, V12, P830, DOI 10.1038/nsmb1005-830; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Guzzi C, 2011, ORG BIOMOL CHEM, V9, P7705, DOI 10.1039/c1ob05938f; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Johnson TR, 2012, J VIROL, V86, P1339, DOI 10.1128/JVI.06096-11; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keeler J., 2010, UNDERSTANDING NMR SP, V2; Kneller D. G., 1993, UCSF SPARKY NMR DISP; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Leckband DE, 2011, BIOCHEMISTRY-US, V50, P6125, DOI 10.1021/bi2003444; Lian LY, 2011, PROTEIN NMR SPECTROSCOPY: PRACTICAL TECHNIQUES AND APPLICATIONS, P1, DOI 10.1002/9781119972006; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Mari S, 2005, ANGEW CHEM INT EDIT, V44, P296, DOI 10.1002/anie.200461574; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Nielbo S, 2004, BIOCHEMISTRY-US, V43, P8636, DOI 10.1021/bi049570s; Onizuka T, 2012, FEBS J, V279, P2645, DOI 10.1111/j.1742-4658.2012.08643.x; Pavlicek J, 2003, BIOCHEMISTRY-US, V42, P9295, DOI 10.1021/bi0272981; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Prost LR, 2012, ACS CHEM BIOL, V7, P1603, DOI 10.1021/cb300260p; Reina JJ, 2008, ORG BIOMOL CHEM, V6, P2743, DOI 10.1039/b802144a; Reina JJ, 2007, CHEMMEDCHEM, V2, P1030, DOI 10.1002/cmdc.200700047; Sambrook J., 2001, MOL CLONING LAB MANU; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder GA, 2005, J MOL BIOL, V347, P979, DOI 10.1016/j.jmb.2005.01.063; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; SUDMEIER JL, 1980, J MAGN RESON, V40, P377, DOI 10.1016/0022-2364(80)90261-9; Timpano G, 2008, CHEMBIOCHEM, V9, P1921, DOI 10.1002/cbic.200800139; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yu QD, 2009, J MOL BIOL, V387, P1075, DOI 10.1016/j.jmb.2009.02.046	68	12	12	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22745	22757		10.1074/jbc.M113.458299	http://dx.doi.org/10.1074/jbc.M113.458299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788638	Green Published, hybrid			2022-12-28	WOS:000330596300052
J	Stephenson, JR; Paavola, KJ; Schaefer, SA; Kaur, B; Van Meir, EG; Hall, RA				Stephenson, Jason R.; Paavola, Kevin J.; Schaefer, Stacy A.; Kaur, Balveen; Van Meir, Erwin G.; Hall, Randy A.			Brain-specific Angiogenesis Inhibitor-1 Signaling, Regulation, and Enrichment in the Postsynaptic Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EMERGING ROLES; ADHESION-GPCRS; APOPTOTIC CELLS; BETA-ARRESTINS; BAI1; GENE; SCAFFOLD; FAMILY; VASCULOSTATIN	Brain-specific angiogenesis inhibitor-1 (BAI1) is an adhesion G protein-coupled receptor that has been studied primarily for its anti-angiogenic and anti-tumorigenic properties. We found that overexpression of BAI1 results in activation of the Rho pathway via a G alpha(12/13)-dependent mechanism, with truncation of the BAI1 N terminus resulting in a dramatic enhancement in receptor signaling. This constitutive activity of the truncated BAI1 mutant also resulted in enhanced downstream phosphorylation of ERK as well as increased receptor association with beta-arrestin2 and increased ubiquitination of the receptor. To gain insights into the regulation of BAI1 signaling, we screened the C terminus of BAI1 against a proteomic array of PDZ domains to identify novel interacting partners. These screens revealed that the BAI1 C terminus interacts with a variety of PDZ domains from synaptic proteins, including MAGI-3. Removal of the BAI1 PDZ-binding motif resulted in attenuation of receptor signaling to Rho but had no effect on ERK activation. Conversely, co-expression with MAGI-3 was found to potentiate signaling to ERK by constitutively active BAI1 in a manner that was dependent on the PDZ-binding motif of the receptor. Biochemical fractionation studies revealed that BAI1 is highly enriched in post-synaptic density fractions, a finding consistent with our observations that BAI1 can interact with PDZ proteins known to be concentrated in the post-synaptic density. These findings demonstrate that BAI1 is a synaptic receptor that can activate both the Rho and ERK pathways, with the N-terminal and C-terminal regions of the receptor playing key roles in the regulation of BAI1 signaling activity.	[Stephenson, Jason R.; Paavola, Kevin J.; Schaefer, Stacy A.; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Mol Neurooncol Lab, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Rm 5113,1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu	kaur, Balveen/E-3355-2011	Van Meir, Erwin G./0000-0003-2444-7707; Stephenson, Jason/0000-0002-7926-8055; Hall, Randy/0000-0002-8318-8728	National Institutes of Health [NS072394, CA086335, CA163722]; NATIONAL CANCER INSTITUTE [R01CA150153, R01CA163722, R01CA086335, P01CA163205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394, P30NS045758, R01NS064607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants NS072394 (to R. A. H.) and CA086335 and CA163722 (to E. G. V. M.).	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Apperson ML, 1996, J NEUROSCI, V16, P6839; Arac D, 2012, ANN NY ACAD SCI, V1276, P1, DOI 10.1111/j.1749-6632.2012.06820.x; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Cork SM, 2011, J MOL MED, V89, P743, DOI 10.1007/s00109-011-0759-x; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Ito H, 2012, J NEUROSCI RES, V90, P1776, DOI 10.1002/jnr.23074; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Koh JT, 2001, MOL BRAIN RES, V87, P223, DOI 10.1016/S0169-328X(01)00004-3; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kudo S, 2007, ONCOL REP, V18, P785; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lanoue V, 2013, MOL PSYCHIATR, V18, P943, DOI 10.1038/mp.2013.46; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Mori K, 2002, NEUROSCI RES, V43, P69, DOI 10.1016/S0168-0102(02)00018-4; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Okajima D, 2011, J PHYSIOL SCI, V61, P47, DOI 10.1007/s12576-010-0120-0; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2010, ADV EXP MED BIOL, V706, P167; Rahman MA, 1999, PHILOS T ROY SOC B, V354, P379, DOI 10.1098/rstb.1999.0390; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V247, P597, DOI 10.1006/bbrc.1998.8603; Sokolowski JD, 2011, BRAIN BEHAV IMMUN, V25, P915, DOI 10.1016/j.bbi.2010.09.021; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Xiao Xin-ru, 2006, Zhonghua Yi Xue Za Zhi, V86, P1342; Yang XM, 2010, FEBS LETT, V584, P2207, DOI 10.1016/j.febslet.2010.03.039; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yoon KC, 2005, GENE THER, V12, P617, DOI 10.1038/sj.gt.3302442; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	64	74	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22248	22256		10.1074/jbc.M113.489757	http://dx.doi.org/10.1074/jbc.M113.489757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782696	hybrid, Green Published			2022-12-28	WOS:000330596300007
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The x-ray crystal structure of mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome (vol 288, pg 22399, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019; Wijeyewickrema, Lakshmi/A-9676-2015	Coetzer, Theresa/0000-0003-0706-3808; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Wilmann, Pascal/0000-0002-8376-5150; Whisstock, James/0000-0003-4200-5611				Tang YQ, 2013, J BIOL CHEM, V288, P22399, DOI 10.1074/jbc.A113.483875	1	20	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28307	28307		10.1074/jbc.A113.483875	http://dx.doi.org/10.1074/jbc.A113.483875			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23792966	Green Published, hybrid			2022-12-28	WOS:000330612800055
J	Zoued, A; Durand, E; Bebeacua, C; Brunet, YR; Douzi, B; Cambillau, C; Cascales, E; Journet, L				Zoued, Abdelrahim; Durand, Eric; Bebeacua, Cecilia; Brunet, Yannick R.; Douzi, Badreddine; Cambillau, Christian; Cascales, Eric; Journet, Laure			TssK Is a Trimeric Cytoplasmic Protein Interacting with Components of Both Phage-like and Membrane Anchoring Complexes of the Type VI Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ENTEROAGGREGATIVE ESCHERICHIA-COLI; BACTERIAL TYPE VI; PSEUDOMONAS-AERUGINOSA; ELECTRON-MICROSCOPY; INNER MEMBRANE; TAILED PHAGES; APPARATUS; CRITERIA; TUBULES	The Type VI secretion system (T6SS) is a macromolecular machine that mediates bacteria-host or bacteria-bacteria interactions. The T6SS core apparatus assembles from 13 proteins that form two sub-assemblies: a phage-like complex and a trans-envelope complex. The Hcp, VgrG, TssE, and TssB/C subunits are structurally and functionally related to components of the tail of contractile bacteriophages. This phage-like structure is thought to be anchored to the membrane by a trans-envelope complex composed of the TssJ, TssL, and TssM proteins. However, how the two sub-complexes are connected remains unknown. Here we identify TssK, a protein that establishes contacts with the two T6SS sub-complexes through direct interactions with TssL, Hcp, and TssC. TssK is a cytoplasmic protein assembling trimers that display a three-armed shape, as revealed by TEM and SAXS analyses. Fluorescence microscopy experiments further demonstrate the requirement of TssK for sheath assembly. Our results suggest a central role for TssK by linking both complexes during T6SS assembly.	[Zoued, Abdelrahim; Brunet, Yannick R.; Cascales, Eric; Journet, Laure] Aix Marseille Univ, CNRS, UMR 7255, Inst Microbiol Mediterranee,Lab Ingn Syst Macromo, F-13402 Marseille 20, France; [Durand, Eric; Bebeacua, Cecilia; Douzi, Badreddine; Cambillau, Christian] Aix Marseille Univ, CNRS, UMR 6098, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Journet, L (corresponding author), Aix Marseille Univ, CNRS, UMR7255, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	ljournet@imm.cnrs.fr	Durand, Eric/E-6739-2017; Douzi, Badreddine/ABA-4540-2021; CASCALES, ERIC/G-7420-2011; douzi, Badreddine/Z-5707-2019	Durand, Eric/0000-0002-0577-8220; Douzi, Badreddine/0000-0003-3140-4713; CASCALES, ERIC/0000-0003-0611-9179; Journet, Laure/0000-0002-5847-2962; Zoued, Abdelrahim/0000-0002-6973-1755	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille University; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; CNRS; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]; French Ministere de la Recherche; Fondation pour la Recherche Medicale [SPF20101221116]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministere de la Recherche(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), the Aix-Marseille University, and a grant from the Agence Nationale de la Recherche (ANR-10-JCJC-1303-03) (to E. C.). This work was also supported by the CNRS, the Aix-Marseille University, and by grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (FRM DEQ2011-0421282) (to C. C.).; Supported by doctoral fellowships from the French Ministere de la Recherche.; Supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale (SPF20101221116).	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Casabona MG, 2013, PROTEOMICS, V13, P2419, DOI 10.1002/pmic.201200565; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	53	80	80	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27031	27041		10.1074/jbc.M113.499772	http://dx.doi.org/10.1074/jbc.M113.499772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921384	hybrid, Green Published			2022-12-28	WOS:000330597300005
J	Krantz, KC; Puchalla, J; Thapa, R; Kobayashi, C; Bisher, M; Viehweg, J; Carr, CM; Rye, HS				Krantz, Kelly C.; Puchalla, Jason; Thapa, Rajan; Kobayashi, Callie; Bisher, Margaret; Viehweg, Julie; Carr, Chavela M.; Rye, Hays S.			Clathrin Coat Disassembly by the Yeast Hsc70/Ssa1p and Auxilin/Swa2p Proteins Observed by Single-particle Burst Analysis Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ENDOCYTOSIS; UNCOATING ATPASE; BUDDING YEAST; IN-VIVO; VESICLES; MECHANISM; HSC70; DISSOCIATION; CHAPERONE; COMPLEX	The role of clathrin-coated vesicles in receptor-mediated endocytosis is conserved among eukaryotes, and many of the proteins required for clathrin coat assembly and disassembly have orthologs in yeast and mammals. In yeast, dozens of proteins have been identified as regulators of the multistep reaction required for endocytosis, including those that regulate disassembly of the clathrin coat. In mammalian systems, clathrin coat disassembly has been reconstituted using neuronal clathrin baskets mixed with the purified chaperone ATPase 70-kDa heat shock cognate (Hsc70), plus a clathrin-specific co-chaperone, such as the synaptic protein auxilin. Yet, despite previous characterization of the yeast Hsc70 ortholog, Ssa1p, and the auxilin-like ortholog, Swa2p, testing mechanistic models for disassembly of nonneuronal clathrin coats has been limited by the absence of a functional reconstitution assay. Here we use single-particle burst analysis spectroscopy, in combination with fluorescence correlation spectroscopy, to follow the population dynamics of fluorescently tagged yeast clathrin baskets in the presence of purified Ssa1p and Swa2p. An advantage of this combined approach for mechanistic studies is the ability to measure, as a function of time, changes in the number and size of objects from a starting population to the reaction products. Our results indicate that Ssa1p and Swa2p cooperatively disassemble yeast clathrin baskets into fragments larger than the individual triskelia, suggesting that disassembly of clathrin-coated vesicles may proceed through a partially uncoated intermediate.	[Krantz, Kelly C.; Bisher, Margaret; Viehweg, Julie] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Puchalla, Jason] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Thapa, Rajan; Kobayashi, Callie; Carr, Chavela M.; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Princeton University; Princeton University; Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [R01 GM065421]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065421 (to H. S. R.). This work was also supported by and the Beckman Foundation (Beckman Young Investigator) (to H. S. R.).	AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Ferguson ML, 2006, BIOCHEMISTRY-US, V45, P5916, DOI 10.1021/bi052568w; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; GAO BC, 1991, J BIOL CHEM, V266, P19565; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jiang RF, 2000, J BIOL CHEM, V275, P8439, DOI 10.1074/jbc.275.12.8439; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Ma YC, 2002, J BIOL CHEM, V277, P49267, DOI 10.1074/jbc.M203695200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Needham PG, 2008, ARCH BIOCHEM BIOPHYS, V478, P167, DOI 10.1016/j.abb.2008.07.023; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; PRASAD K, 1994, J BIOL CHEM, V269, P6931; Puchalla J, 2008, P NATL ACAD SCI USA, V105, P14400, DOI 10.1073/pnas.0805969105; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rapoport I, 2008, MOL BIOL CELL, V19, P405, DOI 10.1091/mbc.E07-09-0870; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P44; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Smith CJ, 2004, J MOL BIOL, V336, P461, DOI 10.1016/j.jmb.2003.12.006; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	47	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26721	26730		10.1074/jbc.M113.491753	http://dx.doi.org/10.1074/jbc.M113.491753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913685	Green Published, hybrid			2022-12-28	WOS:000330594500037
J	Hicks, DA; Makova, NZ; Gough, M; Parkin, ET; Nalivaeva, NN; Turner, AJ				Hicks, David A.; Makova, Natalia Z.; Gough, Mallory; Parkin, Edward T.; Nalivaeva, Natalia N.; Turner, Anthony J.			The Amyloid Precursor Protein Represses Expression of Acetylcholinesterase in Neuronal Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; COPPER-BINDING DOMAIN; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; SECRETED FORMS; NEURITE OUTGROWTH; GENE-EXPRESSION; ALPHA-SECRETASE; BETA-PEPTIDES; APP	The toxic role of amyloid beta peptides in Alzheimer's disease is well documented. Their generation is via sequential beta- and gamma-secretase cleavage of the membrane-bound amyloid precursor protein (APP). Other APP metabolites include the soluble ectodomains sAPP alpha and sAPP beta and also the amyloid precursor protein intracellular domain (AICD). In this study, we examined whether APP is involved in the regulation of acetylcholinesterase (AChE), which is a key protein of the cholinergic system and has been shown to accelerate amyloid fibril formation and increase their toxicity. Overexpression of the neuronal specific isoform, APP(695), in the neuronal cell lines SN56 and SH-SY5Y substantially decreased levels of AChE mRNA, protein, and catalytic activity. Although similar decreases in mRNA levels were observed of the proline-rich anchor of AChE, PRiMA, no changes were seen in mRNA levels of the related enzyme, butyrylcholinesterase, nor of the high-affinity choline transporter. A gamma-secretase inhibitor did not affect AChE transcript levels or enzyme activity in SN56 (APP(695)) or SH-SY5Y (APP(695)) cells, showing that regulation of AChE by APP does not require the generation of AICD or amyloid beta peptide. Treatment of wildtype SN56 cells with siRNA targeting APP resulted in a significant up-regulation in AChE mRNA levels. Mutagenesis studies suggest that the observed transcriptional repression of AChE is mediated by the E1 region of APP, specifically its copper-binding domain, but not the C-terminal YENTPY motif. In conclusion, AChE is regulated in two neuronal cell lines by APP in a manner independent of the generation of sAPP alpha, sAPP beta, and AICD.	[Hicks, David A.; Makova, Natalia Z.; Nalivaeva, Natalia N.; Turner, Anthony J.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Gough, Mallory; Parkin, Edward T.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England; [Nalivaeva, Natalia N.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	University of Leeds; Lancaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Turner, AJ (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	a.j.turner@leeds.ac.uk	Nalivaeva, Natalia/K-6522-2018	Nalivaeva, Natalia/0000-0002-7134-3540; Parkin, Edward/0000-0003-3270-3184	UK Biotechnology and Biological Sciences Research Council; UK Medical Research Council; Alzheimer's Research UK; Russian Foundation for Basic Research [FBR 13-04-00388]; Russian Academy of Sciences; Medical Research Council [G0802189] Funding Source: researchfish; MRC [G0802189] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (studentship support to D. A. H.), the UK Medical Research Council, Alzheimer's Research UK, Russian Foundation for Basic Research Grant FBR 13-04-00388, and the Fundamental Sciences to Medicine Programme of the Russian Academy of Sciences.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BARGER SW, 1995, J NEUROCHEM, V64, P2087; BARGER SW, 1995, BIOCHEM J, V311, P45, DOI 10.1042/bj3110045; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang KA, 2010, BMB REP, V43, P656, DOI [10.3858/BMBRep.2010.43.10.656, 10.5483/BMBRep.2010.43.10.656]; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Clarke NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034747; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halliday AC, 2012, PROTEIN PEPTIDE LETT, V19, P165; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Henderson Z, 2010, BRAIN RES, V1344, P34, DOI 10.1016/j.brainres.2010.05.022; Hicks D, 2011, J NEUROCHEM, V116, P742, DOI 10.1111/j.1471-4159.2010.07032.x; Hicks DA, 2013, CHEM-BIOL INTERACT, V203, P302, DOI 10.1016/j.cbi.2012.09.019; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Isacson O, 2002, TRENDS NEUROSCI, V25, P79, DOI 10.1016/S0166-2236(02)02037-4; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kong GKW, 2008, EUR BIOPHYS J BIOPHY, V37, P269, DOI 10.1007/s00249-007-0234-3; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Noda Y, 2013, NEUROSCI LETT, V547, P10, DOI 10.1016/j.neulet.2013.04.057; Ohkawara T, 2011, GENE, V475, P1, DOI 10.1016/j.gene.2010.11.014; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Sandbrink R, 1996, ANN NY ACAD SCI, V777, P281, DOI 10.1111/j.1749-6632.1996.tb34433.x; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Toiber D, 2009, J NEURAL TRANSM, V116, P1435, DOI 10.1007/s00702-009-0249-2; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Van Dam D, 2005, NEUROCHEM INT, V46, P409, DOI 10.1016/j.neuint.2004.11.005; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	79	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26039	26051		10.1074/jbc.M113.461269	http://dx.doi.org/10.1074/jbc.M113.461269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897820	Green Published, hybrid			2022-12-28	WOS:000330623300034
J	Honda, A; Hatori, M; Hirose, M; Honda, C; Izu, H; Inoue, K; Hirasawa, R; Matoba, S; Togayachi, S; Miyoshi, H; Ogura, A				Honda, Arata; Hatori, Masanori; Hirose, Michiko; Honda, Chizumi; Izu, Haruna; Inoue, Kimiko; Hirasawa, Ryutaro; Matoba, Shogo; Togayachi, Sumie; Miyoshi, Hiroyuki; Ogura, Atsuo			Naive-like Conversion Overcomes the Limited Differentiation Capacity of Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NEURAL DIFFERENTIATION; DEFINED FACTORS; RABBIT EMBRYOS; SELF-RENEWAL; IN-VITRO; ES CELLS; MOUSE; LINES; GENERATION	Although induced pluripotent stem (iPS) cells are indistinguishable from ES cells in their expression of pluripotent markers, their differentiation into targeted cells is often limited. Here, we examined whether the limited capacity of iPS cells to differentiate into neural lineage cells could be mitigated by improving their base-line level of pluripotency, i.e. by converting them into the so-called "naive" state. In this study, we used rabbit iPS and ES cells because of the easy availability of both cell types and their typical primed state characters. Repeated passages of the iPS cells permitted their differentiation into early neural cell types (neural stem cells, neurons, and glial astrocytes) with efficiencies similar to ES cells. However, unlike ES cells, their ability to differentiate later into neural cells (oligodendrocytes) was severely compromised. In contrast, after these iPS cells had been converted to a naive-like state, they readily differentiated into mature oligodendrocytes developing characteristic ramified branches, which could not be attained even with ES cells. These results suggest that the naive-like conversion of iPS cells might endow them with a higher differentiation capacity.	[Honda, Arata; Honda, Chizumi; Izu, Haruna] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8891692, Japan; [Honda, Arata; Hatori, Masanori; Hirose, Michiko; Inoue, Kimiko; Hirasawa, Ryutaro; Matoba, Shogo; Togayachi, Sumie; Miyoshi, Hiroyuki; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Honda, Arata] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med 5, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1138657, Japan	University of Miyazaki; RIKEN; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tokyo	Honda, A (corresponding author), Miyazaki Univ, Org Promot Tenure Track, 5200 Kibara, Miyazaki 8891692, Japan.	a-honda@med.miyazaki-u.ac.jp	Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016; Miyoshi, Hiroyuki/G-9808-2013	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X; 	PRESTO of the Japan Science and Technology Agency; Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology; Sumitomo Foundation	PRESTO of the Japan Science and Technology Agency; Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology; Sumitomo Foundation	This work was supported by PRESTO of the Japan Science and Technology Agency, a grant-in-aid for scientific research (B) and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology, and a grant for basic science research projects from Sumitomo Foundation.	Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Ben-Nun IF, 2011, NAT METHODS, V8, P829, DOI [10.1038/NMETH.1706, 10.1038/nmeth.1706]; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Familari M, 2006, MOL REPROD DEV, V73, P123, DOI 10.1002/mrd.20376; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Honda A, 2009, EXP CELL RES, V315, P2033, DOI 10.1016/j.yexcr.2009.01.024; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Koehler KR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-82; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015947; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Okita K, 2010, EXP CELL RES, V316, P2565, DOI 10.1016/j.yexcr.2010.04.023; Osteil P, 2013, BIOL OPEN, V2, P613, DOI 10.1242/bio.20134242; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Shiomi Masashi, 2004, J Atheroscler Thromb, V11, P184; Sipp D, 2009, CELL STEM CELL, V5, P360, DOI 10.1016/j.stem.2009.09.005; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vroemen M, 2005, EXP NEUROL, V195, P127, DOI 10.1016/j.expneurol.2005.04.012; Wang SF, 2008, J BIOL CHEM, V283, P35929, DOI 10.1074/jbc.M804091200; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; Xu F, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580752; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	56	37	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26157	26166		10.1074/jbc.M113.502492	http://dx.doi.org/10.1074/jbc.M113.502492			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880763	hybrid, Green Published			2022-12-28	WOS:000330623300044
J	Yazicioglu, MN; Monaldini, L; Chu, K; Khazi, FR; Murphy, SL; Huang, HS; Margaritis, P; High, KA				Yazicioglu, Mustafa N.; Monaldini, Luca; Chu, Kirk; Khazi, Fayaz R.; Murphy, Samuel L.; Huang, Heshu; Margaritis, Paris; High, Katherine A.			Cellular Localization and Characterization of Cytosolic Binding Partners for Gla Domain-containing Proteins PRRG4 and PRRG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYGLUTAMIC ACID PROTEINS; WW DOMAIN; IDENTIFICATION; RECEPTOR; NUCLEUS; COMPLEX; MAGI-1; KINASE; FAMILY; LIGASE	The genes encoding a family of proteins termed proline-rich gamma-carboxyglutamic acid (PRRG) proteins were identified and characterized more than a decade ago, but their functions remain unknown. These novel membrane proteins have an extracellular gamma-carboxyglutamic acid (Gla) protein domain and cytosolic WW binding motifs. We screened WW domain arrays for cytosolic binding partners for PRRG4 and identified novel protein-protein interactions for the protein. We also uncovered a new WW binding motif in PRRG4 that is essential for these newly found protein-protein interactions. Several of the PRRG-interacting proteins we identified are essential for a variety of physiologic processes. Our findings indicate possible novel and previously unidentified functions for PRRG proteins.	[Yazicioglu, Mustafa N.; Monaldini, Luca; Chu, Kirk; Khazi, Fayaz R.; Murphy, Samuel L.; Huang, Heshu; Margaritis, Paris; High, Katherine A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Margaritis, Paris; High, Katherine A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [High, Katherine A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute	High, KA (corresponding author), Childrens Hosp Philadelphia, 3501 Civ Ctr Blvd,5060 CTRB, Philadelphia, PA 19104 USA.	high@email.chop.edu	High, Katherine A./AAB-9322-2020	High, Katherine/0000-0002-0805-6223	National Institutes of Health [P01 HL64190]; Howard Hughes Medical Institute; Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant P01 HL64190 (to K. A. H.), Howard Hughes Medical Institute, and the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia. M. N. Y., L. M., K. C., F. R. K., S. L. M., and K. A. H. are inventors on a patent related to using PRRG2 and PRRG4 as tumor markers. The remaining authors declare no competing financial interests.	BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Goruppi S, 1996, ONCOGENE, V12, P471; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Husain M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-12; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Kulman JD, 2007, P NATL ACAD SCI USA, V104, P8767, DOI 10.1073/pnas.0703195104; Latourelle JC, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-98; Mayhew MW, 2006, J PROTEOME RES, V5, P2417, DOI 10.1021/pr060140t; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086	23	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25908	25914		10.1074/jbc.M113.484683	http://dx.doi.org/10.1074/jbc.M113.484683			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23873930	Green Published, hybrid			2022-12-28	WOS:000330623300021
J	Elustondo, PA; White, AE; Hughes, ME; Brebner, K; Pavlov, E; Kane, DA				Elustondo, Pia A.; White, Adrienne E.; Hughes, Meghan E.; Brebner, Karen; Pavlov, Evgeny; Kane, Daniel A.			Physical and Functional Association of Lactate Dehydrogenase (LDH) with Skeletal Muscle Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT; OXIDATION; SHUTTLE; POPULATIONS; EXERCISE; CELLS; MCT1; SPECIFICITY; METABOLISM; FIBERS	The intracellular lactate shuttle hypothesis posits that lactate generated in the cytosol is oxidized by mitochondrial lactate dehydrogenase (LDH) of the same cell. To examine whether skeletal muscle mitochondria oxidize lactate, mitochondrial respiratory oxygen flux (JO(2)) was measured during the sequential addition of various substrates and cofactors onto permeabilized rat gastrocnemius muscle fibers, as well as isolated mitochondrial subpopulations. Addition of lactate did not alter JO2. However, subsequent addition of NAD(+) significantly increased JO2, and was abolished by the inhibitor of mitochondrial pyruvate transport, alpha-cyano-4-hydroxycinnamate. In experiments with isolated subsarcolemmal and intermyofibrillar mitochondrial subpopulations, only subsarcolemmal exhibited NAD(+)-dependent lactate oxidation. To further investigate the details of the physical association of LDH with mitochondria in muscle, immunofluorescence/confocal microscopy and immunoblotting approaches were used. LDH clearly colocalized with mitochondria in intact, as well as permeabilized fibers. LDH is likely localized inside the outer mitochondrial membrane, but not in the mitochondrial matrix. Collectively, these results suggest that extra-matrix LDH is strategically positioned within skeletal muscle fibers to functionally interact with mitochondria.	[Elustondo, Pia A.; Pavlov, Evgeny] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada; [White, Adrienne E.; Hughes, Meghan E.; Kane, Daniel A.] St Francis Xavier Univ, Dept Human Kinet, Antigonish, NS B2G 2W5, Canada; [Brebner, Karen] St Francis Xavier Univ, Dept Psychol, Antigonish, NS B2G 2W5, Canada	Dalhousie University; Saint Francis Xavier University - Canada; Saint Francis Xavier University - Canada	Kane, DA (corresponding author), St Francis Xavier Univ, Dept Human Kinet, Antigonish, NS B2G 2W5, Canada.	dkane@stfx.ca	Kane, Daniel A/F-6651-2014	Kane, Daniel A/0000-0002-9409-3257	NSERC; CFI; NSHRF; StFX UCR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); NSHRF; StFX UCR	This work was supported in part by grants from NSERC (to E. P.), CFI (to D. A. K., E. P., and K. B., separately), NSHRF (to K. B. and E. P., separately), and StFX UCR (to D. A. K.).	BABA N, 1971, J CELL BIOL, V51, P621, DOI 10.1083/jcb.51.3.621; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; Bonen A, 2007, J PHYSIOL-LONDON, V584, P707, DOI 10.1113/jphysiol.2007.143008; BRANDT RB, 1987, ARCH BIOCHEM BIOPHYS, V259, P412, DOI 10.1016/0003-9861(87)90507-8; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Brooks GA, 2002, J PHYSIOL-LONDON, V541, P333, DOI 10.1113/jphysiol.2002.023705; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; Brooks GEA, 2007, J PHYSIOL-LONDON, V584, P705, DOI 10.1113/jphysiol.2007.142992; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cruz RSD, 2012, SCI WORLD J, DOI 10.1100/2012/420984; Donovan CM, 2000, MED SCI SPORT EXER, V32, P772, DOI 10.1097/00005768-200004000-00009; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; ELANDER A, 1985, CLIN SCI, V69, P153, DOI 10.1042/cs0690153; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, pE686, DOI 10.1152/ajpendo.00476.2012; JOFFE M, 1983, COMP BIOCHEM PHYS B, V76, P783, DOI 10.1016/0305-0491(83)90393-0; Kane DA, 2011, AM J PHYSIOL-ENDOC M, V300, pE528, DOI 10.1152/ajpendo.00389.2010; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Nakae J, 1999, HISTOCHEM CELL BIOL, V112, P427; Nakae Y, 1997, J HISTOCHEM CYTOCHEM, V45, P1427, DOI 10.1177/002215549704501011; PAGLIASSOTTI MJ, 1990, AM J PHYSIOL, V258, pE635, DOI 10.1152/ajpendo.1990.258.4.E635; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Passarella S, 2008, FEBS LETT, V582, P3569, DOI 10.1016/j.febslet.2008.09.042; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Ponsot E, 2005, J CELL PHYSIOL, V203, P479, DOI 10.1002/jcp.20245; POPINIGIS J, 1991, ACTA BIOCHIM POL, V38, P169; Rasmussen HN, 2002, J PHYSIOL-LONDON, V541, P575, DOI 10.1113/jphysiol.2002.019216; Sahlin K, 2002, J PHYSIOL-LONDON, V541, P569, DOI 10.1113/jphysiol.2002.016683; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKILLETE.DN, 1972, ARCH BIOCHEM BIOPHYS, V152, P92, DOI 10.1016/0003-9861(72)90197-X; SZCZESNAKACZMAREK A, 1990, INT J BIOCHEM, V22, P617, DOI 10.1016/0020-711X(90)90038-5; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095	40	32	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25309	25317		10.1074/jbc.M113.476648	http://dx.doi.org/10.1074/jbc.M113.476648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23873936	hybrid, Green Published			2022-12-28	WOS:000330619000029
J	Heymann, JB; Bartho, JD; Rybakova, D; Venugopal, HP; Winkler, DC; Sen, A; Hurst, MRH; Mitra, AK				Heymann, J. Bernard; Bartho, Joseph D.; Rybakova, Daria; Venugopal, Hari P.; Winkler, Dennis C.; Sen, Anindito; Hurst, Mark R. H.; Mitra, Alok K.			Three-dimensional Structure of the Toxin-delivery Particle Antifeeding Prophage of Serratia entomophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON EVOLUTIONARY ORIGIN; PSEUDOMONAS-AERUGINOSA; TAIL LENGTH; GRASS GRUB; SECRETION APPARATUS; AMBER DISEASE; BACTERIOPHAGE-T4; PROTEIN; SHEATH; PHAGE	The Serratia entomophila antifeeding prophage (Afp) is a bullet-shaped toxin-delivery apparatus similar to the R-pyocins of Pseudomonas aeruginosa. Morphologically it resembles the sheathed tail of bacteriophages such as T4, including a baseplate at one end. It also shares features with the type VI secretion systems. Cryo-electron micrographs of tilted Afp specimens (up to 60 degrees) were analyzed to determine the correct cyclic symmetry to overcome the limitation imposed by exclusively side views in nominally untilted specimens. An asymmetric reconstruction shows clear 6-fold cyclic symmetry contrary to a previous conclusion of 4-fold symmetry based on analysis of only the preferred side views (Sen, A., Rybakova, D., Hurst, M. R., and Mitra, A. K. (2010) J. Bacteriol. 192, 4522-4525). Electron tomography of negatively stained Afp revealed right-handed helical striations in many of the particles, establishing the correct hand. Higher quality micrographs of untilted specimens were processed to produce a reconstruction at 2.0-nm resolution with imposed 6-fold symmetry. The helical parameters of the sheath were determined to be 8.14 nm for the subunit rise along and 40.5 degrees for the rotation angle around the helix. The sheath is similar to that of the T4 phage tail but with a different arrangement of the subdomain of the polymerizing sheath protein( s). The central tube is similar to the diameter and axial width of the Hcp1 hexamer of P. aeruginosa type VI secretion system. The tube extends through the baseplate into a needle resembling the "puncture device" of the T4 tail. The tube contains density that may be the toxin and/or a length-determining protein.	[Heymann, J. Bernard; Winkler, Dennis C.] NIAMS, NIH, Bethesda, MD 20892 USA; [Bartho, Joseph D.; Venugopal, Hari P.; Sen, Anindito; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Rybakova, Daria; Hurst, Mark R. H.] Agresearch, Innovat Farm Syst, Christchurch 8140, New Zealand	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Auckland; AgResearch - New Zealand	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	a.mitra@auckland.ac.nz	Heymann, Bernard/H-8265-2019; Mitra, Alok/P-7800-2016	Heymann, Bernard/0000-0002-8872-5326; Winkler, Dennis/0000-0003-1445-6554; Hurst, Mark/0000-0001-5826-5253; Rybakova, Daria/0000-0002-1756-6014; Mitra, Alok/0000-0003-0891-5697; Bartho, Joseph Dale/0000-0003-3853-2347	Faculty Research Development Fund from the University of Auckland; Foundation of Research, Science and Technology, New Zealand [C10X0804]; Intramural Research Program of NIAMS, National Institutes of Health	Faculty Research Development Fund from the University of Auckland; Foundation of Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology); Intramural Research Program of NIAMS, National Institutes of Health	This work was supported by a Faculty Research Development Fund from the University of Auckland (to A. K. M.), by Foundation of Research, Science and Technology, New Zealand Grant C10X0804 (to M. R. H. H.), and by the Intramural Research Program of NIAMS, National Institutes of Health (to J. B. H. and D. C. W.).	ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Glare TR, 1996, FEMS MICROBIOL LETT, V139, P117, DOI 10.1016/0378-1097(96)00128-0; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2013, J STRUCT BIOL, V184, P43, DOI 10.1016/j.jsb.2013.05.006; Heymann JB, 2005, J BIOL CHEM, V280, P7156, DOI 10.1074/jbc.M411712200; Hurst MRH, 2007, FEMS MICROBIOL LETT, V270, P42, DOI 10.1111/j.1574-6968.2007.00645.x; Hurst MRN, 2011, PLASMID, V65, P32, DOI 10.1016/j.plasmid.2010.10.001; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; ISHII SHIN-ICHI, 1965, J MOL BIOL, V13, P428; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Nguyen AH, 1999, BIOSCI BIOTECH BIOCH, V63, P1360, DOI 10.1271/bbb.63.1360; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rybakova D, 2013, MOL MICROBIOL, V89, P702, DOI 10.1111/mmi.12305; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sen A, 2010, J BACTERIOL, V192, P4522, DOI 10.1128/JB.00224-10; TAKEDA Y, 1975, J BIOCHEM-TOKYO, V77, P679, DOI 10.1093/oxfordjournals.jbchem.a130770; TAKEDA Y, 1983, J BIOCHEM-TOKYO, V94, P1013, DOI 10.1093/oxfordjournals.jbchem.a134398; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vianelli A, 2000, J BACTERIOL, V182, P680, DOI 10.1128/JB.182.3.680-688.2000; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006	37	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25276	25284		10.1074/jbc.M113.456145	http://dx.doi.org/10.1074/jbc.M113.456145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857636	hybrid, Green Published			2022-12-28	WOS:000330619000026
J	Huang, MLH; Austin, CJD; Sari, MA; Rahmanto, YS; Ponka, P; Vyoral, D; Richardson, DR				Huang, Michael Li-Hsuan; Austin, Christopher J. D.; Sari, Marie-Agnes; Rahmanto, Yohan Suryo; Ponka, Prem; Vyoral, Daniel; Richardson, Des R.			Hepcidin Bound to alpha(2)-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; GROWTH-FACTOR-BETA; LOW-DENSITY-LIPOPROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; BINDING-PROTEIN; ALPHA-MACROGLOBULINS; PLASMA-CLEARANCE; LDL RECEPTOR; FACTOR-BB; ALPHA-2-MACROGLOBULIN	Hepcidin regulates iron metabolism by down-regulating ferroportin-1 (Fpn1). We demonstrated that hepcidin is complexed to the blood transport protein, alpha(2)-macroglobulin (alpha M-2) (Peslova, G., Petrak, J., Kuzelova, K., Hrdy, I., Halada, P., Kuchel, P. W., Soe-Lin, S., Ponka, P., Sutak, R., Becker, E., Huang, M. L., Suryo Rahmanto, Y., Richardson, D. R., and Vyoral, D. (2009) Blood 113, 6225-6236). However, nothing is known about the mechanism of hepcidin binding to alpha M-2 or the effects of the alpha M-2.hepcidin complex in vivo. We show that decreased Fpn1 expression can be mediated by hepcidin bound to native alpha M-2 and also, for the first time, hepcidin bound to methylamine-activated alpha M-2 (alpha M-2-MA). Passage of high molecular weight alpha M-2.hepcidin or alpha M-2-MA.hepcidin complexes (approximate to 725 kDa) through a Sephadex G-25 size exclusion column retained their ability to decrease Fpn1 expression. Further studies using ultrafiltration indicated that hepcidin binding to alpha M-2 and alpha M-2-MA was labile, resulting in some release from the protein, and this may explain its urinary excretion. To determine whether alpha(2)MMA.hepcidin is delivered to cells via the alpha M-2 receptor (Lrp1), we assessed alpha(2)Muptake and Fpn1 expression in Lrp1-/- and Lrp1(+)/(+) cells. Interestingly, alpha M-2.hepcidin or alpha M-2-MA.hepcidin demonstrated similar activities at decreasing Fpn1 expression in Lrp1-/- and Lrp1(+)/(+) cells, indicating that Lrp1 is not essential for Fpn1 regulation. In vivo, hepcidin bound to alpha M-2 or alpha M-2-MA did not affect plasma clearance of alpha M-2/alpha M-2-MA. However, serum iron levels were reduced to a significantly greater extent in mice treated with alpha M-2.hepcidin or alpha M-2-MA.hepcidin relative to unbound hepcidin. This effect could be mediated by the ability of alpha M-2 or alpha M-2-MA to retard kidney filtration of bound hepcidin, increasing its half-life. A model is proposed that suggests that unlike proteases, which are irreversibly bound to activated alpha M-2, hepcidin remains labile and available to down-regulate Fpn1.	[Huang, Michael Li-Hsuan; Austin, Christopher J. D.; Rahmanto, Yohan Suryo; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Sari, Marie-Agnes] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, CNRS, UMR8601, F-75006 Paris, France; [Ponka, Prem] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Vyoral, Daniel] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic; [Vyoral, Daniel] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague 12853 2, Czech Republic	University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Lady Davis Institute; McGill University; Institute of Hematology Prague; Charles University Prague	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Huang, Michael L.-H./AAK-2237-2020; Girelli, Domenico/B-1183-2008; Ponka, Prem/A-4123-2011; Suryo Rahmanto, Yohan/K-8043-2018	Huang, Michael L.-H./0000-0003-0693-7833; Girelli, Domenico/0000-0001-9684-1899; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Ponka, Prem/0000-0001-5835-1477; Richardson, Des/0000-0002-5506-3274	Canadian Institutes of Health Research; Project for Conceptual Development of Research Organizations of the Czech Ministry of Health [00023736]; Czech Ministry of Education [PRVOUK P24/LF1/3]; European Fund for Regional Development [ERDF OPPK CZ.2.16/3.1.00/24, ERDF OPPK CZ.2.16/3.1.00/28007 001]; National Health and Medical Research Council of Australia [571123, 632698]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Project for Conceptual Development of Research Organizations of the Czech Ministry of Health; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); European Fund for Regional Development(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by operating grants from the Canadian Institutes of Health Research.; Supported by the Project for Conceptual Development of Research Organizations (00023736) of the Czech Ministry of Health; Grant PRVOUK P24/LF1/3 from the Czech Ministry of Education; and Grants ERDF OPPK CZ.2.16/3.1.00/24001 and ERDF OPPK CZ.2.16/3.1.00/28007 from the European Fund for Regional Development.; Supported by Senior Principal Research Fellowship 571123 and Project Grant 632698 from the National Health and Medical Research Council of Australia. To whom correspondence should be addressed: Dept. of Pathology, Blackburn Bldg., D06, University of Sydney, NSW 2006, Australia. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Colledge N. R., 2010, DAVIDSONS PRINCIPLES, P459; CROOKSTON KP, 1993, BIOCHEM J, V293, P443, DOI 10.1042/bj2930443; CROOKSTON KP, 1994, BIOCHEM BIOPH RES CO, V200, P1578, DOI 10.1006/bbrc.1994.1631; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; GONIAS SL, 1983, ANN NY ACAD SCI, V421, P457, DOI 10.1111/j.1749-6632.1983.tb18139.x; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; HALL SW, 1992, BIOCHEM J, V281, P569, DOI 10.1042/bj2810569; Hocquellet A, 2012, PEPTIDES, V36, P303, DOI 10.1016/j.peptides.2012.06.001; Huang MLH, 2011, ANTIOXID REDOX SIGN, V15, P3003, DOI 10.1089/ars.2011.3921; HUANG SS, 1988, J BIOL CHEM, V263, P1535; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Itkonen O, 2012, CLIN CHIM ACTA, V413, P696, DOI 10.1016/j.cca.2011.12.015; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kluver E, 2002, J PEPT RES, V59, P241, DOI 10.1034/j.1399-3011.2002.00980.x; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Koliaraki V, 2008, BIOCHIMIE, V90, P726, DOI 10.1016/j.biochi.2008.01.012; Kong WN, 2008, J CELL BIOCHEM, V104, P629, DOI 10.1002/jcb.21654; KRATZSCH J, 1995, J CLIN ENDOCR METAB, V80, P585, DOI 10.1210/jc.80.2.585; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LAMARRE J, 1990, LAB INVEST, V62, P545; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Mathew S, 2003, BIOCHEM J, V374, P123, DOI 10.1042/BJ20021655; MATSUDA T, 1989, J IMMUNOL, V142, P148; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; NIEMULLER CA, 1995, ENDOCRINOLOGY, V136, P5343, DOI 10.1210/en.136.12.5343; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OVERBERGH L, 1995, J LIPID RES, V36, P1774; PANYUTICH A, 1991, AM J RESP CELL MOL, V5, P101, DOI 10.1165/ajrcmb/5.2.101; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Pizzo S. V., 2000, HEMOSTASIS THROMBOSI, P367; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; Sari M.-A., 2011, AM J HEMATOL, V86, pE14; SKOGH T, 1982, GUT, V23, P1077, DOI 10.1136/gut.23.12.1077; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Westwood M, 2001, J BIOL CHEM, V276, P41668, DOI 10.1074/jbc.M102793200; WOLLENBERG GK, 1991, AM J PATHOL, V138, P265; Yeh KY, 2009, AM J PHYSIOL-GASTR L, V296, pG55, DOI 10.1152/ajpgi.90298.2008	65	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25450	25465		10.1074/jbc.M113.471573	http://dx.doi.org/10.1074/jbc.M113.471573			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846698	hybrid, Green Published			2022-12-28	WOS:000330619000041
J	Noller, HF				Noller, Harry F.			By Ribosome Possessed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Calif Santa Cruz, Ctr Mol Biol RNA, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu						BARRELL BG, 1971, PROCEDURES NUCLEIC A, V2, P751; NOMURA M, 1969, COLD SPRING HARB SYM, V34, P49, DOI 10.1101/SQB.1969.034.01.009; TRAKHANOV S, 1989, J MOL BIOL, V209, P327, DOI 10.1016/0022-2836(89)90282-9	3	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24872	24885		10.1074/jbc.X113.497511	http://dx.doi.org/10.1074/jbc.X113.497511			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23814064	hybrid, Green Published			2022-12-28	WOS:000330612300052
J	Ordureau, A; Enesa, K; Nanda, S; Le Francois, B; Peggie, M; Prescott, A; Albert, PR; Cohen, P				Ordureau, Alban; Enesa, Karine; Nanda, Sambit; Le Francois, Brice; Peggie, Mark; Prescott, Alan; Albert, Paul R.; Cohen, Philip			DEAF1 Is a Pellino1-interacting Protein Required for Interferon Production by Sendai Virus and Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; UBIQUITIN LIGASE PELLINO; FACTOR-I DEAF-1; KAPPA-B; ACTIVATION; IDENTIFICATION; EXPRESSION; INDUCTION; KINASE; IRAK1	Double-stranded (ds) RNA of viral origin, a ligand for Melanoma Differentiation-associated gene 5 (MDA5) and Toll-Like Receptor 3 (TLR3), induces the TANK-Binding Kinase 1 (TBK1)-dependent phosphorylation and activation of Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquitin ligase Pellino1, which are required for interferon beta (IFN beta) gene transcription. Here, we report that Pellino1 interacts with the transcription factor Deformed Epidermal Autoregulatory Factor 1 (DEAF1). The interaction is independent of the E3 ligase activity of Pellino1, but weakened by the phosphorylation of Pellino1. We show that DEAF1 binds to the IFN beta promoter and to IRF3 and IRF7, that it is required for the transcription of the IFN beta gene and IFN beta secretion in MEFs infected with Sendai virus or transfected with poly(I:C). DEAF1 is also needed for TLR3-dependent IFN beta production. Taken together, our results identify DEAF1 as a novel component of the signal transduction network by which dsRNA of viral origin stimulates IFN beta production.	[Ordureau, Alban; Enesa, Karine; Nanda, Sambit; Peggie, Mark; Cohen, Philip] Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Prescott, Alan] Univ Dundee, Sir James Black Ctr, Coll Life Sci, Dundee DD1 5EH, Scotland; [Le Francois, Brice; Albert, Paul R.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada	University of Dundee; University of Dundee; University of Ottawa; Ottawa Hospital Research Institute	Cohen, P (corresponding author), Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Albert, Paul/E-4804-2010; Ordureau, Alban/C-7558-2012; Prescott, Alan/Y-5956-2018	Albert, Paul/0000-0002-1809-3554; Ordureau, Alban/0000-0002-4924-8520; Prescott, Alan/0000-0002-0747-7317	UK Medical Research Council; Medical Research Council [MC_EX_G0800765, MR/K000985/1, MC_EX_UU_G0800765, MC_UU_12016/11, MC_U127084348] Funding Source: researchfish; MRC [MR/K000985/1, MC_EX_UU_G0800765, MC_U127084348, MC_UU_12016/11, MC_EX_G0800765] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council.	Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; Enesa K, 2012, J BIOL CHEM, V287, P34825, DOI 10.1074/jbc.M112.367557; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lee YS, 2010, BIOCHEM BIOPH RES CO, V393, P836, DOI 10.1016/j.bbrc.2010.02.094; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Manne U, 2001, CLIN CANCER RES, V7, P3495; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	41	18	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24569	24580		10.1074/jbc.M113.479550	http://dx.doi.org/10.1074/jbc.M113.479550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846693	Green Published, hybrid			2022-12-28	WOS:000330612300025
J	Takeshita, Y; Hashimoto, Y; Nawa, M; Uchino, H; Matsuoka, M				Takeshita, Yuji; Hashimoto, Yuichi; Nawa, Mikiro; Uchino, Hiroyuki; Matsuoka, Masaaki			SH3-binding Protein 5 Mediates the Neuroprotective Effect of the Secreted Bioactive Peptide Humanin by Inhibiting c-Jun NH2-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; IN-VIVO; PRECURSOR PROTEIN; MEMORY IMPAIRMENT; ISCHEMIA/REPERFUSION INJURY; RELEVANT INSULTS; BINDING-PROTEIN; MAP-KINASE	Humanin is a secreted bioactive peptide that suppresses cell toxicity caused by a variety of insults. The neuroprotective effect of Humanin against Alzheimer disease (AD)-related death is mediated by the binding of Humanin to its heterotrimeric Humanin receptor composed of ciliary neurotrophic receptor alpha, WSX-1, and gp130, as well as the activation of intracellular signaling pathways including a JAK2 and STAT3 signaling axis. Despite the elucidation of the signaling pathways by which Humanin mediates its neuroprotection, the transcriptional targets of Humanin that behaves as effectors of Humanin remains undefined. In the present study, Humanin increased the mRNA and protein expression of SH3 domain-binding protein 5 (SH3BP5), which has been known to be a JNK interactor, in neuronal cells. Similar to Humanin treatment, overexpression of SH3BP5 inhibited AD-related neuronal death, while siRNA-mediated knockdown of endogenous SH3BP5 expression attenuated the neuroprotective effect of Humanin. These results indicate that SH3BP5 is a downstream effector of Humanin. Furthermore, biochemical analysis has revealed that SH3BP5 binds to JNK and directly inhibits JNK through its two putative mitogen-activated protein kinase interaction motifs (KIMs).	[Takeshita, Yuji; Hashimoto, Yuichi; Nawa, Mikiro; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan; [Takeshita, Yuji; Uchino, Hiroyuki] Tokyo Med Univ, Dept Anesthesiol, Shinjuku Ku, Tokyo 1600023, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp	Hashimoto, Yuichi/N-1508-2015	Hashimoto, Yuichi/0000-0001-5863-3618	Promotion of Science and Technology project for private universities; Ministry of Education, Culture, Sports, Science, and Technology (MEXT);  [23390059];  [25460343]; Grants-in-Aid for Scientific Research [24790264] Funding Source: KAKEN	Promotion of Science and Technology project for private universities; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in-aid for Scientific Research (B) (Grant 23390059) (to M. M.), the Promotion of Science and Technology project for private universities, with a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to M. M.), and the Grant-in-Aid for Scientific Research (C) (Grant 25460343) (to Y. H.).	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2013, J BIOL CHEM, V288, P1079, DOI 10.1074/jbc.M112.421354; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2009, BIOCHEM BIOPH RES CO, V389, P95, DOI 10.1016/j.bbrc.2009.08.095; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kawasumi M, 2002, NEUROSIGNALS, V11, P236, DOI 10.1159/000067424; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; Kunesova G, 2008, PEPTIDES, V29, P1982, DOI 10.1016/j.peptides.2008.06.019; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matsuoka M, 2011, J ALZHEIMERS DIS, V24, P27, DOI 10.3233/JAD-2011-102076; Matsuoka Masaaki, 2009, Recent Pat CNS Drug Discov, V4, P37; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada M, 2005, BEHAV BRAIN RES, V164, P139, DOI 10.1016/j.bbr.2005.03.026; Yamadori T, 1999, P NATL ACAD SCI USA, V96, P6341, DOI 10.1073/pnas.96.11.6341; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012	53	15	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24691	24704		10.1074/jbc.M113.469692	http://dx.doi.org/10.1074/jbc.M113.469692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861391	Green Published, hybrid			2022-12-28	WOS:000330612300036
J	Wang, GR; Surks, HK; Tang, KM; Zhu, Y; Mendelsohn, ME; Blanton, RM				Wang, Guang-rong; Surks, Howard K.; Tang, K. Mary; Zhu, Yan; Mendelsohn, Michael E.; Blanton, Robert M.			Steroid-sensitive Gene 1 Is a Novel Cyclic GMP-dependent Protein Kinase I Substrate in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NITRIC-OXIDE; MYOSIN PHOSPHATASE; PHOSPHORYLATION; EXPRESSION; BINDING; ALPHA; VIVO; DETERMINANTS; HYPERTROPHY	NO, via its second messenger cGMP, activates protein kinase GI (PKGI) to induce vascular smooth muscle cell relaxation. The mechanisms by which PKGI kinase activity regulates cardiovascular function remain incompletely understood. Therefore, to identify novel protein kinase G substrates in vascular cells, a lambda phage coronary artery smooth muscle cell library was constructed and screened for phosphorylation by PKGI. The screen identified steroid-sensitive gene 1 (SSG1), which harbors several predicted PKGI phosphorylation sites. We observed direct and cGMP-regulated interaction between PKGI and SSG1. In cultured vascular smooth muscle cells, both the NO donor S-nitrosocysteine and atrial natriuretic peptide induced SSG1 phosphorylation, and mutation of SSG1 at each of the two predicted PKGI phosphorylation sites completely abolished its basal phosphorylation by PKGI. We detected high SSG1 expression in cardiovascular tissues. Finally, we found that activation of PKGI with cGMP regulated SSG1 intracellular distribution.	[Blanton, Robert M.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center	Blanton, RM (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 80, Boston, MA 02111 USA.	rblanton@tuftsmedicalcenter.org			National Institutes of Health [HL077378, HL55309, HL074069, AG042367-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055309, P01HL077378, R01HL074069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL077378 and HL55309 (to M. E. M.), HL074069 (to H. K. S.), and AG042367-01 (to R. M. B.).	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Blanton RM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003731; Busse R, 1996, J VASC RES, V33, P181, DOI 10.1159/000159147; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hofmann F, 2000, J CELL SCI, V113, P1671; Ignarro LJ, 1996, KIDNEY INT, pS2; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Lincoln TM, 1996, METHOD ENZYMOL, V269, P149; LINCOLN TM, 1994, CYCLIC GMP BIOCH PHY; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; Marcantonio D, 2001, J MOL ENDOCRINOL, V26, P175, DOI 10.1677/jme.0.0260175; Marcantonio D, 2001, ENDOCRINOLOGY, V142, P2409, DOI 10.1210/endo.142.6.8154; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mirotsou M, 2006, PHYSIOL GENOMICS, V27, P86, DOI 10.1152/physiolgenomics.00028.2006; Murad F, 1996, JAMA-J AM MED ASSOC, V276, P1189, DOI 10.1001/jama.276.14.1189; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tamura N, 1996, HYPERTENSION, V27, P552, DOI 10.1161/01.HYP.27.3.552; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0	35	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24972	24983		10.1074/jbc.M113.456244	http://dx.doi.org/10.1074/jbc.M113.456244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23831687	Green Published, hybrid			2022-12-28	WOS:000330612300060
J	Mehrotra, S; Sharma, B; Joshi, S; Kroczynska, B; Majchrzak, B; Stein, BL; McMahon, B; Altman, JK; Licht, JD; Baker, DP; Eklund, EA; Wickrema, A; Verma, A; Fish, EN; Platanias, LC				Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Majchrzak, Beata; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Baker, Darren P.; Eklund, Elizabeth A.; Wickrema, Amittha; Verma, Amit; Fish, Eleanor N.; Platanias, Leonidas C.			Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; POLYCYTHEMIA-VERA; PEGYLATED INTERFERON-ALPHA-2B; ESSENTIAL THROMBOCYTHEMIA; MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; MAMMALIAN TARGET; GENE-EXPRESSION; MESSENGER-RNA; ALPHA	The mechanisms of generation of the antineoplastic effects of interferons (IFNs) in malignant hematopoietic cells remain to be precisely defined. We examined the activation of type I IFN-dependent signaling pathways in malignant cells transformed by Jak2V617F, a critical pathogenic mutation in myeloproliferative neoplasms (MPNs). Our studies demonstrate that during engagement of the type I IFN receptor (IFNAR), there is activation of Jak-Stat pathways and also engagement of Mnk kinases. Activation of Mnk kinases is regulated by the Mek/Erk pathway and is required for the generation of IFN-induced growth inhibitory responses, but Mnk kinase activation does not modulate IFN-regulated Jak-Stat signals. We demonstrate that for type I IFNs to exert suppressive effects in malignant hematopoietic progenitors from patients with polycythemia vera, induction of Mnk kinase activity is required, as evidenced by studies involving pharmacological inhibition of Mnk or siRNA-mediated Mnk knockdown. Altogether, these findings provide evidence for key and essential roles of the Mnk kinase pathway in the generation of the antineoplastic effects of type I IFNs in Jak2V617F-dependent MPNs.	[Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Verma, Amit] Albert Einstein Coll Med, Div Hematol Oncol, Bronx, NY 10467 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Biogen; University of Chicago; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, Lurie 3-107,303 East Super, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Licht, Jonathan/L-4239-2019; mehrotra, swarna/F-2688-2015; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369	National Institutes of Health [CA155566, CA77816, CA161796]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA155566, R01CA161796, R01CA121192, P30CA060553, R01CA077816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA155566, CA77816, and CA161796 (to L. C. P.); by a Merit Review grant from the Department of Veterans Affairs (to L. C. P.). D. P. B. is an employee of Biogen Idec and an owner of Biogen Idec stock.	Altman JK, 2013, BLOOD, V121, P3675, DOI 10.1182/blood-2013-01-477216; Alvarado Y, 2003, CANCER CHEMOTH PHARM, V51, P81, DOI 10.1007/s00280-002-0533-4; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Gowin K, 2012, HAEMATOL-HEMATOL J, V97, P1570, DOI 10.3324/haematol.2011.061390; Hou JQ, 2012, ONCOTARGET, V3, P118; Ianotto JC, 2009, BRIT J HAEMATOL, V146, P223, DOI 10.1111/j.1365-2141.2009.07745.x; Indraccolo S, 2010, AUTOIMMUNITY, V43, P244, DOI 10.3109/08916930903510963; Inoue M, 2013, IMMUNOLOGY, V139, P11, DOI 10.1111/imm.12081; Joshi Sonali, 2015, BioMolecular Concepts, V6, P85, DOI 10.1515/bmc-2011-2000; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Karussis D, 2013, BIODRUGS, V27, P113, DOI 10.1007/s40259-013-0011-z; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Lamers MH, 2012, ANTIVIR THER, V17, P1029, DOI 10.3851/IMP2306; Langer C, 2005, HAEMATOLOGICA, V90, P1333; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu M, 2010, EXP HEMATOL, V38, P472, DOI 10.1016/j.exphem.2010.03.005; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Panaretakis T, 2008, MOL BIOL CELL, V19, P41, DOI 10.1091/mbc.E07-04-0358; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Peschel C, 1996, LEUKEMIA LYMPHOMA, V22, P129, DOI 10.3109/10428199609074370; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Samuelsson J, 2006, CANCER-AM CANCER SOC, V106, P2397, DOI 10.1002/cncr.21900; Scagnolari C, 2013, EXPERT OPIN BIOL TH, V13, P693, DOI 10.1517/14712598.2013.764409; Sharma B, 2012, J BIOL CHEM, V287, P42352, DOI 10.1074/jbc.M112.400721; Silver RT, 2011, BLOOD, V117, P6669, DOI 10.1182/blood-2010-11-320069; SILVER RT, 1988, LANCET, V2, P403; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stein BL, 2013, J INTERF CYTOK RES, V33, P145, DOI 10.1089/jir.2012.0120; Tai AW, 2009, J HEPATOL, V50, P412, DOI 10.1016/j.jhep.2008.11.010; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, LEUKEMIA LYMPHOMA, V43, P703, DOI 10.1080/10428190290016782; Xiong ZY, 2007, CLIN IMMUNOL, V122, P279, DOI 10.1016/j.clim.2006.10.006; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	65	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23814	23822		10.1074/jbc.M113.476192	http://dx.doi.org/10.1074/jbc.M113.476192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814052	Green Published, hybrid			2022-12-28	WOS:000330611400021
J	Cormier, A; Drubin, DG; Barnes, G				Cormier, Anthony; Drubin, David G.; Barnes, Georjana			Phosphorylation Regulates Kinase and Microtubule Binding Activities of the Budding Yeast Chromosomal Passenger Complex in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; SPINDLE ASSEMBLY CHECKPOINT; CELL-DIVISION; ESCHERICHIA-COLI; CLEAVAGE FURROW; INCENP BINDS; SURVIVIN; ACTIVATION; LOCALIZATION; SEGREGATION	The chromosomal passenger complex (CPC) is a key regulator of mitosis in eukaryotes. It comprises four essential and conserved proteins known in mammals/yeasts as Aurora B/Ipl1, INCENP/Sli15, Survivin/Bir1, and Borealin/Nbl1. These subunits act together in a highly controlled fashion. Regulation of Aurora B/Ipl1 kinase activity and localization is critical for CPC function. Although regulation of CPC localization and kinase activity in vivo has been investigated elsewhere, studies on the complete, four-subunit CPC and its basic biochemical properties are only beginning. Here we describe the biochemical characterization of purified and complete Saccharomyces cerevisiae four-subunit CPC. We determined the affinity of the CPC for microtubules and demonstrated that the binding of CPC to microtubules is primarily electrostatic in nature and depends on the acidic C-terminal tail (E-hook) of tubulin. Moreover, phosphorylation of INCENP/Sli15 on its microtubule binding region also negatively regulates CPC affinity for microtubules. Furthermore, we show that phosphorylation of INCENP/Sli15 is required for activation of the kinase Aurora B/Ipl1 and can occur in trans. Although phosphorylation of INCENP/Sli15 is essential for activation, we determined that a version of the CPC lacking the INCENP/Sli15 microtubule binding region (residues Glu-91 to Ile-631) is able to form an intact complex that retains microtubule binding activity. Thus, we conclude that this INCENP/Sli15 linker domain plays a largely regulatory function and is not essential for complex formation or microtubule binding.	[Cormier, Anthony; Drubin, David G.; Barnes, Georjana] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Barnes, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gbarnes@berkeley.edu			National Institutes of Health [R01 GM47842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 GM47842 (to G.B.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 2008, BIOCHEM SOC T, V36, P367, DOI 10.1042/BST0360367; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Nakajima Y, 2009, MOL BIOL CELL, V20, P1772, DOI 10.1091/mbc.E08-10-1011; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Vader G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-10; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Woodruff JB, 2010, J CELL BIOL, V191, P795, DOI 10.1083/jcb.201006028; Yang J, 2009, BIOCHEM J, V417, P355, DOI 10.1042/BJ20081365; Zimmermann D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025473	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23203	23211		10.1074/jbc.M113.491480	http://dx.doi.org/10.1074/jbc.M113.491480			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814063	Green Published, hybrid			2022-12-28	WOS:000330598200027
J	Chavan, H; Khan, MMT; Tegos, G; Krishnamurthy, P				Chavan, Hemantkumar; Khan, Mohiuddin Md Taimur; Tegos, George; Krishnamurthy, Partha			Efficient Purification and Reconstitution of ATP Binding Cassette Transporter B6 (ABCB6) for Functional and Structural Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; LIPID FLIPPASE; MECHANISM; EXPRESSION; PROTEOLIPOSOMES; RESISTANCE; LOCALIZES; MUTATIONS	The mitochondrial ATP binding cassette transporter ABCB6 has been associated with a broad range of physiological functions, including growth and development, therapy-related drug resistance, and the new blood group system Langereis. ABCB6 has been proposed to regulate heme synthesis by shuttling coproporphyrinogen III from the cytoplasm into the mitochondria. However, direct functional information of the transport complex is not known. To understand the role of ABCB6 in mitochondrial transport, we developed an in vitro system with pure and active protein. ABCB6 overexpressed in HEK293 cells was solubilized from mitochondrial membranes and purified to homogeneity. Purified ABCB6 showed a high binding affinity for MgATP (K-d = 0.18 mu M) and an ATPase activity with a K-m of 0.99 mM. Reconstitution of ABCB6 into liposomes allowed biochemical characterization of the ATPase including (i) substrate-stimulated ATPase activity, (ii) transport kinetics of its proposed endogenous substrate coproporphyrinogen III, and (iii) transport kinetics of substrates identified using a high throughput screening assay. Mutagenesis of the conserved lysine to alanine (K629A) in the Walker A motif abolished ATP hydrolysis and substrate transport. These results suggest a direct interaction between mitochondrial ABCB6 and its transport substrates that is critical for the activity of the transporter. Furthermore, the simple immunoaffinity purification of ABCB6 to near homogeneity and efficient reconstitution of ABCB6 into liposomes might provide the basis for future studies on the structure/function of ABCB6.	[Chavan, Hemantkumar; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Khan, Mohiuddin Md Taimur] Washington State Univ, Dept Chem Engn & Bioengn, Pullman, WA 99146 USA; [Khan, Mohiuddin Md Taimur] Pacific NW Natl Lab, Div Bioenergy & Biotechnol, Richland, WA 99352 USA; [Tegos, George] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Tegos, George] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Chavan, Hemantkumar; Krishnamurthy, Partha] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tegos, George] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02114 USA	University of Kansas; University of Kansas Medical Center; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of New Mexico; University of New Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Krishnamurthy, P (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pkasturi@kumc.edu	Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020	Chavan, Hemantkumar/0000-0002-9963-6230	National Institutes of Health [P20RR021940, R03MH093193]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR021940 and R03MH093193.	Abele R, 2009, CURR OPIN CELL BIOL, V21, P508, DOI 10.1016/j.ceb.2009.04.008; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; Chavan H, 2012, J BIOL CHEM, V287, P32054, DOI 10.1074/jbc.M112.371476; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Emadi-Konjin HP, 2002, BBA-GENE STRUCT EXPR, V1574, P117, DOI 10.1016/S0167-4781(01)00340-2; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Palmeira A, 2012, CURR MED CHEM, V19, P1946, DOI 10.2174/092986712800167392; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Polireddy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040005; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; Saison C, 2013, VOX SANG, V104, P159, DOI 10.1111/j.1423-0410.2012.01650.x; Sharom FJ, 2005, J BIOENERG BIOMEMBR, V37, P481, DOI 10.1007/s10863-005-9496-6; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wink M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00130; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908; Zhang C., 2013, J INVEST DE IN PRESS; Zhao SG, 2012, ANN SURG ON IN PRESS	50	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22658	22669		10.1074/jbc.M113.485284	http://dx.doi.org/10.1074/jbc.M113.485284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792964	hybrid, Green Published			2022-12-28	WOS:000330596300045
J	Fan, MY; Krutilina, R; Sun, J; Sethuraman, A; Yang, CH; Wu, ZH; Yue, JM; Pfeffer, LM				Fan, Meiyun; Krutilina, Raisa; Sun, Jing; Sethuraman, Aarti; Yang, Chuan He; Wu, Zhao-hui; Yue, Junming; Pfeffer, Lawrence M.			Comprehensive Analysis of MicroRNA (miRNA) Targets in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MESSENGER-RNAS; WIDE IDENTIFICATION; ARGONAUTE PROTEINS; CYCLE REGULATION; AUTOPHAGY; METASTASIS; SITES; APOPTOSIS	MicroRNAs (miRNAs) regulate mRNA stability and translation through the action of the RNAi-induced silencing complex. In this study, we systematically identified endogenous miRNA target genes by using AGO2 immunoprecipitation (AGO2-IP) and microarray analyses in two breast cancer cell lines, MCF7 and MDA-MB-231, representing luminal and basal-like breast cancer, respectively. The expression levels of similar to 70% of the AGO2-IP mRNAs were increased by DROSHA or DICER1 knockdown. In addition, integrated analysis of miRNA expression profiles, mRNA-AGO2 interaction, and the 3 '-UTR of mRNAs revealed that >60% of the AGO2-IP mRNAs were putative targets of the 50 most abundantly expressed miRNAs. Together, these results suggested that the majority of the AGO2-associated mRNAs were bona fide miRNA targets. Functional enrichment analysis uncovered that the AGO2-IP mRNAs were involved in regulation of cell cycle, apoptosis, adhesion/migration/invasion, stress responses (e. g. DNA damage and endoplasmic reticulum stress and hypoxia), and cell-cell communication (e.g. Notch and Ephrin signaling pathways). A role of miRNAs in regulating cell migration/invasion and stress response was further defined by examining the impact of DROSHA knockdown on cell behaviors. We demonstrated that DROSHA knockdown enhanced cell migration and invasion, whereas it sensitized cells to cell death induced by suspension culture, glucose depletion, and unfolding protein stress. Data from an orthotopic xenograft model showed that DROSHA knockdown resulted in reduced growth of primary tumors but enhanced lung metastasis. Taken together, these results suggest that miRNAs collectively function to promote survival of tumor cells under stress but suppress cell migration/invasion in breast cancer cells.	Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Ctr Adult Canc Res, Memphis, TN 38163 USA; Univ Tennessee, Hlth Sci Ctr, Dept Lab Med, Ctr Adult Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Fan, MY (corresponding author), 19 South Manassas St, Memphis, TN 38163 USA.	mfan2@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA140346, CA133322]; NATIONAL CANCER INSTITUTE [R01CA149251, R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140346 (to M. F.) and CA133322 (to L. M. P.).	Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hassan MQ, 2010, J CELL BIOCHEM, V110, P817, DOI 10.1002/jcb.22562; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwasaki YW, 2013, RNA, V19, P490, DOI 10.1261/rna.036608.112; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicklas JA, 2003, J FORENSIC SCI, V48, P936; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valdmanis PN, 2012, NUCLEIC ACIDS RES, V40, P3704, DOI 10.1093/nar/gkr1274; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang BD, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-98; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	66	35	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27480	27493		10.1074/jbc.M113.491803	http://dx.doi.org/10.1074/jbc.M113.491803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921383	Green Published, hybrid			2022-12-28	WOS:000330597300043
J	Justesen, BH; Hansen, RW; Martens, HJ; Theorin, L; Palmgren, MG; Martinez, KL; Pomorski, TG; Fuglsang, AT				Justesen, Bo Hojen; Hansen, Randi Westh; Martens, Helle Juel; Theorin, Lisa; Palmgren, Michael G.; Martinez, Karen L.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe			Active Plasma Membrane P-type H+-ATPase Reconstituted into Nanodiscs Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANOSCALE LIPID-BILAYERS; BLUE NATIVE ELECTROPHORESIS; PHOSPHOLIPID-BILAYER; ERYTHROCYTE CA-2+-ATPASE; ELECTRON CRYOMICROSCOPY; PROTON TRANSLOCATION; CYTOCHROME-P450 3A4; SCAFFOLD PROTEINS; BINDING; ACTIVATION	Plasma membrane H+-ATPases form a subfamily of P-type ATPases responsible for pumping protons out of cells and are essential for establishing and maintaining the crucial transmembrane proton gradient in plants and fungi. Here, we report the reconstitution of the Arabidopsis thaliana plasma membrane H+-ATPase isoform 2 into soluble nanoscale lipid bilayers, also termed nanodiscs. Based on native gel analysis and cross-linking studies, the pump inserts into nanodiscs as a functional monomer. Insertion of the H+-ATPase into nanodiscs has the potential to enable structural and functional characterization using techniques normally applicable only for soluble proteins.	[Justesen, Bo Hojen; Theorin, Lisa; Palmgren, Michael G.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg C, Denmark; [Justesen, Bo Hojen; Martens, Helle Juel; Theorin, Lisa; Palmgren, Michael G.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark; [Hansen, Randi Westh; Martinez, Karen L.] Univ Copenhagen, Dept Chem, Bionanotechnol & Nanomed Lab, DK-2100 Copenhagen, Denmark; [Hansen, Randi Westh; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Pomorski, TG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	tgp@life.ku.dk; atf@life.ku.dk	Palmgren, Michael/A-9808-2013; Fuglsang, Anja Thoe/A-6733-2015; Martens, Helle/H-7710-2014; Martens, Helle/AAG-9725-2020; martinez, karen L/J-5933-2013; Pomorski, Thomas Günther/G-4804-2014; Martinez, Karen/W-3709-2019; fuglsang, anja thoe t/E-1683-2012	Palmgren, Michael/0000-0002-9982-6114; Fuglsang, Anja Thoe/0000-0003-1153-8394; Martens, Helle/0000-0002-3011-4557; Martens, Helle/0000-0002-3011-4557; martinez, karen L/0000-0003-0932-8080; Pomorski, Thomas Günther/0000-0002-4889-0829; Martinez, Karen/0000-0003-0932-8080; fuglsang, anja thoe t/0000-0003-1153-8394; Hansen, Randi Westh/0000-0001-5547-683X	UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen; Danish National Research Foundation through the PUMPKIN Center of Excellence; Carlsberg Foundation	UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen; Danish National Research Foundation through the PUMPKIN Center of Excellence; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen, by the Danish National Research Foundation through the PUMPKIN Center of Excellence, and by an equipment grant from the Carlsberg Foundation.	ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BLANCO G, 1994, P NATL ACAD SCI USA, V91, P8542, DOI 10.1073/pnas.91.18.8542; Borch J, 2008, ANAL CHEM, V80, P6245, DOI 10.1021/ac8000644; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; Dach I, 2012, J BIOL CHEM, V287, P41963, DOI 10.1074/jbc.M112.398768; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Duan H, 2004, ARCH BIOCHEM BIOPHYS, V424, P141, DOI 10.1016/j.abb.2004.02.010; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Fuglsang AT, 2011, SIGNAL COMMUN PLANTS, P39, DOI 10.1007/978-3-642-14369-4_2; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gluck JM, 2011, ANAL BIOCHEM, V408, P46, DOI 10.1016/j.ab.2010.08.028; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Hayashi Y, 2010, PLANT CELL PHYSIOL, V51, P1186, DOI 10.1093/pcp/pcq078; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUANG LS, 1990, BIOCHIM BIOPHYS ACTA, V1039, P241, DOI 10.1016/0167-4838(90)90192-I; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jahn T, 2001, J MOL BIOL, V309, P465, DOI 10.1006/jmbi.2001.4688; Jelich-Ottmann C, 2001, J BIOL CHEM, V276, P39852, DOI 10.1074/jbc.M106746200; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P9618, DOI 10.1002/anie.200801711; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; MacColl R, 1996, J BIOL CHEM, V271, P17157, DOI 10.1074/jbc.271.29.17157; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; RADOMSKY ML, 1990, BIOMATERIALS, V11, P619, DOI 10.1016/0142-9612(90)90018-L; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skar-Gislinge N, 2010, J AM CHEM SOC, V132, P13713, DOI 10.1021/ja1030613; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILSEN B, 1987, J BIOL CHEM, V262, P10511; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	62	15	15	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26419	26429		10.1074/jbc.M112.446948	http://dx.doi.org/10.1074/jbc.M112.446948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23836891	Green Published, hybrid			2022-12-28	WOS:000330594500007
J	Kwon, HS; Johnson, TV; Joe, MK; Abu-Asab, M; Zhang, J; Chan, CC; Tomarev, SI				Kwon, Heung Sun; Johnson, Thomas V.; Joe, Myung Kuk; Abu-Asab, Mones; Zhang, Jun; Chan, Chi Chao; Tomarev, Stanislav I.			Myocilin Mediates Myelination in the Peripheral Nervous System through ErbB2/3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; SCHWANN-CELLS; WALLERIAN DEGENERATION; MUTATIONS; GLIOMEDIN; RANVIER; GENE; EXPRESSION; PROTEINS; NODES	The glaucoma-associated gene, myocilin, is expressed in ocular and non-ocular tissues including the peripheral nervous system, but its functions in these tissues remain poorly understood. We demonstrate that in sciatic nerve, myocilin is expressed in Schwann cells with high concentrations at the nodes of Ranvier. There, myocilin interacts with gliomedin, neurofascin, and NrCAM, which are essential for node formation and function. Treatment of isolated dorsal root ganglion cultures with myocilin stimulates clustering of the nodal proteins neurofascin and sodium channel Na(v)1.2. Sciatic nerves of myocilin null mice express reduced levels of several myelin-associated and basal membrane proteins compared with those of wild-type littermates. They also demonstrate reduced myelin sheath thickness and partial disorganization of the nodes. Myocilin signaling through ErbB2/3 receptors may contribute to these observed effects. Myocilin binds to ErbB2/ErbB3, activates these receptors, and affects the downstream PI3K-AKT signaling pathway. These data implicate a role for myocilin in the development and/or maintenance of myelination and nodes of Ranvier in sciatic nerve.	[Kwon, Heung Sun; Johnson, Thomas V.; Joe, Myung Kuk; Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA; [Abu-Asab, Mones; Zhang, Jun; Chan, Chi Chao] NEI, Histol Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Rm 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov	Johnson, Thomas V/C-9351-2011	Johnson, Thomas V/0000-0002-5372-5457; Abu-Asab, Mones/0000-0002-4047-1232	Intramural Research Program of the NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000318, ZIAEY000222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Intramural Research Program of the NEI, National Institutes of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the NEI, National Institutes of Health.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agrawal D, 2009, J STRUCT BIOL, V168, P521, DOI 10.1016/j.jsb.2009.06.019; Albrecht DE, 2008, GLIA, V56, P611, DOI 10.1002/glia.20636; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Davies AM, 1998, CURR BIOL, V8, pR15, DOI 10.1016/S0960-9822(98)70009-0; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Lemke G., 2006, SCI STKE 2006, P11; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Mckee KK, 2012, J CELL SCI, V125, P4609, DOI 10.1242/jcs.107995; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nakagawa M, 2001, GLIA, V35, P101, DOI 10.1002/glia.1075; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; PORTER S, 1986, J NEUROSCI, V6, P3070; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; Wiggs JL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1674; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005	48	27	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26357	26371		10.1074/jbc.M112.446138	http://dx.doi.org/10.1074/jbc.M112.446138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897819	Green Published, hybrid			2022-12-28	WOS:000330594500002
J	Hilbers, F; Eggers, R; Pradela, K; Friedrich, K; Herkenhoff-Hesselmann, B; Becker, E; Deckers-Hebestreit, G				Hilbers, Florian; Eggers, Ruth; Pradela, Kamila; Friedrich, Kathleen; Herkenhoff-Hesselmann, Brigitte; Becker, Elisabeth; Deckers-Hebestreit, Gabriele			Subunit delta Is the Key Player for Assembly of the H+-translocating Unit of Escherichia coli FOF1 ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ADENOSINE-TRIPHOSPHATASE; HIGH-LEVEL EXPRESSION; ALPHA-SUBUNIT; BETA-SUBUNIT; F-0 COMPLEX; MEMBRANE INSERTION; PROTON CONDUCTION; F1F0-ATP SYNTHASE; TERMINAL REGION; EPSILON-SUBUNIT	The ATP synthase (FOF1) of Escherichia coli couples the translocation of protons across the cytoplasmic membrane to the synthesis or hydrolysis of ATP. This nanomotor is composed of the rotor c(10)gamma epsilon and the stator ab(2)alpha(3)beta(3)delta. To study the assembly of this multimeric enzyme complex consisting of membraneintegral as well as peripheral hydrophilic subunits, we combined nearest neighbor analyses by intermolecular disulfide bond formation or purification of partially assembled FOF1 complexes by affinity chromatography with the use of mutants synthesizing different sets of FOF1 subunits. Together with a time-delayed in vivo assembly system, the results demonstrate that FOF1 is assembled in a modular way via subcomplexes, thereby preventing the formation of a functionalH(+)-translocating unit as intermediate product. Surprisingly, during the biogenesis of FOF1, F-1 subunit delta is the key player in generating stable F-O. Subunit delta serves as clamp between ab(2) and c(10)alpha(3)beta(3)gamma epsilon and guarantees that the open H+ channel is concomitantly assembled within coupled FOF1 to maintain the low membrane proton permeability essential for viability, a general prerequisite for the assembly of multimeric H+-translocating enzymes.	[Hilbers, Florian; Eggers, Ruth; Pradela, Kamila; Friedrich, Kathleen; Herkenhoff-Hesselmann, Brigitte; Becker, Elisabeth; Deckers-Hebestreit, Gabriele] Univ Osnabruck, Dept Microbiol, D-49069 Osnabruck, Germany	University Osnabruck	Deckers-Hebestreit, G (corresponding author), Univ Osnabruck, Dept Microbiol, Barbarastr 11, D-49069 Osnabruck, Germany.	deckers-hebestreit@biologie.uni-osnabrueck.de			Deutsche Forschungsgemeinschaft [DE482/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DE482/1-1.	ALSHAWI MK, 1990, J BIOL CHEM, V265, P5595; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Birkenhager R, 1999, EUR J BIOCHEM, V264, P385, DOI 10.1046/j.1432-1327.1999.00652.x; Brandt K, 2013, J BIOL CHEM, V288, P24465, DOI 10.1074/jbc.M113.465633; Brandt K, 2013, J BIOENERG BIOMEMBR, V45, P15, DOI 10.1007/s10863-012-9474-8; Brockmann B, 2013, J BACTERIOL, V195, P4074, DOI 10.1128/JB.00468-13; BRUSILOW WSA, 1993, MOL MICROBIOL, V9, P419, DOI 10.1111/j.1365-2958.1993.tb01703.x; CAGNON C, 1991, PROTEIN ENG, V4, P843, DOI 10.1093/protein/4.7.843; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DECKERSHEBESTREIT G, 1992, J BIOL CHEM, V267, P12364; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Douglas M, 1979, Methods Enzymol, V56, P58; DUNN SD, 1980, J BIOL CHEM, V255, P113; DUNN SD, 1980, J BIOL CHEM, V255, P6891; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; EYA S, 1991, ARCH BIOCHEM BIOPHYS, V284, P71, DOI 10.1016/0003-9861(91)90265-K; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; FILLINGAME RH, 1986, J BACTERIOL, V165, P244, DOI 10.1128/jb.165.1.244-251.1986; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Greie JC, 2000, J BIOENERG BIOMEMBR, V32, P357, DOI 10.1023/A:1005523902800; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; Krebstakies T, 2008, BIOCHEMISTRY-US, V47, P6907, DOI 10.1021/bi800173a; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Liu J, 2013, J BACTERIOL, V195, P220, DOI 10.1128/JB.01493-12; MCCARTHY JEG, 1988, J BIOENERG BIOMEMBR, V20, P19, DOI 10.1007/BF00762136; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; MONTICELLO RA, 1994, J BACTERIOL, V176, P1383, DOI 10.1128/jb.176.5.1383-1389.1994; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P1; NIELSEN J, 1981, MOL GEN GENET, V184, P33, DOI 10.1007/BF00271191; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; PATI S, 1989, J BIOL CHEM, V264, P2640; PATI S, 1991, BIOCHEMISTRY-US, V30, P4710, DOI 10.1021/bi00233a011; PATI S, 1992, MOL MICROBIOL, V6, P3559, DOI 10.1111/j.1365-2958.1992.tb01791.x; Pierson HE, 2011, J BIOL CHEM, V286, P38583, DOI 10.1074/jbc.M111.294868; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHATZ G, 1968, J BIOL CHEM, V243, P2192; SCHNEIDER E, 1984, P NATL ACAD SCI-BIOL, V81, P7279, DOI 10.1073/pnas.81.23.7279; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Senior AE, 2006, BIOCHEMISTRY-US, V45, P15893, DOI 10.1021/bi0619730; SOLOMON KA, 1988, J BIOL CHEM, V263, P5402; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STERNWEIS PC, 1978, J BIOL CHEM, V253, P3123; Strahl H, 2008, EXTREMOPHILES, V12, P741, DOI 10.1007/s00792-008-0177-3; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5027; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; WALKER JE, 1986, CHEM SCRIPTA, V26B, P263; Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198; WISE JG, 1990, J BIOL CHEM, V265, P10403; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200	74	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25880	25894		10.1074/jbc.M113.484675	http://dx.doi.org/10.1074/jbc.M113.484675			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23864656	hybrid, Green Published			2022-12-28	WOS:000330623300019
J	Mitra, S; Traughber, CA; Brannon, MK; Gomez, S; Capelluto, DGS				Mitra, Sharmistha; Traughber, C. Alicia; Brannon, Mary K.; Gomez, Stephanie; Capelluto, Daniel G. S.			Ubiquitin Interacts with the Tollip C2 and CUE Domains and Inhibits Binding of Tollip to Phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; INNATE IMMUNITY; VHS DOMAIN; PROTEINS; RECEPTOR; RECOGNITION; PATHWAY; UBIQUITYLATION; COMPLEX; SYSTEM	A large number of cellular signaling processes are directed through internalization, via endocytosis, of polyubiquitinated cargo proteins. Tollip is an adaptor protein that facilitates endosomal cargo sorting for lysosomal degradation. Tollip preferentially binds phosphatidylinositol 3-phosphate (PtdIns(3) P) via its C2 domain, an association that may be required for endosomal membrane targeting. Here, we show that Tollip binds ubiquitin through its C2 and CUE domains and that its association with the C2 domain inhibits PtdIns(3) P binding. NMR analysis demonstrates that the C2 and CUE domains bind to overlapping sites on ubiquitin, suggesting that two ubiquitin molecules associate with Tollip simultaneously. Hydrodynamic studies reveal that ubiquitin forms heterodimers with the CUE domain, indicating that the association disrupts the dimeric state of the CUE domain. We propose that, in the absence of polyubiquitinated cargo, the dual binding of ubiquitin partitions Tollip into membrane-bound and membrane-free states, a function that contributes to the engagement of Tollip in both membrane trafficking and cytosolic pathways.	[Mitra, Sharmistha; Traughber, C. Alicia; Brannon, Mary K.; Gomez, Stephanie; Capelluto, Daniel G. S.] Virginia Tech, Dept Biol Sci, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Capelluto, DGS (corresponding author), 1981 Kraft Dr,Rm 2007, Blacksburg, VA 24061 USA.	capellut@vt.edu	Mitra, Sharmistha/AAJ-8881-2021	Mitra, Sharmistha/0000-0002-7259-1482	American Heart Association; Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust; Multicultural Academic Opportunities Program undergraduate scholarship; McNair summer undergraduate scholarship; Virginia Tech-AMP scholarship	American Heart Association(American Heart Association); Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust; Multicultural Academic Opportunities Program undergraduate scholarship; McNair summer undergraduate scholarship; Virginia Tech-AMP scholarship	This work was supported in part by the American Heart Association and the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust (to D. G. S. C.).; Supported by an American Heart Association pre-doctoral fellowship.; Supported by a Multicultural Academic Opportunities Program undergraduate scholarship.; Supported by both the McNair summer undergraduate and Virginia Tech-AMP scholarships.	Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; Azurmendi HF, 2010, MOL CELLS, V30, P581, DOI 10.1007/s10059-010-0145-5; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bissig C, 2012, METHOD CELL BIOL, V108, P19, DOI 10.1016/B978-0-12-386487-1.00002-X; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Ciarrocchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004404; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lange A, 2012, J BIOL CHEM, V287, P18687, DOI 10.1074/jbc.M111.324954; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhu L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388009	40	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25780	25791		10.1074/jbc.M113.484170	http://dx.doi.org/10.1074/jbc.M113.484170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880770	hybrid, Green Published			2022-12-28	WOS:000330623300011
J	Hone, AJ; Ruiz, M; Scadden, M; Christensen, S; Gajewiak, J; Azam, L; McIntosh, JM				Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael			Positional Scanning Mutagenesis of alpha-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for alpha 6/alpha 3 beta 2 beta 3 and alpha 3 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; CHOLINERGIC-RECEPTORS; NIGROSTRIATAL DAMAGE; DOPAMINE RELEASE; RAT RETINA; BINDING; SUBTYPES; BRAIN; MII; EXPRESSION	The nicotinic acetylcholine receptor (nAChR) subtype alpha 6 beta 2* (the asterisk denotes the possible presence of additional subunits) has been identified as an important molecular target for the pharmacotherapy of Parkinson disease and nicotine dependence. The alpha 6 subunit is closely related to the alpha 3 subunit, and this presents a problem in designing ligands that discriminate between alpha 6 beta 2* and alpha 3 beta 2* nAChRs. We used positional scanning mutagenesis of alpha-conotoxin PeIA, which targets both alpha 6 beta 2* and alpha 3 beta 2*, in combination with mutagenesis of the alpha 6 and alpha 3 subunits, to gain molecular insights into the interaction of PeIA with heterologously expressed alpha 6/alpha 3 beta 2 beta 3 and alpha 3 beta 2 receptors. Mutagenesis of PeIA revealed that Asn(11) was located in an important position that interacts with the alpha 6 and alpha 3 subunits. Substitution of Asn(11) with a positively charged amino acid essentially abolished the activity of PeIA for alpha 3 beta 2 but not for alpha 6/alpha 3 beta 2 beta 3 receptors. These results were used to synthesize a PeIA analog that was > 15,000- fold more potent on alpha 6/alpha 3 beta 2 beta 3 than alpha 3 beta 2 receptors. Analogs with an N11R substitution were then used to show a critical interaction between the 11th position of PeIA and Glu(152) of the alpha 6 subunit and Lys(152) of the alpha 3 subunit. The results of these studies provide molecular insights into designing ligands that selectively target alpha 6 beta 2* nAChRs.	[McIntosh, J. Michael] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84132 USA; [Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	McIntosh, JM (corresponding author), Dept Psychiat, 50 North 1900 East, Salt Lake City, UT 84132 USA.	mcintosh.mike@gmail.com			National Institutes of Health [GM103801, GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM103801 and GM48677.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2010, TOXINS, V2, P1471, DOI 10.3390/toxins2061471; Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Beissner M, 2012, MOL PHARMACOL, V82, P711, DOI 10.1124/mol.112.078683; Bohr IJ, 2005, EXP NEUROL, V191, P292, DOI 10.1016/j.expneurol.2004.10.004; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Cordero-Erausquin M, 2004, PAIN, V109, P308, DOI 10.1016/j.pain.2004.01.034; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Endo T, 2005, J NEUROPHYSIOL, V94, P3893, DOI 10.1152/jn.00211.2005; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Gotti C, 2005, MOL PHARMACOL, V67, P2007, DOI 10.1124/mol.105.011940; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; Huang LPZ, 2011, NEUROPHARMACOLOGY, V60, P861, DOI 10.1016/j.neuropharm.2010.12.032; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kim HW, 2012, FASEB J, V26, P4102, DOI 10.1096/fj.12-204487; Kulak JM, 2002, MOL PHARMACOL, V61, P230, DOI 10.1124/mol.61.1.230; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Liu LW, 2012, MOL PHARMACOL, V81, P541, DOI 10.1124/mol.111.076661; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SL, 2013, J BIOL CHEM, V288, P894, DOI 10.1074/jbc.M112.427898; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Perez XA, 2010, MOL PHARMACOL, V78, P971, DOI 10.1124/mol.110.067561; Pucci L, 2011, FASEB J, V25, P3775, DOI 10.1096/fj.10-179853; Quik M, 2001, J NEUROSCI, V21, P5494, DOI 10.1523/JNEUROSCI.21-15-05494.2001; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Wooters TE, 2011, BRIT J PHARMACOL, V163, P346, DOI 10.1111/j.1476-5381.2011.01220.x	47	40	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25428	25439		10.1074/jbc.M113.482059	http://dx.doi.org/10.1074/jbc.M113.482059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846688	Green Published, hybrid			2022-12-28	WOS:000330619000039
J	Bosch, B; Berger, AC; Khandelwal, S; Heipertz, EL; Scharf, B; Santambrogio, L; Roche, PA				Bosch, Berta; Berger, Adam C.; Khandelwal, Sanjay; Heipertz, Erica L.; Scharf, Brian; Santambrogio, Laura; Roche, Paul A.			Disruption of Multivesicular Body Vesicles Does Not Affect Major Histocompatibility Complex (MHC) Class II-Peptide Complex Formation and Antigen Presentation by Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL HOMEOSTASIS; COMPARTMENTS; TRANSPORT; DISEASE; TRAFFICKING; MOLECULES; CLATHRIN; PATHWAY; BODIES; GENE	The antigen processing compartments in antigen-presenting cells (APCs) have well known characteristics of multivesicular bodies (MVBs). However, the importance of MVB integrity to APC function remains unknown. In this study, we have altered the ultrastructure of the MVB by perturbing cholesterol content genetically through the use of a deletion of the lipid transporter Niemann-Pick type C1 (NPC1). Immunofluorescence and electron microscopic analyses reveal that the antigen processing compartments in NPC1(-/-) dendritic cells (DCs) have an abnormal ultrastructure in that the organelles are enlarged and the intraluminal vesicles are almost completely absent and those remaining are completely disorganized. MHC-II is restricted to the limiting membrane of these enlarged MVBs where it colocalizes with the peptide editor H2-DM. Curiously, proteolytic removal of the chaperone protein Invariant chain from MHC-II, degradation of internalized foreign antigens, and antigenic-peptide binding to nascent MHC-II are normal in NPC1(-/-) DCs. Antigen-pulsed NPC1(-/-) DCs are able to effectively activate antigen-specific CD4 T cells in vitro, and immunization of NPC1(-/-) mice reveals surprisingly normal CD4 T cell activation in vivo. Our data thus reveal that the localization of MHC-II on the intraluminal vesicles of multivesicular antigen processing compartments is not required for efficient antigen presentation by DCs.	[Bosch, Berta; Berger, Adam C.; Khandelwal, Sanjay; Heipertz, Erica L.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Scharf, Brian; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol Microbiol & Immunol, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine	Roche, PA (corresponding author), NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (to P. A. R.).	Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; DEMEL RA, 1965, J BIOL CHEM, V240, P2749; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084952102000605; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; Stang E, 1998, J IMMUNOL, V160, P4696; STPIERRE Y, 1990, J IMMUNOL, V145, P812; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANIER MT, 1991, DEV NEUROSCI-BASEL, V13, P307, DOI 10.1159/000112178; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	25	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24286	24292		10.1074/jbc.M113.461996	http://dx.doi.org/10.1074/jbc.M113.461996			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846690	Green Published, hybrid			2022-12-28	WOS:000330612300001
J	Mateyak, MK; Kinzy, TG				Mateyak, Maria K.; Kinzy, Terri Goss			ADP-ribosylation of Translation Elongation Factor 2 by Diphtheria Toxin in Yeast Inhibits Translation and Cell Separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FACTOR-II; PROTEIN-SYNTHESIS; RIBOSOMAL TRANSLOCASE; DIPHTHAMIDE; BIOSYNTHESIS; NUCLEOTIDE; RESISTANT; MUTANTS; TARGET	Eukaryotic translation elongation factor 2 (eEF2) facilitates the movement of the peptidyl tRNA-mRNA complex from the A site of the ribosome to the P site during protein synthesis. ADP-ribosylation (ADP(R)) of eEF2 by bacterial toxins on a unique diphthamide residue inhibits its translocation activity, but the mechanism is unclear. We have employed a hormone-inducible diphtheria toxin (DT) expression system in Saccharomyces cerevisiae which allows for the rapid induction of ADP(R)-eEF2 to examine the effects of DT in vivo. ADP(R) of eEF2 resulted in a decrease in total protein synthesis consistent with a defect in translation elongation. Association of eEF2 with polyribosomes, however, was unchanged upon expression of DT. Upon prolonged exposure to DT, cells with an abnormal morphology and increased DNA content accumulated. This observation was specific to DT expression and was not observed when translation elongation was inhibited by other methods. Examination of these cells by electron microscopy indicated a defect in cell separation following mitosis. These results suggest that expression of proteins late in the cell cycle is particularly sensitive to inhibition by ADP(R)-eEF2.	[Mateyak, Maria K.; Kinzy, Terri Goss] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes La, Piscataway, NJ 08854 USA.	kinzytg@rutgers.edu		Kinzy, Terri/0000-0003-1394-9226; Mateyak, Maria/0000-0003-0859-1901	National Institutes of Health [R21 AI076245]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health R21 AI076245.	Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; BERMEK E, 1972, FEBS LETT, V23, P95, DOI 10.1016/0014-5793(72)80293-X; BERMEK E, 1976, J BIOL CHEM, V251, P6544; BURKE DJ, 1991, MOL CELL BIOL, V11, P3691, DOI 10.1128/MCB.11.7.3691; BURNS G, 1986, FEBS LETT, V208, P217, DOI 10.1016/0014-5793(86)81021-3; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; DUNLOP PC, 1983, J BIOL CHEM, V258, P4754; Esposito A. M., 2010, J VIS EXP, V15, P1948; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Falnes PO, 2000, J BIOL CHEM, V275, P4363, DOI 10.1074/jbc.275.6.4363; FENDRICK JL, 1989, P NATL ACAD SCI USA, V86, P554, DOI 10.1073/pnas.86.2.554; FOLEY BT, 1995, J BIOL CHEM, V270, P23218, DOI 10.1074/jbc.270.39.23218; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; KIMATA Y, 1994, J BIOL CHEM, V269, P13497; LEE H, 1984, P NATL ACAD SCI-BIOL, V81, P2703, DOI 10.1073/pnas.81.9.2703; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; MARZOUKI A, 1989, FEBS LETT, V255, P72, DOI 10.1016/0014-5793(89)81063-4; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; McIsaac RS, 2011, MOL BIOL CELL, V22, P4447, DOI 10.1091/mbc.E11-05-0466; Meitinger F, 2012, CELL CYCLE, V11, P219, DOI 10.4161/cc.11.2.18857; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; MONTANARO L, 1976, BIOCHEM J, V156, P15, DOI 10.1042/bj1560015; MONTANARO L, 1971, BIOCHIM BIOPHYS ACTA, V238, P493, DOI 10.1016/0005-2787(71)90628-9; MURAKAMI S, 1982, MOL CELL BIOL, V2, P588, DOI 10.1128/MCB.2.5.588; NYGARD O, 1990, J BIOL CHEM, V265, P6030; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PHAN LD, 1993, J BIOL CHEM, V268, P8665; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Uthman S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003334; Valente L, 2003, CELL MOL LIFE SCI, V60, P2115, DOI 10.1007/s00018-003-2334-2; VANNESS BG, 1980, J BIOL CHEM, V255, P717; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	51	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24647	24655		10.1074/jbc.M113.488783	http://dx.doi.org/10.1074/jbc.M113.488783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853096	Green Published, hybrid			2022-12-28	WOS:000330612300032
J	Babayeva, S; Rocque, B; Aoudjit, L; Zilber, Y; Li, J; Baldwin, C; Kawachi, H; Takano, T; Torban, E				Babayeva, Sima; Rocque, Brittany; Aoudjit, Lamine; Zilber, Yulia; Li, Jane; Baldwin, Cindy; Kawachi, Hiroshi; Takano, Tomoko; Torban, Elena			Planar Cell Polarity Pathway Regulates Nephrin Endocytosis in Developing Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; POLYCYSTIC KIDNEY-DISEASE; SLIT DIAPHRAGM; EMBRYONIC-DEVELOPMENT; NEPHROTIC SYNDROME; BETA-ARRESTIN; E-CADHERIN; VANGL2; MORPHOGENESIS; TRAFFICKING	The noncanonical Wnt/planar cell polarity (PCP) pathway controls a variety of cell behaviors such as polarized protrusive cell activity, directional cell movement, and oriented cell division and is crucial for the normal development of many tissues. Mutations in the PCP genes cause malformation in multiple organs. Recently, the PCP pathway was shown to control endocytosis of PCP and non-PCP proteins necessary for cell shape remodeling and formation of specific junctional protein complexes. During formation of the renal glomerulus, the glomerular capillary becomes enveloped by highly specialized epithelial cells, podocytes, that display unique architecture and are connected via specialized cell-cell junctions (slit diaphragms) that restrict passage of protein into the urine; podocyte differentiation requires active remodeling of cytoskeleton and junctional protein complexes. We report here that in cultured human podocytes, activation of the PCP pathway significantly stimulates endocytosis of the core slit diaphragm protein, nephrin, via a clathrin/beta-arrestin-dependent endocytic route. In contrast, depletion of the PCP protein Vangl2 leads to an increase of nephrin at the cell surface; loss of Vangl2 functions in Looptail mice results in disturbed glomerular maturation. We propose that the PCP pathway contributes to podocyte development by regulating nephrin turnover during junctional remodeling as the cells differentiate.	[Babayeva, Sima; Rocque, Brittany; Aoudjit, Lamine; Zilber, Yulia; Li, Jane; Baldwin, Cindy; Takano, Tomoko; Torban, Elena] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol, Niigata 9502181, Japan	McGill University; Niigata University	Torban, E (corresponding author), McGill Univ, Dept Med, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	elena.torban@mcgill.ca		Li, Jane/0000-0003-4988-4436	Research Institute-McGill University Health Center; Canadian Institute of Health Research [MOP-97759, MOP-102646]	Research Institute-McGill University Health Center; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by a Research Institute-McGill University Health Center graduate scholarship award.; Supported by Canadian Institute of Health Research Operating Grant MOP-97759.; Supported by Canadian Institute of Health Research Operating Grant MOP-102646.	Babayeva S, 2011, AM J PHYSIOL-RENAL, V300, pF549, DOI 10.1152/ajprenal.00566.2009; Belotti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046213; Carroll TJ, 2012, CURR TOP DEV BIOL, V101, P185, DOI 10.1016/B978-0-12-394592-1.00011-9; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Czachorowski M, 2009, BIOCHEMISTRY-US, V48, P8422, DOI 10.1021/bi900606y; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Komiya Yuko, 2008, Organogenesis, V4, P68; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Strutt H, 2011, DEV CELL, V20, P511, DOI 10.1016/j.devcel.2011.03.018; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Torban E, 2012, CURR TOP DEV BIOL, V101, P237, DOI 10.1016/B978-0-12-394592-1.00005-3; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang B, 2011, HUM MOL GENET, V20, P271, DOI 10.1093/hmg/ddq462; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Williams BB, 2012, J CELL SCI, V125, P2141, DOI 10.1242/jcs.097964; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yates LL, 2010, HUM MOL GENET, V19, P4663, DOI 10.1093/hmg/ddq397; Ye X, 2011, DEVELOPMENT, V138, P1161, DOI 10.1242/dev.057620; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	57	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24035	24048		10.1074/jbc.M113.452904	http://dx.doi.org/10.1074/jbc.M113.452904			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824190	Green Published, hybrid			2022-12-28	WOS:000330611400041
J	Dai, CL; Shi, JH; Chen, YX; Iqbal, K; Liu, F; Gong, CX				Dai, Chun-Ling; Shi, Jianhua; Chen, Yanxing; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin			Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHEXIMIDE-INDUCED APOPTOSIS; UBIQUITIN LIGASE; PHOSPHOINOSITIDE 3-KINASE; GLUCOSE-HOMEOSTASIS; P53 STABILITY; MICE LACKING; MDM2; PHOSPHORYLATION; PROMOTES; SKP2	The homeostasis of protein metabolism is maintained and regulated by the rates of protein biosynthesis and degradation in living systems. Alterations of protein degradation may regulate protein biosynthesis through a feedback mechanism. Whether a change in protein biosynthesis modulates protein degradation has not been reported. In this study, we found that inhibition of protein biosynthesis induced phosphorylation/activation of AKT and led to phosphorylation of AKT target substrates, including FoxO1, GSK3 alpha/beta, p70S6K, AS160, and the E3 ubiquitin ligase MDM2. Phosphorylation of ribosomal protein S6 was also modulated by inhibition of protein biosynthesis. The AKT phosphorylation/activation was mediated mainly through the PI3K pathway because it was blocked by the PI3K inhibitor LY294002. The activated AKT phosphorylated MDM2 at Ser(166) and promoted degradation of the tumor suppressor p53. These findings suggest that inhibition of protein biosynthesis can alter degradation of some proteins through activation of AKT. This study reveals a novel regulation of protein degradation and calls for caution in blocking protein biosynthesis to study the half-life of proteins.	[Dai, Chun-Ling; Shi, Jianhua; Chen, Yanxing; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Shi, Jianhua; Liu, Fei; Gong, Cheng-Xin] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Institute for Basic Research in Developmental Disabilities; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com; chengxin.gong@csi.cuny.edu	Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	National Institutes of Health [R01 AG027429, R03 TW008123, R01 AG031969, R01 AG019158]; New York State Office for People with Developmental Disabilities; Alzheimer's Association [IIRG-10-170405, IIRG-10-173154]; National Natural Science Foundation of China [81030059]; Jiangsu Natural Science Foundation [BK2011387]; FOGARTY INTERNATIONAL CENTER [R03TW008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031969, R01AG019158, R01AG027429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office for People with Developmental Disabilities; Alzheimer's Association(Alzheimer's Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027429, R03 TW008123, R01 AG031969, and R01 AG019158. This work was also supported by the New York State Office for People with Developmental Disabilities, Alzheimer's Association Grants IIRG-10-170405 and IIRG-10-173154, National Natural Science Foundation of China Grant 81030059, and Jiangsu Natural Science Foundation Grant BK2011387.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chandrasekharan UM, 2004, J BIOL CHEM, V279, P46678, DOI 10.1074/jbc.M406441200; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; COHEN JJ, 1984, J IMMUNOL, V132, P38; Coxon FP, 1998, MOL PHARMACOL, V54, P631; delPeso L, 1997, SCIENCE, V278, P687; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemi R, 2002, J BIOL CHEM, V277, P8961, DOI 10.1074/jbc.M109391200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; ISHII HH, 1995, IMMUNOL CELL BIOL, V73, P463, DOI 10.1038/icb.1995.72; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kaur P, 2008, CARCINOGENESIS, V29, P2210, DOI 10.1093/carcin/bgn201; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tsuchida T, 2002, PATHOL INT, V52, P181, DOI 10.1046/j.1440-1827.2002.01336.x; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	60	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23875	23883		10.1074/jbc.M112.445148	http://dx.doi.org/10.1074/jbc.M112.445148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23843462	Green Published, hybrid			2022-12-28	WOS:000330611400027
J	Dimaki, M; Xouri, G; Symeonidou, IE; Sirinian, C; Nishitani, H; Taraviras, S; Lygerou, Z				Dimaki, Maria; Xouri, Georgia; Symeonidou, Ioanna-Eleni; Sirinian, Chaido; Nishitani, Hideo; Taraviras, Stavros; Lygerou, Zoi			Cell Cycle-dependent Subcellular Translocation of the Human DNA Licensing Inhibitor Geminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT; S-PHASE; REPLICATION; CDT1; REREPLICATION; EXPRESSION; E2F; CHROMATIN; PROTEIN; XENOPUS	Once per cell cycle replication is crucial for maintaining genome integrity. Geminin interacts with the licensing factor Cdt1 to prevent untimely replication and is controlled by APC/C-dependent cell cycle specific proteolysis during mitosis and in G(1). We show here that human geminin, when expressed in human cells in culture under a constitutive promoter, is excluded from the nucleus during part of the G(1) phase and at the transition from G(0) to G(1). The N-terminal 30 amino acids of geminin, which contain its destruction box, are essential for nuclear exclusion. In addition, 30 amino acids within the central domain of geminin are required for both nuclear exclusion and nuclear accumulation. Cdt1 overexpression targets geminin to the nucleus, while reducing Cdt1 levels by RNAi leads to the appearance of endogenous geminin in the cytoplasm. Our data propose a novel means of regulating the balance of Cdt1/geminin in human cells, at the level of the subcellular localization of geminin.	[Dimaki, Maria; Xouri, Georgia; Symeonidou, Ioanna-Eleni; Sirinian, Chaido; Lygerou, Zoi] Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece; [Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26500, Greece; [Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of Patras; University of Patras; University of Hyogo	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece.	lygerou@med.upatras.gr	Taraviras, Stavros/AAJ-4690-2020	Taraviras, Stavros/0000-0002-7455-647X; Nishitani, Hideo/0000-0001-5907-9380	Karatheodori Program (University of Patras); Association for International Cancer Research; European Research Council	Karatheodori Program (University of Patras); Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Karatheodori Program (University of Patras), the Association for International Cancer Research, and the European Research Council.	Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Boos A, 2006, BIOL CELL, V98, P363, DOI 10.1042/BC20060007; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Iliou MS, 2013, MECH AGEING DEV, V134, P10, DOI 10.1016/j.mad.2012.10.001; Kingsbury SR, 2005, EXP CELL RES, V309, P56, DOI 10.1016/j.yexcr.2005.05.027; Kulartz M, 2004, BIOCHEM BIOPH RES CO, V315, P1011, DOI 10.1016/j.bbrc.2004.01.164; Li A, 2004, CELL CYCLE, V3, P443; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Luo LF, 2007, MOL CELL BIOL, V27, P4737, DOI 10.1128/MCB.00123-07; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Pines J, 1996, BIOCHEM SOC T, V24, P15, DOI 10.1042/bst0240015; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	42	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23953	23963		10.1074/jbc.M113.453092	http://dx.doi.org/10.1074/jbc.M113.453092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814078	Green Published, hybrid			2022-12-28	WOS:000330611400034
J	Kanda, T; Horikoshi, N; Murata, T; Kawashima, D; Sugimoto, A; Narita, Y; Kurumizaka, H; Tsurumi, T				Kanda, Teru; Horikoshi, Naoki; Murata, Takayuki; Kawashima, Daisuke; Sugimoto, Atsuko; Narita, Yohei; Kurumizaka, Hitoshi; Tsurumi, Tatsuya			Interaction between Basic Residues of Epstein-Barr Virus EBNA1 Protein and Cellular Chromatin Mediates Viral Plasmid Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ANTIGEN 1; MOBILITY GROUP-I; TRANSCRIPTIONAL ACTIVATION; DNA-BINDING; REPLICATION; DOMAINS; LATENT; EBV; NUCLEOSOME; CELLS	The Epstein-Barr virus (EBV) genome is episomally maintained in latently infected cells. The viral protein EBNA1 is a bridging molecule that tethers EBV episomes to host mitotic chromosomes as well as to interphase chromatin. EBNA1 localizes to cellular chromosomes (chromatin) via its chromosome binding domains (CBDs), which are rich in glycine and arginine residues. However, the molecular mechanism by which the CBDs of EBNA1 attach to cellular chromatin is still under debate. Mutation analyses revealed that stepwise substitution of arginine residues within the CBD1 (amino acids 40-54) and CBD2 (amino acids 328-377) regions with alanines progressively impaired chromosome binding activity of EBNA1. The complete arginine-to-alanine substitutions within the CBD1 and -2 regions abolished the ability of EBNA1 to stably maintain EBV-derived oriP plasmids in dividing cells. Importantly, replacing the same arginines with lysines had minimal effect, if any, on chromosome binding of EBNA1 as well as on its ability to stably maintain oriP plasmids. Furthermore, a glycine-arginine-rich peptide derived from the CBD1 region bound to reconstituted nucleosome core particles in vitro, as did a glycine-lysine rich peptide, whereas a glycine-alanine rich peptide did not. These results support the idea that the chromosome binding of EBNA1 is mediated by electrostatic interactions between the basic amino acids within the CBDs and negatively charged cellular chromatin.	[Kanda, Teru; Murata, Takayuki; Kawashima, Daisuke; Sugimoto, Atsuko; Narita, Yohei; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Horikoshi, Naoki; Kurumizaka, Hitoshi] Waseda Univ, Struct Biol Lab, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Aichi Cancer Center; Waseda University	Kanda, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	tkanda@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Narita, Yohei/0000-0002-8867-3669; Horikoshi, Naoki/0000-0003-1842-6934; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Ministry of Health Labor and Welfare; MEXT, Japan; Grants-in-Aid for Scientific Research [11J06154] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to T. K. and T. T.), by a grant-in-aid for Scientific Research from the Ministry of Health Labor and Welfare (to T. K.), and by Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan (to H. K.).	Abe A, 2004, BIOCHEM BIOPH RES CO, V320, P920, DOI 10.1016/j.bbrc.2004.06.040; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Botchan M, 2004, CELL, V117, P280, DOI 10.1016/S0092-8674(04)00410-6; Calos MP, 1998, P NATL ACAD SCI USA, V95, P4084, DOI 10.1073/pnas.95.8.4084; Coppotelli G, 2013, BIOCHEM BIOPH RES CO, V431, P706, DOI 10.1016/j.bbrc.2013.01.054; Coppotelli G, 2011, J BIOL CHEM, V286, P19565, DOI 10.1074/jbc.M111.224782; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; GOTOH E, 1995, BIOMED RES-TOKYO, V16, P63, DOI 10.2220/biomedres.16.63; Harrer M, 2004, J CELL SCI, V117, P3459, DOI 10.1242/jcs.01160; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Howden SE, 2006, HUM GENE THER, V17, P833, DOI 10.1089/hum.2006.17.833; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Jourdan N, 2012, J VIROL, V86, P5314, DOI 10.1128/JVI.06303-11; Kanda T, 2001, J CELL SCI, V114, P49; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kanda T, 2001, MOL CELL BIOL, V21, P3576, DOI 10.1128/MCB.21.10.3576-3588.2001; Kennedy G, 2003, MOL CELL BIOL, V23, P6901, DOI 10.1128/MCB.23.19.6901-6908.2003; Kirchmaier AL, 1997, J VIROL, V71, P1766, DOI 10.1128/JVI.71.3.1766-1775.1997; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Nayyar VK, 2009, J CELL SCI, V122, P4341, DOI 10.1242/jcs.060913; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; REEVES R, 1990, J BIOL CHEM, V265, P8573; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; SNUDDEN DK, 1994, EMBO J, V13, P4840, DOI 10.1002/j.1460-2075.1994.tb06810.x; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Van Scoy S, 2000, VIROLOGY, V275, P145, DOI 10.1006/viro.2000.0508; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	46	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24189	24199		10.1074/jbc.M113.491167	http://dx.doi.org/10.1074/jbc.M113.491167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836915	hybrid, Green Published			2022-12-28	WOS:000330611400057
J	Lu, YY; Hao, BX; Graeff, R; Wong, CWM; Wu, WT; Yue, JB				Lu, Yingying; Hao, Bai-Xia; Graeff, Richard; Wong, Connie W. M.; Wu, Wu-Tian; Yue, Jianbo			Two Pore Channel 2 (TPC2) Inhibits Autophagosomal-Lysosomal Fusion by Alkalinizing Lysosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; EMBRYONIC STEM-CELLS; 2-PORE CHANNELS; REGULATES AUTOPHAGY; RELEASE CHANNEL; NAADP; CA2+; CALCIUM; MATURATION	Autophagy is an evolutionarily conserved lysosomal degradation pathway, yet the underlying mechanisms remain poorly understood. Nicotinic acid adenine dinucleotide phosphate (NAADP), one of the most potent Ca2+ mobilizing messengers, elicits Ca2+ release from lysosomes via the two pore channel 2 (TPC2) in many cell types. Here we found that overexpression of TPC2 in HeLa or mouse embryonic stem cells inhibited autophagosomal-lysosomal fusion, thereby resulting in the accumulation of autophagosomes. Treatment of TPC2 expressing cells with a cell permeant-NAADP agonist, NAADP-AM, further induced autophagosome accumulation. On the other hand, TPC2 knockdown or treatment of cells with Ned-19, a NAADP antagonist, markedly decreased the accumulation of autophagosomes. TPC2-induced accumulation of autophagosomes was also markedly blocked by ATG5 knockdown. Interestingly, inhibiting mTOR activity failed to increase TPC2-induced autophagosome accumulation. Instead, we found that overexpression of TPC2 alkalinized lysosomal pH, and lysosomal re-acidification abolished TPC2-induced autophagosome accumulation. In addition, TPC2 overexpression had no effect on general endosomal-lysosomal degradation but prevented the recruitment of Rab-7 to autophagosomes. Taken together, our data demonstrate that TPC2/NAADP/Ca2+ signaling alkalinizes lysosomal pH to specifically inhibit the later stage of basal autophagy progression.	[Lu, Yingying; Hao, Bai-Xia; Graeff, Richard; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Wong, Connie W. M.; Wu, Wu-Tian] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Connie W. M.; Wu, Wu-Tian] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Wu-Tian] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447	Research Grant Council [HKU 782709M, HKU 785911M, HKU 785213M]; Leukemia and Lymphoma Society of America	Research Grant Council(Hong Kong Research Grants Council); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council Grants HKU 782709M, HKU 785911M, and HKU 785213M and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	Bankers-Fulbright JL, 2004, J CELL SCI, V117, P5749, DOI 10.1242/jcs.01498; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cardenas C, 2012, CELL CALCIUM, V52, P44, DOI 10.1016/j.ceca.2012.03.001; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Christensen KA, 2002, J CELL SCI, V115, P599; Churamani D, 2013, BIOCHEM J, V453, P147, DOI 10.1042/BJ20130474; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Davis LC, 2012, CURR BIOL, V22, P2331, DOI 10.1016/j.cub.2012.10.035; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; DiCiccio JE, 2011, J GEN PHYSIOL, V137, P385, DOI 10.1085/jgp.201110596; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Gomez-Suaga P, 2012, BIOCHEM SOC T, V40, P1140, DOI 10.1042/BST20120138; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Hooper R, 2012, ADV EXP MED BIOL, V740, P325, DOI 10.1007/978-94-007-2888-2_14; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Kayala KMN, 2012, BRAIN RES, V1489, P8, DOI 10.1016/j.brainres.2012.10.036; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morgan AJ, 2007, J BIOL CHEM, V282, P37730, DOI 10.1074/jbc.M704630200; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Neely KM, 2011, AUTOPHAGY, V7, P664, DOI 10.4161/auto.7.6.15448; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Su M, 2011, J NEUROCHEM, V117, P112, DOI 10.1111/j.1471-4159.2011.07180.x; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066077; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	81	73	75	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24247	24263		10.1074/jbc.M113.484253	http://dx.doi.org/10.1074/jbc.M113.484253			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836916	Green Published, hybrid			2022-12-28	WOS:000330611400062
J	O'Donnell, AF; Huang, LQ; Thorner, J; Cyert, MS				O'Donnell, Allyson F.; Huang, Laiqiang; Thorner, Jeremy; Cyert, Martha S.			A Calcineurin-dependent Switch Controls the Trafficking Function of alpha-Arrestin Aly1/Art6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; CLATHRIN-MEDIATED ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; BETA-ARRESTINS; IN-VIVO; INTRACELLULAR TRAFFICKING; INTERACTING PROTEIN; SIGNALING PATHWAY; UBIQUITIN; RECEPTOR	Proper regulation of plasma membrane protein endocytosis by external stimuli is required for cell growth and survival. In yeast, excess levels of certain nutrients induce endocytosis of the cognate permeases to prevent toxic accumulation of metabolites. The alpha-arrestins, a family of trafficking adaptors, stimulate ubiquitin-dependent and clathrin-mediated endocytosis by interacting with both a client permease and the ubiquitin ligase Rsp5. However, the molecular mechanisms that control alpha-arrestin function are not well understood. Here, we show that alpha-arrestin Aly1/Art6 is a phosphoprotein that specifically interacts with and is dephosphorylated by the Ca2+- and calmodulin-dependent phosphoprotein phosphatase calcineurin/PP2B. Dephosphorylation of Aly1 by calcineurin at a subset of phospho-sites is required for Aly1-mediated trafficking of the aspartic acid and glutamic acid transporter Dip5 to the vacuole, but it does not alter Rsp5 binding, ubiquitinylation, or stability of Aly1. In addition, dephosphorylation of Aly1 by calcineurin does not regulate the ability of Aly1 to promote the intracellular sorting of the general amino acid permease Gap1. These results suggest that phosphorylation of Aly1 inhibits its vacuolar trafficking function and, conversely, that dephosphorylation of Aly1 by calcineurin serves as a regulatory switch to promote Aly1-mediated trafficking to the vacuole.	[O'Donnell, Allyson F.; Huang, Laiqiang; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [O'Donnell, Allyson F.; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [O'Donnell, Allyson F.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Stanford University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, 337 Campus Dr West, Stanford, CA 94305 USA.	mcyert@stanford.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X; Cyert, Martha/0000-0003-3825-7437; O'Donnell, Allyson/0000-0003-0966-288X	National Institutes of Health [S10 RR025622-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We gratefully acknowledge Marko Kaksonen (EMBL, Heidelberg, Germany) for providing the MKY yeast strains prior to their publication; Sandra Lemmon (University of Miami, FL) for providing the anti-Bmh antibody; and colleagues Alexander Sorkin, Jeffrey Brodsky, and Adam Kwiatkowski (University of Pittsburgh) for use of reagents and equipment. We thank Catherine Baty and Jenny Karlsson at the Center for Biological Imaging for assistance with cell imaging. We thank Lori Kohlstaedt (supported by National Institutes of Health Grant S10 RR025622-01) and the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at the University of California, Berkeley, for generating and analyzing the MS data.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Ausubel F. M., 1991, CURRENT PROTOCOLS MO; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BAUM P, 1978, P NATL ACAD SCI USA, V75, P4962, DOI 10.1073/pnas.75.10.4962; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; HARPER JW, 1993, CELL, V75, P805; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Hong MH, 2009, J NEUROCHEM, V108, P102, DOI 10.1111/j.1471-4159.2008.05740.x; James P, 1996, GENETICS, V144, P1425; Jee C, 2012, J MOL BIOL, V417, P165, DOI 10.1016/j.jmb.2012.01.012; Jiang B, 1999, J BIOL CHEM, V274, P18543, DOI 10.1074/jbc.274.26.18543; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kamble C, 2011, J BIOSCIENCES, V36, P79, DOI 10.1007/s12038-011-9018-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Luttrell LM, 2002, J CELL SCI, V115, P455; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Marion S, 2007, J BIOL CHEM, V282, P18937, DOI 10.1074/jbc.M700090200; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pina FJ, 2011, EUKARYOT CELL, V10, P63, DOI 10.1128/EC.00241-10; Polo S, 2008, CELL, V135, P590, DOI 10.1016/j.cell.2008.10.032; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Roberg KJ, 1997, GENETICS, V147, P1569; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Sambrook J., 1989, MOL CLONING LAB MANU, p[153, 510]; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; SCHWANINGER M, 1993, N-S ARCH PHARMACOL, V348, P541; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stark C., 2010, DATABASE-OXFORD, V2010, DOI DOI 10.1093/DATABASE/BAP026; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Xue J, 2011, J BIOL CHEM, V286, P30295, DOI 10.1074/jbc.M111.273110; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	90	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24063	24080		10.1074/jbc.M113.478511	http://dx.doi.org/10.1074/jbc.M113.478511			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824189	Green Published, hybrid			2022-12-28	WOS:000330611400043
J	Nakayama, K				Nakayama, Koh			cAMP-response Element-binding Protein (CREB) and NF-kappa B Transcription Factors Are Activated during Prolonged Hypoxia and Cooperatively Regulate the Induction of Matrix Metalloproteinase MMP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELLS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; KINASE; PHOSPHORYLATION; CHONDROCYTES; FIBROBLASTS; RECRUITMENT; HIF-1-ALPHA; PATHWAY	Responses to low levels of oxygen (hypoxia) are essential to maintain homeostasis. During the hypoxic response, gene expression is altered by various transcription factors. The transcription factor, hypoxia-inducible factor (HIF), plays a central role in the hypoxic response. The alpha subunit of HIF, which is actively degraded during normoxia, becomes stabilized during hypoxia, which leads to HIF activation. A microarray analysis of HeLa cells showed that expression of matrix metalloproteinase 1 (MMP1) was markedly induced during prolonged hypoxia. CREB and NF-kappa B binding sites were identified in the MMP1 promoter region between 1945 and 1896 nucleotides upstream of the transcription start site. Assays with luciferase reporters demonstrated that HIF activity was induced during the early phase of hypoxia, whereas CREB and NF-kappa B were activated during the later (prolonged) phase. Depletion of CREB and/or NF-kappa B reduced MMP1 induction during prolonged hypoxia both at the mRNA and protein levels. A chromatin immunoprecipitation assay demonstrated binding of CREB and NF-kappa B to the MMP1 promoter. Finally, cell migration and invasion on a collagen matrix and pulmonary metastasis in nude mice were inhibited after depletion of CREB and NF-kappa B in MDA-MB-231 cells. Taken together, these results suggest that the cooperative action of CREB and NF-kappa B plays an important role to induce MMP1 expression during prolonged hypoxia and regulates cell migration and invasion in cancer cells.	Tokyo Med & Dent Univ, Med Res Inst, Oxygen Biol Lab, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Nakayama, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Oxygen Biol Lab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nakayama.mtt@mri.tmd.ac.jp	Nakayama, Koh/U-9232-2019		Japan Society for the Promotion of Science; Takeda Science Foundation; Uehara Memorial Foundation; Sumitomo Foundation; Nakajima Foundation; Kanzawa Medical Research Foundation; Osaka Cancer Research Foundation; Fugaku Trust for Medicinal Research; Astellas Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Nakajima Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Osaka Cancer Research Foundation; Fugaku Trust for Medicinal Research; Astellas Foundation(Astellas Pharmaceuticals)	This study was supported by a Grant-in-Aid for Scientific Research C (Japan Society for the Promotion of Science).; Supported by the Takeda Science Foundation, the Uehara Memorial Foundation, the Sumitomo Foundation, the Nakajima Foundation, the Kanzawa Medical Research Foundation, the Osaka Cancer Research Foundation, the Fugaku Trust for Medicinal Research, and a research grant from the Astellas Foundation. To whom correspondence should be addressed: Oxygen Biology Laboratory, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Tel.: 813-5803-4815; E-mail: nakayama.mtt@mri.tmd.ac.jp.	Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Akiyama Y., 1995, TFSEARCH SEARCHING T; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hadad N, 2011, J IMMUNOL, V186, P1816, DOI 10.4049/jimmunol.1000193; Han YP, 2001, J CELL SCI, V114, P131; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Lin JL, 2008, FEBS LETT, V582, P2615, DOI 10.1016/j.febslet.2008.06.033; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park JK, 2010, INT J ONCOL, V36, P181, DOI 10.3892/ijo_00000489; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yamanaka M, 2000, J DERMATOL SCI, V24, P99, DOI 10.1016/S0923-1811(00)00086-4; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yokoo T, 1996, AM J PHYSIOL-RENAL, V270, pF123, DOI 10.1152/ajprenal.1996.270.1.F123	39	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22584	22595		10.1074/jbc.M112.421636	http://dx.doi.org/10.1074/jbc.M112.421636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775082	Green Published, hybrid			2022-12-28	WOS:000330596300039
J	Yuan, DP; Keeble, AH; Hibbert, RG; Fabiane, S; Gould, HJ; McDonnell, JM; Beavil, AJ; Sutton, BJ; Dhaliwal, B				Yuan, Daopeng; Keeble, Anthony H.; Hibbert, Richard G.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder			Ca2+-dependent Structural Changes in the B-cell Receptor CD23 Increase Its Affinity for Human Immunoglobulin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Calcium; FC Receptors; Immunology; X-ray Crystallography; CD23; Immunoglobulin E	MANNOSE-BINDING PROTEIN; FC-EPSILON-RI; LECTIN DOMAIN; CRYSTAL-STRUCTURE; IGE SYNTHESIS; CALCIUM; SITE; FC-EPSILON-RII/CD23; CARBOHYDRATE; REFINEMENT	Immunoglobulin E (IgE) antibodies play a fundamental role in allergic disease and are a target for therapeutic intervention. IgE functions principally through two receptors, FcERI and CD23 (FcERII). Minute amounts of allergen trigger mast cell or basophil degranulation by cross-linking IgE-bound FcERI, leading to an inflammatory response. The interaction between IgE and CD23 on B-cells regulates IgE synthesis. CD23 is unique among Ig receptors in that it belongs to the C-type (calcium-dependent) lectin-like superfamily. Although the interaction of CD23 with IgE is carbohydrate-independent, calcium has been reported to increase the affinity for IgE, but the structural basis for this activity has previously been unknown. We have determined the crystal structures of the human lectin-like head domain of CD23 in its Ca2+-free and Ca2+-bound forms, as well as the crystal structure of the Ca2+-bound head domain of CD23 in complex with a subfragment of IgE-Fc consisting of the dimer of CE3 and CE4 domains (FcE3-4). Together with site-directed mutagenesis, the crystal structures of four Ca2+ ligand mutants, isothermal titration calorimetry, surface plasmon resonance, and stopped-flow analysis, we demonstrate that Ca2+ binds at the principal and evolutionarily conserved binding site in CD23. Ca2+ binding drives Pro-250, at the base of an IgE-binding loop (loop 4), from the trans to the cis configuration with a concomitant conformational change and ordering of residues in the loop. These Ca2+-induced structural changes in CD23 lead to additional interactions with IgE, a more entropically favorable interaction, and a 30-fold increase in affinity of a single head domain of CD23 for IgE. Taken together, these results suggest that binding of Ca2+ brings an extra degree of modulation to CD23 function.	[Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] Kings Coll London, London SE1 1UL, England; [Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] MRC, London SE1 1UL, England; [Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] Asthma UK Ctr Allerg Mech Asthma, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Hibbert, Richard G.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of London; King's College London; University of London; King's College London; University of Oxford	Sutton, BJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	brian.sutton@kcl.ac.uk; bal.dhaliwal@kcl.ac.uk		Beavil, Andrew/0000-0002-0768-122X; Dhaliwal, Balvinder/0000-0001-5455-3303; Keeble, Anthony/0000-0002-4873-6960; Gould, Hannah/0000-0003-0411-688X; McDonnell, James/0000-0001-9037-2980	Wellcome Trust, Asthma UK; Medical Research Council (United Kingdom); Diamond Light Source; MRC [G1100090, G0501494] Funding Source: UKRI; Medical Research Council [G1000758, MR/J006742/1, G1100090, G0501494, G1000758B] Funding Source: researchfish; Asthma UK [08/039, MRC-AsthmaUKCentre] Funding Source: researchfish	Wellcome Trust, Asthma UK; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was supported by the Wellcome Trust, Asthma UK, the Medical Research Council (United Kingdom), and Diamond Light Source.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Atkins P., 2001, MOL SUBSTANCES; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEAVIL AJ, 1992, P NATL ACAD SCI USA, V89, P753, DOI 10.1073/pnas.89.2.753; BETTLER B, 1992, J BIOL CHEM, V267, P185; Borthakur S, 2012, J BIOL CHEM, V287, P31457, DOI 10.1074/jbc.C112.397059; Carlsson F, 2007, SCAND J IMMUNOL, V66, P261, DOI 10.1111/j.1365-3083.2007.01953.x; Chen BH, 2002, IMMUNOLOGY, V107, P373, DOI 10.1046/j.1365-2567.2002.01512.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P544, DOI 10.1016/j.jaci.2007.05.025; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Kelly AE, 1998, J IMMUNOL, V161, P6696; LARSSON L, 1978, CLIN CHEM, V24, P1962; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17977, DOI 10.1021/bi9819733; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Petersen OH, 2002, BIOL RES, V35, P177, DOI 10.4067/S0716-97602002000200008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RICHARDS ML, 1990, J IMMUNOL, V144, P2638; Schrodinger L., 2011, PYMOL GRAPH SYST VER; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; VERCELLI D, 1989, NATURE, V338, P649, DOI 10.1038/338649a0; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	50	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21667	21677		10.1074/jbc.M113.480657	http://dx.doi.org/10.1074/jbc.M113.480657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775083	hybrid, Green Published			2022-12-28	WOS:000328841900019
J	Song, CL; Zhu, SC; Wu, CY; Kang, JH				Song, Chenlin; Zhu, Songcheng; Wu, Chuanyue; Kang, Jiuhong			Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL PROLIFERATION; CARCINOMA-CELLS; OVARIAN-CANCER; IN-VITRO; INVASION; ACTIVATION; MIGRATION; PROTEIN; MATRIX-METALLOPROTEINASE-9	Aberrant expression of histone deacetylases (HDACs) is associated with carcinogenesis. Some HDAC inhibitors are widely considered as promising anticancer therapeutics. A major obstacle for development of HDAC inhibitors as highly safe and effective anticancer therapeutics is that our current knowledge on the contributions of different HDACs in various cancer types remains scant. Here we report that the expression level of HDAC10 was significantly lower in patients exhibiting lymph node metastasis compared with that in patients lacking lymph node metastasis in human cervical squamous cell carcinoma. Forced expression of HDAC10 in cervical cancer cells significantly inhibited cell motility and invasiveness in vitro and metastasis in vivo. Mechanistically, HDAC10 suppresses expression of matrix metalloproteinase (MMP) 2 and 9 genes, which are known to be critical for cancer cell invasion and metastasis. At the molecular level, HDAC10 binds to MMP2 and -9 promoter regions, reduces the histone acetylation level, and inhibits the binding of RNA polymerase II to these regions. Furthermore, an HDAC10 mutant lacking histone deacetylase activity failed to mimic the functions of full-length protein. These results identify a critical role of HDAC10 in suppression of cervical cancer metastasis, underscoring the importance of developing isoform-specific HDAC inhibitors for treatment of certain cancer types such as cervical squamous cell carcinoma.	[Song, Chenlin; Zhu, Songcheng; Kang, Jiuhong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu; jhkang@tongji.edu.cn			National Institutes of Health [GM65188]; Ministry of Science and Technology [2011CB965100, 2010CB944900, 2011CBA01100, 2011DFA30480, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31171432, 31101061, 31210103905, 31071306, 31000378, 81170499]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education [IRT1168, 20110072110039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65188(to C. W.). This work was also supported by Ministry of Science and Technology Grants 2011CB965100, 2010CB944900, 2011CBA01100, 2011DFA30480, 2010CB945000, and 2012CB966603; National Natural Science Foundation of China Grants 91219305, 31171432, 31101061, 31210103905, 31071306, 31000378, and 81170499; Science and Technology Commission of Shanghai Municipality Grants 11ZR1438500 and 11XD1405300; and Ministry of Education Grants IRT1168 and 20110072110039.	[Anonymous], 2013, MERCK MAN HOM HLTH H; Armenian Medical Network, 2013, CERV CANC; Armstrong EP, 2010, J MANAGE CARE PHARM, V16, P217, DOI 10.18553/jmcp.2010.16.3.217; Berube M, 2005, MOL VIS, V11, P1101; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Boothello R., 2011, MATRIX METALLOPROTEI; Branca M, 2006, ANTICANCER RES, V26, P1543; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Hellebrekers DMEI, 2007, BBA-REV CANCER, V1775, P76, DOI 10.1016/j.bbcan.2006.07.003; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Im Hogune, 2004, Methods Mol Biol, V284, P129; Kato Y, 2002, ONCOL REP, V9, P565; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee JH, 2010, MOL CELLS, V30, P107, DOI 10.1007/s10059-010-0094-z; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Nair SA, 2003, J CANCER RES CLIN, V129, P123, DOI 10.1007/s00432-002-0411-9; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Roomi MW, 2010, ONCOL REP, V23, P605, DOI 10.3892/or_00000675; Sato T, 2004, GYNECOL ONCOL, V92, P47, DOI 10.1016/j.ygyno.2003.09.012; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114, DOI 10.1093/nar/30.5.1114; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vasala K., 2008, ACTA U OUL D, V983; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wang XX, 2013, TUMOR BIOL, V34, P2721, DOI 10.1007/s13277-013-0824-x; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu P., 2009, MED J W CHINA, V21, P2040; Yang YH, 2013, MOL BIOL REP, V40, P4241, DOI 10.1007/s11033-013-2506-6; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yu G, 2013, MOL CELL BIOCHEM, V380, P239, DOI 10.1007/s11010-013-1679-6; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhou Cai-yun, 2002, Ai Zheng, V21, P735	48	87	99	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28021	28033		10.1074/jbc.M113.498758	http://dx.doi.org/10.1074/jbc.M113.498758			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897811	hybrid, Green Published			2022-12-28	WOS:000330612800028
J	Mameza, MG; Dvoretskova, E; Bamann, M; Honck, HH; Guler, T; Boeckers, TM; Schoen, M; Verpelli, C; Sala, C; Barsukov, I; Dityatev, A; Kreienkamp, HJ				Mameza, Marie Germaine; Dvoretskova, Elena; Bamann, Margarete; Hoenck, Hans-Hinrich; Gueler, Tuerkan; Boeckers, Tobias M.; Schoen, Michael; Verpelli, Chiara; Sala, Carlo; Barsukov, Igor; Dityatev, Alexander; Kreienkamp, Hans-Juergen			SHANK3 Gene Mutations Associated with Autism Facilitate Ligand Binding to the Shank3 Ankyrin Repeat Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY PROTEINS; ARCHITECTURAL FRAMEWORK; SCAFFOLDING PROTEINS; SYNAPTIC PROTEINS; SPECTRUM DISORDER; FAMILY; SHARPIN; EXPRESSION; BEHAVIORS; COMPLEX	Shank/ProSAP proteins are major scaffold proteins of the postsynaptic density; mutations in the human SHANK3 gene are associated with intellectual disability or autism spectrum disorders. We have analyzed the functional relevance of several SHANK3 missense mutations affecting the N-terminal portion of the protein by expression of wild-type and mutant Shank3 in cultured neurons and by binding assays in heterologous cells. Postsynaptic targeting of recombinant Shank3 was unaltered. In electrophysiological experiments, both wild-type and L68P mutant forms of Shank3 were equally effective in restoring synaptic function after knockdown of endogenous Shank3. We observed that several mutations affected binding to interaction partners of the Shank3 ankyrin repeat region. One of these mutations, L68P, improved binding to both ligands. Leu-68 is located N-terminal to the ankyrin repeats, in a highly conserved region that we identify here as a novel domain termed the Shank/ProSAP N-terminal (SPN) domain. We show that the SPN domain interacts with the ankyrin repeats in an intramolecular manner, thereby restricting access of either Sharpin or alpha-fodrin. The L68P mutation disrupts this blockade, thus exposing the Shank3 ankyrin repeat region to its ligands. Our data identify a new type of regulation of Shank proteins and suggest that mutations in the SHANK3 gene do not necessarily induce a loss of function, but may represent a gain of function with respect to specific interaction partners.	[Mameza, Marie Germaine; Bamann, Margarete; Hoenck, Hans-Hinrich; Gueler, Tuerkan; Kreienkamp, Hans-Juergen] Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Dvoretskova, Elena; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Boeckers, Tobias M.; Schoen, Michael] Univ Ulm, Inst Anat & Cell Biol, D-89069 Ulm, Germany; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Dept Med Biotechnol & Translat Med, I-20129 Milan, Italy; [Sala, Carlo] Neurol Inst Fdn Carlo Besta, Dept Neuromuscular Dis & Neuroimmunol, I-20133 Milan, Italy; [Barsukov, Igor] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dityatev, Alexander] Deutsch Zentrum Neurodegenerat Erkrankungen, Mol Neuroplast Grp, D-39120 Magdeburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto Italiano di Tecnologia - IIT; Ulm University; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; IRCCS Istituto Neurologico Besta; University of Liverpool; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kreienkamp, HJ (corresponding author), Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	Kreienkamp@uke.de	Sala, Carlo/A-2493-2009; Dityatev, Alexander/A-4034-2008; Verpelli, Chiara/K-6673-2016; Verpelli, Chiara/AAH-1140-2020	Sala, Carlo/0000-0003-0662-9523; Dityatev, Alexander/0000-0002-0472-0553; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Deutsche Forschungsgemeinschaft [FOR885, IRP2, Kr1312/3-2]; Telethon Fondazione Onlus [GGP11095]; Istituto Italiano di Tecnologia; Seed grant; Ministry of Health in the frame of European Research Area Network NEURON; Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Telethon Fondazione Onlus(Fondazione Telethon); Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); Seed grant; Ministry of Health in the frame of European Research Area Network NEURON; Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR885, IRP2, and Kr1312/3-2 (to H.-J. K.), Telethon Fondazione Onlus Grant GGP11095 (to C. S. and A. D.), Istituto Italiano di Tecnologia (to A. D.) and Seed grant (to C. S.), Ministry of Health in the frame of European Research Area Network NEURON (to C. S.), and Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program 2012-2014 (to C. S.).	Alie A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-34; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kreienkamp H-J., 2008, V186, P365, DOI 10.1007/978-3-540-72843-6_15; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sheng M, 2000, J CELL SCI, V113, P1851; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	39	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26697	26708		10.1074/jbc.M112.424747	http://dx.doi.org/10.1074/jbc.M112.424747			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897824	Green Published, hybrid			2022-12-28	WOS:000330594500035
J	Zaccardi, MJ; Yezdimer, EM; Boehr, DD				Zaccardi, Margot J.; Yezdimer, Eric M.; Boehr, David D.			Functional Identification of the General Acid and Base in the Dehydration Step of Indole-3-glycerol Phosphate Synthase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEGLYCEROL-PHOSPHATE; ESCHERICHIA-COLI; SULFOLOBUS-SOLFATARICUS; MYCOBACTERIUM-TUBERCULOSIS; BIFUNCTIONAL ENZYME; GROUND-STATE; ACTIVE-SITE; MECHANISM; STABILITY; ISOMERASE	The tryptophan biosynthetic enzyme indole-3-glycerol phosphate synthase is a proposed target for new antimicrobials and is a favored starting framework in enzyme engineering studies. Forty years ago, Parry proposed that the enzyme mechanism proceeds through two intermediates in a series of condensation, decarboxylation, and dehydration steps. X-ray crystal structures have suggested that Lys-110 (numbering according to the Sulfolobus solfataricus enzyme) behaves as a general acid both in the condensation and dehydration steps, but did not reveal an efficient pathway for the reprotonation of this critical residue. Our mutagenesis and kinetic experiments suggest an alternative mechanism whereby Lys-110 acts as a general acid in the condensation step, but another invariant residue, Lys-53, acts as the general acid in the dehydration step. These studies also indicate that the conserved residue Glu-51 acts as the general base in the dehydration step. The revised mechanism effectively divides the active site into discrete regions where the catalytic surfaces containing Lys-110 and Lys-53/Glu-51 catalyze the ring closure (i.e. condensation and decarboxylation) and dehydration steps, respectively. These results can be leveraged toward the development of novel inhibitors against this validated antimicrobial target and toward the rational engineering of the enzyme to produce indole derivatives that are highly prized by the pharmaceutical and agricultural industries.	[Zaccardi, Margot J.; Yezdimer, Eric M.; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA.	ddb12@psu.edu			National Science Foundation Career Grant [MCB1053993]; Div Of Molecular and Cellular Bioscience [1053993] Funding Source: National Science Foundation	National Science Foundation Career Grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Career Grant MCB1053993 (to D. D. B.).	Barden T.C., 2010, TOP HETEROCYCL CHEM, V26, P31; Czekster CM, 2008, TETRAHEDRON LETT, V49, P5914, DOI 10.1016/j.tetlet.2008.07.149; Czekster CM, 2009, ARCH BIOCHEM BIOPHYS, V486, P19, DOI 10.1016/j.abb.2009.04.001; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; EBERHARD M, 1989, FEBS LETT, V245, P219, DOI 10.1016/0014-5793(89)80225-X; EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013; Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Houlihan W. J., 1972, INDOLES; Humphrey GR, 2006, CHEM REV, V106, P2875, DOI 10.1021/cr0505270; Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531; Mazumder-Shivakumar D, 2004, P NATL ACAD SCI USA, V101, P14379, DOI 10.1073/pnas.0406002101; Mazumder-Shivakumar D, 2004, J AM CHEM SOC, V126, P5936, DOI 10.1021/ja049512u; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sasaki T, 2012, J BIOSCI BIOENG, V113, P726, DOI 10.1016/j.jbiosc.2012.01.012; Schlee S, 2013, BIOCHEMISTRY-US, V52, P132, DOI 10.1021/bi301342j; Schneider B, 2005, BIOCHEMISTRY-US, V44, P16405, DOI 10.1021/bi051640n; Shen HB, 2010, J MICROBIOL, V48, P337, DOI 10.1007/s12275-010-9315-6; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; WITKOP B, 1951, J AM CHEM SOC, V73, P2188, DOI 10.1021/ja01149a079; WITKOP B, 1951, J AM CHEM SOC, V73, P713, DOI 10.1021/ja01146a066; Zaccardi MJ, 2012, BIOCHEM BIOPH RES CO, V418, P324, DOI 10.1016/j.bbrc.2012.01.020	25	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26350	26356		10.1074/jbc.M113.487447	http://dx.doi.org/10.1074/jbc.M113.487447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900843	Green Published, hybrid			2022-12-28	WOS:000330594500001
J	Butler, CF; Peet, C; Mason, AE; Voice, MW; Leys, D; Munro, AW				Butler, Christopher F.; Peet, Caroline; Mason, Amy E.; Voice, Michael W.; Leys, David; Munro, Andrew W.			Key Mutations Alter the Cytochrome P450 BM3 Conformational Landscape and Remove Inherent Substrate Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; SELF-SUFFICIENT; HEME IRON; SINGLE-MUTATION; BINDING; P450BM3; SITE; LIGAND; IDENTIFICATION; METABOLITES	Cytochrome P450 monooxygenases (P450s) have enormous potential in the production of oxychemicals, due to their unparalleled regio- and stereoselectivity. The Bacillus megaterium P450 BM3 enzyme is a key model system, with several mutants (many distant from the active site) reported to alter substrate selectivity. It has the highest reported monooxygenase activity of the P450 enzymes, and this catalytic efficiency has inspired protein engineering to enable its exploitation for biotechnologically relevant oxidations with structurally diverse substrates. However, a structural rationale is lacking to explain how these mutations have such effects in the absence of direct change to the active site architecture. Here, we provide the first crystal structures of BM3 mutants in complex with a human drug substrate, the proton pump inhibitor omeprazole. Supported by solution data, these structures reveal how mutation alters the conformational landscape and decreases the free energy barrier for transition to the substrate-bound state. Our data point to the importance of such "gatekeeper" mutations in enabling major changes in substrate recognition. We further demonstrate that these mutants catalyze the same 5-hydroxylation reaction as performed by human CYP2C19, the major human omeprazolemetabolizing P450 enzyme.	[Butler, Christopher F.; Mason, Amy E.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Peet, Caroline; Voice, Michael W.] Cypex Ltd, Dundee DD2 1NH, Scotland	University of Manchester	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F00883X1]; Industrial CASE Studentship from Cypex Ltd. [BB/G01698/1]; Biotechnology and Biological Sciences Research Council [BB/F002521/1, BB/K001884/1, BB/F00883X/1] Funding Source: researchfish; BBSRC [BB/K001884/1, BB/F002521/1, BB/F00883X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Industrial CASE Studentship from Cypex Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Research Grant BB/F00883X1 (to A. W. M. and D. L. supporting A. E. M.) and Industrial CASE Studentship BB/G01698/1 from Cypex Ltd. (to A. W. M. and M. W. V. supporting C. F. B.).	Abelo A, 2000, DRUG METAB DISPOS, V28, P966; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Carmichael AB, 2001, EUR J BIOCHEM, V268, P3117, DOI 10.1046/j.1432-1327.2001.02212.x; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dietrich M, 2009, J BIOTECHNOL, V139, P115, DOI 10.1016/j.jbiotec.2008.10.002; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; Girvan HM, 2007, J BIOL CHEM, V282, P564, DOI 10.1074/jbc.M607949200; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Ibeanu GC, 1996, J BIOL CHEM, V271, P12496, DOI 10.1074/jbc.271.21.12496; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Kuper J, 2012, ACTA CRYSTALLOGR F, V68, P1013, DOI 10.1107/S1744309112031570; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Li HY, 1999, BBA-MOL CELL BIOL L, V1441, P141, DOI 10.1016/S1388-1981(99)00161-4; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 1996, EUR J BIOCHEM, V239, P403, DOI 10.1111/j.1432-1033.1996.0403u.x; NARHI LO, 1986, J BIOL CHEM, V261, P7160; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Peters MW, 2003, J AM CHEM SOC, V125, P13442, DOI 10.1021/ja0303790; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; RENBERG L, 1989, DRUG METAB DISPOS, V17, P69; Romero PA, 2013, P NATL ACAD SCI USA, V110, pE193, DOI 10.1073/pnas.1215251110; Sawayama AM, 2009, CHEM-EUR J, V15, P11723, DOI 10.1002/chem.200900643; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Tsotsou GE, 2012, CHEM-EUR J, V18, P3582, DOI 10.1002/chem.201102470; Venkataraman H, 2012, CHEMBIOCHEM, V13, P520, DOI 10.1002/cbic.201100750; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Whitehouse CJC, 2010, CHEMBIOCHEM, V11, P2549, DOI 10.1002/cbic.201000421; Whitehouse CJC, 2009, CHEMBIOCHEM, V10, P1654, DOI 10.1002/cbic.200900279; Xu F, 2007, PROTEIN ENG DES SEL, V20, P473, DOI 10.1093/protein/gzm028; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014	58	51	54	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25387	25399		10.1074/jbc.M113.479717	http://dx.doi.org/10.1074/jbc.M113.479717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23828198	Green Published, hybrid			2022-12-28	WOS:000330619000036
J	Gupta, D; Leahy, AA; Monga, N; Peshavaria, M; Jetton, TL; Leahy, JL				Gupta, Dhananjay; Leahy, Averi A.; Monga, Navjot; Peshavaria, Mina; Jetton, Thomas L.; Leahy, Jack L.			Peroxisome Proliferator-activated Receptor gamma(PPAR gamma) and Its Target Genes Are Downstream Effectors of FoxO1 Protein in Islet beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; GLYCEROL PHOSPHATE DEHYDROGENASE; MALATE-PYRUVATE SHUTTLE; PANCREATIC-ISLETS; PPAR-GAMMA; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; RESPONSE ELEMENT; DOWN-REGULATION; FATTY RATS	The molecular mechanisms and signaling pathways that drive islet beta-cell compensation and failure are not fully resolved. We have used in vitro and in vivo systems to show that FoxO1, an integrator of metabolic stimuli, inhibits PPAR gamma expression in beta-cells, thus transcription of its target genes (Pdx1, glucose-dependent insulinotropic polypeptide (GIP) receptor, and pyruvate carboxylase) that are important regulators of beta-cell function, survival, and compensation. FoxO1 inhibition of target gene transcription is normally relieved when upstream activation induces its translocation from the nucleus to the cytoplasm. Attesting to the central importance of this pathway, islet expression of PPAR gamma and its target genes was enhanced in nondiabetic insulin-resistant rats and markedly reduced with diabetes induction. Insight into the impaired PPAR gamma signaling with hyperglycemia was obtained with confocal microscopy of pancreas sections that showed an intense nuclear FoxO1 immunostaining pattern in the beta-cells of diabetic rats in contrast to the nuclear and cytoplasmic FoxO1 in nondiabetic rats. These findings suggest a FoxO1/PPAR gamma-mediated network acting as a core component of beta-cell adaptation to metabolic stress, with failure of this response from impaired FoxO1 activation causing or exacerbating diabetes.	Univ Vermont, Div Endocrinol Diabet & Metab, Burlington, VT 05405 USA; Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Leahy, JL (corresponding author), Univ Vermont, Colchester Res Facil, 208 S Pk Dr, Colchester, VT 05446 USA.	jleahy@uvm.edu		Gibson MD, PhD, Averi/0000-0003-2118-5430	National Institutes of Health [DK56818]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056818, R56DK056818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56818 (to J. L. L.). This work was also supported by the American Diabetes Association (to M. P.).	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Cline GW, 2011, DIABETES METAB J, V35, P458, DOI 10.4093/dmj.2011.35.5.458; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Ivashchenko CY, 2007, AM J PHYSIOL-GASTR L, V293, pG319, DOI 10.1152/ajpgi.00056.2007; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050128; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Leahy JL, 2009, CURR DIABETES REP, V9, P215, DOI 10.1007/s11892-009-0035-4; Liu YQ, 2005, AM J PHYSIOL-ENDOC M, V288, pE471, DOI 10.1152/ajpendo.00427.2004; Liu YQ, 2004, J BIOL CHEM, V279, P7470, DOI 10.1074/jbc.M307921200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Welters HJ, 2012, ENDOCRINOLOGY, V153, P4593, DOI 10.1210/en.2012-1243; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	57	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25440	25449		10.1074/jbc.M113.486852	http://dx.doi.org/10.1074/jbc.M113.486852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23788637	Green Published, hybrid			2022-12-28	WOS:000330619000040
J	Mu, D				Mu, David			The Complexity of Thyroid Transcription Factor 1 with Both Pro- and Anti-oncogenic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE NUCLEAR FACTOR-3; SQUAMOUS-CELL CARCINOMA; FACTOR-I; LUNG-CANCER; GENE AMPLIFICATION; TUMOR-SUPPRESSOR; TARGET GENE; ALPHA-GENE; EXPRESSION	After the original identification of thyroid transcription factor 1 (TTF-1 or NKX2-1) biochemical activity as a transcriptional regulator of thyroglobulin in 1989, the bulk of the ensuing research has concentrated on elucidating the roles of NKX2-1 in the development of lung and thyroid tissues. Motivated by its specific expression pattern, pathologists adopted the NKX2-1 immunoreactivity to distinguish pulmonary from nonpulmonary nonthyroid adenocarcinomas. Interestingly, the concept of NKX2-1 as an active participant in lung tumorigenesis did not take hold until 2007. This minireview contrasts the recent advancements of NKX2-1-related observations primarily in the realm of pulmonary malignancies.	[Mu, David] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA; [Mu, David] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Mu, D (corresponding author), Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA.	mud@evms.edu	Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	National Institutes of Health [CA127547]; NATIONAL CANCER INSTITUTE [R01CA127547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA127547.	Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Barlesi F, 2005, BRIT J CANCER, V93, P450, DOI 10.1038/sj.bjc.6602717; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; BOEHM T, 1988, EMBO J, V7, P2011, DOI 10.1002/j.1460-2075.1988.tb03040.x; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Deutsch L, 2012, GENE CHROMOSOME CANC, V51, P618, DOI 10.1002/gcc.21950; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fabbro D, 1996, EUR J CANCER, V32A, P512, DOI 10.1016/0959-8049(95)00560-9; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hoshi S, 2009, CARCINOGENESIS, V30, P1614, DOI 10.1093/carcin/bgp167; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Kang SM, 2013, CANCER LETT, V335, P487, DOI 10.1016/j.canlet.2013.03.006; Kang Y, 2004, MOL CARCINOGEN, V40, P212, DOI 10.1002/mc.20034; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kimura S, 2011, J THROID RES, V2011, DOI 10.4061/2011/710213; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Lin L, 2002, CANCER RES, V62, P5273; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Matoso A, 2010, APPL IMMUNOHISTO M M, V18, P142, DOI 10.1097/PAI.0b013e3181bdf4e7; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Minoo P, 2000, Respir Res, V1, P109, DOI 10.1186/rr20; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Muraguchi T, 2011, CANCER RES, V71, P1135, DOI 10.1158/0008-5472.CAN-10-2304; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Niimi T, 2001, MOL CELL BIOL, V21, P7380, DOI 10.1128/MCB.21.21.7380-7390.2001; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ordonez NG, 2012, APPL IMMUNOHISTO M M, V20, P525, DOI 10.1097/PAI.0b013e318251d8c1; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Perner S, 2009, J PATHOL, V217, P65, DOI 10.1002/path.2443; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Puglisi F, 1999, MODERN PATHOL, V12, P318; Qi Ji, 2012, Front Med, V6, P134, DOI 10.1007/s11684-012-0188-4; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rice SJ, 2013, J BIOL CHEM, V288, P16348, DOI 10.1074/jbc.M113.474643; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sozzi G, 2011, CELL CYCLE, V10, P2045, DOI 10.4161/cc.10.13.15712; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Stenhouse G, 2004, J CLIN PATHOL, V57, P383, DOI 10.1136/jcp.2003.007138; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tang XM, 2011, CLIN CANCER RES, V17, P2434, DOI 10.1158/1078-0432.CCR-10-1412; Tian JM, 2006, CANCER RES, V66, P10399, DOI 10.1158/0008-5472.CAN-06-1564; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	96	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					24992	25000		10.1074/jbc.R113.491647	http://dx.doi.org/10.1074/jbc.R113.491647			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23818522	Green Published, hybrid			2022-12-28	WOS:000330619000001
J	Shelkovnikova, TA; Peters, OM; Deykin, AV; Connor-Robson, N; Robinson, H; Ustyugov, AA; Bachurin, SO; Ermolkevich, TG; Goldman, IL; Sadchikova, ER; Kovrazhkina, EA; Skvortsova, VI; Ling, SC; Da Cruz, S; Parone, PA; Buchman, VL; Ninkina, NN				Shelkovnikova, Tatyana A.; Peters, Owen M.; Deykin, Alexey V.; Connor-Robson, Natalie; Robinson, Hannah; Ustyugov, Alexey A.; Bachurin, Sergey O.; Ermolkevich, Tatyana G.; Goldman, Igor L.; Sadchikova, Elena R.; Kovrazhkina, Elena A.; Skvortsova, Veronica I.; Ling, Shuo-Chien; Da Cruz, Sandrine; Parone, Philippe A.; Buchman, Vladimir L.; Ninkina, Natalia N.			Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GAMMA-SYNUCLEIN; MUTATIONS; OVEREXPRESSION; EXPRESSION; FEATURES; FUS/TLS; TDP-43	Dysfunction of two structurally and functionally related proteins, FUS and TAR DNA-binding protein of 43 kDa (TDP-43), implicated in crucial steps of cellular RNA metabolism can cause amyotrophic lateral sclerosis (ALS) and certain other neurodegenerative diseases. The proteins are intrinsically aggregate- prone and form non-amyloid inclusions in the affected nervous tissues, but the role of these proteinaceous aggregates in disease onset and progression is still uncertain. To address this question, we designed a variant of FUS, FUS 1-359, which is predominantly cytoplasmic, highly aggregate-prone, and lacks a region responsible for RNA recognition and binding. Expression of FUS 1-359 in neurons of transgenic mice, at a level lower than that of endogenous FUS, triggers FUSopathy associated with severe damage of motor neurons and their axons, neuroinflammatory reaction, and eventual loss of selective motor neuron populations. These pathological changes cause abrupt development of a severe motor phenotype at the age of 2.5-4.5 months and death of affected animals within several days of onset. The pattern of pathology in transgenic FUS 1-359 mice recapitulates several key features of human ALS with the dynamics of the disease progression compressed in line with shorter mouse lifespan. Our data indicate that neuronal FUS aggregation is sufficient to cause ALS-like phenotype in transgenic mice.	[Shelkovnikova, Tatyana A.; Peters, Owen M.; Connor-Robson, Natalie; Robinson, Hannah; Ustyugov, Alexey A.; Buchman, Vladimir L.; Ninkina, Natalia N.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Shelkovnikova, Tatyana A.; Ustyugov, Alexey A.; Bachurin, Sergey O.; Buchman, Vladimir L.; Ninkina, Natalia N.] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Moscow Region, Russia; [Deykin, Alexey V.; Ermolkevich, Tatyana G.; Goldman, Igor L.; Sadchikova, Elena R.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Kovrazhkina, Elena A.; Skvortsova, Veronica I.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Ling, Shuo-Chien; Da Cruz, Sandrine; Parone, Philippe A.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ling, Shuo-Chien; Da Cruz, Sandrine; Parone, Philippe A.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Cardiff University; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Pirogov Russian National Research Medical University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Buchman, VL (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	buchmanvl@cf.ac.uk; ninkinan@cf.ac.uk	Sadchikova, Elena/AAN-4754-2021; Shelkovnikova, Tatyana/F-2023-2018; Ninkina, Natalia N/A-1732-2011; Sergey, Bachurin/I-1708-2018; Kovrazhkina, Elena/AAR-2425-2021; Deykin, Alexey V./J-9637-2012; Ustyugov, Aleksey/AAA-8286-2019; Robinson, Hannah/GVQ-6674-2022; Buchman, Vladimir L/A-4814-2010; Ustyugov, Aleksey/D-3112-2012	Shelkovnikova, Tatyana/0000-0003-1367-5309; Deykin, Alexey V./0000-0001-9960-0863; Ustyugov, Aleksey/0000-0003-1977-4797; Buchman, Vladimir L/0000-0002-7631-8352; Ustyugov, Aleksey/0000-0003-1977-4797; Robinson, Hannah/0000-0003-4817-2111; Sadchikova, Elena/0000-0003-2039-7108; LING, Shuo-Chien/0000-0002-0300-8812; Connor-Robson, Natalie/0000-0001-8350-6928; Peters, Owen/0000-0002-6824-0663	Wellcome Trust [075615/Z/04/z]; Russian Federation Program [8829]; Russian Foundation for Basic Research [12-04-01610]; Russian Federation State [14.518.11.7040]; Program of Russian Academy of Sciences "Fundamental Sciences for Medicine"; Short-Term European Molecular Biology Organization (EMBO) Fellowship [ASTF 351-2011]; Cardiff Neuroscience and Mental Health Research Institute (NMHRI)	Wellcome Trust(Wellcome TrustEuropean Commission); Russian Federation Program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation State; Program of Russian Academy of Sciences "Fundamental Sciences for Medicine"(Russian Academy of Sciences); Short-Term European Molecular Biology Organization (EMBO) Fellowship; Cardiff Neuroscience and Mental Health Research Institute (NMHRI)	This work was supported by research grants from the Wellcome Trust (Grant 075615/Z/04/z) and Russian Federation Program (Agreement 8829) (to V. L. B.), the Russian Foundation for Basic Research (Grant 12-04-01610) and Russian Federation State (Contract 14.518.11.7040) (to E. R. S.), and the Program of Russian Academy of Sciences "Fundamental Sciences for Medicine" (to N. N. N.).; Supported by the Short-Term European Molecular Biology Organization (EMBO) Fellowship (Grant ASTF 351-2011).; Supported by the Cardiff Neuroscience and Mental Health Research Institute (NMHRI) 4-year Ph. D. Studentship Programme.	Chen YB, 2011, PROTEIN CELL, V2, P477, DOI 10.1007/s13238-011-1065-7; Cohen NR, 2011, ACTA NEUROPATHOL, V121, P421, DOI 10.1007/s00401-010-0738-2; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Huang C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002011; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lashley T, 2011, BRAIN, V134, P2548, DOI 10.1093/brain/awr160; Miguel L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.008; Mitchell JC, 2013, ACTA NEUROPATHOL, V125, P273, DOI 10.1007/s00401-012-1043-z; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Murakami T, 2012, HUM MOL GENET, V21, P1, DOI 10.1093/hmg/ddr417; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peters OM, 2012, NEUROBIOL DIS, V48, P124, DOI 10.1016/j.nbd.2012.06.016; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Verbeeck C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-53; Xia RH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-10; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109	24	67	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25266	25274		10.1074/jbc.M113.492017	http://dx.doi.org/10.1074/jbc.M113.492017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867462	Green Published, hybrid			2022-12-28	WOS:000330619000025
J	Berry, DC; Jacobs, H; Marwarha, G; Gely-Pernot, A; O'Byrne, SM; DeSantis, D; Klopfenstein, M; Feret, B; Dennefeld, C; Blaner, WS; Croniger, CM; Mark, M; Noy, N; Ghyselinck, NB				Berry, Daniel C.; Jacobs, Hugues; Marwarha, Gurdeep; Gely-Pernot, Aurore; O'Byrne, Sheila M.; DeSantis, David; Klopfenstein, Muriel; Feret, Betty; Dennefeld, Christine; Blaner, William S.; Croniger, Colleen M.; Mark, Manuel; Noy, Noa; Ghyselinck, Norbert B.			The STRA6 Receptor Is Essential for Retinol-binding Protein-induced Insulin Resistance but Not for Maintaining Vitamin A Homeostasis in Tissues Other Than the Eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATTHEW-WOOD-SYNDROME; ADIPOSE CELL LINE; MOUSE EMBRYOGENESIS; MICE LACKING; NUCLEAR RECEPTORS; SERTOLI-CELLS; ACID; GENE; MUTATIONS; EXPRESSION	The plasma membrane protein STRA6 is thought to mediate uptake of retinol from its blood carrier retinol-binding protein (RBP) into cells and to function as a surface receptor that, upon binding of holo-RBP, activates a JAK/STAT cascade. It was suggested that STRA6 signaling underlies insulin resistance induced by elevated serum levels of RBP in obese animals. To investigate these activities in vivo, we generated and analyzed Stra6-null mice. We show that the contribution of STRA6 to retinol uptake by tissues in vivo is small and that, with the exception of the eye, ablation of Stra6 has only a modest effect on retinoid homeostasis and does not impair physiological functions that critically depend on retinoic acid in the embryo or in the adult. However, ablation of Stra6 effectively protects mice from RBP-induced suppression of insulin signaling. Thus one biological function of STRA6 in tissues other than the eye appears to be the coupling of circulating holo-RBP levels to cell signaling, in turn regulating key processes such as insulin response.	[Berry, Daniel C.; Marwarha, Gurdeep; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Berry, Daniel C.; DeSantis, David; Croniger, Colleen M.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Jacobs, Hugues; Gely-Pernot, Aurore; Klopfenstein, Muriel; Feret, Betty; Dennefeld, Christine; Mark, Manuel; Ghyselinck, Norbert B.] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, UMR7104,INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Jacobs, Hugues] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Case Western Reserve University; Case Western Reserve University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	noa.noy@case.edu; norbert@igbmc.fr	GHYSELINCK, Norbert/I-6999-2015	GHYSELINCK, Norbert/0000-0003-4042-6818; MARWARHA, GURDEEP/0000-0001-5556-0003	National Institutes of Health [DK59630]; Fondation pour la Recherche Medicale [DEQ20071210544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, U2CDK059630, R01DK068437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to L. El Fertak and R. Combe who performed and analyzed the hyperinsulinemic-euglycemic clamp experiments in the Phenotyping Department of the Mouse Clinical Institute of Illkirch. The Mouse Metabolic Phenotyping Center of Case Western Reserve University is supported by National Institutes of Health Grant DK59630. The Stra6-null mouse line was established at the Mouse Clinic Institute in the Genetic Engineering and Model Validation Department of Inserm and supported by Fondation pour la Recherche Medicale Grant DEQ20071210544 (to N. B. G. and M. M.).	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Antal Cristina, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a04s80; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; BLANER WS, 1987, J BIOL CHEM, V262, P53; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 1997, DEVELOPMENT, V124, P399; FEX G, 1988, BIOCHIM BIOPHYS ACTA, V944, P249, DOI 10.1016/0005-2736(88)90438-5; Gavrilova R, 2009, AM J MED GENET A, V149A, P2241, DOI 10.1002/ajmg.a.32998; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HELLER J, 1975, J BIOL CHEM, V250, P3613; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1990, BIOCHEMISTRY-US, V29, P3883, DOI 10.1021/bi00468a013; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Ruiz A, 2007, INVEST OPHTH VIS SCI, V48, P5377, DOI 10.1167/iovs.07-0673; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SOPRANO DR, 1981, J BIOL CHEM, V256, P8256; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Vernet N, 2006, EMBO J, V25, P5816, DOI 10.1038/sj.emboj.7601447; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	54	91	93	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24528	24539		10.1074/jbc.M113.484014	http://dx.doi.org/10.1074/jbc.M113.484014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839944	Green Published, hybrid			2022-12-28	WOS:000330612300021
J	Ghosh-Choudhury, N; Mandal, CC; Das, F; Ganapathy, S; Ahuja, S; Choudhury, GG				Ghosh-Choudhury, Nandini; Mandal, Chandi C.; Das, Falguni; Ganapathy, Suthakar; Ahuja, Seema; Choudhury, Goutam Ghosh			c-Abl-dependent Molecular Circuitry Involving Smad5 and Phosphatidylinositol 3-Kinase Regulates Bone Morphogenetic Protein-2-induced Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; BMP-2 GENE-TRANSCRIPTION; TGF-BETA; TYROSINE KINASE; OSTEOBLAST DIFFERENTIATION; SIGNAL-TRANSDUCTION; IMATINIB MESYLATE; CELL-DIFFERENTIATION; PRECURSOR CELLS	Skeletal remodeling consists of timely formation and resorption of bone by osteoblasts and osteoclasts in a quantitative manner. Patients with chronic myeloid leukemia receiving inhibitors of c-Abl tyrosine kinase often show reduced bone remodeling due to impaired osteoblast and osteoclast function. BMP-2 plays a significant role in bone generation and resorption by contributing to the formation of mature osteoblasts and osteoclasts. The effects of c-Abl on BMP-2-induced bone remodeling and the underlying mechanisms are not well studied. Using a pharmacological inhibitor and expression of a dominant negative mutant of c-Abl, we show an essential role of this tyrosine kinase in the development of bone nodules containing mature osteoblasts and formation of multinucleated osteoclasts in response to BMP-2. Calvarial osteoblasts prepared from c-Abl null mice showed the absolute requirement of this tyrosine kinase in maturation of osteoblasts and osteoclasts. Activation of phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling by BMP-2 leads to osteoblast differentiation. Remarkably, inhibition of c-Abl significantly suppressed BMP-2-stimulated PI 3-kinase activity and its downstream Akt phosphorylation. Interestingly, c-Abl regulated BMP-2-induced osteoclastogenic CSF-1 expression. More importantly, we identified the requirements of c-Abl in BMP-2 autoregulation and the expressions of alkaline phosphatase and osterix that are necessary for osteoblast differentiation. c-Abl contributed to BMP receptor-specific Smad-dependent transcription of CSF-1, osterix, and BMP-2. Finally, c-Abl associates with BMP receptor IA and regulates phosphorylation of Smad in response to BMP-2. We propose that activation of c-Abl is an important step, which induces into two signaling pathways involving noncanonical PI 3-kinase and canonical Smads to integrate BMP-2-induced osteogenesis.	[Ghosh-Choudhury, Nandini; Ahuja, Seema; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi C.; Ganapathy, Suthakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Das, Falguni; Ahuja, Seema; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ghosh-Choudhury, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.	choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 AR52425, RO1 DK50190]; Veterans Affairs Merit Review grant; CTRC P30 Cancer Center Support Grant [CA 054174]; Veterans Affairs Merit Review grants; Cancer Prevention Research Institute of Texas; Veterans Affairs Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grant(US Department of Veterans Affairs); CTRC P30 Cancer Center Support Grant; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Cancer Prevention Research Institute of Texas; Veterans Affairs Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR52425 (to N. G. C.) and RO1 DK50190 (to G. G. C.). This work was also supported by Veterans Affairs Merit Review grant and CTRC P30 Cancer Center Support Grant CA 054174 (to N. G. C.) and in part by Veterans Affairs Merit Review grants (to G. G. C.).; Recipient of a fellowship from the Cancer Prevention Research Institute of Texas.; Recipient of Veterans Affairs Senior Research Career Scientist Award.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Allington TM, 2011, CELLS TISSUES ORGANS, V193, P98, DOI 10.1159/000320163; Antoku S, 2008, J CELL SCI, V121, P3071, DOI 10.1242/jcs.031575; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Atfi A, 2005, EMBO REP, V6, P985, DOI 10.1038/sj.embor.7400501; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen S, 2009, AM J PHYSIOL-HEART C, V297, pH533, DOI 10.1152/ajpheart.00237.2009; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Ghosh-Choudhury NG, 2003, J BIOL CHEM, V278, P21998, DOI 10.1074/jbc.M302277200; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; GhoshChoudhury N, 1997, BIOCHEM BIOPH RES CO, V231, P196, DOI 10.1006/bbrc.1996.5962; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jain SK, 1996, BLOOD, V88, P1542; Kaplan MS, 2003, J GERONTOL A-BIOL, V58, P1018; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Kua HY, 2012, NAT CELL BIOL, V14, P727, DOI 10.1038/ncb2528; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nurmio M, 2011, TOXICOL APPL PHARM, V254, P267, DOI 10.1016/j.taap.2011.04.019; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Rastogi MV, 2012, PEDIATR BLOOD CANCER, V59, P840, DOI 10.1002/pbc.24121; Ren SY, 2005, EXP HEMATOL, V33, P1222, DOI 10.1016/j.exphem.2005.06.030; Sattler M, 1996, ONCOGENE, V12, P839; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Tokonzaba E, 2006, CHEM BIOL DRUG DES, V67, P230, DOI 10.1111/j.1747-0285.2006.00361.x; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhao Jean J, 2006, Sci STKE, V2006, ppe52, DOI 10.1126/stke.3652006pe52	78	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24503	24517		10.1074/jbc.M113.455733	http://dx.doi.org/10.1074/jbc.M113.455733			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23821550	Green Published, hybrid			2022-12-28	WOS:000330612300019
J	Kurz, S; Jin, CS; Hykollari, A; Gregorich, D; Giomarelli, B; Vasta, GR; Wilson, IBH; Paschinger, K				Kurz, Simone; Jin, Chunsheng; Hykollari, Alba; Gregorich, Daniel; Giomarelli, Barbara; Vasta, Gerardo R.; Wilson, Iain B. H.; Paschinger, Katharina			Hemocytes and Plasma of the Eastern Oyster (Crassostrea virginica) Display a Diverse Repertoire of Sulfated and Blood Group A-modified N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PERKINSUS-MARINUS; MASS-SPECTROMETRIC ANALYSIS; SNAIL BIOMPHALARIA-GLABRATA; LINKED CARBOHYDRATE CHAINS; SCHISTOSOMA-MANSONI; TRICHOMONAS-VAGINALIS; OLIGOSACCHARIDES; BINDING; HEMOCYANIN; FUCOSE	The eastern oyster (Crassostrea virginica) has become a useful model system for glycan-dependent host-parasite interactions due to the hijacking of the oyster galectin CvGal1 for host entry by the protozoan parasite Perkinsus marinus, the causative agent of Dermo disease. In this study, we examined the N-glycans of both the hemocytes, which via CvGal1 are the target of the parasite, and the plasma of the oyster. In combination with HPLC fractionation, exoglycosidase digestion, and fragmentation of the glycans, mass spectrometry revealed that the major N-glycans of plasma are simple hybrid structures, sometimes methylated and core alpha 1,6-fucosylated, with terminal alpha 1,3-linked galactose; a remarkable high degree of sulfation of such glycans was observed. Hemocytes express a larger range of glycans, including core-difucosylated paucimannosidic forms, whereas bi- and triantennary glycans were found in both sources, including structures carrying sulfated and methylated variants of the histo-blood group A epitope. The primary features of the oyster whole hemocyte N-glycome were also found in dominin, the major plasma glycoprotein, which had also been identified as a CvGal1 glycoprotein ligand associated with hemocytes. The occurrence of terminal blood group moieties on oyster dominin and on hemocyte surfaces can account in part for their affinity for the endogenous CvGal1.	[Kurz, Simone; Hykollari, Alba; Gregorich, Daniel; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng] Univ Gothenburg, Inst Biomed, Dept Med Biochem, SE-40530 Gothenburg, Sweden; [Giomarelli, Barbara; Vasta, Gerardo R.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Giomarelli, Barbara; Vasta, Gerardo R.] Inst Marine & Environm Technol, Baltimore, MD 21202 USA	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009; Kurz, Simone/J-2390-2018	Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136; Kurz, Simone/0000-0003-2062-2512	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P21946]; Schrodinger Scholarship [J3160]; National Science Foundation [IOS-0822257, IOS-1063729]; Forderung der Wissenschaftlichen Forschung [W1224]; Direct For Biological Sciences [1063729, 1050518] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 21946] Funding Source: researchfish	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Schrodinger Scholarship; National Science Foundation(National Science Foundation (NSF)); Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant P21946 (to K. P.), Schrodinger Scholarship J3160 (to C. J.), and Grants IOS-0822257 and IOS-1063729 from the National Science Foundation (to G. R. V.).; Supported by the Forderung der Wissenschaftlichen Forschung-funded Doctoral Programme "Biomolecular Technology of Proteins" Grant W1224.	Akilov OE, 2007, J LEUKOCYTE BIOL, V81, P1188, DOI 10.1189/jlb.0706439; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Chu FLE, 1997, DIS AQUAT ORGAN, V28, P61, DOI 10.3354/dao028061; Dame Richard, 2002, Aquatic Ecology, V36, P51, DOI 10.1023/A:1013354807515; Demeure K, 2007, ANAL CHEM, V79, P8678, DOI 10.1021/ac070849z; Dolashka-Angelova P, 2003, BIOCHEM J, V374, P185, DOI 10.1042/BJ20030291; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Gauthier JD, 2004, J PARASITOL, V90, P446, DOI 10.1645/GE-3269; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Gielens C, 2005, BIOCHEM BIOPH RES CO, V331, P562, DOI 10.1016/j.bbrc.2005.03.217; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Harvey DJ, 2005, RAPID COMMUN MASS SP, V19, P287, DOI 10.1002/rcm.1761; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Lehr T, 2010, EXP PARASITOL, V126, P592, DOI 10.1016/j.exppara.2010.06.031; Lin Z, 2011, BIOCHEMISTRY-US, V50, P6340, DOI 10.1021/bi200343h; Lommerse JPM, 1997, EUR J BIOCHEM, V249, P195, DOI 10.1111/j.1432-1033.1997.00195.x; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Natsuka S, 2006, J BIOCHEM, V140, P87, DOI 10.1093/jb/mvj131; Neville DCA, 2009, J PROTEOME RES, V8, P681, DOI 10.1021/pr800704t; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Oliver JL, 1999, J INVERTEBR PATHOL, V74, P173, DOI 10.1006/jipa.1999.4879; Paschinger K, 2012, INT J PARASITOL, V42, P279, DOI 10.1016/j.ijpara.2012.01.002; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Poulin R, 2008, OIKOS, V117, P331, DOI 10.1111/j.2007.0030-1299.16435.x; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Reece SE, 2009, EVOL APPL, V2, P11, DOI 10.1111/j.1752-4571.2008.00060.x; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Scotti PD, 2007, NEW ZEAL J MAR FRESH, V41, P91, DOI 10.1080/00288330709509898; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Tian P, 2008, J FOOD PROTECT, V71, P1696, DOI 10.4315/0362-028X-71.8.1696; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; van der Vlist M, 2011, CURR OPIN HIV AIDS, V6, P348, DOI 10.1097/COH.0b013e328349a2d1; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; Vasta G. R., 2008, ANIMAL LECTINS; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Wenzel T, 2006, RAPID COMMUN MASS SP, V20, P785, DOI 10.1002/rcm.2378; Wright AC, 2002, MOL BIOCHEM PARASIT, V123, P73, DOI 10.1016/S0166-6851(02)00090-7; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Yoshino TP, 2008, GENE, V411, P46, DOI 10.1016/j.gene.2008.01.003; Yoshino TP, 2013, EXP PARASITOL, V133, P28, DOI 10.1016/j.exppara.2012.10.002; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	62	37	37	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24410	24428		10.1074/jbc.M113.478933	http://dx.doi.org/10.1074/jbc.M113.478933			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824194	Green Published, hybrid			2022-12-28	WOS:000330612300012
J	Bar-Rogovsky, H; Hugenmatter, A; Tawfik, DS				Bar-Rogovsky, Hagit; Hugenmatter, Adrian; Tawfik, Dan S.			The Evolutionary Origins of Detoxifying Enzymes THE MAMMALIAN SERUM PARAOXONASES (PONs) RELATE TO BACTERIAL HOMOSERINE LACTONASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCESTRAL PROTEIN RECONSTRUCTION; DIRECTED EVOLUTION; GLUTATHIONE TRANSFERASES; SEQUENCE ALIGNMENT; FAMILY; PHARMACOGENETICS; PROMISCUITY; DUPLICATION; ALGORITHM; HYDROLASE	Serum paraoxonases (PONs) are detoxifying lactonases that were first identified in mammals. Three mammalian families are known, PON1, 2, and 3 that reside primarily in the liver. They catalyze essentially the same reaction, lactone hydrolysis, but differ in their substrate specificity. Although some members are highly specific, others have a broad specificity profile. The evolutionary origins and substrate specificities of PONs therefore remain poorly understood. Here, we report a newly identified family of bacterial PONs, and the reconstruction of the ancestor of the three families of mammalian PONs. Both the mammalian ancestor and the characterized bacterial PONX_OCCAL were found to efficiently hydrolyze N-acyl homoserine lactones that mediate quorum sensing in many bacteria, including pathogenic ones. The mammalian PONs may therefore relate to a newly identified family of bacterial, PON-like "quorum-quenching" lactonases. The appearance of PONs in metazoa is likely to relate to innate immunity rather than detoxification. Unlike the bacterial PON, the mammalian ancestor also hydrolyzes, with low efficiency, lactones other than homoserine lactones, thus preceding the detoxifying functions that diverged later in two of the three mammalian families. The bifunctionality of the mammalian ancestor and the trade-off between the quorum-quenching and detoxifying lactonase activities explain the broad and overlapping specificities of some mammalian PONs versus the singular specificity of others.	[Bar-Rogovsky, Hagit; Hugenmatter, Adrian; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il			Defense Threat Reduction Agency; Sasson and Marjorie Peress Philanthropic Fund	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Sasson and Marjorie Peress Philanthropic Fund	This work was supported by the Defense Threat Reduction Agency and the Sasson and Marjorie Peress Philanthropic Fund.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20; Barkman T, 2009, NATURE, V462, pE1, DOI 10.1038/nature08663; Bates PA, 2001, PROTEINS, P39; BURCHELL B, 1991, DNA CELL BIOL, V10, P487, DOI 10.1089/dna.1991.10.487; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Chang BSW, 2005, METHOD ENZYMOL, V395, P652, DOI 10.1016/S0076-6879(05)95034-9; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Connelly PW, 2011, BBA-MOL CELL BIOL L, V1811, P39, DOI 10.1016/j.bbalip.2010.10.002; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HEARSE DJ, 1973, BIOCHEM J, V132, P519, DOI 10.1042/bj1320519; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2009, BIOCHEMISTRY-US, V48, P6644, DOI 10.1021/bi900583y; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; La Du BN, 1999, CHEM-BIOL INTERACT, V119, P379, DOI 10.1016/S0009-2797(99)00049-6; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Ma F, 2009, APPL MICROBIOL BIOT, V83, P135, DOI 10.1007/s00253-009-1890-2; MACKNESS MI, 1989, BIOCHEM PHARMACOL, V38, P385, DOI 10.1016/0006-2952(89)90376-6; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Ohno S., 1970, P1; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shield AJ, 2004, MOL PSYCHIATR, V9, P151, DOI 10.1038/sj.mp.4001386; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tokuriki N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2246; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Weinshilboum R, 2001, DRUG METAB DISPOS, V29, P601; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Witte I, 2012, J LIPIDS, V2012, DOI 10.1155/2012/342806; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	81	85	93	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23914	23927		10.1074/jbc.M112.427922	http://dx.doi.org/10.1074/jbc.M112.427922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23788644	Green Published, hybrid			2022-12-28	WOS:000330611400031
J	Mizanur, RM; Frasca, V; Swaminathan, S; Bavari, S; Webb, R; Smith, LA; Ahmed, SA				Mizanur, Rahman M.; Frasca, Verna; Swaminathan, Subramanyam; Bavari, Sina; Webb, Robert; Smith, Leonard A.; Ahmed, S. Ashraf			The C Terminus of the Catalytic Domain of Type A Botulinum Neurotoxin May Facilitate Product Release from the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-STRUCTURE PIPELINE; LIGHT-CHAIN; SUBSTRATE RECOGNITION; TRYPTOPHAN SYNTHASE; SEROTYPE-A; N-TERMINUS; PROTEOLYTIC ACTIVITY; CRYSTAL-STRUCTURE; PROTEASE ACTIVITY; IDENTIFICATION	Botulinum neurotoxins are the most toxic of all compounds. The toxicity is related to a poor zinc endopeptidase activity located in a 50-kDa domain known as light chain (Lc) of the toxin. The C-terminal tail of Lc is not visible in any of the currently available x-ray structures, and it has no known function but undergoes autocatalytic truncations during purification and storage. By synthesizing C-terminal peptides of various lengths, in this study, we have shown that these peptides competitively inhibit the normal catalytic activity of Lc of serotypeA(LcA) and have defined the length of the mature LcA to consist of the first 444 residues. Two catalytically inactive mutants also inhibited LcA activity. Our results suggested that the C terminus of LcA might interact at or near its own active site. By using synthetic C-terminal peptides from LcB, LcC1, LcD, LcE, and LcF and their respective substrate peptides, we have shown that the inhibition of activity is specific only for LcA. Although a potent inhibitor with a K-i of 4.5 mu M, the largest of our LcA C-terminal peptides stimulated LcA activity when added at near-stoichiometric concentration to three versions of LcA differing in their C-terminal lengths. The result suggested a product removal role of the LcA C terminus. This suggestion is supported by a weak but specific interaction determined by isothermal titration calorimetry between an LcA C-terminal peptide and N-terminal product from a peptide substrate of LcA. Our results also underscore the importance of using a mature LcA as an inhibitor screening target.	[Mizanur, Rahman M.; Bavari, Sina; Webb, Robert; Ahmed, S. Ashraf] US Army, Integrated Toxicol Div, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Frasca, Verna] GE Healthcare Life Sci, Northampton, MA 01060 USA; [Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Smith, Leonard A.] Off Chief Scientist, Ft Detrick, MD 20854 USA	General Electric; United States Department of Energy (DOE); Brookhaven National Laboratory	Ahmed, SA (corresponding author), US Army, Integrated Toxicol Div, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.	syed.ahmed@amedd.army.mil	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant [JSTOCBD3.10012_06_RD_B]; National Research Council	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant; National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported in part by Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant JSTOCBD3.10012_06_RD_B (to S. A. A.).; Supported by the National Research Council through the research associateship program.	Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; AHMED SA, 1986, BIOCHEMISTRY-US, V25, P4233, DOI 10.1021/bi00363a010; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; AHMED SA, 1987, BIOCHEMISTRY-US, V26, P5492, DOI 10.1021/bi00391a042; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; DasGupta BR, 2005, PROTEIN J, V24, P337, DOI 10.1007/s10930-005-7589-z; DASGUPTA BR, 1990, BIOCHIMIE, V72, P661, DOI 10.1016/0300-9084(90)90048-L; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Gilsdorf J, 2006, PROTEIN EXPRES PURIF, V46, P256, DOI 10.1016/j.pep.2005.09.024; Hale M, 2011, J BIOL CHEM, V286, P1802, DOI 10.1074/jbc.M110.146464; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Kucera NJ, 2011, P NATL ACAD SCI USA, V108, P1308, DOI 10.1073/pnas.1017085108; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Liu ZJ, 2005, ACTA CRYSTALLOGR D, V61, P679, DOI 10.1107/S0907444905013132; MacDonald JA, 2012, BIOCHEMISTRY-US, V51, P2694, DOI 10.1021/bi2019018; Mathews C. K., 1990, BIOCHEMISTRY-US, P339; Mizanur Rahman M, 2012, Int J Biochem Mol Biol, V3, P313; Molles B. E., 2010, 40 INT BOT RES COORD; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Nilsson Lisa O, 2002, Biochim Biophys Acta, V1598, P199, DOI 10.1016/S0167-4838(02)00362-X; Peng DG, 2010, BIOCHEMISTRY-US, V49, P5832, DOI 10.1021/bi1000867; Rawat R, 2008, PROTEIN EXPRES PURIF, V60, P165, DOI 10.1016/j.pep.2008.03.010; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Silhar P, 2013, ACS MED CHEM LETT, V4, P283, DOI 10.1021/ml300428s; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sugahara Michihiro, 2008, Journal of Structural and Functional Genomics, V9, P21, DOI 10.1007/s10969-008-9042-y; Thompson AA, 2011, BIOCHEMISTRY-US, V50, P4019, DOI 10.1021/bi2001483; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Weber-Ban E, 2001, BIOCHEMISTRY-US, V40, P3497, DOI 10.1021/bi002690p	48	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24223	24233		10.1074/jbc.M113.451286	http://dx.doi.org/10.1074/jbc.M113.451286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23779108	Green Published, hybrid			2022-12-28	WOS:000330611400060
J	Yoshida, T; Galvez, S; Tiwari, S; Rezk, BM; Semprun-Prieto, L; Higashi, Y; Sukhanov, S; Yablonka-Reuveni, Z; Delafontaine, P				Yoshida, Tadashi; Galvez, Sarah; Tiwari, Sumit; Rezk, Bashir M.; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Yablonka-Reuveni, Zipora; Delafontaine, Patrice			Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; SELF-RENEWAL; RECEPTOR BLOCKADE; PHYSICAL FUNCTION; WEIGHT-LOSS; STEM-CELLS; ANG-II; EXPRESSION	Cachexia is a serious complication of many chronic diseases, such as congestive heart failure (CHF) and chronic kidney disease (CKD). Although patients with advanced CHF or CKD often have increased angiotensin II (Ang II) levels and cachexia and Ang II causes skeletal muscle wasting in rodents, the potential effects of Ang II on muscle regeneration are unknown. Muscle regeneration is highly dependent on the ability of a pool of muscle stem cells (satellite cells) to proliferate and to repair damaged myofibers or form new myofibers. Here we show that Ang II reduced skeletal muscle regeneration via inhibition of satellite cell (SC) proliferation. Ang II reduced the number of regenerating myofibers and decreased expression of SC proliferation/differentiation markers (MyoD, myogenin, and active-Notch) after cardiotoxin-induced muscle injury in vivo and in SCs cultured in vitro. Ang II depleted the basal pool of SCs, as detected in Myf5(nLacZ/+) mice and by FACS sorting, and this effect was inhibited by Ang II AT1 receptor (AT1R) blockade and in AT1aR-null mice. AT1R was highly expressed in SCs, and Notch activation abrogated the AT1R-mediated antiproliferative effect of Ang II in cultured SCs. In mice that developed CHF postmyocardial infarction, there was skeletal muscle wasting and reduced SC numbers that were inhibited by AT1R blockade. Ang II inhibition of skeletal muscle regeneration via AT1 receptor-dependent suppression of SC Notch and MyoD signaling and proliferation is likely to play an important role in mechanisms leading to cachexia in chronic disease states such as CHF and CKD.	[Yoshida, Tadashi; Galvez, Sarah; Tiwari, Sumit; Rezk, Bashir M.; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	Tulane University; University of Washington; University of Washington Seattle	Delafontaine, P (corresponding author), Tulane Univ, Sch Med, Inst Heart & Vasc, 1430 Tulane Ave,SL 48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Yoshida, Tadashi/0000-0002-4544-1497; Sukhanov, Sergiy/0000-0002-9223-4263; Delafontaine, Patrice/0000-0003-3744-3617	NHLBI National Institutes of Health [R01-HL070241, R01-HL080682]; National Institutes of Health National Center for Research Resources [P20-RR018766]; NIGMS National Institutes of Health [P20-GM103514, P30-GM103337, U54-GM104940]; NIA National Institutes of Health [R01AG021566, R01AG035377]; NIAMS National Institutes of Health [R21AR057794]; Muscular Dystrophy Association [135908]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080682, R21HL113705, R01HL070241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103514, P30GM103337, U54GM104940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021566, R01AG035377] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in whole or in part, by NHLBI National Institutes of Health Grants R01-HL070241 and R01-HL080682; National Institutes of Health National Center for Research Resources Grant P20-RR018766; NIGMS National Institutes of Health Grants P20-GM103514, P30-GM103337, and U54-GM104940; NIA National Institutes of Health Grants R01AG021566 and R01AG035377; and NIAMS National Institutes of Health Grant R21AR057794. This work was also supported by Muscular Dystrophy Association Grant 135908.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Ararat E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005144; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; Silva ACSE, 2006, PEDIATR RES, V60, P734, DOI 10.1203/01.pdr.0000246100.14061.bc; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Gray SL, 2009, J AM GERIATR SOC, V57, P297, DOI 10.1111/j.1532-5415.2008.02121.x; GRAZIANI G, 1993, KIDNEY INT, V44, P107, DOI 10.1038/ki.1993.219; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Johnston APW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015212; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lutken SC, 2009, AM J PHYSIOL-RENAL, V297, pF1678, DOI 10.1152/ajprenal.00010.2009; Masson S, 1998, PHARMACOL RES, V37, P213, DOI 10.1006/phrs.1998.0288; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; SEGERSVARD H, 2013, J RENIN ANG IN PRESS; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081; Skurk T, 2004, ARTERIOSCL THROM VAS, V24, P1199, DOI 10.1161/01.ATV.0000131266.38312.2e; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Sumukadas D, 2007, CAN MED ASSOC J, V177, P867, DOI 10.1503/cmaj.061339; Sun CK, 2007, INT HEART J, V48, P533, DOI 10.1536/ihj.48.533; Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; Yablonka-Reuveni Z, 2011, STEM CELLS BIOL REG, P173, DOI 10.1007/978-1-61779-021-8_11; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yoshida T, 2012, ENDOCRINOLOGY, V153, P1411, DOI 10.1210/en.2011-1764; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	54	57	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23823	23832		10.1074/jbc.M112.449074	http://dx.doi.org/10.1074/jbc.M112.449074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23831688	Green Published, hybrid			2022-12-28	WOS:000330611400022
J	Roche, CJ; Cassera, MB; Dantsker, D; Hirsch, RE; Friedman, JM				Roche, Camille J.; Cassera, Maria B.; Dantsker, David; Hirsch, Rhoda Elison; Friedman, Joel M.			Generating S-Nitrosothiols from Hemoglobin MECHANISMS, CONFORMATIONAL DEPENDENCE, AND PHYSIOLOGICAL RELEVANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRITE REDUCTASE-ACTIVITY; RED-BLOOD-CELLS; HYPOXIC VASODILATION; SUSTAINED-RELEASE; OXYGEN DELIVERY; MET HEMOGLOBIN; T-STATE; OXIDE; DEOXYHEMOGLOBIN; NO	In vitro, ferrous deoxy-hemes in hemoglobin (Hb) react with nitrite to generate nitric oxide (NO) through a nitrite reductase reaction. In vivo studies indicate Hb with nitrite can be a source of NO bioactivity. The nitrite reductase reaction does not appear to account fully for this activity because free NO is short lived especially within the red blood cell. Thus, the exporting of NO bioactivity both out of the RBC and over a large distance requires an additional mechanism. A nitrite anhydrase (NA) reaction in which N2O3, a potent S-nitrosating agent, is produced through the reaction of NO with ferric heme-bound nitrite has been proposed (Basu, S., Grubina, R., Huang, J., Conradie, J., Huang, Z., Jeffers, A., Jiang, A., He, X., Azarov, I., Seibert, R., Mehta, A., Patel, R., King, S. B., Hogg, N., Ghosh, A., Gladwin, M. T., and Kim-Shapiro, D. B. (2007) Nat. Chem. Biol. 3, 785-794) as a possible mechanism. Legitimate concerns, including physiological relevance and the nature of the mechanism, have been raised concerning the NA reaction. This study addresses these concerns demonstrating NO and nitrite with ferric hemes under near physiological conditions yield an intermediate having the properties of the purported NA heme-bound N2O3 intermediate. The results indicate that ferric heme sites, traditionally viewed as a source of potential toxicity, can be functionally significant, especially for partially oxygenated/partially met-R state Hb that arises from the NO dioxygenation reaction. In the presence of low levels of nitrite and either NO or a suitable reductant such as L-cysteine, these ferric heme sites can function as a generator for the formation of S-nitrosothiols such as S-nitrosoglutathione and, as such, should be considered as a source of RBC-derived and exportable bioactive NO.	[Roche, Camille J.; Dantsker, David; Hirsch, Rhoda Elison; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Cassera, Maria B.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu			National Institutes of Health [P01-HL110900-01A1, P01-HL071064, R21HL 106421]; FJC, a foundation of philanthropic funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900, P01HL071064, R21HL106421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FJC, a foundation of philanthropic funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL110900-01A1, P01-HL071064, and R21HL 106421. This work was also supported by FJC, a foundation of philanthropic funds.	Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Balazy M, 1998, J BIOL CHEM, V273, P32009, DOI 10.1074/jbc.273.48.32009; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bonaventura C, 2013, ANTIOXID REDOX SIGN, V18, P2298, DOI 10.1089/ars.2012.4947; Cabrales P, 2005, AM J PHYSIOL-HEART C, V289, pH2392, DOI 10.1152/ajpheart.00225.2005; CABRALES P., 2007, TRANSFUS ALTERN TRAN, V9, P281; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2284, DOI 10.1089/ars.2012.5099; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Chen KJ, 2008, NITRIC OXIDE-BIOL CH, V18, P47, DOI 10.1016/j.niox.2007.09.088; Chen QY, 2012, BLOOD CELL MOL DIS, V48, P91, DOI 10.1016/j.bcmd.2011.12.002; Chen QY, 2004, BLOOD CELL MOL DIS, V33, P303, DOI 10.1016/j.bcmd.2004.07.006; Chen ZZ, 2012, ANAL CHEM, V84, P4687, DOI 10.1021/ac300255n; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fernandez BO, 2004, INORG CHEM, V43, P5393, DOI 10.1021/ic049532x; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Fernandez BO, 2003, INORG CHEM, V42, P2, DOI 10.1021/ic020519r; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; Foster MW, 2005, HYPERTENSION, V45, P15, DOI 10.1161/01.HYP.0000150160.41992.71; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Gladwin M. T., 2008, ACCOUNTS CHEM RES, V47, P6059; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2012, NATURE, V491, P344, DOI 10.1038/nature11640; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Gow AJ, 2006, BLOOD, V108, P3224, DOI 10.1182/blood-2006-05-023572; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Helms C, 2013, FREE RADICAL BIO MED, V61, P464, DOI 10.1016/j.freeradbiomed.2013.04.028; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Hopmann KH, 2011, CHEM-EUR J, V17, P6348, DOI 10.1002/chem.201003578; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Ignarro LJ, 2009, NITRIC OXIDE BIOL PA; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Khan I, 2000, BIOCHEMISTRY-US, V39, P16099, DOI 10.1021/bi000536x; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; LALEZARI I, 1990, BIOCHEMISTRY-US, V29, P1515, DOI 10.1021/bi00458a024; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; Lui FE, 2009, BIOCHEMISTRY-US, V48, P11912, DOI 10.1021/bi9014105; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Mayer B, 2000, NITRIC OXIDE; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; Nachuraju P, 2011, RESUSCITATION, V82, P607, DOI 10.1016/j.resuscitation.2010.12.025; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Namin SM, 2013, NITRIC OXIDE-BIOL CH, V28, P39, DOI 10.1016/j.niox.2012.10.001; Navati MS, 2010, J PHYS CHEM B, V114, P2938, DOI 10.1021/jp909425z; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Rifkind JM, 2006, ANTIOXID REDOX SIGN, V8, P1193, DOI 10.1089/ars.2006.8.1193; Rifkind JM, 2011, NITRIC OXIDE-BIOL CH, V24, P102, DOI 10.1016/j.niox.2011.01.001; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2012, NITRIC OXIDE-BIOL CH, V27, P32, DOI 10.1016/j.niox.2012.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Salgado MT, 2011, J AM CHEM SOC, V133, P13010, DOI 10.1021/ja1115088; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, BIOCHEMISTRY-US, V43, P13674, DOI 10.1021/bi048531d; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Stamler J S, 1995, Curr Top Microbiol Immunol, V196, P19; Stamler JS, 2008, NAT MED, V14, P1008, DOI 10.1038/nm1008-1008; Stamler JS, 2003, NEW ENGL J MED, V349, P402; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Tullett JM, 2001, BIOCHEM PHARMACOL, V62, P1239, DOI 10.1016/S0006-2952(01)00750-X; Wanat A, 2002, J BIOL INORG CHEM, V7, P165, DOI 10.1007/s007750100284; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c; Yi J, 2009, J AM CHEM SOC, V131, P18119, DOI 10.1021/ja904726q; Yurcisin BM, 2013, ANN SURG, V257, P971, DOI 10.1097/SLA.0b013e3182822c52	101	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22408	22425		10.1074/jbc.M113.482679	http://dx.doi.org/10.1074/jbc.M113.482679			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775069	hybrid, Green Published			2022-12-28	WOS:000330596300023
J	Perzlmaier, AF; Richter, F; Seufert, W				Perzlmaier, Angelika F.; Richter, Frank; Seufert, Wolfgang			Translation Initiation Requires Cell Division Cycle 123 (Cdcl23) to Facilitate Biogenesis of the Eukaryotic Initiation Factor 2 (elF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Biology; Protein Assembly; Protein Synthesis; Protein-Protein Interactions; Translation Initiation Factors; Yeast Genetics; Cdc123; eIF2; Translation Initiation	SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; EXPRESSION; SEQUENCE; SUBUNIT; ENCODES; ASSOCIATION; INTERACTOME; MECHANISM; SELECTION	The eukaryotic translation initiation factor 2 (eIF2) is central to the onset of protein synthesis and its modulation in response to physiological demands. eIF2, a heterotrimeric G-protein, is activated by guanine nucleotide exchange to deliver the initiator methionyl-tRNA to the ribosome. Here we report that assembly of the eIF2 complex in vivo depends on Cdc123, a cell proliferation protein conserved among eukaryotes. Mutations of CDC123 in budding yeast reduced the association of eIF2 subunits, diminished polysome levels, and increased GCN4 expression indicating that Cdc123 is critical for eIF2 activity. Cdc123 bound the unassembled eIF2 subunit, but not the eIF2 complex, and the C-terminal domain III region of eIF2 was both necessary and sufficient for Cdc123 binding. Alterations of the binding site revealed a strict correlation between Cdc123 binding, the biological function of eIF2, and its ability to assemble with eIF2 and eIF2. Interestingly, high levels of Cdc123 neutralized the assembly defect and restored the biological function of an eIF2 mutant. Moreover, the combined overexpression of eIF2 subunits rescued an otherwise inviable cdc123 deletion mutant. Thus, Cdc123 is a specific eIF2 assembly factor indispensable for the onset of protein synthesis. Human Cdc123 is encoded by a disease risk locus, and, therefore, eIF2 biogenesis control by Cdc123 may prove relevant for normal cell physiology and human health. This work identifies a novel step in the eukaryotic translation initiation pathway and assigns a biochemical function to a protein that is essential for growth and viability of eukaryotic cells.	[Perzlmaier, Angelika F.; Seufert, Wolfgang] Univ Regensburg, Dept Genet, D-93040 Regensburg, Germany; [Richter, Frank] Univ Stuttgart, Inst Ind Genet, D-70569 Stuttgart, Germany	University of Regensburg; University of Stuttgart	Seufert, W (corresponding author), Univ Regensburg, Dept Genet, D-93040 Regensburg, Germany.	Wolfgang.Seufert@ur.de	Seufert, Wolfgang/F-7136-2019	Seufert, Wolfgang/0000-0001-8938-9064				Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; HANICJOYCE PJ, 1987, EXP CELL RES, V172, P134, DOI 10.1016/0014-4827(87)90100-5; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoja MR, 2000, EXP CELL RES, V259, P239, DOI 10.1006/excr.2000.4948; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; OHNO K, 1984, INT J QUANTUM CHEM, P1; Okuda A, 1996, EXP CELL RES, V223, P242, DOI 10.1006/excr.1996.0078; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKORSKI RS, 1989, GENETICS, V122, P19; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Wiese A, 2001, APPL MICROBIOL BIOT, V55, P750, DOI 10.1007/s002530000574; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	45	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21537	21546		10.1074/jbc.M113.472290	http://dx.doi.org/10.1074/jbc.M113.472290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775072	Green Published, hybrid			2022-12-28	WOS:000328841900007
J	Patel, R; Apostolatos, A; Carter, G; Ajmo, J; Gali, M; Cooper, DR; You, M; Bisht, KS; Patel, NA				Patel, Rekha; Apostolatos, Andre; Carter, Gay; Ajmo, Joanne; Gali, Meghanath; Cooper, Denise R.; You, Min; Bisht, Kirpal S.; Patel, Niketa A.			Protein Kinase C delta (PKC delta) Splice Variants Modulate Apoptosis Pathway in 3T3L1 Cells during Adipogenesis IDENTIFICATION OF PKC delta II INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; CANCER CELLS; PPAR-GAMMA; NT2 CELLS; TNF-ALPHA; RESVERATROL; INSULIN; EXPRESSION; ISOFORM; DIFFERENTIATION	Increased food intake and lack of physical activity results in excess energy stored in adipocytes, and this imbalance contributes to obesity. New adipocytes are required for storage of energy in the white adipose tissue. This process of adipogenesis is widely studied in differentiating 3T3L1 preadipocytes in vitro. We have identified a key signaling kinase, protein kinase C delta (PKC delta), whose alternative splice variant expression is modulated during adipogenesis. We demonstrate that PKC delta II splice variant promotes survival in differentiating 3T3L1 cells through the Bcl2 pathway. Here we demonstrate that resveratrol, a naturally occurring polyphenol, increases apoptosis and inhibits adipogenesis along with disruption of PKC delta alternative splicing during 3T3L1 differentiation. Importantly, we have identified a PKC delta II splice variant inhibitor. This inhibitor may be a valuable tool with therapeutic implications in obesity.	[Carter, Gay; Cooper, Denise R.; Patel, Niketa A.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Patel, Rekha; Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Ajmo, Joanne; You, Min] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Gali, Meghanath; Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu		Patel, Niketa A./0000-0003-4811-8596; Apostolatos, Andre/0000-0002-4527-7084	Department of Veterans Affairs Medical Research grant; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	Department of Veterans Affairs Medical Research grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Department of Veterans Affairs Medical Research grant (to N. A. P.).	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Ao L, 2008, TOXICOL IN VITRO, V22, P116, DOI 10.1016/j.tiv.2007.08.013; Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Apostolatos H, 2010, J BIOL CHEM, V285, P25987, DOI 10.1074/jbc.M110.100735; Atten MJ, 2005, INVEST NEW DRUG, V23, P111, DOI 10.1007/s10637-005-5855-8; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Carter G., 2013, ISRN OBES, V2013, P161345; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Kawahigashi H, 1998, BBA-GENE STRUCT EXPR, V1397, P305, DOI 10.1016/S0167-4781(98)00021-9; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Liu SM, 2011, CELL SIGNAL, V23, P1366, DOI 10.1016/j.cellsig.2011.03.019; MADER I, 1997, FASEB J, V24; MAGNELLI L, 1994, BIOCHEM BIOPH RES CO, V204, P84, DOI 10.1006/bbrc.1994.2429; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; McCracken MA, 2003, MOL CANCER THER, V2, P273; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; Shibasaki M, 2002, DIABETOLOGIA, V45, P518, DOI 10.1007/s00125-002-0786-9; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Xiao YY, 2010, FEBS J, V277, P687, DOI 10.1111/j.1742-4658.2009.07514.x; Yip WK, 2008, ONCOL REP, V19, P319; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129	41	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26834	26846		10.1074/jbc.M113.482638	http://dx.doi.org/10.1074/jbc.M113.482638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902767	Green Published, hybrid			2022-12-28	WOS:000330594500049
J	Ramabhadran, V; Hatch, AL; Higgs, HN				Ramabhadran, Vinay; Hatch, Anna L.; Higgs, Henry N.			Actin Monomers Activate Inverted Formin 2 by Competing with Its Autoinhibitory Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; MOUSE FORMIN; INF2; NUCLEATION; POLYMERIZATION; PROTEIN; MDIA1; MECHANISM; DOMAIN; RHO	INF2 is an unusual formin protein in that it accelerates both actin polymerization and depolymerization, the latter through an actin filament-severing activity. Similar to other formins, INF2 possesses a dimeric formin homology 2 (FH2) domain that binds filament barbed ends and is critical for polymerization and depolymerization activities. In addition, INF2 binds actin monomers through its diaphanous autoregulatory domain (DAD) that resembles a Wiskott-Aldrich syndrome protein homology 2 (WH2) sequence C-terminal to the FH2 that participates in both polymerization and depolymerization. INF2-DAD is also predicted to participate in an autoinhibitory interaction with the N-terminal diaphanous inhibitory domain (DID). In this work, we show that actin monomer binding to the DAD of INF2 competes with the DID/DAD interaction, thereby activating actin polymerization. INF2 is autoinhibited in cells because mutation of a key DID residue results in constitutive INF2 activity. In contrast, purified full-length INF2 is constitutively active in biochemical actin polymerization assays containing only INF2 and actin monomers. Addition of proteins that compete with INF2-DAD for actin binding (profilin or the WH2 from Wiskott-Aldrich syndrome protein) decrease full-length INF2 activity while not significantly decreasing activity of an INF2 construct lacking the DID sequence. Profilin-mediated INF2 inhibition is relieved by an anti-N-terminal antibody for INF2 that blocks the DID/DAD interaction. These results suggest that free actin monomers can serve as INF2 activators by competing with the DID/DAD interaction. We also find that, in contrast to past results, the DID-containing N terminus of INF2 does not directly bind the Rho GTPase Cdc42.	[Ramabhadran, Vinay; Hatch, Anna L.; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM069818 (to H. N. H.). This work was also supported by a National Science Foundation predoctoral fellowship (to A. L. H.).	Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; Higashida C, 2013, NAT CELL BIOL, V15, P395, DOI 10.1038/ncb2693; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	40	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26847	26855		10.1074/jbc.M113.472415	http://dx.doi.org/10.1074/jbc.M113.472415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921379	Green Published, hybrid			2022-12-28	WOS:000330594500050
J	Ayoub, E; Hall, A; Scott, AM; Chagnon, MJ; Miquel, G; Halle, M; Noda, M; Bikfalvi, A; Tremblay, ML				Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Miquel, Geraldine; Halle, Maxime; Noda, Masaharu; Bikfalvi, Andreas; Tremblay, Michel L.			Regulation of the Src Kinase-associated Phosphoprotein 55 Homologue by the Protein Tyrosine Phosphatase PTP-PEST in the Control of Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-TRAPPING SYSTEM; SKAP-HOM; SH3 DOMAIN; ADHESION; IDENTIFICATION; MIGRATION; ADAPTER; PHOSPHORYLATION; ACTIVATION; RECEPTOR	PTP-PEST is a cytosolic ubiquitous protein tyrosine phosphatase (PTP) that contains, in addition to its catalytic domain, several protein-protein interaction domains that allow it to interface with several signaling pathways. Among others, PTP-PEST is a key regulator of cellular motility and cytoskeleton dynamics. The complexity of the PTP-PEST interactome underscores the necessity to identify its interacting partners and physiological substrates in order to further understand its role in focal adhesion complex turnover and actin organization. Using a modified yeast substrate trapping two-hybrid system, we identified a cytosolic adaptor protein named Src kinase-associated phosphoprotein 55 homologue (SKAP-Hom) as a novel substrate of PTP-PEST. To confirm PTP-PEST interaction with SKAP-Hom, in vitro pull down assays were performed demonstrating that the PTP catalytic domain and Proline-rich 1 (P1) domain are respectively binding to the SKAP-Hom Y260 and Y297 residues and its SH3 domain. Subsequently, we generated and rescued SKAP-Hom-deficient mouse embryonic fibroblasts (MEFs) with WT SKAP-Hom, SKAP-Hom tyrosine mutants (Y260F, Y260F/Y297F), or SKAP-Hom SH3 domain mutant (W335K). Given the role of PTP-PEST, wound-healing and trans-well migration assays were performed using the generated lines. Indeed, SKAP-Hom-deficient MEFs showed a defect in migration compared with WT-rescued MEFs. Interestingly, the SH3 domain mutant-rescued MEFs showed an enhanced cell migration corresponding potentially with higher tyrosine phosphorylation levels of SKAP-Hom. These findings suggest a novel role of SKAP-Hom and its phosphorylation in the regulation of cellular motility. Moreover, these results open new avenues by which PTP-PEST regulates cellular migration, a hallmark of metastasis.	[Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Halle, Maxime; Tremblay, Michel L.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Halle, Maxime; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Miquel, Geraldine; Bikfalvi, Andreas] INSERM, U1029, F-33405 Talence, France; [Miquel, Geraldine; Bikfalvi, Andreas] Univ Bordeaux, F-33405 Talence, France	McGill University; McGill University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tremblay, ML (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X	CRS/Rob Lutterman Pancreatic Cancer Research Grant; Samuel Champlain foundation; McGill Integrated Cancer Research Training Program studentship; Victor K.S. Lui Fellowship; Graduate Excellence Fellowship from McGill Faculty of Medicine; Canderel Studentship; Fonds de la Recherche en Sante du Quebec (FRSQ)	CRS/Rob Lutterman Pancreatic Cancer Research Grant; Samuel Champlain foundation; McGill Integrated Cancer Research Training Program studentship; Victor K.S. Lui Fellowship; Graduate Excellence Fellowship from McGill Faculty of Medicine; Canderel Studentship; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was funded by the CRS/Rob Lutterman Pancreatic Cancer Research Grant and the Samuel Champlain foundation (to M. L. T. and A. B.).; Recipient of the McGill Integrated Cancer Research Training Program studentship, Victor K.S. Lui Fellowship, and Graduate Excellence Fellowship from McGill Faculty of Medicine.; Recipients of the Canderel Studentship.; Recipient of a doctoral training award from Fonds de la Recherche en Sante du Quebec (FRSQ).	Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bourette RP, 2005, CELL SIGNAL, V17, P941, DOI 10.1016/j.cellsig.2004.11.009; CASTELLANOS RMP, 1985, J BIOL CHEM, V260, P8240; CHAREST A, 1995, GENOMICS, V28, P501, DOI 10.1006/geno.1995.1181; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Chen PL, 2002, PROTEIN EXPRES PURIF, V24, P481, DOI 10.1006/prep.2001.1599; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Curtis DJ, 2000, EXP HEMATOL, V28, P1250, DOI 10.1016/S0301-472X(00)00537-3; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Playford MP, 2006, J BIOL CHEM, V281, P34104, DOI 10.1074/jbc.M606277200; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC2288, DOI 10.1152/ajpcell.00503.2006; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; St-Pierre J, 2012, CELL METAB, V15, P292, DOI 10.1016/j.cmet.2012.02.004; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Wu Y, 1998, J BIOL CHEM, V273, P30487, DOI 10.1074/jbc.273.46.30487; Yu X, 2011, J BIOL CHEM, V286, P30526, DOI 10.1074/jbc.M111.254722; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11	52	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25739	25748		10.1074/jbc.M113.501007	http://dx.doi.org/10.1074/jbc.M113.501007			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897807	hybrid, Green Published			2022-12-28	WOS:000330623300007
J	Natarajan, M; Lester, GMS; Lee, C; Missra, A; Wasserman, GA; Steffen, M; Gilmour, DS; Henderson, AJ				Natarajan, Malini; Lester, Gillian M. Schiralli; Lee, Chanhyo; Missra, Anamika; Wasserman, Gregory A.; Steffen, Martin; Gilmour, David. S.; Henderson, Andrew J.			Negative Elongation Factor (NELF) Coordinates RNA Polymerase II Pausing, Premature Termination, and Chromatin Remodeling to Regulate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; P-TEFB; TRANSCRIPTION ELONGATION; HISTONE DEACETYLASES; MEDIATED TRANSCRIPTION; GENE-EXPRESSION; HIV LATENCY; T-CELLS; POL-II; COMPLEX	A barrier to eradicating HIV infection is targeting and eliminating latently infected cells. Events that contribute to HIV transcriptional latency include repressive chromatin structure, transcriptional interference, the inability of Tat to recruit positive transcription factor b, and poor processivity of RNA polymerase II (RNAP II). In this study, we investigated mechanisms by which negative elongation factor (NELF) establishes and maintains HIV latency. Negative elongation factor (NELF) induces RNAPII promoter proximal pausing and limits provirus expression in HIV-infected primary CD4(+) T cells. Decreasing NELF expression overcomes RNAP II pausing to enhance HIV transcription elongation in infected primary T cells, demonstrating the importance of pausing in repressing HIV transcription. We also show that RNAP II pausing is coupled to premature transcription termination and chromatin remodeling. NELF interacts with Pcf11, a transcription termination factor, and diminishing Pcf11 in primary CD4(+) T cells induces HIV transcription elongation. In addition, we identify NCoR1-GPS2-HDAC3 as a NELF-interacting corepressor complex that is associated with repressed HIV long terminal repeats. We propose a model in which NELF recruits Pcf11 and NCoR1-GPS2-HDAC3 to paused RNAP II, reinforcing repression of HIV transcription and establishing a critical checkpoint for HIV transcription and latency.	[Natarajan, Malini] Penn State Univ, Integrated Biosci Grad Program, University Pk, PA 16802 USA; [Natarajan, Malini; Lester, Gillian M. Schiralli; Lee, Chanhyo; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med & Infect Dis, Boston, MA 02118 USA; [Wasserman, Gregory A.; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Steffen, Martin] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Missra, Anamika; Gilmour, David. S.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University; Boston University; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Henderson, AJ (corresponding author), Dept Med Infect Dis, 650 Albany St,EBRC 648, Boston, MA 02118 USA.	andrew.henderson@bmc.org		Schiralli Lester, Gillian/0000-0002-1750-7751; Wasserman, Gregory/0000-0002-0136-272X; Henderson, Andrew/0000-0002-9299-5302	National Institutes of Health [AI077463, AI097117]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097117, R56AI097117, R01AI077463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077463 and AI097117.	Ahmad Q Rushdy, 2005, Proteome Sci, V3, P6, DOI 10.1186/1477-5956-3-6; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Demonte D, 2004, BIOCHEM PHARMACOL, V68, P1231, DOI 10.1016/j.bcp.2004.05.040; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Goodwin MM, 2010, J VIROL, V84, P12039, DOI 10.1128/JVI.00396-10; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; KESSLER M, 1991, P NATL ACAD SCI USA, V88, P10018, DOI 10.1073/pnas.88.22.10018; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Natarajan M, 2010, J BIOL CHEM, V285, P17338, DOI 10.1074/jbc.M109.085324; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Planelles V, 2011, CURR HIV RES, V9, P568, DOI 10.2174/157016211798998826; Powell MLC, 2010, J VIROL, V84, P4451, DOI 10.1128/JVI.02390-09; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Sreenath K, 2010, VIROLOGY, V400, P76, DOI 10.1016/j.virol.2010.01.017; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Villanueva R, 2006, ONCOL REP, V16, P581; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhang ZQ, 2007, GENE DEV, V21, P1609, DOI 10.1101/gad.1542707; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002	70	40	40	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25995	26003		10.1074/jbc.M113.496489	http://dx.doi.org/10.1074/jbc.M113.496489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884411	Green Published, hybrid			2022-12-28	WOS:000330623300030
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			Modulation of Human Mitochondrial Voltage-dependent Anion Channel 2 (hVDAC-2) Structural Stability by Cysteine-assisted Barrel-lipid Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VDAC ISOFORMS; DETERGENT MICELLES; ALZHEIMERS-DISEASE; MEMBRANE-PROTEINS; BILAYER NANODISCS; N-TERMINUS; APOPTOSIS; FLUORESCENCE; HEXOKINASE; EXPRESSION	Human mitochondrial voltage-dependent anion channel 2 (hVDAC-2), the most predominant isoform seen in brain mitochondria, is not only crucial for cell survival but is also implicated in Alzheimer disease. The abundance of cysteines in this isoform is particularly fascinating, as hVDAC-1 cysteines have no associated functional role. We report a detailed biophysical examination of a Cys-less mutant of hVDAC-2, and its behavioral comparison with the wild type protein. Our findings suggest that cysteine mutation results in the formation of a better barrel at the expense of weakened protein-lipid interactions. The wild type protein displays stronger lipid association, despite being less structured. A reversal in behavior of both proteins is observed in the case of chemical denaturation, with the Cys-less mutant exhibiting lowered unfolding free energies. In bicellar systems comprising 14-C phosphocholines, we observe that protein-lipid interactions are weakened in both constructs, resulting in barrel structure destabilization. Our biochemical and biophysical studies together reveal key structural roles for the cysteine residues. We find that minor conformational variations in local residues are sufficient to define the membrane protein dynamics in hVDAC-2. Such subtle sequence variations contribute to differential stability of VDACs and may have implications in their in vivo regulation and recycling.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal 462023, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Transit Campus ITI Govindpura, Bhopal 462023, India.	maha@iiserb.ac.in	Mahalakshmi, Radhakrishnan/B-3143-2008; Maurya, Svetlana/H-3664-2018	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550; Maurya, Svetlana/0000-0002-4700-2711	Department of Biotechnology Grant from the government of India [BT/01/IYBA/2009, BT/HRD/35/02/25/2009]; Council of Scientific and Industrial Research (India); Department of Biotechnology	Department of Biotechnology Grant from the government of India; Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by the Department of Biotechnology Grant BT/01/IYBA/2009 and BT/HRD/35/02/25/2009 from the government of India (to R.M.).; Supported by a senior research fellowship from the Council of Scientific and Industrial Research (India).; A recipient of the Ramalingaswami Fellowship from the Department of Biotechnology. To whom correspondence should be addressed: Dept. of Biological Sciences, Indian Institute of Science Education and Research, Transit campus: ITI Govindpura, Bhopal 462023, India. Tel.: 91-755-4092318; Fax: 91-755-4092392; E-mail: maha@iiserb.ac.in.	Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 1996, Ion Channels, V4, P169; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1438, DOI 10.1016/j.bbamem.2011.11.014; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Etzkorn M, 2013, STRUCTURE, V21, P394, DOI 10.1016/j.str.2013.01.005; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, METHOD ENZYMOL, V492, P189, DOI 10.1016/B978-0-12-381268-1.00018-5; Poleti MD, 2010, J MOL NEUROSCI, V41, P48, DOI 10.1007/s12031-009-9278-4; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; SWAMINATHAN R, 1994, BIOPHYS J, V67, P2013, DOI 10.1016/S0006-3495(94)80685-X; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; Zhang XP, 2012, PROTEIN CELL, V3, P790, DOI 10.1007/s13238-012-2069-7	39	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25584	25592		10.1074/jbc.M113.493692	http://dx.doi.org/10.1074/jbc.M113.493692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23873934	hybrid, Green Published			2022-12-28	WOS:000330619000053
J	Jung, J; Sethi, A; Gaiotto, T; Han, JJ; Jeoh, T; Gnanakaran, S; Goodwin, PM				Jung, Jaemyeong; Sethi, Anurag; Gaiotto, Tiziano; Han, Jason J.; Jeoh, Tina; Gnanakaran, Sandrasegaram; Goodwin, Peter M.			Binding and Movement of Individual Cel7A Cellobiohydrolases on Crystalline Cellulose Surfaces Revealed by Single-molecule Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLULASES; ENZYMATIC-HYDROLYSIS; 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE; LIMITED PROTEOLYSIS; SUBSTRATE; ENZYMES; DOMAIN; ADSORPTION; KINETICS; PROBES	The efficient catalytic conversion of biomass to bioenergy would meet a large portion of energy requirements in the near future. A crucial step in this process is the enzyme-catalyzed hydrolysis of cellulose to glucose that is then converted into fuel such as ethanol by fermentation. Here we use single-molecule fluorescence imaging to directly monitor the movement of individual Cel7A cellobiohydrolases from Trichoderma reesei (TrCel7A) on the surface of insoluble cellulose fibrils to elucidate molecular level details of cellulase activity. The motion of multiple, individual TrCel7A cellobiohydrolases was simultaneously recorded with similar to 15-nm spatial resolution. Time-resolved localization microscopy provides insights on the activity of TrCel7A on cellulose and informs on nonproductive binding and diffusion. Wemeasured single-molecule residency time distributions of TrCel7A bound to cellulose both in the presence of and absence of cellobiose the major product and a potent inhibitor of Cel7A activity. Combining these results with a kinetic model of TrCel7A binding provides microscopic insight into interactions between TrCel7A and the cellulose substrate.	[Jung, Jaemyeong; Han, Jason J.; Goodwin, Peter M.] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87544 USA; [Sethi, Anurag; Gnanakaran, Sandrasegaram] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Gaiotto, Tiziano] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; [Jeoh, Tina] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Davis	Goodwin, PM (corresponding author), Los Alamos Natl Lab, Mail Stop K771, Los Alamos, NM 87545 USA.	pmg@lanl.gov		Jeoh, Tina/0000-0002-0727-4237; Gnanakaran, S/0000-0002-9368-3044	Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant [20100129ER]; U.S. Department of Energy [DE-AC52-06NA25396]; Div Of Chem, Bioeng, Env, & Transp Sys [1055518] Funding Source: National Science Foundation	Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant(United States Department of Energy (DOE)Los Alamos National Laboratory); U.S. Department of Energy(United States Department of Energy (DOE)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant 20100129ER and U.S. Department of Energy Contract DE-AC52-06NA25396. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science.	[Anonymous], 2006, DEC 2005 WORKSH; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; CHANZY H, 1984, FEBS LETT, V172, P193, DOI 10.1016/0014-5793(84)81124-2; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHERNOGLAZOV VM, 1989, ANAL BIOCHEM, V179, P186, DOI 10.1016/0003-2697(89)90222-4; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Helbert W, 2003, BIOMACROMOLECULES, V4, P481, DOI 10.1021/bm020076i; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2002, BIOTECHNOL PROGR, V18, P760, DOI 10.1021/bp0200402; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lavenson DM, 2011, CELLULOSE, V18, P1543, DOI 10.1007/s10570-011-9588-x; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Medve J, 1998, J CHROMATOGR A, V808, P153, DOI 10.1016/S0021-9673(98)00132-0; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Sangseethong K, 1998, CARBOHYD RES, V314, P245, DOI 10.1016/S0008-6215(98)00294-8; Santa-Maria M, 2010, BIOMACROMOLECULES, V11, P2000, DOI 10.1021/bm100366h; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	35	32	32	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24164	24172		10.1074/jbc.M113.455758	http://dx.doi.org/10.1074/jbc.M113.455758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818525	Green Published, hybrid			2022-12-28	WOS:000330611400055
J	Lu, YX; Denlinger, DL; Xu, WH				Lu, Yu-Xuan; Denlinger, David L.; Xu, Wei-Hua			Polycomb Repressive Complex 2 (PRC2) Protein ESC Regulates Insect Developmental Timing by Mediating H3K27me3 and Activating Prothoracicotropic Hormone Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; ELEGANS LIFE-SPAN; COTTON BOLLWORM; DIAPAUSE; CHROMATIN; ENHANCER; DISTINCT; BINDING	The decision made by insects to develop into adults or halt development (enter diapause and prolong lifespan) is commonly based on environmental signals that provide reliable predictors of future seasons of adversity. For example, the short day lengths of early autumn accurately foretell the advent of winter, but little is known about the molecular mechanisms that preside over the hormonal events dictating whether the insect proceeds with development or enters diapause. In Helicoverpa armigera we show that day length affects H3K27me3 by affecting polycomb repressive complex 2 (PRC2) protein extra sex comb (ESC) and regulates the prothoracicotropic hormone (PTTH) gene, thus directly influencing developmental timing. ESC expression in brains of developing (nondiapause) pupae is higher than in brains from diapausing pupae. High ESC expression is localized in two pairs of PTTH neurosecretory cells, and H3K27me3 recruits on the PTTH promoter. Double strand ESC and PRC2 inhibitor (DzNep) treatment in vitro show that ESC triggers PTTH promoter activity, which in turn depends on PRC2 methyltransferase activity. Injection of DzNep into pupae programmed for development reduces the H3K27me3 mark and PTTH gene expression, thereby delaying development. Although ESC is best known as a transcriptional repressor, our results show that ESC prompts development and metamorphosis. We believe this is the first report showing that the PRC2 complex functions as an activator and that a low level of H3K27me3 can prolong lifespan (i.e. induce diapause) by controlling PTTH gene expression in insects.	[Lu, Yu-Xuan; Xu, Wei-Hua] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China; [Denlinger, David L.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA; [Denlinger, David L.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	Sun Yat Sen University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Denlinger, DL (corresponding author), Ohio State Univ, Dept Entomol, 318 West 12th Ave, Columbus, OH 43210 USA.	denlinger.1@osu.edu; xuweihua@mail.sysu.edu.cn	Lu, Yu-Xuan/GYU-8582-2022; Lu, Yu-Xuan/AHE-5003-2022	Lu, Yu-Xuan/0000-0001-6751-5250; Xu, wei-hua/0000-0003-1696-3330	Natural Scientific Foundation of China [31230066]; National Basic Research Program of China, Ministry of Science and Technology [2012CB114101]; United States Department of Agriculture National Institute of Food and Agriculture Grant [2011-67013-30199]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China, Ministry of Science and Technology; United States Department of Agriculture National Institute of Food and Agriculture Grant	This work was supported by Natural Scientific Foundation of China Grant-in-aid 31230066, National Basic Research Program of China, Ministry of Science and Technology Grant 2012CB114101 (to W.-H. X.), and United States Department of Agriculture National Institute of Food and Agriculture Grant 2011-67013-30199 (D. L. D.).	Bao B, 2011, INSECT BIOCHEM MOLEC, V41, P670, DOI 10.1016/j.ibmb.2011.04.009; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Hou CL, 2007, CHINESE SCI BULL, V52, P2095, DOI 10.1007/s11434-007-0310-1; Hu Patrick J, 2007, WormBook, P1; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Ohtsuka K, 2011, INSECT BIOCHEM MOLEC, V41, P356, DOI 10.1016/j.ibmb.2011.02.002; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PHILLIPS JR, 1966, ANN ENTOMOL SOC AM, V59, P154, DOI 10.1093/aesa/59.1.154; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tian R, 2013, J INSECT PHYSIOL, V59, P588, DOI 10.1016/j.jinsphys.2013.03.006; Tie F, 2005, BIOCHEM BIOPH RES CO, V332, P622, DOI 10.1016/j.bbrc.2005.04.157; Tie F, 1998, DEVELOPMENT, V125, P3483; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Wei ZJ, 2011, MOL BIOL REP, V38, P1121, DOI 10.1007/s11033-010-0209-9; Wei ZJ, 2005, J INSECT PHYSIOL, V51, P691, DOI 10.1016/j.jinsphys.2005.03.005; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Q, 2012, J PROTEOME RES, V11, P1042, DOI 10.1021/pr200796a; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003273	43	28	32	5	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23554	23564		10.1074/jbc.M113.482497	http://dx.doi.org/10.1074/jbc.M113.482497			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814061	Green Published, hybrid			2022-12-28	WOS:000330598200059
J	Dou, L; Zhao, T; Wang, LL; Huang, XQ; Jiao, J; Gao, D; Zhang, HX; Shen, T; Man, Y; Wang, S; Li, J				Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian			miR-200s Contribute to Interleukin-6 (IL-6)-induced Insulin Resistance in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; MICRORNAS; OBESITY; EXPRESSION; CELLS; MICE	By influencing the activity of the PI3K/AKT pathway, IL-6 acts as an important regulator of hepatic insulin resistance. miR-200s have been shown to control growth by regulating PI3K, but the role of miR-200s in the development of hepatic insulin resistance remains unclear. The present study showed that elevated serum concentration of IL-6 is associated with decreased levels of miR-200s, impaired activation of the AKT/glycogen synthase kinase (GSK) pathway, and reduced glycogenesis that occurred in the livers of db/db mice. As shown in the murine NCTC 1469 hepatocytes and the primary hepatocytes treated with 10 ng/ml IL-6 for 24 h and in 12-week-old male C57BL/6J mice injected with 16 mu g/ml IL-6 by pumps for 7 days, IL-6 administration induced insulin resistance through downregulation of miR-200s. Moreover, IL-6 treatment inhibited the phosphorylation of AKT and GSK and decreased the glycogenesis. The effects of IL-6 could be diminished by suppression of FOG2 expression. We concluded that IL-6 treatment may impair the activities of the PI3K/AKT/GSK pathway and inhibit the synthesis of glycogen, perhaps via down-regulating miR-200s while augmenting FOG2 expression.	[Dou, Lin; Zhao, Ting; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Li, Jian] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian] Beijing Inst Geriatr, Key Lab Geriatr, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian] Beijing Hosp, Minist Hlth, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Hospital	Li, J (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing 100730, Peoples R China.	lijian@bjhmoh.cn	Lin, Xin/L-9950-2013	Lin, Xin/0000-0002-7491-8928	National Basic Research Program of China [2012CB517502]; National Natural Science Foundation of China [81270887, 81070634, 81270495]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB517502 and National Natural Science Foundation of China Grants 81270887, 81070634, and 81270495.	Allen TL, 2010, DIABETOLOGIA, V53, P399, DOI 10.1007/s00125-009-1627-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; David M, 2010, J INTERF CYTOK RES, V30, P825, DOI 10.1089/jir.2010.0080; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jack BHA, 2010, J BIOL CHEM, V285, P32405, DOI 10.1074/jbc.M110.141317; Joglekar MV, 2011, INDIAN J EXP BIOL, V49, P401; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Oh YS, 2011, DIABETES-METAB RES, V27, P813, DOI 10.1002/dmrr.1233; Ono K, 2011, CELL RES, V21, P864, DOI 10.1038/cr.2011.78; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Reddy MA, 2012, ARTERIOSCL THROM VAS, V32, P721, DOI 10.1161/ATVBAHA.111.241109; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Ulvila J, 2004, BIOCHEM J, V381, P887, DOI 10.1042/BJ20040387; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	28	53	58	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22596	22606		10.1074/jbc.M112.423145	http://dx.doi.org/10.1074/jbc.M112.423145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798681	hybrid, Green Published			2022-12-28	WOS:000330596300040
J	Liu, SP; Misquitta, YR; Olland, A; Johnson, MA; Kelleher, KS; Kriz, R; Lin, LL; Stahl, M; Mosyak, L				Liu, Shenping; Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia			Crystal Structure of a Human I kappa B Kinase beta Asymmetric Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; IKK-BETA; ACTIVATION; BINDING; INHIBITOR; PATHWAY; COMPLEX; ALPHA; PHOSPHORYLATION; ENZYME	Phosphorylation of inhibitor of nuclear transcription factor kappa B (I kappa B) by I kappa B kinase (IKK) triggers the degradation of I kappa B and migration of cytoplasmic kappa B to the nucleus where it promotes the transcription of its target genes. Activation of IKK is achieved by phosphorylation of its main subunit, IKK beta, at the activation loop sites. Here, we report the 2.8 angstrom resolution crystal structure of human IKK beta (hIKK beta), which is partially phosphorylated and bound to the staurosporine analog K252a. The hIKK beta protomer adopts a trimodular structure that closely resembles that from Xenopus laevis (xIKK beta): an N-terminal kinase domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization domain (SDD). Although hIKK beta and xIKK beta utilize a similar dimerization mode, their overall geometries are distinct. In contrast to the structure resembling closed shears reported previously for xIKK beta, hIKK beta exists as an open asymmetric dimer in which the two KDs are further apart, with one in an active and the other in an inactive conformation. Dimer interactions are limited to the C-terminal six-helix bundle that acts as a hinge between the two subunits. The observed domain movements in the structures of IKK beta may represent trans-phosphorylation steps that accompany IKK beta activation.	[Liu, Shenping; Misquitta, Yohann R.] Pfizer Worldwide Res, Struct Biol & Biophys Grp, Groton, CT 06340 USA; [Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia] Pfizer Worldwide Res, Global Biotherapeut Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Worldwide Res, Struct Biol & Biophys, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com; lidia.mosyak@pfizer.com						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Young ERR, 2012, RSC DRUG DISCOV, V26, P255, DOI 10.1039/9781849735346-00255; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	46	80	88	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22758	22767		10.1074/jbc.M113.482596	http://dx.doi.org/10.1074/jbc.M113.482596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792959	hybrid, Green Published			2022-12-28	WOS:000330596300053
J	Bezold, KL; Shaffer, JF; Khosa, JK; Hoye, ER; Harris, SP				Bezold, Kristina L.; Shaffer, Justin F.; Khosa, Jaskiran K.; Hoye, Elaine R.; Harris, Samantha P.			A Gain-of-Function Mutation in the M-domain of Cardiac Myosin-binding Protein-C Increases Binding to Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; Cardiac Muscle; Cardiomyopathy; Contractile Protein; Protein Phosphorylation; Myosin-binding Protein C; Tri-helix Bundle	N-TERMINAL DOMAINS; KINASE-A PHOSPHORYLATION; TROPONIN-I; F-ACTIN; MOTIF; MUSCLE; THICK; IDENTIFICATION; ACCELERATION; CONTRACTION	The M-domain is the major regulatory subunit of cardiac myosin-binding protein-C (cMyBP-C) that modulates actin and myosin interactions to influence muscle contraction. However, the precise mechanism(s) and the specific residues involved in mediating the functional effects of the M-domain are not fully understood. Positively charged residues adjacent to phosphorylation sites in the M-domain are thought to be critical for effects of cMyBP-C on cross-bridge interactions by mediating electrostatic binding with myosin S2 and/or actin. However, recent structural studies revealed that highly conserved sequences downstream of the phosphorylation sites form a compact tri-helix bundle. Here we used site-directed mutagenesis to probe the functional significance of charged residues adjacent to the phosphorylation sites and conserved residues within the tri-helix bundle. Results confirm that charged residues adjacent to phosphorylation sites and residues within the tri-helix bundle are important for mediating effects of the M-domain on contraction. In addition, four missense variants within the tri-helix bundle that are associated with human hypertrophic cardiomyopathy caused either loss-of-function or gain-of-function effects on force. Importantly, the effects of the gain-of-function variant, L348P, increased the affinity of the M-domain for actin. Together, results demonstrate that functional effects of the M-domain are not due solely to interactions with charged residues near phosphorylatable serines and provide the first demonstration that the tri-helix bundle contributes to the functional effects of the M-domain, most likely by binding to actin.	[Bezold, Kristina L.; Shaffer, Justin F.; Khosa, Jaskiran K.; Hoye, Elaine R.; Harris, Samantha P.] Univ Calif Davis, Davis, CA 95618 USA	University of California System; University of California Davis	Harris, SP (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 1 Shields Ave, Davis, CA 95616 USA.	samharris@ucdavis.edu			National Institutes of Health [HL080367]; Department of Defense National Defense Science and Engineering Graduate (NDSEG); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense National Defense Science and Engineering Graduate (NDSEG); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080367 (to S. P. H.) and Department of Defense National Defense Science and Engineering Graduate (NDSEG) and American Heart Association fellowships (to K. L. B.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Ackermann MA, 2013, FASEB J, V27, P3217, DOI 10.1096/fj.13-228882; [Anonymous], 2010, PYMOL MOL GRAPH SYST; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Howarth JW, 2012, J BIOL CHEM, V287, P8254, DOI 10.1074/jbc.M111.309591; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Lu YL, 2012, J BIOL CHEM, V287, P31596, DOI 10.1074/jbc.M112.383299; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Michalek AJ, 2013, BIOPHYS J, V104, P442, DOI [10.1016/j.bpj.2012.10.021, 10.1016/j.bpj.2012.12.021]; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; Shaffer JF, 2007, FEBS LETT, V581, P1501, DOI 10.1016/j.febslet.2007.03.007; Shaffer JF, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/789798; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Weith AE, 2012, J MUSCLE RES CELL M, V33, P449, DOI 10.1007/s10974-012-9312-y; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e	52	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21496	21505		10.1074/jbc.M113.474346	http://dx.doi.org/10.1074/jbc.M113.474346			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23782699	hybrid, Green Published			2022-12-28	WOS:000328841900003
J	Zhou, X; Hao, Q; Liao, JM; Liao, P; Lu, H				Zhou, Xiang; Hao, Qian; Liao, Jun-ming; Liao, Peng; Lu, Hua			Ribosomal Protein S14 Negatively Regulates c-Myc Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Oncogene; p53; Proliferation; Signal Transduction; Transcription Regulation; 5-q Syndrome; c-Myc; Ribosomal Protein L11; Ribosomal Protein S14	TRANSGENIC MICE; DNA-BINDING; ESSENTIAL COFACTOR; GENE-EXPRESSION; ACTIVATES P53; MDM2; L11; DEGRADATION; ARF; PHOSPHORYLATION	The ribosomal gene RPS14 is associated with the cancer-prone 5q-syndrome, which is caused by an interstitial deletion of the long arm of human chromosome 5. Previously, we found that ribosomal protein S14 (RPS14) binds to and inactivates MDM2, consequently leading to p53-dependent cell-cycle arrest and growth inhibition. However, it remains elusive whether RPS14 regulates cell proliferation in a p53-independent manner. Here, we show that RPS14 interacts with the Myc homology box II (MBII) and the C-terminal basic helix-loop-helix leucine zipper (bHLH-LZ) domains of the oncoprotein c-Myc. Further, RPS14 inhibited c-Myc transcriptional activity by preventing the recruitment of c-Myc and its cofactor, TRRAP, to the target gene promoters, as thus suppressing c-Myc-induced cell proliferation. Also, siRNA-mediated RPS14 depletion elevated c-Myc transcriptional activity determined by its target gene, Nucleolin, expression. Interestingly, RPS14 depletion also resulted in the induction of c-Myc mRNA and subsequent protein levels. Consistent with this, RPS14 promoted c-Myc mRNA turnover through an Argonaute 2 (Ago2)- and microRNA-mediated pathway. Taken together, our study demonstrates that RPS14 negates c-Myc functions by directly inhibiting its transcriptional activity and mediating its mRNA degradation via miRNA.	[Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Lu, Hua] Tulane Univ, Sch Med, Ctr Canc, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Liao, Peng/Y-1896-2019; Zhou, Xiang/J-5046-2017	Liao, Peng/0000-0002-8409-5574; Zhou, Xiang/0000-0002-1172-7948	National Institutes of Health-NCI [CA095441, CA 079721, CA129828, CA 172468]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA129828, R01CA172468, R01CA079721] Funding Source: NIH RePORTER	National Institutes of Health-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part by National Institutes of Health-NCI Grants CA095441, CA 079721, CA129828, and CA 172468 (to H.L.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Amente S, 2006, CANCER BIOL THER, V5, P287, DOI 10.4161/cbt.5.3.2389; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chan SP, 2009, DEV BIOL, V334, P152, DOI 10.1016/j.ydbio.2009.07.011; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Court EL, 2004, LEUKEMIA RES, V28, P743, DOI 10.1016/j.leukres.2003.11.011; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, NEOPLASIA, V8, P630, DOI 10.1593/neo.06334; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhou X., ONCOGENE, V32, P388; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	65	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21793	10.1074/jbc.M112.445122	http://dx.doi.org/10.1074/jbc.M112.445122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775087	Green Published, hybrid			2022-12-28	WOS:000328841900029
J	Petti, LM; Talbert-Slagle, K; Hochstrasser, ML; Dimaio, D				Petti, Lisa M.; Talbert-Slagle, Kristina; Hochstrasser, Megan L.; Dimaio, Daniel			A Single Amino Acid Substitution Converts a Transmembrane Protein Activator of the Platelet-derived Growth Factor beta Receptor into an Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E5 PROTEIN; SIMIAN SARCOMA-VIRUS; MOUSE C127 CELLS; TRANSFORMING PROTEIN; EGF RECEPTOR; PRODUCTIVE INTERACTION; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; PDGF RECEPTOR; DOMAIN	Receptors for PDGF play an important role in cell proliferation and migration and have been implicated in certain cancers. The 44-amino acid E5 protein of bovine papillomavirus binds to and activates the PDGF beta receptor (PDGF beta R), resulting in oncogenic transformation of cultured fibroblasts. Previously, we isolated an artificial 36-amino acid transmembrane protein, pTM36-4, which transforms cells because of its ability to activate the PDGF beta R despite limited sequence similarity to E5. Here, we demonstrated complex formation between the PDGF beta R and three pTM36-4 mutants: T21E, T21Q, and T21N. T21Q retained wild type transforming activity and activated the PDGF beta R in a ligand-independent manner as a consequence of binding to the transmembrane domain of the PDGF beta R, but T21E and T21N were severely defective. In fact, T21N substantially inhibited E5-induced PDGF beta R activation and transformation in both mouse and human fibroblasts. T21N did not prevent E5 from binding to the receptor, and genetic evidence suggested that T21N and E5 bind to nonidentical sites in the transmembrane domain of the receptor. T21N also inhibited transformation and PDGF beta R activation induced by v-Sis, a viral homologue of PDGF-BB, as well as PDGF-induced mitogenesis and signaling by preventing phosphorylation of the PDGF beta R at particular tyrosine residues. These results demonstrated that T21N acts as a novel inhibitor of the PDGF beta R and validated a new strategy for designing highly specific short transmembrane protein inhibitors of growth factor receptors and possibly other transmembrane proteins.	[Petti, Lisa M.; Dimaio, Daniel] Yale Univ, Sch Med, Dept Genet, Dept Mol Biophys & Biochem,Dept Therapeut Radiol, New Haven, CT 06510 USA; [Petti, Lisa M.; Dimaio, Daniel] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Talbert-Slagle, Kristina] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Hochstrasser, Megan L.] Univ Calif Berkeley, Berkeley, CA 94704 USA	Yale University; Yale University; Yale University; University of California System; University of California Berkeley	Dimaio, D (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	Daniel.dimaio@yale.edu		Hochstrasser, Megan/0000-0002-4404-078X	National Institutes of Health [CA37157]; NATIONAL CANCER INSTITUTE [R37CA037157, R01CA037157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA37157. This work was also supported by a generous gift from Mrs. Laurel Schwartz.	Adduci AJ, 1999, J BIOL CHEM, V274, P10249, DOI 10.1074/jbc.274.15.10249; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; BRAND T, 1993, J BIOL CHEM, V268, P11500; BURKHARDT A, 1987, EMBO J, V6, P2381, DOI 10.1002/j.1460-2075.1987.tb02515.x; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DRUMMONDBARBOSA D, 1995, MOL CELL BIOL, V15, P2570; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Freeman-Cook LL, 2005, J MOL BIOL, V345, P907, DOI 10.1016/j.jmb.2004.10.072; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; GOLDSTEIN DJ, 1992, EMBO J, V11, P4851, DOI 10.1002/j.1460-2075.1992.tb05591.x; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; HORWITZ BH, 1988, MOL CELL BIOL, V8, P4071, DOI 10.1128/MCB.8.10.4071; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Klein O, 1999, J VIROL, V73, P3264, DOI 10.1128/JVI.73.4.3264-3272.1999; Klein O, 1998, J VIROL, V72, P8921, DOI 10.1128/JVI.72.11.8921-8932.1998; Lai CC, 1998, P NATL ACAD SCI USA, V95, P15241, DOI 10.1073/pnas.95.26.15241; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lee CT, 2003, CANCER GENE THER, V10, P57, DOI 10.1038/sj.cgt.7700524; Matsushita C, 2013, P NATL ACAD SCI USA, V110, P1646, DOI 10.1073/pnas.1215207110; MEYER AN, 1994, P NATL ACAD SCI USA, V91, P4634, DOI 10.1073/pnas.91.11.4634; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nappi VM, 2002, J BIOL CHEM, V277, P47149, DOI 10.1074/jbc.M209582200; Nappi VM, 2002, J VIROL, V76, P7976, DOI 10.1128/JVI.76.16.7976-7986.2002; NILSON LA, 1995, J VIROL, V69, P5869, DOI 10.1128/JVI.69.9.5869-5874.1995; NILSON LA, 1993, MOL CELL BIOL, V13, P4137, DOI 10.1128/MCB.13.7.4137; Oates J, 2008, BIOCHEMISTRY-US, V47, P8985, DOI 10.1021/bi8006252; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PETTI L, 1992, P NATL ACAD SCI USA, V89, P6736, DOI 10.1073/pnas.89.15.6736; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Petti LM, 2000, CELL GROWTH DIFFER, V11, P395; Popa A, 2012, J VIROL, V86, P3014, DOI 10.1128/JVI.05826-11; Ptacek JB, 2007, P NATL ACAD SCI USA, V104, P11945, DOI 10.1073/pnas.0704348104; RIESE DJ, 1995, ONCOGENE, V10, P1431; SCHLEGEL R, 1986, SCIENCE, V233, P464, DOI 10.1126/science.3014660; STAEBLER A, 1995, J VIROL, V69, P6507, DOI 10.1128/JVI.69.10.6507-6517.1995; Surti T, 1998, PROTEINS, V33, P601; Talbert-Slagle K, 2009, J VIROL, V83, P9773, DOI 10.1128/JVI.00946-09; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073	48	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27273	27286		10.1074/jbc.M113.470054	http://dx.doi.org/10.1074/jbc.M113.470054			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908351	Green Published, hybrid			2022-12-28	WOS:000330597300024
J	Wang, Q; Shen, BR; Zheng, PL; Feng, H; Guo, YG; Cao, WY; Chen, L; Liu, X; Zhao, GD; Xu, SZ; Shen, WD; Chen, JG; Teng, JL				Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Zhao, Guodong; Xu, Sizheng; Shen, Weide; Chen, Jianguo; Teng, Junlin			BmCREC Is an Endoplasmic Reticulum (ER) Resident Protein and Required for ER/Golgi Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA SUPERCOILING FACTOR; POSTERIOR SILK GLAND; BOMBYX-MORI; INTRACELLULAR-TRANSPORT; DROSOPHILA-MELANOGASTER; CA2+-BINDING PROTEIN; GOLGI; SECRETION; SEQUENCE; CELLS	Silkworm posterior silkgland is a model for studying intracellular trafficking. Here, using this model, we identify several potential cargo proteins of BmKinesin-1 and focus on one candidate, BmCREC. BmCREC (also known as Bombyx mori DNA supercoiling factor, BmSCF) was previously proposed to supercoil DNA in the nucleus. However, we show here that BmCREC is localized in the ER lumen. Its C-terminal tetrapeptide HDEF is recognized by the KDEL receptor, and subsequently it is retrogradely transported by coat protein I (COPI) vesicles to the ER. Lacking the HDEF tetrapeptide of BmCREC or knocking down COPI subunits results in decreased ER retention and simultaneously increased secretion of BmCREC. Furthermore, we find that BmCREC-knock down markedly disrupts the morphology of the ER and Golgi apparatus and leads to a defect of posterior silkgland tube expansion. Together, our results clarify the ER retention mechanism of BmCREC and reveal that BmCREC is indispensable for maintaining ER/Golgi morphology.	[Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Xu, Sizheng; Chen, Jianguo; Teng, Junlin] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Xu, Sizheng; Chen, Jianguo; Teng, Junlin] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Zhao, Guodong; Shen, Weide] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215006, Peoples R China	Peking University; Peking University; Peking University; Soochow University - China	Chen, JG (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn	Chen, Liangyi/F-1352-2010; Guo, Yige/B-6670-2016	Chen, Liangyi/0000-0003-1270-7321; Guo, Yige/0000-0001-5573-2020; Shen, Birong/0000-0002-1208-506X; Wang, Qiao/0000-0001-6416-1733; Zheng, Pengli/0000-0002-3797-4023	National Natural Science Foundation of China [31271424]; Major State Basic Research Development Program of China (973 Program) [2010CB833705]; China Agriculture Research System [CARS-22-ZJ0305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China Grant 31271424, the Major State Basic Research Development Program of China (973 Program) Grant 2010CB833705, and the China Agriculture Research System Grant CARS-22-ZJ0305.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Kakei M, 2005, J INSECT PHYSIOL, V51, P17, DOI 10.1016/j.jinsphys.2004.10.012; Kaletta K, 1998, FEBS LETT, V434, P377, DOI 10.1016/S0014-5793(98)01013-8; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kobayashi M, 1998, MOL CELL BIOL, V18, P6737, DOI 10.1128/MCB.18.11.6737; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; MORIMOTO T, 1968, J CELL BIOL, V38, P604, DOI 10.1083/jcb.38.3.604; OHTA T, 1990, P NATL ACAD SCI USA, V87, P5307, DOI 10.1073/pnas.87.14.5307; OHTA T, 1995, J BIOL CHEM, V270, P15571, DOI 10.1074/jbc.270.26.15571; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SASAKI S, 1981, J CELL SCI, V50, P19; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035344; Wang Qiao, 2012, Front Biosci (Elite Ed), V4, P998, DOI 10.2741/E435; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	46	2	3	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26649	26657		10.1074/jbc.M113.463018	http://dx.doi.org/10.1074/jbc.M113.463018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921381	Green Published, hybrid			2022-12-28	WOS:000330594500030
J	Yin, SS; Zhang, JM; Mao, YJ; Hu, Y; Cui, LX; Kang, N; He, W				Yin, Shanshan; Zhang, Jianmin; Mao, Yujia; Hu, Yu; Cui, Lianxian; Kang, Ning; He, Wei			Vav1-phospholipase C-gamma 1 (Vav1-PLC-gamma 1) Pathway Initiated by T Cell Antigen Receptor (TCR gamma delta) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during gamma delta T Cell Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; RESTING NK CELLS; PHOSPHOLIPASE C-GAMMA-1; GRANULE POLARIZATION; NEGATIVE REGULATION; EFFECTOR FUNCTIONS; INDUCED CALCIUM; C-CBL; VAV1; RECOGNITION	T cell antigen receptor gamma delta (TCR gamma delta) and natural killer group 2, member D (NKG2D) are two crucial receptors for gamma delta T cell cytotoxicity. Compelling evidences suggest that gamma delta T cell cytotoxicity is TCR gamma delta-dependent and can be co-stimulated by NKG2D. However, the molecular mechanism of underlying TCR gamma delta-dependent activation of gamma delta T cells remains unclear. In this study we demonstrated that TCR gamma delta but not NKG2D engagement induced lytic granule polarization and promoted gamma delta T cell cytotoxicity. TCR gamma delta activation alone was sufficient to trigger Vav1-dependent phospholipase C-gamma 1 signaling, resulting in lytic granule polarization and effective killing, whereas NKG2D engagement alone failed to trigger cytotoxicity-related signaling to overcome the inhibitory effect of Cbl-b; therefore, NKG2D engagement alone could not induce effective killing. However, NKG2D ligation augmented the activation of gamma delta T cell cytotoxicity through the Vav1-phospholipase C-gamma 1 pathway. Vav1 overexpression or Cbl-b knockdown not only enhanced TCR gamma delta activation-initiated killing but also enabled NKG2D activation alone to induce gamma delta T cell cytotoxicity. Taken together, our results suggest that the activation of gamma delta T cell cytotoxicity requires a strong activation signal to overcome the inhibitory effect of Cbl-b. Our finding provides new insights into the molecular mechanisms underlying the initiation of gamma delta T cell cytotoxicity and likely implications for optimizing gamma delta T cell-based cancer immunotherapy.	[Kang, Ning; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kang, N (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	n.kang@ibms.pumc.edu.cn; hewei@ngd.org.cn			Beijing Natural Science Foundation [5122031]; National Natural Science Foundation of China [30972776]; National High Technology Research and Development Program (863 Program) [2006AA02Z480, 2007AA021109]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Beijing Natural Science Foundation Grant 5122031, National Natural Science Foundation of China Grant 30972776, and National High Technology Research and Development Program (863 Program) Grants 2006AA02Z480 and 2007AA021109.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Chiang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018542; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Dai YM, 2012, J BIOL CHEM, V287, P16812, DOI 10.1074/jbc.M111.327650; Dalton JE, 2004, J IMMUNOL, V173, P3660, DOI 10.4049/jimmunol.173.6.3660; Das A, 2010, J IMMUNOL, V185, P4698, DOI 10.4049/jimmunol.1001220; Estefania E, 2007, J IMMUNOL, V178, P4402, DOI 10.4049/jimmunol.178.7.4402; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZX, 2011, INT IMMUNOPHARMACOL, V11, P496, DOI 10.1016/j.intimp.2011.01.001; MamiChouaib F, 1996, HUM IMMUNOL, V51, P13, DOI 10.1016/S0198-8859(96)00164-4; Morita CT, 1999, MICROBES INFECT, V1, P175, DOI 10.1016/S1286-4579(99)80032-X; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nedellec S, 2010, J IMMUNOL, V185, P55, DOI 10.4049/jimmunol.1000373; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Rothenfusser S, 2002, CELL IMMUNOL, V215, P32, DOI 10.1016/S0008-8749(02)00001-1; Schmitz ML, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.276pe38; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sieger N, 2013, ARTHRITIS RHEUM-US, V65, P770, DOI 10.1002/art.37818; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Swat W, 2003, INT IMMUNOL, V15, P215, DOI 10.1093/intimm/dxg021; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325	52	19	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26448	26462		10.1074/jbc.M113.484600	http://dx.doi.org/10.1074/jbc.M113.484600			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897818	Green Published, hybrid			2022-12-28	WOS:000330594500010
J	Ying, TL; Chen, WZ; Feng, Y; Wang, YP; Gong, R; Dimitrov, DS				Ying, Tianlei; Chen, Weizao; Feng, Yang; Wang, Yanping; Gong, Rui; Dimitrov, Dimiter S.			Engineered Soluble Monomeric IgG1 CH3 Domain GENERATION, MECHANISMS OF FUNCTION, AND IMPLICATIONS FOR DESIGN OF BIOLOGICAL THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL-FC-RECEPTOR; ANTIBODY DOMAIN; INCREASED-STABILITY; CRYSTAL-STRUCTURE; BINDING-SITE; GAMMA-RIII; HALF-LIFE; GLYCOPROTEIN; FRAGMENTS; PROTEINS	Most of the therapeutic antibodies approved for clinical use are full-size IgG1 molecules. The interaction of the IgG1 Fc with the neonatal Fc receptor (FcRn) plays a critical role in maintaining their long half-life. We have hypothesized that isolated Fc domains could be engineered to functionally mimic full-size IgG1 (nanoantibodies) but with decreased (10-fold) size. Here, we report for the first time the successful generation of a soluble, monomeric CH3 domain (mCH3). In contrast to the wild-type dimeric CH3, the mCH3 exhibited pH-dependent binding to FcRn similar to that of Fc. The binding free energy of mCH3 to FcRn was higher than that of isolated CH2 but lower than that of Fc. Therefore, CH3 may contribute a larger portion of the free energy of binding to FcRn than CH2. A fusion protein of mCH3 with an engineered antibody domain (m36.4) also bound to FcRn in a pH-dependent fashion and exhibited significantly higher neutralizing activity against HIV-1 than m36.4-Fc fusion proteins. The m36.4-mCH3 fusion protein was monomeric, stable, soluble, and expressed at a high level in Escherichia coli. We also found that engineering an additional disulfide bond in mCH3 remarkably increased its thermal stability, whereas the FcRn binding was not affected. These data suggest that mCH3 could not only help in the exploration of the dual mechanisms of the CH3 contribution to Fc functions (dimerization and FcRn interactions) but could also be used for the development of candidate therapeutics with optimized half-life, enhanced tissue penetration, access to sterically restricted binding sites, and increased therapeutic efficacy.	[Ying, Tianlei; Chen, Weizao; Feng, Yang; Wang, Yanping; Gong, Rui; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Wang, Yanping] SAIC Frederick Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Ying, TL (corresponding author), NCI, Prot Interact Grp, NIH, Bldg 469,Rm 150B, Frederick, MD 21702 USA.	yingt@mail.nih.gov	应, 天雷/P-5396-2019	应, 天雷/0000-0002-9597-2843	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health, NCI [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010701] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research and by federal funds from the National Institutes of Health, NCI, under Contract N01-CO-12400.	BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Flanagan Meg L, 2007, Methods Mol Biol, V378, P33, DOI 10.1007/978-1-59745-323-3_3; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	37	42	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25154	25164		10.1074/jbc.M113.484154	http://dx.doi.org/10.1074/jbc.M113.484154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867459	hybrid, Green Published			2022-12-28	WOS:000330619000015
J	Liu, BY; Shats, I; Angus, SP; Gatza, ML; Nevins, JR				Liu, Beiyu; Shats, Igor; Angus, Steven P.; Gatza, Michael L.; Nevins, Joseph R.			Interaction of E2F7 Transcription Factor with E2F1 and C-terminal-binding Protein (CtBP) Provides a Mechanism for E2F7-dependent Transcription Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER; CELL-CYCLE; DNA; ACTIVATION; NETWORK; IDENTIFICATION; ORGANIZATION; RECRUITMENT; DISTINCT; COMPLEX	Previous work has identified distinct functions for E2F proteins during a cellular proliferative response including a role for E2F1-3 in the activation of transcription at G1/S and a role for E2F4-8 in repressing the same group of E2F1-3 target genes as cells progress through S phase. We now find that E2F7 and E2F8, which are induced by E2F1-3 at G1/S, can form a heterodimer with E2F1 through interactions involving the DNA-binding domains of the two proteins. In vitro DNA interaction assays demonstrate the formation of an E2F1-E2F7 complex, as well as an E2F7-E2F7 complex on adjacent E2F-binding sites. We also show that E2F7 recruits the co-repressor C-terminal-binding protein (CtBP) and that CtBP2 is essential for E2F7 to repress E2F1 transcription. Taken together, these findings suggest a mechanism for the repression of transcription by E2F7.	[Liu, Beiyu; Shats, Igor; Angus, Steven P.; Gatza, Michael L.; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, 2121 CIEMAS Bldg,Box 3382 DUMC, Durham, NC 27710 USA.	j.nevins@duke.edu	Shats, Igor/AAD-8775-2019	Shats, Igor/0000-0001-6449-5979; Angus, Steven/0000-0002-7655-657X; Gatza, Michael/0000-0001-6796-7791	National Institutes of Health Grants [CA104663, CA106520]; NATIONAL CANCER INSTITUTE [R01CA106520, R01CA104663] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104663 and CA106520 (to J. R. N.).	Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carvajal L. A., GENES DEV, V26, P1533; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585; RAYCHAUDHURI P, 1990, J VIROL, V64, P2702, DOI 10.1128/JVI.64.6.2702-2710.1990; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Wong JV, 2011, CELL CYCLE, V10; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	41	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24581	24589		10.1074/jbc.M113.467506	http://dx.doi.org/10.1074/jbc.M113.467506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853115	Green Published, hybrid			2022-12-28	WOS:000330612300026
J	Mary, S; Fehrentz, JA; Damian, M; Gaibelet, G; Orcel, H; Verdie, P; Mouillac, B; Martinez, J; Marie, J; Baneres, JL				Mary, Sophie; Fehrentz, Jean-Alain; Damian, Marjorie; Gaibelet, Gerald; Orcel, Helene; Verdie, Pascal; Mouillac, Bernard; Martinez, Jean; Marie, Jacky; Baneres, Jean-Louis			Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation A STUDY WITH A PURIFIED HETERODIMER ASSEMBLED INTO LIPID DISCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; RHODOPSIN; ACTIVATION; EXPRESSION; ARRESTIN; AGONIST; BINDING; DIMER; SUFFICIENT; DOMAIN	Heterodimerization of G protein-coupled receptors has an impact on their signaling properties, but the molecular mechanisms underlying heteromer-directed selectivity remain elusive. Using purified monomers and dimers reconstituted into lipid discs, we explored how dimerization impacts the functional and structural behavior of the ghrelin receptor. In particular, we investigated how a naturally occurring truncated splice variant of the ghrelin receptor exerts a dominant negative effect on ghrelin signaling upon dimerization with the full-length receptor. We provide direct evidence that this dominant negative effect is due to the ability of the non-signaling truncated receptor to restrict the conformational landscape of the full-length protein. Indeed, associating both proteins within the same disc blocks all agonist-and signaling protein-induced changes in ghrelin receptor conformation, thus preventing it from activating its cognate G protein and triggering arrestin 2 recruitment. This is an unambiguous demonstration that allosteric conformational events within dimeric assemblies can be directly responsible for modulation of signaling mediated by G protein-coupled receptors.	[Mary, Sophie; Fehrentz, Jean-Alain; Damian, Marjorie; Gaibelet, Gerald; Verdie, Pascal; Martinez, Jean; Marie, Jacky; Baneres, Jean-Louis] Univ Montpellier 1 & 2, IBMM, CNRS, UMR 5247,Fac Pharm, F-34093 Montpellier 5, France; [Gaibelet, Gerald; Orcel, Helene; Mouillac, Bernard] Univ Montpellier 1 & 2, IGF, INSERM, U661,UMR 5203,CNRS, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Baneres, JL (corresponding author), Fac Pharm Montpellier, IBMM, 15 Ave Charles Flahault,BP 14491, F-34093 Montpellier 5, France.	baneres@univ-montp1.fr	verdie, pascal/AAM-4228-2020; MOUILLAC, Bernard/M-3896-2014; Martinez, Jean/R-9421-2019	MOUILLAC, Bernard/0000-0002-3906-8673; Martinez, Jean/0000-0002-9267-4621; VERDIe, Pascal/0000-0002-5807-0293; Baneres, jean-louis/0000-0001-7078-1285	Centre National de la Recherche Scientifique (CNRS); Montpellier I University; Agence Nationale pour la Recherche [PCV08_323163, ANR-10-BLAN-1208]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Montpellier I University; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), by Montpellier I University, and by Agence Nationale pour la Recherche Contracts PCV08_323163 and ANR-10-BLAN-1208.	Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Cordoba-Chacon J, 2011, ANN NY ACAD SCI, V1220, P6, DOI 10.1111/j.1749-6632.2011.05985.x; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kojima M, 2010, ANN NY ACAD SCI, V1200, P140, DOI 10.1111/j.1749-6632.2010.05516.x; Kozasa Tohru, 2003, V237, P21; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Nag K, 2007, BIOCHEM BIOPH RES CO, V362, P1037, DOI 10.1016/j.bbrc.2007.08.107; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wise Helen, 2012, J Mol Signal, V7, P13, DOI 10.1186/1750-2187-7-13; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328	45	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24656	24665		10.1074/jbc.M113.453423	http://dx.doi.org/10.1074/jbc.M113.453423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839942	hybrid, Green Published			2022-12-28	WOS:000330612300033
J	Sato, M; Sinha, PK; Torres-Bacete, J; Matsuno-Yagi, A; Yagi, T				Sato, Motoaki; Sinha, Prem Kumar; Torres-Bacete, Jesus; Matsuno-Yagi, Akemi; Yagi, Takao			Energy Transducing Roles of Antiporter-like Subunits in Escherichia coli NDH-1 with Main Focus on Subunit NuoN (ND2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; IRON-SULFUR CLUSTERS; CONSERVED CHARGED RESIDUES; PARACOCCUS-DENITRIFICANS; MEMBRANE DOMAIN; UBIQUINONE OXIDOREDUCTASE; PERIPHERAL SUBUNITS; PROTON TRANSLOCATION; CRYSTAL-STRUCTURE	The proton-translocating NADH-quinone oxidoreductase (complex I/NDH-1) contains a peripheral and a membrane domain. Three antiporter-like subunits in the membrane domain, NuoL, NuoM, and NuoN (ND5, ND4 and ND2, respectively), are structurally similar. We analyzed the role of NuoN in Escherichia coli NDH-1. The lysine residue at position 395 in NuoN((N)Lys(395)) is conserved in NuoL ((L)Lys(399)) but is replaced by glutamic acid ((M)Glu(407)) in NuoM. Our mutation study on (N)Lys(395) suggests that this residue participates in the proton translocation. Furthermore, we found that (M)Glu(407) is also essential and most likely interacts with conserved (L)Arg(175). Glutamic acids, (N)Glu(133), (M)Glu(144), and (L)Glu(144), are corresponding residues. Unlike mutants of (M)Glu(144) and (L)Glu(144), mutation of (N)Glu(133) scarcely affected the energy-transducing activities. However, a double mutant of (N)Glu(133) and nearby (K)Glu(72) showed significant inhibition of these activities. This suggests that (N)Glu(133) bears a functional role similar to (L)Glu(144) and (M)Glu(144) but its mutation can be partially compensated by the nearby carboxyl residue. Conserved prolines located at loops of discontinuous transmembrane helices of NuoL, NuoM, and NuoN were shown to play a similar role in the energy-transducing activity. It seems likely that NuoL, NuoM, and NuoN pump protons by a similar mechanism. Our data also revealed that (N)Lys(158) is one of the key interaction points with helix HL in NuoL. A truncation study indicated that the C-terminal amphipathic segments of (N)TM14 interacts with the (M)beta sheet located on the opposite side of helix HL. Taken together, the mechanism of H+ translocation in NDH-1 is discussed.	[Sato, Motoaki; Sinha, Prem Kumar; Torres-Bacete, Jesus; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health United States Public Health Service Grant [GM33712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grant GM33712 (to T. Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; Drose S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Ohnishi T, 2010, NATURE, V465, P428, DOI 10.1038/465428a; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Sinha PK, 2012, J BIOL CHEM, V287, P17363, DOI 10.1074/jbc.M111.329649; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2012, J BIOL CHEM, V287, P42763, DOI 10.1074/jbc.M112.422824; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	54	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24705	24716		10.1074/jbc.M113.482968	http://dx.doi.org/10.1074/jbc.M113.482968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23864658	hybrid, Green Published			2022-12-28	WOS:000330612300037
J	Singh, PK; Sarwar, M; Maklashina, E; Kotlyar, V; Rajagukguk, S; Tomasiak, TM; Cecchini, G; Iverson, TM				Singh, Prashant K.; Sarwar, Maruf; Maklashina, Elena; Kotlyar, Violetta; Rajagukguk, Sany; Tomasiak, Thomas M.; Cecchini, Gary; Iverson, Tina M.			Plasticity of the Quinone-binding Site of the Complex II Homolog Quinol:Fumarate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI FUMARATE REDUCTASE; SUCCINATE-UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; CATALYTIC-ACTIVITY; ELECTRON-TRANSFER; MENAQUINONE; DEHYDROGENASE; PROTEINS; ORIENTATIONS; INHIBITORS	Respiratory processes often use quinone oxidoreduction to generate a transmembrane proton gradient, making the 2H(+)/2e(-) quinone chemistry important for ATP synthesis. There are a variety of quinones used as electron carriers between bioenergetic proteins, and some respiratory proteins can functionally interact with more than one quinone type. In the case of complex II homologs, which couple quinone chemistry to the inter-conversion of succinate and fumarate, the redox potentials of the biologically available ubiquinone and menaquinone aid in driving the chemical reaction in one direction. In the complex II homolog quinol: fumarate reductase, it has been demonstrated that menaquinol oxidation requires at least one proton shuttle, but many of the remaining mechanistic details of menaquinol oxidation are not fully understood, and little is known about ubiquinone reduction. In the current study, structural and computational studies suggest that the sequential removal of the two menaquinol protons may be accompanied by a rotation of the naphthoquinone ring to optimize the interaction with a second proton shuttling pathway. However, kinetic measurements of site-specific mutations of quinol: fumarate reductase variants show that ubiquinone reduction does not use the same pathway. Computational docking of ubiquinone followed by mutagenesis instead suggested redundant proton shuttles lining the ubiquinone-binding site or from direct transfer from solvent. These data show that the quinone-binding site provides an environment that allows multiple amino acid residues to participate in quinone oxidoreduction. This suggests that the quinone-binding site in complex II is inherently plastic and can robustly interact with different types of quinones.	[Singh, Prashant K.; Sarwar, Maruf; Tomasiak, Thomas M.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Maklashina, Elena; Kotlyar, Violetta; Rajagukguk, Sany; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Adm Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu; tina.iverson@vanderbilt.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086, R01GM079419, R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817.	Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2003, FEBS LETT, V545, P31, DOI 10.1016/S0014-5793(03)00390-9; Cheng VWT, 2008, BIOCHEMISTRY-US, V47, P9107, DOI 10.1021/bi801008e; Crofts A. R., 2013, BIOCH BIOPH IN PRESS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; HOLLANDER R, 1976, FEBS LETT, V72, P98, DOI 10.1016/0014-5793(76)80821-6; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Leger C, 2001, BIOCHEMISTRY-US, V40, P11234, DOI 10.1021/bi010889b; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Luna-Chavez C, 2000, PROTEIN EXPRES PURIF, V19, P188, DOI 10.1006/prep.2000.1238; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P1877, DOI 10.1016/j.bbabio.2010.02.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafa G, 2008, J BIOL CHEM, V283, P28169, DOI 10.1074/jbc.M804938200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 2007, BIOCHEMISTRY-US, V46, P8234, DOI 10.1021/bi7005256; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pokkuluri PR, 2002, BIOCHEMISTRY-US, V41, P5998, DOI 10.1021/bi0118963; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; Rothery RA, 1998, EUR J BIOCHEM, V254, P588, DOI 10.1046/j.1432-1327.1998.2540588.x; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; SMITH MW, 1983, J BACTERIOL, V154, P344, DOI 10.1128/JB.154.1.344-350.1983; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Tomasiak TM, 2011, J BIOL CHEM, V286, P3047, DOI 10.1074/jbc.M110.192849; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	45	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24293	24301		10.1074/jbc.M113.487082	http://dx.doi.org/10.1074/jbc.M113.487082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836905	Green Published, hybrid			2022-12-28	WOS:000330612300002
J	Jensen, MV; Haldeman, JM; Zhang, HT; Lu, DH; Huising, MO; Vale, WW; Hohmeier, HE; Rosenberg, P; Newgard, CB				Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Huising, Mark O.; Vale, Wylie W.; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.			Control of Voltage-gated Potassium Channel Kv2.2 Expression by Pyruvate-Isocitrate Cycling Regulates Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NMR ISOTOPOMER ANALYSIS; SENSITIVE K+ CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; ELECTRICAL-ACTIVITY; STATE DEPENDENCE; ISLETS; ANAPLEROSIS; ADENOVIRUS	Recent studies have shown that the pyruvate-isocitrate cycling pathway, involving the mitochondrial citrate/isocitrate carrier and the cytosolic NADP-dependent isocitrate dehydrogenase (ICDc), is involved in control of glucose-stimulated insulin secretion (GSIS). Here we demonstrate that pyruvate-isocitrate cycling regulates expression of the voltage-gated potassium channel family member Kv2.2 in islet b-cells. siRNA-mediated suppression of ICDc, citrate/isocitrate carrier, or Kv2.2 expression impaired GSIS, and the effect of ICDc knockdown was rescued by re-expression of Kv2.2. Moreover, chronic exposure of b-cells to elevated fatty acids, which impairs GSIS, resulted in decreased expression of Kv2.2. Surprisingly, knockdown of ICDc or Kv2.2 increased rather than decreased outward K+ current in the 832/13 b-cell line. Immunoprecipitation studies demonstrated interaction of Kv2.1 and Kv2.2, and co-overexpression of the two channels reduced outward K+ current compared with overexpression of Kv2.1 alone. Also, siRNA-mediated knockdown of ICDc enhanced the suppressive effect of the Kv2.1-selective inhibitor stromatoxin1 on K+ currents. Our data support a model in which a key function of the pyruvate-isocitrate cycle is to maintain levels of Kv2.2 expression sufficient to allow it to serve as a negative regulator of Kv channel activity.	[Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Inst Mol Physiol, Durham, NC 27704 USA; [Jensen, Mette V.; Haldeman, Jonathan M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; [Zhang, Hengtao; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; [Huising, Mark O.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn, Labs Peptide Biol, La Jolla, CA 92037 USA; [Huising, Mark O.] Salk Inst Biol Studies, Salk Ctr Nutr Genom, La Jolla, CA 92037 USA	Duke University; Duke University; Duke University; Duke University; Salk Institute; Salk Institute	Newgard, CB (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Independence Pk Facil, 4321 Med Pk Dr, Durham, NC 27704 USA.	chris.newgard@duke.edu	Huising, Mark O./H-3885-2019	Huising, Mark O./0000-0002-6594-2205; Rosenberg, Paul/0000-0002-5659-160X; Haldeman, Jonathan/0000-0002-8270-7039	National Institutes of Health [DK42583, DK026741]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK42583 (to C. B. N.) and DK026741 (to W. W. V. and M. O. H.). This work was also supported by the Juvenile Diabetes Research Foundation (to M. O. H.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, J BIOL CHEM, V269, P21234; Blaine JT, 1998, J NEUROSCI, V18, P9585; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Chouinard SW, 2000, RECEPTOR CHANNEL, V7, P237; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fink M, 1996, J BIOL CHEM, V271, P26341, DOI 10.1074/jbc.271.42.26341; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hermanstyne TO, 2010, J COMP NEUROL, V518, P4298, DOI 10.1002/cne.22457; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Li XY, 2013, IEEE T VIS COMPUT GR, V19, P344, DOI 10.1109/TVCG.2012.109; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MacDonald PE, 2003, J PHYSIOL-LONDON, V546, P647, DOI 10.1113/jphysiol.2002.035709; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Pedersen MG, 2010, BIOPHYS J, V99, P3200, DOI 10.1016/j.bpj.2010.09.004; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Sigalla J, 1997, HUM GENE THER, V8, P1625, DOI 10.1089/hum.1997.8.13-1625; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	68	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23128	23140		10.1074/jbc.M113.491654	http://dx.doi.org/10.1074/jbc.M113.491654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23788641	Green Published, hybrid			2022-12-28	WOS:000330598200020
J	Wang, XL; Yu, YYL; Myers, N; Hansen, TH				Wang, Xiaoli; Yu, Y. Y. Lawrence; Myers, Nancy; Hansen, Ted H.			Decoupling the Role of Ubiquitination for the Dislocation Versus Degradation of Major Histocompatibility Complex (MHC) Class I Proteins during Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; MEMBRANE-PROTEIN; HEAVY-CHAINS; MISFOLDED PROTEINS; ANTIGEN PRESENTATION; CYTOPLASMIC TAIL; QUALITY CONTROL; PEPTIDE; ATPASE; RETROTRANSLOCATION	Aberrantly or excessively expressed proteins in the endoplasmic reticulum are identified by quality control mechanisms and dislocated to the cytosol for proteasome-mediated, ubiquitin-dependent degradation by a process termed endoplasmic reticulum-associated degradation (ERAD). In addition to its role in degradation, ubiquitination has also been implicated in substrate dislocation, although whether direct ubiquitin conjugation of ERAD substrates is required for dislocation has been difficult to ascertain. An obstacle in probing the mechanism of quality control-induced ERAD is the paucity of ERAD substrates being dislocated and detected at any given time. To obviate this problem, we report here the use of a sensitive biotinylation system to probe the dislocation of major histocompatibility complex I (MHCI) heavy chain substrates in the absence of immune evasion proteins. Using this assay system the dislocation of MHCI heavy chains was found not to require potential ubiquitin conjugation sites in the cytoplasmic tail or Lys residues in the ectodomain. By contrast, dislocation of MHCI heavy chains did require deubiquitinating enzyme activity and rapid proteasome-mediated degradation required Lys residues in MHCI heavy chain ectodomain. These combined findings support the model that the endoplasmic reticulum quality control-induced dislocation of MHCI heavy chains may not require direct ubiquitination/deubiquitination as is required for proteasome-mediated degradation post dislocation.	[Wang, Xiaoli; Yu, Y. Y. Lawrence; Myers, Nancy; Hansen, Ted H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Wang, XL (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	xiwang@pathology.wustl.edu; hansen@pathology.wustl.edu			National Institutes of Health [AI019687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI019687.	Albring J, 2004, MOL IMMUNOL, V40, P733, DOI 10.1016/j.molimm.2003.08.008; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Burr Marian L, 2013, Methods Mol Biol, V960, P109, DOI 10.1007/978-1-62703-218-6_9; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Seiberlich V, 2012, BBA-MOL CELL RES, V1823, P2057, DOI 10.1016/j.bbamcr.2012.04.011; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tsai YC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001038; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	66	10	10	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23295	23306		10.1074/jbc.M113.482018	http://dx.doi.org/10.1074/jbc.M113.482018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801327	hybrid, Green Published			2022-12-28	WOS:000330598200035
J	Zhang, WJ; Zeng, FX; Liu, YW; Zhao, Y; Lv, H; Niu, LW; Teng, MK; Li, X				Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu			Crystal Structures and RNA-binding Properties of the RNA Recognition Motifs of Heterogeneous Nuclear Ribonucleoprotein L INSIGHTS INTO ITS ROLES IN ALTERNATIVE SPLICING REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS HNRNP L; MESSENGER-RNA; DOMAINS; GENE; PTB; TRANSLATION; REFINEMENT; ISOFORMS; ELEMENTS; EXPORT	Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is an abundant RNA-binding protein implicated in many bioprocesses, including pre-mRNA processing, mRNA export of intronless genes, internal ribosomal entry site-mediated translation, and chromatin modification. It contains four RNA recognition motifs (RRMs) that bind with CA repeats or CA-rich elements. In this study, surface plasmon resonance spectroscopy assays revealed that all four RRM domains contribute to RNA binding. Furthermore, we elucidated the crystal structures of hnRNP L RRM1 and RRM34 at 2.0 and 1.8 angstrom, respectively. These RRMs all adopt the typical beta 1 alpha 1 beta 2 beta 3 alpha 2 beta 4 topology, except for an unusual fifth beta-strand in RRM3. RRM3 and RRM4 interact intimately with each other mainly through helical surfaces, leading the two beta-sheets to face opposite directions. Structure-based mutations and surface plasmon resonance assay results suggested that the beta-sheets of RRM1 and RRM34 are accessible for RNA binding. FRET-based gel shift assays (FRET-EMSA) and steady-state FRET assays, together with cross-linking and dynamic light scattering assays, demonstrated that hnRNP L RRM34 facilitates RNA looping when binding to two appropriately separated binding sites within the same target pre-mRNA. EMSA and isothermal titration calorimetry binding studies with in vivo target RNA suggested that hnRNP L-mediated RNA looping may occur in vivo. Our study provides a mechanistic explanation for the dual functions of hnRNP L in alternative splicing regulation as an activator or repressor.	[Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Teng, MK (corresponding author), Univ Sci & Technol China, Sch Life Sci, Rm 419, Hefei 230026, Anhui, Peoples R China.	mkteng@ustc.edu.cn; sachem@ustc.edu.cn		Li, Xu/0000-0001-5221-0817; Zhang, Wenjuan/0000-0002-3011-9956	Chinese Ministry of Science and Technology [2012CB917200, 2009CB825500]; Chinese National Natural Science Foundation [31270014, 31130018, 30900224]; Science and Technological Fund of Anhui Province for Outstanding Youth Grant [10040606Y11]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province for Outstanding Youth Grant	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB917200 and 2009CB825500, Chinese National Natural Science Foundation Grants 31270014, 31130018, and 30900224, and Science and Technological Fund of Anhui Province for Outstanding Youth Grant 10040606Y11.	Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hamilton BJ, 1999, BIOCHEM BIOPH RES CO, V261, P646, DOI 10.1006/bbrc.1999.1040; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preussner M, 2012, NUCLEIC ACIDS RES, V40, P5666, DOI 10.1093/nar/gks221; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Rueda D, 2003, BIOCHEMISTRY-US, V42, P9924, DOI 10.1021/bi0347757; Rueda David, 2006, V335, P289; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Shenkerling G, 2010, J CLIN INVEST, V120, P3798, DOI 10.1172/JCI45037; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Skrisovska L, 2008, J MOL BIOL, V375, P151, DOI 10.1016/j.jmb.2007.09.030; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200	49	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22636	22649		10.1074/jbc.M113.463901	http://dx.doi.org/10.1074/jbc.M113.463901			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782695	Green Published, hybrid			2022-12-28	WOS:000330596300043
J	Rishavy, MA; Hallgren, KW; Wilson, LA; Usubalieva, A; Runge, KW; Berkner, KL				Rishavy, Mark A.; Hallgren, Kevin W.; Wilson, Lee A.; Usubalieva, Aisulu; Runge, Kurt W.; Berkner, Kathleen L.			The Vitamin K Oxidoreductase Is a Multimer That Efficiently Reduces Vitamin K Epoxide to Hydroquinone to Allow Vitamin K-dependent Protein Carboxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IX; BACTERIAL HOMOLOG; ACTIVE-SITE; FACTOR-X; REDUCTASE; MECHANISM; CELLS; INHIBITION; WARFARIN; IDENTIFICATION	The vitamin K oxidoreductase (VKORC1) recycles vitamin K to support the activation of vitamin K-dependent (VKD) proteins, which have diverse functions that include hemostasis and calcification. VKD proteins are activated by Glu carboxylation, which depends upon the oxygenation of vitamin K hydroquinone (KH2). The vitamin K epoxide (KO) product is recycled by two reactions, i.e. KO reduction to vitamin K quinone (K) and then to KH2, and recent studies have called into question whether VKORC1 reduces K to KH2. Analysis in insect cells lacking endogenous carboxylation components showed that r-VKORC1 reduces KO to efficiently drive carboxylation, indicating KH2 production. Direct detection of the vitamin K reaction products is confounded by KH2 oxidation, and we therefore developed a new assay that stabilized KH2 and allowed quantitation. Purified VKORC1 analyzed in this assay showed efficient KO to KH2 reduction. Studies in 293 cells expressing tagged r-VKORC1 revealed that VKORC1 is a multimer, most likely a dimer. A monomer can only perform one reaction, and a dimer is therefore interesting in explaining how VKORC1 accomplishes both reactions. An inactive mutant (VKORC1(C132A/C135A)) was dominant negative in heterodimers with wild type VKORC1, resulting in decreased KO reduction in cells and carboxylation in vitro. The results are significant regarding human VKORC1 mutations, as warfarin-resistant patients have mutant and wild type VKORC1 alleles. A VKORC1 dimer indicates a mixed population of homodimers and heterodimers that may have different functional properties, and VKORC1 reduction may therefore be more complex in these patients than appreciated previously.	[Rishavy, Mark A.; Hallgren, Kevin W.; Wilson, Lee A.; Usubalieva, Aisulu; Berkner, Kathleen L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Runge, Kurt W.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Berkner, KL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org	Runge, Kurt/AAW-9308-2021	Runge, Kurt/0000-0001-8492-0530; Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [RO1 81093]; American Heart Association [SDG 0735317N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081093, R01HL055666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 81093. This work was also supported by Grant SDG 0735317N from the American Heart Association.	Au N, 2008, DRUG METAB REV, V40, P355, DOI 10.1080/03602530801952187 ; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Berkner KL, 1998, P NATL ACAD SCI USA, V95, P466, DOI 10.1073/pnas.95.2.466; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Davidson KW, 1997, METHOD ENZYMOL, V282, P408; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; FASCO MJ, 1982, BIOCHEM BIOPH RES CO, V104, P187, DOI 10.1016/0006-291X(82)91957-X; Fieser LF, 1941, J BIOL CHEM, V137, P659; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2011, J BIOL CHEM, V286, P44821, DOI 10.1074/jbc.M111.249177; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; Sun YM, 2005, BLOOD, V106, P3811, DOI 10.1182/blood-2005-06-2495; Tie JK, 2012, J BIOL CHEM, V287, P33945, DOI 10.1074/jbc.M112.402941; Tie JK, 2012, ANTIOXID REDOX SIGN, V16, P329, DOI 10.1089/ars.2011.4043; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; Wajih N, 2005, J BIOL CHEM, V280, P10540, DOI 10.1074/jbc.M413982200; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003	35	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31556	31566		10.1074/jbc.M113.497297	http://dx.doi.org/10.1074/jbc.M113.497297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	23918929	hybrid, Green Published			2022-12-28	WOS:000330596200015
J	Havukainen, H; Munch, D; Baumann, A; Zhong, S; Halskau, O; Krogsgaard, M; Amdam, GV				Havukainen, Heli; Muench, Daniel; Baumann, Anne; Zhong, Shi; Halskau, Oyvind; Krogsgaard, Michelle; Amdam, Gro V.			Vitellogenin Recognizes Cell Damage through Membrane Binding and Shields Living Cells from Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN INITIATING DOMAIN; LOW-DENSITY-LIPOPROTEIN; HONEY-BEE WORKERS; APOLIPOPROTEIN-B; APOPTOTIC CELLS; OXIDATIVE STRESS; STRUCTURAL BASIS; PLASMA-MEMBRANE; APIS-MELLIFERA; PROTEIN	Large lipid transfer proteins are involved in lipid transportation and diverse other molecular processes. These serum proteins include vitellogenins, which are egg yolk precursors and pathogen pattern recognition receptors, and apolipoprotein B, which is an anti-inflammatory cholesterol carrier. In the honey bee, vitellogenin acts as an antioxidant, and elevated vitellogenin titer is linked to prolonged life span in this animal. Here, we show that vitellogenin has cell and membrane binding activity and that it binds preferentially to dead and damaged cells. Vitellogenin binds directly to phosphatidylcholine liposomes and with higher affinity to liposomes containing phosphatidylserine, a lipid of the inner leaflet of cell membranes that is exposed in damaged cells. Vitellogenin binding to live cells, furthermore, improves cell oxidative stress tolerance. This study can shed more light on why large lipid transfer proteins have a well conserved alpha-helical domain, because we locate the lipid bilayer-binding ability of vitellogenin largely to this region. We suggest that recognition of cell damage and oxidation shield properties are two mechanisms that allow vitellogenin to extend honey bee life span.	[Havukainen, Heli; Muench, Daniel; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Havukainen, Heli; Baumann, Anne] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Havukainen, Heli; Zhong, Shi; Krogsgaard, Michelle] NYU, Inst Canc, New York, NY 10016 USA; [Havukainen, Heli] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Havukainen, Heli; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Halskau, Oyvind] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway	Norwegian University of Life Sciences; University of Bergen; New York University; University of Helsinki; Arizona State University; Arizona State University-Tempe; University of Bergen	Havukainen, H (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	hohavukainen@gmail.com		Salmela, Heli/0000-0002-6917-2922; Halskau, Oyvind/0000-0003-2517-1060	National Institutes of Health, NIA [P01 AG22500]; Research Council of Norway [180504, 185306, 191699]; PEW Charitable Trust; Norwegian Cancer Society [58240001]; National Program for Research in Functional Genomics (FUGE); Norwegian Research Council; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Council of Norway(Research Council of Norway); PEW Charitable Trust; Norwegian Cancer Society(Norwegian Cancer Society); National Program for Research in Functional Genomics (FUGE); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant P01 AG22500. This work was also supported by Research Council of Norway Grants 180504, 185306, and 191699; the PEW Charitable Trust; and Norwegian Cancer Society Grant 58240001. The PROBE work was partly supported by the National Program for Research in Functional Genomics (FUGE) funded by the Norwegian Research Council.	Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; BERGER D, 1990, FEBS LETT, V277, P33, DOI 10.1016/0014-5793(90)80803-Q; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Campanella C, 2011, MOL REPROD DEV, V78, P161, DOI 10.1002/mrd.21282; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Cho NH, 2009, IMMUNOLOGY, V128, pe479, DOI 10.1111/j.1365-2567.2008.03002.x; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Cocca BA, 2001, P NATL ACAD SCI USA, V98, P13826, DOI 10.1073/pnas.241510698; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; FISCHER HD, 1980, J BIOL CHEM, V255, P5069; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gasparovic Ana Cipak, 2013, Methods Mol Biol, V965, P283, DOI 10.1007/978-1-62703-239-1_19; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Havukainen H, 2012, J EXP BIOL, V215, P1837, DOI 10.1242/jeb.065623; Havukainen H, 2011, MOL ECOL, V20, P5111, DOI 10.1111/j.1365-294X.2011.05351.x; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hayward A, 2010, FEBS LETT, V584, P1273, DOI 10.1016/j.febslet.2010.02.056; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kent CF, 2011, MOL ECOL, V20, P5226, DOI 10.1111/j.1365-294X.2011.05299.x; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Korb LC, 1997, J IMMUNOL, V158, P4525; Ledford AS, 2006, J BIOL CHEM, V281, P8871, DOI 10.1074/jbc.M507657200; Ledford AS, 2009, J LIPID RES, V50, P108, DOI 10.1194/jlr.M800324-JLR200; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Montaville P, 2002, J BIOL CHEM, V277, P24684, DOI 10.1074/jbc.M109595200; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; SIVARAM P, 1994, J BIOL CHEM, V269, P9409; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Tait JF, 2004, ANAL BIOCHEM, V329, P112, DOI 10.1016/j.ab.2004.02.043; Thapa A, 2008, BIOTECHNIQUES, V44, P787, DOI 10.2144/000112728; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tomkin GH, 2010, EXPERT REV CARDIOVAS, V8, P1015, DOI [10.1586/erc.10.45, 10.1586/ERC.10.45]; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tseng DY, 2001, COMP BIOCHEM PHYS A, V129, P909, DOI 10.1016/S1095-6433(01)00355-5; Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Villalba JM, 1997, MOL ASPECTS MED, V18, pS7; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	62	72	76	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28369	28381		10.1074/jbc.M113.465021	http://dx.doi.org/10.1074/jbc.M113.465021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897804	Green Published, hybrid			2022-12-28	WOS:000330612800065
J	Juenemann, K; Schipper-Krom, S; Wiemhoefer, A; Kloss, A; Sanz, AS; Reits, EAJ				Juenemann, Katrin; Schipper-Krom, Sabine; Wiemhoefer, Anne; Kloss, Alexander; Sanz, Alicia Sanz; Reits, Eric A. J.			Expanded Polyglutamine-containing N-terminal Huntingtin Fragments Are Entirely Degraded by Mammalian Proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; NEURONAL INTRANUCLEAR INCLUSIONS; TRIPEPTIDYL-PEPTIDASE-II; MUTANT HUNTINGTIN; AGGREGATE FORMATION; REG-ALPHA; HALF-LIFE; NEUROLOGICAL PHENOTYPE; DEPENDENT PROTEOLYSIS; PROTEIN AGGREGATION	Huntington disease is a neurodegenerative disorder caused by an expanded polyglutamine (polyQ) repeat within the protein huntingtin (Htt). N-terminal fragments of the mutant Htt (mHtt) proteins containing the polyQ repeat are aggregation-prone and form intracellular inclusion bodies. Improving the clearance of mHtt fragments by intracellular degradation pathways is relevant to obviate toxic mHtt species and subsequent neurodegeneration. Because the proteasomal degradation pathway has been the subject of controversy regarding the processing of expanded polyQ repeats, we examined whether the proteasome can efficiently degrade Htt-exon1 with an expanded polyQ stretch both in neuronal cells and in vitro. Upon targeting mHtt-exon1 to the proteasome, rapid and complete clearance of mHtt-exon1 was observed. Proteasomal degradation of mHtt-exon1 was devoid of polyQ peptides as partial cleavage products by incomplete proteolysis, indicating that mammalian proteasomes are capable of efficiently degrading expanded polyQ sequences without an inhibitory effect on the proteasomal activity.	[Juenemann, Katrin; Schipper-Krom, Sabine; Wiemhoefer, Anne; Sanz, Alicia Sanz; Reits, Eric A. J.] Univ Amsterdam, Acad Med Ctr, Dept Cellbiol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Kloss, Alexander] Charite, Inst Biochem CCM, D-10117 Berlin, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Juenemann, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cellbiol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	k.junemann@amc.uva.nl; e.a.reits@amc.uva.nl			Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW [91796315]; Prinses Beatrix Fonds Grant [W.OR10-25]; Hersenstichting Grant [KS2010(1)-06]	Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW; Prinses Beatrix Fonds Grant; Hersenstichting Grant	This work was supported by Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW, 91796315; by Prinses Beatrix Fonds Grant W.OR10-25; and by Hersenstichting Grant KS2010(1)-06.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bhutani N, 2007, EMBO J, V26, P1385, DOI 10.1038/sj.emboj.7601592; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; JOHNSON GD, 1990, ARCH BIOCHEM BIOPHYS, V276, P305, DOI 10.1016/0003-9861(90)90724-D; Johnston SC, 1997, PROTEIN SCI, V6, P2469; Juenemann K, 2011, NEUROTOX RES, V20, P120, DOI 10.1007/s12640-010-9227-6; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masson P, 2009, EUKARYOT CELL, V8, P844, DOI 10.1128/EC.00165-08; Menendez-Benito V, 2005, METHOD ENZYMOL, V399, P490, DOI 10.1016/S0076-6879(05)99034-4; Menzies FM, 2010, HUM MOL GENET, V19, P4573, DOI 10.1093/hmg/ddq385; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mo XY, 1999, J IMMUNOL, V163, P5851; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raspe M, 2009, J CELL SCI, V122, P3262, DOI 10.1242/jcs.045567; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rockel B, 2012, BBA-PROTEINS PROTEOM, V1824, P237, DOI 10.1016/j.bbapap.2011.07.002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zoeger A, 2006, CLIN CHEM, V52, P2079, DOI 10.1373/clinchem.2006.072496	82	51	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27068	27084		10.1074/jbc.M113.486076	http://dx.doi.org/10.1074/jbc.M113.486076			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908352	Green Published, hybrid			2022-12-28	WOS:000330597300008
J	Tsushima, Y; Nishizawa, H; Tochino, Y; Nakatsuji, H; Sekimoto, R; Nagao, H; Shirakura, T; Kato, K; Imaizumi, K; Takahashi, H; Tamura, M; Maeda, N; Funahashi, T; Shimomura, I				Tsushima, Yu; Nishizawa, Hitoshi; Tochino, Yoshihiro; Nakatsuji, Hideaki; Sekimoto, Ryohei; Nagao, Hirofumi; Shirakura, Takashi; Kato, Kenta; Imaizumi, Keiichiro; Takahashi, Hiroyuki; Tamura, Mizuho; Maeda, Norikazu; Funahashi, Tohru; Shimomura, Iichiro			Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL FAT ACCUMULATION; XANTHINE-OXIDOREDUCTASE; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; ADIPOCYTOKINE DYSREGULATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; IN-VIVO; HYPOXIA; RAT	Obesity is often accompanied by hyperuricemia. However, purine metabolism in various tissues, especially regarding uric acid production, has not been fully elucidated. Here we report, using mouse models, that adipose tissue could produce and secrete uric acid through xanthine oxidoreductase (XOR) and that the production was enhanced in obesity. Plasma uric acid was elevated in obese mice and attenuated by administration of the XOR inhibitor febuxostat. Adipose tissue was one of major organs that had abundant expression and activities of XOR, and adipose tissues in obese mice had higher XOR activities than those in control mice. 3T3-L1 and mouse primary mature adipocytes produced and secreted uric acid into culture medium. The secretion was inhibited by febuxostat in a dose-dependent manner or by gene knockdown of XOR. Surgical ischemia in adipose tissue increased local uric acid production and secretion via XOR, with a subsequent increase in circulating uric acid levels. Uric acid secretion from whole adipose tissue was increased in obese mice, and uric acid secretion from 3T3-L1 adipocytes was increased under hypoxia. Our results suggest that purine catabolism in adipose tissue could be enhanced in obesity.	[Tsushima, Yu; Nishizawa, Hitoshi; Tochino, Yoshihiro; Nakatsuji, Hideaki; Sekimoto, Ryohei; Nagao, Hirofumi; Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Tsushima, Yu; Shirakura, Takashi; Kato, Kenta; Takahashi, Hiroyuki; Tamura, Mizuho] Teijin Pharma Ltd, Teijin Inst Biomed Res, Hino, Tokyo 1918512, Japan; [Imaizumi, Keiichiro] Teijin Ltd, Kondo Lab, Hino, Tokyo 1918512, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan	Osaka University; Teijin Pharma Limited; Teijin Limited; Osaka University	Nishizawa, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan.	hitoshin1127@endmet.med.osaka-u.ac.jp			Kowa Co. Ltd.;  [24591351];  [22590979];  [22126008]	Kowa Co. Ltd.; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research (C) 24591351 (to H. N.) and 22590979 (to N. M.) and by Scientific Research on Innovative Areas Grant 22126008 (to T. F.). Tohru Funahashi is a member of the Department of Metabolism and Atherosclerosis, a sponsored course endowed by Kowa Co. Ltd. In this work, Osaka University's academia-industry collaboration policy positions the collaboration between Osaka University and Teijin Pharma Ltd.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; AOKI T, 1984, ANAL BIOCHEM, V143, P113, DOI 10.1016/0003-2697(84)90564-5; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Coutinho TD, 2007, AM J HYPERTENS, V20, P83, DOI 10.1016/j.amjhyper.2006.06.015; DELEYN P, 1993, AM J PHYSIOL, V264, pL329, DOI 10.1152/ajplung.1993.264.4.L329; Evrard PA, 1996, PHARMACEUT RES, V13, P12, DOI 10.1023/A:1016056628685; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goossens GH, 2012, CURR OPIN CLIN NUTR, V15, P539, DOI 10.1097/MCO.0b013e328358fa87; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hikita M, 2007, INTERNAL MED, V46, P1353, DOI 10.2169/internalmedicine.46.0045; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; KAMIIKE W, 1982, J BIOCHEM-TOKYO, V91, P1349, DOI 10.1093/oxfordjournals.jbchem.a133822; KATHER H, 1972, BIOCHEM J, V128, P1089, DOI 10.1042/bj1281089; KATHER H, 1990, J CLIN INVEST, V85, P106, DOI 10.1172/JCI114399; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Kim TH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-3; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; KUROSAKI M, 1995, BIOCHEM J, V306, P225, DOI 10.1042/bj3060225; LAZZARINO G, 1992, FREE RADICAL BIO MED, V13, P489, DOI 10.1016/0891-5849(92)90143-5; Leyva F, 1998, METABOLISM, V47, P657, DOI 10.1016/S0026-0495(98)90026-9; Lin Shi-Dou, 2006, J Chin Med Assoc, V69, P512; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tamba S, 2008, INTERNAL MED, V47, P1175, DOI 10.2169/internalmedicine.47.0603; TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1, DOI 10.5551/jat.E580; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; VANBILSEN M, 1989, AM J PHYSIOL, V257, pH47, DOI 10.1152/ajpheart.1989.257.1.H47; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wang G, 2008, INT J BIOCHEM CELL B, V40, P461, DOI 10.1016/j.biocel.2007.08.008; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; YAMASHITA S, 1986, INT J OBESITY, V10, P255; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; ZAGER RA, 1991, CIRC RES, V68, P185, DOI 10.1161/01.RES.68.1.185	55	202	214	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27138	27149		10.1074/jbc.M113.485094	http://dx.doi.org/10.1074/jbc.M113.485094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913681	hybrid, Green Published			2022-12-28	WOS:000330597300013
J	Grove, JI; Alandiyjany, MN; Delahay, RM				Grove, Jane I.; Alandiyjany, Maher N.; Delahay, Robin M.			Site-specific Relaxase Activity of a VirD2-like Protein Encoded within the tfs4 Genomic Island of Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV SECRETION SYSTEM; DNA TRANSFER; PLASTICITY REGION; DUODENAL-ULCER; CONJUGATIVE ELEMENTS; NICKING REACTION; SXT/R391 FAMILY; TRANSFER ORIT; MOBILIZATION; SEQUENCE	Four different type IV secretion systems are variously represented in the genomes of different Helicobacter pylori strains. Two of these, encoded by tfs3 and tfs4 gene clusters are contained within self-transmissible genomic islands. Although chromosomal excision of tfs4 circular intermediates is reported to be dependent upon the function of a tfs4-encoded XerD tyrosine-like recombinase, other factors required for transfer to a recipient cell have not been demonstrated. Here, we characterize the functional activity of a putative tfs4-encoded VirD2-like relaxase protein. Tfs4 VirD2 was purified as a fusion to maltose-binding protein and demonstrated to bind and nick both super-coiled duplex DNA and oligonucleotides in vitro in a manner dependent upon the presence of Mg2+ but independently of any auxiliary proteins. Unusually, concentration-dependent nicking of duplex DNA appeared to require only transient protein-DNA interaction. Although phylogenetically distinct from established relaxase families, site-specific cleavage of oligonucleotides by Tfs4 VirD2 required the nick region sequence 5'-ATC-CTG-3' common to transfer origins (oriT) recognized by MOBP conjugative relaxases. Cleavage resulted in covalent attachment of MBP-VirD2 to the 5'-cleaved end, consistent with conventional relaxase activity. Identification of an oriT-like sequence upstream of tfs4 virD2 and demonstration of VirD2 protein-protein interaction with a putative VirC1 relaxosome component indicate that transfer initiation of the tfs4 genomic island is analogous to mechanisms underlying mobilization of other integrated mobile elements, such as integrating conjugative elements, requiring site-specific targeting of relaxase activity to a cognate oriT sequence.	[Delahay, Robin M.] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Nottingham, Nottingham Digest Dis Ctr, Natl Inst Hlth Res, Biomed Res Unit, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Delahay, RM (corresponding author), Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England.	rob.delahay@nottingham.ac.uk		Delahay, Rob/0000-0002-7108-565X; Grove, Jane/0000-0002-9950-7201	Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit; Medical Research Council [G0901104]; MRC [G0901104] Funding Source: UKRI	Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was performed in facilities supported by the Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit and supported by Medical Research Council Grant G0901104 (to R. M. D.).	Aras RA, 2003, P NATL ACAD SCI USA, V100, P13579, DOI 10.1073/pnas.1735481100; Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Backert S, 2005, MICROBIOL-SGM, V151, P3493, DOI 10.1099/mic.0.28250-0; Backert S, 1998, MOL MICROBIOL, V30, P673, DOI 10.1046/j.1365-2958.1998.01086.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Ceccarelli D, 2008, J BACTERIOL, V190, P5328, DOI 10.1128/JB.00150-08; Daccord A, 2010, MOL MICROBIOL, V78, P576, DOI 10.1111/j.1365-2958.2010.07364.x; de Jonge R, 2004, FEMS IMMUNOL MED MIC, V41, P161, DOI 10.1016/j.femsim.2004.03.003; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; FURUYA N, 1991, J BACTERIOL, V173, P6612, DOI 10.1128/jb.173.20.6612-6617.1991; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Graham DY, 1998, HELICOBACTER, V3, P145, DOI 10.1046/j.1523-5378.1998.08031.x; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; James P, 1996, GENETICS, V144, P1425; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lee CA, 2007, J BACTERIOL, V189, P7254, DOI 10.1128/JB.00932-07; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; MATSON SW, 1991, J BIOL CHEM, V266, P16232; MATSON SW, 1993, J BACTERIOL, V175, P2599, DOI 10.1128/JB.175.9.2599-2606.1993; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pansegrau W, 1996, J BIOL CHEM, V271, P13068, DOI 10.1074/jbc.271.22.13068; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; PANSEGRAU W, 1990, P NATL ACAD SCI USA, V87, P6555, DOI 10.1073/pnas.87.17.6555; PANSEGRAU W, 1991, NUCLEIC ACIDS RES, V19, P3455, DOI 10.1093/nar/19.12.3455; Parker C, 2005, PLASMID, V53, P113, DOI 10.1016/j.plasmid.2004.12.007; Rocco JM, 2006, J BACTERIOL, V188, P2207, DOI 10.1128/JB.188.6.2207-2213.2006; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; SCHERZINGER E, 1992, NUCLEIC ACIDS RES, V20, P41, DOI 10.1093/nar/20.1.41; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Kregten M, 2009, MOL PLANT MICROBE IN, V22, P1356, DOI 10.1094/MPMI-22-11-1356; Vedantam G, 2006, MOL MICROBIOL, V59, P288, DOI 10.1111/j.1365-2958.2005.04934.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WATERS VL, 1991, P NATL ACAD SCI USA, V88, P1456, DOI 10.1073/pnas.88.4.1456; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	54	16	18	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26385	26396		10.1074/jbc.M113.496430	http://dx.doi.org/10.1074/jbc.M113.496430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900838	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000330594500004
J	Roth, BM; Ishimaru, D; Hennig, M				Roth, Braden M.; Ishimaru, Daniella; Hennig, Mirko			The Core Microprocessor Component DiGeorge Syndrome Critical Region 8 (DGCR8) Is a Nonspecific RNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS-SOLUTIONS; HYDROGEN-BONDS; HEAVY-WATER; WEB SERVER; IN-VITRO; RECOGNITION; MICRORNAS; VISCOSITY; DROSHA; DIFFUSION	MicroRNA (miRNA) biogenesis follows a conserved succession of processing steps, beginning with the recognition and liberation of an miRNA-containing precursor miRNA hairpin from a large primary miRNA transcript (pri-miRNA) by the Microprocessor, which consists of the nuclear RNase III Drosha and the double-stranded RNA-binding domain protein DGCR8 (DiGeorge syndrome critical region protein 8). Current models suggest that specific recognition is driven by DGCR8 detection of single-stranded elements of the pri-miRNA stem-loop followed by Drosha recruitment and pri-miRNA cleavage. Because count-less RNA transcripts feature single-stranded-dsRNA junctions and DGCR8 can bind hundreds of mRNAs, we explored correlations between RNA binding properties of DGCR8 and specific pri-miRNA substrate processing. We found that DGCR8 bound single-stranded, double-stranded, and random hairpin transcripts with similar affinity. Further investigation of DGCR8/pri-mir-16 interactions by NMR detected intermediate exchange regimes over a wide range of stoichiometric ratios. Diffusion analysis of DGCR8/pri-mir-16 interactions by pulsed field gradient NMR lent further support to dynamic complex formation involving free components in exchange with complexes of varying stoichiometry, although in vitro processing assays showed exclusive cleavage of pri-mir-16 variants bearing single-stranded flanking regions. Our results indicate that DGCR8 binds RNA nonspecifically. Therefore, a sequential model of DGCR8 recognition followed by Drosha recruitment is unlikely. Known RNA substrate requirements are broad and include 70-nucleotide hairpins with unpaired flanking regions. Thus, specific RNA processing is likely facilitated by preformed DGCR8-Drosha heterodimers that can discriminate between authentic substrates and other hairpins.	[Roth, Braden M.; Ishimaru, Daniella; Hennig, Mirko] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hennig, M (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 70 President St,POB 250509, Charleston, SC 29425 USA.	hennig@musc.edu	Roth, Braden/L-9386-2015	Roth, Braden/0000-0001-7559-7671	National Science Foundation [MCB 0845512, DBI 1126230]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB 0845512 and DBI 1126230 (to M. H.).	Arraiano CM, 2008, METHOD ENZYMOL, V447, P131, DOI 10.1016/S0076-6879(08)02208-8; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Corcoran MM, 2004, GENE CHROMOSOME CANC, V40, P285, DOI 10.1002/gcc.20046; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x; DORDICK R, 1979, J COLLOID INTERF SCI, V72, P206, DOI 10.1016/0021-9797(79)90102-4; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fernandes MX, 2001, J AM CHEM SOC, V123, P12037, DOI 10.1021/ja011361x; Goddard T.D., 2004, SPARKY 3; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hall KB, 1999, METH MOL B, V118, P105; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Han Kyungsook, 2002, Bioinformatics, V18 Suppl 1, pS321; Harris KR, 2004, J CHEM ENG DATA, V49, P1064, DOI 10.1021/je049918m; Jones G, 1929, J AM CHEM SOC, V51, P2950, DOI 10.1021/ja01385a012; KESTIN J, 1985, PHYSICA A, V134, P38, DOI 10.1016/0378-4371(85)90155-4; Koh HR, 2013, P NATL ACAD SCI USA, V110, P151, DOI 10.1073/pnas.1212917110; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee SJ, 2011, CURR OPIN STRUC BIOL, V21, P101, DOI 10.1016/j.sbi.2010.11.004; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; McCullough DF, 2010, BIOCHEM SOC T, V38, P1565, DOI 10.1042/BST0381565; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Rasia RM, 2010, BIOCHEMISTRY-US, V49, P8237, DOI 10.1021/bi100672x; Roth B. M., 2012, BIOMOL NMR IN PRESS; Roth B. M., 2011, RNA STRUCTURE DETERM, P205; Sambrook J, 1989, MOL CLONING, V3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SENEAR DF, 1986, BIOCHEMISTRY-US, V25, P7344, DOI 10.1021/bi00371a016; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Stefl R, 2006, STRUCTURE, V14, P345, DOI 10.1016/j.str.2005.11.013; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wittmann J, 2011, ANN RHEUM DIS, V70, pI92, DOI 10.1136/ard.2010.140152; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Wostenberg C, 2010, BIOPHYS J, V99, P248, DOI 10.1016/j.bpj.2010.04.010; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	31	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26785	26799		10.1074/jbc.M112.446880	http://dx.doi.org/10.1074/jbc.M112.446880			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23893406	hybrid, Green Published			2022-12-28	WOS:000330594500043
J	Shokolenko, IN; Fayzulin, RZ; Katyal, S; McKinnon, PJ; Wilson, GL; Alexeyev, MF				Shokolenko, Inna N.; Fayzulin, Rafik Z.; Katyal, Sachin; McKinnon, Peter J.; Wilson, Glenn L.; Alexeyev, Mikhail F.			Mitochondrial DNA Ligase Is Dispensable for the Viability of Cultured Cells but Essential for mtDNA Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 8-OXOGUANINE GLYCOSYLASE; OXIDATIVE STRESS; REPAIR CAPACITY; STRAND BREAKS; RINR-38 CELLS; DAMAGE; REPLICATION; EXPRESSION; PROTECTS; NUCLEAR	Multiple lines of evidence support the notion that DNA ligase III (LIG3), the only DNA ligase found in mitochondria, is essential for viability in both whole organisms and in cultured cells. Previous attempts to generate cells devoid of mitochondrial DNA ligase failed. Here, we report, for the first time, the derivation of viable LIG3-deficient mouse embryonic fibroblasts. These cells lack mtDNA and are auxotrophic for uridine and pyruvate, which may explain the apparent lethality of the Lig3 knock-out observed in cultured cells in previous studies. Cells with severely reduced expression of LIG3 maintain normal mtDNA copy number and respiration but show reduced viability in the face of alkylating and oxidative damage, increased mtDNA degradation in response to oxidative damage, and slow recovery from mtDNA depletion. Our findings clarify the cellular role of LIG3 and establish that the loss of viability in LIG3-deficient cells is conditional and secondary to the rho(0) phenotype.	[Shokolenko, Inna N.; Fayzulin, Rafik Z.; Wilson, Glenn L.; Alexeyev, Mikhail F.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Shokolenko, Inna N.] Univ S Alabama, Dept Biomed Sci, Mobile, AL 36688 USA; [Katyal, Sachin; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of South Alabama; University of South Alabama; St Jude Children's Research Hospital	Alexeyev, MF (corresponding author), Univ S Alabama, Dept Cell Biol & Neurosci, 5851 USA Dr North,MSB1201, Mobile, AL 36688 USA.	malexeye@southalabama.edu		Katyal, Sachin/0000-0002-7790-4054	National Institutes of Health [S10RR027535]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535, R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the excellent technical assistance by Victoriya Pastukh, Luanne Oliveira, and Larysa Yuzefovich. The purchase and operation of the Nikon A1R confocal system was supported by National Institutes of Health Grant S10RR027535.	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arakawa H, 2012, NUCLEIC ACIDS RES, V40, P2599, DOI 10.1093/nar/gkr1024; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Cai SB, 2005, CANCER RES, V65, P3319, DOI 10.1158/0008-5472.CAN-04-3335; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; DESJARDINS P, 1986, SOMAT CELL MOLEC GEN, V12, P133, DOI 10.1007/BF01560660; Dobson AW, 2000, J BIOL CHEM, V275, P37518, DOI 10.1074/jbc.M000831200; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042; Driggers WJ, 1997, NUCLEIC ACIDS RES, V25, P4362, DOI 10.1093/nar/25.21.4362; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Inoue K, 1997, J BIOL CHEM, V272, P15510, DOI 10.1074/jbc.272.24.15510; Katyal S, 2011, CELL CYCLE, V10, P2269, DOI 10.4161/cc.10.14.16495; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Okamaoto M, 2003, CURR GENET, V43, P364, DOI 10.1007/s00294-003-0393-4; Pallotti F., 2007, MITOCHONDRIA, P4; Pastukh V, 2008, MOL BIOL REP, V35, P215, DOI 10.1007/s11033-007-9073-7; Perez-Jannotti RM, 2001, J BIOL CHEM, V276, P48978, DOI 10.1074/jbc.M107177200; PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113; Poulton Joanna, 2009, Neuromuscul Disord, V19, P439, DOI 10.1016/j.nmd.2009.04.009; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rappa G, 2007, EUR J HAEMATOL, V78, P440, DOI 10.1111/j.1600-0609.2007.00833.x; Rime M, 2004, MOL CANCER THER, V3, P955; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; SEGALBENDIRDJIAN E, 1988, CANCER RES, V48, P4982; Shokolenko IN, 2003, DNA REPAIR, V2, P471, DOI 10.1016/S1568-7864(03)00019-3; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Simsek D, 2011, CELL CYCLE, V10, P3636, DOI 10.4161/cc.10.21.18094; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Storici F., 2011, DNA REPAIR PATHWAYS, P339; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	49	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26594	26605		10.1074/jbc.M113.472977	http://dx.doi.org/10.1074/jbc.M113.472977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23884459	Green Published, hybrid			2022-12-28	WOS:000330594500025
J	Norgan, AP; Davies, BA; Azmi, IF; Schroeder, AS; Payne, JA; Lynch, GM; Xu, ZH; Katzmann, DJ				Norgan, Andrew P.; Davies, Brian A.; Azmi, Ishara F.; Schroeder, Andreas S.; Payne, Johanna A.; Lynch, Gregory M.; Xu, Zhaohui; Katzmann, David J.			Relief of Autoinhibition Enhances Vta1 Activation of Vps4 via the Vps4 Stimulatory Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCRT-III; STRUCTURAL BASIS; MEMBRANE ASSOCIATION; ENDOSOMAL TRANSPORT; ATPASE ACTIVITY; PROTEIN; COMPLEX; RECOGNITION; DOMAIN; IST1	The endosomal sorting complexes required for transport (ESCRTs) impact multiple cellular processes including multivesicular body sorting, abscission, and viral budding. The AAA-ATPase Vps4 is required for ESCRT function, and its full activity is dependent upon the co-factor Vta1. The Vta1 carboxyl-terminal Vta1 SBP1 Lip5 (VSL) domain stimulates Vps4 function by facilitating oligomerization of Vps4 into its active state. Here we report the identification of the Vps4 stimulatory element (VSE) within Vta1 that is required for additional stimulation of Vps4 activity in vitro and in vivo. VSE activity is autoinhibited in a manner dependent upon the unstructured linker region joining the amino-terminal microtubule interacting and trafficking domains and the carboxyl-terminal VSL domain. The VSE is also required for Vta1-mediated Vps4 stimulation by ESCRT-III subunits Vps60 and Did2. These results suggest that ESCRT-III binding to the Vta1 microtubule interacting and trafficking domains relieves linker region autoinhibition of the VSE to produce maximal activation of Vps4 during ESCRT function.	[Norgan, Andrew P.; Davies, Brian A.; Azmi, Ishara F.; Schroeder, Andreas S.; Payne, Johanna A.; Lynch, Gregory M.; Katzmann, David J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Lynch, Gregory M.] Becker Middle Sch, Becker, MN 55308 USA; [Xu, Zhaohui] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Mayo Clinic; University of Michigan System; University of Michigan	Katzmann, DJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	katzmann.david@mayo.edu			National Institutes of Health [R01 GM73024]; National Institutes of Health F30 Predoctoral Fellowship [1F30DA26762]; American Heart Association [09PRE2220147]; Mayo Graduate School; Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769, R01GM073024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F30 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mayo Graduate School; Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM73024 (to A. P. N) and National Institutes of Health F30 Predoctoral Fellowship 1F30DA26762 (to A. P. N.). This work was also supported by American Heart Association Predoctoral Fellowship 09PRE2220147 (to A. P. N.), the Mayo Graduate School (to A. P. N.), and a Fraternal Order of the Eagles postdoctoral fellowship (to B. A. D.).	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2012, CELL, V151, P356, DOI 10.1016/j.cell.2012.08.039; Jouvenet N, 2012, CELL MOL LIFE SCI, V69, P4121, DOI 10.1007/s00018-012-1035-0; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Morita E, 2012, FEBS J, V279, P1399, DOI 10.1111/j.1742-4658.2012.08534.x; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schiel JA, 2013, TRENDS CELL BIOL, V23, P319, DOI 10.1016/j.tcb.2013.02.003; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Vajjhala PR, 2006, FEBS J, V273, P2357, DOI 10.1111/j.1742-4658.2006.05238.x; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang ZZ, 2013, BIOMOL NMR ASSIGN, V7, P331, DOI 10.1007/s12104-012-9439-1; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	55	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26147	26156		10.1074/jbc.M113.494112	http://dx.doi.org/10.1074/jbc.M113.494112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880759	Green Published, hybrid			2022-12-28	WOS:000330623300043
J	Canalis, E; Adams, DJ; Boskey, A; Parker, K; Kranz, L; Zanotti, S				Canalis, Ernesto; Adams, Douglas J.; Boskey, Adele; Parker, Kristen; Kranz, Lauren; Zanotti, Stefano			Notch Signaling in Osteocytes Differentially Regulates Cancellous and Cortical Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MUSCLE PARALYSIS; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; TRANSCRIPTION COMPLEXES; STRUCTURAL BASIS; EXPRESSION; OSTEOPROTEGERIN; CELLS; MICE	Notch receptors play a role in skeletal development and homeostasis, and Notch activation in undifferentiated and mature osteoblasts causes osteopenia. In contrast, Notch activation in osteocytes increases bone mass, but the mechanisms involved and exact functions of Notch are not known. In this study, Notch1 and -2 were inactivated preferentially in osteocytes by mating Notch1/2 conditional mice, where Notch alleles are flanked by loxP sequences, with transgenics expressing Cre directed by the Dmp1 (dentin matrix protein 1) promoter. Notch1/2 conditional null male and female mice exhibited an increase in trabecular bone volume due to an increase in osteoblasts and decrease in osteoclasts. In male null mice, this was followed by an increase in osteoclast number and normalization of bone volume. To activate Notch preferentially in osteocytes, Dmp1-Cre transgenics were crossed with Rosa(Notch) mice, where a loxP-flanked STOP cassette is placed between the Rosa26 promoter and Notch1 intracellular domain sequences. Dmp1-Cre(+/-); Rosa(Notch) mice exhibited an increase in trabecular bone volume due to decreased bone resorption and an increase in cortical bone due to increased bone formation. Biomechanical and chemical properties were not affected. Osteoprotegerin mRNA was increased, sclerostin and dickkopf1 mRNA were decreased, and Wnt signaling was enhanced in Dmp1-Cre(+/-); Rosa(Notch) femurs. Botulinum toxin A-induced muscle paralysis caused pronounced osteopenia in control mice, but bone mass was preserved in mice harboring the Notch activation in osteocytes. In conclusion, Notch plays a unique role in osteocytes, up-regulates osteoprotegerin and Wnt signaling, and differentially regulates trabecular and cortical bone homeostasis.	[Canalis, Ernesto; Parker, Kristen; Kranz, Lauren; Zanotti, Stefano] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Canalis, Ernesto; Zanotti, Stefano] Univ Connecticut, Sch Med, Farmington, CT 06030 USA; [Adams, Douglas J.] Univ Connecticut, Dept Orthoped Surg, Ctr Hlth, Farmington, CT 06030 USA; [Boskey, Adele] Hosp Special Surg, New York, NY 10021 USA	Saint Francis Hospital & Medical Center; University of Connecticut; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org		Boskey, Adele/0000-0002-6181-2219	National Institutes of Health Grant from NIDDK [DK045227]; National Institutes of Health Grant from NIAMS [AR063049]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIDDK; National Institutes of Health Grant from NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from NIDDK (to E. C.) and Grant AR063049 from NIAMS (to E. C.).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Blaustein JD, 2012, ENDOCRINOLOGY, V153, P2539, DOI 10.1210/en.2012-1365; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gourion-Arsiquaud S, 2013, J BONE MINER RES, V28, P150, DOI 10.1002/jbmr.1724; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; GROSS TS, 1995, J ORTHOPAED RES, V13, P708, DOI 10.1002/jor.1100130510; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Ominsky MS, 2009, J BONE MINER RES, V24, P1234, DOI [10.1359/JBMR.090215, 10.1359/jbmr.090215]; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RMR, 2002, J CELL BIOCHEM, V85, P252, DOI 10.1002/jcb.10125; Poliachik SL, 2010, BONE, V46, P18, DOI 10.1016/j.bone.2009.10.025; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sahlgren C, 2006, REGEN MED, V1, P195, DOI 10.2217/17460751.1.2.195; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; WAKLEY GK, 1992, AM J PHYSIOL, V263, pE1029; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2012, CALCIFIED TISSUE INT, V90, P69, DOI 10.1007/s00223-011-9541-x; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	69	73	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25614	25625		10.1074/jbc.M113.470492	http://dx.doi.org/10.1074/jbc.M113.470492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23884415	Green Published, hybrid			2022-12-28	WOS:000330619000056
J	Gadi, J; Jung, SH; Lee, MJ; Jami, A; Ruthala, K; Kim, KM; Cho, NH; Jung, HS; Kim, CH; Lim, SK				Gadi, Jogeswar; Jung, Seung-Hyun; Lee, Min-Jung; Jami, Ajita; Ruthala, Kalyani; Kim, Kyoung-Min; Cho, Nam-Hoon; Jung, Han-Sung; Kim, Cheol-Hee; Lim, Sung-Kil			The Transcription Factor Protein Sox11 Enhances Early Osteoblast Differentiation by Facilitating Proliferation and the Survival of Mesenchymal and Osteoblast Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; EXPRESSION PATTERNS; GENE-EXPRESSION; RUNX2; ZEBRAFISH; REPAIR; SUGGESTS; DEFECTS; THERAPY; OSTERIX	Sox11 deletion mice are known to exhibit developmental defects of craniofacial skeletal malformations, asplenia, and hypoplasia of the lung, stomach, and pancreas. Despite the importance of Sox11 in the developing skeleton, the role of Sox11 in osteogenesis has not been studied yet. In this study, we identified that Sox11 is an important transcription factor for regulating the proliferation and survival of osteoblast precursor cells as well as the self-renewal potency of mesenchymal progenitor cells via up-regulation of Tead2. Furthermore, Sox11 also plays an important role in the segregation of functional osteoblast lineage progenitors from osteochondrogenic progenitors. Facilitation of osteoblast differentiation from mesenchymal cells was achieved by enhanced expression of the osteoblast lineage specific transcription factors Runx2 and Osterix. Morpholino-targeted disruption of Sox11 in zebrafish impaired organogenesis, including the bones, which were under mineralized. These results indicated that Sox11 plays a crucial role in the proliferation and survival of mesenchymal and osteoblast precursors by Tead2, and osteogenic differentiation by regulating Runx2 and Osterix.	[Gadi, Jogeswar; Jami, Ajita; Kim, Kyoung-Min; Lim, Sung-Kil] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 120752, South Korea; [Gadi, Jogeswar; Jami, Ajita; Kim, Kyoung-Min; Lim, Sung-Kil] Yonsei Univ, Coll Med, Dept Internal Med, Endocrine Res Inst, Seoul 120752, South Korea; [Lee, Min-Jung; Jami, Ajita; Ruthala, Kalyani; Kim, Kyoung-Min; Lim, Sung-Kil] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Cho, Nam-Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea; [Ruthala, Kalyani] Yonsei Univ, Coll Med, Dept Anat, Embryol Lab, Seoul 120752, South Korea; [Jung, Seung-Hyun; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Lab Dev Genet, Taejon 305764, South Korea; [Lee, Min-Jung; Jung, Han-Sung] Yonsei Univ, Coll Dent, Res Ctr Orofacial Hard Tissue Regenerat, Div Anat & Dev Biol,Dept Oral Biol, Seoul 120752, South Korea; [Jung, Seung-Hyun] KIOM, Diabet Complicat Res Ctr, Div Tradit Korean Med TKM, Taejon 305811, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Yonsei University; Yonsei University Health System; Korea Institute of Oriental Medicine (KIOM)	Lim, SK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol, 50 Yonsei Ro, Seoul 120752, South Korea.	lsk@yuhs.ac	Jung, Han-Sung/I-3848-2012	Kim, Cheol-Hee/0000-0002-3019-0699; Jung, Han Sung/0000-0002-5563-7039; Jung, Han-Sung/0000-0003-2795-531X; jo, namhun/0000-0002-0045-6441	National Research Foundation of Korea (NRF) [20120000486]; Korean government (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) Grant No. 20120000486 funded by the Korean government (MEST).	Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024638; De Martino S, 2000, DEV DYNAM, V217, P279, DOI 10.1002/(SICI)1097-0177(200003)217:3<279::AID-DVDY6>3.0.CO;2-S; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Hargrave M, 1997, DEV DYNAM, V210, P79, DOI 10.1002/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6; Hartmann C, 2009, CURR OPIN GENET DEV, V19, P437, DOI 10.1016/j.gde.2009.09.001; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hauptmann G, 2000, METH MOL B, V137, P139; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park SJ, 2010, BONE, V46, P1498, DOI 10.1016/j.bone.2010.02.027; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209	32	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25400	25413		10.1074/jbc.M112.413377	http://dx.doi.org/10.1074/jbc.M112.413377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23888050	hybrid, Green Published			2022-12-28	WOS:000330619000037
J	Amako, Y; Igloi, Z; Mankouri, J; Kazlauskas, A; Saksela, K; Dallas, M; Peers, C; Harris, M				Amako, Yutaka; Igloi, Zsofia; Mankouri, Jamel; Kazlauskas, Arunas; Saksela, Kalle; Dallas, Mark; Peers, Chris; Harris, Mark			Hepatitis C Virus NS5A Inhibits Mixed Lineage Kinase 3 to Block Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; BETA-CATENIN; SRC-HOMOLOGY-3 DOMAIN; POTASSIUM CURRENTS; CORE PROTEIN; PHOSPHORYLATION; STRESS; IDENTIFICATION; REPLICATION; ACTIVATION	Hepatitis C virus (HCV) infection results in the activation of numerous stress responses including oxidative stress, with the potential to induce an apoptotic state. Previously we have shown that HCV attenuates the stress-induced, p38MAPK-mediated up-regulation of the K+ channel Kv2.1, to maintain the survival of infected cells in the face of cellular stress. We demonstrated that this effect was mediated by HCV non-structural 5A (NS5A) protein, which impaired p38MAPK activity through a polyproline motif-dependent interaction, resulting in reduction of phosphorylation activation of Kv2.1. In this study, we investigated the host cell proteins targeted by NS5A to mediate Kv2.1 inhibition. We screened a phage-display library expressing the entire complement of human SH3 domains for novel NS5A-host cell interactions. This analysis identified mixed lineage kinase 3 (MLK3) as a putative NS5A interacting partner. MLK3 is a serine/threonine protein kinase that is a member of the MAPK kinase kinase (MAP3K) family and activates p38MAPK. An NS5A-MLK3 interaction was confirmed by co-immunoprecipitation and Western blot analysis. We further demonstrate a novel role of MLK3 in the modulation of Kv2.1 activity, whereby MLK3 overexpression leads to the up-regulation of channel activity. Accordingly, coexpression of NS5A suppressed this stimulation. Additionally we demonstrate that overexpression of MLK3 induced apoptosis, which was also counteracted by NS5A. We conclude that NS5A targets MLK3 with multiple downstream consequences for both apoptosis and K+ homeostasis.	[Amako, Yutaka; Igloi, Zsofia; Mankouri, Jamel; Harris, Mark] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Dallas, Mark; Peers, Chris] Univ Leeds, Div Cardiovasc & Diabet Res, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Kazlauskas, Arunas; Saksela, Kalle] Univ Helsinki, Cent Hosp, Haartman Inst, Dept Virol, FI-00014 Helsinki, Finland; [Kazlauskas, Arunas; Saksela, Kalle] HUSLAB, FI-00014 Helsinki, Finland	University of Leeds; University of Leeds; University of Helsinki; Helsinki University Central Hospital	Harris, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	m.harris@leeds.ac.uk	Dallas, Mark/Q-6117-2019; Dallas, Mark L/A-6654-2013	Dallas, Mark/0000-0002-5190-0522; Harris, Mark/0000-0002-9821-1003; Peers, Chris/0000-0002-8354-346X; Saksela, Kalle/0000-0003-0827-122X; Mankouri, Jamel/0000-0002-4325-3687	Wellcome Trust [090805]; Marie Curie Career Integration Grant from the European Commission [304072 HCVFAO FP7-PEOPLE-2011-CIG]	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Career Integration Grant from the European Commission	This study was supported by a grant (to M. H. and C. P.) from the Wellcome Trust (Grant Number 090805).; Recipient of a Marie Curie Career Integration Grant (304072 HCVFAO FP7-PEOPLE-2011-CIG) from the European Commission.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; GALLO KA, 1994, J BIOL CHEM, V269, P15092; He Y, 2006, HEPATITIS C VIRUSES; Higgs MR, 2013, ONCOGENE, V32, P4683, DOI 10.1038/onc.2012.484; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Humphrey RK, 2013, J BIOL CHEM, V288, P2428, DOI 10.1074/jbc.M112.425884; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kim KY, 2004, J BIOL CHEM, V279, P29478, DOI 10.1074/jbc.M313947200; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Milward A, 2010, J GEN VIROL, V91, P373, DOI 10.1099/vir.0.015305-0; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Norris CA, 2012, J NEUROSCI, V32, P8865, DOI 10.1523/JNEUROSCI.0937-12.2012; Pal S, 2003, J NEUROSCI, V23, P4798; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tang RX, 2012, WORLD J GASTROENTERO, V18, P1485, DOI 10.3748/wjg.v18.i13.1485; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Thylur RP, 2011, J BIOL CHEM, V286, P37470, DOI 10.1074/jbc.M111.298943; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	46	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24753	24763		10.1074/jbc.M113.491985	http://dx.doi.org/10.1074/jbc.M113.491985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23857585	Green Published, hybrid			2022-12-28	WOS:000330612300041
J	Kimura, M; Okumura, N; Kose, S; Takao, T; Imamoto, N				Kimura, Makoto; Okumura, Nobuaki; Kose, Shingo; Takao, Toshifumi; Imamoto, Naoko			Identification of Cargo Proteins Specific for Importin-beta with Importin-alpha Applying a Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based in Vitro Transport System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; PORE-TARGETING COMPLEX; CAP-BINDING COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; QUANTITATIVE PROTEOMICS; MAMMALIAN-CELLS; SEQUENCE; EXPORT; EXPRESSION; RECEPTORS	The human importin (Imp)-beta family consists of 21 nucleocytoplasmic transport carrier proteins, which transport thousands of proteins (cargoes) across the nuclear envelope through nuclear pores in specific directions. To understand the nucleocytoplasmic transport in a physiological context, the specificity of cargoes for their cognate carriers should be determined; however, only a limited number of nuclear proteins have been linked to specific carriers. To address this biological question, we recently developed a novel method to identify carrier-specific cargoes. This method includes the following three steps: (i) the cells are labeled by stable isotope labeling by amino acids in cell culture (SILAC); (ii) the labeled cells are permeabilized, and proteins in the unlabeled cell extracts are transported into the nuclei of the permeabilized cells by a particular carrier; and (iii) the proteins in the nuclei are quantitatively identified by LCMS/MS. The effectiveness of this method was demonstrated by the identification of transportin (Trn)-specific cargoes. Here, we applied this method to identify cargo proteins specific for Imp-beta, which is a predominant carrier that exclusively utilizes Imp-alpha as an adapter for cargo binding. We identified candidate cargoes, which included previously reported and potentially novel Imp-beta cargoes. In in vitro binding assays, most of the candidate cargoes bound to Imp-alpha in one of three binding modes: directly, via Imp-alpha, or via other cargoes. Thus, our method is effective for identifying a variety of Imp-beta cargoes. The identified Imp-beta and Trn cargoes were compared, ensuring the carrier specificity of the method and illustrating the complexity of these transport pathways.	[Kimura, Makoto; Kose, Shingo; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Okumura, Nobuaki] Osaka Univ, Inst Prot Res, Lab Homeostat Integrat, Suita, Osaka 5650871, Japan; [Takao, Toshifumi] Osaka Univ, Inst Prot Res, Lab Prot Profiling & Funct Prote, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; Osaka University	Kimura, M (corresponding author), RIKEN, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	makimura@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022; Kimura, Makoto/0000-0003-0868-5334	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Grants-in-Aid for Scientific Research [23570164] Funding Source: KAKEN	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the RIKEN Special Project Funding for Basic Science in Cellular System Project Research and the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)," which was initiated by the Council for Science and Technology Policy (CSTP) (to N. I.).	Antoine M, 2005, BIOCHEM BIOPH RES CO, V335, P146, DOI 10.1016/j.bbrc.2005.07.069; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; Blazek E, 2006, PROTEOMICS, V6, P2070, DOI 10.1002/pmic.200500449; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chou CW, 2010, FEBS LETT, V584, P4151, DOI 10.1016/j.febslet.2010.08.044; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Hieda M, 2001, J BIOL CHEM, V276, P16824, DOI 10.1074/jbc.M008299200; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Huang JG, 2010, GENE, V451, P38, DOI 10.1016/j.gene.2009.11.009; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kimura M, 2013, MOL CELL PROTEOMICS, V12, P145, DOI 10.1074/mcp.M112.019414; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Koike M, 1999, ONCOGENE, V18, P7495, DOI 10.1038/sj.onc.1203247; Koike M, 1999, EXP CELL RES, V250, P401, DOI 10.1006/excr.1999.4507; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsubae M, 2000, FEBS LETT, V468, P171, DOI 10.1016/S0014-5793(00)01218-7; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P6572, DOI 10.1073/pnas.93.13.6572; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038990; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Sato M, 2011, J COMP NEUROL, V519, P1770, DOI 10.1002/cne.22600; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Wang CI, 2012, MOL CELL PROTEOMICS, V11, P1105, DOI 10.1074/mcp.M111.016592; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	60	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24540	24549		10.1074/jbc.M113.489286	http://dx.doi.org/10.1074/jbc.M113.489286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846694	hybrid, Green Published			2022-12-28	WOS:000330612300022
J	Yan, R; Konarev, PV; Iannuzzi, C; Adinolfi, S; Roche, B; Kelly, G; Simon, L; Martin, SR; Py, B; Barras, F; Svergun, DI; Pastore, A				Yan, Robert; Konarev, Petr V.; Iannuzzi, Clara; Adinolfi, Salvatore; Roche, Beatrice; Kelly, Geoff; Simon, Lea; Martin, Stephen R.; Py, Beatrice; Barras, Frederic; Svergun, Dmitri I.; Pastore, Annalisa			Ferredoxin Competes with Bacterial Frataxin in Binding to the Desulfurase IscS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE; ELECTRON-TRANSFER; BIOLOGICAL MACROMOLECULES; ADRENODOXIN REDUCTASE; SOLUTION SCATTERING; BOVINE ADRENODOXIN; CLUSTER FORMATION; CRYSTAL-STRUCTURE; 4FE-4S CLUSTERS; 2FE-2S CLUSTER	The bacterial iron-sulfur cluster (isc) operon is an essential machine that is highly conserved from bacteria to primates and responsible for iron-sulfur cluster biogenesis. Among its components are the genes for the desulfurase IscS that provides sulfur for cluster formation, and a specialized ferredoxin (Fdx) whose role is still unknown. Preliminary evidence suggests that IscS and Fdx interact but nothing is known about the binding site and the role of the interaction. Here, we have characterized the interaction using a combination of biophysical tools and mutagenesis. By modeling the Fdx.IscS complex based on experimental restraints we show that Fdx competes for the binding site of CyaY, the bacterial ortholog of frataxin and sits in a cavity close to the enzyme active site. By in vivo mutagenesis in bacteria we prove the importance of the surface of interaction for cluster formation. Our data provide the first structural insights into the role of Fdx in cluster assembly.	[Yan, Robert; Iannuzzi, Clara; Adinolfi, Salvatore; Kelly, Geoff; Simon, Lea; Martin, Stephen R.; Pastore, Annalisa] MRC Natl Inst Med Res, London NW7 1AA, England; [Konarev, Petr V.; Svergun, Dmitri I.] DESY, EMBL, D-22603 Hamburg, Germany; [Roche, Beatrice; Py, Beatrice; Barras, Frederic] Aix Marseille Univ, F-13009 Marseille, France; [Py, Beatrice; Barras, Frederic] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, UMR 7283, F-13009 Marseille, France	MRC National Institute for Medical Research; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Pastore, A (corresponding author), MRC Natl Inst Med Res, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	Yan, Robert/GYU-0395-2022; Konarev, Petr V/W-1380-2017	Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696; ADINOLFI, Salvatore/0000-0003-1319-5516; Barras, Frederic/0000-0003-3458-2574; IANNUZZI, Clara/0000-0003-0092-5997	Medical Research Council; European Union EFACTS consortium; Medical Research Council [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887, MC_PC_13054] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union EFACTS consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Medical Research Council and the European Union EFACTS consortium.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Heinz A, 2005, BIOCHEM BIOPH RES CO, V338, P491, DOI 10.1016/j.bbrc.2005.08.077; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Muller EC, 2001, EUR J BIOCHEM, V268, P1837, DOI 10.1046/j.1432-1327.2001.02058.x; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	48	59	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24777	24787		10.1074/jbc.M113.480327	http://dx.doi.org/10.1074/jbc.M113.480327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839945	Green Published, hybrid			2022-12-28	WOS:000330612300043
J	Byeon, B; Wang, W; Barski, A; Ranallo, RT; Bao, K; Schones, DE; Zhao, KJ; Wu, C; Wu, WH				Byeon, Boseon; Wang, Wei; Barski, Artem; Ranallo, Ryan T.; Bao, Kan; Schones, Dustin E.; Zhao, Keji; Wu, Carl; Wu, Wei-Hua			The ATP-dependent Chromatin Remodeling Enzyme Fun30 Represses Transcription by Sliding Promoter-proximal Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H2A.Z; FREE REGIONS; DNA; COMPLEX; YEAST; FAMILY; POSITIONS; BIOLOGY; GENES	The evolutionarily conserved ATP-dependent chromatin remodeling enzyme Fun30 has recently been shown to play important roles in heterochromatin silencing and DNA repair. However, how Fun30 remodels nucleosomes is not clear. Here we report a nucleosome sliding activity of Fun30 and its role in transcriptional repression. We observed that Fun30 repressed the expression of genes involved in amino acid and carbohydrate metabolism, the stress response, and meiosis. In addition, Fun30 was localized at the 5' and 3' ends of genes and within the open reading frames of its targets. Consistent with its role in gene repression, we observed that Fun30 target genes lacked histone modifications often associated with gene activation and showed an increased level of ubiquitinated histone H2B. Furthermore, a genome-wide nucleosome mapping analysis revealed that the length of the nucleosome-free region at the 5' end of a subset of genes was changed in Fun30-depleted cells. In addition, the positions of the -1, +2, and +3 nucleosomes at the 5' end of target genes were shifted significantly, whereas the position of the +1 nucleosome remained largely unchanged in the fun30 Delta mutant. Finally, we demonstrated that affinity-purified, single-component Fun30 exhibited a nucleosome sliding activity in an ATP-dependent manner. These results define a role for Fun30 in the regulation of transcription and indicate that Fun30 remodels chromatin at the 5' end of genes by sliding promoter-proximal nucleosomes.	[Byeon, Boseon; Wang, Wei; Bao, Kan; Wu, Wei-Hua] Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Barski, Artem; Schones, Dustin E.; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Ranallo, Ryan T.; Wu, Carl; Wu, Wei-Hua] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, WH (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, CA-3012,1462 Laney Walker Blvd, Augusta, GA 30912 USA.	wwu@gru.edu		Barski, Artem/0000-0002-1861-5316	NHLBI National Institutes of Health; NCI National Institutes of Health [1K22CA122453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI National Institutes of Health intramural research support (to K. Z.), NCI National Institutes of Health intramural research support (to C. W.), and NCI National Institutes of Health Grant 1K22CA122453 (to W.-H. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen KF, 2013, GENOME RES, V23, P312, DOI 10.1101/gr.141952.112; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CLARK MW, 1992, YEAST, V8, P133, DOI 10.1002/yea.320080208; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Cristianini N, 2007, INTRODUCTION TO COMPUTATIONAL GENOMICS: A CASE STUDIES APPROACH, P38; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durand-Dubief M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002974; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Jansen A, 2011, MICROBIOL MOL BIOL R, V75, P301, DOI 10.1128/MMBR.00046-10; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mizuguchi G, 2012, METHOD ENZYMOL, V512, P275, DOI 10.1016/B978-0-12-391940-3.00012-3; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2010, ESSAYS BIOCHEM, V48, P75, DOI [10.1042/bse0480075, 10.1042/BSE0480075]; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thoma F, 1996, METHOD ENZYMOL, V274, P197; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	62	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23182	23193		10.1074/jbc.M113.471979	http://dx.doi.org/10.1074/jbc.M113.471979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23779104	Green Published, hybrid			2022-12-28	WOS:000330598200025
J	Choi, J; Lin, A; Shrier, E; Lau, LF; Grant, MB; Chaqour, B				Choi, Jinok; Lin, Ann; Shrier, Eric; Lau, Lester F.; Grant, Maria B.; Chaqour, Brahim			Degradome Products of the Matricellular Protein CCN1 as Modulators of Pathological Angiogenesis in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-INDUCED RETINOPATHY; GENE-EXPRESSION; ENDOTHELIAL-CELLS; ADHESION RECEPTOR; CYR61 CCN1; FAMILY; IDENTIFICATION; MUSCLE; ALPHA(6)BETA(1); MECHANISMS	CCN1 is a matricellular protein involved in normal vascular development and tissue repair. CCN1 exhibits cell-and context-dependent activities that are reflective of its tetramodular structure phylogenetically linked to four domains found in various matrix proteins. Here, we show that vitreal fluids from patients with proliferative diabetic retinopathy (PDR) were enriched with a two-module form of CCN1 comprising completely or partially the insulin-like growth factor-binding protein (IGFBP) and von Willebrand factor type C (vWC) domains. The two-and three-module forms comprising, in addition to IGFBP and vWC, the thrombospondin type 1 (TSP1) repeats are CCN1 degradome products by matrix metalloproteinase-2 and -14. The functional significance of CCN1 and its truncated variants was determined in the mouse model of oxygen-induced retinopathy, which simulates neovascular growth associated with PDR and assesses treatment outcomes. In this model, lentivirus-mediated expression of either CCN1 or the IGFBP-vWC-TSP1 form reduced ischemia-induced neovascularization, whereas ectopic expression of the IGFBP-vWC variant exacerbated pathological angiogenesis. The IGFBP-vWC form has potent proangiogenic properties promoting retinal endothelial cell growth, migration, and three-dimensional tubular structure formation, whereas the IGFBP-vWC-TSP1 variant suppressed cell growth and angiogenic gene expression. Both IGFBP-vWC and IGFBP-vWC-TSP1 forms exhibited predictable variations of their domain folding that enhanced their functional potential. These data provide new insights into the formation and activities of CCN1-truncated variants and raise the predictive value of the form containing completely or partially the IGFBP and vWC domains as a surrogate marker of CCN1 activity in PDR distinguishing pathological from physiological angiogenesis.	[Choi, Jinok; Lin, Ann; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Shrier, Eric; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Shrier, Eric/AAA-3869-2020; Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lau, Lester/0000-0002-4364-2914	National Institutes of Health from NEI [EY022091-01, EY019387 -01A1, EY01260-12, EY007739-23]; NATIONAL EYE INSTITUTE [R01EY007739, R01EY022091, R29EY007739, R21EY019387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022091-01 and EY019387 -01A1 (to B. C.) and EY01260-12 and EY007739-23 from NEI (to M. B. G.).	Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Boosani CS, 2011, PHARMACEUTICALS, V4, P1551, DOI 10.3390/ph4121551; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; Huwiler KG, 2002, BIOCHEMISTRY-US, V41, P14329, DOI 10.1021/bi026463u; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; MacKenzie TC, 2002, MOL THER, V6, P349, DOI 10.1006/mthe.2002.0681; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pendurthi UR, 2005, CANCER RES, V65, P9705, DOI 10.1158/0008-5472.CAN-05-0982; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHLINGEMANN RO, 1991, AM J PATHOL, V138, P1335; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Wang H, 2013, EXP EYE RES, V108, P110, DOI 10.1016/j.exer.2012.11.023; Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6; Zhang X, 2012, GRAEF ARCH CLIN EXP, V250, P661, DOI 10.1007/s00417-011-1882-7; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	59	25	27	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23075	23089		10.1074/jbc.M113.475418	http://dx.doi.org/10.1074/jbc.M113.475418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798676	Green Published, hybrid			2022-12-28	WOS:000330598200016
J	Schlam, D; Bohdanowicz, M; Chatilialoglu, A; Steinberg, BE; Ueyama, T; Du, GW; Grinstein, S; Fairn, GD				Schlam, Daniel; Bohdanowicz, Michal; Chatilialoglu, Alexandros; Steinberg, Benjamin E.; Ueyama, Takehiko; Du, Guangwei; Grinstein, Sergio; Fairn, Gregory D.			Diacylglycerol Kinases Terminate Diacylglycerol Signaling during the Respiratory Burst Leading to Heterogeneous Phagosomal NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PROTEIN-KINASE; PLASMA-MEMBRANE; GAMMA; PHOSPHORYLATION; P47(PHOX); DYNAMICS; BINDING; SYSTEM; METABOLISM	It is commonly assumed that all phagosomes have identical molecular composition. This assumption has remained largely unchallenged due to a paucity of methods to distinguish individual phagosomes. We devised an assay that extends the utility of nitro blue tetrazolium for detection and quantification of NAPDH oxidase (NOX) activity in individual phagosomes. Implementation of this assay revealed that in murine macrophages there is heterogeneity in the ability of individual phagosomes to generate superoxide, both between and within cells. To elucidate the molecular basis of the variability in NOX activation, we employed genetically encoded fluorescent biosensors to evaluate the uniformity in the distribution of phospholipid mediators of the oxidative response. Despite variability in superoxide generation, the distribution of phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-phosphate, and phosphatidic acid was nearly identical in all phagosomes. In contrast, diacylglycerol (DAG) was not generated uniformly across the phagosomal population, varying in a manner that directly mirrored superoxide production. Modulation of DAG levels suggested that NOX activation is precluded when phagosomes fail to reach a critical DAG concentration. In particular, forced expression of diacylglycerol kinase beta abrogated DAG accumulation at the phagosome, leading to impaired respiratory burst. Conversely, pharmacological inhibition of DAG kinases or expression of an inactive diacylglycerol kinase beta mutant increased the proportion of DAG-positive phagosomes, concomitantly potentiating phagosomal NOX activity. Our data suggest that diacylglycerol kinases limit the extent of NADPH oxidase activation, curtailing the production of potentially harmful reactive oxygen species. The resulting heterogeneity in phagosome responsiveness could enable the survival of a fraction of invading microorganisms.	[Schlam, Daniel; Bohdanowicz, Michal; Chatilialoglu, Alexandros; Steinberg, Benjamin E.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Schlam, Daniel; Bohdanowicz, Michal; Grinstein, Sergio] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Ueyama, Takehiko] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Fairn, Gregory D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Fairn, Gregory D.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kobe University; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Fairn, GD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 209 Victoria St, Toronto, ON M5B 1W8, Canada.	fairng@smh.ca		Fairn, Greg/0000-0001-6508-168X; Du, Guangwei/0000-0003-4193-6975	Cystic Fibrosis Canada; Canadian Institutes for Health Research [MOP7075, MOP93634]; St. Michael's Hospital New Investigator Fund; Canadian Institutes of Health Research	Cystic Fibrosis Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); St. Michael's Hospital New Investigator Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Cystic Fibrosis Canada, Canadian Institutes for Health Research Grants MOP7075 and MOP93634, and St. Michael's Hospital New Investigator Fund (to G. D. F.).; Supported by an M.D./Ph.D. scholarship from the Canadian Institutes of Health Research.	Afzal M, 2003, BIOCHEM BIOPH RES CO, V304, P619, DOI 10.1016/S0006-291X(03)00641-7; Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; BAEHNER RL, 1968, NEW ENGL J MED, V278, P971, DOI 10.1056/NEJM196805022781801; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Check J, 2010, MOL IMMUNOL, V47, P756, DOI 10.1016/j.molimm.2009.10.012; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; DIGREGORIO KA, 1987, AM J PHYSIOL, V252, pC677, DOI 10.1152/ajpcell.1987.252.6.C677; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Flannagan RS, 2010, METHODS MOL BIOL, V591, P121, DOI 10.1007/978-1-60761-404-3_7; Goebel WS, 2002, J PEDIAT HEMATOL ONC, V24, P787, DOI 10.1097/00043426-200212000-00026; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PERRY DK, 1992, J IMMUNOL, V149, P2749; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shindo M, 2003, J BIOL CHEM, V278, P18448, DOI 10.1074/jbc.M300400200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; TYAGI SR, 1992, INFECT IMMUN, V60, P2481, DOI 10.1128/IAI.60.6.2481-2487.1992; Ueyama T, 2004, J IMMUNOL, V173, P4582, DOI 10.4049/jimmunol.173.7.4582; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wattenberg BW, 2007, SCI STKE, pe43; WHITE JR, 1989, AGENTS ACTIONS, V27, P410, DOI 10.1007/BF01972837; Yaffe MB, 2002, STRUCTURE, V10, P1288, DOI 10.1016/S0969-2126(02)00860-2; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	48	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23090	23104		10.1074/jbc.M113.457606	http://dx.doi.org/10.1074/jbc.M113.457606			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814057	Green Published, hybrid			2022-12-28	WOS:000330598200017
J	Bournier, M; Tissot, N; Mari, S; Boucherez, J; Lacombe, E; Briat, JF; Gaymard, F				Bournier, Marc; Tissot, Nicolas; Mari, Stephane; Boucherez, Jossia; Lacombe, Eric; Briat, Jean-Francois; Gaymard, Frederic			Arabidopsis Ferritin 1 (AtFer1) Gene Regulation by the Phosphate Starvation Response 1 (AtPHR1) Transcription Factor Reveals a Direct Molecular Link between Iron and Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR PHR1; DEFICIENCY; PLANTS; IDENTIFICATION; EXPRESSION; THALIANA; STORAGE	A yeast one-hybrid screening allowed the selection of PHR1 as a factor that interacted with the AtFer1 ferritin gene promoter. In mobility shift assays, PHR1 and its close homologue PHL1 (PHR1-like 1) interact with Element 2 of the AtFer1 promoter, containing a P1BS (PHR1 binding site). In a loss of function mutant for genes encoding PHR1 and PHL1 (phr1 phl1 mutant), the response of AtFer1 to phosphate starvation was completely lost, showing that the two transcription factors regulate AtFer1 expression upon phosphate starvation. This regulation does not involve the IDRS (iron-dependent regulatory sequence) present in the AtFer1 promoter and involved in the iron-dependent regulation. The phosphate starvation response of AtFer1 is not linked to the iron status of plants and is specifically initiated by phosphate deficiency. Histochemical localization of iron, visualized by Perls DAB staining, was strongly altered in a phr1 phl1 mutant, revealing that both PHR1 and PHL1 are major factors involved in the regulation of iron homeostasis.	[Bournier, Marc; Tissot, Nicolas; Mari, Stephane; Boucherez, Jossia; Briat, Jean-Francois; Gaymard, Frederic] Univ Montpellier 2, Inst Natl Rech Agron, Agro M CNRS, Lab Biochim & Physiol Mol Plantes,UMR 5004, F-34060 Montpellier 1, France; [Lacombe, Eric] IRD, Dept Plant Resistance Pests, F-34394 Montpellier 5, France	INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Gaymard, F (corresponding author), 2 Pl Viala, F-34060 Montpellier 1, France.	gaymard@supagro.inra.fr		Lacombe, Eric/0000-0001-5100-4173	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique (CNRS) (to M. B.).	Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; CUMBUS IP, 1977, PLANT SOIL, V48, P651, DOI 10.1007/BF00145775; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DEKOCK PC, 1979, ANN BOT-LONDON, V43, P737, DOI 10.1093/oxfordjournals.aob.a085687; Duc C, 2009, J BIOL CHEM, V284, P36271, DOI 10.1074/jbc.M109.059873; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Hilton RJ, 2012, BIOMETALS, V25, P259, DOI 10.1007/s10534-011-9500-z; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Mathan K. K., 1977, PLANT SOIL, V48, P413, DOI DOI 10.1007/BF00010097; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Nilsson L, 2012, PHYSIOL PLANTARUM, V144, P35, DOI 10.1111/j.1399-3054.2011.01520.x; Oropeza-Aburto A, 2012, J EXP BOT, V63, P2189, DOI 10.1093/jxb/err446; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; PICH A, 1991, J EXP BOT, V42, P1517, DOI 10.1093/jxb/42.12.1517; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Roschzttardtz H, 2010, PLANT SIGNAL BEHAV, V5, P56, DOI 10.4161/psb.5.1.10159; Roschzttardtz H, 2009, PLANT PHYSIOL, V151, P1329, DOI 10.1104/pp.109.144444; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Schaumloffel D, 2003, J ANAL ATOM SPECTROM, V18, P120, DOI 10.1039/b209819a; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Strozycki PM, 2010, MOL BIOL EVOL, V27, P91, DOI 10.1093/molbev/msp196; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; WADE VJ, 1993, BIOCHIM BIOPHYS ACTA, V1161, P91, DOI 10.1016/0167-4838(93)90201-2; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562	39	105	115	7	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22670	22680		10.1074/jbc.M113.482281	http://dx.doi.org/10.1074/jbc.M113.482281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788639	Green Published, hybrid			2022-12-28	WOS:000330596300046
J	Stawikowska, R; Cudic, M; Giulianotti, M; Houghten, RA; Fields, GB; Minond, D				Stawikowska, Roma; Cudic, Mare; Giulianotti, Marc; Houghten, Richard A.; Fields, Gregg B.; Minond, Dmitriy			Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PEPTIDE EXOSITE INHIBITORS; FACTOR-ALPHA; CONVERTING-ENZYME; FACTOR-VIIA; SPECIFICITY; PROTEINASES; SITE; DISCOVERY; TARGET	ADAM proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off target toxicity. Targeting secondary substrate binding sites (exosites) can potentially work as an alternative strategy for drug discovery; however, there are only a few reports of potential exosites in ADAM protease structures. In the study presented here, we utilized a series of TNF alpha-based substrates to probe ADAM10 and 17 interactions with its canonical substrate to identify the structural features that determine ADAM protease substrate specificity. We found that noncatalytic domains of ADAM17 did not directly bind the substrates used in the study but affected the binding nevertheless, most likely because of steric hindrance. Additionally, noncatalytic domains of ADAM17 affected the size/shape of the carbohydrate-binding pocket contained within the catalytic domain of ADAM17. This suggests that noncatalytic domains of ADAM17 play a role in substrate specificity and might help explain differences in substrate repertoires of ADAM17 and its closest homologue, ADAM10. We also addressed the question of which substrate features can affect ADAM protease specificity. We found that all ADAM proteases tested (i.e., ADAM10,12, and 17) significantly decreased activity when the TNF alpha-derived sequence was induced into alpha-helical conformation, suggesting that conformation plays a role in determining ADAM protease substrate specificity. These findings can help in the discovery of ADAM isoform- and substrate-specific inhibitors.	[Stawikowska, Roma; Cudic, Mare; Giulianotti, Marc; Houghten, Richard A.; Fields, Gregg B.; Minond, Dmitriy] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Torrey Pines Institute for Molecular Studies, Florida	Minond, D (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	dminond@tpims.org		Minond, Dmitriy/0000-0003-2473-5944; Giulianotti, Marc/0000-0002-2232-3789	National Institutes of Health [DA033985, CA098799, DA031370]; James and Esther King Biomedical Research Program Grant [2KN05]; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031370, R03DA033985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program Grant; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA033985 (to D. M.), CA098799 (to G. B. F.), and DA031370 (to R. A. H.). This work was also supported by James and Esther King Biomedical Research Program Grant 2KN05 (to D. M.), the Multiple Sclerosis National Research Institute (to G. B. F.), and the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Georgiadis D, 2008, BIOORGAN MED CHEM, V16, P8781, DOI 10.1016/j.bmc.2008.08.058; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Hall T, 2009, ARCH BIOCHEM BIOPHYS, V491, P106, DOI 10.1016/j.abb.2009.09.005; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Minond D, 2012, J BIOL CHEM, V287, P36473, DOI 10.1074/jbc.M112.389114; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642	38	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22871	22879		10.1074/jbc.M113.462267	http://dx.doi.org/10.1074/jbc.M113.462267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779109	Green Published, hybrid			2022-12-28	WOS:000330596300063
J	Lum, MA; Balaburski, GM; Murphy, ME; Black, AR; Black, JD				Lum, Michelle A.; Balaburski, Gregor M.; Murphy, Maureen E.; Black, Adrian R.; Black, Jennifer D.			Heat Shock Proteins Regulate Activation-induced Proteasomal Degradation of the Mature Phosphorylated Form of Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TURN MOTIF PHOSPHORYLATION; SMALL-MOLECULE INHIBITOR; INDUCED DOWN-REGULATION; PKC-ALPHA; PERMISSIVE ACTIVATION; MULTIDRUG-RESISTANT; IN-VIVO; HSP70; DEPHOSPHORYLATION; AKT	Although alterations in stimulus-induced degradation of PKC have been implicated in disease, mechanistic understanding of this process remains limited. Evidence supports the existence of both proteasomal and lysosomal mechanisms of PKC processing. An established pathway involves rate-limiting priming site dephosphorylation of the activated enzyme and proteasomal clearance of the dephosphorylated protein. However, here we show that agonists promote down-regulation of endogenous PKC alpha with minimal accumulation of a nonphosphorylated species in multiple cell types. Furthermore, proteasome and lysosome inhibitors predominantly protect fully phosphorylated PKC alpha, pointing to this form as a substrate for degradation. Failure to detect substantive dephosphorylation of activated PKC alpha was not due to rephosphorylation because inhibition of Hsp70/Hsc70, which is required for re-priming, had only a minor effect on agonist-induced accumulation of nonphosphorylated protein. Thus, PKC degradation can occur in the absence of dephosphorylation. Further analysis revealed novel functions for Hsp70/Hsc70 and Hsp90 in the control of agonist-induced PKC alpha processing. These chaperones help to maintain phosphorylation of activated PKC alpha but have opposing effects on degradation of the phosphorylated protein; Hsp90 is protective, whereas Hsp70/Hsc70 activity is required for proteasomal processing of this species. Notably, down-regulation of nonphosphorylated PKC alpha shows little Hsp70/Hsc70 dependence, arguing that phosphorylated and nonphosphorylated species are differentially targeted for proteasomal degradation. Finally, lysosomal processing of activated PKC alpha is not regulated by phosphorylation or Hsps. Collectively, these data demonstrate that phosphorylated PKC alpha is a direct target for agonist-induced proteasomal degradation via an Hsp-regulated mechanism, and highlight the existence of a novel pathway of PKC desensitization in cells.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Balaburski, Gregor M.; Murphy, Maureen E.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute; The Wistar Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jennifer.black@unmc.edu		Murphy, Maureen/0000-0001-7644-7296	National Institutes of Health [DK60632, DK54909]; Cancer Center Grants [CA16056, CA036727]; Head and Neck Cancer Keystone at the Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [P30CA036727, P01CA114046, R01CA139319, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Grants; Head and Neck Cancer Keystone at the Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632 (to J. D. B.) and DK54909 (to J. D. B.), and Cancer Center Grants CA16056 and CA036727. This work was also supported by the Head and Neck Cancer Keystone at the Fox Chase Cancer Center (to G. M. B.).	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Balaburski G., 2012, AACR ANN M; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Basu A, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P409, DOI 10.1007/978-1-60761-543-9_21; Black A R, 1991, Methods Achiev Exp Pathol, V15, P126; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BORNER C, 1989, J BIOL CHEM, V264, P13902; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Carmena D, 2007, BIOCHEM SOC T, V35, P1043, DOI 10.1042/BST0351043; CAZAUBON S, 1994, BIOCHEM J, V301, P443, DOI 10.1042/bj3010443; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chiosis G, 2003, MOL CANCER THER, V2, P123; CloudHeflin BA, 1996, EUR J BIOCHEM, V239, P796, DOI 10.1111/j.1432-1033.1996.0796u.x; Corbett A, 2012, EXPERT REV NEUROTHER, V12, P535, DOI [10.1586/ern.12.43, 10.1586/ERN.12.43]; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Faghiri Z, 2006, INVEST OPHTH VIS SCI, V47, P397, DOI 10.1167/iovs.05-0290; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fiszer-Kierzkowska A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-27; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Gysin S, 1996, EUR J BIOCHEM, V240, P747, DOI 10.1111/j.1432-1033.1996.0747h.x; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Huang H, 2004, BIOCHEM BIOPH RES CO, V316, P1002, DOI 10.1016/j.bbrc.2004.02.149; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Irie K, 2012, MED RES REV, V32, P518, DOI 10.1002/med.20220; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liao Y, 2010, AM J TRANSL RES, V2, P19; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Mashukova A, 2009, J CELL SCI, V122, P2491, DOI 10.1242/jcs.046979; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakamura M, 2006, BIOCHEM BIOPH RES CO, V351, P340, DOI 10.1016/j.bbrc.2006.09.163; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prevostel C, 2000, J CELL SCI, V113, P2575; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Su CH, 2011, CELL SIGNAL, V23, P1824, DOI 10.1016/j.cellsig.2011.06.018; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; WARD NE, 1991, CANCER LETT, V58, P189, DOI 10.1016/0304-3835(91)90099-4; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Zemskov EA, 2003, NEUROREPORT, V14, P1435, DOI 10.1097/00001756-200308060-00006; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	91	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27112	27127		10.1074/jbc.M112.437095	http://dx.doi.org/10.1074/jbc.M112.437095			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900841	Green Published, hybrid			2022-12-28	WOS:000330597300011
J	Zeiger, W; Vetrivel, KS; Buggia-Prevot, V; Nguyen, PD; Wagner, SL; Villereal, ML; Thinakaran, G				Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Nguyen, Phuong D.; Wagner, Steven L.; Villereal, Mitchel L.; Thinakaran, Gopal			Ca2+ Influx through Store-operated Ca2+ Channels Reduces Alzheimer Disease beta-Amyloid Peptide Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-AMINOETHOXYDIPHENYL BORATE 2-APB; PRECURSOR PROTEIN; CALCIUM-RELEASE; PRESENILIN; ENTRY; STIM1; FIBROBLASTS; INCREASE; REVEALS; SENSOR	Alzheimer disease (AD), the leading cause of dementia, is characterized by the accumulation of beta-amyloid peptides (A beta) in senile plaques in the brains of affected patients. Many cellular mechanisms are thought to play important roles in the development and progression of AD. Several lines of evidence point to the dysregulation of Ca2+ homeostasis as underlying aspects of AD pathogenesis. Moreover, direct roles in the regulation of Ca2+ homeostasis have been demonstrated for proteins encoded by familial AD-linked genes such as PSEN1, PSEN2, and APP, as well as A beta peptides. Whereas these studies support the hypothesis that disruption of Ca2+ homeostasis contributes to AD, it is difficult to disentangle the effects of familial AD-linked genes on A beta production from their effects on Ca2+ homeostasis. Here, we developed a system in which cellular Ca2+ homeostasis could be directly manipulated to study the effects on amyloid precursor protein metabolism and A beta production. We overexpressed stromal interaction molecule 1 (STIM1) and Orai1, the components of the store-operated Ca2+ entry pathway, to generate cells with constitutive and store depletion-induced Ca2+ entry. We found striking effects of Ca2+ entry induced by overex-pression of the constitutively active STIM1(D76A) mutant on amyloid precursor protein metabolism. Specifically, constitutive activation of Ca2+ entry by expression of STIM1D76A significantly reduced A beta secretion. Our results suggest that disruptions in Ca2+ homeostasis may influence AD pathogenesis directly through the modulation of A beta production.	[Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Villereal, Mitchel L.] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Villereal, ML (corresponding author), Univ Chicago, Dept Pharmacol & Physiol Sci, Abbott 102,947 E 58th St, Chicago, IL 60637 USA.	mvillere@bsd.uchicago.edu; gopal@uchicago.edu	Zeiger, William/Z-4395-2019		 [S10OD010649]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010649] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. S. Sisodia (University of Chicago) for the HEK-APP and HEK-APPswe cells. The YFP-STIM1 and YFP-STIM1-D76A expression vectors were a generous gift of T. Meyer (Stanford University). The Orai1<INF>myc</INF> cDNA was a generous gift of M. Prakriya (Northwestern University). Confocal imaging was performed at the Integrated Microscopy Core Facility at the University of Chicago (supported by Grant S10OD010649).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Baba A, 2003, J NEUROSCI, V23, P7737; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bouron A, 2005, DEV BRAIN RES, V159, P64, DOI 10.1016/j.devbrainres.2005.07.001; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Chatzistavraki M, 2013, J ALZHEIMERS DIS, V34, P407, DOI 10.3233/JAD-121768; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; COLVIN RA, 1991, ANN NY ACAD SCI, V639, P325, DOI 10.1111/j.1749-6632.1991.tb17320.x; Coon AL, 1999, NEUROBIOL AGING, V20, P597, DOI 10.1016/S0197-4580(99)00068-8; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; Gong P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-87; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Green K. N., 2007, V45, P507; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirashima N, 1996, NEUROBIOL AGING, V17, P549; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kloskowska E, 2008, NEUROSCI LETT, V436, P250, DOI 10.1016/j.neulet.2008.03.034; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Linde CI, 2011, AM J PHYSIOL-CELL PH, V300, pC1502, DOI 10.1152/ajpcell.00379.2010; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Meckler X, 2010, J NEUROSCI, V30, P16160, DOI 10.1523/JNEUROSCI.4436-10.2010; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; PETERSON C, 1986, P NATL ACAD SCI USA, V83, P7999, DOI 10.1073/pnas.83.20.7999; PETERSON C, 1988, NEUROBIOL AGING, V9, P261, DOI 10.1016/S0197-4580(88)80063-0; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Santos SF, 2011, NEUROBIOL AGING, V32, P2308, DOI 10.1016/j.neurobiolaging.2010.01.006; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Selkoe DJ, 2011, BIOL ALZHEIMER DIS; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2011, J BIOL CHEM, V286, P26166, DOI 10.1074/jbc.M111.260471; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	64	34	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26955	26966		10.1074/jbc.M113.473355	http://dx.doi.org/10.1074/jbc.M113.473355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902769	Green Published, hybrid			2022-12-28	WOS:000330594500060
J	Odintsova, E; van Niel, G; Conjeaud, H; Raposo, G; Iwamoto, R; Mekada, E; Berditchevski, F				Odintsova, Elena; van Niel, Guillaume; Conjeaud, Helene; Raposo, Graca; Iwamoto, Ryo; Mekada, Eisuke; Berditchevski, Fedor			Metastasis Suppressor Tetraspanin CD82/KAI1 Regulates Ubiquitylation of Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE DYNAMICS; MEMBRANE-PROTEINS; EGF; INTEGRIN; CBL; ENDOCYTOSIS; TRAFFICKING; BINDING; MORPHOGENESIS	Ligand-induced ubiquitylation of EGF receptor (EGFR) is an important regulatory mechanism that controls endocytic trafficking of the receptor and its signaling potential. Here we report that tetraspanin CD82/KAI1 specifically suppresses ubiquitylation of EGFR after stimulation with heparin-binding EGF or amphiregulin and alters the rate of recruitment of the activated receptor to EEA1-positive endosomes. The suppressive effect of CD82 is dependent on the heparin-binding domain of the ligand. Deletion of the C-terminal cytoplasmic domain of CD82 (CD82 Delta C mutant) inhibits endocytic trafficking of the tetraspanin and compromises its activity toward heparin-binding EGF-activated EGFR. Reduced ubiquitylation of EGFR is accompanied by PKC-dependent increase in serine phosphorylation of c-Cbl in cells expressing elevated levels of CD82. Furthermore, phosphorylation of threonine 654 (PKC phosphorylation site) in the juxtamembrane domain of the receptor is considerably increased in CD82-expressing cells. These results describe previously unsuspected links between tetraspanin proteins and ubiquitylation of their molecular partners (e. g., EGFR). Our data identify CD82 as a new regulator of c-Cbl, which discriminatively controls the activity of this E3 ubiquitin ligase toward heparin-binding ligand-EGFR pairs. Taken together, these observations provide an important new insight into the modulatory role of CD82 in endocytic trafficking of EGF receptor.	[Odintsova, Elena; Berditchevski, Fedor] Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [van Niel, Guillaume; Raposo, Graca] Inst Curie, Ctr Rech, F-75248 Paris, France; [van Niel, Guillaume; Raposo, Graca] CNRS, Unite Mixte Rech 144, F-75248 Paris, France; [Conjeaud, Helene] Univ Paris 07, UMR CNRS 7057, F-75205 Paris, France; [Iwamoto, Ryo; Mekada, Eisuke] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	University of Birmingham; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Osaka University	Odintsova, E (corresponding author), Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	e.odintsova@bham.ac.uk	van Niel, Guillaume/A-6585-2011; van Niel, Guillaume/HCI-8445-2022	van Niel, Guillaume/0000-0002-8651-9705; Mekada, Eisuke/0000-0001-8858-4781; Raposo, graca/0000-0001-9590-1298	Breast Cancer Campaign Grants [2008MaySP18, 2007PR22, 2003:712]; Grants-in-Aid for Scientific Research [24570212] Funding Source: KAKEN	Breast Cancer Campaign Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Breast Cancer Campaign Grants 2008MaySP18, 2007PR22, and 2003:712 (to E. O. and F. B.).	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cotton CU, 2013, TRAFFIC, V14, P337, DOI 10.1111/tra.12032; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; Iwamoto R, 2010, DEVELOPMENT, V137, P2205, DOI 10.1242/dev.048926; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Melander F, 2004, BIOCHEM BIOPH RES CO, V317, P1000, DOI 10.1016/j.bbrc.2004.03.147; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Pedraza-Alva G, 2001, J BIOL CHEM, V276, P729, DOI 10.1074/jbc.M008494200; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; SHEARER M, 1992, INT J CANCER, V51, P602, DOI 10.1002/ijc.2910510417; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takazaki R, 2004, J BIOL CHEM, V279, P47335, DOI 10.1074/jbc.M408556200; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	44	46	47	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26323	26334		10.1074/jbc.M112.439380	http://dx.doi.org/10.1074/jbc.M112.439380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897813	hybrid, Green Published			2022-12-28	WOS:000330623300061
J	Sela, D; Conkright, JJ; Chen, L; Gilmore, J; Washburn, MP; Florens, L; Conaway, RC; Conaway, JW				Sela, Dotan; Conkright, Juliana J.; Chen, Lu; Gilmore, Joshua; Washburn, Michael P.; Florens, Laurence; Conaway, Ronald C.; Conaway, Joan Weliky			Role for Human Mediator Subunit MED25 in Recruitment of Mediator to Promoters by Endoplasmic Reticulum Stress-responsive Transcription Factor ATF6 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UNFOLDED PROTEIN RESPONSE; HEAD MODULE; ER STRESS; COACTIVATOR COMPLEX; ACTIVATION DOMAIN; NUCLEAR RECEPTORS; LUMINAL DOMAIN; ATF6; VP16	Transcription factor ATF6 alpha functions as a master regulator of endoplasmic reticulum (ER) stress response genes. In response to ER stress, ATF6 alpha translocates from its site of latency in the ER membrane to the nucleus, where it activates RNA polymerase II transcription of ER stress response genes upon binding sequence-specifically to ER stress response enhancer elements (ERSEs) in their promoter-regulatory regions. In a recent study, we demonstrated that ATF6 alpha activates transcription of ER stress response genes by a mechanism involving recruitment to ERSEs of the multisubunit Mediator and several histone acetyltransferase (HAT) complexes, including Spt-Ada-Gcn5 (SAGA) and Ada-Two-A-containing (ATAC) (Sela, D., Chen, L., Martin-Brown, S., Washburn, M. P., Florens, L., Conaway, J. W., and Conaway, R. C. (2012) J. Biol. Chem. 287, 23035-23045). In this study, we extend our investigation of the mechanism by which ATF6 alpha supports recruitment of Mediator to ER stress response genes. We present findings arguing that Mediator subunit MED25 plays a critical role in this process and identify a MED25 domain that serves as a docking site on Mediator for the ATF6 alpha transcription activation domain.	[Sela, Dotan; Conkright, Juliana J.; Chen, Lu; Gilmore, Joshua; Washburn, Michael P.; Florens, Laurence; Conaway, Ronald C.; Conaway, Joan Weliky] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Lu; Conaway, Ronald C.; Conaway, Joan Weliky] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org	Chen, Lu/AAN-4886-2021	Chen, Lu/0000-0002-4571-7975; Conaway, Joan/0000-0002-2786-0663; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	National Institutes of Health [GM041628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM041628 (to R. C. C. and J. W. C.) and by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation.	Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Eletsky A., 2011, J STRUCT FUNCT GENOM, V12, P166; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gim BS, 2001, MOL CELL BIOL, V21, P5242, DOI 10.1128/MCB.21.15.5242-5255.2001; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lee YC, 1997, MOL CELL BIOL, V17, P4622, DOI 10.1128/MCB.17.8.4622; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sela D, 2012, J BIOL CHEM, V287, P23035, DOI 10.1074/jbc.M112.369504; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Tomomori-Sato Chieri, 2013, Methods Mol Biol, V977, P273, DOI 10.1007/978-1-62703-284-1_22; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	44	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26179	26187		10.1074/jbc.M113.496968	http://dx.doi.org/10.1074/jbc.M113.496968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23864652	hybrid, Green Published			2022-12-28	WOS:000330623300048
J	Poluri, KM; Joseph, PRB; Sawant, KV; Rajarathnam, K				Poluri, Krishna Mohan; Joseph, Prem Raj B.; Sawant, Kirti V.; Rajarathnam, Krishna			Molecular Basis of Glycosaminoglycan Heparin Binding to the Chemokine CXCL1 Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL-ACTIVATING PEPTIDE-2; GROWTH-STIMULATORY ACTIVITY; NMR CHEMICAL-SHIFTS; SULFATE; INTERLEUKIN-8; SURFACE; OLIGOMERIZATION; DYNAMICS; DOMAIN; CXCR2	Glycosaminoglycan (GAG)-bound and soluble chemokine gradients in the vasculature and extracellular matrix mediate neutrophil recruitment to the site of microbial infection and sterile injury in the host tissue. However, the molecular principles by which chemokine-GAG interactions orchestrate these gradients are poorly understood. This, in part, can be directly attributed to the complex interrelationship between the chemokine monomer-dimer equilibrium and binding geometry and affinities that are also intimately linked to GAG length. To address some of this missing knowledge, we have characterized the structural basis of heparin binding to the murine CXCL1 dimer. CXCL1 is a neutrophil-activating chemokine and exists as both monomers and dimers (K-d = 36 mu M). To avoid interference from monomer-GAG interactions, we designed a trapped dimer (dCXCL1) by introducing a disulfide bridge across the dimer interface. We characterized the binding of GAG heparin octasaccharide to dCXCL1 using solution NMR spectroscopy. Our studies show that octasaccharide binds orthogonally to the interhelical axis and spans the dimer interface and that heparin binding enhances the structural integrity of the C-terminal helical residues and stability of the dimer. We generated a quadruple mutant (H20A/K22A/K62A/K66A) on the basis of the binding data and observed that this mutant failed to bind heparin octasaccharide, validating our structural model. We propose that the stability enhancement of dimers upon GAG binding regulates in vivo neutrophil trafficking by increasing the lifetime of "active" chemokines, and that this structural knowledge could be exploited for designing inhibitors that disrupt chemokine- GAG interactions and neutrophil homing to the target tissue.	[Poluri, Krishna Mohan; Joseph, Prem Raj B.; Sawant, Kirti V.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Poluri, Krishna Mohan; Joseph, Prem Raj B.; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-142 Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sawant, Kirti/L-1602-2013; Sawant, Kirti V/H-3778-2013; Poluri, Krishna Mohan/H-6083-2013	Poluri, Krishna Mohan/0000-0003-3801-7134	National Institutes of Health [P01 HL107152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL107152 (to K. R.).	Bazar E, 2010, CHEMBIOCHEM, V11, P1997, DOI 10.1002/cbic.201000207; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bitomsky W, 1999, J AM CHEM SOC, V121, P3004, DOI 10.1021/ja983319g; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gandhi NS, 2011, J CHEM INF MODEL, V51, P335, DOI 10.1021/ci1003366; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jang JE, 2011, J CLIN INVEST, V121, P1397, DOI 10.1172/JCI45336; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Jasnin M, 2012, METHODS MOL BIOL, V836, P161, DOI 10.1007/978-1-61779-498-8_11; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIM KS, 1994, J BIOL CHEM, V269, P32909; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; MALKOWSKI MG, 1995, J BIOL CHEM, V270, P7077, DOI 10.1074/jbc.270.13.7077; McCornack MA, 2004, BIOCHEMISTRY-US, V43, P10090, DOI 10.1021/bi049751u; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Permi P, 2004, PROG NUCL MAG RES SP, V44, P97, DOI 10.1016/j.pnmrs.2003.12.001; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Prabhakar Vikas, 2009, V534, P147, DOI 10.1007/978-1-59745-022-5_11; Qian YQ, 1999, J MOL BIOL, V294, P1065, DOI 10.1006/jmbi.1999.3333; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Shao WP, 1998, BIOCHEMISTRY-US, V37, P8303, DOI 10.1021/bi980112r; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Shriver Zachary, 2012, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-642-23056-1_8; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	65	45	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25143	25153		10.1074/jbc.M113.492579	http://dx.doi.org/10.1074/jbc.M113.492579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23864653	hybrid, Green Published			2022-12-28	WOS:000330619000014
J	Wang, YL; Huang, ZP; Nayak, PS; Matthews, BD; Warburton, D; Shi, W; Sanchez-Esteban, J				Wang, Yulian; Huang, Zheping; Nayak, Pritha S.; Matthews, Benjamin D.; Warburton, David; Shi, Wei; Sanchez-Esteban, Juan			Strain-induced Differentiation of Fetal Type II Epithelial Cells Is Mediated via the Integrin alpha(6)beta(1)-ADAM17/Tumor Necrosis Factor-alpha-converting Enzyme (TACE) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LUNG BRANCHING MORPHOGENESIS; FERRIC-OXIDE BEADS; EGFR LIGANDS; MICE LACKING; PULMONARY HYPOPLASIA; IN-VITRO; MECHANOTRANSDUCTION; MATURATION; ADAMS	Mechanical forces are critical for normal fetal lung development. However, the mechanisms regulating this process are not well-characterized. We hypothesized that strain-induced release of HB-EGF and TGF-alpha is mediated via integrin-ADAM17/TACE interactions. Employing an in vitro system to simulate mechanical forces in fetal lung development, we showed that mechanical strain of fetal epithelial cells actives TACE, releases HB-EGF and TGF-alpha, and promotes differentiation. In contrast, in samples incubated with the TACE inhibitor IC-3 or in cells isolated from TACE knock-out mice, mechanical strain did not release ligands or promote cell differentiation, which were both rescued after transfection of ADAM17. Cell adhesion assay and co-immunoprecipitation experiments in wildtype and TACE knock-out cells using several TACE constructs demonstrated not only that integrins alpha 6 and beta 1 bind to TACE via the disintegrin domain but also that mechanical strain enhances these interactions. Furthermore, force applied to these integrin receptors by magnetic beads activated TACE and shed HB-EGF and TGF-alpha. The contribution of integrins alpha(6) and beta(1) to differentiation-of fetal epithelial cells by strain was demonstrated by blocking their binding site with specific antibodies and by culturing the cells on membranes coated with anti-integrin alpha(6) and beta(1) antibodies. In conclusion, mechanical strain releases HB-EGF and TGF-alpha and promotes fetal type II cell differentiation via alpha(6)beta(1) integrin-ADAM17/TACE signaling pathway. These investigations provide novel mechanistic information on how mechanical forces promote fetal lung development and specifically differentiation of epithelial cells. This information could be also relevant to other tissues exposed to mechanical forces.	[Wang, Yulian; Huang, Zheping; Nayak, Pritha S.; Sanchez-Esteban, Juan] Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02905 USA; [Wang, Yulian; Huang, Zheping; Nayak, Pritha S.; Sanchez-Esteban, Juan] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Matthews, Benjamin D.] Harvard Univ, Sch Med, Vasc Biol Program, Dept Med, Boston, MA 02115 USA; [Matthews, Benjamin D.] Harvard Univ, Sch Med, Vasc Biol Program, Dept Pathol, Boston, MA 02115 USA; [Matthews, Benjamin D.] Harvard Univ, Sch Med, Vasc Biol Program, Dept Surg, Boston, MA 02115 USA; [Matthews, Benjamin D.] Boston Childrens Hosp, Boston, MA 02115 USA; [Warburton, David; Shi, Wei] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA	Women & Infants Hospital Rhode Island; Brown University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Children's Hospital Los Angeles; University of Southern California	Sanchez-Esteban, J (corresponding author), Women & Infants Hosp Rhode Isl, Dept Pediat, 101 Dudley St, Providence, RI 02905 USA.	jsanchezesteban@wihri.org	Warburton, David/AAD-5709-2020		National Institutes of Health [R01 HD052670, P20 RR018728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052670] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD052670 (to J. S-E.) and P20 RR018728.	Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bridges LC, 2005, CURR PHARM DESIGN, V11, P837, DOI 10.2174/1381612053381747; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Chen JX, 2001, AM J PHYSIOL-CELL PH, V280, pC1475, DOI 10.1152/ajpcell.2001.280.6.C1475; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dideberg V, 2006, PHARMACOGENET GENOM, V16, P727, DOI 10.1097/01.fpc.0000230117.26581.a4; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1998, PFLUG ARCH EUR J PHY, V435, P320; GOLDSTEIN JD, 1980, J PEDIATR-US, V97, P282, DOI 10.1016/S0022-3476(80)80496-3; Gooz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033350; Harding R., 1997, LUNG SCI FDN, P2093; Heidemann J, 2006, INT J ONCOL, V28, P77; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Huang ZP, 2012, J BIOL CHEM, V287, P18091, DOI 10.1074/jbc.M111.313163; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Joe P, 1997, AM J PHYSIOL-LUNG C, V272, pL95, DOI 10.1152/ajplung.1997.272.1.L95; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Liu MY, 2000, J APPL PHYSIOL, V89, P2078, DOI 10.1152/jappl.2000.89.5.2078; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Luks FI, 2001, J PEDIATR SURG, V36, P196, DOI 10.1053/jpsu.2001.20051; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; MOESSINGER AC, 1990, J CLIN INVEST, V86, P1270, DOI 10.1172/JCI114834; Nath D, 2000, J CELL SCI, V113, P2319; Papadakis K, 1997, J PEDIATR SURG, V32, P347, DOI 10.1016/S0022-3468(97)90208-6; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rama K. M., 1997, LUNG GROWTH DEV, P119; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Esteban J, 2006, AM J PHYSIOL-LUNG C, V290, pL343, DOI 10.1152/ajplung.00189.2005; Sanchez-Esteban J, 2004, AM J RESP CELL MOL, V30, P76, DOI 10.1165/rcmb.2003-0121OC; Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; SCARPELLI EM, 1975, PEDIATR RES, V9, P190, DOI 10.1203/00006450-197504000-00010; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shiomi T, 2011, AM J RESP CELL MOL, V45, P376, DOI 10.1165/rcmb.2010-0234OC; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Smith KM, 2002, J CELL BIOL, V159, P893, DOI 10.1083/jcb.200206023; Torday JS, 1998, AM J MED SCI, V316, P205, DOI 10.1097/00000441-199809000-00010; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YL, 2006, AM J PHYSIOL-LUNG C, V291, pL820, DOI 10.1152/ajplung.00068.2006; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; WIGGLESWORTH JS, 1979, EARLY HUM DEV, V3, P51, DOI 10.1016/0378-3782(79)90020-3; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176; Zhao JS, 2001, INT J DEV BIOL, V45, P623; Zscheppang K, 2007, AM J PHYSIOL-LUNG C, V293, pL429, DOI 10.1152/ajplung.00451.2006	62	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25646	25657		10.1074/jbc.M113.473777	http://dx.doi.org/10.1074/jbc.M113.473777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23888051	Green Published, hybrid			2022-12-28	WOS:000330619000059
J	Arendt, W; Groenewold, MK; Hebecker, S; Dickschat, JS; Moser, J				Arendt, Wiebke; Groenewold, Maike K.; Hebecker, Stefanie; Dickschat, Jeroen S.; Moser, Juergen			Identification and Characterization of a Periplasmic Aminoacyl-phosphatidylglycerol Hydrolase Responsible for Pseudomonas aeruginosa Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOBIUM-TROPICI CIAT899; ALANYL-PHOSPHATIDYLGLYCEROL; LYSYL-PHOSPHATIDYLGLYCEROL; ANAEROBIC SURVIVAL; BACTERIAL-MEMBRANE; PEPTIDE RESISTANCE; MPRF; PH; ADAPTATION; PROTEIN	Specific aminoacylation of the phospholipid phosphatidylglycerol (PG) with alanine (or with lysine) was shown to render various organisms less susceptible to antimicrobial agents and environmental stresses. In this study, we make use of the opportunistic pathogen Pseudomonas aeruginosa to decode ORF PA0919-dependent lipid homeostasis. Analysis of the polar lipid content of the deletion mutant Delta PA0919 indicated significantly enlarged levels of alanyl-PG. The resulting phenotype manifested an increased susceptibility to several antimicrobial compounds when compared with the wild type. A pH-dependent PA0919 promoter located within the upstream gene PA0920 was identified. Localization experiments demonstrated that the PA0919 protein is anchored to the periplasmic surface of the inner bacterial membrane. The recombinant overproduction of wild type and several site-directed mutant proteins in the periplasm of Escherichia coli facilitated a detailed in vitro analysis of the enzymatic PA0919 function. A series of artificial substrates (p-nitrophenyl esters of various amino acids/aliphatic acids) indicated enzymatic hydrolysis of the alanine, glycine, or lysine moiety of the respective ester substrates. Our final in vitro activity assay in the presence of radioactively labeled alanyl-PG then revealed hydrolysis of the aminoacyl linkage, resulting in the formation of alanine and PG. Consequently, PA0919 was termed alanyl-PG hydrolase. The elucidated enzymatic activity implies a new regulatory circuit for the appropriate tuning of cellular alanyl-PG concentrations.	[Arendt, Wiebke; Groenewold, Maike K.; Hebecker, Stefanie; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Dickschat, Jeroen S.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de	Tauchert, Maike/AAZ-3990-2021	Tauchert, Maike/0000-0001-6777-0948	Deutsche Forschungsgemeinschaft Grant [MO 1749/1-1]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MO 1749/1-1.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Arendt W, 2012, J BACTERIOL, V194, P1401, DOI 10.1128/JB.06576-11; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Dowhan W., 2002, NEW COMPR BIOCH, P1, DOI DOI 10.1016/50167-7306(02)36003-4; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; Fujiwara Atushi, 1998, Annals of the Phytopathological Society of Japan, V64, P191, DOI 10.3186/jjphytopath.64.191; Hebecker S, 2011, MOL MICROBIOL, V80, P935, DOI 10.1111/j.1365-2958.2011.07621.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOUTSMULLER UMT, 1963, BIOCHIM BIOPHYS ACTA, V70, P211; Jensch T, 1997, J BASIC MICROB, V37, P115, DOI 10.1002/jobm.3620370206; Ke D, 2009, TETRAHEDRON, V65, P8269, DOI 10.1016/j.tet.2009.07.048; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; MACFARLANE MG, 1962, NATURE, V196, P136, DOI 10.1038/196136a0; Majumder Parimal, 1999, Annals of the Phytopathological Society of Japan, V65, P254, DOI 10.3186/jjphytopath.65.254; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Moser J, 1999, J BIOL CHEM, V274, P30679, DOI 10.1074/jbc.274.43.30679; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; PAN SQ, 1995, MOL MICROBIOL, V17, P259, DOI 10.1111/j.1365-2958.1995.mmi_17020259.x; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Qiu T, 2010, AFR J BIOTECHNOL, V9, P8679; Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; SACRE MM, 1977, CHEM PHYS LIPIDS, V20, P305, DOI 10.1016/0009-3084(77)90071-8; Sambrook J., 2001, MOL CLONING LAB MANU; SCHNABEL E, 1964, LIEBIGS ANN CHEM, V674, P218; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Slavetinsky CJ, 2012, ANTIMICROB AGENTS CH, V56, P3492, DOI 10.1128/AAC.00370-12; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vinuesa P, 2003, MOL PLANT MICROBE IN, V16, P159, DOI 10.1094/MPMI.2003.16.2.159; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; WIRAWAN IGP, 1993, J BACTERIOL, V175, P3208, DOI 10.1128/JB.175.10.3208-3212.1993; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	57	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24717	24730		10.1074/jbc.M113.482935	http://dx.doi.org/10.1074/jbc.M113.482935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23792962	hybrid, Green Published			2022-12-28	WOS:000330612300038
J	Horwich, AL				Horwich, Arthur L.			Chaperonin-mediated Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; GROEL-GROES; CRYSTAL-STRUCTURE; YEAST MITOCHONDRIA; CENTRAL CAVITY; HEAT-SHOCK; ATP; SUBSTRATE; BINDING; COMPLEX	We have been studying chaperonins these past twenty years through an initial discovery of an action in protein folding, analysis of structure, and elucidation of mechanism. Some of the highlights of these studies were presented recently upon sharing the honor of the 2013 Herbert Tabor Award with my early collaborator, Ulrich Hartl, at the annual meeting of the American Society for Biochemistry and Molecular Biology in Boston. Here, some of the major findings are recounted, particularly recognizing my collaborators, describing how I met them and how our great times together propelled our thinking and experiments.	[Horwich, Arthur L.] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Horwich, Arthur L.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Horwich, AL (corresponding author), Howard Hughes Med Inst, New Haven, CT 06510 USA.	arthur.horwich@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; CHENG MY, 1987, P NATL ACAD SCI USA, V84, P4063, DOI 10.1073/pnas.84.12.4063; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; EPSTEIN CJ, 1963, COLD SPRING HARB SYM, V28, P439, DOI 10.1101/SQB.1963.028.01.060; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SAIBIL H, 1991, NATURE, V353, P25, DOI 10.1038/353025b0; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Tyagi NK, 2011, FEBS LETT, V585, P1969, DOI 10.1016/j.febslet.2011.05.031; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	45	17	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23622	23632		10.1074/jbc.X113.497321	http://dx.doi.org/10.1074/jbc.X113.497321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23803606	hybrid, Green Published			2022-12-28	WOS:000330611400001
J	Layer, JH; Weil, PA				Layer, Justin H.; Weil, P. Anthony			Direct TFIIA-TFIID Protein Contacts Drive Budding Yeast Ribosomal Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; CORE PROMOTER DNA; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; IN-VIVO; CRYSTAL-STRUCTURE; ACTIVATED TRANSCRIPTION; TFIIA/TBP/DNA COMPLEX; FUNCTIONAL-ANALYSIS	We have previously shown that yeast TFIID provides coactivator function on the promoters of ribosomal protein-encoding genes (RPGs) by making direct contact with the transactivator repressor activator protein 1 (Rap1). Further, our structural studies of assemblies generated with purified Rap1, TFIID, and TFIIA on RPG enhancer-promoter DNA indicate that Rap1-TFIID interaction induces dramatic conformational rearrangements of enhancer-promoter DNA and TFIID-bound TFIIA. These data indicate a previously unknown yet critical role for yeast TFIIA in the integration of activator-TFIID contacts with promoter conformation and downstream preinitiation complex formation and/or function. Here we describe the use of systematic mutagenesis to define how specific TFIIA contacts contribute to these processes. We have verified that TFIIA is required for RPG transcription in vivo and in vitro, consistent with the existence of a critical Rap1-TFIIA-TFIID interaction network. We also identified essential points of contact for TFIIA and Rap1 within the Rap1 binding domain of the Taf4 subunit of TFIID. These data suggest a mechanism for how interactions between TFIID, TFIIA, and Rap1 contribute to the high rate of transcription initiation seen on RPGs in vivo.	[Layer, Justin H.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [GM52461]; NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052461, R56GM052461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52461 (to P. A. W.). RNA-Seq analyses were supported in part by NCI, National Institutes of Health, Cancer Center Support Grant P30 CA068485, utilizing the Genome Sciences Shared Resource.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belinchon NM, 2004, FEMS YEAST RES, V4, P751, DOI 10.1016/j.femsyr.2004.02.004; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kraemer SM, 2001, MOL CELL BIOL, V21, P1737, DOI 10.1128/MCB.21.5.1737-1746.2001; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu Q, 1999, MOL CELL BIOL, V19, P8673; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; SIKORSKI RS, 1989, GENETICS, V122, P19; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; VANDYKE MW, 1989, MOL CELL BIOL, V9, P342, DOI 10.1128/MCB.9.1.342; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005	93	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23273	23294		10.1074/jbc.M113.486829	http://dx.doi.org/10.1074/jbc.M113.486829			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814059	Green Published, hybrid			2022-12-28	WOS:000330598200034
J	Sakuraba, J; Shintani, T; Tani, S; Noda, M				Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu			Substrate Specificity of R3 Receptor-like Protein-tyrosine Phosphatase Subfamily toward Receptor Protein-tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PC12 CELLS; NEURITE OUTGROWTH; TRAPPING SYSTEM; EPH RECEPTORS; DIFFERENTIATION; ROLES; PHOSPHORYLATION; CD148; IDENTIFICATION	Receptor-like protein-tyrosine phosphatases (RPTPs) are involved in various aspects of cellular functions, such as proliferation, differentiation, survival, migration, and metabolism. A small number of RPTPs have been reported to regulate activities of some cellular proteins including receptor protein-tyrosine kinases (RPTKs). However, our understanding about the roles of individual RPTPs in the regulation of RPTKs is still limited. The R3 RPTP subfamily reportedly plays pivotal roles in the development of several tissues including the vascular and nervous systems. Here, we examined enzyme-substrate relationships between the four R3 RPTP subfamily members and 21 RPTK members selected from 14 RPTK subfamilies by using a mammalian two-hybrid system with substrate-trapping RPTP mutants. Among the 84 RPTP-RPTK combinations conceivable, we detected 30 positive interactions: 25 of the enzyme-substrate relationships were novel. We randomly chose several RPTKs assumed to be substrates for R3 RPTPs, and validated the results of this screen by in vitro dephosphorylation assays, and by cell-based assays involving overexpression and knockdown experiments. Because their functional relationships were verified without exception, it is probable that the RPTKs identified as potential substrates are actually physiological substrates for the R3 RPTPs. Interestingly, some RPTKs were recognized as substrates by all R3 members, but others were recognized by only one or a few members. The enzyme-substrate relationships identified in the present study will shed light on physiological roles of the R3 RPTP subfamily.	[Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Shintani, Takafumi/0000-0002-6165-2307	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chen ZY, 2001, NEUROSCIENCE, V104, P593, DOI 10.1016/S0306-4522(01)00093-8; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Flanagan JG, 1997, CELL, V90, P403; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gatto G, 2013, J NEUROSCI, V33, P5399, DOI 10.1523/JNEUROSCI.4707-12.2013; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Gonzalez-Brito MR, 2009, MOL CELL NEUROSCI, V42, P458, DOI 10.1016/j.mcn.2009.09.009; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Keane MM, 1996, CANCER RES, V56, P4236; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; SANO M, 1992, J NEUROCHEM, V58, P837, DOI 10.1111/j.1471-4159.1992.tb09333.x; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Xu YR, 2012, NEOPLASIA, V14, P1015, DOI 10.1593/neo.12870	42	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23421	23431		10.1074/jbc.M113.458489	http://dx.doi.org/10.1074/jbc.M113.458489			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814054	hybrid, Green Published			2022-12-28	WOS:000330598200045
J	Sorino, C; Bruno, T; Desantis, A; Di Certo, MG; Iezzi, S; De Nicola, F; Catena, V; Floridi, A; Chessa, L; Passananti, C; Cundari, E; Fanciulli, M				Sorino, Cristina; Bruno, Tiziana; Desantis, Agata; Di Certo, Maria Grazia; Iezzi, Simona; De Nicola, Francesca; Catena, Valeria; Floridi, Aristide; Chessa, Luciana; Passananti, Claudio; Cundari, Enrico; Fanciulli, Maurizio			Centrosomal Che-1 Protein Is Involved in the Regulation of Mitosis and DNA Damage Response by Mediating Pericentrin (PCNT)-dependent Chk1 Protein Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; P53 TRANSCRIPTION; CHECKPOINT; ATM; PHOSPHORYLATION; SUPPRESSION; PARTNER; BIOLOGY; GROWTH	To combat threats posed by DNA damage, cells have evolved mechanisms, collectively termed DNA damage response (DDR). These mechanisms detect DNA lesions, signal their presence, and promote their repair. Centrosomes integrate G(2)/M checkpoint control and repair signals in response to genotoxic stress, acting as an efficient control mechanism when G(2)/M checkpoint function fails and mitosis begins in the presence of damaged DNA. Che-1 is an RNA polymerase II-binding protein involved in the regulation of gene transcription, induction of cell proliferation, and DDR. Here we provide evidence that in addition to its nuclear localization, Che-1 localizes at interphase centrosomes, where it accumulates following DNA damage or spindle poisons. We show that Che-1 depletion generates supernumerary centrosomes, multinucleated cells, and multipolar spindle formation. Notably, Che-1 depletion abolishes the ability of Chk1 to bind pericentrin and to localize at centrosomes, which, in its turn, deregulates the activation of centrosomal cyclin B-Cdk1 and advances entry into mitosis. Our results reinforce the notion that Che-1 plays an important role in DDR and that its contribution seems to be relevant for the spindle assembly checkpoint.	[Sorino, Cristina; Bruno, Tiziana; Desantis, Agata; Iezzi, Simona; De Nicola, Francesca; Floridi, Aristide; Fanciulli, Maurizio] Regina Elena Inst Canc Res, Mol Med Area, Lab Epigenet, I-00144 Rome, Italy; [Di Certo, Maria Grazia] IRCCS Santa Lucia Fdn, CNR IBCN, I-00143 Rome, Italy; [Catena, Valeria] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00161 Rome, Italy; [Passananti, Claudio] Univ Roma La Sapienza, Dept Mol Med, CNR IBPM, I-00161 Rome, Italy; [Cundari, Enrico] Univ Roma La Sapienza, Dept Genet, CNR IBPM, I-00185 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS Santa Lucia; University of L'Aquila; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Fanciulli, M (corresponding author), Regina Elena Inst Canc Res, Mol Med Area, Lab Epigenet, Via E Chianesi 53, I-00144 Rome, Italy.	fanciulli@ifo.it	Catena, Valeria/AAA-3267-2021; Iezzi, Simona/AAA-3275-2021; bruno, tiziana/AAC-4913-2022; De Nicola, Francesca/AAC-6887-2022; Passananti, Claudio/K-9593-2016; fanciulli, maurizio/ABH-6745-2020; Sorino, Cristina/AAB-9941-2022; Maria Grazia, Di Certo/AAW-8769-2020	Catena, Valeria/0000-0002-9639-1944; Iezzi, Simona/0000-0002-7484-5861; bruno, tiziana/0000-0003-0352-4523; Sorino, Cristina/0000-0002-6100-289X; De Nicola, FRANCESCA/0000-0002-2187-7544; PASSANANTI, CLAUDIO/0000-0002-9288-5736	Italian Association for Cancer Research (AIRC); AIRC	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC) (to M. F.).; Recipient of an AIRC fellowship.	Blomberg-Wirschell M, 1998, METHOD ENZYMOL, V298, P228, DOI 10.1016/S0076-6879(98)98022-3; Bruno T, 2008, CELL DEATH DIFFER, V15, P515, DOI 10.1038/sj.cdd.4402284; Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Bruno T, 2010, CANCER CELL, V18, P122, DOI 10.1016/j.ccr.2010.05.027; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo Maria, 2004, Journal de la Societe de Biologie, V198, P97; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chila R, 2013, CELL CYCLE, V12, P1083, DOI 10.4161/cc.24090; Ciciarello M, 2001, J BIOL CHEM, V276, P19205, DOI 10.1074/jbc.M009528200; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Floridi A, 2007, CELL CYCLE, V6, P804, DOI 10.4161/cc.6.7.4043; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hopker K, 2012, EMBO J, V31, P3961, DOI 10.1038/emboj.2012.236; Ishigaki S, 2010, CELL DEATH DIFFER, V17, P774, DOI 10.1038/cdd.2009.175; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; Loffler H, 2007, CELL CYCLE, V6, P2541; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Passananti C, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-21; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Salisbury JL, 1999, BIOL CELL, V91, P451, DOI 10.1016/S0248-4900(99)80086-0; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yang CY, 2012, DNA REPAIR, V11, P185, DOI 10.1016/j.dnarep.2011.10.018; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	37	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23348	23357		10.1074/jbc.M113.465302	http://dx.doi.org/10.1074/jbc.M113.465302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798705	Green Published, hybrid			2022-12-28	WOS:000330598200039
J	Park, JT; Kato, M; Yuan, H; Castro, N; Lanting, L; Wang, M; Natarajan, R				Park, Jung Tak; Kato, Mitsuo; Yuan, Hang; Castro, Nancy; Lanting, Linda; Wang, Mei; Natarajan, Rama			FOG2 Protein Down-regulation by Transforming Growth Factor-beta 1-induced MicroRNA-200b/c Leads to Akt Kinase Activation and Glomerular Mesangial Hypertrophy Related to Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-INDUCED HYPERTROPHY; INDUCED COLLAGEN EXPRESSION; TGF-BETA; KIDNEY-DISEASE; PHOSPHOINOSITIDE 3-KINASE; FIBRONECTIN EXPRESSION; TRANSCRIPTOME ANALYSIS; SIGNAL-TRANSDUCTION; RENAL HYPERTROPHY; CELL HYPERTROPHY	Glomerular hypertrophy is a hallmark of diabetic nephropathy. Akt kinase activated by transforming growth factor-beta 1 (TGF-beta) plays an important role in glomerular mesangial hypertrophy. However, the mechanisms of Akt activation by TGF-beta are not fully understood. Recently, miR-200 and its target FOG2 were reported to regulate the activity of phosphatidylinositol 3-kinase (the upstream activator of Akt) in insulin signaling. Here, we show that TGF-beta activates Akt in glomerular mesangial cells by inducing miR-200b and miR-200c, both of which target FOG2, an inhibitor of phosphatidylinositol 3-kinase activation. FOG2 expression was reduced in the glomeruli of diabetic mice as well as TGF-beta-treated mouse mesangial cells (MMC). FOG2 knockdown by siRNAs in MMC activated Akt and increased the protein content/cell ratio suggesting hypertrophy. A significant increase of miR-200b/c levels was detected in diabetic mouse glomeruli and TGF-beta-treated MMC. Transfection of MMC with miR-200b/c mimics significantly decreased the expression of FOG2. Conversely, miR-200b/c inhibitors attenuated TGF-beta-induced decrease in FOG2 expression. Furthermore, miR-200b/c mimics increased the protein content/cell ratio, whereas miR-200b/c inhibitors abrogated the TGF-beta-induced increase in protein content/cell. In addition, down-regulation of FOG2 by miR-200b/c could activate not only Akt but also ERK, which was also through PI3K activation. These data suggest a new mechanism for TGF-beta induced Akt activation through FOG2 down-regulation by miR-200b/c, which can lead to glomerular mesangial hypertrophy in the progression of diabetic nephropathy.	[Park, Jung Tak; Kato, Mitsuo; Yuan, Hang; Castro, Nancy; Lanting, Linda; Wang, Mei; Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Div Mol Diabet Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Park, Jung Tak/0000-0002-2325-8982	National Institutes of Health [DK081705, DK058191]; NIDDK; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081705, R01DK058191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081705 and DK058191 (to R. N.) and an NIDDK supplement (for N. C.). This work was also supported by a mentor-based post-doctoral fellowship from the American Diabetes Association (to N. C.).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Brosius Frank C, 2010, Expert Rev Endocrinol Metab, V5, P51; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Chuang TD, 2007, KIDNEY INT, V71, P867, DOI 10.1038/sj.ki.5002155; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Goruppi S, 2002, EMBO J, V21, P5427, DOI 10.1093/emboj/cdf535; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Lee HT, 2008, AM J PHYSIOL-RENAL, V294, pF371, DOI 10.1152/ajprenal.00277.2007; Lin CL, 2006, KIDNEY INT, V69, P1593, DOI 10.1038/sj.ki.5000329; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; OBryan GT, 1997, SEMIN NEPHROL, V17, P93; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; SHARMA K, 1994, AM J PHYSIOL-RENAL, V267, pF1094, DOI 10.1152/ajprenal.1994.267.6.F1094; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang G, 2010, LAB INVEST, V90, P98, DOI 10.1038/labinvest.2009.118; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wolf G, 2003, DIABETOLOGIA, V46, P1090, DOI 10.1007/s00125-003-1163-z; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhu YQ, 2005, DIABETES, V54, P1976, DOI 10.2337/diabetes.54.7.1976; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	64	64	68	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22469	22480		10.1074/jbc.M113.453043	http://dx.doi.org/10.1074/jbc.M113.453043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788640	Green Published, hybrid			2022-12-28	WOS:000330596300028
J	Wei, Z; Huang, D; Gao, F; Chang, WH; An, WJ; Coetzee, GA; Wang, K; Lu, WG				Wei, Zong; Huang, David; Gao, Fan; Chang, Wen-Hsuan; An, Woojin; Coetzee, Gerhard A.; Wang, Kai; Lu, Wange			Biological Implications and Regulatory Mechanisms of Long-range Chromosomal Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; GLOBIN LOCUS REQUIRES; CHROMATIN INTERACTIONS; SPATIAL-ORGANIZATION; NUCLEAR SPECKLES; TRANSCRIPTION; GENOME; TRANSLOCATIONS; DOMAINS; GENES	Development of high-throughput sequencing-based methods has enabled us to examine nuclear architecture at unprecedented resolution, allowing further examination of the function of long-range chromosomal interactions. Here, we review methods used to investigate novel long-range chromosomal interactions and genome-wide organization of chromatin. We further discuss transcriptional activation and silencing in relation to organization and positioning of gene loci and regulation of chromatin organization through protein complexes and noncoding RNAs.	[Wei, Zong; Huang, David; Gao, Fan; Chang, Wen-Hsuan] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wei, Zong; Huang, David; Gao, Fan; Chang, Wen-Hsuan; An, Woojin; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Gao, Fan; Wang, Kai] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Prevent Med & Psychiat, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	wangelu@usc.edu	Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020	Chang, Wen-Hsuan/0000-0002-6155-8644; Coetzee, Gerhard/0000-0001-8820-8364; Wei, Zong/0000-0002-4691-0101				Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; CREMER C, 1982, CYTOMETRY, V2, P287; Cremer T, 2006, EUR J HISTOCHEM, V50, P223; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ferrai C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000588; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gao F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-345; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Gonzalez-Suarez I, 2009, CELL CYCLE, V8, P3860, DOI 10.4161/cc.8.23.10092; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guillot PV, 2004, EXP CELL RES, V295, P460, DOI 10.1016/j.yexcr.2004.01.020; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Iborra FJ, 1996, EXP CELL RES, V229, P167, DOI 10.1006/excr.1996.0355; Iborra FJ, 1996, J CELL SCI, V109, P1427; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Levi V, 2005, BIOPHYS J, V89, P4275, DOI 10.1529/biophysj.105.066670; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Radford IR, 2002, INT J RADIAT BIOL, V78, P1081, DOI 10.1080/0955300021000034684; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2004, CHROMOSOMA, V112, P410; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Su JH, 2020, CELL, V182, P1641, DOI 10.1016/j.cell.2020.07.032; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	97	17	18	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22369	22377		10.1074/jbc.R113.485292	http://dx.doi.org/10.1074/jbc.R113.485292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779110	Green Published, hybrid			2022-12-28	WOS:000330596300018
J	Du, ZY; Tong, XM; Ye, X				Du, Zhaoyang; Tong, Xiaomei; Ye, Xin			Cyclin D1 Promotes Cell Cycle Progression through Enhancing NDR1/2 Kinase Activity Independent of Cyclin-dependent Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; CDK INHIBITORS; PROTEIN-KINASE; ACTIVATION; MECHANISM; PHOSPHORYLATION; REPRESSES; APOPTOSIS; RECEPTOR; FAMILY	Cyclin/cyclin-dependent kinases (Cdks) are critical protein kinases in regulating cell cycle progression. Among them, cyclin D1/Cdk4 exerts its function mainly in the G(1) phase. By using the tandem affinity purification tag approach, we identified a set of proteins interacting with Cdk4, including NDR1/2. Interestingly, confirming the interactions between NDR1/2 and cyclin D1/Cdk4, we observed that NDR1/2 interacted with cyclin D1 independent of Cdk4, but NDR1/2 and cyclin D1/Cdk4 did not phosphorylate each other. In addition, we found that NDR1/2 did not affect the kinase activity of cyclin D1/Cdk4 upon phosphorylation of GST-Rb. However, cyclin D1 but not Cdk4 promoted the kinase activity of NDR1/2. We also demonstrated that cyclin D1 K112E, which could not bind Cdk4, enhanced the kinase activity of NDR1/2. To test whether cyclin D1 promotes G(1)/S transition though enhancing NDR1/2 kinase activity, we performed flow cytometry analysis using cyclin D1 and cyclin D1 K112E Tet-On inducible cell lines. The data show that both cyclin D1 and cyclin D1 K112E promoted G(1)/S transition. Importantly, knockdown of NDR1/2 almost completely abolished the function of cyclin D1 K112E in promoting G(1)/S transition. Consistently, we found that the protein level of p21 was reduced in cells overexpressing cyclin D1 K112E but not when NDR1/2 was knocked down. Taken together, these results reveal a novel function of cyclin D1 in promoting cell cycle progression by enhancing NDR kinase activity independent of Cdk4.	[Du, Zhaoyang; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Du, Zhaoyang] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2012CB519003, 2011CB504705]; Chinese Academy of Sciences Innovation Project [KSCX2-EW-J-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences Innovation Project(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 81272272, Ministry of Science and Technology of China Grants 2012CB519003 and 2011CB504705, and Chinese Academy of Sciences Innovation Project KSCX2-EW-J-6.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; HARPER JW, 1993, CELL, V75, P805; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kohler RS, 2010, MOL CELL BIOL, V30, P4507, DOI 10.1128/MCB.00150-10; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Suzuki A, 2006, J BIOL CHEM, V281, P13915, DOI 10.1074/jbc.M511354200; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Zhou YP, 2011, MOL CELL BIOL, V31, P3603, DOI 10.1128/MCB.01389-10; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	24	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26678	26687		10.1074/jbc.M113.466433	http://dx.doi.org/10.1074/jbc.M113.466433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897809	Green Published, hybrid			2022-12-28	WOS:000330594500033
J	Heissler, SM; Liu, X; Korn, ED; Sellers, JR				Heissler, Sarah M.; Liu, Xiong; Korn, Edward D.; Sellers, James R.			Kinetic Characterization of the ATPase and Actin-activated ATPase Activities of Acanthamoeba castellanii Myosin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE NONMUSCLE MYOSIN; MOTOR DOMAIN; DICTYOSTELIUM-DISCOIDEUM; II-C; ADENOSINE-TRIPHOSPHATASE; 50/20-KDA JUNCTION; MGATPASE ACTIVITY; IN-VITRO; ISOFORM; PHOSPHORYLATION	Phosphorylation of Ser-639 in loop-2 of the catalytic motor domain of the heavy chain of Acanthamoeba castellanii myosin-2 and the phosphomimetic mutation S639D have been shown previously to down-regulate the actin-activated ATPase activity of both the full-length myosin and single-headed subfragment-1 (Liu, X., Lee, D. Y., Cai, S., Yu, S., Shu, S., Levine, R. L., and Korn, E. D. (2013) Proc. Natl. Acad. Sci. U. S. A. 110, E23-E32). In the present study we determined the kinetic constants for each step in the myosin and actomyosin ATPase cycles of recombinant wild-type S1 and S1-S639D. The kinetic parameter predominantly affected by the S639D mutation is the actin-activated release of inorganic phosphate from the acto myosin.ADP.P-i complex, which is the rate-limiting step in the steady-state actomyosin ATPase cycle. As consequence of this change, the duty ratio of this conventional myosin decreases. We speculate on the effect of Ser-639 phosphorylation on the processive behavior of myosin-2 filaments.	[Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-R3519, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov		Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006117, ZIAHL001786] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Brzeska H., 1996, J BIOL CHEM, V271, P16986; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves M A, 1995, Biophys J, V68, p194S; Geeves M. A, 1995, BIOPHYS J, V68, p199S; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Knetsch MLW, 1999, J BIOL CHEM, V274, P20133, DOI 10.1074/jbc.274.29.20133; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Liu X, 2013, P NATL ACAD SCI USA, V110, pE23, DOI 10.1073/pnas.1219713110; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MARUTA H, 1977, J BIOL CHEM, V252, P6501; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; POLLARD TD, 1978, J BIOL CHEM, V253, P4798; POLLARD TD, 1982, J CELL BIOL, V95, P816, DOI 10.1083/jcb.95.3.816; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; SINARD JH, 1989, J CELL BIOL, V109, P1537, DOI 10.1083/jcb.109.4.1537; SINARD JH, 1989, CELL MOTIL CYTOSKEL, V12, P42, DOI 10.1002/cm.970120106; SPUDICH JA, 1975, J BIOL CHEM, V250, P7485; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; WAGNER PD, 1981, NATURE, V292, P560, DOI 10.1038/292560a0; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200	46	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26709	26720		10.1074/jbc.M113.485946	http://dx.doi.org/10.1074/jbc.M113.485946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897814	Green Published, hybrid			2022-12-28	WOS:000330594500036
J	Shestakova, A; Curtiss, M; Davies, BA; Katzmann, DJ; Babst, M				Shestakova, Anna; Curtiss, Matt; Davies, Brian A.; Katzmann, David J.; Babst, Markus			The Linker Region Plays a Regulatory Role in Assembly and Activity of the Vps4 AAA ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; ESCRT-III; STRUCTURAL BASIS; MIT DOMAIN; PROTEIN; YEAST; LIP5; AUTOINHIBITION; CYTOKINESIS; TRAFFICKING	The AAA-type ATPase Vps4 functions with components of the ESCRT (endosomal sorting complex required for transport) machinery in membrane fission events that are essential for endosomal maturation, cytokinesis, and the formation of retroviruses. A key step in these events is the assembly of monomeric Vps4 into the active ATPase complex, which is aided in part by binding of Vps4 via its N-terminal MIT (microtubule interacting and trafficking) domain to its substrate ESCRT-III. We found that the 40-amino acid linker region between the MIT and the ATPase domain of Vps4 is not required for proper function but plays a role in regulating Vps4 assembly and ATPase activity. Deletion of the linker is expected to bring the MIT domains into close proximity to the central pore of the Vps4 complex. We propose that this localization of the MIT domain in linker-deleted Vps4 mimics a repositioning of the MIT domain normally caused by binding of Vps4 to ESCRT-III. This structure would allow the Vps4 complex to engage ESCRT-III subunits with both the pore and the MIT domain simultaneously, which might be essential for the ATP-driven disassembly of ESCRT-III.	[Shestakova, Anna; Curtiss, Matt; Babst, Markus] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA; [Shestakova, Anna; Curtiss, Matt; Babst, Markus] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Davies, Brian A.; Katzmann, David J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55902 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Mayo Clinic	Babst, M (corresponding author), Univ Utah, Dept Biol, 257 South 1400 E, Salt Lake City, UT 84112 USA.	babst@biology.utah.edu			National Institutes of Health [R01GM074171, R01GM73024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074171, R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074171 (to M. B.) and R01GM73024 (to D. J. K.).	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Darsow T, 2000, METHOD ENZYMOL, V327, P95, DOI 10.1016/S0076-6879(00)27270-4; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	30	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26810	26819		10.1074/jbc.M113.497032	http://dx.doi.org/10.1074/jbc.M113.497032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913684	hybrid, Green Published			2022-12-28	WOS:000330594500045
J	Ehmann, H; Hartwich, H; Salzig, C; Hartmann, N; Clement-Ziza, M; Ushakov, K; Avraham, KB; Bininda-Emonds, ORP; Hartmann, AK; Lang, P; Friauf, E; Nothwang, HG				Ehmann, Heike; Hartwich, Heiner; Salzig, Christian; Hartmann, Nadja; Clement-Ziza, Mathieu; Ushakov, Kathy; Avraham, Karen B.; Bininda-Emonds, Olaf R. P.; Hartmann, Alexander K.; Lang, Patrick; Friauf, Eckhard; Nothwang, Hans Gerd			Time-dependent Gene Expression Analysis of the Developing Superior Olivary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL-CHANGES; HEARING IMPAIRMENT; AUDITORY-SYSTEM; BRAIN; MOUSE; NEURONS; RAT; CHANNELS; SEROTONIN; REORGANIZATION	The superior olivary complex (SOC) is an essential auditory brainstem relay involved in sound localization. To identify the genetic program underlying its maturation, we profiled the rat SOC transcriptome at postnatal days 0, 4, 16, and 25 (P0, P4, P16, and P25, respectively), using genome-wide microarrays (41,012 oligonucleotides (oligos)). Differences in gene expression between two consecutive stages were highest between P4 and P16 (3.6%) and dropped to 0.06% between P16 and P25. To identify SOC-related genetic programs, we also profiled the entire brain at P4 and P25. The number of differentially expressed oligonucleotides between SOC and brain almost doubled from P4 to P25 (4.4% versus 7.6%). These data demonstrate considerable molecular specification around hearing onset, which is rapidly finalized. Prior to hearing onset, several transcription factors associated with the peripheral auditory system were up-regulated, probably coordinating the development of the auditory system. Additionally, crystallin-gamma subunits and serotonin-related genes were highly expressed. The molecular repertoire of mature neurons was sculpted by SOC-related up-and down-regulation of voltage-gated channels and G-proteins. Comparison with the brain revealed a significant enrichment of hearing impairment-related oligos in the SOC (26 in the SOC, only 11 in the brain). Furthermore, 29 of 453 SOC-related oligos mapped within 19 genetic intervals associated with hearing impairment. Together, we identified sequential genetic programs in the SOC, thereby pinpointing candidates that may guide its development and ensure proper function. The enrichment of hearing impairment-related genes in the SOC may have implications for restoring hearing because central auditory structures might be more severely affected than previously appreciated.	[Ehmann, Heike; Hartmann, Nadja; Friauf, Eckhard] Univ Kaiserslautern, Dept Biol, Anim Physiol Grp, D-67663 Kaiserslautern, Germany; [Hartwich, Heiner; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Neurogenet Grp, D-26111 Oldenburg, Germany; [Salzig, Christian; Lang, Patrick] Fraunhofer Inst Ind Math ITWM, Dept Syst Anal Prognosis & Control, D-67663 Kaiserslautern, Germany; [Clement-Ziza, Mathieu] Tech Univ Dresden, Biotechnol Zentrum, D-01062 Dresden, Germany; [Ushakov, Kathy; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Ushakov, Kathy; Avraham, Karen B.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Bininda-Emonds, Olaf R. P.] Carl von Ossietzky Univ Oldenburg, Dept Systemat & Evolutionary Biol, D-26111 Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, D-26111 Oldenburg, Germany; [Hartmann, Alexander K.] Carl von Ossietzky Univ Oldenburg, Computat Theoret Phys Grp, D-26111 Oldenburg, Germany; [Nothwang, Hans Gerd] Ctr Excellence Hearing4all, D-26111 Oldenburg, Germany	University of Kaiserslautern; Carl von Ossietzky Universitat Oldenburg; Fraunhofer Gesellschaft; Technische Universitat Dresden; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Bininda-Emonds, Olaf R.P:/C-5405-2008; Clément-Ziza, Mathieu/J-4146-2012; Friauf, Eckhard/D-7529-2012	Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X; Clément-Ziza, Mathieu/0000-0003-2763-249X; Friauf, Eckhard/0000-0002-1833-1698; Nothwang, Hans Gerd/0000-0001-7695-6437; Avraham, Karen B/0000-0002-4913-251X	A4 grant of the State Rhineland Palatinate within the Hochschulprogramm Wissen-Schafft-Zukunft; Deutsche Forschungsgemeinschaft [428/5-1]; Cluster of Excellence Hearing4all; Research Center (CM)2 of the University of Kaiserslautern; Israel Science Foundation [1320/11]; I-CORE Gene Regulation in Complex Human Disease, Center [41/11]; Ph.D. program Hearing of the State of Lower Saxony	A4 grant of the State Rhineland Palatinate within the Hochschulprogramm Wissen-Schafft-Zukunft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Hearing4all; Research Center (CM)2 of the University of Kaiserslautern; Israel Science Foundation(Israel Science Foundation); I-CORE Gene Regulation in Complex Human Disease, Center; Ph.D. program Hearing of the State of Lower Saxony	This work was supported by an A4 grant of the State Rhineland Palatinate within the Hochschulprogramm Wissen-Schafft-Zukunft, Deutsche Forschungsgemeinschaft Grant 428/5-1 (to H. G. N.), the Cluster of Excellence Hearing4all (H. G. N.), the Research Center (CM)2 of the University of Kaiserslautern, Israel Science Foundation Grant 1320/11, and I-CORE Gene Regulation in Complex Human Disease, Center 41/11 (to K. B. A.).; Supported in part by a stipend in the Ph.D. program Hearing of the State of Lower Saxony.	Alasti F, 2008, AM J HUM GENET, V82, P982, DOI 10.1016/j.ajhg.2008.02.015; Allen PD, 2012, J NEUROSCI, V32, P2538, DOI 10.1523/JNEUROSCI.1958-11.2012; Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; Chermak G.D., 1997, CENTRAL AUDITORY PRO; Di Bonito M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003249; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Duncan JS, 2012, ADV EXP MED BIOL, V739, P173, DOI 10.1007/978-1-4614-1704-0_11; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Efron B., 1994, MONOGRAPHS STAT APPL; Ehmann H, 2008, HEARING RES, V245, P65, DOI 10.1016/j.heares.2008.08.008; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; FRIAUF E, 1990, NEUROSCI LETT, V120, P58, DOI 10.1016/0304-3940(90)90167-8; FRIAUF E, 1993, J COMP NEUROL, V334, P59, DOI 10.1002/cne.903340105; Friauf E, 1999, J COMP NEUROL, V412, P17; Friauf E, 2004, SPR HDB AUD, V23, P49; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Griffiths TD, 2002, CURR OPIN NEUROL, V15, P31, DOI 10.1097/00019052-200202000-00006; Harris JA, 2005, J COMP NEUROL, V493, P460, DOI 10.1002/cne.20776; Hartmann A. K., 2009, PRACTICAL GUIDE COMP; Hirtz JJ, 2012, J NEUROSCI, V32, P14602, DOI 10.1523/JNEUROSCI.0765-12.2012; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Howell DM, 2007, J COMP NEUROL, V504, P533, DOI 10.1002/cne.21443; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurteau GJ, 2002, ANAL BIOCHEM, V307, P304, DOI 10.1016/S0003-2697(02)00058-1; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kapatos G, 1999, J NEUROCHEM, V72, P669, DOI 10.1046/j.1471-4159.1999.0720669.x; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Karschin C, 2001, MOL CELL NEUROSCI, V18, P632, DOI 10.1006/mcne.2001.1045; Klug A, 2006, J NEUROPHYSIOL, V96, P1547, DOI 10.1152/jn.01381.2005; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kulesza RJ, 2011, BRAIN RES, V1367, P360, DOI 10.1016/j.brainres.2010.10.015; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Lohmann C, 1999, J NEUROBIOL, V41, P596, DOI 10.1002/(SICI)1097-4695(199912)41:4<596::AID-NEU14>3.0.CO;2-T; Lukose R, 2011, BRAIN RES, V1398, P102, DOI 10.1016/j.brainres.2011.05.013; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Oertel D, 2009, J PHYSIOL-LONDON, V587, P2417, DOI 10.1113/jphysiol.2009.173575; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Rosengauer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049503; Rosenhall U, 2003, EAR HEARING, V24, P206, DOI 10.1097/01.AUD.0000069326.11466.7E; Roth DAE, 2012, DEV MED CHILD NEUROL, V54, P23, DOI 10.1111/j.1469-8749.2011.04149.x; RUSSELL FA, 1995, J COMP NEUROL, V352, P607, DOI 10.1002/cne.903520409; Sachs L., 2009, ANGEW STAT; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; Satheesh SV, 2012, HUM MOL GENET, V21, P3896, DOI 10.1093/hmg/dds217; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Scott LL, 2007, J PHYSIOL-LONDON, V583, P647, DOI 10.1113/jphysiol.2007.136366; Smith PH, 2002, SPR HDB AUD, V15, P6; Song P, 2006, J BIOL CHEM, V281, P15582, DOI 10.1074/jbc.M512866200; Stead JDH, 2006, J NEUROSCI, V26, P345, DOI 10.1523/JNEUROSCI.2755-05.2006; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Tallal P, 2012, P NATL ACAD SCI USA, V109, P16406, DOI 10.1073/pnas.1214122109; TAYLOR MJ, 1982, CAN J NEUROL SCI, V9, P429, DOI 10.1017/S0317167100044346; Teagle HFB, 2010, EAR HEARING, V31, P325, DOI 10.1097/AUD.0b013e3181ce693b; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Vazquez-Echeverria C, 2008, DEV BIOL, V322, P167, DOI 10.1016/j.ydbio.2008.07.025; Vetter DE, 2002, NAT GENET, V31, P363, DOI 10.1038/ng914; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WAHLE P, 1992, J NEUROSCI METH, V41, P153, DOI 10.1016/0165-0270(92)90057-K; Zhao GY, 2008, NEUROSCI RES, V61, P420, DOI 10.1016/j.neures.2008.04.014	83	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25865	25879		10.1074/jbc.M113.490508	http://dx.doi.org/10.1074/jbc.M113.490508			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893414	Green Published, hybrid			2022-12-28	WOS:000330623300018
J	Long, PM; Moffett, JR; Namboodiri, AMA; Viapiano, MS; Lawler, SE; Jaworski, DM				Long, Patrick M.; Moffett, John R.; Namboodiri, Aryan M. A.; Viapiano, Mariano S.; Lawler, Sean E.; Jaworski, Diane M.			N-Acetylaspartate (NAA) and N-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; ISOCITRATE DEHYDROGENASE 1; CENTRAL-NERVOUS-SYSTEM; CANAVAN-DISEASE; HUMAN ASPARTOACYLASE; NEURAL PROGENITORS; TISSUE INHIBITOR; PRECURSOR CELLS; IDH1 MUTATION; IN-VITRO	Metabolic reprogramming is a pathological feature of cancer and a driver of tumor cell transformation. N-Acetylaspartate (NAA) is one of the most abundant amino acid derivatives in the brain and serves as a source of metabolic acetate for oligodendrocyte myelination and protein/histone acetylation or a precursor for the synthesis of the neurotransmitter N-acetylaspartylglutamate (NAAG). NAA and NAAG as well as aspartoacylase (ASPA), the enzyme responsible for NAA degradation, are significantly reduced in glioma tumors, suggesting a possible role for decreased acetate metabolism in tumorigenesis. This study sought to examine the effects of NAA and NAAG on primary tumor-derived glioma stem-like cells (GSCs) from oligodendroglioma as well as proneural and mesenchymal glioblastoma, relative to oligodendrocyte progenitor cells (Oli-Neu). Although the NAA dicarboxylate transporter NaDC3 is primarily thought to be expressed by astrocytes, all cell lines expressed NaDC3 and, thus, are capable of NAA up-take. Treatment with NAA or NAAG significantly increased GSC growth and suppressed differentiation of Oli-Neu cells and proneural GSCs. Interestingly, ASPA was expressed in both the cytosol and nuclei of GSCs and exhibited greatest nuclear immunoreactivity in differentiation-resistant GSCs. Both NAA and NAAG elicited the expression of a novel immunoreactive ASPA species in select GSC nuclei, suggesting differential ASPA regulation in response to these metabolites. Therefore, this study highlights a potential role for nuclear ASPA expression in GSC malignancy and suggests that the use of NAA or NAAG is not an appropriate therapeutic approach to increase acetate bioavailability in glioma. Thus, an alternative acetate source is required.	[Long, Patrick M.; Jaworski, Diane M.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Moffett, John R.; Namboodiri, Aryan M. A.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Viapiano, Mariano S.; Lawler, Sean E.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02215 USA	University of Vermont; Uniformed Services University of the Health Sciences - USA; Harvard University; Brigham & Women's Hospital	Jaworski, DM (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, 149 Beaumont Ave,HSRF 418, Burlington, VT 05405 USA.	diane.jaworski@uvm.edu	Viapiano, Mariano/AAE-5787-2019	Viapiano, Mariano/0000-0002-8756-388X	National Institutes of Health (NIH) [R01NS045225]; Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium; Neuroscience COBRE [NIH NCRR P20 RR016435]; NATIONAL CANCER INSTITUTE [P30CA022435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045225] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium; Neuroscience COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01NS045225 (NINDS and Center for Research Resources (NCRR)) and Pilot Project grants from the Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium and Neuroscience COBRE (NIH NCRR P20 RR016435) (to D. M. J.).	Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; Becker I, 2010, J BIOL CHEM, V285, P29156, DOI 10.1074/jbc.M110.111765; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; DADAMO AF, 1973, J NEUROCHEM, V20, P1275, DOI 10.1111/j.1471-4159.1973.tb00097.x; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Goldberg R P, 1980, Adv Exp Med Biol, V132, P413; GOLDSTEIN FB, 1959, BIOCHIM BIOPHYS ACTA, V33, P583, DOI 10.1016/0006-3002(59)90161-1; Hershfield JR, 2006, FASEB J, V20, P2139, DOI 10.1096/fj.05-5358fje; Jaworski DM, 2006, J NEUROCHEM, V98, P234, DOI 10.1111/j.1471-4159.2006.03855.x; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kaul R, 1996, AM J HUM GENET, V59, P95; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; Kirmani BF, 2003, DEV BRAIN RES, V140, P105, DOI 10.1016/S0165-3806(02)00592-8; Kumar S, 2009, J NEUROSCI RES, V87, P3415, DOI 10.1002/jnr.22233; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Le Coq J, 2006, BIOCHEMISTRY-US, V45, P5878, DOI 10.1021/bi052608w; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Lluri G, 2008, EXP CELL RES, V314, P11, DOI 10.1016/j.yexcr.2007.06.007; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; Luyt K, 2006, J NEUROCHEM, V99, P641, DOI 10.1111/j.1471-4159.2006.04103.x; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Madiraju Padma, 2009, Epigenetics, V4, P399; Mattan NS, 2010, NEUROBIOL DIS, V40, P432, DOI 10.1016/j.nbd.2010.07.003; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett JR, 2011, GLIA, V59, P1414, DOI 10.1002/glia.21186; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Rijpkema M, 2003, NMR BIOMED, V16, P12, DOI 10.1002/nbm.807; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	49	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26188	26200		10.1074/jbc.M113.487553	http://dx.doi.org/10.1074/jbc.M113.487553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884408	Green Published, hybrid			2022-12-28	WOS:000330623300049
J	Loutet, SA; Kobylarz, MJ; Chau, CHT; Murphy, MEP				Loutet, Slade A.; Kobylarz, Marek J.; Chau, Crystal H. T.; Murphy, Michael E. P.			IruO Is a Reductase for Heme Degradation by IsdI and IsdG Proteins in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; THIOREDOXIN REDUCTASE; DEGRADING ENZYMES; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-ANTHRACIS; BINDING PROPERTIES; STRESS-RESPONSE; IRON TRANSPORT; IDENTIFICATION; PURIFICATION	Staphylococcus aureus is a common hospital-and community-acquired bacterium that can cause devastating infections and is often multidrug-resistant. Iron acquisition is required by S. aureus during an infection, and iron acquisition pathways are potential targets for therapies. The gene NWMN2274 in S. aureus strain Newman is annotated as an oxidoreductase of the diverse pyridine nucleotide-disulfide oxidoreductase (PNDO) family. Weshow that NWMN2274 is an electron donor to IsdG and IsdI catalyzing the degradation of heme, and we have renamed this protein IruO. Recombinant IruO is a FAD-containing NADPH-dependent reductase. In the presence of NADPH and IruO, either IsdI or IsdG degraded bound heme 10-fold more rapidly than with the chemical reductant ascorbic acid. Varying IsdI-heme substrate and monitoring loss of the heme Soret band gave a K-m of 15 +/- 4 mu M, a k(cat) of 5.2 +/- 0.7 min(-1), and a k(cat)/K-m of 5.8 x 10(3) M-1 s(-1). From HPLC and electronic spectra, the major heme degradation products are 5-oxo-delta-bilirubin and 15-oxo-beta-bilirubin (staphylobilins), as observed with ascorbic acid. Although heme degradation by IsdI or IsdG can occur in the presence of H2O2, the addition of catalase and superoxide dismutase did not disrupt NADPH/IruO heme degradation reactions. The degree of electron coupling between IruO and IsdI or IsdG remains to be determined. Homologs of IruO were identified by sequence similarity in the genomes of Gram-positive bacteria that possess IsdG-family heme oxygenases. A phylogeny of these homologs identifies a distinct clade of pyridine nucleotide-disulfide oxidoreductases likely involved in iron uptake systems. IruO is the likely in vivo reductant required for heme degradation by S. aureus.	[Loutet, Slade A.; Kobylarz, Marek J.; Chau, Crystal H. T.; Murphy, Michael E. P.] Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014	Canadian Institutes of Health Research [MOP-49597]; Natural Science and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Canadian Institutes of Health Research Grant MOP-49597 (to M. E. P. M.).; Holds a Natural Science and Engineering Research Council post-doctoral fellowship.	Aliverti A, 1999, METH MOL B, V131, P9; Allard M, 2006, MICROBES INFECT, V8, P1679, DOI 10.1016/j.micinf.2006.01.022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bieger B, 2001, J MOL BIOL, V307, P1, DOI 10.1006/jmbi.2000.4441; BONKOVSKY HL, 1990, EUR J BIOCHEM, V189, P155, DOI 10.1111/j.1432-1033.1990.tb15472.x; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; Carlson P, 2009, AM HIST, V44, P34; Chang W, 2006, ENVIRON SCI TECHNOL, V40, P5124, DOI 10.1021/es060354b; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Glaser P, 2001, SCIENCE, V294, P849; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Haley KP, 2011, J BACTERIOL, V193, P4749, DOI 10.1128/JB.00436-11; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Heilbronner S, 2011, FEMS MICROBIOL LETT, V322, P60, DOI 10.1111/j.1574-6968.2011.02339.x; Jang HJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-411; Kirkensgaard KG, 2009, ACTA CRYSTALLOGR D, V65, P932, DOI 10.1107/S0907444909021817; Komori H, 2010, PROTEIN SCI, V19, P2279, DOI 10.1002/pro.508; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KURIYAN J, 1991, NATURE, V352, P172, DOI 10.1038/352172a0; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mason WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006668; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; NAVARRO JA, 1991, BIOCHEMISTRY-US, V30, P2192, DOI 10.1021/bi00222a024; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira MA, 2010, BIOCHEMISTRY-US, V49, P3317, DOI 10.1021/bi901962p; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Pluym M, 2007, BIOCHEMISTRY-US, V46, P12777, DOI 10.1021/bi7009585; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Seo D, 2004, ARCH MICROBIOL, V182, P80, DOI 10.1007/s00203-004-0701-5; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Tiedemann MT, 2012, J AM CHEM SOC, V134, P16578, DOI 10.1021/ja305115y; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; WEINBERG ED, 1977, AM J CLIN NUTR, V30, P1485, DOI 10.1093/ajcn/30.9.1485; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Xiong AM, 2000, MICROBIOL-UK, V146, P659, DOI 10.1099/00221287-146-3-659; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12	78	21	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25749	25759		10.1074/jbc.M113.470518	http://dx.doi.org/10.1074/jbc.M113.470518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893407	Green Published, hybrid			2022-12-28	WOS:000330623300008
J	Monneau, YR; Soufari, H; Nelson, CJ; Mackereth, CD				Monneau, Yoan R.; Soufari, Heddy; Nelson, Christopher J.; Mackereth, Cameron D.			Structure and Activity of the Peptidyl-Prolyl Isomerase Domain from the Histone Chaperone Fpr4 toward Histone H3 Proline Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERASE; NMR CHEMICAL-SHIFTS; SACCHAROMYCES-CEREVISIAE; IMMUNOSUPPRESSANT FK506; FK506-BINDING PROTEIN; BINDING-PROTEIN; BIOLOGICAL MACROMOLECULES; CATALYTIC DOMAIN; GENE-EXPRESSION; YEAST	The FK506-binding protein (FKBP) family of peptidyl-prolyl isomerases (PPIases) is characterized by a common catalytic domain that binds to the inhibitors FK506 and rapamycin. As one of four FKBPs within the yeast Saccharomyces cerevisiae, Fpr4 has been described as a histone chaperone, and is in addition implicated in epigenetic function in part due to its mediation of cis-trans conversion of proline residues within histone tails. To better understand the molecular details of this activity, we have determined the solution structure of the Fpr4 C-terminal PPIase domain by using NMR spectroscopy. This canonical FKBP domain actively increases the rate of isomerization of three decapeptides derived from the N terminus of yeast histone H3, whereas maintaining intrinsic cis and trans populations. Observation of the uncatalyzed and Fpr4-catalyzed isomerization rates at equilibrium demonstrate Pro16 and Pro30 of histone H3as the major proline targets of Fpr4, with little activity shown against Pro38. This alternate ranking of the three target prolines, as compared with affinity determination or the classical chymotrypsin-based fluorescent assay, reveals the mechanistic importance of substrate residues C-terminal to the peptidylprolyl bond.	[Monneau, Yoan R.; Soufari, Heddy; Mackereth, Cameron D.] Inst Europeen Chim & Biol, F-33607 Pessac, France; [Soufari, Heddy; Mackereth, Cameron D.] Univ Bordeaux, INSERM, U869, F-33076 Bordeaux, France; [Nelson, Christopher J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Victoria	Mackereth, CD (corresponding author), Inst Europeen Chim & Biol, 2 Rue Robert Escarpit, F-33607 Pessac, France.	c.mackereth@iecb.u-bordeaux.fr	Monneau, Yoan Rocky/GQQ-2938-2022; Mackereth, Cameron D./F-7946-2013	Monneau, Yoan Rocky/0000-0003-0773-6603; Mackereth, Cameron D./0000-0002-0776-7947	Institut de Chimie des Substances Naturelles; France Canada Research Fund; Aquitaine regional government; Inserm; French national equipment network	Institut de Chimie des Substances Naturelles; France Canada Research Fund; Aquitaine regional government(Region Nouvelle-Aquitaine); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French national equipment network	This work was supported in part by the Institut de Chimie des Substances Naturelles, the France Canada Research Fund, the Aquitaine regional government, Inserm, and the French national equipment network for NMR spectroscopy.	Alag R, 2013, EUKARYOT CELL, V12, P627, DOI 10.1128/EC.00016-13; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CLARDY J, 1993, ANN NY ACAD SCI, V685, P37, DOI 10.1111/j.1749-6632.1993.tb35848.x; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; Geitner AJ, 2012, J MOL BIOL, V420, P335, DOI 10.1016/j.jmb.2012.04.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Greenwood AI, 2011, J BIOMOL NMR, V51, P21, DOI 10.1007/s10858-011-9538-9; Gudavicius G, 2013, BIOCHEM SOC T, V41, P761, DOI 10.1042/BST20130013; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2010, CELL RES, V20, P357, DOI 10.1038/cr.2010.22; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Monneau YR, 2012, BIOMOL NMR ASSIGN, V6, P123, DOI 10.1007/s12104-011-9338-x; MOORE JM, 1991, NATURE, V351, P248, DOI 10.1038/351248a0; Mulder FAA, 2009, CHEMBIOCHEM, V10, P1477, DOI 10.1002/cbic.200900086; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Suzuki R, 2003, J MOL BIOL, V328, P1149, DOI 10.1016/S0022-2836(03)00379-6; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weiss MS, 1998, NAT STRUCT BIOL, V5, P676, DOI 10.1038/1368; Xiao HJ, 2006, FEBS LETT, V580, P4357, DOI 10.1016/j.febslet.2006.06.093	54	17	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25826	25837		10.1074/jbc.M113.479964	http://dx.doi.org/10.1074/jbc.M113.479964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888048	hybrid, Green Published			2022-12-28	WOS:000330623300015
J	Park, YK; Park, B; Lee, S; Choi, K; Moon, Y; Park, H				Park, Young-Kwon; Park, Bongju; Lee, Seongyeol; Choi, Kang; Moon, Yunwon; Park, Hyunsung			Hypoxia-inducible Factor-2 alpha-dependent Hypoxic Induction of Wnt10b Expression in Adipogenic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BETA-CATENIN; STEM-CELLS; EMBRYONIC-DEVELOPMENT; INHIBIT ADIPOGENESIS; INSULIN-RESISTANCE; BINDING PROTEIN; GENE-EXPRESSION; FACTOR 1-ALPHA; DNA-BINDING	Adipocyte hyperplasia and hypertrophy in obesity can lead to many changes in adipose tissue, such as hypoxia, metabolic dysregulation, and enhanced secretion of cytokines. In this study, hypoxia increased the expression of Wnt10b in both human and mouse adipogenic cells, but not in hypoxia-inducible factor (HIF)-2 alpha-deficient adipogenic cells. Chromatin immunoprecipitation analysis revealed that HIF-2 alpha, but not HIF-1 alpha, bound to the Wnt10b enhancer region as well as upstream of the Wnt1 gene, which is encoded by an antisense strand of the Wnt10b gene. Hypoxia-conditioned medium(H-CM) induced phosphorylation of lipoprotein-receptor-related protein 6 as well as beta-catenin-dependent gene expression in normoxic cells, which suggests that H-CM contains canonical Wnt signals. Furthermore, adipogenesis of both human mesenchymal stem cells and mouse preadipocytes was inhibited by H-CM even under normoxic conditions. These results suggest that O-2 concentration gradients influence the formation of Wnt ligand gradients, which are involved in the regulation of pluripotency, cell proliferation, and cell differentiation.	[Park, Young-Kwon; Park, Bongju; Lee, Seongyeol; Choi, Kang; Moon, Yunwon; Park, Hyunsung] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Park, H (corresponding author), Univ Seoul, Dept Life Sci, Siripdae Gil 13, Seoul 130743, South Korea.	hspark@uos.ac.kr		Park, Young-Kwon/0000-0002-3473-7233	National Research Foundation of Korea (NRF); Korea government [2011-0016318, 2012M3A9B6055343]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korea government (Grants 2011-0016318 and 2012M3A9B6055343) (to H. P.).	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Park YK, 2010, J BIOL CHEM, V285, P3289, DOI 10.1074/jbc.M109.059212; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	45	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26311	26322		10.1074/jbc.M113.500835	http://dx.doi.org/10.1074/jbc.M113.500835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23900840	Green Published, hybrid			2022-12-28	WOS:000330623300060
J	Viskov, C; Elli, S; Urso, E; Gaudesi, D; Mourier, P; Herman, F; Boudier, C; Casu, B; Torri, G; Guerrini, M				Viskov, Christian; Elli, Stefano; Urso, Elena; Gaudesi, Davide; Mourier, Pierre; Herman, Frederic; Boudier, Christian; Casu, Benito; Torri, Giangiacomo; Guerrini, Marco			Heparin Dodecasaccharide Containing Two Antithrombin-binding Pentasaccharides STRUCTURAL FEATURES AND BIOLOGICAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARIN; ANTICOAGULANT ACTIVITIES; OLIGOSACCHARIDES; BIOSYNTHESIS; OCTASACCHARIDES; SEQUENCE; AFFINITY; 3-O-SULFOTRANSFERASE; CONFORMATION; SULFATE	The antithrombin (AT) binding properties of heparin and low molecular weight heparins are strongly associated to the presence of the pentasaccharide sequence AGA*IA (A(NAc,6S)-GlcUA-A(NS,3,6S)-I-2S-A(NS,6S)). By using the highly chemoselective depolymerization to prepare new ultra low molecular weight heparin and coupling it with the original separation techniques, it was possible to isolate a polysaccharide with a biosynthetically unexpected structure and excellent antithrombotic properties. It consisted of a dodecasaccharide containing an unsaturated uronate unit at the nonreducing end and two contiguous AT-binding sequences separated by a nonsulfated iduronate residue. This novel oligosaccharide was characterized byNMRspectroscopy, and its binding with AT was determined by fluorescence titration, NMR, and LC-MS. The dodecasaccharide displayed a significantly increased anti-FXa activity compared with those of the pentasaccharide, fondaparinux, and low molecular weight heparin enoxaparin.	[Elli, Stefano; Urso, Elena; Gaudesi, Davide; Casu, Benito; Torri, Giangiacomo; Guerrini, Marco] Ist Ric Chim & Biochim G Ronzoni, I-20133 Milan, Italy; Sanofi, F-94403 Vitry Sur Seine, France; [Boudier, Christian] Univ Strasbourg, CNRS, UMR 7213, Fac Pharm,Lab Biophoton & Pharmacol, F-67401 Illkirch Graffenstaden, France	Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guerrini, M (corresponding author), Ist Ric Chim & Biochim G Ronzoni, NMR Ctr, Via G Colombo 81, I-20133 Milan, Italy.	guerrini@ronzoni.it	Elli, Stefano/AAW-7126-2021; Elli, Stefano SE/U-7406-2018; Boudier, Christian/N-3841-2018	Elli, Stefano/0000-0003-0686-2480; Elli, Stefano SE/0000-0003-0686-2480; Boudier, Christian/0000-0002-5534-6389; Torri, Giangiacomo/0000-0002-2077-1203; Guerrini, Marco/0000-0001-7246-9113	EC [261863]	EC(European CommissionEuropean Commission Joint Research Centre)	We thank Dr. Detlef Moskau (Bruker Biospin, Zurich, Switzerland) for the access to the 800 MHz NMR spectrometer. The 900 MHz spectra were recorded with the support of Dr. Hans Wienk, at the SONNMR Large Scale Facility in Utrecht, The Netherlands, and supported by Access to Research Infrastructure Activity in the 7th Framework Program of the EC (Project Number 261863, Bio-NMR).	Barowcliffe T. W., 2012, HEPARIN CENTURY PROG, P3; Biberovic V, 2011, Mixtures of sulfated oligosaccharides, Patent No. [US8003623, 8003623, 8,003,623 B2]; Bisio A, 2009, THROMB HAEMOSTASIS, V102, P865, DOI 10.1160/TH09-02-0081; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052; Gray E, 2008, THROMB HAEMOSTASIS, V99, P807, DOI 10.1160/TH08-01-0032; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Guerrini M, 2006, BIOCHEM J, V399, P191, DOI 10.1042/BJ20060656; Guerrini M, 2013, BIOCHEM J, V449, P343, DOI 10.1042/BJ20121309; Guerrini M, 2010, J MED CHEM, V53, P8030, DOI 10.1021/jm100771s; HORNER AA, 1988, BIOCHEM J, V251, P141, DOI 10.1042/bj2510141; Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265; JESKE W, 1995, SEMIN THROMB HEMOST, V21, P193, DOI 10.1055/s-2007-1000395; JORDAN RE, 1982, J BIOL CHEM, V257, P400; KUSCHE M, 1988, J BIOL CHEM, V263, P15474; Lever Rebecca, 2012, Handb Exp Pharmacol, P281, DOI 10.1007/978-3-642-23056-1_12; Lima MA, 2013, THROMB HAEMOSTASIS, V109, P471, DOI 10.1160/TH12-11-0795; LINDAHL U, 1986, TRENDS BIOCHEM SCI, V11, P221, DOI 10.1016/0968-0004(86)90011-3; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Mourier P., 2012, Patent WO, Patent No. [2012/140580 A1, 2012140580]; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; PEJLER G, 1987, J BIOL CHEM, V262, P11413; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; ROSENFELD L, 1988, J BIOL CHEM, V263, P262; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10365, DOI 10.1073/pnas.97.19.10365; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Toida T, 1996, J BIOL CHEM, V271, P32040, DOI 10.1074/jbc.271.50.32040; Viskov C, 2009, J THROMB HAEMOST, V7, P1143, DOI 10.1111/j.1538-7836.2009.03447.x; WLAD H, 1994, J BIOL CHEM, V269, P24538	32	38	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25895	25907		10.1074/jbc.M113.485268	http://dx.doi.org/10.1074/jbc.M113.485268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23843463	hybrid, Green Published			2022-12-28	WOS:000330623300020
J	Zhao, PS; Canals, M; Murphy, JE; Klingler, D; Eriksson, EM; Pelayo, JC; Hardt, M; Bunnett, NW; Poole, DP				Zhao, Peishen; Canals, Meritxell; Murphy, Jane E.; Klingler, Diana; Eriksson, Emily M.; Pelayo, Juan-Carlos; Hardt, Markus; Bunnett, Nigel W.; Poole, Daniel P.			Agonist-biased Trafficking of Somatostatin Receptor 2A in Enteric Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ARRESTIN; CELLS; INTERNALIZATION; ENDOSOMES; MOUSE; ENDOCYTOSIS; OCTREOTIDE; EXPRESSION; ISOFORMS	Somatostatin (SST) 14 and SST 28 activate somatostatin 2A receptors (SSTR2A) on enteric neurons to control gut functions. SST analogs are treatments of neuroendocrine and bleeding disorders, cancer, and diarrhea, with gastrointestinal side effects of constipation, abdominal pain, and nausea. How endogenous agonists and drugs differentially regulate neuronal SSTR2A is unexplored. We evaluated SSTR2A trafficking in murine myenteric neurons and neuroendocrine AtT-20 cells by microscopy and determined whether agonist degradation by endosomal endothelin-converting enzyme 1 (ECE-1) controls SSTR2A trafficking and association with beta-arrestins, key regulators of receptors. SST-14, SST-28, and peptide analogs (octreotide, lanreotide, and vapreotide) stimulated clathrin-and dynamin-mediated internalization of SSTR2A, which colocalized with ECE-1 in endosomes and the Golgi. After incubation with SST-14, SSTR2A recycled to the plasma membrane, which required active ECE-1 and an intact Golgi. SSTR2A activated by SST-28, octreotide, lanreotide, or vapreotide was retained within the Golgi and did not recycle. Although ECE-1 rapidly degraded SST-14, SST-28 was resistant to degradation, and ECE-1 did not degrade SST analogs. SST-14 and SST-28 induced transient interactions between SSTR2A and beta-arrestins that were stabilized by an ECE-1 inhibitor. Octreotide induced sustained SSTR2A/beta-arrestin interactions that were not regulated by ECE-1. Thus, when activated by SST-14, SSTR2A internalizes and recycles via the Golgi, which requires ECE-1 degradation of SST-14 and receptor dissociation from beta-arrestins. After activation by ECE-1-resistant SST-28 and analogs, SSTR2A remains in endosomes because of sustained beta-arrestin interactions. Therapeutic SST analogs are ECE-1-resistant and retain SSTR2A in endosomes, which may explain their long-lasting actions.	[Zhao, Peishen; Canals, Meritxell; Bunnett, Nigel W.; Poole, Daniel P.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Murphy, Jane E.; Pelayo, Juan-Carlos] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Klingler, Diana; Hardt, Markus] Forsyth Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Eriksson, Emily M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Harvard University; Forsyth Institute; University of California System; University of California San Francisco	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu; Daniel.Poole@Monash.edu	Poole, Daniel/AET-6645-2022; Zhao, Peishen/AFQ-6840-2022; Hardt, Markus/M-8569-2019	Poole, Daniel/0000-0002-6168-8422; Hardt, Markus/0000-0002-2300-216X; Canals, Meritxell/0000-0002-7942-5006; Eriksson, Emily/0000-0002-7851-973X; Bunnett, Nigel W./0000-0003-3367-0644	NIDCR National Institutes of Health [1R01DE019796]; National Health and Medical Research Council (NHMRC) [63303, 103188]; Monash University; NHMRC [454858]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	NIDCR National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by NIDCR National Institutes of Health Grant 1R01DE019796 (to M. H. and N. W. B). This work was also supported by National Health and Medical Research Council (NHMRC) Grants 63303 and 103188 and Monash University (to N. W. B.) and by NHMRC Grant 454858 (to D. P. P.).	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Gilroy John J, 2002, Treat Endocrinol, V1, P149, DOI 10.2165/00024677-200201030-00002; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HOFLAND LJ, 1995, ENDOCRINOLOGY, V136, P3698, DOI 10.1210/en.136.9.3698; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kocan M, 2010, FRONT ENDOCRINOL, V1, P12; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Liu QS, 2005, MOL PHARMACOL, V68, P90, DOI 10.1124/mol.105.011767; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nunn C, 2004, BRIT J PHARMACOL, V142, P150, DOI 10.1038/sj.bjp.0705735; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Sarret P, 2004, J BIOL CHEM, V279, P8029, DOI 10.1074/jbc.M310792200; Sarret P, 1999, J BIOL CHEM, V274, P19294, DOI 10.1074/jbc.274.27.19294; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Sternini C, 1997, J COMP NEUROL, V386, P396; Van Op den Bosch J, 2009, REGUL PEPTIDES, V156, P1; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yang LH, 1998, J MED CHEM, V41, P2175, DOI 10.1021/jm980194h	32	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25689	25700		10.1074/jbc.M113.496414	http://dx.doi.org/10.1074/jbc.M113.496414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23913690	Green Published, hybrid			2022-12-28	WOS:000330623300003
J	Roberts, DJ; Tan-Sah, VP; Smith, JM; Miyamoto, S				Roberts, David J.; Tan-Sah, Valerie P.; Smith, Jeffery M.; Miyamoto, Shigeki			Akt Phosphorylates HK-II at Thr-473 and Increases Mitochondrial HK-II Association to Protect Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; DEPENDENT ANION CHANNEL; C-TERMINAL HALVES; HEXOKINASE-II; CYCLOPHILIN-D; PERMEABILITY TRANSITION; MAMMALIAN HEXOKINASE; ENERGY-METABOLISM; BOUND HEXOKINASE; CELL METABOLISM	Hexokinase II (HK-II) is an enzyme that catalyzes the first step in glycolysis and localizes not only in the cytosol but also at mitochondria. Akt, activated by insulin-like growth factor 1 (IGF-1) treatment in neonatal rat ventricular myocytes, translocates to mitochondria and increases mitochondrial HK-II binding. Expression of an HK-II-dissociating peptide diminished IGF-1-induced increases in mitochondrial HK-II as well as protection against hydrogen peroxide treatment, suggesting an important role of mitochondrial HK-II in IGF-1/Akt-mediated protection. We hypothesized, on the basis of an Akt phosphorylation consensus sequence present in HK-II, that Thr-473 is the target of Akt kinase activity. Indeed, recombinant kinase-active Akt robustly phosphorylates WT HK-II, but not Thr-473 mutants. Phosphomimetic (T473D) HK-II, but not non-phosphorylatable (T473A) HK-II, constitutively increased mitochondrial binding compared with WTHK-II and concomitantly confers greater protection against hydrogen peroxide. Glucose 6-phosphate (G-6P), a product of the catalytic activity of HK-II, is well known to dissociate HK-II from mitochondria. Addition of G-6P to isolated mitochondria dose-dependently dissociates WT HK-II, and this response is inhibited significantly in mitochondria isolated from cardiomyocytes expressing T473D HK-II. Pretreatment with IGF-1 also inhibits G-6P-induced overexpressed or endogenous HK-II dissociation, and this response was blocked by Akt inhibition. These results show that Akt phosphorylation of HK-II at Thr-473 is responsible for the Akt-mediated increase in HK-II binding to mitochondria. This increase is, at least in part, due to the decreased sensitivity to G-6P-induced dissociation. Thus, phosphorylation-mediated regulation of mitochondrial HK-II would be a critical component of the protective effect of Akt.	[Roberts, David J.; Tan-Sah, Valerie P.; Smith, Jeffery M.; Miyamoto, Shigeki] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Miyamoto, S (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smiyamoto@ucsd.edu	Miyamoto, Shigeki/L-4004-2019		National Institutes of Health [HL097037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097037, R56HL097037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL097037 (to S. M.).	Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Ahn KJ, 2009, BMB REP, V42, P350, DOI 10.5483/BMBRep.2009.42.6.350; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; ARORA KK, 1988, J BIOL CHEM, V263, P17422; AUBERTFOUCHER E, 1984, ARCH BIOCHEM BIOPHYS, V232, P391, DOI 10.1016/0003-9861(84)90554-X; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Culbert AA, 2002, BBA-GENE STRUCT EXPR, V1578, P43, DOI 10.1016/S0167-4781(02)00481-5; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Jennings RB, 2001, J MOL CELL CARDIOL, V33, P1571, DOI 10.1006/jmcc.2001.1425; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1449, DOI 10.1016/0022-2828(91)90190-W; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591; Li C, 2013, FREE RADICAL BIO MED, V60, P29, DOI 10.1016/j.freeradbiomed.2013.01.013; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Matsui T, 2001, CIRCULATION, V104, P330; MAYER SE, 1966, MOL PHARMACOL, V2, P393; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; ROSE IA, 1967, J BIOL CHEM, V242, P1635; RUSSELL RR, 1992, J CLIN INVEST, V90, P1972, DOI 10.1172/JCI116076; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2; Yang JY, 2013, J MOL CELL CARDIOL, V59, P167, DOI 10.1016/j.yjmcc.2013.02.016; Zuurbier CJ, 2005, AM J PHYSIOL-HEART C, V289, pH496, DOI 10.1152/ajpheart.01182.2004	64	147	151	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23798	23806		10.1074/jbc.M113.482026	http://dx.doi.org/10.1074/jbc.M113.482026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836898	hybrid, Green Published			2022-12-28	WOS:000330611400019
J	Vezzi, V; Onaran, HO; Molinari, P; Guerrini, R; Balboni, G; Calo, G; Costa, T				Vezzi, Vanessa; Onaran, H. Ongun; Molinari, Paola; Guerrini, Remo; Balboni, Gianfranco; Calo, Girolamo; Costa, Tommaso			Ligands Raise the Constraint That Limits Constitutive Activation in G Protein-coupled Opioid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX MODEL; BETA(2) ADRENERGIC-RECEPTOR; DMT-TIC PHARMACOPHORE; INVERSE AGONISTS; ALPHA-1B-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BINDING PROTEINS; WILD-TYPE; ANTAGONISM; MUTATION	Using a cell-free bioluminescence resonance energy transfer strategy we compared the levels of spontaneous and ligand-induced receptor-G protein coupling in delta (DOP) and mu (MOP) opioid receptors. In this assay GDP can suppress spontaneous coupling, thus allowing its quantification. The level of constitutive activity was 4-5 times greater at the DOP than at the MOP receptor. A series of opioid analogues with a common peptidomimetic scaffold displayed remarkable inversions of efficacy in the two receptors. Agonists that enhanced coupling above the low intrinsic level of the MOP receptor were inverse agonists in reducing the greater level of constitutive coupling of the DOP receptor. Yet the intrinsic activities of such ligands are identical when scaled over the GDP base line of both receptors. This pattern is in conflict with the predictions of the ternary complex model and the "two state" extensions. According to this theory, the order of spontaneous and ligand-induced coupling cannot be reversed if a shift of the equilibrium between active and inactive forms raises constitutive activation in one receptor type. We propose that constitutive activation results from a lessened intrinsic barrier that restrains spontaneous coupling. Any ligand, regardless of its efficacy, must enhance this constraint to stabilize the ligand-bound complexed form.	[Vezzi, Vanessa; Molinari, Paola; Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy; [Onaran, H. Ongun] Ankara Univ, Fac Med, Dept Pharmacol, Mol Biol & Technol Res & Dev Unit, TR-06100 Ankara, Turkey; [Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Balboni, Gianfranco] Univ Cagliari, Dept Life & Environm Sci, I-09124 Cagliari, Italy; [Calo, Girolamo] Univ Ferrara, Dept Med Sci, I-09124 Ferrara, Italy	Istituto Superiore di Sanita (ISS); Ankara University; University of Ferrara; University of Cagliari; University of Ferrara	Costa, T (corresponding author), Ist Super Sanita, Dip Farmaco, Viale Regina Elena 299, I-00161 Rome, Italy.	tomcosta@iss.it	Vezzi, Vanessa/H-7084-2018; Onaran, Ongun/AAI-5348-2020; Gianfranco, Balboni/K-1503-2019; costa, tommaso/AAD-3714-2019	Vezzi, Vanessa/0000-0002-7649-345X; Onaran, Ongun/0000-0001-6766-4774; costa, tommaso/0000-0002-8729-3357; molinari, paola/0000-0002-8454-0121; Guerrini, Remo/0000-0002-7619-0918	TUBITAK, the Scientific and Technological Research Council of Turkey [SBAG 110S 159]	TUBITAK, the Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported in part by Grant SBAG 110S 159 (to H. O. O.) from TUBITAK, the Scientific and Technological Research Council of Turkey.	ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; Balboni G, 2005, J MED CHEM, V48, P8112, DOI 10.1021/jm058259l; Balboni G, 2004, J MED CHEM, V47, P4066, DOI 10.1021/jm040033f; Balboni G, 2003, BIOORGAN MED CHEM, V11, P5435, DOI 10.1016/j.bmc.2003.09.039; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Casella I, 2011, BIOCHEM J, V438, P191, DOI 10.1042/BJ20110374; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; COSTA T, 1992, MOL PHARMACOL, V41, P549; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Kaya AI, 2009, J PHARMACOL EXP THER, V329, P350, DOI 10.1124/jpet.108.149989; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Neilan CL, 1999, BRIT J PHARMACOL, V128, P556, DOI 10.1038/sj.bjp.0702816; ONARAN HO, 1993, MOL PHARMACOL, V43, P245; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pradines JR, 2001, J MATH BIOL, V43, P313, DOI 10.1007/s002850100086; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salvadori S, 1997, J MED CHEM, V40, P3100, DOI 10.1021/jm9607663; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Soudijn W, 2005, MED RES REV, V25, P398, DOI 10.1002/med.20031; Tryoen-Toth P, 2005, J PHARMACOL EXP THER, V313, P410, DOI 10.1124/jpet.104.077321; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; Zocher M, 2012, STRUCTURE, V20, P1391, DOI 10.1016/j.str.2012.05.010	37	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23964	23978		10.1074/jbc.M113.474452	http://dx.doi.org/10.1074/jbc.M113.474452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836900	Green Published, hybrid			2022-12-28	WOS:000330611400035
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The x-ray crystal structure of mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome (vol 288, pg 22399, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019; Wijeyewickrema, Lakshmi/A-9676-2015	Coetzer, Theresa/0000-0003-0706-3808; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Wilmann, Pascal/0000-0002-8376-5150; Whisstock, James/0000-0003-4200-5611				Tang YQ, 2013, J BIOL CHEM, V288, P22399, DOI 10.1074/jbc.A113.483875	1	20	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					28307	28307		10.1074/jbc.M113.483875	http://dx.doi.org/10.1074/jbc.M113.483875			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792966	hybrid, Green Published			2022-12-28	WOS:000330596300022
J	Safratowich, BD; Lor, C; Bianchi, L; Carvelli, L				Safratowich, Bryan D.; Lor, Chee; Bianchi, Laura; Carvelli, Lucia			Amphetamine Activates an Amine-gated Chloride Channel to Generate Behavioral Effects in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Dopamine Transporters; Electrophysiology; Ion Channels; Membrane Proteins; Amphetamine	DOPAMINE TRANSPORTER; C-ELEGANS; RAT STRIATUM; RECEPTORS; LOCOMOTOR; HYPERACTIVITY; CLEARANCE; COCAINE; PSYCHOSTIMULANTS; INHIBITION	Amphetamine is a highly addictive psychostimulant, which is thought to generate its effects by promoting release of dopamine through reverse activation of dopamine transporters. However, some amphetamine-mediated behaviors persist in dopamine transporter knock-out animals, suggesting the existence of alternative amphetamine targets. Here we demonstrate the identification of a novel amphetamine target by showing that in Caenorhabditis elegans, a large fraction of the behavioral effects of amphetamine is mediated through activation of the amine-gated chloride channel, LGC-55. These findings bring to light alternative pathways engaged by amphetamine, and urge rethinking of the molecular mechanisms underlying the effects of this highly-addictive psychostimulant.	[Safratowich, Bryan D.; Lor, Chee; Carvelli, Lucia] Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA; [Bianchi, Laura] Univ Miami, Dept Physiol & Biophys, Miller Sch Med, Miami, FL 33136 USA	University of North Dakota Grand Forks; University of Miami	Carvelli, L (corresponding author), Univ N Dakota, Dept Pharmacol Physiol & Therapeut, 504 Hamline St, Grand Forks, ND 58202 USA.	lucia.carvelli@med.und.edu			National Institutes of Health [R21 DA024797, RGS-09-043-01-DDC5, R01 NS070969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024797] Funding Source: NIH RePORTER; Direct For Biological Sciences [1359243, 0851869] Funding Source: National Science Foundation; EPSCoR [0814442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DA024797 (to L. C.) and Grants RGS-09-043-01-DDC5 and R01 NS070969 (to L. B.).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; BLANC G, 1994, EUR J NEUROSCI, V6, P293, DOI 10.1111/j.1460-9568.1994.tb00272.x; BRENNER S, 1974, GENETICS, V77, P71; Budygin EA, 2004, P NATL ACAD SCI USA, V101, P7781, DOI 10.1073/pnas.0401418101; Budygin EA, 2000, NEUROSCI LETT, V281, P9, DOI 10.1016/S0304-3940(00)00813-2; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Carboni E, 2001, J NEUROSCI, V21; Carvelli L, 2010, MOL PHARMACOL, V78, P151, DOI 10.1124/mol.109.062703; Chase Daniel L, 2007, WormBook, P1; Darracq L, 1998, J NEUROSCI, V18, P2729; DICKINSON SL, 1988, PSYCHOPHARMACOLOGY, V96, P521, DOI 10.1007/BF02180034; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Revel FG, 2012, NEUROPSYCHOPHARMACOL, V37, P2580, DOI 10.1038/npp.2012.109; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1988, PROG NEURO-PSYCHOPH, V12, P233, DOI 10.1016/0278-5846(88)90040-1; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schafer WR, 2004, NEUROPHARMACOLOGY, V47, P123, DOI 10.1016/j.neuropharm.2004.06.026; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; ZACZEK R, 1991, J PHARMACOL EXP THER, V257, P830; Zahniser NR, 1999, J PHARMACOL EXP THER, V289, P266; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9	32	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21630	21637		10.1074/jbc.M113.484139	http://dx.doi.org/10.1074/jbc.M113.484139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775081	Green Published, hybrid			2022-12-28	WOS:000328841900015
J	Zanotti, S; Canalis, E				Zanotti, Stefano; Canalis, Ernesto			Hairy and Enhancer of Split-related with YRPW Motif (HEY)2 Regulates Bone Remodeling in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Interleukin; Notch; Osteoblasts; Osteoclast; HEY2; Bone Remodeling	OSTEOBLAST LINEAGE; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; CAUSES OSTEOPENIA; GENE-EXPRESSION; STROMAL CELLS; I COLLAGEN; NOTCH; RAT; OSTEOPOROSIS	Notch induces Hairy and Enhancer of Split-related with YRPW motif (Hey)1, Hey2, and HeyL expression in osteoblasts, but the contributions of these genes to the skeletal effects of Notch are not fully understood. HEY1 misexpression has limited skeletal impact, female HeyL null mice display increased bone mass, and Hey2 inactivation is developmentally lethal. To inactivate Hey2 in immature or mature osteoblasts, Hey2(loxP/loxP) mice were crossed with transgenics expressing CRE under the control of the osterix (Osx-Cre) or osteocalcin (Oc-Cre) promoters to generate Osx-Cre(+/-);Hey2(/) or Oc-Cre(+/-);Hey2(/) mice. Trabecular bone volume increased in 3-month-old Osx-Cre(+/-);Hey2(/) and Oc-Cre(+/-);Hey2(/) male mice and in 1-month-old Oc-Cre(+/-);Hey2(/) female mice, although 3-month-old Oc-Cre(+/-);Hey2(/) females developed osteopenia. Alkaline phosphatase liver/bone/kidney (ALPL) expression and activity were suppressed in osteoblasts from Oc-Cre(+/-);Hey2(/) mice of both sexes. To overexpress HEY2 in osteoblasts, transgenic mice where a 3.6-kb fragment of the rat collagen type-I 1 promoter directs HEY2 expression were created. Three-month-old Hey2 transgenic males exhibited decreased osteoblast activity and increased bone resorption and developed osteopenia at 6 months of age. Hey2 transgenic females exhibited reduced osteoblast number and function, but no changes in bone resorption. HEY2 overexpression in osteoblasts from mice of both sexes inhibited ALPL expression and activity and suppressed osteocalcin transcripts in cells from male mice only. HEY2 overexpression in osteoblasts from male mice enhanced bone resorption by co-cultured splenocytes and induced interleukin-6, a molecule that promotes osteoclastogenesis. In conclusion, HEY2 decreases skeletal mass and regulates bone remodeling in male mice.	[Zanotti, Stefano; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org			National Institutes of Health from NIDDK [DK045227]; Arthritis Foundation [5371]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Arthritis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK (to E. C.) and Research Fellowship Award 5371 from the Arthritis Foundation (to S. Z.).	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Boban I, 2006, BONE, V39, P1302, DOI 10.1016/j.bone.2006.06.025; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Garnero P, 2001, CLIN CHEM, V47, P694; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Irwin N., 1989, MOL CLONING LAB MANU; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Scheller EL, 2011, CELLS TISSUES ORGANS, V194, P268, DOI 10.1159/000324745; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sokal R. R, 1981, BIOMETRY; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wyzga N, 2004, BONE, V35, P614, DOI 10.1016/j.bone.2004.04.022; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	55	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21547	21557		10.1074/jbc.M113.489435	http://dx.doi.org/10.1074/jbc.M113.489435			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23782701	hybrid, Green Published			2022-12-28	WOS:000328841900008
J	Roeder, AM; Roettger, Y; Stundel, A; Dodel, R; Geyer, A				Roeder, Andreas M.; Roettger, Yvonne; Stuendel, Anne; Dodel, Richard; Geyer, Armin			Synthetic Dimeric A beta(28-40) Mimics the Complex Epitope of Human Anti-A beta Autoantibodies against Toxic A beta Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; AQUEOUS ENVIRONMENT; PEPTIDE; ANTIBODIES; CONFORMATION; NEUROTOXICITY; STABILIZATION; A-BETA-42	Covalently linked carboxyl-terminal segments of the beta-amyloid peptide (A beta) were tested for their qualification as minimal conformational epitopes of the naturally occurring human autoantibodies against beta-amyloid (nAbs-A beta). nAbs-A beta specifically recognize the toxic oligomers of A beta and not the monomeric or the fibrillar forms of A beta. The synthetic dimers of A beta (28-40) described herein mimic the toxic A beta oligomers but are not kinetic intermediates with uncertain compositions. CD spectra identified a surprisingly rich conformational behavior of selected miniamyloids. We observed a highly cooperative conformational transition of beta-sheet to alpha-helix upon the addition of the helix enforcing co-solvent hexafluoroisopropanol. The CD curves of dimer 9 resembled, in a completely reversible manner, the CD spectra measured during the irreversible fibrillation of the parent A beta (1-40). Synthetic peptide epitopes with high affinities for nAbs-A beta are needed to identify the physiological roles of nAbs-A beta and are promising epitopes for vaccination experiments.	[Roeder, Andreas M.; Geyer, Armin] Univ Marburg, Fac Chem, D-35032 Marburg, Germany; [Roettger, Yvonne; Stuendel, Anne; Dodel, Richard] Univ Marburg, Dept Neurol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, Baldingerstr, D-35043 Marburg, Germany.	dodel@med.uni-marburg.de; geyer@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft for financial support and Dr. L. C. Andrei-Selmer and Dr. M. Burg-Roderfeld for technical support.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Dodel R, 2011, [No title captured], Patent No. [PCT/EP2011/071239, 2011071239]; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kok WM, 2009, CHEM COMMUN, P6228, DOI 10.1039/b912784d; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Muller-Schiffmann A, 2011, ACS CHEM NEUROSCI, V2, P242, DOI 10.1021/cn200011h; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Takano K, 2008, CURR ALZHEIMER RES, V5, P540, DOI 10.2174/156720508786898424; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	37	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27638	27645		10.1074/jbc.M113.463273	http://dx.doi.org/10.1074/jbc.M113.463273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23846683	hybrid, Green Published			2022-12-28	WOS:000330597300057
J	Cheng, CY; Chen, JS; Fang, C; Xia, Y; Shan, Y; Liu, Y; Wen, GL; Song, HH; Fang, WH				Cheng, Changyong; Chen, Jianshun; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Song, Houhui; Fang, Weihuan			Listeria monocytogenes aguA1, but Not aguA2, Encodes a Functional Agmatine Deiminase BIOCHEMICAL CHARACTERIZATION OF ITS CATALYTIC PROPERTIES AND ROLES IN ACID TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERUGINOSA ARGININE DEIMINASE; STREPTOCOCCUS-MUTANS UA159; SWISS-MODEL WORKSPACE; LISTERIA-MONOCYTOGENES; PSEUDOMONAS-AERUGINOSA; LOW PH; ENTEROCOCCUS-FAECALIS; CRYSTAL-STRUCTURES; GENE-CLUSTER; SYSTEM	Listeria monocytogenes is adaptable to low pH environments and therefore crosses the intestinal barrier to establish systemic infections. L. monocytogenes aguA1 and aguA2 encode putative agmatine deiminases (AgDIs) AguA1 and AguA2. Transcription of aguA1 and aguA2 was significantly induced at pH 5.0. Deletion of aguA1 significantly impaired its survival both in gastric fluid at pH 2.5 and in mouse stomach, whereas aguA2 deletion did not show significant defect of survival in gastric fluid. With agmatine as the sole substrate, AguA1 expressed in Escherichia coli was optimal at 25 C and over a wide range of pH from 3.5 to 10.5. Recombinant AguA2 showed no deiminase activity. Sitedirected mutagenesis revealed that all nine AguA1 mutants completely lost enzymatic activity. AguA2 acquired AgDI activity only when Cys-157 was mutated to glycine. AguA1 mutation at the same site, G157C, also inactivated the enzyme. Thus, we have discovered Gly-157 as a novel residue other than the known catalytic triad (Cys-His-Glu/Asp) in L. monocytogenes that is critical for enzyme activity. Of the two putative AgDIs, we conclude that only AguA1 functionally participates in the AgDI pathway and mediates acid tolerance in L. monocytogenes.	[Cheng, Changyong; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Fang, Weihuan] Zhejiang Univ, Inst Prevent Vet Med, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou 310058, Zhejiang, Peoples R China; [Cheng, Changyong; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Fang, Weihuan] Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Jianshun] Zhejiang Fisheries Tech Extens Ctr, Hangzhou 310012, Zhejiang, Peoples R China; [Song, Houhui; Fang, Weihuan] Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan 311300, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University	Fang, WH (corresponding author), Zhejiang Univ, Inst Prevent Vet Med, 388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	whfang@zju.edu.cn		Cheng, Changyong/0000-0002-7530-5605	National Natural Science Foundation of China [31101829, 31272570]; Natural Science Foundation of Zhejiang Province [Q12C190019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China Grants 31101829 and 31272570 and Natural Science Foundation of Zhejiang Province Grant Q12C190019.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P365, DOI 10.1089/fpd.2008.0207; Chen JS, 2009, J MICROBIOL BIOTECHN, V19, P238, DOI 10.4014/jmb.0805.304; Cheng CY, 2013, J MED MICROBIOL, V62, P813, DOI 10.1099/jmm.0.055145-0; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Cotter PD, 2001, J FOOD PROTECT, V64, P1362, DOI 10.4315/0362-028X-64.9.1362; Cotter PD, 2000, INT J FOOD MICROBIOL, V60, P137, DOI 10.1016/S0168-1605(00)00305-6; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; DRIESSEN AJM, 1988, J BACTERIOL, V170, P4522, DOI 10.1128/jb.170.10.4522-4527.1988; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Galkin A, 2004, J BIOL CHEM, V279, P14001, DOI 10.1074/jbc.M313410200; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Janowitz T, 2003, FEBS LETT, V544, P258, DOI 10.1016/S0014-5793(03)00515-5; Jiang LL, 2008, INT J FOOD MICROBIOL, V121, P53, DOI 10.1016/j.ijfoodmicro.2007.10.007; Jones JE, 2010, BIOCHEMISTRY-US, V49, P9413, DOI 10.1021/bi101405y; Jones JE, 2010, BIOORG CHEM, V38, P62, DOI 10.1016/j.bioorg.2009.11.004; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Lu XF, 2006, BIOCHEMISTRY-US, V45, P1162, DOI 10.1021/bi051591e; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; ODriscoll B, 1996, APPL ENVIRON MICROB, V62, P1693, DOI 10.1128/AEM.62.5.1693-1698.1996; PARK KH, 1991, BIOCHEM BIOPH RES CO, V174, P32, DOI 10.1016/0006-291X(91)90480-U; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Sakakibara Y, 2003, PROTEIN EXPRES PURIF, V30, P88, DOI 10.1016/S1046-5928(03)00071-8; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; VANNETTEN P, 1989, INT J FOOD MICROBIOL, V8, P299, DOI 10.1016/0168-1605(89)90001-9; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wei YZ, 2007, PROTEINS, V66, P740, DOI 10.1002/prot.21235; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Yanagisawa H, 2001, PHYTOCHEMISTRY, V56, P643, DOI 10.1016/S0031-9422(00)00491-X	46	20	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26606	26615		10.1074/jbc.M113.477380	http://dx.doi.org/10.1074/jbc.M113.477380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918931	Green Published, hybrid			2022-12-28	WOS:000330594500026
J	Essalmani, R; Susan-Resiga, D; Chamberland, A; Asselin, MC; Canuel, M; Constam, D; Creemers, JW; Day, R; Gauthier, D; Prat, A; Seidah, NG				Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Asselin, Marie-Claude; Canuel, Maryssa; Constam, Daniel; Creemers, John W.; Day, Robert; Gauthier, Dany; Prat, Annik; Seidah, Nabil G.			Furin Is the Primary in Vivo Convertase of Angiopoietin-like 3 and Endothelial Lipase in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PROPROTEIN CONVERTASES; LIPID-METABOLISM; HDL CHOLESTEROL; PROTEIN; ANGPTL3; PLASMA; ACTIVATION; BINDING; MICE	The proprotein convertases (PCs) furin, PC5/6, and PACE4 exhibit unique and/or complementary functions. Their knockout (KO) in mice resulted in strong and specific phenotypes demonstrating that, in vivo, these PCs are unique and essential during development. However, they also exhibit redundant functions. Liver angiopoietin-like 3 (ANGPTL3) inhibits lipolysis by binding to lipoprotein lipases. It is found in the plasma as full length and truncated forms. The latter is more active and generated by cleavage at a furin-like site. Endothelial lipase (EL) binds heparin sulfate proteoglycans on cell surfaces and catalyzes the hydrolysis of HDL phospholipids. EL activity is regulated by two endogenous inhibitors, ANGPTL3 and ANGPTL4, and by PCs that inactivate EL through cleavage releasing the N-terminal catalytic and C-terminal lipid-binding domains. Herein, because furin and PC5/6 complete KOs are lethal, we used mice lacking furin or PC5/6 specifically in hepatocytes (hKO) or mice completely lacking PACE4. In primary hepatocytes, ANGPTL3 was processed into a shorter form of ANGPTL3 intracellularly by furin only, and extracellularly mainly by PACE4. In vivo, the absence of furin in hepatocytes reduced by similar to 50% the circulating levels of cleaved ANGPTL3, while the lack of PACE4 had only a minor effect. Analysis of the EL processing in primary hepatocytes and in vivo revealed that it is mostly cleaved by furin. However, the lack of furin or PC5/6 in hepatocytes and complete PACE4 KO did not appreciably modify plasma HDL levels or EL activity. Thus, inhibition of furin in liver would not be expected to modify the plasma lipid profiles.	[Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Asselin, Marie-Claude; Canuel, Maryssa; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Gauthier, Dany] Univ Montreal, Inst Rech Clin Montreal, Lab Neuropeptides Struct & Metab, Montreal, PQ H2W 1R7, Canada; [Constam, Daniel] Ecole Polytech Fed Lausanne, CH-1066 Lausanne, Switzerland; [Creemers, John W.] Katholieke Univ Leuven, Ctr Human Genet, Biochem Neuroendocrinol Lab, B-3000 Louvain, Belgium; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; KU Leuven; University of Sherbrooke	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Constam, Daniel B./0000-0002-6256-3891	CIHR [44363]; Strauss Foundation; Canada Chair [216684]	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by a CIHR Grant 44363, a Strauss Foundation grant, and a Canada Chair Number 216684.	Basu D, 2013, J LIPID RES, V54, P282, DOI 10.1194/jlr.D031112; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Constam DB, 2000, GENE DEV, V14, P1146; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fujimoto K, 2006, EXP ANIM TOKYO, V55, P27, DOI 10.1538/expanim.55.27; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Hara T, 2011, J LIPID RES, V52, P57, DOI 10.1194/jlr.M008417; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; Marchesi C, 2011, J MOL MED, V89, P1103, DOI 10.1007/s00109-011-0776-9; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McCoy MG, 2002, J LIPID RES, V43, P921; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Qiu G, 2007, CARDIOVASC RES, V76, P528, DOI 10.1016/j.cardiores.2007.08.002; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	46	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26410	26418		10.1074/jbc.M113.501304	http://dx.doi.org/10.1074/jbc.M113.501304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918928	Green Published, hybrid			2022-12-28	WOS:000330594500006
J	Boczkowska, M; Rebowski, G; Dominguez, R				Boczkowska, Malgorzata; Rebowski, Grzegorz; Dominguez, Roberto			Glia Maturation Factor (GMF) Interacts with Arp2/3 Complex in a Nucleotide State-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-DEPOLYMERIZING FACTOR; ALDRICH-SYNDROME PROTEIN; NUCLEATION-PROMOTING FACTOR; FACTOR HOMOLOGY DOMAIN; ATP HYDROLYSIS; WASP/SCAR PROTEINS; FILAMENT NETWORKS; STRUCTURAL BASIS; FACTOR-GAMMA; BOUND ACTIN	Glia maturation factor (GMF) is a member of the actin-depolymerizing factor (ADF)/cofilin family. ADF/cofilin promotes disassembly of aged actin filaments, where as GMF interacts specifically with Arp2/3 complex at branch junctions and promotes debranching. A distinguishing feature of ADF/cofilin is that it binds tighter to ADP-bound than to ATP-bound monomeric or filamentous actin. The interaction is also regulated by phosphorylation at Ser-3 of mammalian cofilin, which inhibits binding to actin. However, it is unknown whether these two factors play a role in the interaction of GMF with Arp2/3 complex. Here we show using isothermal titration calorimetry that mammalian GMF has very low affinity for ATP-bound Arp2/3 complex but binds ADP-bound Arp2/3 complex with 0.7 mu M affinity. The phosphomimetic mutation S2E in GMF inhibits this interaction. GMF does not bind monomeric ATP- or ADP-actin, confirming its specificity for Arp2/3 complex. We further show that mammalian Arp2/3 complex nucleation activated by the WCA region of the nucleation-promoting factor N-WASP is not affected by GMF, whereas nucleation activated by the WCA region of WAVE2 is slightly inhibited at high GMF concentrations. Together, the results suggest that GMF functions by a mechanism similar to that of other ADF/cofilin family members, displaying a preference for ADP-Arp2/3 complex and undergoing inhibition by phosphorylation of a serine residue near the N terminus. Arp2/3 complex nucleation occurs in the ATP state, and nucleotide hydrolysis promotes debranching, suggesting that the higher affinity of GMF for ADP-Arp2/3 complex plays a physiological role by promoting debranching of aged branch junctions without interfering with Arp2/3 complex nucleation.	[Boczkowska, Malgorzata; Rebowski, Grzegorz; Dominguez, Roberto] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu			National Institutes of Health [R01 GM073791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073791.	Aerbajinai W, 2013, J IMMUNOL, V190, P6093, DOI 10.4049/jimmunol.1203048; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dominguez R, 2010, CURR OPIN STRUC BIOL, V20, P217, DOI 10.1016/j.sbi.2009.12.012; Gandhi M, 2010, CURR BIOL, V20, P861, DOI 10.1016/j.cub.2010.03.026; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Ikeda K, 2006, CIRC RES, V99, P424, DOI 10.1161/01.RES.0000237662.23539.0b; Inagaki M, 2004, BBA-GEN SUBJECTS, V1670, P208, DOI 10.1016/j.bbagen.2003.12.006; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Luan Q, 2013, NAT STRUCT MOL BIOL, V20, P1062, DOI 10.1038/nsmb.2628; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Okreglak V, 2007, J CELL BIOL, V178, P1251, DOI 10.1083/jcb.200703092; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Stolmeier D, 2013, NEUROCHEM RES, V38, P1580, DOI 10.1007/s11064-013-1059-3; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	51	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25683	25688		10.1074/jbc.C113.493338	http://dx.doi.org/10.1074/jbc.C113.493338			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897816	Green Published, hybrid			2022-12-28	WOS:000330623300002
J	Huang, KM; Jia, JP; Wu, CW; Yao, MZ; Li, M; Jin, JJ; Jiang, CZ; Cai, Y; Pei, DQ; Pan, GJ; Yao, HJ				Huang, Kaimeng; Jia, Jinping; Wu, Changwei; Yao, Mingze; Li, Min; Jin, Jingji; Jiang, Cizhong; Cai, Yong; Pei, Duanqing; Pan, Guangjin; Yao, Hongjie			Ribosomal RNA Gene Transcription Mediated by the Master Genome Regulator Protein CCCTC-binding Factor (CTCF) Is Negatively Regulated by the Condensin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I; NUCLEOLAR PROTEIN; SMC PROTEINS; CELL-GROWTH; DNA; INSULATION; CYCLE; ORGANIZATION; INTERPHASE; INTEGRITY	CCCTC-binding factor (CTCF) is a ubiquitously expressed "master weaver" and plays multiple functions in the genome, including transcriptional activation/repression, chromatin insulation, imprinting, X chromosome inactivation, and high-order chromatin organization. It has been shown that CTCF facilitates the recruitment of the upstream binding factor onto ribosomal DNA (rDNA) and regulates the local epigenetic state of rDNA repeats. However, the mechanism by which CTCF modulates rRNA gene transcription has not been well understood. Here we found that wild-type CTCF augments the pre-rRNA level, cell size, and cell growth in cervical cancer cells. In contrast, RNA interference-mediated knockdown of CTCF reduced pre-rRNA transcription. CTCF positively regulates rRNA gene transcription in a RNA polymerase I-dependent manner. We identified an RRGR motif as a putative nucleolar localization sequence in the C-terminal region of CTCF that is required for activating rRNA gene transcription. Using mass spectrometry, we identified SMC2 and SMC4, two subunits of condensin complexes that interact with CTCF. Condensin negatively regulates CTCF-mediated rRNA gene transcription. Knockdown of SMC2 expression significantly facilitates the loading of CTCF and the upstream binding factor onto the rDNA locus and increases histone acetylation across the rDNA locus. Taken together, our study suggests that condensin competes with CTCF in binding to a specific rDNA locus and negatively regulates CTCF-mediated rRNA gene transcription.	[Huang, Kaimeng; Jia, Jinping; Wu, Changwei; Yao, Mingze; Pei, Duanqing; Pan, Guangjin; Yao, Hongjie] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol,Guangzhou Inst Biomed & Hl, Guangzhou 510530, Guangdong, Peoples R China; [Huang, Kaimeng; Jin, Jingji; Cai, Yong] Jilin Univ, Coll Life Sci, Changchun 130012, Jilin, Peoples R China; [Li, Min; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Jilin University; Tongji University	Pan, GJ (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol,Guangzhou Inst Biomed & Hl, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn; yao_hongjie@gibh.ac.cn	Huang, Kaimeng/K-6572-2014	Huang, Kaimeng/0000-0002-0552-209X	National Natural Science Foundation of China [31271391, 81201580]; Guangdong Science and Technology Planning Project of Province, China [2011A060901019]; Chinese Academy of Sciences [KSZD-EW-Z-003-1-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Planning Project of Province, China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation of China (Grants 31271391 and 81201580), by Guangdong Science and Technology Planning Project of Province, China (Grant 2011A060901019), and by Chinese Academy of Sciences (Grant KSZD-EW-Z-003-1-5).	Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Goendoer A, 2008, EMBO REP, V9, P327, DOI 10.1038/embor.2008.46; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Griese JJ, 2010, NUCLEIC ACIDS RES, V38, P3454, DOI 10.1093/nar/gkq038; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guerrero PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016401; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Ivanovska I, 2006, CELL CYCLE, V5, P2064, DOI 10.4161/cc.5.18.3253; Kim JH, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-50; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lu JR, 2012, TRANSCR-AUSTIN, V3, P73, DOI 10.4161/trns.19634; Machin F, 2004, CURR BIOL, V14, P125, DOI 10.1016/j.cub.2004.01.001; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qi CF, 2003, P NATL ACAD SCI USA, V100, P633, DOI 10.1073/pnas.0237127100; Rasko JEJ, 2001, CANCER RES, V61, P6002; Recillas-Targa F, 2011, BIOCHEM CELL BIOL, V89, P479, DOI [10.1139/o11-031, 10.1139/O11-031]; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Tang M, 2011, P NATL ACAD SCI USA, V108, P15231, DOI 10.1073/pnas.1104662108; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Tsang CK, 2007, CELL CYCLE, V6, P2213, DOI 10.4161/cc.6.18.4733; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326	48	40	41	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26067	26077		10.1074/jbc.M113.486175	http://dx.doi.org/10.1074/jbc.M113.486175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884423	hybrid, Green Published			2022-12-28	WOS:000330623300036
J	Cho, Y; Hazen, BC; Russell, AP; Kralli, A				Cho, Yoshitake; Hazen, Bethany C.; Russell, Aaron P.; Kralli, Anastasia			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 (PGC-1)- and Estrogen-related Receptor (ERR)-induced Regulator in Muscle 1 (PERM1) Is a Tissue-specific Regulator of Oxidative Capacity in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA ERR-ALPHA; MITOCHONDRIAL BIOGENESIS; NUCLEAR RECEPTOR; GENE-EXPRESSION; FIBER-TYPE; TRANSCRIPTIONAL CONTROL; ENERGY-METABOLISM; PGC-1 COACTIVATORS; CREATINE-KINASE	Mitochondrial oxidative metabolism and energy transduction pathways are critical for skeletal and cardiac muscle function. The expression of genes important for mitochondrial biogenesis and oxidative metabolism are under the control of members of the peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) family of transcriptional coactivators and the estrogen-related receptor (ERR) subfamily of nuclear receptors. Perturbations in PGC-1 and/or ERR activities have been associated with alterations in capacity for endurance exercise, rates of muscle atrophy, and cardiac function. The mechanism( s) by which PGC-1 and ERR proteins regulate muscle-specific transcriptional programs is not fully understood. We show here that PGC-1 alpha and ERRs induce the expression of a so far uncharacterized muscle-specific protein, PGC-1- and ERR-induced regulator in muscle 1 (Perm1), which regulates the expression of selective PGC-1/ERR target genes. Perm1 is required for the basal as well as PGC-1 alpha-enhanced expression of genes with roles in glucose and lipid metabolism, energy transfer, and contractile function. Silencing of Perm1 in cultured myotubes compromises respiratory capacity and diminishes PGC-1 alpha-induced mitochondrial biogenesis. Our findings support a role for Perm1 acting downstream of PGC-1 alpha and ERRs to regulate muscle-specific pathways important for energy metabolism and contractile function. Elucidating the function of Perm1 may enable novel approaches for the treatment of disorders with compromised skeletal muscle bioenergetics, such as mitochondrial myopathies and age-related/disease-associated muscle atrophies.	[Cho, Yoshitake; Hazen, Bethany C.; Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood 3125, Australia	Scripps Research Institute; Deakin University	Kralli, A (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kralli@scripps.edu		Russell, Aaron/0000-0002-7323-9501	National Institutes of Health from the NIDDK [R01DK095686]; American Heart Association Postdoctoral Fellowship [12POST8610009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095686] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK095686 from the NIDDK (to A. K.). This work was also supported by American Heart Association Postdoctoral Fellowship 12POST8610009 (to Y. C.).	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gorselink M, 2001, AM J PHYSIOL-ENDOC M, V281, pE619, DOI 10.1152/ajpendo.2001.281.3.E619; Greenhaff PL, 2001, J PHYSIOL-LONDON, V537, P657; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ingwall JS, 2009, CIRC-HEART FAIL, V2, P275, DOI 10.1161/CIRCHEARTFAILURE.109.885301; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacIntosh B., 2005, SKELETAL MUSCLE FORM, P208; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	70	62	73	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25207	25218		10.1074/jbc.M113.489674	http://dx.doi.org/10.1074/jbc.M113.489674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836911	hybrid, Green Published			2022-12-28	WOS:000330619000020
J	Masuho, I; Xie, KQ; Martemyanov, KA				Masuho, Ikuo; Xie, Keqiang; Martemyanov, Kirill A.			Macromolecular Composition Dictates Receptor and G Protein Selectivity of Regulator of G Protein Signaling (RGS) 7 and 9-2 Protein Complexes in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEP DOMAIN; R7BP; BINDING; LOCALIZATION; INHIBITION	Regulator of G protein signaling (RGS) proteins play essential roles in the regulation of signaling via G protein-coupled receptors (GPCRs). With hundreds of GPCRs and dozens of G proteins, it is important to understand how RGS regulates selective GPCR-G protein signaling. In neurons of the striatum, two RGS proteins, RGS7 and RGS9-2, regulate signaling by mu-opioid receptor (MOR) and dopamine D2 receptor (D2R) and are implicated in drug addiction, movement disorders, and nociception. Both proteins form trimeric complexes with the atypical G protein beta subunit G beta 5 and a membrane anchor, R7BP. In this study, we examined GTPase-accelerating protein (GAP) activity as well as G alpha and GPCR selectivity of RGS7 and RGS9-2 complexes in live cells using a bioluminescence resonance energy transfer-based assay that monitors dissociation of G protein subunits. We showed that RGS9-2/G beta 5 regulated both Gi and Go with a bias toward Go, but RGS7/G beta 5 could serve as a GAP only for Go. Interestingly, R7BP enhanced GAP activity of RGS7 and RGS9-2 toward Go and Gi and enabled RGS7 to regulate Gi signaling. Neither RGS7 nor RGS9-2 had any activity toward Gz, Gs, or Gq in the absence or presence of R7BP. We also observed no effect of GPCRs (MOR and D2R) on the G protein bias of R7 RGS proteins. However, the GAP activity of RGS9-2 showed a strong receptor preference for D2R over MOR. Finally, RGS7 displayed an four times greater GAP activity relative to RGS9-2. These findings illustrate the principles involved in establishing G protein and GPCR selectivity of striatal RGS proteins.	[Masuho, Ikuo; Xie, Keqiang; Martemyanov, Kirill A.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33410 USA	Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst Florida, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014; Xie, Keqiang/D-4437-2015		National Institutes of Health [DA021743, DA026405]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA021743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA021743 and DA026405.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garzon J, 2003, NEUROPSYCHOPHARMACOL, V28, P1983, DOI 10.1038/sj.npp.1300263; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rojkova AM, 2003, J BIOL CHEM, V278, P12507, DOI 10.1074/jbc.M207302200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie KQ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00049; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	41	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25129	25142		10.1074/jbc.M113.462283	http://dx.doi.org/10.1074/jbc.M113.462283			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857581	hybrid, Green Published			2022-12-28	WOS:000330619000013
J	Stilger, KL; Sullivan, WJ				Stilger, Krista L.; Sullivan, William J., Jr.			Elongator Protein 3 (Elp3) Lysine Acetyltransferase Is a Tail-anchored Mitochondrial Protein in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN5-RELATED N-ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; RADICAL MECHANISMS; ACETYLATION; COMPLEX; SUBUNIT; SPECIFICITY; ACETYLOME; CLUSTER; DOMAIN	Lysine acetylation has recently emerged as an important, widespread post-translational modification occurring on proteins that reside in multiple cellular compartments, including the mitochondria. However, no lysine acetyltransferase (KAT) has been definitively localized to this organelle to date. Here we describe the identification of an unusual homologue of Elp3 in early-branching protozoa in the phylum Apicomplexa. Elp3 is the catalytic subunit of the well-conserved transcription Elongator complex; however, Apicomplexa lack all other Elongator subunits, suggesting that the Elp3 in these organisms plays a role independent of transcription. Surprisingly, Elp3 in the parasites of this phylum, including Toxoplasma gondii (TgElp3), possesses a unique C-terminal transmembrane domain (TMD) that localizes the protein to the mitochondrion. As TgElp3 is devoid of known mitochondrial targeting signals, we used selective permeabilization studies to reveal that this KAT is oriented with its catalytic components facing the cytosol and its C-terminal TMD inserted into the outer mitochondrial membrane, consistent with a tail-anchored membrane protein. Elp3 trafficking to mitochondria is not exclusive to Toxoplasma as we also present evidence that a form of Elp3 localizes to these organelles in mammalian cells, supporting the idea that Elp3 performs novel functions across eukaryotes that are independent of transcriptional elongation. Importantly, we also present genetic studies that suggest TgElp3 is essential in Toxoplasma and must be positioned at the mitochondrial surface for parasite viability.	[Stilger, Krista L.; Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Sullivan, WJ (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS A-503, Indianapolis, IN 46202 USA.	wjsulliv@iu.edu		Fleck, Krista/0000-0001-6863-8631	National Institutes of Health [R01AI77502]; American Heart Association Predoctoral Fellowship [12PRE11940015]; Indiana Clinical and Translational Sciences Institute (CTSI) Career Development Award PHS (NCCR) [5TL1RR025759-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Indiana Clinical and Translational Sciences Institute (CTSI) Career Development Award PHS (NCCR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI77502 (to W. J. S.), American Heart Association Predoctoral Fellowship Grant 12PRE11940015 (to K. L. S.), and Indiana Clinical and Translational Sciences Institute (CTSI) Career Development Award PHS (NCCR) 5TL1RR025759-03 (to K. L. S.).	Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barton D, 2009, NEUROSCI LETT, V455, P60, DOI 10.1016/j.neulet.2009.03.006; Bhatti MM, 2006, EUKARYOT CELL, V5, P62, DOI 10.1128/EC.5.1.62-76.2006; Bhatti MM, 2005, J BIOL CHEM, V280, P5902, DOI 10.1074/jbc.M410656200; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Creppe C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/924898; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Dutnall RN, 1998, COLD SPRING HARB SYM, V63, P501, DOI 10.1101/sqb.1998.63.501; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Glatt S, 2012, TRANSCR-AUSTIN, V3, P273, DOI 10.4161/trns.21525; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230; Li F, 2005, MOL GENET GENOMICS, V273, P264, DOI 10.1007/s00438-005-1120-2; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Slaugenhaupt S. A., 2002, CLIN AUTON RES, V12, P15; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Sullivan WJ, 2004, BIOCHEM J, V380, P523, DOI 10.1042/BJ20040262; Sun F, 2012, PLANT SIGNAL BEHAV, V7, P927, DOI 10.4161/psb.20769; Vanagas L, 2012, EXPERT REV ANTI-INFE, V10, P1189, DOI [10.1586/eri.12.100, 10.1586/ERI.12.100]; Versees W, 2010, MOL MICROBIOL, V76, P1065, DOI 10.1111/j.1365-2958.2010.07162.x; Vonlaufen N, 2010, J BIOL CHEM, V285, P11154, DOI 10.1074/jbc.M109.066134; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Xu DY, 2012, PLANT J, V69, P792, DOI 10.1111/j.1365-313X.2011.04831.x; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d	52	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25318	25329		10.1074/jbc.M113.491373	http://dx.doi.org/10.1074/jbc.M113.491373			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23878194	hybrid, Green Published			2022-12-28	WOS:000330619000030
J	Drucker, P; Pejic, M; Galla, HJ; Gerke, V				Druecker, Patrick; Pejic, Milena; Galla, Hans-Joachim; Gerke, Volker			Lipid Segregation and Membrane Budding Induced by the Peripheral Membrane Binding Protein Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EXOCYTOSIS; PHOSPHOLIPID-BINDING; LIGHT-CHAIN; P11; SUBSTRATE; COMPLEX; KINASE; RAFTS; P36; ASSOCIATION	The formation of dynamic membrane microdomains is an important phenomenon in many signal transduction and membrane trafficking events. It is driven by intrinsic properties of membrane lipids and integral as well as membrane-associated proteins. Here we analyzed the ability of one peripherally associated membrane protein, annexin A2 (AnxA2), to induce the formation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2)-rich domains in giant unilamellar vesicles (GUVs) of complex lipid composition. AnxA2 is a cytosolic protein that can bind PI(4,5)P-2 and other acidic phospholipids in a Ca2+-dependent manner and that has been implicated in cellular membrane dynamics in endocytosis and exocytosis. We show that AnxA2 binding to GUVs induces lipid phase separation and the recruitment of PI(4,5)P-2, cholesterol and glycosphingolipids into larger clusters. This property is observed for the full-length monomeric protein, a mutant derivative comprising the C-terminal protein core domain and for AnxA2 residing in a heterotetrameric complex with its intracellular binding partner S100A10. All AnxA2 derivatives inducing PI(4,5)P-2 clustering are also capable of forming interconnections between PI(4,5)P-2-rich microdomains of adjacent GUVs. Furthermore, they can induce membrane indentations rich in PI(4,5)P-2 and inward budding of these membrane domains into the lumen of GUVs. This inward vesiculation is specific for AnxA2 and not shared with other PI(4,5)P-2-binding proteins such as the pleckstrin homology (PH) domain of phospholipase C delta 1. Together our results indicate that annexins such as AnxA2 can efficiently induce membrane deformations after lipid segregation, a mechanism possibly underlying annexin functions in membrane trafficking.	[Druecker, Patrick; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Pejic, Milena; Gerke, Volker] Univ Munster, ZMBE, Inst Med Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Gerke, V (corresponding author), Univ Munster, ZMBE, Inst Med Biochem, Von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de		Drucker, Patrick/0000-0003-3353-5880	German Research Council [DFG SFB 858]	German Research Council(German Research Foundation (DFG))	This work was supported by German Research Council Grant DFG SFB 858, Project B4.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GERKE V, 1985, J BIOL CHEM, V260, P1688; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gruenberg Jean, 1993, Trends in Cell Biology, V3, P224, DOI 10.1016/0962-8924(93)90116-I; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Harrist AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005020; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; JOHNSSON N, 1990, J BIOL CHEM, V265, P14464; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Juhasz J, 2012, BBA-BIOMEMBRANES, V1818, P19, DOI 10.1016/j.bbamem.2011.09.006; Kauscher U, 2013, LANGMUIR, V29, P7377, DOI 10.1021/la3045434; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; KUBE E, 1992, J BIOL CHEM, V267, P14175; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Menke M, 2004, CHEMBIOCHEM, V5, P1003, DOI 10.1002/cbic.200400004; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nazmi AR, 2012, BIOL CHEM, V393, P1141, DOI 10.1515/hsz-2012-0179; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; OSBORN M, 1988, EXP CELL RES, V175, P81, DOI 10.1016/0014-4827(88)90257-1; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rosengarth A., 2004, ANNEXINS, V1, P129; Ross M, 2003, BIOCHEMISTRY-US, V42, P3131, DOI 10.1021/bi027069z; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; THIEL C, 1991, J BIOL CHEM, V266, P14732; THIEL C, 1992, J CELL SCI, V103, P733; Tran JT, 2002, ACTA CRYSTALLOGR D, V58, P1854, DOI 10.1107/S0907444902013288; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zobiack N, 2002, J CELL SCI, V115, P91	58	66	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24764	24776		10.1074/jbc.M113.474023	http://dx.doi.org/10.1074/jbc.M113.474023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861394	hybrid, Green Published			2022-12-28	WOS:000330612300042
J	Fan, GF; Lin, G; Lucito, R; Tonks, NK				Fan, Gaofeng; Lin, Guang; Lucito, Robert; Tonks, Nicholas K.			Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK/PTK6 in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; THERAPEUTIC TARGET; BRK; EXPRESSION; ACTIVATION; PATHWAY; IDENTIFICATION; INHIBITION; CARCINOMA	Ovarian cancer, which is the leading cause of death from gynecological malignancies, is a heterogeneous disease known to be associated with disruption of multiple signaling pathways. Nevertheless, little is known regarding the role of protein phosphatases in the signaling events that underlie the disease; such knowledge will be essential to gain a complete understanding of the etiology of the disease and how to treat it. We have demonstrated that protein-tyrosine phosphatase 1B (PTP1B) was underexpressed in a panel of ovarian carcinoma-derived cell lines, compared with immortalized human ovarian surface epithelial cell lines. Stable restoration of PTP1B in those cancer cell lines substantially decreased cell migration and invasion, as well as proliferation and anchorage-independent survival. Mechanistically, the pro-survival IGF-1R signaling pathway was attenuated upon ectopic expression of PTP1B. This was due to dephosphorylation by PTP1B of IGF-1R beta-subunit and BRK/PTK6, an SRC-like protein-tyrosine kinase that physically and functionally interacts with the IGF-1R beta-subunit. Restoration of PTP1B expression led to enhanced activation of BAD, one of the major pro-death members of the BCL-2 family, which triggered cell death through apoptosis. Conversely, inhibition of PTP1B with a small molecular inhibitor, MSI-1436, increased proliferation and migration of immortalized HOSE cell lines. These data reveal an important role for PTP1B as a negative regulator of BRK and IGF-1R beta signaling in ovarian cancer cells.	[Fan, Gaofeng; Lin, Guang; Lucito, Robert; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	Tonks@cshl.edu	Lucito, Robert/AID-7159-2022; Fan, Gaofeng/H-2996-2013	Fan, Gaofeng/0000-0002-6729-2867	National Institutes of Health [CA53840, GM55989]; STARR Foundation; Department of Defense Congressional funds; Cold Spring Harbor Laboratory Cancer Centre [CA45508]; Gladowsky Breast Cancer Foundation; Hansen Foundation; Irving Hansen Foundation; Islip Breast Cancer Coalition; Fannie Rippel Foundation; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [P30CA045508, R37CA053840, R01CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STARR Foundation; Department of Defense Congressional funds(United States Department of Defense); Cold Spring Harbor Laboratory Cancer Centre; Gladowsky Breast Cancer Foundation; Hansen Foundation; Irving Hansen Foundation; Islip Breast Cancer Coalition; Fannie Rippel Foundation; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 and GM55989 (to N. K. T.). This work was also supported by a grant from the STARR Foundation, Department of Defense Congressional funds (to R. L. and N. K. T.), Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508, and from The Gladowsky Breast Cancer Foundation, Hansen Foundation, Irving Hansen Foundation, Islip Breast Cancer Coalition, Fannie Rippel Foundation, Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund.	Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Bruchim I, 2013, EXPERT OPIN THER TAR, V17, P307, DOI 10.1517/14728222.2013.749863; Buckley DA, 2002, J CLIN PATHOL-MOL PA, V55, P46, DOI 10.1136/mp.55.1.46; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Mabuchi S, 2011, CURR MED CHEM, V18, P2960, DOI 10.2174/092986711796150450; Mhawech-Fauceglia P., 2012, PATHOL RES INT, V2012; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Ostrander JH, 2010, CURR OPIN PHARMACOL, V10, P662, DOI 10.1016/j.coph.2010.08.007; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Szkandera J, 2013, INT J MOL SCI, V14, P1179, DOI 10.3390/ijms14011179; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tupper J, 2011, ARCH DERMATOL RES, V303, P293, DOI 10.1007/s00403-010-1118-4; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	54	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24923	24934		10.1074/jbc.M113.482737	http://dx.doi.org/10.1074/jbc.M113.482737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23814047	hybrid, Green Published			2022-12-28	WOS:000330612300056
J	Konvalinka, A; Zhou, J; Dimitromanolakis, A; Drabovich, AP; Fang, F; Gurley, S; Coffman, T; John, R; Zhang, SL; Diamandis, EP; Scholey, JW				Konvalinka, Ana; Zhou, Joyce; Dimitromanolakis, Apostolos; Drabovich, Andrei P.; Fang, Fei; Gurley, Susan; Coffman, Thomas; John, Rohan; Zhang, Shao-Ling; Diamandis, Eleftherios P.; Scholey, James W.			Determination of an Angiotensin II-regulated Proteome in Primary Human Kidney Cells by Stable Isotope Labeling of Amino Acids in Cell Culture (SILAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HYPERTENSIVE-RATS; URINARY HEME OXYGENASE-1; PROXIMAL TUBULAR CELLS; IGA NEPHROPATHY; DIABETIC-NEPHROPATHY; CONVERTING-ENZYME; GENE-EXPRESSION; RENAL-DISEASE; BIOLOGICAL NETWORKS; COMBINATION THERAPY	Angiotensin II (AngII), the major effector of the renin-angiotensin system, mediates kidney disease progression by signaling through the AT-1 receptor (AT-1R), but there are no specific measures of renal AngII activity. Accordingly, we sought to define an AngII-regulated proteome in primary human proximal tubular cells (PTEC) to identify potential AngII activity markers in the kidney. We utilized stable isotope labeling with amino acids (SILAC) in PTECs to compare proteomes of AngII-treated and control cells. Of the 4618 quantified proteins, 83 were differentially regulated. SILAC ratios for 18 candidates were confirmed by a different mass spectrometry technique called selected reaction monitoring. Both SILAC and selected reaction monitoring revealed heme oxygenase-1 (HO-1) as the most significantly up-regulated protein in response to AngII stimulation. AngII-dependent regulation of the HO-1 gene and protein was further verified in PTECs. To extend these in vitro observations, we overlaid a network of significantly enriched gene ontology terms from our AngII-regulated proteins with a dataset of differentially expressed kidney genes from AngII-treated wild type mice and AT-1R knock-out mice. Five gene ontology terms were enriched in both datasets and included HO-1. Furthermore, HO-1 kidney expression and urinary excretion were reduced in AngII-treated mice with PTEC-specific AT-1R deletion compared with AngII-treated wild-type mice, thus confirming AT-1R-mediated regulation of HO-1. Our in vitro approach identified novel molecular markers of AngII activity, and the animal studies demonstrated that these markers are relevant in vivo. These interesting proteins hold promise as specific markers of renal AngII activity in patients and in experimental models.	[Konvalinka, Ana; Zhou, Joyce; Fang, Fei; Scholey, James W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Konvalinka, Ana; Scholey, James W.] Univ Toronto, Div Nephrol, Dept Med, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Dimitromanolakis, Apostolos; Drabovich, Andrei P.; John, Rohan; Diamandis, Eleftherios P.] Univ Toronto, Dept Pathol & Lab Med, Toronto, ON M5G 2C4, Canada; [Dimitromanolakis, Apostolos; Drabovich, Andrei P.; Diamandis, Eleftherios P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1W7, Canada; [Gurley, Susan; Coffman, Thomas] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Gurley, Susan; Coffman, Thomas] Durham Vet Affairs Med Ctr, Durham, NC 27710 USA; [Zhang, Shao-Ling] Univ Montreal, Hop Hotel Dieu, Fac Med, Montreal, PQ H2W 1T8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Universite de Montreal	Konvalinka, A (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Nephrol, 8N-859,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	ana.konvalinka@mail.utoronto.ca	Konvalinka, Ana/ABE-9480-2020; Konvalinka, Ana/AAH-9581-2020; Drabovich, Andrei/E-9347-2012	Konvalinka, Ana/0000-0001-6672-355X; Drabovich, Andrei/0000-0003-3049-7145; John, Rohan/0000-0001-7946-3013	Kidney Foundation of Canada; operating grant from the Kidney Foundation of Canada; operating grant from the AMGEN Canada	Kidney Foundation of Canada; operating grant from the Kidney Foundation of Canada; operating grant from the AMGEN Canada	Recipient of a fellowship grant from the Kidney Foundation of Canada. To whom correspondence should be addressed: Division of Nephrology, Toronto General Hospital, University Health Network, 8N-859, 200 Elizabeth St., Toronto, Ontario M5G 2C4, Canada. Tel.: 416-586-4800 (Ext. 2968); Fax: 416-340-4999; E-mail: ana. konvalinka@mail.utoronto.ca.; Supported by operating grants from the Kidney Foundation of Canada and from the AMGEN Canada Investigator Sponsored Initiative Research Program.	Aizawa T, 2000, HYPERTENSION, V35, P800, DOI 10.1161/01.HYP.35.3.800; Aizawa T, 2001, KIDNEY INT, V59, P645, DOI 10.1046/j.1523-1755.2001.059002645.x; Alam J, 2003, AM J PHYSIOL-RENAL, V284, pF743, DOI 10.1152/ajprenal.00376.2002; Aminzadeh MA, 2012, TRANSL RES, V160, P309, DOI 10.1016/j.trsl.2012.03.003; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chang SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/521076; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; da Silva JL, 2001, KIDNEY INT, V59, P1448, DOI 10.1046/j.1523-1755.2001.0590041448.x; Drabovich AP, 2012, MOL CELL PROTEOMICS, V11, P422, DOI 10.1074/mcp.M111.015214; Drabovich AP, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.004127-1, 10.1074/mcp.M110.004127]; Drabovich AP, 2010, J PROTEOME RES, V9, P1236, DOI 10.1021/pr900729g; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; DZAU VJ, 1993, ARCH INTERN MED, V153, P937, DOI 10.1001/archinte.153.8.937; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; Harrison-Bernard LM, 2002, AM J PHYSIOL-RENAL, V282, pF19, DOI 10.1152/ajprenal.0335.2000; Haugen EN, 2000, KIDNEY INT, V58, P144, DOI 10.1046/j.1523-1755.2000.00150.x; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Imig JD, 1999, AM J PHYSIOL-RENAL, V277, pF303, DOI 10.1152/ajprenal.1999.277.2.F303; Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218, DOI 10.1152/ajprenal.1999.276.2.F218; INGELFINGER JR, 1990, J CLIN INVEST, V85, P417, DOI 10.1172/JCI114454; JOHNSTON CI, 1992, J HYPERTENS, V10, pS13; KIFOR I, 1991, ENDOCRINOLOGY, V129, P823, DOI 10.1210/endo-129-2-823; Kim JA, 2012, AM J PHYSIOL-ENDOC M, V302, pE201, DOI 10.1152/ajpendo.00497.2011; Knight SF, 2007, MICROCIRCULATION, V14, P349, DOI 10.1080/10739680701283018; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Laverman GD, 2002, KIDNEY INT, V62, P1020, DOI 10.1046/j.1523-1755.2002.00536.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; Liu F, 2008, J AM SOC NEPHROL, V19, P269, DOI 10.1681/ASN.2007010074; Liu GC, 2012, AM J PHYSIOL-RENAL, V302, pF784, DOI 10.1152/ajprenal.00455.2011; Lodha S, 2002, MOL MED, V8, P830, DOI 10.1007/BF03402088; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Makhanova NA, 2010, PHYSIOL GENOMICS, V42A, P211, DOI 10.1152/physiolgenomics.00063.2010; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; MENDELSOHN FAO, 1982, KIDNEY INT, pS78; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mills KT, 2012, NEPHROL DIAL TRANSPL, V27, P3176, DOI 10.1093/ndt/gfs011; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; NAFTILAN AJ, 1991, J CLIN INVEST, V87, P1300, DOI 10.1172/JCI115133; Navar LG, 2004, CURR OPIN NEPHROL HY, V13, P107, DOI 10.1097/00041552-200401000-00015; Nishiyama A, 2011, NEPHROL DIAL TRANSPL, V26, P170, DOI 10.1093/ndt/gfq371; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; PURDY RE, 1988, CIRC RES, V63, P748, DOI 10.1161/01.RES.63.4.748; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; REAMS G, 1994, NEPHRON, V67, P450, DOI 10.1159/000188215; Reblin T, 2001, AM J KIDNEY DIS, V38, P619, DOI 10.1053/ajkd.2001.26889; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; SCHELLING P, 1991, J HYPERTENS, V9, P3; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; TANG SS, 1995, AM J PHYSIOL-RENAL, V268, pF435, DOI 10.1152/ajprenal.1995.268.3.F435; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; VOS PF, 1994, J AM SOC NEPHROL, V5, P215; Wagner C, 1998, KIDNEY INT, V54, pS78, DOI 10.1046/j.1523-1755.1998.06716.x; Wanner C, 1997, KIDNEY INT, pS102; Weidekamm C, 2002, WIEN KLIN WOCHENSCHR, V114, P725; WILCOX CS, 1991, KIDNEY INT, V40, P1090, DOI 10.1038/ki.1991.319; Wolf G, 1997, AM J KIDNEY DIS, V29, P153, DOI 10.1016/S0272-6386(97)90023-8; Wolf G, 2005, KIDNEY INT, V67, P799, DOI 10.1111/j.1523-1755.2005.00145.x; WOLF G, 1990, AM J PHYSIOL, V259, pF768, DOI 10.1152/ajprenal.1990.259.5.F768; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yokoyama T, 2011, AM J NEPHROL, V33, P414, DOI 10.1159/000327020; Zager RA, 1999, KIDNEY INT, V56, P1788, DOI 10.1046/j.1523-1755.1999.00745.x; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhuo JL, 2007, J RENIN-ANGIO-ALDO S, V8, P23, DOI 10.3317/jraas.2007.003; Zhuo JL, 2002, HYPERTENSION, V39, P116, DOI 10.1161/hy0102.100780; ZIMMERMAN JB, 1987, J CLIN INVEST, V80, P443, DOI 10.1172/JCI113092	91	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24834	24847		10.1074/jbc.M113.485326	http://dx.doi.org/10.1074/jbc.M113.485326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846697	Green Published, hybrid			2022-12-28	WOS:000330612300048
J	Raedts, J; Lundgren, M; Kengen, SWM; Li, JP; van der Oost, J				Raedts, John; Lundgren, Magnus; Kengen, Serve W. M.; Li, Jin-Ping; van der Oost, John			A Novel Bacterial Enzyme with D-Glucuronyl C5-epimerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; HEPARAN-SULFATE; HEPARIN/HEPARAN SULFATE; ESCHERICHIA-COLI; BIOSYNTHESIS; POLYSACCHARIDE; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES; PURIFICATION; DATABASE	Glycosaminoglycans are biologically active polysaccharides that are found ubiquitously in the animal kingdom. The biosynthesis of these complex polysaccharides involves complicated reactions that turn the simple glycosaminoglycan backbone into highly heterogeneous structures. One of the modification reactions is the epimerization of D-glucuronic acid to its C5-epimer L-iduronic acid, which is essential for the function of heparan sulfate. Although L-iduronic acid residues have been shown to exist in polysaccharides of some prokaryotes, there has been no experimental evidence for the existence of a prokaryotic D-glucuronyl C5-epimerase. This work for the first time reports on the identification of a bacterial enzyme with D-glucuronyl C5-epimerase activity. A gene of the marine bacterium Bermanella marisrubri sp. RED65 encodes a protein (RED65_08024) of 448 amino acids that has an overall 37% homology to the human D-glucuronic acid C5-epimerase. Alignment of this peptide with the human and mouse sequences revealed a 60% similarity at the carboxyl terminus. The recombinant protein expressed in Escherichia coli showed epimerization activity toward substrates generated from heparin and the E. coli K5 capsular polysaccharide, thereby providing the first evidence for bacterial D-glucuronyl C5-epimerase activity. These findings may eventually be used for modification of mammalian glycosaminoglycans.	[Raedts, John; Kengen, Serve W. M.; van der Oost, John] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Lundgren, Magnus] Uppsala Univ, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden; [Li, Jin-Ping] Uppsala Univ, Dept Med Biochem, S-75123 Uppsala, Sweden	Wageningen University & Research; Uppsala University; Uppsala University	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem, S-75123 Uppsala, Sweden.	jin-ping.li@imbim.uu.se; john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019	Kengen, Serve/0000-0001-6139-8946	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program; Swedish Research Council [K2012-67X-21128-04-4]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was carried out in close collaboration with MSD Oss (formerly NV Organon/Schering Plough) and was supported by The Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program and Swedish Research Council Grant K2012-67X-21128-04-4.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aono E, 2010, MOL BIOSYST, V6, P1216, DOI 10.1039/c000396d; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; CAMPBELL P, 1983, ANAL BIOCHEM, V131, P146, DOI 10.1016/0003-2697(83)90146-X; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Chung JY, 1998, FEMS MICROBIOL LETT, V166, P289, DOI 10.1111/j.1574-6968.1998.tb13903.x; Clarke BR, 1999, J BACTERIOL, V181, P2279, DOI 10.1128/JB.181.7.2279-2285.1999; CONRAD HE, 1980, BIOCHEM J, V191, P355, DOI 10.1042/bj1910355; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Hanniffy OM, 1998, CARBOHYD RES, V307, P291, DOI 10.1016/S0008-6215(97)10108-2; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Li JP, 2010, PROG MOL BIOL TRANSL, V93, P59, DOI 10.1016/S1877-1173(10)93004-4; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perepelov AV, 2008, CARBOHYD RES, V343, P571, DOI 10.1016/j.carres.2007.10.013; Pinhassi J, 2009, INT J SYST EVOL MICR, V59, P373, DOI 10.1099/ijs.0.002113-0; Raedts J, 2011, GLYCOCONJUGATE J, V28, P57, DOI 10.1007/s10719-011-9324-7; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; VUILLARD L, 1995, BIOCHEM J, V305, P337, DOI 10.1042/bj3050337; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WHITFIELD DM, 1991, ANAL BIOCHEM, V194, P259, DOI 10.1016/0003-2697(91)90228-L; WIELAND F, 1986, FEBS LETT, V195, P77, DOI 10.1016/0014-5793(86)80134-X; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002	32	13	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24332	24339		10.1074/jbc.M113.476440	http://dx.doi.org/10.1074/jbc.M113.476440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824188	Green Published, hybrid			2022-12-28	WOS:000330612300005
J	Rajendran, G; Dutta, D; Hong, J; Paul, A; Saha, B; Mahato, B; Ray, S; Home, P; Ganguly, A; Weiss, ML; Paul, S				Rajendran, Ganeshkumar; Dutta, Debasree; Hong, James; Paul, Arindam; Saha, Biswarup; Mahato, Biraj; Ray, Soma; Home, Pratik; Ganguly, Avishek; Weiss, Mark L.; Paul, Soumen			Inhibition of Protein Kinase C Signaling Maintains Rat Embryonic Stem Cell Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SELF-RENEWAL; METHYLATION; DIFFERENTIATION; BLASTOCYSTS; ACTIVATION; GENERATION; MICRORNAS; BINDING; MURINE	Embryonic stem cell (ESC) pluripotency is orchestrated by distinct signaling pathways that are often targeted to maintain ESC self-renewal or their differentiation to other lineages. We showed earlier that inhibition of PKC signaling maintains pluripotency in mouse ESCs. Therefore, in this study, we investigated the importance of protein kinase C signaling in the context of rat ESC (rESC) pluripotency. Here we show that inhibition of PKC signaling is an efficient strategy to establish and maintain pluripotent rESCs and to facilitate reprogramming of rat embryonic fibroblasts to rat induced pluripotent stem cells. The complete developmental potential of rESCs was confirmed with viable chimeras and germ line transmission. Our molecular analyses indicated that inhibition of a PKC zeta-NF-kappa B-microRNA-21/microRNA-29 regulatory axis contributes to the maintenance of rESC self-renewal. In addition, PKC inhibition maintains ESC-specific epigenetic modifications at the chromatin domains of pluripotency genes and, thereby, maintains their expression. Our results indicate a conserved function of PKC signaling in balancing self-renewal versus differentiation of both mouse and rat ESCs and indicate that targeting PKC signaling might be an efficient strategy to establish ESCs from other mammalian species.	[Rajendran, Ganeshkumar; Dutta, Debasree; Paul, Arindam; Saha, Biswarup; Mahato, Biraj; Ray, Soma; Home, Pratik; Ganguly, Avishek; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Hong, James; Weiss, Mark L.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	University of Kansas; University of Kansas Medical Center; Kansas State University	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014; Saha, Biswarup/T-7341-2019; Weiss, Mark L/C-7364-2014; /AAD-2084-2020; Ganguly, Avishek/R-6138-2019	Saha, Biswarup/0000-0003-2797-7308; 	National institutes of Health [HL094892, HL106311, L104322, HD062546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062546, R21HD075233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106311, R21HL094892, R21HL104322] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National institutes of Health grants HL094892, HL106311, L104322, and HD062546 (to S. P.). This work was also supported by a gift from the Ronald. D. Deffenbaugh Foundation.	Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; He Hong, 2009, Open Stem Cell J, V1, P30; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Hong J, 2013, STEM CELLS DEV, V22, P431, DOI 10.1089/scd.2012.0279; Hong J, 2012, STEM CELLS DEV, V21, P1571, DOI 10.1089/scd.2011.0370; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li J, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-4; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yan HX, 2012, CARCINOGENESIS, V33, P2001, DOI 10.1093/carcin/bgs238; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	34	26	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24351	24362		10.1074/jbc.M113.455725	http://dx.doi.org/10.1074/jbc.M113.455725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846691	Green Published, hybrid			2022-12-28	WOS:000330612300007
J	Gingras, AR; Puzon-McLaughlin, W; Ginsberg, MH				Gingras, Alexandre R.; Puzon-McLaughlin, Wilma; Ginsberg, Mark H.			The Structure of the Ternary Complex of Krev Interaction Trapped 1 (KRIT1) Bound to Both the Rap1 GTPase and the Heart of Glass (HEG1) Cytoplasmic Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; EFFECTOR INTERACTION; CONCENTRIC GROWTH; RAS BINDING; ASSOCIATION; DOMAINS	Loss of function mutation in Krev interaction trapped 1 (KRIT1) causes autosomal dominant familial cerebral cavernous malformations and disrupts cardiovascular development. The biological function of KRIT1 requires that its FERM (band 4.1, ezrin, radixin, moesin) domain physically interact with both the small GTPase Rap1 and the cytoplasmic tail of the Heart of glass (HEG1) membrane anchor. In this study, we show that the KRIT1 FERM domain can bind both Rap1 and HEG1 simultaneously, and we solved the crystal structure of the KRIT1-Rap1-HEG1 ternary complex. Rap1 binds on the surface of the F1 and F2 subdomains, in an interaction that leaves its Switch II region accessible to other potential effectors. HEG1 binds in a hydrophobic pocket at the KRIT1 F1 and F3 interface, and there is no overlap with the Rap1-binding site. Indeed, the affinity of KRIT1 or the KRIT1-Rap1 complex for HEG1 is comparable (K-d = 1.2 and 0.96 mu M, respectively) showing that there is no competition between the two sites. Furthermore, analysis of this structure revealed a specific ionic interaction between the F2 lobe of KRIT1 and Rap1 that could explain the remarkable Rap1 specificity of KRIT1. This structural insight enabled design of KRIT1(K570I), a mutant that binds Rap1 with 8-fold lower affinity and exhibits increased binding to HRas. These data show that HEG1 can recruit the Rap1-KRIT complex to the plasma membrane where Rap1's Switch II region remains accessible and reveals an important determinant of KRIT1's specificity for Rap1.	[Gingras, Alexandre R.; Puzon-McLaughlin, Wilma; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gingras, AR (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	agingras@ucsd.edu	Gingras, Alexandre R/E-1867-2011	Gingras, Alexandre R/0000-0002-5373-0176	National Institutes of Health [HL106489, GM094663]; American Heart Association [12SDG11610043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL106489 and GM094663 (to M. H. G.). This work was also supported by American Heart Association Scientist Development Grant 12SDG11610043 (to A. R. G.).	Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Collaborative Computational Project No. 4, 1994, ACTA CRYSTALLOGR D, V66, P125; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Kabsch W., 2010, J APPL CRYSTALLOGR, V26, P795; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Liquori CL, 2007, AM J HUM GENET, V80, P69, DOI 10.1086/510439; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469; Mayer Chad L, 2009, BMC Res Notes, V2, P135, DOI 10.1186/1756-0500-2-135; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027	32	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23639	23649		10.1074/jbc.M113.462911	http://dx.doi.org/10.1074/jbc.M113.462911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814056	Green Published, hybrid			2022-12-28	WOS:000330611400003
J	Xie, LW; Collins, JF				Xie, Liwei; Collins, James F.			Transcription Factors Sp1 and Hif2 alpha Mediate Induction of the Copper-transporting ATPase (Atp7a) Gene in Intestinal Epithelial Cells during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; IRON-DEPRIVATION; RAT DUODENUM; MITHRAMYCIN; PROMOTER; BINDING; DEFICIENCY; EXPRESSION; ALPHA; MICE	Genes with G/C-rich promoters were up-regulated in the duodenal epithelium of iron-deficient rats including those encoding iron (e. g. Dmt1 and Dcytb) and copper (e. g. Atp7a and Mt1) metabolism-related proteins. It was shown previously that an intestinal copper transporter (Atp7a) was co-regulated with iron transport-related genes by a hypoxia-inducible transcription factor, Hif2 alpha. In the current study, we sought to test the role of Sp1 in transcriptional regulation of Atp7a expression during iron deprivation/hypoxia. Initial studies in IEC-6 cells showed that mithramycin, an Sp1 inhibitor, reduced expression of Atp7a and iron transport-related genes (Dmt1, Dcytb, and Fpn1) and blocked their induction by CoCl2, a hypoxia mimetic. Consistent with this, overexpression of Sp1 increased endogenous Atp7a mRNA and protein expression and stimulated Atp7a, Dmt1, and Dcytb promoter activity. Site-directed mutagenesis and functional analysis of a basal Atp7a promoter construct revealed four functional Sp1 binding sites that were necessary for Hif2 alpha-mediated induction of promoter activity. Furthermore, chromatin immunoprecipitation (ChIP) assays confirmed that Sp1 specifically interacts with the Atp7a promoter in IEC-6 cells and in rat duodenal enterocytes. This investigation has thus revealed a novel aspect of Atp7a gene regulation in which Sp1 may be necessary for the HIF-mediated induction of gene transcription during iron deficiency/hypoxia. Understanding regulation of Atp7a expression may help further clarify the physiological role of copper in the maintenance of iron homeostasis. Furthermore, this Sp1/Hif2 alpha regulatory mechanism may have broader implications for understanding the genetic response of the intestinal epithelium to maintain whole-body iron homeostasis during states of deficiency.	[Xie, Liwei; Collins, James F.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, 572 Newell Dr,FSN Bldg 441, Gainesville, FL 32611 USA.	jfcollins@ufl.edu			National Institutes of Health [1R01-DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-DK074867 (to J.F.C.).	Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Collins JF, 2009, AM J PHYSIOL-GASTR L, V297, pG695, DOI 10.1152/ajpgi.00203.2009; Collins JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-420; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Fuqua BK, 2012, J TRACE ELEM MED BIO, V26, P115, DOI 10.1016/j.jtemb.2012.03.015; Gulec S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066010; Hu ZH, 2010, AM J PHYSIOL-CELL PH, V299, pC930, DOI 10.1152/ajpcell.00238.2010; Jiang LL, 2011, AM J PHYSIOL-GASTR L, V301, pG877, DOI 10.1152/ajpgi.00261.2011; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaler S G, 1994, Adv Pediatr, V41, P263; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mura C, 2004, FASEB J, V18, P1922, DOI 10.1096/fj.04-2520fje; NAVEH Y, 1981, PEDIATRICS, V68, P397; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Rohlff C, 1998, INT J ONCOL, V12, P383; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SCHNEDL W, 1977, HUM GENET, V36, P299, DOI 10.1007/BF00446280; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tsuji Y, 1998, J BIOL CHEM, V273, P2984, DOI 10.1074/jbc.273.5.2984; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wada T, 2006, BIOL PHARM BULL, V29, P49, DOI 10.1248/bpb.29.49; WARD DC, 1965, SCIENCE, V149, P1259, DOI 10.1126/science.149.3689.1259; Xie LW, 2013, AM J PHYSIOL-CELL PH, V304, pC257, DOI 10.1152/ajpcell.00336.2012; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Yuan Y, 2001, BIOCHEM BIOPH RES CO, V288, P849, DOI 10.1006/bbrc.2001.5835	43	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23943	23952		10.1074/jbc.M113.489500	http://dx.doi.org/10.1074/jbc.M113.489500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814049	hybrid, Green Published			2022-12-28	WOS:000330611400033
J	Kremer, KN; Peterson, KL; Schneider, PA; Meng, XW; Dai, H; Hess, AD; Smith, BD; Rodriguez-Ramirez, C; Karp, JE; Kaufmann, SH; Hedin, KE				Kremer, Kimberly N.; Peterson, Kevin L.; Schneider, Paula A.; Meng, X. Wei; Dai, Haiming; Hess, Allan D.; Smith, B. Douglas; Rodriguez-Ramirez, Christie; Karp, Judith E.; Kaufmann, Scott H.; Hedin, Karen E.			CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-X-L, Noxa, and Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOGENOUS LEUKEMIA; CD8(+) T-CELLS; STEM-CELLS; PHOSPHATIDYLSERINE EXPOSURE; FACTOR-I; TRANSENDOTHELIAL MIGRATION; HEMATOPOIETIC STEM; MEDIATED APOPTOSIS; NOD/SCID MICE; BREAST-CANCER	The CXCR4 chemokine receptor promotes survival of many different cell types. Here, we describe a previously unsuspected role for CXCR4 as a potent inducer of apoptosis in acute myeloid leukemia (AML) cell lines and a subset of clinical AML samples. We show that SDF-1, the sole ligand for CXCR4, induces the expected migration and ERK activation in the KG1a AML cell line transiently overexpressing CXCR4, but ERK activation did not lead to survival. Instead, SDF-1 treatment led via a CXCR4-dependent mechanism to apoptosis, as evidenced by increased annexin V staining, condensation of chromatin, and cleavage of both procaspase-3 and PARP. This SDF-1-induced death pathway was partially inhibited by hypoxia, which is often found in the bone marrow of AML patients. SDF-1-induced apoptosis was inhibited by dominant negative procaspase-9 but not by inhibition of caspase-8 activation, implicating the intrinsic apoptotic pathway. Further analysis showed that this pathway was activated by multiple mechanisms, including up-regulation of Bak at the level of mRNA and protein, stabilization of the Bak activator Noxa, and down-regulation of antiapoptotic Bcl-X-L. Furthermore, adjusting expression levels of Bak, Bcl-X-L, or Noxa individually altered the level of apoptosis in AML cells, suggesting that the combined modulation of these family members by SDF-1 coordinates their interplay to produce apoptosis. Thus, rather than mediating survival, SDF-1 may be a means to induce apoptosis of CXCR4-expressing AML cells directly in the SDF-1-rich bone marrow microenvironment if the survival cues of the bone marrow are disrupted.	[Kremer, Kimberly N.; Rodriguez-Ramirez, Christie; Hedin, Karen E.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Peterson, Kevin L.; Schneider, Paula A.; Meng, X. Wei; Dai, Haiming; Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Hedin, KE (corresponding author), Mayo Clin, Dept Immunol, Guggenheim Bldg,3rd Floor,200 First St SW, Rochester, MN 55905 USA.	hedin.karen@mayo.edu		Hedin, Karen/0000-0003-1010-923X; Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407; Rodriguez-Ramirez, Christie/0000-0002-3413-4926	National Institutes of Health [RO1 CA166741, U02 CA70095]; Mayo Foundation; Joanne G. and Gary N. Owen Fund in Immunology Research; Alma B. Stevenson Endowment Fund for Medical Research; NATIONAL CANCER INSTITUTE [P30CA015083, U01CA070095, R01CA166741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Joanne G. and Gary N. Owen Fund in Immunology Research; Alma B. Stevenson Endowment Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA166741 and U02 CA70095. This work was also supported by the Mayo Foundation, the Joanne G. and Gary N. Owen Fund in Immunology Research, and the Alma B. Stevenson Endowment Fund for Medical Research.	Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Charrad RS, 2002, BLOOD, V99, P290, DOI 10.1182/blood.V99.1.290; Clements D, 2010, J IMMUNOL, V185, P1812, DOI 10.4049/jimmunol.0902149; Colamussi ML, 2001, J LEUKOCYTE BIOL, V69, P263; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Endo M, 2008, CURR HIV RES, V6, P34; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Estey EH, 2012, LEUKEMIA, V26, P861, DOI 10.1038/leu.2011.317; Fathi AT, 2010, CANCER TREAT REV, V36, P142, DOI 10.1016/j.ctrv.2009.12.004; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Gupta M, 2012, BLOOD, V119, P476, DOI 10.1182/blood-2011-04-346601; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Karimian G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043156; KAUFMANN SH, 1986, J BIOL CHEM, V261, P1962; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Kremer KN, 2011, J IMMUNOL, V187, P3177, DOI 10.4049/jimmunol.1100206; Kremer KN, 2011, J IMMUNOL, V187, P1440, DOI 10.4049/jimmunol.1100820; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Monaco G, 2004, STEM CELLS, V22, P188, DOI 10.1634/stemcells.22-2-188; Opferman JT, 2008, CELL DEATH DIFFER, V15, P234, DOI 10.1038/sj.cdd.4402182; Pusic I, 2010, CURR OPIN HEMATOL, V17, P319, DOI 10.1097/MOH.0b013e328338b7d5; Rahmani M, 2012, BLOOD, V119, P6089, DOI 10.1182/blood-2011-09-378141; Sacanna E, 2011, ONCOLOGY-BASEL, V80, P225, DOI 10.1159/000327585; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schimmer Aaron D, 2007, Curr Treat Options Oncol, V8, P277, DOI 10.1007/s11864-007-0037-x; Sermeus A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047519; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Speetjens FM, 2009, CANCER MICROENVIRON, V2, P1, DOI 10.1007/s12307-008-0016-1; Spinello I, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.24; Stolzel F, 2010, HAEMATOL-HEMATOL J, V95, P171, DOI 10.3324/haematol.2009.016568; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Ullrich CK, 2000, BLOOD, V96, P1438, DOI 10.1182/blood.V96.4.1438.h8001438_1438_1442; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yao X, 2011, J INT MED RES, V39, P1253, DOI 10.1177/147323001103900413; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	68	40	44	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22899	22914		10.1074/jbc.M113.449926	http://dx.doi.org/10.1074/jbc.M113.449926			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798675	hybrid, Green Published			2022-12-28	WOS:000330598200003
J	Bjorkblom, B; Adilbayeva, A; Maple-Grodem, J; Piston, D; Okvist, M; Xu, XM; Brede, C; Larsen, JP; Moller, SG				Bjorkblom, Benny; Adilbayeva, Altynai; Maple-Grodem, Jodi; Piston, Dominik; Okvist, Mats; Xu, Xiang Ming; Brede, Cato; Larsen, Jan Petter; Moller, Simon Geir			Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; DJ-1-DEFICIENT MICE; ANDROGEN RECEPTOR; OXIDATIVE STRESS; MUTATIONS; GENE; ASSOCIATION; STABILITY; EXPOSURE; IRON	The progressive loss of motor control due to reduction of dopamine-producing neurons in the substantia nigra pars compacta and decreased striatal dopamine levels are the classically described features of Parkinson disease (PD). Neuronal damage also progresses to other regions of the brain, and additional non-motor dysfunctions are common. Accumulation of environmental toxins, such as pesticides and metals, are suggested risk factors for the development of typical late onset PD, although genetic factors seem to be substantial in early onset cases. Mutations of DJ-1 are known to cause a form of recessive early onset Parkinson disease, highlighting an important functional role for DJ-1 in early disease prevention. This study identifies human DJ-1 as a metal-binding protein able to evidently bind copper as well as toxic mercury ions in vitro. The study further characterizes the cytoprotective function of DJ-1 and PD-mutated variants of DJ-1 with respect to induced metal cytotoxicity. The results show that expression of DJ-1 enhances the cells' protective mechanisms against induced metal toxicity and that this protection is lost for DJ-1PD mutations A104T and D149A. The study also shows that oxidation site-mutated DJ-1 C106A retains its ability to protect cells. We also show that concomitant addition of dopamine exposure sensitizes cells to metal-induced cytotoxicity. We also confirm that redox-active dopamine adducts enhance metal-catalyzed oxidation of intracellular proteins in vivo by use of live cell imaging of redox-sensitive S3roGFP. The study indicates that even a small genetic alteration can sensitize cells to metal-induced cell death, a finding that may revive the interest in exogenous factors in the etiology of PD.	[Bjorkblom, Benny; Maple-Grodem, Jodi; Piston, Dominik; Xu, Xiang Ming; Larsen, Jan Petter; Moller, Simon Geir] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway; [Bjorkblom, Benny; Adilbayeva, Altynai; Maple-Grodem, Jodi; Piston, Dominik; Xu, Xiang Ming; Moller, Simon Geir] Univ Stavanger, Ctr Organelle Res, N-4036 Stavanger, Norway; [Okvist, Mats] European Synchrotron Radiat Facil, F-38000 Grenoble, France; [Brede, Cato] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway; [Moller, Simon Geir] St Johns Univ, Dept Biol Sci, New York, NY 11439 USA	Stavanger University Hospital; Universitetet i Stavanger; European Synchrotron Radiation Facility (ESRF); Stavanger University Hospital; Saint John's University	Bjorkblom, B (corresponding author), Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway.	bjorkblom@uis.no	Adilbayeva, Altynai/AAM-7989-2020; Grødem, jodi M/H-5482-2012; Brede, Cato/AGZ-6186-2022	Adilbayeva, Altynai/0000-0003-1636-280X; Brede, Cato/0000-0003-2691-6052; Maple-Grodem, Jodi/0000-0001-7142-0078; Moller, Simon/0000-0002-0460-3592	Western Norway Regional Health Authority Helse Vest Project [911575]	Western Norway Regional Health Authority Helse Vest Project	This work was supported by Western Norway Regional Health Authority Helse Vest Project Grant 911575.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Ciarimboli G, 2008, XENOBIOTICA, V38, P936, DOI [10.1080/00498250701882482, 10.1080/00498250701882482 ]; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Diez S, 2009, REV ENVIRON CONTAM T, V198, P111, DOI 10.1007/978-0-387-09647-6_3; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; ITO S, 1988, BIOCHEM PHARMACOL, V37, P1707, DOI 10.1016/0006-2952(88)90432-7; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Marsden CD, 1996, OXFORD TXB MED, V3, P3998; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; MARTTILA RJ, 1988, NEUROLOGY, V38, P1217, DOI 10.1212/WNL.38.8.1217; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; NGIM CH, 1989, NEUROEPIDEMIOLOGY, V8, P128, DOI 10.1159/000110175; Nyholm D, 2002, CLIN NEUROPHARMACOL, V25, P89, DOI 10.1097/00002826-200203000-00006; Okada M, 2002, BIOL PHARM BULL, V25, P853, DOI 10.1248/bpb.25.853; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Sikk K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/865319; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; WANG JD, 1989, BRIT J IND MED, V46, P856; Werner P., 2007, PARKINSONS DIS MOVEM, P67; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	71	56	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22809	22820		10.1074/jbc.M113.482091	http://dx.doi.org/10.1074/jbc.M113.482091			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792957	Green Published, hybrid			2022-12-28	WOS:000330596300058
J	Cai, YQ; Balli, D; Ustiyan, V; Fulford, L; Hiller, A; Misetic, V; Zhang, YF; Paluch, AM; Waltz, SE; Kasper, S; Kalin, TV				Cai, Yuqi; Balli, David; Ustiyan, Vladimir; Fulford, Logan; Hiller, Andrea; Misetic, Vinko; Zhang, Yufang; Paluch, Andrew M.; Waltz, Susan E.; Kasper, Susan; Kalin, Tanya V.			Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M1 TRANSCRIPTION FACTOR; TRANSGENIC MOUSE; RESPIRATORY EPITHELIUM; LIVER-REGENERATION; CANCER DEVELOPMENT; TUMOR SUPPRESSION; FORKHEAD; PROGRESSION; MICE; ARF	The treatment of advanced prostate cancer (PCa) remains a challenge. Identification of new molecular mechanisms that regulate PCa initiation and progression would provide targets for the development of new cancer treatments. The Foxm1 transcription factor is highly up-regulated in tumor cells, inflammatory cells, and cells of tumor microenvironment. However, its functions in different cell populations of PCa lesions are unknown. To determine the role of Foxm1 in tumor cells during PCa development, we generated two novel transgenic mouse models, one exhibiting Foxm1 gain-of-function and one exhibiting Foxm1 loss-of-function under control of the prostate epithelial-specific Probasin promoter. In the transgenic adenocarcinoma mouse prostate (TRAMP) model of PCa that uses SV40 large T antigen to induce PCa, loss of Foxm1 decreased tumor growth and metastasis. Decreased prostate tumorigenesis was associated with a decrease in tumor cell proliferation and the down-regulation of genes critical for cell proliferation and tumor metastasis, including Cdc25b, Cyclin B1, Plk-1, Lox, and Versican. In addition, tumor-associated angiogenesis was decreased, coinciding with reduced Vegf-A expression. The mRNA and protein levels of 11 beta-Hsd2, an enzyme playing an important role in tumor cell proliferation, were down-regulated in Foxm1-deficient PCa tumors in vivo and in Foxm1-depleted TRAMP C2 cells in vitro. Foxm1 bound to, and increased transcriptional activity of, the mouse 11 beta-Hsd2 promoter through the -892/-879 region, indicating that 11 beta-Hsd2 was a direct transcriptional target of Foxm1. Without TRAMP, overexpression of Foxm1 either alone or in combination with inhibition of a p19(ARF) tumor suppressor caused a robust epithelial hyperplasia, but was insufficient to induce progression from hyperplasia to PCa. Foxm1 expression in prostate epithelial cells is critical for prostate carcinogenesis, suggesting that inhibition of Foxm1 is a promising therapeutic approach for prostate cancer chemotherapy.	[Cai, Yuqi; Balli, David; Ustiyan, Vladimir; Fulford, Logan; Hiller, Andrea; Zhang, Yufang; Kalin, Tanya V.] Cincinnati Childrens Res Fdn, Perinatal Inst, Div Pulm Biol, Cincinnati, OH 45229 USA; [Misetic, Vinko] Univ Lausanne Hosp, CHUV Head & Neck Canc Res Lab Biopole 3 DB11, Dept Otorhinolaryngol & Head & Neck Surg, CH-1066 Epalinges, Switzerland; [Zhang, Yufang; Paluch, Andrew M.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45229 USA; [Kasper, Susan] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kalin, TV (corresponding author), 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Tatiana.kalin@cchmc.org		Waltz, Susan/0000-0003-3572-4642	National Institutes of Health [R01 CA142724]; Department of Defense [PC080478]; NATIONAL CANCER INSTITUTE [R01CA125379, R01CA142724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA142724 (to T. V. K.) and Department of Defense Award PC080478 (to T. V. K.).	Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Balli D, 2012, ONCOGENE, V31, P3875, DOI 10.1038/onc.2011.549; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Berges RR, 1995, CLIN CANCER RES, V1, P473; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Maddison LA, 2000, GENESIS, V26, P154, DOI 10.1002/(SICI)1526-968X(200002)26:2<154::AID-GENE18>3.0.CO;2-2; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Uzgare AR, 2003, PROSTATE, V55, P128, DOI 10.1002/pros.10212; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang IC, 2010, DEV BIOL, V347, P301, DOI 10.1016/j.ydbio.2010.08.027; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	59	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22527	22541		10.1074/jbc.M113.455089	http://dx.doi.org/10.1074/jbc.M113.455089			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775078	hybrid, Green Published			2022-12-28	WOS:000330596300033
J	Sirrieh, RE; MacLean, DM; Jayaraman, V				Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi			Amino-terminal Domain Tetramer Organization and Structural Effects of Zinc Binding in the N-Methyl-D-aspartate (NMDA) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; ALLOSTERIC INTERACTION; SUBUNIT ARRANGEMENT; AMPA RECEPTOR; DYNAMICS; ACTIVATION; MECHANISM; DESENSITIZATION; IDENTIFICATION; INHIBITION	N-Methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the mammalian central nervous system. An important feature of these receptors is their capacity for allosteric regulation by small molecules, such as zinc, which bind to their amino-terminal domain (ATD). Zinc inhibition through high affinity binding to the ATD has been examined through functional studies; however, there is no direct measurement of associated conformational changes. We used luminescence resonance energy transfer to show that the ATDs undergo a cleft closure-like conformational change upon binding zinc, but no changes are observed in intersubunit distances. Furthermore, we find that the ATDs are more closely packed than the related AMPA receptors. These results suggest that the stability of the upper lobe contacts between ATDs allow for the efficient propagation of the cleft closure conformational change toward the ligand-binding domain and transmembrane segments, ultimately inhibiting the channel.	[Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu		MacLean, David/0000-0001-8294-6075	Houston Area Molecular Biophysics Training Program National Institutes of Health [2T32GM008280]; American Heart Association; National Institutes of Health [GM094246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM094246] Funding Source: NIH RePORTER	Houston Area Molecular Biophysics Training Program National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Houston Area Molecular Biophysics Training Program National Institutes of Health Grant 2T32GM008280.; Supported by an American Heart Association postdoctoral fellowship.; Supported by National Institutes of Health Grant GM094246. To whom correspondence should be addressed: Center for Membrane Biology, Dept. of Biochemistry and Molecular Biology, University of Texas Health Science Center, MSB 6.174, 6431 Fannin St., Houston, TX 77030. Tel.: 713-500-6236; Fax: 713-500-6297; E-mail: vasanthi.jayaraman@uth.tmc.edu.	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Brimecombe JC, 1999, J PHARMACOL EXP THER, V291, P785; Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chazot PL, 1999, METH MOL B, V128, P33; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2012, J PHYSIOL-LONDON, V590, P63, DOI 10.1113/jphysiol.2011.213850; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suzuki Y, 2013, J BIOL CHEM, V288, P778, DOI 10.1074/jbc.M112.422311; Tang C. M., 2001, CURR PROTOCOLS NEURO, V5; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	38	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22555	22564		10.1074/jbc.M113.482356	http://dx.doi.org/10.1074/jbc.M113.482356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792960	Green Published, hybrid			2022-12-28	WOS:000330596300035
J	Hsieh, ML; James, TD; Knipling, L; Waddell, MB; White, S; Hinton, DM				Hsieh, Meng-Lun; James, Tamara D.; Knipling, Leslie; Waddell, M. Brett; White, Stephen; Hinton, Deborah M.			Architecture of the Bacteriophage T4 Activator MotA/Promoter DNA Interaction during Sigma Appropriation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; MOTA TRANSCRIPTION FACTOR; ASIA PROTEIN; MIDDLE PROMOTER; CRYSTAL-STRUCTURE; OPEN COMPLEXES; REGION 4; BINDING; SUBUNIT; DOMAIN	Gene expression can be regulated through factors that direct RNA polymerase to the correct promoter sequence at the correct time. Bacteriophage T4 controls its development in this way using phage proteins that interact with host RNA polymerase. Using a process called sigma appropriation, the T4 co-activator AsiA structurally remodels the sigma(70) subunit of host RNA polymerase, while a T4 activator, MotA, engages the C terminus of sigma(70) and binds to a DNA promoter element, the MotA box. Structures for the N-terminal (NTD) and C-terminal (CTD) domains of MotA are available, but no structure exists for MotA with or without DNA. We report the first molecular map of the MotA/DNA interaction within the sigma-appropriated complex, which we obtained by using the cleaving reagent, iron bromoacetamidobenzyl-EDTA (FeBABE). We conjugated surface-exposed, single cysteines in MotA with FeBABE and performed cleavage reactions in the context of stable transcription complexes. The DNA cleavage sites were analyzed using ICM Molsoft software and three-dimensional physical models of MotA(NTD), MotA(CTD), and the DNA to investigate shape complementarity between the protein and the DNA and to position MotA on the DNA. We found that the unusual "double wing" motif present within MotA(CTD) resides in the major groove of the MotA box. In addition, we have used surface plasmon resonance to show that MotA alone is in a very dynamic equilibrium with the MotA element. Our results demonstrate the utility of fine resolution FeBABE mapping to determine the architecture of protein-DNA complexes that have been recalcitrant to traditional structure analyses.	[Hsieh, Meng-Lun; James, Tamara D.; Knipling, Leslie; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [James, Tamara D.] NYU, Struct Biol Program, Sackler Inst, Langone Med Ctr, New York, NY 10016 USA; [Waddell, M. Brett] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [White, Stephen] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); New York University; NYU Langone Medical Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hinton, DM (corresponding author), NIH, Bldg 8,Rm 2A-13, Bethesda, MD 20892 USA.	dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021; White, Stephen W/N-8164-2018	Knipling, Leslie/0000-0002-2636-6460; Hsieh, Meng-Lun/0000-0002-6360-005X	National Institutes of Health [GM066934]; Cancer Center Core Grant [CA21765]; NIDDK; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066934 (to S. W.), Cancer Center Core Grant CA21765, and by the Intramural Research Program of the NIDDK. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC; to S. W.)	Bonocora RP, 2008, MOL MICROBIOL, V69, P331, DOI 10.1111/j.1365-2958.2008.06276.x; Bonocora RP, 2011, J BIOL CHEM, V286, P39290, DOI 10.1074/jbc.M111.278762; Boucher PE, 2003, MOL CELL, V11, P163, DOI 10.1016/S1097-2765(03)00007-8; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Cicero MP, 1998, BIOCHEMISTRY-US, V37, P4977, DOI 10.1021/bi972337s; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 1998, MOL MICROBIOL, V27, P819, DOI 10.1046/j.1365-2958.1998.00729.x; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; Decker K. B., 2013, ANN REV MIC IN PRESS; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Decker KB, 2011, J MOL BIOL, V409, P692, DOI 10.1016/j.jmb.2011.04.017; Finnin MS, 1997, EMBO J, V16, P1992, DOI 10.1093/emboj/16.8.1992; FINNIN MS, 1993, J MOL BIOL, V232, P301, DOI 10.1006/jmbi.1993.1384; Gerber JS, 1996, J BACTERIOL, V178, P6133, DOI 10.1128/jb.178.21.6133-6139.1996; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; Hinton DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-289; HINTON DM, 1991, J BIOL CHEM, V266, P18034; Hinton DM, 1996, J MOL BIOL, V256, P235, DOI 10.1006/jmbi.1996.0082; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; King JM, 2012, J BACTERIOL, V194, P2573, DOI 10.1128/JB.00107-12; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Li N, 2002, MOL MICROBIOL, V43, P1079, DOI 10.1046/j.1365-2958.2002.02809.x; Li N, 2001, BIOCHEMISTRY-US, V40, P4293, DOI 10.1021/bi0028284; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; MARCHAMEGADZIE R, 1995, MOL MICROBIOL, V15, P649, DOI 10.1111/j.1365-2958.1995.tb02374.x; Marr MT, 2004, NUCLEIC ACIDS RES, V32, P1083, DOI 10.1093/nar/gkh261; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Mukherjee Srabani, 2003, Biological Procedures Online, V5, P78, DOI 10.1251/bpo49; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Pahari S, 1997, FEBS LETT, V411, P60, DOI 10.1016/S0014-5793(97)00668-6; Pai KS, 1996, P NATL ACAD SCI USA, V93, P10647, DOI 10.1073/pnas.93.20.10647; Pal D, 2003, J MOL BIOL, V325, P827, DOI 10.1016/S0022-2836(02)01307-4; Pande S, 2002, J BACTERIOL, V184, P3957, DOI 10.1128/JB.184.14.3957-3964.2002; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SCHMIDT RP, 1992, J BIOL CHEM, V267, P11399; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Sharma M, 1999, J MOL BIOL, V290, P905, DOI 10.1006/jmbi.1999.2928; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; STEVENS A, 1973, BIOCHEM BIOPH RES CO, V54, P488, DOI 10.1016/0006-291X(73)91447-2; Stoskiene G, 2007, MOL MICROBIOL, V64, P421, DOI 10.1111/j.1365-2958.2007.05659.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Yuan AH, 2009, P NATL ACAD SCI USA, V106, P6597, DOI 10.1073/pnas.0812832106	56	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27607	27618		10.1074/jbc.M113.475434	http://dx.doi.org/10.1074/jbc.M113.475434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902794	hybrid, Green Published			2022-12-28	WOS:000330597300055
J	Lu, J; Vodnala, SK; Gustavsson, AL; Gustafsson, TN; Sjoberg, B; Johansson, HA; Kumar, S; Tjernberg, A; Engman, L; Rottenberg, ME; Holmgren, A				Lu, Jun; Vodnala, Suman K.; Gustavsson, Anna-Lena; Gustafsson, Tomas N.; Sjoberg, Birger; Johansson, Henrik A.; Kumar, Sangit; Tjernberg, Agneta; Engman, Lars; Rottenberg, Martin E.; Holmgren, Arne			Ebsulfur Is a Benzisothiazolone Cytocidal Inhibitor Targeting the Trypanothione Reductase of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; AFRICAN TRYPANOSOMES; DRUG DESIGN; LEISHMANIA-DONOVANI; OXIDATIVE STRESS; BINDING-SITES; ACTIVE-SITE; METABOLISM; MECHANISM; GLUTATHIONE	Trypanosoma brucei is the causing agent of African trypanosomiasis. These parasites possess a unique thiol redox system required for DNA synthesis and defense against oxidative stress. It includes trypanothione and trypanothione reductase (TryR) instead of the thioredoxin and glutaredoxin systems of mammalian hosts. Here, we show that the benzisothiazolone compound ebsulfur (EbS), a sulfur analogue of ebselen, is a potent inhibitor of T. brucei growth with a favorable selectivity index over mammalian cells. EbS inhibited the TryR activity and decreased non-protein thiol levels in cultured parasites. The inhibition of TryR by EbS was irreversible and NADPH-dependent. EbS formed a complex with TryR and caused oxidation and inactivation of the enzyme. EbS was more toxic for T. brucei than for Trypanosoma cruzi, probably due to lower levels of TryR and trypanothione in T. brucei. Furthermore, inhibition of TryR produced high intracellular reactive oxygen species. Hydrogen peroxide, known to be constitutively high in T. brucei, enhanced the EbS inhibition of TryR. The elevation of reactive oxygen species production in parasites caused by EbS induced a programmed cell death. Soluble EbS analogues were synthesized and cured T. brucei brucei infection in mice when used together with nifurtimox. Altogether, EbS and EbS analogues disrupt the trypanothione system, hampering the defense against oxidative stress. Thus, EbS is a promising lead for development of drugs against African trypanosomiasis.	[Lu, Jun; Gustafsson, Tomas N.; Johansson, Henrik A.; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Vodnala, Suman K.; Rottenberg, Martin E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Gustavsson, Anna-Lena; Sjoberg, Birger] Karolinska Inst, Chem Biol Consortium Sweden, Sci Life Lab, Div Translat Med, SE-17177 Stockholm, Sweden; [Johansson, Henrik A.; Engman, Lars] Uppsala Univ, Dept Chem BMC, SE-75123 Uppsala, Sweden; [Kumar, Sangit] IISER Bhopal, Dept Chem, Bhopal, MP, India; [Tjernberg, Agneta] Swedish Orphan Biovitrum AB, SE-11276 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University; Indian Institute of Science Education & Research (IISER) - Bhopal; Swedish Orphan Biovitrum	Rottenberg, ME (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.	Martin.Rottenberg@ki.se; Arne.Holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835; Gustavsson, Anna-Lena/0000-0003-4332-2336; Rottenberg, Martin/0000-0003-0514-7434; Gustafsson, Tomas/0000-0002-4495-8267; KUMAR, SANGIT/0000-0003-0658-8709	Swedish Cancer Society [961]; Swedish Research Council [13x-3529, 70409201]; Vinnova	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova)	This work was supported by Swedish Cancer Society Grant 961, Swedish Research Council Grants 13x-3529 and 70409201, Vinnova, The K. A. Wallenberg Foundation, the Ake Wiberg Stiftelse, and the Karolinska Institutet.	ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; BENSON TJ, 1992, BIOCHEM J, V286, P9, DOI 10.1042/bj2860009; Bhakuni BS, 2012, TETRAHEDRON LETT, V53, P1354, DOI 10.1016/j.tetlet.2012.01.003; Bonse S, 1999, J MED CHEM, V42, P5448, DOI 10.1021/jm990386s; Cerecetto H, 2011, FUTURE MICROBIOL, V6, P847, DOI 10.2217/FMB.11.74; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; Dumas M., 1999, PROGR HUMAN AFRICAN, P215; ENGMAN L, 1989, J ORG CHEM, V54, P2964, DOI 10.1021/jo00273a035; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; Gustafsson TN, 2007, ACTA CRYSTALLOGR D, V63, P833, DOI 10.1107/S0907444907026303; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; He J, 2012, BIOORGAN MED CHEM, V20, P3816, DOI 10.1016/j.bmc.2012.04.033; Holmgren A., 2007, U.S. Patent Appl., Patent No. [2011/2088, 130, 20112088]; HOMBURG CHE, 1995, BLOOD, V85, P532; HUNTER WN, 1992, J MOL BIOL, V227, P322, DOI 10.1016/0022-2836(92)90701-K; Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; KITZ R, 1962, J BIOL CHEM, V237, P3245; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; KRAUTHSIEGEL RL, 1995, FASEB J, V9, P1138, DOI 10.1096/fasebj.9.12.7672506; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kristensson K, 2002, CURR TOP MICROBIOL, V265, P227; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI22104; Meiering S, 2005, J MED CHEM, V48, P4793, DOI 10.1021/jm050027z; MLOCHOWSKI J, 1993, LIEBIGS ANN CHEM, P1239; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; Olin-Sandoval V, 2010, CURR DRUG TARGETS, V11, P1614, DOI 10.2174/1389450111009011614; Patterson S, 2011, J MED CHEM, V54, P6514, DOI 10.1021/jm200312v; Ranganathan S, 2002, TETRAHEDRON, V58, P2861, DOI 10.1016/S0040-4020(02)00159-X; Richardson JL, 2009, CHEMMEDCHEM, V4, P1333, DOI 10.1002/cmdc.200900097; Saravanamuthu A, 2004, J BIOL CHEM, V279, P29493, DOI 10.1074/jbc.M403187200; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schmidt Armin, 2002, Current Topics in Medicinal Chemistry, V2, P1239, DOI 10.2174/1568026023393048; Sharlow ER, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000659; Spinks D, 2009, CHEMMEDCHEM, V4, P2060, DOI 10.1002/cmdc.200900262; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Tsuda A, 2006, PARASITOL INT, V55, P135, DOI 10.1016/j.parint.2006.01.001; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wojtowicz H., 2004, Farmaco (Lausanne), V59, P863, DOI 10.1016/j.farmac.2004.07.003; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399	52	42	45	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27456	27468		10.1074/jbc.M113.495101	http://dx.doi.org/10.1074/jbc.M113.495101			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900839	hybrid, Green Published			2022-12-28	WOS:000330597300041
J	Pettengill, M; Robson, S; Tresenriter, M; Millan, JL; Usheva, A; Bingham, T; Belderbos, M; Bergelson, I; Burl, S; Kampmann, B; Gelinas, L; Kollmann, T; Bont, L; Levy, O				Pettengill, Matthew; Robson, Simon; Tresenriter, Megan; Millan, Jose Luis; Usheva, Anny; Bingham, Taiese; Belderbos, Mirjam; Bergelson, Ilana; Burl, Sarah; Kampmann, Beate; Gelinas, Laura; Kollmann, Tobias; Bont, Louis; Levy, Ofer			Soluble Ecto-5 '-nucleotidase (5 '-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE ANION GENERATION; INNATE IMMUNITY; HUMAN-NEUTROPHILS; PHYSIOLOGICAL MODULATOR; BASIC MECHANISMS; CELL-DEVELOPMENT; HUMAN NEWBORN; A2 ADENOSINE; ATP; ACTIVATION	Extracellular adenosine, a key regulator of physiology and immune cell function that is found at elevated levels in neonatal blood, is generated by phosphohydrolysis of adenine nucleotides released from cells and catabolized by deamination to inosine. Generation of adenosine monophosphate (AMP) in blood is driven by cell-associated enzymes, whereas conversion of AMP to adenosine is largely mediated by soluble enzymes. The identities of the enzymes responsible for these activities in whole blood of neonates have been defined in this study and contrasted to adult blood. We demonstrate that soluble 5 '-nucleotidase (5 '-NT) and alkaline phosphatase (AP) mediate conversion of AMP to adenosine, whereas soluble adenosine deaminase (ADA) catabolizes adenosine to inosine. Newborn blood plasma demonstrates substantially higher adenosine-generating 5 '-NT and AP activity and lower adenosine-metabolizing ADA activity than adult plasma. In addition to a role in soluble purine metabolism, abundant AP expressed on the surface of circulating neonatal neutrophils is the dominant AMPase on these cells. Plasma samples from infant observational cohorts reveal a relative plasma ADA deficiency at birth, followed by a gradual maturation of plasma ADA through infancy. The robust adenosine-generating capacity of neonates appears functionally relevant because supplementation with AMP inhibited whereas selective pharmacologic inhibition of 5 '-NT enhanced Toll-like receptor-mediated TNF-alpha production in neonatal whole blood. Overall, we have characterized previously unrecognized age-dependent expression patterns of plasma purine-metabolizing enzymes that result in elevated plasma concentrations of anti-inflammatory adenosine in new-borns. Targeted manipulation of purine-metabolizing enzymes may benefit this vulnerable population.	[Pettengill, Matthew; Tresenriter, Megan; Bingham, Taiese; Bergelson, Ilana; Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA 02115 USA; [Robson, Simon; Usheva, Anny] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Pettengill, Matthew; Robson, Simon; Usheva, Anny; Bingham, Taiese; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Millan, Jose Luis] Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Belderbos, Mirjam; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, NL-3584 CX Utrecht, Netherlands; [Burl, Sarah; Kampmann, Beate] MRC Unit, Vaccinol Theme Grp, Fajara, Gambia; [Burl, Sarah; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London W2 1PG, England; [Gelinas, Laura] Univ British Columbia, Dept Med, Expt Med Program, Vancouver, BC V6T 1Z4, Canada; [Kollmann, Tobias] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1Z4, Canada	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Sanford Burnham Prebys Medical Discovery Institute; Utrecht University; Utrecht University Medical Center; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of British Columbia; University of British Columbia	Levy, O (corresponding author), Boston Childrens Hosp, Div Infect Dis, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	ofer.levy@childrens.harvard.edu	Robson, Simon C./AAA-8537-2021	Pettengill, Matthew/0000-0002-4579-0187; Levy, Ofer/0000-0002-5859-1945; Kollmann, Tobias/0000-0003-2403-9762; Gelinas, Laura/0000-0003-3713-4275; Belderbos, Mirjam/0000-0002-6164-2918	National Institutes of Health (NIH) [1R01AI100135-01]; NIH [T32 HD055148, R01 HL094400, R21 CA164970, P01 HL087203]; NIH, NIDCR [R01 DE012889]; NIH, NIAMS [R01 AR053102]; NIH, NIAID [N01 AI50023]; European Society for Pediatric Infectious Diseases; Medical Research Council, United Kingdom; Canadian Institutes of Health Research; Burroughs Wellcome Career Award in the Biomedical Sciences, a Michael Smith Foundation for Health Research Career Investigator Award; AllerGen NCE [07-A1A, 07-B2B]; Bill and Melinda Gates Foundation Global Health Award [OPPGH5284]; Grand Challenges Explorations Award [OPP1035192]; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA164970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087203, R01HL062458, R01HL094400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050023, T32AI007061, R01AI100135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Society for Pediatric Infectious Diseases; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Career Award in the Biomedical Sciences, a Michael Smith Foundation for Health Research Career Investigator Award; AllerGen NCE; Bill and Melinda Gates Foundation Global Health Award; Grand Challenges Explorations Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant 1R01AI100135-01 (to O.L.); NIH Training Grant T32 HD055148 (to M.P.); NIH Grants R01 HL094400, R21 CA164970, and P01 HL087203 (to S.R.); NIH, NIDCR, Grant R01 DE012889 and NIH, NIAMS, Grant R01 AR053102 (to J.L.M.); and NIH, NIAID, Grant N01 AI50023 (to T.R.K.).; Supported by a European Society for Pediatric Infectious Diseases travel grant.; Supported by the Medical Research Council, United Kingdom.; Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research.; Supported in part by a Burroughs Wellcome Career Award in the Biomedical Sciences, a Michael Smith Foundation for Health Research Career Investigator Award, and the AllerGen NCE Grants 07-A1A and 07-B2B.; The laboratory of this author is supported in part by Bill and Melinda Gates Foundation Global Health Award OPPGH5284 and Grand Challenges Explorations Award OPP1035192. To whom correspondence should be addressed: Dept. of Medicine, Division of Infectious Diseases, Boston Children's Hospital, 300 Longwood Ave., Boston, MA 02115. Tel.: 617-919-2904; Fax: 617-730-0254; E-mail: ofer.levy@childrens.harvard.edu.	Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; BALAZOVICH KJ, 1990, J IMMUNOL, V144, P631; Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Belderbos ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033419; BORN GVR, 1984, J PHYSIOL-LONDON, V354, P419, DOI 10.1113/jphysiol.1984.sp015385; Bouma MG, 1997, J IMMUNOL, V158, P5400; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; COCKCROFT S, 1989, FEBS LETT, V245, P25, DOI 10.1016/0014-5793(89)80184-X; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; CROFTON PM, 1987, CLIN CHEM, V33, P1778; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; CRONSTEIN BN, 1985, J IMMUNOL, V135, P1366; CRONSTEIN BN, 1986, J CLIN INVEST, V78, P760, DOI 10.1172/JCI112638; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; DEMEESTER I, 1994, EUR J IMMUNOL, V24, P566, DOI 10.1002/eji.1830240311; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Gao Zhan-Guo, 2008, BMC Pharmacology, V8, P20, DOI 10.1186/1471-2210-8-20; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; Herrera C, 2001, MOL PHARMACOL, V59, P127, DOI 10.1124/mol.59.1.127; HIRSCHHORN R, 1973, LANCET, V2, P1217; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Letho MT, 1998, BIOCHEM J, V332, P101, DOI 10.1042/bj3320101; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; LOCKITCH G, 1988, CLIN CHEM, V34, P1622; LOW MG, 1987, BIOCHEM J, V244, P1; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Millan J.L., 2006, MAMMALIAN ALKALINE P; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Proytcheva M. A., 2011, DIAGNOSTIC PEDIAT HE, P5; Remington J. S., 2011, INFECT DIS FETUS NEW, P80; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; ROSALKI SB, 1984, CLIN CHEM, V30, P1182; SCHELONKA RL, 1994, J PEDIATR-US, V125, P603, DOI 10.1016/S0022-3476(94)70018-4; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Sergienko E, 2009, J BIOMOL SCREEN, V14, P824, DOI 10.1177/1087057109338517; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Solter PF, 1999, AM J VET RES, V60, P1010; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Sud'ina F, 1998, FEBS LETT, V423, P243, DOI 10.1016/S0014-5793(98)00102-1; SUSSMAN HH, 1968, NATURE, V218, P359, DOI 10.1038/218359a0; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; THOMPSON LF, 1986, J IMMUNOL, V137, P2496; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Weetman AP, 1999, THYROID, V9, P643, DOI 10.1089/thy.1999.9.643; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2012, FASEB J, V26, P3875, DOI 10.1096/fj.12-205658; Yoneyama Y., 2003, Archives of Gynecology and Obstetrics, V267, P205; Yoneyama Y, 2000, AM J OBSTET GYNECOL, V182, P1200, DOI 10.1067/mob.2000.104832; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683	75	64	67	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27315	27326		10.1074/jbc.M113.484212	http://dx.doi.org/10.1074/jbc.M113.484212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23897810	hybrid, Green Published			2022-12-28	WOS:000330597300028
J	Barneaud-Rocca, D; Etchebest, C; Guizouarn, H				Barneaud-Rocca, Damien; Etchebest, Catherine; Guizouarn, Helene			Structural Model of the Anion Exchanger 1 (SLC4A1) and Identification of Transmembrane Segments Forming the Transport Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; HUMAN ERYTHROCYTE BAND-3; CELL-VOLUME REGULATION; MEMBRANE DOMAIN; PROTEIN AE1; CATION LEAK; TOPOLOGY; STOMATOCYTOSIS; RESIDUES; REGION	The anion exchanger 1 (AE1), a member of bicarbonate transporter family SLC4, mediates an electroneutral chloride/bicarbonate exchange in physiological conditions. However, some point mutations in AE1 membrane-spanning domain convert the electroneutral anion exchanger into a Na+ and K+ conductance or induce a cation leak in a still functional anion exchanger. The molecular determinants that govern ion movement through this transporter are still unknown. The present study was intended to identify the ion translocation pathway within AE1. In the absence of a resolutive three-dimensional structure of AE1 membrane-spanning domain, in silico modeling combined with site-directed mutagenesis experiments was done. Astructural model of AE1 membrane-spanning domain is proposed, and this model is based on the structure of a uracil-proton symporter. This model was used to design cysteine-scanning mutagenesis on transmembrane (TM) segments 3 and 5. By measuring AE1 anion exchange activity or cation leak, it is proposed that there is a unique transport site comprising TM3-5 and TM8 that should function as an anion exchanger and a cation leak.	[Barneaud-Rocca, Damien; Guizouarn, Helene] Univ Nice Sophia Antipolis, Inst Biol Valrose, UMR7277, F-06100 Nice, France; [Barneaud-Rocca, Damien; Guizouarn, Helene] CNRS, UMR7277, F-06100 Nice, France; [Barneaud-Rocca, Damien; Guizouarn, Helene] INSERM, U1091, F-06100 Nice, France; [Etchebest, Catherine] INSERM, U665, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, UMR S665, F-75015 Paris, France; [Etchebest, Catherine] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Etchebest, Catherine] Lab Excellence GR Ex, F-75739 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guizouarn, H (corresponding author), Inst Biol Valrose, Batiment Sci Nat,28 Av Valrose, F-06108 Nice 2, France.	helene.guizouarn@unice.fr	etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Guizouarn, Helene/0000-0002-8757-6672				Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Bamberg E, 1992, The Band 3 Proteins: Anion Transporters, Binding Proteins Senescent Antigens; Barneaud-Rocca D, 2011, J BIOL CHEM, V286, P8909, DOI 10.1074/jbc.M110.166819; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bohm R, 1996, BBA-BIOMEMBRANES, V1280, P238, DOI 10.1016/0005-2736(95)00303-7; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; Chu C, 2010, BIOCHEM J, V426, P379, DOI 10.1042/BJ20091525; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Ellory JC, 2009, PHILOS T R SOC B, V364, P189, DOI 10.1098/rstb.2008.0154; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FIEVET B, 1995, EMBO J, V14, P5158, DOI 10.1002/j.1460-2075.1995.tb00200.x; Fievet B, 1998, P NATL ACAD SCI USA, V95, P10996, DOI 10.1073/pnas.95.18.10996; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Groves JD, 1999, BIOCHEM J, V344, P699, DOI 10.1042/0264-6021:3440699; Groves JD, 1999, BIOCHEM J, V344, P687, DOI 10.1042/0264-6021:3440687; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Guizouarn H, 2011, BRIT J HAEMATOL, V152, P655, DOI 10.1111/j.1365-2141.2010.08454.x; Hirai T, 2011, BIOCHEM CELL BIOL, V89, P148, DOI [10.1139/o10-160, 10.1139/O10-160]; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P1049, DOI 10.3324/haematol.2008.002873; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Kanki T, 2002, BIOCHEMISTRY-US, V41, P13973, DOI 10.1021/bi026619q; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; LINDENTHAL S, 1991, P NATL ACAD SCI USA, V88, P6540, DOI 10.1073/pnas.88.15.6540; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Parker MD, 2007, J PHYSIOL-LONDON, V581, P33, DOI 10.1113/jphysiol.2007.128389; Passow H, 1980, Ann N Y Acad Sci, V341, P361, DOI 10.1111/j.1749-6632.1980.tb47184.x; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; PUCEAT M, 1995, J BIOL CHEM, V270, P1315, DOI 10.1074/jbc.270.3.1315; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V300, pC1034, DOI 10.1152/ajpcell.00447.2010; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; WAINWRIGHT SD, 1990, BIOCHEM J, V272, P265, DOI 10.1042/bj2720265; Walsh S, 2008, AM J PHYSIOL-RENAL, V295, pF343, DOI 10.1152/ajprenal.00587.2007; Walsh S, 2009, BIOCHEM BIOPH RES CO, V382, P668, DOI 10.1016/j.bbrc.2009.03.062; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamaguchi T, 2010, J STRUCT BIOL, V169, P406, DOI 10.1016/j.jsb.2009.12.009; Zaki L, 1996, CELL MOL BIOL, V42, P1053; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	49	31	32	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26372	26384		10.1074/jbc.M113.465989	http://dx.doi.org/10.1074/jbc.M113.465989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23846695	hybrid, Green Published			2022-12-28	WOS:000330594500003
J	Justiniano, SE; Elavazhagan, S; Fatehchand, K; Shah, P; Mehta, P; Roda, JM; Mo, XK; Cheney, C; Hertlein, E; Eubank, TD; Marsh, C; Muthusamy, N; Butchar, JP; Byrd, JC; Tridandapani, S				Justiniano, Steven E.; Elavazhagan, Saranya; Fatehchand, Kavin; Shah, Prexy; Mehta, Payal; Roda, Julie M.; Mo, Xiaokui; Cheney, Carolyn; Hertlein, Erin; Eubank, Timothy D.; Marsh, Clay; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela			Fc gamma Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; KAPPA-B-ALPHA; HUMAN MONOCYTES; BISPECIFIC ANTIBODY; TUMOR ANGIOGENESIS; MESSENGER-RNA; CELLS; EXPRESSION; CANCER; MICRORNA	Monocytes/macrophages are potent mediators of antitumor antibody therapy, where they engage target cells via Fc gamma receptors (Fc gamma R). Binding of these cells to opsonized tumor targets elicits cytokine production, phagocytosis, and antibody-mediated cellular cytotoxicity. Here we show for the first time that activation of monocyte Fc gamma R results in the secretion of soluble vascular endothelial growth factor receptor-1 (VEGFR-1/sFlt-1), which serves to antagonize VEGF-mediated angiogenesis and tumor growth. Consistent with this, using a murine solid tumor model of antibody therapy, we show that sFlt-1 is involved in restricting tumor growth. Analyzing the mechanism of induction of sFlt-1, we found that the Erk and PI3K pathways were required for transcription, and NF-kappa B was required for translation. Upon closer examination of the role of NF-kappa B, we found that a microRNA, miR181a, negatively regulates Fc gamma R-mediated sFlt-1 production and that NF-kappa B serves to antagonize this microRNA. Taken together, these results demonstrate a novel and biologically important function of monocytes and macrophages during antibody therapy.	[Justiniano, Steven E.; Elavazhagan, Saranya; Shah, Prexy; Roda, Julie M.; Eubank, Timothy D.; Marsh, Clay; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Fatehchand, Kavin; Tridandapani, Susheela] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Mehta, Payal; Tridandapani, Susheela] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Cheney, Carolyn; Hertlein, Erin; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, 473 W 12th Ave, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011; Roda, Julie/G-8932-2015	Roda, Julie/0000-0001-5631-9908; Eubank, Tim/0000-0002-8225-7824; Justiniano, Steven/0000-0003-1381-9309	National Institutes of Health [R01CA162411, P01 CA095426, K12CA133250, T32 60013191]; American Cancer Society [IRG-67-003-47]; Leukemia and Lymphoma Society [P50-CA140158]; Harry Mangurian Foundation; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, P50CA140158, R01CA162411, K12CA133250, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Harry Mangurian Foundation; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA162411, P01 CA095426, and K12CA133250 (to J. P. B., X. M., N. M., J. C. B., and S. T.) and Postdoctoral Fellowship T32 60013191 (to S. E. J.). This work was also supported by American Cancer Society Grant IRG-67-003-47 (to J. P. B.) and The Leukemia and Lymphoma Society Grant P50-CA140158, The Harry Mangurian Foundation, and The D. Warren Brown Foundation (to J. P. B. and N. M.).	Akewanlop C, 2001, CANCER RES, V61, P4061; ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Banks RE, 1998, MOL HUM REPROD, V4, P377, DOI 10.1093/molehr/4.4.377; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; CASADO JA, 1994, IMMUNOLOGY, V83, P148; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dudoit S, 2003, BIOTECHNIQUES, P45; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2011, BLOOD, V117, P323, DOI 10.1182/blood-2010-01-261792; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; FANGER MW, 1992, IMMUNOL RES, V11, P203, DOI 10.1007/BF02919127; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh AK, 2009, BLOOD, V113, P5568, DOI 10.1182/blood-2008-10-185686; HOLM S, 1979, SCAND J STAT, V6, P65; Hunt TK, 2008, ADV EXP MED BIOL, V614, P73, DOI 10.1007/978-0-387-74911-2_9; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; KINDT GC, 1993, AM J PHYSIOL, V265, pL178, DOI 10.1152/ajplung.1993.265.2.L178; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; Krussel JS, 1999, MOL HUM REPROD, V5, P452, DOI 10.1093/molehr/5.5.452; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parihar R, 2004, CLIN CANCER RES, V10, P5027, DOI 10.1158/1078-0432.CCR-04-0265; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Seoudi AM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002122; SHAW GM, 1978, J CLIN INVEST, V62, P1172, DOI 10.1172/JCI109236; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tailor TD, 2010, MOL CANCER THER, V9, P1798, DOI 10.1158/1535-7163.MCT-09-0856; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Verbeke G, 2000, LINEAR MIXED MODELS, P23; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Watanabe M, 1999, BREAST CANCER RES TR, V53, P199, DOI 10.1023/A:1006145507567	51	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26800	26809		10.1074/jbc.M113.485185	http://dx.doi.org/10.1074/jbc.M113.485185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902770	Green Published, hybrid			2022-12-28	WOS:000330594500044
J	Lau, C; Kim, Y; Chia, D; Spielmann, N; Eibl, G; Elashoff, D; Wei, F; Lin, YL; Moro, A; Grogan, T; Chiang, S; Feinstein, E; Schafer, C; Farrell, J; Wong, DTW				Lau, Chang; Kim, Yong; Chia, David; Spielmann, Nadine; Eibl, Guido; Elashoff, David; Wei, Fang; Lin, Yi-Ling; Moro, Aune; Grogan, Tristan; Chiang, Samantha; Feinstein, Eric; Schafer, Christopher; Farrell, James; Wong, David T. W.			Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOMA; FAMILY; GENES; CELLS	Recent studies have demonstrated that discriminatory salivary biomarkers can be readily detected upon the development of systemic diseases such as pancreatic cancer, breast cancer, lung cancer, and ovarian cancer. However, the utility of salivary biomarkers for the detection of systemic diseases has been undermined due to the absence of the biological and mechanistic rationale as to why distal diseases from the oral cavity would lead to the development of discriminatory biomarkers in saliva. Here, we examine the hypothesis that pancreatic tumor-derived exosomes are mechanistically involved in the development of pancreatic cancer-discriminatory salivary transcriptomic biomarkers. We first developed a pancreatic cancer mouse model that yielded discriminatory salivary biomarkers by implanting the mouse pancreatic cancer cell line Panc02 into the pancreas of the syngeneic host C57BL/6. The role of pancreatic cancer-derived exosomes in the development of discriminatory salivary biomarkers was then tested by engineering a Panc02 cell line that is suppressed for exosome biogenesis, implanting into the C56BL/6 mouse, and examining whether the discriminatory salivary biomarker profile was ablated or disrupted. Suppression of exosome biogenesis results in the ablation of discriminatory salivary biomarker development. This study supports that tumor-derived exosomes provide a mechanism in the development of discriminatory biomarkers in saliva and distal systemic diseases.	[Lau, Chang; Kim, Yong; Spielmann, Nadine; Wei, Fang; Lin, Yi-Ling; Chiang, Samantha; Feinstein, Eric; Schafer, Christopher; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90095 USA; [Wong, David T. W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wong, David T. W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Wong, David T. W.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Los Angeles, CA 90095 USA; [Eibl, Guido; Moro, Aune] Univ Calif Los Angeles, Dept Surg, Ctr Excellence Pancreat Dis, Los Angeles, CA 90095 USA; [Chia, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Elashoff, David; Grogan, Tristan] Univ Calif Los Angeles, David Geffen Sch Med, Stat Core, Los Angeles, CA 90095 USA; [Wong, David T. W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wong, DTW (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave,73-017 CHS, Los Angeles, CA 90095 USA.	dtww@ucla.edu			National Institutes of Health from USPHS [R01DE17170, UH2/UH3 TR000923, T32DE07296]; SOD from the UCLA School of Dentistry [441901-69749-FWEI-FY11DR]; NATIONAL CANCER INSTITUTE [R01CA122042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UH2TR000923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296, R01DE017170] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; SOD from the UCLA School of Dentistry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE17170, UH2/UH3 TR000923, and T32DE07296 from USPHS. This work was also supported by SOD Faculty Seed Grants 441901-69749-FWEI-FY11DR from the UCLA School of Dentistry. D. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX. Intellectual property that David Wong invented and that was patented by University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Banham AH, 2001, CANCER RES, V61, P8820; CHARDIN P, 1988, BIOCHIMIE, V70, P865, DOI 10.1016/0300-9084(88)90226-X; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Iser WB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001240; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Lau CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033037; Lee YH, 2012, J MOL MED, V90, P427, DOI 10.1007/s00109-011-0829-0; Lee YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/clinchem.2010.159210; Liu LX, 2002, WORLD J GASTROENTERO, V8, P580, DOI 10.3748/wjg.v8.i4.580; Morikane K, 1999, CANCER IMMUNOL IMMUN, V47, P287, DOI 10.1007/s002620050533; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Qazi KR, 2010, THORAX, V65, P1016, DOI 10.1136/thx.2009.132027; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2002, J CELL SCI, V115, P2505; Somasundaram R, 2012, NAT MED, V18, P853, DOI 10.1038/nm.2775; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Wei F, 2009, CLIN CANCER RES, V15, P4446, DOI 10.1158/1078-0432.CCR-09-0050; Wei F, 2009, SMALL, V5, P1784, DOI 10.1002/smll.200900369; Xiao H, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012112; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010	30	168	178	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26888	26897		10.1074/jbc.M113.452458	http://dx.doi.org/10.1074/jbc.M113.452458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23880764	Green Published, hybrid			2022-12-28	WOS:000330594500054
J	He, H; Zhang, SZ; Tighe, S; Son, J; Tseng, SCG				He, Hua; Zhang, Suzhen; Tighe, Sean; Son, Ji; Tseng, Scheffer C. G.			Immobilized Heavy Chain-Hyaluronic Acid Polarizes Lipopolysaccharide-activated Macrophages toward M2 Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMNIOTIC MEMBRANE TRANSPLANTATION; ALPHA-TRYPSIN INHIBITOR; CELLS IN-VITRO; KINASE C-DELTA; NF-KAPPA-B; NEUTROPHIL APOPTOSIS; FUNCTIONAL-CHARACTERIZATION; INFLAMMATORY MACROPHAGE; ALTERNATIVE ACTIVATION; RHEUMATOID-ARTHRITIS	Despite the known anti-inflammatory effect of amniotic membrane, its action mechanism remains largely unknown. HC-HA complex (HC-HA) purified from human amniotic membrane consists of high molecular weight hyaluronic acid (HA) covalently linked to the heavy chain (HC) 1 of inter-alpha-trypsin inhibitor. In this study, we show that soluble HC-HA also contained pentraxin 3 and induced the apoptosis of both formyl-Met-Leu-Phe or LPS-activated neutrophils and LPS-activated macrophages while not affecting the resting cells. This enhanced apoptosis was caused by the inhibition of cell adhesion, spreading, and proliferation caused by HC-HA binding of LPS-activated macrophages and preventing adhesion to the plastic surface. Preferentially, soluble HC-HA promoted phagocytosis of apoptotic neutrophils in resting macrophages, whereas immobilized HC-HA promoted phagocytosis in LPS-activated macrophages. Upon concomitant LPS stimulation, immobilized HC-HA but not HA polarized macrophages toward the M2 phenotype by down-regulating IRF5 protein and preventing its nuclear localization and by down-regulating IL-12, TNF-alpha, andNOsynthase 2. Additionally, IL-10, TGF-beta 1, peroxisome proliferator-activated receptor gamma, LIGHT (TNF superfamily 14), and sphingosine kinase-1 were up-regulated, and such M2 polarization was dependent on TLR ligation. Collectively, these data suggest that HC-HA is a unique matrix component different from HA and uses multiple mechanisms to suppress M1 while promoting M2 phenotype. This anti-inflammatory action of HC-HA is highly desirable to promote wound healing in diseases heightened by unsuccessful transition from M1 to M2 phenotypes.	[He, Hua; Zhang, Suzhen; Tighe, Sean; Tseng, Scheffer C. G.] TissueTech Inc, Miami, FL 33173 USA; [Son, Ji; Tseng, Scheffer C. G.] Ocular Surface Res Educ Fdn, Miami, FL 33173 USA; [Tseng, Scheffer C. G.] Ocular Surface Ctr, Miami, FL 33173 USA		Tseng, SCG (corresponding author), Ocular Surface Ctr, 7000 SW 97 Ave,Suite 213, Miami, FL 33173 USA.	stseng@ocularsurface.com	Zhang, Suzhen/J-8011-2013	Son, Ji/0000-0002-5130-4763	National Institutes of Health [RO1 EY06819, R43 EY21045, R44 EY017497]; TissueTech, Inc.; NATIONAL EYE INSTITUTE [R01EY006819, R43EY021045, R44EY017497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TissueTech, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY06819, R43 EY21045, and R44 EY017497 (to S. C. G. T.). This work was also supported by a research grant from TissueTech, Inc.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Bauer D, 2007, EXP EYE RES, V85, P335, DOI 10.1016/j.exer.2007.05.009; Bauer D, 2012, INVEST OPHTH VIS SCI, V53, P799, DOI 10.1167/iovs.11-7617; Bauer D, 2009, INVEST OPHTH VIS SCI, V50, P3188, DOI 10.1167/iovs.08-3041; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bouchard Charles S, 2004, Ocul Surf, V2, P201; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; Delgado M, 1999, J IMMUNOL, V162, P4685; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717; FORRESTER JV, 1980, IMMUNOLOGY, V40, P435; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Heiligenhaus A, 2001, INVEST OPHTH VIS SCI, V42, P1969; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Khwaja A, 1999, BLOOD, V94, P291, DOI 10.1182/blood.V94.1.291.413k10_291_301; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; LEE GW, 1993, J IMMUNOL, V150, P1804; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; Li W, 2006, EXP EYE RES, V82, P282, DOI 10.1016/j.exer.2005.06.022; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MOSSER DM, 1992, J LEUKOCYTE BIOL, V52, P369, DOI 10.1002/jlb.52.4.369; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Otake K, 2008, J SURG RES, V149, P243, DOI 10.1016/j.jss.2008.01.011; Park WC, 2000, INVEST OPHTH VIS SCI, V41, P2906; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Paun A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001246; Perdiguero E, 2012, CELL CYCLE, V11, P877, DOI 10.4161/cc.11.5.19374; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Ravasi T, 2002, J IMMUNOL, V168, P44, DOI 10.4049/jimmunol.168.1.44; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Shimmura S, 2001, CORNEA, V20, P408, DOI 10.1097/00003226-200105000-00015; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210; TAMOTO K, 1994, MICROBIOL IMMUNOL, V38, P73, DOI 10.1111/j.1348-0421.1994.tb01746.x; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Wang MX, 2001, J CATARACT REFR SURG, V27, P310, DOI 10.1016/S0886-3350(00)00467-3; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhu L, 2010, INT ARCH ALLERGY IMM, V153, P223, DOI 10.1159/000314362; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	89	87	91	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25792	25803		10.1074/jbc.M113.479584	http://dx.doi.org/10.1074/jbc.M113.479584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23878196	Green Published, hybrid			2022-12-28	WOS:000330623300012
J	Menon, D; Board, PG				Menon, Deepthi; Board, Philip G.			A Role for Glutathione Transferase Omega 1 (GSTO1-1) in the Glutathionylation Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-GLUTATHIONYLATION; AGE-AT-ONSET; REDOX SIGNAL-TRANSDUCTION; ALZHEIMER-DISEASE; PARKINSON-DISEASE; ACTIVE-SITE; CELL-DEATH; RISK; POLYMORPHISMS; ASSOCIATION	The glutathionylation of intracellular protein thiols can protect against irreversible oxidation and can act as a redox switch regulating metabolic pathways. In this study we discovered that the Omega class glutathione transferase GSTO1-1 plays a significant role in the glutathionylation cycle. The catalytic activity of GSTO1-1 was determined in vitro by assaying the deglutathionylation of a synthetic peptide by tryptophan fluorescence quenching and in T47-D epithelial breast cancer cells by both immunoblotting and the direct determination of total glutathionylation. Mutating the active site cysteine residue (Cys-32) ablated the deglutathionylating activity of GSTO1-1. Furthermore, we demonstrate that the expression of GSTO1-1 in T47-D cells that are devoid of endogenous GSTO1-1 resulted in a 50% reduction in total glutathionylation levels. Mass spectrometry and immunoprecipitation identified beta-actin as a protein that is specifically deglutathionylated by GSTO1-1 in T47-D cells. In contrast to the deglutathionylation activity, we also found that GSTO1-1 is associated with the rapid glutathionylation of cellular proteins when the cells are exposed to S-nitrosoglutathione. The common A140D genetic polymorphism in GSTO1 was found to have significant effects on the kinetics of both the deglutathionylation and glutathionylation reactions. Genetic variation in GSTO1-1 has been associated with a range of diseases, and the discovery that a frequent GSTO1-1 polymorphism affects glutathionylation cycle reactions reveals a common mechanism where it can act on multiple proteins and pathways.	[Menon, Deepthi; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Biosci, Canberra, ACT 2600, Australia	Australian National University; John Curtin School of Medical Research	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au						Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Anathy V, 2012, MOL CELL BIOL, V32, P3464, DOI 10.1128/MCB.00125-12; Andonova IE, 2010, BREAST CANCER RES TR, V121, P497, DOI 10.1007/s10549-009-0589-5; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Bedhomme M, 2012, BIOCHEM J, V445, P337, DOI 10.1042/BJ20120505; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2004, INT J BIOCHEM CELL B, V36, P1599, DOI 10.1016/j.biocel.2004.01.026; Board PG, 2001, DRUG METAB DISPOS, V29, P544; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Capurso C, 2010, REJUV RES, V13, P645, DOI 10.1089/rej.2010.1052; Carletti B, 2011, NEUROSCIENCE, V192, P285, DOI 10.1016/j.neuroscience.2011.05.060; Chariyalertsak S, 2009, TUMORI, V95, P739, DOI 10.1177/030089160909500617; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; De Giessen EV, 2008, AMYOTROPH LATERAL SC, V9, P81, DOI 10.1080/17482960701702553; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Granja F, 2005, EUR J CANCER PREV, V14, P277, DOI 10.1097/00008469-200506000-00013; Harju TH, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-48; Jarry A, 2004, CANCER RES, V64, P4227, DOI 10.1158/0008-5472.CAN-04-0254; Kodym R, 1999, J BIOL CHEM, V274, P5131, DOI 10.1074/jbc.274.8.5131; Kolsch H, 2007, STROKE, V38, P2847, DOI 10.1161/STROKEAHA.107.484162; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Li YJ, 2006, NEUROBIOL AGING, V27, P1087, DOI 10.1016/j.neurobiolaging.2005.05.013; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lindahl M, 2011, ANTIOXID REDOX SIGN, V14, P2581, DOI 10.1089/ars.2010.3551; Masoudi M, 2009, MOL BIOL REP, V36, P781, DOI 10.1007/s11033-008-9245-0; Menon D, 2013, ANAL BIOCHEM, V433, P132, DOI 10.1016/j.ab.2012.10.009; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Pongstaporn W, 2006, J EXP CLIN CANC RES, V25, P107; Pongstaporn W, 2009, J CANCER RES CLIN, V135, P673, DOI 10.1007/s00432-008-0501-4; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Robinson A, 2004, BIOCHEM J, V379, P541, DOI 10.1042/BJ20031656; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Schmuck E, 2008, INT J BIOCHEM CELL B, V40, P2553, DOI 10.1016/j.biocel.2008.04.017; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Staab CA, 2008, BIOCHEM J, V413, P493, DOI 10.1042/BJ20071666; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; STENBERG G, 1991, FEBS LETT, V293, P153, DOI 10.1016/0014-5793(91)81174-7; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o; Townsend DM, 2009, BIOMED PHARMACOTHER, V63, P79, DOI 10.1016/j.biopha.2008.08.004; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Wang YH, 2009, TOXICOL APPL PHARM, V241, P111, DOI 10.1016/j.taap.2009.08.008; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Yanbaeva DG, 2009, FREE RADICAL RES, V43, P738, DOI 10.1080/10715760903038440; Yin ZL, 2001, J HISTOCHEM CYTOCHEM, V49, P983, DOI 10.1177/002215540104900806; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h; Zhou HN, 2012, J MOL BIOL, V420, P190, DOI 10.1016/j.jmb.2012.04.014; Zhou HN, 2011, J BIOL CHEM, V286, P4271, DOI 10.1074/jbc.M110.197822	62	84	84	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25769	25779		10.1074/jbc.M113.487785	http://dx.doi.org/10.1074/jbc.M113.487785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888047	Green Published, hybrid			2022-12-28	WOS:000330623300010
J	Boggaram, V; Gottipati, KR; Wang, XS; Samten, B				Boggaram, Vijay; Gottipati, Koteswara R.; Wang, Xisheng; Samten, Buka			Early Secreted Antigenic Target of 6 kDa (ESAT-6) Protein of Mycobacterium tuberculosis Induces Interleukin-8 (IL-8) Expression in Lung Epithelial Cells via Protein Kinase Signaling and Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA STABILITY; P38 MAP KINASE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; AIRWAY EPITHELIUM; BOVIS BCG; MACROPHAGES; ACTIVATION; INFECTION	Early secreted antigenic target of 6 kDa (ESAT-6) of Mycobacterium tuberculosis is critical for the virulence and pathogenicity of M. tuberculosis. IL-8, a major chemotactic cytokine for neutrophils and T lymphocytes, plays important roles in the development of lung injury. To further understand the role of ESAT-6 in lung pathology associated with tuberculosis development, we studied the effects of ESAT-6 on the regulation of IL-8 expression in lung epithelial cells. ESAT-6 induced IL-8 expression by increasing IL-8 gene transcription and mRNA stability. ESAT-6 induction of IL-8 promoter activity was dependent on nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1) binding and sensitive to pharmacological inhibition of PKC and ERK and p38 MAPK pathways. ESAT-6 activated ERK and p38 MAPK phosphorylation and rapidly induced reactive oxygen species (ROS) production. Dimethylthiourea but not mannitol inhibited IL-8 induction by ESAT-6, further supporting the involvement of ROS in the induction of IL-8 expression. Exposure of mice to ESAT-6 induced localized inflammatory cell aggregate formation with characteristics of early granuloma concomitant with increased keratinocyte chemoattractant CXCL1 staining in bronchiolar and alveolar type II epithelial cells and alveolar macrophages. Our studies have identified a signal transduction pathway involving ROS, PKC, ERK, and p38 MAPKs and NF-kappa B and AP-1 in the ESAT-6 induction of IL-8 expression in lung epithelial cells. This has important implications for the understanding of lung innate immune responses to tuberculosis and the pathogenesis of lung injury in tuberculosis.	[Boggaram, Vijay] Univ Texas Hlth Ctr Tyler, Dept Cell & Mol Biol, Tyler, TX 75708 USA; Univ Texas Hlth Ctr Tyler, Ctr Pulm Infect Dis Control, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Boggaram, V (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cell & Mol Biol, 11937 US Highway 271, Tyler, TX 75708 USA.	vijay.boggaram@uthct.edu	Samten, Buka/AAV-3140-2021		National Institutes of Health [AI099345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI099345 (to B. S.). This work was also supported by institutional funds (to V. B.).	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Berhane K, 2001, GENE, V268, P141, DOI 10.1016/S0378-1119(01)00417-6; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Boggaram V, 2003, FRONT BIOSCI-LANDMRK, V8, pD751, DOI 10.2741/1062; BOGGARAM V, 1994, J BIOL CHEM, V269, P27767; Booth JL, 1999, AM J RESP CELL MOL, V21, P521, DOI 10.1165/ajrcmb.21.4.3677; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chroneos ZC, 2009, TUBERCULOSIS, V89, pS10, DOI 10.1016/S1472-9792(09)70005-8; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cormet-Boyaka E, 2012, TOXICOL SCI, V125, P418, DOI 10.1093/toxsci/kfr310; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dempsey EC, 2007, PHARMACOL RES, V55, P545, DOI 10.1016/j.phrs.2007.04.010; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233; GREENBERG ME, 1997, CURRENT PROTOCOLS MO; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hofmann M, 2004, BIOCHEM BIOPH RES CO, V316, P673, DOI 10.1016/j.bbrc.2004.02.101; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Lakshminarayanan V, 1998, J BIOL CHEM, V273, P32670, DOI 10.1074/jbc.273.49.32670; LARSEN CG, 1995, J IMMUNOL, V155, P2151; Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6; Lee HM, 2009, J CLIN IMMUNOL, V29, P46, DOI 10.1007/s10875-008-9222-3; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Lin WN, 2009, CELL SIGNAL, V21, P1385, DOI 10.1016/j.cellsig.2009.04.006; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Ma PL, 2004, J LEUKOCYTE BIOL, V76, P278, DOI 10.1189/jlb.1203653; Martin LD, 1997, EUR RESPIR J, V10, P2139, DOI 10.1183/09031936.97.10092139; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Salh Baljinder S., 2000, Molecular Cell Biology Research Communications, V4, P158, DOI 10.1006/mcbr.2001.0271; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shin DM, 2008, CELL MICROBIOL, V10, P1893, DOI 10.1111/j.1462-5822.2008.01179.x; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Sparkman L, 2004, AM J PHYSIOL-LUNG C, V287, pL764, DOI 10.1152/ajplung.00165.2004; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; SUEOKA E, 1995, JPN J CANCER RES, V86, P749, DOI 10.1111/j.1349-7006.1995.tb02464.x; Tang H, 2013, J IMMUNOL, V190, P438, DOI 10.4049/jimmunol.1201827; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thorpe CM, 2001, INFECT IMMUN, V69, P6140, DOI 10.1128/IAI.69.10.6140-6147.2001; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Vuong H, 2002, AM J PHYSIOL-LUNG C, V282, pL215, DOI 10.1152/ajplung.00125.2001; Wang XS, 2012, J IMMUNOL, V189, P3092, DOI 10.4049/jimmunol.1200573; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x	71	38	44	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25500	25511		10.1074/jbc.M112.448217	http://dx.doi.org/10.1074/jbc.M112.448217			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867456	hybrid, Green Published			2022-12-28	WOS:000330619000045
J	Tam, MF; Rice, NW; Maillett, DH; Simplaceanu, V; Ho, NT; Tam, TCS; Shen, TJ; Ho, C				Tam, Ming F.; Rice, Natalie W.; Maillett, David H.; Simplaceanu, Virgil; Ho, Nancy T.; Tam, Tsuey Chyi S.; Shen, Tong-Jian; Ho, Chien			Autoxidation and Oxygen Binding Properties of Recombinant Hemoglobins with Substitutions at the alpha Val-62 or beta Val-67 Position of the Distal Heme Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; HUMAN NORMAL ADULT; EXCHANGEABLE PROTON NMR; HYDROGEN-BONDS; QUATERNARY STRUCTURE; HIGH COOPERATIVITY; BLOOD SUBSTITUTES; LIGAND-BINDING; ALPHA-CHAINS; MECHANISM	The E11 valine in the distal heme pocket of either the alpha- or beta-subunit of human adult hemoglobin (Hb A) was replaced by leucine, isoleucine, or phenylalanine. Recombinant proteins were expressed in Escherichia coli and purified for structural and functional studies. H-1 NMR spectra were obtained for the CO and deoxy forms of Hb A and the mutants. The mutations did not disturb the alpha(1)beta(2) interface in either form, whereas the H-bond between alpha His-103 and beta-Gln-131 in the alpha(1)beta(1) interfaces of the deoxy alpha-subunit mutants was weakened. Localized structural changes in the mutated heme pocket were detected for the CO form of recombinant Hb (rHb) (alpha V62F), rHb (beta V67I), and rHb (beta V67F) compared with Hb A. In the deoxy form the proximal histidyl residue in the beta-subunit of rHb (beta V67F) has been altered. Furthermore, the interactions between the porphyrin ring and heme pocket residues have been perturbed in rHb (alpha V62I), rHb (alpha V62F), and rHb (beta V67F). Functionally, the oxygen binding affinity (P-50), cooperativity (n(50)), and the alkaline Bohr Effect of the three alpha-subunit mutants and rHb (beta V67L) are similar to those of Hb A. rHb (beta V67I) and rHb (beta V67F) exhibit low and high oxygen affinity, respectively. rHb (beta V67F) has P-50 values lower that those reported for rHb (alpha L29F), a B10 mutant studied previously in our laboratory (Wiltrout, M. E., Giovannelli, J. L., Simplaceanu, V., Lukin, J. A., Ho, N. T., and Ho, C. (2005) Biochemistry 44, 7207-7217). These E11 mutations do not slow down the autoxidation and azide-induced oxidation rates of the recombinant proteins. Results from this study provide new insights into the roles of E11 mutants in the structure-function relationship in hemoglobin.	[Tam, Ming F.; Rice, Natalie W.; Maillett, David H.; Simplaceanu, Virgil; Ho, Nancy T.; Tam, Tsuey Chyi S.; Shen, Tong-Jian; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Ho, C (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 Fifth Ave, Pittsburgh, PA 15213 USA.	chienho@andrew.cmu.edu	Ho, Chien/O-6112-2016	Ho, Chien/0000-0002-4094-9232	National Institutes of Health [HL-024525, GM-0846140]; Arnold and Mabel Beckman Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024525, R37HL024525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-024525 and GM-0846140. This work was also supported by The Arnold and Mabel Beckman Foundation and the Howard Hughes Medical Institute.	ACKERS GK, 1975, BIOCHEMISTRY-US, V14, P5128, DOI 10.1021/bi00694a017; Barrick D, 2001, BIOCHEMISTRY-US, V40, P3780, DOI 10.1021/bi002165q; BENESCH RE, 1973, ANAL BIOCHEM, V55, P245, DOI 10.1016/0003-2697(73)90309-6; Birukou I, 2011, BIOCHEMISTRY-US, V50, P7361, DOI 10.1021/bi200923k; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brillet Thomas, 2012, Am J Mol Biol, V2, P1; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Chang CK, 2002, BIOCHEMISTRY-US, V41, P5644, DOI 10.1021/bi011919d; CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929; Cole RH, 2007, BIOPHYS CHEM, V128, P63, DOI 10.1016/j.bpc.2007.03.004; DALVIT C, 1985, BIOCHEMISTRY-US, V24, P3398, DOI 10.1021/bi00335a003; Dickerson R. E., 1983, HEMOGLOBIN STRUCTURE, P26; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; EATON JW, 1974, SCIENCE, V183, P743, DOI 10.1126/science.183.4126.743; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fang TY, 2000, BIOCHEMISTRY-US, V39, P13708, DOI 10.1021/bi001115i; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; Fitzgerald MC, 2011, MED J AUSTRALIA, V194, P471, DOI 10.5694/j.1326-5377.2011.tb03064.x; FRONTICELLI C, 1993, BIOCHEMISTRY-US, V32, P1235, DOI 10.1021/bi00056a006; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; ISHIMORI K, 1992, BIOCHEMISTRY-US, V31, P3256, DOI 10.1021/bi00127a030; JAFFE E R, 1982, Haematologia, V15, P389; Jeong ST, 1999, BIOCHEMISTRY-US, V38, P13433, DOI 10.1021/bi991271t; Karavitis M, 1998, J BIOL CHEM, V273, P23740, DOI 10.1074/jbc.273.37.23740; LAMAR GN, 1980, BIOCHEM BIOPH RES CO, V96, P1172, DOI 10.1016/0006-291X(80)90075-3; LINDSTROM TR, 1972, BIOCHEMISTRY-US, V11, P1677, DOI 10.1021/bi00759a023; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; Lukin JA, 2000, P NATL ACAD SCI USA, V97, P10354, DOI 10.1073/pnas.190254697; MACDONALD VW, 1994, METHOD ENZYMOL, V231, P480; Maillett D. H., 2003, THESIS RICE U; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; NAGAI K, 1985, P NATL ACAD SCI USA, V82, P7252, DOI 10.1073/pnas.82.21.7252; NAGAI K, 1987, NATURE, V329, P858, DOI 10.1038/329858a0; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; RUSSU IM, 1987, BIOCHIM BIOPHYS ACTA, V914, P40, DOI 10.1016/0167-4838(87)90159-2; RUSSU IM, 1984, BIOCHIM BIOPHYS ACTA, V785, P123, DOI 10.1016/0167-4838(84)90136-5; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SEHGAL LR, 1984, SURGERY, V95, P433; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Simplaceanu V, 2000, BIOPHYS J, V79, P1146, DOI 10.1016/S0006-3495(00)76368-5; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; TAKAHASHI S, 1980, BIOCHEMISTRY-US, V19, P5196, DOI 10.1021/bi00564a007; TAME J, 1991, J MOL BIOL, V218, P761, DOI 10.1016/0022-2836(91)90264-7; Tsuruga M, 1997, BBA-PROTEIN STRUCT M, V1337, P96, DOI 10.1016/S0167-4838(96)00156-2; TUCKER PW, 1978, P NATL ACAD SCI USA, V75, P1076, DOI 10.1073/pnas.75.3.1076; Varnado CL, 2013, ANTIOXID REDOX SIGN, V18, P2314, DOI 10.1089/ars.2012.4917; WALLACE WJ, 1982, J BIOL CHEM, V257, P4966; Weir N, 2009, BIOPHYS J, V96, p558A, DOI 10.1016/j.bpj.2008.12.3665; Wiltrout ME, 2005, BIOCHEMISTRY-US, V44, P7207, DOI 10.1021/bi048289a; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493; Wu X, 2013, HEMOGLOBIN IN PRESS; Yuan Y, 2010, BIOCHEMISTRY-US, V49, P10606, DOI 10.1021/bi100927p; ZHAO XF, 1995, J BIOL CHEM, V270, P20763, DOI 10.1074/jbc.270.35.20763	65	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25512	25521		10.1074/jbc.M113.474841	http://dx.doi.org/10.1074/jbc.M113.474841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867463	Green Published, hybrid			2022-12-28	WOS:000330619000046
J	Xiao, GZ; Zhang, T; Yu, SB; Lee, SJ; Calabuig-Navarro, V; Yamauchi, J; Ringquist, S; Dong, HH				Xiao, Guozhi; Zhang, Ting; Yu, Shibing; Lee, Sojin; Calabuig-Navarro, Virtu; Yamauchi, Jun; Ringquist, Steven; Dong, H. Henry			ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR 4; OSTEOCALCIN GENE-EXPRESSION; INDUCED LIVER STEATOSIS; HEPATIC STEATOSIS; PPAR-GAMMA; INSULIN-RESISTANCE; FATTY LIVER; PARATHYROID-HORMONE; DIABETES-MELLITUS; ANABOLIC ACTIONS	Hypertriglyceridemia is the most common lipid disorder in obesity and type 2 diabetes. It results from increased production and/or decreased clearance of triglyceride-rich lipoproteins. To better understand the pathophysiology of hypertriglyceridemia, we studied hepatic regulation of triglyceride metabolism by the activating transcription factor 4 (ATF4), a member of the basic leucine zipper-containing protein subfamily. We determined the effect of ATF4 on hepatic lipid metabolism in Atf4(-/-) mice fed regular chow or provided with free access to fructose drinking water. ATF4 depletion preferentially attenuated hepatic lipogenesis without affecting hepatic triglyceride production and fatty acid oxidation. This effect prevented excessive fat accumulation in the liver of Atf4(-/-) mice, when compared with wild-type littermates. To gain insight into the underlying mechanism, we showed that ATF4 depletion resulted in a significant reduction in hepatic expression of peroxisome proliferator-activated receptor-gamma, a nuclear receptor that acts to promote lipogenesis in the liver. This effect was accompanied by a significant reduction in hepatic expression of sterol regulatory element-binding protein 1c (SREBP-1c), acetyl-CoA carboxylase, and fatty-acid synthase, three key functions in the lipogenic pathway in Atf4(-/-) mice. Of particular significance, we found that Atf4(-/-) mice, as opposed to wild-type littermates, were protected against the development of steatosis and hypertriglyceridemia in response to high fructose feeding. These data demonstrate that ATF4 plays a critical role in regulating hepatic lipid metabolism in response to nutritional cues.	[Xiao, Guozhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Xiao, Guozhi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhang, Ting; Lee, Sojin; Calabuig-Navarro, Virtu; Yamauchi, Jun; Ringquist, Steven; Dong, H. Henry] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Yu, Shibing] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15224 USA	Rush University; Nankai University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GZ (corresponding author), Rush Univ, Med Ctr, Dept Biochem, Cohn Res Bldg,Rm 518,1735 West Harrison St, Chicago, IL 60612 USA.	Guozhi_Xiao@rush.edu; dongh@pitt.edu	Calabuig, Virtu/AAB-2990-2021; Zhang, Ting/J-5074-2015	Calabuig, Virtu/0000-0001-6277-7040; Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK087764, AR059647]; Chinese Ministry of Science and Technology [2009CB918902]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK087764 (to H. H. D.) and AR059647 (to G. X.).; Recipient of Chinese Ministry of Science and Technology Award 2009CB918902. To whom correspondence may be addressed: Dept. of Biochemistry, Rush University Medical Center, Cohn Research Bldg., Rm. 518, 1735 West Harrison St., Chicago, IL 60612. Tel.: 312-942-4879; Fax: 312-942-3053; E-mail: Guozhi_Xiao@rush.edu.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Bard JM, 2001, ARTERIOSCL THROM VAS, V21, P407, DOI 10.1161/01.ATV.21.3.407; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Betteridge DJ, 2000, DIABETES OBES METAB, V2, pS31, DOI 10.1046/j.1463-1326.2000.00021.x; Brewer HB, 1999, AM J CARDIOL, V83, p3F; Brodsky JL, 2008, TRENDS ENDOCRIN MET, V19, P254, DOI 10.1016/j.tem.2008.07.002; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548; Knopp RH, 2003, AM J CARDIOL, V91, p24E, DOI 10.1016/S0002-9149(02)03385-4; Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Marcoux C, 2001, METABOLISM, V50, P112, DOI 10.1053/meta.2001.19452; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Olivieri O, 2002, J LIPID RES, V43, P1450, DOI 10.1194/jlr.M200145-JLR200; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Qu S, 2007, AM J PHYSIOL-ENDOC M, V292, pE421, DOI 10.1152/ajpendo.00157.2006; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; STEWART MW, 1994, J INTERN MED, V236, P41; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang LH, 2008, METABOLISM, V57, P1115, DOI 10.1016/j.metabol.2008.03.017; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	54	82	87	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25350	25361		10.1074/jbc.M113.470526	http://dx.doi.org/10.1074/jbc.M113.470526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23888053	Green Published, hybrid			2022-12-28	WOS:000330619000033
J	Lefevre, J; Savarin, P; Gans, P; Hamon, L; Clement, MJ; David, MO; Bosc, C; Andrieux, A; Curmi, PA				Lefevre, Julien; Savarin, Philippe; Gans, Pierre; Hamon, Loic; Clement, Marie-Jeanne; David, Marie-Odile; Bosc, Christophe; Andrieux, Annie; Curmi, Patrick A.			Structural Basis for the Association of MAP6 Protein with Microtubules and Its Regulation by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-STABLE MICROTUBULES; STOP GENE MTAP6; BINDING DOMAIN; IN-VITRO; TUBULIN; BRAIN; PHOSPHORYLATION; SCHIZOPHRENIA; EXPRESSION; STABILITY	Microtubules are highly dynamic alpha beta-tubulin polymers. In vitro and in living cells, microtubules are most often cold-and nocodazole-sensitive. When present, the MAP6/STOP family of proteins protects microtubules from cold-and nocodazole-induced depolymerization but the molecular and structure determinants by which these proteins stabilize microtubules remain under debate. We show here that a short protein fragment from MAP6-N, which encompasses its Mn1 and Mn2 modules (MAP6(90-177)), recapitulates the function of the full-length MAP6-N protein toward microtubules, i.e. its ability to stabilize microtubules in vitro and in cultured cells in ice-cold conditions or in the presence of nocodazole. We further show for the first time, using biochemical assays and NMR spectroscopy, that these effects result from the binding of MAP6(90-177) to microtubules with a 1:1 MAP6(90-177): tubulin heterodimer stoichiometry. NMR data demonstrate that the binding of MAP6(90-177) to microtubules involve its two Mn modules but that a single one is also able to interact with microtubules in a closely similar manner. This suggests that the Mn modules represent each a full microtubule binding domain and that MAP6 proteins may stabilize microtubules by bridging tubulin heterodimers from adjacent protofilaments or within a protofilament. Finally, we demonstrate that Ca2+-calmodulin competes with microtubules for MAP6(90-177) binding and that the binding mode of MAP6(90-177) to microtubules and Ca2+-calmodulin involves a common stretch of amino acid residues on the MAP6(90-177) side. This result accounts for the regulation of microtubule stability in cold condition by Ca2+-calmodulin.	[Lefevre, Julien; Savarin, Philippe; Hamon, Loic; Clement, Marie-Jeanne; David, Marie-Odile; Curmi, Patrick A.] Univ Evry Val dEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France; [Gans, Pierre] Inst Biol Struct Jean Pierre Ebel, Lab Resonance Magnet Nucl, F-38027 Grenoble, France; [Bosc, Christophe; Andrieux, Annie] Univ Grenoble 1, Team Physiopathol Cytosquelette, INSERM, U836,Inst Neurosci,CEA,iRTSV,GPC, F-38042 Grenoble 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lefevre, J (corresponding author), Univ Evry Val dEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France.	julien.lefevre@univ-evry.fr; pcurmi@univ-evry.fr	Bosc, Christophe/Q-8877-2019; DAVID, Marie-Odile/AAE-2972-2021; David, Marie-Odile MO/B-2917-2014; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; CURMI, Patrick/G-4036-2013	Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; hamon, loic/0000-0003-2032-7994; CURMI, Patrick A./0000-0001-5045-8501	PRES UniversSud	PRES UniversSud	Recipient of a postdoctoral fellowship from the PRES UniversSud. To whom correspondence may be addressed. Tel.: 33-1-69-47-01-83; E-mail: julien.lefevre@univ-evry.fr.	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BAN C, 1994, ACTA CRYSTALLOGR D, V50, P50, DOI 10.1107/S0907444993007991; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Benardais K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012753; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Bonnet C, 2002, BIOCHEM BIOPH RES CO, V297, P787, DOI 10.1016/S0006-291X(02)02294-5; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Bouvier D, 2003, BIOCHEMISTRY-US, V42, P11484, DOI 10.1021/bi034746w; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delotterie D, 2010, PSYCHOPHARMACOLOGY, V208, P131, DOI 10.1007/s00213-009-1712-3; Delphin C, 2012, J BIOL CHEM, V287, P35127, DOI 10.1074/jbc.M112.398339; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Denarier E, 1998, BIOCHEM BIOPH RES CO, V243, P791, DOI 10.1006/bbrc.1998.8179; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOB D, 1982, BIOCHEMISTRY-US, V21, P509, DOI 10.1021/bi00532a015; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAKIUCHI S, 1981, FEBS LETT, V132, P141, DOI 10.1016/0014-5793(81)80448-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE YC, 1984, J BIOL CHEM, V259, P8041; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Makarov AA, 2007, BIOCHEMISTRY-US, V46, P14899, DOI 10.1021/bi701803s; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MARGOLIS RL, 1990, EMBO J, V9, P4095, DOI 10.1002/j.1460-2075.1990.tb07631.x; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P110, DOI 10.3109/15622970903490626; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MINAMI Y, 1993, J BIOL CHEM, V268, P9604; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PADILLA R, 1990, MOL CELL BIOCHEM, V97, P35; Shimizu H, 2006, SCHIZOPHR RES, V84, P244, DOI 10.1016/j.schres.2006.03.017; WEBB BC, 1980, BIOCHEMISTRY-US, V19, P1993, DOI 10.1021/bi00550a041; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	51	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24910	24922		10.1074/jbc.M113.457267	http://dx.doi.org/10.1074/jbc.M113.457267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23831686	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000330612300055
J	Parveen, N; Varman, R; Nair, S; Das, G; Ghosh, S; Mukhopadhyay, S				Parveen, Nazia; Varman, Raja; Nair, Shiny; Das, Gobardhan; Ghosh, Sudip; Mukhopadhyay, Sangita			Endocytosis of Mycobacterium tuberculosis Heat Shock Protein 60 Is Required to Induce Interleukin-10 Production in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; HEAT-SHOCK PROTEINS; IMMUNE-RESPONSES; DENDRITIC CELLS; TNF-ALPHA; SIGNALING CASCADES; IL-10 PRODUCTION	Understanding the signaling pathways involved in the regulation of anti-inflammatory and pro-inflammatory responses in tuberculosis is extremely important in tailoring a macrophage innate response to promote anti-tuberculosis immunity in the host. Although the role of toll-like receptors (TLRs) in the regulation of anti-inflammatory and pro-inflammatory responses is known, the detailed molecular mechanisms by which the Mycobacterium tuberculosis bacteria modulate these innate responses are not clearly understood. In this study, we demonstrate that M. tuberculosis heat shock protein 60 (Mtbhsp60, Cpn60.1, and Rv3417c) interacts with both TLR2 and TLR4 receptors, but its interaction with TLR2 leads to clathrin-dependent endocytosis resulting in an increased production of interleukin (IL)-10 and activated p38 MAPK. Blockage of TLR2-mediated endocytosis inhibited IL-10 production but induced production of tumor necrosis factor (TNF)-alpha and activated ERK1/2. In contrast, upon interaction with TLR4, Mtbhsp60 remained predominantly localized on the cell surface due to poorer endocytosis of the protein that led to decreased IL-10 production and p38 MAPK activation. The Escherichia coli homologue of hsp60 was found to be retained mainly on the macrophage surface upon interaction with either TLR2 or TLR4 that triggered predominantly a pro-inflammatory-type immune response. Our data suggest that cellular localization of Mtbhsp60 upon interaction with TLRs dictates the type of polarization in the innate immune responses in macrophages. This information is likely to help us in tailoring the host protective immune responses against M. tuberculosis.	[Parveen, Nazia; Varman, Raja; Nair, Shiny; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500001, Andhra Pradesh, India; [Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Ghosh, Sudip] Natl Inst Nutr, Mol Biol Unit, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	sangita@cdfd.org.in		Parveen, Nazia/0000-0002-2918-9498; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India [Imm./18/11/12/2008-ECD-1]; Department of Biotechnology, Government of India [BT/PR12854/BRB/10/730/2009]; Department of Biotechnology; Council of Scientific and Industrial Research, India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Indian Council of Medical Research, Government of India Grant Imm./18/11/12/2008-ECD-1, the Department of Biotechnology, Government of India Grant BT/PR12854/BRB/10/730/2009, and a core grant from the Department of Biotechnology (to Centre for DNA Fingerprinting and Diagnostics).; Supported by a research fellowship from the Council of Scientific and Industrial Research, India.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barton GM, 2004, NAT IMMUNOL, V5, P472, DOI 10.1038/ni0504-472; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Cabo-Bilbao A, 2006, J STRUCT BIOL, V155, P482, DOI 10.1016/j.jsb.2006.06.008; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Cavalli V, 2001, FEBS LETT, V498, P190, DOI 10.1016/S0014-5793(01)02484-X; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark AC, 1998, METHOD ENZYMOL, V290, P100; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Goldfeld A, 2007, TUBERCULOSIS, V87, pS26, DOI 10.1016/j.tube.2007.05.003; Guex N., 1996, Experientia (Basel), V52, pA26; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hayashi T, 2006, J THROMB HAEMOST, V4, P1763, DOI 10.1111/j.1538-7836.2006.02042.x; Henderson B, 2009, CELL STRESS CHAPERON, V14, P329, DOI 10.1007/s12192-008-0087-4; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jones BW, 2001, ANN RHEUM DIS, V60, pIII6; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Khan N, 2008, CELL MICROBIOL, V10, P1711, DOI 10.1111/j.1462-5822.2008.01161.x; Khan N, 2007, INT IMMUNOL, V19, P477, DOI 10.1093/intimm/dxm012; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee J., 2012, MEDIAT INFLAMM, V2012; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcatili A, 1997, MICROBIOL-UK, V143, P45, DOI 10.1099/00221287-143-1-45; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Mukhopadhyay S, 2004, FEBS LETT, V567, P275, DOI 10.1016/j.febslet.2004.04.081; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; O'Garra A, 2004, ADV IMMUNOL, V83, P133; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Qamra R, 2004, J MOL BIOL, V342, P605, DOI 10.1016/j.jmb.2004.07.066; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; RETZLAFF C, 1994, INFECT IMMUN, V62, P5689, DOI 10.1128/IAI.62.12.5689-5693.1994; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2007, CURR MOL MED, V7, P327; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Tabona P, 1998, J IMMUNOL, V161, P1414; Tse HM, 2002, J IMMUNOL, V168, P825, DOI 10.4049/jimmunol.168.2.825; Tsuei AC, 2012, CELL STRESS CHAPERON, V17, P23, DOI 10.1007/s12192-011-0282-6; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yokota S, 2006, INT IMMUNOL, V18, P573, DOI 10.1093/intimm/dxh399; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	95	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24956	24971		10.1074/jbc.M113.461004	http://dx.doi.org/10.1074/jbc.M113.461004			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846686	Green Published, hybrid			2022-12-28	WOS:000330612300059
J	Mainprize, IL; Bean, JD; Bouwman, C; Kimber, MS; Whitfield, C				Mainprize, Iain L.; Bean, Jordan D.; Bouwman, Catrien; Kimber, Matthew S.; Whitfield, Chris			The UDP-glucose Dehydrogenase of Escherichia coli K-12 Displays Substrate Inhibition by NAD That Is Relieved by Nucleotide Triphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-1 CAPSULAR POLYSACCHARIDES; COLANIC ACID BIOSYNTHESIS; PROTEIN-TYROSINE KINASES; GRAM-NEGATIVE BACTERIA; GROUP-A STREPTOCOCCI; KLEBSIELLA-PNEUMONIAE; BACILLUS-SUBTILIS; K ANTIGENS; EXTRACELLULAR POLYSACCHARIDES; POLYMYXIN RESISTANCE	UDP-glucose dehydrogenase (Ugd) generates UDP-glucuronic acid, an important precursor for the production of many hexuronic acid-containing bacterial surface glycostructures. In Escherichia coli K-12, Ugd is important for biosynthesis of the environmentally regulated exopolysaccharide known as colanic acid, whereas in other E. coli isolates, the same enzyme is required for production of the constitutive group 1 capsular polysaccharides, which act as virulence determinants. Recent studies have implicated tyrosine phosphorylation in the activation of Ugd from E. coli K-12, although it is not known if this is a feature shared by bacterial Ugd proteins. The activities of Ugd from E. coli K-12 and from the group 1 capsule prototype (serotype K30) were compared. Surprisingly, for both enzymes, site-directed Tyr -> Phe mutants affecting the previously proposed phosphorylation site retained similar kinetic properties to the wild-type protein. Purified Ugd from E. coli K-12 had significant levels of NAD substrate inhibition, which could be alleviated by the addition of ATP and several other nucleotide triphosphates. Mutations in a previously identified UDP-glucuronic acid allosteric binding site decreased the binding affinity of the nucleotide triphosphate. Ugd from E. coli serotype K30 was not inhibited by NAD, but its activity still increased in the presence of ATP.	[Mainprize, Iain L.; Bean, Jordan D.; Bouwman, Catrien; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Mainprize, Iain/0000-0002-8872-5350	Canadian Institutes of Health Research [FRN-9623]; National Science and Engineering Research Council of Canada [327280]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Operating Grant FRN-9623 (to C. W.) and National Science and Engineering Research Council of Canada Grant 327280 (to M. S. K.).	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boels IC, 2001, APPL ENVIRON MICROB, V67, P3033, DOI 10.1128/AEM.67.7.3033-3040.2001; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhamdhere G, 2010, MOL MICROBIOL, V77, P743, DOI 10.1111/j.1365-2958.2010.07245.x; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 1997, J BACTERIOL, V179, P3232, DOI 10.1128/jb.179.10.3232-3238.1997; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Gruszczyk J, 2011, J BIOL CHEM, V286, P17112, DOI 10.1074/jbc.M110.216002; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Ho JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021664; Hung RJ, 2007, J BIOL CHEM, V282, P17738, DOI 10.1074/jbc.M701824200; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; JAYARATNE P, 1994, J BACTERIOL, V176, P3126, DOI 10.1128/jb.176.11.3126-3139.1994; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Pagni M, 1999, MICROBIOL-UK, V145, P1049, DOI 10.1099/13500872-145-5-1049; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; SCHILLER JG, 1973, BIOCHIM BIOPHYS ACTA, V293, P1, DOI 10.1016/0005-2744(73)90369-0; Shi L, 2010, CURR PROTEOMICS, V7, P188, DOI 10.2174/157016410792928198; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; YUASA R, 1969, J BACTERIOL, V100, P433, DOI 10.1128/JB.100.1.433-444.1969	61	13	13	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23064	23074		10.1074/jbc.M113.486613	http://dx.doi.org/10.1074/jbc.M113.486613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792965	Green Published, hybrid			2022-12-28	WOS:000330598200015
J	Zheng, J; Rubin, EJ; Bifani, P; Mathys, V; Lim, V; Au, M; Jang, J; Nam, J; Dick, T; Walker, JR; Pethe, K; Camacho, LR				Zheng, Jun; Rubin, Eric J.; Bifani, Pablo; Mathys, Vanessa; Lim, Vivian; Au, Melvin; Jang, Jichan; Nam, Jiyoun; Dick, Thomas; Walker, John R.; Pethe, Kevin; Camacho, Luis R.			para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROPTEROATE SYNTHASE; CRYSTAL-STRUCTURE; RIBOFLAVIN; EXPRESSION; RESISTANCE; EFFICIENT; REVEALS; WR99210; SCREEN; BCG	para-Aminosalicylic acid (PAS) is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis. Although it has been in clinical use for over 60 years, its mechanism(s) of action remains elusive. Here we report that PAS is a prodrug targeting dihydrofolate reductase (DHFR) through an unusual and novel mechanism of action. We provide evidences that PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity. Interestingly, PAS is recognized by DHPS as efficiently as its natural substrate para-amino benzoic acid. Chemical inhibition of DHPS or mutation in DHFS prevents the formation of the antimetabolite, thereby conferring resistance to PAS. In addition, we identified a bifunctional enzyme (riboflavin biosynthesis protein (RibD)), a putative functional analog of DHFR in a knock-out strain. This finding is further supported by the identification of PAS-resistant clinical isolates encoding a RibD overexpression mutation displaying cross-resistance to genuine DHFR inhibitors. Our findings reveal that a metabolite of PAS inhibits DHFR in the folate pathway. RibD was shown to act as a functional analog of DHFR, and as for DHFS, both were shown to be associated in PAS resistance in laboratory strains and clinical isolates.	[Zheng, Jun; Bifani, Pablo; Lim, Vivian; Au, Melvin; Dick, Thomas; Camacho, Luis R.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mathys, Vanessa] Sci Inst Publ Hlth, Inst Pasteur, Lab Mol Pathol TB, B-1050 Brussels, Belgium; [Jang, Jichan; Nam, Jiyoun; Pethe, Kevin] Inst Pasteur Korea, Songnam 463400, South Korea; [Walker, John R.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis; Harvard University; Harvard T.H. Chan School of Public Health; Institut Pasteur Korea; Novartis	Zheng, J (corresponding author), Vela Res Pte Ltd, Singapore 117406, Singapore.	zhjunyy@hotmail.com; camacholuis112@gmail.com	Dick, Thomas/AAB-4109-2019; Pethe, Kevin/L-1199-2013; Pethe, Kevin/F-9495-2015; Dick, Thomas/AAC-4824-2019; Zheng, Jun/AAN-4698-2020	Dick, Thomas/0000-0002-9604-9452; Pethe, Kevin/0000-0003-0297-0150; Zheng, Jun/0000-0001-6329-4518; Bifani, Pablo/0000-0001-9651-6439; Rubin, Eric/0000-0001-5120-962X; Pethe, Kevin/0000-0003-0916-8873	Korean Ministry of Education, Science and Technology	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We acknowledge several scientists at Novartis: Bryan Yeung, Ravinder Kondreddi, and Ranga Rao for providing NITD344; Boon Heng Lee and Koh Sin for technical help with MIC assays and LC/MS analysis; Whitney Barnes for whole genome sequencing; Veronique Dartois for critical review of the manuscript; and Paul Smith for support and stimulating discussions. The Institute Pasteur-Korea receives support from the Korean Ministry of Education, Science and Technology.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BROWN GM, 1982, ADV ENZYMOL RAMB, V53, P345; Chakraborty S, 2013, SCIENCE, V339, P88, DOI 10.1126/science.1228980; Chen SC, 2006, J BIOL CHEM, V281, P7605, DOI 10.1074/jbc.M510254200; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Freuler F, 2008, PROTEIN EXPRES PURIF, V59, P232, DOI 10.1016/j.pep.2008.02.003; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Gerum AB, 2002, ANTIMICROB AGENTS CH, V46, P3362, DOI 10.1128/AAC.46.11.3362-3369.2002; Green J. C., 1996, ESCHERICHIA COLI SAL, P665; HekmatNejad M, 1997, EXP PARASITOL, V87, P222, DOI 10.1006/expr.1997.4228; Kurabachew M, 2008, J ANTIMICROB CHEMOTH, V62, P713, DOI 10.1093/jac/dkn269; LEHMANN J, 1946, LANCET, V250, P15; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Mathieu M, 2005, J BIOL CHEM, V280, P18916, DOI 10.1074/jbc.M413799200; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Nopponpunth V, 1999, J BACTERIOL, V181, P6814, DOI 10.1128/JB.181.21.6814-6821.1999; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; RATLEDGE C, 1972, AM REV RESPIR DIS, V106, P774, DOI 10.1164/arrd.1972.106.5.774; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; SHIOTA T, 1964, J BIOL CHEM, V239, P2259; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; WHO, 2011, WORLD REPORT ON DISABILITY, P1; YOUMANS GP, 1947, J BACTERIOL, V54, P409, DOI 10.1128/JB.54.4.409-416.1947; Young PG, 2008, ACTA CRYSTALLOGR D, V64, P745, DOI 10.1107/S0907444908012262	33	115	120	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23447	23456		10.1074/jbc.M113.475798	http://dx.doi.org/10.1074/jbc.M113.475798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23779105	Green Published, hybrid			2022-12-28	WOS:000330598200051
J	Agarwal, S; Kazi, JU; Ronnstrand, L				Agarwal, Shruti; Kazi, Julhash U.; Ronnstrand, Lars			Phosphorylation of the Activation Loop Tyrosine 823 in c-Kit Is Crucial for Cell Survival and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR/C-KIT; GASTROINTESTINAL STROMAL TUMORS; PDGF BETA-RECEPTOR; PROTEIN-COUPLED RECEPTORS; MAST-CELLS; TESTICULAR SEMINOMAS; KINASE PATHWAY; EGF RECEPTOR; MUTATIONS; CHEMOTAXIS	The receptor tyrosine kinase c-Kit, also known as the stem cell factor receptor, plays a key role in several developmental processes. Activating mutations in c-Kit lead to alteration of these cellular processes and have been implicated in many human cancers such as gastrointestinal stromal tumors, acute myeloid leukemia, testicular seminomas and mastocytosis. Regulation of the catalytic activity of several kinases is known to be governed by phosphorylation of tyrosine residues in the activation loop of the kinase domain. However, in the case of c-Kit phosphorylation of Tyr-823 has been demonstrated to be a late event that is not required for kinase activation. However, because phosphorylation of Tyr-823 is a ligand-activated event, we sought to investigate the functional consequences of Tyr-823 phosphorylation. By using a tyrosine-to-phenylalanine mutant of tyrosine 823, we investigated the impact of Tyr-823 on c-Kit signaling. We demonstrate here that Tyr-823 is crucial for cell survival and proliferation and that mutation of Tyr-823 to phenylalanine leads to decreased sustained phosphorylation and ubiquitination of c-Kit as compared with the wild-type receptor. Furthermore, the mutated receptor was, upon ligand-stimulation, quickly internalized and degraded. Phosphorylation of the E3 ubiquitin ligase Cbl was transient, followed by a substantial reduction in phosphorylation of downstream signaling molecules such as Akt, Erk, p38, Shc, and Gab2. Thus, we propose that activation loop tyrosine 823 is crucial for activation of both the MAPK and PI3K pathways and that its disruption leads to a destabilization of the c-Kit receptor and decreased survival of cells.	[Agarwal, Shruti; Kazi, Julhash U.; Ronnstrand, Lars] Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Kazi, Julhash U./D-9190-2011	Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Research Council; Swedish Cancer Foundation; Gunnar Nilssons Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Gunnar Nilssons Cancer Foundation	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Foundation, and the Gunnar Nilssons Cancer Foundation.	Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Calabuig-Farinas S, 2011, INT J SURG PATHOL, V19, P448, DOI 10.1177/1066896911402327; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Kazi JU, 2013, EXP HEMATOL, V41, P585, DOI 10.1016/j.exphem.2013.03.005; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kitamura Y, 2001, MUTAT RES-FUND MOL M, V477, P165, DOI 10.1016/S0027-5107(01)00117-8; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lennartsson J, 2003, EXP CELL RES, V288, P110, DOI 10.1016/S0014-4827(03)00206-4; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Smith JA, 2010, CELL SIGNAL, V22, P427, DOI 10.1016/j.cellsig.2009.10.014; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Sun JM, 2009, J BIOL CHEM, V284, P11039, DOI 10.1074/jbc.M808058200; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Wardega P, 2010, CELL SIGNAL, V22, P1363, DOI 10.1016/j.cellsig.2010.05.004; Willmore-Payne C, 2006, MODERN PATHOL, V19, P1164, DOI 10.1038/modpathol.3800623; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200	42	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22460	22468		10.1074/jbc.M113.474072	http://dx.doi.org/10.1074/jbc.M113.474072			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23803604	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000330596300027
J	Larabee, JL; Shakir, SM; Barua, S; Ballard, JD				Larabee, Jason L.; Shakir, Salika M.; Barua, Soumitra; Ballard, Jimmy D.			Increased cAMP in Monocytes Augments Notch Signaling Mechanisms by Elevating RBP-J and Transducin-like Enhancer of Split (TLE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Bacterial Toxins; Cyclic AMP (cAMP); Monocytes; Notch Pathway	ANTHRAX TOXIN; CYCLIC-AMP; MACROPHAGES; TRANSCRIPTION; INHIBITION; ACTIVATION; EXPRESSION; REPRESSION; RESPONSES; PROTEINS	In cells of the innate immune system, pathological increases in intracellular cAMP attenuate immune responses and contribute to infections by bacteria such as Bacillus anthracis. In this work, cAMP from B. anthracis edema toxin (ET) is found to activate the Notch signaling pathway in both mouse macrophages and human monocytes. ET as well as a cell-permeable activator of PKA induce Notch target genes (HES1, HEY1, IL2RA, and IL7R) and are able to significantly enhance the induction of these Notch target genes by a Toll-like receptor ligand. Elevated cAMP also resulted in increased levels of Groucho/transducin-like enhancer of Split (TLE) and led to increased amounts of a transcriptional repressor complex consisting of TLE and the Notch target Hes1. To address the mechanism used by ET to activate Notch signaling, components of Notch signaling were examined, and results revealed that ET increased levels of recombinant recognition sequence binding protein at the J site (RBP-J), a DNA binding protein and principal transcriptional regulator of Notch signaling. Overexpression studies indicated that RBP-J was sufficient to activate Notch signaling and potentiate LPS-induced Notch signaling. Further examination of the mechanism used by ET to activate Notch signaling revealed that C/EBP , a transcription factor activated by cAMP, helped activate Notch signaling and up-regulated RBP-J. These studies demonstrate that cAMP activates Notch signaling and increases the expression of TLE, which could be an important mechanism utilized by cAMP to suppress immune responses.	[Larabee, Jason L.; Shakir, Salika M.; Barua, Soumitra; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1062,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [U19 AI 062629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19 AI 062629 (to J.D.B.).	Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Larabee JL, 2011, INFECT IMMUN, V79, P3302, DOI 10.1128/IAI.05070-11; Larabee JL, 2011, J BIOL CHEM, V286, P19364, DOI 10.1074/jbc.M111.224543; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lewis Julian, 2009, Journal of Biology (London), V8, P44, DOI 10.1186/jbiol145; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	28	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21526	21536		10.1074/jbc.M113.465120	http://dx.doi.org/10.1074/jbc.M113.465120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775085	hybrid, Green Published			2022-12-28	WOS:000328841900006
J	Whitney, JC; Chou, S; Russell, AB; Biboy, J; Gardiner, TE; Ferrin, MA; Brittnacher, M; Vollmer, W; Mougous, JD				Whitney, John C.; Chou, Seemay; Russell, Alistair B.; Biboy, Jacob; Gardiner, Taylor E.; Ferrin, Michael A.; Brittnacher, Mitchell; Vollmer, Waldemar; Mougous, Joseph D.			Identification, Structure, and Function of a Novel Type VI Secretion Peptidoglycan Glycoside Hydrolase Effector-Immunity Pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; STRUCTURE REFINEMENT; PSEUDOMONAS-PUTIDA; LYSOZYME; SYSTEM; INSIGHTS; BACTERIA; PHENIX; INHIBITION; EVOLUTION	Bacteria employ type VI secretion systems (T6SSs) to facilitate interactions with prokaryotic and eukaryotic cells. Despite the widespread identification of T6SSs among Gram-negative bacteria, the number of experimentally validated substrate effector proteins mediating these interactions remains small. Here, employing an informatics approach, we define novel families of T6S peptidoglycan glycoside hydrolase effectors. Consistent with the known intercellular self-intoxication exhibited by the T6S pathway, we observe that each effector gene is located adjacent to a hypothetical open reading frame encoding a putative periplasmically localized immunity determinant. To validate our sequence-based approach, we functionally investigate a representative family member from the soil-dwelling bacterium Pseudomonas protegens. We demonstrate that this protein is secreted in a T6SS-dependent manner and that it confers a fitness advantage in growth competition assays with Pseudomonas putida. In addition, we determined the 1.4 angstrom x-ray crystal structure of this effector in complex with its cognate immunity protein. The structure reveals the effector shares highest overall structural similarity to a glycoside hydrolase family associated with peptidoglycan N-acetylglucosaminidase activity, suggesting that T6S peptidoglycan glycoside hydrolase effector families may comprise significant enzymatic diversity. Our structural analyses also demonstrate that self-intoxication is prevented by the immunity protein through direct occlusion of the effector active site. This work significantly expands our current understanding of T6S effector diversity.	[Whitney, John C.; Chou, Seemay; Russell, Alistair B.; Gardiner, Taylor E.; Ferrin, Michael A.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brittnacher, Mitchell] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Newcastle University - UK	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu		Ferrin, Michael/0000-0002-9899-1169; Russell, Alistair/0000-0002-5342-2309	National Institutes of Health [AI080609]; Howard Hughes Medical Institute Life Sciences Research Foundation Fellowship; National Science Foundation [DGE-0718124]; Mary Gates Undergraduate Research Scholarships; Biotechnology and Biological Sciences Research Council [BB/I020012/1]; Burroughs Wellcome fund; BBSRC [BB/I020012/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Life Sciences Research Foundation Fellowship; National Science Foundation(National Science Foundation (NSF)); Mary Gates Undergraduate Research Scholarships; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Burroughs Wellcome fund(Burroughs Wellcome Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI080609. The atomic coordinates and structure factors (code 4KT3) have been deposited in the Protein Data Bank (http://wwpdb.org/).; Supported by a Howard Hughes Medical Institute Life Sciences Research Foundation Fellowship.; Supported by a Graduate Research Fellowship from National Science Foundation Grant DGE-0718124.; Supported by Mary Gates Undergraduate Research Scholarships. Supported by the Biotechnology and Biological Sciences Research Council (BB/I020012/1).; An investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome fund.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; DEFLAUN MF, 1994, APPL ENVIRON MICROB, V60, P2637, DOI 10.1128/AEM.60.7.2637-2642.1994; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Dong C, 2013, BIOCHEM J, V454, P59, DOI 10.1042/BJ20130193; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Gerard F, 2011, J BACTERIOL, V193, P205, DOI 10.1128/JB.01119-10; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUROKI R, 1995, NAT STRUCT BIOL, V2, P1007, DOI 10.1038/nsb1195-1007; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leysen S, 2013, CELL MOL LIFE SCI, V70, P1113, DOI 10.1007/s00018-012-1184-1; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Rodriguez-Herva JJ, 1999, ENVIRON MICROBIOL, V1, P479, DOI 10.1046/j.1462-2920.1999.00058.x; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357	53	74	77	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26616	26624		10.1074/jbc.M113.488320	http://dx.doi.org/10.1074/jbc.M113.488320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23878199	Green Published, hybrid			2022-12-28	WOS:000330594500027
J	Alvarez-Navarro, C; Cragnolini, JJ; Dos Santos, HG; Barnea, E; Admon, A; Morreale, A; de Castro, JAL				Alvarez-Navarro, Carlos; Cragnolini, Juan J.; Dos Santos, Helena G.; Barnea, Eilon; Admon, Arie; Morreale, Antonio; Lopez de Castro, Jose A.			Novel HLA-B27-restricted Epitopes from Chlamydia trachomatis Generated upon Endogenous Processing of Bacterial Proteins Suggest a Role of Molecular Mimicry in Reactive Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ANTIGENS; HL-A 27; ANKYLOSING-SPONDYLITIS; HLA-B27 SUBTYPE; III SECRETION; INFECTED CELLS; PEPTIDES; IDENTIFICATION; DISEASE; DEGRADATION	Reactive arthritis (ReA) is an HLA-B27-associated spondy-loarthropathy that is triggered by diverse bacteria, including Chlamydia trachomatis, a frequent intracellular parasite. HLA-B27-restricted T-cell responses are elicited against this bacterium in ReA patients, but their pathogenetic significance, autoimmune potential, and relevant epitopes are unknown. High resolution and sensitivity mass spectrometry was used to identify HLA-B27 ligands endogenously processed and presented by HLA-B27 from three chlamydial proteins for which T-cell epitopes were predicted. Fusion protein constructs of ClpC, Na+-translocating NADH-quinone reductase subunit A, and DNA primase were expressed in HLA-B27(+) cells, and their HLA-B27-bound peptidomes were searched for endogenous bacterial ligands. A non-predicted peptide, distinct from the predicted T-cell epitope, was identified from ClpC. A peptide recognized by T-cells in vitro, NQRA(330-338), was detected from the reductase subunit. This is the second HLA-B27-restricted T-cell epitope from C. trachomatis with relevance in ReA demonstrated to be processed and presented in live cells. A novel peptide from the DNA primase, DNAP(211-223), was also found. This was a larger variant of a known epitope and was highly homologous to a self-derived natural ligand of HLA-B27. All three bacterial peptides showed high homology with human sequences containing the binding motif of HLA-B27. Molecular dynamics simulations further showed a striking conformational similarity between DNAP(211-223) and its homologous and much more flexible human-derived HLA-B27 ligand. The results suggest that molecular mimicry between HLA-B27-restricted bacterial and self-derived epitopes is frequent and may play a role in ReA.	[Alvarez-Navarro, Carlos; Cragnolini, Juan J.; Dos Santos, Helena G.; Morreale, Antonio; Lopez de Castro, Jose A.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Alvarez-Navarro, Carlos; Cragnolini, Juan J.; Dos Santos, Helena G.; Morreale, Antonio; Lopez de Castro, Jose A.] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Technion Israel Institute of Technology	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es		Admon, Arie/0000-0003-0504-3950	Plan Nacional de I+D+i Grants [SAF2008/00461, SAF2011/25681]; Red de Inflamacion y Enfermedades Reumaticas, Instituto de Salud Carlos III [RD08/0075]; USA-Israel Binational Science Foundation [BSF 2009393]; Comunidad Autonoma de Madrid [S2010-BMD-2457BIPEDD2]; Plan Nacional de I+D+i Grant [BFU2011-24595]; AMAROUTO program (Fundacion Severo Ochoa); Fundacion Ramon Areces	Plan Nacional de I+D+i Grants; Red de Inflamacion y Enfermedades Reumaticas, Instituto de Salud Carlos III; USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Comunidad Autonoma de Madrid(Comunidad de Madrid); Plan Nacional de I+D+i Grant; AMAROUTO program (Fundacion Severo Ochoa); Fundacion Ramon Areces	This work was supported in part by Plan Nacional de I+D+i Grants SAF2008/00461 and SAF2011/25681 and Red de Inflamacion y Enfermedades Reumaticas, Instituto de Salud Carlos III, Grant RD08/0075 (to J. A. L. C.); USA-Israel Binational Science Foundation Grant BSF 2009393 (to A. A.); and Comunidad Autonoma de Madrid Grant S2010-BMD-2457BIPEDD2 (to A. M.).; Supported by Plan Nacional de I+D+i Grant BFU2011-24595.; Supported by the AMAROUTO program (Fundacion Severo Ochoa) and an institutional grant of the Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa. Present address: Repsol, Technology Center, Mostoles, 28045 Madrid, Spain.	Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Appel H, 2004, ARTHRITIS RES THER, V6, pR521, DOI 10.1186/ar1221; Bachmaier K, 2005, CURR TOP MICROBIOL, V296, P153; Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Beagley KW, 2000, J REPROD IMMUNOL, V48, P47, DOI 10.1016/S0165-0378(00)00069-3; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; BEATTY WL, 1994, ANN NY ACAD SCI, V730, P304, DOI 10.1111/j.1749-6632.1994.tb44274.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BREWERTON DA, 1973, LANCET, V2, P996, DOI 10.1016/S0140-6736(73)91091-X; BREWERTON DA, 1973, LANCET, V1, P904; CALVO V, 1990, J IMMUNOL, V144, P4038; Carter JD, 2010, CURR OPIN RHEUMATOL, V22, P424, DOI 10.1097/BOR.0b013e32833a43a2; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Colmegna I, 2004, CLIN MICROBIOL REV, V17, P348, DOI 10.1128/CMR.17.2.348-369.2004; Cragnolini JJ, 2008, MOL CELL PROTEOMICS, V7, P170, DOI 10.1074/mcp.M700386-MCP200; Cragnolini JJ, 2009, MOL CELL PROTEOMICS, V8, P1850, DOI 10.1074/mcp.M900107-MCP200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Fourneau JM, 2004, MOL IMMUNOL, V40, P1095, DOI 10.1016/j.molimm.2003.11.011; Garcia-Medel N., 2012, MOL CELL PROTEOMICS, V11, P1; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Jendro MC, 2004, MED MICROBIOL IMMUN, V193, P45, DOI 10.1007/s00430-003-0182-1; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim GT, 2012, INT J RHEUM DIS, V15, pE113, DOI 10.1111/j.1756-185X.2012.01748.x; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Kuon W, 2001, J IMMUNOL, V167, P4738, DOI 10.4049/jimmunol.167.8.4738; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; Loomis WP, 2002, CURR OPIN MICROBIOL, V5, P87, DOI 10.1016/S1369-5274(02)00291-6; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; Nurzia E, 2010, CLIN IMMUNOL, V135, P476, DOI 10.1016/j.clim.2010.01.009; Paradela A, 2000, J IMMUNOL, V164, P329, DOI 10.4049/jimmunol.164.1.329; Paradela A, 1998, J IMMUNOL, V161, P5481; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popov I, 2002, J IMMUNOL, V169, P4033, DOI 10.4049/jimmunol.169.7.4033; Popov I, 2001, J IMMUNOL, V167, P3375, DOI 10.4049/jimmunol.167.6.3375; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schiellerup P, 2008, J RHEUMATOL, V35, P480; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Starnbach MN, 2003, J IMMUNOL, V171, P4742, DOI 10.4049/jimmunol.171.9.4742; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Swanborg Robert H., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000160; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Ying SM, 2006, INFECT IMMUN, V74, P6057, DOI 10.1128/IAI.00760-06; Yu H, 2009, J IMMUNOL, V182, P1602, DOI 10.4049/jimmunol.182.3.1602; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014	76	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25810	25825		10.1074/jbc.M113.493247	http://dx.doi.org/10.1074/jbc.M113.493247			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23867464	Green Published, hybrid			2022-12-28	WOS:000330623300014
J	Grass, GD; Tolliver, LB; Bratoeva, M; Toole, BP				Grass, G. Daniel; Tolliver, Lauren B.; Bratoeva, Momka; Toole, Bryan P.			CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INDUCER; COLLAGENASE-STIMULATORY FACTOR; ANCHORAGE-INDEPENDENT GROWTH; MAMMARY-CARCINOMA CELLS; EXTRACELLULAR-MATRIX; CANCER-CELLS; RAS ACTIVATION; MONOCARBOXYLATE TRANSPORTERS; TUMOR PROGRESSION; HYALURONAN-CD44 INTERACTIONS	The immunoglobulin superfamily glycoprotein CD147 (emmprin; basigin) is associated with an invasive phenotype in various types of cancers, including malignant breast cancer. We showed recently that up-regulation of CD147 in non-transformed, non-invasive breast epithelial cells is sufficient to induce an invasive phenotype characterized by membrane type-1 matrix metalloproteinase (MT1-MMP)-dependent invadopodia activity (Grass, G. D., Bratoeva, M., and Toole, B. P. (2012) Regulation of invadopodia formation and activity by CD147. J. Cell Sci. 125, 777-788). Here we found that CD147 induces breast epithelial cell invasiveness by promoting epidermal growth factor receptor (EGFR)-Ras-ERK signaling in a manner dependent on hyaluronan-CD44 interaction. Furthermore, CD147 promotes assembly of signaling complexes containing CD147, CD44, and EGFR in lipid raftlike domains. We also found that oncogenic Ras regulates CD147 expression, hyaluronan synthesis, and formation of CD147-CD44-EGFR complexes, thus forming a positive feedback loop that may amplify invasiveness. Last, we showed that malignant breast cancer cells are heterogeneous in their expression of surface-associated CD147 and that high levels of membrane CD147 correlate with cell surface EGFR and CD44 levels, activated EGFR and ERK1, and activated invadopodia. Future studies should evaluate CD147 as a potential therapeutic target and disease stratification marker in breast cancer.	[Grass, G. Daniel; Tolliver, Lauren B.; Bratoeva, Momka; Toole, Bryan P.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Toole, Bryan P.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Toole, BP (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	toolebp@musc.edu			National Institutes of Health [R01 CA073839, R01 CA082867]; Department of Defense Predoctoral Fellowship [W81XWH-10-1-0083]; IDEA [OC050368]; South Carolina Clinical and Translational Research Institute (National Institutes of Health, NCRR) [UL1RR029882]; NATIONAL CANCER INSTITUTE [R01CA073839, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Predoctoral Fellowship(United States Department of Defense); IDEA; South Carolina Clinical and Translational Research Institute (National Institutes of Health, NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA073839 and R01 CA082867. This work was also supported by Department of Defense Predoctoral Fellowship W81XWH-10-1-0083 (to G. D. G.) and IDEA Grant OC050368 (to B. P. T.) and by the South Carolina Clinical and Translational Research Institute (National Institutes of Health, NCRR, Grant UL1RR029882).	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; BISWAS C, 1995, CANCER RES, V55, P434; BISWAS C, 1984, CANCER LETT, V24, P201, DOI 10.1016/0304-3835(84)90137-X; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Botta GP, 2012, MOL CANCER RES, V10, P183, DOI 10.1158/1541-7786.MCR-11-0399; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Caldieri G, 2012, EUR J CELL BIOL, V91, P961, DOI 10.1016/j.ejcb.2012.03.005; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Caudroy S, 1999, J HISTOCHEM CYTOCHEM, V47, P1575, DOI 10.1177/002215549904701209; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen L, 2010, REPRODUCTION, V139, P1057, DOI 10.1530/REP-10-0069; Cui HY, 2012, BIOCHEM BIOPH RES CO, V419, P517, DOI 10.1016/j.bbrc.2012.02.049; Dai L, 2013, AM J PATHOL, V182, P577, DOI 10.1016/j.ajpath.2012.10.011; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Edward M, 2011, WOUND REPAIR REGEN, V19, P379, DOI 10.1111/j.1524-475X.2011.00678.x; ELLIS SM, 1989, CANCER RES, V49, P3385; Fanelli A, 2003, AM J PHYSIOL-ENDOC M, V285, pE1223, DOI 10.1152/ajpendo.00172.2003; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Grass GD, 2012, J CELL SCI, V125, P777, DOI 10.1242/jcs.097956; Guo HM, 1997, J BIOL CHEM, V272, P24; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kato N, 2011, AM J PATHOL, V178, P572, DOI 10.1016/j.ajpath.2010.10.009; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lesley J, 2000, J BIOL CHEM, V275, P26967; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Neel NF, 2012, MOL CELL BIOL, V32, P1374, DOI 10.1128/MCB.06291-11; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Polette M, 1997, J HISTOCHEM CYTOCHEM, V45, P703, DOI 10.1177/002215549704500508; Pons M, 2011, AM J PATHOL, V178, P2665, DOI 10.1016/j.ajpath.2011.02.006; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qin Z, 2011, LEUKEMIA, V25, P1598, DOI 10.1038/leu.2011.144; Ramos DM, 2011, ANTICANCER RES, V31, P1205; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; ROCHLITZ CF, 1989, CANCER RES, V49, P357; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Sameshima T, 2000, CANCER LETT, V157, P177, DOI 10.1016/S0304-3835(00)00485-7; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stamatakos M, 2010, ONKOLOGIE, V33, P540, DOI 10.1159/000319697; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Yabushita H, 2003, ONCOL REP, V10, P89; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yamaoka T, 2011, AM J PHYSIOL-GASTR L, V301, pG368, DOI 10.1152/ajpgi.00327.2010; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhu C, 2011, ONCOL REP, V25, P425, DOI 10.3892/or.2010.1088; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	88	72	77	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26089	26104		10.1074/jbc.M113.497685	http://dx.doi.org/10.1074/jbc.M113.497685			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888049	Green Published, hybrid			2022-12-28	WOS:000330623300038
J	Jorgensen, R; Pesnot, T; Lee, HJ; Palcic, MM; Wagner, GK				Jorgensen, Rene; Pesnot, Thomas; Lee, Ho Jun; Palcic, Monica M.; Wagner, Gerd K.			Base-modified Donor Analogues Reveal Novel Dynamic Features of a Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-A; GROUP-B TRISACCHARIDE; CONFORMATIONAL-CHANGES; INHIBITION; SUBSTRATE; MECHANISMS; COMPLEX; GENE	Glycosyltransferases (GTs) are enzymes that are involved, as Nature's "glycosylation reagents," in many fundamental biological processes including cell adhesion and blood group biosynthesis. Although of similar importance to that of other large enzyme families such as protein kinases and proteases, the undisputed potential of GTs for chemical biology and drug discovery has remained largely unrealized to date. This is due, at least in part, to a relative lack of GT inhibitors and tool compounds for structural, mechanistic, and cellular studies. In this study, we have used a novel class of GT donor analogues to obtain new structural and enzymological information for a representative blood group GT. These analogues interfere with the folding of an internal loop and the C terminus, which are essential for catalysis. Our experiments have led to the discovery of an entirely new active site folding mode for this enzyme family, which can be targeted in inhibitor development, similar to the DFG motif in protein kinases. Taken together, our results provide new insights into substrate binding, dynamics, and utilization in this important enzyme family, which can very likely be harnessed for the rational development of new GT inhibitors and probes.	[Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark; [Jorgensen, Rene; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Pesnot, Thomas] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Lee, Ho Jun] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Wagner, Gerd K.] Kings Coll London, Sch Biomed Sci, Inst Pharmaceut Sci, London SE1 9NH, England; [Wagner, Gerd K.] Kings Coll London, Dept Chem, London SE1 9NH, England	Statens Serum Institut; University of East Anglia; University of Alberta; University of London; King's College London; University of London; King's College London	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk; gerd.wagner@kcl.ac.uk	Wagner, Gerd/D-4759-2013; Jørgensen, René/P-5619-2014	Wagner, Gerd/0000-0003-1086-2301; Jørgensen, René/0000-0003-0672-466X	Engineering and Physical Sciences Research Council [EP/D059186/1]; Medical Research Council [G0901746]; Danish Council for Independent Research/Natural Sciences; Medical Sciences; EPSRC [EP/D059186/1] Funding Source: UKRI; MRC [G0901746] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Medical Sciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Engineering and Physical Sciences Research Council Grant EP/D059186/1 (to G. K. W.), the Medical Research Council Grant G0901746 (to G. K. W.), and the Danish Council for Independent Research/Natural Sciences (to M. M. P.) and Medical Sciences (to R. J.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Descroix K, 2012, J MED CHEM, V55, P2015, DOI 10.1021/jm201154p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Jorgensen R, 2012, ANGEW CHEM INT EDIT, V51, P4171, DOI 10.1002/anie.201108345; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martin MP, 2012, ACS CHEM BIOL, V7, P698, DOI 10.1021/cb200508b; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; SETO NOL, 1995, EUR J BIOCHEM, V234, P323, DOI 10.1111/j.1432-1033.1995.323_c.x; Weadge J. T., 2008, WILEY ENCY CHEM BIOL, V2, P198; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200; Yazer MH, 2005, VOX SANG, V89, P161, DOI 10.1111/j.1423-0410.2005.00688.x	27	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26201	26208		10.1074/jbc.M113.465963	http://dx.doi.org/10.1074/jbc.M113.465963			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23836908	Green Published, hybrid			2022-12-28	WOS:000330623300050
J	Ma, S; Hockings, C; Anwari, K; Kratina, T; Fennell, S; Lazarou, M; Ryan, MT; Kluck, RM; Dewson, G				Ma, Stephen; Hockings, Colin; Anwari, Khatira; Kratina, Tobias; Fennell, Stephanie; Lazarou, Michael; Ryan, Michael T.; Kluck, Ruth M.; Dewson, Grant			Assembly of the Bak Apoptotic Pore A CRITICAL ROLE FOR THE BAK PROTEIN alpha 6 HELIX IN THE MULTIMERIZATION OF HOMODIMERS DURING APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; CYTOCHROME-C; MITOCHONDRIAL APOPTOSIS; CONFORMATIONAL-CHANGES; PROAPOPTOTIC BAX; BH3 DOMAIN; CELL-DEATH; NATIVE ELECTROPHORESIS; OLIGOMERIZES BAK; ACTIVATION	Bak and Bax are the essential effectors of the intrinsic pathway of apoptosis. Following an apoptotic stimulus, both undergo significant changes in conformation that facilitates their self-association to form pores in the mitochondrial outer membrane. However, the molecular structures of Bak and Bax oligomeric pores remain elusive. To characterize how Bak forms pores during apoptosis, we investigated its oligomerization under native conditions using blue native PAGE. We report that, in a healthy cell, inactive Bak is either monomeric or in a large complex involving VDAC2. Following an apoptotic stimulus, activated Bak forms BH3:groove homodimers that represent the basic stable oligomeric unit. These dimers multimerize to higher-order oligomers via a labile interface independent of both the BH3 domain and groove. Linkage of the alpha 6:alpha 6 interface is sufficient to stabilize higher-order Bak oligomers on native PAGE, suggesting an important role in the Bak oligomeric pore. Mutagenesis of the alpha 6 helix disrupted apoptotic function because a chimera of Bak with the alpha 6 derived from Bcl-2 could be activated by truncated Bid (tBid) and could form BH3:groove homodimers but could not form high molecular weight oligomers or mediate cell death. An alpha 6 peptide could block Bak function but did so upstream of dimerization, potentially implicating alpha 6 as a site for activation by BH3-only proteins. Our examination of native Bak oligomers indicates that the Bak apoptotic pore forms by the multimerization of BH3:groove homodimers and reveals that Bak alpha 6 is not only important for Bak oligomerization and function but may also be involved in how Bak is activated by BH3-only proteins.	[Ma, Stephen; Hockings, Colin; Anwari, Khatira; Kratina, Tobias; Fennell, Stephanie; Kluck, Ruth M.; Dewson, Grant] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Ma, Stephen; Hockings, Colin; Kratina, Tobias; Fennell, Stephanie; Kluck, Ruth M.; Dewson, Grant] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Lazarou, Michael] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Ryan, Michael T.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia	Walter & Eliza Hall Institute; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); La Trobe University	Dewson, G (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	dewson@wehi.edu.au	dewson, grant/C-7646-2013; Kluck, Ruth M/C-8413-2013	dewson, grant/0000-0003-4251-8898; Kluck, Ruth M/0000-0002-7101-1925; Lazarou, Michael/0000-0003-2150-5545; Hockings, Colin/0000-0002-0248-0517	Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Support Scheme; Worldwide Cancer Research [10-0230] Funding Source: researchfish	Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Worldwide Cancer Research	This work was supported by Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Support Scheme.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Lazarou M, 2010, J BIOL CHEM, V285, P36876, DOI 10.1074/jbc.M110.159301; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Ross K, 2009, CELL DEATH DIFFER, V16, P697, DOI 10.1038/cdd.2008.194; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zhou LY, 2008, J CELL SCI, V121, P2186, DOI 10.1242/jcs.024703	53	56	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26027	26038		10.1074/jbc.M113.490094	http://dx.doi.org/10.1074/jbc.M113.490094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893415	hybrid, Green Published			2022-12-28	WOS:000330623300033
J	Li, Y; He, LN; Zeng, N; Sahu, D; Cadenas, E; Shearn, C; Li, W; Stiles, BL				Li, Yang; He, Lina; Zeng, Ni; Sahu, Divya; Cadenas, Enrique; Shearn, Colin; Li, Wei; Stiles, Bangyan L.			Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Signaling Regulates Mitochondrial Biogenesis and Respiration via Estrogen-related Receptor alpha (ERR alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; CANCER-CELLS; COACTIVATOR PGC-1; BREAST-CANCER; COPY NUMBER; METABOLISM; STRESS	Mitochondrial abnormalities are associated with cancer development, yet how oncogenic signals affect mitochondrial functions has not been fully understood. In this study, we investigate the relationship between mitochondrial alterations and PI3K/protein kinase B (AKT) signaling activation using hepatocytes and liver tissues as our experimental models. We show here that liver-specific deletion of Pten, which leads to activation of PI3K/AKT, is associated with elevated oxidative stress, increased mitochondrial mass, and augmented respiration accompanied by enhanced glycolysis. Consistent with these observations, estrogen-related receptor alpha (ERR alpha), an orphan nuclear receptor known for its role in mitochondrial biogenesis, is up-regulated in the absence of phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Our pharmacological and genetic studies show that PI3K/AKT activity regulates the expression of ERR alpha and mitochondrial biogenesis/respiration. Furthermore, cAMP-response element-binding protein, as a downstream target of AKT, plays a role in the regulation of ERR alpha, independent of PKA signaling. ERR alpha regulates reactive oxygen species production, and ERR alpha knockdown attenuates proliferation and colony-forming potential in Pten-null hepatocytes. Finally, analysis of clinical datasets from liver tissues showed a negative correlation between expressions of ERR alpha and PTEN in patients with liver cancer. Therefore, this study has established a previously unrecognized link between a growth signal and mitochondrial metabolism.	[Li, Yang; He, Lina; Zeng, Ni; Cadenas, Enrique; Stiles, Bangyan L.] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Stiles, Bangyan L.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Cadenas, Enrique] Univ So Calif, Keck Sch Med, Dept Biochem, Los Angeles, CA 90033 USA; [Sahu, Divya; Li, Wei] Univ So Calif, Dept Dermatol, Norris Comprehens Canc Ctr, Keck Med Ctr, Los Angeles, CA 90033 USA; [Shearn, Colin] Univ Colorado, Sch Pharm, Aurora, CO 80045 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus	Stiles, BL (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	bstiles@usc.edu			National Institutes of Health from University of Southern California Liver Center [P30DK48522]; NCI [5U 54 CA114868, R01CA154986-01A1]; National Institutes of Health from NIDDK [R01 DK084241-01A1]; NATIONAL CANCER INSTITUTE [R01CA154986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075928, R01DK084241, P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health from University of Southern California Liver Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Pilot Grant P30DK48522 from University of Southern California Liver Center and Grants 5U 54 CA114868 and R01CA154986-01A1 from NCI.; Supported by National Institutes of Health Grant R01 DK084241-01A1 from NIDDK.	Abid MDN, 2013, INT J MOL MED, V32, P389, DOI 10.3892/ijmm.2013.1394; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Bellavia M, 2012, MED HYPOTHESES, V79, P731, DOI 10.1016/j.mehy.2012.08.012; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cui XJ, 2012, ANTIOXID REDOX SIGN, V16, P1212, DOI 10.1089/ars.2012.4532; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Han A, 2012, BIOL OPEN, V1, P1169, DOI 10.1242/bio.20122246; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martel-Gallegos G, 2013, BBA-GEN SUBJECTS, V1830, P4650, DOI 10.1016/j.bbagen.2013.05.023; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shaik ZP, 2008, AM J PHYSIOL-RENAL, V294, pF423, DOI 10.1152/ajprenal.00463.2007; Shaywitz AJ, 2008, CELL METAB, V8, P179, DOI 10.1016/j.cmet.2008.08.011; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vivekanandan P, 2010, MODERN PATHOL, V23, P790, DOI 10.1038/modpathol.2010.51; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Yao J, 2012, NEUROBIOL AGING, V33, P1507, DOI 10.1016/j.neurobiolaging.2011.03.001; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zamkova M, 2013, CELL CYCLE, V12, P826, DOI 10.4161/cc.23723; Zeng N, 2011, MOL CANCER RES, V9, P1708, DOI 10.1158/1541-7786.MCR-11-0299	65	46	46	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25007	25024		10.1074/jbc.M113.450353	http://dx.doi.org/10.1074/jbc.M113.450353			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836899	hybrid, Green Published			2022-12-28	WOS:000330619000003
J	Moore, KJ; Fillingame, RH				Moore, Kyle J.; Fillingame, Robert H.			Obstruction of Transmembrane Helical Movements in Subunit a Blocks Proton Pumping by F1Fo ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS PATHWAYS; ESCHERICHIA-COLI; CROSS-LINKING; C-RING; ROTOR RING; MEMBRANE; H+; SECTOR; STOICHIOMETRY; MECHANISM	Subunit a plays a key role in promoting H+ transport-coupled rotary motion of the subunit c ring in F1Fo ATP synthase. H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-o subunit c. H+ are thought to reach cAsp61 via aqueous half-channels formed byTMHs2-5 of subunit a. Movements of TMH4 and TMH5 have been proposed to facilitate protonation of cAsp61 from a half channel centered in a four helix bundle at the periplasmic side of subunit a. The possible necessity of these proposed TMH movements was investigated by assaying ATP driven H+ pumping function before and after cross-linking paired Cys substitutions at the center of TMHs within subunit a. The cross-linking of the Cys pairs aG218C/I248C in TMH4 and TMH5, and aL120C/H245C in TMH2 and TMH5, inhibited H+ pumping by 85-90%. H+ pumping function was largely unaffected by modification of the same Cys residues in the absence of cross-link formation. The inhibition is consistent with the proposed requirement for TMH movements during the gating of periplasmic H+ access to cAsp61. The cytoplasmic loops of subunit a have been implicated in gating H+ release to the cytoplasm, and previous cross-linking experiments suggest that the chemically reactive regions of the loops may pack as a single domain. Here we show that Cys substitutions in these domains can be cross-linked with retention of function and conclude that these domains need not undergo large conformational changes during enzyme function.	[Moore, Kyle J.; Fillingame, Robert H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	rhfillin@wisc.edu			National Institutes of Health [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023105, R01GM023105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM23105 from the National Institutes of Health.	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; EYA S, 1991, ARCH BIOCHEM BIOPHYS, V284, P71, DOI 10.1016/0003-9861(91)90265-K; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Gohlke H, 2012, J BIOL CHEM, V287, P36536, DOI 10.1074/jbc.M112.398396; Hakulinen JK, 2012, P NATL ACAD SCI USA, V109, pE2050, DOI 10.1073/pnas.1203971109; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	36	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25535	25541		10.1074/jbc.M113.496794	http://dx.doi.org/10.1074/jbc.M113.496794			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23864659	hybrid, Green Published			2022-12-28	WOS:000330619000048
J	Xiao, XW; Guo, P; Shiota, C; Prasadan, K; El-Gohary, Y; Wiersch, J; Gaffar, I; Gittes, GK				Xiao, Xiangwei; Guo, Ping; Shiota, Chiyo; Prasadan, Krishna; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Gittes, George K.			Neurogenin3 Activation Is Not Sufficient to Direct Duct-to-Beta Cell Transdifferentiation in the Adult Pancreas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELL; PRIMARY MECHANISM; ENDOCRINE-CELLS; GROWTH-FACTOR; EXPRESSION; REGENERATION; PROLIFERATION; PROGENITORS; LINEAGE; ALPHA	It remains controversial whether adult pancreatic ducts harbor facultative beta cell progenitors. Because neurogenin3 (Ngn3) is a key determinant of pancreatic endocrine cell neogenesis during embryogenesis, many studies have also relied upon Ngn3 expression as evidence of beta cell neogenesis in adults. Recently, however, Ngn3 as a marker of adult beta cell neogenesis has been called into question by reports of Ngn3 expression in fully-developed beta cells. Nevertheless, direct evidence as to whether Ngn3 activation in adult pancreatic duct cells may lead to duct-to-beta cell transdifferentiation is lacking. Here we studied two models of Ngn3 activation in adult pancreatic duct cells (low-dose alloxan treatment and pancreatic duct ligation) and lineage-traced Ngn3-activated duct cells by labeling them through intraductal infusion with a cell-tagging dye, CFDA-SE No dye-labeled beta cells were found during the follow-up in either model, suggesting that activation of Ngn3 in duct cells is not sufficient to direct their transdifferentiation into beta cells. Therefore, Ngn3 activation in duct cells is not a signature for adult beta cell neogenesis.	[Xiao, Xiangwei; Guo, Ping; Shiota, Chiyo; Prasadan, Krishna; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Gittes, George K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Surg, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, XW (corresponding author), 4401 Penn Ave, Pittsburgh, PA 15224 USA.	xiangwei.xiao@chp.edu; gittesgk@upmc.edu	xiao, xiangwei/K-1218-2012	Xiao, Xiangwei/0000-0003-0890-9203; El-Gohary, Yousef/0000-0002-8655-0948	National Institutes of Health [R01 DK064952, R01 DK083541]; Cochrane-Weber endowed Fund in Diabetes Research; Children's Hospital of Pittsburgh Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083541, R01DK064952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cochrane-Weber endowed Fund in Diabetes Research; Children's Hospital of Pittsburgh Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK064952 and R01 DK083541 (to G. K. G.), the Cochrane-Weber endowed Fund in Diabetes Research (to X. X.), and the Children's Hospital of Pittsburgh Foundation.	Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Figeac F, 2012, MOL THER, V20, P1944, DOI 10.1038/mt.2012.112; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hickey RD, 2013, STEM CELL RES, V11, P503, DOI 10.1016/j.scr.2013.02.005; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Ji BA, 2008, GENESIS, V46, P390, DOI 10.1002/dvg.20411; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kaestner KH, 2007, J CLIN INVEST, V117, P2380, DOI 10.1172/JCI33375; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kodama S, 2005, BIOCHEM BIOPH RES CO, V327, P1170, DOI 10.1016/j.bbrc.2004.12.120; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Liang XD, 2011, WORLD J GASTROENTERO, V17, P2812, DOI 10.3748/wjg.v17.i23.2812; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pipeleers D, 2002, ANN NY ACAD SCI, V958, P69; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Scharfmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003559; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Weinberg N, 2007, FORBES, V179, P56; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	61	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25297	25308		10.1074/jbc.M113.484022	http://dx.doi.org/10.1074/jbc.M113.484022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867457	hybrid, Green Published			2022-12-28	WOS:000330619000028
J	Bocedi, A; Fabrini, R; Farrotti, A; Stella, L; Ketterman, AJ; Pedersen, JZ; Allocati, N; Lau, PCK; Grosse, S; Eltis, LD; Ruzzini, A; Edwards, TE; Morici, L; Del Grosso, E; Guidoni, L; Bovi, D; Lo Bello, M; Federici, G; Parker, MW; Board, PG; Ricci, G				Bocedi, Alessio; Fabrini, Raffaele; Farrotti, Andrea; Stella, Lorenzo; Ketterman, Albert J.; Pedersen, Jens Z.; Allocati, Nerino; Lau, Peter C. K.; Grosse, Stephan; Eltis, Lindsay D.; Ruzzini, Antonio; Edwards, Thomas E.; Morici, Laura; Del Grosso, Erica; Guidoni, Leonardo; Bovi, Daniele; Lo Bello, Mario; Federici, Giorgio; Parker, Michael W.; Board, Philip G.; Ricci, Giorgio			The Impact of Nitric Oxide Toxicity on the Evolution of the Glutathione Transferase Superfamily A PROPOSAL FOR AN EVOLUTIONARY DRIVING FORCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGLUTATHIONYL-IRON COMPLEX; S-TRANSFERASE; ACTIVE-SITE; IN-VIVO; FUNCTIONAL POLYMORPHISM; OCHROBACTRUM-ANTHROPI; CRYSTAL-STRUCTURE; PROTON RELEASE; NO-CARRIERS; BINDING	Glutathione transferases (GSTs) are protection enzymes capable of conjugating glutathione (GSH) to toxic compounds. During evolution an important catalytic cysteine residue involved in GSH activation was replaced by serine or, more recently, by tyrosine. The utility of these replacements represents an enigma because they yield no improvements in the affinity toward GSH or in its reactivity. Here we show that these changes better protect the cell from nitric oxide (NO) insults. In fact the dinitrosyl.diglutathionyl.iron complex (DNDGIC), which is formed spontaneously when NO enters the cell, is highly toxic when free in solution but completely harmless when bound to GSTs. By examining 42 different GSTs we discovered that only the more recently evolved Tyr-based GSTs display enough affinity for DNDGIC (K-D < 10(-9) M) to sequester the complex efficiently. Ser-based GSTs and Cys-based GSTs show affinities 10(2)-10(4) times lower, not sufficient for this purpose. The NO sensitivity of bacteria that express only Cys-based GSTs could be related to the low or null affinity of their GSTs for DNDGIC. GSTs with the highest affinity (Tyr-based GSTs) are also over-represented in the perinuclear region of mammalian cells, possibly for nucleus protection. On the basis of these results we propose that GST evolution in higher organisms could be linked to the defense against NO.	[Bocedi, Alessio; Fabrini, Raffaele; Farrotti, Andrea; Stella, Lorenzo; Morici, Laura; Del Grosso, Erica; Ricci, Giorgio] Univ Rome, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pedersen, Jens Z.; Lo Bello, Mario] Univ Rome, Dept Biol, I-00133 Rome, Italy; [Ketterman, Albert J.] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom 73170, Thailand; [Allocati, Nerino] Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Natl Res Council Canada, Montreal, PQ 3775, Canada; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Dept Chem, Montreal, PQ 3775, Canada; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ 3775, Canada; [Eltis, Lindsay D.; Ruzzini, Antonio] Univ British Columbia, Dept Microbiol & Biochem, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Edwards, Thomas E.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA; [Edwards, Thomas E.] Emerald BioStruct Inc, Bainbridge Isl, WA 98110 USA; [Guidoni, Leonardo; Bovi, Daniele] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Guidoni, Leonardo] Univ Aquila, Dept Phys & Chem Sci, I-67100 Laquila, Italy; [Federici, Giorgio] Childrens Hosp IRCCS Bambin Gesu, I-00165 Rome, Italy; [Parker, Michael W.] St Vincents Inst Med Res, ACRF Rational Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Board, Philip G.] Australian Natl Univ, Mol Genet Grp, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Sapienza University Rome; Sapienza University Rome; Mahidol University; G d'Annunzio University of Chieti-Pescara; McGill University; National Research Council Canada; McGill University; McGill University; University of British Columbia; Sapienza University Rome; University of L'Aquila; IRCCS Bambino Gesu; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; Australian National University; John Curtin School of Medical Research	Ricci, G (corresponding author), Univ Rome, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Parker, Michael W/F-9069-2013; Bovi, Daniele/E-2166-2015; Guidoni, Leonardo/G-3759-2011; Ruzzini, Antonio/M-2776-2017; Del Grosso, Erica/GPT-3066-2022; Stella, Lorenzo/A-7996-2010; Eltis, Lindsay D/J-8272-2015	Parker, Michael W/0000-0002-3101-1138; Guidoni, Leonardo/0000-0002-2497-9482; Ruzzini, Antonio/0000-0002-5697-5371; Stella, Lorenzo/0000-0002-5489-7381; Eltis, Lindsay D/0000-0002-6774-8158; Del Grosso, Erica/0000-0002-0022-7796; Edwards, Thomas/0000-0002-0474-8003; Ricci, Giorgio/0000-0002-7108-2846; ALLOCATI, Nerino/0000-0003-2670-8085	Italian Institution FONDAZIONE ROMA-Terzo Settore grant; Mahidol University; European Research Council [240624]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council	Italian Institution FONDAZIONE ROMA-Terzo Settore grant; Mahidol University; European Research Council(European Research Council (ERC)European Commission); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Italian Institution FONDAZIONE ROMA-Terzo Settore grant (to G. R.), grants from the Mahidol University (to A. J. K.), and European Research Council Project 240624 "MultiscaleChemBio" within the VII Framework Program of the European Union (to L. G.).; Supported by the Victorian Government's Operational Infrastructure Support Program and is a National Health and Medical Research Council Senior Principal Research Fellow.	Allocati N, 2008, PROTEINS, V71, P16, DOI 10.1002/prot.21835; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Caccuri AM, 2002, BIOCHEMISTRY-US, V41, P4686, DOI 10.1021/bi0158425; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Caccuri AM, 2001, J BIOL CHEM, V276, P5427, DOI 10.1074/jbc.M002819200; Caccuri AM, 1998, BIOCHEMISTRY-US, V37, P3028, DOI 10.1021/bi971903g; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edwards TE, 2011, ACTA CRYSTALLOGR F, V67, P1038, DOI 10.1107/S1744309111009493; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Favaloro B, 1998, BIOCHEM J, V335, P573, DOI 10.1042/bj3350573; FLATGAARD JE, 1993, CANCER CHEMOTH PHARM, V33, P63, DOI 10.1007/BF00686025; Fortin PD, 2006, J BACTERIOL, V188, P4424, DOI 10.1128/JB.01849-05; Gal A, 1996, P NATL ACAD SCI USA, V93, P15102, DOI 10.1073/pnas.93.26.15102; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hoppner J, 2004, ACTA CRYSTALLOGR D, V60, P1496, DOI 10.1107/S090744490401460X; Johnson KA, 2003, BIOCHEMISTRY-US, V42, P10084, DOI 10.1021/bi034449r; Keese MA, 1997, BIOCHEM PHARMACOL, V54, P1307, DOI 10.1016/S0006-2952(97)00348-1; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Lobysheva II, 1999, FEBS LETT, V454, P177, DOI 10.1016/S0014-5793(99)00777-2; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOZER TJ, 1983, BIOCHEMISTRY-US, V22, P1068, DOI 10.1021/bi00274a011; Nebert Daniel W., 2004, Human Genomics, V1, P460; Neese F, 2000, CHEM PHYS LETT, V325, P93, DOI 10.1016/S0009-2614(00)00662-X; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; NOODLEMAN L, 1988, J AM CHEM SOC, V110, P1001, DOI 10.1021/ja00212a003; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Pearson WR, 2005, METHOD ENZYMOL, V401, P186, DOI 10.1016/S0076-6879(05)01012-8; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tan KL, 1996, BIOCHEM J, V319, P315, DOI 10.1042/bj3190315; Tetlow N, 2004, PHARMACOGENETICS, V14, P657, DOI 10.1097/00008571-200410000-00003; Tetlow N, 2004, PHARMACOGENETICS, V14, P111, DOI 10.1097/00008571-200402000-00005; TOMAREV SI, 1993, J BIOL CHEM, V268, P4534; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Wongsantichon J, 2010, BIOCHEM J, V428, P25, DOI 10.1042/BJ20091939; Ye SF, 2010, J AM CHEM SOC, V132, P3646, DOI 10.1021/ja9091616	64	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24936	24947		10.1074/jbc.M113.476135	http://dx.doi.org/10.1074/jbc.M113.476135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828197	hybrid, Green Published			2022-12-28	WOS:000330612300057
J	Kawauchi, J; Inoue, M; Fukuda, M; Uchida, Y; Yasukawa, T; Conaway, RC; Conaway, JW; Aso, T; Kitajima, S				Kawauchi, Junya; Inoue, Makoto; Fukuda, Mizue; Uchida, Yohei; Yasukawa, Takashi; Conaway, Ronald C.; Conaway, Joan W.; Aso, Teijiro; Kitajima, Shigetaka			Transcriptional Properties of Mammalian Elongin A and Its Role in Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR ELONGIN; GENE-EXPRESSION; IN-VIVO; FACTOR-SIII; FACTORS TFIIS; INITIATION; PROMOTER; COMPLEX; ATF3	Elongin A was shown previously to be capable of potently activating the rate of RNA polymerase II (RNAPII) transcription elongation in vitro by suppressing transient pausing by the enzyme at many sites along DNA templates. The role of Elongin A in RNAPII transcription in mammalian cells, however, has not been clearly established. In this report, we investigate the function of Elongin A in RNAPII transcription. We present evidence that Elongin A associates with the IIO form of RNAPII at sites of newly transcribed RNA and is relocated to dotlike domains distinct from those containing RNAPII when cells are treated with the kinase inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Significantly, Elongin A is required for maximal induction of transcription of the stress response genes ATF3 and p21 in response to several stimuli. Evidence from structure-function studies argues that Elongin A transcription elongation activity, but not its ubiquitination activity, is most important for its function in induction of transcription of ATF3 and p21. Taken together, our data provide new insights into the function of Elongin A in RNAPII transcription and bring to light a previously unrecognized role for Elongin A in the regulation of stress response genes.	[Kawauchi, Junya; Inoue, Makoto; Fukuda, Mizue; Uchida, Yohei; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Dept Biochem Genet, Med Res Inst, Tokyo 1138510, Japan; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nankoku, Kochi 7838505, Japan; [Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Tokyo Medical & Dental University (TMDU); Kochi University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp		Conaway, Joan/0000-0002-2786-0663	Japan Society for the Promotion of Science KAKENHI [18012015, 18055008, 21590302, 21590311, 24118002]; Medical Research Institute, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [24590279] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Institute, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 18012015, 18055008, and 21590302 (to S. K.), 21590311 (to T. A.), and 24118002 (to J. K.) and by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 2000, J BIOL CHEM, V275, P6546, DOI 10.1074/jbc.275.9.6546; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; Grande MA, 1997, J CELL SCI, V110, P1781; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hai T, 1999, GENE EXPRESSION, V7, P321; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lis JT, 2000, GENE DEV, V14, P792; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miyata K, 2007, CELL DEATH DIFFER, V14, P716, DOI 10.1038/sj.cdd.4402067; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; TAN SY, 1994, J BIOL CHEM, V269, P25684; vanSteensel B, 1996, J CELL SCI, V109, P787; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; Yamazaki K, 2003, J BIOL CHEM, V278, P13585, DOI 10.1074/jbc.C300047200; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yasukawa T, 2007, BIOCHEM BIOPH RES CO, V352, P237, DOI 10.1016/j.bbrc.2006.11.012; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	68	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24302	24315		10.1074/jbc.M113.496703	http://dx.doi.org/10.1074/jbc.M113.496703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828199	Green Published, hybrid			2022-12-28	WOS:000330612300003
J	Axelgaard, E; Jensen, L; Dyrlund, TF; Nielsen, HJ; Enghild, JJ; Thiel, S; Jensenius, JC				Axelgaard, Esben; Jensen, Lisbeth; Dyrlund, Thomas F.; Nielsen, Hans J.; Enghild, Jan J.; Thiel, Steffen; Jensenius, Jens C.			Investigations on Collectin Liver 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; PATHWAY; PROTEIN; IDENTIFICATION; PROTEASE-2; FICOLINS; CLONING; CL-11; SITE	Collectins are pattern recognition molecules of the innate immune system showing binding to carbohydrate structures on microorganisms in a calcium-dependent manner. Recently, three novel collectins, collectin liver 1 (CL-L1), collectin kidney 1 (CL-K1 and CL-11), and collectin placenta 1 (CL-P1), were discovered. The roles of these three collectins remain largely unknown. Here, we present a time-resolved immunofluorometric assay for quantification of CL-L1. The concentration of CL-L1 in donor plasma (n = 210) was distributed log-normally with a median value of 3.0 mu g/ml (range 1.5-5.5 mu g/ml). We observed on average 30% higher concentrations of CL-L1 in plasma as compared with serum. Size analysis by gel-permeation chromatography showed CL-L1 in serum to elute as large 700-800-kDa complexes and smaller 200-300-kDa complexes. CL-L1 showed specific binding to mannose-TSK beads in a Ca2+-dependent manner. This binding could be inhibited by mannose and glucose, but not galactose, indicating that CL-L1 binds via its carbohydrate-recognition domain and has ligand specificity similar to that of mannan-binding lectin. Western blot analysis of CL-L1 showed the presence of several oligomeric forms in serum. Ontogeny studies showed CL-L1 to be present at birth at near adult levels. CL-L1 levels exhibit low variation in healthy adults over a 1-year period. During acute-phase responses, the CL-L1 levels display only minor variations. In serum, CL-L1 was found in complexes with mannan-binding lectin-associated serine proteases, suggesting a role in the lectin pathway of complement activation. The presented data establish a basis for future studies on the biological role of CL-L1.	[Axelgaard, Esben; Jensen, Lisbeth; Thiel, Steffen; Jensenius, Jens C.] Aarhus Univ, Dept Biomed, Fac Hlth Sci, DK-8000 Aarhus C, Denmark; [Dyrlund, Thomas F.; Enghild, Jan J.] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nielsen, Hans J.] Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Thiel, S (corresponding author), Aarhus Univ, Dept Biomed, Bartholin Bldg,Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	st@microbiology.au.dk		Thiel, Steffen/0000-0002-4817-155X; Axelgaard, Esben/0000-0003-1494-0493; Enghild, Jan Johannes/0000-0001-9292-9172; Nielsen, Hans Jorgen/0000-0003-2619-4379	Danish Council for Independent Research, Medical Sciences; Lundbeck Foundation; Novo Nordic Foundation	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation)	This work was supported by The Danish Council for Independent Research, Medical Sciences, and the Lundbeck Foundation and the Novo Nordic Foundation.	Bordet J, 1909, ZENTR BAKTERIOL PARA, V49, P260; Degn SE, 2011, J IMMUNOL METHODS, V373, P89, DOI 10.1016/j.jim.2011.08.006; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Kawai T, 2002, BIOSCI BIOTECH BIOCH, V66, P2134, DOI 10.1271/bbb.66.2134; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Ohtani K, 1999, J BIOL CHEM, V274, P13681, DOI 10.1074/jbc.274.19.13681; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Ohtani K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493945; PERSSON A, 1988, BIOCHEMISTRY-US, V27, P8576, DOI 10.1021/bi00423a011; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Ytting H, 2006, CLIN EXP IMMUNOL, V144, P239, DOI 10.1111/j.1365-2249.2006.03068.x; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044	29	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23407	23420		10.1074/jbc.M113.492603	http://dx.doi.org/10.1074/jbc.M113.492603			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814060	hybrid, Green Published			2022-12-28	WOS:000330598200044
J	Galdieri, L; Chang, J; Mehrotra, S; Vancura, A				Galdieri, Luciano; Chang, Jennifer; Mehrotra, Swati; Vancura, Ales			Yeast Phospholipase C Is Required for Normal Acetyl-CoA Homeostasis and Global Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; CHROMATIN-REMODELING COMPLEXES; RIBOSOMAL-PROTEIN GENES; SACCHAROMYCES-CEREVISIAE; INOSITOL PYROPHOSPHATES; GENOME-WIDE; HEXOSE TRANSPORTERS; GLUCOSE SENSORS; TELOMERE LENGTH; CODING REGIONS	Phospholipase C (Plc1p) is required for the initial step of inositol polyphosphate (InsP) synthesis, and yeast cells with deletion of the PLC1 gene are completely devoid of any InsPs and display aberrations in transcriptional regulation. Here we show that Plc1p is required for a normal level of histone acetylation; plc1 Delta cells that do not synthesize any InsPs display decreased acetylation of bulk histones and global hypoacetylation of chromatin histones. In accordance with the role of Plc1p in supporting histone acetylation, plc1 Delta mutation is synthetically lethal with mutations in several subunits of SAGA and NuA4 histone acetyltransferase (HAT) complexes. Conversely, the growth rate, sensitivity to multiple stresses, and the transcriptional defects of plc1 Delta cells are partially suppressed by deletion of histone deacetylase HDA1. The histone hypoacetylation in plc1 Delta cells is due to the defect in degradation of repressor Mth1p, and consequently lower expression of HXT genes and reduced conversion of glucose to acetyl-CoA, a substrate for HATs. The histone acetylation and transcriptional defects can be partially suppressed and the overall fitness improved in plc1 Delta cells by increasing the cellular concentration of acetyl-CoA. Together, our data indicate that Plc1p and InsPs are required for normal acetyl-CoA homeostasis, which, in turn, regulates global histone acetylation.	[Galdieri, Luciano; Chang, Jennifer; Mehrotra, Swati; Vancura, Ales] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Saint John's University	Vancura, A (corresponding author), 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Galdieri, Luciano/GYD-4538-2022	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health [GM087674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106324, R15GM087674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087674 (to A. V.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; DeLillo N, 2003, MOL GENET GENOMICS, V269, P261, DOI 10.1007/s00438-003-0832-4; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Desai P, 2009, MOL GENET GENOMICS, V281, P511, DOI 10.1007/s00438-009-0427-9; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Friis RMN, 2009, BIOCHEM CELL BIOL, V87, P107, DOI 10.1139/O08-097; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Galdieri L, 2012, METHODS MOL BIOL, V809, P255, DOI 10.1007/978-1-61779-376-9_17; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Guha N, 2007, MOL BIOL CELL, V18, P2419, DOI 10.1091/mbc.E06-10-0946; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; Hogan C, 2007, MUTAT RES-FUND MOL M, V618, P41, DOI 10.1016/j.mrfmmm.2006.07.010; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRAAKMAN LS, 1993, MOL GEN GENET, V239, P196, DOI 10.1007/BF00281618; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2003, P NATL ACAD SCI USA, V100, P7551, DOI 10.1073/pnas.1332299100; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin HY, 2000, MOL CELL BIOL, V20, P3597, DOI 10.1128/MCB.20.10.3597-3607.2000; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roberts SM, 1997, GENETICS, V147, P451; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Smedsgaard J, 2005, J EXP BOT, V56, P273, DOI 10.1093/jxb/eri068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2008, NAT CHEM BIOL, V4, P16, DOI 10.1038/nchembio0108-16; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Yoshida A, 2012, J BIOL CHEM, V287, P701, DOI 10.1074/jbc.M111.322222; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Yu YX, 2003, MOL CELL BIOL, V23, P1910, DOI 10.1128/MCB.23.6.1910-1921.2003; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	106	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27986	27998		10.1074/jbc.M113.492348	http://dx.doi.org/10.1074/jbc.M113.492348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913687	Green Published, hybrid			2022-12-28	WOS:000330612800025
J	Viegas, CSB; Simes, DC; Williamson, MK; Cavaco, S; Laize, V; Price, PA; Cancela, ML				Viegas, Carla S. B.; Simes, Dina C.; Williamson, Matthew K.; Cavaco, Sofia; Laize, Vincent; Price, Paul A.; Leonor Cancela, M.			Sturgeon Osteocalcin Shares Structural Features with Matrix Gla Protein EVOLUTIONARY RELATIONSHIP AND FUNCTIONAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; FISH SPARUS-AURATA; VITAMIN-K; XENOPUS-LAEVIS; TELEOST FISH; CALCIFIED CARTILAGE; TISSUE DISTRIBUTION; ORGANIC MATRIX; MESSENGER-RNA; BONE	Osteocalcin (OC) and matrix Gla protein (MGP) are considered evolutionarily related because they share key structural features, although they have been described to exert different functions. In this work, we report the identification and characterization of both OC and MGP from the Adriatic sturgeon, a ray-finned fish characterized by a slow evolution and the retention of many ancestral features. Sturgeon MGP shows a primary structure, post-translation modifications, and patterns of mRNA/protein distribution and accumulation typical of known MGPs, and it contains seven possible Gla residues that would make the sturgeon protein the most gamma-carboxylated among known MGPs. In contrast, sturgeon OC was found to present a hybrid structure. Indeed, although exhibiting protein domains typical of known OCs, it also contains structural features usually found in MGPs (e. g. a putative phosphorylated propeptide). Moreover, patterns of OC gene expression and protein accumulation overlap with those reported for MGP; OC was detected in bone cells and mineralized structures but also in soft and cartilaginous tissues. We propose that, in a context of a reduced rate of evolution, sturgeon OC has retained structural features of the ancestral protein that emerged millions of years ago from the duplication of an ancient MGP gene and may exhibit intermediate functional features.	[Leonor Cancela, M.] Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal; [Williamson, Matthew K.; Price, Paul A.] Univ Algarve, GenoGla Diagnost, CCMAR CIMAR LA, P-8005139 Faro, Portugal; [Leonor Cancela, M.] Univ Algarve, Dept Biomed Sci & Med, P-8005139 Faro, Portugal; [Simes, Dina C.] Univ Calif San Diego, Div Biol, La Jolla, CA USA	Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; University of California System; University of California San Diego	Cancela, ML (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Campus Gambelas, P-8005139 Faro, Portugal.	lcancela@ualg.pt	Laizé, Vincent/B-4463-2008; Viegas, Carla/N-6314-2019; Simes, Dina Costa/N-2789-2014; Viegas, Carla CSB/N-6695-2014; Viegas, Carla/B-7217-2013	Laizé, Vincent/0000-0001-9565-9198; Viegas, Carla/0000-0002-5765-3665; Simes, Dina Costa/0000-0002-5145-4753; Viegas, Carla CSB/0000-0002-5765-3665; Cancela, M. Leonor/0000-0003-3114-6662; Viegas, Carla/0000-0002-1545-6479	Portuguese Science and Technology Foundation [POCTI/MAR/57921/2004, SFRH/BD/9077/2002]; Fundo Europeu De Desenvolvimento Regional (FEDER) (Portugal); National Funding; Center of Marine Sciences (CCMAR); Fundação para a Ciência e a Tecnologia [POCI/MAR/57921/2004] Funding Source: FCT	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Fundo Europeu De Desenvolvimento Regional (FEDER) (Portugal); National Funding; Center of Marine Sciences (CCMAR); Fundação para a Ciência e a Tecnologia	This work was supported in part by grant POCTI/MAR/57921/2004 from the Portuguese Science and Technology Foundation (including funds from Fundo Europeu De Desenvolvimento Regional (FEDER) (Portugal) and National Funding) and by Center of Marine Sciences (CCMAR) funding.; Recipient of Ph.D. Fellowship SFRH/BD/9077/2002 from the Portuguese Science and Technology Foundation.	Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Cancela ML, 2001, J BONE MINER RES, V16, P1611, DOI 10.1359/jbmr.2001.16.9.1611; CANCELA ML, 1995, INT J PEPT PROT RES, V46, P419, DOI 10.1111/j.1399-3011.1995.tb01076.x; Conceicao N, 2005, FEBS J, V272, P1501, DOI 10.1111/j.1742-4658.2005.04590.x; Conceicao N, 2008, BBA-GENE REGUL MECH, V1779, P28, DOI 10.1016/j.bbagrm.2007.11.003; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; FRASER JD, 1988, J BIOL CHEM, V263, P11033; GUNDBERG CM, 1992, J BONE MINER RES, V7, P73; HALE JE, 1988, J BIOL CHEM, V263, P5820; Hall B.K., 2015, BONES CARTILAGE DEV; Hashimoto F, 2001, ARCH ORAL BIOL, V46, P585, DOI 10.1016/S0003-9969(01)00022-X; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208; Hinoi E, 2009, ANN NY ACAD SCI, V1173, pE20, DOI 10.1111/j.1749-6632.2009.05061.x; HOSODA K, 1993, J BONE MINER RES, V8, P553; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Krieger J, 2002, MOL BIOL EVOL, V19, P891, DOI 10.1093/oxfordjournals.molbev.a004146; Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200; Laize V, 2006, J BIOL CHEM, V281, P15037, DOI 10.1074/jbc.M600373200; LIAN JB, 1978, FED PROC, V37, P2615; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Ortiz-Delgado JB, 2005, HISTOCHEM CELL BIOL, V124, P123, DOI 10.1007/s00418-005-0015-y; OTAWARA Y, 1986, J BIOL CHEM, V261, P828; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Pinto JP, 2001, GENE, V270, P77, DOI 10.1016/S0378-1119(01)00426-7; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; PRICE PA, 1994, PROTEIN SCI, V3, P822; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; PRICE PA, 1985, VITAM HORM, V42, P65; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; RICE JS, 1994, J BONE MINER RES, V9, P567; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Simes DC, 2004, CALCIFIED TISSUE INT, V74, P170, DOI 10.1007/s00223-003-0079-4; Simes DC, 2003, J BONE MINER RES, V18, P244, DOI 10.1359/jbmr.2003.18.2.244; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Thomas JT, 2006, J BIOL CHEM, V281, P26725, DOI 10.1074/jbc.M603851200; Viegas CSB, 2010, J APPL ICHTHYOL, V26, P214, DOI 10.1111/j.1439-0426.2010.01408.x; Viegas CSB, 2009, AM J PATHOL, V175, P2288, DOI 10.2353/ajpath.2009.090474; Viegas CSB, 2008, J BIOL CHEM, V283, P36655, DOI 10.1074/jbc.M802761200; Viegas CSB, 2002, GENE, V289, P97, DOI 10.1016/S0378-1119(02)00480-8; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097	51	9	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27801	27811		10.1074/jbc.M113.450213	http://dx.doi.org/10.1074/jbc.M113.450213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23884418	hybrid, Green Published			2022-12-28	WOS:000330612800009
J	van Vliet, SJ; Vuist, IM; Lenos, K; Tefsen, B; Kalay, H; Garcia-Vallejo, JJ; van Kooyk, Y				van Vliet, Sandra J.; Vuist, Ilona M.; Lenos, Kristiaan; Tefsen, Boris; Kalay, Hakan; Garcia-Vallejo, Juan J.; van Kooyk, Yvette			Human T Cell Activation Results in Extracellular Signal-regulated Kinase (ERK)-Calcineurin-dependent Exposure of Tn Antigen on the Cell Surface and Binding of the Macrophage Galactose-type Lectin (MGL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; TRANSCRIPTIONAL REGULATION; GNT-V; PROTEIN; GENE; CD45; EXPRESSION; RECOGNITION; CHAPERONE; GLYCANS	The C-type lectin macrophage galactose-type lectin (MGL) exerts an immunosuppressive role reflected by its interaction with terminal GalNAc moieties, such as the Tn antigen, on CD45 of effector T cells, thereby down-regulating T cell receptor signaling, cytokine responses, and induction of T cell death. Here, we provide evidence for the pathways that control the specific expression of GalNAc moieties on human CD4(+) T cells. GalNAc epitopes were readily detectable on the cell surface after T cell activation and required de novo protein synthesis. Expression of GalNAc-containing MGL ligands was completely dependent on PKC and did not involve NF-kappa B. Instead, activation of the downstream ERK MAPK pathway led to decreased mRNA levels and activity of the core 1 beta 3GalT enzyme and its chaperone Cosmc, favoring the expression of Tn antigen. In conclusion, expression of GalNAc moieties mirrors the T cell activation status, and thus only highly stimulated T cells are prone to the suppressive action of MGL.	[van Vliet, Sandra J.; Vuist, Ilona M.; Lenos, Kristiaan; Tefsen, Boris; Kalay, Hakan; Garcia-Vallejo, Juan J.; van Kooyk, Yvette] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Vliet, SJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1081 BT Amsterdam, Netherlands.	s.vanvliet@vumc.nl	Garcia-Vallejo, Juan/H-4162-2012; Vallejo, Juan Garcia/AAA-3765-2020; Tefsen, Boris/J-1503-2012; Van Vliet, Sandra/AAO-9534-2020	Garcia-Vallejo, Juan/0000-0001-6238-7069; Tefsen, Boris/0000-0001-6668-217X; van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665	Dutch Organization for Health and Disease (NWO) VENI [863.10.017]; VU Medical Center Institute for Cancer and Immunology [CCA2011-5-03]; Dutch Technology Foundation (STW) [10622]; Mizutani Foundation for Glycoscience Research [090032]	Dutch Organization for Health and Disease (NWO) VENI; VU Medical Center Institute for Cancer and Immunology; Dutch Technology Foundation (STW)(Technologiestichting STW); Mizutani Foundation for Glycoscience Research	This work was supported by Dutch Organization for Health and Disease (NWO) VENI Grant 863.10.017, VU Medical Center Institute for Cancer and Immunology Grant CCA2011-5-03, Dutch Technology Foundation (STW) Grant 10622, and Mizutani Foundation for Glycoscience Research Grant 090032.	Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Antonopoulos A, 2012, J BIOL CHEM, V287, P11240, DOI 10.1074/jbc.M111.320820; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Cheng J, 2011, IMMUNOL RES, V50, P113, DOI 10.1007/s12026-011-8216-z; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; GALILI U, 1988, J BIOL CHEM, V263, P17755; Garcia GG, 2005, EUR J IMMUNOL, V35, P622, DOI 10.1002/eji.200425538; Garcia-Vallejo JJ, 2005, J BIOL CHEM, V280, P12676, DOI 10.1074/jbc.M410093200; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Garcia-Vallejo Juan J., 2006, V347, P187; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; LANZAVECCHIA A, 1988, J EXP MED, V167, P345, DOI 10.1084/jem.167.2.345; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Taniguchi A, 2008, CURR DRUG TARGETS, V9, P310, DOI 10.2174/138945008783954998; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu AM, 2009, GLYCOCONJUGATE J, V26, P899, DOI 10.1007/s10719-008-9119-7; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024	49	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27519	27532		10.1074/jbc.M113.471045	http://dx.doi.org/10.1074/jbc.M113.471045			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23918927	hybrid, Green Published			2022-12-28	WOS:000330597300048
J	Ahsan, A; Ray, D; Ramanand, SG; Hegde, A; Whitehead, C; Rehemtulla, A; Morishima, Y; Pratt, WB; Osawa, Y; Lawrence, TS; Nyati, MK				Ahsan, Aarif; Ray, Dipankar; Ramanand, Susmita G.; Hegde, Ashok; Whitehead, Christopher; Rehemtulla, Alnawaz; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi; Lawrence, Theodore S.; Nyati, Mukesh K.			Destabilization of the Epidermal Growth Factor Receptor (EGFR) by a Peptide That Inhibits EGFR Binding to Heat Shock Protein 90 and Receptor Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE DOMAIN; CHAPERONE MACHINERY; TYROSINE KINASES; NECK-CANCER; IN-VITRO; HSP90; DEGRADATION; GELDANAMYCIN; ACTIVATION; CELLS	An eight-amino acid segment is known to be responsible for the marked difference in the rates of degradation of the EGF receptor (ErbB1) and ErbB2 upon treatment of cells with the Hsp90 inhibitor geldanamycin. We have scrambled the first six amino acids of this segment of the EGF receptor (EGFR), which lies in close association with the ATP binding cleft and the dimerization face. Scrambling these six amino acids markedly reduces EGFR stability, EGF-stimulated receptor dimerization, and autophosphorylation activity. Two peptides were synthesized as follows: one containing the wildtype sequence of the eight-amino acid segment, which we call Disruptin; and one with the scrambled sequence. Disruptin inhibits Hsp90 binding to the EGFR and causes slow degradation of the EGFR in two EGFR-dependent cancer cell lines, whereas the scrambled peptide is inactive. This effect is specific for EGFR versus other Hsp90 client proteins. In the presence of EGF, Disruptin, but not the scrambled peptide, inhibits EGFR dimerization and causes rapid degradation of the EGFR. In contrast to the Hsp90 inhibitor geldanamycin, Disruptin inhibits cancer cell growth by a nonapoptotic mechanism. Disruptin provides proof of concept for the development of a new class of anti-tumor drugs that specifically cause EGFR degradation.	[Ahsan, Aarif; Ray, Dipankar; Ramanand, Susmita G.; Hegde, Ashok; Rehemtulla, Alnawaz; Lawrence, Theodore S.; Nyati, Mukesh K.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Whitehead, Christopher] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nyati, MK (corresponding author), Univ Michigan, Sch Med, Dept Radiat Oncol, Med Sci Bldg 1, Ann Arbor, MI 48109 USA.	nyati@umich.edu			National Institutes of Health [R01CA131290, R01CA160981, GM077430, P50CA097248]; Cancer Center Support Grant [P30CA46592]; Michigan Institute for Clinical and Health Research; James Stuart and Barbara Padnos Funds for Cancer Research; Alfred Taubman Scholarship; NATIONAL CANCER INSTITUTE [P30CA046592, P50CA097248, R01CA131290, R01CA160981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Michigan Institute for Clinical and Health Research; James Stuart and Barbara Padnos Funds for Cancer Research; Alfred Taubman Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA131290 (to M. K. N.), R01CA160981 (to D. R.), GM077430 (to Y. O.), P50CA097248 (project IV to M. K. N.), P50CA097248 (Career Development award to A. A.), and Cancer Center Support Grant P30CA46592. This work was also supported by the Michigan Institute for Clinical and Health Research (to M. K. N.), the James Stuart and Barbara Padnos Funds for Cancer Research (to M. K. N.), and an Alfred Taubman Scholarship (to T. S. L.). This project is a component of the University of Michigan Medical School's Fast Forward Strategic Research Initiative.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Ahsan A, 2009, CANCER RES, V69, P5108, DOI 10.1158/0008-5472.CAN-09-0466; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bisht KS, 2003, CANCER RES, V63, P8984; Burtness B, 2005, EXPERT OPIN BIOL TH, V5, P1085, DOI 10.1517/14712598.5.8.1085; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hostein I, 2001, CANCER RES, V61, P4003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; LaBelle JL, 2012, J CLIN INVEST, V122, P2018, DOI 10.1172/JCI46231; LAWRENCE TS, 1988, CANCER RES, V48, P725; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morishima Y, 2011, BIOCHEMISTRY-US, V50, P7146, DOI 10.1021/bi200751t; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Shrivastava A, 2009, CURR PHARM DESIGN, V15, P675, DOI 10.2174/138161209787315620; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Tikhomirov O, 2003, CANCER RES, V63, P39; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	40	26	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26879	26886		10.1074/jbc.M113.492280	http://dx.doi.org/10.1074/jbc.M113.492280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897823	Green Published, hybrid			2022-12-28	WOS:000330594500053
J	Yoon, C; Van Niekerk, EA; Henry, K; Ishikawa, T; Orita, S; Tuszynski, MH; Campana, WM				Yoon, Choya; Van Niekerk, Erna A.; Henry, Kenneth; Ishikawa, Tetsuhiro; Orita, Sumihisa; Tuszynski, Mark H.; Campana, W. Marie			Low-density Lipoprotein Receptor-related Protein 1 (LRP1)-dependent Cell Signaling Promotes Axonal Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; AMYLOID PRECURSOR PROTEIN; PRIMARY SENSORY NEURONS; NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; APOLIPOPROTEIN-E; SCHWANN-CELLS; TRK RECEPTORS	Low-density lipoprotein receptors (LRPs) are present extensively on cells outside of the nervous system and classically exert roles in lipoprotein metabolism. It has been reported recently that LRP1 activation could phosphorylate the neurotrophin receptor TrkA in PC12 cells and increase neurite outgrowth from developing cerebellar granule cells. These intriguing findings led us to explore the hypothesis that LRP1 activation would activate canonical neurotrophic factor signaling in adult neurons and promote axonal regeneration after spinal cord injury. We now find that treatment of adult rat dorsal root ganglion neurons in vitro with LRP1 agonists (the receptor binding domain of alpha-2-macroglobulin or the hemopexin domain of matrix metalloproteinase 9) induces TrkC, Akt, and ERK activation; significantly increases neurite outgrowth (p < 0.01); and overcomes myelin inhibition (p < 0.05). These effects require Src family kinase activation, a classic LRP1-mediated Trk transactivator. Moreover, intrathecal infusions of LRP1 agonists significantly enhance sensory axonal sprouting and regeneration after spinal cord injury in rats compared with control-infused animals (p < 0.05). A significant role is established for lipoprotein receptors in sprouting and regeneration after CNS injury, identifying a novel class of therapeutic targets to explore for traumatic neurological disorders.	[Yoon, Choya; Van Niekerk, Erna A.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Henry, Kenneth; Ishikawa, Tetsuhiro; Orita, Sumihisa; Campana, W. Marie] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Tuszynski, Mark H.; Campana, W. Marie] Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; [Tuszynski, Mark H.] Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Campana, WM (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@ucsd.edu		Orita, Sumihisa/0000-0003-2676-5469	National Institutes of Health [NINDS-R01NS-057456, P30NS047101]; Veterans Administration; Neurosciences Imaging Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS057456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Neurosciences Imaging Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NINDS-R01NS-057456 and P30NS047101. This work was also supported by the Veterans Administration, by the Neurosciences Imaging Center, and by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Andersen OM, 2006, TRENDS NEUROSCI, V29, P687, DOI 10.1016/j.tins.2006.09.002; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; Christensen MD, 1997, EXP NEUROL, V147, P463, DOI 10.1006/exnr.1997.6608; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Goto JJ, 2002, J MOL NEUROSCI, V19, P37, DOI 10.1007/s12031-002-0008-4; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2011, J NEUROSCI, V31, P13376, DOI 10.1523/JNEUROSCI.2850-11.2011; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Tsoulfas P, 1996, J BIOL CHEM, V271, P5691, DOI 10.1074/jbc.271.10.5691; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Ulery PG, 2000, J CLIN INVEST, V106, P1077, DOI 10.1172/JCI11455; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; WOLF BB, 1992, AM J PATHOL, V141, P37	53	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26557	26568		10.1074/jbc.M113.478552	http://dx.doi.org/10.1074/jbc.M113.478552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23867460	hybrid, Green Published			2022-12-28	WOS:000330594500022
J	Rasmussen, NR; Wright, TM; Brooks, SA; Hacker, KE; Debebe, Z; Sendor, AB; Walker, MP; Ben Major, M; Green, J; Wahl, GM; Rathmell, WK				Rasmussen, Neal R.; Wright, Tricia M.; Brooks, Samira A.; Hacker, Kathryn E.; Debebe, Zufan; Sendor, Adam B.; Walker, Matthew P.; Ben Major, Michael; Green, Jennifer; Wahl, Geoffrey M.; Rathmell, W. Kimryn			Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; PATHWAY; INHIBITION; CARCINOMA; TARGET; GENES	Expression of the receptor tyrosine kinase-like orphan receptor 2 (Ror2) has been identified in an increasing array of tumor types and is known to play a role as an important mediator of Wnt signaling cascades. In this study, we aimed to clarify Ror2 interactions with the Wnt pathways within the context of renal cell carcinoma (RCC). An examination of Ror2 expression in primary human RCC tumors showed a significant correlation with several Wnt signaling genes, including the classical feedback target gene Axin2. We provide evidence that Ror2 expression results in a partially activated state for canonical Wnt signaling through an increased signaling pool of beta-catenin, leading to an enhancement of downstream target genes following Wnt3a stimulation in both renal and renal carcinoma-derived cells. Additionally, inhibition of low-density lipoprotein receptor-related protein 6 (LRP6) with either siRNA or dickkopf decreased the response to Wnt3a stimulation, but no change was seen in the increased beta-catenin pool associated with Ror2 expression, suggesting that LRP6 cofactor recruitment is necessary for a Wnt3a-induced signal but that it does not participate in the Ror2 effect on beta-catenin signaling. These results highlight a new role for Ror2 in conveying a tonic signal to stabilize soluble beta-catenin and create a poised state of enhanced responsiveness to Wnt3a exogenous signals in RCC.	[Rasmussen, Neal R.; Wright, Tricia M.; Hacker, Kathryn E.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Rasmussen, Neal R.; Wright, Tricia M.; Brooks, Samira A.; Hacker, Kathryn E.; Debebe, Zufan; Sendor, Adam B.; Walker, Matthew P.; Ben Major, Michael; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brooks, Samira A.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Ben Major, Michael] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Green, Jennifer; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	Rathmell@med.unc.edu		Major, Michael/0000-0002-6753-8513; Sendor, Adam/0000-0003-4958-4660; Rasmussen, Neal/0000-0002-5343-9119	National Institutes of Health [R01 CA121781, T32 ES007126, T32 GM008719, T32 HL069768-09]; National Institutes of Health/UNC Research Training Service Award [T32-CA009156]; National Institutes of Health Initiative for Maximizing Student Diversity Training Grants [R25GM055336, NCI-F31CA132543]; American Cancer Society [RSG-10-192-01]; Howard Hughes Medical Institute Translational Medicine Program; Medical Scientist Training Program [T32 GM008719]; NATIONAL CANCER INSTITUTE [T32CA071341, R01CA121781, T32CA009156, F31CA132543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, R25GM055336, T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/UNC Research Training Service Award; National Institutes of Health Initiative for Maximizing Student Diversity Training Grants; American Cancer Society(American Cancer Society); Howard Hughes Medical Institute Translational Medicine Program; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA121781 (to W. K. R.), T32 ES007126 (to S. A. B.), and T32 GM008719 (to K. E. H.); by National Institutes of Health Vascular Biology Training Grant T32 HL069768-09 (to N. R. R.); by National Institutes of Health/UNC Research Training Service Award T32-CA009156 (to Z. D.); and National Institutes of Health Initiative for Maximizing Student Diversity Training Grants R25GM055336 and NCI-F31CA132543 (to T. M. W.). This work was also supported by American Cancer Society Research Scholar Grant RSG-10-192-01 (to W. K. R.), by the Howard Hughes Medical Institute Translational Medicine Program (to S. A. B.), and by Medical Scientist Training Program T32 GM008719 (to K. E. H.).	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hsu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047649; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Li CG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-11; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Majid S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-7; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; O'Connell RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012009; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teng BL, 2011, MOL ONCOL, V5, P465, DOI 10.1016/j.molonc.2011.06.002; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Wright TM, 2010, J BIOL CHEM, V285, P12916, DOI 10.1074/jbc.M109.073924; Yamagata K, 2012, J BIOL CHEM, V287, P1588, DOI 10.1074/jbc.M111.315127; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496	34	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26301	26310		10.1074/jbc.M113.466086	http://dx.doi.org/10.1074/jbc.M113.466086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893409	Green Published, hybrid			2022-12-28	WOS:000330623300059
J	Yuen, EY; Zhong, P; Li, XN; Wei, J; Yan, Z				Yuen, Eunice Y.; Zhong, Ping; Li, Xiangning; Wei, Jing; Yan, Zhen			Restoration of Glutamatergic Transmission by Dopamine D-4 Receptors in Stressed Animals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; PREFRONTAL CORTEX; HOMEOSTATIC REGULATION; CA2+ PERMEABILITY; WORKING-MEMORY; MECHANISMS; HYPERACTIVITY; POLYMORPHISM; NEURONS; BRAIN	The prefrontal cortex (PFC), a key brain region for cognitive and emotional processes, is highly regulated by dopaminergic inputs. The dopamine D-4 receptor, which is enriched in PFC, has been implicated in mental disorders, such as attention deficit-hyperactivity disorder and schizophrenia. Recently we have found homeostatic regulation of AMPA receptor-mediated synaptic transmission in PFC pyramidal neurons by the D-4 receptor, providing a potential mechanism for D-4 in stabilizing cortical excitability. Because stress is tightly linked to adaptive and maladaptive changes associated with mental health and disorders, we examined the synaptic actions of D-4 in stressed rats. We found that neural excitability was elevated by acute stress and dampened by repeated stress. D-4 activation produced a potent reduction of excitatory transmission in acutely stressed animals and a marked increase of excitatory transmission in repeatedly stressed animals. These effects of D-4 targeted GluA2-lacking AMPA receptors and relied on the bi-directional regulation of calcium/calmodulin kinase II activity. The restoration of PFC glutamatergic transmission in stress conditions may enable D-4 receptors to serve as a synaptic stabilizer in normal and pathological conditions.	[Yuen, Eunice Y.; Zhong, Ping; Li, Xiangning; Wei, Jing; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Li, Xiangning/AGH-1884-2022		National Institutes of Health [MH084233, MH085774]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233, R25MH077823, R01MH085774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH084233 and MH085774 (to Z. Y.).	Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Caracciolo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019398; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Cheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu ZL, 2004, MOL PHARMACOL, V66, P948, DOI 10.1124/mol.104.001404; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Marie RM, 2003, CURR OPIN NEUROL, V16, pS29, DOI 10.1097/00019052-200312002-00006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rowe DC, 1998, MOL PSYCHIATR, V3, P419, DOI 10.1038/sj.mp.4000432; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tarazi FI, 2004, J RECEPT SIG TRANSD, V24, P131, DOI 10.1081/LRST-200032076; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; TSUBOKAWA H, 1995, J NEUROPHYSIOL, V74, P218, DOI 10.1152/jn.1995.74.1.218; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Yuen EY, 2011, J BIOL CHEM, V286, P24957, DOI 10.1074/jbc.M111.221416; Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; Zhong P, 2008, MOL CELL NEUROSCI, V38, P290, DOI 10.1016/j.mcn.2008.03.003	56	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26112	26120		10.1074/jbc.M112.396648	http://dx.doi.org/10.1074/jbc.M112.396648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884421	hybrid, Green Published			2022-12-28	WOS:000330623300040
J	Kang, K; Peng, X; Zhang, XY; Wang, YN; Zhang, LS; Gao, L; Weng, TT; Zhang, HH; Ramchandran, R; Raj, JU; Gou, DM; Liu, L				Kang, Kang; Peng, Xiao; Zhang, Xiaoying; Wang, Yuna; Zhang, Lishu; Gao, Li; Weng, Tingting; Zhang, Honghao; Ramchandran, Ramaswamy; Raj, J. Usha; Gou, Deming; Liu, Lin			MicroRNA-124 Suppresses the Transactivation of Nuclear Factor of Activated T Cells by Targeting Multiple Genes and Inhibits the Proliferation of Pulmonary Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; REGULATES EXPRESSION; MIR-124; NFATC3; DIFFERENTIATION; HYPERTENSION; CALCINEURIN; CALMODULIN; MYOCARDIN; CALCIUM	Abnormal proliferation and phenotypic modulation of pulmonary artery smooth muscle cells (PASMC) contributes to the pathogenesis of numerous cardiovascular disorders, including pulmonary arterial hypertension (PAH). The nuclear factor of activated T cells (NFAT) signaling pathway is linked to PASMC proliferation and PAH. MicroRNAs (miRNAs) are small non-coding RNAs that function in diverse biological processes. To systemically identify the specific miRNAs that regulate the NFAT pathway, a human primary miRNA library was applied for cell-based high throughput screening with the NFAT luciferase reporter system. Eight miRNAs were found to modulate NFAT activity efficiently. Of them, miR-124 robustly inhibited NFAT reporter activity and decreased both the dephosphorylation and the nuclear translocation of NFAT. miR-124 also inhibited NFAT-dependent transcription of IL-2 in Jurkat T cells. miR-124 exerted its effects by targeting multiple genes, including a known component of the NFAT pathway, NFATc1, and two new regulators of NFAT signaling, CAMTA1 (calmodulin-binding transcription activator 1) and PTBP1 (polypyrimidine tract-binding protein 1). Physiologically, miR-124 was down-regulated by hypoxia in human PASMC, consistent with the activation of NFAT during this process. Down-regulation of miR-124 was also observed in 3-week hypoxia-treated mouse lungs. Furthermore, the overexpression of miR-124 not only inhibited human PASMC proliferation but also maintained its differentiated phenotype by repressing the NFAT pathway. Taken together, our data provide the first evidence that miR-124 acts as an inhibitor of the NFAT pathway. Down-regulation of miR-124 in hypoxia-treated PASMC and its antiproliferative and prodifferentiation effects imply a potential value for miR124 in the treatment of PAH.	[Kang, Kang; Peng, Xiao; Zhang, Xiaoying; Wang, Yuna; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Guangdong, Peoples R China; [Zhang, Lishu; Gao, Li; Weng, Tingting; Zhang, Honghao; Gou, Deming; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Ramchandran, Ramaswamy; Raj, J. Usha; Gou, Deming] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA	Shenzhen University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gou, DM (corresponding author), Shenzhen Univ, Coll Life Sci, Nanhai Ave 3688, Shenzhen 518060, Guangdong, Peoples R China.	dmgou@szu.edu.cn; lin.liu@okstate.edu		Zhang, Honghao/0000-0002-2338-6992	National Natural Science Foundation of China [81170047]; National Basic Research Program of China 973 Program [2012CB124701]; Shenzhen Overseas High Level Talents Innovation Program [YFZZ20111009]; Shenzhen Municipal Basic Research Program [JC201006010725A]; American Heart Association [0865162F]; National Institutes of Health from NHLBI [R01 HL083188, R01 HL071628, R01 HL052146, R01 HL075187]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL075187, R01HL052146, R01HL083188] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Shenzhen Overseas High Level Talents Innovation Program; Shenzhen Municipal Basic Research Program; American Heart Association(American Heart Association); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China Grant 81170047 (to D. G.), National Basic Research Program of China 973 Program Grant 2012CB124701, Shenzhen Overseas High Level Talents Innovation Program Grant YFZZ20111009 (to D. G.), Shenzhen Municipal Basic Research Program Grant JC201006010725A (to D. G.), American Heart Association Grant-in-aid 0865162F (to D. G.), and National Institutes of Health Grants R01 HL083188, R01 HL071628, and R01 HL052146 (to L. L.) and R01 HL075187 (to J. U. R.) from NHLBI.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bierer R, 2011, AM J PHYSIOL-LUNG C, V301, pL872, DOI 10.1152/ajplung.00405.2010; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martin SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm141; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-123; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	60	89	101	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25414	25427		10.1074/jbc.M113.460287	http://dx.doi.org/10.1074/jbc.M113.460287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853098	hybrid, Green Published			2022-12-28	WOS:000330619000038
J	Shakespear, MR; Hohenhaus, DM; Kelly, GM; Kamal, NA; Gupta, P; Labzin, LI; Schroder, K; Garceau, V; Barbero, S; Iyer, A; Hume, DA; Reid, RC; Irvine, KM; Fairlie, DP; Sweet, MJ				Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Garceau, Valerie; Barbero, Sheila; Iyer, Abishek; Hume, David A.; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.			Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INNATE IMMUNE-RESPONSES; IN-VIVO; SYSTEMIC INFLAMMATION; TRANSCRIPTION FACTOR; CELL-FUNCTION; INHIBITORS; ACTIVATION; LIPOPOLYSACCHARIDE; PROTEIN	Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducible production of key proinflammatory mediators. Here we investigated HDAC-dependent inflammatory responses in mouse macrophages. Of the classical Hdacs, Hdac7 was expressed at elevated levels in inflammatory macrophages (thioglycollate-elicited peritoneal macrophages) as compared with bone marrow-derived macrophages and the RAW264 cell line. Overexpression of a specific, alternatively spliced isoform of Hdac7 lacking the N-terminal 22 amino acids (Hdac7-u), but not the Refseq Hdac7 (Hdac7-s), promoted LPS-inducible expression of Hdac-dependent genes (Edn1, Il-12p40, and Il-6) in RAW264 cells. A novel class IIa-selective HDAC inhibitor reduced recombinant human HDAC7 enzyme activity as well as TLR-induced production of inflammatory mediators in thioglycollate-elicited peritoneal macrophages. Both LPS and Hdac7-u up-regulated the activity of the Edn1 promoter in an HDAC-dependent fashion in RAW264 cells. Ahypoxia-inducible factor (HIF) 1 binding site in this promoter was required for HDAC-dependent TLR-inducible promoter activity and for Hdac7-and HIF-1 alpha-mediated transactivation. Coimmunoprecipitation assays showed that both Hdac7-u and Hdac7-s interacted with HIF-1 alpha, whereas only Hdac7-s interacted with the transcriptional repressor CtBP1. Thus, Hdac7-u positively regulates HIF-1 alpha-dependent TLR signaling in macrophages, whereas an interaction with CtBP1 likely prevents Hdac7-s from exerting this effect. Hdac7 may represent a potential inflammatory disease target.	[Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Barbero, Sheila; Iyer, Abishek; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Barbero, Sheila; Iyer, Abishek; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Garceau, Valerie; Hume, David A.] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland	University of Queensland; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Sweet, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.sweet@imb.uq.edu.au	Reid, Robert/D-8041-2012; Labzin, Larisa/AAC-8618-2020; Iyer, Abishek/C-9767-2017; Sweet, Matthew J/F-2229-2011; Schroder, Kate/C-6132-2008; Irvine, Katharine M/A-5559-2011; Shakespear, Melanie/G-4867-2014; Fairlie, David P/F-8865-2014	Reid, Robert/0000-0002-0829-239X; Iyer, Abishek/0000-0001-9533-5265; Sweet, Matthew J/0000-0002-0406-8139; Schroder, Kate/0000-0001-9261-3805; Irvine, Katharine M/0000-0002-6716-1605; Shakespear, Melanie/0000-0002-9517-0699; Fairlie, David P/0000-0002-7856-8566; Labzin, Larisa/0000-0001-9098-4493; Hume, David/0000-0002-2615-1478	National Health and Medical Research Council of Australia [569735, APP1047921]; Cancer Council Queensland [511205]; Australian Research Council [FF0668733, FT100100657]; National Health and Medical Research Council [APP1027369, APP1003470]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; BBSRC [BBS/E/D/20251969] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Health and Medical Research Council of Australia Grants ID 569735 and APP1047921 and by Cancer Council Queensland Grant ID 511205.; Supported by Australian Research Council Federation Fellowship FF0668733 and National Health and Medical Research Council Senior Principal Research Fellowship APP1027369.; Supported by Australian Research Council Future Fellowship FT100100657 and honorary National Health and Medical Research Council of Australia Senior Research Fellowship APP1003470.	Aude-Garcia C, 2010, BIOCHEM J, V430, P237, DOI 10.1042/BJ20100131; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barneda-Zahonero B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003503; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bosisio D, 2008, J LEUKOCYTE BIOL, V84, P1540, DOI 10.1189/jlb.0708401; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dhaun N, 2012, BRIT J PHARMACOL, V167, P720, DOI 10.1111/j.1476-5381.2012.02070.x; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Higashiyama R, 2010, MOD RHEUMATOL, V20, P11, DOI 10.1007/s10165-009-0224-7; Huang QQ, 2010, J LEUKOCYTE BIOL, V88, P253, DOI 10.1189/jlb.0310126; Iglarz M, 2010, CLIN SCI, V119, P453, DOI 10.1042/CS20100222; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SH, 2007, ONCOL REP, V17, P647; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tessier P, 2009, BIOORG MED CHEM LETT, V19, P5684, DOI 10.1016/j.bmcl.2009.08.010; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200	59	67	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25362	25374		10.1074/jbc.M113.496281	http://dx.doi.org/10.1074/jbc.M113.496281			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853092	Green Published, hybrid			2022-12-28	WOS:000330619000034
J	Vitturi, DA; Chen, CS; Woodcock, SR; Salvatore, SR; Bonacci, G; Koenitzer, JR; Stewart, NA; Wakabayashi, N; Kensler, TW; Freeman, BA; Schopfer, FJ				Vitturi, Dario A.; Chen, Chen-Shan; Woodcock, Steven R.; Salvatore, Sonia R.; Bonacci, Gustavo; Koenitzer, Jeffrey R.; Stewart, Nicolas A.; Wakabayashi, Nobunao; Kensler, Thomas W.; Freeman, Bruce A.; Schopfer, Francisco J.			Modulation of Nitro-fatty Acid Signaling PROSTAGLANDIN REDUCTASE-1 IS A NITROALKENE REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLD YELLOW ENZYME; ALKENAL/ONE OXIDOREDUCTASE; OLEIC ACID; NITROAROMATIC COMPOUNDS; LINOLEIC-ACID; CANCER-CELLS; PPAR-GAMMA; REDUCTASE; NITRATION; PROTEIN	Inflammation, characterized by the activation of both resident and infiltrated immune cells, is accompanied by increased production of oxidizing and nitrating species. Nitrogen dioxide, the proximal nitrating species formed under these conditions, reacts with unsaturated fatty acids to yield nitroalkene derivatives. These electrophilic products modulate protein function via post-translational modification of susceptible nucleophilic amino acids. Nitroalkenes react with Keap1 to instigate Nrf2 signaling, activate heat shock response gene expression, and inhibit NF-kappa B-mediated signaling, inducing net anti-inflammatory and tissue-protective metabolic responses. We report the purification and characterization of a NADPH-dependent liver enzyme that reduces the nitroalkene moiety of nitro-oleic acid, yielding the inactive product nitro-stearic acid. Prostaglandin reductase-1 (PtGR-1) was identified as a nitroalkene reductase by protein purification and proteomic studies. Kinetic measurements, inhibition studies, immunological and molecular biology approaches as well as clinical analyses confirmed this identification. Overexpression of PtGR-1 in HEK293T cells promoted nitroalkene metabolism to inactive nitroalkanes, an effect that abrogated the Nrf2-dependent induction of heme oxygenase-1 expression by nitro-oleic acid. These results situate PtGR-1 as a critical modulator of both the steady state levels and signaling activities of fatty acid nitroalkenes in vivo.	[Vitturi, Dario A.; Chen, Chen-Shan; Woodcock, Steven R.; Salvatore, Sonia R.; Bonacci, Gustavo; Koenitzer, Jeffrey R.; Wakabayashi, Nobunao; Kensler, Thomas W.; Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Stewart, Nicolas A.] Univ Pittsburgh, Biomed Mass Spectrometry Center, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower E1340, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; fjs2@pitt.edu	Schopfer, Francisco Jose/AAE-8125-2020; Vitturi, Dario/Z-3469-2019; Kensler, Thomas W/D-8686-2014; Schopfer, Francisco/AAW-6505-2021; Robert, Jacques/B-2179-2008; Woodcock, Steven/AAE-9199-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; Kensler, Thomas W/0000-0002-6676-261X; Robert, Jacques/0000-0003-4380-1476; Vitturi, Dario/0000-0003-0354-4567; Salvatore, Sonia/0000-0002-9942-3905; Stewart, Nicolas/0000-0002-8969-4242	National Institutes of Health [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA094076, P30CA047904] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064937, R37HL058115, R01HL058115, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project used University of Pittsburgh Cancer Institute shared resources that were supported in part by National Institutes of Health P30CA047904.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bates DJP, 2011, BIOCHEMISTRY-US, V50, P7765, DOI 10.1021/bi2005784; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOLAND MP, 1991, BIOCHEM PHARMACOL, V41, P867, DOI 10.1016/0006-2952(91)90190-G; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bonacci G, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.225029; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Clish CB, 2001, BIOCHEM BIOPH RES CO, V288, P868, DOI 10.1006/bbrc.2001.5841; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dick RA, 2004, CLIN CANCER RES, V10, P1492, DOI 10.1158/1078-0432.CCR-03-0162; Dick RA, 2001, J BIOL CHEM, V276, P40803, DOI 10.1074/jbc.M105487200; Dick RA, 2004, J BIOL CHEM, V279, P17269, DOI 10.1074/jbc.M400427200; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; French CE, 1998, APPL ENVIRON MICROB, V64, P2864; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Gorczynski MJ, 2009, J MED CHEM, V52, P4631, DOI 10.1021/jm900326c; Gow A, 1996, ARCH BIOCHEM BIOPHYS, V333, P42, DOI 10.1006/abbi.1996.0362; HANSEN HS, 1979, BIOCHIM BIOPHYS ACTA, V574, P136, DOI 10.1016/0005-2760(79)90092-4; Higdon A, 2012, BIOCHEM J, V442, P453, DOI 10.1042/BJ20111752; Ichikawa T, 2008, ENDOCRINOLOGY, V149, P4086, DOI 10.1210/en.2007-1639; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Knox RJ, 2004, METHOD ENZYMOL, V382, P194; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4671, DOI 10.1016/0006-2952(88)90336-X; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Manini P, 2008, CHEM PHYS LIPIDS, V151, P51, DOI 10.1016/j.chemphyslip.2007.09.007; Meah Y, 2000, P NATL ACAD SCI USA, V97, P10733, DOI 10.1073/pnas.190345597; Messiha HL, 2005, J BIOL CHEM, V280, P10695, DOI 10.1074/jbc.M410595200; Nemeikaie-Ceniene A, 2004, ACTA BIOCHIM POL, V51, P1081; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/NCHEMBIO.1018, 10.1038/nchembio.1018]; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Piskorski R, 2007, J CHEM ECOL, V33, P1787, DOI 10.1007/s10886-007-9341-y; Primiano T, 1998, CARCINOGENESIS, V19, P999, DOI 10.1093/carcin/19.6.999; Primiano T, 1996, CARCINOGENESIS, V17, P2297, DOI 10.1093/carcin/17.11.2297; Rocha BS, 2012, FREE RADICAL BIO MED, V52, P693, DOI 10.1016/j.freeradbiomed.2011.11.011; Rudnicki M, 2011, ARTERIOSCL THROM VAS, V31, P1360, DOI 10.1161/ATVBAHA.111.224626; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sevior DK, 2012, INT J BIOCHEM CELL B, V44, P257, DOI 10.1016/j.biocel.2011.11.011; Stuermer R, 2007, CURR OPIN CHEM BIOL, V11, P203, DOI 10.1016/j.cbpa.2007.02.025; Trostchansky A, 2011, J BIOL CHEM, V286, P12891, DOI 10.1074/jbc.M110.154518; Tsikas D, 2009, LIPIDS, V44, P855, DOI 10.1007/s11745-009-3332-4; VRKOC J, 1974, TETRAHEDRON LETT, P1463; Wang HP, 2010, PPAR RES, V2010, DOI 10.1155/2010/601562; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woodcock SR, 2013, FREE RADICAL BIO MED, V59, P14, DOI 10.1016/j.freeradbiomed.2012.11.015; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yu X, 2006, J BIOL CHEM, V281, P26245, DOI 10.1074/jbc.M604620200; Yu X, 2012, J PHARMACOL EXP THER, V343, P426, DOI 10.1124/jpet.112.195768; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404; Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625	70	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25626	25637		10.1074/jbc.M113.486282	http://dx.doi.org/10.1074/jbc.M113.486282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23878198	hybrid, Green Published			2022-12-28	WOS:000330619000057
J	Hawse, WF; Gloor, BE; Ayres, CM; Kho, K; Nuter, E; Baker, BM				Hawse, William F.; Gloor, Brian E.; Ayres, Cory M.; Kho, Kevin; Nuter, Elizabeth; Baker, Brian M.			Peptide Modulation of Class I Major Histocompatibility Complex Protein Molecular Flexibility and the Implications for Immune Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; MHC CLASS-I; IMMUNOGLOBULIN-LIKE RECEPTOR; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; ANTIGENIC PEPTIDES; BINDING MECHANISM; HLA-B27 SUBTYPES; VACCINE-DESIGN; LIGAND	T cells use the alpha beta Tcell receptor (TCR) to recognize antigenic peptides presented by class I major histocompatibility complex proteins (pMHCs) on the surfaces of antigen-presenting cells. Flexibility in both TCRs and peptides plays an important role in antigen recognition and discrimination. Less clear is the role of flexibility in the MHC protein; although recent observations have indicated that mobility in the MHC can impact TCR recognition in a peptide-dependent fashion, the extent of this behavior is unknown. Here, using hydrogen/deuterium exchange, fluorescence anisotropy, and structural analyses, we show that the flexibility of the peptide binding groove of the class I MHC protein HLA-A*0201 varies significantly with different peptides. The variations extend throughout the binding groove, impacting regions contacted by TCRs as well as other activating and inhibitory receptors of the immune system. Our results are consistent with statistical mechanical models of protein structure and dynamics, in which the binding of different peptides alters the populations and exchange kinetics of sub-states in the MHC conformational ensemble. Altered MHC flexibility will influence receptor engagement, impacting conformational adaptations, entropic penalties associated with receptor recognition, and the populations of binding-competent states. Our results highlight a previously unrecognized aspect of the "altered self" mechanism of immune recognition and have implications for specificity, cross-reactivity, and antigenicity in cellular immunity.	[Hawse, William F.; Gloor, Brian E.; Ayres, Cory M.; Kho, Kevin; Nuter, Elizabeth; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Baker, Brian M.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Baker, BM (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	brian-baker@nd.edu	Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964	National Institutes of Health Grant from the NIGMS [GM067079]; National Science Foundation [MCB-0448298]; American Cancer Society [PF-11-143-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIGMS; National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067079 from the NIGMS (to B. M. B.). This work was also supported by Grant MCB-0448298 from the National Science Foundation.; Supported by Fellowship PF-11-143-01 from the American Cancer Society.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Cerutti DS, 2008, BIOCHEMISTRY-US, V47, P12065, DOI 10.1021/bi800894u; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Miller DW, 1997, PROTEIN SCI, V6, P2166; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Painter CA, 2012, IMMUNOL REV, V250, P144, DOI 10.1111/imr.12003; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Reichert D, 2012, J BIOMOL STRUCT DYN, V30, P617, DOI 10.1080/07391102.2012.689695; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	50	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24372	24381		10.1074/jbc.M113.490664	http://dx.doi.org/10.1074/jbc.M113.490664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836912	hybrid, Green Published			2022-12-28	WOS:000330612300009
J	Mastrocola, AS; Kim, SH; Trinh, AT; Rodenkirch, LA; Tibbetts, RS				Mastrocola, Adam S.; Kim, Sang Hwa; Trinh, Anthony T.; Rodenkirch, Lance A.; Tibbetts, Randal S.			The RNA-binding Protein Fused in Sarcoma (FUS) Functions Downstream of Poly(ADP-ribose) Polymerase (PARP) in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; AMYOTROPHIC-LATERAL-SCLEROSIS; CELL-FREE FORMATION; HISTONE H2AX; IN-VIVO; REPAIR; GENE; ACTIVATION; PHOSPHORYLATION; TDP-43	The list of factors that participate in the DNA damage response to maintain genomic stability has expanded significantly to include a role for proteins involved in RNA processing. Here, we provide evidence that the RNA-binding protein fused in sarcoma/translocated in liposarcoma (FUS) is a novel component of the DNA damage response. We demonstrate that FUS is rapidly recruited to sites of laser-induced DNA double-strand breaks (DSBs) in a manner that requires poly(ADP-ribose) (PAR) polymerase activity, but is independent of ataxia-telangiectasia mutated kinase function. FUS recruitment is mediated by the arginine/glycine-rich domains, which interact directly with PAR. In addition, we identify a role for the prion-like domain in promoting accumulation of FUS at sites of DNA damage. Finally, depletion of FUS diminished DSB repair through both homologous recombination and nonhomologous end-joining, implicating FUS as an upstream participant in both pathways. These results identify FUS as a new factor in the immediate response to DSBs that functions downstream of PAR polymerase to preserve genomic integrity.	[Mastrocola, Adam S.; Kim, Sang Hwa; Trinh, Anthony T.; Tibbetts, Randal S.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Mastrocola, Adam S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Rodenkirch, Lance A.] Univ Wisconsin, WM Keck Lab Biol Imaging, Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Human Oncol, 1111 Highland Ave, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health Grants [CA115783, T32 ES007015]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA115783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA115783 (to R. S. T) and T32 ES007015 (to A. S. M.).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Ahn JY, 2000, CANCER RES, V60, P5934; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hong ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060208; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krietsch J., 2012, MOL ASPECTS MED S, VS0098-2997, P00139; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Oh SM, 2010, ONCOGENE, V29, P1017, DOI 10.1038/onc.2009.411; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pitson G, 2004, INT J RADIAT ONCOL, V60, P522, DOI 10.1016/j.ijrobp.2004.03.009; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STOLOW DT, 1995, NUCLEIC ACIDS RES, V23, P835, DOI 10.1093/nar/23.5.835; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zinszner H, 1997, J CELL SCI, V110, P1741	82	156	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24731	24741		10.1074/jbc.M113.497974	http://dx.doi.org/10.1074/jbc.M113.497974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23833192	hybrid, Green Published			2022-12-28	WOS:000330612300039
J	Brown, AC; Balashova, NV; Epand, RM; Epand, RF; Bragin, A; Kachlany, SC; Walters, MJ; Du, YR; Boesze-Battaglia, K; Lally, ET				Brown, Angela C.; Balashova, Nataliya V.; Epand, Richard M.; Epand, Raquel F.; Bragin, Alvina; Kachlany, Scott C.; Walters, Michael J.; Du, Yurong; Boesze-Battaglia, Kathleen; Lally, Edward T.			Aggregatibacter actinomycetemcomitans Leukotoxin Utilizes a Cholesterol Recognition/Amino Acid Consensus Site for Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; ESCHERICHIA-COLI HEMOLYSIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LIPID RAFTS; BENZODIAZEPINE-RECEPTOR; BORDETELLA-PERTUSSIS; ALPHA-HEMOLYSIN; UNILAMELLAR VESICLES; SIGNAL-TRANSDUCTION; FATTY-ACYLATION	Aggregatibacter actinomycetemcomitans produces a repeats-in-toxin (RTX) leukotoxin (LtxA) that selectively kills human immune cells. Binding of LtxA to its beta(2) integrin receptor (lymphocyte function-associated antigen-1 (LFA-1)) results in the clustering of the toxin.receptor complex in lipid rafts. Clustering occurs only in the presence of LFA-1 and cholesterol, and LtxA is unable to kill cells lacking either LFA-1 or cholesterol. Here, the interaction of LtxA with cholesterol was measured using surface plasmon resonance and differential scanning calorimetry. The binding of LtxA to phospholipid bilayers increased by 4 orders of magnitude in the presence of 40% cholesterol relative to the absence of cholesterol. The affinity was specific to cholesterol and required an intact secondary structure. LtxA contains two cholesterol recognition/amino acid consensus (CRAC) sites; CRAC(336) ((LEEYSKR339)-L-333) is highly conserved among RTX toxins, whereas CRAC(503) ((VDYLK505)-V-501) is unique to LtxA. A peptide corresponding to CRAC(336) inhibited the ability of LtxA to kill Jurkat (Jn.9) cells. Although peptides corresponding to both CRAC(336) and CRAC(503) bind cholesterol, only CRAC(336) competitively inhibited LtxA binding to this sterol. A panel of full-length LtxA CRAC mutants demonstrated that an intact CRAC(336) site was essential for LtxA cytotoxicity. The conservation of CRAC(336) among RTX toxins suggests that this mechanism may be conserved among RTX toxins.	[Brown, Angela C.; Walters, Michael J.; Du, Yurong; Lally, Edward T.] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Bragin, Alvina; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Balashova, Nataliya V.; Kachlany, Scott C.] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA; [Epand, Richard M.; Epand, Raquel F.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; McMaster University	Lally, ET (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, 240 S 40th St,317 Levy Bldg, Philadelphia, PA 19104 USA.	lally@toxin.dental.upenn.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	National Institutes of Health [R01DE009517, F32DE020950, K99DE022795, R01EY018705, R01EY10420]; Canadian Institutes of Health Research [MOP 86608]; NATIONAL EYE INSTITUTE [R21EY018705, R01EY010420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE020950, K99DE022795, R01DE009517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE009517 (to E. T. L.), F32DE020950 and K99DE022795 (to A. C. B.), and R01EY018705 and R01EY10420 (to K. B.-B.). This work was also supported by Canadian Institutes of Health Research Grant MOP 86608 (to R. M. E.).	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; Balashova NV, 2009, GENE, V443, P42, DOI 10.1016/j.gene.2009.05.002; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Besenicar MP, 2010, METHODS MOL BIOL, V627, P191, DOI 10.1007/978-1-60761-670-2_12; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Brown AC, 2007, LANGMUIR, V23, P11180, DOI 10.1021/la700633b; Brown AC, 2012, CELL MICROBIOL, V14, P869, DOI 10.1111/j.1462-5822.2012.01762.x; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cherry LK, 2001, J IMMUNOL, V167, P6171, DOI 10.4049/jimmunol.167.11.6171; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Crosby JA, 2007, GENE, V388, P83, DOI 10.1016/j.gene.2006.10.004; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Epand RM, 2000, BIOPHYS J, V78, P866, DOI 10.1016/S0006-3495(00)76644-6; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Fong KP, 2011, MOL ORAL MICROBIOL, V26, P262, DOI 10.1111/j.2041-1014.2011.00617.x; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HARDIE KR, 1991, MOL MICROBIOL, V5, P1669, DOI 10.1111/j.1365-2958.1991.tb01914.x; Herlax V, 2003, CHEM PHYS LIPIDS, V122, P185, DOI 10.1016/S0009-3084(02)00191-3; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LALLY ET, 1991, J PERIODONTAL RES, V26, P268, DOI 10.1111/j.1600-0765.1991.tb01655.x; LALLY ET, 1991, MICROB PATHOGENESIS, V11, P111, DOI 10.1016/0882-4010(91)90004-T; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lear JD, 2000, BBA-PROTEIN STRUCT M, V1476, P350, DOI 10.1016/S0167-4838(99)00241-1; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Norkin LC, 1999, IMMUNOL REV, V168, P13, DOI 10.1111/j.1600-065X.1999.tb01279.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SCHULTZ AM, 1989, J VIROL, V63, P2370, DOI 10.1128/JVI.63.5.2370-2373.1989; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Taichman N S, 1987, Oral Microbiol Immunol, V2, P97, DOI 10.1111/j.1399-302X.1987.tb00270.x; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walters M. J., 2013, MOL ORAL MI IN PRESS; WEAVER TA, 1990, J VIROL, V64, P3995, DOI 10.1128/JVI.64.8.3995-4001.1990; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	75	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23607	23621		10.1074/jbc.M113.486654	http://dx.doi.org/10.1074/jbc.M113.486654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792963	Green Published, hybrid			2022-12-28	WOS:000330598200064
J	Jensen, DD; Godfrey, CB; Niklas, C; Canals, M; Kocan, M; Poole, DP; Murphy, JE; Alemi, F; Cottrell, GS; Korbmacher, C; Lambert, NA; Bunnett, NW; Corvera, CU				Jensen, Dane D.; Godfrey, Cody B.; Niklas, Christian; Canals, Meritxell; Kocan, Martina; Poole, Daniel P.; Murphy, Jane E.; Alemi, Farzad; Cottrell, Graeme S.; Korbmacher, Christoph; Lambert, Nevin A.; Bunnett, Nigel W.; Corvera, Carlos U.			The Bile Acid Receptor TGR5 Does Not Interact with beta-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MU-OPIOID RECEPTOR; RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT ENDOCYTOSIS; ACTIVATED RECEPTOR-2; KINASE ACTIVATION; EGF RECEPTOR; GPBAR1 TGR5	TGR5 is a G protein-coupled receptor that mediates bile acid (BA) effects on energy balance, inflammation, digestion, and sensation. The mechanisms and spatiotemporal control of TGR5 signaling are poorly understood. We investigated TGR5 signaling and trafficking in transfected HEK293 cells and colonocytes (NCM460) that endogenously express TGR5. BAs (deoxycholic acid (DCA), taurolithocholic acid) and the selective agonists oleanolic acid and 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N, 5-dimethylisoxazole-4-carboxamide stimulated cAMP formation but did not induce TGR5 endocytosis or recruitment of beta-arrestins, as assessed by confocal microscopy. DCA, taurolithocholic acid, and oleanolic acid did not stimulate TGR5 association with beta-arrestin 1/2 or G protein-coupled receptor kinase (GRK) 2/5/6, as determined by bioluminescence resonance energy transfer. 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N, 5-dimethylisoxazole-4-carboxamide stimulated a low level of TGR5 interaction with beta-arrestin 2 and GRK2. DCA induced cAMP formation at the plasma membrane and cytosol, as determined using exchange factor directly regulated by cAMP (Epac2)-based reporters, but cAMP signals did not desensitize. AG1478, an inhibitor of epidermal growth factor receptor tyrosine kinase, the metalloprotease inhibitor batimastat, and methyl-beta-cyclodextrin and filipin, which block lipid raft formation, prevented DCA stimulation of ERK1/2. Bioluminescence resonance energy transfer analysis revealed TGR5 and EGFR interactions that were blocked by disruption of lipid rafts. DCA stimulated TGR5 redistribution to plasma membrane microdomains, as localized by immunogold electron microscopy. Thus, TGR5 does not interact with beta-arrestins, desensitize, or traffic to endosomes. TGR5 signals from plasma membrane rafts that facilitate EGFR interaction and transactivation. An understanding of the spatiotemporal control of TGR5 signaling provides insights into the actions of BAs and therapeutic TGR5 agonists/antagonists.	[Jensen, Dane D.; Niklas, Christian; Canals, Meritxell; Kocan, Martina; Poole, Daniel P.; Bunnett, Nigel W.] Monash Inst Pharma Sci, Parkville, Vic 3052, Australia; [Godfrey, Cody B.; Murphy, Jane E.; Alemi, Farzad; Corvera, Carlos U.] Univ Calif San Francisco, Dept Surg, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Niklas, Christian; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Cottrell, Graeme S.] Univ Reading, Dept Pharm & Pharmacol, Reading Sch Pharm, Reading RG6 6UB, Berks, England; [Lambert, Nevin A.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Erlangen Nuremberg; University of Reading; University System of Georgia; Augusta University	Bunnett, NW (corresponding author), Monash Inst Pharma Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; carlos.corvera@ucsfmedctr.org	Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Niklas, Christian/0000-0002-8887-0996; Kocan, Martina/0000-0003-3468-6197; Jensen, Dane D./0000-0001-6540-2375; Cottrell, Graeme/0000-0001-9098-7627; Bunnett, Nigel W./0000-0003-3367-0644; Canals, Meritxell/0000-0002-7942-5006	National Institutes of Health from NIDDK [P30-DK026743]; Northern California Institute for Research and Education; Veterans Health Administration; National Health and Medical Research Council (NHMRC) [63303, 103188]; Monash University; NHMRC [454858]; British Heart Foundation [FS/08/017/25027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Northern California Institute for Research and Education; Veterans Health Administration(US Department of Veterans Affairs); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30-DK026743 from NIDDK (to C. U. C.). This work was also supported by the Northern California Institute for Research and Education, the Veterans Health Administration, National Health and Medical Research Council (NHMRC) Grants 63303 and 103188, and Monash University (to N. W. B.); by NHMRC Grant 454858 (to D. P. P.); and by British Heart Foundation Grant FS/08/017/25027 (to G. S. C.).	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Evans KA, 2009, J MED CHEM, V52, P7962, DOI 10.1021/jm901434t; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2011, DIGEST DIS, V29, P45, DOI 10.1159/000324127; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kocan M, 2010, FRONT ENDOCRINOL, V1, P12; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lavoie B, 2010, J PHYSIOL-LONDON, V588, P3295, DOI 10.1113/jphysiol.2010.192146; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Olivares-Reyes JA, 2005, MOL PHARMACOL, V68, P356, DOI 10.1124/mol.104.010637; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Savage EE, 2013, BIOTECHNIQUES, V54, P217, DOI 10.2144/000114013; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yang JI, 2007, BIOCHEM BIOPH RES CO, V361, P156, DOI 10.1016/j.bbrc.2007.07.001; Yasuda H, 2007, BIOCHEM BIOPH RES CO, V354, P154, DOI 10.1016/j.bbrc.2006.12.168; Yin X, 2008, MOL PHARMACOL, V74, P1223, DOI 10.1124/mol.108.048504	62	70	70	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22942	22960		10.1074/jbc.M113.455774	http://dx.doi.org/10.1074/jbc.M113.455774			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818521	Green Published, hybrid			2022-12-28	WOS:000330598200006
J	Nakamura, H; Moriyama, Y; Makiyama, T; Emori, S; Yamashita, H; Yamazaki, R; Murayama, T				Nakamura, Hiroyuki; Moriyama, Yuta; Makiyama, Tomohiko; Emori, Shunsuke; Yamashita, Hisahiro; Yamazaki, Risa; Murayama, Toshihiko			Lactosylceramide Interacts with and Activates Cytosolic Phospholipase A(2)alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; C2 DOMAIN; INTERFACIAL BINDING; ENDOTHELIAL-CELLS; CATALYTIC DOMAIN; L929 CELLS; A(2); INHIBITION; EXPRESSION; ADHESION	Lactosylceramide (LacCer) is a member of the glycosphingolipid family and is known to be a bioactive lipid in various cell physiological processes. However, the direct targets of LacCer and cellular events mediated by LacCer are largely unknown. In this study, we examined the effect of LacCer on the release of arachidonic acid (AA) and the activity of cytosolic phospholipase A(2)alpha (cPLA(2)alpha). In CHO-W11A cells, treatment with 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP), an inhibitor of glucosylceramide synthase, reduced the glycosphingolipid level, and the release of AA induced by A23187 or platelet-activating factor was inhibited. The addition of LacCer reversed the PPMP effect on the stimulus-induced AA release. Exogenous LacCer stimulated the release of AA, which was decreased by treatment with an inhibitor of cPLA(2)alpha or silencing of the enzyme. Treatment of CHO-W11A cells with LacCer induced the translocation of full-length cPLA(2)alpha and its C2 domain from the cytosol to the Golgi apparatus. LacCer also induced the translocation of the D43N mutant of cPLA(2)alpha. Treatment of L929 cells with TNF-alpha induced LacCer generation and mediated the translocation of cPLA(2)alpha and AA release, which was attenuated by treatment with PPMP. In vitro studies were then conducted to test whether LacCer interacts directly with cPLA(2)alpha. Phosphatidylcholine vesicles containing LacCer increased cPLA(2)alpha activity. LacCer bound to cPLA(2)alpha and its C2 domain in a Ca2+-independent-manner. Thus, we propose that LacCer is a direct activator of cPLA(2)alpha.	[Nakamura, Hiroyuki; Moriyama, Yuta; Makiyama, Tomohiko; Emori, Shunsuke; Yamashita, Hisahiro; Yamazaki, Risa; Murayama, Toshihiko] Chiba Univ, Lab Chem Pharmacol, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Chiba University	Nakamura, H (corresponding author), Chiba Univ, Lab Chem Pharmacol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nakahiro@faculty.chiba-u.jp	Nakamura, Hiroyuki/AFV-2078-2022; Nakamura, Hiroyuki/B-4089-2015	Nakamura, Hiroyuki/0000-0001-6328-9727; Nakamura, Hiroyuki/0000-0001-6328-9727; Makiyama, Tomohiko/0000-0001-6636-2897; Yamazaki, Risa/0000-0001-9717-6763	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790056]; Grants-in-Aid for Scientific Research [24790066] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 22790056 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; CHATTERJEE S, 1991, BIOCHEM BIOPH RES CO, V181, P554, DOI 10.1016/0006-291X(91)91225-2; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Hayter HL, 2001, FEBS LETT, V507, P151, DOI 10.1016/S0014-5793(01)02967-2; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Jayadev S, 1997, J BIOL CHEM, V272, P17196, DOI 10.1074/jbc.272.27.17196; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Martin SF, 2006, GLYCOCONJUGATE J, V23, P147, DOI 10.1007/s10719-006-7920-8; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakamura H, 2006, BIOCHEM PHARMACOL, V71, P850, DOI 10.1016/j.bcp.2005.12.027; Nakamura H, 2004, EUR J PHARMACOL, V484, P9, DOI 10.1016/j.ejphar.2003.10.053; Nakamura H, 2010, J LIPID RES, V51, P720, DOI 10.1194/jlr.M002428; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Pannu R, 2005, J BIOL CHEM, V280, P13742, DOI 10.1074/jbc.M411959200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shimizu M, 2008, BIOCHEM PHARMACOL, V75, P1358, DOI 10.1016/j.bcp.2007.11.020; Singh RD, 2006, J BIOL CHEM, V281, P30660, DOI 10.1074/jbc.M606194200; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200	30	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23264	23272		10.1074/jbc.M113.491431	http://dx.doi.org/10.1074/jbc.M113.491431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801329	Green Published, hybrid			2022-12-28	WOS:000330598200033
J	Mendez, DL; Mandt, RE; Elgin, SCR				Mendez, Deanna L.; Mandt, Rebecca E.; Elgin, Sarah C. R.			Heterochromatin Protein 1a (HP1a) Partner Specificity Is Determined by Critical Amino Acids in the Chromo Shadow Domain and C-terminal Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; GENE; EXPRESSION; MUTATIONS; MECHANISM; SUGGESTS; ISOFORM; BINDING; HINGE	Drosophila melanogaster Heterochromatin Protein 1a (HP1a) is an essential protein critical for heterochromatin assembly and regulation. Its chromo shadow domain (CSD) homodimerizes, a requirement for binding protein partners that contain a PXVXL motif. How does HP1a select among its many different PXVXL-containing partners? HP1a binds tightly to Heterochromatin Protein 2 (HP2), but weakly to PIWI. We investigated differences in homodimerization and the impact of the C-terminal extension (CTE) by contrasting HP1a to its paralogue, HP1b. HP1a and HP1b differ in the dimerization interface, with HP1a having an Arg at position 188 rather than Glu. We find that while this substitution reduces the dimerization constant, it does not impact the binding surface as demonstrated by unchanged partner binding affinities. However, the CTE (only 4 residues in HP1a as compared with 87 residues in HP1b) is critical; the charged residues in HP1a are necessary for tight peptide binding. Examining a panel of amino acid substitutions in the HP1a CSD, we find that Leu-165 in HP1a interacts with HP2 but not PIWI, supporting the conclusion that different sites in the binding surface provide discrimination for partner selection. Partner sequence is also critical for affinity, as the remaining difference in binding between HP2 and PIWI polypeptides is eliminated by swapping the PXVXL motifs between the two. Taken together, these studies indicate that the binding surface of the HP1a CSD plus its short CTE provide the needed discrimination among HP1a's partners, and that the CTE is important for differentiating the interactions of the Drosophila HP1 paralogs.	[Mendez, Deanna L.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Mandt, Rebecca E.] Grinnell Coll, Grinnell, IA 50112 USA	Washington University (WUSTL)	Elgin, SCR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	selgin@biology.wustl.edu		Mendez, Deanna/0000-0002-0481-4816; Elgin, Sarah C. R./0000-0002-5176-2510	National Institutes of Health [GM068388]; National Science Foundation [0852037]; Washington University, St Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Washington University, St Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant GM068388 (to S. C. R. E.), the National Science Foundation under Grant No. 0852037-Cellular and Developmental Biology Research Apprenticeship Program (CD-BioRAP) at Washington University, St. Louis, and by Washington University, St Louis.	Abel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005089; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Demeler B., 2005, ULTRASCAN COMPREHENS; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Lu BY, 2000, GENETICS, V155, P699; Mendez D. L., 2012, KEY FACTORS DROSOPHI; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Shaffer CD, 2002, P NATL ACAD SCI USA, V99, P14332, DOI 10.1073/pnas.212458899; Shaffer CD, 2006, GENETICS, V174, P1189, DOI 10.1534/genetics.106.057604; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	27	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22315	22323		10.1074/jbc.M113.468413	http://dx.doi.org/10.1074/jbc.M113.468413			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793104	Green Published, hybrid			2022-12-28	WOS:000330596300013
J	Cetinbas, N; Huang-Hobbs, H; Tognon, C; Leprivier, G; An, JH; McKinney, S; Bowden, M; Chow, C; Gleave, M; McIntosh, LP; Sorensen, PH				Cetinbas, Naniye; Huang-Hobbs, Helen; Tognon, Cristina; Leprivier, Gabriel; An, Jianghong; McKinney, Steven; Bowden, Mary; Chow, Connie; Gleave, Martin; McIntosh, Lawrence P.; Sorensen, Poul H.			Mutation of the Salt Bridge-forming Residues in the ETV6-SAM Domain Interface Blocks ETV6-NTRK3-induced Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CHRONIC MYELOMONOCYTIC LEUKEMIA; GENE FUSION; SAM DOMAIN; CHROMOSOMAL TRANSLOCATION; CONGENITAL FIBROSARCOMA; TERMINAL SEQUENCE; TEL GENE; RECEPTOR; ACTIVATION	The ETV6-NTRK3 (EN) chimeric oncogene is expressed in diverse tumor types. EN is generated by a t(12;15) translocation, which fuses the N-terminal SAM (sterile alpha-motif) domain of the ETV6 (or TEL) transcription factor to the C-terminal PTK (protein-tyrosine kinase) domain of the neurotrophin-3 receptor NTRK3. SAM domain-mediated polymerization of EN leads to constitutive activation of the PTK domain and constitutive signaling of the Ras-MAPK and PI3K-Akt pathways, which are essential for EN oncogenesis. Here we show through complementary biophysical and cellular biological techniques that mutation of Lys-99, which participates in a salt bridge at the SAM polymer interface, reduces self-association of the isolated SAM domain as well as high molecular mass complex formation of EN and abrogates the transformation activity of EN. We also show that mutation of Asp-101, the intermolecular salt bridge partner of Lys-99, similarly blocks transformation of NIH3T3 cells by EN, reduces EN tyrosine phosphorylation, inhibits Akt and Mek1/2 signaling downstream of EN, and abolishes tumor formation in nude mice. In contrast, mutations of Glu-100 and Arg-103, residues in the vicinity of the interdomain Lys-99-Asp-101 salt bridge, have little or no effect on these oncogenic characteristics of EN. Our results underscore the importance of specific electrostatic interactions for SAM polymerization and EN transformation.	[Cetinbas, Naniye; Tognon, Cristina; Leprivier, Gabriel; Chow, Connie; Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Cetinbas, Naniye; Tognon, Cristina; Leprivier, Gabriel; McKinney, Steven; Sorensen, Poul H.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Huang-Hobbs, Helen; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Huang-Hobbs, Helen; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [An, Jianghong] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Bowden, Mary; Gleave, Martin] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Bowden, Mary; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Sorensen, PH (corresponding author), BC Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	psor@mail.ubc.ca		Gleave, Martin/0000-0003-4235-0167	Canadian Institutes for Health Research [MOP119599]; British Columbia Cancer Foundation; Canadian Cancer Society Research Institute [017308]; Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP119599 and funds from the British Columbia Cancer Foundation through generous donations from Team Finn and Ride to Conquer Cancer (to P. H. S.) and Canadian Cancer Society Research Institute Grant 017308 (to L. P. M.).; Supported by a Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Chakrabarti SR, 2000, P NATL ACAD SCI USA, V97, P13281, DOI 10.1073/pnas.240315897; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Forghieri F, 2011, EUR J HAEMATOL, V86, P352, DOI 10.1111/j.1600-0609.2011.01576.x; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kazakov DV, 2010, AM J SURG PATHOL, V34, P1226, DOI 10.1097/PAS.0b013e3181e4f49d; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knezevich SR, 1998, CANCER RES, V58, P5046; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; PAPADOPOULOS P, 1995, CANCER RES, V55, P34; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Schultz J, 1997, PROTEIN SCI, V6, P249; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yagasaki F, 2001, CANCER RES, V61, P8371; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	42	12	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27940	27950		10.1074/jbc.M113.475301	http://dx.doi.org/10.1074/jbc.M113.475301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23798677	Green Published, hybrid			2022-12-28	WOS:000330612800021
J	Croft, W; Hill, C; McCann, E; Bond, M; Esparza-Franco, M; Bennett, J; Rand, D; Davey, J; Ladds, G				Croft, Wayne; Hill, Claire; McCann, Eilish; Bond, Michael; Esparza-Franco, Manuel; Bennett, Jeannette; Rand, David; Davey, John; Ladds, Graham			A Physiologically Required G Protein-coupled Receptor (GPCR)-Regulator of G Protein Signaling (RGS) Interaction That Compartmentalizes RGS Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PLASMA-MEMBRANE; DEP-DOMAIN; P-FACTOR; PHEROMONE; REGULATORS; EXPRESSION; PALMITOYLATION; IDENTIFICATION; TRANSLOCATION	G protein-coupled receptors (GPCRs) can interact with regulator of G protein signaling (RGS) proteins. However, the effects of such interactions on signal transduction and their physiological relevance have been largely undetermined. Ligand-bound GPCRs initiate by promoting exchange of GDP for GTP on the G alpha subunit of heterotrimeric G proteins. Signaling is terminated by hydrolysis of GTP to GDP through intrinsic GTPase activity of the G alpha subunit, a reaction catalyzed by RGS proteins. Using yeast as a tool to study GPCR signaling in isolation, we define an interaction between the cognate GPCR (Mam2) and RGS (Rgs1), mapping the interaction domains. This reaction tethers Rgs1 at the plasma membrane and is essential for physiological signaling response. In vivo quantitative data inform the development of a kinetic model of the GTPase cycle, which extends previous attempts by including GPCR-RGS interactions. In vivo and in silico data confirm that GPCR-RGS interactions can impose an additional layer of regulation through mediating RGS subcellular localization to compartmentalize RGS activity within a cell, thus highlighting their importance as potential targets to modulate GPCR signaling pathways.	[Croft, Wayne; McCann, Eilish; Bond, Michael; Bennett, Jeannette; Davey, John; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Hill, Claire] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Esparza-Franco, Manuel; Rand, David] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Ladds, G (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England.	Graham.Ladds@warwick.ac.uk	Rand, David A/J-9085-2012	Rand, David A/0000-0002-2217-3274; Ladds, Graham/0000-0001-7320-9612	Warwick Postgraduate Research Scholarship; University Hospitals of Coventry and Warwickshire National Health Service Trust; Biotechnology and Biological Sciences Research Council [BB/G01227X/1]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1] Funding Source: UKRI	Warwick Postgraduate Research Scholarship; University Hospitals of Coventry and Warwickshire National Health Service Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Warwick Postgraduate Research Scholarship (to M. B.), the University Hospitals of Coventry and Warwickshire National Health Service Trust (to G. L.), Biotechnology and Biological Sciences Research Council Grant BB/G01227X/1 (to W.C., J.B., and G.L.), and the Birmingham Science City Research Alliance (to G.L.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; DAVEY J, 1995, METH MOL G, V6, P247, DOI DOI 10.1016/S1067-2389(06)80016-6; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; Didmon M, 2002, CURR GENET, V41, P241, DOI 10.1007/s00294-002-0301-3; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Druey KM, 1998, J BIOL CHEM, V273, P18405, DOI 10.1074/jbc.273.29.18405; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Elliott CM, 2012, J R SOC INTERFACE, V9, P3027, DOI 10.1098/rsif.2012.0276; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; Garzon J, 2004, NEUROPSYCHOPHARMACOL, V29, P1091, DOI 10.1038/sj.npp.1300408; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hepler JR, 2003, MOL PHARMACOL, V64, P547, DOI 10.1124/mol.64.3.547; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hill C, 2008, CELL SIGNAL, V20, P323, DOI 10.1016/j.cellsig.2007.10.016; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; IMAI Y, 1991, MOL CELL BIOL, V11, P3088, DOI 10.1128/MCB.11.6.3088; IMAI Y, 1992, MOL CELL BIOL, V12, P1827, DOI 10.1128/MCB.12.4.1827; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Ladds G, 2000, MOL MICROBIOL, V37, P606, DOI 10.1046/j.1365-2958.2000.02028.x; Ladds G, 2005, MOL MICROBIOL, V55, P482, DOI 10.1111/j.1365-2958.2004.04394.x; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; Ladds G, 2000, MOL MICROBIOL, V36, P377, DOI 10.1046/j.1365-2958.2000.01855.x; Ladds G, 2004, CURR OPIN DRUG DISC, V7, P683; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Milligan G, 1998, TRENDS ENDOCRIN MET, V9, P13, DOI 10.1016/S1043-2760(98)00004-6; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; ONARAN HO, 1993, MOL PHARMACOL, V43, P245; Pereira PS, 2001, GENES CELLS, V6, P789, DOI 10.1046/j.1365-2443.2001.00465.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Smith B, 2009, CELL SIGNAL, V21, P1151, DOI 10.1016/j.cellsig.2009.03.004; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Turner EM, 2012, ACS MED CHEM LETT, V3, P146, DOI 10.1021/ml200263y; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yildirim N, 2004, METHOD ENZYMOL, V389, P383; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	63	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27327	27342		10.1074/jbc.M113.497826	http://dx.doi.org/10.1074/jbc.M113.497826			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900842	Green Published, hybrid			2022-12-28	WOS:000330597300029
J	Kang, J; Kim, E; Kim, W; Seong, KM; Youn, H; Kim, JW; Kim, J; Youn, B				Kang, JiHoon; Kim, EunGi; Kim, Wanyeon; Seong, Ki Moon; Youn, HyeSook; Kim, Jung Woo; Kim, Joon; Youn, BuHyun			Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITOR; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; IONIZING-RADIATION; PANCREATIC-CANCER; DOWN-REGULATION; SIGNALING PATHWAY; GENE-EXPRESSION; POOR-PROGNOSIS; NECK-CANCER	Radioresistance is a major cause of decreasing the efficiency of radiotherapy for non-small cell lung cancer (NSCLC). To understand the radioresistance mechanisms in NSCLC, we focused on the radiation-induced Notch-1 signaling pathway involved in critical cell fate decisions by modulating cell proliferation. In this study, we investigated the use of Notch-1-regulating flavonoid compounds as novel therapeutic drugs to regulate radiosensitivity in NSCLC cells, NCI-H1299 and NCI-H460, with different levels of radioresistance. Rhamnetin and cirsiliol were selected as candidate Notch-1-regulating radiosensitizers based on the results of assay screening for activity and pharmacological properties. Treatment with rhamnetin or cirsiliol reduced the proliferation of NSCLC cells through the suppression of radiation-induced Notch-1 expression. Indeed, rhamnetin and cirsiliol increased the expression of tumor-suppressive microRNA, miR-34a, in a p53-dependent manner, leading to inhibition of Notch-1 expression. Consequently, reduced Notch-1 expression promoted apoptosis through significant down-regulation of the nuclear factor-kappa B pathway, resulting in a radiosensitizing effect on NSCLC cells. Irradiation-induced epithelial-mesenchymal transition was also notably attenuated in the presence of rhamnetin and cirsiliol. Moreover, an in vivo xenograft mouse model confirmed the radiosensitizing and epithelial-mesenchymal transition inhibition effects of rhamnetin and cirsiliol we observed in vitro. In these mice, tumor volume was significantly reduced by combinational treatment with irradiation and rhamnetin or cirsiliol compared with irradiation alone. Taken together, our findings provided evidence that rhamnetin and cirsiliol can act as promising radiosensitizers that enhance the radiotherapeutic efficacy by inhibiting radiation-induced Notch-1 signaling associated with radioresistance possibly via miR-34a-mediated pathways.	[Kang, JiHoon; Kim, EunGi; Kim, Wanyeon; Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Seong, Ki Moon] Korea Hydro & Nucl Power Co Ltd, Div Radiat Effect Res, Radiat Hlth Res Inst, Seoul 132703, South Korea; [Youn, HyeSook] Sejong Univ, Dept Biosci & Biotechnol, Inst Biosci, Seoul 143747, South Korea; [Kim, Jung Woo] Pai Chai Univ, Dept Life Sci & Biotechnol, Taejon 302735, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Joon] Korea Univ, BioInst, Seoul 136701, South Korea	Pusan National University; Korea Hydro & Nuclear Power; Sejong University; Pai Chai University; Korea University; Korea University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	bhyoun72@pusan.ac.kr	Seong, Ki Moon/Y-6083-2019; Kim, EunGi/AAZ-6121-2021		Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0003201]; National R&D Program for Cancer Control; Ministry for Health and Welfare, Republic of Korea [1320100]; Radiation Technology R&D Program through the National Research Foundation of Korea; Ministry of Science, ITC & Future Planning [2013M2A2A7042502]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Radiation Technology R&D Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ITC & Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0003201), a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1320100), and the Radiation Technology R&D Program through the National Research Foundation of Korea funded by the Ministry of Science, ITC & Future Planning (2013M2A2A7042502).	Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Baumann M, 2004, LUNG CANCER, V45, pS187, DOI 10.1016/j.lungcan.2004.07.975; Bianco C, 2002, CLIN CANCER RES, V8, P3250; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen SM, 2011, CANCER LETT, V306, P76, DOI 10.1016/j.canlet.2011.02.034; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hillman GG, 2011, RADIOTHER ONCOL, V101, P329, DOI 10.1016/j.radonc.2011.10.020; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Ji XM, 2012, INT J CANCER, V131, P2668, DOI 10.1002/ijc.27549; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kashat M, 2012, AM J TRANSL RES, V4, P432; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Kim W, 2013, PHARMACOL RES, V70, P90, DOI 10.1016/j.phrs.2013.01.005; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kim W, 2010, J RADIAT RES, V51, P285, DOI 10.1269/jrr.09141; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koh PK, 2012, CANCER TREAT REV, V38, P626, DOI 10.1016/j.ctrv.2011.11.003; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li Y, 2010, BIOL-TARGETS THER, V4, P163; Lin JT, 2010, ANN SURG ONCOL, V17, P2976, DOI 10.1245/s10434-010-1118-9; Lin J, 2010, ARCH MED RES, V41, P519, DOI 10.1016/j.arcmed.2010.10.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nishimura Y, 2007, INT J RADIAT ONCOL, V69, P786, DOI 10.1016/j.ijrobp.2007.04.008; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Okuhashi Y, 2011, ANTICANCER RES, V31, P893; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pan H, 2012, INT J MOL MED, V30, P337, DOI 10.3892/ijmm.2012.990; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Park CC, 2003, P NATL ACAD SCI USA, V100, P10728, DOI 10.1073/pnas.1832185100; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toschi L, 2010, TARGET ONCOL, V5, P5, DOI 10.1007/s11523-010-0132-y; Wang AM, 2009, J CELL BIOCHEM, V106, P682, DOI 10.1002/jcb.22065; Wang M, 2011, CANCER RES, V71, P6261, DOI 10.1158/0008-5472.CAN-11-0213; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059319; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yu SD, 2011, ONCOL REP, V26, P1323, DOI 10.3892/or.2011.1402; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhang SL, 2013, J CELL MOL MED, V17, P854, DOI 10.1111/jcmm.12068; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	83	137	145	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27343	27357		10.1074/jbc.M113.490482	http://dx.doi.org/10.1074/jbc.M113.490482			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902763	hybrid, Green Published			2022-12-28	WOS:000330597300030
J	Young, HE; Donohue, MP; Smirnova, TI; Smirnov, AI; Zhou, P				Young, Hayley E.; Donohue, Matthew P.; Smirnova, Tatyana I.; Smirnov, Alex I.; Zhou, Pei			The UDP-diacylglucosamine Pyrophosphohydrolase LpxH in Lipid A Biosynthesis Utilizes Mn2+ Cluster for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; Q-BAND EPR; ESCHERICHIA-COLI; PROTEIN PHOSPHATASE; MAGNETIC-PROPERTIES; STRUCTURAL BASIS; SPIN PARAMETERS; ACTIVE-SITES; X-BAND; BINDING	In Escherichia coli and the majority of beta- and gamma-proteobacteria, the fourth step of lipid A biosynthesis, i.e. cleavage of the pyrophosphate group of UDP-2,3-diacyl-GlcN, is carried out by LpxH. LpxH has been previously suggested to contain signature motifs found in the calcineurin-like phosphoesterase (CLP) family of metalloenzymes; however, it cleaves a pyrophosphate bond instead of a phosphoester bond, and its substrate contains nucleoside diphosphate moieties more common to the Nudix family rather than to the CLP family. Furthermore, the extent of biochemical data fails to demonstrate a significant level of metal activation in enzymatic assays, which is inconsistent with the behavior of a metalloenzyme. Here, we report cloning, purification, and detailed enzymatic characterization of Haemophilus influenzae LpxH (HiLpxH). HiLpxH shows over 600-fold stimulation of hydrolase activity in the presence of Mn2+. EPR studies reveal the presence of a Mn2+ cluster in LpxH. Finally, point mutants of residues in the conserved metal-binding motifs of the CLP family greatly inhibit HiLpxH activity, highlighting their importance in enzyme function. Contrary to previous analyses of LpxH, we find HiLpxH does not obey surface dilution kinetics. Overall, our work unambiguously establishes LpxH as a calcineurin-like phosphoesterase containing a Mn2+ cluster coordinated by conserved residues. These results set the scene for further structural investigation of the enzyme and for design of novel antibiotics targeting lipid A biosynthesis.	[Young, Hayley E.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Donohue, Matthew P.; Smirnova, Tatyana I.; Smirnov, Alex I.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	Duke University; University of North Carolina; North Carolina State University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Smirnov, Alex I/Q-9818-2016; Donohue, Matthew/I-3967-2016; Zhou, Pei/O-6704-2019	Smirnov, Alex I/0000-0002-0037-2555; Donohue, Matthew/0000-0003-4117-0930; Zhou, Pei/0000-0002-7823-3416; Smirnova, Tatyana/0000-0001-7867-7116	National Institutes of Health [DE-FG02-02ER15354]; National Science Foundation [MCB-0451510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the late Dr. Christian R. H. Raetz for his meaningful contributions to the foundations of this work as well as supportive guidance. Additionally, we thank Dr. Louis Metzger and the members of the Raetz laboratory for helpful discussions. The EPR experiments at North Carolina State University were supported by National Institutes of Health Grant DE-FG02-02ER15354 (to A. I. S.) and National Science Foundation Grant MCB-0451510 (to T. I. S.).	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Battistuzzi G, 1997, BIOCHEM J, V323, P593, DOI 10.1042/bj3230593; Blanchard S, 2003, CHEM-EUR J, V9, P4260, DOI 10.1002/chem.200304759; Blanchard S, 2003, INORG CHEM, V42, P4568, DOI 10.1021/ic0301066; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAKRABORTY P, 1994, POLYHEDRON, V13, P683, DOI 10.1016/S0277-5387(00)84746-4; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Epel B, 2005, J BIOL INORG CHEM, V10, P636, DOI 10.1007/s00775-005-0015-3; Gelasco A, 1997, INORG CHEM, V36, P1829, DOI 10.1021/ic970140i; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Golombek AP, 2003, J MAGN RESON, V165, P33, DOI 10.1016/j.jmr.2003.07.001; Hayden JA, 2010, J BIOL INORG CHEM, V15, P729, DOI 10.1007/s00775-010-0640-3; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Howard T, 2000, INORG CHEM, V39, P3379, DOI 10.1021/ic0000247; KESSISSOGLOU DP, 1987, INORG CHEM, V26, P2487, DOI 10.1021/ic00262a030; KOONIN EV, 1994, PROTEIN SCI, V3, P356; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MABAD B, 1986, INORG CHEM, V25, P1420, DOI 10.1021/ic00229a025; MATHUR P, 1983, J AM CHEM SOC, V105, P7093, DOI 10.1021/ja00362a012; MATHUR P, 1987, J AM CHEM SOC, V109, P5227, DOI 10.1021/ja00251a030; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Opiyo SO, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-362; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rusnak F, 1999, BIOCHEMISTRY-US, V38, P6943, DOI 10.1021/bi982606u; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schenk G, 1999, ACTA CRYSTALLOGR D, V55, P2051, DOI 10.1107/S0907444999012597; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; SMIRNOV AI, 1995, J MAGN RESON SER A, V113, P65, DOI 10.1006/jmra.1995.1057; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Tzima TD, 2013, POLYHEDRON, V52, P706, DOI 10.1016/j.poly.2012.07.084; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; White DJ, 2001, BIOCHEMISTRY-US, V40, P8918, DOI 10.1021/bi010637a; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	47	13	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					26987	27001		10.1074/jbc.M113.497636	http://dx.doi.org/10.1074/jbc.M113.497636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23897835	Green Published, hybrid			2022-12-28	WOS:000330597300002
J	Anderson, DM; Feix, JB; Monroe, AL; Peterson, FC; Volkman, BF; Haas, AL; Frank, DW				Anderson, David M.; Feix, Jimmy B.; Monroe, Andrew L.; Peterson, Francis C.; Volkman, Brian F.; Haas, Arthur L.; Frank, Dara W.			Identification of the Major Ubiquitin-binding Domain of the Pseudomonas aeruginosa ExoU A(2) Phospholipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TYPE-III; EXOENZYME-S; CYTOTOXIN EXOU; PROTEIN; TOXIN; ACTIVATION; EFFECTOR; LOCALIZATION; EXPLOITATION; PREDICTION	Numerous Gram-negative bacterial pathogens use type III secretion systems to deliver effector molecules into the cytoplasm of a host cell. Many of these effectors have evolved to manipulate the host ubiquitin system to alter host cell physiology or the location, stability, or function of the effector itself. ExoU is a potent A(2) phospholipase used by Pseudomonas aeruginosa to destroy membranes of infected cells. The enzyme is held in an inactive state inside of the bacterium due to the absence of a required eukaryotic activator, which was recently identified as ubiquitin. This study sought to identify the region of ExoU required to mediate this interaction and determine the properties of ubiquitin important for binding, ExoU activation, or both. Biochemical and biophysical approaches were used to map the ubiquitin-binding domain to a C-terminal four-helix bundle of ExoU. The hydrophobic patch of ubiquitin is required for full binding affinity and activation. Binding and activation were uncoupled by introducing an L8R substitution in ubiquitin. Purified L8R demonstrated a parental binding phenotype to ExoU but did not activate the phospholipase in vitro. Utilizing these new biochemical data and intermolecular distance measurements by double electron-electron resonance, we propose a model for an ExoU-monoubiquitin complex.	[Anderson, David M.; Monroe, Andrew L.; Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Anderson, David M.; Monroe, Andrew L.; Frank, Dara W.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Feix, Jimmy B.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Frank, DW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	frankd@mcw.edu	Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	National Institutes of Health [P41 EB001980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049577, R01AI104922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The National Biomedical EPR Center, Department of Biophysics, is supported by National Institutes of Health Grant P41 EB001980.	Anderson DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002823; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Benson MA, 2011, BIOPHYS J, V100, P1335, DOI 10.1016/j.bpj.2011.01.056; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; IGLEWSKI BH, 1978, P NATL ACAD SCI USA, V75, P3211, DOI 10.1073/pnas.75.7.3211; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubori T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00145; Liu SY, 1997, J BACTERIOL, V179, P1609, DOI 10.1128/jb.179.5.1609-1613.1997; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Schmalzer KM, 2010, J BACTERIOL, V192, P1801, DOI 10.1128/JB.00904-09; Steele-Mortimer O, 2011, TRAFFIC, V12, P162, DOI 10.1111/j.1600-0854.2010.01137.x; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Tan KS, 2010, J IMMUNOL, V184, P5160, DOI 10.4049/jimmunol.0902663; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899	43	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26741	26752		10.1074/jbc.M113.478529	http://dx.doi.org/10.1074/jbc.M113.478529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23908356	hybrid, Green Published			2022-12-28	WOS:000330594500039
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series on Redox-active Protein Modifications and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The dynamics of redox metabolism necessitate cellular strategies for sensing redox changes and for responding to them. A common mechanism for receiving and transmitting redox changes is via reversible modifications of protein cysteine residues. A plethora of cysteine modifications have been described, including sulfenylation, glutathionylation, and disulfide formation. These post-translational modifications have the potential to alter protein structure and/or function and to modulate cellular processes ranging from division to death and from circadian rhythms to secretion. The focus of this thematic minireview series is cysteine modifications in response to reactive oxygen and nitrogen species.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			NHLBI NIH HHS [R01 HL058984, HL58984] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cremers CM, 2013, J BIOL CHEM, V288, P26489, DOI 10.1074/jbc.R113.462929; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Stangherlin A, 2013, J BIOL CHEM, V288, P26505, DOI 10.1074/jbc.R113.457564	7	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26463	26463		10.1074/jbc.R113.502583	http://dx.doi.org/10.1074/jbc.R113.502583			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861402	Green Published, hybrid			2022-12-28	WOS:000330594500011
J	Jutras, BL; Chenail, AM; Carroll, DW; Miller, MC; Zhu, HN; Bowman, A; Stevenson, B				Jutras, Brandon L.; Chenail, Alicia M.; Carroll, Dustin W.; Miller, M. Clarke; Zhu, Haining; Bowman, Amy; Stevenson, Brian			Bpur, the Lyme Disease Spirochete's PUR Domain Protein IDENTIFICATION AS A TRANSCRIPTIONAL MODULATOR AND CHARACTERIZATION OF NUCLEIC ACID INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; WHOLE-GENOME SEQUENCES; OUTER-SURFACE PROTEIN; BORRELIA-BURGDORFERI INFECTION; POSTNATAL BRAIN-DEVELOPMENT; INHIBITOR FACTOR-H; BINDING PROTEIN; GENE-EXPRESSION; CP32 PROPHAGES; ERP PROTEINS	The PUR domain is a nucleic acid-binding motif found in critical regulatory proteins of higher eukaryotes and in certain species of bacteria. During investigations into mechanisms by which the Lyme disease spirochete controls synthesis of its Erp surface proteins, it was discovered that the borrelial PUR domain protein, Bpur, binds with high affinity to double-stranded DNA adjacent to the erp transcriptional promoter. Bpur was found to enhance the effects of the erp repressor protein, BpaB. Bpur also bound single-stranded DNA and RNA, with relative affinities RNA > double-stranded DNA > single-stranded DNA. Rational site-directed mutagenesis of Bpur identified amino acid residues and domains critical for interactions with nucleic acids, and it revealed that the PUR domain has a distinct mechanism of interaction with each type of nucleic acid ligand. These data shed light on both gene regulation in the Lyme spirochete and functional mechanisms of the widely distributed PUR domain.	[Jutras, Brandon L.; Chenail, Alicia M.; Bowman, Amy; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Carroll, Dustin W.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Miller, M. Clarke] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Louisville; University of Kentucky	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, MS Chandler Med Ctr 421, Lexington, KY 40536 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011; Zhu, Haining/A-6076-2008	Miller, M. Clarke/0000-0002-9877-6581; Zhu, Haining/0000-0001-5498-6694; Jutras, Brandon/0000-0002-7989-1031	National Institutes of Health [R01-AI044254, R21-AI106260]; National Research Fund for Tick-borne Diseases; University of Kentucky; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106260, R01AI044254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Fund for Tick-borne Diseases; University of Kentucky; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI044254 and R21-AI106260. This work was also supported by a grant from the National Research Fund for Tick-borne Diseases and a University of Kentucky grant-in-aid (to B. S.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams C. A., 2007, PROTEIN INTERACTIONS, P417; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; Babb K, 2006, J BACTERIOL, V188, P4331, DOI 10.1128/JB.00005-06; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Brissette CA, 2009, MICROBIOL-SGM, V155, P863, DOI 10.1099/mic.0.024604-0; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Brisson D, 2013, APPL ENVIRON MICROB, V79, P4115, DOI 10.1128/AEM.00817-13; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Chang JC, 2011, PHYSIOL PLANTARUM, V143, P219, DOI 10.1111/j.1399-3054.2011.01501.x; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Darbinian N, 2001, J NEUROIMMUNOL, V121, P3, DOI 10.1016/S0165-5728(01)00372-1; Darbinian N, 2008, J ALZHEIMERS DIS, V15, P71; de Oliveira FMB, 2004, MOL BIOCHEM PARASIT, V135, P21, DOI 10.1016/j.molbiopara.2003.12.009; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; Graebsch A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013402; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; HAAS S, 1993, MOL CELL BIOL, V13, P3103, DOI 10.1128/MCB.13.5.3103; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hokkanen S, 2012, HUM MOL GENET, V21, P473, DOI 10.1093/hmg/ddr476; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Inoue T, 2009, PROSTATE, V69, P861, DOI 10.1002/pros.20936; Jimenez-Castells C, 2012, ANAL CHEM, V84, P6515, DOI 10.1021/ac300766z; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Jutras Brandon L, 2012, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01f01s24; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kenedy MR, 2011, INFECT IMMUN, V79, P1451, DOI 10.1128/IAI.01274-10; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Kong TQ, 2007, J IMMUNOL, V179, P1934, DOI 10.4049/jimmunol.179.3.1934; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; Muralidharan V, 2001, J CELL PHYSIOL, V186, P406, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1039>3.0.CO;2-P; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; OLMSTED MC, 1991, BIOPOLYMERS, V31, P1593, DOI 10.1002/bip.360311314; Penberthy WT, 2004, DEV BIOL, V275, P225, DOI 10.1016/j.ydbio.2004.08.007; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Riley SP, 2009, NUCLEIC ACIDS RES, V37, P1973, DOI 10.1093/nar/gkp027; Rosa P, 1999, METHOD MICROBIOL, V29, P209; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schutzer SE, 2012, J BACTERIOL, V194, P545, DOI 10.1128/JB.06263-11; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Tretiakova A, 1998, J BIOL CHEM, V273, P22241, DOI 10.1074/jbc.273.35.22241; Wang HC, 2008, ANTICANCER RES, V28, P1441; Wang H, 2007, CANCER BIOL THER, V6, P596, DOI 10.4161/cbt.6.4.3889; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Witze ES, 2009, DEV BIOL, V327, P12, DOI 10.1016/j.ydbio.2008.11.015; Wortman MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-81; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Wywial E, 2009, GENE, V445, P26, DOI 10.1016/j.gene.2009.05.017; Yu L, 2012, ANAL BIOCHEM, V428, P137, DOI 10.1016/j.ab.2012.06.002; Zhao S, 2010, AM J PHYSIOL-ENDOC M, V298, pE524, DOI 10.1152/ajpendo.00597.2009; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	85	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26220	26234		10.1074/jbc.M113.491357	http://dx.doi.org/10.1074/jbc.M113.491357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23846702	Green Published, hybrid			2022-12-28	WOS:000330623300052
J	Zheng, H; Li, SH; Hsu, P; Qu, CK				Zheng, Hong; Li, Shanhu; Hsu, Peter; Qu, Cheng-Kui			Induction of a Tumor-associated Activating Mutation in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhances Mitochondrial Metabolism, Leading to Oxidative Stress and Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; OF-FUNCTION MUTATION; NOONAN-SYNDROME; CELLULAR SENESCENCE; PHOSPHOTYROSINE PHOSPHATASE; FUNCTIONAL CONSEQUENCES; ONCOGENIC RAS; MOUSE MODEL; IN-VIVO; DISEASE	Activating mutations in Ptpn11 (Shp2), a protein tyrosine phosphatase involved in diverse cell signaling pathways, are associated with pediatric leukemias and solid tumors. However, the pathogenic effects of these mutations have not been fully characterized. Here, we report that induction of the Ptpn11(E76K/+) mutation, the most common and active Ptpn11 mutation found in leukemias and solid tumors, in primary mouse embryonic fibroblasts resulted in proliferative arrest and premature senescence. As a result, apoptosis was markedly increased. These cellular responses were accompanied and mediated by up-regulation of p53 and p21. Moreover, intracellular levels of reactive oxygen species (ROS), byproducts of mitochondrial oxidative phosphorylation, were elevated in Ptpn11(E76K/+) cells. Since Shp2 is also distributed to the mitochondria (in addition to the cytosol), the impact of the Ptpn11(E76K/+) mutation on mitochondrial function was analyzed. These analyses revealed that oxygen consumption of Ptpn11(E76K/+) cells and the respiratory function of Ptpn11(E76K/+) mitochondria were significantly increased. Furthermore, we found that phosphorylation of mitochondrial Stat3, one of the substrates of Shp2 phosphatase, was greatly decreased in the mutant cells with the activating mutation Ptpn11(E76K/+). This study provides novel insights into the initial effects of tumor-associated Ptpn11 mutations.	[Zheng, Hong; Li, Shanhu; Hsu, Peter; Qu, Cheng-Kui] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Med,Div Hematol & Oncol, Cleveland, OH 44106 USA	Case Western Reserve University	Qu, CK (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cxq6@case.edu			National Institutes of Health [HL068212, HD070716]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD070716] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Grants HL068212 and HD070716 (to C. K. Q.).	AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200; Yu WM, 2003, ONCOGENE, V22, P5995, DOI 10.1038/sj.onc.1206846; Zhang WJ, 2009, J BIOL CHEM, V284, P22353, DOI 10.1074/jbc.M109.020495; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	50	26	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25727	25738		10.1074/jbc.M113.462291	http://dx.doi.org/10.1074/jbc.M113.462291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884424	Green Published, hybrid			2022-12-28	WOS:000330623300006
J	Yadav, H; Lee, JH; Lloyd, J; Walter, P; Rane, SG				Yadav, Hariom; Lee, Ji-Hyeon; Lloyd, John; Walter, Peter; Rane, Sushil G.			Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT-MICROBIOTA INTERACTIONS; INSULIN-RESISTANCE; PLASMA-CONCENTRATIONS; OBESITY; INFLAMMATION; HEALTH; ENERGY; PREBIOTICS; LINK	Obesity and diabetes are associated with excess caloric intake and reduced energy expenditure resulting in a negative energy balance. The incidence of diabetes has reached epidemic proportions, and childhood diabetes and obesity are increasing alarmingly. Therefore, it is important to develop safe, easily deliverable, and economically viable treatment alternatives for these diseases. Here, we provide data supporting the candidacy of probiotics as such a therapeutic modality against obesity and diabetes. Probiotics are live bacteria that colonize the gastrointestinal tract and impart beneficial effects for health. However, their widespread prescription as medical therapies is limited primarily because of the paucity of our understanding of their mechanism of action. Here, we demonstrate that the administration of a probiotic, VSL#3, prevented and treated obesity and diabetes in several mouse models. VSL#3 suppressed body weight gain and insulin resistance via modulation of the gut flora composition. VSL#3 promoted the release of the hormone GLP-1, resulting in reduced food intake and improved glucose tolerance. The VSL#3-induced changes were associated with an increase in the levels of a short chain fatty acid (SCFA), butyrate. Using a cell culture system, we demonstrate that butyrate stimulated the release of GLP-1 from intestinal L-cells, thereby providing a plausible mechanism for VSL#3 action. These findings suggest that probiotics such as VSL#3 can modulate the gut microbiota-SCFA-hormone axis. Moreover, our results indicate that probiotics are of potential therapeutic utility to counter obesity and diabetes.	[Yadav, Hariom; Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Lloyd, John] NIDDK, Biol Chem Lab, NIH, Bethesda, MD 20892 USA; [Walter, Peter] NIDDK, Clin Mass Spectrometry Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rane, SG (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health from the Intramural Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107, ZICDK075039] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health from the Intramural Program of NIDDK.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Belkina AC, 2010, CURR OPIN ENDOCRINOL, V17, P472, DOI 10.1097/MED.0b013e32833c5c48; BROWN JP, 1977, CRC CR REV FOOD SCI, V8, P229, DOI 10.1080/10408397709527224; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Delzenne N, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c2; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ehrlich SD, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c1; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Fehervari Z., 2012, NAT IMMUNOL, V13, P946; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hussain SS, 2013, INT J OBESITY, V37, P625, DOI 10.1038/ijo.2012.93; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kazaks A, 2003, PRIMARY CARE, V30, P301, DOI 10.1016/S0095-4543(03)00011-3; Kim MS, 2011, ANN NY ACAD SCI, V1229, P140, DOI 10.1111/j.1749-6632.2011.06098.x; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin CY, 2010, NUTR METAB CARDIOVAS, V20, P713, DOI 10.1016/j.numecd.2009.06.005; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mengheri E, 2008, J CLIN GASTROENTEROL, V42, pS177, DOI 10.1097/MCG.0b013e31817eedc4; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Parise RA, 2008, J CHROMATOGR B, V872, P141, DOI 10.1016/j.jchromb.2008.07.032; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Rijkers GT, 2011, BRIT J NUTR, V106, P1291, DOI 10.1017/S000711451100287X; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Spiller R, 2005, GASTROENTEROLOGY, V128, P783, DOI 10.1053/j.gastro.2005.01.018; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002; Zhu X., 2007, U. S. Patent, Patent No. [7,276,358 B1, 7276358]	50	403	431	14	109	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25088	25097		10.1074/jbc.M113.452516	http://dx.doi.org/10.1074/jbc.M113.452516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836895	Green Published, hybrid			2022-12-28	WOS:000330619000009
J	Kig, C; Beullens, M; Beke, L; Van Eynde, A; Linders, JT; Brehmer, D; Bollen, M				Kig, Cenk; Beullens, Monique; Beke, Lijs; Van Eynde, Aleyde; Linders, Johannes T.; Brehmer, Dirk; Bollen, Mathieu			RETRACTED: Maternal Embryonic Leucine Zipper Kinase (MELK) Reduces Replication Stress in Glioblastoma Cells (Retracted article. See vol. 292, pg. 12786, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ASYMMETRIC NEUROBLAST DIVISIONS; PROTEIN-KINASE; STEM-CELLS; SINGLE-CELL; IN-VIVO; S-PHASE; DNA; PHOSPHORYLATION; CHECKPOINT; PATHWAY	Maternal embryonic leucine zipper kinase (MELK) belongs to the subfamily of AMP-activated Ser/Thr protein kinases. The expression of MELK is very high in glioblastoma-type brain tumors, but it is not clear how this contributes to tumor growth. Here we show that the siRNA-mediated loss of MELK in U87 MG glioblastoma cells causes a G(1)/S phase cell cycle arrest accompanied by cell death or a senescence-like phenotype that can be rescued by the expression of siRNA-resistant MELK. This cell cycle arrest is mediated by an increased expression of p21(WAF1/CIP1), an inhibitor of cyclin-dependent kinases, and is associated with the hypophosphorylation of the retinoblastoma protein and the down-regulation of E2F target genes. The increased expression of p21 can be explained by the consecutive activation of ATM (ataxia telangiectasia mutated), Chk2, and p53. Intriguingly, the activation of p53 in MELK-deficient cells is not due to an increased stability of p53 but stems from the loss of MDMX(mouse double minute-X), an inhibitor of p53 transactivation. The activation of the ATM-Chk2 pathway in MELK-deficient cells is associated with the accumulation of DNA double-strand breaks during replication, as demonstrated by the appearance of gamma H2AXfoci. Replication stress in these cells is also illustrated by an increased number of stalled replication forks and a reduced fork progression speed. Our data indicate that glioblastoma cells have elevated MELK protein levels to better cope with replication stress during unperturbed S phase. Hence, MELK inhibitors hold great potential for the treatment of glioblastomas as such or in combination with DNA-damaging therapies.	[Kig, Cenk; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu] Univ Louvain, Lab Biosignaling & Therapeut, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Beke, Lijs; Linders, Johannes T.; Brehmer, Dirk] Janssen Res & Dev, B-2340 Beerse, Belgium	Johnson & Johnson; Janssen Pharmaceuticals	Bollen, M (corresponding author), Univ Louvain, Lab Biosignaling & Therapeut, Dept Cellular & Mol Med, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.be			National Science Foundation Flanders Grant [G.0.686.10.N.10]	National Science Foundation Flanders Grant	This work was supported by National Science Foundation Flanders Grant G.0.686.10.N.10.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Castelli S, 2012, BIOL CHEM, V393, P1327, DOI 10.1515/hsz-2012-0240; Chien SC, 2013, GENETICS, V193, P897, DOI 10.1534/genetics.112.148106; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; HOY CA, 1989, CYTOMETRY, V10, P718, DOI 10.1002/cyto.990100608; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Krempler A, 2007, CELL CYCLE, V6, P1682, DOI 10.4161/cc.6.14.4480; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Le Page Y, 2011, J CELL SCI, V124, P958, DOI 10.1242/jcs.069567; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; MIRZAYANS R, 2012, J BIOMED BI IN PRESS; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2011, NEURO-ONCOLOGY, V13, P622, DOI 10.1093/neuonc/nor023; Niesler CU, 2007, EXP PHYSIOL, V92, P207, DOI 10.1113/expphysiol.2006.034736; SCHWAB RA, 2011, J VIS EXP IN PRESS; Schwarz JK, 2003, MOL CANCER RES, V1, P598; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2012, J BIOL CHEM, V287, P20797, DOI 10.1074/jbc.M112.347757; SHAPIRO HM, 1988, PRACTICAL FLOW CYTOM, P133; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shono T, 2002, CANCER RES, V62, P1069; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; STROBER W, 2001, CURR PROTOCOLS IMMUN, V21; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; TYRSTED G, 1982, BIOCHEM PHARMACOL, V31, P3107, DOI 10.1016/0006-2952(82)90087-9; Verlinden L, 2005, J BIOL CHEM, V280, P37319, DOI 10.1074/jbc.M503587200; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106	54	32	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24200	24212		10.1074/jbc.M113.471433	http://dx.doi.org/10.1074/jbc.M113.471433			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836907	Green Published, hybrid			2022-12-28	WOS:000330611400058
J	Frankel, LK; Sallans, L; Bellamy, H; Goettert, JS; Limbach, PA; Bricker, TM				Frankel, Laurie K.; Sallans, Larry; Bellamy, Henry; Goettert, Jost S.; Limbach, Patrick A.; Bricker, Terry M.			Radiolytic Mapping of Solvent-Contact Surfaces in Photosystem II of Higher Plants EXPERIMENTAL IDENTIFICATION OF PUTATIVE WATER CHANNELS WITHIN THE PHOTOSYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CHOLESTEROL OXIDASE; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; PSBQ PROTEIN; COMPLEX; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY; ARABIDOPSIS	Photosystem II uses water as an enzymatic substrate. It has been hypothesized that this water is vectored to the active site for water oxidation via water channels that lead from the surface of the protein complex to the Mn4O5Ca metal cluster. The radiolysis of water by synchrotron radiation produces amino acid residue-modifying OH center dot and is a powerful technique to identify regions of proteins that are in contact with water. In this study, we have used this technique to oxidatively modify buried amino acid residues in higher plant Photosystem II membranes. Fourier transform ion cyclotron resonance mass spectrometry was then used to identify these oxidized amino acid residues that were located in several core Photosystem II subunits (D1, D2, CP43, and CP47). While, as expected, the majority of the identified oxidized residues (approximate to 75%) are located on the solvent-exposed surface of the complex, a number of buried residues on these proteins were also modified. These residues form groups which appear to lead from the surface of the complex to the Mn4O5Ca cluster. These residues may be in contact with putative water channels in the photosystem. These results are discussed within the context of a number of largely computational studies that have identified putative water channels in Photosystem II.	[Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA; [Sallans, Larry; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA; [Bellamy, Henry; Goettert, Jost S.] Louisiana State Univ, J Bennett Johnston Sr Ctr Adv Microstruct & Devic, Baton Rouge, LA 70806 USA	Louisiana State University System; Louisiana State University; University of Cincinnati; Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu	Limbach, Patrick/A-9188-2009	Limbach, Patrick/0000-0003-1526-4546	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy [DE-FG02-98ER20310]; National Institutes of Health [RR019900, GM58843]; State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058843, R56GM058843] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy through Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.). Additional support was provided by National Institutes of Health Grants RR019900 and GM58843 (to P. A. L.) and the State of Louisiana (to H. B. and J. S. G.).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Barry BA, 2006, P NATL ACAD SCI USA, V103, P7288, DOI 10.1073/pnas.0600216103; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frankel LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058042; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; GHANOTAKIS DF, 1983, FEBS LETT, V153, P231, DOI 10.1016/0014-5793(83)80154-9; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Ho FM, 2012, BBA-BIOENERGETICS, V1817, P106, DOI 10.1016/j.bbabio.2011.04.009; Kallio JP, 2011, BIOCHEMISTRY-US, V50, P4396, DOI 10.1021/bi200486b; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Klauss A, 2012, BBA-BIOENERGETICS, V1817, P1196, DOI 10.1016/j.bbabio.2012.04.017; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; Liu RT, 2003, BIOCHEMISTRY-US, V42, P12447, DOI 10.1021/bi0352973; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; RABILLOUD T, 1995, ELECTROPHORESIS, V16, P1414, DOI 10.1002/elps.11501601234; Renzone Giovanni, 2007, Current Proteomics, V4, P1; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Sun G, 2004, ELECTROPHORESIS, V25, P959, DOI 10.1002/elps.200305800; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vassiliev S, 2010, BIOCHEMISTRY-US, V49, P1873, DOI 10.1021/bi901900s; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23565	23572		10.1074/jbc.M113.487033	http://dx.doi.org/10.1074/jbc.M113.487033			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814046	hybrid, Green Published			2022-12-28	WOS:000330598200060
J	Pallesen, LJ; Solodovnikova, N; Sharma, AK; Walden, WE				Pallesen, Leif J.; Solodovnikova, Natalia; Sharma, Anil K.; Walden, William E.			Interaction with Cfd1 Increases the Kinetic Lability of FeS on the Nbp35 Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; REGULATORY PROTEIN-1; CFD1-NBP35 COMPLEX; 4FE-4S CLUSTER; MITOCHONDRIA; MATURATION; MUTATIONS; CYTOSOL	P-loop NTPases of the ApbC/Nbp35 family are involved in FeS protein maturation in nearly all organisms and are proposed to function as scaffolds for initial FeS cluster assembly. In yeast and animals, Cfd1 and Nbp35 are homologous P-loop NTPases that form a heterotetrameric complex essential for FeS protein maturation through the cytosolic FeS cluster assembly (CIA) pathway. Cfd1 is conserved in animals, fungi, and several archaeal species, but in many organisms, only Nbp35 is present, raising the question of the unique roles played by Cfd1 and Nbp35. To begin to investigate this issue, we examined Cfd1 and Nbp35 function in budding yeast. About half of each protein was detected in a heterocomplex in logarithmically growing yeast. Nbp35 readily bound Fe-55 when fed to cells, whereas Fe-55 binding by free Cfd1 could not be detected. Rapid Fe-55 binding to and release from Nbp35 was impaired by Cfd1 deficiency. A Cfd1 mutation that caused a defect in heterocomplex stability supported iron binding to Nbp35 but impaired iron release. Our results suggest a model in which Cfd1-Nbp35 interaction increases the lability of assembled FeS on the Nbp35 scaffold for transfer to target apo-FeS proteins.	[Pallesen, Leif J.; Solodovnikova, Natalia; Sharma, Anil K.; Walden, William E.] Rush Med Coll, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Rush University	Walden, WE (corresponding author), Rush Med Coll, Dept Microbiol & Immunol MC 790, 835 S Wolcott Ave, Chicago, IL 60612 USA.	wwalden@uic.edu	Sharma, Anil K./AAP-1909-2020	Sharma, Anil K./0000-0002-9768-1644	National Institutes of Health [DK047281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK047281 (to W. E. W.).	Angelaccio S, 2002, ANAL BIOCHEM, V306, P346, DOI 10.1006/abio.2002.5689; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; EIDE D, 1992, J BIOL CHEM, V267, P20774; GROVES WE, 1968, ANAL BIOCHEM, V22, P195, DOI 10.1016/0003-2697(68)90307-2; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KOHLHAW GB, 1988, METHOD ENZYMOL, V166, P423; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	37	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23358	23367		10.1074/jbc.M113.486878	http://dx.doi.org/10.1074/jbc.M113.486878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798678	Green Published, hybrid			2022-12-28	WOS:000330598200040
J	Sato, M; Murakami, K; Uno, M; Nakagawa, Y; Katayama, S; Akagi, K; Masuda, Y; Takegoshi, K; Irie, K				Sato, Mizuho; Murakami, Kazuma; Uno, Mayumi; Nakagawa, Yu; Katayama, Sumie; Akagi, Ken-ichi; Masuda, Yuichi; Takegoshi, Kiyonori; Irie, Kazuhiro			Site-specific Inhibitory Mechanism for Amyloid beta 42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ALZHEIMERS-DISEASE; FIBRIL FORMATION; A-BETA; OXIDATIVE STRESS; PROTEIN OLIGOMERIZATION; SECONDARY STRUCTURE; MOLECULAR TWEEZERS; PLAQUE BURDEN; MOUSE MODEL	The aggregation of the 42-residue amyloid beta-protein (A beta 42) is involved in the pathogenesis of Alzheimer disease (AD). Numerous flavonoids exhibit inhibitory activity against A beta 42 aggregation, but their mechanism remains unclear in the molecular level. Here we propose the site-specific inhibitory mechanism of (+)-taxifolin, a catechol-type flavonoid, whose 3',4'-dihydroxyl groups of the B-ring plays a critical role. Addition of sodium periodate, an oxidant, strengthened suppression of A beta 42 aggregation by (+)-taxifolin, whereas no inhibition was observed under anaerobic conditions, suggesting the inhibition to be associated with the oxidation to form o-quinone. Because formation of the A beta 42-taxifolin adduct was suggested by mass spectrometry, A beta 42 mutants substituted at Arg(5), Lys(16), and/or Lys(28) with norleucine (Nle) were prepared to identify the residues involved in the conjugate formation. (+)-Taxifolin did not suppress the aggregation of A beta 42 mutants at Lys(16) and/or Lys(28) except for the mutant at Arg(5). In addition, the aggregation of A beta 42 was inhibited by other catechol-type flavonoids, whereas that of K16Nle-A beta 42 was not. In contrast, some non-catechol-type flavonoids suppressed the aggregation of K16Nle-A beta 42 as well as A beta 42. Furthermore, interaction of (+)-taxifolin with the beta-sheet region in A beta 42 was not observed using solid-state NMR unlike curcumin of the non-catechol-type. These results demonstrate that catechol-type flavonoids could specifically suppress A beta 42 aggregation by targeting Lys residues. Although the anti-AD activity of flavonoids has been ascribed to their antioxidative activity, the mechanism that the o-quinone reacts with Lys residues of A beta 42 might be more intrinsic. The Lys residues could be targets for Alzheimer disease therapy.	[Sato, Mizuho; Murakami, Kazuma; Uno, Mayumi; Nakagawa, Yu; Irie, Kazuhiro] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068502, Japan; [Masuda, Yuichi; Takegoshi, Kiyonori] Kyoto Univ, Dept Chem, Grad Sch Sci, Kyoto 6068502, Japan; [Nakagawa, Yu] RIKEN Adv Sci Inst, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Katayama, Sumie; Akagi, Ken-ichi] Natl Inst Biomed Innovat, Osaka 5670085, Japan; [Masuda, Yuichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Kyoto University; Kyoto University; RIKEN; National Institute of Health Sciences - Japan; Tohoku University	Irie, K (corresponding author), Kitashirakawa Oiwake Cho,Sakyo Ku, Kyoto 6068502, Japan.	irie@kais.kyoto-u.ac.jp	Murakami, Kazuma/GQA-7062-2022; Irie, Kazuhiro/A-6121-2014	Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568; Takegoshi, Kiyonori/0000-0002-4613-2987; AKAGI, Ken-ichi/0000-0002-7051-4598	Ministry of Education, Culture, Sports, Science and Technology, Japan [21248015, 22603006, 22.4068]; Asahi Beer Science Promotion Foundation; Kato Memorial Bioscience Foundation; Grants-in-Aid for Scientific Research [21248015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Beer Science Promotion Foundation; Kato Memorial Bioscience Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (A) 21248015 (to K. I.) and (C) 22603006 (to K. M.), and Promotion of Science for Young Scientists Grant 22.4068 (to M. S.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and by funds from the Asahi Beer Science Promotion Foundation (to K. I.) and Kato Memorial Bioscience Foundation (to K.M.).	Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; BOOTH AN, 1958, J AM PHARM ASSOC, V47, P183, DOI 10.1002/jps.3030470310; Bruschweiler R, 2004, J CHEM PHYS, V121, P409, DOI 10.1063/1.1755652; FIELDS CG, 1989, INT J PEPT PROT RES, V33, P298; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRAHAM DG, 1977, J BIOL CHEM, V252, P5729; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Grill JD, 2010, EXPERT REV NEUROTHER, V10, P711, DOI [10.1586/ern.10.29, 10.1586/ERN.10.29]; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jeon SH, 2008, ARCH PHARM RES, V31, P978, DOI 10.1007/s12272-001-1255-9; Keshet B, 2010, PROTEIN SCI, V19, P2291, DOI 10.1002/pro.509; Kiehlmann E, 2003, J NAT PROD, V66, P1562, DOI 10.1021/np034005w; Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; KUROYANAGI M, 1982, CHEM PHARM BULL, V30, P1602; LeVine H, 2012, BIOCHEMISTRY-US, V51, P307, DOI 10.1021/bi201288x; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Mecocci P, 2012, BBA-MOL BASIS DIS, V1822, P631, DOI 10.1016/j.bbadis.2011.10.006; MORAZZONI P, 1993, EUR J DRUG METAB PH, V18, P289, DOI 10.1007/BF03188811; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Murata N, 2010, BIOSCI BIOTECH BIOCH, V74, P2299, DOI 10.1271/bbb.100524; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Roschek B, 2009, PHYTOCHEMISTRY, V70, P1255, DOI 10.1016/j.phytochem.2009.06.003; Rossi L, 2008, NEUROCHEM RES, V33, P2390, DOI 10.1007/s11064-008-9696-7; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato M, 2013, BIOSCI BIOTECH BIOCH, V77, P1100, DOI 10.1271/bbb.120925; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P473, DOI 10.1021/cn3000247; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Trbovic N, 2004, J MAGN RESON, V171, P277, DOI 10.1016/j.jmr.2004.08.007; Ushikubo H, 2012, NEUROSCI LETT, V513, P51, DOI 10.1016/j.neulet.2012.02.006; VALENZUELA A, 1985, BIOCHEM BIOPH RES CO, V126, P712, DOI 10.1016/0006-291X(85)90243-8; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vega-Villa KR, 2009, BIOMED CHROMATOGR, V23, P638, DOI 10.1002/bmc.1165; Vu TH, 2010, J BIOSCI BIOENG, V109, P629, DOI 10.1016/j.jbiosc.2009.11.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wiejak S, 1999, CHEM PHARM BULL, V47, P1489; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Yanagisawa D, 2010, BIOMATERIALS, V31, P4179, DOI 10.1016/j.biomaterials.2010.01.142; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	66	157	161	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23212	23224		10.1074/jbc.M113.464222	http://dx.doi.org/10.1074/jbc.M113.464222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792961	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330598200028
J	Seok, S; Kanamaluru, D; Xiao, Z; Ryerson, D; Choi, SE; Suino-Powell, K; Xu, HE; Veenstra, TD; Kemper, JK				Seok, Sunmi; Kanamaluru, Deepthi; Xiao, Zhen; Ryerson, Daniel; Choi, Sung-E; Suino-Powell, Kelly; Xu, H. Eric; Veenstra, Timothy D.; Kemper, Jongsook Kim			Bile Acid Signal-induced Phosphorylation of Small Heterodimer Partner by Protein Kinase C zeta Is Critical for Epigenomic Regulation of Liver Metabolic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RECEPTOR-SHP; FARNESOID X RECEPTOR; OBESITY; REPRESSION; EXPRESSION; MICE; FXR; BIOSYNTHESIS; MICRORNA-34A; CHOLESTASIS	Bile acids (BAs) are recently recognized key signaling molecules that control integrative metabolism and energy expenditure. BAs activate multiple signaling pathways, including those of nuclear receptors, primarily farnesoid X receptor (FXR), membrane BA receptors, and FXR-induced FGF19 to regulate the fed-state metabolism. Small heterodimer partner (SHP) has been implicated as a key mediator of these BA signaling pathways by recruitment of chromatin modifying proteins, but the key question of how SHP transduces BA signaling into repressive histone modifications at liver metabolic genes remains unknown. Here we show that protein kinase C zeta (PKC zeta) is activated by BA or FGF19 and phosphorylates SHP at Thr-55 and that Thr-55 phosphorylation is critical for the epigenomic coordinator functions of SHP. PKC zeta is coimmunopreciptitated with SHP and both are recruited to SHP target genes after bile acid or FGF19 treatment. Activated phosphorylated PKC zeta and phosphorylated SHP are predominantly located in the nucleus after FGF19 treatment. Phosphorylation at Thr-55 is required for subsequent methylation at Arg-57, a naturally occurring mutation site in metabolic syndrome patients. Thr-55 phosphorylation increases interaction of SHP with chromatin modifiers and their occupancy at selective BA-responsive genes. This molecular cascade leads to repressive modifications of histones at metabolic target genes, and consequently, decreased BA pools and hepatic triglyceride levels. Remarkably, mutation of Thr-55 attenuates these SHP-mediated epigenomic and metabolic effects. This study identifies PKC zeta as a novel key upstream regulator of BA-regulated SHP function, revealing the role of Thr-55 phosphorylation in epigenomic regulation of liver metabolism.	[Seok, Sunmi; Kanamaluru, Deepthi; Ryerson, Daniel; Choi, Sung-E; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiao, Zhen; Veenstra, Timothy D.] SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Van Andel Institute	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jongsook@illinois.edu	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK71662, DK66202, DK62777, DK95842]; National Institutes of Health NCI [HHSN261200800001E]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662, R01DK095842, R56DK062777, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK71662 (to H. E. X.), DK66202 (to H. E. X.), DK62777 (to J. K. K.), and DK95842 (to J. K. K.) and federal funds from National Institutes of Health NCI Contract HHSN261200800001E.	Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Connelly Sheila, 2004, Methods Mol Biol, V246, P37; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mitro N, 2007, HEPATOLOGY, V46, P885, DOI 10.1002/hep.21819; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Smith Z, 2013, MOL CELL ENDOCRINOL, V368, P59, DOI 10.1016/j.mce.2012.04.008; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064	39	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23252	23263		10.1074/jbc.M113.452037	http://dx.doi.org/10.1074/jbc.M113.452037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23824184	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330598200032
J	Schmid, CL; Streicher, JM; Groer, CE; Munro, TA; Zhou, L; Bohn, LM				Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Munro, Thomas A.; Zhou, Lei; Bohn, Laura M.			Functional Selectivity of 6 '-Guanidinonaltrindole (6 '-GNTI) at kappa-Opioid Receptors in Striatal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN 2A RECEPTOR; G-PROTEIN; BETA-ARRESTIN; IN-VIVO; NOR-BINALTORPHIMINE; AGONIST SALVINORIN; REGULATED KINASE; DRUG-SEEKING; RATS; ACTIVATION	There is considerable evidence to suggest that drug actions at the kappa-opioid receptor (KOR) may represent a means to control pain perception and modulate reward thresholds. As a G protein-coupled receptor (GPCR), the activation of KOR promotes G alpha(i/o) protein coupling and the recruitment of beta-arrestins. It has become increasingly evident that GPCRs can transduce signals that originate independently via G protein pathways and beta-arrestin pathways; the ligand-dependent bifurcation of such signaling is referred to as "functional selectivity" or "signaling bias." Recently, a KOR agonist, 6'-guanidinonaltrindole (6'-GNTI), was shown to display bias toward the activation of G protein-mediated signaling over beta-arrestin2 recruitment. Therefore, we investigated whether such ligand bias was preserved in striatal neurons. Although the reference KOR agonist U69,593 induces the phosphorylation of ERK1/2 and Akt, 6'-GNTI only activates the Akt pathway in striatal neurons. Using pharmacological tools and beta-arrestin2 knock-out mice, we show that KOR-mediated ERK1/2 phosphorylation in striatal neurons requires beta-arrestin2, whereas Akt activation depends upon G protein signaling. These findings reveal a point of KOR signal bifurcation that can be observed in an endogenous neuronal setting and may prove to be an important indicator when developing biased agonists at the KOR.	[Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Zhou, Lei; Bohn, Laura M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Zhou, Lei; Bohn, Laura M.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Munro, Thomas A.] McLean Hosp, Mailman Res Ctr, Belmont, MA 02478 USA; [Munro, Thomas A.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Bohn, LM (corresponding author), Scripps Inst, Dept Mol Therapeut, 130 Scripps Way,Rm 2A2, Jupiter, FL 33458 USA.	lbohn@scripps.edu	Bohn, Laura M/A-7483-2014; Munro, Thomas Anthony/B-2712-2009	Bohn, Laura M/0000-0002-6474-8179; Munro, Thomas Anthony/0000-0002-3366-7149; Schmid Mason, Cullen/0000-0002-2882-1842; Streicher, John/0000-0002-4173-7362	National Institutes of Health [R01 DA031927]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA031927 (to L. M. B.).	Aldrich JV, 2009, P NATL ACAD SCI USA, V106, P18396, DOI 10.1073/pnas.0910180106; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BODKIN JA, 1995, J CLIN PSYCHOPHARM, V15, P49, DOI 10.1097/00004714-199502000-00008; Bohn Laura M, 2010, Drug Discov Today Technol, V7, pe37, DOI 10.1016/j.ddtec.2010.06.005; Bohn Laura M., 2009, P71, DOI 10.1007/978-1-60327-335-0_5; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; BROADBEAR JH, 1994, PSYCHOPHARMACOLOGY, V115, P311, DOI 10.1007/BF02245071; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Cohen BM, 2008, INT J NEUROPSYCHOPH, V11, P243, DOI 10.1017/S1461145707008073; Cowen DS, 2005, J NEUROCHEM, V93, P910, DOI 10.1111/j.1471-4159.2005.03107.x; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; GLICK SD, 1995, BRAIN RES, V681, P147, DOI 10.1016/0006-8993(95)00306-B; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Knoll AT, 2011, BIOL PSYCHIAT, V70, P425, DOI 10.1016/j.biopsych.2011.03.017; Ko MCH, 2003, BRAIN RES, V982, P38, DOI 10.1016/S0006-8993(03)02938-X; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Negus SS, 1997, J PHARMACOL EXP THER, V282, P44; Potter DN, 2011, BIOL PSYCHIAT, V70, P744, DOI 10.1016/j.biopsych.2011.05.021; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Rives ML, 2012, J BIOL CHEM, V287, P27050, DOI 10.1074/jbc.C112.387332; Schenk S, 1999, PSYCHOPHARMACOLOGY, V144, P339, DOI 10.1007/s002130051016; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; Spetea M., 2013, CURR PHARM IN PRESS; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Van't Veer A, 2013, NEUROPSYCHOPHARMACOL, V38, P1585, DOI 10.1038/npp.2013.58; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Walsh SL, 2001, J PHARMACOL EXP THER, V299, P147; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	41	65	69	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22387	22398		10.1074/jbc.M113.476234	http://dx.doi.org/10.1074/jbc.M113.476234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775075	Green Published, hybrid			2022-12-28	WOS:000330596300020
J	Ensign, SPF; Mathews, LT; Eschbacher, JM; Loftus, JC; Symons, MH; Tran, NL				Ensign, Shannon P. Fortin; Mathews, Lan T.; Eschbacher, Jennifer M.; Loftus, Joseph C.; Symons, Marc H.; Tran, Nhan L.			The Src Homology 3 Domain-containing Guanine Nucleotide Exchange Factor Is Overexpressed in High-grade Gliomas and Promotes Tumor Necrosis Factor-like Weak Inducer of Apoptosis-Fibroblast Growth Factor-inducible 14-induced Cell Migration and Invasion via Tumor Necrosis Factor Receptor-associated Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Signaling; Glioblastoma; Guanine Nucleotide Exchange Factor (GEF); Rho GTPases	NF-KAPPA-B; ACTIN STRESS FIBERS; ACTIVATES RAC1; RHO GTPASES; GLIOBLASTOMA; PROTEINS; SURVIVAL; TRAF2; PHOSPHORYLATION; MOLECULES	Glioblastoma (GB) is the highest grade of primary adult brain tumors, characterized by a poorly defined and highly invasive cell population. Importantly, these invading cells are attributed with having a decreased sensitivity to radiation and chemotherapy. TNF-like weak inducer of apoptosis (TWEAK)-Fn14 ligand-receptor signaling is one mechanism in GB that promotes cell invasiveness and survival and is dependent upon the activity of multiple Rho GTPases, including Rac1. Here we report that Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF), a RhoG-specific guanine nucleotide exchange factor, is overexpressed in GB tumors and promotes TWEAK-Fn14-mediated glioma invasion. Importantly, levels of SGEF expression in GB tumors inversely correlate with patient survival. SGEF mRNA expression is increased in GB cells at the invasive rim relative to those in the tumor core, and knockdown of SGEF expression by shRNA decreases glioma cell migration in vitro and invasion ex vivo. Furthermore, we showed that, upon TWEAK stimulation, SGEF is recruited to the Fn14 cytoplasmic tail via TRAF2. Mutation of the Fn14-TRAF domain site or depletion of TNF receptor-associated factor 2 (TRAF2) expression by siRNA oligonucleotides blocked SGEF recruitment to Fn14 and inhibited SGEF activity and subsequent GB cell migration. We also showed that knockdown of either SGEF or RhoG diminished TWEAK activation of Rac1 and subsequent lamellipodia formation. Together, these results indicate that SGEF-RhoG is an important downstream regulator of TWEAK-Fn14-driven GB cell migration and invasion.	[Ensign, Shannon P. Fortin; Mathews, Lan T.; Tran, Nhan L.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ 85004 USA; [Ensign, Shannon P. Fortin] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85724 USA; [Eschbacher, Jennifer M.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Loftus, Joseph C.] Mayo Clin, Scottsdale, AZ 85259 USA; [Symons, Marc H.] North Shore Long Isl Jewish, Ctr Oncol & Cell Biol, Feinstein Inst Med Res, Manhasset, NY 11030 USA	Translational Genomics Research Institute; University of Arizona; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Northwell Health	Tran, NL (corresponding author), Translat Genom Res Inst, Canc & Cell Biol Div, 445 N 5th St, Phoenix, AZ 85004 USA.	ntran@tgen.org		Fortin Ensign, Shannon/0000-0002-7433-528X; Mathews, Ian/0000-0003-4773-7985	National Institutes of Health [R01 CA130940]; Achievement Reward for College Scientists Foundation Eller scholarship; Science Foundation Arizona fellowship; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA130940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Reward for College Scientists Foundation Eller scholarship; Science Foundation Arizona fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130940 (to N. L. T.). This work was also supported by an Achievement Reward for College Scientists Foundation Eller scholarship and a Science Foundation Arizona fellowship (to S. P. F. E.).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; ANDO S, 1992, J BIOL CHEM, V267, P25709; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; BURGER PC, 1988, J NEUROSURG, V68, P698, DOI 10.3171/jns.1988.68.5.0698; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Lin WJ, 2011, P NATL ACAD SCI USA, V108, P18354, DOI 10.1073/pnas.1109427108; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Prieto-Sanchez RM, 2003, J BIOL CHEM, V278, P37916, DOI 10.1074/jbc.M301437200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sampetrean O, 2011, NEOPLASIA, V13, P784, DOI 10.1593/neo.11624; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Subbaiah VK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002543; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	52	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21887	10.1074/jbc.M113.468686	http://dx.doi.org/10.1074/jbc.M113.468686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775076	Green Published, hybrid			2022-12-28	WOS:000328841900037
J	Yamamoto, K; Matsuoka, T; Kawashima, S; Takebe, S; Kubo, N; Miyatsuka, T; Kaneto, H; Shimomura, I				Yamamoto, Kaoru; Matsuoka, Taka-aki; Kawashima, Satoshi; Takebe, Satomi; Kubo, Noriyo; Miyatsuka, Takeshi; Kaneto, Hideaki; Shimomura, Iichiro			A Novel Function of Onecut1 Protein as a Negative Regulator of MafA Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Diabetes; Insulin Synthesis; Islet; Transcription Factors	PANCREATIC BETA-CELLS; INSULIN GENE; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; PDX-1 GENE; DIFFERENTIATION; SEQUENCES; ENDODERM; HNF-6; IDENTIFICATION	The transcription factor MafA is a key regulator of insulin gene expression and maturation of islet cells. Despite its importance, the regulatory mechanism of MafA gene expression is still unclear. To identify the transcriptional regulators of MafA, we examined various transcription factors, which are potentially involved in cell differentiation. An adenovirus-mediated overexpression study clearly demonstrated that Onecut1 suppresses the promoter activity of MafA through the Foxa2-binding cis-element on the MafA enhancer region (named area A). However, ChIP analysis showed that Foxa2 but not Onecut1 could directly bind to area A. Furthermore, overexpression of Onecut1 inhibited the binding of Foxa2 onto area A upon ChIP analysis. Importantly, insertion of a mutation in the Foxa2-binding site of area A significantly decreased the promoter activity of MafA. These findings suggest that Onecut1 suppresses MafA gene expression through the Foxa2-binding site. In the mouse pancreas, MafA expression was first detected at the latest stage of cell differentiation and was scarcely observed in Onecut1-positive cells during pancreas development. In addition, Onecut1 expression was significantly increased in the islets of diabetic db/db mice, whereas MafA expression was markedly decreased. The improved glucose levels of db/db mice with insulin injections significantly reduced Onecut1 expression and rescued the reduction of MafA expression. These in vivo experiments also suggest that Onecut1 is a negative regulator of MafA gene expression. This study implicates the novel role of Onecut1 in the control of normal cell differentiation and its involvement in cell dysfunction under diabetic conditions by suppressing MafA gene expression.	[Yamamoto, Kaoru; Matsuoka, Taka-aki; Kawashima, Satoshi; Takebe, Satomi; Kubo, Noriyo; Miyatsuka, Takeshi; Kaneto, Hideaki; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Osaka University	Matsuoka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	matsuoka@endmet.med.osaka-u.ac.jp			Juvenile Diabetes Research Foundation [2-2005-946]; KAKENHI [10379258]; Grants-in-Aid for Scientific Research [24591328] Funding Source: KAKEN	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Juvenile Diabetes Research Foundation Career Development Award 2-2005-946 (to T. M.) and KAKENHI Grant 10379258 (to T. M.).	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Gannon M, 2000, DEVELOPMENT, V127, P2883; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Tweedie E, 2006, DIABETES, V55, P3264, DOI 10.2337/db06-0090; Villasenor A, 2008, DEV DYNAM, V237, P3270, DOI 10.1002/dvdy.21740; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006	37	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21648	21658		10.1074/jbc.M113.481424	http://dx.doi.org/10.1074/jbc.M113.481424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775071	hybrid, Green Published			2022-12-28	WOS:000328841900017
J	Absalom, NL; Quek, G; Lewis, TM; Qudah, T; von Arenstorff, I; Ambrus, JI; Harpsoe, K; Karim, N; Balle, T; Mcleod, MD; Chebib, M				Absalom, Nathan L.; Quek, Gracia; Lewis, Trevor M.; Qudah, Taima; von Arenstorff, Ida; Ambrus, Joseph I.; Harpsoe, Kasper; Karim, Nasiara; Balle, Thomas; Mcleod, Malcolm D.; Chebib, Mary			Covalent Trapping of Methyllycaconitine at the alpha 4-alpha 4 Interface of the alpha 4 beta 2 Nicotinic Acetylcholine Receptor ANTAGONIST BINDING SITE AND MODE OF RECEPTOR INHIBITION REVEALED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL SUBUNIT INTERFACES; POSITIVE ALLOSTERIC MODULATOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; LIGAND-SELECTIVITY; PROTEIN; AGONIST; DOMAIN; STOICHIOMETRY; GALANTHAMINE	The alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs) are widely expressed in the brain and are implicated in a variety of physiological processes. There are two stoichiometries of the alpha 4 beta 2 nAChR, (alpha 4)(2)(beta 2)(3) and (alpha 4)(3)(beta 2)(2), with different sensitivities to acetylcholine (ACh), but their pharmacological profiles are not fully understood. Methyllycaconitine (MLA) is known to be an antagonist of nAChRs. Using the two-electrode voltage clamp technique and alpha 4 beta 2 nAChRs in the Xenopus oocyte expression system, we demonstrate that inhibition by MLA occurs via two different mechanisms; that is, a direct competitive antagonism and an apparently insurmountable mechanism that only occurs after preincubation with MLA. We hypothesized an additional MLA binding site in the alpha 4-alpha 4 interface that is unique to this stoichiometry. To prove this, we covalently trapped a cysteine-reactive MLA analog at an alpha 4 beta 2 receptor containing an alpha 4(D204C) mutation predicted by homology modeling to be within reach of the reactive probe. We demonstrate that covalent trapping results in irreversible reduction of ACh-elicited currents in the (alpha 4)(3)(beta 2)(2) stoichiometry, indicating that MLA binds to the alpha 4-alpha 4 interface of the (alpha 4)(3)(beta 2)(2) and providing direct evidence of ligand binding to the alpha 4-alpha 4 interface. Consistent with other studies, we propose that the alpha 4-alpha 4 interface is a structural target for potential therapeutics that modulate (alpha 4)(3)(beta 2)(2) nAChRs.	[Karim, Nasiara; Balle, Thomas; Chebib, Mary] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Lewis, Trevor M.] Univ New South Wales Med, Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Ambrus, Joseph I.; Mcleod, Malcolm D.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia; [Harpsoe, Kasper] Univ Copenhagen, Fac Hlth & Med Sci, NFF Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Sydney; University of New South Wales Sydney; Australian National University; University of Copenhagen	Chebib, M (corresponding author), Univ Sydney, Fac Pharm, Pharm Bldg A15, Camperdown, NSW 2006, Australia.	mary.collins@sydney.edu.au	Harpsøe, Kasper/V-6870-2018; Lewis, Trevor/A-2939-2011; McLeod, Malcolm D./AAT-2884-2020; McLeod, Malcolm D/C-9966-2014	Harpsøe, Kasper/0000-0002-9326-9644; Lewis, Trevor/0000-0003-1864-6806; McLeod, Malcolm D./0000-0002-2343-3226; McLeod, Malcolm D/0000-0002-2343-3226; Balle, Thomas/0000-0002-0233-8350	Australian Research Council [DP0986469]; Faculty Development Scholarship from the University of Malakand, Pakistan; John Lamberton Scholarship; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Faculty Development Scholarship from the University of Malakand, Pakistan; John Lamberton Scholarship; Australian Postgraduate Award(Australian Government)	This work was supported by Australian Research Council Discovery Project DP0986469.; Supported by a Faculty Development Scholarship from the University of Malakand, Pakistan, and the John Lamberton Scholarship.; Supported by an Australian Postgraduate Award and a John Lamberton Scholarship.	Absalom NL, 2004, EXP PHYSIOL, V89, P145, DOI 10.1113/expphysiol.2003.026815; Akdemir A, 2011, BIOORGAN MED CHEM, V19, P6107, DOI 10.1016/j.bmc.2011.08.028; ALKONDON M, 1992, MOL PHARMACOL, V41, P802; Ambrus JI, 2012, CHEM COMMUN, V48, P6699, DOI 10.1039/c2cc32442c; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arias HR, 2010, BIOCHEMISTRY-US, V49, P4169, DOI 10.1021/bi901999v; Bisson WH, 2005, J MED CHEM, V48, P5123, DOI 10.1021/jm040881a; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; DRASDO A, 1992, MOL CELL NEUROSCI, V3, P237, DOI 10.1016/1044-7431(92)90043-2; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang XQ, 2006, J MED CHEM, V49, P7661, DOI 10.1021/jm0606701; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Quek GXJ, 2010, ACS CHEM NEUROSCI, V1, P796, DOI 10.1021/cn100073x; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rowbotham MC, 2009, PAIN, V146, P245, DOI 10.1016/j.pain.2009.06.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schapira Matthieu, 2002, BMC Structural Biology, V2, P1, DOI 10.1186/1472-6807-2-1; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Zwart R, 2006, EUR J PHARMACOL, V539, P10, DOI 10.1016/j.ejphar.2006.03.077	47	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26521	26532		10.1074/jbc.M113.475053	http://dx.doi.org/10.1074/jbc.M113.475053			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23893416	Green Published, hybrid			2022-12-28	WOS:000330594500019
J	Li, L; Francklyn, C; Carter, CW				Li, Li; Francklyn, Christopher; Carter, Charles W., Jr.			Aminoacylating Urzymes Challenge the RNA World Hypothesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; GENETIC-CODE; MOLECULAR EVOLUTION; AMINO-ACIDS; SYNTHETASE; PROTEINS; BINDING; DOMAIN; MODEL; REACTIVITY	We describe experimental evidence that ancestral peptide catalysts substantially accelerated development of genetic coding. Structurally invariant 120-130-residue Urzymes (Ur = primitive plus enzyme) derived from Class I and Class II aminoacyl-tRNA synthetases (aaRSs) acylate tRNA far faster than the uncatalyzed rate of nonribosomal peptide bond formation from activated amino acids. These new data allow us to demonstrate statistically indistinguishable catalytic profiles for Class I and II aaRSs in both amino acid activation and tRNA acylation, over a time period extending to well before the assembly of full-length enzymes and even further before the Last Universal Common Ancestor. Both Urzymes also exhibit similar to 60% of the contemporary catalytic proficiencies. Moreover, they are linked by ancestral sense/antisense genetic coding, and their evident modularities suggest descent from even simpler ancestral pairs also coded by opposite strands of the same gene. Thus, aaRS Urzymes substantially pre-date modern aaRS but are, nevertheless, highly evolved. Their unexpectedly advanced catalytic repertoires, sense/antisense coding, and ancestral modularities imply considerable prior protein-tRNA co-evolution. Further, unlike ribozymes that motivated the RNA World hypothesis, Class I and II Urzyme.tRNA pairs represent consensus ancestral forms sufficient for codon-directed synthesis of nonrandom peptides. By tracing aaRS catalytic activities back to simpler ancestral peptides, we demonstrate key steps for a simpler and hence more probable peptide.RNA development of rapid coding systems matching amino acids with anticodon trinucleotides.	[Li, Li; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Francklyn, Christopher] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Vermont	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			NIGMS/National Institutes of Health [78227, 54899]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227, R01GM054899] Funding Source: NIH RePORTER	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS/National Institutes of Health Grants 78227 ( to C. W. C.) and 54899 (to C.F.).	Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Berezovsky IN, 2000, FEBS LETT, V466, P283, DOI 10.1016/S0014-5793(00)01091-7; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; CARTER CW, 1974, P NATL ACAD SCI USA, V71, P283, DOI 10.1073/pnas.71.2.283; Cech TR, 2009, CELL, V136, P599, DOI 10.1016/j.cell.2009.02.002; Chandrasekaran SN, 2013, MOL BIOL EVOL, V30, P1588, DOI 10.1093/molbev/mst070; CHURCH GM, 1977, P NATL ACAD SCI USA, V74, P1458, DOI 10.1073/pnas.74.4.1458; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fournier GP, 2011, ORIGINS LIFE EVOL B, V41, P621, DOI 10.1007/s11084-011-9261-2; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1992, EUR J BIOCHEM, V206, P315, DOI 10.1111/j.1432-1033.1992.tb16929.x; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; HARTLEIN M, 1995, J MOL EVOL, V40, P519; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; JOSEPH DR, 1971, J BIOL CHEM, V246, P7602; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; Koonin E. V., 2012, LOGIC CHANCE NATURE, P351; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; SAS, 2007, SAS VERS 6; Schall OF, 1998, J ORG CHEM, V63, P8661, DOI 10.1021/jo971874f; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Wolfson AD, 1998, RNA, V4, P1019, DOI 10.1017/S1355838298980700; Xin Y, 2000, J MOL BIOL, V303, P299, DOI 10.1006/jmbi.2000.4126; Yarus M, 2000, RNA, V6, P475, DOI 10.1017/S1355838200002569; Yarus M., 2011, LIFE RNA WORLD ANCES, P132; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	41	49	56	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26856	26863		10.1074/jbc.M113.496125	http://dx.doi.org/10.1074/jbc.M113.496125			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23867455	Green Published, hybrid			2022-12-28	WOS:000330594500051
J	Patnode, ML; Cheng, CW; Chou, CC; Singer, MS; Elin, MS; Uchimura, K; Crocker, PR; Khoo, KH; Rosen, SD				Patnode, Michael L.; Cheng, Chu-Wen; Chou, Chi-Chi; Singer, Mark S.; Elin, Matilda S.; Uchimura, Kenji; Crocker, Paul R.; Khoo, Kay-Hooi; Rosen, Steven D.			Galactose 6-O-Sulfotransferases Are Not Required for the Generation of Siglec-F Ligands in Leukocytes or Lung Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE; SIALIC ACIDS; COUNTER-RECEPTOR; MOUSE-MODELS; GLYCAN ARRAY; MAST-CELLS; L-SELECTIN; MSIGLEC-F; IN-VIVO; EOSINOPHILS	Eosinophil accumulation is a characteristic feature of the immune response to parasitic worms and allergens. The cell surface carbohydrate-binding receptor Siglec-F is highly expressed on eosinophils and negatively regulates their accumulation during inflammation. Although endogenous ligands for Siglec-F have yet to be biochemically defined, binding studies using glycan arrays have implicated galactose 6-O-sulfate (Gal6S) as a partial recognition determinant for this receptor. Only two sulfotransferases are known to generate Gal6S, namely keratan sulfate galactose 6-O-sulfotransferase (KSGal6ST) and chondroitin 6-O-sulfotransferase 1 (C6ST-1). Here we use mice deficient in both KSGal6ST and C6ST-1 to determine whether these sulfotransferases are required for the generation of endogenous Siglec-F ligands. First, we characterize ligand expression on leukocyte populations and find that ligands are predominantly expressed on cell types also expressing Siglec-F, namely eosinophils, neutrophils, and alveolar macrophages. We also detect Siglec-F ligand activity in bronchoalveolar lavage fluid fractions containing polymeric secreted mucins, including MUC5B. Consistent with these observations, ligands in the lung increase dramatically during infection with the parasitic nematode, Nippostrongylus brasiliensis, which is known to induce eosinophil accumulation and mucus production. Surprisingly, Gal6S is undetectable in sialylated glycans from eosinophils and BAL fluid analyzed by mass spectrometry. Furthermore, none of the ligands we describe are diminished in mice lacking KSGal6ST and C6ST-1, indicating that neither of the known galactose 6-O-sulfotransferases is required for ligand synthesis. These results establish that ligands for Siglec-F are present on several cell types that are relevant during allergic lung inflammation and argue against the widely held view that Gal6S is critical for glycan recognition by this receptor.	[Patnode, Michael L.; Singer, Mark S.; Elin, Matilda S.; Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Patnode, Michael L.; Singer, Mark S.; Elin, Matilda S.; Rosen, Steven D.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Cheng, Chu-Wen; Chou, Chi-Chi; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Uchimura, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Academia Sinica - Taiwan; University of Dundee; Nagoya University	Rosen, SD (corresponding author), 513 Parnassus Ave, San Francisco, CA USA.	steven.rosen@ucsf.edu	Khoo, Kay-Hooi/E-1989-2019; Uchimura, Kenji/C-9635-2014; Uchimura, Kenji/AFV-1802-2022; Chou, Chi-Chi/X-6053-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X; Chou, Chi-Chi/0000-0002-7862-7757; Crocker, Paul/0000-0001-6230-0293; Rosen, Steven/0000-0002-6245-701X; Patnode, Michael/0000-0003-1981-5261	National Institutes of Health [GM-23547, GM-57411]; Academia Sinica; Taiwan National Science Council [99-2311-B-001-021-MY3]; Taiwan National Core Facility Program for Biotechnology [NSC100-2325-B-001-029, NSC101-2319-B-001-003]; Wellcome Trust Senior Fellowship [WT081882]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023547, R01GM057411, R01GM023547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan National Core Facility Program for Biotechnology; Wellcome Trust Senior Fellowship(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-23547 and GM-57411 (to S. D. R.), Academia Sinica and Taiwan National Science Council Grant 99-2311-B-001-021-MY3 (to K. H. K.), the Taiwan National Core Facility Program for Biotechnology Grants NSC100-2325-B-001-029 and NSC101-2319-B-001-003 to the Core Facilities for Protein Structural Analysis at Academia Sinica, and Wellcome Trust Senior Fellowship WT081882 (to P. R. C.).	Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Camberis M., 2003, CURR PROTOC IMMUNOL, V19; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Carvalho EM, 2006, PARASITE IMMUNOL, V28, P525, DOI 10.1111/j.1365-3024.2006.00894.x; Cho JY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-154; Chokhawala HA, 2007, CHEMBIOCHEM, V8, P194, DOI 10.1002/cbic.200600410; COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Ducreux J, 2009, IMMUNOL LETT, V124, P77, DOI 10.1016/j.imlet.2009.04.006; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; Guzman-Aranguez A, 2010, OCUL SURF, V8, P8, DOI 10.1016/S1542-0124(12)70213-6; Habuchi O, 1996, GLYCOBIOLOGY, V6, P51, DOI 10.1093/glycob/6.1.51; Habuchi O, 1997, GLYCOBIOLOGY, V7, P405, DOI 10.1093/glycob/7.3.405; Hemmerich S, 2000, GLYCOBIOLOGY, V10, P849, DOI 10.1093/glycob/10.9.849; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hosono-Fukao T, 2012, AM J PATHOL, V180, P2056, DOI 10.1016/j.ajpath.2012.01.015; Hudson SA, 2009, J PHARMACOL EXP THER, V330, P608, DOI 10.1124/jpet.109.152439; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; Kikly KK, 2000, J ALLERGY CLIN IMMUN, V105, P1093, DOI 10.1067/mai.2000.107127; Kitazume S, 1996, J BIOL CHEM, V271, P6694, DOI 10.1074/jbc.271.12.6694; Kiwamoto T, 2013, CURR OPIN ALLERGY CL, V13, P106, DOI 10.1097/ACI.0b013e32835b594a; Kiwamoto T, 2012, PHARMACOL THERAPEUT, V135, P327, DOI 10.1016/j.pharmthera.2012.06.005; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Lauder RM, 2011, GLYCOCONJUGATE J, V28, P453, DOI 10.1007/s10719-011-9343-4; Lee NA, 1997, J IMMUNOL, V158, P1332; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morimoto N, 2001, ANAL CHEM, V73, P5422, DOI 10.1021/ac0104328; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Nath D, 1999, IMMUNOLOGY, V98, P213; Norris HH, 2007, J LEUKOCYTE BIOL, V82, P1531, DOI 10.1189/jlb.1106667; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Oyoshi MK, 2012, P NATL ACAD SCI USA, V109, P4992, DOI 10.1073/pnas.1203127109; Patnode ML, 2013, GLYCOBIOLOGY, V23, P381, DOI 10.1093/glycob/cws166; Rapoport EM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P496, DOI 10.1134/S0006297906050051; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Redelinghuys P, 2011, J BIOL CHEM, V286, P34522, DOI 10.1074/jbc.M111.243410; Rhodes JM, 2008, BIOCHEM SOC T, V36, P1482, DOI 10.1042/BST0361482; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Song DJ, 2009, CLIN IMMUNOL, V131, P157, DOI 10.1016/j.clim.2008.11.009; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Suzukawa M, 2013, J IMMUNOL, V190, P5939, DOI 10.4049/jimmunol.1203455; Suzuki-Inoue K, 2011, J THROMB HAEMOST, V9, P44, DOI 10.1111/j.1538-7836.2011.04335.x; Swanson BJ, 2007, CANCER RES, V67, P10222, DOI 10.1158/0008-5472.CAN-06-2483; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Thornton DJ, 2001, GLYCOBIOLOGY, V11, P969, DOI 10.1093/glycob/11.11.969; Tomita M, 2000, RESPIRATION, V67, P565, DOI 10.1159/000067475; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; TORRES RM, 1992, J IMMUNOL, V149, P2641; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Yamakawa N, 2007, BIOCHIMIE, V89, P1396, DOI 10.1016/j.biochi.2007.04.010; Yu SY, 2013, GLYCOCONJUGATE J, V30, P183, DOI 10.1007/s10719-012-9396-z; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	85	35	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26533	26545		10.1074/jbc.M113.485409	http://dx.doi.org/10.1074/jbc.M113.485409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23880769	Green Published, hybrid			2022-12-28	WOS:000330594500020
J	Herrera, I; Cisneros, J; Maldonado, M; Ramirez, R; Ortiz-Quintero, B; Anso, E; Chandel, NS; Selman, M; Pardo, A				Herrera, Iliana; Cisneros, Jose; Maldonado, Mariel; Ramirez, Remedios; Ortiz-Quintero, Blanca; Anso, Elena; Chandel, Navdeep S.; Selman, Moises; Pardo, Annie			Matrix Metalloproteinase (MMP)-1 Induces Lung Alveolar Epithelial Cell Migration and Proliferation, Protects from Apoptosis, and Represses Mitochondrial Oxygen Consumption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; I COLLAGEN; EXPRESSION; PATHOGENESIS; METABOLISM; EMPHYSEMA; THERAPY; RELEASE	Idiopathic pulmonary fibrosis is a devastating lung disorder of unknown etiology. Although its pathogenesis is unclear, considerable evidence supports an important role of aberrantly activated alveolar epithelial cells (AECs), which produce a large variety of mediators, including several matrix metalloproteases (MMPs), which participate in fibroblast activation and lung remodeling. MMP-1 has been shown to be highly expressed in AECs from idiopathic pulmonary fibrosis lungs although its role is unknown. In this study, we explored the role of MMP-1 in several AECs functions. Mouse lung epithelial cells (MLE12) transfected with human Mmp-1 showed significantly increased cell growth and proliferation at 36 and 48 h of culture (p < 0.01). Also, MMP-1 promoted MLE12 cell migration through collagen I, accelerated wound closing, and protected cells from staurosporine- and bleomycin-induced apoptosis compared with mock cells (p < 0.01). MLE12 cells expressing human MMP-1 showed a significant repression of oxygen consumption ratio compared with the cells with the empty vector. As under hypoxic conditions hypoxia-inducible factor-1 alpha (HIF-1 alpha) mediates a transition from oxidative to glycolytic metabolism, we analyzed activation of HIF-1 alpha. Higher activation of this factor was detected in MMP-1-transfected cells under normoxia and hypoxia. Likewise, a significant decrease of both total and mitochondrial reactive oxygen species was observed in MMP-1-transfected cells. Paralleling these findings, attenuation of MMP-1 expression by shRNA in A549 (human) AECs markedly reduced proliferation and migration (p < 0.01) and increased the oxygen consumption ratio. These findings indicate that epithelial expression of MMP-1 inhibits mitochondrial function, increases HIF-1 alpha expression, decreases reactive oxygen species production, and contributes to a proliferative, migratory, and anti-apoptotic AEC phenotype.	[Herrera, Iliana; Maldonado, Mariel; Ramirez, Remedios; Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Cisneros, Jose; Ortiz-Quintero, Blanca; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City 14080, DF, Mexico; [Anso, Elena; Chandel, Navdeep S.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Universidad Nacional Autonoma de Mexico; Northwestern University	Pardo, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Ciudad Univ, Mexico City 04510, DF, Mexico.	apardos@unam.mx		Maldonado, Mariel/0000-0002-4227-2704; Cisneros, Jose/0000-0002-4592-4464; ortiz, blanca/0000-0001-6298-0073; HERRERA, ILIANA/0000-0002-4086-7456	Consejo Nacional de Ciencia y Tecnologia, Mexico [177641]; UNAM	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia, Mexico Grant 177641.; This paper constitutes a partial fulfillment of the Graduate Program in Bio-medical Sciences of the Universidad Nacional Autonoma de Mexico (UNAM). Supported by the Consejo Nacional de Ciencia y Tecnologia, Mexico and UNAM.	Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Conant K, 2002, J NEUROCHEM, V82, P885, DOI 10.1046/j.1471-4159.2002.01038.x; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hamanaka RB, 2011, SCIENCE, V334, P1219, DOI 10.1126/science.1215637; Hatfield KJ, 2010, CURR MED CHEM, V17, P4448; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Limb GA, 2005, AM J PATHOL, V166, P1555, DOI 10.1016/S0002-9440(10)62371-1; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; Mateos J, 2012, J PROTEOMICS, V75, P2869, DOI 10.1016/j.jprot.2011.12.042; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Rajah Roopa, 1995, Progress in Growth Factor Research, V6, P273, DOI 10.1016/0955-2235(95)00012-7; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; WALAKOVITS LA, 1992, ARTHRITIS RHEUM, V35, P35, DOI 10.1002/art.1780350106; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	32	76	79	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25964	25975		10.1074/jbc.M113.459784	http://dx.doi.org/10.1074/jbc.M113.459784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902766	Green Published, hybrid			2022-12-28	WOS:000330623300027
J	Mellor, L; Knudson, CB; Hida, D; Askew, EB; Knudson, W				Mellor, Liliana; Knudson, Cheryl B.; Hida, Daisuke; Askew, Emily B.; Knudson, Warren			Intracellular Domain Fragment of CD44 Alters CD44 Function in Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BOVINE ARTICULAR CHONDROCYTES; TUMOR-CELL MIGRATION; PROTEIN-KINASE-C; NF-KAPPA-B; HYALURONIC-ACID; SIGNALING PATHWAY; CARCINOMA-CELLS; SOLUBLE CD44; PERICELLULAR MATRICES	The hyaluronan receptor CD44 undergoes sequential proteolytic cleavage at the cell surface. The initial cleavage of the CD44 extracellular domain is followed by a second intramembranous cleavage of the residual CD44 fragment, liberating the C-terminal cytoplasmic tail of CD44. In this study conditions that promote CD44 cleavage resulted in a diminished capacity to assemble and retain pericellular matrices even though sufficient non-degraded full-length CD44 remained. Using stable and transient overexpression of the cytoplasmic domain of CD44, we determined that the intracellular domain interfered with anchoring of the full-length CD44 to the cytoskeleton and disrupted the ability of the cells to bind hyaluronan and assemble a pericellular matrix. Co-immunoprecipitation assays were used to determine whether the mechanism of this interference was due to competition with actin adaptor proteins. CD44 of control chondrocytes was found to interact and co-immunoprecipitate with both the 65-and 130-kDa isoforms of ankyrin-3. Moreover, this interaction with ankyrin-3 proteins was diminished in cells overexpressing the CD44 intracellular domain. Mutating the putative ankyrin binding site of the transiently transfected CD44 intracellular domain diminished the inhibitory effects of this protein on matrix retention. Although CD44 in other cells types has been shown to interact with members of the ezrin/radixin/moesin (ERM) family of adaptor proteins, only modest interactions between CD44 and moesin could be demonstrated in chondrocytes. The data suggest that release of the CD44 intracellular domain into the cytoplasm of cells such as chondrocytes exerts a competitive or dominant-negative effect on the function of full-length CD44.	[Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu	Askew, Eldon W/F-5347-2014	Liliana, Mellor/0000-0001-6560-6634	National Institutes of Health [R01-AR43384, R01-AR39507, RO1-AR043384-15S1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043384, R01AR039507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR43384 (to W. K.) and R01-AR39507 (to C. B. K.) and RO1-AR043384-15S1 (NIAMS; Research Supplemental to Promote Diversity in Health-related Research; to L. M.).	Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P906, DOI 10.1016/j.joca.2008.12.007; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Cichy J, 2002, J BIOL CHEM, V277, P44440, DOI 10.1074/jbc.M207437200; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GUO YJ, 1994, CANCER RES, V54, P422; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; HUA Q, 1993, J CELL SCI, V106, P365; Kawano Y, 2000, J BIOL CHEM, V275, P29628, DOI 10.1074/jbc.M002440200; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P83; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; KUCHARSKA AM, 1990, J ORTHOPAED RES, V8, P781, DOI 10.1002/jor.1100080602; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; Liu DC, 1996, CELL IMMUNOL, V174, P73, DOI 10.1006/cimm.1996.0295; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marhaba R, 2004, J MOL HISTOL, V35, P211; Masson D, 1999, BRIT J CANCER, V80, P1995, DOI 10.1038/sj.bjc.6690633; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Nofal GA, 2002, J HISTOCHEM CYTOCHEM, V50, P1313, DOI 10.1177/002215540205001004; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Ohno S, 2005, ARTHRITIS RHEUM-US, V52, P800, DOI 10.1002/art.20937; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Schmitz I, 2010, OSTEOARTHR CARTILAGE, V18, P447, DOI 10.1016/j.joca.2009.10.007; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Yamane N, 1999, ONCOLOGY-BASEL, V56, P232, DOI 10.1159/000011970; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhu D, 2000, J CELL PHYSIOL, V183, P182, DOI 10.1002/(SICI)1097-4652(200005)183:2<182::AID-JCP5>3.0.CO;2-O	67	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25838	25850		10.1074/jbc.M113.494872	http://dx.doi.org/10.1074/jbc.M113.494872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884413	Green Published, hybrid			2022-12-28	WOS:000330623300016
J	Patel, M; Predescu, D; Tandon, R; Bardita, C; Pogoriler, J; Bhorade, S; Wang, MH; Comhair, S; Ryan-Hemnes, A; Chen, JW; Machado, R; Husain, A; Erzurum, S; Predescu, S				Patel, Monal; Predescu, Dan; Tandon, Rajive; Bardita, Cristina; Pogoriler, Jennifer; Bhorade, Sangeeta; Wang, Minhua; Comhair, Suzy; Ryan-Hemnes, Anna; Chen, Jiwang; Machado, Roberto; Husain, Aliya; Erzurum, Serpil; Predescu, Sanda			A Novel p38 Mitogen-activated Protein Kinase/Elk-1 Transcription Factor-dependent Molecular Mechanism Underlying Abnormal Endothelial Cell Proliferation in Plexogenic Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANZYME-B EXPRESSION; SIGNALING CONTRIBUTES; PLEXIFORM LESIONS; MAP KINASE; LUNG; INTERSECTIN; SURVIVAL; INJURY; LIPOPOLYSACCHARIDE; INDUCTION	Plexiform lesions (PLs), the hallmark of plexogenic pulmonary arterial hypertension (PAH), contain phenotypically altered, proliferative endothelial cells (ECs). The molecular mechanism that contributes to EC proliferation and formation of PLs is poorly understood. We now show that a decrease in intersectin-1s (ITSN-1s) expression due to granzyme B (GrB) cleavage during inflammation associated with PAH and the high p38/Erk1/2(MAPK) activity ratio caused by the GrB/ITSN cleavage products lead to EC proliferation and selection of a proliferative/plexiform EC phenotype. We used human pulmonary artery ECs of PAH subjects (ECPAH), paraffin-embedded and frozen human lung tissue, and animal models of PAH in conjunction with microscopy imaging, biochemical, and molecular biology approaches to demonstrate that GrB cleaves ITSN-1s, a prosurvival protein of lung ECs, and generates two biologically active fragments, an N-terminal fragment (GrB-EHITSN) with EC proliferative potential and a C-terminal product with dominant negative effects on Ras/Erk1/2. The proliferative potential of GrB-EHITSN is mediated via sustained phosphorylation of p38(MAPK) and Elk-1 transcription factor and abolished by chemical inhibition of p38(MAPK). Moreover, lung tissue of PAH animal models and human specimens and ECPAH express lower levels of ITSN-1s compared with controls and the GrB-EHITSN cleavage product. Moreover, GrB immunoreactivity is associated with PLs in PAH lungs. The concurrent expression of the two cleavage products results in a high p38/Erk1/2MAPK activity ratio, which is critical for EC proliferation. Our findings identify a novel GrB-EHITSN-dependent pathogenic p38(MAPK)/Elk-1 signaling pathway involved in the poorly understood process of PL formation in severe PAH.	[Patel, Monal; Predescu, Dan; Tandon, Rajive; Bardita, Cristina; Wang, Minhua; Predescu, Sanda] Rush Univ, Med Ctr, Dept Med & Pharmacol, Chicago, IL 60612 USA; [Patel, Monal; Predescu, Dan; Tandon, Rajive; Bardita, Cristina; Wang, Minhua; Predescu, Sanda] Rush Univ, Med Ctr, Dept Vasc Biol, Chicago, IL 60612 USA; [Patel, Monal; Predescu, Dan; Tandon, Rajive; Bardita, Cristina; Wang, Minhua; Predescu, Sanda] Rush Univ, Med Ctr, Dept Pulm & Crit Care Med, Chicago, IL 60612 USA; [Pogoriler, Jennifer; Husain, Aliya] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bhorade, Sangeeta] Univ Chicago, Ctr Lung Transplant, Chicago, IL 60637 USA; [Comhair, Suzy; Erzurum, Serpil] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Ryan-Hemnes, Anna] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Nashville, TN 37240 USA; [Chen, Jiwang; Machado, Roberto] Univ Illinois, Sect Pulm Crit Care Med Sleep & Allergy, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; University of Chicago; University of Chicago; Cleveland Clinic Foundation; Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, S (corresponding author), Rush Univ, Med Ctr, Dept Pharmacol, 1735 W Harrison St,1535 JS, Chicago, IL 60612 USA.	sanda_predescu@rush.edu		Machado, Roberto/0000-0002-3722-5954; Predescu, Sanda/0000-0002-9386-6756	National Institutes of Health [HL089462, HL089462-02S1, HL60917]; Rush University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, R01HL089462, R37HL060917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089462, HL089462-02S1 (to S. P.), and HL60917 (to S. E.). This work was also supported by start-up funds from Rush University.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Adams A, 2000, J BIOL CHEM, V275, P27414; Aliotta JM, 2009, STEM CELLS DEV, V18, P773, DOI 10.1089/scd.2008.0237; Ars C, 2009, EUR RESPIR J, V34, P1494, DOI 10.1183/09031936.00140109; Austin ED, 2010, RESP MED, V104, P454, DOI 10.1016/j.rmed.2009.10.004; Bardita C, 2013, APOPTOSIS, V18, P57, DOI 10.1007/s10495-012-0762-x; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Buzza MS, 2001, CELL IMMUNOL, V210, P21, DOI 10.1006/cimm.2001.1806; CLEMENT MV, 1994, TRANSPLANTATION, V57, P322, DOI 10.1097/00007890-199402150-00002; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Cool CD, 1997, HUM PATHOL, V28, P434, DOI 10.1016/S0046-8177(97)90032-0; Cypel M, 2013, EUR J CARDIO-THORAC, V43, P419, DOI 10.1093/ejcts/ezs461; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; De Perrot M, 2001, TRANSPLANTATION, V72, P1505, DOI 10.1097/00007890-200111150-00006; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; George J, 2011, J HYPERTENS, V29, P299, DOI 10.1097/HJH.0b013e328340a0e4; GIL J, 1982, ANN NY ACAD SCI, V384, P31, DOI 10.1111/j.1749-6632.1982.tb21359.x; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; HAIES DM, 1981, AM REV RESPIR DIS, V123, P533; Han JY, 2006, NEUROSCI LETT, V398, P113, DOI 10.1016/j.neulet.2005.12.065; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Hostetter DR, 2007, J BIOL CHEM, V282, P27865, DOI 10.1074/jbc.M704312200; Huang J, 2012, EXP BIOL MED, V237, P956, DOI 10.1258/ebm.2012.011382; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Knezevic I, 2011, J CELL MOL MED, V15, P2364, DOI 10.1111/j.1582-4934.2010.01226.x; Kropyvko S, 2010, MOL BIOL REP, V37, P2789, DOI 10.1007/s11033-009-9824-8; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Maxwell JR, 2002, J IMMUNOL, V168, P4372, DOI 10.4049/jimmunol.168.9.4372; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Predescu D., 2012, CANC RES S1, V72; Predescu DN, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/672705; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Seta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023439; Shi RL, 2004, TRANSPL IMMUNOL, V12, P103, DOI 10.1016/j.trim.2003.11.002; Singla S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-46; Susanto O, 2012, TISSUE ANTIGENS, V80, P477, DOI 10.1111/tan.12014; Suzuki YJ, 2007, AM J RESP CELL MOL, V36, P678, DOI 10.1165/rcmb.2006-0359OC; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Venkateswaran RV, 2008, ANN THORAC SURG, V85, P278, DOI 10.1016/j.athoracsur.2007.07.092; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wang W, 2011, MOL BIOL REP, V38, P3277, DOI 10.1007/s11033-010-0390-x; Welsh DJ, 2001, AM J RESP CRIT CARE, V164, P282, DOI 10.1164/ajrccm.164.2.2008054; Wuyts WA, 2005, J HEART LUNG TRANSPL, V24, P875, DOI 10.1016/j.healun.2004.05.003; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	61	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25701	25716		10.1074/jbc.M113.502674	http://dx.doi.org/10.1074/jbc.M113.502674			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23893408	hybrid, Green Published			2022-12-28	WOS:000330623300004
J	Kato, Y; Yagi, H; Kaji, Y; Oshika, T; Goto, Y				Kato, Yusuke; Yagi, Hisashi; Kaji, Yuichi; Oshika, Tetsuro; Goto, Yuji			Benzalkonium Chloride Accelerates the Formation of the Amyloid Fibrils of Corneal Dystrophy-associated Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL TRANSITION; KERATO-EPITHELIN MUTATIONS; ACID-CONTAINING PROTEINS; HOT-SPOTS; IN-VITRO; AGGREGATION; PREDICTION; BETA(2)-MICROGLOBULIN; KERATOEPITHELIN; MECHANISM	Corneal dystrophies are genetic disorders resulting in progressive corneal clouding due to the deposition of amyloid fibrils derived from keratoepithelin, also called transforming growth factor beta-induced protein (TGFBI). The formation of amyloid fibrils is often accelerated by surfactants such as sodium dodecyl sulfate (SDS). Most eye drops contain benzalkonium chloride (BAC), a cationic surfactant, as a preservative substance. In the present study, we aimed to reveal the role of BAC in the amyloid fibrillation of keratoepithelin-derived peptides in vitro. We used three types of 22-residue synthetic peptides covering Leu110-Glu131 of the keratoepithelin sequence: an R-type peptide with wild-type R124, a C-type peptide with C124 associated with lattice corneal dystrophy type I, and a H-type peptide with H124 associated with granular corneal dystrophy type II. The time courses of spontaneous amyloid fibrillation and seed-dependent fibril elongation were monitored in the presence of various concentrations of BAC or SDS using thioflavin T fluorescence. BAC and SDS accelerated the fibrillation of all synthetic peptides in the absence and presence of seeds. Optimal acceleration occurred near the CMC, which suggests that the unstable and dynamic interactions of keratoepithelin peptides with amphipathic surfactants led to the formation of fibrils. These results suggest that eye drops containing BAC may deteriorate corneal dystrophies and that those without BAC are preferred especially for patients with corneal dystrophies.	[Kato, Yusuke; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kaji, Yuichi; Oshika, Tetsuro] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Osaka University; University of Tsukuba	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Grant for Scientific Research, Japan [22810014, 24370067, 24592618]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Grant for Scientific Research, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Ministry of Education, Science, Sports, and Grant for Scientific Research, 22810014 (2010-2011), 24370067 (2012-2015), and 24592618 (2012-2015), Japan and by the Takeda Science Foundation.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Adriaens E, 2001, PHARMACEUT RES, V18, P937, DOI 10.1023/A:1010928025753; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El Kochairi I, 2006, MOL VIS, V12, P461; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hoshino M, 1997, FEBS LETT, V416, P72, DOI 10.1016/S0014-5793(97)01172-1; Kaji Y, 2012, BRIT J OPHTHALMOL, V96, P1127, DOI 10.1136/bjophthalmol-2012-301728; Kaji Y, 2010, CHEM BIODIVERS, V7, P1364, DOI 10.1002/cbdv.200900329; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Millucci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021870; Mullen W, 1973, Surv Ophthalmol, V17, P469; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Ozawa D, 2011, J BIOL CHEM, V286, P10856, DOI 10.1074/jbc.M111.222901; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Schmitt-Bernard CF, 2002, EUR J BIOCHEM, V269, P5149, DOI 10.1046/j.1432-1033.2002.03205.x; Schmitt-Bernard CF, 2000, BIOCHEM BIOPH RES CO, V273, P649, DOI 10.1006/bbrc.2000.2955; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Stoppini M, 2004, PHARMACOL RES, V50, P419, DOI 10.1016/j.phrs.2003.12.025; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	44	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25109	25118		10.1074/jbc.M113.477695	http://dx.doi.org/10.1074/jbc.M113.477695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861389	Green Published, hybrid			2022-12-28	WOS:000330619000011
J	Brandt, K; Maiwald, S; Herkenhoff-Hesselmann, B; Gnirss, K; Greie, JC; Dunn, SD; Deckers-Hebestreit, G				Brandt, Karsten; Maiwald, Sarah; Herkenhoff-Hesselmann, Brigitte; Gnirss, Kerstin; Greie, Joerg-Christian; Dunn, Stanley D.; Deckers-Hebestreit, Gabriele			Individual Interactions of the b Subunits within the Stator of the Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; 2ND STALK; PERIPHERAL STALK; H+-ATPASE; DIMERIZATION DOMAIN; F1F0-ATP SYNTHASE; TERMINAL REGION; EPSILON-SUBUNIT; DELTA SUBUNITS; ALPHA-SUBUNIT	FOF1 ATP synthases are rotary nanomotors that couple proton translocation across biological membranes to the synthesis/hydrolysis of ATP. During catalysis, the peripheral stalk, composed of two b subunits and subunit delta in Escherichia coli, counteracts the torque generated by the rotation of the central stalk. Here we characterize individual interactions of the b subunits within the stator by use of monoclonal antibodies and nearest neighbor analyses via intersubunit disulfide bond formation. Antibody binding studies revealed that the C-terminal region of one of the two b subunits is principally involved in the binding of subunit delta, whereas the other one is accessible to antibody binding without impact on the function of FOF1. Individually substituted cysteine pairs suitable for disulfide cross-linking between the b subunits and the other stator subunits (b-alpha, b-beta, b-delta, and b-a) were screened and combined with each other to discriminate between the two b subunits (i.e. b(I) and b(II)). The results show the b dimer to be located at a non-catalytic alpha/beta cleft, with b(I) close to subunit alpha, whereas b(II) is proximal to subunit beta. Furthermore, b(I) can be linked to subunit delta as well as to subunit a. Among the subcomplexes formed were a-b(I)-alpha, b(II)-beta, alpha-b(I)-b(II)-beta, and a-b(I)-delta. Taken together, the data obtained define the different positions of the two b subunits at a non-catalytic interface and imply that each b subunit has a different role in generating stability within the stator. We suggest that b(I) is functionally related to the single b subunit present in mitochondrial ATP synthase.	[Brandt, Karsten; Maiwald, Sarah; Herkenhoff-Hesselmann, Brigitte; Gnirss, Kerstin; Greie, Joerg-Christian; Deckers-Hebestreit, Gabriele] Univ Osnabruck, Dept Microbiol, D-49069 Osnabruck, Germany; [Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University Osnabruck; Western University (University of Western Ontario)	Deckers-Hebestreit, G (corresponding author), Univ Osnabruck, Dept Microbiol, Barbarastr 11, D-49076 Osnabruck, Germany.	deckers-hebestreit@biologie.uni-osnabrueck.de	Dunn, Stanley/D-3418-2013		Deutsche Forschungsgemeinschaft [DE482/1-1]; Canadian Institutes of Health Research [MT-10237]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Deutsche Forschungsgemeinschaft Grant DE482/1-1 (to G. D.-H.) and by Canadian Institutes of Health Research Grant MT-10237 (to S. D. D.).	Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Birkenhager R, 1999, EUR J BIOCHEM, V264, P385, DOI 10.1046/j.1432-1327.1999.00652.x; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; DECKERSHEBESTREIT G, 1992, J BIOL CHEM, V267, P12364; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; DeLeon-Rangel J, 2013, FEBS LETT, V587, P892, DOI 10.1016/j.febslet.2013.02.012; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Dunn S. D., 2004, HDB ATPASES, P311; DUNN SD, 1980, J BIOL CHEM, V255, P6891; Dunn SD, 2001, BIOCHEMISTRY-US, V40, P187, DOI 10.1021/bi001821j; Fillingame RH, 2000, J EXP BIOL, V203, P9; FRIEDL P, 1979, EUR J BIOCHEM, V100, P175, DOI 10.1111/j.1432-1033.1979.tb02046.x; GABELLINI N, 1988, BIOCHIM BIOPHYS ACTA, V934, P227, DOI 10.1016/0005-2728(88)90186-7; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; HERRMANN RG, 1993, FEBS LETT, V326, P192, DOI 10.1016/0014-5793(93)81789-3; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jager H, 1998, EUR J BIOCHEM, V251, P122, DOI 10.1046/j.1432-1327.1998.2510122.x; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Krebstakies T, 2008, BIOCHEMISTRY-US, V47, P6907, DOI 10.1021/bi800173a; KUMAMOTO CA, 1986, J BIOL CHEM, V261, P37; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; Motz C, 2004, J BIOL CHEM, V279, P49074, DOI 10.1074/jbc.M404543200; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Peng GH, 2006, FEBS LETT, V580, P5934, DOI 10.1016/j.febslet.2006.09.062; PORTER ACG, 1985, J BIOL CHEM, V260, P8182; Priya R, 2009, J BACTERIOL, V191, P7538, DOI 10.1128/JB.00540-09; Priya R, 2008, J BIOENERG BIOMEMBR, V40, P245, DOI 10.1007/s10863-008-9154-x; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sorgen PL, 1999, J BIOL CHEM, V274, P36261, DOI 10.1074/jbc.274.51.36261; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Weber J, 2004, J BIOL CHEM, V279, P25673, DOI 10.1074/jbc.M402738200; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Wilkens S, 2000, J BIOENERG BIOMEMBR, V32, P333, DOI 10.1023/A:1005567717821; Wise JG, 2009, BIOPHYS J, V96, P2823, DOI 10.1016/j.bpj.2008.12.3938; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	71	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24465	24479		10.1074/jbc.M113.465633	http://dx.doi.org/10.1074/jbc.M113.465633			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846684	Green Published, hybrid			2022-12-28	WOS:000330612300016
J	Sun, CC; Qiao, HF; Zhou, Q; Wang, Y; Wu, YY; Zhou, Y; Li, Y				Sun, Changcheng; Qiao, Haifa; Zhou, Qin; Wang, Yan; Wu, Yuying; Zhou, Yi; Li, Yong			Modulation of GluK2a Subunit-containing Kainate Receptors by 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSSY FIBER SYNAPSES; DIFFERENTIAL REGULATION; SYNAPTIC-TRANSMISSION; MOLECULAR-MECHANISMS; GLUTAMATE RECEPTORS; AUXILIARY SUBUNIT; ION CHANNELS; GLUR6; TRAFFICKING; PHOSPHORYLATION	Kainate receptors (KARs) are one of the ionotropic glutamate receptors that mediate excitatory postsynaptic currents (EPSCs) with characteristically slow kinetics. Although mechanisms for the slow kinetics of KAR-EPSCs are not totally understood, recent evidence has implicated a regulatory role of KAR-associated proteins. Here, we report that decay kinetics of GluK2a-containing receptors is modulated by closely associated 14-3-3 proteins. 14-3-3 binding requires PKC-dependent phosphorylation of serine residues localized in the carboxyl tail of the GluK2a subunit. In transfected cells, 14-3-3 binding to GluK2a slows desensitization kinetics of both homomeric GluK2a and heteromeric GluK2a/GluK5 receptors. Moreover, KAR-EPSCs at mossy fiber-CA3 synapses decay significantly faster in the 14-3-3 functional knock-out mice. Collectively, these results demonstrate that 14-3-3 proteins are an important regulator of GluK2a-containing KARs and may contribute to the slow decay kinetics of native KAR-EPSCs.	[Sun, Changcheng; Zhou, Qin; Wang, Yan; Li, Yong] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Qiao, Haifa; Wu, Yuying; Zhou, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Shanghai Jiao Tong University; State University System of Florida; Florida State University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	liyong68@shsmu.edu.cn	Li, Yong/ABB-5588-2021		National Natural Science Foundation of China [81171230, 30970937]; National Basic Research Program of China Grant [2010CB912001]; Major Research Plan of the National Natural Science Foundation of China Grant [91132303]; Shanghai Pujiang Program Grant [11PJ1406100]; Shanghai Committee of Science and Technology Grant [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Grant(National Basic Research Program of China); Major Research Plan of the National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program Grant; Shanghai Committee of Science and Technology Grant	This work was supported by National Natural Science Foundation of China Grants 81171230 and 30970937 (to Y. L.), National Basic Research Program of China Grant 2010CB912001 (to Y. L.), Major Research Plan of the National Natural Science Foundation of China Grant 91132303 (to T. L. X. and Y. L.), the Shanghai Pujiang Program Grant 11PJ1406100 (to Y. L.), and Shanghai Committee of Science and Technology Grant 11DZ2260200.	Barberis A., 2012, FAST PERFUSION METHO, P173; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Basiry SS, 1999, J NEUROSCI, V19, P644; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P199, DOI 10.1113/jphysiol.2004.077412; Fisher JL, 2011, J NEUROSCI, V31, P17113, DOI 10.1523/JNEUROSCI.3685-11.2011; Fleck MW, 2003, J NEUROSCI, V23, P1219; Foote Molly, 2012, Int J Biochem Mol Biol, V3, P152; Frerking M, 2002, J NEUROSCI, V22, P7434; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Goldin M, 2007, J NEUROSCI, V27, P9560, DOI 10.1523/JNEUROSCI.1237-07.2007; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Kwon HB, 2008, NEURON, V60, P1082, DOI 10.1016/j.neuron.2008.10.045; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang EJ, 2007, J PHYSIOL-LONDON, V578, P259, DOI 10.1113/jphysiol.2006.118448; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	63	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24676	24690		10.1074/jbc.M113.462069	http://dx.doi.org/10.1074/jbc.M113.462069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861400	Green Published, hybrid			2022-12-28	WOS:000330612300035
J	Jeon, S; Jha, MK; Ock, J; Seo, J; Jin, M; Cho, H; Lee, WH; Suk, K				Jeon, Sangmin; Jha, Mithilesh Kumar; Ock, Jiyeon; Seo, Jungwan; Jin, Myungwon; Cho, Heejung; Lee, Won-Ha; Suk, Kyoungho			Role of Lipocalin-2-Chemokine Axis in the Development of Neuropathic Pain following Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; GELATINASE-ASSOCIATED LIPOCALIN; DORSAL-ROOT GANGLIA; GENE-EXPRESSION; NEUTROPHIL INFILTRATION; MECHANICAL ALLODYNIA; GLIAL ACTIVATION; SPINAL GLIA; MOUSE-BRAIN; RAT MODELS	Lipocalin 2 (LCN2), which is also known as 24p3 and neutrophil gelatinase-associated lipocalin (NGAL), binds small, hydrophobic ligands and interacts with cell surface receptor 24p3R to regulate diverse cellular processes. In the present study, we examined the role of LCN2 in the pathogenesis of neuropathic pain using a mouse model of spared nerve injury (SNI). Lcn2 mRNA levels were significantly increased in the dorsal horn of the spinal cord after SNI, and LCN2 protein was mainly localized in neurons of the dorsal and ventral horns. LCN2 receptor 24p3R was expressed in spinal neurons and microglia after SNI. Lcn2-deficient mice exhibited significantly less mechanical pain hypersensitivity during the early phase after SNI, and an intrathecal injection of recombinant LCN2 protein elicited mechanical pain hypersensitivity in naive animals. Lcn2 deficiency, however, did not affect acute nociceptive pain. Lcn2-deficient mice showed significantly less microglial activation and proalgesic chemokine (CCL2 and CXCL1) production in the spinal cord after SNI than wild-type mice, and recombinant LCN2 protein induced the expression of these chemokines in cultured neurons. Furthermore, the expression of LCN2 and its receptor was detected in neutrophils and macrophages in the sciatic nerve following SNI, suggesting the potential role of peripheral LCN2 in neuropathic pain. Taken together, our results indicate that LCN2 plays a critical role in the development of pain hypersensitivity following peripheral nerve injury and suggest that LCN2 mediates neuropathic pain by inducing chemokine expression and subsequent microglial activation.	[Jeon, Sangmin; Jha, Mithilesh Kumar; Ock, Jiyeon; Seo, Jungwan; Jin, Myungwon; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 700422, South Korea; [Cho, Heejung] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr		Jha, Mithilesh Kumar/0000-0002-9526-0053	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea by National Research Foundation (NRF) [A111345]; Ministry of Education, Science and Technology (MEST) of the Korean government [2012-0009328]; Kyungpook National University	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea by National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST) of the Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kyungpook National University	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111345), by National Research Foundation (NRF) grants funded by the Ministry of Education, Science and Technology (MEST) of the Korean government (Grant 2012-0009328), and by the Kyungpook National University Research Fund, 2012.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Brack A, 2004, PAIN, V111, P1, DOI 10.1016/j.pain.2004.06.020; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Flower DR, 1996, BIOCHEM J, V318, P1; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Jeon SM, 2009, BRAIN RES, V1251, P103, DOI 10.1016/j.brainres.2008.11.046; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jin SX, 2003, J NEUROSCI, V23, P4017; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; KJELDSEN L, 1994, BLOOD, V83, P799; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacManus JP, 2004, J CEREBR BLOOD F MET, V24, P657, DOI 10.1097/01.WCB.0000123141.67811.91; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Nilsen-Hamilton M, 2003, ANN NY ACAD SCI, V995, P94, DOI 10.1111/j.1749-6632.2003.tb03213.x; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Poh KW, 2012, J NEUROSCI, V32, P35, DOI 10.1523/JNEUROSCI.2389-11.2012; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaw SK, 2008, EXP NEUROL, V210, P286, DOI 10.1016/j.expneurol.2007.11.024; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Watkins LR, 2007, BRAIN BEHAV IMMUN, V21, P131, DOI 10.1016/j.bbi.2006.10.011; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	66	27	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24116	24127		10.1074/jbc.M113.454140	http://dx.doi.org/10.1074/jbc.M113.454140			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836894	Green Published, hybrid			2022-12-28	WOS:000330611400047
J	Lu, HR; Hallstrom, TC				Lu, Huarui; Hallstrom, Timothy C.			The Nuclear Protein UHRF2 Is a Direct Target of the Transcription Factor E2F1 in the Induction of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; HEMI-METHYLATED DNA; RING FINGER PROTEIN; SRA DOMAIN; RETINOBLASTOMA GENE; TUMOR SUPPRESSORS; UBIQUITIN LIGASE; S PHASE; P53; NIRF	The E2F1 transcription factor is active in many types of solid tumors and can function as either an oncogene or tumor suppressor in vivo. E2F1 activity is connected with a variety of cell fates including proliferation, apoptosis, senescence, differentiation, and autophagy, and these effects are mediated through differential target gene expression. E2F1-induced cell death is an innate anti-cancer mechanism to kill cells with a spontaneous oncogenic mutation that might otherwise form a cancer. Relatively little is known about the molecular circuitry that tips E2F1 balance toward proliferation during normal growth versus apoptosis during oncogenic stress, and which pathways mediate this decision. To further explore these mechanisms, we utilized an unbiased shRNA screen to identify candidate genes that mediate E2F1-induced cell death. We identified the ubiquitin-like with PHD and ring finger domains 2 (UHRF2) gene as an important mediator of E2F1-induced cell death. UHRF2 encodes a nuclear protein involved in cell-cycle regulation. Several of these domains have been shown to be essential for the regulation of cell proliferation, and UHRF2 has been implicated as an oncogene in some settings. Other reports have suggested that UHRF2 causes growth arrest, functions as a tumor suppressor, and is deleted in a variety of tumors. We show that UHRF2 is a transcriptional target of E2F, that it directly interacts with E2F1, and is required for E2F1 induction of apoptosis and transcription of a number of important apoptotic regulators.	[Lu, Huarui; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hallstrom, TC (corresponding author), 420 Delaware St SE, Minneapolis, MN 55455 USA.	halls026@umn.edu			Children's Cancer Research Fund, Minneapolis, MN	Children's Cancer Research Fund, Minneapolis, MN	This work was supported in part by Children's Cancer Research Fund, Minneapolis, MN.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hellerbrand C, 2008, GUT, V57, P243, DOI 10.1136/gut.2007.129544; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Hu JJ, 2010, BMB REP, V43, P17, DOI 10.5483/BMBRep.2010.43.1.017; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Koguchi K, 1997, BBA-GENE STRUCT EXPR, V1353, P209, DOI 10.1016/S0167-4781(97)00106-1; Li YY, 2004, BIOCHEM BIOPH RES CO, V319, P464, DOI 10.1016/j.bbrc.2004.04.190; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2011, CELL CYCLE, V10, P3284, DOI 10.4161/cc.10.19.17176; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rodriguez JM, 2006, J BIOL CHEM, V281, P22729, DOI 10.1074/jbc.M604705200; Rogoff HA, 2002, MOL CELL BIOL, V22, P5308, DOI 10.1128/MCB.22.15.5308-5318.2002; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	46	25	28	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23833	23843		10.1074/jbc.M112.447276	http://dx.doi.org/10.1074/jbc.M112.447276			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23833190	Green Published, hybrid			2022-12-28	WOS:000330611400023
J	Nemeth, BC; Wartmann, T; Halangk, W; Sahin-Toth, M				Nemeth, Balazs Csaba; Wartmann, Thomas; Halangk, Walter; Sahin-Toth, Miklos			Autoactivation of Mouse Trypsinogens Is Regulated by Chymotrypsin C via Cleavage of the Autolysis Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; POLYACRYLAMIDE-GELS; ZYMOGEN ACTIVATION; ESCHERICHIA-COLI; BOVINE TRYPSIN; EXPRESSION; PROTEINS; PURIFICATION; DEGRADATION	Chymotrypsin C (CTRC) is a proteolytic regulator of trypsinogen autoactivation in humans. CTRC cleavage of the trypsinogen activation peptide stimulates autoactivation, whereas cleavage of the calcium binding loop promotes trypsinogen degradation. Trypsinogen mutations that alter these regulatory cleavages lead to increased intrapancreatic trypsinogen activation and cause hereditary pancreatitis. The aim of this study was to characterize the regulation of autoactivation of mouse trypsinogens by mouse Ctrc. We found that the mouse pancreas expresses four trypsinogen isoforms to high levels, T7, T8, T9, and T20. Only the T7 activation peptide was cleaved by mouse Ctrc, causing negligible stimulation of autoactivation. Surprisingly, mouse Ctrc poorly cleaved the calcium binding loop in all mouse trypsinogens. In contrast, mouse Ctrc readily cleaved the Phe-150-Gly-151 peptide bond in the autolysis loop of T8 and T9 and inhibited autoactivation. Mouse chymotrypsin B also cleaved the same peptide bond but was 7-fold slower. T7 was less sensitive to chymotryptic regulation, which involved slow cleavage of the Leu-149-Ser-150 peptide bond in the autolysis loop. Modeling indicated steric proximity of the autolysis loop and the activation peptide in trypsinogen, suggesting the cleaved autolysis loop may directly interfere with activation. We conclude that autoactivation of mouse trypsinogens is under the control of mouse Ctrc with some notable differences from the human situation. Thus, cleavage of the trypsinogen activation peptide or the calcium binding loop by Ctrc is unimportant. Instead, inhibition of autoactivation via cleavage of the autolysis loop is the dominant mechanism that can mitigate intrapancreatic trypsinogen activation.	[Nemeth, Balazs Csaba; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Wartmann, Thomas; Halangk, Walter] Otto Von Guericke Univ, Dept Surg, Div Expt Surg, D-39120 Magdeburg, Germany	Boston University; Otto von Guericke University	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Nemeth, Balazs/0000-0001-5338-7577; Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01DK058088, R01DK082412, R01DK082412-S2, R01DK095753]; Deutsche Forschungsgemeinschaft [DFG HA2080/7-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095753, R01DK058088, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK058088, R01DK082412, R01DK082412-S2, and R01DK095753 (to M. S.-T.). This work was also supported by Grant DFG HA2080/7-1 from the Deutsche Forschungsgemeinschaft.	Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Hayashi H, 2011, P NATL ACAD SCI USA, V108, P18766, DOI 10.1073/pnas.1116273108; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; LUTCKE H, 1989, NUCLEIC ACIDS RES, V17, P6736; MAROUX S, 1969, BIOCHIM BIOPHYS ACTA, V181, P59, DOI 10.1016/0005-2795(69)90227-X; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ohmura K, 1999, J BIOL CHEM, V274, P29426, DOI 10.1074/jbc.274.41.29426; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 1999, J BIOL CHEM, V274, P29699, DOI 10.1074/jbc.274.42.29699; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Selig L, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-30; SMITH RL, 1969, J BIOL CHEM, V244, P4704; STEVENSON BJ, 1986, NUCLEIC ACIDS RES, V14, P8307, DOI 10.1093/nar/14.21.8307; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Wang J, 2010, LAB INVEST, V90, P654, DOI 10.1038/labinvest.2010.44; WATANABE T, 1982, BIOCHIM BIOPHYS ACTA, V717, P439, DOI 10.1016/0304-4165(82)90285-9; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	34	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24049	24062		10.1074/jbc.M113.478800	http://dx.doi.org/10.1074/jbc.M113.478800			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814066	Green Published, hybrid			2022-12-28	WOS:000330611400042
J	Rodriguez, VB; Kidd, BA; Interlandi, G; Tchesnokova, V; Sokurenko, EV; Thomas, WE				Rodriguez, Victoria B.; Kidd, Brian A.; Interlandi, Gianluca; Tchesnokova, Veronika; Sokurenko, Evgeni V.; Thomas, Wendy E.			Allosteric Coupling in the Bacterial Adhesive Protein FimH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; TYPE-1 FIMBRIAL ADHESIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; BOND; BINDING; FORCE; COLONIZATION; AFFINITY	The protein FimH is expressed by the majority of commensal and uropathogenic strains of Escherichia coli on the tips of type 1 fimbriae and mediates adhesion via a catch bond to its ligand mannose. Crystal structures of FimH show an allosteric conformational change, but it remains unclear whether all of the observed structural differences are part of the allosteric mechanism. Here we use the protein structural analysis tool Rosetta-Design combined with human insight to identify and synthesize 10 mutations in four regions that we predicted would stabilize one of the conformations of that region. The function of each variant was characterized by measuring binding to the ligand mannose, whereas the allosteric state was determined using a conformation-specific monoclonal antibody. These studies demonstrated that each region investigated was indeed part of the FimH allosteric mechanism. However, the studies strongly suggested that some regions were more tightly coupled to mannose binding and others to antibody binding. In addition, we identified many FimH variants that appear locked in the low affinity state. Knowledge of regulatory sites outside the active and effector sites as well as the ability to make FimH variants locked in the low affinity state may be crucial to the future development of novel antiadhesive and antimicrobial therapies using allosteric regulation to inhibit FimH.	[Rodriguez, Victoria B.; Kidd, Brian A.; Interlandi, Gianluca; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Tchesnokova, Veronika; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thomas, WE (corresponding author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.	wendyt@u.washington.edu		Thomas, Wendy/0000-0001-8602-0819; Kidd, Brian/0000-0003-2110-1145	National Institutes of Health [1RO1 AI50940]; University of Washington [1RO1 AI50940]; National Science Foundation (NSF) [CBET-1132860]; Integrative Graduate Education and Research Traineeship Fellowship Award NSF [DGE-0504573]; University of Washington Initiatives Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); National Science Foundation (NSF)(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship Fellowship Award NSF; University of Washington Initiatives Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 AI50940 and Molecular Biophysics Training Grant 1RO1 AI50940 (University of Washington; to B. A. K. and V. B. R.). This work was also supported by National Science Foundation (NSF) Grant CBET-1132860, Integrative Graduate Education and Research Traineeship Fellowship Award NSF #DGE-0504573 (to B. A. K.), and the University of Washington Initiatives Fund (to B. A. K.).	Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2002, PYMOL USERS MANUAL; Ding AM, 2010, APPL ENVIRON MICROB, V76, P1294, DOI 10.1128/AEM.02083-09; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hartmann M, 2011, EUR J ORG CHEM, V2011, P3583, DOI 10.1002/ejoc.201100407; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kisiela DI, 2011, J BIOL CHEM, V286, P38136, DOI 10.1074/jbc.M111.237511; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li ZJ, 2000, BIOTECHNOL PROGR, V16, P1086, DOI 10.1021/bp000117r; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Nilsson LM, 2008, STRUCTURE, V16, P1047, DOI 10.1016/j.str.2008.03.012; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schito GC, 2009, INT J ANTIMICROB AG, V34, P407, DOI 10.1016/j.ijantimicag.2009.04.012; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sokurenko EV, 2001, MOL MICROBIOL, V41, P675, DOI 10.1046/j.1365-2958.2001.02545.x; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas W, 2008, ANNU REV BIOMED ENG, V10, P39, DOI 10.1146/annurev.bioeng.10.061807.160427; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Whitfield M, 2010, BIOPHYS J, V99, P2470, DOI 10.1016/j.bpj.2010.08.045; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	55	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24128	24139		10.1074/jbc.M113.461376	http://dx.doi.org/10.1074/jbc.M113.461376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821547	Green Published, hybrid			2022-12-28	WOS:000330611400048
J	Rojko, N; Kristan, KC; Viero, G; Zerovnik, E; Macek, P; Dalla Serra, M; Anderluh, G				Rojko, Nejc; Kristan, Katarina C.; Viero, Gabriella; Zerovnik, Eva; Macek, Peter; Dalla Serra, Mauro; Anderluh, Gregor			Membrane Damage by an alpha-Helical Pore-forming Protein, Equinatoxin II, Proceeds through a Succession of Ordered Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; N-TERMINAL REGION; SEA-ANEMONE; LIPID-MEMBRANES; STICHOLYSIN-I; ACTINIA-EQUINA; TOXIN; MECHANISM; MUTANTS; PREPORE	Actinoporin equinatoxin II (EqtII) is an archetypal example of alpha-helical pore-forming toxins that porate cellular membranes by the use of alpha-helices. Previous studies proposed several steps in the pore formation: binding of monomeric protein onto the membrane, followed by oligomerization and insertion of the N-terminal alpha-helix into the lipid bilayer. We studied these separate steps with an EqtII triple cysteine mutant. The mutant was engineered to monitor the insertion of the N terminus into the lipid bilayer by labeling Cys-18 with a fluorescence probe and at the same time to control the flexibility of the N-terminal region by the disulfide bond formed between cysteines introduced at positions 8 and 69. The insertion of the N terminus into the membrane proceeded shortly after the toxin binding and was followed by oligomerization. The oxidized, non-lytic, form of the mutant was still able to bind to membranes and oligomerize at the same level as the wild-type or the reduced form. However, the kinetics of the N-terminal helix insertion, the release of calcein from erythrocyte ghosts, and hemolysis of erythrocytes was much slower when membrane-bound oxidized mutant was reduced by the addition of the reductant. Results show that the N-terminal region needs to be inserted in the lipid membrane before the oligomerization into the final pore and imply that there is no need for a stable prepore formation. This is different from beta-pore-forming toxins that often form beta-barrel pores via a stable prepore complex.	[Rojko, Nejc; Kristan, Katarina C.; Macek, Peter; Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Viero, Gabriella; Dalla Serra, Mauro] CNR, Ist Biofis, I-38123 Trento, Italy; [Viero, Gabriella; Dalla Serra, Mauro] Fdn Bruno Kessler, I-38123 Trento, Italy; [Zerovnik, Eva] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia; [Anderluh, Gregor] Natl Inst Chem, Ljubljana 1000, Slovenia; [Anderluh, Gregor] En Fist Ctr Excellence, Ljubljana 1000, Slovenia	University of Ljubljana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Bruno Kessler; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia	Anderluh, G (corresponding author), Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	gregor.anderluh@ki.si	Serra, Mauro Dalla/A-6218-2010; Serra, Mauro Dalla/AAK-9299-2021; Zerovnik, Eva/AAB-6498-2022; Maček, Peter/Y-9877-2019; Viero, Gabriella/G-2096-2012; Maček, Peter/U-4662-2017; Anderluh, Gregor/C-6905-2014	Serra, Mauro Dalla/0000-0003-1048-2739; Serra, Mauro Dalla/0000-0003-1048-2739; Maček, Peter/0000-0001-6470-7759; Viero, Gabriella/0000-0002-6755-285X; Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Slovenian Research Agency.	Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 1998, BIOCHEM BIOPH RES CO, V242, P187, DOI 10.1006/bbrc.1997.7944; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Anderluh G, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P141; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Comai M, 2002, MOL MICROBIOL, V44, P1251, DOI 10.1046/j.1365-2958.2002.02943.x; Dalla Serra M, 2000, METH MOL B, V145, P171; Dalla Serra M, 2001, ELS, DOI [10.1002/9780470015902.a0002655.pub2, DOI 10.1002/9780470015902.A0002655.PUB2]; Drechsler A, 2006, BIOCHEMISTRY-US, V45, P1818, DOI 10.1021/bi052166o; Fang Y, 1997, BIOCHEMISTRY-US, V36, P9518, DOI 10.1021/bi970600j; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Jimenez-Juarez N, 2008, PEPTIDES, V29, P318, DOI 10.1016/j.peptides.2007.09.026; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MACEK P, 1995, EUR J BIOCHEM, V234, P329, DOI 10.1111/j.1432-1033.1995.329_c.x; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Pardo-Cea MA, 2011, FEBS J, V278, P2080, DOI 10.1111/j.1742-4658.2011.08123.x; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Viero G, 2008, CELL MOL LIFE SCI, V65, P312, DOI 10.1007/s00018-007-7491-2; Whitson KB, 2004, ANAL BIOCHEM, V324, P227, DOI 10.1016/j.ab.2003.09.023	45	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23704	23715		10.1074/jbc.M113.481572	http://dx.doi.org/10.1074/jbc.M113.481572			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23803608	hybrid, Green Published			2022-12-28	WOS:000330611400011
J	Tee, MK; Miller, WL				Tee, Meng Kian; Miller, Walter L.			Phosphorylation of Human Cytochrome P450c17 by p38 alpha Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; SIDE-CHAIN-CLEAVAGE; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; ACTIVATED PROTEIN-KINASE; NEONATAL PIG TESTIS; SERINE PHOSPHORYLATION; INSULIN-RECEPTOR; PREMATURE ADRENARCHE; MICROSOMAL CYTOCHROME-P-450; 17,20-LYASE ACTIVITY	Cytochrome P450c17, a steroidogenic enzyme encoded by the CYP17A1 gene, catalyzes the steroid 17 alpha-hydroxylation needed for glucocorticoid synthesis, which may or may not be followed by 17,20 lyase activity needed for sex steroid synthesis. Whether or not P450c17 catalyzes 17,20 lyase activity is determined by three post-translational mechanisms influencing availability of reducing equivalents donated by P450 oxidoreductase (POR). These are increased amounts of POR, the allosteric action of cytochrome b(5) to promote POR-P450c17 interaction, and Ser/Thr phosphorylation of P450c17, which also appears to promote POR-P450c17 interaction. The kinase(s) that phosphorylates P450c17 is unknown. In a series of kinase inhibition experiments, the pyridinyl imidazole drugs SB202190 and SB203580 inhibited 17,20 lyase but not 17 alpha-hydroxylase activity in human adrenocortical HCI-H295A cells, suggesting an action on p38 alpha or p38 beta. Co-transfection of non-steroidogenic COS-1 cells with P450c17 and p38 expression vectors showed that p38 alpha, but not p38 beta, conferred 17,20 lyase activity on P450c17. Antiserum to P450c17 co-immunoprecipitated P450c17 and both p38 isoforms; however, knockdown of p38 alpha, but not knockdown of p38 beta, inhibited 17,20 lyase activity in NCI-H295A cells. Bacterially expressed human P450c17 was phosphorylated by p38 alpha in vitro at a non-canonical site, conferring increased 17,20 lyase activity. This phosphorylation increased the maximum velocity, but not the Michaelis constant, of the 17,20 lyase reaction. p38 alpha phosphorylates P450c17 in a fashion that confers increased 17,20 lyase activity, implying that the production of adrenal androgens (adrenarche) is a regulated event.	[Tee, Meng Kian; Miller, Walter L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Rm 1427 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.	wlmlab@ucsf.edu			National Institutes of Health [R01DK37922, R01GM73020]; University of California San Francisco Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Academic Senate(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01DK37922 and R01GM73020. This work was also supported by a grant from the University of California San Francisco Academic Senate and a private donation.	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; APTER D, 1979, ACTA PAEDIATR SCAND, V68, P599, DOI 10.1111/j.1651-2227.1979.tb05062.x; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Biason-Lauber A, 2000, ENDOCRINOLOGY, V141, P1446, DOI 10.1210/en.141.4.1446; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; Bremer AA, 2008, FERTIL STERIL, V89, P1039, DOI 10.1016/j.fertnstert.2008.02.091; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; CHIN JE, 1993, J BIOL CHEM, V268, P6338; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; CUTLER GB, 1978, ENDOCRINOLOGY, V103, P2112, DOI 10.1210/endo-103-6-2112; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Diamanti-Kandarakis E, 2005, HUM REPROD UPDATE, V11, P631, DOI 10.1093/humupd/dmi025; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; FEVOLD HR, 1989, MOL ENDOCRINOL, V3, P968, DOI 10.1210/mend-3-6-968; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Gao LL, 2013, MOL CELL ENDOCRINOL, V374, P108, DOI 10.1016/j.mce.2013.04.012; GAZDAR AF, 1990, CANCER RES, V50, P5488; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Govind A, 1999, J CLIN ENDOCR METAB, V84, P38, DOI 10.1210/jc.84.1.38; Guasti L, 2013, MOL CELL ENDOCRINOL, V371, P182, DOI 10.1016/j.mce.2013.01.014; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Idkowiak J, 2011, EUR J ENDOCRINOL, V165, P189, DOI 10.1530/EJE-11-0223; IMAI T, 1993, J BIOL CHEM, V268, P19681; Inagaki K, 2009, ENDOCRINOLOGY, V150, P1921, DOI 10.1210/en.2008-0851; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; KOMINAMI S, 1992, J STEROID BIOCHEM, V42, P57, DOI 10.1016/0960-0760(92)90011-7; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LeeRobichaud P, 1997, BIOCHEM J, V321, P857, DOI 10.1042/bj3210857; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Manna P. R., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mathieu AP, 2002, J STEROID BIOCHEM, V80, P99, DOI 10.1016/S0960-0760(01)00172-8; Mesiano S, 1997, J CLIN ENDOCR METAB, V82, P1390, DOI 10.1210/jc.82.5.1390; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2009, REV ENDOCR METAB DIS, V10, P3, DOI 10.1007/s11154-008-9102-4; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Miller WL, 1997, STEROIDS, V62, P133, DOI 10.1016/S0039-128X(96)00172-9; Miller WL, 1999, ACTA PAEDIATR, V88, P60, DOI 10.1111/j.1651-2227.1999.tb14405.x; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; OMURA T, 1962, J BIOL CHEM, V237, P1375; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; OPPENHEIMER E, 1995, J CLIN ENDOCR METAB, V80, P614, DOI 10.1210/jc.80.2.614; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Pandey AV, 2003, J BIOL CHEM, V278, P2837, DOI 10.1074/jbc.M209527200; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remer T, 1999, J CLIN ENDOCR METAB, V84, P3936, DOI 10.1210/jc.84.11.3936; Rodriguez H, 1997, J CLIN ENDOCR METAB, V82, P365, DOI 10.1210/jc.82.2.365; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; SAKAI N, 1992, FEBS LETT, V301, P60, DOI 10.1016/0014-5793(92)80210-8; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; SKLAR CA, 1980, J CLIN ENDOCR METAB, V51, P548, DOI 10.1210/jcem-51-3-548; SMAIL PJ, 1982, ENDOCRINOLOGY, V111, P844, DOI 10.1210/endo-111-3-844; STADTMAUER L, 1986, J BIOL CHEM, V261, P3402; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; TREMBLAY Y, 1994, DNA CELL BIOL, V13, P1199, DOI 10.1089/dna.1994.13.1199; VOUTILAINEN R, 1987, P NATL ACAD SCI USA, V84, P1590, DOI 10.1073/pnas.84.6.1590; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P202, DOI 10.1210/jcem-63-1-202; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	94	35	37	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23903	23913		10.1074/jbc.M113.460048	http://dx.doi.org/10.1074/jbc.M113.460048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836902	Green Published, hybrid			2022-12-28	WOS:000330611400030
J	Zhang, Y; Teng, F; Luo, GZ; Wang, M; Tong, M; Zhao, XY; Wang, L; Wang, XJ; Zhou, Q				Zhang, Ying; Teng, Fei; Luo, Guan-Zheng; Wang, Meng; Tong, Man; Zhao, Xiaoyang; Wang, Liu; Wang, Xiu-Jie; Zhou, Qi			MicroRNA-323-3p Regulates the Activity of Polycomb Repressive Complex 2 (PRC2) via Targeting the mRNA of Embryonic Ectoderm Development (Eed) Gene in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3; METHYLATION; EZH2; DIFFERENTIATION; PLURIPOTENCY; ACTIVATION; PROTEIN; MARKS; TRANSLATION	PRC2 (Polycomb repressive complex 2) mediates epigenetic gene silencing by catalyzing the triple methylation of histone H3 Lys-27 (H3K27me3) to establish a repressive epigenetic state. PRC2 is involved in the regulation of many fundamental biological processes and is especially essential for embryonic stem cells. However, how the formation and function of PRC2 are regulated is largely unknown. Here, we show that a microRNA encoded by the imprinted Dlk1-Dio3 region of mouse chromosome 12, miR-323-3p, targets Eed (embryonic ectoderm development) mRNA, which encodes one of the core components of PRC2, the EED protein. Binding of miR-323-3p to Eed mRNA resulted in reduced EED protein abundance and cellular H3K27me3 levels, indicating decreased PRC2 activity. Such regulation seems to be conserved among mammals, at least between mice and humans. We demonstrate that induced pluripotent stem cells with varied developmental abilities had different miR-323-3p as well as EED and H3K27me3 levels, indicating that miR-323-3p may be involved in the regulation of stem cell pluripotency through affecting PRC2 activity. Mouse embryonic fibroblast cells had much higher miR-323-3p expression and nearly undetectable H3K27me3 levels. These findings identify miR-323-3p as a new regulator for PRC2 and provide a new approach for regulating PRC2 activity via microRNAs.	[Zhang, Ying; Teng, Fei; Zhao, Xiaoyang; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Wang, Meng; Tong, Man; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China; [Teng, Fei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China.	xjwang@genetics.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019	ZHAO, Xiao-Yang/0000-0003-2544-8293	Ministry of Science and Technology of China [2011CBA01101]; Chinese Academy of Sciences [XDA01020101, XDA01020105]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by Grant 2011CBA01101 (to Q.Z. and X.-J.W.) from the Ministry of Science and Technology of China and by Strategic Priority Research Program Grants XDA01020101 (to Q.Z.) and XDA01020105 (to X.-J.W.) from the Chinese Academy of Sciences.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Faust C, 1998, DEVELOPMENT, V125, P4495; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lin SL, 2005, GENE, V356, P32, DOI 10.1016/j.gene.2005.04.036; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	7	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23659	23665		10.1074/jbc.M113.475608	http://dx.doi.org/10.1074/jbc.M113.475608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821546	Green Published, hybrid			2022-12-28	WOS:000330611400005
J	Zhou, XJ; Ding, Q; Chen, ZY; Yun, HF; Wang, HB				Zhou, Xianju; Ding, Qi; Chen, Zhuoyou; Yun, Huifang; Wang, Hongbing			Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N-methyl-D-aspartate Receptor Function and Neuronal Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; IN-VITRO; CELL-DEATH; DEVELOPMENTAL-CHANGES; DEPENDENT REGULATION; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ROLES; CORTICAL-NEURONS; NR2B SUBUNITS	GluN2A and GluN2B are the major subunits of functional NMDA receptors (NMDAR). Previous studies have suggested that GluN2A and GluN2B may differentially mediate NMDAR function at synaptic and extrasynaptic locations and play opposing roles in excitotoxicity, such as neurodegeneration triggered by ischemic stroke and brain injury. By using pharmacological and molecular approaches to suppress or enhance the function of GluN2A and GluN2B in cultured cortical neurons, we examined NMDAR-mediated, bidirectional regulation of prosurvival signaling (i.e. the cAMP response element-binding protein (CREB)-Bdnf cascade) and cell death. Inhibition of GluN2A or GluN2B attenuated the up-regulation of prosurvival signaling triggered by the activation of either synaptic or extrasynaptic NMDAR. Inhibition of GluN2A or GluN2B also attenuated the down-regulation of prosurvival signaling triggered by the coactivation of synaptic and extrasynaptic receptors. The effects of GluN2B on CREB-Bdnf signaling were larger than those of GluN2A. Consistently, compared with suppression of GluN2A, suppression of GluN2B resulted in more reduction of NMDA- and oxygen glucose deprivation-induced excitotoxicity as well as NMDAR-mediated elevation of intracellular calcium. Moreover, excitotoxicity and down-regulation of CREB were exaggerated in neurons overexpressing GluN2A or GluN2B. Together, we found that GluN2A and GluN2B are involved in the function of both synaptic and extrasynaptic NMDAR, demonstrating that they play similar rather than opposing roles in NMDAR-mediated bidirectional regulation of prosurvival signaling and neuronal death.	[Zhou, Xianju; Ding, Qi; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Zhou, Xianju; Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Zhou, Xianju; Chen, Zhuoyou] Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Neurol, Changzhou 213003, Peoples R China; [Yun, Huifang] Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Anesthesiol, Changzhou 213003, Peoples R China	Michigan State University; Michigan State University; Nanjing Medical University; Nanjing Medical University	Zhou, XJ (corresponding author), Changzhou 2 Peoples Hosp, Dept Neurol, 29 Xinglong Alley, Changzhou 213003, Peoples R China.	hippocampus2007@gmail.com; wangho@msu.edu			National Institutes of Health [MH093445, NS072668]; American Heart Association [10POST4450000]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS072668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH093445 and NS072668. This work was also supported by American Heart Association Postdoctoral Fellowship 10POST4450000.	Barneda-Zahonero B, 2012, J BIOL CHEM, V287, P11351, DOI 10.1074/jbc.M111.272427; Benarroch EE, 2011, NEUROLOGY, V76, P1750, DOI 10.1212/WNL.0b013e31821b7cc9; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; BRORSON JR, 1994, J NEUROSCI, V14, P187; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Friedman LK, 2010, INT J DEV NEUROSCI, V28, P195, DOI 10.1016/j.ijdevneu.2009.11.002; Gao C, 2010, HIPPOCAMPUS, V20, P1072, DOI 10.1002/hipo.20705; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Miwa H, 2008, J PHYSIOL-LONDON, V586, P2539, DOI 10.1113/jphysiol.2007.147652; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morikawa E, 1998, J NEUROSCI, V18, P9727; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Navon H, 2012, J MOL NEUROSCI, V46, P100, DOI 10.1007/s12031-011-9532-4; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; PIZZI M, 1991, EUR J PHARMACOL, V209, P169, DOI 10.1016/0014-2999(91)90166-N; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Stanika RI, 2012, J NEUROSCI, V32, P6642, DOI 10.1523/JNEUROSCI.6008-11.2012; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhou XJ, 2012, J NEUROCHEM, V122, P295, DOI 10.1111/j.1471-4159.2012.07787.x; Zhou XJ, 2011, J NEUROCHEM, V119, P1205, DOI 10.1111/j.1471-4159.2011.07528.x; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	58	80	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24151	24159		10.1074/jbc.M113.482000	http://dx.doi.org/10.1074/jbc.M113.482000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839940	hybrid, Green Published			2022-12-28	WOS:000330611400050
J	Abelein, A; Kaspersen, JD; Nielsen, SB; Jensen, GV; Christiansen, G; Pedersen, JS; Danielsson, J; Otzen, DE; Graslund, A				Abelein, Axel; Kaspersen, Jorn Dovling; Nielsen, Soren Bang; Jensen, Grethe Vestergaard; Christiansen, Gunna; Pedersen, Jan Skov; Danielsson, Jens; Otzen, Daniel E.; Graslund, Astrid			Formation of Dynamic Soluble Surfactant-induced Amyloid beta Peptide Aggregation Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ANGLE NEUTRON-SCATTERING; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; CONGO RED; FIBRILS; MICELLES; FIBRILLATION; PROBES	Intermediate amyloidogenic states along the amyloid beta peptide (A beta) aggregation pathway have been shown to be linked to neurotoxicity. To shed more light on the different structures that may arise during A beta aggregation, we here investigate surfactant-induced A beta aggregation. This process leads to co-aggregates featuring a beta-structure motif that is characteristic for mature amyloid-like structures. Surfactants induce secondary structure in A beta in a concentration-dependent manner, from predominantly random coil at low surfactant concentration, via beta-structure to the fully formed beta-helical state at high surfactant concentration. The beta-rich state is the most aggregation-prone as monitored by thioflavin T fluorescence. Small angle x-ray scattering reveals initial globular structures of surfactant-A beta co-aggregated oligomers and formation of elongated fibrils during a slow aggregation process. Alongside this slow (minutes to hours time scale) fibrillation process, much faster dynamic exchange (k(ex) similar to 1100 s(-1)) takes place between free and co-aggregate-bound peptide. The two hydrophobic segments of the peptide are directly involved in the chemical exchange and interact with the hydrophobic part of the co-aggregates. Our findings suggest a model for surfactant-induced aggregation where free peptide and surfactant initially co-aggregate to dynamic globular oligomers and eventually form elongated fibrils. When interacting with beta-structure promoting substances, such as surfactants, A beta is kinetically driven toward an aggregation-prone state.	[Abelein, Axel; Danielsson, Jens; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Kaspersen, Jorn Dovling; Jensen, Grethe Vestergaard; Pedersen, Jan Skov] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Kaspersen, Jorn Dovling; Jensen, Grethe Vestergaard; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Nielsen, Soren Bang; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	Stockholm University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Graslund, A (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	astrid@dbb.su.se	Danielsson, Jens/AAG-6915-2021; Kaspersen, Jørn Døvling/O-6317-2015; Nielsen, Søren B/D-5936-2011; Pedersen, Jan Skov/A-8346-2008; Jensen, Grethe V./D-9079-2015	Pedersen, Jan Skov/0000-0002-7768-0206; Jensen, Grethe V./0000-0002-0625-0620; Abelein, Axel/0000-0002-8079-3017; Danielsson, Jens/0000-0002-6048-6896; Otzen, Daniel/0000-0002-2918-8989; Christiansen, Gunna/0000-0003-0540-1367	Swedish Research Council; Swedish Brain Foundation; EMBO; Danish Research Foundation (inSPIN); Lundbeck Foundation (BioNet 2); Danish Research Council, Natural Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; EMBO(European Molecular Biology Organization (EMBO)); Danish Research Foundation (inSPIN); Lundbeck Foundation (BioNet 2); Danish Research Council, Natural Sciences	This work was supported by the Swedish Research Council (to A. G.), the Swedish Brain Foundation (to A. G.), EMBO (to A. A.), the Danish Research Foundation (inSPIN) (to D. E. O.), the Lundbeck Foundation (BioNet 2) (to J. D. K., S. B. N., J. S. P., and D. E. O.), and the Danish Research Council, Natural Sciences (to J. S. P., S. B. N., and D. E. O.).	Abelein A, 2012, FEBS LETT, V586, P3991, DOI 10.1016/j.febslet.2012.09.035; Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; ANANTHAPADMANABHAN KP, 1985, LANGMUIR, V1, P352, DOI 10.1021/la00063a015; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; Andreasen M, 2012, J BIOL CHEM, V287, P34730, DOI 10.1074/jbc.M112.379552; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom M, 1999, J PHYS CHEM B, V103, P8502, DOI 10.1021/jp990535i; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Danielsson J, 2005, FEBS J, V272, P3938, DOI 10.1111/j.1742-4658.2005.04812.x; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halle B, 2003, P NATL ACAD SCI USA, V100, P12135, DOI 10.1073/pnas.2033320100; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; KINNING DJ, 1984, MACROMOLECULES, V17, P1712, DOI 10.1021/ma00139a013; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kowalewski J., 2006, NUCL SPIN RELAXATION, P243; Kuzyk A, 2010, J BIOL CHEM, V285, P31202, DOI 10.1074/jbc.M110.142174; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t; Liao CR, 2013, ANALYST, V138, P3991, DOI 10.1039/c3an00295k; Lin JM, 2009, SOFT MATTER, V5, P3913, DOI 10.1039/b908203d; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MUKERJEE P, 1967, J PHYS CHEM-US, V71, P4166, DOI 10.1021/j100872a702; Neugebauer T., 1943, ANN PHYS LPZ, V434, P509; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; OSTER G, 1952, ACTA CRYSTALLOGR, V5, P272, DOI 10.1107/S0365110X5200071X; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Pedersen JS, 1996, J APPL CRYSTALLOGR, V29, P646, DOI 10.1107/S0021889896006589; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x	65	39	40	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23518	23528		10.1074/jbc.M113.470450	http://dx.doi.org/10.1074/jbc.M113.470450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775077	Green Published, hybrid			2022-12-28	WOS:000330598200056
J	Hu, WX; Zhao, J; Pei, G				Hu, Wenxiang; Zhao, Jian; Pei, Gang			Activation of Aryl Hydrocarbon Receptor (AhR) by Tranilast, an Anti-allergy Drug, Promotes miR-302 Expression and Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; GENERATION; MOUSE; INDUCTION; MICRORNAS; FIBROBLASTS; INVOLVEMENT; TARGETS; GROWTH	MiR-302 has been shown to regulate pluripotency genes and help somatic cell reprogramming. Thus, promotion of endogenous miR-302 expression could be a desirable way to facilitate cell reprogramming. By using a luciferase reporter system of the miR-302 promoter, we screened and found that an anti-allergy drug, tranilast, could significantly promote miR-302 expression. Further experiments revealed that two aryl hydrocarbon receptor (AhR) binding motifs on the miR-302 promoter are critical and that activation of AhR is required for tranilast-induced miR-302 expression. Consistently, not only tranilast but other AhR agonists promoted miR-302 expression. Furthermore, the activation of AhR facilitated cell reprogramming in a miR-302-dependent way. These results elucidate that miR-302 expression can be regulated by AhR and thus provide a strategy for promoting somatic cell reprogramming by AhR ligands.	[Hu, Wenxiang; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Hu, Wenxiang; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, Shanghai 200031, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017; Zhao, Jian/E-2008-2019	Hu, Wenxiang/0000-0002-6754-5625; Zhao, Jian/0000-0002-8862-0591	Chinese Academy of Sciences [XDA01010302]; Ministry of Science and Technology [2011CB910202, 2009CB940903]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Chinese Academy of Sciences (XDA01010302) and the Ministry of Science and Technology (2011CB910202 and 2009CB940903).	Akahoshi E., 2006, ENV HLTH, V5, P1; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kang H, 2012, J BIOL CHEM, V287, P38656, DOI 10.1074/jbc.M112.390898; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lindsey S, 2012, STEM CELL REV REP, V8, P1223, DOI 10.1007/s12015-012-9384-5; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Muraro MJ, 2013, STEM CELLS, V31, P838, DOI 10.1002/stem.1340; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nukaya M, 2010, TOXICOL SCI, V118, P554, DOI 10.1093/toxsci/kfq305; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Reyes-Hernandez OD, 2010, BIOCHEM PHARMACOL, V80, P932, DOI 10.1016/j.bcp.2010.05.007; Rogosnitzky M, 2012, ANTICANCER RES, V32, P2471; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; SUZAWA H, 1992, JPN J PHARMACOL, V60, P85, DOI 10.1254/jjp.60.85; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313; Zhang ZH, 2013, STEM CELLS DEV, V22, P2268, DOI 10.1089/scd.2012.0650	58	32	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22972	22984		10.1074/jbc.M113.475624	http://dx.doi.org/10.1074/jbc.M113.475624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23821545	hybrid, Green Published			2022-12-28	WOS:000330598200008
J	Liebminger, E; Grass, J; Altmann, F; Mach, L; Strasser, R				Liebminger, Eva; Grass, Josephine; Altmann, Friedrich; Mach, Lukas; Strasser, Richard			Characterizing the Link between Glycosylation State and Enzymatic Activity of the Endo-beta 1,4-glucanase KORRIGAN1 from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX N-GLYCANS; MEMBRANE-BOUND ENDO-1,4-BETA-GLUCANASE; ER QUALITY-CONTROL; CELLULOSE BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; GLUCOSIDASE-II; CELL-WALL; MOLECULAR-CLONING; GOLGI-APPARATUS; INNATE IMMUNITY	Defects in N-glycosylation and N-glycan processing frequently cause alterations in plant cell wall architecture, including changes in the structure of cellulose, which is the most abundant plant polysaccharide. KORRIGAN1 (KOR1) is a glycoprotein enzyme with an essential function during cellulose biosynthesis in Arabidopsis thaliana. KOR1 is a membrane-anchored endo-beta 1,4-glucanase and contains eight potential N-glycosylation sites in its extracellular domain. Here, we expressed A. thaliana KOR1 as a soluble, enzymatically active protein in insect cells and analyzed its N-glycosylation state. Structural analysis revealed that all eight potential N-glycosylation sites are utilized. Individual elimination of evolutionarily conserved N-glycosylation sites did not abolish proper KOR1 folding, but mutations of Asn-216, Asn-324, Asn-345, and Asn-567 resulted in considerably lower enzymatic activity. In contrast, production of wild-type KOR1 in the presence of the class I alpha-mannosidase inhibitor kifunensine, which abolished the conversion of KOR1 N-glycans into complex structures, did not affect the activity of the enzyme. To address N-glycosylation site occupancy and N-glycan composition of KOR1 under more natural conditions, we expressed a chimeric KOR1-Fc-GFP fusion protein in leaves of Nicotiana benthamiana. Although Asn-108 and Asn-133 carried oligomannosidic N-linked oligosaccharides, the six other glycosylation sites were modified with complex N-glycans. Interestingly, the partially functional KOR1 G429R mutant encoded by the A. thaliana rsw2-1 allele displayed only oligomannosidic structures when expressed in N. benthamiana, indicating its retention in the endoplasmic reticulum. In summary, our data indicate that utilization of several N-glycosylation sites is important for KOR1 activity, whereas the structure of the attached N-glycans is not critical.	[Liebminger, Eva; Mach, Lukas; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Grass, Josephine; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, BOKU, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020	Strasser, Richard/0000-0001-8764-6530; Mach, Lukas/0000-0001-9013-5408; Altmann, Friedrich/0000-0002-0112-7877	Austria Science Fund [P23906-B20, P20817]; Austrian Science Fund (FWF) [P 23906, P 20817] Funding Source: researchfish	Austria Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austria Science Fund Grants P23906-B20 and P20817.	Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; Farid A, 2013, PLANT PHYSIOL, V162, P24, DOI 10.1104/pp.113.215509; Farid A, 2011, PLANT J, V68, P314, DOI 10.1111/j.1365-313X.2011.04688.x; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Guerriero G, 2010, J INTEGR PLANT BIOL, V52, P161, DOI 10.1111/j.1744-7909.2010.00935.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebminger E, 2012, PHYTOCHEMISTRY, V84, P24, DOI 10.1016/j.phytochem.2012.08.023; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Maloney VJ, 2012, NEW PHYTOL, V193, P1076, DOI 10.1111/j.1469-8137.2011.03998.x; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Master ER, 2004, BIOCHEMISTRY-US, V43, P10080, DOI 10.1021/bi049453x; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Ruiz-May E, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00117; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Sarkar M, 1998, GLYCOCONJUGATE J, V15, P193, DOI 10.1023/A:1006928624913; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 1999, GLYCOBIOLOGY, V9, P779, DOI 10.1093/glycob/9.8.779; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; von Numers N, 2010, MOL PLANT, V3, P740, DOI 10.1093/mp/ssq017; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Zhang Y, 2011, PHYTOCHEMISTRY, V72, P1109, DOI 10.1016/j.phytochem.2010.10.019; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	55	35	36	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22270	22280		10.1074/jbc.M113.475558	http://dx.doi.org/10.1074/jbc.M113.475558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782689	hybrid, Green Published			2022-12-28	WOS:000330596300009
J	Santa Maria, SR; Kwon, Y; Sung, P; Klein, HL				Santa Maria, Sergio R.; Kwon, YoungHo; Sung, Patrick; Klein, Hannah L.			Characterization of the Interaction between the Saccharomyces cerevisiae Rad51 Recombinase and the DNA Translocase Rdh54	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; DNA Damage Response; DNA Recombination; DNA Repair; Genomic Instability; DNA Recombinases; DNA Translocases; DNA-Protein Interactions; Rad51	PROTEIN TID1P; YEAST RAD51; DMC1; HOMOLOG; REPAIR; CHROMATIN	The Saccharomyces cerevisiae Rdh54 protein is a member of the Swi2/Snf2 family of DNA translocases required for meiotic and mitotic recombination and DNA repair. Rdh54 interacts with the general recombinases Rad51 and Dmc1 and promotes D-loop formation with either recombinase. Rdh54 also mediates the removal of Rad51 from undamaged chromatin in mitotic cells, which prevents formation of nonrecombinogenic complexes that can otherwise become toxic for cell growth. To determine which of the mitotic roles of Rdh54 are dependent on Rad51 complex formation, we finely mapped the Rad51 interaction domain in Rdh54, generated N-terminal truncation variants, and characterized their attributes biochemically and in cells. Here, we provide evidence suggesting that the N-terminal region of Rdh54 is not necessary for the response to the DNA-damaging agent methyl methanesulfonate. However, truncation variants missing 75-200 residues at the N terminus are sensitive to Rad51 overexpression. Interestingly, a hybrid protein containing the N-terminal region of Rad54, responsible for Rad51 interaction, fused to the Swi2/Snf2 core of Rdh54 is able to effectively complement the sensitivity to both methyl methanesulfonate and excess Rad51 in rdh54 null cells. Altogether, these results reveal a distinction between damage sensitivity and Rad51 removal with regard to Rdh54 interaction with Rad51.	[Santa Maria, Sergio R.; Klein, Hannah L.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	New York University; Yale University	Klein, HL (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	hannah.klein@nyumc.org		Klein, Hannah/0000-0003-4228-8535	National Institutes of Health [CA146940]; American Cancer Society Postdoctoral Fellowship [PF-11088-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA146940 (to H. L. K. and P. S.). Supported by American Cancer Society Postdoctoral Fellowship PF-11088-01-DMC.	Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Dresser ME, 1997, GENETICS, V147, P533; Ferrari M, 2013, DNA REPAIR, V12, P347, DOI 10.1016/j.dnarep.2013.02.004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Holzen TM, 2006, GENE DEV, V20, P2593, DOI 10.1101/gad.1447106; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Kateneva AV, 2005, J CELL BIOL, V171, P241, DOI 10.1083/jcb.200505020; Klein HL, 1997, GENETICS, V147, P1533; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kwon YH, 2008, J BIOL CHEM, V283, P10445, DOI 10.1074/jbc.M800082200; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Shah PP, 2010, MOL CELL, V39, P862, DOI 10.1016/j.molcel.2010.08.028; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2003, GENETICS, V163, P1273; Tanaka K, 2002, NUCLEIC ACIDS RES, V30, P1346, DOI 10.1093/nar/30.6.1346; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5	24	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21999	10.1074/jbc.M113.480475	http://dx.doi.org/10.1074/jbc.M113.480475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23798704	Green Published, hybrid			2022-12-28	WOS:000328841900046
J	Seidah, NG; Sadr, MS; Chretien, M; Mbikay, M				Seidah, Nabil G.; Sadr, Mohamad S.; Chretien, Michel; Mbikay, Majambu			The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cardiovascular Disease; Cell Surface Receptor; Cholesterol Metabolism; Intracellular Processing; Low Density Lipoprotein (LDL); Protease; Furin-like Protease; Precursor Processing; Proprotein Convertase; Secretory Proteins	DENSITY-LIPOPROTEIN-RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; NEUROENDOCRINE PROTEIN 7B2; FEVER VIRUS GLYCOPROTEIN; 9 PCSK9; PROHORMONE CONVERTASES; SITE-1 PROTEASE; POSTTRANSLATIONAL MODIFICATIONS; CLEAVAGE-SPECIFICITY; LIVER-REGENERATION	The secretory proprotein convertase (PC) family comprises nine members: PC1/3, PC2, furin, PC4, PC5/6, PACE4, PC7, SKI-1/S1P, and PCSK9. The first seven PCs cleave their substrates at single or paired basic residues, and SKI-1/S1P cleaves its substrates at non-basic residues in the Golgi. PCSK9 cleaves itself once, and the secreted inactive protease escorts specific receptors for lysosomal degradation. It regulates the levels of circulating LDL cholesterol and is considered a major therapeutic target in phase III clinical trials. In vivo, PCs exhibit unique and often essential functions during development and/or in adulthood, but certain convertases also exhibit complementary, redundant, or opposite functions.	[Seidah, Nabil G.; Sadr, Mohamad S.] Univ Montreal, Lab Biochem Neuroendocrinol, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Chretien, Michel; Mbikay, Majambu] Univ Montreal, Lab Funct Endoproteolysis, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Chretien, Michel; Mbikay, Majambu] OHRI, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Seidah, NG (corresponding author), Univ Montreal, Lab Biochem Neuroendocrinol, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; MBIKAY, Majambu/ABF-8356-2020	Seidah, Nabil/0000-0001-6503-9342; CHRETIEN, Michel/0000-0002-8588-4460; MBIKAY, Majambu/0000-0003-4854-6507	Canadian Institutes of Health Research (CIHR) [MOP-44363, MOP-93792, MOP-102741, MOP-102618, CTP-82946, CCI 102942, HSF NA 6346, PEA 6575]; Canada Chair [216684]; Strauss Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Chair; Strauss Foundation	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-44363, MOP-93792, MOP-102741, MOP-102618, CTP-82946, CCI 102942, HSF NA 6346, and PEA 6575; Canada Chair 216684 (to N. G . S.); and Strauss Foundation grants (to M. C. and N. G. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Anini Y, 2010, INT J OBESITY, V34, P1599, DOI 10.1038/ijo.2010.90; BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Blanchet M, 2012, ANTIVIR RES, V95, P159, DOI 10.1016/j.antiviral.2012.05.006; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; Chretien M, 2011, METHODS MOL BIOL, V768, P13, DOI 10.1007/978-1-61779-204-5_2; Constam DB, 2000, GENE DEV, V14, P1146; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Dhanvantari S, 1996, MOL ENDOCRINOL, V10, P342, DOI 10.1210/me.10.4.342; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Helwig M, 2013, J BIOL CHEM, V288, P1114, DOI 10.1074/jbc.M112.417071; Janis MT, 2013, ATHEROSCLEROSIS, V228, P380, DOI 10.1016/j.atherosclerosis.2013.03.029; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kincaid AE, 2001, NEUROSCIENCE, V105, P891, DOI 10.1016/S0306-4522(01)00229-9; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Lipari MT, 2012, J BIOL CHEM, V287, P43482, DOI 10.1074/jbc.M112.380618; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922; MARCINKIEWICZ M, 1994, NEUROSCI LETT, V177, P91, DOI 10.1016/0304-3940(94)90052-3; Maret D, 2012, NEOPLASIA, V14, P880, DOI 10.1593/neo.121250; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Mbikay M, 2007, DEV BIOL, V306, P584, DOI 10.1016/j.ydbio.2007.03.523; Mbikay M, 2010, FEBS LETT, V584, P701, DOI 10.1016/j.febslet.2009.12.018; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Parker R. A., 2013, J LIPID RES, DOI 10.1194/jlr. M038331; Pasquato A, 2012, VIROLOGY, V423, P14, DOI 10.1016/j.virol.2011.11.008; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Rutschmann S, 2012, G3-GENES GENOM GENET, V2, P499, DOI 10.1534/g3.112.002196; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2013, CURR PHARM DESIGN, V19, P3161; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Steiner DF, 2011, METHODS MOL BIOL, V768, P3, DOI 10.1007/978-1-61779-204-5_1; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tassew NG, 2012, DEV CELL, V22, P391, DOI 10.1016/j.devcel.2011.11.022; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	100	121	126	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21473	21481		10.1074/jbc.R113.481549	http://dx.doi.org/10.1074/jbc.R113.481549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775089	Green Published, hybrid			2022-12-28	WOS:000328841900001
J	Gosein, V; Miller, GJ				Gosein, Varin; Miller, Gregory J.			Roles of Phosphate Recognition in Inositol 1,3,4,5,6-Pentakisphosphate 2-Kinase (IPK1) Substrate Binding and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASE; SPECIFICITY	Inositol phosphate kinases (IPKs) sequentially phosphorylate inositol phosphates (IPs) to yield a group of small signaling molecules involved in diverse cellular processes. IPK1(inositol 1,3,4,5,6-pentakisphosphate 2-kinase) phosphorylates inositol 1,3,4,5,6-pentakisphosphate to inositol 1,2,3,4,5,6-hexakisphosphate; however, the mechanism of IP recognition employed by IPK1 is currently unresolved. We demonstrated previously that IPK1 possesses an unstable N-terminal lobe in the absence of IP, which led us to propose that the phosphate profile of the IP was linked to stabilization of IPK1. Here, we describe a systematic study to determine the roles of the 1-, 3-, 5-, and 6-phosphate groups of inositol 1,3,4,5,6-pentakisphosphate in IP binding and IPK1 activation. The 5- and 6-phosphate groups were the most important for IP binding to IPK1, and the 1- and 3-phosphate groups were more important for IPK1 activation than the others. Moreover, we demonstrate that there are three critical residues (Arg-130, Lys-170, and Lys-411) necessary for IPK1 activity. Arg-130 is the only substrate-binding N-terminal lobe residue that can render IPK1 inactive; its 1-phosphate is critical for full IPK1 activity and for stabilization of the active conformation of IPK1. Taken together, our results support the model for recognition of the IP substrate by IPK1 in which (i) the 4-, 5-, and 6-phosphates are initially recognized by the C-terminal lobe, and subsequently, (ii) the interaction between the 1-phosphate and Arg-130 stabilizes the N-terminal lobe and activates IPK1. This model of IP recognition, believed to be unique among IPKs, could be exploited for selective inhibition of IPK1 in future studies that investigate the role of higher IPs.	[Gosein, Varin; Miller, Gregory J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Miller, Gregory J.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Miller, Gregory J.] Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA	McGill University; McGill University; Catholic University of America	Miller, GJ (corresponding author), Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA.	millergj@cua.edu			Canadian Institutes of Health Research (CIHR) Operating Grant [MOP-93687]; CIHR Strategic Training Initiative in Chemical Biology grant	Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Initiative in Chemical Biology grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-93687 (to G. J. M.) and a CIHR Strategic Training Initiative in Chemical Biology grant (to V. G.).	Chamberlain PP, 2007, J BIOL CHEM, V282, P28117, DOI 10.1074/jbc.M703121200; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hilton JM, 2001, J BIOL CHEM, V276, P16341, DOI 10.1074/jbc.M011122200; Banos-Sanz JI, 2012, J BIOL CHEM, V287, P29237, DOI 10.1074/jbc.M112.363671; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Shi Yihui, 2006, V39, P265; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0	15	8	9	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26908	26913		10.1074/jbc.M113.487777	http://dx.doi.org/10.1074/jbc.M113.487777			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23884422	Green Published, hybrid			2022-12-28	WOS:000330594500056
J	Lo Conte, M; Carroll, KS				Lo Conte, Mauro; Carroll, Kate S.			The Redox Biochemistry of Protein Sulfenylation and Sulfinylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTEINE-SULFENIC ACID; DISULFIDE BOND FORMATION; NF-KAPPA-B; SULFINIC ACID; HYDROGEN-PEROXIDE; TYROSINE PHOSPHATASES; REVERSIBLE OXIDATION; NITRILE HYDRATASE; CELL-ADHESION; POSTTRANSLATIONAL MODIFICATION	Controlled generation of reactive oxygen species orchestrates numerous physiological signaling events (Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15). A major cellular target of reactive oxygen species is the thiol side chain (RSH) of Cys, which may assume a wide range of oxidation states (i.e. -2 to +4). Within this context, Cys sulfenic (Cys-SOH) and sulfinic (Cys-SO2H) acids have emerged as important mechanisms for regulation of protein function. Although this area has been under investigation for over a decade, the scope and biological role of sulfenic/sulfinic acid modifications have been recently expanded with the introduction of new tools for monitoring cysteine oxidation in vitro and directly in cells. This minireview discusses selected recent examples of protein sulfenylation and sulfinylation from the literature, highlighting the role of these post-translational modifications in cell signaling.	[Lo Conte, Mauro; Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA	Scripps Research Institute	Carroll, KS (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.	kcarroll@scripps.edu		Carroll, Kate/0000-0002-7624-9617	National Institutes of Health [R01GM102187]; NATIONAL CANCER INSTITUTE [R01CA174864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM102187 (to K. S. C.). This is the first third article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; Arakawa T, 2009, J AM CHEM SOC, V131, P14838, DOI 10.1021/ja903979s; Bosco MB, 2012, PROTIST, V163, P188, DOI 10.1016/j.protis.2011.07.001; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; Cotto-Rios XM, 2012, CELL REP, V2, P1475, DOI 10.1016/j.celrep.2012.11.011; Crump KE, 2012, EUR J IMMUNOL, V42, P2152, DOI 10.1002/eji.201142289; DAVIS FA, 1986, J ORG CHEM, V51, P1033, DOI 10.1021/jo00357a017; de Rezende FF, 2012, FREE RADICAL BIO MED, V53, P521, DOI 10.1016/j.freeradbiomed.2012.05.032; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Enami S, 2009, J PHYS CHEM B, V113, P9356, DOI 10.1021/jp904316n; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hamann M, 2002, METHOD ENZYMOL, V348, P146, DOI 10.1016/S0076-6879(02)48634-X; Holyoak T, 2013, BIOCHEMISTRY-US, V52, P466, DOI 10.1021/bi301341r; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Johansson Magnus, 2007, BMC Biochemistry, V8, P26, DOI 10.1186/1471-2091-8-26; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leonard SE, 2011, ANGEW CHEM INT EDIT, V50, P4423, DOI 10.1002/anie.201007871; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Lo Conte M, 2012, ANGEW CHEM INT EDIT, V51, P6502, DOI 10.1002/anie.201201812; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; McGrath AJ, 2010, J AM CHEM SOC, V132, P16759, DOI 10.1021/ja1083046; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Regazzoni L, 2009, J CHROMATOGR B, V877, P3456, DOI 10.1016/j.jchromb.2009.05.020; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Seo YH, 2009, BIOORG MED CHEM LETT, V19, P356, DOI 10.1016/j.bmcl.2008.11.073; Slavica A, 2005, APPL ENVIRON MICROB, V71, P8061, DOI 10.1128/AEM.71.12.8061-8068.2005; Smith JK, 2012, FREE RADICAL BIO MED, V52, P1101, DOI 10.1016/j.freeradbiomed.2011.12.025; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Song MY, 2011, ANTIOXID REDOX SIGN, V15, P1549, DOI 10.1089/ars.2010.3648; Svoboda LK, 2012, CIRC RES, V111, P842, DOI 10.1161/CIRCRESAHA.111.263525; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Wetzelberger K, 2010, J BIOL CHEM, V285, P26135, DOI 10.1074/jbc.M110.146423; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yano T, 2008, CHEM LETT, V37, P672, DOI 10.1246/cl.2008.672	100	211	214	1	85	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26480	26488		10.1074/jbc.R113.467738	http://dx.doi.org/10.1074/jbc.R113.467738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861405	hybrid, Green Published			2022-12-28	WOS:000330594500014
J	Cuervo, A; Pulido-Cid, M; Chagoyen, M; Arranz, R; Gonzalez-Garcia, VA; Garcia-Doval, C; Caston, JR; Valpuesta, JM; van Raaij, MJ; Martin-Benito, J; Carrascosa, JL				Cuervo, Ana; Pulido-Cid, Mar; Chagoyen, Monica; Arranz, Rocio; Gonzalez-Garcia, Veronica A.; Garcia-Doval, Carmela; Caston, Jose R.; Valpuesta, Jose M.; van Raaij, Mark J.; Martin-Benito, Jaime; Carrascosa, Jose L.			Structural Characterization of the Bacteriophage T7 Tail Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; STRUCTURE PREDICTION; TERMINAL DOMAIN; PORTAL VERTEX; DNA; PROTEIN; GENOME; RESOLUTION; CONNECTOR; PARTICLE	Most bacterial viruses need a specialized machinery, called "tail," to inject their genomes inside the bacterial cytoplasm without disrupting the cellular integrity. Bacteriophage T7 is a well characterized member of the Podoviridae family infecting Escherichia coli, and it has a short noncontractile tail that assembles sequentially on the viral head after DNA packaging. The T7 tail is a complex of around 2.7 MDa composed of at least four proteins as follows: the connector (gene product 8, gp8), the tail tubular proteins gp11 and gp12, and the fibers (gp17). Using cryo-electron microscopy and single particle image reconstruction techniques, we have determined the precise topology of the tail proteins by comparing the structure of the T7 tail extracted from viruses and a complex formed by recombinant gp8, gp11, and gp12 proteins. Furthermore, the order of assembly of the structural components within the complex was deduced from interaction assays with cloned and purified tail proteins. The existence of common folds among similar tail proteins allowed us to obtain pseudo-atomic threaded models of gp8 (connector) and gp11 (gatekeeper) proteins, which were docked into the corresponding cryo-EM volumes of the tail complex. This pseudoatomic model of the connector-gatekeeper interaction revealed the existence of a common molecular architecture among viruses belonging to the three tailed bacteriophage families, strongly suggesting that a common molecular mechanism has been favored during evolution to coordinate the transition between DNA packaging and tail assembly.	[Cuervo, Ana; Pulido-Cid, Mar; Arranz, Rocio; Gonzalez-Garcia, Veronica A.; Garcia-Doval, Carmela; Caston, Jose R.; Valpuesta, Jose M.; van Raaij, Mark J.; Martin-Benito, Jaime; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Struct Macromol Dept, Madrid 28049, Spain; [Chagoyen, Monica] CSIC, Ctr Nacl Biotecnol, Dept Syst Biol, Madrid 28049, Spain; [Carrascosa, Jose L.] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Carrascosa, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain.	jlcarras@cnb.csic.es	van Raaij, Mark J/B-3678-2009; Valpuesta, Jose M/AAA-6002-2019; Cuervo, Ana/AAB-1464-2020; Valpuesta, José M/T-1977-2017; Caston, Jose/AAB-8825-2021; Chagoyen, Monica/J-4391-2013; Caston, Jose R/L-5896-2014	van Raaij, Mark J/0000-0002-4781-1375; Valpuesta, José M/0000-0001-7468-8053; Caston, Jose/0000-0003-2350-9048; Chagoyen, Monica/0000-0001-6911-1591; Caston, Jose R/0000-0003-2350-9048; Arranz, Rocio/0000-0001-5321-0915; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Garcia Doval, Carmela/0000-0002-3422-9490	Ministry of Economy and Competitiveness [BFU2011-29038, BFU2011-25090, BFU2011-24843, BFU2011-25902]	Ministry of Economy and Competitiveness	This work was supported by Grants BFU2011-29038 (to J. L. C.), BFU2011-25090 (to J. M.-B.), BFU2011-24843 (to M. J. v. R.), and BFU2011-25902 (to J. R. C.) from the Ministry of Economy and Competitiveness.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Choi KH, 2008, J MOL BIOL, V378, P726, DOI 10.1016/j.jmb.2008.02.059; Cuervo A., 2012, BACTERIOPHAGES STRUC, P1, DOI 10.1002/9780470015902.a0024053; Cuervo A, 2012, CURR OPIN BIOTECH, V23, P529, DOI 10.1016/j.copbio.2011.11.029; Dauden MI, 2013, J BIOL CHEM, V288, P16998, DOI 10.1074/jbc.M112.448951; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fumagalli L, 2012, NAT MATER, V11, P808, DOI [10.1038/NMAT3369, 10.1038/nmat3369]; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Garcia-Doval C, 2012, ACTA CRYSTALLOGR F, V68, P166, DOI 10.1107/S1744309111051049; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Lorenzen K, 2008, J MOL BIOL, V379, P385, DOI 10.1016/j.jmb.2008.02.017; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sambrook J., 1989, MOL CLONING LAB MANU, P74; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Serwer Philip, 2012, Bacteriophage, V2, P239; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Tavares P, 2012, ADV EXP MED BIOL, V726, P585, DOI 10.1007/978-1-4614-0980-9_25; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	46	49	54	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26290	26299		10.1074/jbc.M113.491209	http://dx.doi.org/10.1074/jbc.M113.491209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884409	Green Published, hybrid			2022-12-28	WOS:000330623300058
J	Garner, JM; Fan, MY; Yang, CH; Du, ZY; Sims, M; Davidoff, AM; Pfeffer, LM				Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Davidoff, Andrew M.; Pfeffer, Lawrence M.			Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor kappa B Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; GENE-EXPRESSION; BREAST-CANCER; IN-VITRO; GROWTH; PROTEINS; RECEPTOR; SURVIVAL; LINES	Malignant gliomas are locally aggressive, highly vascular tumors that have a dismal prognosis, and present therapies provide little improvement in the disease course and outcome. Many types of malignancies, including glioblastoma, originate from a population of cancer stem cells (CSCs) that are able to initiate and maintain tumors. Although CSCs only represent a small fraction of cells within a tumor, their high tumor-initiating capacity and therapeutic resistance drives tumorigenesis. Therefore, it is imperative to identify pathways associated with CSCs to devise strategies to selectively target them. In this study, we describe a novel relationship between glioblastoma CSCs and the Notch pathway, which involves the constitutive activation of STAT3 and NF-kappa B signaling. Glioma CSCs were isolated and maintained in vitro using an adherent culture system, and the biological properties were compared with the traditional cultures of CSCs grown as multicellular spheres under nonadherent culture conditions. Interestingly, both adherent and spheroid glioma CSCs show constitutive activation of the STAT3/NF-kappa B signaling pathway and up-regulation of STAT3- and NF-kappa B-dependent genes. Gene expression profiling also identified components of the Notch pathway as being deregulated in glioma CSCs, and the deregulated expression of these genes was sensitive to treatment with STAT3 and NF-kappa B inhibitors. This finding is particularly important because Notch signaling appears to play a key role in CSCs in a variety of cancers and controls cell fate determination, survival, proliferation, and the maintenance of stem cells. The constitutive activation of STAT3 and NF-kappa B signaling pathways that leads to the regulation of Notch pathway genes in glioma CSCs identifies novel therapeutic targets for the treatment of glioma.	[Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN 38163 USA; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Canc Res Bldg,19 South Manassas St Room 154, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from the National Cancer Institute and the Assisi Foundation of Memphis [21766]; UTHSC Muirhead Chair Endowment; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from the National Cancer Institute and the Assisi Foundation of Memphis; UTHSC Muirhead Chair Endowment; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133322 (to L. M. P. and A. M. D.). This work was also supported by Department of Defense Grant W81XWH-11-1-0533 (to L. M. P.), by Cancer Center Support Grant 21766 from the National Cancer Institute and the Assisi Foundation of Memphis (to A. M. D.), by the UTHSC Muirhead Chair Endowment (to L. M. P.), and by the American Lebanese Syrian Associated Charities (to A. M. D.).	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Du ZY, 2009, J BIOL CHEM, V284, P27808, DOI 10.1074/jbc.M109.028324; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Gill JS, 2002, BIOMATERIALS, V23, P2773, DOI 10.1016/S0142-9612(02)00013-3; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hitoshi S, 2011, NAT NEUROSCI, V14, P957, DOI 10.1038/nn.2875; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	39	131	143	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26167	26176		10.1074/jbc.M113.477950	http://dx.doi.org/10.1074/jbc.M113.477950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902772	Green Published, hybrid			2022-12-28	WOS:000330623300045
J	Gill, T; Levine, AD				Gill, Tejpal; Levine, Alan D.			Mitochondria-derived Hydrogen Peroxide Selectively Enhances T Cell Receptor-initiated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; PROTEIN-TYROSINE PHOSPHATASES; REDOX REGULATION; REVERSIBLE INACTIVATION; IMMUNOLOGICAL SYNAPSE; ENDOPLASMIC-RETICULUM; FREE-RADICALS; GROWTH-FACTOR; PHOSPHORYLATION; ACTIVATION	T cell receptor (TCR)-initiated signal transduction is reported to increase production of intracellular reactive oxygen species, such as superoxide (O-2(radical anion)) and hydrogen peroxide (H2O2), as second messengers. Although H2O2 can modulate signal transduction by inactivating protein phosphatases, the mechanism and the subcellular localization of intracellular H2O2 as a second messenger of the TCR are not known. The antioxidant enzyme superoxide dismutase (SOD) catalyzes the dismutation of highly reactive O-2(radical anion) into H2O2 and thus acts as an intracellular generator of H2O2. As charged O-2(radical anion) is unable to diffuse through intracellular membranes, cells express distinct SOD isoforms in the cytosol (Cu,Zn-SOD) and mitochondria (Mn-SOD), where they locally scavenge O-2(radical anion) leading to production of H2O2. A 2-fold organelle-specific overexpression of either SOD in Jurkat T cell lines increases intracellular production of H2O2 but does not alter the levels of intracellular H2O2 scavenging enzymes such as catalase, membrane-bound peroxiredoxin-1 (Prx1), and cytosolic Prx2. We report that overexpression of Mn-SOD enhances tyrosine phosphorylation of TCR-associated membrane proximal signal transduction molecules Lck, LAT, ZAP70, PLC gamma 1, and SLP76 within 1 min of TCR cross-linking. This increase in mitochondrial H2O2 specifically modulates MAPK signaling through the JNK/c Junpathway, whereas overexpressing Cu, Zn-SOD had no effect on any of these TCR-mediated signaling molecules. As mitochondria translocate to the immunological synapse during TCR activation, we hypothesize this translocation provides the effective concentration of H2O2 required to selectively modulate downstream signal transduction pathways.	[Gill, Tejpal; Levine, Alan D.] Case Western Reserve Univ, Div Gastroenterol & Liver Dis, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University	Levine, AD (corresponding author), Case Western Reserve Univ, Sch Med BRB525, Dept Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	alan.levine@case.edu	Gill, Tejpal/AAV-1659-2020; Gill, Tejpal/A-1139-2014	Gill, Tejpal/0000-0001-6248-132X	National Institutes of Health [R21 AI-083609, P30 AR-039750]; Ohio Department of Development Center for Innovative Immunosuppressive Therapeutics [TECH 09-023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Department of Development Center for Innovative Immunosuppressive Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R21 AI-083609 (to A. D. L.) and P30 AR-039750 to the Case Western Reserve University Skin Diseases Research Center and the Ohio Department of Development Center for Innovative Immunosuppressive Therapeutics (Prime Award, TECH 09-023).	Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Davicino Roberto, 2009, Immunopharmacol Immunotoxicol, V31, P130, DOI 10.1080/08923970802520701; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; HARRIS ED, 1992, J NUTR, V122, P636, DOI 10.1093/jn/122.suppl_3.636; Jin YJ, 1998, J IMMUNOL, V161, P1743; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kesarwani P, 2013, ANTIOXID REDOX SIGN, V18, P1497, DOI 10.1089/ars.2011.4073; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; Lu SP, 2007, FREE RADICAL BIO MED, V42, P936, DOI 10.1016/j.freeradbiomed.2006.11.027; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MOREL I, 1990, BIOCHEM PHARMACOL, V39, P1647, DOI 10.1016/0006-2952(90)90107-V; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; NATHAN CF, 1979, J EXP MED, V149, P84, DOI 10.1084/jem.149.1.84; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nyakeriga AM, 2012, CYTOM PART A, V81A, P797, DOI 10.1002/cyto.a.22070; O'Loghlen A, 2003, ARCH BIOCHEM BIOPHYS, V417, P194, DOI 10.1016/S0003-9861(03)00368-0; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2012, CELL CALCIUM, V52, P57, DOI 10.1016/j.ceca.2012.02.005; Quintana A, 2009, CELL CALCIUM, V45, P109, DOI 10.1016/j.ceca.2008.07.003; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Reyes BMR, 2005, J IMMUNOL, V175, P2158, DOI 10.4049/jimmunol.175.4.2158; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sambrook J., 2001, MOL CLONING LAB MANU; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; STAAL FJT, 1994, P NATL ACAD SCI USA, V91, P3619, DOI 10.1073/pnas.91.9.3619; Walsh PT, 2002, IMMUNOLOGY, V107, P461, DOI 10.1046/j.1365-2567.2002.01525.x; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0	52	34	35	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26246	26255		10.1074/jbc.M113.476895	http://dx.doi.org/10.1074/jbc.M113.476895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880762	Green Published, hybrid			2022-12-28	WOS:000330623300054
J	Jiang, SN; Park, DW; Stigler, WS; Creighton, J; Ravi, S; Darley-Usmar, V; Zmijewski, JW				Jiang, Shaoning; Park, Dae Won; Stigler, William S.; Creighton, Judy; Ravi, Saranya; Darley-Usmar, Victor; Zmijewski, Jaroslaw W.			Mitochondria and AMP-activated Protein Kinase-dependent Mechanism of Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PERSISTENT CELL-MIGRATION; FIND-ME SIGNALS; APOPTOTIC CELLS; ENDOTHELIAL-CELLS; GAMMA-SUBUNITS; ENERGY SENSOR; T-CELLS; CLEARANCE; LYSOPHOSPHATIDYLCHOLINE	Defective clearance of apoptotic cells is frequently associated with perpetuation of inflammatory conditions. Our results show a rapid activation of AMP-activated kinase (AMPK) in macrophages upon exposure to apoptotic cells or lysophosphatidylcholine, a specific phospholipid that is produced and released from dying cells. AMPK activation resulted from inhibition of mitochondrial oxygen consumption and ATP production and further depended on Ca2+ mobilization and mitochondrial reactive oxygen species generation. Once activated, AMPK increased microtubule synthesis and chemokinesis and provided adaptation to energy demand during tracking and engulfment. Uptake of apoptotic cells was increased in lungs of mice that received lysophosphatidylcholine. Furthermore, inhibition of AMPK diminished clearance of apoptotic thymocytes in vitro and in dexamethasone-treated mice. Taken together, we conclude that the mitochondrial AMPK axis is a sensor and enhancer of tracking and removal of apoptotic cell, processes crucial to resolution of inflammatory conditions and a return to tissue homeostasis.	[Jiang, Shaoning; Park, Dae Won; Stigler, William S.; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Creighton, Judy] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Darley-Usmar, Victor; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Park, Dae Won] Korea Univ, Ansan Hosp, Div Infect Dis, Ansan 425707, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine)	Zmijewski, JW (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII-304, Birmingham, AL 35294 USA.	zmijewsk@uab.edu	Kim, Il/L-6481-2019; Ha, C/GZL-9046-2022	Park, Dae Won/0000-0002-7653-686X; Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health [GM87748, HL107585, P30 AR 48311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102296, R01HL107585, R03HL110803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM87748 and HL107585 (to J. W. Z.) and P30 AR 48311 (to the Flow Cytometry Core, Arthritis and Musculoskeletal Center, University of Alabama at Birmingham).	Bae HB, 2013, J IMMUNOL, V190, P2273, DOI 10.4049/jimmunol.1200625; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Banerjee S, 2011, J IMMUNOL, V187, P4686, DOI 10.4049/jimmunol.1101500; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P1053, DOI 10.1124/jpet.105.092122; Chan O, 2012, J BIOL CHEM, V287, P29406, DOI 10.1074/jbc.M112.348946; Chang WG, 2012, CARDIOVASC DRUG THER, V26, P467, DOI 10.1007/s10557-012-6422-0; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Gaskin FS, 2011, AM J PHYSIOL-HEART C, V300, pH1352, DOI 10.1152/ajpheart.00944.2010; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Laiosa MD, 2003, J IMMUNOL, V171, P4582, DOI 10.4049/jimmunol.171.9.4582; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Peter C, 2012, AUTOIMMUNITY, V45, P568, DOI 10.3109/08916934.2012.719947; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031056; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yuan YP, 1996, J BIOL CHEM, V271, P27090, DOI 10.1074/jbc.271.43.27090; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	60	45	46	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26013	26026		10.1074/jbc.M113.489468	http://dx.doi.org/10.1074/jbc.M113.489468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897815	Green Published, hybrid			2022-12-28	WOS:000330623300032
J	Montersino, S; Orru, R; Barendregt, A; Westphal, AH; van Duijn, E; Mattevi, A; van Berkel, WJH				Montersino, Stefania; Orru, Roberto; Barendregt, Arjan; Westphal, Adrie H.; van Duijn, Esther; Mattevi, Andrea; van Berkel, Willem J. H.			Crystal Structure of 3-Hydroxybenzoate 6-Hydroxylase Uncovers Lipid-assisted Flavoprotein Strategy for Regioselective Aromatic Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; COENZYME-Q BIOSYNTHESIS; PSEUDOMONAS-FLUORESCENS; MASS-SPECTROMETRY; ESCHERICHIA-COLI; SUBSTRATE; ENZYME; SEQUENCE; PROTEIN; IDENTIFICATION	3-Hydroxybenzoate 6-hydroxylase (3HB6H) from Rhodococcus jostii RHA1 is a dimeric flavoprotein that catalyzes the NADH-and oxygen-dependent para-hydroxylation of 3-hydroxybenzoate to 2,5-dihydroxybenzoate. In this study, we report the crystal structure of 3HB6H as expressed in Escherichia coli. The overall fold of 3HB6H is similar to that of p-hydroxybenzoate hydroxylase and other flavoprotein aromatic hydroxylases. Unexpectedly, a lipid ligand is bound to each 3HB6H monomer. Mass spectral analysis identified the ligand as a mixture of phosphatidylglycerol and phosphatidylethanolamine. The fatty acid chains occupy hydrophobic channels that deeply penetrate into the interior of the substrate-binding domain of each subunit, whereas the hydrophilic part is exposed on the protein surface, connecting the dimerization domains via a few interactions. Most remarkably, the terminal part of a phospholipid acyl chain is directly involved in the substrate-binding site. Co-crystallized chloride ion and the crystal structure of the H213S variant with bound 3-hydroxybenzoate provide hints about oxygen activation and substrate hydroxylation. Essential roles are played by His-213 in catalysis and Tyr-105 in substrate binding. This phospholipid-assisted strategy to control regioselective aromatic hydroxylation is of relevance for optimization of flavin-dependent biocatalysts.	[Montersino, Stefania; Westphal, Adrie H.; van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Orru, Roberto; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Barendregt, Arjan; van Duijn, Esther] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Barendregt, Arjan; van Duijn, Esther] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; University of Pavia; Utrecht University; Utrecht University	Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 9, I-27100 Pavia, Italy.	andrea.mattevi@unipv.it; willem.vanberkel@wur.nl	Mattevi, Andrea/R-4469-2019; Orru, Roberto/E-9779-2013; van Berkel, Willem J.H./O-2431-2014; Westphal, Adrie Herman/L-3517-2019; mattevi, andrea/K-5464-2012	Mattevi, Andrea/0000-0002-9523-7128; van Berkel, Willem J.H./0000-0002-6551-2782; Westphal, Adrie Herman/0000-0003-4264-6267; mattevi, andrea/0000-0002-9523-7128	Integrated Biosynthesis Organic Synthesis program of the Netherlands Organization for Scientific Research (NWO)	Integrated Biosynthesis Organic Synthesis program of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Integrated Biosynthesis Organic Synthesis program of the Netherlands Organization for Scientific Research (NWO).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; Chun J, 1996, J IND MICROBIOL, V17, P205, DOI 10.1007/BF01574694; Clarke CF, 2011, CHEM BIOL, V18, P1069, DOI 10.1016/j.chembiol.2011.09.006; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; Eppink MHM, 1997, PROTEIN SCI, V6, P2454; Eppink MHM, 1998, J BIOL CHEM, V273, P21031, DOI 10.1074/jbc.273.33.21031; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FINNERTY WR, 1992, ANNU REV MICROBIOL, V46, P193, DOI 10.1146/annurev.mi.46.100192.001205; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kachalova GS, 2010, J MOL BIOL, V396, P785, DOI 10.1016/j.jmb.2009.12.009; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003; McCulloch KM, 2009, BIOCHEMISTRY-US, V48, P4139, DOI 10.1021/bi900149f; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Montersino S., 2008, FLAVINS FLAVOPROTEIN, P51; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oursel D, 2007, RAPID COMMUN MASS SP, V21, P1721, DOI 10.1002/rcm.3013; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Ryan KS, 2007, P NATL ACAD SCI USA, V104, P15311, DOI 10.1073/pnas.0707190104; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STEENNIS PJ, 1973, FEBS LETT, V36, P177, DOI 10.1016/0014-5793(73)80363-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treiber N, 2008, J MOL BIOL, V379, P94, DOI 10.1016/j.jmb.2008.03.032; van Berkel W. J., 1991, CHEM BIOCHEMISTRY, V2, P2; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; VANBERKEL WJH, 1991, EUR J BIOCHEM, V201, P585; Volkers G, 2011, FEBS LETT, V585, P1061, DOI 10.1016/j.febslet.2011.03.012; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; WEIJER WJ, 1983, EUR J BIOCHEM, V133, P109, DOI 10.1111/j.1432-1033.1983.tb07435.x	53	36	36	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26235	26245		10.1074/jbc.M113.479303	http://dx.doi.org/10.1074/jbc.M113.479303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23864660	Green Published, hybrid			2022-12-28	WOS:000330623300053
J	Pitts, MW; Reeves, MA; Hashimoto, AC; Ogawa, A; Kremer, P; Seale, LA; Berry, MJ				Pitts, Matthew W.; Reeves, Mariclair A.; Hashimoto, Ann C.; Ogawa, Ashley; Kremer, Penny; Seale, Lucia A.; Berry, Marla J.			Deletion of Selenoprotein M Leads to Obesity without Cognitive Deficits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ENDOPLASMIC-RETICULUM; THIOREDOXIN REDUCTASE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; ENERGY IMBALANCE; MICE; EXPRESSION; SELENIUM; NEURONS	Selenium is an essential trace element that is co-translationally incorporated into selenoproteins in the form of the 21st amino acid, selenocysteine. This class of proteins largely functions in oxidation-reduction reactions and is critically involved in maintaining proper redox balance essential to health. Selenoprotein M (SelM) is a thioredoxin-like endoplasmic reticulum-resident protein that is highly expressed in the brain and possesses neuroprotective properties. In this study, we first assessed the regional pattern of SelM expression in the mouse brain to provide insights into the potential functional implications of this protein in physiology and behavior. Next, we generated transgenic mice with a targeted deletion of the SelM gene and subjected them to a battery of neurobehavioral tests to evaluate motor coordination, locomotion, and cognitive function in comparison with wild-type controls. Finally, these mice were tested for several measures of metabolic function and body composition. Our results show that SelM knock-out (KO) mice display no deficits in measures of motor coordination and cognitive function but exhibit increased weight gain, elevated white adipose tissue deposition, and diminished hypothalamic leptin sensitivity. These findings suggest that SelM plays an important role in the regulation of body weight and energy metabolism.	[Pitts, Matthew W.; Reeves, Mariclair A.; Hashimoto, Ann C.; Ogawa, Ashley; Kremer, Penny; Seale, Lucia A.; Berry, Marla J.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System	Pitts, MW (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	mwpitts@hawaii.edu	Seale, Lucia Andreia/T-9579-2019; Seale, Lucia/GRF-1325-2022	Seale, Lucia Andreia/0000-0002-0686-7516; Seale, Lucia/0000-0002-0686-7516; Pitts, Matthew/0000-0002-0994-7466	National Institutes of Health [RO1 DK47320, G12 MD007601, G12 RR003061]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047320] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK47320, G12 MD007601, and G12 RR003061.	Auvinen HE, 2012, J ENDOCRINOL, V214, P191, DOI 10.1530/JOE-12-0056; Balthasar N, 2006, OBESITY, V14, P222; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Blouet C, 2012, J NEUROSCI, V32, P9870, DOI 10.1523/JNEUROSCI.0353-12.2012; Blouet C, 2011, J NEUROSCI, V31, P6019, DOI 10.1523/JNEUROSCI.6498-10.2011; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; CUNNINGHAM JJ, 1986, ENDOCRINOLOGY, V118, P98, DOI 10.1210/endo-118-1-98; EDWARDSON JA, 1975, J ENDOCRINOL, V65, P99, DOI 10.1677/joe.0.0650099; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hwang DY, 2005, NEUROCHEM RES, V30, P1009, DOI 10.1007/s11064-005-6787-6; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Marsili A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020832; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Raber J, 1997, J BIOL CHEM, V272, P15057, DOI 10.1074/jbc.272.24.15057; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; RIVIER C, 1982, ENDOCRINOLOGY, V110, P272, DOI 10.1210/endo-110-1-272; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Seale LA, 2012, MOL CELL BIOL, V32, P4141, DOI 10.1128/MCB.00293-12; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	39	66	70	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26121	26134		10.1074/jbc.M113.471235	http://dx.doi.org/10.1074/jbc.M113.471235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880772	Green Published, hybrid			2022-12-28	WOS:000330623300041
J	Saslowsky, DE; te Welscher, YM; Chinnapen, DJF; Wagner, JS; Wan, J; Kern, E; Lencer, WI				Saslowsky, David E.; te Welscher, Yvonne M.; Chinnapen, Daniel J-F; Wagner, Jessica S.; Wan, Joy; Kern, Eli; Lencer, Wayne I.			Ganglioside GM1-mediated Transcytosis of Cholera Toxin Bypasses the Retrograde Pathway and Depends on the Structure of the Ceramide Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; IGG TRANSPORT; LIPID RAFTS; CELLS; GLUCOSYLCERAMIDE; SPHINGOMYELIN; INTOXICATION; ENDOSOMES; PROTEINS; ANALOGS	Cholera toxin causes diarrheal disease by binding ganglioside GM1 on the apical membrane of polarized intestinal epithelial cells and trafficking retrograde through sorting endosomes, the trans-Golgi network (TGN), and into the endoplasmic reticulum. A fraction of toxin also moves from endosomes across the cell to the basolateral plasma membrane by transcytosis, thus breeching the intestinal barrier. Here we find that sorting of cholera toxin into this transcytotic pathway bypasses retrograde transport to the TGN. We also find that GM1 sphingolipids can traffic from apical to basolateral membranes by transcytosis in the absence of toxin binding but only if the GM1 species contain cis-unsaturated or short acyl chains in the ceramide domain. We found previously that the same GM1 species are needed to efficiently traffic retrograde into the TGN and endoplasmic reticulum and into the recycling endosome, implicating a shared mechanism of action for sorting by lipid shape among these pathways.	[Saslowsky, David E.; te Welscher, Yvonne M.; Chinnapen, Daniel J-F; Wagner, Jessica S.; Wan, Joy; Kern, Eli; Lencer, Wayne I.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Saslowsky, David E.; Wagner, Jessica S.; Lencer, Wayne I.] Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Saslowsky, David E.; te Welscher, Yvonne M.; Chinnapen, Daniel J-F; Lencer, Wayne I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saslowsky, DE (corresponding author), Boston Childrens Hosp, Div Gastroenterol, 300 Longwood Ave,Enders Bldg,RM 609, Boston, MA 02115 USA.	david.saslowsky@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	National Institutes of Health [R01 DK48106, R01 DK084424, R21 DK090603, K01 DK073480, P30 DK34854]; Boston Children's Hospital Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048106, R21DK090603, K01DK073480, P30DK034854, R01DK048106, R01DK084424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK48106, R01 DK084424, and R21 DK090603 (to W. I. L.); K01 DK073480 (to D. E. S.); and P30 DK34854 (to the Harvard Digestive Diseases Center). This work was also supported by a Boston Children's Hospital Career Development Award (to D. E. S.).	Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Jobling MG, 2012, MBIO, V3, DOI 10.1128/mBio.00401-12; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Saslowsky DE, 2008, CELL MICROBIOL, V10, P67, DOI 10.1111/j.1462-5822.2007.01015.x; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; VAN GENDEREN I, 1995, J CELL BIOL, V131, P645, DOI 10.1083/jcb.131.3.645; van IJzendoorn SCD, 1998, J CELL BIOL, V142, P683, DOI 10.1083/jcb.142.3.683; vanIjzendoorn SCD, 1997, J CELL BIOL, V137, P347, DOI 10.1083/jcb.137.2.347; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07	21	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25804	25809		10.1074/jbc.M113.474957	http://dx.doi.org/10.1074/jbc.M113.474957			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884419	hybrid, Green Published			2022-12-28	WOS:000330623300013
J	Lawton, TJ; Bowen, KE; Sayavedra-Soto, LA; Arp, DJ; Rosenzweig, AC				Lawton, Thomas J.; Bowen, Kimberly E.; Sayavedra-Soto, Luis A.; Arp, Daniel J.; Rosenzweig, Amy C.			Characterization of a Nitrite Reductase Involved in Nitrifier Denitrification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMMONIA-OXIDIZING BACTERIA; NITROUS-OXIDE PRODUCTION; FAECALIS STRAIN S-6; NITROSOMONAS-EUROPAEA; ALCALIGENES-FAECALIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; TYPE-2 COPPER; MULTICOPPER OXIDASE; KINETIC-ANALYSIS	Nitrifier denitrification is the conversion of nitrite to nitrous oxide by ammonia-oxidizing organisms. This process, which is distinct from denitrification, is active under aerobic conditions in the model nitrifier Nitrosomonas europaea. The central enzyme of the nitrifier dentrification pathway is a copper nitrite reductase (CuNIR). To understand how a CuNIR, typically inactivated by oxygen, functions in this pathway, the enzyme isolated directly from N. europaea (NeNIR) was biochemically and structurally characterized. NeNIR reduces nitrite at a similar rate to other CuNIRs but appears to be oxygen tolerant. Crystal structures of oxidized and reduced NeNIR reveal a substrate channel to the active site that is much more restricted than channels in typical CuNIRs. In addition, there is a second fully hydrated channel leading to the active site that likely acts a water exit pathway. The structure is minimally affected by changes in pH. Taken together, these findings provide insight into the molecular basis for NeNIR oxygen tolerance.	[Lawton, Thomas J.; Bowen, Kimberly E.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Lawton, Thomas J.; Bowen, Kimberly E.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Sayavedra-Soto, Luis A.; Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Northwestern University; Northwestern University; Oregon State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	amyr@northwestern.edu			Agriculture and Food Research Initiative Competitive Grant from the U. S. Department of Agriculture [2010-65115-20380]; Oregon Agricultural Experimental Station	Agriculture and Food Research Initiative Competitive Grant from the U. S. Department of Agriculture; Oregon Agricultural Experimental Station	This work was supported by Agriculture and Food Research Initiative Competitive Grant 2010-65115-20380 from the U. S. Department of Agriculture (to A. C. R.) and a grant from the Oregon Agricultural Experimental Station (to D. J. A).	Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Beaumont HJE, 2005, J BACTERIOL, V187, P6849, DOI 10.1128/JB.187.19.6849-6851.2005; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Bento I, 2006, J BIOL INORG CHEM, V11, P539, DOI 10.1007/s00775-006-0114-9; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Cantera JJL, 2007, ENVIRON MICROBIOL, V9, P765, DOI 10.1111/j.1462-2920.2006.01198.x; Casciotti KL, 2001, APPL ENVIRON MICROB, V67, P2213, DOI 10.1128/AEM.67.5.2213-2221.2001; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chandran K, 2011, BIOCHEM SOC T, V39, P1832, DOI 10.1042/BST20110717; Cho CMH, 2006, APPL ENVIRON MICROB, V72, P4450, DOI 10.1128/AEM.02958-05; Cua LS, 2011, FEMS MICROBIOL LETT, V319, P169, DOI 10.1111/j.1574-6968.2011.02277.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V806, P320, DOI 10.1016/0005-2728(85)90111-2; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V827, P320, DOI 10.1016/0167-4838(85)90217-1; Dodd FE, 1998, J MOL BIOL, V282, P369, DOI 10.1006/jmbi.1998.2007; Dundee L, 2001, SOIL BIOL BIOCHEM, V33, P1563, DOI 10.1016/S0038-0717(01)00059-1; Ellis MJ, 2003, J MOL BIOL, V328, P429, DOI 10.1016/S0022-2836(03)00308-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldsmith RH, 2011, P NATL ACAD SCI USA, V108, P17269, DOI 10.1073/pnas.1113572108; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1968, BIOCHIM BIOPHYS ACTA, V162, P49, DOI 10.1016/0005-2728(68)90213-2; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; Hough MA, 2008, BIOCHEMISTRY-US, V47, P13547, DOI 10.1021/bi801369y; Impagliazzo A, 2004, J AM CHEM SOC, V126, P5658, DOI 10.1021/ja049619h; Jacobson F, 2005, ACTA CRYSTALLOGR D, V61, P1190, DOI 10.1107/S0907444905017488; Jacobson F, 2007, J BIOL CHEM, V282, P6347, DOI 10.1074/jbc.M605746200; Jason J, 2007, ARCH MICROBIOL, V188, P349, DOI 10.1007/s00203-007-0255-4; KAKUTANI T, 1981, J BIOCHEM-TOKYO, V89, P463, DOI 10.1093/oxfordjournals.jbchem.a133221; KAKUTANI T, 1981, J BIOCHEM, V89, P453, DOI 10.1093/oxfordjournals.jbchem.a133220; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lawton TJ, 2011, METHOD ENZYMOL, V496, P423, DOI 10.1016/B978-0-12-386489-5.00017-8; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; Leferink NGH, 2012, FEBS J, V279, P2174, DOI 10.1111/j.1742-4658.2012.08601.x; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DJ, 1983, J GEN MICROBIOL, V129, P1645; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; Murphy MEP, 1997, J BIOL CHEM, V272, P28455, DOI 10.1074/jbc.272.45.28455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nojiri M, 2009, NATURE, V462, P117, DOI 10.1038/nature08507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POTH M, 1985, APPL ENVIRON MICROB, V49, P1134, DOI 10.1128/AEM.49.5.1134-1141.1985; RITCHIE GAF, 1974, BIOCHEM J, V138, P471, DOI 10.1042/bj1380471; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schmidt I, 2004, MICROBIOL-SGM, V150, P4107, DOI 10.1099/mic.0.27382-0; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P214, DOI 10.1111/j.1462-2920.2005.00882.x; Stein LY, 1998, APPL ENVIRON MICROB, V64, P4098; VANDEKAMP M, 1990, EUR J BIOCHEM, V194, P109; Wijma HJ, 2006, J BIOL CHEM, V281, P16340, DOI 10.1074/jbc.M601610200; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	60	36	37	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25575	25583		10.1074/jbc.M113.484543	http://dx.doi.org/10.1074/jbc.M113.484543			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857587	hybrid, Green Published			2022-12-28	WOS:000330619000052
J	Murakami, Y; Watari, K; Shibata, T; Uba, M; Ureshino, H; Kawahara, A; Abe, H; Izumi, H; Mukaida, N; Kuwano, M; Ono, M				Murakami, Yuichi; Watari, Kosuke; Shibata, Tomohiro; Uba, Manami; Ureshino, Hiroki; Kawahara, Akihiko; Abe, Hideyuki; Izumi, Hiroto; Mukaida, Naofumi; Kuwano, Michihiko; Ono, Mayumi			N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1 alpha by Human Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; METASTASIS SUPPRESSOR GENE; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; PANCREATIC-CANCER; PROSTATE-CANCER; MACROPHAGES; NDRG1; CAP43/NDRG1/DRG-1; OVEREXPRESSION	The expression of N-myc downstream-regulated gene 1 (NDRG1) was significantly correlated with tumor angiogenesis and malignant progression together with poor prognosis in gastric cancer. However, the underlying mechanism for the role of NDRG1 in the malignant progression of gastric cancer remains unknown. Here we examined whether and how NDRG1 could modulate tumor angiogenesis by human gastric cancer cells. We established NU/Cap12 and NU/Cap32 cells overexpressing NDRG1 in NUGC-3 cells, which show lower tumor angiogenesis in vivo. Compared with parental NU/Mock3, NU/Cap12, and NU/Cap32 cells: 1) induced higher tumor angiogenesis than NU/Mock3 cells accompanied by infiltration of tumor-associated macrophages in mouse dorsal air sac assay and Matrigel plug assay; 2) showed much higher expression of CXC chemokines, MMP-1, and the potent angiogenic factor VEGF-A; 3) increased the expression of the representative inflammatory cytokine, IL-1 alpha; 4) augmented JNK phosphorylation and nuclear expression of activator protein 1 (AP-1). Further analysis demonstrated that knockdown of AP-1 (Jun and/or Fos) resulted in down-regulation of the expression of VEGF-A, CXC chemokines, and MMP-1, and also suppressed expression of IL-1 alpha in NDRG1-overexpressing cell lines. Treatment with IL-1 receptor antagonist (IL-1ra) resulted in down-regulation of JNK and c-Jun phosphorylation, and the expression of VEGF-A, CXC chemokines, and MMP-1 in NU/Cap12 and NU/Cap32 cells. Finally, administration of IL-1ra suppressed both tumor angiogenesis and infiltration of macrophages by NU/Cap12 in vivo. Together, activation of JNK/AP-1 thus seems to promote tumor angiogenesis in relationship to NDRG1-induced inflammatory stimuli by gastric cancer cells.	[Murakami, Yuichi; Watari, Kosuke; Shibata, Tomohiro; Uba, Manami; Ureshino, Hiroki; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 8128582, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Lab Mol Canc Biol, Fukuoka 8128582, Japan; [Murakami, Yuichi] St Marys Hosp, Kurume, Fukuoka 8308543, Japan; [Kawahara, Akihiko; Abe, Hideyuki] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka 8300011, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 8078555, Japan; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9200934, Japan	Kyushu University; Kyushu University; Kurume University; University of Occupational & Environmental Health - Japan; Kanazawa University	Ono, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 8128582, Japan.	mono@phar.kyushu-u.ac.jp	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851; Watari, Kosuke/0000-0003-0260-2323	Japan Society for the Promotion of Science (JSPS) [23300350]; 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23300350] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (B) 23300350 from the Japan Society for the Promotion of Science (JSPS) (to M. O.) and the 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan (to M. K.).	Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Fotovati A, 2006, CLIN CANCER RES, V12, P3010, DOI 10.1158/1078-0432.CCR-05-1962; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guadagni S, 2000, WORLD J SURG, V24, P1550, DOI 10.1007/s002680010276; Guang RJ, 2000, CANCER RES, V60, P749; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; ISHIKAWA Y, 1995, J BIOL CHEM, V270, P4158, DOI 10.1074/jbc.270.8.4158; Kawahara A, 2011, EXP THER MED, V2, P471, DOI 10.3892/etm.2011.222; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koshiji M, 2007, WORLD J GASTROENTERO, V13, P2803, DOI 10.3748/wjg.v13.i20.2803; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sohda M, 2009, ANTICANCER RES, V29, P965; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25025	25037		10.1074/jbc.M113.472068	http://dx.doi.org/10.1074/jbc.M113.472068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846687	Green Published, hybrid			2022-12-28	WOS:000330619000004
J	Toseland, CP; Webb, MR				Toseland, Christopher P.; Webb, Martin R.			ATPase Mechanism of the 5'-3' DNA Helicase, RecD2 EVIDENCE FOR A PRE-HYDROLYSIS CONFORMATION CHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT NUCLEOTIDE ANALOGS; PHOSPHATE-BINDING PROTEIN; PCRA HELICASE; INORGANIC-PHOSPHATE; ESCHERICHIA-COLI; INITIATOR PROTEIN; RNA HELICASE; STRANDED-DNA; TRANSLOCATION; CYCLE	The superfamily 1 helicase, RecD2, is a monomeric, bacterial enzyme with a role in DNA repair, but with 5'-3' activity unlike most enzymes from this superfamily. Rate constants were determined for steps within the ATPase cycle of RecD2 in the presence of ssDNA. The fluorescent ATP analog, mantATP (2'(3')-O( N-methylanthraniloyl) ATP), was used throughout to provide a complete set of rate constants and determine the mechanism of the cycle for a single nucleotide species. Fluorescence stopped-flow measurements were used to determine rate constants for adenosine nucleotide binding and release, quenched-flow measurements were used for the hydrolytic cleavage step, and the fluorescent phosphate biosensor was used for phosphate release kinetics. Some rate constants could also be measured using the natural substrate, ATP, and these suggested a similar mechanism to that obtained with mantATP. The data show that a rearrangement linked to Mg2+ coordination, which occurs before the hydrolysis step, is rate-limiting in the cycle and that this step is greatly accelerated by bound DNA. This is also shown here for the PcrA 3'-5' helicase and so may be a general mechanism governing superfamily 1 helicases. The mechanism accounts for the tight coupling between translocation and ATPase activity.	[Toseland, Christopher P.; Webb, Martin R.] MRC Natl Inst Med Res, London NW7 1AA, England; [Toseland, Christopher P.] Univ Munich, Inst Zellulare Physiol, D-80336 Munich, Germany; [Toseland, Christopher P.] Univ Munich, Inst Physiol, Ctr NanoSci, D-80336 Munich, Germany	MRC National Institute for Medical Research; University of Munich; University of Munich	Webb, MR (corresponding author), MRC Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	mwebb@nimr.mrc.ac.uk	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535; Webb, Martin/0000-0002-0134-9621	Medical Research Council, UK [U117512742]; MRC [MC_U117512742] Funding Source: UKRI; Medical Research Council [MC_U117512742] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council, UK Grant U117512742	Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cao WX, 2011, J MOL BIOL, V409, P399, DOI 10.1016/j.jmb.2011.04.004; Chisty LT, 2013, NUCLEIC ACIDS RES, V41, P5010, DOI 10.1093/nar/gkt194; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P3309, DOI 10.1021/bi00465a023; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Leatherbarrow R J, 2007, GRAFIT VERSION 6; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14550, DOI 10.1021/bi00252a023; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Toseland CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038270; Toseland CP, 2011, METHODS MOL BIOL, V778, P161, DOI 10.1007/978-1-61779-261-8_11; Toseland CP, 2010, METHODS, V51, P259, DOI 10.1016/j.ymeth.2010.02.012; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Webb Martin R., 2003, P131; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334	33	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25183	25193		10.1074/jbc.M113.484667	http://dx.doi.org/10.1074/jbc.M113.484667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839989	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000330619000018
J	Semache, M; Zarrouki, B; Fontes, G; Fogarty, S; Kikani, C; Chawki, MB; Rutter, J; Poitout, V				Semache, Meriem; Zarrouki, Bader; Fontes, Ghislaine; Fogarty, Sarah; Kikani, Chintan; Chawki, Mohammad B.; Rutter, Jared; Poitout, Vincent			Per-Arnt-Sim Kinase Regulates Pancreatic Duodenal Homeobox-1 Protein Stability via Phosphorylation of Glycogen Synthase Kinase 3 beta in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-EXPRESSION; DNA-BINDING ACTIVITY; PAS KINASE; GLUCOSE; TRANSCRIPTION; DOMAIN; ACTIVATION; PDX-1; INHIBITION; MICE	In pancreatic beta-cells, glucose induces the binding of the transcription factor pancreatic duodenal homeobox-1 (PDX-1) to the insulin gene promoter to activate insulin gene transcription. At low glucose levels, glycogen synthase kinase 3 beta (GSK3 beta) is known to phosphorylate PDX-1 on C-terminal serine residues, which triggers PDX-1 proteasomal degradation. We previously showed that the serine/threonine Per-Arnt-Sim domain-containing kinase (PASK) regulates insulin gene transcription via PDX-1. However, the mechanisms underlying this regulation are unknown. In this study, we aimed to identify the role of PASK in the regulation of PDX-1 phosphorylation, protein expression, and stability in insulin-secreting cells and isolated rodent islets of Langerhans. We observed that glucose induces a decrease in overall PDX-1 serine phosphorylation and that overexpression of WT PASK mimics this effect. In vitro, PASK directly phosphorylates GSK3 beta on its inactivating phosphorylation site Ser(9). Overexpression of a kinase-dead (KD), dominant negative version of PASK blocks glucose-induced Ser(9) phosphorylation of GSK3 beta. Accordingly, GSK3 beta Ser(9) phosphorylation is reduced in islets from pask-null mice. Overexpression of WT PASK or KD GSK3 beta protects PDX-1 from degradation and results in increased PDX-1 protein abundance. Conversely, overexpression of KD PASK blocks glucose-induction of PDX-1 protein. We conclude that PASK phosphorylates and inactivates GSK3 beta, thereby preventing PDX-1 serine phosphorylation and alleviating GSK3 beta-mediated PDX-1 protein degradation in pancreatic beta-cells.	[Semache, Meriem; Zarrouki, Bader; Fontes, Ghislaine; Chawki, Mohammad B.; Poitout, Vincent] Univ Montreal, Montreal Diabet Res Ctr, CRCHUM, Quebec City, PQ H1W 4A4, Canada; [Semache, Meriem; Poitout, Vincent] Univ Montreal, Dept Biochem, Quebec City, PQ H1W 4A4, Canada; [Zarrouki, Bader; Poitout, Vincent] Univ Montreal, Dept Med, Quebec City, PQ H1W 4A4, Canada; [Fogarty, Sarah; Kikani, Chintan; Rutter, Jared] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Utah System of Higher Education; University of Utah	Poitout, V (corresponding author), CRCHUM Technopole Angus,2901 Rachel Est, Montreal, PQ H1W 4A4, Canada.	vincent.poitout@umontreal.ca		Poitout, Vincent/0000-0002-6555-5053; Chawki, Mohammad B./0000-0002-6220-3618; Kikani, Chintan/0000-0003-1140-0192	National Institutes of Health [R01 DK-58096, R01 DK-071962]; Fonds de Recherche en Sante du Quebec; Eli Lilly; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058096, R01DK071962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Eli Lilly(Eli Lilly); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK-58096 (to V. P.) and R01 DK-071962 (to J. R.).; Recipient of a doctoral studentship from the Fonds de Recherche en Sante du Quebec.; Supported by a postdoctoral fellowship from Eli Lilly.; Supported by a Mentor-based postdoctoral fellowship from the American Diabetes Association.	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; An R, 2006, BIOCHEM SOC T, V34, P791, DOI 10.1042/BST0340791; An R, 2010, BIOCHEM BIOPH RES CO, V399, P155, DOI 10.1016/j.bbrc.2010.07.035; Ben Shushan E, 1999, DNA CELL BIOL, V18, P471, DOI 10.1089/104454999315196; Borter E, 2007, DIABETES, V56, P113, DOI 10.2337/db06-0798; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Cardon CM, 2012, SEMIN CELL DEV BIOL, V23, P626, DOI 10.1016/j.semcdb.2011.12.007; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; da Silva Xavier G, 2004, P NATL ACAD SCI USA, V101, P8319, DOI 10.1073/pnas.0307737101; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Grose JH, 2010, SENSORS-BASEL, V10, P5668, DOI 10.3390/s100605668; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kebede M, 2012, P NATL ACAD SCI USA, V109, P2376, DOI 10.1073/pnas.1114350109; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Lebrun P, 2005, J BIOL CHEM, V280, P38203, DOI 10.1074/jbc.M504842200; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Meng R, 2010, CELL MOL LIFE SCI, V67, P2481, DOI 10.1007/s00018-010-0348-0; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Poitout V., 2004, INT TXB DIABETES MEL, P98; Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Semplici F, 2011, J BIOL CHEM, V286, P44005, DOI 10.1074/jbc.M111.254995; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Wilson WA, 2005, P NATL ACAD SCI USA, V102, P16596, DOI 10.1073/pnas.0508481102; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7	45	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24825	24833		10.1074/jbc.M113.495945	http://dx.doi.org/10.1074/jbc.M113.495945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853095	Green Published, hybrid			2022-12-28	WOS:000330612300047
J	Tsygankova, OM; Wang, HB; Meinkoth, JL				Tsygankova, Oxana M.; Wang, Hongbin; Meinkoth, Judy L.			Tumor Cell Migration and Invasion Are Enhanced by Depletion of Rap1 GTPase-activating Protein (Rap1GAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN ENDOCYTOSIS; DOWN-REGULATION; PLATELET CYTOSKELETON; BINDING PROTEIN; IN-VIVO; ADHESION; RAC; CANCER; MECHANISMS; MUTATION	The functional significance of the widespread down-regulation of Rap1 GTPase-activating protein (Rap1GAP), a negative regulator of Rap activity, in human tumors is unknown. Here we show that human colon cancer cells depleted of Rap1GAP are endowed with more aggressive migratory and invasive properties. Silencing Rap1GAP enhanced the migration of confluent and single cells. In the latter, migration distance, velocity, and directionality were increased. Enhanced migration was a consequence of increased endogenous Rap activity as silencing Rap expression selectively abolished the migration of Rap1GAP-depleted cells. ROCK-mediated cell contractility was suppressed in Rap1GAP-depleted cells, which exhibited a spindle-shaped morphology and abundant membrane protrusions. Tumor cells can switch between Rho/ROCK-mediated contractility-based migration and Rac1-mediated mesenchymal motility. Strikingly, the migration of Rap1GAP-depleted, but not control cells required Rac1 activity, suggesting that loss of Rap1GAP alters migratory mechanisms. Inhibition of Rac1 activity restored membrane blebbing and increased ROCK activity in Rap1GAP-depleted cells, suggesting that Rac1 contributes to the suppression of contractility. Collectively, these findings identify Rap1GAP as a critical regulator of aggressive tumor cell behavior and suggest that the level of Rap1GAP expression influences the migratory mechanisms that are operative in tumor cells.	[Tsygankova, Oxana M.; Wang, Hongbin; Meinkoth, Judy L.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Meinkoth, JL (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 421 Curie Blvd,BRB 2-3, Philadelphia, PA 19104 USA.	meinkoth@upenn.edu						Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Choi SC, 2005, EMBO J, V24, P985, DOI 10.1038/sj.emboj.7600571; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Friedl P, 2003, BIOCHEM SOC SYMP, V70, P277, DOI 10.1042/bss0700277; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Jeon TJ, 2007, J CELL BIOL, V179, P833, DOI 10.1083/jcb.200705068; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kortholt A, 2008, CELL SIGNAL, V20, P1415, DOI 10.1016/j.cellsig.2008.02.006; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Lin KBL, 2010, ONCOGENE, V29, P608, DOI 10.1038/onc.2009.345; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Matsuse M, 2009, ENDOCR J, V56, P161, DOI 10.1507/endocrj.K08E-244; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Myagmar BE, 2005, BIOCHEM BIOPH RES CO, V329, P1046, DOI 10.1016/j.bbrc.2005.02.069; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Suh HN, 2010, AM J PHYSIOL-CELL PH, V298, pC1159, DOI 10.1152/ajpcell.00496.2009; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; TORTI M, 1994, P NATL ACAD SCI USA, V91, P4239, DOI 10.1073/pnas.91.10.4239; Torti M, 1999, J CELL BIOCHEM, V75, P675, DOI 10.1002/(SICI)1097-4644(19991215)75:4<675::AID-JCB13>3.0.CO;2-M; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; Vuchak LA, 2011, CELL ADHES MIGR, V5, P323, DOI 10.4161/cam.5.4.17041; White GC, 1998, THROMB HAEMOSTASIS, V79, P832; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	48	18	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24636	24646		10.1074/jbc.M113.464594	http://dx.doi.org/10.1074/jbc.M113.464594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23864657	hybrid, Green Published			2022-12-28	WOS:000330612300031
J	Dias, J; Renault, L; Perez, J; Mirande, M				Dias, Jose; Renault, Louis; Perez, Javier; Mirande, Marc			Small-angle X-ray Solution Scattering Study of the Multi-aminoacyl-tRNA Synthetase Complex Reveals an Elongated and Multi-armed particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; EUKARYOTIC MULTISYNTHETASE COMPLEX; LEUCYL-TRANSFER RNA; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; MULTIENZYME COMPLEX; ELECTRON-MICROSCOPY; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; BINDING DOMAIN	In animal cells, nine aminoacyl-tRNA synthetases are associated with the three auxiliary proteins p18, p38, and p43 to form a stable and conserved large multi-aminoacyl-tRNA synthetase complex (MARS), whose molecular mass has been proposed to be between 1.0 and 1.5 MDa. The complex acts as a molecular hub for coordinating protein synthesis and diverse regulatory signal pathways. Electron microscopy studies defined its low resolution molecular envelope as an overall rather compact, asymmetric triangular shape. Here, we have analyzed the composition and homogeneity of the native mammalian MARS isolated from rabbit liver and characterized its overall internal structure, size, and shape at low resolution by hydrodynamic methods and small-angle x-ray scattering in solution. Our data reveal that the MARS exhibits a much more elongated and multi-armed shape than expected from previous reports. The hydrodynamic and structural features of the MARS are large compared with other supramolecular assemblies involved in translation, including ribosome. The large dimensions and non-compact structural organization of MARS favor a large protein surface accessibility for all its components. This may be essential to allow structural rearrangements between the catalytic and cis-acting tRNA binding domains of the synthetases required for binding the bulky tRNA substrates. This non-compact architecture may also contribute to the spatiotemporal controlled release of some of its components, which participate in non-canonical functions after dissociation from the complex.	[Dias, Jose; Renault, Louis; Mirande, Marc] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Perez, Javier] Orme Merisiers St Aubin, SOLEIL Synchrotron, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Renault, L (corresponding author), CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Louis.Renault@lebs.cnrs-gif.fr; Marc.Mirande@lebs.cnrs-gif.fr		Dias, Jose/0000-0002-7625-0618; RENAULT, Louis/0000-0003-1722-074X	Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer; Agence Nationale de Recherche sur le SIDA	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique, the Association pour la Recherche sur le Cancer, and the Agence Nationale de Recherche sur le SIDA.	Agou F, 1996, J BIOL CHEM, V271, P29295, DOI 10.1074/jbc.271.46.29295; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GULIK A, 1984, MOL BIOL REP, V10, P23, DOI 10.1007/BF00775150; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; JOHNSON DL, 1981, P NATL ACAD SCI-BIOL, V78, P4059, DOI 10.1073/pnas.78.7.4059; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; Kim K. R., 2013, PROTEINS, DOI [10.1002/prot.24306, DOI 10.1002/PR0T.24306]; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim Y, 2000, J BIOL CHEM, V275, P27062; Koehler C, 2013, NUCLEIC ACIDS RES, V41, P667, DOI 10.1093/nar/gks1072; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; Norcum MT, 1999, J BIOL CHEM, V274, P12205, DOI 10.1074/jbc.274.18.12205; Norcum MT, 2002, FEBS LETT, V512, P298, DOI 10.1016/S0014-5793(02)02262-7; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Norcum MT, 1999, FEBS LETT, V447, P217; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019	64	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23979	23989		10.1074/jbc.M113.489922	http://dx.doi.org/10.1074/jbc.M113.489922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836901	hybrid, Green Published			2022-12-28	WOS:000330611400036
J	Karmakar, S; Jin, YT; Nagaich, AK				Karmakar, Sudipan; Jin, Yetao; Nagaich, Akhilesh K.			Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) alpha and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ER alpha Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; STEROID-HORMONE RECEPTORS; FACTOR-KAPPA-B; GENE-EXPRESSION; DNA-BINDING; COACTIVATOR AIB1; MONOAMINE-OXIDASE; ZINC-FINGER; TUMOR-CELLS; CROSS-TALK	The role of glucocorticoids in the inhibition of estrogen (17-beta-estradiol (E2))-regulated estrogen receptor (ER)-positive breast cancer cell proliferation is well established. We and others have seen that synthetic glucocorticoid dexamethasone (Dex) antagonizes E2-stimulated endogenous ER alpha target gene expression. However, how glucocorticoids negatively regulate the ER alpha signaling pathway is still poorly understood. ChIP studies using ER alpha- and glucocorticoid receptor (GR)-positive MCF-7 cells revealed that GR occupies several ER alpha-binding regions (EBRs) in cells treated with E2 and Dex simultaneously. Interestingly, there was little or no GR loading to these regions when cells were treated with E2 or Dex alone. The E2+Dex-dependent GR recruitment is associated with the displacement of ER alpha and steroid receptor coactivator-3 from the target EBRs leading to the repression of ER alpha-mediated transcriptional activation. The recruitment of GR to EBRs requires assistance from ER alpha and FOXA1 and is facilitated by AP1 binding within the EBRs. The GR binding to EBRs is mediated via direct protein-protein interaction between the GR DNA-binding domain and ER alpha. Limited mutational analyses indicate that arginine 488 located within the C-terminal zinc finger domain of the GR DNA-binding domain plays a critical role in stabilizing this interaction. Together, the results of this study unravel a novel mechanism involved in glucocorticoid inhibition of ER alpha transcriptional activity and E2-mediated cell proliferation and thus establish a foundation for future exploitation of the GR signaling pathway in the treatment of ER-positive breast cancer.	[Karmakar, Sudipan; Jin, Yetao; Nagaich, Akhilesh K.] US FDA, CDER, OPS, Div Therapeut Prot,OBP, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Nagaich, AK (corresponding author), US FDA, CDER, OPS, Div Therapeut Prot,OBP, 29 Lincoln Dr, Bethesda, MD 20892 USA.	akhilesh.nagaich@fda.hhs.gov			Food and Drug Administration Commissioner's Fellowship	Food and Drug Administration Commissioner's Fellowship	This project was supported in part by a Food and Drug Administration Commissioner's Fellowship (to S. K.).	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Azorsa DO, 2001, BREAST CANCER RES TR, V70, P89, DOI 10.1023/A:1012972808558; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Biswas D. K., 2005, SCI STKE, V2005, ppe27; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Chen K, 2011, MOL PHARMACOL, V79, P308, DOI 10.1124/mol.110.067439; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; HALL RE, 1990, INT J CANCER, V46, P1081, DOI 10.1002/ijc.2910460622; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Karmakar S, 2010, MOL ENDOCRINOL, V24, P1187, DOI 10.1210/me.2009-0480; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P3782, DOI 10.1128/MCB.13.6.3782; Kim MJ, 2007, EMBO J, V26, P3075, DOI 10.1038/sj.emboj.7601755; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; LIPPMAN M, 1976, CANCER RES, V36, P4602; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Safe S., 2001, VITAMINS HORMONES; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Sumikawa T, 2008, INT J ONCOL, V32, P683; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Vaidya JS, 2010, CURR PHARM DESIGN, V16, P3593; Volden PA, 2013, BRAIN BEHAV IMMUN, V30, pS26, DOI 10.1016/j.bbi.2012.10.022; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Yang LM, 1997, CANCER RES, V57, P4652; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Zhang CW, 2006, INT J ONCOL, V29, P1295; ZHOU F, 1989, MOL CELL ENDOCRINOL, V66, P189	72	82	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24020	24034		10.1074/jbc.M113.473819	http://dx.doi.org/10.1074/jbc.M113.473819			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814048	hybrid, Green Published			2022-12-28	WOS:000330611400040
J	Cavallini, A; Brewerton, S; Bell, A; Sargent, S; Glover, S; Hardy, C; Moore, R; Calley, J; Ramachandran, D; Poidinger, M; Karran, E; Davies, P; Hutton, M; Szekeres, P; Bose, S				Cavallini, Annalisa; Brewerton, Suzanne; Bell, Amanda; Sargent, Samantha; Glover, Sarah; Hardy, Clare; Moore, Roger; Calley, John; Ramachandran, Devaki; Poidinger, Michael; Karran, Eric; Davies, Peter; Hutton, Michael; Szekeres, Philip; Bose, Suchira			An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; HYPERPHOSPHORYLATION; TANGLES; AGGREGATION; EIF2-ALPHA; FILAMENTS; DOMAINS; PATHWAY	Neurofibrillary tangles, one of the hallmarks of Alzheimer disease (AD), are composed of paired helical filaments of abnormally hyperphosphorylated tau. The accumulation of these proteinaceous aggregates in AD correlates with synaptic loss and severity of dementia. Identifying the kinases involved in the pathological phosphorylation of tau may identify novel targets for AD. We used an unbiased approach to study the effect of 352 human kinases on their ability to phosphorylate tau at epitopes associated with AD. The kinases were overexpressed together with the longest form of human tau in human neuroblastoma cells. Levels of total and phosphorylated tau (epitopes Ser(P)-202, Thr(P)-231, Ser(P)-235, and Ser(P)-396/404) were measured in cell lysates using AlphaScreen assays. GSK3 alpha, GSK3 beta, and MAPK13 were found to be the most active tau kinases, phosphorylating tau at all four epitopes. We further dissected the effects of GSK3 alpha and GSK3 beta using pharmacological and genetic tools in hTau primary cortical neurons. Pathway analysis of the kinases identified in the screen suggested mechanisms for regulation of total tau levels and tau phosphorylation; for example, kinases that affect total tau levels do so by inhibition or activation of translation. A network fishing approach with the kinase hits identified other key molecules putatively involved in tau phosphorylation pathways, including the G-protein signaling through the Ras family of GTPases (MAPK family) pathway. The findings identify novel tau kinases and novel pathways that may be relevant for AD and other tauopathies.	[Cavallini, Annalisa; Brewerton, Suzanne; Bell, Amanda; Sargent, Samantha; Glover, Sarah; Hardy, Clare; Moore, Roger; Hutton, Michael; Szekeres, Philip; Bose, Suchira] Eli Lilly & Co Ltd, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Calley, John] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Ramachandran, Devaki; Poidinger, Michael] Eli Lilly & Co Ltd, Singapore Ctr Drug Discovery, Lilly Singapore, Singapore 237994, Singapore; [Karran, Eric] Alzheimers Res UK, Cambridge CB21 6AD, England; [Davies, Peter] Albert Einstein Coll Med, Einstein Inst Med Res, Manhasset, NY 11030 USA	Eli Lilly; Eli Lilly; Yeshiva University	Bose, S (corresponding author), Eli Lilly & Co Ltd, Erl Wood Manor, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England.	bose_suchira@lilly.com		Poidinger, Michael/0000-0002-1047-2277				Allen B, 2002, J NEUROSCI, V22, P9340; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Atzori C, 2001, J NEUROPATH EXP NEUR, V60, P1190, DOI 10.1093/jnen/60.12.1190; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Buee-Scherrer V, 2002, FEBS LETT, V515, P151, DOI 10.1016/S0014-5793(02)02460-2; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Dijkstra E., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/14728222.7.2.187; Hernandez F, 2003, NEUROBIOL AGING, V24, P1087, DOI 10.1016/j.neurobiolaging.2003.04.002; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee VHL, 2011, INT J PHARMACEUT, V415, P1, DOI 10.1016/j.ijpharm.2011.03.035; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nuss J. M., 2002, U. S. Patent, Patent No. [20,020,156,087, 20020156087]; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008	41	74	75	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23331	23347		10.1074/jbc.M113.463984	http://dx.doi.org/10.1074/jbc.M113.463984			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798682	Green Published, hybrid			2022-12-28	WOS:000330598200038
J	Liu, JY; Stevens, PD; Eshleman, NE; Gao, TY				Liu, Jianyu; Stevens, Payton D.; Eshleman, Nichole E.; Gao, Tianyan			Protein Phosphatase PPM1G Regulates Protein Translation and Cell Growth by Dephosphorylating 4E Binding Protein 1 (4E-BP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; PHOSPHORYLATION; MTOR; PHLPP; S6K1; AKT; ACTIVATION; MECHANISMS; INITIATION; RAPAMYCIN	Protein translation initiation is a tightly controlled process responding to nutrient availability and mitogen stimulation. Serving as one of the most important negative regulators of protein translation, 4E binding protein 1 (4E-BP1) binds to translation initiation factor 4E and inhibits cap-dependent translation in a phosphorylation-dependent manner. Although it has been demonstrated previously that the phosphorylation of 4E-BP1 is controlled by mammalian target of rapamycin in the mammalian target of rapamycin complex 1, the mechanism underlying the dephosphorylation of 4E-BP1 remains elusive. Here, we report the identification of PPM1G as the phosphatase of 4E-BP1. A coimmunoprecipitation experiment reveals that PPM1G binds to 4E-BP1 in cells and that purified PPM1G dephosphorylates 4E-BP1 in vitro. Knockdown of PPM1G in 293E and colon cancer HCT116 cells results in an increase in the phosphorylation of 4E-BP1 at both the Thr-37/46 and Ser-65 sites. Furthermore, the time course of 4E-BP1 dephosphorylation induced by amino acid starvation or mammalian target of rapamycin inhibition is slowed down significantly in PPM1G knockdown cells. Functionally, the amount of 4E-BP1 bound to the cap-dependent translation initiation complex is decreased when the expression of PPM1G is depleted. As a result, the rate of cap-dependent translation, cell size, and protein content are increased in PPM1G knockdown cells. Taken together, our study has identified protein phosphatase PPM1G as a novel regulator of cap-dependent protein translation by negatively controlling the phosphorylation of 4E-BP1.	[Liu, Jianyu; Stevens, Payton D.; Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Eshleman, Nichole E.] Univ Kentucky, Mansfield Univ, Lexington, KY 40536 USA; [Eshleman, Nichole E.] Univ Kentucky, Res Experiences Undergrad REU Program, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01 CA133429-01A1]; American Cancer Society [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133429-01A1 (to T. G.). This work was also supported by American Cancer Society Grant RSG0822001TBE (to T.G.).	Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Fadden P, 1997, J BIOL CHEM, V272, P10240; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	32	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23225	23233		10.1074/jbc.M113.492371	http://dx.doi.org/10.1074/jbc.M113.492371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814053	hybrid, Green Published			2022-12-28	WOS:000330598200029
J	Luo, M; Velikovsky, CA; Yang, XB; Siddiqui, MA; Hong, X; Barchi, JJ; Gildersleeve, JC; Pancer, Z; Mariuzza, RA				Luo, Ming; Velikovsky, C. Alejandro; Yang, Xinbo; Siddiqui, Maqbool A.; Hong, Xia; Barchi, Joseph J., Jr.; Gildersleeve, Jeffrey C.; Pancer, Zeev; Mariuzza, Roy A.			Recognition of the Thomsen-Friedenreich Pancarcinoma Carbohydrate Antigen by a Lamprey Variable Lymphocyte Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; STRUCTURAL INSIGHTS; BINDING; EVOLUTION; ANTIBODY; THERMODYNAMICS; GLYCOSYLATION; SPECIFICITY; SITES	Variable lymphocyte receptors (VLRs) are leucine-rich repeat proteins that mediate adaptive immunity in jawless vertebrates. VLRs were recently shown to recognize glycans, such as the tumor-associated Thomsen-Friedenreich antigen (TF alpha; Gal beta 1-3GalNAc alpha), with a selectivity rivaling or exceeding that of lectins and antibodies. To understand the basis for TF alpha recognition by one such VLR (VLRB.aGPA.23), we measured thermodynamic parameters for the binding interaction and determined the structure of the VLRB.aGPA.23-TF alpha complex to 2.2 angstrom resolution. In the structure, four tryptophan residues form a tight hydrophobic cage encasing the TF alpha disaccharide that completely excludes buried water molecules. This cage together with hydrogen bonding of sugar hydroxyls to polar side chains explains the exquisite selectivity of VLRB.aGPA.23. The topology of the glycan-binding site of VLRB.aGPA.23 differs markedly from those of lectins or antibodies, which typically consist of long, convex grooves for accommodating the oligosaccharide. Instead, the TF alpha disaccharide is sandwiched between a variable loop and the concave surface of the VLR formed by the beta-strands of the leucine-rich repeat modules. Longer oligosaccharides are predicted to extend perpendicularly across the beta-strands, requiring them to bend to match the concavity of the VLR solenoid.	[Luo, Ming; Velikovsky, C. Alejandro; Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Luo, Ming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Luo, Ming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Velikovsky, C. Alejandro; Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Siddiqui, Maqbool A.; Barchi, Joseph J., Jr.; Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, Ctr Canc Res, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Hong, Xia; Pancer, Zeev] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Baltimore, MD 21202 USA; [Hong, Xia; Pancer, Zeev] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21202 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Gildersleeve, Jeffrey/N-3392-2014; Barchi, Joseph J/N-3784-2014	Gildersleeve, Jeffrey/0000-0002-3744-6423; Barchi, Joseph/0000-0001-9906-0799	National Institutes of Health (NIH) [AI036900, AI083892]; NIH, NCI; National Science Foundation [MCB-0614672]; China Scholarship Council; NATIONAL CANCER INSTITUTE [ZIABC010740, ZIABC011232, ZIABC010451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036900, R21AI083892, R01AI036900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI036900 (to R. A. M.) and AI083892 (to Z. P.) and by the intramural research program of the NIH, NCI (to J. J. B. and J. C. G.). This work was also supported by National Science Foundation Grant MCB-0614672 (to Z. P.).; Supported by the Joint Supervision Ph.D. Project of the China Scholarship Council.	Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Almogren Adel, 2012, Front Biosci (Schol Ed), V4, P840; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Deng L, 2013, ANNU REV BIOPHYS, V42, P191, DOI 10.1146/annurev-biophys-083012-130422; Deng L, 2010, P NATL ACAD SCI USA, V107, P13408, DOI 10.1073/pnas.1005475107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hong X, 2013, ACS CHEM BIOL, V8, P152, DOI 10.1021/cb300399s; Hu D, 2012, J BIOL CHEM, V287, P20313, DOI 10.1074/jbc.M112.351965; Imberty A, 2005, CURR OPIN STRUC BIOL, V15, P525, DOI 10.1016/j.sbi.2005.08.003; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kirchdoerfer RN, 2012, STRUCTURE, V20, P479, DOI 10.1016/j.str.2012.01.009; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; Mallajosyula SS, 2011, J PHYS CHEM B, V115, P11215, DOI 10.1021/jp203695t; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PISANO A, 1993, GLYCOBIOLOGY, V3, P429, DOI 10.1093/glycob/3.5.429; Powlesland AS, 2009, GLYCOBIOLOGY, V19, P899, DOI 10.1093/glycob/cwp065; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sakai K, 2010, J BIOCHEM, V147, P809, DOI 10.1093/jb/mvq014; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun W, 2010, CURR PHARM DESIGN, V16, P2269, DOI 10.2174/138161210791792877; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Varki A., 2009, ESSENTIALS GLYCOBIOL; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387	37	30	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23597	23606		10.1074/jbc.M113.480467	http://dx.doi.org/10.1074/jbc.M113.480467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782692	hybrid, Green Published			2022-12-28	WOS:000330598200063
J	Ozkan-Dagliyan, I; Chiou, YY; Ye, R; Hassan, BH; Ozturk, N; Sancar, A				Ozkan-Dagliyan, Irem; Chiou, Yi-Ying; Ye, Rui; Hassan, Bachar H.; Ozturk, Nuri; Sancar, Aziz			Formation of Arabidopsis Cryptochrome 2 Photobodies in Mammalian Nuclei APPLICATION AS AN OPTOGENETIC DNA DAMAGE CHECKPOINT SWITCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT INTERACTION; BLUE-LIGHT; COP1 ACTIVITY; PROTEIN; PHYTOCHROME; MECHANISMS; CRY2; SPA1; PHOSPHORYLATION; DEGRADATION	Nuclear bodies are discrete suborganelle structures that perform specialized functions in eukaryotic cells. In plant cells, light can induce de novo formation of nuclear bodies called photobodies (PBs) composed of the photosensory pigments, phytochrome (PHY) or cryptochrome (CRY). The mechanisms of formation, the exact compositions, and the functions of plant PBs are not known. Here, we have expressed Arabidopsis CRY2 (AtCRY2) in mammalian cells and analyzed its fate after blue light exposure to understand the requirements for PB formation, the functions of PBs, and their potential use in cell biology. We found that light efficiently induces AtCRY2-PB formation in mammalian cells, indicating that, other than AtCRY2, no plant-specific proteins or nucleic acids are required for AtCRY2-PB formation. Irradiation of AtCRY2 led to its degradation; however, degradation was not dependent upon photobody formation. Furthermore, we found that AtCRY2 photobody formation is associated with light-stimulated interaction with mammalian COP1 E3 ligase. Finally, we demonstrate that by fusing AtCRY2 to the TopBP1 DNA damage checkpoint protein, light-induced AtCRY2 PBs can be used to activate DNA damage signaling pathway in the absence of DNA damage.	[Ozkan-Dagliyan, Irem; Chiou, Yi-Ying; Ye, Rui; Hassan, Bachar H.; Ozturk, Nuri; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011; 邱, 奕穎/E-8593-2018	Ozturk, Nuri/0000-0001-5206-4127; 邱, 奕穎/0000-0002-8742-8848	National Institutes of Health [GM31082, GM032833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031082, R37GM031082, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31082 and GM032833 (to A. S.).	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Gu NN, 2012, MOL PLANT, V5, P85, DOI 10.1093/mp/ssr052; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Van Buskirk EK, 2012, PLANT PHYSIOL, V158, P52, DOI 10.1104/pp.111.186411; Wang HY, 1999, CURR BIOL, V9, P711, DOI 10.1016/S0960-9822(99)80314-5; Weidler G, 2012, PLANT CELL, V24, P2610, DOI 10.1105/tpc.112.098210; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yu XH, 2009, PLANT CELL, V21, P118, DOI 10.1105/tpc.108.061663; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zuo ZC, 2012, MOL PLANT, V5, P726, DOI 10.1093/mp/sss007; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	32	29	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23244	23251		10.1074/jbc.M113.493361	http://dx.doi.org/10.1074/jbc.M113.493361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23833191	Green Published, hybrid			2022-12-28	WOS:000330598200031
J	Djokic, J; Fagotto-Kaufmann, C; Bartels, R; Nelea, V; Reinhardt, DP				Djokic, Jelena; Fagotto-Kaufmann, Christine; Bartels, Rainer; Nelea, Valentin; Reinhardt, Dieter P.			Fibulin-3,-4, and-5 Are Highly Susceptible to Proteolysis, Interact with Cells and Heparin, and Form Multimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; MACULAR DEGENERATION; PROTEIN; FIBRILLIN-1; EXPRESSION; ELASTOGENESIS; BINDING; FIBULIN-5/DANCE; MUTATIONS; MOLECULES	Extracellular short fibulins, fibulin-3, -4, and -5, are components of the elastic fiber/microfibril system and are implicated in the formation and homeostasis of elastic tissues. In this study, we report new structural and functional properties of the short fibulins. Full-length human short fibulins were recombinantly expressed in human embryonic kidney cells and purified by immobilized metal ion affinity chromatography. All three fibulins showed various levels of degradation after the purification procedure. N-terminal sequencing revealed that all three fibulins are highly susceptible to proteolysis within the N-terminal linker region of the first calcium-binding epidermal growth factor domain. Proteolytic susceptibility of the linker correlated with its length. Exposure of these fibulins to matrix metalloproteinase (MMP)-1, -2, -3, -7, -9, and -12 resulted in similar proteolytic fragments with MMP-7 and -12 being the most potent proteases. Fibulin-3 proteolysis was almost completely inhibited in cell culture by the addition of 25 mu M doxycycline (a broad spectrum MMP inhibitor). Reducible fibulin-4 dimerization and multimerization were consistently observed by SDS-PAGE, Western blotting, and mass spectrometry. Atomic force microscopy identified monomers, dimers, and multimers in purified fibulin-4 preparations with sizes of similar to 10-15, similar to 20-25, and similar to 30-50 nm, respectively. All short fibulins strongly adhered to human fibroblasts and smooth muscle cells. Although only fibulin-5 has an RGD integrin binding site, all short fibulins adhere at a similar level to the respective cells. Solid phase binding assays detected strong calcium-dependent binding of the short fibulins to immobilized heparin, suggesting that these fibulins may bind cell surface-located heparan sulfate.	[Djokic, Jelena; Nelea, Valentin; Reinhardt, Dieter P.] McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ H3A 0C7, Canada; [Fagotto-Kaufmann, Christine; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 0C7, Canada; [Bartels, Rainer] Airway Res Ctr North, Res Ctr Borstel, Div Struct Biochem, Leibniz Ctr Med & Biosci, D-23845 Borstel, Germany	McGill University; McGill University; Forschungszentrum Borstel	Reinhardt, DP (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	Natural Sciences and Engineering Research Council of Canada [RGPIN 375738-09]; Canadian Institutes of Health Research [MOP-106494]; Network for Oral and Bone Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Network for Oral and Bone Health Research	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 375738-09, Canadian Institutes of Health Research Grant MOP-106494, and the Network for Oral and Bone Health Research.	ALBIN RJ, 1987, AM REV RESPIR DIS, V135, P1281; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Cooley MA, 2011, BIOL EXTRACELL MATR, P337, DOI 10.1007/978-3-642-16555-9_10; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Franco C, 2006, AM J PATHOL, V168, P1697, DOI 10.2353/ajpath.2006.050613; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gu W, 2011, EUR J DERMATOL, V21, P717, DOI 10.1684/ejd.2011.1449; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Hubmacher D, 2010, J BIOL CHEM, V285, P1188, DOI 10.1074/jbc.M109.021246; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; Jones RPO, 2010, INVEST OPHTH VIS SCI, V51, P2356, DOI 10.1167/iovs.09-4620; Jones RPO, 2009, J BIOL CHEM, V284, P25938, DOI 10.1074/jbc.M109.011627; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; Kapustin A, 2012, BIOCHEM J, V443, P491, DOI 10.1042/BJ20110348; Kett WC, 2005, ANAL BIOCHEM, V339, P206, DOI 10.1016/j.ab.2005.01.054; Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Li DQ, 2000, INVEST OPHTH VIS SCI, V41, P404; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; McLaughlin PJ, 2007, HUM MOL GENET, V16, P3059, DOI 10.1093/hmg/ddm264; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; VINE N, 1991, CLIN SCI, V81, P233, DOI 10.1042/cs0810233; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Xin X, 2011, BIOL PHARM BULL, V34, P480, DOI 10.1248/bpb.34.480; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	47	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22821	22835		10.1074/jbc.M112.439158	http://dx.doi.org/10.1074/jbc.M112.439158			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782690	Green Published, hybrid			2022-12-28	WOS:000330596300059
J	Smith, AM; Harrison, JS; Sprague, KM; Roy, H				Smith, Angela M.; Harrison, Jesse S.; Sprague, Kevin M.; Roy, Herve			A Conserved Hydrolase Responsible for the Cleavage of Aminoacylphosphatidylglycerol in the Membrane of Enterococcus faecium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; LYSYL-PHOSPHATIDYLGLYCEROL; ANTIMICROBIAL PEPTIDES; IV SECRETION; RESISTANCE; VIRULENCE; PROTEIN; MPRF; SUSCEPTIBILITY; DAPTOMYCIN	Aminoacylphosphatidylglycerol synthases (aaPGSs) are enzymes that transfer amino acids from aminoacyl-tRNAs (aa-tRNAs) to phosphatidylglycerol (PG) to form aa-PG in the cytoplasmic membrane of bacteria. aa-PGs provide bacteria with resistance to a range of antimicrobial compounds and stress conditions. Enterococcus faecium encodes a triple-specific aaPGS (RakPGS) that utilizes arginine, alanine, and lysine as substrates. Here we identify a novel hydrolase (AhyD), encoded immediately adjacent to rakPGS in E. faecium, which is responsible for the hydrolysis of aa-PG. The genetic synteny of aaPGS and ahyD is conserved in >60 different bacterial species. Deletion of ahyD in E. faecium resulted in increased formation of Ala-PG and Lys-PG and increased sensitivity to bacitracin. Our results suggest that AhyD and RakPGS act together to maintain optimal levels of aa-PG in the bacterial membrane to confer resistance to certain antimicrobial compounds and stress conditions.	[Smith, Angela M.; Harrison, Jesse S.; Sprague, Kevin M.; Roy, Herve] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Roy, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 12722 Res Pkwy, Orlando, FL 32826 USA.	herve.roy@ucf.edu						Arendt W, 2012, J BACTERIOL, V194, P1401, DOI 10.1128/JB.06576-11; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Bao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038458; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; den Kamp JA O P, 1965, Biochim Biophys Acta, V106, P438; DITTMER JC, 1964, J LIPID RES, V5, P126; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; GOULD RM, 1970, J BACTERIOL, V104, P1135, DOI 10.1128/JB.104.3.1135-1144.1970; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; HAEST CWM, 1972, BIOCHIM BIOPHYS ACTA, V255, P720, DOI 10.1016/0005-2736(72)90385-9; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Kahm M., 2010, J STAT SOFTW, V33, pi07; KALOGERAKI VS, 1995, J BACTERIOL, V177, P892, DOI 10.1128/jb.177.4.892-897.1995; KANG HW, 1994, BIOSCI BIOTECH BIOCH, V58, P2024, DOI 10.1271/bbb.58.2024; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Nallapareddy SR, 2006, APPL ENVIRON MICROB, V72, P334, DOI 10.1128/AEM.72.1.334-345.2006; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; ODONOVAN CA, 1994, DIAGN MICR INFEC DIS, V18, P105, DOI 10.1016/0732-8893(94)90074-4; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peschel A, 2001, PEPTIDES, V22, P1651, DOI 10.1016/S0196-9781(01)00500-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; RUBIN HE, 1982, J DAIRY SCI, V65, P197, DOI 10.3168/jds.S0022-0302(82)82177-2; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vinuesa P, 2003, MOL PLANT MICROBE IN, V16, P159, DOI 10.1094/MPMI.2003.16.2.159; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005	44	14	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22768	22776		10.1074/jbc.M113.484402	http://dx.doi.org/10.1074/jbc.M113.484402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793054	Green Published, hybrid			2022-12-28	WOS:000330596300054
J	Sunahori, K; Nagpal, K; Hedrich, CM; Mizui, M; Fitzgerald, LM; Tsokos, GC				Sunahori, Katsue; Nagpal, Kamalpreet; Hedrich, Christian M.; Mizui, Masayuki; Fitzgerald, Lisa M.; Tsokos, George C.			The Catalytic Subunit of Protein Phosphatase 2A (PP2Ac) Promotes DNA Hypomethylation by Suppressing the Phosphorylated Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Kinase (MEK)/Phosphorylated ERK/DNMT1 Protein Pathway in T-cells from Controls and Systemic Lupus Erythematosus Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Epigenetics; ERK; Protein Phosphatase; T-cell; SLE	EPIGENETIC MECHANISMS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; METHYLATION; DEMETHYLATION; LYMPHOCYTES; DETERMINES; DISEASE; TARGETS; ENZYMES	DNA hypomethylation is a characteristic feature of systemic lupus erythematosus (SLE) immune cells. Numerous reports have implicated the involvement of the MEK/ERK pathway in the reduction of DNA methyltransferase (DNMT) expression, hence inducing the transcription of methylation-sensitive genes in SLE patients. However, the molecular mechanisms involved remain unclear. Here, we investigated whether the catalytic subunit of protein phosphatase 2A (PP2Ac), which is overexpressed in SLE T-cells, contributes to reduced DNA methylation. We show that both chemical suppression and siRNA silencing of PP2Ac in T-cells resulted in sustained phosphorylation of MEK and ERK following stimulation with phorbol 12-myristate 13-acetate and ionomycin. Furthermore, PP2Ac suppression resulted in increased DNMT enzyme activity, DNA hypermethylation, and decreased expression of methylation-sensitive genes. Similarly, in SLE T-cells, suppression of PP2Ac resulted in increased MEK/ERK phosphorylation, enhanced DNMT1 expression and suppressed expression of the methylation-sensitive CD70 gene. Our results demonstrate that PP2A regulates DNA methylation by influencing the phosphorylation of MEK/ERK. We propose that enhanced PP2Ac in SLE T-cells may dephosphorylate and activate the signaling pathway upstream of DNMT1, thus disturbing the tight control of methylation-sensitive genes, which are involved in SLE pathogenesis.	[Sunahori, Katsue; Nagpal, Kamalpreet; Hedrich, Christian M.; Mizui, Masayuki; Fitzgerald, Lisa M.; Tsokos, George C.] Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nagpal, K (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	knagpal@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Mizui, Masayuki/AAD-1432-2019; tsokos, george C/O-3360-2013	Mizui, Masayuki/0000-0003-2543-8108; tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	NIAID NIH HHS [R01 AI068787] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Crispin JC, 2007, ANN RHEUM DIS, V66, P65, DOI 10.1136/ard.2007.078493; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Gorelik G, 2009, AUTOIMMUN REV, V8, P196, DOI 10.1016/j.autrev.2008.07.043; Hedrich CM, 2012, P NATL ACAD SCI USA, V109, P16606, DOI 10.1073/pnas.1210129109; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Lavoie G, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-31; Liu Y, 2009, CLIN IMMUNOL, V132, P257, DOI 10.1016/j.clim.2009.03.529; Lu Q, 2007, J IMMUNOL, V179, P6352, DOI 10.4049/jimmunol.179.9.6352; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Lu QJ, 2002, BLOOD, V99, P4503, DOI 10.1182/blood.V99.12.4503; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Singer NG, 1996, IMMUNOLOGY, V88, P537; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Zhao M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/931018; Zhao M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3214	33	68	72	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21936	10.1074/jbc.M113.467266	http://dx.doi.org/10.1074/jbc.M113.467266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775084	hybrid, Green Published			2022-12-28	WOS:000328841900041
J	Mishra, S; Mohan, S; Godavarthi, S; Sen, R				Mishra, Saurabh; Mohan, Shalini; Godavarthi, Sapna; Sen, Ranjan			The Interaction Surface of a Bacterial Transcription Elongation Factor Required for Complex Formation with an Antiterminator during Transcription Antitermination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI NUSA; LAMBDA N PROTEIN; RNA-EXIT CHANNEL; PHAGE-LAMBDA; BACTERIOPHAGE-LAMBDA; ALPHA-SUBUNIT; NUT RNA; POLYMERASE; TERMINATION; BINDING	The bacterial transcription elongation factor, NusA, functions as an antiterminator when it is bound to the lambdoid phage derived antiterminator protein, N. The mode of N-NusA interaction is unknown, knowledge of which is essential to understand the anti-termination process. It was reported earlier that in the absence of the transcription elongation complex (EC), N interacts with the C-terminal AR1 domain of NusA. However, the functional significance of this interaction is obscure. Here we identified mutations in NusA N terminus (NTD) specifically defective for N-mediated antitermination. These are located at a convex surface of the NusA-NTD, situated opposite its concave RNA polymerase(RNAP) binding surface. These NusA mutants disrupt the N-nut site interactions on the nascent RNA emerging out of a stalled EC. In the N/NusA-modified EC, a Cys-53 (S53C) from the convex surface of the NusA-NTD forms a specific disulfide(S-S) bridge with a Cys-39 (S39C) of the NusA binding region of the N protein. We conclude that when bound to the EC, the N interaction surface of NusA shifts from the AR1 domain to its NTD domain. This occurred due to a massive away-movement of the adjacent AR2 domain of NusA upon binding to the EC. We propose that the close proximity of this altered N-interaction site of NusA to its RNAP binding surface, enables N to influence the NusA-RNAP interaction during transcription antitermination that in turn facilitates the conversion of NusA into an antiterminator.	[Mishra, Saurabh; Mohan, Shalini; Godavarthi, Sapna; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Sen, Ranjan/AAP-7075-2021		Department of Science and Technology, Government of India; Centre for DNA Fingerprinting and Diagnostics	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics	This work was supported by the Department of Science and Technology, Government of India and Centre for DNA Fingerprinting and Diagnostics intramural funding.	Banerjee S, 2006, J MICROBIOL, V44, P11; Berdygulova Z, 2012, NUCLEIC ACIDS RES, V40, P4052, DOI 10.1093/nar/gkr1285; Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Bonin I, 2004, P NATL ACAD SCI USA, V101, P13762, DOI 10.1073/pnas.0405883101; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; Cheeran A, 2007, J BIOL CHEM, V282, P30997, DOI 10.1074/jbc.M704864200; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; FRIEDMAN DI, 1974, VIROLOGY, V58, P141, DOI 10.1016/0042-6822(74)90149-4; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; LAU LF, 1983, J BIOL CHEM, V258, P9391; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Mah TF, 1999, MOL MICROBIOL, V34, P523, DOI 10.1046/j.1365-2958.1999.01618.x; Mah TF, 2000, GENE DEV, V14, P2664, DOI 10.1101/gad.822900; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Muteeb G, 2012, NUCLEIC ACIDS RES, V40, P11213, DOI 10.1093/nar/gks872; Muteeb G, 2010, METHODS MOL BIOL, V634, P411, DOI 10.1007/978-1-60761-652-8_29; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; Neely MN, 2000, MOL MICROBIOL, V38, P1074, DOI 10.1046/j.1365-2958.2000.02217.x; NODWELL JR, 1993, CELL, V72, P261, DOI 10.1016/0092-8674(93)90665-D; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Prasch S, 2006, BIOCHEMISTRY-US, V45, P4542, DOI 10.1021/bi0523411; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Sen R, 2002, MOL MICROBIOL, V46, P215, DOI 10.1046/j.1365-2958.2002.03154.x; Sen R., 2008, NUS FACTORS ESCHERIC; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SIGMUND CD, 1988, BIOCHEMISTRY-US, V27, P5622, DOI 10.1021/bi00415a034; VanGilst MR, 1997, J MOL BIOL, V274, P160, DOI 10.1006/jmbi.1997.1389; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3; Zhou Y, 2001, J MOL BIOL, V310, P33, DOI 10.1006/jmbi.2001.4722	38	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28089	28103		10.1074/jbc.M113.472209	http://dx.doi.org/10.1074/jbc.M113.472209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913688	Green Published, hybrid			2022-12-28	WOS:000330612800034
J	Kemp, LE; Rusch, M; Adibekian, A; Bullen, HE; Graindorge, A; Freymond, C; Rottmann, M; Braun-Breton, C; Baumeister, S; Porfetye, AT; Vetter, IR; Hedberg, C; Soldati-Favre, D				Kemp, Louise E.; Rusch, Marion; Adibekian, Alexander; Bullen, Hayley E.; Graindorge, Arnault; Freymond, Celine; Rottmann, Matthias; Braun-Breton, Catherine; Baumeister, Stefan; Porfetye, Arthur T.; Vetter, Ingrid R.; Hedberg, Christian; Soldati-Favre, Dominique			Characterization of a Serine Hydrolase Targeted by Acyl-protein Thioesterase Inhibitors in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; SARCOCYSTIS-MURIS APICOMPLEXA; SMALL-MOLECULE INHIBITION; DENSE-GRANULE ANTIGEN; HOST-CELL INVASION; MAXIMUM-LIKELIHOOD; H-RAS; MALARIA PARASITES; PLASMODIUM; DEPALMITOYLATION	In eukaryotic organisms, cysteine palmitoylation is an important reversible modification that impacts protein targeting, folding, stability, and interactions with partners. Evidence suggests that protein palmitoylation contributes to key biological processes in Apicomplexa with the recent palmitome of the malaria parasite Plasmodium falciparum reporting over 400 substrates that are modified with palmitate by a broad range of protein S-acyl transferases. Dynamic palmitoylation cycles require the action of an acyl-protein thioesterase (APT) that cleaves palmitate from substrates and conveys reversibility to this posttranslational modification. In this work, we identified candidates for APT activity in Toxoplasma gondii. Treatment of parasites with low micromolar concentrations of beta-lactone- or triazole urea-based inhibitors that target human APT1 showed varied detrimental effects at multiple steps of the parasite lytic cycle. The use of an activity-based probe in combination with these inhibitors revealed the existence of several serine hydrolases that are targeted by APT1 inhibitors. The active serine hydrolase, TgASH1, identified as the homologue closest to human APT1 and APT2, was characterized further. Biochemical analysis of TgASH1 indicated that this enzyme cleaves substrates with a specificity similar to APTs, and homology modeling points toward an APT-like enzyme. TgASH1 is dispensable for parasite survival, which indicates that the severe effects observed with the beta-lactone inhibitors are caused by the inhibition of non-TgASH1 targets. Other ASH candidates for APT activity were functionally characterized, and one of them was found to be resistant to gene disruption due to the potential essential nature of the protein.	[Kemp, Louise E.; Bullen, Hayley E.; Graindorge, Arnault; Soldati-Favre, Dominique] Univ Geneva, Dept Microbiol & Mol Med, CMU, CH-1211 Geneva 4, Switzerland; [Rusch, Marion; Hedberg, Christian] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Baumeister, Stefan; Porfetye, Arthur T.; Vetter, Ingrid R.] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Adibekian, Alexander] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Freymond, Celine; Rottmann, Matthias] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Freymond, Celine; Rottmann, Matthias] Univ Basel, CH-4003 Basel, Switzerland; [Braun-Breton, Catherine] Univ Montpellier 2, CNRS, UMR 5235, Montpellier, France	University of Geneva; Max Planck Society; Max Planck Society; University of Geneva; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Soldati-Favre, D (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	dominique.soldati-favre@unige.ch		Rottmann, Matthias/0000-0002-2207-7899; Soldati-Favre, Dominique/0000-0003-4156-2109; Bullen, Hayley/0000-0003-4923-3019; Graindorge, Arnault/0000-0002-6076-3646	FP7 [215281]; Swiss National Foundation [FN3100A0-116722]; Swiss National Centre for Competence in Research: Chemical Biology; Fonds der Chemischen Industrie	FP7; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss National Centre for Competence in Research: Chemical Biology; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Supported by FP7-funded Marie Curie Initial Training Network Project 215281-InterMal Training and Swiss National Foundation Grant FN3100A0-116722.; Supported by the Swiss National Centre for Competence in Research: Chemical Biology and the Fonds der Chemischen Industrie.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dekker FJ, 2011, BIOORGAN MED CHEM, V19, P1376, DOI 10.1016/j.bmc.2010.11.025; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Ding M, 2000, J CELL SCI, V113, P2409; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Freyer B, 1999, PARASITOL RES, V85, P923, DOI 10.1007/s004360050659; Freyer B, 1998, PARASITOL RES, V84, P583, DOI 10.1007/s004360050453; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta P, 2003, P NATL ACAD SCI USA, V100, P12325, DOI 10.1073/pnas.2033229100; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hedberg C, 2011, ANGEW CHEM INT EDIT, V50, P9832, DOI 10.1002/anie.201102965; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones ML, 2012, TRENDS PARASITOL, V28, P496, DOI 10.1016/j.pt.2012.08.009; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Mercker M, 2009, CURR GENET, V55, P151, DOI 10.1007/s00294-009-0232-3; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Resh M. D., 2006, SCI STKE, V2006, pre14; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	66	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27002	27018		10.1074/jbc.M113.460709	http://dx.doi.org/10.1074/jbc.M113.460709			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913689	hybrid, Green Published			2022-12-28	WOS:000330597300003
J	Martin-Marcos, P; Nanda, J; Luna, RE; Wagner, G; Lorsch, JR; Hinnebusch, AG				Martin-Marcos, Pilar; Nanda, Jagpreet; Luna, Rafael E.; Wagner, Gerhard; Lorsch, Jon R.; Hinnebusch, Alan G.			beta-Hairpin Loop of Eukaryotic Initiation Factor 1 (eIF1) Mediates 40 S Ribosome Binding to Regulate Initiator tRNA(Met) Recruitment and Accuracy of AUG Selection in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; SUBUNIT; RECOGNITION; PROTEIN; FIDELITY; POSITION; ELEMENTS; RELEASE; COMPLEX; STEP	Recognition of the translation initiation codon is thought to require dissociation of eIF1 from the 40 S ribosomal subunit, enabling irreversible GTP hydrolysis (P-i release) by the eIF2.GTP.Met-tRNAi ternary complex (TC), rearrangement of the 40 S subunit to a closed conformation incompatible with scanning, and stable binding of Met-tRNA(i) to the P site. The crystal structure of a Tetrahymena 40 S.eIF1 complex revealed several basic amino acids in eIF1 contacting 18 S rRNA, and we tested the prediction that their counterparts in yeast eIF1 are required to prevent premature eIF1 dissociation from scanning ribosomes at non-AUG triplets. Supporting this idea, substituting Lys-60 in helix alpha 1, or either Lys-37 or Arg-33 in beta-hairpin loop-1, impairs binding of yeast eIF1 to 40 S.eIF1A complexes in vitro, and it confers increased initiation at UUG codons (Sui(-) phenotype) or lethality, in a manner suppressed by overexpressing the mutant proteins or by an eIF1A mutation (17-21) known to impede eIF1 dissociation in vitro. The eIF1 Sui(-) mutations also derepress translation of GCN4 mRNA, indicating impaired ternary complex loading, and this Gcd(-) phenotype is likewise suppressed by eIF1 overexpression or the 17-21 mutation. These findings indicate that direct contacts of eIF1 with 18 S rRNA seen in the Tetrahymena 40 S.eIF1 complex are crucial in yeast to stabilize the open conformation of the 40 S subunit and are required for rapid TC loading and ribosomal scanning and to impede rearrangement to the closed complex at non-AUG codons. Finally, we implicate the unstructured N-terminal tail of eIF1 in blocking rearrangement to the closed conformation in the scanning preinitiation complex.	[Martin-Marcos, Pilar; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Nanda, Jagpreet; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Luna, Rafael E.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Harvard University; Harvard Medical School	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu; ahinnebusch@nih.gov		Lorsch, Jon/0000-0002-4521-4999; Nanda, Jagpreet/0000-0002-6629-4641	National Institutes of Health [GM62128, CA068262]; Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62128 (to J. R. L.) and CA068262 (to G. W.) and by the Intramural Research Program (to P. M. M. and A. G. H.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2008, MOL CELL BIOL, V28, P6877, DOI 10.1128/MCB.01147-08; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Cui Y, 1998, MOL CELL BIOL, V18, P1506, DOI 10.1128/MCB.18.3.1506; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; REID GA, 1982, J BIOL CHEM, V257, P3056; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	27	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27546	27562		10.1074/jbc.M113.498642	http://dx.doi.org/10.1074/jbc.M113.498642			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23893413	Green Published, hybrid			2022-12-28	WOS:000330597300050
J	Seino, J; Wang, L; Harada, Y; Huang, CC; Ishii, K; Mizushima, N; Suzuki, T				Seino, Junichi; Wang, Li; Harada, Yoichiro; Huang, Chengcheng; Ishii, Kumiko; Mizushima, Noboru; Suzuki, Tadashi			Basal Autophagy Is Required for the Efficient Catabolism of Sialyloligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BETA-N-ACETYLGLUCOSAMINIDASE; FREE OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; ALPHA-MANNOSIDASE; CELLS; GLYCANS; CYTOSOL; IDENTIFICATION; EXPRESSION	Macroautophagy is an essential, homeostatic process involving degradation of a cell's own components; it plays a role in catabolizing cellular components, such as protein or lipids, and damaged or excess organelles. Here, we show that in Atg5(-/-) cells, sialyloligosaccharides specifically accumulated in the cytosol. Accumulation of these glycans was observed under non-starved conditions, suggesting that non-induced, basal autophagy is essential for their catabolism. Interestingly, once accumulated in the cytosol, sialylglycans cannot be efficiently catabolized by resumption of the autophagic process, suggesting that functional autophagy is important for preventing sialyloligosaccharides from accumulating in the cytosol. Moreover, knockdown of sialin, a lysosomal transporter of sialic acids, resulted in a significant reduction of sialyloligosaccharides, implying that autophagy affects the substrate specificity of this transporter. This study thus provides a surprising link between basal autophagy and catabolism of N-linked glycans.	[Seino, Junichi; Wang, Li; Harada, Yoichiro; Huang, Chengcheng; Ishii, Kumiko; Suzuki, Tadashi] RIKEN, Max Planck Joint Res Ctr, Global Res Cluster, Glycometabolome Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Huang, Chengcheng; Suzuki, Tadashi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan	RIKEN; Saitama University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Suzuki, T (corresponding author), RIKEN, Max Planck Joint Res Ctr, Global Res Cluster, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	huang, chengcheng/GRX-5340-2022; Suzuki, Tadashi/I-4536-2014; Mizushima, Noboru/C-3635-2009; Suzuki, Tadashi/AAX-5707-2021	Mizushima, Noboru/0000-0002-6258-6444; Suzuki, Tadashi/0000-0003-1030-7631	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22570148]; Global Center of Excellence program; Mizutani Foundation for Glycoscience	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience	This work was supported in part by a Grant-in-aid for Scientific Research C (22570148) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Global Center of Excellence program; and the Mizutani Foundation for Glycoscience (to T.S.).	Costanzi E, 2006, BBA-GEN SUBJECTS, V1760, P1580, DOI 10.1016/j.bbagen.2006.06.011; DORLAND L, 1978, EUR J BIOCHEM, V87, P323, DOI 10.1111/j.1432-1033.1978.tb12381.x; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ishizuka A, 2008, BIOCHEM J, V413, P227, DOI 10.1042/BJ20071562; Kato A, 2011, J BIOCHEM, V149, P415, DOI 10.1093/jb/mvq153; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Koseki K, 2012, BIOCHEM BIOPH RES CO, V428, P142, DOI 10.1016/j.bbrc.2012.10.028; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KURIYAMA M, 1981, J BIOL CHEM, V256, P2316; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Murase T, 2010, CARBOHYD RES, V345, P1702, DOI 10.1016/j.carres.2010.05.020; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Ohashi S, 1999, J BIOCHEM-TOKYO, V126, P852, DOI 10.1093/oxfordjournals.jbchem.a022526; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Yabu M, 2013, GLYCOBIOLOGY, V23, P634, DOI 10.1093/glycob/cws132; Yabu M, 2013, GLYCOCONJUGATE J, V30, P247, DOI 10.1007/s10719-012-9435-9; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	40	35	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26898	26907		10.1074/jbc.M113.464503	http://dx.doi.org/10.1074/jbc.M113.464503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23880766	Green Published, hybrid			2022-12-28	WOS:000330594500055
J	Cruz-Gallardo, I; Aroca, A; Persson, C; Karlsson, BG; Diaz-Moreno, I				Cruz-Gallardo, Isabel; Aroca, Angeles; Persson, Cecilia; Karlsson, B. Goran; Diaz-Moreno, Irene			RNA Binding of T-cell Intracellular Antigen-1 (TIA-1) C-terminal RNA Recognition Motif Is Modified by pH Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STRESS GRANULES; MESSENGER-RNAS; PROTEIN COMPLEX; DOMAIN; NMR; PHOSPHORYLATION; IDENTIFICATION; HEMAGGLUTININ; RECRUITMENT; REGULATOR	T-cell intracellular antigen-1 (TIA-1) is a DNA/RNA-binding protein that regulates critical events in cell physiology by the regulation of pre-mRNA splicing and mRNA translation. TIA-1 is composed of three RNA recognition motifs (RRMs) and a glutamine-rich domain and binds to uridine-rich RNA sequences through its C-terminal RRM2 and RRM3 domains. Here, we show that RNA binding mediated by either isolated RRM3 or the RRM23 construct is controlled by slight environmental pH changes due to the protonation/deprotonation of TIA-1 RRM3 histidine residues. The auxiliary role of the C-terminal RRM3 domain in TIA-1 RNA recognition is poorly understood, and this work provides insight into its binding mechanisms.	[Cruz-Gallardo, Isabel; Aroca, Angeles; Diaz-Moreno, Irene] Univ Seville, Consejo Super Invest Cient CSIC, Inst Bioquim Vegetal & Fotosintesis IBVF, Ctr Invest Cient Isla Cartuja CicCartuja, Seville 41092, Spain; [Persson, Cecilia; Karlsson, B. Goran] Univ Gothenburg, Swedish NMR Ctr, SE-40530 Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Gothenburg	Diaz-Moreno, I (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis IBVF, CicCartuja, Avda Amer Vespucio 49, Seville 41092, Spain.	idiazmoreno@us.es	Díaz-Moreno, Irene/E-7181-2010; Aguilar, Angeles Aroca/G-1162-2014; Cruz-Gallardo, Isabel/J-7042-2014; Karlsson, Göran/E-8686-2011	Díaz-Moreno, Irene/0000-0002-5318-7644; Aguilar, Angeles Aroca/0000-0003-4915-170X; Cruz-Gallardo, Isabel/0000-0002-5936-2749; Karlsson, Goran/0000-0002-1821-4715	Andalusian Government [P07-CVI-02896, P11-CVI-7216, BIO198]; European Community [261863]; Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Andalusian Government; European Community(European Commission); Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	This work was supported in part by Andalusian Government Grants P07-CVI-02896, P11-CVI-7216, and BIO198. Access to the Bio-NMR research infrastructure is co-funded under the 7th Framework Programme of European Community (FP7/2007-2013) Grant agreement 261863.; Supported by a short-term fellowship from the Federation of the Societies of Biochemistry and Molecular Biology (FEBS).	Anderson P, 2002, J CELL SCI, V115, P3227; Aroca A, 2011, FEBS LETT, V585, P2958, DOI 10.1016/j.febslet.2011.07.037; AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; Bauer WJ, 2012, J MOL BIOL, V415, P727, DOI 10.1016/j.jmb.2011.11.040; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Goddard T. D., 2006, SPARKY 3; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruse C, 1996, BIOCHEM J, V320, P247, DOI 10.1042/bj3200247; Kruse C, 2000, BIOCHEM J, V346, P107, DOI 10.1042/0264-6021:3460107; Kumar AO, 2008, BIOCHEM BIOPH RES CO, V367, P813, DOI 10.1016/j.bbrc.2008.01.027; Kuwasako K, 2008, BIOCHEMISTRY-US, V47, P6437, DOI 10.1021/bi7024723; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360; Netter C, 2009, RNA, V15, P1305, DOI 10.1261/rna.1359909; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Santiveri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024481; Scheiba RM, 2012, EUR BIOPHYS J BIOPHY, V41, P597, DOI 10.1007/s00249-012-0827-3; Seksek O, 1996, J CELL SCI, V109, P257; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; Vollbrandt T, 2004, INT J BIOCHEM CELL B, V36, P1306, DOI 10.1016/j.biocel.2003.11.006; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669	39	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25986	25994		10.1074/jbc.M113.489070	http://dx.doi.org/10.1074/jbc.M113.489070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902765	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330623300029
J	Wang, SH; Li, Y; Hsu, PH; Lee, SY; Kim, Y; Lee, EYHP				Wang, Shaohui; Li, Ying; Hsu, Pang-Hung; Lee, Sou-Ying; Kim, Yoon; Lee, Eva Y. -H. P.			Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3 beta in the Brca1-deficient Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MICE LACKING; PHOSPHORYLATION; ACTIVATION; ABNORMALITIES; INHIBITION; PATHWAYS; ALPHA; BRCA1; CELLS	Germ line mutations of the BRCA1 gene increase the risk of breast and ovarian cancer, but the basis of this tissue-specific tumor predisposition is not fully understood. Previously, we reported that the progesterone receptors are stabilized in Brca1-deficient mammary epithelial cells, and treating with anti-progesterone delays mammary tumorigenesis in Brca1/p53 conditional knock-out mice, suggesting that the progesterone has a critical role in breast carcinogenesis. To further explore how the stability of progesterone receptor is modulated, here, we have found that glycogen synthase kinase (GSK)-3 beta phosphorylation of progesterone receptor-A (PR-A) facilitates its ubiquitination. GSK-3 beta-mediated phosphorylation of serine 390 in PR-A regulates its subsequent ubiquitination and protein stability. Expression of PR-A(S390A) mutant in the human breast epithelial cells, MCF-10A, results in enhanced proliferation and formation of aberrant acini structure in the three-dimensional culture. Consistently, reduction of phosphorylation of serine 390 of PR-A and GSK-3 beta activity is observed in the Brca1-deficient mammary gland. Taken together, these results provide important aspects of tissue specificity of BRCA1-mediated suppression of breast carcinogenesis.	[Wang, Shaohui; Lee, Sou-Ying; Kim, Yoon; Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Li, Ying] Capital Med Univ, Beijing 100069, Peoples R China; [Hsu, Pang-Hung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	University of California System; University of California Irvine; Capital Medical University; Academia Sinica - Taiwan	Lee, EYHP (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	elee@uci.edu	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434	National Institutes of Health [R01CA137102, BCRF-35127]; NATIONAL CANCER INSTITUTE [R01CA137102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA137102 and BCRF-35127 (to E. Y.-H. P. L.).	Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Chlebowski RT, 2012, JNCI-J NATL CANCER I, V104, P517, DOI 10.1093/jnci/djs014; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Grisouard J, 2009, J STEROID BIOCHEM, V117, P87, DOI 10.1016/j.jsbmb.2009.08.002; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Hilton HN, 2012, MOL CELL ENDOCRINOL, V361, P191, DOI 10.1016/j.mce.2012.04.010; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma YX, 2007, MOL ENDOCRINOL, V21, P1905, DOI 10.1210/me.2006-0397; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Spokoini R, 2010, MOL ENDOCRINOL, V24, P1136, DOI 10.1210/me.2009-0466; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725	28	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26265	26274		10.1074/jbc.M113.476556	http://dx.doi.org/10.1074/jbc.M113.476556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880761	Green Published, hybrid			2022-12-28	WOS:000330623300056
J	Doyle, SL; Shirey, KA; McGettrick, AF; Kenny, EF; Carpenter, S; Caffrey, BE; Gargan, S; Quinn, SR; Caamano, JH; Moynagh, P; Vogel, SN; O'Neill, LA				Doyle, Sarah L.; Shirey, Kari Ann; McGettrick, Anne F.; Kenny, Elaine F.; Carpenter, Susan; Caffrey, Brian E.; Gargan, Siobhan; Quinn, Susan R.; Caamano, Jorge H.; Moynagh, Paul; Vogel, Stefanie N.; O'Neill, Luke A.			Nuclear Factor kappa B2 p52 Protein Has a Role in Antiviral Immunity through I kappa B Kinase epsilon-dependent Induction of Sp1 Protein and Interleukin 15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; UP-REGULATION; IKK-EPSILON; GENE-EXPRESSION; SPLENIC MICROARCHITECTURE; SIGNALING PATHWAY; IE2 PROTEIN; IL-15 GENE; ACTIVATION; PROMOTER	In this study we describe a previously unreported function for NF kappa B2, an NF kappa B family transcription factor, in antiviral immunity. NF kappa B2 is induced in response to poly(I: C), a mimic of viral dsRNA. Poly(I: C), acting via TLR3, induces p52-dependent transactivation of a reporter gene in a manner that requires the kinase activity of I kappa B kinase epsilon (IKK epsilon) and the transactivating potential of RelA/p65. We identify a novel NF kappa B2 binding site in the promoter of the transcription factor Sp1 that is required for Sp1 gene transcription activated by poly(I: C). We show that Sp1 is required for IL-15 induction by both poly(I: C) and respiratory syncytial virus, a response that also requires NF kappa B2 and IKK epsilon. Our study identifies NF kappa B2 as a target for IKK epsilon in antiviral immunity and describes, for the first time, a role for NF kappa B2 in the regulation of gene expression in response to viral infection.	[Doyle, Sarah L.; McGettrick, Anne F.; Kenny, Elaine F.; Carpenter, Susan; Quinn, Susan R.; O'Neill, Luke A.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Immunol Res Ctr, Dublin 2, Ireland; [Shirey, Kari Ann; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Caffrey, Brian E.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Gargan, Siobhan; Moynagh, Paul] Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland; [Caamano, Jorge H.] Univ Birmingham, IBR MRC, Ctr Immune Regulat, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England	Trinity College Dublin; University System of Maryland; University of Maryland Baltimore; Trinity College Dublin; Maynooth University; University of Birmingham	Doyle, SL (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dept Clin Med, Our Ladys Childrens Hosp,Natl Childrens Res Ctr, Dublin 12, Ireland.	Sarah.Doyle@tcd.ie	Caamano, Jorge/I-6778-2012; Caamano, Jorge/O-7530-2019	Caamano, Jorge/0000-0003-3530-7056; Caamano, Jorge/0000-0003-3530-7056; O'Neill, Luke/0000-0002-4333-2748; Moynagh, Paul/0000-0002-4139-3061; Doyle, Sarah/0000-0002-6294-9380	National Institutes of Health [AI18797]; Science Foundation Ireland Immunology Research Cluster [07/SRC/B1144]; European Union FP7 INFLA-CARE Collaborative Research Program [223151]; Biotechnology and Biological Sciences Research Council [BB/D018234/1]; School of Immunity and Infection of the College of Medicine of the University of Birmingham, United Kingdom; BBSRC [BB/D018234/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018797, R37AI018797, R01AI018797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland Immunology Research Cluster(Science Foundation Ireland); European Union FP7 INFLA-CARE Collaborative Research Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Immunity and Infection of the College of Medicine of the University of Birmingham, United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI18797 (to S. N. V.). This work was also supported by Science Foundation Ireland Immunology Research Cluster Grant S. F. I. 07/SRC/B1144, by European Union FP7 INFLA-CARE Collaborative Research Program Contract 223151 (to J. H. C.), by Biotechnology and Biological Sciences Research Council Grant BB/D018234/1 (to J. H. C.), and by the School of Immunity and Infection of the College of Medicine of the University of Birmingham, United Kingdom.	Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000; Bao XY, 2010, VIROLOGY, V408, P224, DOI 10.1016/j.virol.2010.09.016; Bin LH, 2011, J ALLERGY CLIN IMMUN, V127, P430, DOI 10.1016/j.jaci.2010.11.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Carroll HP, 2008, RHEUMATOLOGY, V47, P1269, DOI 10.1093/rheumatology/ken257; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Ennaciri J, 2007, J LEUKOCYTE BIOL, V81, P625, DOI 10.1189/jlb.0806507; Fawaz LM, 1999, J IMMUNOL, V163, P4473; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gauzzi MC, 2010, IMMUNOBIOLOGY, V215, P713, DOI 10.1016/j.imbio.2010.05.008; Gupta CK, 1996, VACCINE, V14, P1417, DOI 10.1016/S0264-410X(96)00096-5; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; Huang Shenghai, 2009, Weishengwu Xuebao, V49, P239; Indukuri H, 2006, VIROLOGY, V353, P155, DOI 10.1016/j.virol.2006.05.022; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Loregian A, 2003, J CELL PHYSIOL, V196, P251, DOI 10.1002/jcp.10271; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; Opitz OG, 2000, CANCER RES, V60, P2825; Rossi A, 2006, J GEN VIROL, V87, P1613, DOI 10.1099/vir.0.81691-0; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; WALKER S, 1992, J VIROL, V66, P1543, DOI 10.1128/JVI.66.3.1543-1550.1992; Wang LL, 2002, J CLIN INVEST, V110, P1175, DOI 10.1172/JCI200215536; Washizu J, 1998, IMMUNOGENETICS, V48, P1, DOI 10.1007/s002510050393; Wietek C, 2006, J BIOL CHEM, V281, P34973, DOI 10.1074/jbc.M607018200; Xu JP, 2002, SCI CHINA SER C, V45, P604, DOI 10.1007/BF02879748; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997	45	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25066	25075		10.1074/jbc.M113.469122	http://dx.doi.org/10.1074/jbc.M113.469122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23873932	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000330619000007
J	Leal, SS; Cardoso, I; Valentine, JS; Gomes, CM				Leal, Sonia S.; Cardoso, Isabel; Valentine, Joan S.; Gomes, Claudio M.			Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid A LINK TO TOXIC EFFECTS OF CALCIUM OVERLOAD IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEXES; TRANSGENIC MICE; METAL-IONS; CU,ZN-SUPEROXIDE DISMUTASE; SELECTIVE VULNERABILITY; MOTOR-NEURONS; AMPA RECEPTOR; WILD-TYPE; INTRACELLULAR CALCIUM; PROTEIN CONFORMATION	Imbalance in metal ion homeostasis is a hallmark in neurodegenerative conditions involving protein deposition, and amyotrophic lateral sclerosis (ALS) is no exception. In particular, Ca2+ dysregulation has been shown to correlate with superoxide dismutase-1 (SOD1) aggregation in a cellular model of ALS. Here we present evidence that SOD1 aggregation is enhanced and modulated by Ca2+. We show that at physiological pH, Ca2+ induces conformational changes that increase SOD1 beta-sheet content, as probed by far UV CD and attenuated total reflectance- FTIR, and enhances SOD1 hydrophobicity, as probed by ANS fluorescence emission. Moreover, dynamic light scattering analysis showed that Ca2+ boosts the onset of SOD1 aggregation. In agreement, Ca2+ decreases SOD1 critical concentration and nucleation time during aggregation kinetics, as evidenced by thioflavin T fluorescence emission. Attenuated total reflectance FTIR analysis showed that Ca2+ induced aggregates consisting preferentially of antiparallel beta-sheets, thus suggesting a modulation effect on the aggregation pathway. Transmission electron microscopy and analysis with conformational anti-fibril and anti-oligomer antibodies showed that oligomers and amyloidogenic aggregates constitute the prevalent morphology of Ca2+ -induced aggregates, thus indicating that Ca2+ diverts SOD1 aggregation from fibrils toward amorphous aggregates. Interestingly, the same heterogeneity of conformations is found in ALS-derived protein inclusions. We thus hypothesize that transient variations and dysregulation of cellular Ca2+ levels contribute to the formation of SOD1 aggregates in ALS patients. In this scenario, Ca2+ may be considered as a pathogenic effector in the formation of ALS proteinaceous inclusions.	[Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780756 Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Valentine, Joan S.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Universidade Nova de Lisboa; Universidade do Porto; University of California System; University of California Los Angeles	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Valentine, Joan S/B-6665-2008; Gomes, Cláudio M./A-8152-2008; Leal, Sónia/F-1129-2015; Cardoso, Isabel/K-3903-2013	Valentine, Joan S/0000-0002-7174-925X; Gomes, Cláudio M./0000-0003-4662-6933; Leal, Sónia/0000-0001-8445-0065; Cardoso, Isabel/0000-0003-2472-7055	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) [PTDC/QUI-BIQ/117789/2010, PTDC/EBB-BIO/117793/2010, SFRH/BPD/47477/2008, PEst-OE/EQB/LA0004/2011]	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) through Research Grants PTDC/QUI-BIQ/117789/2010 and PTDC/EBB-BIO/117793/2010 (to C. M. G.), Postdoctoral Fellowship SFRH/BPD/47477/2008 (to S. S. L.), and Strategic Grant PEst-OE/EQB/LA0004/2011 (to the Instituto Tecnologia Quimica e Biologica Laboratorio Associado).	Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beers DR, 2001, J NEUROCHEM, V79, P499, DOI 10.1046/j.1471-4159.2001.00582.x; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Franks KM, 2002, BIOESSAYS, V24, P1130, DOI 10.1002/bies.10193; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jaiswal MK, 2009, MOL PHARMACOL, V75, P478, DOI 10.1124/mol.108.050831; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kim HJ, 2007, EXP MOL MED, V39, P574, DOI 10.1038/emm.2007.63; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Kuner R, 2005, ANN NY ACAD SCI, V1053, P269, DOI 10.1196/annals.1344.024; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li Y, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3592581; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lowe R, 2004, PROTEIN SCI, V13, P3245, DOI 10.1110/ps.04879704; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nath S, 2011, MOL CELL NEUROSCI, V46, P516, DOI 10.1016/j.mcn.2010.12.004; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen MS, 2001, J BIOL CHEM, V276, P22680, DOI 10.1074/jbc.M101181200; Nobbmann Ulf, 2007, Biotechnol Genet Eng Rev, V24, P117; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Okuno A, 2006, BBA-PROTEINS PROTEOM, V1764, P1407, DOI 10.1016/j.bbapap.2006.06.006; Palecek J, 1999, J PHYSIOL-LONDON, V520, P485, DOI 10.1111/j.1469-7793.1999.00485.x; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Roy J, 1998, J NEUROSCI, V18, P9673; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Sabado J, 2013, J NEUROPATH EXP NEUR, V72, P646, DOI 10.1097/NEN.0b013e318297fd10; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Sasaki S, 2005, ACTA NEUROPATHOL, V109, P247, DOI 10.1007/s00401-004-0939-7; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shaw PJ, 2000, J NEUROL, V247, P17; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202; Tamano H, 2011, METALLOMICS, V3, P656, DOI 10.1039/c1mt00008j; Tateno M, 2004, HUM MOL GENET, V13, P2183, DOI 10.1093/hmg/ddh246; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Tradewell ML, 2011, NEUROBIOL DIS, V42, P265, DOI 10.1016/j.nbd.2011.01.016; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; van de Weert M, 2001, ANAL BIOCHEM, V297, P160, DOI 10.1006/abio.2001.5337; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Vandenberghe W, 2000, J NEUROSCI, V20, P123, DOI 10.1523/JNEUROSCI.20-01-00123.2000; Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; von Lewinski F, 2008, NEUROSCI LETT, V445, P224, DOI 10.1016/j.neulet.2008.08.084; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Williams TL, 1997, ANN NEUROL, V42, P200, DOI 10.1002/ana.410420211; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Yates D, 2010, NAT REV NEUROL, V6, P57, DOI [10.1038/nrneurol.2010.154, 10.1038/nrneurol.2010.169, 10.1038/nrneurol.2010.58, 10.1038/nrneurol.2009.230, 10.1038/nrneurol.2010.20]	112	47	47	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25219	25228		10.1074/jbc.M113.470740	http://dx.doi.org/10.1074/jbc.M113.470740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861388	Green Published, hybrid			2022-12-28	WOS:000330619000021
J	Shechter, N; Zaltzman, L; Weiner, A; Brumfeld, V; Shimoni, E; Fridmann-Sirkis, Y; Minsky, A				Shechter, Nelia; Zaltzman, Liron; Weiner, Allon; Brumfeld, Vlad; Shimoni, Eyal; Fridmann-Sirkis, Yael; Minsky, Abraham			Stress-induced Condensation of Bacterial Genomes Results in Re-pairing of Sister Chromosomes IMPLICATIONS FOR DOUBLE STRAND DNA BREAK REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; STALLED REPLICATION FORKS; SEPARATE CELL HALVES; HOMOLOGOUS RECOMBINATION; BACILLUS-SUBTILIS; CHROMATID COHESION; SEQUENCE HOMOLOGY; DOUBLE HELICES; IN-VIVO; ORGANIZATION	Genome condensation is increasingly recognized as a generic stress response in bacteria. To better understand the physiological implications of this response, we used fluorescent markers to locate specific sites on Escherichia coli chromosomes following exposure to cytotoxic stress. We find that stress-induced condensation proceeds through a nonrandom, zipper-like convergence of sister chromosomes, which is proposed to rely on the recently demonstrated intrinsic ability of identical double-stranded DNA molecules to specifically identify each other. We further show that this convergence culminates in spatial proximity of homologous sites throughout chromosome arms. We suggest that the resulting apposition of homologous sites can explain how repair of double strand DNA breaks might occur in a mechanism that is independent of the widely accepted yet physiologically improbable genome-wide search for homologous templates. We claim that by inducing genome condensation and orderly convergence of sister chromosomes, diverse stress conditions prime bacteria to effectively cope with severe DNA lesions such as double strand DNA breaks.	[Shechter, Nelia; Zaltzman, Liron; Weiner, Allon; Fridmann-Sirkis, Yael; Minsky, Abraham] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Brumfeld, Vlad; Shimoni, Eyal] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Minsky, A (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	avi.minsky@weizmann.ac.il		Weiner, Allon/0000-0002-8552-721X	Israel Science Foundation; Academy of Sciences and Humanities; Minerva Foundation, Germany	Israel Science Foundation(Israel Science Foundation); Academy of Sciences and Humanities; Minerva Foundation, Germany	This work was supported by the Israel Science Foundation funded by the Academy of Sciences and Humanities and by the Minerva Foundation, Germany.	Baldwin GS, 2008, J PHYS CHEM B, V112, P1060, DOI 10.1021/jp7112297; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Boccard F, 2005, MOL MICROBIOL, V57, P9, DOI 10.1111/j.1365-2958.2005.04651.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cherstvy AG, 2011, J MOL RECOGNIT, V24, P283, DOI 10.1002/jmr.1050; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 1998, GENES CELLS, V3, P65, DOI 10.1046/j.1365-2443.1998.00175.x; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Danilowicz C, 2009, P NATL ACAD SCI USA, V106, P19824, DOI 10.1073/pnas.0911214106; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; Delmas S, 2013, MOL MICROBIOL, V87, P168, DOI 10.1111/mmi.12091; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Goobes R, 2001, J AM CHEM SOC, V123, P12692, DOI 10.1021/ja016577d; GronbechJensen N, 1997, PHYS REV LETT, V78, P2477, DOI 10.1103/PhysRevLett.78.2477; Inoue S, 2007, BIOCHEMISTRY-US, V46, P164, DOI 10.1021/bi061539y; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; Ko KC, 2012, ANTIMICROB AGENTS CH, V56, P1725, DOI 10.1128/AAC.05874-11; Kornyshev AA, 1999, PHYS REV LETT, V82, P4138, DOI 10.1103/PhysRevLett.82.4138; Kornyshev AA, 2001, PHYS REV LETT, V86, P3666, DOI 10.1103/PhysRevLett.86.3666; Kornyshev AA, 2009, P NATL ACAD SCI USA, V106, P4683, DOI 10.1073/pnas.0811208106; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Levin-Zaidman S, 2000, P NATL ACAD SCI USA, V97, P6791, DOI 10.1073/pnas.090532397; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Libby EA, 2012, P NATL ACAD SCI USA, V109, P7445, DOI 10.1073/pnas.1109479109; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; McGlynn P, 2004, CURR OPIN GENET DEV, V14, P107, DOI 10.1016/j.gde.2004.01.001; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Minsky A, 2004, ANNU REV BIOPH BIOM, V33, P317, DOI 10.1146/annurev.biophys.33.110502.133328; Minsky A, 2003, MOL MICROBIOL, V50, P367, DOI 10.1046/j.1365-2958.2003.03705.x; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Nielsen HJ, 2007, J BACTERIOL, V189, P8660, DOI 10.1128/JB.01212-07; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Smith BT, 2002, J BACTERIOL, V184, P488, DOI 10.1128/JB.184.2.488-493.2002; Strey HH, 1998, CURR OPIN STRUC BIOL, V8, P309, DOI 10.1016/S0959-440X(98)80063-8; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2005, J CELL BIOCHEM, V96, P506, DOI 10.1002/jcb.20519; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Todd BA, 2008, BIOPHYS J, V94, P4775, DOI 10.1529/biophysj.107.127332; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wang X, 2010, P NATL ACAD SCI USA, V107, P12547, DOI 10.1073/pnas.1000105107; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; WOLDRINGH CL, 1995, FEMS MICROBIOL LETT, V131, P235; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Zimmerman SB, 1996, FEBS LETT, V390, P245, DOI 10.1016/0014-5793(96)00725-9; Zimmerman SB, 2002, J STRUCT BIOL, V138, P199, DOI 10.1016/S1047-8477(02)00036-9	73	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25659	25667		10.1074/jbc.M113.473025	http://dx.doi.org/10.1074/jbc.M113.473025			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23884460	hybrid, Green Published			2022-12-28	WOS:000330619000061
J	Belzil, C; Neumayer, G; Vassilev, AP; Yap, KL; Konishi, H; Rivest, S; Sanada, K; Ikura, M; Nakatani, Y; Nguyen, MD				Belzil, Camille; Neumayer, Gernot; Vassilev, Alex P.; Yap, Kyoko L.; Konishi, Hiroaki; Rivest, Serge; Sanada, Kamon; Ikura, Mitsuhiko; Nakatani, Yoshihiro; Minh Dang Nguyen			A Ca2+-dependent Mechanism of Neuronal Survival Mediated by the Microtubule-associated Protein p600	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; METHYL-D-ASPARTATE; KINASE-II CLUSTERS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; CNS NEURONS; CALCIUM; CALMODULIN	In acute and chronic neurodegeneration, Ca2+ mishandling and disruption of the cytoskeleton compromise neuronal integrity, yet abnormalities in the signaling roles of cytoskeletal proteins remain largely unexplored. We now report that the microtubule-associated protein p600 (also known as UBR4) promotes neuronal survival. Following depletion of p600, glutamate-induced Ca2+ influx through NMDA receptors, but not AMPA receptors, initiates a degenerative process characterized by endoplasmic reticulum fragmentation and endoplasmic reticulum Ca2+ release via inositol 1,4,5-trisphosphate receptors. Downstream of NMDA receptors, p600 associates with the calmodulin-calmodulin-dependent protein kinase II alpha complex. A direct and atypical p600/calmodulin interaction is required for neuronal survival. Thus, p600 counteracts specific Ca2+-induced death pathways through regulation of Ca2+ homeostasis and signaling.	[Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Vassilev, Alex P.] NICHD, NIH, Bethesda, MD 20892 USA; [Yap, Kyoko L.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Rivest, Serge] Univ Laval, Ctr Hosp Univ Laval, Ctr Rech, Quebec City, PQ G1V 0A6, Canada; [Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; University of Tokyo; Harvard University; Dana-Farber Cancer Institute	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, HMRB 151,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957; Rivest, Serge/0000-0002-6082-770X; Ikura, Mitsuhiko/0000-0002-9524-1303	Canadian Institutes of Health Research (CIHR); Human Frontier Science Program Organization (HFSPO); Brenda Strafford Chair Foundation in Alzheimer's disease; Alberta Innovates Health Solutions (AIHS); Ted Fong/Hotchkiss Brain Institute; Austrian Academy of Sciences at the University of Calgary; Achievers in Medical Sciences award; CIHR; Canadian Cancer Society; AIHS; Grants-in-Aid for Scientific Research [24650161] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Brenda Strafford Chair Foundation in Alzheimer's disease; Alberta Innovates Health Solutions (AIHS); Ted Fong/Hotchkiss Brain Institute; Austrian Academy of Sciences at the University of Calgary; Achievers in Medical Sciences award; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); AIHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR), the Human Frontier Science Program Organization (HFSPO), and the Brenda Strafford Chair Foundation in Alzheimer's disease (to M. D. N.).; Recipient of an Alberta Innovates Health Solutions (AIHS) studentship and a Ted Fong/Hotchkiss Brain Institute doctoral scholarship.; Recipient of a doctoral fellowship of the Austrian Academy of Sciences at the University of Calgary and an Achievers in Medical Sciences award.; Supported by CIHR and the Canadian Cancer Society and holder of a Canada Research Chair.; Recipient of a New Investigator Award from the CIHR and a Scholarship from AIHS.	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Colbran R. J., 1992, NEUROCHEM INT, V2; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Dhavan R, 2002, J NEUROSCI, V22, P7879; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kim S. T., 2013, AUTOPHAGY; KOCHHAR A, 1991, BRAIN RES, V542, P141, DOI 10.1016/0006-8993(91)91008-O; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2001, BIOCHEM SOC SYMP, V67, P151, DOI 10.1042/bss0670151; Meng FJ, 2003, BRAIN RES, V967, P161, DOI 10.1016/S0006-8993(02)04267-1; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Nakaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066269; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Qi YP, 1997, J NEUROSCI, V17, P1217; Rami A, 2009, NEUROPATH APPL NEURO, V35, P449, DOI 10.1111/j.1365-2990.2009.01034.x; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; TAFT WC, 1988, BRAIN RES, V447, P159, DOI 10.1016/0006-8993(88)90978-X; Tao-Cheng JH, 2002, NEUROSCIENCE, V115, P435, DOI 10.1016/S0306-4522(02)00451-7; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Verkhratsky A, 2004, BIOL RES, V37, P693; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	53	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24452	24464		10.1074/jbc.M113.483107	http://dx.doi.org/10.1074/jbc.M113.483107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861403	hybrid, Green Published			2022-12-28	WOS:000330612300015
J	Toulabi, L; Wu, XC; Cheng, YS; Mao, YX				Toulabi, Leila; Wu, Xiaochun; Cheng, Yanshu; Mao, Yuxin			Identification and Structural Characterization of a Legionella Phosphoinositide Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; SUBSTRATE RECOGNITION; PHAGOSOME MATURATION; LEGIONNAIRES-DISEASE; LIPID-PHOSPHATASE; SUBVERSION; SCATTERING; MECHANISM; INSIGHTS	Bacterial pathogen Legionella pneumophila is the causative agent of Legionnaires' disease, which is associated with intracellular replication of the bacteria in macrophages of human innate immune system. Recent studies indicate that pathogenic bacteria can subvert host cell phosphoinositide (PI) metabolism by translocated virulence effectors. However, in which manner Legionella actively exploits PI lipids to benefit its infection is not well characterized. Here we report that L. pneumophila encodes an effector protein, named SidP, that functions as a PI-3-phosphatase specifically hydrolyzing PI(3) P and PI(3,5)P-2 in vitro. This activity of SidP rescues the growth phenotype of a yeast strain defective in PI(3) P phosphatase activity. Crystal structure of SidP orthologue from Legionella longbeachae reveals that this unique PI-3-phosphatase is composed of three distinct domains: a large catalytic domain, an appendage domain that is inserted into the N-terminal portion of the catalytic domain, and a C-terminal alpha-helical domain. SidP has a small catalytic pocket that presumably provides substrate specificity by limiting the accessibility of bulky PIs with multiple phosphate groups. Together, our identification of a unique family of Legionella PI phosphatases highlights a common scheme of exploiting host PI lipids in many intracellular bacterial pathogen infections.	[Mao, Yuxin] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Mao, YX (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	ym253@cornell.edu		Mao, Yuxin/0000-0002-5064-1397	NIGMS, National Institutes of Health (NIH), via NSF [DMR-0225180]; Center for Research Resources, NIH [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094347] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH), via NSF; Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Zhao-Qing Luo for critical discussion and reagents and Dr. Richard Gillilan (MacCHESS, Cornell University) for technical help in BioSAXS data collection and analysis. The x-ray data were collected at MacCHESS beamline A1. CHESS (Cornell High Energy Synchrotron Source) is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH), via NSF Award DMR-0225180, and the MacCHESS resource is supported by Center for Research Resources, NIH Award RR-01646.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dubuisson JF, 2006, AUTOPHAGY, V2, P179, DOI 10.4161/auto.2831; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; Hsu FS, 2012, P NATL ACAD SCI USA, V109, P13567, DOI 10.1073/pnas.1207903109; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MCKINNEY RM, 1981, ANN INTERN MED, V94, P739, DOI 10.7326/0003-4819-94-6-739; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Zhong SR, 2012, BIOCHEMISTRY-US, V51, P3170, DOI 10.1021/bi300086c; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	58	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24518	24527		10.1074/jbc.M113.474239	http://dx.doi.org/10.1074/jbc.M113.474239			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23843460	Green Published, hybrid			2022-12-28	WOS:000330612300020
J	van Saparoea, HBV; Glas, M; Vernooij, IGWH; Bitter, W; den Blaauwen, T; Luirink, J				van Saparoea, H. Bart van den Berg; Glas, Marjolein; Vernooij, Ingrid G. W. H.; Bitter, Wilbert; den Blaauwen, Tanneke; Luirink, Joen			Fine-mapping the Contact Sites of the Escherichia coli Cell Division Proteins FtsB and FtsL on the FtsQ Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTAL LOCALIZATION; FUNCTIONAL DOMAINS; MEMBRANE-PROTEIN; MUTANT ALLELES; DIVISOME; RECRUIT; COMPLEX; PBP3; RING	Escherichia coli cell division is effected by a large assembly of proteins called the divisome, of which a subcomplex consisting of three bitopic inner membrane proteins, FtsQ, FtsB, and FtsL, is an essential part. These three proteins, hypothesized to link cytoplasmic to periplasmic events during cell division, contain large periplasmic domains that are of major importance for function and complex formation. The essential nature of this subcomplex, its low abundance, and its multiple interactions with key divisome components in the relatively accessible periplasm make it an attractive target for the development of protein-protein interaction inhibitors. Although the crystal structure of the periplasmic domain of FtsQ has been solved, the structure of the FtsQBL complex is unknown, with only very crude indications of the interactions in this complex. In this study, we used in vivo site-specific photo cross-linking to probe the surface of the FtsQ periplasmic domain for its interaction interfaces with FtsB and FtsL. An interaction hot spot for FtsB was identified around residue Ser-250 in the C-terminal region of FtsQ and a membrane-proximal interaction region for both proteins around residue Lys-59. Sequence alignment revealed a consensus motif overlapping with the C-terminal interaction hot spot, underlining the importance of this region in FtsQ. The identification of contact sites in the FtsQBL complex will guide future development of interaction inhibitors that block cell division.	[van Saparoea, H. Bart van den Berg; Glas, Marjolein; Vernooij, Ingrid G. W. H.; Bitter, Wilbert; Luirink, Joen] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam	Luirink, J (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.luirink@vu.nl	Bitter, W/CAJ-5778-2022; Luirink, Joen/AAB-8658-2021; Bitter, Wilbert/ABG-3726-2020; Bitter, Wilbert/AAA-6872-2019	Bitter, Wilbert/0000-0001-8347-6511; den Blaauwen, Tanneke/0000-0002-5403-5597; Luirink, J./0000-0001-8431-0804; van den Berg van Saparoea, Bart/0000-0003-3337-5506	European Commission [HEALTH-F3-2009-223431]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Contract HEALTH-F3-2009-223431 (DIVINOCELL).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Buddelmeijer N, 1998, J BACTERIOL, V180, P6107; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chen JC, 2002, J BACTERIOL, V184, P695, DOI 10.1128/JB.184.3.695-705.2002; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Deseke E, 1998, EUR J ORG CHEM, V1998, P243, DOI 10.1002/(SICI)1099-0690(199802)1998:2<243::AID-EJOC243>3.0.CO;2-I; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Grenga L, 2010, NEW BIOTECHNOL, V27, P870, DOI 10.1016/j.nbt.2010.05.002; Grenga L, 2008, FEMS MICROBIOL LETT, V287, P163, DOI 10.1111/j.1574-6968.2008.01317.x; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 2009, J BACTERIOL, V191, P333, DOI 10.1128/JB.00331-08; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Robichon C, 2011, J BACTERIOL, V193, P4988, DOI 10.1128/JB.00324-11; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Voges D, 2004, BIOCHEM BIOPH RES CO, V318, P601, DOI 10.1016/j.bbrc.2004.04.064; Weiss DS, 1997, MOL MICROBIOL, V25, P671, DOI 10.1046/j.1365-2958.1997.5041869.x; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	44	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24340	24350		10.1074/jbc.M113.485888	http://dx.doi.org/10.1074/jbc.M113.485888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846696	Green Published, hybrid			2022-12-28	WOS:000330612300006
J	Steelman, AJ; Smith, R; Welsh, CJ; Li, JR				Steelman, Andrew J.; Smith, Roger; Welsh, C. Jane; Li, Jianrong			Galectin-9 Protein Is Up-regulated in Astrocytes by Tumor Necrosis Factor and Promotes Encephalitogenic T-cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; IFN-GAMMA; AUTOIMMUNE ENCEPHALOMYELITIS; REACTIVE ASTROCYTES; ENDOTHELIAL-CELLS; TIM-3 EXPRESSION; CONTROLLED TRIAL; NATALIZUMAB; ACTIVATION; INDUCTION	Demyelination and axonal damage in multiple sclerosis (MS) are thought to be a consequence of inflammatory processes that are perpetuated by activated glia and infiltrating leukocytes. Galectin-9 is a beta-galactoside binding lectin capable of modulating immune responses and appears to be up-regulated in MS. However, its role in the pathogenesis of MS has yet to be determined. Here, we report that proinflammatory cytokines induce galectin-9 (Gal-9) expression in primary astrocytes and the mechanism by which TNF up-regulates Gal-9. Astrocytes did not express Gal-9 under basal conditions nor did IL-6, IL-10, or IL-13 trigger Gal-9 expression. In contrast, IL-1 beta, IFN-gamma, and particularly TNF up-regulated Gal-9 in astrocytes. TNF-induced Gal-9 expression was dependent on TNF receptor 1 (TNFR1) as TNF failed to induce Gal-9 in TNFR1(-/-) astrocytes. Blockade of the JNK MAP kinase pathway with the JNK inhibitor SP600125 abrogated TNF-induced Gal-9, whereas p38 and MEK inhibitors had minimal effects. Furthermore, specific knockdown of c-Jun via siRNA in astrocytes before TNF treatment greatly suppressed Gal-9 transcription, suggesting that TNF induces astroglial Gal-9 through the TNF/TNFR1/JNK/c-Jun signaling pathway. Finally, utilizing astrocytes from Lgals9 mutant (Gal-9(-/-)) mice as well as a myelin basic protein-specific Tim-3(+) encephalitogenic T-cell clone (LCN-8), we found that conditioned medium from TNF-stimulated Gal-9(-/-) but not Gal-9(-/-) astrocytes increased the percentage of apoptotic encephalitogenic T-cells. Together, our results suggest that Gal-9 is induced in astrocytes by TNF via the JNK/c-Jun pathway and that astrocyte-derived Gal-9 may function as an immunoregulatory protein in response to ongoing neuroinflammation.	[Steelman, Andrew J.; Welsh, C. Jane; Li, Jianrong] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Smith, Roger; Welsh, C. Jane] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Li, JR (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, Mail Stop 4458, College Stn, TX 77843 USA.	jrli@cvm.tamu.edu	Li, Jianrong/C-4126-2011	Li, Jianrong/0000-0002-8232-9322; Smith, Roger/0000-0001-5645-8422	National Institutes of Health [R01NS060017]; National Multiple Sclerosis Society [RG3975, RG4586, FG1937]; College of Veterinary Medicine Texas AM University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060017, R56NS060017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); College of Veterinary Medicine Texas AM University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS060017 (to J. L.). This work was also supported by National Multiple Sclerosis Society Research Grants RG3975 and RG4586 (to J. L.) and Postdoctoral Fellowship FG1937 (to A. J. S.) and a College of Veterinary Medicine Texas A&M University postdoctoral research training grant (to A. J. S.).	Abdelbary NH, 2011, J INFECT DIS, V203, P948, DOI 10.1093/infdis/jiq153; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Allen SJ, 2010, J VIROL, V84, P12315, DOI 10.1128/JVI.01600-10; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Bachmann R, 1999, AM J PATHOL, V154, P1417, DOI 10.1016/S0002-9440(10)65395-3; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; Bechmann I, 2002, J NEUROIMMUNOL, V132, P60, DOI 10.1016/S0165-5728(02)00311-9; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Ferber IA, 1996, J IMMUNOL, V156, P5; Gimsa U, 2004, J MOL MED-JMM, V82, P364, DOI 10.1007/s00109-004-0531-6; Hara H, 2011, J NEUROIMMUNOL, V233, P135, DOI 10.1016/j.jneuroim.2010.12.011; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Imaizumi T, 2007, GLYCOBIOLOGY, V17, p12C, DOI 10.1093/glycob/cwm045; Ishikawa A, 2004, IMMUNOL CELL BIOL, V82, P410, DOI 10.1111/j.0818-9641.2004.01248.x; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kim S, 2012, BRAIN PATHOL, V22, P41, DOI 10.1111/j.1750-3639.2011.00501.x; Kim S, 2011, J NEUROCHEM, V116, P53, DOI 10.1111/j.1471-4159.2010.07084.x; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Koito Hisami, 2009, J Vis Exp, DOI 10.3791/1304; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lensch M, 2006, INT J BIOCHEM CELL B, V38, P1741, DOI 10.1016/j.biocel.2006.04.004; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Park WS, 2011, BIOCHEM BIOPH RES CO, V411, P259, DOI 10.1016/j.bbrc.2011.06.110; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stancic M, 2011, NEUROPATH APPL NEURO, V37, P654, DOI 10.1111/j.1365-2990.2011.01184.x; Steelman AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-89; Steelman AJ, 2009, BRAIN BEHAV IMMUN, V23, P830, DOI 10.1016/j.bbi.2009.03.010; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Xiao BG, 1998, J NEUROIMMUNOL, V89, P113, DOI 10.1016/S0165-5728(98)00123-4; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	58	48	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23776	23787		10.1074/jbc.M113.451658	http://dx.doi.org/10.1074/jbc.M113.451658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836896	Green Published, hybrid			2022-12-28	WOS:000330611400017
J	Dai, YN; Chi, CB; Zhou, K; Cheng, W; Jiang, YL; Ren, YM; Ruan, K; Chen, YX; Zhou, CZ				Dai, Ya-Nan; Chi, Chang-Biao; Zhou, Kang; Cheng, Wang; Jiang, Yong-Liang; Ren, Yan-Min; Ruan, Ke; Chen, Yuxing; Zhou, Cong-Zhao			Structure and Catalytic Mechanism of Yeast 4-Amino-4-deoxychorismate Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-AMINOBENZOIC ACID; ESCHERICHIA-COLI; AMINODEOXYCHORISMATE LYASE; COENZYME Q(10); GENE; BIOSYNTHESIS; SYNTHASE; PURIFICATION; EVOLUTION; ENCODES	Saccharomyces cerevisiae Abz2 is a pyridoxal 5'-phosphate (PLP)-dependent lyase that converts 4-amino-4-deoxychorismate (ADC) to para-aminobenzoate and pyruvate. To investigate the catalytic mechanism, we determined the 1.9 angstrom resolution crystal structure of Abz2 complexed with PLP, representing the first eukaryotic ADC lyase structure. Unlike Escherichia coli ADClyase, whose dimerization is critical to the formation of the active site, the overall structure of Abz2 displays as a monomer of two domains. At the interdomain cleft, a molecule of cofactor PLP forms a Schiff base with residue Lys-251. Computational simulations defined a basic clamp to orientate the substrate ADC in a proper pose, which was validated by site-directed mutageneses combined with enzymatic activity assays. Altogether, we propose a putative catalytic mechanism of a unique class of monomeric ADC lyases led by yeast Abz2.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014; Zhou, Kang/ABH-7206-2020; Ruan, Ke/N-1995-2013	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Zhou, Kang/0000-0002-3034-2808; Jiang, YongLiang/0000-0001-5441-4936; Ruan, Ke/0000-0001-9358-0451	Ministry of Science and Technology of China [2012CB911000]; National Natural Science Foundation of China [31170695]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Project 2012CB911000 and National Natural Science Foundation of China Grant 31170695.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basset GJC, 2004, PLANT J, V40, P453, DOI 10.1111/j.1365-313X.2004.02231.x; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Chang Z, 2001, MICROBIOL-SGM, V147, P2113, DOI 10.1099/00221287-147-8-2113; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; CRIADO LM, 1993, GENE, V126, P135, DOI 10.1016/0378-1119(93)90602-Y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; GREEN JM, 1991, J BIOL CHEM, V266, P12971; GREEN JM, 1992, J BACTERIOL, V174, P5317, DOI 10.1128/JB.174.16.5317-5323.1992; James TY, 2002, J BASIC MICROB, V42, P91, DOI 10.1002/1521-4028(200205)42:2<91::AID-JOBM91>3.0.CO;2-8; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, J BIOCHEM, V128, P29, DOI 10.1093/oxfordjournals.jbchem.a022727; NICHOLS BP, 1989, J BIOL CHEM, V264, P8597; O'Rourke PEF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024158; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Ortega RM, 1997, AM J CLIN NUTR, V66, P803; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2009, ACTA CRYSTALLOGR F, V65, P1234, DOI 10.1107/S1744309109050052; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Schadt HS, 2009, J AM CHEM SOC, V131, P3481, DOI 10.1021/ja809283u; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Triglia T, 1999, EXP PARASITOL, V92, P154, DOI 10.1006/expr.1999.4400; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; YE QZ, 1990, P NATL ACAD SCI USA, V87, P9391, DOI 10.1073/pnas.87.23.9391; Zhang YR, 2009, MICROBIOL-SGM, V155, P2450, DOI 10.1099/mic.0.026336-0	42	4	4	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22985	22992		10.1074/jbc.M113.480335	http://dx.doi.org/10.1074/jbc.M113.480335			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818518	hybrid, Green Published			2022-12-28	WOS:000330598200009
J	Osmakov, DI; Kozlov, SA; Andreev, YA; Koshelev, SG; Sanamyan, NP; Sanamyan, KE; Dyachenko, IA; Bondarenko, DA; Murashev, AN; Mineev, KS; Arseniev, AS; Grishin, EV				Osmakov, Dmitry I.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Koshelev, Sergey G.; Sanamyan, Nadezhda P.; Sanamyan, Karen E.; Dyachenko, Igor A.; Bondarenko, Dmitry A.; Murashev, Arkadii N.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.			Sea Anemone Peptide with Uncommon beta-Hairpin Structure Inhibits Acid-sensing Ion Channel 3 (ASIC3) and Reveals Analgesic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUE DISTRIBUTION ANALYSIS; GATED NA+ CHANNELS; ANTIMICROBIAL PEPTIDE; INFLAMMATORY PAIN; SPIDER VENOM; INSECTICIDAL PEPTIDES; POLYPEPTIDE INHIBITOR; SENSITIVE CHANNEL; SENSORY NEURONS; TOXINS	Three novel peptides were isolated from the venom of the sea anemone Urticina grebelnyi. All of them are 29 amino acid peptides cross-linked by two disulfide bridges, with a primary structure similar to other sea anemone peptides belonging to structural group 9a. The structure of the gene encoding the shared precursor protein of the identified peptides was determined. One peptide, pi-AnmTX Ugr 9a-1 (short name Ugr 9-1), produced a reversible inhibition effect on both the transient and the sustained current of human ASIC3 channels expressed in Xenopus laevis oocytes. It completely blocked the transient component (IC50 10 +/- 0.6 mu M) and partially (48 +/- 2%) inhibited the amplitude of the sustained component (IC50 1.44 +/- 0.19 mu M). Using in vivo tests in mice, Ugr 9-1 significantly reversed inflammatory and acid-induced pain. The other two novel peptides, AnmTX Ugr 9a-2 (Ugr 9-2) and AnmTX Ugr 9a-3 (Ugr 9-3), did not inhibit the ASIC3 current. NMR spectroscopy revealed that Ugr 9-1 has an uncommon spatial structure, stabilized by two S-S bridges, with three classical beta-turns and twisted beta-hairpin without interstrand disulfide bonds. This is a novel peptide spatial structure that we propose to name boundless beta-hairpin.	[Osmakov, Dmitry I.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Koshelev, Sergey G.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Sanamyan, Nadezhda P.; Sanamyan, Karen E.] Russian Acad Sci, Kamchatka Branch, Pacific Inst Geog, Far Eastern Branch, Petropavlovsk Kamchatski 683000, Russia; [Dyachenko, Igor A.; Bondarenko, Dmitry A.; Murashev, Arkadii N.] Russian Acad Sci, Branch Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 142290, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	ay@land.ru	Mineev, Konstantin S/Q-3948-2018; Mineev, Konstantin/E-4151-2010; Osmakov, Dmitry/H-5560-2019; Kozlov, Sergey A/D-1548-2012; Andreev, Yaroslav A/C-6627-2012; DI Igor, Dyachenko/K-9060-2017; Mineev, Konstantin/AAC-6662-2019; Bondarenko, Dmitry A/T-9356-2017	Mineev, Konstantin S/0000-0002-2418-9421; Mineev, Konstantin/0000-0002-2418-9421; Kozlov, Sergey A/0000-0002-0242-4240; Mineev, Konstantin/0000-0002-2418-9421; Bondarenko, Dmitry A/0000-0002-8055-0066; Sanamyan, Nadya/0000-0002-9987-0668; Osmakov, Dmitry/0000-0001-6588-5012; Andreev, Yaroslav/0000-0002-7628-0980	Russian Academy of Sciences; Ministry of Education and Science of the Russian Federation [8063]; Russian Foundation for Basic Research [12-04-33151, 12-04-90442, 12-04-01068]	Russian Academy of Sciences(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Programs of the Russian Academy of Sciences "Molecular and Cell Biology" and "Fundamental Sciences for Medicine," the Federal Program of The Ministry of Education and Science of the Russian Federation (Agreement 8063), and Russian Foundation for Basic Research Grants 12-04-33151, 12-04-90442, and 12-04-01068.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anangi R, 2012, MAR DRUGS, V10, P1605, DOI 10.3390/md10071605; Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Carli A, 1996, TOXICON, V34, P496, DOI 10.1016/0041-0101(95)00157-3; Castaneda O, 2009, TOXICON, V54, P1119, DOI 10.1016/j.toxicon.2009.02.032; Corzo G, 2009, BBA-PROTEINS PROTEOM, V1794, P1190, DOI 10.1016/j.bbapap.2009.04.004; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Dubinnyi MA, 2012, J BIOL CHEM, V287, P32993, DOI 10.1074/jbc.M112.366427; EFREMOV RG, 1995, J PHYS CHEM-US, V99, P10658, DOI 10.1021/j100026a033; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Honma T, 2005, TOXICON, V45, P33, DOI 10.1016/j.toxicon.2004.09.013; Honma T, 2008, PEPTIDES, V29, P536, DOI 10.1016/j.peptides.2007.12.010; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2012, RUSS J BIOORG CHEM+, V38, P578, DOI 10.1134/S1068162012060064; Kozlov S, 2012, PEPTIDES, V33, P240, DOI 10.1016/j.peptides.2011.12.008; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lovelace ES, 2006, J MED CHEM, V49, P6561, DOI 10.1021/jm060299h; Marino A, 2004, COMP BIOCHEM PHYS C, V139, P295, DOI 10.1016/j.cca.2004.12.008; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sanamyan NP, 2006, J NAT HIST, V40, P359, DOI 10.1080/00222930600703532; Shenkarev ZO, 2011, BIOCHEMISTRY-US, V50, P6255, DOI 10.1021/bi200746t; Shiomi K, 2009, TOXICON, V54, P1112, DOI 10.1016/j.toxicon.2009.02.031; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; TERRY AS, 1988, J BIOL CHEM, V263, P5745; Umetsu Y, 2009, J BIOL CHEM, V284, P29625, DOI 10.1074/jbc.M109.011148; Vassilevski AA, 2008, RECENT PATENTS INFLA, V2, P58, DOI 10.2174/187221308783399261; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; Zaharenko AJ, 2008, COMP BIOCHEM PHYS D, V3, P219, DOI 10.1016/j.cbd.2008.04.002	49	54	68	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23116	23127		10.1074/jbc.M113.485516	http://dx.doi.org/10.1074/jbc.M113.485516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801332	hybrid, Green Published			2022-12-28	WOS:000330598200019
J	Hales, EC; Orr, SM; Gedman, AL; Taub, JW; Matherly, LH				Hales, Eric C.; Orr, Steven M.; Gedman, Amanda Larson; Taub, Jeffrey W.; Matherly, Larry H.			Notch1 Receptor Regulates AKT Protein Activation Loop (Thr(308)) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; SIGNALING PATHWAY; GENE IEX-1; PTEN; MUTATIONS; 2A; INHIBITION; SUBUNIT; PHOSPHORYLATION; HOLOENZYME	Notch1 activating mutations occur in more than 50% of T-cell acute lymphoblastic leukemia (T-ALL) cases and increase expression of Notch1 target genes, some of which activate AKT. HES1 transcriptionally silences phosphatase and tensin homolog (PTEN), resulting in AKT activation, which is reversed by Notch1 inhibition with gamma-secretase inhibitors (GSIs). Mutational loss of PTEN is frequent in T-ALL and promotes resistance to GSIs due to AKT activation. GSI treatments increased AKT-Thr(308) phosphorylation and signaling in PTEN-deficient, GSI-resistant T-ALL cell lines (Jurkat, CCRF-CEM, and MOLT3), suggesting that Notch1 represses AKT independent of its PTEN transcriptional effects. AKT-Thr(308) phosphorylation and downstream signaling were also increased by knocking down Notch1 in Jurkat (N1KD) cells. This was blocked by treatment with the AKT inhibitor perifosine. The PI3K inhibitor wortmannin and the protein phosphatase type 2A (PP2A) inhibitor okadaic acid both impacted AKT-Thr(308) phosphorylation to a greater extent in nontargeted control than N1KD cells, suggesting decreased dephosphorylation of AKT-Thr(308) by PP2A in the latter. Phosphorylations of AMP-activated protein kinase alpha (AMPK alpha)-Thr(172) and p70S6K-Thr(389), both PP2A substrates, were also increased in both N1KD and GSI-treated cells and responded to okadaic acid treatment. A transcriptional regulatory mechanism was implied because ectopic expression of dominant-negative mastermind-like protein 1 increased and wild-type HES1 decreased phosphorylation of these PP2A targets. This was independent of changes in PP2A subunit levels or in vitro PP2A activity, but was accompanied by decreased association of PP2A with AKT in N1KD cells. These results suggest that Notch1 can regulate PP2A dephosphorylation of critical cellular regulators including AKT, AMPK alpha, and p70S6K.	[Hales, Eric C.; Orr, Steven M.; Gedman, Amanda Larson; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Matherly, Larry H.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Childrens Hosp Michigan, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Children's Hospital of Michigan	Matherly, LH (corresponding author), Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, 110 E Warren Ave,Rm 3120, Detroit, MI 48201 USA.	matherly@karmanos.org			Herrick Foundation; Wayne State University; Ring Screw Textron Endowed Chair for Pediatric Research; National Institutes of Health Training Grant from the NCI [T32 CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER	Herrick Foundation; Wayne State University; Ring Screw Textron Endowed Chair for Pediatric Research; National Institutes of Health Training Grant from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Herrick Foundation and Wayne State University and the Ring Screw Textron Endowed Chair for Pediatric Research (to J. W. T.).; Supported by National Institutes of Health Training Grant T32 CA009531 from the NCI.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bonnet M, 2011, BLOOD, V117, P6650, DOI 10.1182/blood-2011-02-336842; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Cristobal I, 2011, LEUKEMIA, V25, P606, DOI 10.1038/leu.2010.294; DAMUNI Z, 1994, FEBS LETT, V352, P311, DOI 10.1016/0014-5793(94)00981-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Dey-Guha I, 2011, P NATL ACAD SCI USA, V108, P12845, DOI 10.1073/pnas.1109632108; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gallagher Sean R, 2006, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1002as75; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gedman AL, 2009, LEUKEMIA, V23, P1417, DOI 10.1038/leu.2009.64; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kox C, 2010, LEUKEMIA, V24, P2005, DOI 10.1038/leu.2010.203; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LERGA A, 1995, BIOCHEM BIOPH RES CO, V215, P889, DOI 10.1006/bbrc.1995.2547; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liao Y, 2010, AM J TRANSL RES, V2, P19; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Meijerink JPP, 2010, BEST PRACT RES CL HA, V23, P307, DOI 10.1016/j.beha.2010.08.002; Nagase H, 2011, CURR STEM CELL RES T, V6, P131, DOI 10.2174/157488811795495459; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Nyakern M, 2006, MOL CANCER THER, V5, P1559, DOI 10.1158/1535-7163.MCT-06-0076; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pui CH, 2010, LEUKEMIA, V24, P371, DOI 10.1038/leu.2009.252; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Qin L, 2011, J BIOCHEM, V150, P151, DOI 10.1093/jb/mvr066; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200	61	36	39	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22836	22848		10.1074/jbc.M113.451625	http://dx.doi.org/10.1074/jbc.M113.451625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788636	hybrid, Green Published			2022-12-28	WOS:000330596300060
J	Sampath, V; Liu, BS; Tafrov, S; Srinivasan, M; Rieger, R; Chen, EI; Sternglanz, R				Sampath, Vinaya; Liu, Bingsheng; Tafrov, Stefan; Srinivasan, Madhusudhan; Rieger, Robert; Chen, Emily I.; Sternglanz, Rolf			Biochemical Characterization of Hpa2 and Hpa3, Two Small Closely Related Acetyltransferases from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Acetylase; Histone Modification; Mass Spectrometry (MS); Polyamines; Translation; Acetyltransferase	ACID-N-ACETYLTRANSFERASE; D-AMINO ACIDS; HISTONE ACETYLTRANSFERASE; HAT COMPLEX; YEAST; PROTEIN; ACETYLATION; METABOLISM; EXPRESSION; GENES	Based on their sequences, the Saccharomyces cerevisiae Hpa2 and Hpa3 proteins are annotated as two closely related members of the Gcn5 acetyltransferase family. Here, we describe the biochemical characterization of Hpa2 and Hpa3 as bona fide acetyltransferases with different substrate specificities. Mutational and MALDI-TOF analyses showed that Hpa3 translation initiates primarily from Met-19 rather than the annotated start site, Met-1, with a minor product starting at Met-27. When expressed in Escherichia coli and assayed in vitro, Hpa2 and Hpa3 (from Met-19) acetylated histones and polyamines. Whereas Hpa2 acetylated histones H3 and H4 (at H3 Lys-14, H4 Lys-5, and H4 Lys-12), Hpa3 acetylated only histone H4 (at Lys-8). Additionally, Hpa2, but not Hpa3, acetylated certain small basic proteins. Hpa3, but not Hpa2, has been reported to acetylate d-amino acids, and we present results consistent with that. Overexpression of Hpa2 or Hpa3 is toxic to yeast cells. However, their deletions do not show any standard phenotypic defects. These results suggest that Hpa2 and Hpa3 are similar but distinct acetyltransferases that might have overlapping roles with other known acetyltransferases in vivo in acetylating histones and other small proteins.	[Sampath, Vinaya; Liu, Bingsheng; Tafrov, Stefan; Srinivasan, Madhusudhan; Sternglanz, Rolf] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Rieger, Robert; Chen, Emily I.] SUNY Stony Brook, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sternglanz, R (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rolf@life.bio.sunysb.edu			National Institutes of Health [R01 GM55641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM55641 (to R.S.).	Angus-Hill ML, 1999, J MOL BIOL, V294, P1311, DOI 10.1006/jmbi.1999.3338; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bartel P.L., 1993, CELLULAR INTERACTION; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guthrie C, 1991, GUIDE YEAST GENETICS; John S, 2000, GENE DEV, V14, P1196; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; LIBBY PR, 1978, J BIOL CHEM, V253, P233; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; RYTKA J, 1975, J BACTERIOL, V121, P562, DOI 10.1128/JB.121.2.562-570.1975; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Yow GY, 2006, ARCH MICROBIOL, V185, P39, DOI 10.1007/s00203-005-0060-x; Yow GY, 2004, ARCH MICROBIOL, V182, P396, DOI 10.1007/s00203-004-0724-y; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128	29	15	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21506	21513		10.1074/jbc.M113.486274	http://dx.doi.org/10.1074/jbc.M113.486274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775086	Green Published, hybrid			2022-12-28	WOS:000328841900004
J	Saverioni, D; Notari, S; Capellari, S; Poggiolini, I; Giese, A; Kretzschmar, HA; Parchi, P				Saverioni, Daniela; Notari, Silvio; Capellari, Sabina; Poggiolini, Ilaria; Giese, Armin; Kretzschmar, Hans A.; Parchi, Piero			Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; STRAIN VARIATION; TRUNCATED FORMS; SCRAPIE; VARIANT; PRPSC; CLASSIFICATION; INSIGHTS; GLYCOSAMINOGLYCANS; CONFORMATION	Prion diseases are characterized by tissue accumulation of a misfolded, beta-sheet-enriched isoform (scrapie prion protein (PrPSc)) of the cellular prion protein (PrPC). At variance with PrPC, PrPSc shows a partial resistance to protease digestion and forms highly aggregated and detergent-insoluble polymers, two properties that have been consistently used to distinguish the two proteins. In recent years, however, the idea that PrPSc itself comprises heterogeneous species has grown. Most importantly, a putative proteinase K (PK)-sensitive form of PrPSc (sPrP(Sc)) is being increasingly investigated for its possible role in prion infectivity, neurotoxicity, and strain variability. The study of sPrP(Sc), however, remains technically challenging because of the need of separating it from PrPC without using proteases. In this study, we have systematically analyzed both PK resistance and the aggregation state of purified PrPSc across the whole spectrum of the currently characterized human prion strains. The results show that PrPSc isolates manifest significant strain-specific differences in their PK digestion profile that are only partially explained by differences in the size of aggregates, suggesting that other factors, likely acting on PrPSc aggregate stability, determine its resistance to proteolysis. Fully protease-sensitive low molecular weight aggregates were detected in all isolates but in a limited proportion of the overall PrPSc (i.e. <10%), arguing against a significant role of slowly sedimenting PK-sensitive PrPSc in the biogenesis of prion strains. Finally, we highlight the limitations of current operational definitions of sPrP(Sc) and of the quantitative analytical measurements that are not based on the isolation of a fully PK-sensitive PrPSc form.	[Capellari, Sabina; Parchi, Piero] Ist Sci Neurol Bologna, IRCCS, I-40139 Bologna, Italy; [Saverioni, Daniela; Capellari, Sabina; Poggiolini, Ilaria; Parchi, Piero] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, I-40123 Bologna, Italy; [Giese, Armin; Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-81377 Munich, Germany; [Notari, Silvio] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Munich; Case Western Reserve University	Parchi, P (corresponding author), Ist Sci Neurol Bologna, IRCCS, Via Altura 3, I-40139 Bologna, Italy.	piero.parchi@unibo.it	capellari, sabina/F-5545-2012; Giese, Armin/F-3271-2010; Parchi, Piero/L-9833-2015	capellari, sabina/0000-0003-1631-1439; Giese, Armin/0000-0002-8238-4102; Parchi, Piero/0000-0002-9444-9524	Italian Ministry of Health [RF-2009-1474624]; University of Bologna [RFO 2008-2010]; Gino Galletti Foundation	Italian Ministry of Health(Ministry of Health, Italy); University of Bologna; Gino Galletti Foundation	This work was supported by Italian Ministry of Health Grant RF-2009-1474624, University of Bologna Grants RFO 2008-2010, and the Gino Galletti Foundation.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Choi YG, 2004, J BIOL CHEM, V279, P30402, DOI 10.1074/jbc.M400854200; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Falsig J, 2008, HFSP J, V2, P332, DOI 10.2976/1.2990786; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Ghetti B, 2003, CLIN LAB MED, V23, P65, DOI 10.1016/S0272-2712(02)00064-1; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Immel F, 2007, J BIOL CHEM, V282, P7912, DOI 10.1074/jbc.M608652200; Ironside JW, 2010, HAEMOPHILIA, V16, P175, DOI 10.1111/j.1365-2516.2010.02317.x; Jansen C, 2011, J NEUROPATH EXP NEUR, V70, P698, DOI 10.1097/NEN.0b013e3182270c54; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kobayashi A, 2005, J GEN VIROL, V86, P237, DOI 10.1099/vir.0.80389-0; Masel J, 1999, P ROY SOC B-BIOL SCI, V266, P1927, DOI 10.1098/rspb.1999.0868; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Moda F, 2012, BRAIN PATHOL, V22, P662, DOI 10.1111/j.1750-3639.2012.00572.x; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Pham N, 2008, BIOCHEM BIOPH RES CO, V368, P875, DOI 10.1016/j.bbrc.2008.01.172; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thackray AM, 2007, J VIROL, V81, P12119, DOI 10.1128/JVI.01434-07; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Weber P, 2008, BIOCHEM BIOPH RES CO, V369, P924, DOI 10.1016/j.bbrc.2008.02.115; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhou Xiao-bo, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P118; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200; Zsila F, 2006, BIOCHEM BIOPH RES CO, V346, P1267, DOI 10.1016/j.bbrc.2006.06.033	63	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27972	27985		10.1074/jbc.M113.477547	http://dx.doi.org/10.1074/jbc.M113.477547			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897825	hybrid, Green Published			2022-12-28	WOS:000330612800024
J	Uenishi, E; Shibasaki, T; Takahashi, H; Seki, C; Hamaguchi, H; Yasuda, T; Tatebe, M; Oiso, Y; Takenawa, T; Seino, S				Uenishi, Eita; Shibasaki, Tadao; Takahashi, Harumi; Seki, Chihiro; Hamaguchi, Hitomi; Yasuda, Takao; Tatebe, Masao; Oiso, Yutaka; Takenawa, Tadaomi; Seino, Susumu			Actin Dynamics Regulated by the Balance of Neuronal Wiskott-Aldrich Syndrome Protein (N-WASP) and Cofilin Activities Determines the Biphasic Response of Glucose-induced Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULE EXOCYTOSIS; BETA-CELL; DIABETES-MELLITUS; NEUROENDOCRINE CELLS; PANCREATIC-ISLETS; IN-VIVO; CDC42; PHOSPHORYLATION; KINASE; RHO	Actin dynamics in pancreatic beta-cells is involved in insulin secretion. However, the molecular mechanisms of the regulation of actin dynamics by intracellular signals in pancreatic beta-cells and its role in phasic insulin secretion are largely unknown. In this study, we elucidate the regulation of actin dynamics by neuronal Wiskott-Aldrich syndrome protein (N-WASP) and cofilin in pancreatic beta-cells and demonstrate its role in glucose-induced insulin secretion (GIIS). N-WASP, which promotes actin polymerization through activation of the actin nucleation factor Arp2/3 complex, was found to be activated by glucose stimulation in insulin-secreting clonal pancreatic beta-cells (MIN6-K8 beta-cells). Introduction of a dominant-negative mutant of N-WASP, which lacks G-actin and Arp2/3 complex-binding region VCA, into MIN6-K8 beta-cells or knockdown of N-WASP suppressed GIIS, especially the second phase. We also found that cofilin, which severs F-actin in its dephosphorylated (active) form, is converted to the phosphorylated (inactive) form by glucose stimulation in MIN6-K8 beta-cells, thereby promoting F-actin remodeling. In addition, the dominant-negative mutant of cofilin, which inhibits activation of endogenous cofilin, or knockdown of cofilin reduced the second phase of GIIS. However, the first phase of GIIS occurs in the G-actin predominant state, in which cofilin activity predominates over N-WASP activity. Thus, actin dynamics regulated by the balance of N-WASP and cofilin activities determines the biphasic response of GIIS.	[Uenishi, Eita; Shibasaki, Tadao; Takahashi, Harumi; Seki, Chihiro; Hamaguchi, Hitomi; Yasuda, Takao; Tatebe, Masao; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Kobe, Hyogo 6500017, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Takenawa, Tadaomi; Seino, Susumu] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 6500017, Japan; [Uenishi, Eita; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan; [Seino, Susumu] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Kobe University; Kobe University; Kobe University; Kobe University; Nagoya University; Japan Science & Technology Agency (JST)	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp			CREST grant from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology	CREST grant from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a CREST grant from the Japan Science and Technology Agency, a grant-in-aid for scientific research, and a grant for the Global Centers of Excellence Program "Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation" from the Ministry of Education, Culture, Sports, Science and Technology.	Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; CERASI E, 1967, ACTA ENDOCRINOL-COP, V55, P278, DOI 10.1530/acta.0.0550278; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; DAVIS SN, 1993, METABOLISM, V42, P30, DOI 10.1016/0026-0495(93)90168-N; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gong Chunhong, 2004, Angiogenesis, V7, P313, DOI 10.1007/s10456-004-7960-2; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P5824, DOI 10.1210/jc.86.12.5824; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kepner EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1072, DOI 10.1152/ajpendo.00312.2011; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Lopez JP, 2010, AM J PHYSIOL-ENDOC M, V299, pE772, DOI 10.1152/ajpendo.00199.2010; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; PORTE D JR, 1991, American Journal of Medicine, V90, p8S, DOI 10.1016/0002-9343(91)90412-Q; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; SNABES MC, 1982, BIOCHEM BIOPH RES CO, V104, P207, DOI 10.1016/0006-291X(82)91960-X; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; SOMERS G, 1979, ENDOCRINOLOGY, V104, P255, DOI 10.1210/endo-104-1-255; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; VANOBBER.E, 1973, J CLIN INVEST, V52, P1041, DOI 10.1172/JCI107269; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yasuda T, 2010, CELL METAB, V12, P117, DOI 10.1016/j.cmet.2010.05.017	58	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25851	25864		10.1074/jbc.M113.464420	http://dx.doi.org/10.1074/jbc.M113.464420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23867458	Green Published, hybrid			2022-12-28	WOS:000330623300017
J	Witt, RM; Hecht, ML; Pazyra-Murphy, MF; Cohen, SM; Noti, C; van Kuppevelt, TH; Fuller, M; Chan, JA; Hopwood, JJ; Seeberger, PH; Segal, RA				Witt, Rochelle M.; Hecht, Marie-Lyn; Pazyra-Murphy, Maria F.; Cohen, Samuel M.; Noti, Christian; van Kuppevelt, Toin H.; Fuller, Maria; Chan, Jennifer A.; Hopwood, John J.; Seeberger, Peter H.; Segal, Rosalind A.			Heparan Sulfate Proteoglycans Containing a Glypican 5 Core and 2-O-Sulfo-iduronic Acid Function as Sonic Hedgehog Co-receptors to Promote Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; DALLY-LIKE; INTRAFLAGELLAR TRANSPORT; CELL-PROLIFERATION; TOUT-VELU; PROTEINS; PATHWAY; BINDING; ROLES; CDO	Sonic Hedgehog (Shh) signaling is crucial for growth, cell fate determination, and axonal guidance in the developing nervous system. Although the receptors Patched (Ptch1) and Smoothened (Smo) are required for Shh signaling, a number of distinct co-receptors contribute to these critical responses to Shh. Several membrane-embedded proteins such as Boc, Cdo, and Gas1 bind Shh and promote signaling. In addition, heparan sulfate proteoglycans (HSPGs) have also been implicated in the initiation of Shh responses. However, the attributes of HSPGs that function as co-receptors for Shh have not yet been defined. Here, we identify HSPGs containing a glypican 5 core protein and 2-O-sulfo-iduronic acid residues at the nonreducing ends of the glycans as co-receptors for Shh. These HSPG co-receptors are expressed by cerebellar granule cell precursors and promote Shh binding and signaling. At the subcellular level, these HSPG co-receptors are located adjacent to the primary cilia that act as Shh signaling organelles. Thus, Shh binds to HSPG co-receptors containing a glypican 5 core and 2-O-sulfo-iduronic acid to promote neural precursor proliferation.	[Witt, Rochelle M.; Pazyra-Murphy, Maria F.; Cohen, Samuel M.; Segal, Rosalind A.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Witt, Rochelle M.; Pazyra-Murphy, Maria F.; Cohen, Samuel M.; Segal, Rosalind A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02215 USA; [Hecht, Marie-Lyn; Seeberger, Peter H.] Max Planck Inst Colloids & Interfaces, D-14476 Golm, Germany; [Hecht, Marie-Lyn; Noti, Christian] Fed Inst Technol ETH Zurich, CH-8093 Zurich, Switzerland; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Fuller, Maria; Hopwood, John J.] SA Pathol, Lysosomal Dis Res Unit, Womens & Childrens Hosp, Adelaide, SA 5006, Australia; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada; [Seeberger, Peter H.] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Radboud University Nijmegen; SA Pathology; University of Calgary; Free University of Berlin	Seeberger, PH (corresponding author), Max Planck Inst Colloids & Interfaces, Muhlenberg 1, D-14476 Golm, Germany.	peter.seeberger@mpikg.mpg.de; Rosalind_segal@dfci.harvard.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015		National Institutes of Health Director's Pioneer Award [DP1 0D000839]; Quan Fellowship; Swiss National Science Foundation; ETH Zurich; Max-Planck Society; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000839] Funding Source: NIH RePORTER	National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quan Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Max-Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's Pioneer Award (Grant DP1 0D000839; to R. A. S.). This work was also supported by a Quan Fellowship (to R. M. W.), the Swiss National Science Foundation (to M. L. H.), ETH Zurich (to P. H. S.), the Max-Planck Society (to P. H. S.), and an ERC advanced grant (to P. H. S. and Harvard NeuroDiscovery Center).	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Farshi P, 2011, J BIOL CHEM, V286, P23608, DOI 10.1074/jbc.M110.206474; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Fuller M, 2006, GLYCOBIOLOGY, V16, P318, DOI 10.1093/glycob/cwj072; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Ho M, 2011, EUR J CANCER, V47, P333, DOI 10.1016/j.ejca.2010.10.024; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Rudd TR, 2012, MOL BIOSYST, V8, P1499, DOI 10.1039/c2mb25019e; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Shih PC, 2009, J BIOL CHEM, V284, P36535, DOI 10.1074/jbc.M109.037267; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; ten Dam GB, 2004, J BIOL CHEM, V279, P38346, DOI 10.1074/jbc.M404166200; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yan D, 2008, NAT CELL BIOL, V10, P761, DOI 10.1038/ncb0708-761; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	56	47	47	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26275	26288		10.1074/jbc.M112.438937	http://dx.doi.org/10.1074/jbc.M112.438937			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23867465	Green Published, hybrid			2022-12-28	WOS:000330623300057
J	Carignan, D; Desy, O; Ghani, K; Caruso, M; de Campos-Lima, PO				Carignan, Damien; Desy, Olivier; Ghani, Karim; Caruso, Manuel; de Campos-Lima, Pedro O.			The Size of the Unbranched Aliphatic Chain Determines the Immunomodulatory Potency of Short and Long Chain n-Alkanols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED LYMPHOCYTES; GENERAL-ANESTHESIA; ACUTE ALCOHOL; LIPID RAFTS; IN-VIVO; ETHANOL; CHANNEL; DYSREGULATION; ISOPROPANOL; INHIBITION	Aliphatic n-alkanols are a family of ubiquitous substances that display general anesthetic properties in accordance to their degree of hydrophobicity. In addition, the immunomodulatory activity of one of its members, ethanol, has long been recognized. We reasoned that because unbranched aliphatic n-alkanols are structurally very similar they might have an immunological impact that mirrors their anesthetic potency. We report the impact of the homologous C-1-C-12 alcohol series on the ability of activated primary human lymphocytes to produce IFN-gamma. Methanol enhanced IFN-gamma production whereas C-2-C-10 alcohols reduced the release of this cytokine. The activity of the n-alkanol series was observed within a wide concentration window ranging from millimolar levels for short chain alcohols to micromolar amounts for C-7-C-10 alcohols. There was a clear correlation between immunomodulatory activity and hydrophobicity of the compounds, but a cutoff effect was evident at C-11. n-Alkanols were shown to act downstream of the cell membrane because T cell receptor early signaling was preserved. The activation of the nuclear factor of activated T cells (NFAT) was down-regulated progressively in accordance to the size of the n-alkanol aliphatic chains with a clear downward trend that was interrupted at C-11. The nuclear factor-kappa B (NF-kappa B) signaling was also compromised, but the cutoff appeared earlier at C-10. The pattern of immunomodulation and transcriptional dysregulation induced by the n-alkanol series suggested the existence of interaction pockets of defined dimensions within intracellular targets that compromise the activation of NFAT and NF-kappa B transcription factors and ultimately modulate the effector function of the T lymphocyte.	[Carignan, Damien; Desy, Olivier; Ghani, Karim; Caruso, Manuel; de Campos-Lima, Pedro O.] Univ Laval, Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada	Laval University	de Campos-Lima, PO (corresponding author), Univ Laval, Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada.	pdclima@ymail.com	de Campos-Lima, Pedro Otavio/I-3495-2013	de Campos-Lima, Pedro Otavio/0000-0001-8024-8628; Carignan, Damien/0000-0002-3086-2010; Caruso, Manuel/0000-0002-7609-2015	National Sciences and Engineering Research Council of Canada [327062-2012]; Canada Foundation for Innovation [4087]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by National Sciences and Engineering Research Council of Canada Grant 327062-2012 and the Canada Foundation for Innovation Grant 4087 (to P. O. d. C.-L.).	Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; BELL GH, 1973, CHEM PHYS LIPIDS, V10, P1, DOI 10.1016/0009-3084(73)90036-4; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Carignan D, 2012, TOXICOL SCI, V125, P144, DOI 10.1093/toxsci/kfr283; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Desy O, 2008, J IMMUNOL, V181, P2348, DOI 10.4049/jimmunol.181.4.2348; Desy O, 2012, TOXICOL LETT, V210, P44, DOI 10.1016/j.toxlet.2012.01.005; Desy O, 2010, TOXICOL SCI, V117, P303, DOI 10.1093/toxsci/kfq212; Dickinson R, 2000, ANESTHESIOLOGY, V93, P837, DOI 10.1097/00000542-200009000-00035; Eckenhoff R G, 2001, Mol Interv, V1, P258; Franks NP, 2004, ANESTHESIOLOGY, V101, P235, DOI 10.1097/00000542-200407000-00034; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1982, NATURE, V300, P487, DOI 10.1038/300487a0; FRANKS NP, 1985, NATURE, V316, P349, DOI 10.1038/316349a0; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Klemm WR, 1998, ALCOHOL, V15, P249, DOI 10.1016/S0741-8329(97)00130-4; KOBLIN DD, 1994, ANESTH ANALG, V79, P1043; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; MCCREERY MJ, 1978, NEUROPHARMACOLOGY, V17, P451, DOI 10.1016/0028-3908(78)90050-3; Meyer HH., 1899, ARCH EXP PATH PHARMA, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oak S, 2006, J IMMUNOL, V176, P7628, DOI 10.4049/jimmunol.176.12.7628; Overton E., 1901, STUDIEN NARKOSE ZUGL; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; PRINGLE MJ, 1981, MOL PHARMACOL, V19, P49; Qiao J, 2002, HUM GENE THER, V13, P881, DOI 10.1089/10430340252899046; RAMASWAMY S, 1994, BIOCHEMISTRY-US, V33, P5230, DOI 10.1021/bi00183a028; Saeed RW, 2004, J IMMUNOL, V173, P6376, DOI 10.4049/jimmunol.173.10.6376; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Taieb J, 2002, J LEUKOCYTE BIOL, V72, P1142; Veenstra G, 2009, ECOTOX ENVIRON SAFE, V72, P1016, DOI 10.1016/j.ecoenv.2008.07.012; Zhao XJ, 2003, J IMMUNOL, V170, P2923, DOI 10.4049/jimmunol.170.6.2923	35	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24948	24955		10.1074/jbc.M113.466334	http://dx.doi.org/10.1074/jbc.M113.466334			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839943	hybrid, Green Published			2022-12-28	WOS:000330612300058
J	Yang, SL; Roselli, F; Patchev, AV; Yu, S; Almeida, OFX				Yang, Silei; Roselli, Francesco; Patchev, Alexandre V.; Yu, Shuang; Almeida, Osborne F. X.			Non-receptor-tyrosine Kinases Integrate Fast Glucocorticoid Signaling in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA-RECEPTORS; PROTEIN-COUPLED RECEPTORS; MEDIATED CA2+ ELEVATION; BETA-GAMMA-SUBUNITS; C-ABL; MINERALOCORTICOID RECEPTORS; DIFFERENTIAL ROLES; PTP-PEST; ACTIVATION	Despite numerous descriptions of rapid effects of corticosterone on neuronal function, the intracellular mechanisms responsible for these changes remain elusive. The present comprehensive analysis reveals that signaling from a membrane-located G protein-coupled receptor activates PKC, Akt/PKB, and PKA, which subsequently trigger the phosphorylation of the tyrosine kinases Pyk2, Src, and Abl. These changes induce rapid cytoskeletal rearrangements (increased PSD-95 co-clustering) within the post-synaptic density; these events are accompanied by increased surfaceNMDAreceptor expression, reflecting corticosterone-induced inhibition of NMDA receptor endocytosis. Notably, none of these signaling mechanisms require de novo protein synthesis. The observed up-regulation of ERK1/2 (downstream of NMDA receptor signaling) together with the fact that c-Abl integrates cytoplasmic and nuclear functions introduces a potential mechanism through which rapid signaling initiated at the plasma membrane may eventually determine the long term integrated response to corticosterone by impacting on the transcriptional machinery that is regulated by classical, nuclear mineralocorticoid, and glucocorticoid receptors.	[Yang, Silei; Roselli, Francesco; Patchev, Alexandre V.; Yu, Shuang; Almeida, Osborne F. X.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Roselli, Francesco] Univ Bari, Dept Neurol & Psychiat Sci, I-70121 Bari, Italy	Max Planck Society; Universita degli Studi di Bari Aldo Moro	Almeida, OFX (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	osa@mpipsykl.mpg.de	roselli, francesco/G-6701-2013; Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899	Max Planck Society; EU [LSHM-CT-2005-018652, 259772]	Max Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission)	Both authors contributed equally to this work and were supported by fellowships from the Max Planck Society.; Supported through EU Integrated Projects Crescendo Contract LSHM-CT-2005-018652 and SWITCHBOX Contract Grant Agreement 259772.	Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Aoto H, 2002, CELL STRUCT FUNCT, V27, P47, DOI 10.1247/csf.27.47; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dorey R, 2011, NEUROPSYCHOPHARMACOL, V36, P2639, DOI 10.1038/npp.2011.152; Dushek O, 2012, IMMUNOL REV, V250, P258, DOI 10.1111/imr.12008; Evanson NK, 2010, ENDOCRINOLOGY, V151, P4811, DOI 10.1210/en.2010-0285; Ferris CF, 2010, PSYCHONEUROENDOCRINO, V35, P5, DOI 10.1016/j.psyneuen.2009.09.003; Gao CL, 2009, BIOCHEM J, V420, P49, DOI 10.1042/BJ20090037; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Heidinger V, 2002, J NEUROSCI, V22, P5452; Hsin H, 2010, J NEUROSCI, V30, P11983, DOI 10.1523/JNEUROSCI.1029-10.2010; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komatsuzaki Y, 2005, BIOCHEM BIOPH RES CO, V335, P1002, DOI 10.1016/j.bbrc.2005.07.173; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; McGarrigle D., 2007, SCI STKE, V392, pp, DOI [10.1126/stke.3922007pe35, DOI 10.1126/STKE.3922007PE35]; Mikics E, 2007, PSYCHONEUROENDOCRINO, V32, P160, DOI 10.1016/j.psyneuen.2006.12.002; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; PARK DG, 1993, J BIOL CHEM, V268, P4573; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Prager EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014344; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Radulovic J, 1999, J NEUROSCI, V19, P5016; Riedemann T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-2; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Sanchez-Arevalo L. V. J., 2013, ONCOGENE; Sato S, 2004, BIOCHEM BIOPH RES CO, V321, P510, DOI 10.1016/j.bbrc.2004.06.168; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schmidt P, 2001, MOL ENDOCRINOL, V15, P553, DOI 10.1210/me.15.4.553; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Venero C, 1999, EUR J NEUROSCI, V11, P2465, DOI 10.1046/j.1460-9568.1999.00668.x; Xu J, 2012, J BIOL CHEM, V287, P20942, DOI 10.1074/jbc.M112.368654; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422; Zrihan-Licht S, 2004, INT J ONCOL, V24, P153	64	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23725	23739		10.1074/jbc.M113.470146	http://dx.doi.org/10.1074/jbc.M113.470146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818519	Green Published, hybrid			2022-12-28	WOS:000330611400013
J	Al-Huseini, LMA; Yeang, HXA; Sethu, S; Alhumeed, N; Hamdam, JM; Tingle, Y; Djouhri, L; Kitteringham, N; Park, BK; Goldring, CE; Sathish, JG				Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.			Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; HEME OXYGENASE-1; TNF-ALPHA; T-CELLS; MATURATION; CREB; EXPRESSION; IL-10; LIPOPOLYSACCHARIDE	Nrf2 is a redox-responsive transcription factor that has been implicated in the regulation of DC immune function. Loss of Nrf2 results in increased co-stimulatory molecule expression, enhanced T cell stimulatory capacity, and increased reactive oxygen species (ROS) levels in murine immature DCs (iDCs). It is unknown whether altered immune function of Nrf2-deficient DCs (Nrf2(-/-) iDCs) is due to elevated ROS levels. Furthermore, it is unclear which intracellular signaling pathways are involved in Nrf2-mediated regulation of DC function. Using antioxidant vitamins to reset ROS levels in Nrf2(-/-) iDCs, we show that elevated ROS is not responsible for the altered phenotype and function of these DCs. Pharmacological inhibitors were used to explore the role of key MAPKs in mediating the altered phenotype and function in Nrf2(-/-) iDCs. We demonstrate that the increased co-stimulatory molecule expression (MHC II and CD86) and antigen-specific T cell activation capacity observed in Nrf2(-/-) iDCs was reversed by inhibition of p38 MAPK but not JNK. Importantly, we provide evidence for increased phosphorylation of cAMP-responsive element binding protein (CREB) and activating transcription factor 1 (ATF1), transcription factors that are downstream of p38 MAPK. The increased phosphorylation of CREB/ATF1 in Nrf2(-/-) iDCs was sensitive to p38 MAPK inhibition. We also show data to implicate heme oxygenase-1 as a potential molecular link between Nrf2 and CREB/ATF1. These results indicate that dysregulation of p38 MAPK-CREB/ATF1 signaling axis underlies the altered function and phenotype in Nrf2-deficient DCs. Our findings provide new insights into the mechanisms by which Nrf2 mediates regulation of DC function.	[Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, MRC, Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.] Al Qadisiyah Univ, Coll Med, Dept Pharmacol & Therapeut, Diwaniyah, Iraq	University of Liverpool; University of Liverpool; University of Al-Qadisiyah	Sathish, JG (corresponding author), Univ Liverpool, MRC, Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	Jean.Sathish@liv.ac.uk	Alhumeed, Naif/AAR-7956-2021; Sethu, Swaminathan/R-8577-2019; Al-Huseini, Laith M Abbas/S-6613-2019	Alhumeed, Naif/0000-0001-5221-3073; Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	Iraqi Ministry of Higher Education and Scientific Research; Saudi Ministry of Higher Education; Biotechnology and Biological Sciences Research Council; King Abdullah Scholarships Program; Medical Research Council [G0700654B] Funding Source: researchfish	Iraqi Ministry of Higher Education and Scientific Research; Saudi Ministry of Higher Education; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King Abdullah Scholarships Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in whole or in part by studentships from the Iraqi Ministry of Higher Education and Scientific Research (to L. M. A. A), the Saudi Ministry of Higher Education and King Abdullah Scholarships Program (to N. A), and the Biotechnology and Biological Sciences Research Council (to J. H.).	Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Bergamo P, 2008, IMMUNOL LETT, V117, P181, DOI 10.1016/j.imlet.2008.02.001; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Cheng C, 2010, CIRC RES, V106, P1656, DOI 10.1161/CIRCRESAHA.110.216945; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong YJ, 2011, CELL IMMUNOL, V266, P192, DOI 10.1016/j.cellimm.2010.10.005; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim SS, 2013, J CELL BIOCHEM, V114, P1115, DOI 10.1002/jcb.24452; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Roche M, 2009, CELL BIOL TOXICOL, V25, P635, DOI 10.1007/s10565-008-9118-2; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sato K, 1999, J IMMUNOL, V162, P3865; Schumacher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042301; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vaishnav D, 2003, BIOCHEM BIOPH RES CO, V307, P855, DOI 10.1016/S0006-291X(03)01287-7; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545; Wu BJ, 2006, J EXP MED, V203, P1117, DOI 10.1084/jem.20052321; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Yet SF, 2002, METHOD ENZYMOL, V353, P163; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375	54	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22281	22288		10.1074/jbc.M113.483420	http://dx.doi.org/10.1074/jbc.M113.483420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775080	Green Published, hybrid			2022-12-28	WOS:000330596300010
J	Henle, SJ; Carlstrom, LP; Cheever, TR; Henley, JR				Henle, Steven J.; Carlstrom, Lucas P.; Cheever, Thomas R.; Henley, John R.			Differential Role of PTEN Phosphatase in Chemotactic Growth Cone Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH; ADHESIONS; CALCIUM; KINASE; INHIBITOR; PTEN/MTOR; INTEGRIN; 3-KINASE; ACT	Negatively targeting the tumor suppressor and phosphoinositide phosphatase PTEN (phosphatase and tensin homologue) promotes axon regrowth after injury. How PTEN functions in axon guidance has remained unknown. Here we report the differential role of PTEN in chemotactic guidance of axonal growth cones. Down-regulating PTEN expression in Xenopus laevis spinal neurons selectively abolished growth cone chemorepulsion but permitted chemoattraction. These findings persisted during cAMP-dependent switching of turning behaviors. Live cell imaging using a GFP biosensor revealed rapid PTEN-dependent depression of phosphatidylinositol 3,4,5-trisphosphate levels in the growth cone induced by the repellent myelin-associated glycoprotein. Moreover, down-regulating PTEN expression blocked negative remodeling of beta 1-integrin adhesions triggered by myelin-associated glycoprotein, yet permitted integrin clustering by a positive chemotropic treatment. Thus, PTEN negatively regulates growth cone phosphatidylinositol 3,4,5-trisphosphate levels and mediates chemorepulsion, whereas chemoattraction is PTEN-independent. Regenerative therapies targeting PTEN may therefore suppress growth cone repulsion to soluble cues while permitting attractive guidance, an essential feature for re-forming functional neural circuits.	[Henle, Steven J.; Cheever, Thomas R.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Carlstrom, Lucas P.] Mayo Clin, Med Scientist Training Program, Rochester, MN 55905 USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Henley, JR (corresponding author), Mayo Clin, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	Henley.john@mayo.edu		Henle, Steven/0000-0002-8007-1030; Henley, John/0000-0003-1846-5941	National Institutes of Health Grants [NS067311, NS080322]; John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080322, R01NS067311] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS067311 (to J. R. H.) and NS080322 (to T. R. C.). This work was also supported by a John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic) (to J. R. H.).	Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Carlstrom LP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-82; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Keizer-Gunnink I, 2007, J CELL BIOL, V177, P579, DOI 10.1083/jcb.200611046; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perdigoto AL, 2011, MOL CELL NEUROSCI, V46, P235, DOI 10.1016/j.mcn.2010.09.006; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	32	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20837	20842		10.1074/jbc.C113.487066	http://dx.doi.org/10.1074/jbc.C113.487066			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23775074	Green Published, hybrid			2022-12-28	WOS:000322014400008
J	Auer, M; Gruber, C; Bellei, M; Pirker, KF; Zamocky, M; Kroiss, D; Teufer, SA; Hofbauer, S; Soudi, M; Battistuzzi, G; Furtmuller, PG; Obinger, C				Auer, Markus; Gruber, Clemens; Bellei, Marzia; Pirker, Katharina F.; Zamocky, Marcel; Kroiss, Daniela; Teufer, Stefan A.; Hofbauer, Stefan; Soudi, Monika; Battistuzzi, Gianantonio; Furtmueller, Paul G.; Obinger, Christian			A Stable Bacterial Peroxidase with Novel Halogenating Activity and an Autocatalytically Linked Heme Prosthetic Group	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LACTOPEROXIDASE; HUMAN MYELOPEROXIDASE; REDOX THERMODYNAMICS; CRYSTAL-STRUCTURE; EVOLUTION; OXIDATION; COUPLE; HALIDE; MECHANISMS; KINETICS	Reconstructing the phylogenetic relationships of the main evolutionary lines of the mammalian peroxidases lactoperoxidase and myeloperoxidase revealed the presence of novel bacterial heme peroxidase subfamilies. Here, for the first time, an ancestral bacterial heme peroxidase is shown to possess a very high bromide oxidation activity (besides conventional peroxidase activity). The recombinant protein allowed monitoring of the autocatalytic peroxide-driven formation of covalent heme to protein bonds. Thereby, the high spin ferric rhombic heme spectrum became similar to lactoperoxidase, the standard reduction potential of the Fe(III)/Fe(II) couple shifted to more positive values (-145 +/- 10 mV at pH 7), and the conformational and thermal stability of the protein increased significantly. We discuss structure-function relationships of this new peroxidase in relation to its mammalian counterparts and ask for its putative physiological role.	[Auer, Markus; Gruber, Clemens; Pirker, Katharina F.; Zamocky, Marcel; Kroiss, Daniela; Teufer, Stefan A.; Hofbauer, Stefan; Soudi, Monika; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41100 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, I-41100 Modena, Italy; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia	University of Natural Resources & Life Sciences, Vienna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Slovak Academy of Sciences	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Furtmüller, Paul G./Y-5819-2018; Zamocky, Marcel/AAC-2882-2019; Hofbauer, Stefan/I-3889-2014; Battistuzzi, Gianantonio/L-7183-2015	Furtmüller, Paul G./0000-0002-1199-2469; Zamocky, Marcel/0000-0002-2443-2823; Hofbauer, Stefan/0000-0003-3375-7715; Battistuzzi, Gianantonio/0000-0003-4716-5745; Grunwald-Gruber, Clemens/0000-0002-6097-8348; Obinger, Christian/0000-0002-7133-3430	Austrian Science Funds FWF [P20664, P25538]; Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project [W1224]	Austrian Science Funds FWF(Austrian Science Fund (FWF)); Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project	This work was supported by Austrian Science Funds FWF Projects P20664 and P25538 and Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project W1224.	Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2002, J AM CHEM SOC, V124, P26, DOI 10.1021/ja017188m; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P2646, DOI 10.1128/AEM.01656-07; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Santamaria-Hernando S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040698; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Soderhall K, 1999, DEV COMP IMMUNOL, V23, P263; Soudi M, 2012, CHEM BIODIVERS, V9, P1776, DOI 10.1002/cbdv.201100438; Stampler J, 2011, ARCH BIOCHEM BIOPHYS, V516, P21, DOI 10.1016/j.abb.2011.09.007; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g	41	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27181	27199		10.1074/jbc.M113.477067	http://dx.doi.org/10.1074/jbc.M113.477067			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23918925	Green Published, hybrid			2022-12-28	WOS:000330597300017
J	Apostolidis, SA; Rauen, T; Hedrich, CM; Tsokos, GC; Crispin, JC				Apostolidis, Sokratis A.; Rauen, Thomas; Hedrich, Christian M.; Tsokos, George C.; Crispin, Jose C.			Protein Phosphatase 2A Enables Expression of Interleukin 17 (IL-17) through Chromatin Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARYL-HYDROCARBON RECEPTOR; T-CELL APOPTOSIS; ROR-GAMMA-T; REGULATORY NETWORK; T(H)17 DEVELOPMENT; GENE LOCUS; PP2A; DIFFERENTIATION; TRANSCRIPTION	Protein phosphatase 2A (PP2A) is a heterotrimeric serine/threonine phosphatase involved in essential cellular functions. T cells from patients with systemic lupus erythematosus (SLE) express high levels of the catalytic subunit of PP2A (PP2Ac). A mouse overexpressing PP2Ac in T cells develops glomerulonephritis in an IL-17-dependent manner. Here, using microarray analyses, we demonstrate that increased expression of PP2Ac grants T cells the capacity to produce an array of proinflammatory effector molecules. Because IL-17 is important in the expression of glomerulonephritis, we studied the mechanism through which PP2Ac dysregulation facilitates its production. We report that PP2Ac is involved in the regulation of the Il17 locus by enhancing histone 3 acetylation through a mechanism that involves activation of interferon regulatory factor 4. Increased histone 3 acetylation of the Il17 locus is shared between T cells of PP2Ac transgenic mice and patients with SLE. We propose that, by promoting the inflammatory capacity of T cells, PP2Ac dysregulation contributes to the pathogenesis of SLE.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave,CLS 928, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu; jcrispin@bidmc.harvard.edu	Crispín, José/I-4919-2019; Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Rauen, Thomas/GLR-8682-2022; tsokos, george C/O-3360-2013	Crispín, José/0000-0002-7590-3621; tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [RO1 AI068787]; Alliance for Lupus Research grant; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research grant; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI068787 (to G. C. T.). This work was also supported by an Alliance for Lupus Research grant (to J. C. C.).; Recipient of an Arthritis Foundation postdoctoral fellowship award.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crispin JC, 2012, J IMMUNOL, V188, P3567, DOI 10.4049/jimmunol.1200143; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isgro J, 2013, ARTHRITIS RHEUM-US, V65, P1592, DOI 10.1002/art.37934; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lech M, 2011, J AM SOC NEPHROL, V22, P1443, DOI 10.1681/ASN.2010121260; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; R Development Core Team, 2009, R LANG ENV STAT COMP; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Stirzaker RA, 2012, LUPUS, V21, P656, DOI 10.1177/0961203312436862; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wang Y, 2010, CLIN EXP IMMUNOL, V159, P1, DOI 10.1111/j.1365-2249.2009.04031.x; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	66	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26775	26784		10.1074/jbc.M113.483743	http://dx.doi.org/10.1074/jbc.M113.483743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918926	Green Published, hybrid			2022-12-28	WOS:000330594500042
J	Ding, SL; Wang, JX; Jiao, JQ; Tu, X; Wang, Q; Liu, F; Li, Q; Gao, J; Zhou, QY; Gu, DF; Li, PF				Ding, Su-Ling; Wang, Jian-Xun; Jiao, Jian-Qin; Tu, Xin; Wang, Qing; Liu, Fang; Li, Qian; Gao, Jie; Zhou, Qun-Yong; Gu, Dong-Feng; Li, Pei-Feng			A Pre-microRNA-149 (miR-149) Genetic Variation Affects miR-149 Maturation and Its Ability to Regulate the Puma Protein in Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; MICRORNAS; EXPRESSION; DISEASE; HEART; RISK; SNP; POLYMORPHISM; ALTERS; DEATH	MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that function as negative regulators of gene expression. They are transcribed from endogenous DNA and form hairpin structures (termed as pre-miRNAs) that are processed to form mature miRNAs. It remains largely unknown as to the molecular consequences of the natural genetic variation in pre-miRNAs. Here, we report that an A -> G polymorphism (rs71428439) is located in Homo sapiens miR-149 stem-loop region. This polymorphism results in a change in the structure of the miR-149 precursor. Our results showed that the genotype distribution of this polymorphism in myocardial infarction cases was significantly different from that in the control subjects. We examined the biological significance of this polymorphism on the production of mature miR-149, and we observed that the G-allelic miR-149 precursor displayed a lower production of mature miR-149 compared with the A-allelic one. Further investigations disclosed that miR-149 could withstand mitochondrial fission and apoptosis through targeting the pro-apoptotic factor p53-up-regulated modulator of apoptosis (Puma). Enforced expression of miR-149 promoted cell survival, whereas knockdown of miR-149 rendered cells to be sensitive to apoptotic stimulation. Intriguingly, the A to G variation led pre-miR-149 to elicit an attenuated effect on the inhibition of mitochondrial fission and apoptosis. Finally, this polymorphism exerts its influence on cardiac function in the mouse model of myocardial infarction. These data suggest that this polymorphism in the miR-149 pre-cursor may result in important phenotypic traits of myocardial infarction. Our findings warrant further investigations on the relationship between miR-149 polymorphism and myocardial infarction.	[Ding, Su-Ling; Wang, Jian-Xun; Jiao, Jian-Qin; Liu, Fang; Li, Qian; Gao, Jie; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Tu, Xin; Wang, Qing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Gu, Dong-Feng] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China; [Gu, Dong-Feng] Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Huazhong University of Science & Technology; University of California System; University of California Irvine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gu, DF (corresponding author), Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China.	gudongfeng@vip.sina.com	Liu, Fang/F-3539-2019; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021; Ding, Suling/GZL-5430-2022	Liu, Fang/0000-0002-8325-1213; Li, Peifeng/0000-0002-0969-9407; Wang, Jianxun/0000-0002-3731-6514	National Natural Science Foundation of China [31010103911, 81230005]; National Basic Research Program of China, 973 Program [2011CB965300]; Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund [81128002, H0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China, 973 Program(National Basic Research Program of China); Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund	This work was supported by National Natural Science Foundation of China Grants 31010103911 and 81230005, National Basic Research Program of China, 973 Program Grant 2011CB965300, and Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund 81128002, H0203.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Dorn GW, 2012, CIRC RES, V110, P958, DOI 10.1161/CIRCRESAHA.111.260752; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Li Q, 2012, PROTEIN CELL, V3, P410, DOI 10.1007/s13238-012-2921-9; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Musunuru K, 2010, ANNU REV GENOM HUM G, V11, P91, DOI 10.1146/annurev-genom-082509-141637; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Qi L, 2012, NEUROSCI LETT, V515, P1, DOI 10.1016/j.neulet.2012.02.061; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Tu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051606; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang MW, 2012, MOL CARCINOGEN, V51, pE21, DOI 10.1002/mc.20863	39	46	46	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26865	26877		10.1074/jbc.M112.440453	http://dx.doi.org/10.1074/jbc.M112.440453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23873935	hybrid, Green Published			2022-12-28	WOS:000330594500052
J	Liu, HD; Liu, KD; Huang, ZN; Park, CM; Thimmegowda, NR; Jang, JH; Ryoo, IJ; He, L; Kim, SO; Oi, NM; Lee, KW; Soung, NK; Bode, AM; Yang, YF; Zhou, XM; Erikson, RL; Ahn, JS; Hwang, J; Kim, KE; Dong, ZG; Kim, BY				Liu, Haidan; Liu, Kangdong; Huang, Zunnan; Park, Chan-Mi; Thimmegowda, N. R.; Jang, Jae-Hyuk; Ryoo, In-Ja; He, Long; Kim, Sun-Ok; Oi, Naomi; Lee, Ki Won; Soung, Nak-Kyun; Bode, Ann M.; Yang, Yifeng; Zhou, Xinmin; Erikson, Raymond L.; Ahn, Jong-Seog; Hwang, Joonsung; Kim, Kyoon Eon; Dong, Zigang; Kim, Bo-Yeon			A Chrysin Derivative Suppresses Skin Cancer Growth by Inhibiting Cyclin-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-TRANSFORMATION; MOLECULAR TARGETS; PROTEIN-KINASES; CDK INHIBITORS; PHOSPHORYLATION; PROLIFERATION; TRANSCRIPTION; FIBROBLASTS; MECHANISMS; EXPRESSION	Chrysin (5,7-dihydroxyflavone), a natural flavonoid widely distributed in plants, reportedly has chemopreventive properties against various cancers. However, the anticancer activity of chrysin observed in in vivo studies has been disappointing. Here, we report that a chrysin derivative, referred to as compound 69407, more strongly inhibited EGF-induced neoplastic transformation of JB6 P+ cells compared with chrysin. It attenuated cell cycle progression of EGF-stimulated cells at the G1 phase and inhibited the G1/S transition. It caused loss of retinoblastoma phosphorylation at both Ser-795 and Ser-807/811, the preferred sites phosphorylated by Cdk4/6 and Cdk2, respectively. It also suppressed anchorage-dependent and -independent growth of A431 human epidermoid carcinoma cells. Compound 69407 reduced tumor growth in the A431 mouse xenograft model and retinoblastoma phosphorylation at Ser795 and Ser-807/811. Immunoprecipitation kinase assay results showed that compound 69407 attenuated endogenous Cdk4 and Cdk2 kinase activities in EGF-stimulated JB6 P+ cells. Pulldown and in vitro kinase assay results indicated that compound 69407 directly binds with Cdk2 and Cdk4 in an ATP-independent manner and inhibited their kinase activities. A binding model between compound 69407 and a crystal structure of Cdk2 predicted that compound 69407 was located inside the Cdk2 allosteric binding site. The binding was further verified by a point mutation binding assay. Overall results indicated that compound 69407 is an ATP-noncompetitive cyclin-dependent kinase inhibitor with anti-tumor effects, which acts by binding inside the Cdk2 allosteric pocket. This study provides new insights for creating a general pharmacophore model to design and develop novel ATP-noncompetitive agents with chemopreventive or chemotherapeutic potency.	[Liu, Haidan; Liu, Kangdong; Park, Chan-Mi; Thimmegowda, N. R.; He, Long; Kim, Sun-Ok; Soung, Nak-Kyun; Hwang, Joonsung; Kim, Bo-Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Ochang 363883, Cheongwon, South Korea; [Liu, Haidan; Liu, Kangdong; Huang, Zunnan; Oi, Naomi; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Jang, Jae-Hyuk; Ryoo, In-Ja; Ahn, Jong-Seog] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Cheongwon 363883, Chungcheongbuk, South Korea; [Liu, Haidan; Yang, Yifeng; Zhou, Xinmin] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha 410011, Hunan, Peoples R China; [Liu, Haidan] Cent S Univ, Xiangya Hosp 2, Clin Ctr Gene Diag & Therapy, Changsha 410011, Hunan, Peoples R China; [Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Erikson, Raymond L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Liu, Kangdong] Zhengzhou Univ, Basic Med Coll, Zhengzhou 450001, Peoples R China; [Kim, Kyoon Eon] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon 305764, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Minnesota System; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Central South University; Central South University; Seoul National University (SNU); Harvard University; Zhengzhou University; Chungnam National University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu; bykim@kribb.re.kr	Lee, Ki Won/M-4114-2018; Huang, Zunnan/M-5214-2019	Huang, Zunnan/0000-0002-5821-703X; Kim, Kyoon/0000-0001-5133-1692; He, Long/0000-0003-4721-9221	National Institutes of Health [CA120388, CA1666011, R37 CA081064, CA172457, ES016548]; Hormel Foundation; National Research Foundation of Korea [2010-0029233]; Korea Government (MSIFP) [2010-0029233]; World Class Institute Program [WCI 2009-002]; Ministry of Science, ICT and Future Planning, Korea; NATIONAL CANCER INSTITUTE [R21CA172457, R01CA016660, R01CA166011, R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Korea Government (MSIFP)(Korean Government); World Class Institute Program; Ministry of Science, ICT and Future Planning, Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA120388, CA1666011, R37 CA081064, CA172457, and ES016548. This work was also supported by The Hormel Foundation, National Research Foundation of Korea Grant 2010-0029233 funded by the Korea Government (MSIFP), Leap Research Program Grant 2010-0029233), and World Class Institute Program (WCI 2009-002) funded by the Ministry of Science, ICT and Future Planning, Korea.	Ali S, 2009, CANCER RES, V69, P6208, DOI 10.1158/0008-5472.CAN-09-0301; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Bode AM, 2001, CANCER RES, V61, P850; Bode AM, 2006, MOL CARCINOGEN, V45, P422, DOI 10.1002/mc.20222; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FAN Z, 1993, CANCER RES, V53, P4637; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Galijatovic A, 2000, PHARMACEUT RES, V17, P21, DOI 10.1023/A:1007506222436; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Haas K, 1997, ONCOGENE, V15, P179, DOI 10.1038/sj.onc.1201171; He ZW, 2008, MOL CARCINOGEN, V47, P172, DOI 10.1002/mc.20299; Huet X, 1996, MOL CELL BIOL, V16, P3789; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kang NJ, 2008, J BIOL CHEM, V283, P20664, DOI 10.1074/jbc.M800263200; Kim DJ, 2011, CANCER PREV RES, V4, P1842, DOI 10.1158/1940-6207.CAPR-11-0158; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Lamba V, 2012, CURR PHARM DESIGN, V18, P2936, DOI 10.2174/138161212800672813; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Lee KW, 2008, INT J CANCER, V123, P2487, DOI 10.1002/ijc.23830; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Li HQ, 2009, BIOORGAN MED CHEM, V17, P6264, DOI 10.1016/j.bmc.2009.07.046; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; Lv PC, 2010, BIOORGAN MED CHEM, V18, P1117, DOI 10.1016/j.bmc.2009.12.048; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mizuno H, 2006, MOL CARCINOGEN, V45, P1, DOI 10.1002/mc.20160; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Otake Y, 2002, DRUG METAB DISPOS, V30, P576, DOI 10.1124/dmd.30.5.576; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sotillo E, 2008, J BIOL CHEM, V283, P11280, DOI 10.1074/jbc.M709055200; Su Tin Tin, 2004, Sci STKE, V2004, ppe11; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137; Zheng X, 2003, BIOORG MED CHEM LETT, V13, P881, DOI 10.1016/S0960-894X(02)01081-8; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	56	30	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25924	25937		10.1074/jbc.M113.464669	http://dx.doi.org/10.1074/jbc.M113.464669			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23888052	Green Published, hybrid			2022-12-28	WOS:000330623300023
J	Neumann, S; Schmid, SL				Neumann, Sylvia; Schmid, Sandra L.			Dual Role of BAR Domain-containing Proteins in Regulating Vesicle Release Catalyzed by the GTPase, Dynamin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DEPENDENT CONFORMATIONAL-CHANGES; EXCESS MEMBRANE RESERVOIR; SH3 DOMAIN; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; AMPHIPATHIC HELICES; SUPPORTED BILAYERS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS	Dynamin-2 (Dyn2) is ubiquitously expressed and catalyzes membrane fission during clathrin-mediated endocytosis in nonneuronal cells. We have previously shown that Dyn2 inefficiently generates membrane curvature and only mediates fission of highly curved membranes. This led to the hypothesis that other endocytic accessory proteins (EAPs) generate curvature needed to sculpt a sufficiently narrow neck to trigger Dyn2 assembly and fission. Candidates for this activity are EAPs that bind to the dynamin proline/arginine-rich domain (PRD) through their SH3 (src homology-3) domains and also encode curvature-generating BAR (Bin/Amphiphysin/Rvs) domains. We show that at low concentrations, amphiphysin and endophilin, but not SNX9 or the curvature-generating epsin N-terminal homology (ENTH) domain, are able to generate tubules from planar membrane templates and to synergize with Dyn2 Delta PRD to catalyze vesicle release. Unexpectedly, SH3-PRD interactions were inhibitory and reciprocally regulate scaffold assembly. Of the three proteins studied, only full-length amphiphysin functions synergistically with full-length Dyn2 to catalyze vesicle release. The differential activity of these proteins correlates with the relative potency of their positive, curvature-generating activity, and the negative regulatory effects mediated by SH3 domain interactions. Our findings reveal opportunities for the spatio-temporal coordination of membrane curvature generation, dynamin assembly, and fission during clathrin-mediated endocytosis.	[Neumann, Sylvia; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.schmid@utsouthwestern.edu		Schmid, Sandra/0000-0002-1690-7024	National Institutes of Health [R01GM42455, MH61345]; AHA Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061345, R37MH061345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM42455 and MH61345 (to S. L. S.) and an AHA Fellowship (to S. N.).	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Dores MR, 2010, TRAFFIC, V11, P151, DOI 10.1111/j.1600-0854.2009.01003.x; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Goh SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051628; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Lai CL, 2012, J MOL BIOL, V423, P800, DOI 10.1016/j.jmb.2012.08.010; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055691; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Neumann S, 2013, NAT PROTOC, V8, P213, DOI 10.1038/nprot.2012.152; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Rao YJ, 2012, EUR J CELL BIOL, V91, P226, DOI 10.1016/j.ejcb.2011.02.004; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Vazquez FX, 2013, BIOPHYS J, V104, P396, DOI 10.1016/j.bpj.2012.12.009; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	63	46	48	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25119	25128		10.1074/jbc.M113.490474	http://dx.doi.org/10.1074/jbc.M113.490474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861397	Green Published, hybrid			2022-12-28	WOS:000330619000012
J	Ochi, A; Makabe, K; Yamagami, R; Hirata, A; Sakaguchi, R; Hou, YM; Watanabe, K; Nureki, O; Kuwajima, K; Hori, H				Ochi, Anna; Makabe, Koki; Yamagami, Ryota; Hirata, Akira; Sakaguchi, Reiko; Hou, Ya-Ming; Watanabe, Kazunori; Nureki, Osamu; Kuwajima, Kunihiro; Hori, Hiroyuki			The Catalytic Domain of Topological Knot tRNA Methyltransferase (TrmH) Discriminates between Substrate tRNA and Nonsubstrate tRNA via an Induced-fit Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							23S RIBOSOMAL-RNA; BOWEN-CONRADI SYNDROME; ESCHERICHIA-COLI K-12; ACID-SEQUENCE MOTIFS; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; THERMUS-THERMOPHILUS; POSTTRANSCRIPTIONAL MODIFICATION; GM18 METHYLTRANSFERASE; RECOGNITION MECHANISM	A conserved guanosine at position 18 (G18) in the D-loop of tRNAs is often modified to 2'-O-methylguanosine (Gm). Formation of Gm18 in eubacterial tRNA is catalyzed by tRNA (Gm18) methyltransferase (TrmH). TrmH enzymes can be divided into two types based on their substrate tRNA specificity. Type I TrmH, including Thermus thermophilus TrmH, can modify all tRNA species, whereas type II TrmH, for example Escherichia coli TrmH, modifies only a subset of tRNA species. Our previous crystal study showed that T. thermophilus TrmH is a class IV S-adenosyl-L-methionine-dependent methyltransferase, which maintains a topological knot structure in the catalytic domain. Because TrmH enzymes have short stretches at the N and C termini instead of a clear RNA binding domain, these stretches are believed to be involved in tRNA recognition. In this study, we demonstrate by site-directed mutagenesis that both N-and C-terminal regions function in tRNA binding. However, in vitro and in vivo chimera protein studies, in which four chimeric proteins of type I and II TrmHs were used, demonstrated that the catalytic domain discriminates substrate tRNAs from nonsubstrate tRNAs. Thus, the N- and C-terminal regions do not function in the substrate tRNA discrimination process. Pre-steady state analysis of complex formation between mutant TrmH proteins and tRNA by stopped-flow fluorescence measurement revealed that the C-terminal region works in the initial binding process, in which nonsubstrate tRNA is not excluded, and that structural movement of the motif 2 region of the catalytic domain in an induced-fit process is involved in substrate tRNA discrimination.	[Ochi, Anna; Yamagami, Ryota; Hirata, Akira; Watanabe, Kazunori; Hori, Hiroyuki] Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Sakaguchi, Reiko; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Nureki, Osamu] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Jefferson University; University of Tokyo; Ehime University	Hori, H (corresponding author), Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Watanabe, Kazunori/G-6671-2012; Hori, Hiroyuki/AAB-3911-2021; NUREKI, OSAMU/G-4960-2014	Watanabe, Kazunori/0000-0003-3678-636X; Hou, Ya-Ming/0000-0001-6546-2597; Yamagami, Ryota/0000-0002-6947-1906	Japan Society for the Promotion Science [21-10011, 23350081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081601, U01GM108972] Funding Source: NIH RePORTER	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Research Fellowship for Young Scientists 21-10011 (to A. O.) and a Grant-in-aid for Science Research 23350081 (to H. H.) from the Japan Society for the Promotion Science.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; Benitez-Paez A, 2010, RNA, V16, P2131, DOI 10.1261/rna.2245910; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; Brule H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q; BYSTROM AS, 1982, MOL GEN GENET, V188, P440, DOI 10.1007/BF00330046; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Chatterjee K, 2012, RNA, V18, P421, DOI 10.1261/rna.030841.111; Chen HY, 2010, J MOL CELL BIOL, V2, P366, DOI 10.1093/jmcb/mjq034; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Christian T, 2010, J MOL BIOL, V400, P204, DOI 10.1016/j.jmb.2010.05.003; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Goto-Ito S, 2008, PROTEINS, V72, P1274, DOI 10.1002/prot.22019; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; HORI H, 1989, J BIOCHEM-TOKYO, V106, P798, DOI 10.1093/oxfordjournals.jbchem.a122933; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kempenaers M, 2010, NUCLEIC ACIDS RES, V38, P6533, DOI 10.1093/nar/gkq451; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; Kuratani M, 2008, J MOL BIOL, V375, P1064, DOI 10.1016/j.jmb.2007.11.023; Lahoud G, 2011, RNA, V17, P1236, DOI 10.1261/rna.2706011; Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Liu JY, 2003, PROTEINS, V53, P326, DOI 10.1002/prot.10479; Liu R. J., 2013, NUCL ACIDS IN PRESS; Lovgren JM, 2001, J BACTERIOL, V183, P6957, DOI 10.1128/JB.183.23.6957-6960.2001; MATSUMOTO T, 1990, J BIOCHEM-TOKYO, V107, P331, DOI 10.1093/oxfordjournals.jbchem.a123047; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Michel G, 2002, STRUCTURE, V10, P1303, DOI 10.1016/S0969-2126(02)00852-3; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; NY T, 1980, J BACTERIOL, V142, P371, DOI 10.1128/JB.142.2.371-379.1980; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Paris Z, 2013, RNA, V19, P649, DOI 10.1261/rna.036665.112; Persson B. C., 1997, NUCLEIC ACIDS RES, V25, P3969, DOI [10.1093/nar/25.20.4093, DOI 10.1093/NAR/25.20.4093]; Pleshe E, 2005, ACTA CRYSTALLOGR F, V61, P722, DOI 10.1107/S1744309105022980; Purta E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-23; Renalier MH, 2005, RNA, V11, P1051, DOI 10.1261/rna.2110805; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Sabina J, 2006, J BIOL CHEM, V281, P6993, DOI 10.1074/jbc.M512841200; Sakaguchi R, 2012, RNA, V18, P1687, DOI 10.1261/rna.032029.111; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SENO T, 1968, BIOCHIM BIOPHYS ACTA, V169, P80, DOI 10.1016/0005-2787(68)90010-5; Taniguchi H, 1998, NUCLEIC ACIDS RES, V26, P1481, DOI 10.1093/nar/26.6.1481; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Treede I, 2003, MOL MICROBIOL, V49, P309, DOI 10.1046/j.1365-2958.2003.03558.x; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Wurm JP, 2012, RNA, V18, P412, DOI 10.1261/rna.028498.111; Wurm JP, 2010, NUCLEIC ACIDS RES, V38, P2387, DOI 10.1093/nar/gkp1189	67	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25562	25574		10.1074/jbc.M113.485128	http://dx.doi.org/10.1074/jbc.M113.485128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867454	hybrid, Green Published			2022-12-28	WOS:000330619000051
J	Carroll, J; Ding, S; Fearnley, IM; Walker, JE				Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			Post-translational Modifications near the Quinone Binding Site of Mammalian Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; PROTEIN ARGININE METHYLTRANSFERASES; NUCLEAR-ENCODED SUBUNITS; AMINO-ACID-SEQUENCE; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; MOLECULAR MASSES; ATP SYNTHASE; IDENTIFICATION	Complex I (NADH: ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 44 protein subunits with one arm buried in the inner membrane of the mitochondrion and the orthogonal arm protruding about 100 angstrom into the matrix. The protruding arm contains the binding sites for NADH, the primary acceptor of electrons flavin mononucleotide (FMN), and a chain of seven iron-sulfur clusters that carries the electrons one at a time from FMN to a coenzyme Q molecule bound in the vicinity of the junction between the two arms. In the structure of the closely related bacterial enzyme from Thermus thermophilus, the quinone is thought to bind in a tunnel that spans the interface between the two arms, with the quinone head group close to the terminal iron-sulfur cluster, N2. The tail of the bound quinone is thought to extend from the tunnel into the lipid bilayer. In the mammalian enzyme, it is likely that this tunnel involves three of the subunits of the complex, ND1, PSST, and the 49-kDa subunit. An arginine residue in the 49-kDa subunit is symmetrically dimethylated on the omega-NG and omega-N-G' nitrogen atoms of the guanidino group and is likely to be close to cluster N2 and to influence its properties. Another arginine residue in the PSST subunit is hydroxylated and probably lies near to the quinone. Both modifications are conserved in mammalian enzymes, and the former is additionally conserved in Pichia pastoris and Paracoccus denitrificans, suggesting that they are functionally significant.	[Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council; MRC [MC_U105663148] Funding Source: UKRI; Medical Research Council [MC_U105663148] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; ARIZMENDI JM, 1992, FEBS LETT, V313, P80, DOI 10.1016/0014-5793(92)81189-S; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Brame CJ, 2004, RAPID COMMUN MASS SP, V18, P877, DOI 10.1002/rcm.1421; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Carroll J, 2007, P NATL ACAD SCI USA, V104, P14330, DOI 10.1073/pnas.0706817104; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; FEARNLEY IM, 1994, BIOCHEM SOC T, V22, P551, DOI 10.1042/bst0220551; FEARNLEY IM, 1989, EMBO J, V8, P665, DOI 10.1002/j.1460-2075.1989.tb03424.x; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmisano G, 2007, PROTEOMICS, V7, P1575, DOI 10.1002/pmic.200600801; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Schilling B, 2005, FEBS LETT, V579, P2485, DOI 10.1016/j.febslet.2005.03.061; Skehel JM, 1998, FEBS LETT, V438, P301, DOI 10.1016/S0014-5793(98)01317-9; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Walker JE, 2009, METHOD ENZYMOL, V456, P111, DOI 10.1016/S0076-6879(08)04406-6; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993	55	28	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24799	24808		10.1074/jbc.M113.488106	http://dx.doi.org/10.1074/jbc.M113.488106			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836892	hybrid, Green Published			2022-12-28	WOS:000330612300045
J	Dotson, RJ; Rabadi, SM; Westcott, EL; Bradley, S; Catlett, SV; Banik, S; Harton, JA; Bakshi, CS; Malik, M				Dotson, Rachel J.; Rabadi, Seham M.; Westcott, Elizabeth L.; Bradley, Stephen; Catlett, Sally V.; Banik, Sukalyani; Harton, Jonathan A.; Bakshi, Chandra Shekhar; Malik, Meenakshi			Repression of Inflammasome by Francisella tularensis during Early Stages of Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE RECOGNITION; AIM2 INFLAMMASOME; INNATE IMMUNITY; CUTTING EDGE; INTERNALIN B; MELANOMA 2; ACTIVATION; PROTEIN; CASPASE-1; SURVIVAL	Francisella tularensis is an important human pathogen responsible for causing tularemia. F. tularensis has long been developed as a biological weapon and is now classified as a category A agent by the Centers for Disease Control because of its possible use as a bioterror agent. F. tularensis represses inflammasome; a cytosolic multi-protein complex that activates caspase-1 to produce proinflammatory cytokines IL-1 beta and IL-18. However, the Francisella factors and the mechanisms through which F. tularensis mediates these suppressive effects remain relatively unknown. Utilizing a mutant of F. tularensis in FTL_0325 gene, this study investigated the mechanisms of inflammasome repression by F. tularensis. We demonstrate that muted IL-1 beta and IL-18 responses generated in macrophages infected with F. tularensis live vaccine strain (LVS) or the virulent SchuS4 strain are due to a predominant suppressive effect on TLR2-dependent signal 1. Our results also demonstrate that FTL_0325 of F. tularensis impacts proIL-1 beta expression as early as 2 h post-infection and delays activation of AIM2 and NLRP3-inflammasomes in a TLR2-dependent fashion. An enhanced activation of caspase-1 and IL-1 beta observed in FTL_0325 mutant-infected macrophages at 24 h post-infection was independent of both AIM2 and NLRP3. Furthermore, F. tularensis LVS delayed pyroptotic cell death of the infected macrophages in an FTL_0325-dependent manner during the early stages of infection. In vivo studies in mice revealed that suppression of IL-1 beta by FTL_0325 early during infection facilitates the establishment of a fulminate infection by F. tularensis. Collectively, this study provides evidence that F. tularensis LVS represses inflammasome activation and that F. tularensis-encoded FTL_0325 mediates this effect.	[Dotson, Rachel J.; Westcott, Elizabeth L.; Bradley, Stephen; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA; [Rabadi, Seham M.; Banik, Sukalyani; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany College of Pharmacy & Health Sciences; New York Medical College; Albany Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, 106 New Scotland Ave, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu	Malik, Meenakshi/F-1501-2015; Harton, Jonathan A/AAW-5283-2021; Harton, Jonathan/F-2848-2010	Malik, Meenakshi/0000-0003-0051-4485; Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877	National Institutes of Health [R21AI075250-01A2, 2P01AI056320, R56AI090072-02]; Albany College of Pharmacy and Health Sciences; New York Medical College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075250, P01AI056320, R56AI101109, R56AI090072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany College of Pharmacy and Health Sciences; New York Medical College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075250-01A2 (to M. M.), 2P01AI056320, and R56AI090072-02 (to C. S. B.). This work was also supported by startup funds from the Albany College of Pharmacy and Health Sciences (to M. M.) and New York Medical College (to C. S. B.).	[Anonymous], 2001, J ENVIRON HEALTH, V64, P47; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Bossi P, 2003, PRESSE MED, V32, P1126; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Chiba S, 2011, MICROBIOL IMMUNOL, V55, P123, DOI 10.1111/j.1348-0421.2010.00292.x; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020609; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Ulland TK, 2013, INFECT IMMUN, V81, P201, DOI 10.1128/IAI.00991-12; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026	50	42	42	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23844	23857		10.1074/jbc.M113.490086	http://dx.doi.org/10.1074/jbc.M113.490086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821549	Green Published, hybrid			2022-12-28	WOS:000330611400024
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Cap Snatching in Yeast L-BC Double-stranded RNA Totivirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; L-A VIRUS; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; COAT PROTEIN; REPLICATION; POLYMERASE; GUANYLYLTRANSFERASE; TRANSCRIPTION; MECHANISM	Yeast L-A double-stranded RNA virus furnishes its transcript with a 5' cap structure by a novel cap-snatching mechanism in which m(7)Gp from a host mRNA cap structure is transferred to the 5'-diphosphate terminus of the viral transcript. His-154 of the coat protein Gag forms an m(7)Gp adduct, and the H154R mutation abolishes both m(7)Gp adduct formation and cap snatching. Here we show that L-BC, another totivirus closely related to L-A, also synthesizes 5'-diphosphorylated transcripts and transfers m(7)Gp from mRNA to the 5' termini of the transcripts. L-BC Gag also covalently binds to the cap structure and the mutation H156R, which corresponds to H154R of L-A Gag, abolishes cap adduct formation. Cap snatching of the L-BC virus is very similar to that of L-A; N7 methylation of the mRNA cap is essential for cap donor activity, and only 5'-diphosphorylated RNA is used as cap acceptor. L-BC cap snatching is also activated by viral transcription. Furthermore, both viruses require Mg2+ and Mn2+ for cap snatching. These cations are not only required for transcription activation but also directly involved in the cap transfer process. These findings support our previous proposal that the cap-snatching mechanism of the L-A virus is shared by fungal totiviruses closely related to L-A. Interestingly, L-A and L-BC viruses accept either viral transcript as cap acceptor in vitro. Because L-A and L-BC viruses cohabit in many yeast strains, it raises the possibility that their cohabitation in the same host may be beneficial for their mutual cap acquisition.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Inst Biol Funct & Genom, Lab P2 1, Zacarias Gonzalez 2, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Fundacion Ramon Areces	Fundacion Ramon Areces	We thank "Fundacion Ramon Areces" for financial support of our Institute.	BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Chakravarty AK, 2012, P NATL ACAD SCI USA, V109, P6072, DOI 10.1073/pnas.1201207109; Chakravarty AK, 2011, P NATL ACAD SCI USA, V108, P21034, DOI 10.1073/pnas.1115560108; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; Chu C, 2011, P NATL ACAD SCI USA, V108, P10104, DOI 10.1073/pnas.1106610108; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Englert M, 2012, P NATL ACAD SCI USA, V109, P15235, DOI 10.1073/pnas.1213795109; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Fujimura T, 2012, J BIOL CHEM, V287, P12797, DOI 10.1074/jbc.M111.327676; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Huang YL, 2005, J BIOL CHEM, V280, P13153, DOI 10.1074/jbc.M412619200; ICHO T, 1989, J BIOL CHEM, V264, P6716; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; Park CM, 1996, VIROLOGY, V216, P451, DOI 10.1006/viro.1996.0083; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; TIPPER DJ, 1984, MICROBIOL REV, V48, P125, DOI 10.1128/MMBR.48.2.125-156.1984; VENKATESAN S, 1980, J BIOL CHEM, V255, P2835; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; WESOLOWSKI M, 1984, MOL CELL BIOL, V4, P181, DOI 10.1128/MCB.4.1.181; WICKENS MP, 1983, J MOL BIOL, V163, P1, DOI 10.1016/0022-2836(83)90027-X; Wickner R.B., 2007, FIELDS VIROLOGY, P737; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	49	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23716	23724		10.1074/jbc.M113.490953	http://dx.doi.org/10.1074/jbc.M113.490953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824187	hybrid, Green Published			2022-12-28	WOS:000330611400012
J	Kang, JW; Park, YS; Kim, MS; Lee, DH; Bak, Y; Ham, SY; Park, SH; Hong, JT; Yoon, DY				Kang, Jeong-Woo; Park, Yun Sun; Kim, Man Sub; Lee, Dong Hun; Bak, Yesol; Ham, Sun Young; Park, Soo Ho; Hong, Jin Tae; Yoon, Do-Young			Interleukin (IL)-32 beta-mediated CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Phosphorylation by Protein Kinase C delta (PKC delta) Abrogates the Inhibitory Effect of C/EBP alpha on IL-10 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; PROINFLAMMATORY CYTOKINE; TRANSCRIPTION FACTORS; LINEAGE COMMITMENT; CELL-DEATH; TNF-ALPHA; ACTIVATION; IL-32; GRANULOPOIESIS; EXPRESSION	We previously reported that IL-32 beta promotes IL-10 production in myeloid cells. However, the underlying mechanism remains elusive. In this study, we demonstrated that IL-32 beta abrogated the inhibitory effect of CCAAT/enhancer-binding protein alpha (C/EBP alpha) on IL-10 expression in U937 cells. We observed that the phosphorylation of C/EBP alpha Ser-21 was inhibited by a PKC delta-specific inhibitor, rottlerin, or IL-32 beta knockdown by siRNA and that IL-32 beta shifted to the membrane from the cytosol upon phorbol 12-myristate 13-acetate treatment. We revealed that IL-32 beta suppressed the binding of C/EBP alpha to IL-10 promoter by using ChIP assay. These data suggest that PKC delta and IL-32 beta may modulate the effect of C/EBP alpha on IL-10 expression. We next demonstrated by immunoprecipitation that IL-32 beta interacted with PKC delta and C/EBP alpha, thereby mediating C/EBP alpha Ser-21 phosphorylation by PKC delta. We showed that IL-32 beta suppressed the inhibitory effect of C/EBP alpha on IL-10 promoter activity. However, the IL-10 promoter activity was reduced to the basal level by rottlerin treatment. When C/EBP alpha serine 21 was mutated to glycine (S21G), the inhibitory effect of C/EBP alpha S21G on IL-10 promoter activity was not modulated by IL-32 beta. Taken together, our results show that IL-32 beta-mediated C/EBP alpha Ser-21 phosphorylation by PKC delta suppressed C/EBP alpha binding to IL-10 promoter, which promoted IL-10 production in U937 cells.	[Kang, Jeong-Woo; Park, Yun Sun; Kim, Man Sub; Lee, Dong Hun; Bak, Yesol; Ham, Sun Young; Park, Soo Ho; Yoon, Do-Young] Konkuk Univ, Dept Biosci & Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361463, Chungbuk, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361463, Chungbuk, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Biomol Informat Ctr, 1 Hwayang Dong, Seoul 143701, South Korea.	jinthong@chungbuk.ac.kr; ydy4218@konkuk.ac.kr			National Research Foundation of Korea (NRF); Korean government [2012R1A2A2A 02008751, 2011-0028213]; Priority Research Centres Program [2012-0006686, A120833]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government); Priority Research Centres Program	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2012R1A2A2A 02008751 and 2011-0028213).; Partially supported by Priority Research Centres Program Grants 2012-0006686 and A120833. To whom correspondence may be addressed. Tel.: 82-2-450-4119; Fax: 82-2-444-4218; E-mail: ydy4218@konkuk.ac.kr.	Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Contreras X, 2004, MICROBES INFECT, V6, P1182, DOI 10.1016/j.micinf.2004.06.008; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Heinhuis B, 2012, CYTOKINE, V60, P321, DOI 10.1016/j.cyto.2012.07.010; Heinhuis B, 2012, J BIOL CHEM, V287, P5733, DOI 10.1074/jbc.M111.288290; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang JW, 2012, J BIOL CHEM, V287, P35556, DOI 10.1074/jbc.M112.400911; Kang JW, 2009, IMMUNOLOGY, V128, pe532, DOI 10.1111/j.1365-2567.2008.03025.x; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Klempt M, 1998, IMMUNOBIOLOGY, V199, P148, DOI 10.1016/S0171-2985(98)80070-3; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Rangatia J, 2002, MOL CELL BIOL, V22, P8681, DOI 10.1128/MCB.22.24.8681-8694.2002; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Wilmanski J, 2005, J LEUKOCYTE BIOL, V78, P85, DOI 10.1189/jlb.0105010; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517	33	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23650	23658		10.1074/jbc.M113.465575	http://dx.doi.org/10.1074/jbc.M113.465575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814099	Green Published, hybrid			2022-12-28	WOS:000330611400004
J	Yang, SF; Gao, ZQ; Li, TT; Yang, M; Zhang, TY; Dong, YH; He, ZG				Yang, Shifan; Gao, Zengqiang; Li, Tingting; Yang, Min; Zhang, Tianyi; Dong, Yuhui; He, Zheng-Guo			Structural Basis for Interaction between Mycobacterium smegmatis Ms6564, a TetR Family Master Regulator, and Its Target DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TAL EFFECTORS; TRANSCRIPTIONAL REGULATION; RESPONSE REGULATOR; ESCHERICHIA-COLI; RECOGNITION; REPRESSOR; TUBERCULOSIS; BINDING; NARL	Master regulators, which broadly affect expression of diverse genes, play critical roles in bacterial growth and environmental adaptation. However, the underlying mechanism by which such regulators interact with their cognate DNA remains to be elucidated. In this study, we solved the crystal structure of a broad regulator Ms6564 in Mycobacterium smegmatis and its protein-operator complex at resolutions of 1.9 and 2.5 angstrom, respectively. Similar to other typical TetR family regulators, two dimeric Ms6564 molecules were found to bind to opposite sides of target DNA. However, the recognition helix of Ms6564 inserted only slightly into the DNA major groove. Unexpectedly, 11 disordered water molecules bridged the interface of TetR family regulator DNA. Although the DNA was deformed upon Ms6564 binding, it still retained the conformation of B-form DNA. Within the DNA-binding domain of Ms6564, only two amino acids residues directly interacted with the bases of cognate DNA. Lys-47 was found to be essential for the specific DNA binding ability of Ms6564. These data indicate that Ms6564 can bind DNA with strong affinity but makes flexible contacts with DNA. Our study suggests that Ms6564 might slide more easily along the genomic DNA and extensively regulate the expression of diverse genes in M. smegmatis.	[Yang, Shifan; Li, Tingting; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Gao, Zengqiang; Zhang, Tianyi; Dong, Yuhui] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Dong, YH (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.	dongyh@ihep.ac.cn; he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014	Dong, Yuhui/0000-0002-4422-4685; Yang, Min/0000-0003-2924-5717	National Natural Science Foundation of China [31121004, 31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31121004, 31025002, and 30930003; Fundamental Research Funds for the Central Universities Grant 2011PY140; the Creative Research Groups of Hubei; and the Hubei Chutian Scholar Program (to H.Z.-G.).	Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bellinzoni M, 2009, J BACTERIOL, V191, P7531, DOI 10.1128/JB.00631-09; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Carette X, 2012, NUCLEIC ACIDS RES, V40, P3018, DOI 10.1093/nar/gkr1113; Coulocheri SA, 2007, BIOCHIMIE, V89, P1291, DOI 10.1016/j.biochi.2007.07.020; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Muller CW, 2001, CURR OPIN STRUC BIOL, V11, P26, DOI 10.1016/S0959-440X(00)00163-9; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Orth P, 2000, NAT STRUCT BIOL, V7, P215; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001	31	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23687	23695		10.1074/jbc.M113.468694	http://dx.doi.org/10.1074/jbc.M113.468694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23803605	Green Published, hybrid			2022-12-28	WOS:000330611400009
J	Jiang, L; Xu, LL; Song, YX; Li, JZ; Mao, JH; Zhao, AZ; He, WC; Yang, JW; Dai, CS				Jiang, Lei; Xu, Lingling; Song, Yuxian; Li, Jianzhong; Mao, Junhua; Zhao, Allan Zijian; He, Weichun; Yang, Junwei; Dai, Chunsun			Calmodulin-dependent Protein Kinase II/cAMP Response Element-binding Protein/Wnt/beta-Catenin Signaling Cascade Regulates Angiotensin II-induced Podocyte Injury and Albuminuria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; NEPHRIN EXPRESSION; CONVERTING ENZYME; CALCIUM ACTIVITY; BLOOD-PRESSURE; GROWTH-FACTOR; ACTIVATION; SYSTEM; GLOMERULOSCLEROSIS; BLOCKADE	Angiotensin II (Ang II) plays a pivotal role in promoting podocyte dysfunction and albuminuria, however, the underlying mechanisms have not been fully delineated. In this study, we found that Ang II induced Wnt1 expression and beta-catenin nuclear translocation in cultured mouse podocytes. Blocking Wnt signaling with Dickkopf-1 (Dkk1) or beta-catenin siRNA attenuated Ang II-induced podocyte injury. Ang II could also induce the phosphorylation of calmodulin-dependent protein kinase (CaMK) II and cAMP response element-binding protein (CREB) in cultured podocytes. Blockade of this pathway with CK59 or CREB siRNA could significantly inhibit Ang II-induced Wnt/beta-catenin signaling and podocyte injury. In in vivo studies, administration of Ang II promoted Wnt/beta-catenin signaling, aggregated podocyte damage, and albuminuria in mice. CK59 could remarkably ameliorate Ang II-induced podocyte injury and albuminuria. Furthermore, ectopic expression of exogenous Dkk1 also attenuated Ang II-induced podocytopathy in mice. Taken together, this study demonstrates that the CaMK II/CREB/Wnt/beta-catenin signaling cascade plays an important role in regulating Ang II-induced podocytopathy. Targeting this signaling pathway may offer renal protection against the development of proteinuric kidney diseases.	[Jiang, Lei; Xu, Lingling; Song, Yuxian; Li, Jianzhong; Mao, Junhua; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing 210003, Jiangsu, Peoples R China; [Zhao, Allan Zijian] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Allan Zijian; Dai, Chunsun] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn; daichunsun@njmu.edu.cn			National Basic Research Program of China 973 Program [2012CB517601, 2011CB504005]; National Science Foundation of China [81070550/H0503, 3171093/C1102]; National Natural Science Foundation of China, General Program [81170780]; Ph.D. Programs Foundation of Ministry of Education of China [20113234110005]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China, General Program(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB517601, National Science Foundation of China Grant 81070550/H0503 (to C. D.), National Basic Research Program of China 973 Program Grant 2011CB504005, and National Science Foundation of China Grant 3171093/C1102 (to J.W.Y.), National Natural Science Foundation of China, General Program Grant 81170780, and Ph.D. Programs Foundation of Ministry of Education of China Grant 20113234110005 (to A.Z.Z.).	Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Benigni A, 2004, SEMIN NEPHROL, V24, P131, DOI 10.1016/j.semnephrol.2003.11.005; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Bensman A, 2010, PEDIATR NEPHROL, V25, P1197, DOI 10.1007/s00467-010-1469-2; BIANCHI C, 1986, AM J PHYSIOL, V251, pF594, DOI 10.1152/ajprenal.1986.251.4.F594; Blanco S, 2005, KIDNEY INT, V67, pS10, DOI 10.1111/j.1523-1755.2005.09303.x; Campbell KN, 2011, CURR DIABETES REV, V7, P3, DOI 10.2174/157339911794273973; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Durvasula RV, 2006, CURR HYPERTENS REP, V8, P132, DOI 10.1007/s11906-006-0009-8; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heikkila E, 2010, NEPHROL DIAL TRANSPL, V25, P2437, DOI 10.1093/ndt/gfq076; Henger A, 1997, KIDNEY INT, V52, P687, DOI 10.1038/ki.1997.383; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hiramatsu N, 2007, J AM SOC NEPHROL, V18, P515, DOI 10.1681/ASN.2006030217; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Hsu HH, 2011, KIDNEY INT, V80, P959, DOI 10.1038/ki.2011.250; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kang YS, 2006, J MOL ENDOCRINOL, V36, P377, DOI 10.1677/jme.1.02033; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kim J, 2012, J IMMUNOL, V188, P182, DOI 10.4049/jimmunol.1102297; Lai KN, 2011, CONTRIB NEPHROL, V170, P135, DOI 10.1159/000325649; Lemley KV, 2012, KIDNEY INT, V81, P9, DOI 10.1038/ki.2011.329; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Moeller MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2101, DOI 10.1093/ndt/gfq182; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; Naves MA, 2012, J NEPHROL, V25, P401, DOI 10.5301/jn.5000017; Nitschke R, 2000, KIDNEY INT, V57, P41, DOI 10.1046/j.1523-1755.2000.00810.x; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Reiser J, 2007, CURR HYPERTENS REP, V9, P403, DOI 10.1007/s11906-007-0074-7; Ruster C, 2011, AM J NEPHROL, V34, P309, DOI 10.1159/000329321; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Sofue T, 2012, AM J HYPERTENS, V25, P604, DOI 10.1038/ajh.2012.1; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Velez JCQ, 2007, AM J PHYSIOL-RENAL, V293, pF398, DOI 10.1152/ajprenal.00050.2007; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang L, 2003, J LAB CLIN MED, V142, P313, DOI 10.1016/S0022-2143(03)00139-2; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	56	32	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23368	23379		10.1074/jbc.M113.460394	http://dx.doi.org/10.1074/jbc.M113.460394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803607	Green Published, hybrid			2022-12-28	WOS:000330598200041
J	Wald, T; Osickova, A; Sulc, M; Benada, O; Semeradtova, A; Rezabkova, L; Veverka, V; Bednarova, L; Maly, J; Macek, P; Sebo, P; Slaby, I; Vondrasek, J; Osicka, R				Wald, Tomas; Osickova, Adriana; Sulc, Miroslav; Benada, Oldrich; Semeradtova, Alena; Rezabkova, Lenka; Veverka, Vaclav; Bednarova, Lucie; Maly, Jan; Macek, Pavel; Sebo, Peter; Slaby, Ivan; Vondrasek, Jiri; Osicka, Radim			Intrinsically Disordered Enamel Matrix Protein Ameloblastin Forms Ribbon-like Supramolecular Structures via an N-terminal Segment Encoded by Exon 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; AMELOGENIN NANOSPHERES; UNSTRUCTURED PROTEINS; MINERALIZED TISSUE; SHEATH PROTEINS; TOOTH ENAMEL; GENE; BIOMINERALIZATION; CLONING; REGION	Tooth enamel, the hardest tissue in the body, is formed by the evolutionarily highly conserved biomineralization process that is controlled by extracellular matrix proteins. The intrinsically disordered matrix protein ameloblastin (AMBN) is the most abundant nonamelogenin protein of the developing enamel and a key element for correct enamel formation. AMBN was suggested to be a cell adhesion molecule that regulates proliferation and differentiation of ameloblasts. Nevertheless, detailed structural and functional studies on AMBN have been substantially limited by the paucity of the purified nondegraded protein. With this study, we have developed a procedure for production of a highly purified form of recombinant human AMBN in quantities that allowed its structural characterization. Using size exclusion chromatography, analytical ultracentrifugation, transmission electron, and atomic force microscopy techniques, we show that AMBN self-associates into ribbon-like supramolecular structures with average widths and thicknesses of 18 and 0.34 nm, respectively. The AMBN ribbons exhibited lengths ranging from tens to hundreds of nm. Deletion analysis and NMR spectroscopy revealed that an N-terminal segment encoded by exon 5 comprises two short independently structured regions and plays a key role in self-assembly of AMBN.	[Wald, Tomas; Osickova, Adriana; Sulc, Miroslav; Benada, Oldrich; Macek, Pavel; Sebo, Peter; Osicka, Radim] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic; [Rezabkova, Lenka] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Slaby, Ivan; Vondrasek, Jiri] Acad Sci Czech Republic, Inst Biotechnol, CR-14220 Prague, Czech Republic; [Wald, Tomas] Prague Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Sulc, Miroslav; Rezabkova, Lenka] Charles Univ Prague, Fac Sci, Prague 12843, Czech Republic; [Semeradtova, Alena; Maly, Jan] Univ JE Purkyne, Fac Sci, Usti Nad Labem 40096, Czech Republic; [Veverka, Vaclav; Bednarova, Lucie; Vondrasek, Jiri] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Chemistry & Technology, Prague; Charles University Prague; University of Jan Evangelista Purkyne; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Osicka, R (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Vvi, Videnska 1083, CR-14220 Prague, Czech Republic.	osicka@biomed.cas.cz	Veverka, Vaclav/P-5251-2019; Osicka, Radim/H-6776-2014; Osickova, Adriana/H-6841-2014; SEBO, Peter/N-2043-2019; Veverka, Vaclav/G-9174-2014; Wald, Tomas/J-6894-2014; Sulc, Miroslav/K-1029-2014; Bednarova, Lucie/E-7622-2012; SEBO, Peter/F-7423-2011; Vondrasek, JIri/A-4244-2008; Benada, Oldřich/H-2437-2014; Maly, Jan/B-6434-2011; Rezabkova, Lenka/O-8229-2017	Veverka, Vaclav/0000-0003-3782-5279; Osicka, Radim/0000-0003-2626-5456; Osickova, Adriana/0000-0002-5739-1183; SEBO, Peter/0000-0002-9755-7715; Veverka, Vaclav/0000-0003-3782-5279; Wald, Tomas/0000-0002-6569-5339; Sulc, Miroslav/0000-0002-2659-0489; SEBO, Peter/0000-0002-9755-7715; Benada, Oldřich/0000-0002-4592-6216; Maly, Jan/0000-0002-7022-2157; Rezabkova, Lenka/0000-0002-7274-8080; Macek, Pavel/0000-0003-3774-7717	Czech Science Foundation [P302/10/0427]; Czech National Cost Project [OC10053]; Internal Grant Agency of Jan Evangelista Purkyne University; Academy of Sciences of the Czech Republic [RVO61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech National Cost Project; Internal Grant Agency of Jan Evangelista Purkyne University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by Grant P302/10/0427 from the Czech Science Foundation (to R. O. and J. V.), Czech National Cost Project OC10053 (to J. M.), Internal Grant Agency of Jan Evangelista Purkyne University (to J. M.), and Academy of Sciences of the Czech Republic Grant RVO61388971.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 2006, CURR TOP DEV BIOL, V74, P57, DOI 10.1016/S0070-2153(06)74003-0; BENADA O, 1990, J ELECTRON MICR TECH, V16, P235, DOI 10.1002/jemt.1060160304; Benseny-Cases N, 2012, CURR ALZHEIMER RES, V9, P962, DOI 10.2174/156720512803251129; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Cerny R, 1996, J BONE MINER RES, V11, P883; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fong C D, 1996, Adv Dent Res, V10, P195; Fukae M, 2006, EUR J ORAL SCI, V114, P212, DOI 10.1111/j.1600-0722.2006.00309.x; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Hansma HG, 2010, J THEOR BIOL, V266, P175, DOI 10.1016/j.jtbi.2010.06.016; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Klinov D, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225102; Kobayashi K, 2007, J DENT RES, V86, P962, DOI 10.1177/154405910708601009; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Makin OS, 2006, CURR OPIN CHEM BIOL, V10, P417, DOI 10.1016/j.cbpa.2006.08.009; Matthews JM, 2012, ADV EXP MED BIOL, V747, P1, DOI 10.1007/978-1-4614-3229-6_1; MORADIANOLDAK J, 1994, ARCH ORAL BIOL, V39, P647, DOI 10.1016/0003-9969(94)90090-6; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Paine ML, 1998, J DENT RES, V77, P496, DOI 10.1177/00220345980770030901; Paine ML, 1996, CONNECT TISSUE RES, V35, P157, DOI 10.3109/03008209609029187; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Sambrook J., 2002, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; STRAWICH E, 1985, FEBS LETT, V184, P188, DOI 10.1016/0014-5793(85)80604-9; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2011, EUR J ORAL SCI, V119, P261, DOI 10.1111/j.1600-0722.2011.00913.x; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Whitehouse C, 2005, ANGEW CHEM INT EDIT, V44, P1965, DOI 10.1002/anie.200462160; Wojtas M, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P3; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X	63	27	27	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22333	22345		10.1074/jbc.M113.456012	http://dx.doi.org/10.1074/jbc.M113.456012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782691	Green Published, hybrid			2022-12-28	WOS:000330596300015
J	Yadav, T; Carrasco, B; Hejna, J; Suzuki, Y; Takeyasu, K; Alonso, JC				Yadav, Tribhuwan; Carrasco, Begona; Hejna, James; Suzuki, Yuki; Takeyasu, Kunio; Alonso, Juan C.			Bacillus subtilis DprA Recruits RecA onto Single-stranded DNA and Mediates Annealing of Complementary Strands Coated by SsbB and SsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-RECOMBINATION; GENOME MAINTENANCE; BINDING PROTEIN; REPAIR; TRANSFORMATION; NUCLEATION; MACHINERY; FILAMENTS; SSDNA	Naturally transformable bacteria recombine internalized ssDNA with a homologous resident duplex (chromosomal transformation) or complementary internalized ssDNAs (plasmid or viral transformation). Bacillus subtilis competence-induced DprA, RecA, SsbB, and SsbA proteins are involved in the early processing of the internalized ssDNA, with DprA physically interacting with RecA. SsbB and SsbA bind and melt secondary structures in ssDNA but limit RecA loading onto ssDNA. DprA binds to ssDNA and facilitates partial dislodging of both single-stranded binding (SSB) proteins from ssDNA. In the absence of homologous duplex DNA, DprA does not significantly increase RecA nucleation onto protein-free ssDNA. DprA facilitates RecA nucleation and filament extension onto SsbB-coated or SsbB plus SsbA-coated ssDNA. DprA facilitates RecA-mediated DNA strand exchange in the presence of both SSB proteins. DprA, which plays a crucial role in plasmid transformation, anneals complementary strands preferentially coated by SsbB to form duplex circular plasmid molecules. Our results provide a mechanistic framework for conceptualizing the coordinated events modulated by SsbB in concert with SsbA and DprA that are crucial for RecA-dependent chromosomal transformation and RecA-independent plasmid transformation.	[Yadav, Tribhuwan; Carrasco, Begona; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, E-28049 Madrid, Spain; [Hejna, James; Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Plaza Murillo 2, E-28049 Madrid, Spain.	jcalonso@cnb.cisc.es	Alonso, Juan Carlos/D-2595-2009; Suzuki, Yuki/H-9950-2015	Alonso, Juan Carlos/0000-0002-5178-7179; Suzuki, Yuki/0000-0003-1848-0105; Carrasco, Begona/0000-0002-5671-1296; Yadav, Tribhuwan/0000-0003-3571-9907	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24115003]; Japan-Spain Bilateral Joint Project Award JSPC-CSIC [2010JP0017]; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Spain Bilateral Joint Project Award JSPC-CSIC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministerio de Economia y Competitividad, Direccion General de Investigacion, Grant BFU2012-39879-C02-01; Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A); Grant-in-aid for Scientific Research on Innovative Areas "Virus-Host Cell Competency" (24115003) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. T.); and Japan-Spain Bilateral Joint Project Award JSPC-CSIC 2010JP0017 (to K. T. and J. C. A.).	Alonso JC, 2013, DNA REPAIR, V12, P162, DOI 10.1016/j.dnarep.2012.12.005; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Attaiech L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002156; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Cardenas PP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003126; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; CEGLOWSKI P, 1990, MOL GEN GENET, V222, P441, DOI 10.1007/BF00633853; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chiesa M, 2012, NANO LETT, V12, P1275, DOI 10.1021/nl2037547; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Deschenes LA, 2000, J AM CHEM SOC, V122, P9567, DOI 10.1021/ja004761d; Fernandez S, 1999, MOL GEN GENET, V261, P567, DOI 10.1007/s004380051002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; Kidane D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000630; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Manfredi C, 2010, NUCLEIC ACIDS RES, V38, P6920, DOI 10.1093/nar/gkq533; Masuda T, 2009, J BIOL CHEM, V284, P30230, DOI 10.1074/jbc.M109.043810; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Sanchez H., 2007, MOL GENETICS RECOMBI, V17, P27; Sanchez H, 2008, NUCLEIC ACIDS RES, V36, P110, DOI 10.1093/nar/gkm759; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173	46	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22437	22450		10.1074/jbc.M113.478347	http://dx.doi.org/10.1074/jbc.M113.478347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779106	Green Published, hybrid			2022-12-28	WOS:000330596300025
J	Yu, J; Deliu, E; Zhang, XQ; Hoffman, NE; Carter, RL; Grisanti, LA; Brailoiu, GC; Madesh, M; Cheung, JY; Force, T; Abood, ME; Koch, WJ; Tilley, DG; Brailoiu, E				Yu, Justine; Deliu, Elena; Zhang, Xue-Quian; Hoffman, Nicholas E.; Carter, Rhonda L.; Grisanti, Laurel A.; Brailoiu, G. Cristina; Madesh, Muniswamy; Cheung, Joseph Y.; Force, Thomas; Abood, Mary E.; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen			Differential Activation of Cultured Neonatal Cardiomyocytes by Plasmalemmal Versus Intracellular G Protein-coupled Receptor 55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CYCLIC ADP-RIBOSE; ANGIOTENSIN-II; CANNABINOID RECEPTOR; ENDOPLASMIC-RETICULUM; CB1 RECEPTORS; IN-VITRO; GPR55; CALCIUM; NAADP	The L-alpha-lysophosphatidylinositol (LPI)-sensitive receptor GPR55 is coupled to Ca2+ signaling. Low levels of GPR55 expression in the heart have been reported. Similar to other G protein-coupled receptors involved in cardiac function, GPR55 may be expressed both at the sarcolemma and intracellularly. Thus, to explore the role of GPR55 in cardiomyocytes, we used calcium and voltage imaging and extracellular administration or intracellular microinjection of GPR55 ligands. We provide the first evidence that, in cultured neonatal ventricular myocytes, LPI triggers distinct signaling pathways via GPR55, depending on receptor localization. GPR55 activation at the sarcolemma elicits, on one hand, Ca2+ entry via L-type Ca2+ channels and, on the other, inositol 1,4,5-trisphosphate-dependent Ca2+ release. The latter signal is further amplified by Ca2+-induced Ca2+ release via ryanodine receptors. Conversely, activation of GPR55 at the membrane of intracellular organelles promotes Ca2+ release from acidic-like Ca2+ stores via the endolysosomal NAADP-sensitive two-pore channels. This response is similarly enhanced by Ca2+-induced Ca2+ release via ryanodine receptors. Extracellularly applied LPI produces Ca2+-independent membrane depolarization, whereas the Ca2+ signal induced by intracellular microinjection of LPI converges to hyperpolarization of the sarcolemma. Collectively, our findings point to GPR55 as a novel G protein-coupled receptor regulating cardiac function at two cellular sites. This work may serve as a platform for future studies exploring the potential of GPR55 as a therapeutic target in cardiac disorders.	[Yu, Justine; Zhang, Xue-Quian; Hoffman, Nicholas E.; Carter, Rhonda L.; Grisanti, Laurel A.; Madesh, Muniswamy; Cheung, Joseph Y.; Force, Thomas; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Deliu, Elena; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19140 USA; [Force, Thomas] Temple Univ, Sch Med, Dept Internal Med, Philadelphia, PA 19140 USA; [Abood, Mary E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Abood, Mary E.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Tilley, DG (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Room 945A,3500 N Broad St, Philadelphia, PA 19140 USA.	douglas.tilley@temple.edu; ebrailou@temple.edu	Deliu, Elena/O-7379-2019	Tilley, Douglas/0000-0002-9681-3377; Force, Thomas/0000-0002-0450-8659; Abood, Mary/0000-0002-1744-2820	National Institutes of Health [HL090804, HL105414, HL086699, DA023204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL105414, R01HL086699, R01HL114124, R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL090804 (to E. B.), HL105414 (to D. G. T.), HL086699 (to M. M.), and DA023204 (to M. E. A.).	Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; [Anonymous], 2010, PROBE REPORTS NIH MO; Ben-Zeev G, 2010, CELL CALCIUM, V47, P514, DOI 10.1016/j.ceca.2010.04.006; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V461, P177, DOI 10.1007/s00424-010-0898-x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E., 2012, 22 ANN S CANN, P25; Brailoiu GC, 2008, NEUROSCIENCE, V151, P701, DOI 10.1016/j.neuroscience.2007.11.031; Brailoiu GC, 2013, EXP PHYSIOL, V98, P679, DOI 10.1113/expphysiol.2012.069377; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Costa VM, 2009, CHEM RES TOXICOL, V22, P129, DOI 10.1021/tx8002577; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Mello WC, 2011, MOL CELL BIOCHEM, V358, P309, DOI 10.1007/s11010-011-0981-4; Deliu E, 2012, J BIOL CHEM, V287, P41023, DOI 10.1074/jbc.M112.418533; Deliu E, 2012, J PAIN, V13, P742, DOI 10.1016/j.jpain.2012.05.011; Deliu E, 2011, AM J PHYSIOL-CELL PH, V301, pC559, DOI 10.1152/ajpcell.00123.2011; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goutsouliak V, 1998, GEN PHARMACOL, V30, P367, DOI 10.1016/S0306-3623(97)00270-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Hu G, 2011, ONCOGENE, V30, P139, DOI 10.1038/onc.2010.502; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Ju YK, 2012, J MOL CELL CARDIOL, V53, P375, DOI 10.1016/j.yjmcc.2012.06.004; Jungsuwadee P, 2009, MOL PHARMACOL, V75, P1117, DOI 10.1124/mol.108.052209; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; Kato K, 2012, J IMMUNOL, V188, P2014, DOI 10.4049/jimmunol.1102405; Kerkela R, 2011, CTS-CLIN TRANSL SCI, V4, P236, DOI 10.1111/j.1752-8062.2011.00294.x; Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Luo DL, 2006, ACTA PHARMACOL SIN, V27, P895, DOI 10.1111/j.1745-7254.2006.00382.x; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Pineiro R, 2012, BBA-MOL CELL BIOL L, V1821, P694, DOI 10.1016/j.bbalip.2012.01.009; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saini HK, 2006, AM J PHYSIOL-HEART C, V291, pH2790, DOI 10.1152/ajpheart.00535.2006; Saito Y, 2012, AM J PHYSIOL-HEART C, V302, pH2018, DOI 10.1152/ajpheart.00955.2011; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Stillitano F, 2008, PHARMACOL RES, V57, P100, DOI 10.1016/j.phrs.2007.12.002; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tica AA, 2011, AM J PHYSIOL-CELL PH, V301, pC1262, DOI 10.1152/ajpcell.00501.2010; VITES AM, 1994, J PHARMACOL EXP THER, V268, P1476; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Weiss S, 2004, J BIOL CHEM, V279, P12503, DOI 10.1074/jbc.M310196200; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Zhao PW, 2013, LIFE SCI, V92, P453, DOI 10.1016/j.lfs.2012.06.039; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	77	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22481	22492		10.1074/jbc.M113.456178	http://dx.doi.org/10.1074/jbc.M113.456178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23814062	Green Published, hybrid			2022-12-28	WOS:000330596300029
J	Bloemink, MJ; Deacon, JC; Resnicow, DI; Leinwand, LA; Geeves, MA				Bloemink, Marieke J.; Deacon, John C.; Resnicow, Daniel I.; Leinwand, Leslie A.; Geeves, Michael A.			The Superfast Human Extraocular Myosin Is Kinetically Distinct from the Fast Skeletal IIa, IIb, and IId Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DROSOPHILA MUSCLE MYOSIN; HEAVY-CHAIN GENE; ATPASE ACTIVITY; ACTOMYOSIN SUBFRAGMENT-1; TEMPERATURE-DEPENDENCE; ADENOSINE-DIPHOSPHATE; FUNCTIONAL DIVERSITY; SHORTENING VELOCITY; RECOVERY STROKE	Humans express five distinct myosin isoforms in the sarcomeres of adult striated muscle (fast IIa, IId, the slow/cardiac isoform I/beta, the cardiac specific isoform alpha, and the specialized extraocular muscle isoform). An additional isoform, IIb, is present in the genome but is not normally expressed in healthy human muscles. Muscle fibers expressing each isoform have distinct characteristics including shortening velocity. Defining the properties of the isoforms in detail has been limited by the availability of pure samples of the individual proteins. Here we study purified recombinant human myosin motor domains expressed in mouse C2C12 muscle cells. The results of kinetic analysis show that among the closely related adult skeletal isoforms, the affinity of ADP for actin.myosin (K-AD) is the characteristic that most readily distinguishes the isoforms. The three fast muscle myosins have K-AD values of 118, 80, and 55 mu M for IId, IIa, and IIb, respectively, which follows the speed in motility assays from fastest to slowest. Extraocular muscle is unusually fast with a far weaker K-AD = 352 mu M. Sequence comparisons and homology modeling of the structures identify a few key areas of sequence that may define the differences between the isoforms, including a region of the upper 50-kDa domain important in signaling between the nucleotide pocket and the actin-binding site.	[Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Deacon, John C.; Resnicow, Daniel I.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Kent; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; LEINWAND, LESLIE/0000-0003-1470-4810; Bloemink, Marieke Johanna/0000-0001-9441-2783	National Institutes of Health [T32 GM65013, GM29090]; Wellcome Trust Program [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, F32GM065013, R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Program(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM65013 (to J. C. D. and D. I. R.) and GM29090 (to L. A. L.). This work was also supported by Wellcome Trust Program Grant 085309 (to M. A. G.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Brueckner JK, 1996, J MUSCLE RES CELL M, V17, P297; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Coviello DA, 1997, AM J HUM GENET, V61, pA329; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kjellgren D, 2003, INVEST OPHTH VIS SCI, V44, P1419, DOI 10.1167/iovs.02-0638; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; LUCAS CA, 1995, J MUSCLE RES CELL M, V16, P368, DOI 10.1007/BF00114502; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; SARTORE S, 1987, J MUSCLE RES CELL M, V8, P161, DOI 10.1007/BF01753992; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Stienen GJM, 1996, J PHYSIOL-LONDON, V493, P299, DOI 10.1113/jphysiol.1996.sp021384; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Yu B, 2005, J CLIN PATHOL, V58, P479, DOI 10.1136/jcp.2004.021642	41	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27469	27479		10.1074/jbc.M113.488130	http://dx.doi.org/10.1074/jbc.M113.488130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908353	hybrid, Green Published			2022-12-28	WOS:000330597300042
J	Palmer, CS; Elgass, KD; Parton, RG; Osellame, LD; Stojanovski, D; Ryan, MT				Palmer, Catherine S.; Elgass, Kirstin D.; Parton, Robert G.; Osellame, Laura D.; Stojanovski, Diana; Ryan, Michael T.			Adaptor Proteins MiD49 and MiD51 Can Act Independently of Mff and Fis1 in Drp1 Recruitment and Are Specific for Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-LIKE PROTEIN-1; PEROXISOMAL FISSION; MAMMALIAN-CELLS; OUTER-MEMBRANE; ANCHORED PROTEINS; FUSION; AUTOPHAGY; DIVISION; DLP1; COMPLEXES	Drp1 (dynamin-related protein 1) is recruited to both mitochondrial and peroxisomal membranes to execute fission. Fis1 and Mff are Drp1 receptor/effector proteins of mitochondria and peroxisomes. Recently, MiD49 and MiD51 were also shown to recruit Drp1 to the mitochondrial surface; however, different reports have ascribed opposing roles in fission and fusion. Here, we show that MiD49 or MiD51 overexpression blocked fission by acting in a dominant-negative manner by sequestering Drp1 specifically at mitochondria, causing unopposed fusion events at mitochondria along with elongation of peroxisomes. Mitochondrial elongation caused by MiD49/51 overexpression required the action of fusion mediators mitofusins 1 and 2. Furthermore, at low level overexpression when MiD49 and MiD51 form discrete foci at mitochondria, mitochondrial fission events still occurred. Unlike Fis1 and Mff, MiD49 and MiD51 were not targeted to the peroxisomal surface, suggesting that they specifically act to facilitate Drp1-directed fission at mitochondria. Moreover, when MiD49 or MiD51 was targeted to the surface of peroxisomes or lysosomes, Drp1 was specifically recruited to these organelles. Moreover, the Drp1 recruitment activity of MiD49/51 appeared stronger than that of Mff or Fis1. We conclude that MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment and suggest that they provide specificity to the division of mitochondria.	[Palmer, Catherine S.; Elgass, Kirstin D.; Osellame, Laura D.; Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Palmer, Catherine S.; Elgass, Kirstin D.; Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, ARC Ctr Excellence Coherent Xray Sci, Melbourne, Vic 3086, Australia; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia	La Trobe University; La Trobe University; University of Queensland; University of Queensland	Ryan, MT (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia.	m.ryan@latrobe.edu.au	; Parton, Robert/C-5673-2009	PALMER, CATHERINE/0000-0002-5124-2400; Stojanovski, Diana/0000-0002-0199-3222; Parton, Robert/0000-0002-7494-5248	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); National Health and Medical Research Council of Australia [569542, 511005]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC).; Supported by Fellowship 569542 and Grant 511005 from the National Health and Medical Research Council of Australia.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Lan L, 2000, BIOCHEM J, V349, P611, DOI 10.1042/0264-6021:3490611; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Okamoto K, 2012, BBA-GEN SUBJECTS, V1820, P595, DOI 10.1016/j.bbagen.2011.08.001; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Scott I, 2006, J EXP BOT, V57, P1275, DOI 10.1093/jxb/erj096; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang XC, 2008, MOL PLANT, V1, P1036, DOI 10.1093/mp/ssn056; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	61	176	189	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27584	27593		10.1074/jbc.M113.479873	http://dx.doi.org/10.1074/jbc.M113.479873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921378	Green Published, hybrid			2022-12-28	WOS:000330597300053
J	Kasza, Z; Fuchs, PF; Tamm, C; Eriksson, AS; O'Callaghan, P; Heindryckx, F; Spillmann, D; Larsson, E; Le Jan, S; Eriksson, I; Gerwins, P; Kjellen, L; Kreuger, J				Kasza, Zsolt; Fuchs, Peder Fredlund; Tamm, Christoffer; Eriksson, Anna S.; O'Callaghan, Paul; Heindryckx, Femke; Spillmann, Dorothe; Larsson, Erik; Le Jan, Sebastien; Eriksson, Inger; Gerwins, Par; Kjellen, Lena; Kreuger, Johan			MicroRNA-24 Suppression of N-Deacetylase/N-Sulfotransferase-1 (NDST1) Reduces Endothelial Cell Responsiveness to Vascular Endothelial Growth Factor A (VEGFA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; DEACETYLASE/N-SULFOTRANSFERASE 1; EXPRESSION; BIOSYNTHESIS; ANGIOGENESIS; CHONDROITIN; MIGRATION; BINDING; DICER; MICE	Heparan sulfate (HS) proteoglycans, present at the plasma membrane of vascular endothelial cells, bind to the angiogenic growth factor VEGFA to modulate its signaling through VEGFR2. The interactions between VEGFA and proteoglycan co-receptors require sulfated domains in the HS chains. To date, it is essentially unknown how the formation of sulfated protein-binding domains in HS can be regulated by microRNAs. In the present study, we show that microRNA-24 (miR-24) targets NDST1 to reduce HS sulfation and thereby the binding affinity of HS for VEGFA. Elevated levels of miR-24 also resulted in reduced levels of VEGFR2 and blunted VEGFA signaling. Similarly, suppression of NDST1 using siRNA led to a reduction in VEGFR2 expression. Consequently, not only VEGFA binding, but also VEGFR2 protein expression is dependent on NDST1 function. Furthermore, overexpression of miR-24, or siRNA-mediated reduction of NDST1, reduced endothelial cell chemotaxis in response to VEGFA. These findings establish NDST1 as a target of miR-24 and demonstrate how such NDST1 suppression in endothelial cells results in reduced responsiveness to VEGFA.	[Kasza, Zsolt; Fuchs, Peder Fredlund; Tamm, Christoffer; Eriksson, Anna S.; O'Callaghan, Paul; Heindryckx, Femke; Spillmann, Dorothe; Le Jan, Sebastien; Eriksson, Inger; Gerwins, Par; Kjellen, Lena; Kreuger, Johan] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Gerwins, Par] Univ Uppsala Hosp, Dept Radiol, SE-75185 Uppsala, Sweden	Uppsala University; University of Gothenburg; Uppsala University; Uppsala University Hospital	Kreuger, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se	LE JAN, Sébastien/AAH-3952-2019; Larsson Lekholm, Erik/HDM-8032-2022; Kreuger, Johan/HDM-1503-2022; O'Callaghan, Paul/T-5308-2018; Larsson Lekholm, Erik/AHE-0932-2022	LE JAN, Sébastien/0000-0003-4027-2855; Larsson Lekholm, Erik/0000-0003-1400-0119; O'Callaghan, Paul/0000-0003-3117-5367; Larsson Lekholm, Erik/0000-0003-1400-0119; Heindryckx, Femke/0000-0002-1987-7676	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Foundation for Strategic Research; Foundation for Proteoglycan Research at Uppsala University; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation for Proteoglycan Research at Uppsala University; Uppsala University	This work was supported by grants from the Swedish Research Council (to J. K., L. K., and P. G.), the Swedish Cancer Society (to J. K., L. K., and P. G.) the Swedish Childhood Cancer Foundation (to J. K. and P. G), the Swedish Foundation for Strategic Research (to J. K.), the Foundation for Proteoglycan Research at Uppsala University (to J. K. and L. K.) and Uppsala University (to J. K., L. K., and P. G.).	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Adhikari N, 2010, J MOL CELL CARDIOL, V49, P287, DOI 10.1016/j.yjmcc.2010.02.022; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Barkefors I, 2011, J BIOL CHEM, V286, P24189, DOI 10.1074/jbc.M110.212209; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Dagalv A, 2011, J BIOL CHEM, V286, P44433, DOI 10.1074/jbc.M111.303891; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Grobe K, 2002, J BIOL CHEM, V277, P30699, DOI 10.1074/jbc.M111904200; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	49	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25956	25963		10.1074/jbc.M113.484360	http://dx.doi.org/10.1074/jbc.M113.484360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884416	Green Published, hybrid			2022-12-28	WOS:000330623300026
J	Luo, SC; Lou, YC; Rajasekaran, M; Chang, YW; Hsiao, CD; Chen, CP				Luo, Shih-Chi; Lou, Yuan-Chao; Rajasekaran, Mahalingam; Chang, Yi-Wei; Hsiao, Chwan-Deng; Chen, Chinpan			Structural Basis of a Physical Blockage Mechanism for the Interaction of Response Regulator PmrA with Connector Protein PmrD from Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POLYMYXIN-RESISTANT; 2-COMPONENT SYSTEM; RECEIVER DOMAIN; ACTIVATION; PHOSPHORYLATION; CHEY; STABILITY; PATHWAYS	In bacteria, the two-component system is the most prevalent for sensing and transducing environmental signals into the cell. The PmrA-PmrB two-component system, responsible for sensing external stimuli of high Fe3+ and mild acidic conditions, can control the genes involved in lipopolysaccharide modification and polymyxin resistance in pathogens. In Klebsiella pneumoniae, the small basic connector protein PmrD protects phospho- PmrA and prolongs the expression of PmrA-activated genes. We previously determined the phospho-PmrA recognition mode of PmrD. However, how PmrA interacts with PmrD and prevents its dephosphorylation remains unknown. To address this question, we solved the x-ray crystal structure of the N-terminal receiver domain of BeF3--activated PmrA ( PmrA(N)) at 1.70 angstrom. With this structure, we applied the data-driven docking method based on NMR chemical shift perturbation to generate the complex model of PmrD-PmrA(N), which was further validated by site-directed spin labeling experiments. In the complex model, PmrD may act as a blockade to prevent phosphatase from contacting with the phosphorylation site on PmrA.	[Luo, Shih-Chi; Lou, Yuan-Chao; Rajasekaran, Mahalingam; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Yi-Wei; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chen, Chinpan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University	Chen, CP (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	bmchinp@ibms.sinica.edu.tw	Mahalingam, Rajasekaran/E-2065-2013; Luo, Shih-Chi/C-1042-2011; Hsiao, Chwan-Deng/AAZ-8869-2021; Chen, Chinpan/O-4202-2018; Chang, Yi-Wei/ABH-1418-2020	Luo, Shih-Chi/0000-0001-7723-3230; Hsiao, Chwan-Deng/0000-0002-7012-1532; Chang, Yi-Wei/0000-0003-2391-473X; Mahalingam, Rajasekaran/0000-0003-2228-5628	Academia Sinica; National Science Council in Taiwan [NSC 97-2311-B-001-013-MY3]; Ministry of Education (Taiwan) under the ATU plan	Academia Sinica(Academia Sinica - Taiwan); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education (Taiwan) under the ATU plan(Ministry of Education, Taiwan)	This work was supported by grants from Academia Sinica and the National Science Council (NSC 97-2311-B-001-013-MY3) in Taiwan and in part by the Ministry of Education (Taiwan) under the ATU plan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Asensio A, 2000, CLIN INFECT DIS, V30, P55, DOI 10.1086/313590; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; CHOTHIA C, 1976, P NATL ACAD SCI USA, V73, P3793, DOI 10.1073/pnas.73.11.3793; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Goddard D., 2008, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Helander IM, 1996, EUR J BIOCHEM, V237, P272, DOI 10.1111/j.1432-1033.1996.0272n.x; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; JANIN J, 1976, J MOL BIOL, V100, P197, DOI 10.1016/S0022-2836(76)80148-9; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Luo SC, 2010, J STRUCT BIOL, V172, P319, DOI 10.1016/j.jsb.2010.06.007; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; O'Connell MR, 2009, PROTEOMICS, V9, P5224, DOI 10.1002/pmic.200900303; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 1989, MOL CLONING LABORATO, V3, pA3; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2003, BIOCHEMISTRY-US, V42, P14075, DOI 10.1021/bi034883t; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	61	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25551	25561		10.1074/jbc.M113.481978	http://dx.doi.org/10.1074/jbc.M113.481978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861396	Green Published, hybrid			2022-12-28	WOS:000330619000050
J	Muramatsu, D; Singh, PB; Kimura, H; Tachibana, M; Shinkai, Y				Muramatsu, Daisuke; Singh, Prim B.; Kimura, Hiroshi; Tachibana, Makoto; Shinkai, Yoichi			Pericentric Heterochromatin Generated by HP1 Protein Interaction-defective Histone Methyltransferase Suv39h1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-9 METHYLATION; EMBRYONIC STEM-CELLS; EPIGENETIC REGULATION; MENTAL-RETARDATION; CHROMO DOMAIN; FISSION YEAST; LOCALIZATION; MAINTENANCE; BINDING; ATRX	Pericentric regions form epigenetically organized silent heterochromatin structures that accumulate histone H3 lysine 9 trimethylation (H3K9me3) and HP1. At pericentric regions, Suv39h is the major enzyme that generates H3K9me3. Suv39h also interacts directly with HP1, a methylated H3K9-binding protein. However, it is not well characterized how HP1 interaction is important for Suv39h accumulation and Suv39h-mediated H3K9me3 formation at the pericentromere. To address this, we introduced the HP1 binding-defective N-terminally truncated mouse Suv39h1 (Delta N) into Suv39h-deficient embryonic stem cells. Interestingly, pericentric accumulation of Delta N and Delta N-mediated H3K9me3 was observed to recover, but HP1 accumulation was only marginally restored. Delta N also rescued DNA methyltransferase Dnmt3a and -3b accumulation and DNA methylation of the pericentromere. In contrast, other pericentric heterochromatin features, such as ATRX protein association and H4K20me3, were not recovered. Finally, derepressed major satellite repeats were partially silenced by Delta N expression. These findings clearly showed that the Suv39h-HP1 binding is dispensable for pericentric H3K9me3 and DNA methylation, but this interaction and HP1 recruitment/accumulation seem to be crucial for complete formation of heterochromatin.	[Muramatsu, Daisuke; Tachibana, Makoto] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068507, Japan; [Muramatsu, Daisuke; Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Wako, Saitama 3510198, Japan; [Singh, Prim B.] Charite, Inst Zell & Neurobiol, D-10117 Berlin, Germany; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tachibana, Makoto] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Shinkai, Yoichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; RIKEN; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Osaka University; Kyoto University; Japan Science & Technology Agency (JST)	Shinkai, Y (corresponding author), RIKEN, Cellular Memory Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yshinkai@riken.jp	Kimura, Hiroshi/B-9524-2015; Singh, Prim/G-1088-2014	Kimura, Hiroshi/0000-0003-0854-083X; Singh, Prim/0000-0002-9571-0974	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by JST-CREST.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, 2007, EPIGENETICS, P23; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Ekwall K, 1996, J CELL SCI, V109, P2637; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Haldar S, 2011, J BIOL CHEM, V286, P9308, DOI 10.1074/jbc.M110.143198; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Kouzarides T, 2007, EPIGENETICS, P191; Krouwels IM, 2005, J CELL BIOL, V170, P537, DOI 10.1083/jcb.200502154; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; VISSEL B, 1989, GENOMICS, V5, P407, DOI 10.1016/0888-7543(89)90003-7; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052977; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	43	24	26	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25285	25296		10.1074/jbc.M113.470724	http://dx.doi.org/10.1074/jbc.M113.470724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836914	Green Published, hybrid			2022-12-28	WOS:000330619000027
J	Dustrude, ET; Wilson, SM; Ju, WN; Xiao, YC; Khanna, R				Dustrude, Erik T.; Wilson, Sarah M.; Ju, Weina; Xiao, Yucheng; Khanna, Rajesh			CRMP2 Protein SUMOylation Modulates NaV1.7 Channel Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; RESPONSE MEDIATOR PROTEIN-2; TRAUMATIC BRAIN-INJURY; SPINAL SENSORY NEURONS; ROOT GANGLION NEURONS; GROWTH CONE COLLAPSE; SUMO MODIFICATION; SLOW INACTIVATION; NEUROPATHIC PAIN; ANTICONVULSANT LACOSAMIDE	Voltage-gated sodium channel (NaV) trafficking is incompletely understood. Post-translational modifications of NaVs and/or auxiliary subunits and protein-protein interactions have been posited as NaV-trafficking mechanisms. Here, we tested if modification of the axonal collapsin response mediator protein 2 (CRMP2) by a small ubiquitin-like modifier (SUMO) could affect NaV trafficking; CRMP2 alters the extent of NaV slow inactivation conferred by the anti-epileptic (R)-lacosamide, implying NaV-CRMP2 functional coupling. Expression of a CRMP2 SUMOylation-incompetent mutant (CRMP2-K374A) in neuronal model catecholamine A differentiated (CAD) cells did not alter lacosamide-induced NaV slow inactivation compared with CAD cells expressing wild type CRMP2. Like wild type CRMP2, CRMP2-K374A expressed robustly in CAD cells. Neurite outgrowth, a canonical CRMP2 function, was moderately reduced by the mutation but was still significantly higher than enhanced GFP-transfected cortical neurons. Notably, huwentoxin-IV-sensitive NaV1.7 currents, which predominate in CAD cells, were significantly reduced in CAD cells expressing CRMP2-K374A. Increasing deSUMOylation with sentrin/SUMO-specific protease SENP1 or SENP2 in wild type CRMP2-expressing CAD cells decreased NaV1.7 currents. Consistent with a reduction in current density, biotinylation revealed a significant reduction in surface NaV1.7 levels in CAD cells expressing CRMP2-K374A; surface NaV1.7 expression was also decreased by SENP1 + SENP2 overexpression. Currents in HEK293 cells stably expressing NaV1.7 were reduced by CRMP2-K374A in a manner dependent on the E2-conjugating enzyme Ubc9. No decrement in current density was observed in HEK293 cells co-expressing CRMP2-K374A and NaV1.1 or NaV1.3. Diminution of sodium currents, largely NaV1.7, was recapitulated in sensory neurons expressing CRMP2-K374A. Our study elucidates a novel regulatory mechanism that utilizes CRMP2 SUMOylation to choreograph NaV1.7 trafficking.	[Dustrude, Erik T.; Wilson, Sarah M.; Khanna, Rajesh] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ju, Weina; Xiao, Yucheng; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 West Walnut St,R2 Bldg,Rm 478, Indianapolis, IN 46202 USA.	khanna5@iu.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health Clinical and Translational Sciences Grant from the Indiana Clinical and Translational Sciences Institute [RR025761]; NCRR Project Development Team; Indiana State Department of Health-Spinal Cord and Brain Injury Fund [A70-9-079138]; National Scientist Development Grant from the American Heart Association [SDG5280023]; Neurofibromatosis New Investigator Award from the Department of Defense/Congressionally Directed Medical Research Program [NF1000099]; Stark fellowships; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER	National Institutes of Health Clinical and Translational Sciences Grant from the Indiana Clinical and Translational Sciences Institute; NCRR Project Development Team; Indiana State Department of Health-Spinal Cord and Brain Injury Fund; National Scientist Development Grant from the American Heart Association; Neurofibromatosis New Investigator Award from the Department of Defense/Congressionally Directed Medical Research Program; Stark fellowships; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Clinical and Translational Sciences Grant RR025761 from the Indiana Clinical and Translational Sciences Institute funded by NCRR Project Development Team. This work was also supported by the Indiana State Department of Health-Spinal Cord and Brain Injury Fund A70-9-079138 (to R. K.), National Scientist Development Grant SDG5280023 from the American Heart Association (to R. K.), and Neurofibromatosis New Investigator Award NF1000099 from the Department of Defense/Congressionally Directed Medical Research Program (to R. K.).; Supported in part by Stark fellowships.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Benson M, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P117, DOI 10.1007/978-90-481-2649-1_7; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; Chi XX, 2007, J NEUROPHYSIOL, V98, P2683, DOI 10.1152/jn.00437.2007; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Duprez E, 1999, J CELL SCI, V112, P381; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Errington AC, 2006, NEUROPHARMACOLOGY, V50, P1016, DOI 10.1016/j.neuropharm.2006.02.002; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Hodgdon KE, 2012, NEUROSCIENCE, V206, P237, DOI 10.1016/j.neuroscience.2011.12.045; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Ju WN, 2013, CHANNELS, V7, P153, DOI 10.4161/chan.24224; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kim CH, 2001, MOL BRAIN RES, V95, P153, DOI 10.1016/S0169-328X(01)00226-1; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; King AM, 2012, ACS CHEM NEUROSCI, V3, P1037, DOI 10.1021/cn300129d; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Park KD, 2010, ORG BIOMOL CHEM, V8, P2803, DOI 10.1039/c000987c; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Theile JW, 2011, MOL PHARMACOL, V80, P724, DOI 10.1124/mol.111.072751; Vacher H, 2012, EPILEPSIA, V53, P21, DOI 10.1111/epi.12032; Wang LH, 1997, J NEUROCHEM, V69, P2261; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P90, DOI 10.1021/cn100089b; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wilson SM, 2012, J BIOL CHEM, V287, P35065, DOI 10.1074/jbc.M112.378695; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; Wolff C, 2012, CNS NEUROSCI THER, V18, P493, DOI 10.1111/j.1755-5949.2012.00313.x; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	80	59	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24316	24331		10.1074/jbc.M113.474924	http://dx.doi.org/10.1074/jbc.M113.474924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836888	Green Published, hybrid			2022-12-28	WOS:000330612300004
J	Parker-Duffen, JL; Nakamura, K; Silver, M; Kikuchi, R; Tigges, U; Yoshida, S; Denzel, MS; Ranscht, B; Walsh, K				Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Kikuchi, Ryosuke; Tigges, Ulrich; Yoshida, Sumiko; Denzel, Martin S.; Ranscht, Barbara; Walsh, Kenneth			T-cadherin Is Essential for Adiponectin-mediated Revascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULE; STIMULATES ANGIOGENESIS; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; IDENTIFIES CDH13; BINDING PROTEIN; SMOOTH-MUSCLE	Adipose tissue secretes protein factors that have systemic actions on cardiovascular tissues. Previous studies have shown that ablation of the adipocyte-secreted protein adiponectin leads to endothelial dysfunction, whereas its overexpression promotes wound healing. However, the receptor(s) mediating the protective effects of adiponectin on the vasculature is not known. Here we examined the role of membrane protein T-cadherin, which localizes adiponectin to the vascular endothelium, in the revascularization response to chronic ischemia. T-cadherin-deficient mice were analyzed in a model of hind limb ischemia where blood flow is surgically disrupted in one limb and recovery is monitored over 28 days by laser Doppler perfusion imaging. In this model, T-cadherin-deficient mice phenocopy adiponectin-deficient mice such that both strains display an impaired blood flow recovery compared with wildtype controls. Delivery of exogenous adiponectin rescued the impaired revascularization phenotype in adiponectin-deficient mice but not in T-cadherin-deficient mice. In cultured endothelial cells, T-cadherin deficiency by siRNA knockdown prevented the ability of adiponectin to promote cellular migration and proliferation. These data highlight a previously unrecognized role for T-cadherin in limb revascularization and show that it is essential for mediating the vascular actions of adiponectin.	[Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Kikuchi, Ryosuke; Yoshida, Sumiko; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Parker-Duffen, Jennifer L.; Walsh, Kenneth] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Tigges, Ulrich; Denzel, Martin S.; Ranscht, Barbara] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Boston University; Boston University; Sanford Burnham Prebys Medical Discovery Institute	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Kikuchi, Ryosuke/AAX-4971-2021; Denzel, Martin/C-9047-2014	Denzel, Martin/0000-0002-5691-3349; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG34972, HL81587, HL68758, HL102680, HL007969, GM008541]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, P01HL068758, R21HL102680, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG34972, HL81587, and HL68758 (to K. W.); HL102680 (to B. R.); and HL007969 and GM008541, predoctoral training grants in cardiovascular biology and biomolecular pharmacology, respectively (to J. P. D.).	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Alvarez G, 2012, J VASC RES, V49, P111, DOI 10.1159/000332332; Andreeva AV, 2010, GENE CHROMOSOME CANC, V49, P775, DOI 10.1002/gcc.20787; Andreeva AV, 2009, AM J PHYSIOL-CELL PH, V297, pC1168, DOI 10.1152/ajpcell.00237.2009; Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; Asada K, 2007, INT J MOL MED, V20, P725; Aslibekyan S., 2013, NUTR METAB IN PRESS; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Coyenechea E, 2009, HORM METAB RES, V41, P55, DOI 10.1055/s-0028-1087204; de Liefde II, 2010, EUR J CARDIOV PREV R, V17, P321, DOI 10.1097/HJR.0b013e32833254ce; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Dong CH, 2011, J LIPID RES, V52, P1411, DOI 10.1194/jlr.P013672; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Jo J, 2012, OBESITY, V20, P1683, DOI 10.1038/oby.2011.128; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Joshi MB, 2009, FASEB J, V23, P4011, DOI 10.1096/fj.09-133611; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2006, EXPERT OPIN THER TAR, V10, P573, DOI 10.1517/14728222.10.4.573; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Peach G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5208; Peake PW, 2006, BIOCHEM BIOPH RES CO, V341, P108, DOI 10.1016/j.bbrc.2005.12.162; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004; Philippova MP, 1998, FEBS LETT, V429, P207, DOI 10.1016/S0014-5793(98)00598-5; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; RANSCHT B, 1991, DEVELOPMENT, V111, P15; Rubina K, 2005, MOL CELL BIOCHEM, V273, P33, DOI 10.1007/s11010-005-0250-5; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Sumner AD, 2012, J CLIN HYPERTENS, V14, P144, DOI 10.1111/j.1751-7176.2011.00580.x; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tkachuk VA, 1998, FEBS LETT, V421, P208, DOI 10.1016/S0014-5793(97)01562-7; Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Wyder L, 2000, CANCER RES, V60, P4682; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	66	108	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24886	24897		10.1074/jbc.M113.454835	http://dx.doi.org/10.1074/jbc.M113.454835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824191	Green Published, hybrid			2022-12-28	WOS:000330612300053
J	Caballero-Franco, C; Choo, MK; Sano, Y; Ritprajak, P; Sakurai, H; Otsu, K; Mizoguchi, A; Park, JM				Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Sakurai, Hiroaki; Otsu, Kinya; Mizoguchi, Atsushi; Park, Jin Mo			Tuning of Protein Kinase Circuitry by p38 alpha Is Vital for Epithelial Tissue Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; MAP KINASE; CELL PROLIFERATION; JNK ACTIVATION; DOUBLE-BLIND; P38; STEM; INHIBITION; ALPHA	The epithelium of mucosal and skin surfaces serves as a permeability barrier and affords mechanisms for local immune defense. Crucial to the development and maintenance of a properly functioning epithelium is the balance of cell proliferation, differentiation, and death. Here we show that this balance depends on cross-regulatory interactions among multiple protein kinase-mediated signals and their coordinated transmission. From an investigation of conditional gene knock-out mice, we find that epithelial-specific loss of the protein kinase p38 alpha leads to aberrant activation of TAK1, JNK, EGF receptor, and ERK in distinct microanatomical areas of the intestines and skin. Consequently, the epithelial tissues display excessive proliferation, inadequate differentiation, and sensitivity to apoptosis. These anomalies leave the tissue prone to damage and collapse at the trigger of an environmental insult. The vulnerability of p38 alpha-deficient epithelium predicts adverse effects of long term pharmacological p38 alpha inhibition; yet such limitations could be overcome by concomitant blockade of one or more of the dysregulated protein kinase signaling pathways.	[Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Mizoguchi, Atsushi; Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ritprajak, Patcharee] Chulalongkorn Univ, Fac Dent, Dept Microbiol & Immunol, Bangkok 10330, Thailand; [Ritprajak, Patcharee] Chulalongkorn Univ, Fac Dent, Dent Res Unit Oral Microbiol, Bangkok 10330, Thailand; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Mizoguchi, Atsushi] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Chulalongkorn University; Chulalongkorn University; University of Toyama; Osaka University; University of London; King's College London; Harvard University; Massachusetts General Hospital	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 Thirteenth St, Charlestown, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu	Sakurai, Hiroaki/AAE-4294-2019	Sakurai, Hiroaki/0000-0003-0657-9570	National Institutes of Health [AI074957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant AI074957 (to J. M. P.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guma M, 2012, ARTHRITIS RHEUM-US, V64, P2887, DOI 10.1002/art.34489; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Ritprajak P, 2012, P NATL ACAD SCI USA, V109, P9089, DOI 10.1073/pnas.1202984109; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vereecke L, 2011, TRENDS MOL MED, V17, P584, DOI 10.1016/j.molmed.2011.05.011; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	49	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23788	23797		10.1074/jbc.M113.452029	http://dx.doi.org/10.1074/jbc.M113.452029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836897	hybrid, Green Published			2022-12-28	WOS:000330611400018
J	Piekna-Przybylska, D; Sharma, G; Bambara, RA				Piekna-Przybylska, Dorota; Sharma, Gaurav; Bambara, Robert A.			Mechanism of HIV-1 RNA Dimerization in the Central Region of the Genome and Significance for Viral Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; G-QUADRUPLEX STRUCTURES; MESSENGER-RNA; REVERSE-TRANSCRIPTASE; G-QUARTET; MOLECULAR-WEIGHT; PROMOTER REGION; SARCOMA-VIRUS; RECOMBINATION; DNA	The genome of HIV-1 consists of two identical or nearly identical RNA molecules. The RNA genomes are held in the same, parallel orientation by interactions at the dimer initiation site (DIS). Previous studies showed that in addition to interactions at DIS, sequences located 100 nucleotides downstream from the 5' splice site can dimerize in vitro through an intermolecular G-quartet structure. Here we report that the highly conserved G-rich sequence in the middle portion of the HIV-1 genome near the central polypurine tract (cPPT) dimerizes spontaneously under high ionic strength in the absence of protein. The antisense RNA does not dimerize, strongly indicating that RNA dimerization does not exclusively involve A: U and G: C base pairing. The cation-dependent reverse transcriptase pausing profile, CD spectra profile, and cation-dependent association and thermal dissociation characteristics indicate G-quartet structures. Different forms of G-quartets are formed including monomers and, significantly, intermolecular dimers. Our results indicate that RNA genome dimerization and parallel alignment initiated through interactions at DIS may be greatly expanded and stabilized by formation of an intermolecular G-quartet at a distant site near the cPPT. It is likely that formation of G-quartet structure near the cPPT in vivo keeps the RNA genomes in proximity over a long range, promoting genetic recombination in numerous hot spots.	[Piekna-Przybylska, Dorota; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Sharma, Gaurav] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Sharma, Gaurav/A-1154-2007	Sharma, Gaurav/0000-0001-9735-9519	National Institutes of Health [GM049573, GM097334]; University of Rochester Developmental Center for AIDS Research Grant [P30 AI078498]; University of Rochester School of Medicine and Dentistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573, R01GM097334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Developmental Center for AIDS Research Grant; University of Rochester School of Medicine and Dentistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049573 (to R. A. B.) and GM097334 (to G. S.) and University of Rochester Developmental Center for AIDS Research Grant P30 AI078498 (NIAID). This work was also supported by the University of Rochester School of Medicine and Dentistry.	AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; BENDER W, 1978, J VIROL, V25, P888, DOI 10.1128/JVI.25.3.888-896.1978; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; Fan J, 2007, INFECT GENET EVOL, V7, P717, DOI 10.1016/j.meegid.2007.07.012; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; KUNG HJ, 1976, CELL, V7, P609, DOI 10.1016/0092-8674(76)90211-7; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Ly H, 1999, J VIROL, V73, P7255, DOI 10.1128/JVI.73.9.7255-7261.1999; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; MANGEL WF, 1974, P NATL ACAD SCI USA, V71, P4541, DOI 10.1073/pnas.71.11.4541; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; Moore MD, 2007, J VIROL, V81, P4002, DOI 10.1128/JVI.02589-06; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; MURTI KG, 1981, J VIROL, V37, P411, DOI 10.1128/JVI.37.1.411-419.1981; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Ortiz-Conde BA, 1999, J VIROL, V73, P7165, DOI 10.1128/JVI.73.9.7165-7174.1999; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Shen N, 2000, J VIROL, V74, P5729, DOI 10.1128/JVI.74.12.5729-5735.2000; Shen W, 2011, J BIOL CHEM, V286, P29838, DOI 10.1074/jbc.M111.262352; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Smargiasso N, 2008, J AM CHEM SOC, V130, P10208, DOI 10.1021/ja801535e; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	47	25	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24140	24150		10.1074/jbc.M113.477265	http://dx.doi.org/10.1074/jbc.M113.477265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839990	Green Published, hybrid			2022-12-28	WOS:000330611400049
J	Trinh, AT; Kim, SH; Chang, HY; Mastrocola, AS; Tibbetts, RS				Trinh, Anthony T.; Kim, Sang Hwa; Chang, Hae-yoon; Mastrocola, Adam S.; Tibbetts, Randal S.			Cyclin-dependent Kinase 1-dependent Phosphorylation of cAMP Response Element-binding Protein Decreases Chromatin Occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB TRANSCRIPTIONAL ACTIVITY; APLYSIA SENSORY NEURONS; DNA-BINDING; KIX DOMAIN; ACTIVATION; COMPLEX; HIPK2; CBP; P53; IDENTIFICATION	The cyclic AMP response element-binding protein (CREB) initiates transcriptional responses to a wide variety of stimuli. CREB activation involves its phosphorylation on Ser-133, which promotes interaction between the CREB kinase-inducible domain (KID) and the KID-interacting domain of the transcriptional coactivator, CREB-binding protein (CBP). The KID also contains a highly conserved phosphorylation cluster, termed the ATM/CK cluster, which is processively phosphorylated in response to DNA damage by the coordinated actions of ataxia-telangiectasia-mutated (ATM) and casein kinases (CKs) 1 and 2. The ATM/CK cluster phosphorylation attenuates CBP binding and CREB transcriptional activity. Paradoxically, it was recently reported that DNA damage activates CREB through homeodomain-interacting protein kinase 2-dependent phosphorylation of Ser-271 near the CREB bZIP DNA binding domain. In this study we sought to further clarify DNA damage-dependent CREB phosphorylation as well as to explore the possibility that the ATM/CK cluster and Ser-271 synergistically or antagonistically modulate CREB activity. We show that, rather than being induced by DNA damage, Ser-270 and Ser-271 of CREB cophosphorylated in a CDK1-dependent manner during G(2)/M phase. Functionally, we show that phosphorylation of CREB on Ser-270/Ser-271 during mitosis correlated with reduced CREB chromatin occupancy. Furthermore, CDK1-dependent phosphorylation of CREB in vitro inhibited its DNA binding activity. The combined results suggest that CDK1-dependent phosphorylation of CREB on Ser-270/Ser-271 facilitates its dissociation from chromatin during mitosis by reducing its intrinsic DNA binding potential.	[Trinh, Anthony T.; Kim, Sang Hwa; Chang, Hae-yoon; Mastrocola, Adam S.; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, Dept Human Oncol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, Dept Human Oncol, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [R01 CA 124722-01]; American Heart Association; Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 124722-01 (to R. S. T.). This work was also supported by an American Heart Association predoctoral fellowship (to A. T. T.) and the Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Chong YH, 2003, MOL PHARMACOL, V63, P690, DOI 10.1124/mol.63.3.690; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; JORDAN MA, 1992, J CELL SCI, V102, P401; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2005, J BIOL CHEM, V280, P15103, DOI 10.1074/jbc.M414144200; Memin E, 2011, EXP CELL RES, V317, P2490, DOI 10.1016/j.yexcr.2011.07.001; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Sakamoto K, 2010, MOL BIOL CELL, V21, P2966, DOI 10.1091/mbc.E10-01-0015; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkaria JN, 1998, CANCER RES, V58, P4375; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	52	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23765	23775		10.1074/jbc.M113.464057	http://dx.doi.org/10.1074/jbc.M113.464057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814058	hybrid, Green Published			2022-12-28	WOS:000330611400016
J	Krupnik, T; Kotabova, E; van Bezouwen, LS; Mazur, R; Garstka, M; Nixon, PJ; Barber, J; Kana, R; Boekema, EJ; Kargul, J				Krupnik, Tomasz; Kotabova, Eva; van Bezouwen, Laura S.; Mazur, Radoslaw; Garstka, Maciej; Nixon, Peter J.; Barber, James; Kana, Radek; Boekema, Egbert J.; Kargul, Joanna			A Reaction Center-dependent Photoprotection Mechanism in a Highly Robust Photosystem II from an Extremophilic Red Alga, Cyanidioschyzon merolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING ANTENNA; OXYGEN-EVOLVING CENTER; CHLOROPHYLL FLUORESCENCE; EXTRINSIC PROTEINS; PHOTOSYNTHETIC ACCLIMATION; PORPHYRIDIUM-CRUENTUM; CYANIDIUM-CALDARIUM; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; CORE COMPLEXES	Members of the rhodophytan order Cyanidiales are unique among phototrophs in their ability to live in extremely low pH levels and moderately high temperatures. The photosynthetic apparatus of the red alga Cyanidioschyzon merolae represents an intermediate type between cyanobacteria and higher plants, suggesting that this alga may provide the evolutionary link between prokaryotic and eukaryotic phototrophs. Although we now have a detailed structural model of photosystem II (PSII) from cyanobacteria at an atomic resolution, no corresponding structure of the eukaryotic PSII complex has been published to date. Here we report the isolation and characterization of a highly active and robust dimeric PSII complex from C. merolae. We show that this complex is highly stable across a range of extreme light, temperature, and pH conditions. By measuring fluorescence quenching properties of the isolated C. merolae PSII complex, we provide the first direct evidence of pH-dependent non-photochemical quenching in the red algal PSII reaction center. This type of quenching, together with high zeaxanthin content, appears to underlie photoprotection mechanisms that are efficiently employed by this robust natural water-splitting complex under excess irradiance. In order to provide structural details of this eukaryotic form of PSII, we have employed electron microscopy and single particle analyses to obtain a 17 angstrom map of the C. merolae PSII dimer in which we locate the position of the protein mass corresponding to the additional extrinsic protein stabilizing the oxygen-evolving complex, PsbQ'. We conclude that this lumenal subunit is present in the vicinity of the CP43 protein, close to the membrane plane.	[Krupnik, Tomasz; Kargul, Joanna] Univ Warsaw, Fac Biol, Dept Plant Mol Physiol, PL-02096 Warsaw, Poland; [Kotabova, Eva; Kana, Radek] Acad Sci Czech Republ, Inst Microbiol, Lab Photosynthesis, CZ-37981 Trebon, Czech Republic; [Kotabova, Eva; Kana, Radek] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [van Bezouwen, Laura S.; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy Grp, NL-9747 AG Groningen, Netherlands; [Mazur, Radoslaw; Garstka, Maciej] Univ Warsaw, Fac Biol, Dept Metab Regulat, PL-02096 Warsaw, Poland; [Nixon, Peter J.; Barber, James] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	University of Warsaw; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Groningen; University of Warsaw; Imperial College London	Kargul, J (corresponding author), Univ Warsaw, Fac Biol, Dept Plant Mol Physiol, Miecznikowa 1, PL-02096 Warsaw, Poland.	j.kargul@biol.uw.edu.pl	Kaňa, Radek/A-6434-2009; Kotabova, Eva/E-4560-2011; Krupnik, Tomasz/Q-3056-2016; Mazur, Radosław/P-3283-2019; Kargul, Joanna/AGD-9163-2022; Garstka, Maciej Z/T-4962-2018; Kargul, Joanna/AAN-4227-2021	Kaňa, Radek/0000-0001-5768-6902; Kotabova, Eva/0000-0003-1092-3020; Mazur, Radosław/0000-0003-3615-1911; Kargul, Joanna/0000-0003-1410-1905; Garstka, Maciej Z/0000-0001-7141-505X; Krupnik, Tomasz/0000-0001-6107-7667; Nixon, Peter/0000-0003-1952-6937	Polish Ministry of Science and Higher Education; European Science Foundation [844/N-ESFEuroSolarFuels/10/2011/0]; European Union; Czech Republic Academy of Sciences [GACR P501-120304, CZ.1.05/2.1.00/03.0110]; BBSRC [BB/I00937X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C507037/1, BB/I00937X/1] Funding Source: researchfish	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Science Foundation(European Science Foundation (ESF)European Commission); European Union(European Commission); Czech Republic Academy of Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Polish Ministry of Science and Higher Education and by European Science Foundation Grant 844/N-ESFEuroSolarFuels/10/2011/0 (to J. K.) and was partially performed with the use of CePT infrastructure financed by the European Union (European Regional Development Fund within the Operational Program "Innovative Economy" for 2007-2013) (to R. M. and M. G.).; Supported by Czech Republic Academy of Sciences Project GACR P501-120304 and Project Algatech (CZ.1.05/2.1.00/03.0110).	Adachi H, 2009, BBA-BIOENERGETICS, V1787, P121, DOI 10.1016/j.bbabio.2008.11.004; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Arteni AA, 2005, J STRUCT BIOL, V149, P325, DOI 10.1016/j.jsb.2004.12.002; Badura A, 2006, PHOTOCHEM PHOTOBIOL, V82, P1385, DOI 10.1562/2006-07-14-RC-969; Barber J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0984; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bruce D, 1997, BIOCHEMISTRY-US, V36, P749, DOI 10.1021/bi962216c; Bumba L, 2004, EUR J BIOCHEM, V271, P2967, DOI 10.1111/j.1432-1033.2004.04226.x; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Ciniglia C, 2004, MOL ECOL, V13, P1827, DOI 10.1111/j.1365-294X.2004.02180.x; Cox N., 2013, BIOCH BIOPH IN PRESS; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Cullen M, 2007, PHOTOCH PHOTOBIO SCI, V6, P1177, DOI 10.1039/b708611n; Cunningham FX, 2007, EUKARYOT CELL, V6, P533, DOI 10.1128/EC.00265-06; CUNNINGHAM FX, 1989, PLANT PHYSIOL, V91, P1179, DOI 10.1104/pp.91.3.1179; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; Dall'Osto L, 2012, J BIOL CHEM, V287, P41820, DOI 10.1074/jbc.M112.405498; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; de Groot HJM, 2010, APPL MAGN RESON, V37, P497, DOI 10.1007/s00723-009-0097-0; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Enami I, 1998, BIOCHEMISTRY-US, V37, P2787, DOI 10.1021/bi9724624; Enami I, 2010, CELL ORIG LIFE EXTRE, V13, P373, DOI 10.1007/978-90-481-3795-4_20; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank H. A., 1993, CAROTENOIDS PHOTOSYN, P252, DOI [10.1007/978-94-011-2124-8_8, DOI 10.1007/978-94-011-2124-8_8]; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Ivanov AG, 2008, PHOTOSYNTH RES, V98, P565, DOI 10.1007/s11120-008-9365-3; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kaminskaya O, 2005, BBA-BIOENERGETICS, V1708, P333, DOI 10.1016/j.bbabio.2005.05.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kana R, 2012, BBA-BIOENERGETICS, V1817, P1237, DOI 10.1016/j.bbabio.2012.02.024; Kargul J., 2012, PHOTSYNTHESIS RES FO, P59; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kargul J, 2007, BBA-BIOENERGETICS, V1767, P404, DOI 10.1016/j.bbabio.2007.01.007; Kato M, 2012, J AM CHEM SOC, V134, P8332, DOI 10.1021/ja301488d; Kirilovsky D., 2013, NONPHOTOCHEMICAL QUE; Koblizek M, 1999, PHOTOSYNTHETICA, V37, P307, DOI 10.1023/A:1007120424769; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0005-2728(92)90097-L; Kuhl H, 1999, EUR J BIOCHEM, V266, P453, DOI 10.1046/j.1432-1327.1999.00877.x; LAVERGNE J, 1982, BIOCHIM BIOPHYS ACTA, V682, P345, DOI 10.1016/0005-2728(82)90048-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Murray JW, 2008, PHOTOSYNTH RES, V98, P523, DOI 10.1007/s11120-008-9366-2; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Nocera DG, 2012, ACCOUNTS CHEM RES, V45, P767, DOI 10.1021/ar2003013; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Oren A, 1995, MAR ECOL PROG SER, V128, P151, DOI 10.3354/meps128151; Pagliano C, 2011, PHOTOSYNTH RES, V108, P33, DOI 10.1007/s11120-011-9650-4; Quigg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047036; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Rudowska L, 2012, BBA-BIOENERGETICS, V1817, P1380, DOI 10.1016/j.bbabio.2012.03.013; Santabarbara S, 2013, PLANT PHYSIOL, V161, P535, DOI 10.1104/pp.112.205260; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shi LX, 2000, J BIOL CHEM, V275, P37945, DOI 10.1074/jbc.M006300200; Siegbahn P. E., 2013, BIOCH BIOPH IN PRESS; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Sproviero EM, 2008, PHILOS T R SOC B, V363, P1149, DOI 10.1098/rstb.2007.2210; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; Vittadello M, 2010, CHEMSUSCHEM, V3, P471, DOI 10.1002/cssc.200900255; Wang ZG, 2010, J INTEGR PLANT BIOL, V52, P793, DOI 10.1111/j.1744-7909.2010.00971.x; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	85	46	46	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23529	23542		10.1074/jbc.M113.484659	http://dx.doi.org/10.1074/jbc.M113.484659			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775073	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000330598200057
J	Singhal, SS; Figarola, J; Singhal, J; Reddy, MA; Liu, XL; Berz, D; Natarajan, R; Awasthi, S				Singhal, Sharad S.; Figarola, James; Singhal, Jyotsana; Reddy, Marpadga A.; Liu, Xueli; Berz, David; Natarajan, Rama; Awasthi, Sanjay			RLIP76 Protein Knockdown Attenuates Obesity Due to a High-fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LEPTIN RESISTANCE; ADIPOCYTE HYPERTROPHY; DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; METABOLIC SYNDROME; GENE-EXPRESSION; KIDNEY-DISEASE; IN-VITRO; EPIDEMIOLOGY	Feeding a Western high-fat diet (HFD) to C57BL/6 mice induces obesity, associated with a chronic inflammatory state, lipid transport, and metabolic derangements, and organ system effects that particularly prominent in the kidneys. Here, we report that RLIP76 homozygous knock-out (RLIP76(-/-)) mice are highly resistant to obesity as well as these other features of metabolic syndrome caused by HFD. The normal increase in pro-inflammatory and fibrotic markers associated with HFD induced obesity in wild-type C57B mice was broadly and nearly completely abrogated in RLIP76(-/-) mice. This is a particularly striking finding because chemical markers of oxidative stress including lipid hydroperoxides and alkenals were significantly higher in RLIP76(-/-) mice. Whereas HFD caused marked suppression of AMPK in wild-type C57B mice, RLIP76(-/-) mice had baseline activation of AMP-activated protein kinase, which was not further affected by HFD. The baseline renal function was reduced in RLIP76(-/-) mice as compared with wild-type, but was unaffected by HFD, in marked contrast to severe renal impairment and glomerulopathy in the wild-type mice given HFD. Our findings confirm a fundamental role of RLIP76 in regulating the function of obesity-promoting pro-inflammatory cytokines, and provide a novel mechanism for targeted therapy of obesity and metabolic syndrome.	[Singhal, Sharad S.; Figarola, James; Singhal, Jyotsana; Reddy, Marpadga A.; Berz, David; Natarajan, Rama; Awasthi, Sanjay] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Liu, Xueli] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Biostat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Singhal, SS (corresponding author), City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	ssinghal@coh.org; sawasthi@coh.org	Awasthi, Sanjay/R-4904-2019	Reddy, Marpadga A/0000-0001-9259-7243; Awasthi, Sanjay/0000-0002-5214-5717; FIGAROLA, JAMES/0000-0003-3948-6282	National Institutes of Health from the NCI [RO1 CA77495]; Perricone Family Foundation, Los Angeles, CA; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [R01CA077495, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Perricone Family Foundation, Los Angeles, CA; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA77495 (to S. A.) from the NCI, and funds from the Perricone Family Foundation, Los Angeles, CA, and the Beckman Research Institute of the City of Hope (to S. A.).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; Awasthi S, 2010, DIABETES, V59, P714, DOI 10.2337/db09-0911; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Beltowski J, 2006, MED SCI MONITOR, V12, pRA112; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; El-Bikai R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3173; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Gil A, 2007, BRIT J NUTR, V98, pS121, DOI 10.1017/S0007114507838050; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kadowaki T, 2002, J DIABETES COMPLICAT, V16, P41, DOI 10.1016/S1056-8727(01)00206-9; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Lee J, 2013, ARCH PHARM RES, V36, P208, DOI 10.1007/s12272-013-0023-8; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Malavazos AE, 2007, NUTR METAB CARDIOVAS, V17, P294, DOI 10.1016/j.numecd.2006.01.001; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; NORDSIEK FW, 1964, AM J PUBLIC HEALTH N, V54, P1689, DOI 10.2105/AJPH.54.10.1689; O'Rourke RW, 2006, CLIN EXP IMMUNOL, V146, P39, DOI 10.1111/j.1365-2249.2006.03186.x; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Okwan-Duodu D, 2013, AM J CANCER RES, V3, P21; Pender JR, 2005, GASTROENTEROL CLIN N, V34, P1, DOI 10.1016/j.gtc.2004.12.010; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Singhal J, 2008, INT J RADIAT ONCOL, V72, P553, DOI 10.1016/j.ijrobp.2008.06.1497; Singhal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024688; Singhal SS, 2011, MOL CANCER THER, V10, P16, DOI 10.1158/1535-7163.MCT-10-0699; SINGMAN HS, 1980, AM J CLIN NUTR, V33, P1183, DOI 10.1093/ajcn/33.6.1183; Skurk T, 2002, HORM METAB RES, V34, P659, DOI 10.1055/s-2002-38253; Strandberg L, 2008, OBESITY, V16, P710, DOI 10.1038/oby.2007.95; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Tanner RM, 2012, CURR HYPERTENS REP, V14, P152, DOI 10.1007/s11906-012-0254-y; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200	57	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23394	23406		10.1074/jbc.M113.480194	http://dx.doi.org/10.1074/jbc.M113.480194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23821548	Green Published, hybrid			2022-12-28	WOS:000330598200043
J	Cheung, KL; Lee, JH; Shu, L; Kim, JH; Sacks, DB; Kong, ANT				Cheung, Ka Lung; Lee, Jong Hun; Shu, Limin; Kim, Jung-Hwan; Sacks, David B.; Kong, Ah-Ng Tony			The Ras GTPase-activating-like Protein IQGAP1 Mediates Nrf2 Protein Activation via the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Kinase (MEK)-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; BINDING PROTEIN; NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; HEME OXYGENASE-1; GENE-EXPRESSION; HEPG2 CELLS; CALMODULIN; INDUCTION; IDENTIFICATION	Nrf2 plays a critical role in the regulation of cellular oxidative stress. MEK-ERK activation has been shown to be one of the major pathways resulting in the activation of Nrf2 and induction of Nrf2 downstream targets, including phase II detoxifying/antioxidant genes in response to oxidative stress and xenobiotics. In this study, IQGAP1 (IQ motif-containing GTPase-activating protein 1), a new Nrf2 interaction partner that we have published previously, was found to modulate MEK-ERK-mediated Nrf2 activation and induction of phase II detoxifying/antioxidant genes. Nrf2 binds directly to the IQ domain (amino acids 699-905) of IQGAP1. Knockdown of IQGAP1 significantly attenuated phenethyl isothiocyanate-or MEK-mediated activation of the MEK-ERK-Nrf2 pathway. Knockdown of IQGAP1 also attenuated MEK-mediated increased stability of Nrf2, which in turn was associated with a decrease in the nuclear translocation of Nrf2 and a decrease in the expression of phase II detoxifying/antioxidant genes. In the aggregate, these results suggest that IQGAP1 may play an important role in the MEK-ERK-Nrf2 signaling pathway.	[Cheung, Ka Lung] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ 08854 USA; [Cheung, Ka Lung; Lee, Jong Hun; Shu, Limin; Kim, Jung-Hwan; Kong, Ah-Ng Tony] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA	Kong, ANT (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	kongt@pharmacy.rutgers.edu	Kong, Ah-Ng Tony/AAX-2828-2020	Kim, Jung Hwan/0000-0002-2975-4899; Sacks, David/0000-0003-3100-0735; Lee, Jong Hun/0000-0002-3083-7595	CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	CLINICAL CENTER		Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brill S, 1996, MOL CELL BIOL, V16, P4869; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kim JH, 2013, ANTIOXID REDOX SIGN, V19, P89, DOI 10.1089/ars.2012.4586; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234	35	34	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22378	22386		10.1074/jbc.M112.444182	http://dx.doi.org/10.1074/jbc.M112.444182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788642	Green Published, hybrid			2022-12-28	WOS:000330596300019
J	Lai, JB; Linder, ME				Lai, Jianbin; Linder, Maurine E.			Oligomerization of DHHC Protein S-Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; SACCHAROMYCES-CEREVISIAE; MEDIATED PALMITOYLATION; DOMAIN; IDENTIFICATION; LOCALIZATION; TRANSFERASE; ACTIVATION; MECHANISM; ENZYMES	The formation of dimers or higher-order oligomers is a property of numerous integral membrane proteins, including ion channels, transporters, and receptors. In this study, we examined whether members of the DHHC-S-acyltransferase family oligomerize in intact cells and in vitro. DHHC-S-acyltransferases are integral membrane proteins that catalyze the addition of palmitate to cysteine residues on proteins at the cytoplasmic face of cell membranes. Bioluminescence resonance energy transfer (BRET) experiments revealed that DHHC2 or DHHC3 (Golgi-specific DHHC zinc finger protein (GODZ)) self-associate when expressed in HEK-293 cells. Homomultimer formation was confirmed by coimmunoprecipitation. Purified DHHC3 resolved predominately as a monomer and dimer on blue native polyacrylamide gels. In intact cells and in vitro, catalytically inactive DHHC proteins displayed a greater propensity to form dimers. BRET signals were higher for the catalytically inactive DHHC2 or DHHC3 than their wild-type counterparts. DHHC3 BRET in cell membranes was decreased by the addition of its lipid substrate palmitoyl-CoA, a treatment that results in autoacylation of the enzyme. Enzyme activity of a covalently linked DHHC3 dimer was less than that of the monomeric form, suggesting that enzyme activity may be modulated by the oligomerization status of the protein.	[Lai, Jianbin; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Linder, ME (corresponding author), Cornell Univ, CVM Box 41, Ithaca, NY 14853 USA.	mel237@cornell.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [RO1GM51466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM51466 (to M. E. L.).	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Batistic O, 2012, PLANT PHYSIOL, V160, P1597, DOI 10.1104/pp.112.203968; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Misumi Y, 2001, J BIOL CHEM, V276, P6867, DOI 10.1074/jbc.M010121200; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	29	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22862	22870		10.1074/jbc.M113.458794	http://dx.doi.org/10.1074/jbc.M113.458794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793055	Green Published, hybrid			2022-12-28	WOS:000330596300062
J	Rosen, O; Weil, S; Manor, R; Roth, Z; Khalaila, I; Sagi, A				Rosen, Ohad; Weil, Simy; Manor, Rivka; Roth, Ziv; Khalaila, Isam; Sagi, Amir			A Crayfish Insulin-like-binding Protein ANOTHER PIECE IN THE ANDROGENIC GLAND INSULIN-LIKE HORMONE PUZZLE IS REVEALED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHERAX-QUADRICARINATUS; IGF-I; GROWTH; RECEPTOR; GENE; IMPLANTATION; PEPTIDE; MEMBER; INTERSEXUALITY; EXPRESSION	Across the animal kingdom, the involvement of insulin-like peptide (ILP) signaling in sex-related differentiation processes is attracting increasing attention. Recently, a gender-specific ILP was identified as the androgenic sex hormone in Crustacea. However, moieties modulating the actions of this androgenic insulin-like growth factor were yet to be revealed. Through molecular screening of an androgenic gland (AG) cDNA library prepared from the crayfish Cherax quadricarinatus, we have identified a novel insulin-like growth factor-binding protein (IGFBP) termed Cq-IGFBP. Based on bioinformatics analyses, the deduced Cq-IGFBP was shown to share high sequence homology with IGFBP family members from both invertebrates and vertebrates. The protein also includes a sequence determinant proven crucial for ligand binding, which according to three-dimensional modeling is assigned to the exposed outer surface of the protein. Recombinant Cq-IGFBP (rCq-IGFBP) protein was produced and, using a "pulldown" methodology, was shown to specifically interact with the insulin-like AG hormone of the crayfish (Cq-IAG). Particularly, using both mass spectral analysis and an immunological tool, rCq-IGFBP was shown to bind the Cq-IAG prohormone. Furthermore, a peptide corresponding to residues 23-38 of the Cq-IAG A-chain was found sufficient for in vitro recognition by rCq-IGFBP. Cq-IGFBP is the first IGFBP family member shown to specifically interact with a gender-specific ILP. Unlike their ILP ligands, IGFBPs are highly conserved across evolution, from ancient arthropods, like crustaceans, to humans. Such conservation places ILP signaling at the center of sex-related phenomena in early animal development.	[Rosen, Ohad; Weil, Simy; Manor, Rivka; Roth, Ziv; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Rosen, Ohad; Weil, Simy; Manor, Rivka; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Roth, Ziv; Khalaila, Isam] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), POB 653, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059	BARD of the United States-Israel Binational Agricultural Research and Development Fund [QB-9308-06]	BARD of the United States-Israel Binational Agricultural Research and Development Fund	This work was supported by Research Grant QB-9308-06 from BARD of the United States-Israel Binational Agricultural Research and Development Fund.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andersen AS, 2000, J BIOL CHEM, V275, P16948, DOI 10.1074/jbc.M001578200; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Bach Leon A, 2004, Clin Biochem Rev, V25, P155; Barki A, 2003, J EXP BIOL, V206, P1791, DOI 10.1242/jeb.00335; Barki A, 2006, HORM BEHAV, V50, P322, DOI 10.1016/j.yhbeh.2006.03.017; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Capoluongo E, 2011, AM J PATHOL, V178, P26, DOI 10.1016/j.ajpath.2010.11.004; Castellanos M, 2008, COMP BIOCHEM PHYS D, V3, P270, DOI 10.1016/j.cbd.2008.07.002; Chan SJ, 2000, AM ZOOL, V40, P213; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes B. E., 2012, FRONT ENDOCRINOL, V3, P1; Gai YC, 2010, FISH SHELLFISH IMMUN, V28, P10, DOI 10.1016/j.fsi.2009.09.013; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hong J, 2002, J BIOL CHEM, V277, P10489, DOI 10.1074/jbc.M109604200; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kelley KM, 2002, J ENDOCRINOL, V175, P3, DOI 10.1677/joe.0.1750003; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Khalaila I, 2001, GEN COMP ENDOCR, V121, P242, DOI 10.1006/gcen.2001.7607; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Li N, 2012, FISH SHELLFISH IMMUN, V33, P229, DOI 10.1016/j.fsi.2012.04.016; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Martin G, 1999, EUR J BIOCHEM, V262, P727, DOI 10.1046/j.1432-1327.1999.00442.x; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Okamoto N, 2009, FEBS J, V276, P1221, DOI 10.1111/j.1742-4658.2008.06859.x; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Pavelic J, 2007, INDIAN J MED RES, V125, P511; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Roth Z, 2010, GLYCOCONJUGATE J, V27, P159, DOI 10.1007/s10719-009-9268-3; Sagi A, 2002, INVERTEBR REPROD DEV, V41, P27, DOI 10.1080/07924259.2002.9652732; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ventura T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097261; Ventura T, 2011, GEN COMP ENDOCR, V173, P381, DOI 10.1016/j.ygcen.2011.05.018; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Walossek D., 1998, CRUSTACEANS BIODIVER, P3; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513	58	41	42	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22289	22298		10.1074/jbc.M113.484279	http://dx.doi.org/10.1074/jbc.M113.484279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775079	Green Published, hybrid			2022-12-28	WOS:000330596300011
J	Vakili, H; Jin, Y; Menticoglou, S; Cattini, PA				Vakili, Hana; Jin, Yan; Menticoglou, Savas; Cattini, Peter A.			CCAAT-enhancer-binding Protein beta (C/EBP beta) and Downstream Human Placental Growth Hormone Genes Are Targets for Dysregulation in Pregnancies Complicated by Maternal Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; TISSUE-SPECIFIC EXPRESSION; INSULIN-SECRETION; CYTOLOGICAL LOCALIZATION; TRANSCRIPTIONAL ENHANCER; CHORIONIC-GONADOTROPIN; LACTOGENIC HORMONES; B ENHANCER; CELL MASS; PITUITARY	Human chorionic somatomammotropin (CS) and placental growth hormone variant (GH-V) act as metabolic adaptors in response to maternal insulin resistance, which occurs in "normal" pregnancy. Maternal obesity can exacerbate this "resistance," suggesting that CS, GH-V, or transcription factors that regulate their production might be targets. The human CS genes, hCS-A and hCS-B, flank the GH-V gene. A significant decrease in pre-term placental CS/GH-V RNA levels was observed in transgenic mice containing the CS/GH-V genes in a model of high fat diet (HFD)-induced maternal obesity. Similarly, a decrease in CS/GH-V RNA levels was detected in term placentas from obese (body mass index (BMI) >= 35 kg/m(2)) versus lean (BMI 20-25 kg/m(2)) women. Aspecific decrease in transcription factor CCAAT-enhancer-binding protein beta (C/EBP beta) RNA levels was also seen with obesity; C/EBP beta is required for mouse placenta development and is expressed, like CS and GH-V, in syncytiotrophoblasts. Binding of C/EBP beta to the CS gene downstream enhancer regions, which by virtue of their position distally flank the GH-V gene, was reduced in placenta chromatin from mice on a HFD and in obese women; a corresponding decrease in RNA polymerase II associated with CS/GH-V promoters was also observed. Detection of decreased endogenous CS/GH-V RNA levels in human placental tumor cells treated with C/EBP beta siRNA is consistent with a direct effect. These data provide evidence for CS/GH-V dysregulation in acute HFD-induced obesity in mouse pregnancy and chronic obesity in human pregnancy and implicate C/EBP beta, a factor associated with CS regulation and placental development.	[Vakili, Hana; Jin, Yan; Cattini, Peter A.] Univ Manitoba, Dept Physiol, Div Endocrinol & Metab Dis, Winnipeg, MB R3E 0J9, Canada; [Menticoglou, Savas] Univ Manitoba, Dept Obstet Gynecol & Reprod Sci, Fac Med, Winnipeg, MB R3E 0J9, Canada	University of Manitoba; University of Manitoba	Cattini, PA (corresponding author), Univ Manitoba, Dept Physiol, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	peter_cattini@umanitoba.ca			Canadian Institutes of Health Research [MT-10853, RPA-12495]; Manitoba Institute of Child Health; Manitoba Health Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health; Manitoba Health Research Council	This work was supported by Canadian Institutes of Health Research Grants MT-10853 and RPA-12495 and a studentship from the Manitoba Institute of Child Health and Manitoba Health Research Council and Canadian Institutes of Health Research.	Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; Bamberger AM, 2004, VIRCHOWS ARCH, V444, P149, DOI 10.1007/s00428-003-0935-7; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOIME I, 1982, BIOL REPROD, V26, P73, DOI 10.1095/biolreprod26.1.73; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; CHEN HW, 1995, DNA CELL BIOL, V14, P681, DOI 10.1089/dna.1995.14.681; COLOSI P, 1982, P NATL ACAD SCI-BIOL, V79, P771, DOI 10.1073/pnas.79.3.771; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Day INM, 2004, J CLIN ENDOCR METAB, V89, P5569, DOI 10.1210/jc.2004-0152; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Farley D, 2009, PLACENTA, V30, P752, DOI 10.1016/j.placenta.2009.06.007; GOOSSENS M, 1986, ANN ENDOCRINOL-PARIS, V47, P363; GORDON YB, 1977, BRIT J OBSTET GYNAEC, V84, P642; Gunasekharan V, 2012, J VIROL, V86, P5393, DOI 10.1128/JVI.07239-11; Haig D, 2008, PLACENTA, V29, pS36, DOI 10.1016/j.placenta.2007.09.010; Handwerger S., 2009, GROWTH GENET HORM, V25, P1; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; Holland MP, 2004, ENDOCRINOLOGY, V145, P1096, DOI 10.1210/en.2003-0777; HOSHINA M, 1982, J CELL BIOL, V93, P190, DOI 10.1083/jcb.93.1.190; Hoshina M, 1984, Nihon Sanka Fujinka Gakkai Zasshi, V36, P397; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; JACQUEMIN P, 1994, DNA CELL BIOL, V13, P1037, DOI 10.1089/dna.1994.13.1037; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; JACQUEMIN P, 1994, MOL CELL BIOL, V14, P93, DOI 10.1128/MCB.14.1.93; Jiang SW, 1999, MOL ENDOCRINOL, V13, P879, DOI 10.1210/me.13.6.879; JIANG SW, 1994, J BIOL CHEM, V269, P10384; Jin Y, 1999, MOL ENDOCRINOL, V13, P1249, DOI 10.1210/me.13.8.1249; Jin Y, 2009, PLACENTA, V30, P226, DOI 10.1016/j.placenta.2008.12.011; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Kawai M, 1999, EUR J ENDOCRINOL, V141, P419, DOI 10.1530/eje.0.1410419; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; KLASSEN ME, 1989, PLACENTA, V10, P321, DOI 10.1016/0143-4004(89)90015-5; Kondegowda NG, 2012, DIABETOLOGIA, V55, P1721, DOI 10.1007/s00125-012-2501-9; Lacroix MC, 2002, ENDOCRINE, V19, P73, DOI 10.1385/ENDO:19:1:73; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lepercq J, 1998, DIABETES, V47, P847, DOI 10.2337/diabetes.47.5.847; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; LYTRAS A, 1994, MOL ENDOCRINOL, V8, P478, DOI 10.1210/me.8.4.478; Lytras A, 1996, MOL CELL ENDOCRINOL, V119, P1, DOI 10.1016/0303-7207(96)03777-X; Lytras A, 2011, J MOL ENDOCRINOL, V47, P179, DOI 10.1530/JME-11-0025; MATT DW, 1985, BIOL REPROD, V32, P969, DOI 10.1095/biolreprod32.4.969; MCWILLIAMS D, 1980, ENDOCRINOLOGY, V107, P761, DOI 10.1210/endo-107-3-761; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; NACHTIGAL MW, 1992, PLACENTA, V13, P371, DOI 10.1016/0143-4004(92)90061-W; NICKEL BE, 1991, ENDOCRINOLOGY, V128, P2353, DOI 10.1210/endo-128-5-2353; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Norquay LD, 2003, MOL ENDOCRINOL, V17, P1027, DOI 10.1210/me.2003-0025; Norquay LD, 2001, BIOCHEM J, V354, P387, DOI 10.1042/0264-6021:3540387; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Radde J, 2004, INT J GYNECOL PATHOL, V23, P373, DOI 10.1097/01.pgp.0000139645.32997.e1; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; ROGERS BL, 1986, NUCLEIC ACIDS RES, V14, P7647, DOI 10.1093/nar/14.19.7647; SAXENA BN, 1969, NEW ENGL J MED, V281, P225, DOI 10.1056/NEJM196907312810501; Schafer-Graf UM, 1998, J PERINAT MED, V26, P27, DOI 10.1515/jpme.1998.26.1.27; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Vakili H, 2012, J BIOL CHEM, V287, P33282, DOI 10.1074/jbc.M112.380949; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; Vickers MH, 2009, AM J PHYSIOL-ENDOC M, V297, pE629, DOI 10.1152/ajpendo.00221.2009; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WALKER WH, 1990, J BIOL CHEM, V265, P12940; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zeck W, 2008, PEDIATR RES, V63, P353, DOI 10.1203/01.pdr.0000304935.19183.07	77	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22849	22861		10.1074/jbc.M113.474999	http://dx.doi.org/10.1074/jbc.M113.474999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782703	hybrid, Green Published			2022-12-28	WOS:000330596300061
J	Zhang, HW; Wu, CW; Matesic, LE; Li, X; Wang, ZY; Boyce, BF; Xing, LP				Zhang, Hengwei; Wu, Chengwu; Matesic, Lydia E.; Li, Xing; Wang, Zhiyu; Boyce, Brendan F.; Xing, Lianping			Ubiquitin E3 Ligase Itch Negatively Regulates Osteoclast Formation by Promoting Deubiquitination of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EDITING ENZYME A20; MEDIATED REGULATION; BONE-RESORPTION; TGF-BETA; C-FMS; MICE; DIFFERENTIATION; EXPRESSION; RESPONSES	Itch is a ubiquitin E3 ligase that regulates protein stability. Itch(-/-) mice develop an autoimmune disease phenotype characterized by itchy skin and multiorgan inflammation. The role of Itch in the regulation of osteoclast function has not been examined. We report that Itch(-/-) bone marrow and spleen cells formed more osteoclasts than cells from WT littermates in response to receptor activator of NF-kappa B ligand (RANKL) and was associated with increased expression of the osteoclastogenic transcription factors c-fos and Nfatc1. Overexpression of Itch in Itch(-/-) cells rescued increased osteoclastogenesis. RANKL increased Itch expression, which can be blocked by a NF-kappa B inhibitor. The murine Itch promoter contains NF-kappa B binding sites. Overexpression of NF-kappa B p65 increased Itch expression, and RANKL promoted the binding of p65 onto the NF-kappa B binding sites in the Itch promoter. Itch(-/-) osteoclast precursors had prolonged RANKL-induced NF-kappa B activation and delayed TNF receptor-associated factor 6 (TRAF6) deubiquitination. In WT osteoclast precursors, Itch bound to TRAF6 and the deubiquitinating enzyme cylindromatosis. Adult Itch(-/-) mice had normal bone volume, but they had significantly increased LPS-induced osteoclastogenesis and bone resorption. Thus, Itch is a new RANKL target gene that is induced during osteoclastogenesis. Itch interacts with the deubiquitinating enzyme and is required for deubiquitination of TRAF6, thus limiting RANKL-induced osteoclast formation.	[Zhang, Hengwei; Wu, Chengwu; Li, Xing; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Matesic, Lydia E.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Li, Xing; Wang, Zhiyu] Hebei Med Univ, Hosp 4, Dept Biotherapy, Shijiazhuang 050011, Hebei, Peoples R China	University of Rochester; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Hebei Medical University	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	lianping_xing@urmc.rochester.edu			National Institutes of Health [AR48697, AR53586, AR43510]; United States Public Health Service; National Natural Science Foundation of China [81202037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, R21AR053586, R01AR048697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48697 and AR53586 (to L. X.) and AR43510 (to B. F. B.) from the United States Public Health Service.; Supported by National Natural Science Foundation of China Grant 81202037 (to Z. W.)	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Darzynkiewick Z., 2004, CYTOMETRY, V75; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Durrington HJ, 2010, J BIOL CHEM, V285, P37641, DOI 10.1074/jbc.M110.132415; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Hengwei Z., 2013, STEM CELLS IN PRESS; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jensen LE, 2003, FEBS LETT, V553, P190, DOI 10.1016/S0014-5793(03)00998-0; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Mabilleau G, 2011, J BIOL CHEM, V286, P3242, DOI 10.1074/jbc.M110.150300; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Xing LP, 2003, J BONE MINER RES, V18, P260, DOI 10.1359/jbmr.2003.18.2.260; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812	43	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22359	22368		10.1074/jbc.M112.442459	http://dx.doi.org/10.1074/jbc.M112.442459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782702	Green Published, hybrid			2022-12-28	WOS:000330596300017
J	Chacon-Martinez, CA; Kiessling, N; Winterhoff, M; Faix, J; Muller-Reichert, T; Jessberger, R				Chacon-Martinez, Carlos Andres; Kiessling, Nadine; Winterhoff, Moritz; Faix, Jan; Mueller-Reichert, Thomas; Jessberger, Rolf			The Switch-associated Protein 70 (SWAP-70) Bundles Actin Filaments and Contributes to the Regulation of F-actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Cofilin; Cytoskeleton; Mast Cell; F-actin Bundling; SWAP-70	ARP2/3 COMPLEX; CELL-ADHESION; COFILIN ACTIVITY; CROSS-LINKING; ADF/COFILIN; TURNOVER; MOTILITY; POLYMERIZATION; MECHANISM; RICH	Coordinated assembly and disassembly of actin into filaments and higher order structures such as stress fibers and lamellipodia are fundamental for cell migration and adhesion. However, the precise spatiotemporal regulation of F-actin structures is not completely understood. SWAP-70, a phosphatidylinositol 3,4,5-trisphosphate-interacting, F-actin-binding protein, participates in actin rearrangements through yet unknown mechanisms. Here, we show that SWAP-70 is an F-actin-bundling protein that oligomerizes through a Gln/Glu-rich stretch within a coiled-coil region. SWAP-70 bundles filaments in parallel and anti-parallel fashion through its C-terminal F-actin binding domain and delays dilution-induced F-actin depolymerization. We further demonstrate that SWAP-70 co-localizes and directly interacts with cofilin, an F-actin severing and depolymerization factor, and contributes to the regulation of cofilin activity in vivo. In line with these activities, upon stem cell factor stimulation, murine bone marrow-derived mast cells lacking SWAP-70 display aberrant regulation of F-actin and actin free barbed ends dynamics. Moreover, proper stem cell factor-dependent cofilin activation via dephosphorylation and subcellular redistribution into a detergent-resistant cytoskeletal compartment also require SWAP-70. Together, these findings reveal an important role of SWAP-70 in the dynamic spatiotemporal regulation of F-actin networks.	[Chacon-Martinez, Carlos Andres; Kiessling, Nadine; Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany; [Mueller-Reichert, Thomas] Tech Univ Dresden, Expt Ctr, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Winterhoff, Moritz; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3062 Hannover, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Hannover Medical School	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, Fiedlerstr 42, D-01307 Dresden, Germany.	rolf.jessberger@tu-dresden.de	Chacón-Martínez, Carlos Andrés/L-1782-2019	Winterhoff, Moritz/0000-0002-9029-9266	Deutsche Forschungsgemeinschaft [SPP1394, SPP1464]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP1394 (to R. J.) and SPP1464 (to J. F.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chopin M, 2011, EUR J IMMUNOL, V41, P3063, DOI 10.1002/eji.201141742; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Hey F, 2012, J BIOL CHEM, V287, P31073, DOI 10.1074/jbc.M112.346767; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; LINDBERG U, 1988, BIOCHIM BIOPHYS ACTA, V967, P391, DOI 10.1016/0304-4165(88)90102-X; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Marshall TW, 2009, J CELL SCI, V122, P3061, DOI 10.1242/jcs.051482; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; WATTS RG, 1992, CELL MOTIL CYTOSKEL, V21, P25, DOI 10.1002/cm.970210104; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667	64	20	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28687	28703		10.1074/jbc.M113.461277	http://dx.doi.org/10.1074/jbc.M113.461277			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23921380	Green Published, hybrid			2022-12-28	WOS:000330298800023
J	Onono, F; Subramanian, T; Sunkara, M; Subramanian, KL; Spielmann, HP; Morris, AJ				Onono, Fredrick; Subramanian, Thangaiah; Sunkara, Manjula; Subramanian, Karunai Leela; Spielmann, H. Peter; Morris, Andrew J.			Efficient Use of Exogenous Isoprenols for Protein Isoprenylation by MDA-MB-231 Cells Is Regulated Independently of the Mevalonate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA REDUCTASE; FARNESOL; INHIBITORS; GERANYLGERANIOL; ACCUMULATION; LOVASTATIN; ANALOGS; LIVER	Mammalian cells can use exogenous isoprenols to generate isoprenoid diphosphate substrates for protein isoprenylation, but the mechanism, efficiency, and biological importance of this process are not known. We developed mass spectrometry-based methods using chemical probes and newly synthesized stable isotope-labeled tracers to quantitate incorporation of exogenously provided farnesol, geranylgeraniol, and unnatural analogs of these isoprenols containing an aniline group into isoprenoid diphosphates and protein isoprenylcysteines by cultured human cancer cell lines. We found that at exogenous isoprenol concentrations > 10 mu M, this process can generate as much as 50% of the cellular isoprenoid diphosphate pool used for protein isoprenylation. Mutational activation of p53 in MDA-MB-231 breast cancer cells up-regulates the mevalonate pathway to promote tumor invasiveness. p53 silencing or pharmacological inhibition of HMG-CoA reductase in these cells decreases protein isoprenylation from endogenously synthesized isoprenoids but enhances the use of exogenous isoprenols for this purpose, indicating that this latter process is regulated independently of the mevalonate pathway. Our observations suggest unique opportunities for design of cancer cell-directed therapies and may provide insights into mechanisms underlying pleiotropic therapeutic benefits and unwanted side effects of mevalonate pathway inhibition.	[Onono, Fredrick; Subramanian, Thangaiah; Spielmann, H. Peter] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr,Kentucky Ctr Struct Biol, Lexington, KY 40536 USA; [Onono, Fredrick; Subramanian, Thangaiah; Spielmann, H. Peter] Univ Kentucky, Coll Med, Dept Chem, Lexington, KY 40536 USA; [Sunkara, Manjula; Subramanian, Karunai Leela; Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY 40536 USA; [Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40502 USA	University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Spielmann, HP (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	hps@uky.edu; a.j.morris@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929	National Institutes of Health [GM50388, GM66152]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388, P20GM103527, R01GM066152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50388 (to A. J. M.) and GM66152 (to H. P. S.). This work was conducted in part with resources provided by the Lexington Veterans Affairs Medical Center.	Beigneux A, 2002, J BIOL CHEM, V277, P38358, DOI 10.1074/jbc.M205183200; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Chang SY, 2012, J LIPID RES, V53, P1176, DOI 10.1194/jlr.M026161; Crick DC, 1998, J NEUROCHEM, V70, P2397; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; FLIESLER SJ, 1995, BIOCHEM BIOPH RES CO, V210, P695, DOI 10.1006/bbrc.1995.1715; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Holstein SA, 2009, LIPIDS, V44, P1055, DOI 10.1007/s11745-009-3355-x; Keller RK, 1996, ARCH BIOCHEM BIOPHYS, V328, P324, DOI 10.1006/abbi.1996.0180; Miriyala S, 2010, J BIOL CHEM, V285, P13918, DOI 10.1074/jbc.M109.083931; Nielsen Sune F, 2013, Ugeskr Laeger, V175, P76; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Ownby SE, 2002, LIPIDS, V37, P185, DOI 10.1007/s11745-002-0879-1; Subramanian T, 2013, J LABELLED COMPD RAD, V56, P370, DOI 10.1002/jlcr.3049; Subramanian T, 2012, SYNLETT, P2539, DOI 10.1055/s-0031-1290461; Subramanian T, 2012, BIOCHEMISTRY-US, V51, P8307, DOI 10.1021/bi3011362; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Tong HX, 2005, ANAL BIOCHEM, V336, P51, DOI 10.1016/j.ab.2004.09.024; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Yang SH, 2011, HUM MOL GENET, V20, P436, DOI 10.1093/hmg/ddq490; Zeichner S, 2012, J CANCER RES THER, V8, P176, DOI 10.4103/0973-1482.98967; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	25	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27444	27455		10.1074/jbc.M113.482307	http://dx.doi.org/10.1074/jbc.M113.482307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908355	hybrid, Green Published			2022-12-28	WOS:000330597300040
J	Hashimi, H; McDonald, L; Stribrna, E; Lukes, J				Hashimi, Hassan; McDonald, Lindsay; Stribrna, Eva; Lukes, Julius			Trypanosome Letm1 Protein Is Essential for Mitochondrial Potassium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; INDUCIBLE EXPRESSION SYSTEM; SENSITIVE K+ CHANNEL; WHS CRITICAL REGION; BLOOD-STREAM FORM; CANDIDATE GENE; CALCIUM; BRUCEI; MEMBRANE; ENCODES	Letm1 is a conserved protein in eukaryotes bearing energized mitochondria. Hemizygous deletion of its gene has been implicated in symptoms of the human disease Wolf-Hirschhorn syndrome. Studies almost exclusively performed in opisthokonts have attributed several roles to Letm1, including maintaining mitochondrial morphology, mediating either calcium or potassium/proton antiport, and facilitating mitochondrial translation. We address the ancestral function of Letm1 in the highly diverged protist and significant pathogen, Trypanosoma brucei. We demonstrate that Letm1 is involved in maintaining mitochondrial volume via potassium/proton exchange across the inner membrane. This role is essential in the vector-dwelling procyclic and mammal-infecting bloodstream stages as well as in Trypanosoma brucei evansi, a form of the latter stage lacking an organellar genome. In the pathogenic bloodstream stage, the mitochondrion consumes ATP to maintain an energized state, whereas that of T. brucei evansi also lacks a conventional proton-driven membrane potential. Thus, Letm1 performs its function in different physiological states, suggesting that ion homeostasis is among the few characterized essential pathways of the mitochondrion at this T. brucei life stage. Interestingly, Letm1 depletion in the procyclic stage can be complemented by exogenous expression of its human counterpart, highlighting the conservation of protein function between highly divergent species. Furthermore, although mitochondrial translation is affected upon Letm1 ablation, it is an indirect consequence of K+ accumulation in the matrix.	[Hashimi, Hassan; McDonald, Lindsay; Stribrna, Eva; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Hashimi, Hassan; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Hashimi, H (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Budweis, Czech Republic.	hassan@paru.cas.cz; jula@paru.cas.cz	Hashimi, Hassan/H-6740-2012; Lukes, Julius/H-6760-2012	Hashimi, Hassan/0000-0002-6678-1618; Lukes, Julius/0000-0002-0578-6618	Czech Grant Agency Grant [P305/12/2261]; Praemium Academiae award	Czech Grant Agency Grant; Praemium Academiae award	This work was supported in part by Czech Grant Agency Grant P305/12/2261 and a Praemium Academiae award ( to J. L.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Battaglia A, 2008, AM J MED GENET C, V148C, P246, DOI 10.1002/ajmg.c.30187; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Clayton AM, 2011, EUKARYOT CELL, V10, P286, DOI 10.1128/EC.00290-10; Costa ADT, 2009, INT J PARASITOL, V39, P955, DOI 10.1016/j.ijpara.2009.01.002; Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kafkova L, 2012, RNA, V18, P1846, DOI 10.1261/rna.033852.112; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Long SJ, 2008, MOL MICROBIOL, V69, P94, DOI 10.1111/j.1365-2958.2008.06260.x; Lukes J, 2010, MICROBIOL MONOGR, V17, P227, DOI 10.1007/978-3-642-12863-9_10; Lupo D, 2011, TRAFFIC, V12, P1457, DOI 10.1111/j.1600-0854.2011.01239.x; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Maslov DA, 2002, MOL BIOCHEM PARASIT, V125, P113, DOI 10.1016/S0166-6851(02)00235-9; Maslov Dmitri A., 2012, P215; Mathias RA, 2011, METHODS, V54, P396, DOI 10.1016/j.ymeth.2011.01.006; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Nebohacova M, 2004, J BIOL CHEM, V279, P7819, DOI 10.1074/jbc.M311360200; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Paris Z, 2011, MOL BIOCHEM PARASIT, V176, P116, DOI 10.1016/j.molbiopara.2010.12.010; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Roldan A, 2011, MOL MICROBIOL, V81, P623, DOI 10.1111/j.1365-2958.2011.07721.x; Schlickum S, 2004, GENOMICS, V83, P254, DOI 10.1016/j.ygeno.2003.08.013; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; South ST, 2007, AM J MED GENET A, V143A, P2137, DOI 10.1002/ajmg.a.31900; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; SPREMULLI L, 1987, BIOCHEM BIOPH RES CO, V147, P1077, DOI 10.1016/S0006-291X(87)80180-8; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xiong ZH, 1997, J BIOL CHEM, V272, P31022, DOI 10.1074/jbc.272.49.31022; Zhang BT, 2012, J BIOL CHEM, V287, P41757, DOI 10.1074/jbc.M112.383836; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	62	45	46	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26914	26925		10.1074/jbc.M113.495119	http://dx.doi.org/10.1074/jbc.M113.495119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23893410	hybrid, Green Published			2022-12-28	WOS:000330594500057
J	Stangherlin, A; Reddy, AB				Stangherlin, Alessandra; Reddy, Akhilesh B.			Regulation of Circadian Clocks by Redox Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GENE-EXPRESSION; OXIDATIVE STRESS; DROSOPHILA-MELANOGASTER; INDIVIDUAL FIBROBLASTS; SITE CYSTEINE; DNA-BINDING; GLUTATHIONE; FEEDBACK; CELL; PEROXIREDOXIN	Living organisms possess biological clocks that resonate with environmental cycles in light, temperature, and food availability. Recently, circadian oscillations in the redox state of peroxiredoxin have been described as an additional non-transcriptional timekeeping mechanism. Of note, this redox cycle is conserved in both prokaryotes and eukaryotes. How the classical "transcription-translation feedback loop" model and this redox oscillation are related is still poorly understood. In this minireview, we describe the most recent evidence pointing to cross-talk between the circadian clock and the redox status of the cell.	[Stangherlin, Alessandra; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, NIHR,Cambridge Biomed Res Ctr, Dept Clin Neurosci,Metab Res Labs,Inst Metab Sci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, NIHR,Cambridge Biomed Res Ctr, Dept Clin Neurosci,Metab Res Labs,Inst Metab Sci, Cambridge CB2 0QQ, England.	abr20@cam.ac.uk	Stangherlin, Alessandra/E-9669-2011	Stangherlin, Alessandra/0000-0001-7296-1183	Wellcome Trust [083643/Z/07/Z]; European Research Council [281348]; EMBO Young Investigators Programme; Medical Research Council (MRC) Centre for Obesity and Related Metabolic Disorders; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Medical Research Council [MC_UU_12012/5/B, G0600717B, G0600717] Funding Source: researchfish; MRC [G0600717] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigators Programme; Medical Research Council (MRC) Centre for Obesity and Related Metabolic Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 083643/Z/07/Z, European Research Council Starting Grant 281348 (MetaCLOCK), the EMBO Young Investigators Programme, the Medical Research Council (MRC) Centre for Obesity and Related Metabolic Disorders, and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. This is the sixth article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Beaver LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050454; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Gyongyosi N, 2013, FREE RADICAL BIO MED, V58, P134, DOI 10.1016/j.freeradbiomed.2012.12.016; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mari M, 2013, BBA-GEN SUBJECTS, V1830, P3317, DOI 10.1016/j.bbagen.2012.10.018; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Olmedo M, 2012, P NATL ACAD SCI USA, V109, P20479, DOI 10.1073/pnas.1211705109; Pani G, 2001, IUBMB LIFE, V52, P7, DOI 10.1080/15216540252774702; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Qian HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033347; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoshida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028227	69	80	83	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26505	26511		10.1074/jbc.R113.457564	http://dx.doi.org/10.1074/jbc.R113.457564			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861436	hybrid, Green Published			2022-12-28	WOS:000330594500017
J	Grozio, A; Sociali, G; Sturla, L; Caffa, I; Soncini, D; Salis, A; Raffaelli, N; De Flora, A; Nencioni, A; Bruzzone, S				Grozio, Alessia; Sociali, Giovanna; Sturla, Laura; Caffa, Irene; Soncini, Debora; Salis, Annalisa; Raffaelli, Nadia; De Flora, Antonio; Nencioni, Alessio; Bruzzone, Santina			CD73 Protein as a Source of Extracellular Precursors for Sustained NAD(+) Biosynthesis in FK866-treated Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT INHIBITION; IN-VITRO; CHS 828; GROWTH; CD38; LYMPHOCYTES; ENZYME; FK866	NAD(+) is mainly synthesized in human cells via the "salvage" pathways starting from nicotinamide, nicotinic acid, or nicotinamide riboside (NR). The inhibition with FK866 of the enzyme nicotinamide phosphoribosyltransferase (NAMPT), catalyzing the first reaction in the "salvage" pathway from nicotinamide, showed potent antitumor activity in several preclinical models of solid and hematologic cancers. In the clinical studies performed with FK866, however, no tumor remission was observed. Here we demonstrate that low micromolar concentrations of extracellular NAD(+) or NAD(+) precursors, nicotinamide mononucleotide (NMN) and NR, can reverse the FK866-induced cell death, this representing a plausible explanation for the failure of NAMPT inhibition as an anti-cancer therapy. NMN is a substrate of both ectoenzymes CD38 and CD73, with generation of NAM and NR, respectively. In this study, we investigated the roles of CD38 and CD73 in providing ectocellular NAD(+) precursors for NAD(+) biosynthesis and in modulating cell susceptibility to FK866. By specifically silencing or overexpressingCD38 and CD73, we demonstrated that endogenous CD73 enables, whereas CD38 impairs, the conversion of extracellular NMN to NRas a precursor for intracellularNAD(+) biosynthesis in human cells. Moreover, cell viability in FK866-treated cells supplemented with extracellular NMN was strongly reduced in tumor cells, upon pharmacological inhibition or specific down-regulation of CD73. Thus, our study suggests that genetic or pharmacologic interventions interfering with CD73 activity may prove useful to increase cancer cell sensitivity to NAMPT inhibitors.	[Grozio, Alessia; Sociali, Giovanna; Sturla, Laura; Salis, Annalisa; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Grozio, Alessia; Sociali, Giovanna; Sturla, Laura; Salis, Annalisa; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Caffa, Irene; Soncini, Debora; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Raffaelli, Nadia] Univ Politecn Marche, Dept Agr, I-60131 Ancona, Italy	University of Genoa; University of Genoa; University of Genoa; Marche Polytechnic University	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 25 1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Caffa, Irene/J-9835-2016; Nencioni, Alessio/K-3692-2018; Bruzzone, Santina/A-4264-2015; Soncini, Debora/AAB-2230-2019; Salis, Annalisa/R-9241-2018	Caffa, Irene/0000-0003-1111-9915; Bruzzone, Santina/0000-0003-2034-3716; Soncini, Debora/0000-0001-5156-498X; NENCIONI, ALESSIO/0000-0001-5068-8884; Salis, Annalisa/0000-0002-3082-2908	European Seventh Framework Program [256986]; Ministero della Salute [GR-2008-1135635]; Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR) [RBLA039LSF_002]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [6108]; Compagnia di San Paolo; University of Genova	European Seventh Framework Program; Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo); University of Genova	This work was supported by the European Seventh Framework Program (project number 256986, PANACREAS), by the Ministero della Salute (GR-2008-1135635), by the Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR, FIRB 2003, RBLA039LSF_002), by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Code 6108) (to A. N.), by the Compagnia di San Paolo, and by the University of Genova.	Bajrami I, 2012, EMBO MOL MED, V4, P1087, DOI 10.1002/emmm.201201250; Beauparlant P, 2009, ANTI-CANCER DRUG, V20, P346, DOI 10.1097/CAD.0b013e3283287c20; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2006, MOL MED, V12, P324, DOI 10.2119/2006-00075.Billington; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S., 2012, MESSENGER, V1, P34, DOI [10.1166/msr.2012.1007, DOI 10.1166/MSR.2012.1007]; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Cea M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022739; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Ferrero E, 1999, J LEUKOCYTE BIOL, V65, P151, DOI 10.1002/jlb.65.2.151; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Forte G, 2012, J IMMUNOL, V189, P2226, DOI 10.4049/jimmunol.1200744; Fuchs D, 2010, INT J CANCER, V126, P2773, DOI 10.1002/ijc.25206; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Goding JW, 1998, IMMUNOL REV, V161, P11, DOI 10.1111/j.1600-065X.1998.tb01568.x; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Hasmann M, 2003, CANCER RES, V63, P7436; Hjarnaa PJV, 1999, CANCER RES, V59, P5751; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Lee H.C., 2012, MESSENGER, V1, P16, DOI [10.1166/msr.2012.1005, DOI 10.1166/MSR.2012.1005]; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lockman JW, 2010, J MED CHEM, V53, P8734, DOI 10.1021/jm101145b; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Salmi M, 2011, FEBS LETT, V585, P1543, DOI 10.1016/j.febslet.2011.04.033; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; UJHAZY P, 1994, INT J CANCER, V59, P83, DOI 10.1002/ijc.2910590117; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang B, 2012, ONCOIMMUNOLOGY, V1, P67, DOI 10.4161/onci.1.1.18068; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544; Zhou XR, 2007, ONCOL REP, V17, P1341; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; Zoppoli G, 2010, EXP HEMATOL, V38, P979, DOI 10.1016/j.exphem.2010.07.013	60	100	104	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25938	25949		10.1074/jbc.M113.470435	http://dx.doi.org/10.1074/jbc.M113.470435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23880765	Green Published, hybrid			2022-12-28	WOS:000330623300024
J	Doppler, HR; Bastea, LI; Lewis-Tuffin, LJ; Anastasiadis, PZ; Storz, P				Doeppler, Heike R.; Bastea, Ligia I.; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.; Storz, Peter			Protein Kinase D1-mediated Phosphorylations Regulate Vasodilator-stimulated Phosphoprotein (VASP) Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENA/VASP PROTEINS; ACTIN CYTOSKELETON; FOCAL ADHESION; BARBED END; C-MU; ACTIVATION; MOTILITY; RHOA; DYNAMICS	Enabled/Vasodilator-stimulated phosphoprotein (Ena/VASP) protein family members link actin dynamics and cellular signaling pathways. VASP localizes to regions of dynamic actin reorganization such as the focal adhesion contacts, the leading edge or filopodia, where it contributes to F-actin filament elongation. Here we identify VASP as a novel substrate for protein kinase D1 (PKD1). We show that PKD1 directly phosphorylates VASP at two serine residues, Ser-157 and Ser-322. These phosphorylations occur in response to RhoA activation and mediate VASP re-localization from focal contacts to the leading edge region. The net result of this PKD1-mediated phosphorylation switch in VASP is increased filopodia formation and length at the leading edge. However, such signaling when persistent induced membrane ruffling and decreased cell motility.	[Doeppler, Heike R.; Bastea, Ligia I.; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.; Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Griffin Room 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			National Institutes of Health [NS069753, GM086435, CA140182]; Florida Department of Health [10BG11]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS069753 (to P. Z. A.), GM086435, and CA140182 (to P. S.). This work was also supported by Bankhead-Coley Grant (10BG11) from the Florida Department of Health (to P. S.).	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hardy L. R., 2012, CURRENT PROTOCOLS NE, P17; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24382	24393		10.1074/jbc.M113.474676	http://dx.doi.org/10.1074/jbc.M113.474676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846685	Green Published, hybrid			2022-12-28	WOS:000330612300010
J	Feng, CG; Ghosh, A; Amin, MN; Giomarelli, B; Shridhar, S; Banerjee, A; Fernandez-Robledo, JA; Bianchet, MA; Wang, LX; Wilson, IBH; Vasta, GR				Feng, Chiguang; Ghosh, Anita; Amin, Mohammed N.; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Bianchet, Mario A.; Wang, Lai-Xi; Wilson, Iain B. H.; Vasta, Gerardo R.			The Galectin CvGal1 from the Eastern Oyster (Crassostrea virginica) Binds to Blood Group A Oligosaccharides on the Hemocyte Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PERKINSUS-MARINUS; GENE ORGANIZATION; GROUP ANTIGEN; LECTIN; RECOGNITION; MEMBRANE; PROTEIN; TRANSMISSION; PERSPECTIVES; SPECIFICITY	The galectin CvGal1 from the eastern oyster (Crassostrea virginica), which possesses four tandemly arrayed carbohydrate recognition domains, was previously shown to display stronger binding to galactosamine and N-acetylgalactosamine relative to D-galactose. CvGal1 expressed by phagocytic cells is "hijacked" by the parasite Perkinsus marinus to enter the host, where it proliferates and causes systemic infection and death. In this study, a detailed glycan array analysis revealed that CvGal1 preferentially recognizes type 2 blood group A oligosaccharides. Homology modeling of the protein and its oligosaccharide ligands supported this preference over type 1 blood group A and B oligosaccharides. The CvGal ligand models were further validated by binding, inhibition, and competitive binding studies of CvGal1 and ABH-specific monoclonal antibodies with intact and deglycosylated glycoproteins, hemocyte extracts, and intact hemocytes and by surface plasmon resonance analysis. A parallel glycomic study carried out on oyster hemocytes (Kurz, S., Jin, C., Hykollari, A., Gregorich, D., Giomarelli, B., Vasta, G. R., Wilson, I. B. H., and Paschinger, K. (2013) J. Biol. Chem. 288,) determined the structures of oligosaccharides recognized by CvGal1. Proteomic analysis of the hemocyte glycoproteins identified beta-integrin and dominin as CvGal1 "self"-ligands. Despite strong CvGal1 binding to P. marinus trophozoites, no binding of ABH blood group antibodies was observed. Thus, parasite glycans structurally distinct from the blood group A oligosaccharides on the hemocyte surface may function as potentially effective ligands for CvGal1. We hypothesize that carbohydrate-based mimicry resulting from the host/parasite co-evolution facilitates CvGal1-mediated cross-linking to beta-integrin, located on the hemocyte surface, leading to cell activation, phagocytosis, and host infection.	[Feng, Chiguang; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Vasta, Gerardo R.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Feng, Chiguang; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Wilson, Iain B. H.; Vasta, Gerardo R.] Inst Marine & Environm Technol, Baltimore, MD 21202 USA; [Ghosh, Anita; Bianchet, Mario A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wilson, Iain B. H.] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Natural Resources & Life Sciences, Vienna	Vasta, GR (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 701 East Pratt St, Baltimore, MD 21202 USA.	GVasta@som.umaryland.edu	Wang, Lai-Xi/E-8755-2019; Wang, Xin/AAN-8435-2021; Ghosh, Anita/AAR-8845-2020; Wilson, Iain/B-3326-2009; wang, xl/Y-8251-2019; Bianchet, Mario a/K-2131-2015; Wang, Lai-Xi/E-8790-2019	Wang, Xin/0000-0002-4457-7376; Wilson, Iain/0000-0001-8996-1518; Bianchet, Mario a/0000-0001-9032-7549; Wang, Lai-Xi/0000-0003-4293-5819; Shridhar, Surekha/0000-0003-1820-7379; , Chiguang/0000-0002-2355-3607	National Institutes of Health [5R01GM070589-06, R01 GM080374]; National Science Foundation [IOS-0822257, IOS-1063729]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589, R01GM080374] Funding Source: NIH RePORTER; Direct For Biological Sciences [1063729] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM070589-06 (to G. R. V.) and R01 GM080374 (to L. X. W.). This work was also supported by Grants IOS-0822257 and IOS-1063729 from the National Science Foundation.	Ahmed H, 2002, GLYCOBIOLOGY, V12, P451, DOI 10.1093/glycob/cwf052; Alavi MR, 2009, J PARASITOL, V95, P900, DOI 10.1645/GE-1864.1; Andrews JD, 1996, J SHELLFISH RES, V15, P13; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; Bianchet MA, 2000, PROTEINS, V40, P378, DOI 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Bushek D, 2002, DIS AQUAT ORGAN, V51, P217, DOI 10.3354/dao051217; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Caceres-Martinez J, 2012, J INVERTEBR PATHOL, V110, P321, DOI 10.1016/j.jip.2012.03.019; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chu FLE, 1996, J SHELLFISH RES, V15, P57; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; Dame Richard, 2002, Aquatic Ecology, V36, P51, DOI 10.1023/A:1013354807515; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Robledo JA, 2008, BIOCHEM BIOPH RES CO, V375, P215, DOI 10.1016/j.bbrc.2008.07.162; Fernandez-Robledo JA, 2008, MOL BIOCHEM PARASIT, V157, P44, DOI 10.1016/j.molbiopara.2007.09.007; Ford SE, 2002, DIS AQUAT ORGAN, V51, P187, DOI 10.3354/dao051187; Gauthier JD, 2004, J PARASITOL, V90, P446, DOI 10.1645/GE-3269; GAUTHIER JD, 1995, J INVERTEBR PATHOL, V66, P156, DOI 10.1006/jipa.1995.1079; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Hager KM, 2008, TRENDS PARASITOL, V24, P51, DOI 10.1016/j.pt.2007.10.008; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Le Guyader FS, 2006, J CLIN MICROBIOL, V44, P3878, DOI 10.1128/JCM.01327-06; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lim J, 2012, BIOL CELL, V104, P631, DOI 10.1111/boc.201200013; Lin Z, 2011, BIOCHEMISTRY-US, V50, P6340, DOI 10.1021/bi200343h; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; PYTELA R, 1994, METHOD ENZYMOL, V245, P420; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Robledo JAF, 2004, J PARASITOL, V90, P1004, DOI 10.1645/GE-240R; Schmitt P, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00160; Schott EJ, 2003, GENE, V309, P1, DOI 10.1016/S0378-1119(03)00469-4; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Thomsson KA, 2000, ANAL CHEM, V72, P4543, DOI 10.1021/ac000631b; Tian P, 2008, J FOOD PROTECT, V71, P1696, DOI 10.4315/0362-028X-71.8.1696; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VASTA GR, 1984, CELL IMMUNOL, V88, P475, DOI 10.1016/0008-8749(84)90179-5; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1982, J INVERTEBR PATHOL, V40, P367, DOI 10.1016/0022-2011(82)90175-6; Vasta GR, 2008, ANIMAL LECTINS FUNCT; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	61	50	51	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24394	24409		10.1074/jbc.M113.476531	http://dx.doi.org/10.1074/jbc.M113.476531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824193	hybrid, Green Published			2022-12-28	WOS:000330612300011
J	Mager, T; Braner, M; Kubsch, B; Hatahet, L; Alkoby, D; Rimon, A; Padan, E; Fendler, K				Mager, Thomas; Braner, Markus; Kubsch, Bastian; Hatahet, Lina; Alkoby, Dudu; Rimon, Abraham; Padan, Etana; Fendler, Klaus			Differential Effects of Mutations on the Transport Properties of the Na+/H+ Antiporter NhaA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-VIII-IX; DEPENDENT DIMERIZATION; CONFORMATIONAL-CHANGES; PH REGULATION; MEMBRANE; OLIGOMERIZATION; MECHANISM; SITE	Na+/H+ antiporters show a marked pH dependence, which is important for their physiological function in eukaryotic and prokaryotic cells. In NhaA, the Escherichia coli Na+/H+ antiporter, specific single site mutations modulating the pH profile of the transporter have been described in the past. To clarify the mechanism by which these mutations influence the pH dependence of NhaA, the substrate dependence of the kinetics of selected NhaA variants was electrophysiologically investigated and analyzed with a kinetic model. It is shown that the mutations affect NhaA activity in quite different ways by changing the properties of the binding site or the dynamics of the transporter. In the first case, pK and/or K-D(Na) are altered, and in the second case, the rate constants of the conformational transition between the inside and the outside open conformation are modified. It is shown that residues as far apart as 15-20 angstrom from the binding site can have a significant impact on the dynamics of the conformational transitions or on the binding properties of NhaA. The implications of these results for the pH regulation mechanism of NhaA are discussed.	[Mager, Thomas; Braner, Markus; Kubsch, Bastian; Hatahet, Lina; Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Alkoby, Dudu; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de		Mager, Thomas/0000-0002-9571-7033; Fendler, Klaus/0000-0002-5699-7060	Deutsche Forschungsgemeinschaft [SFB 807]; Israel Science Foundation [284/12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 807 (to K. F.) and Israel Science Foundation Grant 284/12 (to E. P.).	ADLER LW, 1977, J SUPRAMOL STR CELL, V7, P15, DOI 10.1002/jss.400070103; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Diab M, 2011, J MOL BIOL, V413, P604, DOI 10.1016/j.jmb.2011.08.046; Everberg H, 2006, J CHROMATOGR A, V1118, P244, DOI 10.1016/j.chroma.2006.03.123; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KLINGENBERG M, 1992, STUDY ENZYMES, P367; Kozachkov L, 2013, MOL MEMBR BIOL, V30, P90, DOI 10.3109/09687688.2012.693209; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M., 2002, PRACTICAL GUIDE MEMB, P179; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	32	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24666	24675		10.1074/jbc.M113.484071	http://dx.doi.org/10.1074/jbc.M113.484071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836890	Green Published, hybrid			2022-12-28	WOS:000330612300034
J	Pokidysheva, E; Zientek, KD; Ishikawa, Y; Mizuno, K; Vranka, JA; Montgomery, NT; Keene, DR; Kawaguchi, T; Okuyama, K; Bachinger, HP				Pokidysheva, Elena; Zientek, Keith D.; Ishikawa, Yoshihiro; Mizuno, Kazunori; Vranka, Janice A.; Montgomery, Nathan T.; Keene, Douglas R.; Kawaguchi, Tatsuya; Okuyama, Kenji; Baechinger, Hans Peter			Posttranslational Modifications in Type I Collagen from Different Tissues Extracted from Wild Type and Prolyl 3-Hydroxylase 1 Null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; CROSS-LINKING; 3-HYDROXYPROLINE; MUTATIONS; PROTEINS; DEFICIENCY; ENZYMES; CRTAP	Type I collagen extracted from tendon, skin, and bone of wild type and prolyl 3-hydroxylase 1 (P3H1) null mice shows distinct patterns of 3-hydroxylation and glycosylation of hydroxylysine residues. The A1 site (Pro-986) in the alpha 1-chain of type I collagen is almost completely 3-hydroxylated in every tissue of the wild type mice. In contrast, no 3-hydroxylation of this proline residue was found in P3H1 null mice. Partial 3-hydroxylation of the A3 site (Pro-707) was present in tendon and bone, but absent in skin in both alpha-chains of the wild type animals. Type I collagen extracted from bone of P3H1 null mice shows a large reduction in 3-hydroxylation of the A3 site in both alpha-chains, whereas type I collagen extracted from tendon of P3H1 null mice shows little difference as compared with wild type. These results demonstrate that the A1 site in type I collagen is exclusively 3-hydroxylated by P3H1, and presumably, this enzyme is required for the 3-hydroxylation of the A3 site of both alpha-chains in bone but not in tendon. The increase in glycosylation of hydroxylysine in P3H1 null mice in bone was found to be due to an increased occupancy of normally glycosylated sites. Despite the severe disorganization of collagen fibrils in adult tissues, the D-period of the fibrils is unchanged. Tendon fibrils of newborn P3H1 null mice are well organized with only a slight increase in diameter. The absence of 3-hydroxyproline and/or the increased glycosylation of hydroxylysine in type I collagen disturbs the lateral growth of the fibrils.	[Pokidysheva, Elena; Zientek, Keith D.; Ishikawa, Yoshihiro; Mizuno, Kazunori; Vranka, Janice A.; Montgomery, Nathan T.; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Pokidysheva, Elena; Ishikawa, Yoshihiro; Montgomery, Nathan T.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Kawaguchi, Tatsuya; Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Osaka 5600043, Japan	Oregon Health & Science University; Osaka University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by grants from Shriners Hospital for Children (to H. P. B. and D. R. K.).	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dreisewerd K, 2004, ANAL CHEM, V76, P3482, DOI 10.1021/ac049928q; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; Hosemann R., 1962, DIRECT ANAL DIFFRACT; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OGLE JD, 1962, J BIOL CHEM, V237, P3667; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; RISTELI J, 1978, ANAL BIOCHEM, V84, P423, DOI 10.1016/0003-2697(78)90060-X; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	32	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24742	24752		10.1074/jbc.M113.464156	http://dx.doi.org/10.1074/jbc.M113.464156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861401	Green Published, hybrid			2022-12-28	WOS:000330612300040
J	Rawal, MK; Khan, MF; Kapoor, K; Goyal, N; Sen, S; Saxena, AK; Lynn, AM; Tyndall, JDA; Monk, BC; Cannon, RD; Komath, SS; Prasad, R				Rawal, Manpreet Kaur; Khan, Mohammad Firoz; Kapoor, Khyati; Goyal, Neha; Sen, Sobhan; Saxena, Ajay Kumar; Lynn, Andrew M.; Tyndall, Joel D. A.; Monk, Brian C.; Cannon, Richard D.; Komath, Sneha Sudha; Prasad, Rajendra			Insight into Pleiotropic Drug Resistance ATP-binding Cassette Pump Drug Transport through Mutagenesis of Cdr1p Transmembrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ABC MULTIDRUG TRANSPORTERS; CANDIDA-ALBICANS; P-GLYCOPROTEIN; ANTIFUNGAL EFFLUX; MEMBRANE-PROTEINS; YEAST; EXPRESSION; CLONING; PDR5P	The fungal ATP-binding cassette (ABC) transporter Cdr1 protein (Cdr1p), responsible for clinically significant drug resistance, is composed of two transmembrane domains (TMDs) and two nucleotide binding domains (NBDs). We have probed the nature of the drug binding pocket by performing systematic mutagenesis of the primary sequences of the 12 transmembrane segments (TMSs) found in the TMDs. All mutated proteins were expressed equally well and localized properly at the plasma membrane in the heterologous host Saccharomyces cerevisiae, but some variants differed significantly in efflux activity, substrate specificity, and coupled ATPase activity. Replacement of the majority of the amino acid residues with alanine or glycine yielded neutral mutations, but about 42% of the variants lost resistance to drug efflux substrates completely or selectively. A predicted three-dimensional homology model shows that all the TMSs, apart from TMS4 and TMS10, interact directly with the drug-binding cavity in both the open and closed Cdr1p conformations. However, TMS4 and TMS10 mutations can also induce total or selective drug susceptibility. Functional data and homology modeling assisted identification of critical amino acids within a drug-binding cavity that, upon mutation, abolished resistance to all drugs tested singly or in combinations. The open and closed Cdr1p models enabled the identification of amino acid residues that bordered a drug-binding cavity dominated by hydrophobic residues. The disposition of TMD residues with differential effects on drug binding and transport are consistent with a large polyspecific drug binding pocket in this yeast multidrug transporter.	[Rawal, Manpreet Kaur; Kapoor, Khyati; Goyal, Neha; Saxena, Ajay Kumar; Komath, Sneha Sudha; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Khan, Mohammad Firoz; Sen, Sobhan] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India; [Lynn, Andrew M.] Jawaharlal Nehru Univ, Dept Computat & Integrat Sci, New Delhi 110067, India; [Tyndall, Joel D. A.] Univ Otago, Sch Pharm, Dunedin 9054, New Zealand; [Monk, Brian C.; Cannon, Richard D.] Univ Otago, Sir John Walsh Res Inst, Dunedin 9054, New Zealand	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; University of Otago; University of Otago	Prasad, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47jnu@gmail.com	Rawal, Manpreet Kaur/AAG-5799-2019; KOMATH, SNEHA SUDHA/AAE-6359-2020; tyndall, joel/C-2803-2008; Grieshaber-Bouyer, Ricardo/R-7512-2016; Sen, Sobhan/Q-7523-2019	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; tyndall, joel/0000-0003-0783-1635; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Sen, Sobhan/0000-0002-9047-3455; Monk, Brian/0000-0003-2264-3480; Cannon, Richard/0000-0002-5398-2066	Department of Biotechnology [DBT BT/01/CEIB/10/III/02, DBT BT/PR13641/MED/29/175/2010, DBT BT/PR14879/BRB10/885/2010]; Royal Society of New Zealand [UOO1004]; University Grants Commission, India	Department of Biotechnology; Royal Society of New Zealand(Royal Society of New Zealand); University Grants Commission, India(University Grants Commission, India)	This work was supported in part by Department of Biotechnology Grants DBT BT/01/CEIB/10/III/02, DBT BT/PR13641/MED/29/175/2010, and DBT BT/PR14879/BRB10/885/2010 (to R. P.) and Marsden Grant UOO1004 (to B. C. M.) from the Royal Society of New Zealand.; Supported by a University Grants Commission, India, Senior Research Fellowship award.	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boutet Emmanuel, 2007, V406, P89; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Crowley E, 2010, FEBS J, V277, P3974, DOI 10.1111/j.1742-4658.2010.07789.x; CURRIER SJ, 1989, J BIOL CHEM, V264, P14376; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDWAY M, 1995, ANTIMICROB AGENTS CH, V39, P422, DOI 10.1128/AAC.39.2.422; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Gupta RP, 2011, BIOL CHEM, V392, P53, DOI 10.1515/BC.2011.011; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hofmann K., 1993, BIOL CHEM HOPPE SEYL; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kapoor K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000624; Krishnamurthy S, 1998, YEAST, V14, P535, DOI 10.1002/(SICI)1097-0061(19980430)14:6&lt;535::AID-YEA254&gt;3.0.CO;2-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Niimi K, 2012, MOL MICROBIOL, V85, P747, DOI 10.1111/j.1365-2958.2012.08140.x; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Prasad Rajendra, 2011, J Amino Acids, V2011, P531412, DOI 10.4061/2011/531412; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Puri N, 2009, BBA-BIOMEMBRANES, V1788, P1752, DOI 10.1016/j.bbamem.2009.04.009; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; Saini P, 2005, J ANTIMICROB CHEMOTH, V56, P77, DOI 10.1093/jac/dki183; Saini P, 2006, MICROBIOL-SGM, V152, P1559, DOI 10.1099/mic.0.28471-0; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Shukla S, 2004, BIOCHEM BIOPH RES CO, V322, P520, DOI 10.1016/j.bbrc.2004.07.151; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Tanabe K, 2011, MOL MICROBIOL, V82, P416, DOI 10.1111/j.1365-2958.2011.07820.x; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382	57	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24480	24493		10.1074/jbc.M113.488353	http://dx.doi.org/10.1074/jbc.M113.488353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824183	Green Published, hybrid			2022-12-28	WOS:000330612300017
J	Rosenzweig, JM; Glenn, JD; Calabresi, PA; Whartenby, KA				Rosenzweig, Jason M.; Glenn, Justin D.; Calabresi, Peter A.; Whartenby, Katharine A.			KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; IL-6-DEFICIENT MICE; GENE; DIFFERENTIATION; INTERLEUKIN-6; INDUCTION; KRUPPEL-LIKE-FACTOR-4; LIPOPOLYSACCHARIDE; IDENTIFICATION	The initiation and maintenance of the immune response require a coordinated regulation of signal transduction pathways. Identifying the mechanisms by which these pathways are controlled and modulated is a significant goal of immunology. In the present report, we show a novel role for the zinc finger transcription factor Kruppel-like factor 4 (KLF4) in the modulation of the inflammatory immune response via its regulation of IL-6. We analyzed the role of KLF4 in the production of IL-6 by dendritic cells. Our data indicate that KLF4 can act in a dual function manner. It acts as a transcription factor in that it can bind to and activate the IL-6 promoter at specific binding sites. KLF4 also has a role in the chromatin remodeling of the IL-6 promoter in that cells deficient in KLF4 exhibited a relative hypoacetylation. These results indicate a molecular role for KLF4 in modulating the intensity of the inflammatory response and help to explain its pleiotropic role in different settings.	[Rosenzweig, Jason M.; Glenn, Justin D.; Calabresi, Peter A.; Whartenby, Katharine A.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Neurol, Baltimore, MD 21287 USA; [Whartenby, Katharine A.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Whartenby, KA (corresponding author), Dept Neurol, 601 N Wolfe St, Baltimore, MD 21287 USA.	whartenby@jhmi.edu	Calabresi, Peter A./AAF-2288-2019	Glenn, Justin/0000-0002-3567-6233; Calabresi, Peter/0000-0002-7776-6472	National Multiple Sclerosis Society [R01 NS41435]; Silverman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Silverman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Multiple Sclerosis Society, R01 NS41435, and the Silverman Foundation.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Musselman C.A., NATURE STRUCT MOL BI, V19, P1218; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Patel N. V., CANC EPIDEMIOL BIOMA, V19, P2631; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	33	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23868	23874		10.1074/jbc.M113.479576	http://dx.doi.org/10.1074/jbc.M113.479576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23846700	Green Published, hybrid			2022-12-28	WOS:000330611400026
J	Vest, KE; Leary, SC; Winge, DR; Cobine, PA				Vest, Katherine E.; Leary, Scot C.; Winge, Dennis R.; Cobine, Paul A.			Copper Import into the Mitochondrial Matrix in Saccharomyces cerevisiae Is Mediated by Pic2, a Mitochondrial Carrier Family Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; FLUORESCENT SENSOR; IRON; TRANSPORT; SCO1; TRAFFICKING; MITOFERRIN; MECHANISM; COMPLEX; OXYGEN	Saccharomyces cerevisiae must import copper into the mitochondrial matrix for eventual assembly of cytochrome c oxidase. This copper is bound to an anionic fluorescent molecule known as the copper ligand (CuL). Here, we identify for the first time a mitochondrial carrier family protein capable of importing copper into the matrix. In vitro transport of the CuL into the mitochondrial matrix was saturable and temperature-dependent. Strains with a deletion of PIC2 grew poorly on copper-deficient non-fermentable medium supplemented with silver and under respiratory conditions when challenged with a matrix-targeted copper competitor. Mitochondria from pic2 Delta cells had lower total mitochondrial copper and exhibited a decreased capacity for copper uptake. Heterologous expression of Pic2 in Lactococcus lactis significantly enhanced CuL transport into these cells. Therefore, we propose a novel role for Pic2 in copper import into mitochondria.	[Vest, Katherine E.; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Leary, Scot C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; [Winge, Dennis R.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA	Auburn University System; Auburn University; University of Saskatchewan; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul A/G-3107-2011; Cobine, Paul/AAH-6619-2020	Cobine, Paul A/0000-0001-6012-0985; Cobine, Paul/0000-0001-6012-0985; Vest, Katherine/0000-0002-3391-8649	National Institutes of Health [GM083292]; National Science Foundation [BIO-MCB-1158497]; Saskatchewan Health Research Foundation; Direct For Biological Sciences [1158497] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Saskatchewan Health Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM083292 (to D. R. W.). This work was also supported by National Science Foundation Grant BIO-MCB-1158497 (to P. A. C.) and by Saskatchewan Health Research Foundation Establishment and Natural Sciences and Engineering Research Discovery grants (to S. C. L.).	Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wang YM, 2011, EXP HEMATOL, V39, P784, DOI 10.1016/j.exphem.2011.05.003; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	37	69	69	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23884	23892		10.1074/jbc.M113.470674	http://dx.doi.org/10.1074/jbc.M113.470674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23846699	Green Published, hybrid			2022-12-28	WOS:000330611400028
J	Kibbe, C; Chen, JQ; Xu, GL; Jing, G; Shalev, A				Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath			FOXO1Competes with Carbohydrate Response Element-binding Protein (ChREBP) and Inhibits Thioredoxin-interacting Protein (TXNIP) Transcription in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATED PROTEIN-1; GLUCOSE REGULATION; OXIDATIVE STRESS; GENE-EXPRESSION; FOXO1; PATHWAY; MASS; IDENTIFICATION; APOPTOSIS; FAILURE	Thioredoxin-interacting protein (TXNIP) has emerged as an important factor in pancreatic beta cell biology, and tight regulation of TXNIP levels is necessary for beta cell survival. However, the mechanisms regulating TXNIP expression have only started to be elucidated. The forkhead boxO1 transcription factor (FOXO1) has been reported to up-regulate TXNIP expression in neurons and endothelial cells but to down-regulate TXNIP in liver, and the effects on beta cells have remained unknown. We now have found that FOXO1 binds to the TXNIP promoter in vivo in human islets and INS-1 beta cells and significantly decreases TXNIP expression. TXNIP promoter deletion analyses revealed that an E-box motif conferring carbohydrate response element-binding protein (ChREBP)-mediated, glucose-induced TXNIP expression is necessary and sufficient for this effect, and electromobility shift assays confirmed FOXO1 binding to this site. Moreover, FOXO1 blocked glucose-induced TXNIP expression and reduced glucose-induced ChREBP binding at the TXNIP promoter without affecting ChREBP expression or nuclear localization, suggesting that FOXO1 may compete with ChREBP for binding to the TXNIP promoter. In fact, a FOXO1 DNA-binding mutant (FOXO1-H215R) failed to inhibit TXNIP transcription, and the effects were not restricted to TXNIP as FOXO1 also inhibited transcription of other ChREBP target genes such as liver pyruvate kinase. Together, these results demonstrate that FOXO1 inhibits beta cell TXNIP transcription and suggest that FOXO1 confers this inhibition by interfering with ChREBP DNA binding at target gene promoters. Our findings thereby reveal a novel gene regulatory mechanism and a previously unappreciated cross-talk between FOXO1 and ChREBP, two major metabolic signaling pathways.	[Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath] Univ Alabama Birmingham, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kibbe, Carly] Univ Wisconsin, Dept Pharmacol, Madison, WI 53792 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01DK-078752]; American Diabetes Association [7-07-CD-22, 7-12-BS-167]; Juvenile Diabetes Research Foundation/JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation/JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK-078752. This work was also supported by American Diabetes Association Grants 7-07-CD-22 and 7-12-BS-167 and Juvenile Diabetes Research Foundation/JNJSI Grant 40-2011-1.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Boergesen M, 2011, J BIOL CHEM, V286, P13214, DOI 10.1074/jbc.M110.215467; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Maiese K, 2009, ADV EXP MED BIOL, V665, P242; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699	33	58	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23194	23202		10.1074/jbc.M113.473082	http://dx.doi.org/10.1074/jbc.M113.473082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803610	Green Published, hybrid			2022-12-28	WOS:000330598200026
J	Silvestri, C; Martella, A; Poloso, NJ; Piscitelli, F; Capasso, R; Izzo, A; Woodward, DF; Di Marzo, V				Silvestri, Cristoforo; Martella, Andrea; Poloso, Neil J.; Piscitelli, Fabiana; Capasso, Raffaele; Izzo, Angelo; Woodward, David F.; Di Marzo, Vincenzo			Anandamide-derived Prostamide F-2 alpha Negatively Regulates Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE FEEDBACK LOOP; TOPICAL BIMATOPROST; ADIPOSE-TISSUE; PROSTAGLANDIN-ETHANOLAMIDES; MOLECULAR CHARACTERIZATION; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; LID SULCUS; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTIONAL CONTROL	Lipid mediators variedly affect adipocyte differentiation. Anandamide stimulates adipogenesis via CB1 receptors and peroxisome proliferator-activated receptor gamma. Anandamide may be converted by PTGS2 (COX2) and prostaglandin F synthases, such as prostamide/prostaglandin F synthase, to prostaglandin F-2 alpha ethanolamide (PGF(2 alpha)EA), of which bimatoprost is a potent synthetic analog. PGF(2 alpha)EA/bimatoprost act via prostaglandin F2 alpha FP receptor/FP alt4 splicing variant heterodimers. We investigated whether prostamide signaling occurs in preadipocytes and controls adipogenesis. Exposure of mouse 3T3-L1 or human preadipocytes to PGF(2 alpha)EA/bimatoprost during early differentiation inhibits adipogenesis. PGF(2 alpha)EA is produced from anandamide in preadipocytes and much less so in differentiating adipocytes, which express much less PTGS2, FP, and its alt4 splicing variant. Selective antagonism of PGF(2 alpha)EA receptors counteracts prostamide effects on adipogenesis, as does inhibition of ERK1/2 phosphorylation. Selective inhibition of PGF(2 alpha)EA versus prostaglandin F-2 alpha biosynthesis accelerates adipogenesis. PGF(2 alpha)EA levels are reduced in the white adipose tissue of high fat diet-fed mice where there is a high requirement for new adipocytes. Prostamides also inhibit zebrafish larval adipogenesis in vivo. We propose that prostamide signaling in preadipocytes is a novel anandamide-derived antiadipogenic mechanism.	[Silvestri, Cristoforo; Martella, Andrea; Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Inst Biomol Chem, I-80078 Pozzuoli, Italy; [Poloso, Neil J.; Woodward, David F.] Allergan Pharmaceut Inc, Irvine, CA 92612 USA; [Capasso, Raffaele; Izzo, Angelo] Univ Naples Federico II, Endocannabinoid Res Grp, Dept Pharm, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); AbbVie; Allergan; University of Naples Federico II	Woodward, DF (corresponding author), Allergan Pharmaceut Inc, Irvine, CA 92612 USA.	Woodward_David@Allergan.com; vincenzo.dimarzo@icb.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Piscitelli, Fabiana/A-7100-2014; Silvestri, Cristoforo/Y-2504-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Silvestri, Cristoforo/0000-0001-5635-1545; Capasso, Raffaele/0000-0002-3335-1822; Piscitelli, Fabiana/0000-0001-9343-4622; Izzo, Angelo/0000-0002-8557-2133; Martella, Andrea/0000-0002-4680-7702	Allergan	Allergan(AbbVieAllergan)	Recipients of an Allergan research grant.	Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Chen J, 2005, BRIT J PHARMACOL, V144, P493, DOI 10.1038/sj.bjp.0706044; Choi HY, 2012, J OCUL PHARMACOL TH, V28, P146, DOI 10.1089/jop.2011.0160; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crofford LJ, 2001, GASTROENTEROL CLIN N, V30, P863, DOI 10.1016/S0889-8553(05)70217-X; D'Eon TM, 2008, DIABETES, V57, P1262, DOI 10.2337/db07-1186; DEASUA LJ, 1977, NATURE, V265, P450, DOI 10.1038/265450a0; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FAUST IM, 1984, AM J PHYSIOL, V247, P1038; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Fujimori K, 2010, PROSTAG OTH LIPID M, V93, P52, DOI 10.1016/j.prostaglandins.2010.06.005; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Garber AJ, 2004, MED CLIN N AM, V88, P837, DOI 10.1016/j.mcna.2004.04.001; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Karaliota S, 2009, OBESITY, V17, P1830, DOI 10.1038/oby.2009.177; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Kwok AHY, 2012, GEN COMP ENDOCR, V178, P216, DOI 10.1016/j.ygcen.2012.05.002; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Maccarrone M, 2004, EUR J BIOCHEM, V271, P4666, DOI 10.1111/j.1432-1033.2004.04427.x; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Moriuchi H, 2008, J BIOL CHEM, V283, P792, DOI 10.1074/jbc.M705638200; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SANDOUK T, 1993, AM J PHYSIOL, V264, pC1600, DOI 10.1152/ajpcell.1993.264.6.C1600; SERRERO G, 1992, ENDOCRINOLOGY, V131, P2545, DOI 10.1210/en.131.6.2545; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tanaka A, 2011, AM J PHYSIOL-CELL PH, V301, pC1360, DOI 10.1152/ajpcell.00514.2010; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taniguchi K, 2010, REPRODUCTION, V140, P885, DOI 10.1530/REP-10-0240; TAYLOR L, 1987, ATHEROSCLEROSIS, V65, P227, DOI 10.1016/0021-9150(87)90038-4; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tsuboi K, 2002, PROSTAG OTH LIPID M, V68-9, P535, DOI 10.1016/S0090-6980(02)00054-0; Ueno T, 2011, FEBS J, V278, P2901, DOI 10.1111/j.1742-4658.2011.08213.x; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Woodward DF, 2008, BRIT J PHARMACOL, V153, P410, DOI 10.1038/sj.bjp.0707434; Woodward DF, 2007, BRIT J PHARMACOL, V150, P342, DOI 10.1038/sj.bjp.0706989; Woodward DF, 2004, CARDIOVASC DRUG REV, V22, P103; Woodward DF, 2001, SURV OPHTHALMOL, V45, pS337, DOI 10.1016/S0039-6257(01)00224-7; Woodward JA, 2010, J COSMET DERMATOL-US, V9, P96, DOI 10.1111/j.1473-2165.2010.00487.x; Yam JCS, 2009, J OCUL PHARMACOL TH, V25, P471, DOI 10.1089/jop.2009.0019; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200	76	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23307	23321		10.1074/jbc.M113.489906	http://dx.doi.org/10.1074/jbc.M113.489906			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801328	Green Published, hybrid			2022-12-28	WOS:000330598200036
J	Sun, QA; Wang, BL; Miyagi, M; Hess, DT; Stamler, JS				Sun, Qi-An; Wang, Benlian; Miyagi, Masaru; Hess, Douglas T.; Stamler, Jonathan S.			Oxygen-coupled Redox Regulation of the Skeletal Muscle Ryanodine Receptor/Ca2+ Release Channel (RyR1) SITES AND NATURE OF OXIDATIVE MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; CALCIUM-RELEASE; S-NITROSYLATION; MASS-SPECTROMETRY; FKBP12 BINDING; NITRIC-OXIDE; GLUTATHIONYLATION; IDENTIFICATION; NITROSOGLUTATHIONE; O-2	In mammalian skeletal muscle, Ca2+ release from the sarcoplasmic reticulum (SR) through the ryanodine receptor/Ca2+-release channel RyR1 can be enhanced by S-oxidation or S-nitrosylation of separate Cys residues, which are allosterically linked. S-Oxidation of RyR1 is coupled to muscle oxygen tension (pO(2)) through O-2-dependent production of hydrogen peroxide by SR-resident NADPH oxidase 4. In isolated SR (SR vesicles), an average of six to eight Cys thiols/RyR1 monomer are reversibly oxidized at high (21% O-2) versus low pO(2) (1% O-2), but their identity among the 100 Cys residues/RyR1 monomer is unknown. Here we use isotope-coded affinity tag labeling and mass spectrometry (yielding 93% coverage of RyR1 Cys residues) to identify 13 Cys residues subject to pO(2)-coupled S-oxidation in SR vesicles. Eight additional Cys residues are oxidized at high versus low pO(2) only when NADPH levels are supplemented to enhance NADPH oxidase 4 activity. pO(2)-sensitive Cys residues were largely non-overlapping with those identified previously as hyperreactive by administration of exogenous reagents (three of 21) or as S-nitrosylated. Cys residues subject to pO(2)-coupled oxidation are distributed widely within the cytoplasmic domain of RyR1 in multiple functional domains implicated in RyR1 activity-regulating interactions with the L-type Ca2+ channel (dihydropyridine receptor) and FK506-binding protein 12 as well as in "hot spot" regions containing sites of mutation implicated in malignant hyperthermia and central core disease. pO(2)-coupled disulfide formation was identified, whereas neither S-glutathionylated nor sulfenamide-modified Cys residues were observed. Thus, physiological redox regulation of RyR1 by endogenously generated hydrogen peroxide is exerted through dynamic disulfide formation involving multiple Cys residues.	Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA; Univ Hosp, Cleveland, OH 44106 USA; [Sun, Qi-An; Hess, Douglas T.; Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian; Miyagi, Masaru] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Stamler, JS (corresponding author), Inst Transformat Mol Med, Wolstein Res Bldg 4129,2103 Cornell Rd, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [RO1 HL0591130]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL0591130 (to J. S. S.).	ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Burgoyne JR, 2011, BIOCHEM SOC T, V39, P1260, DOI 10.1042/BST0391260; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Pessah IN, 2000, ANTIOXID REDOX SIGN, V2, P17, DOI 10.1089/ars.2000.2.1-17; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, J BIOL CHEM, V276, P15625, DOI 10.1074/jbc.M100083200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sun JH, 2008, BIOCHEMISTRY-US, V47, P13985, DOI 10.1021/bi8012627; Svoboda LK, 2012, CIRC RES, V111, P842, DOI 10.1161/CIRCRESAHA.111.263525; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z	37	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22961	22971		10.1074/jbc.M113.480228	http://dx.doi.org/10.1074/jbc.M113.480228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798702	Green Published, hybrid			2022-12-28	WOS:000330598200007
J	Nakagawa, T; Ge, Q; Pawlosky, R; Wynn, RM; Veech, RL; Uyeda, K				Nakagawa, Tsutomu; Ge, Qiang; Pawlosky, Robert; Wynn, R. Max; Veech, Richard L.; Uyeda, Kosaku			Metabolite Regulation of Nucleo-cytosolic Trafficking of Carbohydrate Response Element-binding Protein (ChREBP) ROLE OF KETONE BODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SUBCELLULAR-LOCALIZATION; XYLULOSE 5-PHOSPHATE; RAT-LIVER; GLUCOSE; KINASE; GENE; PHOSPHORYLATION; LIPOGENESIS; DEFICIENCY	The carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in converting excess carbohydrate to storage fat in liver. In response to changing glucose levels, ChREBP activity is regulated by nucleo-cytoplasmic shuttling of ChREBP via interactions with 14-3-3 proteins and importins. The nuclear/cytosol trafficking is regulated partly by phosphorylation/dephosphorylation of serine 196 mediated by cAMP-dependent protein kinase and protein phosphatase. Weshow here that protein-free extracts of starved and high fat-fed livers contain metabolites that activate interaction of ChREBP center dot 14-3-3 and inhibit the ChREBP/importin alpha interaction, resulting in cytosolic localization. These metabolites were identified as beta-hydroxybutyrate and acetoacetate. Nuclear localization of GFP-ChREBP is rapidly inhibited in hepatocytes incubated in beta-hydroxybutyrate or fatty acids, and the observed inhibition is closely correlated with the production of ketone bodies. These observations show that ketone bodies play an important role in the regulation of ChREBP activity by restricting ChREBP localization to the cytoplasm, thus inhibiting fat synthesis during periods of ketosis.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA; [Pawlosky, Robert; Veech, Richard L.] NIAAA, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA.	Kosaku.Uyeda@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK06394804]; Veterans Affairs Merit Review; Welch Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Welch Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK06394804. This work was also supported by Veterans Affairs Merit Review and a Welch Grant.	Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Dentin R, 2012, J HEPATOL, V56, P199, DOI 10.1016/j.jhep.2011.07.019; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; LAWSON JWR, 1987, J BIOL CHEM, V262, P3165; Lawson JWR, 1976, GLUCONEOGENESIS ITS; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	25	35	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28358	28367		10.1074/jbc.M113.498550	http://dx.doi.org/10.1074/jbc.M113.498550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23918932	hybrid, Green Published			2022-12-28	WOS:000330612800064
J	Liu, GJ; Fang, Y; Wu, JH				Liu, Guangjian; Fang, Ying; Wu, Jianhua			A Mechanism for Localized Dynamics-driven Affinity Regulation of the Binding of von Willebrand Factor to Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR A1 DOMAIN; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; DISEASE MUTATIONS; SHEAR-STRESS; SNAKE-VENOM; GPIB-ALPHA; PROTEIN; COMPLEX; ACTIVATION	Binding of the A1 domain of von Willebrand factor (vWF) to glycoprotein Ib alpha (GPIb alpha) results in platelet adhesion, activation, and aggregation that initiates primary hemostasis. Both the elevated shear stress and the mutations associated with type 2B von Willebrand disease enhance the interaction between A1 and GPIb alpha. Through molecular dynamics simulations for wildtype vWF-A1 and its eight gain of function mutants (R543Q, I546V, Delta SS, etc.), we found that the gain of function mutations destabilize the N-terminal arm, increase a clock pendulum-like movement of the alpha 2-helix, and turn a closed A1 conformation into a partially open one favoring binding to GPIb alpha. The residue Arg(578) at the alpha 2-helix behaves as a pivot in the destabilization of the N-terminal arm and a consequent dynamic change of the alpha 2-helix. These results suggest a localized dynamics-driven affinity regulation mechanism for vWF-GPIb alpha interaction. Allosteric drugs controlling this intrinsic protein dynamics may be effective in blocking the GPIb-vWF interaction.	[Liu, Guangjian; Fang, Ying; Wu, Jianhua] S China Univ Technol, Sch Biosci & Bioengn, Inst Biomech, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology	Fang, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	yfang@scut.edu.cn; wujianhua@scut.edu.cn			National Natural Science Foundation of China [10972081, 11072080, 31170887]; Guangdong Natural Science Foundation [S2011010005451]; Specialized Research Fund for the Doctoral Program of Higher Education [20110172110030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China Grants 10972081 (to Y. F.) and 11072080 and 31170887 (to J. W.) and by Guangdong Natural Science Foundation Grant S2011010005451 (to J. W.) and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20110172110030 (to J. W.).	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2012, J BIOL CHEM, V287, P14579, DOI 10.1074/jbc.M112.348573; Auton M, 2010, BIOPHYS J, V99, P1192, DOI 10.1016/j.bpj.2010.06.002; Auton M, 2010, J BIOL CHEM, V285, P22829, DOI 10.1074/jbc.M110.103358; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Casana P, 1998, AM J HEMATOL, V59, P57, DOI 10.1002/(SICI)1096-8652(199809)59:1<57::AID-AJH11>3.0.CO;2-Z; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021; Cooney KA, 1996, BLOOD, V87, P2322, DOI 10.1182/blood.V87.6.2322.bloodjournal8762322; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hilbert L, 1998, BRIT J HAEMATOL, V103, P877, DOI 10.1046/j.1365-2141.1998.01040.x; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Ishikawa H, 2008, P NATL ACAD SCI USA, V105, P8619, DOI 10.1073/pnas.0803764105; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Li QH, 2012, EXP CELL RES, V318, P1649, DOI 10.1016/j.yexcr.2012.05.018; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; Miyata S, 1999, J BIOL CHEM, V274, P6586, DOI 10.1074/jbc.274.10.6586; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; RANDI AM, 1992, J BIOL CHEM, V267, P21187; Romijn R. A., 2002, THESIS U UTRECHT; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Wang Y., 2012, BIOL MED PHYS BIOMED, P3, DOI [10.1007/978-1-4614-2146-7_1, DOI 10.1007/978-1-4614-2146-7_1]; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Whitley MJ, 2009, CURR PROTEIN PEPT SC, V10, P116, DOI 10.2174/138920309787847563; Whitten ST, 2005, P NATL ACAD SCI USA, V102, P4282, DOI 10.1073/pnas.0407499102; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P762, DOI 10.2174/157016112803520837	62	16	23	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26658	26667		10.1074/jbc.M113.453803	http://dx.doi.org/10.1074/jbc.M113.453803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902764	Green Published, hybrid			2022-12-28	WOS:000330594500031
J	Spiess, C; Bevers, J; Jackman, J; Chiang, N; Nakamura, G; Dillon, M; Liu, HB; Molina, P; Elliott, JM; Shatz, W; Scheer, JM; Giese, G; Persson, J; Zhang, Y; Dennis, MS; Giulianotti, J; Gupta, P; Reilly, D; Palma, E; Wang, JY; Stefanich, E; Scheerens, H; Fuh, G; Wu, LC				Spiess, Christoph; Bevers, Jack, III; Jackman, Janet; Chiang, Nancy; Nakamura, Gerald; Dillon, Michael; Liu, Hongbin; Molina, Patricia; Elliott, J. Michael; Shatz, Whitney; Scheer, Justin M.; Giese, Glen; Persson, Josefine; Zhang, Yin; Dennis, Mark S.; Giulianotti, James; Gupta, Prateek; Reilly, Dorothea; Palma, Enzo; Wang, Jianyong; Stefanich, Eric; Scheerens, Heleen; Fuh, Germaine; Wu, Lawren C.			Development of a Human IgG4 Bispecific Antibody for Dual Targeting of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DOMAIN INTERFACE; STRUCTURAL BASIS; RECEPTOR; ASTHMA; HETERODIMERS; BLOCKADE; STRATEGY; PLATFORM; DISEASE	Human bispecific antibodies have great potential for the treatment of human diseases. Although human IgG1 bispecific antibodies have been generated, few attempts have been reported in the scientific literature that extend bispecific antibodies to other human antibody isotypes. In this paper, we report our work expanding the knobs-into-holes bispecific antibody technology to the human IgG4 isotype. We apply this approach to generate a bispecific antibody that targets IL-4 and IL-13, two cytokines that play roles in type 2 inflammation. We show that IgG4 bispecific antibodies can be generated in large quantities with equivalent efficiency and quality and have comparable pharmacokinetic properties and lung partitioning, compared with the IgG1 isotype. This work broadens the range of published therapeutic bispecific antibodies with natural surface architecture and provides additional options for the generation of bispecific antibodies with differing effector functions through the use of different antibody isotypes.	[Spiess, Christoph; Bevers, Jack, III; Chiang, Nancy; Nakamura, Gerald; Dillon, Michael; Zhang, Yin; Dennis, Mark S.; Fuh, Germaine] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA 94080 USA; [Jackman, Janet; Wu, Lawren C.] Genentech Res & Early Dev, Dept Immunol, San Francisco, CA 94080 USA; [Liu, Hongbin; Molina, Patricia] Genentech Res & Early Dev, Dept Prot Analyt Chem, San Francisco, CA 94080 USA; [Elliott, J. Michael; Shatz, Whitney; Scheer, Justin M.] Genentech Res & Early Dev, Dept Prot Chem, San Francisco, CA 94080 USA; [Giese, Glen; Persson, Josefine] Genentech Res & Early Dev, Dept Purificat Dev, San Francisco, CA 94080 USA; [Giulianotti, James; Gupta, Prateek; Reilly, Dorothea] Genentech Res & Early Dev, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Palma, Enzo; Stefanich, Eric] Genentech Res & Early Dev, Dept Preclin & Translat Pharmacokinet & Pharmacod, San Francisco, CA 94080 USA; [Wang, Jianyong] Genentech Res & Early Dev, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Scheerens, Heleen] Genentech Res & Early Dev, Dept Pharmacodynam Biomarkers, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Spiess, C (corresponding author), Genentech Res & Early Dev, Dept Antibody Engn, 1 DNA Way, San Francisco, CA 94080 USA.	christsp@gene.com; gml@gene.com		Spiess, Christoph/0000-0002-0570-9700; Shatz-Binder, Whitney/0000-0003-2996-501X				Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Baker KN, 2002, TRENDS BIOTECHNOL, V20, P149, DOI 10.1016/S0167-7799(01)01914-X; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Brightling CE, 2010, CLIN EXP ALLERGY, V40, P42, DOI 10.1111/j.1365-2222.2009.03383.x; Chelius D, 2010, MABS-AUSTIN, V2, P309, DOI 10.4161/mabs.2.3.11791; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dhimolea Eugen, 2012, MAbs, V4, P4, DOI 10.4161/mabs.4.1.18821; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Maes T, 2012, AM J RESP CELL MOL, V47, P261, DOI 10.1165/rcmb.2012-0080TR; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Reilly DE, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P331, DOI 10.1007/978-3-642-01147-4_26; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Ultsch M, 2013, J MOL BIOL, V425, P1330, DOI 10.1016/j.jmb.2013.01.024; Webb S, 2011, NAT BIOTECHNOL, V29, P860, DOI 10.1038/nbt.1994; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wranik BJ, 2012, J BIOL CHEM, V287, P43331, DOI 10.1074/jbc.M112.397869; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	42	49	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26583	26593		10.1074/jbc.M113.480483	http://dx.doi.org/10.1074/jbc.M113.480483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23880771	hybrid, Green Published			2022-12-28	WOS:000330594500024
J	Bloem, E; Meems, H; van den Biggelaar, M; Mertens, K; Meijer, AB				Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.			A3 Domain Region 1803-1818 Contributes to the Stability of Activated Factor VIII and Includes a Binding Site for Activated Factor IX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; A2 SUBUNIT; PROTEIN-C; FACTOR-X; PHOSPHOLIPID-MEMBRANES; A1/A3-C1-C2 DIMER; CRYSTAL-STRUCTURE; HEMOPHILIA-A; FACTOR XASE; FACTOR VA	A recent chemical footprinting study in our laboratory suggested that region 1803-1818 might contribute to A2 domain retention in activated factor VIII (FVIIIa). This site has also been implicated to interact with activated factor IX (FIXa). Asn-1810 further comprises anN-linked glycan, which seems incompatible with a role of the amino acids 1803-1818 for FIXa or A2 domain binding. In the present study, FVIII a stability and FIX a binding were evaluated in a FVIII-N1810C variant, and two FVIII variants in which residues 1803-1810 and 1811-1818 are replaced by the corresponding residues of factor V (FV). Enzyme kinetic studies showed that only FVIII/FV 1811-1818 has a decreased apparent binding affinity for FIXa. Flow cytometry analysis indicated that fluorescent FIXa exhibits impaired complex formation with only FVIII/FV 18111818 on lipospheres. Site-directed mutagenesis revealed that Phe-1816 contributes to the interaction with FIXa. To evaluate FVIIIa stability, the FVIII/FV chimeras were activated by thrombin, and the decline in cofactor function was followed over time. FVIII/FV 1803-1810 and FVIII/FV 1811-1818 but not FVIII-N1810C showed a decreased FVIIIa half-life. However, when the FVIII variants were activated in presence of FIXa, only FVIII/FV 1811-1818 demonstrated an enhanced decline in cofactor function. Surface plasmon resonance analysis revealed that the FVIII variants K1813A/K1818A, E1811A, and F1816A exhibit enhanced dissociation after activation. The results together demonstrate that the glycan at 1810 is not involved in FVIII cofactor function, and that Phe-1816 of region 1811-1818 contributes to FIXa binding. Both regions 1803-1810 and 1811-1818 contribute to FVIIIa stability.	[Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-1066 CX Amsterdam, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl						Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Brinkman HJM, 1997, BIOCHEM J, V323, P735, DOI 10.1042/bj3230735; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fay PJ, 1999, J BIOL CHEM, V274, P29826, DOI 10.1074/jbc.274.42.29826; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; KANE WH, 1988, BLOOD, V71, P539; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LENTING PJ, 1995, J BIOL CHEM, V270, P14884, DOI 10.1074/jbc.270.25.14884; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MERTENS K, 1984, BIOCHEM J, V223, P599, DOI 10.1042/bj2230599; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0	36	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26105	26111		10.1074/jbc.M113.500884	http://dx.doi.org/10.1074/jbc.M113.500884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23884417	hybrid, Green Published			2022-12-28	WOS:000330623300039
J	Still, AJ; Floyd, BJ; Hebert, AS; Bingman, CA; Carson, JJ; Gunderson, DR; Dolan, BK; Grimsrud, PA; Dittenhafer-Reed, KE; Stapleton, DS; Keller, MP; Westphall, MS; Denu, JM; Attie, AD; Coon, JJ; Pagliarini, DJ				Still, Amelia J.; Floyd, Brendan J.; Hebert, Alexander S.; Bingman, Craig A.; Carson, Joshua J.; Gunderson, Drew R.; Dolan, Brendan K.; Grimsrud, Paul A.; Dittenhafer-Reed, Kristin E.; Stapleton, Donald S.; Keller, Mark P.; Westphall, Michael S.; Denu, John M.; Attie, Alan D.; Coon, Joshua J.; Pagliarini, David J.			Quantification of Mitochondrial Acetylation Dynamics Highlights Prominent Sites of Metabolic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KYNURENINE AMINOTRANSFERASE-II; PROTEIN LYSINE ACETYLATION; KETONE-BODY PRODUCTION; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; CRYSTAL-STRUCTURE; SIRT3; LIVER; COA; PHOSPHORYLATION	Lysine acetylation is rapidly becoming established as a key post-translational modification for regulating mitochondrial metabolism. Nonetheless, distinguishing regulatory sites from among the thousands identified by mass spectrometry and elucidating how these modifications alter enzyme function remain primary challenges. Here, we performed multiplexed quantitative mass spectrometry to measure changes in the mouse liver mitochondrial acetylproteome in response to acute and chronic alterations in nutritional status, and integrated these data sets with our compendium of predicted Sirt3 targets. These analyses highlight a subset of mitochondrial proteins with dynamic acetylation sites, including acetyl-CoA acetyltransferase 1 (Acat1), an enzyme central to multiple metabolic pathways. We performed in vitro biochemistry and molecular modeling to demonstrate that acetylation of Acat1 decreases its activity by disrupting the binding of coenzyme A. Collectively, our data reveal an important new target of regulatory acetylation and provide a foundation for investigating the role of select mitochondrial protein acetylation sites in mediating acute and chronic metabolic transitions.	[Still, Amelia J.; Floyd, Brendan J.; Bingman, Craig A.; Carson, Joshua J.; Gunderson, Drew R.; Dolan, Brendan K.; Grimsrud, Paul A.; Stapleton, Donald S.; Keller, Mark P.; Attie, Alan D.; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Hebert, Alexander S.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Dittenhafer-Reed, Kristin E.; Denu, John M.; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Hebert, Alexander S.; Westphall, Michael S.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pagliarini, DJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	pagliarini@wisc.edu	Grimsrud, Paul A./GWZ-9287-2022	Grimsrud, Paul A./0000-0002-4706-914X; Nestler, Amelia/0000-0002-6927-5315; Pagliarini, David J./0000-0002-0001-0087; Dittenhafer-Reed, Kristin/0000-0001-7317-3912; Floyd, Brendan/0000-0003-3185-0174	Searle Scholars Award; Shaw Scientist Award; Glenn Foundation Award; National Institutes of Health [RC1DK086410, U01GM094622, R01DK098672, R01GM080148, DK066369, DK058037, AG038679, GM065386, T32DK007665, T32GM008692, F32DK091049, 5T32GM08349]; National Science Foundation [DGE-1256259]; American Heart Association [12PRE839]; National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672, F32DK091049, R01DK058037, R01DK066369, RC1DK086410, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349, R37GM059785, T32GM007215, T32GM008692, U01GM094622, R01GM065386, R01GM080148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038679] Funding Source: NIH RePORTER	Searle Scholars Award; Shaw Scientist Award; Glenn Foundation Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Searle Scholars Award, a Shaw Scientist Award, a Glenn Foundation Award, and National Institutes of Health Grants RC1DK086410, U01GM094622, and R01DK098672 (to D. J. P.); National Science Foundation Graduate Fellowship DGE-1256259 and National Institutes of Health Training Grant 5T32GM007215-37 (to A. J. S.); National Institutes of Health Grants R01GM080148 (to J. J. Coon), DK066369 and DK058037 (to A. D. A.), AG038679 and GM065386 (to J. M. D.), T32DK007665 and T32GM008692 MSTP (to B. J. F.), and F32DK091049 (to P. A. G.); American Heart Association Grant 12PRE839 (to J. J. Carson); and a National Science Foundation graduate fellowship and National Institutes of Health Training Grant 5T32GM08349 (to K. E. D.).	Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Baez-Ruiz A, 2005, AM J PHYSIOL-GASTR L, V289, pG1015, DOI 10.1152/ajpgi.00488.2004; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; BENOVIC J, 1983, ARCH BIOCHEM BIOPHYS, V221, P329, DOI 10.1016/0003-9861(83)90151-0; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Covian R, 2012, AM J PHYSIOL-HEART C, V303, pH940, DOI 10.1152/ajpheart.00077.2012; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Han Q, 2008, BIOSCIENCE REP, V28, P205, DOI 10.1042/BSR20080085; Han Q, 2008, J BIOL CHEM, V283, P3567, DOI 10.1074/jbc.M708358200; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; HERRERA E, 1967, J LIPID RES, V8, P515; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Korman SH, 2006, MOL GENET METAB, V89, P289, DOI 10.1016/j.ymgme.2006.07.010; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MIDDLETON B, 1973, BIOCHEM J, V132, P731, DOI 10.1042/bj1320731; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Norvell A, 2010, SCIENCE, V327, P964, DOI 10.1126/science.1187159; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Pereira CV, 2012, MITOCHONDRION, V12, P66, DOI 10.1016/j.mito.2011.07.003; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; POPOV KM, 1992, J BIOL CHEM, V267, P13127; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; Vaitheesvaran B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033717; Wenger CD, 2011, NAT METHODS, V8, P933, DOI [10.1038/NMETH.1716, 10.1038/nmeth.1716]; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	72	84	84	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26209	26219		10.1074/jbc.M113.483396	http://dx.doi.org/10.1074/jbc.M113.483396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23864654	Green Published, hybrid			2022-12-28	WOS:000330623300051
J	Wang, L; Wu, XL; Shi, T; Lu, L				Wang, Ling; Wu, Xiaolin; Shi, Ting; Lu, Luo			Epidermal Growth Factor (EGF)-induced Corneal Epithelial Wound Healing through Nuclear Factor kappa B Subtype-regulated CCCTC Binding Factor (CTCF) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; INDUCED PROLIFERATION; EGFR ACTIVATION; CELL-DEATH; RECEPTOR; STRESS; KINASE; EXPRESSION; APOPTOSIS	Epidermal growth factor (EGF) plays an important role in corneal epithelial migration and proliferation to improve the wound healing process. This study aimed to understand the role of NF kappa B in EGF-induced corneal epithelial wound healing through regulation of CTCF activity, which plays important roles in cell motility and migration to promote wound healing. The effect of NF kappa B p50 on corneal epithelial wound healing was investigated by comparing the eyes of wild-type and p50 knockout mice. We found that there was a significant retardation in corneal epithelial wound healing in the corneas of p50 knockout mice. Wound closure rates were measured in human corneal epithelial cells transfected with an NF kappa B activation-sensitive CTCF expression construct to demonstrate the effect of human CTCF expression under the control of EGF-induced NF kappa B activation on wound healing. EGF stimulation activated NF kappa B, which directly triggered the expression of the exogenous human CTCF in transfected cells and, subsequently, promoted human corneal epithelial cell motility, migration, and wound healing. Overexpression of CTCF in corneal epithelial cells and mouse corneas significantly enhanced the wound healing process. Furthermore, the effect of overexpressing NF kappa B p50 in corneal epithelial cells on the promotion of wound healing was abolished by knockdown of CTCF with CTCF-specific shRNA. Thus, a direct regulatory relationship between EGF-induced NF kappa B p50 and CTCF activation affecting corneal epithelial wound healing has been established, indicating that CTCF is, indeed, a NF kappa B p50-targeted and effective gene product in the core transcriptional network downstream from the growth factor-induced NF kappa B signaling pathway.	[Wang, Ling; Wu, Xiaolin; Shi, Ting; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90503 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Grants [R01-EY015281, EY022364]; NATIONAL EYE INSTITUTE [R01EY015281, R01EY022364] Funding Source: NIH RePORTER	National Institutes of Grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Grants R01-EY015281 and EY022364 (to L. L.).	BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Belandia B, 1998, J BIOL CHEM, V273, P30366, DOI 10.1074/jbc.273.46.30366; Bell KD, 2000, CORNEA, V19, P40, DOI 10.1097/00003226-200001000-00009; BUSCHER M, 1988, ONCOGENE, V3, P301; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Holbrook N J, 1996, EXS, V77, P273; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; Islam M, 2001, INVEST OPHTH VIS SCI, V42, P1472; Kang SS, 2000, INVEST OPHTH VIS SCI, V41, P2164; Kang SS, 2001, CURR EYE RES, V23, P397, DOI 10.1076/ceyr.23.6.397.6965; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Qi CF, 2003, P NATL ACAD SCI USA, V100, P633, DOI 10.1073/pnas.0237127100; Rasko JEJ, 2001, CANCER RES, V61, P6002; Wang J, 2012, J BIOL CHEM, V287, P12469, DOI 10.1074/jbc.M111.286641; Wang J, 2010, INVEST OPHTH VIS SCI, V51, P2943, DOI 10.1167/iovs.09-4639; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P946, DOI 10.1167/iovs.11-8747; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Wang YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023984; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1987; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang Y, 1999, INVEST OPHTH VIS SCI, V40, P2819; Zhang Y, 1998, CURR EYE RES, V17, P294, DOI 10.1076/ceyr.17.3.294.5223; Zhang Y, 1996, EXP EYE RES, V63, P265, DOI 10.1006/exer.1996.0115; Zhang Y, 1997, INVEST OPHTH VIS SCI, V38, P1139; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	40	53	53	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24363	24371		10.1074/jbc.M113.458141	http://dx.doi.org/10.1074/jbc.M113.458141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23843455	Green Published, hybrid			2022-12-28	WOS:000330612300008
J	Andersen, JT; Cameron, J; Plumridge, A; Evans, L; Sleep, D; Sandlie, I				Andersen, Jan Terje; Cameron, Jason; Plumridge, Andrew; Evans, Leslie; Sleep, Darrell; Sandlie, Inger			Single-chain Variable Fragment Albumin Fusions Bind the Neonatal Fc Receptor (FcRn) in a Species-dependent Manner IMPLICATIONS FOR IN VIVO HALF-LIFE EVALUATION OF ALBUMIN FUSION THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-ALBUMIN; SACCHAROMYCES-CEREVISIAE; ANTIBODY; PHARMACOKINETICS; IGG; PROTEINS; EXPRESSION; STRAINS; CELLS	Albumin has a serum half-life of 3 weeks in humans. This has been utilized to extend the serum persistence of biopharmaceuticals that are fused to albumin. In light of the fact that the neonatal Fc receptor (FcRn) is a key regulator of albumin homeostasis, it is crucial to address how fusion of therapeutics to albumin impacts binding to FcRn. Here, we report on a detailed molecular investigation on how genetic fusion of a short peptide or an single-chain variable fragment (scFv) fragment to human serum albumin (HSA) influences pH-dependent binding to FcRn from mouse, rat, monkey, and human. We have found that fusion to the N- or C-terminal end of HSA only slightly reduces receptor binding, where the most noticeable effect is seen after fusion to the C-terminal end. Furthermore, in contrast to the observed strong binding to human and monkey FcRn, HSA and all HSA fusions bound very poorly to mouse and rat versions of the receptor. Thus, we demonstrate that conventional rodents are limited as preclinical models for analysis of serum half-life of HSA-based biopharmaceuticals. This finding is explained by cross-species differences mainly found within domain III (DIII) of albumin. Our data demonstrate that although fusion, particularly to the C-terminal end, may slightly reduce the affinity for FcRn, HSA is versatile as a carrier of biopharmaceuticals.	[Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Oslo Univ Hosp Rikshosp, CIR, N-0424 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Oslo Univ Hosp Rikshosp, Dept Immunol, N-0424 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, N-0424 Oslo, Norway; [Cameron, Jason; Plumridge, Andrew; Evans, Leslie; Sleep, Darrell] Novozymes Biopharma UK Ltd, Castle Court, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Novozymes	Andersen, JT (corresponding author), Oslo Univ Hosp Rikshosp, CIR, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@imbv.uio.no; inger.sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Andersen, Jan Terje/0000-0003-1710-1628; Sleep, Darrell/0000-0001-8287-9538	Norwegian Research Council [179573/V40]; South-Eastern Norway Regional Health Authority Grant [39375]	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority Grant	This work was supported in part by the Norwegian Research Council (Grant 179573/V40) and South-Eastern Norway Regional Health Authority Grant 39375 (to J. T. A.).	Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Knudsen LB, 2010, INT J CLIN PRACT, V64, P4, DOI 10.1111/j.1742-1241.2010.02499.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Payne T, 2008, APPL ENVIRON MICROB, V74, P7759, DOI 10.1128/AEM.01178-08; Reichert JM, 2001, NAT BIOTECHNOL, V19, P819, DOI 10.1038/nbt0901-819; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	31	54	62	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24277	24285		10.1074/jbc.M113.463000	http://dx.doi.org/10.1074/jbc.M113.463000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818524	hybrid, Green Published			2022-12-28	WOS:000330611400064
J	Dolmer, K; Campos, A; Gettins, PGW				Dolmer, Klavs; Campos, Andres; Gettins, Peter G. W.			Quantitative Dissection of the Binding Contributions of Ligand Lysines of the Receptor-associated Protein (RAP) to the Low Density Lipoprotein Receptor-related Protein (LRP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; LDL RECEPTOR; HUMAN ALPHA(2)-MACROGLOBULIN; PLASMINOGEN-ACTIVATOR; DOMAIN; RESIDUES; AFFINITY; COMPLEX; SITE; IDENTIFICATION	Although lysines are known to be critical for ligand binding to LDL receptor family receptors, relatively small reductions in affinity have been found when such lysines have been mutated. To resolve this paradox, we have examined the specific binding contributions of four lysines, Lys-253, Lys-256, Lys-270, and Lys-289, in the third domain (D3) of receptor-associated protein (RAP), by eliminating all other lysine residues. Using D3 variants containing lysine subsets, we examined binding to the high affinity fragment CR56 from LRP1. With this simplification, we found that elimination of the lysine pairs Lys-253/Lys-256 and Lys-270/Lys-289 resulted in increases in K-d of 1240- and 100,000-fold, respectively. Each pair contributed additively to overall affinity, with 61% from Lys-270/Lys-289 and 39% from Lys-253/Lys-256. Furthermore, the Lys-270/Lys-289 pair alone could bind different single CR domains with similar affinity. Within the pairs, binding contributions of Lys-270 >> Lys-256 > Lys-253 similar to Lys-289 were deduced. Importantly, however, Lys-289 could significantly compensate for the loss of Lys-270, thus explaining how previous studies have underestimated the importance of Lys-270. Calorimetry showed that favorable enthalpy, from Lys-256 and Lys-270, overwhelmingly drives binding, offset by unfavorable entropy. Our findings support a mode of ligand binding in which a proximal pair of lysines engages the negatively charged pocket of a CR domain, with two such pairs of interactions (requiring two CR domains), appropriately separated, being alone sufficient to provide the low nanomolar affinity found for most protein ligands of LDL receptor family members.	[Dolmer, Klavs; Campos, Andres; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, M-C 669,900 S Ashland, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [GM54414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54414.	Andersen OS, 2001, J GEN PHYSIOL, V117, P1; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; Estrada K, 2008, BIOCHEMISTRY-US, V47, P1532, DOI 10.1021/bi702076y; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Lazic A, 2006, ARCH BIOCHEM BIOPHYS, V450, P167, DOI 10.1016/j.abb.2006.04.007; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	26	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24081	24090		10.1074/jbc.M113.473728	http://dx.doi.org/10.1074/jbc.M113.473728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23798683	hybrid, Green Published			2022-12-28	WOS:000330611400044
J	Frolov, A; Dong, H; Jiang, M; Yang, LH; Cook, EC; Matnani, R; Hammock, BD; Crofford, LJ				Frolov, Andrey; Dong, Hua; Jiang, Min; Yang, Lihua; Cook, Erik C.; Matnani, Rahul; Hammock, Bruce D.; Crofford, Leslie J.			Niemann-Pick Type C2 Deficiency in Human Fibroblasts Confers Robust and Selective Activation of Prostaglandin E2 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); HUMAN COLONIC MYOFIBROBLASTS; RHEUMATOID-ARTHRITIS; E-2 PRODUCTION; CHOLESTEROL HOMEOSTASIS; SYNOVIAL FIBROBLASTS; ENDOTHELIAL-CELLS; LAMINA PROPRIA; STROMAL CELLS; GROWTH-FACTOR	Activated fibroblasts, also known as myofibroblasts, are mediators of several major human pathologies including proliferative fibrotic disorders, invasive tumor growth, rheumatoid arthritis, and atherosclerosis. We previously identified Niemann-Pick type C2 (NPC2) protein as a negative regulator of fibroblast activation (Csepeggi, C., Jiang, M., Kojima, F., Crofford, L. J., and Frolov, A. (2011) J. Biol. Chem. 286, 2078-2087). Here we report that NPC2-deficiency leads to a dramatic up-regulation of the arachidonic acid (AA) metabolic pathway in human fibroblasts. The major enzymes in this pathway, cPLA2 type IVA, COX-2, and mPGES-1, were dramatically up-regulated at both the transcriptional and translational levels. The specific phenotypic changes resulted in a >10-fold increase in the production and secretion of a key modulator of inflammation and immunity, prostaglandin E2. More importantly, AA metabolome profiling by liquid chromatography/tandem mass-spectrometry revealed the very specific nature of prostaglandin E2 up-regulation as the other analyzed AA metabolites derived from the COX-2, cytochrome P450, 5/15-lipoxygenase, and non-enzymatic oxidative pathways were mostly down-regulated. Blocking activity of cPLA2 efficiently suppressed expression of inflammatory cytokines, IL-1 beta and IL-6, thereby identifying cPLA2 as an important regulator of the inflammatory program in NPC2-null cells. Altogether, these studies highlight NPC2 as a specific regulator of AA metabolism and inflammation that suggests potential for NPC2 protein or its related signaling in the treatment of inflammatory diseases characterized by the presence of activated fibroblasts.	[Frolov, Andrey; Yang, Lihua; Cook, Erik C.; Matnani, Rahul; Crofford, Leslie J.] Univ Kentucky, Dept Internal Med, Div Rheumatol, Lexington, KY 40536 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA; [Jiang, Min] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University of Kentucky; University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, 900 S Limestone St,CT Wethington Hlth Sci Bldg,Rm, Lexington, KY 40536 USA.	andrey.frolov@uky.edu	Matnani, Rahul/AAH-1233-2019	Cook, Erik/0000-0003-3863-1708; Matnani, Rahul/0000-0001-6734-3217	National Institutes of Health [RO1AR049010]; American Heart Association [SDG 023017N]; National Institutes of Health (NIH) [RO1 ES ES002710]; NIEHS [P42 ES004699]; NIH [U24DK097154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES002710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AR049010 (to L. J. C.). This work was also supported by American Heart Association Grant SDG 023017N (to A. F.). Partial support for analytical chemistry was provided by National Institutes of Health (NIH) Grant RO1 ES ES002710 (NIEHS) and NIEHS Superfund Research Program Grant P42 ES004699 and NIH Grant U24DK097154 (to B. D. H.).	Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bhattacharyya S, 2012, NAT REV RHEUMATOL, V8, P42, DOI 10.1038/nrrheum.2011.149; Bunt G, 1997, J CELL SCI, V110, P2449; Bunt G, 2000, BIOCHEMISTRY-US, V39, P7847, DOI 10.1021/bi992725p; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Charles RL, 2011, CIRC RES, V108, P324, DOI 10.1161/CIRCRESAHA.110.235879; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Coen M, 2011, ARTERIOSCL THROM VAS, V31, P2391, DOI 10.1161/ATVBAHA.111.231548; Csepeggi C, 2011, J BIOL CHEM, V286, P2078, DOI 10.1074/jbc.M110.135897; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Freeman EJ, 1998, AM J PHYSIOL-CELL PH, V274, pC282, DOI 10.1152/ajpcell.1998.274.1.C282; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hai L, 2011, AM J PHYSIOL-GASTR L, V301, pG356, DOI 10.1152/ajpgi.00354.2010; Heo K, 2006, STEM CELLS, V24, P1549, DOI 10.1634/stemcells.2005-0458; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hwang MK, 2010, CANCER RES, V70, P6859, DOI 10.1158/0008-5472.CAN-09-4393; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Leclerc P, 2013, SCAND J IMMUNOL, V77, P350, DOI 10.1111/sji.12041; LEIZER T, 1987, ARTHRITIS RHEUM, V30, P562, DOI 10.1002/art.1780300511; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Nah SS, 2010, RHEUMATOL INT, V30, P443, DOI 10.1007/s00296-009-0976-6; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Petrovic N, 2006, PROSTAG OTH LIPID M, V81, P126, DOI 10.1016/j.prostaglandins.2006.08.006; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; SA G, 1995, J BIOL CHEM, V270, P2360, DOI 10.1074/jbc.270.5.2360; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Seymour ML, 2003, AM J PHYSIOL-CELL PH, V284, pC1185, DOI 10.1152/ajpcell.00126.2002; SMITH RJ, 1977, J PHARMACOL EXP THER, V200, P647; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	49	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23696	23703		10.1074/jbc.M112.445916	http://dx.doi.org/10.1074/jbc.M112.445916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814065	Green Published, hybrid			2022-12-28	WOS:000330611400010
J	Kottom, TJ; Limper, AH				Kottom, Theodore J.; Limper, Andrew H.			The Pneumocystis Ace2 Transcription Factor Regulates Cell Wall-remodeling Genes and Organism Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; INDUCE EXPRESSION; CARINII; PNEUMONIA; ATTACHMENT; KINASE; GROWTH; FIBRONECTIN; MUTATIONS; PARASITE	Pneumocystis carinii (Pc) beta-glucans are major components of the organism cell wall; yet, the regulation of Pc cell wall genesis and remodeling is not well understood. Ace2 transcription factors, which are present in many fungi, regulate glucanases and other enzymes needed for cell wall remodeling. The cloning and heterologous expression of PcAce2 in ace2 Delta Saccharomyces cerevisiae demonstrated that PcAce2 can restore the defective glucanase and endochitinase gene expression of the mutant as well as regulate cell wall beta-glucan biosynthetic genes. Furthermore, when a reconstructed yeast system was used, PcAce2 activated the transcription of the Pneumocystis gsc1 beta-glucan synthetase, confirming the activity of a Pc transcription factor on a native Pneumocystis promoter and gene for the first time. We further observed that Pneumocystis binding to host extracellular matrix proteins and lung epithelial cells induced the phosphorylation (activation) of the PcAce2 transcription factor. Finally, we present a novel method that confirms the role of PcAce2 in modulating organism virulence using ace2 Delta Candida glabrata infection in neutropenic mice. Together, these results indicate that the adherence of Pc to lung matrix proteins and epithelial cells leads to the activation of the Ace2 transcription factor, which regulates cell wall degradation and biosynthesis genes that are required for cell wall remodeling.	Mayo Clin, Dept Med, Thorac Dis Res Unit, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Limper, AH (corresponding author), Mayo Clin, 8-24 Stabile, Rochester, MN 55905 USA.	limper.andrew@mayo.edu			National Institutes of Health [R01-HL62150, R01-HL55934]; Mayo Foundation; Walter and Leonore Annenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055934, R01HL062150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Walter and Leonore Annenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL62150 and R01-HL55934 (to A. H. L.). This work was also supported by the Mayo Foundation and the Walter and Leonore Annenberg Foundation.	ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Burgess JW, 2008, INFECT IMMUN, V76, P417, DOI 10.1128/IAI.00986-07; Burgess JW, 2009, AM J RESP CELL MOL, V41, P714, DOI 10.1165/rcmb.2008-0098OC; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; CUSHION MT, 1984, INFECT IMMUN, V44, P245, DOI 10.1128/IAI.44.2.245-251.1984; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; Huang Laurence, 2006, Proc Am Thorac Soc, V3, P655, DOI 10.1513/pats.200602-015MS; ITATANI CA, 1988, J PARASITOL, V74, P700, DOI 10.2307/3282193; Kamran M, 2004, EUKARYOT CELL, V3, P546, DOI 10.1128/EC.3.2.546-552.2004; Kottom TJ, 2008, MOL MICROBIOL, V67, P747, DOI 10.1111/j.1365-2958.2007.06093.x; Kottom TJ, 2011, INFECT IMMUN, V79, P4157, DOI 10.1128/IAI.05066-11; Kottom TJ, 2004, INFECT IMMUN, V72, P4628, DOI 10.1128/IAI.72.8.4628-4636.2004; Kottom TJ, 2003, INFECT IMMUN, V71, P6463, DOI 10.1128/IAI.71.11.6463-6471.2003; Kottom TJ, 2000, J BIOL CHEM, V275, P40628, DOI 10.1074/jbc.M002103200; Krajicek BJ, 2010, AM J PHYSIOL-LUNG C, V298, pL252, DOI 10.1152/ajplung.00191.2009; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; LIMPER AH, 1990, J CLIN INVEST, V85, P391, DOI 10.1172/JCI114451; Limper AH, 1997, J LAB CLIN MED, V130, P132, DOI 10.1016/S0022-2143(97)90089-5; MacCallum DM, 2006, INFECT IMMUN, V74, P5244, DOI 10.1128/IAI.00817-06; Maccallum Donna M, 2012, Int J Microbiol, V2012, P363764, DOI 10.1155/2012/363764; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; POTTRATZ ST, 1990, J CLIN INVEST, V85, P351, DOI 10.1172/JCI114445; Saputo S, 2012, EUKARYOT CELL, V11, P708, DOI 10.1128/EC.00044-12; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Thomas CF, 1998, AM J RESP CELL MOL, V18, P297, DOI 10.1165/ajrcmb.18.3.3122; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23893	23902		10.1074/jbc.M113.471243	http://dx.doi.org/10.1074/jbc.M113.471243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23801335	Green Published, hybrid			2022-12-28	WOS:000330611400029
J	Dalghi, MG; Fernandez, MM; Ferreira-Gomes, M; Mangialavori, IC; Malchiodi, EL; Strehler, EE; Rossi, JPFC				Dalghi, Marianela G.; Fernandez, Marisa M.; Ferreira-Gomes, Mariela; Mangialavori, Irene C.; Malchiodi, Emilio L.; Strehler, Emanuel E.; Rossi, Juan Pablo F. C.			Plasma Membrane Calcium ATPase Activity Is Regulated by Actin Oligomers through Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; EPITHELIAL SODIUM-CHANNELS; SEA-URCHIN EGGS; ERYTHROCYTE CA-2+-ATPASE; HIGH-AFFINITY; PHOSPHOINOSITIDE-BINDING; SELF-ASSOCIATION; CA-2+ PUMP; CA2+ PUMP; F-ACTIN	As recently described by our group, plasma membrane calcium ATPase (PMCA) activity can be regulated by the actin cytoskeleton. In this study, we characterize the interaction of purified G-actin with isolated PMCA and examine the effect of G-actin during the first polymerization steps. As measured by surface plasmon resonance, G-actin directly interacts with PMCA with an apparent 1: 1 stoichiometry in the presence of Ca2+ with an apparent affinity in the micromolar range. As assessed by the photoactivatable probe 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125] iodo-4-(trifluoromethyl-3H-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine, the association of PMCA to actin produced a shift in the distribution of the conformers of the pump toward a calmodulin-activated conformation. G-actin stimulates Ca2+ ATPase activity of the enzyme when incubated under polymerizing conditions, displaying a cooperative behavior. The increase in the Ca2+-ATPase activity was related to an increase in the apparent affinity for Ca2+ and an increase in the phosphoenzyme levels at steady state. Although surface plasmon resonance experiments revealed only one binding site for G-actin, results clearly indicate that more than one molecule of G-actin was needed for a regulatory effect on the pump. Polymerization studies showed that the experimental conditions are compatible with the presence of actin in the first stages of assembly. Altogether, these observations suggest that the stimulatory effect is exerted by short oligomers of actin. The functional interaction between actin oligomers and PMCA represents a novel regulatory pathway by which the cortical actin cytoskeleton participates in the regulation of cytosolic Ca2+ homeostasis.	[Dalghi, Marianela G.; Ferreira-Gomes, Mariela; Mangialavori, Irene C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Immunidad Humoral,Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Malchiodi, EL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	emalchiodi@ffyb.uba.ar; jprossi@retina.ar	Mangialavori, Irene/GLU-8182-2022	Mangialavori, Irene/0000-0003-3187-3130; Rossi, Juan Pablo/0000-0001-7087-844X; Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (Argentina)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (Argentina).	Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; BONDER EM, 1989, DEV BIOL, V134, P327, DOI 10.1016/0012-1606(89)90105-X; Bozulic LD, 2007, THROMB HAEMOSTASIS, V97, P587, DOI 10.1160/TH06-08-0438; Bredeston LM, 2002, BIOCHEM J, V361, P355, DOI 10.1042/0264-6021:3610355; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; CANTIELLO HF, 1995, AM J PHYSIOL-RENAL, V269, pF637, DOI 10.1152/ajprenal.1995.269.5.F637; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Carlier MF, 1991, CURR OPIN CELL BIOL, V3, P12, DOI 10.1016/0955-0674(91)90160-Z; CARLIER MF, 1986, J BIOL CHEM, V261, P785; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; FECHHEIMER M, 1993, J CELL BIOL, V123, P1, DOI 10.1083/jcb.123.1.1; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GERSHMAN LC, 1991, J BIOL CHEM, V266, P76; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; JAMES P, 1988, J BIOL CHEM, V263, P2905; JAMES P, 1989, J BIOL CHEM, V264, P8289; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; KATZ S, 1975, BIOCHIM BIOPHYS ACTA, V389, P314, DOI 10.1016/0005-2736(75)90324-7; Khurana S, 2000, J MEMBRANE BIOL, V178, P73, DOI 10.1007/s002320010016; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P1875, DOI 10.1021/bi00459a030; KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7; KRATJE RB, 1983, BIOCHIM BIOPHYS ACTA, V731, P40, DOI 10.1016/0005-2736(83)90395-4; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kusano K, 1999, MOL CELL BIOCHEM, V190, P133, DOI 10.1023/A:1006962210692; LICHTNER R, 1980, BIOCHIM BIOPHYS ACTA, V598, P486, DOI 10.1016/0005-2736(80)90029-2; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori Irene C, 2011, Curr Chem Biol, V5, P118; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; NEYSES L, 1985, J BIOL CHEM, V260, P283; NIGGLI V, 1981, J BIOL CHEM, V256, P395; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rega A. F., 1986, CA2 PLUS PUMP PLASMA, P77; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Roman I, 2006, BBA-BIOMEMBRANES, V1758, P479, DOI 10.1016/j.bbamem.2006.03.019; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; SAFER D, 1991, J BIOL CHEM, V266, P4029; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SARKADI B, 1980, BIOCHIM BIOPHYS ACTA, V598, P326, DOI 10.1016/0005-2736(80)90010-3; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Sheterline P, 1998, ACTIN; SPUDICH A, 1988, CELL MOTIL CYTOSKEL, V9, P85, DOI 10.1002/cm.970090109; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; Straub F. B., 1943, MED CHEM U SZEGED, V3, P23; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Vanagas L, 2007, BBA-BIOMEMBRANES, V1768, P1641, DOI 10.1016/j.bbamem.2007.03.012; Vanagas L, 2013, CELL BIOCHEM BIOPHYS, V66, P187, DOI 10.1007/s12013-012-9467-6; VORHERR T, 1991, J BIOL CHEM, V266, P22; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Xian WJ, 1995, BIOPHYS J, V69, P2695, DOI 10.1016/S0006-3495(95)80140-2; Xu JY, 1998, BIOPHYS J, V74, P2731, DOI 10.1016/S0006-3495(98)77979-2; YAMAMOTO K, 1991, J MOL BIOL, V217, P229, DOI 10.1016/0022-2836(91)90535-E; YIN HL, 1981, J BIOL CHEM, V256, P9693; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x; Zylinska L, 1998, BBA-MOL CELL RES, V1448, P99, DOI 10.1016/S0167-4889(98)00128-1	95	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23380	23393		10.1074/jbc.M113.470542	http://dx.doi.org/10.1074/jbc.M113.470542			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803603	Green Published, hybrid			2022-12-28	WOS:000330598200042
J	Lord, MS; Day, AJ; Youssef, P; Zhuo, L; Watanabe, H; Caterson, B; Whitelock, JM				Lord, Megan S.; Day, Anthony J.; Youssef, Peter; Zhuo, Lisheng; Watanabe, Hideto; Caterson, Bruce; Whitelock, John M.			Sulfation of the Bikunin Chondroitin Sulfate Chain Determines Heavy Chain center dot Hyaluronan Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; CARBOHYDRATE ELECTROPHORESIS FACE; CUMULUS EXTRACELLULAR-MATRIX; FACTOR-STIMULATED GENE-6; PROTEIN LINKAGE REGION; NECROSIS-FACTOR-ALPHA; BIOTINYLATED HYALURONAN; PROTEOGLYCAN BIKUNIN; RHEUMATOID-ARTHRITIS; STRUCTURAL-ANALYSIS	Inter-alpha-trypsin inhibitor (I alpha I) is a complex comprising two heavy chains (HCs) that are covalently bound by an ester bond to chondroitin sulfate (CS), which itself is attached to Ser-10 of bikunin. I alpha I is essential for the trans-esterification of HCs onto hyaluronan (HA). This process is important for the stabilization of HA-rich matrices during ovulation and some inflammatory processes. Bikunin has been isolated previously by anion exchange chromatography with a salt gradient up to 0.5 M NaCl and found to contain unsulfated and 4-sulfated CS disaccharides. In this study, bikunin-containing fractions in plasma and urine were separated by anion exchange chromatography with a salt gradient of 0.1-1.0 M NaCl, and fractions were analyzed for their reactivity with the 4-sulfated CS linkage region antibody (2B6). The fractions that reacted with the 2B6 antibody (0.5-0.8 M NaCl) were found to predominantly contain sulfated CS disaccharides, including disulfated disaccharides, whereas the fractions that did not react with this antibody (0.1-0.5 M NaCl) contained unsulfated and 4-sulfated CS disaccharides. I alpha I in the 0.5-0.8 M NaCl plasma fraction was able to promote the trans-esterification of HCs to HA in the presence of TSG-6, whereas the 0.1-0.5 M NaCl fraction had a much reduced ability to transfer HC proteins to HA, suggesting that the CS containing 4-sulfated linkage region structures and disulfated disaccharides are involved in the HC transfer. Furthermore, these data highlight that the structure of the CS attached to bikunin is important for the transfer of HC onto HA and emphasize a specific role of CS chain sulfation.	[Lord, Megan S.; Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Youssef, Peter] Royal Prince Alfred Hosp, Dept Rheumatol, Camperdown, NSW 2050, Australia; [Zhuo, Lisheng; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci, Aichi 4801195, Japan; [Caterson, Bruce] Cardiff Univ, Cardiff Business Sch, Cardiff CF20 3US, S Glam, Wales	University of New South Wales Sydney; University of Manchester; University of Sydney; Aichi Medical University; Cardiff University	Lord, MS (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	m.lord@unsw.edu.au	Day, Anthony/O-1658-2015; Lord, Megan/D-4673-2013	Day, Anthony/0000-0002-1415-3134; Lord, Megan/0000-0002-0506-9811; Whitelock, John/0000-0003-1835-802X; Caterson, Bruce/0000-0001-6016-0661; Watanabe, Hideto/0000-0001-5291-0696	Australian Research Council [LP0455407]; Arthritis Research UK [18472, 19489]; Medical Research Council [G0701180]; MRC [G0701180] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/15414] Funding Source: researchfish; Versus Arthritis [18472, 19858, 19489] Funding Source: researchfish	Australian Research Council(Australian Research Council); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This work was supported by Australian Research Council Linkage Project Grant LP0455407, Arthritis Research UK Grants 18472 and 19489, and Medical Research Council Grant G0701180.	BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Capon C, 2003, BIOCHIMIE, V85, P101, DOI 10.1016/S0300-9084(03)00066-X; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gao NG, 2003, GLYCOBIOLOGY, V13, p1G, DOI 10.1093/glycob/cwg009; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; HUTADILOK N, 1988, ANN RHEUM DIS, V47, P377, DOI 10.1136/ard.47.5.377; ITOH Y, 1990, J CLIN LAB ANAL, V4, P376, DOI 10.1002/jcla.1860040511; Kakizaki I, 2007, BBA-GEN SUBJECTS, V1770, P171, DOI 10.1016/j.bbagen.2006.09.026; Kanayama S, 2008, CYTOKINE, V42, P191, DOI 10.1016/j.cyto.2007.12.011; Kida D, 1999, J RHEUMATOL, V26, P1230; Klock JC, 1998, METH MOL B, V76, P115; Laremore TN, 2011, INT J MASS SPECTROM, V305, P109, DOI 10.1016/j.ijms.2010.09.020; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Melrose J, 2001, Methods Mol Biol, V171, P53; Melrose J, 1996, ELECTROPHORESIS, V17, P205, DOI 10.1002/elps.1150170134; Mizon C, 2001, EUR J BIOCHEM, V268, P2717, DOI 10.1046/j.1432-1327.2001.02168.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; OCHIAI H, 1988, CHEM PHARM BULL, V36, P3726; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PROKSCH GJ, 1972, J LAB CLIN MED, V79, P491; Pugia MJ, 2005, CLIN CHEM LAB MED, V43, P1, DOI 10.1515/CCLM.2005.001; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sandson J, 1965, Trans Assoc Am Physicians, V78, P304; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Thomas GJ, 1998, AM J PATHOL, V153, P1267, DOI 10.1016/S0002-9440(10)65671-4; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; YAMADA S, 1995, EUR J BIOCHEM, V233, P687, DOI 10.1111/j.1432-1033.1995.687_2.x; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; YUKI Y, 1993, BIOCHIM BIOPHYS ACTA, V1203, P298, DOI 10.1016/0167-4838(93)90098-C; Zhu L, 2008, CONNECT TISSUE RES, V49, P48, DOI 10.1080/03008200701820955; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2002, GLYCOCONJUGATE J, V19, P241, DOI 10.1023/A:1025331929373; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	57	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22930	22941		10.1074/jbc.M112.404186	http://dx.doi.org/10.1074/jbc.M112.404186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801333	Green Published, hybrid			2022-12-28	WOS:000330598200005
J	Wolters, M; Boyle, EC; Lardong, K; Trulzsch, K; Steffen, A; Rottner, K; Ruckdeschel, K; Aepfelbacher, M				Wolters, Manuel; Boyle, Erin C.; Lardong, Kerstin; Truelzsch, Konrad; Steffen, Anika; Rottner, Klemens; Ruckdeschel, Klaus; Aepfelbacher, Martin			Cytotoxic Necrotizing Factor-Y Boosts Yersinia Effector Translocation by Activating Rac Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; MOUSE INFECTION MODEL; ESCHERICHIA-COLI; RHO GTPASES; VIRULENCE FACTOR; PROTEASOMAL DEGRADATION; SIGNALING RESPONSES; KINASE ACTIVATION; ENDOTHELIAL-CELLS; ACTIN-BINDING	Pathogenic Yersinia spp. translocate the effectors YopT, YopE, and YopO/YpkA into target cells to inactivate Rho family GTP-binding proteins and block immune responses. Some Yersinia spp. also secrete the Rho protein activator cytotoxic necrotizing factor-Y (CNF-Y), but it has been unclear how the bacteria may benefit from Rho protein activation. We show here that CNF-Y increases Yop translocation in Yersinia enterocolitica-infected cells up to 5-fold. CNF-Y strongly activated RhoA and also delayed in time Rac1 and Cdc42, but when individually expressed, constitutively active mutants of Rac1, but not of RhoA, increased Yop translocation. Consistently, knock-out or knockdown of Rac1 but not of RhoA, -B, or -C inhibited Yersinia effector translocation in CNF-Y-treated and control cells. Activation or knockdown of Cdc42 also affected Yop translocation but much less efficiently than Rac. The increase in Yop translocation induced by CNF-Y was essentially independent of the presence of YopE, YopT, or YopO in the infecting Yersinia strain, indicating that none of the Yops reported to inhibit translocation could reverse the CNF-Y effect. In summary, the CNF-Y activity of Yersinia strongly enhances Yop translocation through activation of Rac.	[Wolters, Manuel; Boyle, Erin C.; Lardong, Kerstin; Ruckdeschel, Klaus; Aepfelbacher, Martin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany; [Truelzsch, Konrad] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Steffen, Anika; Rottner, Klemens] Univ Bonn, Inst Genet, D-53127 Bonn, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Aepfelbacher, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Martinistr 52, D-20246 Hamburg, Germany.	m.aepfelbacher@uke.de		Rottner, Klemens/0000-0003-4244-4198; Boyle, Erin C./0000-0002-5963-3633; Steffen, Anika/0000-0002-2933-0543	German Research Council	German Research Council(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Council (to K. R.).	Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Aepfelbacher M, 2007, THROMB HAEMOSTASIS, V98, P521, DOI 10.1160/TH07-03-0173; Aepfelbacher M, 2011, EUR J CELL BIOL, V90, P951, DOI 10.1016/j.ejcb.2010.12.004; Aili M, 2006, CELL MICROBIOL, V8, P1020, DOI 10.1111/j.1462-5822.2005.00684.x; Aktories K, 2003, TRENDS MICROBIOL, V11, P152, DOI 10.1016/S0966-842X(03)00042-8; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; BOLIN I, 1982, INFECT IMMUN, V37, P506; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Essler M, 2003, INFECT IMMUN, V71, P5188, DOI 10.1128/IAI.71.9.5188-5193.2003; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gaus K, 2011, INFECT IMMUN, V79, P1166, DOI 10.1128/IAI.00694-10; GEMSKI P, 1980, INFECT IMMUN, V28, P1044; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; Groves E, 2010, J BIOL CHEM, V285, P4087, DOI 10.1074/jbc.M109.071035; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; Holmstrom A, 1995, CONTRIB TO MICROBIOL, V13, P239; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Lockman HA, 2002, INFECT IMMUN, V70, P2708, DOI 10.1128/IAI.70.5.2708-2714.2002; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Nordfelth R, 2001, INFECT IMMUN, V69, P3516, DOI 10.1128/IAI.69.5.3516-3518.2001; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Peters KN, 2012, ADV EXP MED BIOL, V954, P229, DOI 10.1007/978-1-4614-3561-7_29; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schmidt G, 2011, EUR J CELL BIOL, V90, P955, DOI 10.1016/j.ejcb.2010.12.005; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trulzsch K, 2007, ADV EXP MED BIOL, V603, P279; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	68	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23543	23553		10.1074/jbc.M112.448662	http://dx.doi.org/10.1074/jbc.M112.448662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803609	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000330598200058
J	Hillian, AD; McMullen, MR; Sebastian, BM; Rowchowdhury, S; Kashyap, SR; Schauer, PR; Kirwan, JP; Feldstein, AE; Nagy, LE				Hillian, Antoinette D.; McMullen, Megan R.; Sebastian, Becky M.; Rowchowdhury, Sanjoy; Kashyap, Sangeeta R.; Schauer, Philip R.; Kirwan, John P.; Feldstein, Ariel E.; Nagy, Laura E.			Mice Lacking C1q Are Protected from High Fat Diet-induced Hepatic Insulin Resistance and Impaired Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION STIMULATING PROTEIN; DECAY-ACCELERATING FACTOR; OMENTAL ADIPOSE-TISSUE; COMPLEMENT ACTIVATION; LIVER-DISEASE; IN-VITRO; EXPRESSION; ADIPOCYTE; OBESITY; C3A	Complement activation is implicated in the development of obesity and insulin resistance, and loss of signaling by the anaphylatoxin C3a prevents obesity-induced insulin resistance in mice. Here we have identified C1q in the classical pathway as required for activation of complement in response to high fat diets. After 8 weeks of high fat diet, wild-type mice became obese and developed glucose intolerance. This was associated with increased apoptotic cell death and accumulation of complement activation products (C3b/iC3b/C3c) in liver and adipose tissue. Previous studies have shown that high fat diet-induced apoptosis is dependent on Bid; here we report that Bid-mediated apoptosis was required for complement activation in adipose and liver. Although C1qa deficiency had no effect on high fat diet-induced apoptosis, accumulation of complement activation products and the metabolic complications of high fat diet-induced obesity were dependent on C1q. When wild-type mice were fed a high fat diet for only 3 days, hepatic insulin resistance was associated with the accumulation of C3b/iC3b/C3c in the liver. Mice deficient in C3a receptor were protected against this early high fat diet-induced hepatic insulin resistance, whereas mice deficient in the negative complement regulator CD55/DAF were more sensitive to the high fat diet. C1qa(-/-) mice were also protected from high fat diet-induced hepatic insulin resistance and complement activation. Evidence of complement activation was also detected in adipose tissue of obese women compared with lean women. Together, these studies reveal an important role for C1q in the classical pathway of complement activation in the development of high fat diet-induced insulin resistance.	[Hillian, Antoinette D.; McMullen, Megan R.; Sebastian, Becky M.; Rowchowdhury, Sanjoy; Kirwan, John P.; Nagy, Laura E.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Dept Endocrinol Diabet & Metab, Cleveland, OH 44195 USA; [Schauer, Philip R.] Cleveland Clin, Bariatr Metab Inst, Cleveland, OH 44195 USA; [Kirwan, John P.; Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Diego	Nagy, LE (corresponding author), Cleveland Clin, Dept Pathobiol, 9500 Euclid Ave NE40, Cleveland, OH 44195 USA.	nagyL3@ccf.org	Kirwan, John P/G-6942-2012	Schauer, Philip/0000-0002-4029-7537; Kashyap, Sangeeta/0000-0002-7489-6650	National Institutes of Health (NIH) [5R01AA016399, 5R37 AA011876, RO1DK089547, RO1 DK076853, RO1DK082451]; NIH, NCRR [CTSA UL1RR024989];  [T32DK07319]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319, R01DK082451, R01DK089547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016399, R37AA011876] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 5R01AA016399 and 5R37 AA011876 (to L. E. N.), RO1DK089547 (to J. P. K.), RO1 DK076853 and RO1DK082451 (to A. E. F.), support from Grant T32DK07319 (to A. D. H.), and NIH, NCRR, Grant CTSA UL1RR024989 (Case Western Reserve University/Cleveland Clinic).	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; DiScipio RG, 1999, J IMMUNOL, V162, P1127; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flyvbjerg A, 2010, NAT REV ENDOCRINOL, V6, P94, DOI 10.1038/nrendo.2009.266; Galvan MD, 2012, J IMMUNOL, V188, P3716, DOI 10.4049/jimmunol.1102920; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Jauneau AC, 2003, FEBS LETT, V537, P17, DOI 10.1016/S0014-5793(03)00060-7; Kelly KR, 2010, OBESITY, V18, P663, DOI 10.1038/oby.2009.328; Khashab Mouen A, 2008, Curr Gastroenterol Rep, V10, P73, DOI 10.1007/s11894-008-0012-0; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Korb LC, 1997, J IMMUNOL, V158, P4525; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Lin F, 2001, IMMUNOLOGY, V104, P215, DOI 10.1046/j.1365-2567.2001.01287.x; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rivera CA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-52; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schieferdecker HL, 2001, INT IMMUNOPHARMACOL, V1, P469, DOI 10.1016/S1567-5769(00)00038-2; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; SUNDSMO JS, 1985, CLIN IMMUNOL IMMUNOP, V35, P211, DOI 10.1016/0090-1229(85)90067-4; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Weyer C, 2000, DIABETES CARE, V23, P779, DOI 10.2337/diacare.23.6.779; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	54	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22565	22575		10.1074/jbc.M113.465674	http://dx.doi.org/10.1074/jbc.M113.465674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788643	Green Published, hybrid			2022-12-28	WOS:000330596300036
J	Pozzi, N; Chen, ZW; Gohara, DW; Niu, WL; Heyduk, T; Di Cera, E				Pozzi, Nicola; Chen, Zhiwei; Gohara, David W.; Niu, Weiling; Heyduk, Tomasz; Di Cera, Enrico			Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; COAGULATION FACTOR XA; FACTOR-VA; MOLECULAR-DYNAMICS; MEMBRANE-BINDING; PROEXOSITE I; THROMBIN; RECOGNITION; SUBSTRATE; DOMAIN	The zymogen prothrombin is composed of fragment 1 containing a Gla domain and kringle-1, fragment 2 containing kringle-2, and a protease domain containing A and B chains. The prothrombinase complex assembled on the surface of platelets converts prothrombin to thrombin by cleaving at Arg-271 and Arg-320. The three-dimensional architecture of prothrombin and the molecular basis of its activation remain elusive. Here we report the first x-ray crystal structure of prothrombin as a Gladomainless construct carrying an Ala replacement of the catalytic Ser-525. Prothrombin features a conformation 80 angstrom long, with fragment 1 positioned at a 36 degrees angle relative to the main axis of fragment 2 coaxial to the protease domain. High flexibility of the linker connecting the two kringles suggests multiple arrangements for kringle-1 relative to the rest of the prothrombin molecule. Luminescence resonance energy transfer measurements detect two distinct conformations of prothrombin in solution, in a 3:2 ratio, with the distance between the two kringles either fully extended (54 +/- 2 angstrom) or partially collapsed (<= 34 angstrom) as seen in the crystal structure. A molecular mechanism of prothrombin activation emerges from the structure. Of the two sites of cleavage, Arg-271 is located in a disordered region connecting kringle-2 to the A chain, but Arg-320 is well defined within the activation domain and is not accessible to proteolysis in solution. Burial of Arg-320 prevents prothrombin autoactivation and directs prothrombinase to cleave at Arg-271 first. Reversal of the local electrostatic potential then redirects prothrombinase toward Arg-320, leading to thrombin generation via the prethrombin-2 intermediate.	[Pozzi, Nicola; Chen, Zhiwei; Gohara, David W.; Niu, Weiling; Heyduk, Tomasz; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100; Gohara, David/0000-0001-8799-9125	National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, U54HL112303, R29HL049413, R01HL073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL73813, and HL112303 (to E. D. C.).	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1992, PROTEIN SCI, V1, P426; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Case DA, 2012, AMBER 12; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Chen Q, 1997, BIOCHEMISTRY-US, V36, P4701, DOI 10.1021/bi961441r; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; GUINTO ER, 1995, P NATL ACAD SCI USA, V92, P11185, DOI 10.1073/pnas.92.24.11185; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Heyduk E, 1997, ANAL BIOCHEM, V248, P216, DOI 10.1006/abio.1997.2148; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; KOTKOW KJ, 1993, J BIOL CHEM, V268, P15633; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee CJ, 2011, J THROMB HAEMOST, V9, P2123, DOI 10.1111/j.1538-7836.2011.04463.x; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NI F, 1993, J BIOL CHEM, V268, P16899; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozhogina OA, 2009, J STRUCT BIOL, V168, P223, DOI 10.1016/j.jsb.2009.06.003; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmidt A., 1872, PFLU GER ARCH, V6, P413, DOI [10.1007/BF01612263, DOI 10.1007/BF01612263]; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; SELVIN PR, 1994, J AM CHEM SOC, V116, P6029, DOI 10.1021/ja00092a088; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	48	31	32	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22734	22744		10.1074/jbc.M113.466946	http://dx.doi.org/10.1074/jbc.M113.466946			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775088	hybrid, Green Published			2022-12-28	WOS:000330596300051
J	Pluvinage, B; Hehemann, JH; Boraston, AB				Pluvinage, Benjamin; Hehemann, Jan-Hendrik; Boraston, Alisdair B.			Substrate Recognition and Hydrolysis by a Family 50 exo-beta-Agarase, Aga50D, from the Marine Bacterium Saccharophagus degradans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; AGARIVORANS SP NOV.; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-ATLANTICA; STRUCTURE VALIDATION; CELLOBIOHYDROLASE-I; TRICHODERMA-REESEI; ENZYME	The bacteria that metabolize agarose use multiple enzymes of complementary specificities to hydrolyze the glycosidic linkages in agarose, a linear polymer comprising the repeating disaccharide subunit of neoagarobiose (3,6-anhydro-L-galactose-alpha-(1,3)-D-galactose) that are beta-(1,4)-linked. Here we present the crystal structure of a glycoside hydrolase family 50 exo-beta-agarase, Aga50D, from the marine microbe Saccharophagus degradans. This enzyme catalyzes a critical step in the metabolism of agarose by S. degradans through cleaving agarose oligomers into neoagarobiose products that can be further processed into monomers. The crystal structure of Aga50D to 1.9 angstrom resolution reveals a (beta/alpha)(8)-barrel fold that is elaborated with a beta-sandwich domain and extensive loops. The structures of catalytically inactivated Aga50D in complex with non-hydrolyzed neoagarotetraose (2.05 angstrom resolution) and neoagarooctaose (2.30 angstrom resolution) provide views of Michaelis complexes for a beta-agarase. In these structures, the D-galactose residue in the -1 subsite is distorted into a S-1(3) skew boat conformation. The relative positioning of the putative catalytic residues are most consistent with a retaining catalytic mechanism. Additionally, the neoagarooctaose complex showed that this extended substrate made substantial interactions with the beta-sandwich domain, which resembles a carbohydrate-binding module, thus creating additional plus (+) subsites and funneling the polymeric substrate through the tunnel-shaped active site. A synthesis of these results in combination with an additional neoagarobiose product complex suggests a potential exo-processive mode of action of Aga50D on the agarose double helix.	[Pluvinage, Benjamin; Hehemann, Jan-Hendrik; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Hehemann, Jan-Hendrik] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Victoria; Massachusetts Institute of Technology (MIT)	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Hehemann, Jan-Hendrik/0000-0002-8700-2564; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery Accelerator Supplement; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Accelerator Supplement(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and an NSERC Discovery Accelerator Supplement. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; BEZUKLADNIKOV PW, 1986, CARBOHYD RES, V152, P261, DOI 10.1016/S0008-6215(00)90306-9; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Czjzek M, 2012, METHOD ENZYMOL, V510, P183, DOI 10.1016/B978-0-12-415931-0.00010-0; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P1926, DOI 10.1021/bi972162m; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Ruiter GA, 1997, TRENDS FOOD SCI TECH, V8, P389, DOI 10.1016/S0924-2244(97)01091-1; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XT, 2010, MAR DRUGS, V8, P200, DOI 10.3390/md8010200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Genta FA, 2007, BBA-PROTEINS PROTEOM, V1774, P1079, DOI 10.1016/j.bbapap.2007.07.006; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Ha SC, 2011, BIOCHEM BIOPH RES CO, V412, P238, DOI 10.1016/j.bbrc.2011.07.073; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Hosoya S, 2009, INT J SYST EVOL MICR, V59, P1262, DOI 10.1099/ijs.0.003244-0; Hu Z, 2009, J APPL MICROBIOL, V106, P181, DOI 10.1111/j.1365-2672.2008.03990.x; Jean WD, 2006, INT J SYST EVOL MICR, V56, P1245, DOI 10.1099/ijs.0.64130-0; Kim HT, 2010, APPL MICROBIOL BIOT, V86, P227, DOI 10.1007/s00253-009-2256-5; Kirimura K, 1999, J BIOSCI BIOENG, V87, P436, DOI 10.1016/S1389-1723(99)80091-7; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee DG, 2006, BIOTECHNOL LETT, V28, P1925, DOI 10.1007/s10529-006-9171-y; Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200; Liao L, 2011, APPL ENVIRON MICROB, V77, P7077, DOI 10.1128/AEM.05364-11; Lin BK, 2012, WORLD J MICROB BIOT, V28, P1691, DOI 10.1007/s11274-011-0977-y; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikapitiya C, 2010, FISH AQUA SCI, V13, P36; Ohta Y, 2005, BIOTECHNOL APPL BIOC, V41, P183, DOI 10.1042/BA20040083; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; ROBYT JF, 1967, ARCH BIOCHEM BIOPHYS, V122, P8, DOI 10.1016/0003-9861(67)90118-X; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; SUGANO Y, 1993, APPL ENVIRON MICROB, V59, P1549; SUGANO Y, 1994, BBA-GENE STRUCT EXPR, V1218, P105, DOI 10.1016/0167-4781(94)90109-0; Temuujin U, 2011, APPL MICROBIOL BIOT, V92, P749, DOI 10.1007/s00253-011-3347-7; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vijayaraghavan R, 2012, J BASIC MICROB, V52, P705, DOI 10.1002/jobm.201100315; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang WW, 2007, APPL ENVIRON MICROB, V73, P2825, DOI 10.1128/AEM.02872-06; Ziervogel K, 2008, ENVIRON MICROBIOL, V10, P289, DOI 10.1111/j.1462-2920.2007.01451.x	77	47	51	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28078	28088		10.1074/jbc.M113.491068	http://dx.doi.org/10.1074/jbc.M113.491068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921382	Green Published, hybrid			2022-12-28	WOS:000330612800033
J	Block, A; Fristedt, R; Rogers, S; Kumar, J; Barnes, B; Barnes, J; Elowsky, CG; Wamboldt, Y; Mackenzie, SA; Redding, K; Merchant, SS; Basset, GJ				Block, Anna; Fristedt, Rikard; Rogers, Sara; Kumar, Jyothi; Barnes, Brian; Barnes, Joshua; Elowsky, Christian G.; Wamboldt, Yashitola; Mackenzie, Sally A.; Redding, Kevin; Merchant, Sabeeha S.; Basset, Gilles J.			Functional Modeling Identifies Paralogous Solanesyl-diphosphate Synthases That Assemble the Side Chain of Plastoquinone-9 in Plastids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-E; THYLAKOID MEMBRANES; PHOTOSYSTEM-II; ARABIDOPSIS; CHLOROPLAST; TOCOPHEROL; PLASTOCHROMANOL; LOCALIZATION; PLASTOGLOBULES; ACCUMULATION	It is a little known fact that plastoquinone-9, a vital redox cofactor of photosynthesis, doubles as a precursor for the biosynthesis of a vitamin E analog called plastochromanol-8, the physiological significance of which has remained elusive. Gene network reconstruction, GFP fusion experiments, and targeted metabolite profiling of insertion mutants indicated that Arabidopsis possesses two paralogous solanesyl-diphosphate synthases, AtSPS1 (At1g78510) and AtSPS2 (At1g17050), that assemble the side chain of plastoquinone-9 in plastids. Similar paralogous pairs were detected throughout terrestrial plant lineages but were not distinguished in the literature and genomic databases from mitochondrial homologs involved in the biosynthesis of ubiquinone. The leaves of the atsps2 knock-out were devoid of plastochromanol-8 and displayed severe losses of both non-photoactive and photoactive plastoquinone-9, resulting in near complete photoinhibition at high light intensity. Such a photoinhibition was paralleled by significant damage to photosystem II but not to photosystem I. In contrast, in the atsps1 knock-out, a small loss of plastoquinone-9, restricted to the non-photoactive pool, was sufficient to eliminate half of the plastochromanol-8 content of the leaves. Taken together, these results demonstrate that plastochromanol-8 originates from a subfraction of the non-photoactive pool of plastoquinone-9. In contrast to other plastochromanol-8 biosynthetic mutants, neither the single atsps knock-outs nor the atsps1 atsps2 double knock-out displayed any defects in tocopherols accumulation or germination.	[Block, Anna; Rogers, Sara; Kumar, Jyothi; Barnes, Brian; Barnes, Joshua; Elowsky, Christian G.; Wamboldt, Yashitola; Mackenzie, Sally A.; Basset, Gilles J.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Redding, Kevin] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe	Basset, GJ (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Beadle Ctr Genet Res, Lincoln, NE 68588 USA.	gbasset2@unl.edu	Block, Anna/AAF-2556-2020	Block, Anna/0000-0003-1689-4005; Redding, Kevin/0000-0003-2819-4022; Basset, Gilles/0000-0001-5275-9797	National Science Foundation [MCB-0918258, MCB-1148968]; United States Department of Energy [DE-FC02-02ER63421, DE-FG02-12ER16189]; Wenner-Gren Foundation; Center for Plant Science Innovation; Department of Biochemistry at the University of Nebraska-Lincoln; Direct For Biological Sciences [1148968] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Wenner-Gren Foundation; Center for Plant Science Innovation; Department of Biochemistry at the University of Nebraska-Lincoln; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was made possible in part by National Science Foundation Grants MCB-0918258 and MCB-1148968 (to G. J. B.), United States Department of Energy Cooperative Agreements DE-FC02-02ER63421 (to S. S. M.) and DE-FG02-12ER16189 (to S. A. M.), and a Wenner-Gren Foundation grant (to R. F.). This work was also supported by the Center for Plant Science Innovation and the Department of Biochemistry at the University of Nebraska-Lincoln.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASAI K, 1994, BIOCHEM BIOPH RES CO, V202, P340, DOI 10.1006/bbrc.1994.1933; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; Dawson R. M. C., 1986, DATA BIOCH RES, p[132, 138]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ducluzeau AL, 2012, PLANT J, V69, P366, DOI 10.1111/j.1365-313X.2011.04796.x; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Hirooka K, 2005, BIOSCI BIOTECH BIOCH, V69, P592, DOI 10.1271/bbb.69.592; Hirooka K, 2003, BIOCHEM J, V370, P679, DOI 10.1042/BJ20021311; Hsieh FL, 2011, PLANT PHYSIOL, V155, P1079, DOI 10.1104/pp.110.168799; Hundal T, 1995, ARCH BIOCHEM BIOPHYS, V324, P117, DOI 10.1006/abbi.1995.9920; Jones MO, 2013, BIOCHEM J, V449, P729, DOI 10.1042/BJ20120988; Jun L, 2004, PLANT CELL PHYSIOL, V45, P1882, DOI 10.1093/pcp/pch211; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; LEERBECK E, 1967, ACTA CHEM SCAND, V21, P2582, DOI 10.3891/acta.chem.scand.21-2582; Lichtenthaler HK, 1997, TRENDS PLANT SCI, V2, P316, DOI 10.1016/S1360-1385(97)89954-2; Lundquist PK, 2013, PLANT CELL, V25, P1818, DOI 10.1105/tpc.113.111120; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; Mene-Saffrane L, 2010, P NATL ACAD SCI USA, V107, P17815, DOI 10.1073/pnas.1006971107; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Ohara K, 2010, J EXP BOT, V61, P2683, DOI 10.1093/jxb/erq103; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Piller LE, 2011, P NATL ACAD SCI USA, V108, P14354, DOI 10.1073/pnas.1104790108; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rochaix JD, 2013, ANTIOXID REDOX SIGN, V18, P2184, DOI 10.1089/ars.2012.5110; Sadre R, 2010, J BIOL CHEM, V285, P18191, DOI 10.1074/jbc.M110.117929; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Szymanska R, 2010, PLANT CELL PHYSIOL, V51, P537, DOI 10.1093/pcp/pcq017; Szymanska R, 2010, ACTA BIOCHIM POL, V57, P105; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zbierzak AM, 2010, BIOCHEM J, V425, P389, DOI 10.1042/BJ20090704; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	47	37	39	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27594	27606		10.1074/jbc.M113.492769	http://dx.doi.org/10.1074/jbc.M113.492769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913686	Green Published, hybrid			2022-12-28	WOS:000330597300054
J	Radi, R				Radi, Rafael			Peroxynitrite, a Stealthy Biological Oxidant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MANGANESE-SUPEROXIDE-DISMUTASE; PROTEIN-TYROSINE NITRATION; CARBONATE RADICAL-ANION; NITRIC-OXIDE; LIPID-PEROXIDATION; CYTOCHROME-C; URIC-ACID; SUBMITOCHONDRIAL PARTICLES; NITROGEN-DIOXIDE; OXIDATION	Peroxynitrite is the product of the diffusion-controlled reaction of nitric oxide and superoxide radicals. Peroxynitrite, a reactive short-lived peroxide with a pK(a) of 6.8, is a good oxidant and nucleophile. It also yields secondary free radical intermediates such as nitrogen dioxide and carbonate radicals. Much of nitric oxide- and superoxide-dependent cytotoxicity resides on peroxynitrite, which affects mitochondrial function and triggers cell death via oxidation and nitration reactions. Peroxynitrite is an endogenous toxicant but is also a cytotoxic effector against invading pathogens. The biological chemistry of peroxynitrite is modulated by endogenous antioxidant mechanisms and neutralized by synthetic compounds with peroxynitrite-scavenging capacity.	[Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Radi, Rafael] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy			National Institutes of Health [R01 AI095173]; Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA); Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI095173. This work was also supported by grants from the Universidad de la Republica, the Programa de Desarrollo de Ciencias Basicas (PEDECIBA), and the Howard Hughes Medical Institute. This is the first article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	Abriata LA, 2009, J BIOL CHEM, V284, P17, DOI 10.1074/jbc.M807203200; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; Bartesaghi S, 2010, CHEM RES TOXICOL, V23, P821, DOI 10.1021/tx900446r; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Castro L, 2011, FREE RADICAL RES, V45, P37, DOI 10.3109/10715762.2010.516254; Denicola A, 1998, P NATL ACAD SCI USA, V95, P3566, DOI 10.1073/pnas.95.7.3566; DENICOLA A, 1993, ARCH BIOCHEM BIOPHYS, V304, P279, DOI 10.1006/abbi.1993.1350; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Ferrer-Sueta G, 2003, J BIOL CHEM, V278, P27432, DOI 10.1074/jbc.M213302200; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Ferrer-Sueta G, 2006, FREE RADICAL BIO MED, V41, P503, DOI 10.1016/j.freeradbiomed.2006.04.028; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; HALFPENNY E, 1952, J CHEM SOC, P939, DOI 10.1039/jr9520000939; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; MAHONEY LR, 1970, J AM CHEM SOC, V92, P5262, DOI 10.1021/ja00720a068; Massari J, 2011, J AM CHEM SOC, V133, P20761, DOI 10.1021/ja2051414; Masumoto H, 1996, CHEM RES TOXICOL, V9, P262, DOI 10.1021/tx950115u; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Moller MN, 2012, J AM CHEM SOC, V134, P16773, DOI 10.1021/ja307215z; Moreno DM, 2011, ARCH BIOCHEM BIOPHYS, V507, P304, DOI 10.1016/j.abb.2010.12.011; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pattison DI, 2004, BIOCHEMISTRY-US, V43, P4799, DOI 10.1021/bi035946a; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRYOR WA, 1994, P NATL ACAD SCI USA, V91, P11173, DOI 10.1073/pnas.91.23.11173; Quijano C, 2001, J BIOL CHEM, V276, P11631, DOI 10.1074/jbc.M009429200; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 1996, CHEM RES TOXICOL, V9, P828, DOI 10.1021/tx950176s; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Robinson KM, 2004, ARCH BIOCHEM BIOPHYS, V423, P213, DOI 10.1016/j.abb.2003.10.011; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Ross W. G. M., 1995, NDRL NIST SOLUTION K; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Sies H., 2007, ENCY STRESS, V2nd ed., P45, DOI DOI 10.1016/B978-012373947-6.00285-3; Spasojevic I, 2007, FREE RADICAL BIO MED, V42, P1193, DOI 10.1016/j.freeradbiomed.2007.01.019; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Stadler K, 2008, FREE RADICAL BIO MED, V45, P866, DOI 10.1016/j.freeradbiomed.2008.06.023; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szeto HH, 2011, PHARM RES-DORDR, V28, P2669, DOI 10.1007/s11095-011-0476-8; THOMSON L, 1995, ARCH BIOCHEM BIOPHYS, V319, P491, DOI 10.1006/abbi.1995.1321; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Valez V, 2013, ARCH BIOCHEM BIOPHYS, V529, P45, DOI 10.1016/j.abb.2012.10.012; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; ZHU L, 1992, ARCH BIOCHEM BIOPHYS, V298, P452, DOI 10.1016/0003-9861(92)90434-X; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	100	517	528	11	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26464	26472		10.1074/jbc.R113.472936	http://dx.doi.org/10.1074/jbc.R113.472936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861390	Green Published, hybrid			2022-12-28	WOS:000330594500012
J	Blanchetot, C; Verzijl, D; Mujic-Delic, A; Bosch, L; Rem, L; Leurs, R; Verrips, CT; Saunders, M; de Haard, H; Smit, MJ				Blanchetot, Christophe; Verzijl, Dennis; Mujic-Delic, Azra; Bosch, Leontien; Rem, Louise; Leurs, Rob; Verrips, C. Theo; Saunders, Michael; de Haard, Hans; Smit, Martine J.			Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DOMAIN ANTIBODY FRAGMENTS; HEAVY-CHAIN ANTIBODIES; IN-VIVO; DIFFERENTIAL EXPRESSION; ALLOGRAFT-REJECTION; MULTIPLE-SCLEROSIS; BINDING PROTEIN; T-LYMPHOCYTES	Chemokine receptors and their ligands play a prominent role in immune regulation but many have also been implicated in inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, allograft rejection after transplantation, and also in cancer metastasis. Most approaches to therapeutically target the chemokine system involve targeting of chemokine receptors with low molecular weight antagonists. Here we describe the selection and characterization of an unprecedented large and diverse panel of neutralizing Nanobodies (single domain camelid antibodies fragment) directed against several chemokines. We show that the Nanobodies directed against CCL2 (MCP-1), CCL5 (RANTES), CXCL11 (I-TAC), and CXCL12 (SDF-1 alpha) bind the chemokines with high affinity (at nanomolar concentration), thereby blocking receptor binding, inhibiting chemokine-induced receptor activation as well as chemotaxis. Together, we show that neutralizing Nanobodies can be selected efficiently for effective and specific therapeutic treatment against a wide range of immune and inflammatory diseases.	[Blanchetot, Christophe; Rem, Louise; Verrips, C. Theo; de Haard, Hans] Univ Utrecht, Dept Cellular Biol, NL-3584 CH Utrecht, Netherlands; [Blanchetot, Christophe; Rem, Louise; Verrips, C. Theo; de Haard, Hans] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Verzijl, Dennis; Mujic-Delic, Azra; Bosch, Leontien; Leurs, Rob; Smit, Martine J.] Vrije Univ Amsterdam, Div Med Chem, AIMMS, NL-1081 HV Amsterdam, Netherlands; [Saunders, Michael; de Haard, Hans] Ablynx NV, B-9052 Ghent, Belgium	Utrecht University; Utrecht University; Vrije Universiteit Amsterdam	de Haard, H (corresponding author), Univ Utrecht, Dept Cellular Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	hdehaard@argen-x.com; mj.smit@vu.nl	Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; Verzijl, Dennis/0000-0002-7716-9838; Blanchetot, christophe/0000-0001-9152-9978; Smit, Martine/0000-0003-2713-0238	Ablynx N.V.	Ablynx N.V.	This work was supported by Ablynx N.V.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; [Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Comerford L, 2005, IMMUNOL LETT, V96, P163, DOI 10.1016/j.imlet.2004.08.018; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Galzi J.-L., 2012, DRUG DISCOV TODAY, V9, pe245; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Jensen KK, 2003, J VIROL, V77, P624, DOI 10.1128/JVI.77.1.624-630.2003; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Kennedy KJ, 1998, J NEUROIMMUNOL, V92, P98, DOI 10.1016/S0165-5728(98)00187-8; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mulligan MS, 2000, EXP MOL PATHOL, V69, P167, DOI 10.1006/exmp.2000.2327; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nguyen VK, 2001, ADV IMMUNOL, V79, P261, DOI 10.1016/S0065-2776(01)79006-2; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Trinker M., 2012, DRUG DISCOV TODAY, V9, pe253; Tsui Ping, 2007, Human Antibodies, V16, P117; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	54	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25173	25182		10.1074/jbc.M113.467969	http://dx.doi.org/10.1074/jbc.M113.467969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836909	Green Published, hybrid			2022-12-28	WOS:000330619000017
J	Kikuchi, J; Yamada, S; Koyama, D; Wada, T; Nobuyoshi, M; Izumi, T; Akutsu, M; Kano, Y; Furukawa, Y				Kikuchi, Jiro; Yamada, Satoshi; Koyama, Daisuke; Wada, Taeko; Nobuyoshi, Masaharu; Izumi, Tohru; Akutsu, Miyuki; Kano, Yasuhiko; Furukawa, Yusuke			The Novel Orally Active Proteasome Inhibitor K-7174 Exerts Anti-myeloma Activity in Vitro and in Vivo by Down-regulating the Expression of Class I Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFRACTORY MULTIPLE-MYELOMA; BORTEZOMIB RESISTANCE; PRECLINICAL MODELS; KAPPA-B; CELLS; ROMIDEPSIN; APOPTOSIS; CANCER; CYTOTOXICITY; CARFILZOMIB	Bortezomib therapy is now indispensable for multiple myeloma, but is associated with patient inconvenience due to intravenous injection and emerging drug resistance. The development of orally active proteasome inhibitors with distinct mechanisms of action is therefore eagerly awaited. Previously, we identified homopiperazine derivatives as a novel class of proteasome inhibitors with a different mode of proteasome binding from bortezomib. In this study, we show that K-7174, one of proteasome inhibitory homopiperazine derivatives, exhibits a therapeutic effect, which is stronger when administered orally than intravenously, without obvious side effects in a murine myeloma model. Moreover, K-7174 kills bortezomib-resistant myeloma cells carrying a beta 5-subunit mutation in vivo and primary cells from a patient resistant to bortezomib. K-7174 induces transcriptional repression of class I histone deacetylases (HDAC1, -2, and -3) via caspase-8-dependent degradation of Sp1, the most potent transactivator of class I HDAC genes. HDAC1 overexpression ameliorates the cytotoxic effect of K-7174 and abrogates histone hyperacetylation without affecting the accumulation of ubiquitinated proteins in K-7174-treated myeloma cells. Conversely, HDAC inhibitors enhance the activity of K-7174 with an increase in histone acetylation. These results suggest that class I HDACs are critical targets of K-7174-induced cytotoxicity. It is highly anticipated that K-7174 increases the tolerability and convenience of patients by oral administration and has the clinical utility in overcoming bortezomib resistance as a single agent or in combination with HDAC inhibitors.	[Kikuchi, Jiro; Yamada, Satoshi; Koyama, Daisuke; Wada, Taeko; Nobuyoshi, Masaharu; Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan; [Izumi, Tohru; Akutsu, Miyuki; Kano, Yasuhiko] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi 3200834, Japan	Jichi Medical University; Tochigi Prefectural Cancer Center	Furukawa, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	MEXT; JSPS; JST; Japan Leukemia Research Fund; Takeda Science Foundation; Kano Foundation; Mitsui Life Social Welfare Foundation; Osaka Cancer Foundation; International Myeloma Foundation Japan; Grants-in-Aid for Scientific Research [23591405] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kano Foundation; Mitsui Life Social Welfare Foundation; Osaka Cancer Foundation; International Myeloma Foundation Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the High-Tech Research Center Project for Private Universities, Matching Fund Subsidy from MEXT, a Grant-in-Aid for Scientific Research from JSPS (to J. K. and Y. F.), the Adaptable and Seamless Technology transfer Program (A-STEP) from JST, and research grants from Japan Leukemia Research Fund, Takeda Science Foundation, Kano Foundation, Mitsui Life Social Welfare Foundation, and Osaka Cancer Foundation (to J. K.).; Winner of the Award in Aki's Memory from the International Myeloma Foundation Japan. To whom correspondence should be addressed. Tel.: 81-285-58-7400; Fax: 81-285-44-7501; E-mail: furuyu@jichi.ac.jp.	Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chauhan D, 2010, BLOOD, V116, P4906, DOI 10.1182/blood-2010-04-276626; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Delcuve GP, 2013, EXPERT OPIN THER TAR, V17, P29, DOI 10.1517/14728222.2013.729042; Drexler Hans G, 2003, Hum Cell, V16, P101, DOI 10.1111/j.1749-0774.2003.tb00140.x; Franke NE, 2012, LEUKEMIA, V26, P757, DOI 10.1038/leu.2011.256; Friedberg JW, 2011, BLOOD, V117, P2807, DOI 10.1182/blood-2010-11-314708; Fulciniti M, 2011, CLIN CANCER RES, V17, P6500, DOI 10.1158/1078-0432.CCR-11-1036; Harrison SJ, 2011, BLOOD, V118, P6274, DOI 10.1182/blood-2011-03-339879; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2011, INT J HEMATOL, V94, P344, DOI 10.1007/s12185-011-0917-5; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Khan ML, 2011, FUTURE ONCOL, V7, P607, DOI [10.2217/fon.11.42, 10.2217/FON.11.42]; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; Kikuchi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060649; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Knop S, 2011, BLOOD, V118, P6231, DOI 10.1182/blood-2011-09-381046; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lonial S, 2005, BLOOD, V106, P3777, DOI 10.1182/blood-2005-03-1173; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Mannava S, 2012, BLOOD, V119, P1450, DOI 10.1182/blood-2011-04-346676; McConkey D, 2010, BLOOD, V116, P308, DOI 10.1182/blood-2010-04-278507; Miller CP, 2009, BLOOD, V113, P4289, DOI 10.1182/blood-2008-08-174797; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Niesvizky R, 2011, CANCER-AM CANCER SOC, V117, P336, DOI 10.1002/cncr.25584; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Nonomura C, 2008, CANCER RES, V68, P790, DOI 10.1158/0008-5472.CAN-07-1459; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson P, 2008, LEUKEMIA LYMPHOMA, V49, P502, DOI 10.1080/10428190701817258; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shimizu R, 2010, LEUKEMIA, V24, P1760, DOI 10.1038/leu.2010.157; Umetani M, 2000, BIOCHEM BIOPH RES CO, V272, P370, DOI 10.1006/bbrc.2000.2784; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011	44	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25593	25602		10.1074/jbc.M113.480574	http://dx.doi.org/10.1074/jbc.M113.480574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23878197	Green Published, hybrid			2022-12-28	WOS:000330619000054
J	Lee, SJ; No, YR; Dang, DT; Dang, LH; Yang, VW; Shim, H; Yun, CC				Lee, Sei-Jung; No, Yi Ran; Dang, Duyen T.; Dang, Long H.; Yang, Vincent W.; Shim, Hyunsuk; Yun, C. Chris			Regulation of Hypoxia-inducible Factor 1 alpha (HIF-1 alpha) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Kruppel-like Factor 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; CELLULAR-RESPONSE; LPA RECEPTORS; ACTIVATION; EXPRESSION; PROTEIN; INDUCTION; MDM2; PROLIFERATION; TUMOR	Hypoxia-inducible factor 1 alpha (HIF-1 alpha) and p53 are pivotal regulators of tumor growth. Lysophosphatidic acid (LPA) is a lipid mediator that functions as a mitogen by acting through LPA receptors. We have shown previously that LPA stimulates HIF-1 alpha expression in colon cancer cells. To determine the mechanism of HIF-1 alpha induction by LPA, we compared the effect of LPA on HIF-1 alpha in several colon cancer cell lines. LPA transcriptionally induced HIF-1 alpha in colon cancer cells. HIF-1 alpha induction was observed in cells expressing WT p53, where LPA decreased p53 expression. However, LPA failed to induce HIF-1 alpha when the p53 gene was mutated. A decrease in p53 expression was dependent on induction of p53-specific E3 ubiquitin ligase Mdm2 by LPA. Kruppel-like factor 5 (KLF5) is an effector of LPA-induced proliferation of colon cancer cells. Because HIF-1 alpha was necessary for LPA-induced growth of colon cancer cells, we determined the relationship between KLF5 and HIF-1 alpha by a loss-of-function approach. Silencing of KLF5 inhibited LPA-induced HIF-1 alpha induction, suggesting that KLF5 is an upstream regulator of HIF-1 alpha. KLF5 and p53 binding to the Hif1 alpha promoter was assessed by ChIP assay. LPA increased the occupancy of the Hif1 alpha promoter by KLF5, while decreasing p53 binding. Transfection of HCT116 cells with KLF5 or p53 attenuated the binding of the other transcription factor. These results identify KLF5 as a transactivator of HIF-1 alpha and show that LPA regulates HIF-1 alpha by dynamically modulating its interaction with KLF5 and p53.	[Lee, Sei-Jung; No, Yi Ran; Yun, C. Chris] Emory Univ, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Dang, Duyen T.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Dang, Long H.] Univ Florida, Div Hematol & Oncol, Dept Med, Gainesville, FL 32610 USA; [Yang, Vincent W.] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Shim, Hyunsuk] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Shim, Hyunsuk] Emory Univ, Dept Radiol, Atlanta, GA 30322 USA	Emory University; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Div Digest Dis, Dept Med, 615 Michael St,Whitehead Bldg,Suite 201, Atlanta, GA 30322 USA.	ccyun@emory.edu	Lee, Sei-Jung/V-8772-2019		National Institutes of Health [R01 DK071597]; Senior Research Award from the Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Research Award from the Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071597. This work was also supported by a Senior Research Award from the Crohn's and Colitis Foundation of America (to C. C. Y.).	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; Huang MC, 2004, ONCOGENE, V23, P122, DOI 10.1038/sj.onc.1206986; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Lee J, 2006, CLIN CANCER RES, V12, P6351, DOI 10.1158/1078-0432.CCR-06-1252; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; YAGINUMA Y, 1992, CANCER RES, V52, P4196; YAMASHITA N, 1995, GASTROENTEROLOGY, V108, P434, DOI 10.1016/0016-5085(95)90071-3; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yang YZ, 2011, CANCER RES, V71, P6475, DOI 10.1158/0008-5472.CAN-11-1702; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	55	52	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25244	25253		10.1074/jbc.M113.489708	http://dx.doi.org/10.1074/jbc.M113.489708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23880760	Green Published, hybrid			2022-12-28	WOS:000330619000023
J	Sarkar, P; Sardesai, AA; Murakami, KS; Chatterji, D				Sarkar, Paramita; Sardesai, Abhijit A.; Murakami, Katsuhiko S.; Chatterji, Dipankar			Inactivation of the Bacterial RNA Polymerase Due to Acquisition of Secondary Structure by the omega Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; RAY CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-CENTER; BINDING-SITE; PPGPP; GENE; DNA; TRANSCRIPTION; DISORDER	The widely conserved omega subunit encoded by rpoZ is the smallest subunit of Escherichia coli RNA polymerase (RNAP) but is dispensable for bacterial growth. Function of omega is known to be substituted by GroEL in omega-null strain, which thus does not exhibit a discernable phenotype. In this work, we report isolation of omega variants whose expression in vivo leads to a dominant lethal phenotype. Studies show that in contrast to omega, which is largely unstructured, omega mutants display substantial acquisition of secondary structure. By detailed study with one of the mutants, omega(6) bearing N60D substitution, the mechanism of lethality has been deciphered. Biochemical analysis reveals that omega(6) binds to beta ' subunit in vitro with greater affinity than that of omega. The reconstituted RNAP holoenzyme in the presence of omega(6) in vitro is defective in transcription initiation. Formation of a faulty RNAP in the presence of mutant omega results in death of the cell. Furthermore, lethality of omega(6) is relieved in cells expressing the rpoC2112 allele encoding beta ' (2112), a variant beta ' bearing Y457S substitution, immediately adjacent to the beta ' catalytic center. Our results suggest that the enhanced omega(6)-beta ' interaction may perturb the plasticity of the RNAP active center, implicating a role for omega and its flexible state.	[Sarkar, Paramita; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Sardesai, Abhijit A.] Ctr DNA Fingerprinting & Diagnost, Lab Bacterial Genet, Hyderabad 500001, Andhra Pradesh, India; [Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chatterji, D (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in		Murakami, Katsuhiko/0000-0003-2244-0501; Chatterji, Dipankar/0000-0002-9985-0632	Department of Biotechnology, Government of India; Centre of Excellence, Department of Biotechnology, Government of India; National Institutes of Health [GM087350-A1]; Council of Scientific and Industrial Research, Government of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre of Excellence, Department of Biotechnology, Government of India; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Biotechnology, Government of India (to D. C.), Centre of Excellence, Department of Biotechnology, Government of India (to A. A. S.), National Institutes of Health Grant GM087350-A1 (to K. M. S.), and a research fellowship from Council of Scientific and Industrial Research, Government of India (to P. S.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; Borukhov S, 2008, TRENDS MICROBIOL, V16, P126, DOI 10.1016/j.tim.2007.12.006; BURGESS RR, 1969, J BIOL CHEM, V244, P6168; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; Chamberlin M., 1977, RNA POLYMERASE, P17; Chatterji D, 1998, GENES CELLS, V3, P279, DOI 10.1046/j.1365-2443.1998.00190.x; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Chen JC, 2002, J BACTERIOL, V184, P695, DOI 10.1128/JB.184.3.695-705.2002; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; GENTRY D, 1991, J BACTERIOL, V173, P3901, DOI 10.1128/JB.173.12.3901-3903.1991; GENTRY D R, 1990, Protein Expression and Purification, V1, P81, DOI 10.1016/1046-5928(90)90050-9; GENTRY DR, 1993, BIOCHEMISTRY-US, V32, P11224, DOI 10.1021/bi00092a036; Ghosh P, 2001, EUR J BIOCHEM, V268, P4621, DOI 10.1046/j.1432-1327.2001.02381.x; Gross C. A., 1992, TRANSCRIPTIONAL REGU, V1, P129; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HEIL A, 1970, FEBS LETT, V11, P165, DOI 10.1016/0014-5793(70)80519-1; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; IGARASHI K, 1989, NUCLEIC ACIDS RES, V17, P8755, DOI 10.1093/nar/17.21.8755; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Johnston D. E., 1976, RNA POLYMERASE, P413; KASHLEV M, 1993, GENE, V130, P9, DOI 10.1016/0378-1119(93)90340-9; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Mathew R, 2006, TRENDS MICROBIOL, V14, P450, DOI 10.1016/j.tim.2006.08.002; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Mukherjee K, 1999, EUR J BIOCHEM, V266, P228, DOI 10.1046/j.1432-1327.1999.00848.x; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Paliy O, 2008, J PROTEOME RES, V7, P2234, DOI 10.1021/pr800055r; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Sabareesh V, 2010, ANALYST, V135, P2723, DOI 10.1039/c0an00130a; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	68	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25076	25087		10.1074/jbc.M113.468520	http://dx.doi.org/10.1074/jbc.M113.468520			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23843456	Green Published, hybrid			2022-12-28	WOS:000330619000008
J	Mohamed, JS; Lopez, MA; Cox, GA; Boriek, AM				Mohamed, Junaith S.; Lopez, Michael A.; Cox, Gregory A.; Boriek, Aladin M.			Ankyrin Repeat Domain Protein 2 and Inhibitor of DNA Binding 3 Cooperatively Inhibit Myoblast Differentiation by Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; LOOP-HELIX PROTEINS; MUSCULAR-DYSTROPHY; ID PROTEINS; CELL-CYCLE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MYOGENIC DIFFERENTIATION; SATELLITE CELLS; ANKRD2	Ankyrin repeat domain protein 2 (ANKRD2) translocates from the nucleus to the cytoplasm upon myogenic induction. Overexpression of ANKRD2 inhibits C2C12 myoblast differentiation. However, the mechanism by which ANKRD2 inhibits myoblast differentiation is unknown. We demonstrate that the primary myoblasts of mdm (muscular dystrophy with myositis) mice (pMB(mdm)) overexpress ANKRD2 and ID3 (inhibitor of DNA binding 3) proteins and are unable to differentiate into myotubes upon myogenic induction. Although suppression of either ANKRD2 or ID3 induces myoblast differentiation in mdm mice, overexpression of ANKRD2 and inhibition of ID3 or vice versa is insufficient to inhibit myoblast differentiation in WT mice. We identified that ANKRD2 and ID3 cooperatively inhibit myoblast differentiation by physical interaction. Interestingly, although MyoD activates the Ankrd2 promoter in the skeletal muscles of wild-type mice, SREBP-1 (sterol regulatory element binding protein-1) activates the same promoter in the skeletal muscles of mdm mice, suggesting the differential regulation of Ankrd2. Overall, we uncovered a novel pathway in which SREBP-1/ANKRD2/ID3 activation inhibits myoblast differentiation, and we propose that this pathway acts as a critical determinant of the skeletal muscle developmental program.	[Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME 04609 USA	Baylor College of Medicine; Jackson Laboratory	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA.	boriek@bcm.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation.	Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; Bean C, 2005, J MOL BIOL, V349, P349, DOI 10.1016/j.jmb.2005.03.063; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Clever JL, 2010, AM J PHYSIOL-CELL PH, V298, pC1087, DOI 10.1152/ajpcell.00388.2009; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; ELLMEIER W, 1995, DEV DYNAM, V203, P163, DOI 10.1002/aja.1002030205; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; HARA E, 1994, J BIOL CHEM, V269, P2139; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lopez MA, 2008, AM J PHYSIOL-CELL PH, V295, pC1092, DOI 10.1152/ajpcell.16.2008; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Melnikova IN, 1996, CELL GROWTH DIFFER, V7, P1067; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Peterson JM, 2008, AM J PHYSIOL-CELL PH, V295, pC521, DOI 10.1152/ajpcell.00073.2008; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wright WE, 1992, CURR OPIN GENET DEV, V2, P243, DOI 10.1016/S0959-437X(05)80280-1; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092	44	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24560	24568		10.1074/jbc.M112.434423	http://dx.doi.org/10.1074/jbc.M112.434423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824195	Green Published, hybrid			2022-12-28	WOS:000330612300024
J	Cipriano, DJ; Jung, J; Vivona, S; Fenn, TD; Brunger, AT; Bryant, Z				Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.; Bryant, Zev			Processive ATP-driven Substrate Disassembly by the N-Ethylmaleimide-sensitive Factor (NSF) Molecular Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX; CRYSTAL-STRUCTURE; FUSION PROTEIN; SINGLE-MOLECULE; CONFORMATIONAL-CHANGES; TERMINAL DOMAIN; VESICLE FUSION; UVRD HELICASE; DNA; TRANSLOCATION	SNARE proteins promote membrane fusion by forming a four-stranded parallel helical bundle that brings the membranes into close proximity. Post-fusion, the complex is disassembled by an AAA+ ATPase called N-ethylmaleimide-sensitive factor (NSF). We present evidence that NSF uses a processive unwinding mechanism to disassemble SNARE proteins. Using a real-time disassembly assay based on fluorescence dequenching, we correlate NSF-driven disassembly rates with the SNARE-activated ATPase activity of NSF. Neuronal SNAREs activate the ATPase rate of NSF by similar to 26-fold. One SNARE complex takes an average of similar to 5 s to disassemble in a process that consumes similar to 50 ATP. Investigations of substrate requirements show that NSF is capable of disassembling a truncated SNARE substrate consisting of only the core SNARE domain, but not an unrelated four-stranded coiled-coil. NSF can also disassemble an engineered double-length SNARE complex, suggesting a processive unwinding mechanism. We further investigated processivity using single-turnover experiments, which show that SNAREs can be unwound in a single encounter with NSF. We propose a processive helicase-like mechanism for NSF in which similar to 1 residue is unwound for every hydrolyzed ATP molecule.	[Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Jung, Jaemyeong; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Brunger, Axel T.; Bryant, Zev] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Bryant, Zev] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Bryant, Z (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	zevry@stanford.edu		Brunger, Axel/0000-0001-5121-2036	National Institutes of Health [R37-MH63105, DP2-OD004690]; Canadian Institutes of Health Research; American Heart Association; Pew Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Pew Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R37-MH63105 (to A. T. B.) and DP2-OD004690 (to Z.B.).; Supported by postdoctoral fellowships from the Canadian Institutes of Health Research and from the American Heart Association.; Supported by a Pew Scholars Award. To whom correspondence should be addressed. Tel.: 650-724-3090; Fax: 650-723-8544; E-mail: zevry@stanford.edu.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Davies J. M., 2008, THESIS STANFORD U; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Haynes LP, 1998, FEBS LETT, V436, P1, DOI 10.1016/S0014-5793(98)01088-6; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; MORGAN A, 1994, J BIOL CHEM, V269, P29347; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Scales SJ, 2001, P NATL ACAD SCI USA, V98, P14262, DOI 10.1073/pnas.251547598; Schumacher J, 2008, J MOL BIOL, V381, P1, DOI 10.1016/j.jmb.2008.05.075; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swanton E, 2000, J CELL SCI, V113, P1783; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	56	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23436	23445		10.1074/jbc.M113.476705	http://dx.doi.org/10.1074/jbc.M113.476705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775070	hybrid, Green Published			2022-12-28	WOS:000330598200050
J	Li, JBW; Huang, XY; Zhang, RS; Kim, RY; Yang, RY; Kurata, HT				Li, Jenny B. W.; Huang, Xinyang; Zhang, Roger S.; Kim, Robin Y.; Yang, Runying; Kurata, Harley T.			Decomposition of Slide Helix Contributions to ATP-dependent Inhibition of Kir6.2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; POTASSIUM-CHANNEL; SULFONYLUREA RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SENSORINEURAL DEAFNESS; ANDERSENS-SYNDROME; INSULIN-SECRETION; STRUCTURAL BASIS; BINDING-SITE	Regulation of inwardly rectifying potassium channels by intracellular ligands couples cell membrane excitability to important signaling cascades and metabolic pathways. We investigated the molecular mechanisms that link ligand binding to the channel gate in ATP-sensitive Kir6.2 channels. In these channels, the "slide helix" forms an interface between the cytoplasmic (ligand-binding) domain and the transmembrane pore, and many slide helix mutations cause loss of function. Using a novel approach to rescue electrically silent channels, we decomposed the contribution of each interface residue to ATP-dependent gating. We demonstrate that effective inhibition by ATP relies on an essential aspartate at residue 58. Characterization of the functional importance of this conserved aspartate, relative to other residues in the slide helix, has been impossible because of loss-of-function of Asp-58 mutant channels. The Asp-58 position exhibits an extremely stringent requirement for aspartate because even a highly conservative mutation to glutamate is insufficient to restore normal channel function. These findings reveal unrecognized slide helix elements that are required for functional channel expression and control of Kir6.2 gating by intracellular ATP.	[Li, Jenny B. W.; Huang, Xinyang; Zhang, Roger S.; Kim, Robin Y.; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	Canadian Institutes of Health Research (CIHR) [MOP-97998]; National Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-97998 and by a National Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (to H. T. K.).	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; John SA, 2005, J PHYSIOL-LONDON, V568, P931, DOI 10.1113/jphysiol.2005.095638; Khurana A, 2011, J BIOL CHEM, V286, P36686, DOI 10.1074/jbc.M111.249110; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Marthinet E, 2005, J CLIN ENDOCR METAB, V90, P5401, DOI 10.1210/jc.2005-0202; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Ribalet B, 2006, J PHYSIOL-LONDON, V571, P303, DOI 10.1113/jphysiol.2005.100719; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schulze-Bahr E, 2005, CIRC RES, V96, P703, DOI 10.1161/01.RES.0000164186.86838.09; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Shimomura K, 2006, DIABETES, V55, P1705, DOI 10.2337/db05-1640; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tornovsky S, 2004, J CLIN ENDOCR METAB, V89, P6224, DOI 10.1210/jc.2004-1233; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	53	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23038	23049		10.1074/jbc.M113.485789	http://dx.doi.org/10.1074/jbc.M113.485789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798684	Green Published, hybrid			2022-12-28	WOS:000330598200013
J	Spallotta, F; Tardivo, S; Nanni, S; Rosati, JD; Straino, S; Mai, A; Vecellio, M; Valente, S; Capogrossi, MC; Farsetti, A; Martone, J; Bozzoni, I; Pontecorvi, A; Gaetano, C; Colussi, C				Spallotta, Francesco; Tardivo, Silvia; Nanni, Simona; Rosati, Jessica D.; Straino, Stefania; Mai, Antonello; Vecellio, Matteo; Valente, Sergio; Capogrossi, Maurizio C.; Farsetti, Antonella; Martone, Julie; Bozzoni, Irene; Pontecorvi, Alfredo; Gaetano, Carlo; Colussi, Claudia			Detrimental Effect of Class-selective Histone Deacetylase Inhibitors during Tissue Regeneration following Hindlimb Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NITRIC-OXIDE; TRANSCRIPTION FACTOR; PROSTATE-CANCER; HDAC INHIBITORS; CLASS-I; ACTIVATION; DIFFERENTIATION; ANGIOGENESIS; MICE	Histone deacetylase inhibitors (DIs) are promising drugs for the treatment of several pathologies including ischemic and failing heart where they demonstrated efficacy. However, adverse side effects and cardiotoxicity have also been reported. Remarkably, no information is available about the effect of DIs during tissue regeneration following acute peripheral ischemia. In this study, mice made ischemic by femoral artery excision were injected with the DIs MS275 and MC1568, selective for class I and IIa histone deacetylases (HDACs), respectively. In untreated mice, soon after damage, class IIa HDAC phosphorylation and nuclear export occurred, paralleled by dystrophin and neuronal nitric-oxide synthase (nNOS) down-regulation and decreased protein phosphatase 2A activity. Between 14 and 21 days after ischemia, dystrophin and nNOS levels recovered, and class IIa HDACs relocalized to the nucleus. In this condition, the MC1568 compound increased the number of newly formed muscle fibers but delayed their terminal differentiation, whereas MS275 abolished the early onset of the regeneration process determining atrophy and fibrosis. The selective DIs had differential effects on the vascular compartment: MC1568 increased arteriogenesis whereas MS275 inhibited it. Capillarogenesis did not change. Chromatin immunoprecipitations revealed that class IIa HDAC complexes bind promoters of proliferation-associated genes and of class I HDAC1 and 2, high-lighting a hierarchical control between class II and I HDACs during tissue regeneration. Our findings indicate that class-selective DIs interfere with normal mouse ischemic hindlimb regeneration and suggest that their use could be limited by alteration of the regeneration process in peripheral ischemic tissues.	[Spallotta, Francesco; Rosati, Jessica D.; Vecellio, Matteo] Centro Cardiologico Monzino, Lab Biol Vascolare & Med Rigenerativa, I-20138 Milan, Italy; [Tardivo, Silvia; Straino, Stefania; Capogrossi, Maurizio C.] Ist Dermopatico Immacolata, Lab Patol Vascolare, I-00167 Rome, Italy; [Nanni, Simona; Pontecorvi, Alfredo; Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy; [Straino, Stefania] Explora Biotech, I-00131 Rome, Italy; [Mai, Antonello; Valente, Sergio] Univ Roma La Sapienza, Dipartimento Sci Chim, I-00185 Rome, Italy; [Farsetti, Antonella] CNR, Ist Biol Cellulare & Neurobiol, I-00143 Rome, Italy; [Nanni, Simona; Mai, Antonello; Colussi, Claudia] Natl Canc Inst Regina Elena, Dept Expt Oncol, I-00158 Rome, Italy; [Martone, Julie; Bozzoni, Irene] Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy; [Martone, Julie; Bozzoni, Irene] Univ Roma La Sapienza, Ist Biol & Patol Molecolare, I-00185 Rome, Italy; [Gaetano, Carlo] Goethe Univ, Div Cardiovascular Epigenet, Dept Cardiol, D-60325 Frankfurt, Germany	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Goethe University Frankfurt	Colussi, C (corresponding author), Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy.	claudiacolussi@tiscali.it	Vecellio, Matteo Luca/HGB-6768-2022; Spallotta, Francesco/AAB-6261-2019; Tardivo, Silvia/K-2163-2018; Vecellio, Matteo Luca/AAA-9143-2022; Valente, Sergio/K-2198-2016; Mai, Antonello/AAC-2144-2019; Farsetti, Antonella/I-8710-2018; Rosati, Jessica Diana/AAK-6084-2020; Gaetano, Carlo/P-9997-2019; Colussi, Claudia/H-8609-2019; Rosati, Jessica Diana/H-2867-2016	Vecellio, Matteo Luca/0000-0002-8643-1316; Spallotta, Francesco/0000-0002-0466-6286; Tardivo, Silvia/0000-0001-7623-3407; Vecellio, Matteo Luca/0000-0002-8643-1316; Valente, Sergio/0000-0002-2241-607X; Farsetti, Antonella/0000-0002-8603-7925; Rosati, Jessica Diana/0000-0002-4483-386X; Gaetano, Carlo/0000-0002-5238-1832; Rosati, Jessica Diana/0000-0002-4483-386X; bozzoni, irene/0000-0002-3485-8537; MARTONE, Julie/0000-0001-7864-0516; Mai, Antonello/0000-0001-9176-2382; Colussi, Claudia/0000-0002-7727-8911				Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Karagiannis TC, 2010, AGING-US, V2, P659, DOI 10.18632/aging.100203; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Shah MH, 2006, CLIN CANCER RES, V12, P3997, DOI 10.1158/1078-0432.CCR-05-2689; Sneider EB, 2009, J CELL BIOCHEM, V108, P753, DOI 10.1002/jcb.22315; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Straino S, 2004, CIRCULATION, V110, P3341, DOI 10.1161/01.CIR.0000147776.50787.74; Troidl K, 2012, DIABETES-METAB RES, V28, P27, DOI 10.1002/dmrr.2232; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Xu Q, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00044; Yan JL, 2010, MOL THER, V18, P1482, DOI 10.1038/mt.2010.109; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zen AA, 2009, BIOCHEM SOC T, V37, P1221, DOI 10.1042/BST0371221; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22915	22929		10.1074/jbc.M113.484337	http://dx.doi.org/10.1074/jbc.M113.484337			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23836913	Green Published, hybrid			2022-12-28	WOS:000330598200004
J	Asthana, J; Kapoor, S; Mohan, R; Panda, D				Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal			Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC STABILIZATION; ALPHA-TUBULIN; IN-VIVO; ACETYLATION; ACETYLTRANSFERASE; STABILITY; MIGRATION; TRANSPORT; MOTILITY	The post-translational modification of tubulin appears to be a highly controlled mechanism that regulates microtubule functioning. Acetylation of the epsilon-amino group of Lys-40 of alpha-tubulin marks stable microtubules, although the causal relationship between tubulin acetylation and microtubule stability has remained poorly understood. HDAC6, the tubulin deacetylase, plays a key role in maintaining typical distribution of acetylated microtubules in cells. Here, by using tubastatin A, an HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC6, we have explored whether tubulin acetylation has a role in regulating microtubule stability. We found that whereas both pharmacological inhibition of HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC6 activity leads to an increase in microtubule stability against cold and nocodazole-induced depolymerizing conditions. Tubastatin A treatment suppressed the dynamics of individual microtubules in MCF-7 cells and delayed the reassembly of depolymerized microtubules. Interestingly, both the localization of HDAC6 on microtubules and the amount of HDAC6 associated with polymeric fraction of tubulin were found to increase in the tubastatin A-treated cells compared with the control cells, suggesting that the pharmacological inhibition of HDAC6 enhances the binding of HDAC6 to microtubules. The evidence presented in this study indicated that the increased binding of HDAC6, rather than the acetylation per se, causes microtubule stability. The results are in support of a hypothesis that in addition to its deacetylase function, HDAC6 might function as a MAP that regulates microtubule dynamics under certain conditions.	[Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022	Kapoor, Sonia/0000-0003-2226-8748; Asthana, Dr. Jayant/0000-0002-8961-6308	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, Government of India.	AHMAD FJ, 1993, J NEUROSCI, V13, P856; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Drummond DR, 2011, SEMIN CELL DEV BIOL, V22, P927, DOI 10.1016/j.semcdb.2011.09.021; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kapoor S, 2012, BIOCHEM PHARMACOL, V83, P1495, DOI 10.1016/j.bcp.2012.02.012; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WATSON DF, 1990, J NEUROSCI, V10, P3344; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1989, J CELL SCI, V92, P57; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	41	75	76	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22516	22526		10.1074/jbc.M113.489328	http://dx.doi.org/10.1074/jbc.M113.489328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798680	Green Published, hybrid			2022-12-28	WOS:000330596300032
J	Changeux, JP				Changeux, Jean-Pierre			The Concept of Allosteric Interaction and Its Consequences for the Chemistry of the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; LES PROPRIETES ALLOSTERIQUES; L-THREONINE-DESAMINASE; PROTEIN-COUPLED RECEPTOR; 3-DIMENSIONAL FOURIER SYNTHESIS; FRONTAL-LOBE EPILEPSY; AFFINITY BINDING-SITE; IN-VITRO EXCITATION; X-RAY-STRUCTURE	Throughout this Reflections article, I have tried to follow up on the genesis in the 1960s and subsequent evolution of the concept of allosteric interaction and to examine its consequences within the past decades, essentially in the field of the neuroscience. The main conclusion is that allosteric mechanisms built on similar structural principles operate in bacterial regulatory enzymes, gene repressors (and the related nuclear receptors), rhodopsin, G-protein-coupled receptors, neurotransmitter receptors, ion channels, and so on from prokaryotes up to the human brain yet with important features of their own. Thus, future research on these basic cybernetic sensors is expected to develop in two major directions: at the elementary level, toward the atomic structure and molecular dynamics of the conformational changes involved in signal recognition and transduction, but also at a higher level of organization, the contribution of allosteric mechanisms to the modulation of brain functions.	[Changeux, Jean-Pierre] Coll France, F-75005 Paris, France; [Changeux, Jean-Pierre] Inst Pasteur, F-75724 Paris 15, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Changeux, JP (corresponding author), Coll France, F-75005 Paris, France.	changeux@noos.fr						AGNATI LF, 1992, ANN NY ACAD SCI, V673, P180, DOI 10.1111/j.1749-6632.1992.tb27451.x; AGNATI LF, 1980, MED BIOL, V58, P182; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Avale ME, 2008, P NATL ACAD SCI USA, V105, P15991, DOI 10.1073/pnas.0807635105; Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Baker LK, 2013, EUR J NEUROSCI, V37, P1004, DOI 10.1111/ejn.12114; BARTFAI T, 1974, BIOCHEM BIOPH RES CO, V59, P725, DOI 10.1016/S0006-291X(74)80040-9; Bartfai T, 2012, TRENDS PHARMACOL SCI, V33, P9, DOI 10.1016/j.tips.2011.09.006; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BON F, 1982, CR ACAD SCI III-VIE, V295, P199; BON F, 1984, J MOL BIOL, V176, P205, DOI 10.1016/0022-2836(84)90421-2; BOULTER J, 1986, J NEUROSCI RES, V16, P37, DOI 10.1002/jnr.490160106; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Breitmeyer B., 2006, VISUAL MASKING; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; Buc Henri, 2006, Atti della Accademia Nazionali dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti Lincei. Scienze Fisiche e Naturali, V17, P31, DOI 10.1007/BF02904500; Buc H, 2013, J MOL BIOL, V425, P1407, DOI 10.1016/j.jmb.2013.03.015; Cammarata M, 2010, J MOL BIOL, V400, P951, DOI 10.1016/j.jmb.2010.05.057; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; CARTAUD J, 1978, J CELL BIOL, V77, P315, DOI 10.1083/jcb.77.2.315; CARTAUD J, 1993, EUR J NEUROSCI, V5, P191, DOI 10.1111/j.1460-9568.1993.tb00485.x; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CARTAUD J, 1973, FEBS LETT, V33, P109, DOI 10.1016/0014-5793(73)80171-1; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHANGEUX J, 1965, B SOC CHIM BIOL, V47, P267; CHANGEUX J, 1965, B SOC CHIM BIOL, V47, P281; Changeux J.-P., 1972, COMMUNICATIONS ECOLE, P18; Changeux J.-P., 1969, SYMMETRY FUNCTION BI, P235; Changeux J.-P., 1983, NEURONAL MAN BIOL MI; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Changeux Jean-Pierre, 2013, Drug Discov Today Technol, V10, pe223, DOI 10.1016/j.ddtec.2012.07.007; Changeux JP, 2013, J MOL BIOL, V425, P1396, DOI 10.1016/j.jmb.2013.02.033; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Changeux JP, 2011, FASEB J, V25, P2098, DOI 10.1096/fj.11-0702ufm; Changeux JP, 2011, PROTEIN SCI, V20, P1119, DOI 10.1002/pro.658; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Changeux Jean-Pierre, 2012, GOOD TRUE BEAUTIFUL; Changeux JPG, 2012, CURR OPIN ANESTHESIO, V25, P397, DOI 10.1097/ACO.0b013e32835561de; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P531, DOI 10.1021/bi00842a007; CHANGEUX JP, 1964, B SOC CHIM BIOL, V46, P1151; CHANGEUX JP, 1964, B SOC CHIM BIOL, V46, P947; CHANGEUX JP, 1964, B SOC CHIM BIOL, V46, P927; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; CHANGEUX JP, 1963, COLD SPRING HARB SYM, V28, P497, DOI 10.1101/SQB.1963.028.01.066; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHANGEUX JP, 1961, COLD SPRING HARB SYM, V26, P313, DOI 10.1101/SQB.1961.026.01.037; CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P553, DOI 10.1021/bi00842a601; CHANGEUX JP, 1960, CR HEBD ACAD SCI, V250, P1575; CHANGEUX JP, 1958, CR HEBD ACAD SCI, V247, P961; CHANGEUX JP, 1965, B SOC CHIM BIOL, V47, P115; CHANGEUX JP, 1967, P NATL ACAD SCI USA, V57, P335, DOI 10.1073/pnas.57.2.335; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN JB, 1974, MOL PHARMACOL, V10, P904; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Dale H H, 1942, Br Med J, V2, P385; Davis B., 1961, COLD SPRING HARB SYM, V26, P318; Dehaene S, 1989, J Cogn Neurosci, V1, P244, DOI 10.1162/jocn.1989.1.3.244; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DEHAENE S, 1987, P NATL ACAD SCI USA, V84, P2727, DOI 10.1073/pnas.84.9.2727; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2000, PROG BRAIN RES, V126, P217; Dehaene S, 1991, CEREB CORTEX, V1, P62, DOI 10.1093/cercor/1.1.62; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DENNIS M, 1986, FEBS LETT, V207, P243, DOI 10.1016/0014-5793(86)81497-1; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DEVILLERSTHIERY A, 1979, FEBS LETT, V104, P99, DOI 10.1016/0014-5793(79)81092-3; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Edelman GM, 1987, NEURAL DARWINISM THE; Edelstein SJ, 1997, CR ACAD SCI III-VIE, V320, P953, DOI 10.1016/S0764-4469(97)82468-7; Edelstein SJ, 1997, BIOCHEMISTRY-US, V36, P13755, DOI 10.1021/bi9718301; EDELSTEIN SJ, 1971, NATURE, V230, P224, DOI 10.1038/230224a0; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fischer S, 2011, P NATL ACAD SCI USA, V108, P5608, DOI 10.1073/pnas.1011995108; Forman SA, 2013, ANESTHESIOLOGY, V118, P984, DOI 10.1097/ALN.0b013e3182860777; Forman SA, 2012, CURR OPIN ANESTHESIO, V25, P411, DOI 10.1097/ACO.0b013e328354feea; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Fuxe K, 2007, J NEURAL TRANSM, V114, P49, DOI 10.1007/s00702-006-0589-0; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; Garcia HG, 2011, METHOD ENZYMOL, V492, P27, DOI 10.1016/B978-0-12-381268-1.00014-8; GERHART JC, 1968, BIOCHEMISTRY-US, V7, P538, DOI 10.1021/bi00842a600; GERHART JC, 1964, FED PROC, V23, P727; GERHART JC, 1962, J BIOL CHEM, V237, P891; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Grande F., 1967, C BERNARD EXPT MED; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Grunhagen H. H., 1976, J MOL BIOL, V106, P497; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Haldane JBS, 1930, ENZYMES; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P5452, DOI 10.1021/bi00292a029; HEIDMANN T, 1982, CR ACAD SCI III-VIE, V295, P665; HEIDMANN T, 1979, EUR J BIOCHEM, V94, P255, DOI 10.1111/j.1432-1033.1979.tb12893.x; HEIDMANN T, 1980, BIOCHEM BIOPH RES CO, V97, P889, DOI 10.1016/0006-291X(80)91460-6; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; HOKFELT T, 1980, NATURE, V285, P476, DOI 10.1038/285476a0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; HUCHO F, 1973, FEBS LETT, V38, P11, DOI 10.1016/0014-5793(73)80500-9; HUNKAPILLER MW, 1979, BIOCHEM BIOPH RES CO, V91, P164, DOI 10.1016/0006-291X(79)90598-9; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jackson KJ, 2013, EUR J PHARMACOL, V701, P1, DOI 10.1016/j.ejphar.2012.12.005; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Jadey SV, 2011, P NATL ACAD SCI USA, V108, P4328, DOI 10.1073/pnas.1016617108; KAO PN, 1984, J BIOL CHEM, V259, P1662; Karlin A., 1980, CELL SURFACE NEURONA, P191; KASAI M, 1970, CR ACAD SCI D NAT, V270, P1400; KASAI M, 1971, J MEMBRANE BIOL, V6, P1, DOI 10.1007/BF01874112; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; KENDREW JC, 1959, FED PROC, V18, P740; KISTLER J, 1981, P NATL ACAD SCI-BIOL, V78, P3678, DOI 10.1073/pnas.78.6.3678; KISTLER J, 1982, BIOPHYS J, V37, P371, DOI 10.1016/S0006-3495(82)84685-7; Koch C, 2004, SCIENCE, V306, P979, DOI 10.1126/science.1102777; KOSHLAND DE, 1956, J CELL COMPAR PHYSL, V47, P217, DOI 10.1002/jcp.1030470415; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KOSHLAND DE, 1963, COLD SPRING HARB SYM, V28, P473, DOI 10.1101/SQB.1963.028.01.063; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LANGENBUCHCACHAT J, 1988, BIOCHEMISTRY-US, V27, P2337, DOI 10.1021/bi00407a015; Langley JN, 1905, J PHYSIOL-LONDON, V33, P374; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Lee C Y, 1966, Mem Inst Butantan, V33, P555; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Levantino M, 2012, P NATL ACAD SCI USA, V109, P14894, DOI 10.1073/pnas.1205809109; LEVITZKI A, 1974, P NATL ACAD SCI USA, V71, P2773, DOI 10.1073/pnas.71.7.2773; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 2011, J MOL BIOL, V409, P14, DOI 10.1016/j.jmb.2011.02.023; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; LINDSTROM J, 1979, BIOCHEMISTRY-US, V18, P4465, DOI 10.1021/bi00588a003; Liu LW, 2013, BIOL PSYCHIAT, V73, P738, DOI 10.1016/j.biopsych.2012.09.019; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Marchand S, 2002, MOL NEUROBIOL, V26, P117, DOI 10.1385/MN:26:1:117; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Maubourguet N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000229; Melancon BJ, 2012, J MED CHEM, V55, P1445, DOI 10.1021/jm201139r; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morel N, 1999, MOL PHARMACOL, V55, P982, DOI 10.1124/mol.55.6.982; MUIRHEAD H, 1963, NATURE, V199, P633, DOI 10.1038/199633a0; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; Murail S, 2011, BIOPHYS J, V100, P1642, DOI 10.1016/j.bpj.2011.02.032; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; NEUBIG RR, 1980, BIOCHEMISTRY-US, V19, P2770, DOI 10.1021/bi00553a036; NICKEL E, 1973, BRAIN RES, V57, P508, DOI 10.1016/0006-8993(73)90158-3; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NODA M, 1983, NATURE, V301, P251, DOI 10.1038/301251a0; Novick A., 1954, DYNAMICS GROWTH PROC, P21; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Ohno K, 1998, NEUROMUSCULAR DISORD, V8, pXII; OLSEN RW, 1972, FEBS LETT, V28, P96, DOI 10.1016/0014-5793(72)80686-0; Pastrana E, 2010, NAT METHODS, V8, P24, DOI DOI 10.1038/NMETH.F.323; Pauling L, 1935, P NATL ACAD SCI USA, V21, P186, DOI 10.1073/pnas.21.4.186; PERUTZ M. F., 1963, SCIENCE, V140, P863, DOI 10.1126/science.140.3569.863; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; RAFTERY M A, 1974, Journal of Supramolecular Structure, V2, P582, DOI 10.1002/jss.400020506; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROBIN ED, 1979, JAMA-J AM MED ASSOC, V242, P1283, DOI 10.1001/jama.242.12.1283; Rosenberry TL, 2005, CHEM-BIOL INTERACT, V157, P181, DOI 10.1016/j.cbi.2005.10.027; ROSS MJ, 1977, J MOL BIOL, V116, P635, DOI 10.1016/0022-2836(77)90264-9; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; SCHOFFENIELS E, 1957, BIOCHIM BIOPHYS ACTA, V26, P1, DOI 10.1016/0006-3002(57)90047-1; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2012, BIOL PSYCHIAT, V71, P180, DOI 10.1016/j.biopsych.2011.11.019; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; SIGEL E, 1983, J BIOL CHEM, V258, P6965; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 2010, EXPERT REV NEUROTHER, V10, P1859, DOI 10.1586/ERN.10.130; Stephenson F Anne, 2012, J Biol Chem, V287, P40835, DOI 10.1074/jbc.O112.000006; SUMIKAWA K, 1982, NUCLEIC ACIDS RES, V10, P5809, DOI 10.1093/nar/10.19.5809; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Tasneem A, 2005, GENOME BIOL, V6; Tekpinar M, 2013, PROTEINS, V81, P240, DOI 10.1002/prot.24180; Thomsen KR, 2013, P NATL ACAD SCI USA, V110, P4744, DOI 10.1073/pnas.1302374110; Tolu S, 2013, MOL PSYCHIATR, V18, P382, DOI 10.1038/mp.2012.83; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsigelny IF, 2013, GENES BRAIN BEHAV, V12, P147, DOI 10.1111/gbb.12005; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; van Loon AM, 2012, J COGNITIVE NEUROSCI, V24, P965, DOI 10.1162/jocn_a_00197; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; WEBER M, 1974, MOL PHARMACOL, V10, P35; WEILL CL, 1974, BIOCHEM BIOPH RES CO, V61, P997, DOI 10.1016/0006-291X(74)90254-X; WYMAN J, 1948, ADV PROTEIN CHEM, V4, P407, DOI 10.1016/S0065-3233(08)60011-X; Xu YC, 2008, BIOPHYS J, V95, P2500, DOI 10.1529/biophysj.108.129601; Zhang H, 2013, MOL PSYCHIATR, V18, P471, DOI 10.1038/mp.2012.80	254	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					26969	26986		10.1074/jbc.X113.503375	http://dx.doi.org/10.1074/jbc.X113.503375			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23878193	Green Published, hybrid			2022-12-28	WOS:000330597300001
J	Rickhag, M; Owens, WA; Winkler, MT; Strandfelt, KN; Rathje, M; Sorensen, G; Andresen, B; Madsen, KL; Jorgensen, TN; Wortwein, G; Woldbye, DPD; Sitte, H; Daws, LC; Gether, U				Rickhag, Mattias; Owens, William A.; Winkler, Marie-Therese; Strandfelt, Kristine Norgaard; Rathje, Mette; Sorensen, Gunnar; Andresen, Bjorn; Madsen, Kenneth L.; Jorgensen, Trine Nygaard; Wortwein, Gitta; Woldbye, David P. D.; Sitte, Harald; Daws, Lynette C.; Gether, Ulrik			Membrane-permeable C-terminal Dopamine Transporter Peptides Attenuate Amphetamine-evoked Dopamine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE TRANSPORTERS; NEUROTRANSMITTER RELEASE; PROTEIN; COCAINE; PHOSPHORYLATION; EFFLUX; INTERACTS; PLASMA; INTERNALIZATION; TRAFFICKING	The dopamine transporter (DAT) is responsible for sequestration of extracellular dopamine (DA). The psychostimulant amphetamine (AMPH) is a DAT substrate, which is actively transported into the nerve terminal, eliciting vesicular depletion and reversal of DA transport via DAT. Here, we investigate the role of the DAT C terminus in AMPH-evoked DA efflux using cell-permeant dominant-negative peptides. A peptide, which corresponded to the last 24 C-terminal residues of DAT (TAT-C24 DAT) and thereby contained the Ca2+-calmodulin-dependent protein kinase II alpha (CaMKII alpha) binding domain and the PSD-95/Discs-large/ZO-1 (PDZ)-binding sequence of DAT, was made membrane-permeable by fusing it to the cell membrane transduction domain of the HIV-1 Tat protein (TAT-C24WT). The ability of TAT-C24WT but not a scrambled peptide (TAT-C24Scr) to block the CaMKII alpha-DAT interaction was supported by co-immunoprecipitation experiments in heterologous cells. In heterologous cells, we also found that TAT-C24WT, but not TAT-C24Scr, decreased AMPH-evoked 1-methyl-4-phenylpyridinium efflux. Moreover, chronoamperometric recordings in striatum revealed diminished AMPH-evoked DA efflux in mice preinjected with TAT-C24WT. Both in heterologous cells and in striatum, the peptide did not further inhibit efflux upon KN-93-mediated inhibition of CaMKII alpha activity, consistent with a dominant-negative action preventing binding of CaMKII alpha to the DATC terminus. This was further supported by the ability of a peptide with perturbed PDZ-binding sequence, but preserved CaMKII alpha binding (TAT-C24AAA), to diminish AMPH-evoked DA efflux in vivo to the same extent as TAT-C24WT. Finally, AMPH-induced locomotor hyperactivity was attenuated following systemic administration of TAT-C24WT but not TAT-C24Scr. Summarized, our findings substantiate that DAT C-terminal protein-protein interactions are critical for AMPH-evoked DA efflux and suggest that it may be possible to target protein-protein interactions to modulate transporter function and interfere with psychostimulant effects.	[Rickhag, Mattias; Strandfelt, Kristine Norgaard; Rathje, Mette; Sorensen, Gunnar; Andresen, Bjorn; Madsen, Kenneth L.; Jorgensen, Trine Nygaard; Gether, Ulrik] Univ Copenhagen, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab,Fac Hlth & Med Sci, Lundbeck Fdn,Ctr Biomembranes Nanomed, DK-2200 Copenhagen, Denmark; [Owens, William A.; Daws, Lynette C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Winkler, Marie-Therese; Sitte, Harald] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Sorensen, Gunnar; Wortwein, Gitta; Woldbye, David P. D.] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci, Lab Neuropsychiat, DK-2200 Copenhagen, Denmark	Lundbeckfonden; University of Copenhagen; University of Texas System; University of Texas Health San Antonio; Medical University of Vienna; University of Copenhagen	Gether, U (corresponding author), Panum Inst 18 6, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Sitte, Harald/N-2681-2013; Madsen, Kenneth/C-7778-2012; Rickhag, Mattias/AAC-6934-2020; Rickhag, Mattias/AAB-9498-2020; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Madsen, Kenneth/0000-0001-9274-6691; Rickhag, Mattias/0000-0002-9452-6120; Sitte, Harald/0000-0002-1339-7444; Gether, Ulrik/0000-0002-0020-3807; Woldbye, David/0000-0002-6321-3850; Wortwein, Gitta/0000-0001-6981-7885	National Institutes of Health [P01 DA 12408]; Danish Health Medical Research Council; Novo Nordisk Foundation ("Fabrikant Vilhelm Pedersen og Hustrus Mindelegat"); Lundbeck Foundation; University of Copenhagen BioScaRT Program of Excellence; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER; Lundbeck Foundation [R77-2010-6815] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Health Medical Research Council; Novo Nordisk Foundation ("Fabrikant Vilhelm Pedersen og Hustrus Mindelegat"); Lundbeck Foundation(Lundbeckfonden); University of Copenhagen BioScaRT Program of Excellence; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.). This work was also supported by the Danish Health Medical Research Council (to M. R. and U. G.), The Novo Nordisk Foundation ("Fabrikant Vilhelm Pedersen og Hustrus Mindelegat") (to U. G.), The Lundbeck Foundation (to M. R. and U. G.), and University of Copenhagen BioScaRT Program of Excellence (to U. G.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bertaso F, 2008, NAT NEUROSCI, V11, P940, DOI 10.1038/nn.2142; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Callaghan PD, 2005, NEUROCHEM INT, V47, P350, DOI 10.1016/j.neuint.2005.04.026; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; CLAUSING P, 1995, J PHARMACOL EXP THER, V274, P614; Cowell RM, 2000, EUR J PHARMACOL, V389, P59, DOI 10.1016/S0014-2999(99)00828-6; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Daws LC, 2005, J NEUROSCI METH, V143, P49, DOI 10.1016/j.jneumeth.2004.09.011; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kantor L, 1999, J NEUROSCI, V19, P3801; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Owens WA, 2005, J NEUROCHEM, V94, P1402, DOI 10.1111/j.1471-4159.2005.03289.x; Pierce RC, 1997, J NEUROSCI, V17, P3254; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	50	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27534	27544		10.1074/jbc.M112.441295	http://dx.doi.org/10.1074/jbc.M112.441295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23884410	Green Published, hybrid			2022-12-28	WOS:000330597300049
J	Cremers, CM; Jakob, U				Cremers, Claudia M.; Jakob, Ursula			Oxidant Sensing by Reversible Disulfide Bond Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-TYROSINE PHOSPHATASES; OXYR TRANSCRIPTION FACTOR; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GLUTAREDOXIN SYSTEMS; ESCHERICHIA-COLI; SULFENIC ACID; REDOX-SWITCH; DNA-BINDING; REACTIVE OXYGEN	Maintenance of the cellular redox balance is crucial for cell survival. An increase in reactive oxygen, nitrogen, or chlorine species can lead to oxidative stress conditions, potentially damaging DNA, lipids, and proteins. Proteins are very sensitive to oxidative modifications, particularly methionine and cysteine residues. The reversibility of some of these oxidative protein modifications makes them ideally suited to take on regulatory roles in protein function. This is especially true for disulfide bond formation, which has the potential to mediate extensive yet fully reversible structural and functional changes, rapidly adjusting the protein's activity to the prevailing oxidant levels.	[Cremers, Claudia M.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jakob, Ursula] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu			National Institutes of Health [R01 GM065318]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065318 (to U. J.). This is the fourth article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Aroun A, 2012, PHOTOCH PHOTOBIO SCI, V11, P118, DOI 10.1039/c1pp05204g; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Billiet L, 2012, FREE RADICAL BIO MED, V52, P1473, DOI 10.1016/j.freeradbiomed.2011.12.029; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Daithankar VN, 2012, BIOCHEMISTRY-US, V51, P265, DOI 10.1021/bi201672h; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hampton MB, 2002, FEBS LETT, V517, P229, DOI 10.1016/S0014-5793(02)02629-7; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hightower KE, 1999, CURR OPIN CHEM BIOL, V3, P176, DOI 10.1016/S1367-5931(99)80030-1; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hondal RJ, 2013, ANTIOXID REDOX SIGN, V18, P1675, DOI 10.1089/ars.2012.5013; HUTCHISON KA, 1991, J BIOL CHEM, V266, P10505; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Jones DP, 2011, CURR OPIN CHEM BIOL, V15, P103, DOI 10.1016/j.cbpa.2010.12.014; Jung KJ, 2009, FREE RADICAL BIO MED, V47, P983, DOI 10.1016/j.freeradbiomed.2009.07.009; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Levy C, 2008, MOL MICROBIOL, V70, P151, DOI 10.1111/j.1365-2958.2008.06399.x; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Luo DY, 2005, J PHARM SCI-US, V94, P304, DOI 10.1002/jps.20253; Ma LH, 2007, J BIOL CHEM, V282, P31429, DOI 10.1074/jbc.M705953200; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Rozema DB, 1999, BIOCHEMISTRY-US, V38, P13138, DOI 10.1021/bi990794y; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Schippers JHM, 2012, CELL MOL LIFE SCI, V69, P3245, DOI 10.1007/s00018-012-1092-4; Sengupta D, 2005, STRUCTURE, V13, P849, DOI 10.1016/j.str.2005.03.010; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Sun MA, 2012, BIOINFORMATICS, V28, P2551, DOI 10.1093/bioinformatics/bts468; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Thakur KG, 2010, J MOL BIOL, V397, P1199, DOI 10.1016/j.jmb.2010.02.026; Trujillo Madia, 2007, V44, P83; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Wu XS, 1996, MOL CELL BIOL, V16, P1035; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; ZIEGLER DM, 1977, TRENDS BIOCHEM SCI, V2, P79, DOI 10.1016/0968-0004(77)90042-1	98	271	273	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26489	26496		10.1074/jbc.R113.462929	http://dx.doi.org/10.1074/jbc.R113.462929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861395	Green Published, hybrid			2022-12-28	WOS:000330594500015
J	Gajadeera, CS; Weber, J				Gajadeera, Chathurada S.; Weber, Joachim			Escherichia coli F1Fo-ATP Synthase with a b/delta Fusion Protein Allows Analysis of the Function of the Individual b Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F0F1 ATP SYNTHASE; DELTA-SUBUNIT; F1F0-ATP SYNTHASE; PERIPHERAL STALK; ALPHA-SUBUNIT; TERMINAL REGION; MUTANT STRAINS; CROSS-LINKING; C-RING; MECHANISM	The "stator stalk" of F1Fo-ATP synthase is essential for rotational catalysis as it connects the nonrotating portions of the enzyme. In Escherichia coli, the stator stalk consists of two (identical) b subunits and the delta subunit. In mycobacteria, one of the b subunits and the delta subunit are replaced by a b/delta fusion protein; the remaining b subunit is of the shorter b' type. In the present study, it is shown that it is possible to generate a functional E. coli ATP synthase containing a b/delta fusion protein. This construct allowed the analysis of the roles of the individual b subunits. The full-length b subunit (which in this case is covalently linked to delta in the fusion protein) is responsible for connecting the stalk to the catalytic F-1 subcomplex. It is not required for interaction with the membrane-embedded F-o subcomplex, as its transmembrane helix can be removed. Attachment to F-o is the function of the other b subunit which in turn has only a minor (if any at all) role in binding to delta. Also in E. coli the second b subunit can be shortened to a b' type.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; Texas Tech Univ, Ctr Chem Biol, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttu.edu			National Institutes of Health [GM 071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 071462 (to J. W.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Brandt K, 2013, J BIOL CHEM, V288, P24465, DOI 10.1074/jbc.M113.465633; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; DeLeon-Rangel J, 2013, FEBS LETT, V587, P892, DOI 10.1016/j.febslet.2013.02.012; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; Duser MG, 2008, J BIOL CHEM, V283, P33602, DOI 10.1074/jbc.M805170200; Dunn SD, 2000, BBA-BIOENERGETICS, V1458, P356, DOI 10.1016/S0005-2728(00)00086-4; Dunn SD, 2001, BIOCHEMISTRY-US, V40, P187, DOI 10.1021/bi001821j; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Howitt SM, 1996, J BIOL CHEM, V271, P7038, DOI 10.1074/jbc.271.12.7038; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; MCCORMICK KA, 1993, J BIOL CHEM, V268, P24683; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; Weber J, 2003, J BIOL CHEM, V278, P13623, DOI 10.1074/jbc.C300061200; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198	43	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26441	26447		10.1074/jbc.M113.503722	http://dx.doi.org/10.1074/jbc.M113.503722			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23893411	hybrid, Green Published			2022-12-28	WOS:000330594500009
J	Omae, Y; Hanada, Y; Sekimizu, K; Kaito, C				Omae, Yosuke; Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara			Silkworm Apolipophorin Protein Inhibits Hemolysin Gene Expression of Staphylococcus aureus via Binding to Cell Surface Lipoteichoic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAERS 2-COMPONENT SYSTEM; TEICHOIC-ACIDS; VIRULENCE; IDENTIFICATION; REGULATOR; MODEL; LOCUS; AGR; COLONIZATION; PROMOTER	We previously reported that a silkworm hemolymph protein, apolipophorin (ApoLp), binds to the cell surface of Staphylococcus aureus and inhibits expression of the saePQRS operon encoding a two-component system, SaeRS, and hemolysin genes. In this study, we investigated the inhibitory mechanism of ApoLp on S. aureus hemolysin gene expression. ApoLp bound to lipoteichoic acids (LTA), an S. aureus cell surface component. The addition of purified LTA to liquid medium abolished the inhibitory effect of ApoLp against S. aureus hemolysin production. In an S. aureus knockdown mutant of ltaS encoding LTA synthetase, the inhibitory effects of ApoLp on saeQ expression and hemolysin production were attenuated. Furthermore, the addition of anti-LTA monoclonal antibody to liquid medium decreased the expression of S. aureussaeQ and hemolysin genes. In S. aureus strains expressing SaeS mutant proteins with a shortened extracellular domain, ApoLp did not decrease saeQ expression. These findings suggest that ApoLp binds to LTA on the S. aureus cell surface and inhibits S. aureus hemolysin gene expression via a two-component regulatory system, SaeRS.	[Omae, Yosuke; Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Naito Foundation; Genome Pharmaceuticals Institute	Naito Foundation(Naito Memorial Foundation); Genome Pharmaceuticals Institute	This work was supported by grants-in-aid for scientific research. This work was supported in part by the Naito Foundation and the Genome Pharmaceuticals Institute.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; ALY R, 1980, J INFECT DIS, V141, P463, DOI 10.1093/infdis/141.4.463; BONA CA, 1986, IMMUNOL REV, V90, P115, DOI 10.1111/j.1600-065X.1986.tb01480.x; CARRUTHERS MM, 1983, INFECT IMMUN, V40, P444, DOI 10.1128/IAI.40.1.444-446.1983; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Jeong DW, 2011, J BACTERIOL, V193, P4672, DOI 10.1128/JB.00353-11; Ji YD, 2007, METHOD ENZYMOL, V423, P502, DOI 10.1016/S0076-6879(07)23024-1; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2007, DRUG DISCOV THER, V1, P89; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Omae Y, 2012, J BIOL CHEM, V287, P15570, DOI 10.1074/jbc.M112.357848; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; TAUB R, 1992, BIOCHEMISTRY-US, V31, P7431, DOI 10.1021/bi00148a001; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991	46	18	20	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25542	25550		10.1074/jbc.M113.495051	http://dx.doi.org/10.1074/jbc.M113.495051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23873929	Green Published, hybrid			2022-12-28	WOS:000330619000049
J	Sakurama, H; Kiyohara, M; Wada, J; Honda, Y; Yamaguchi, M; Fukiya, S; Yokota, A; Ashida, H; Kumagai, H; Kitaoka, M; Yamamoto, K; Katayama, T				Sakurama, Haruko; Kiyohara, Masashi; Wada, Jun; Honda, Yuji; Yamaguchi, Masanori; Fukiya, Satoru; Yokota, Atsushi; Ashida, Hisashi; Kumagai, Hidehiko; Kitaoka, Motomitsu; Yamamoto, Kenji; Katayama, Takane			Lacto-N-biosidase Encoded by a Novel Gene of Bifidobacterium longum Subspecies longum Shows Unique Substrate Specificity and Requires a Designated Chaperone for Its Active Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; BIOSE; BIFIDUM; 1,2-ALPHA-L-FUCOSIDASE; GALACTOSIDASE; DEGRADATION; TYPE-1; ENZYME	Infant gut-associated bifidobacteria possess species-specific enzymatic sets to assimilate human milk oligosaccharides, and lacto-N-biosidase (LNBase) is a key enzyme that degrades lacto-N- tetraose (Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc), the main component of human milk oligosaccharides, to lacto-N-biose I (Gal beta 1-3GlcNAc) and lactose. We have previously identified LNBase activity in Bifidobacterium bifidum and some strains of Bifidobacterium longum subsp. longum (B. longum). Subsequently, we isolated a glycoside hydrolase family 20 (GH20) LNBase from B. bifidum; however, the genome of the LNBase(+) strain of B. longum contains no GH20 LNBase homolog. Here, we reveal that locus tags BLLJ_1505 and BLLJ_1506 constitute LNBase from B. longum JCM1217. The gene products, designated LnbX and LnbY, respectively, showed no sequence similarity to previously characterized proteins. The purified enzyme, which consisted of LnbX only, hydrolyzed via a retaining mechanism the GlcNAc beta 1-3Gal linkage in lacto-N-tetraose, lacto-N-fucopentaose I (Fuc alpha 1-2Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc), and sialyllacto-N-tetraose a (Neu5Ac alpha 2-3Gal beta 1-3GlcNAc beta 1-3-Gal beta 1-4Gal); the latter two are not hydrolyzed by GH20 LNBase. Among the chromogenic substrates examined, the enzyme acted on p-nitrophenyl (pNP)-beta-lacto-N-bioside I (Gal beta 1-3-GlcNAc beta-pNP) and GalNAc beta 1-3GlcNAc beta-pNP.GalNAc beta 1-3-GlcNAc beta linkage has been found in O-mannosyl glycans of alpha-dystroglycan. Therefore, the enzyme may serve as a new tool for examining glycan structures. In vitro refolding experiments revealed that LnbY and metal ions (Ca2+ and Mg2+) are required for proper folding of LnbX. The LnbX and LnbY homologs have been found only in B. bifidum, B. longum, and a few gut microbes, suggesting that the proteins have evolved in specialized niches.	[Sakurama, Haruko; Kiyohara, Masashi; Wada, Jun; Honda, Yuji; Kumagai, Hidehiko; Yamamoto, Kenji; Katayama, Takane] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Yamaguchi, Masanori] Wakayama Univ, Dept Organ Chem, Wakayama 6408510, Japan; [Fukiya, Satoru; Yokota, Atsushi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Ashida, Hisashi] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Ishikawa Prefecture University; Wakayama University; Hokkaido University; Kindai University (Kinki University); National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Katayama, T (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan.	takane@ishikawa-pu.ac.jp	Kitaoka, Motomitsu/R-1536-2019; Fukiya, Satoru/C-8346-2012; Ashida, Hisashi/HCI-0293-2022	Kitaoka, Motomitsu/0000-0002-0083-1838; Fukiya, Satoru/0000-0002-3147-1070; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24580119, 24580179]; Asahi Glass Foundation; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Institution for Fermentation, Osaka; Grants-in-Aid for Scientific Research [24580119] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Institution for Fermentation, Osaka; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported in part by Grants-in-aid for Scientific Research (C) 24580119 and 24580179 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Asahi Glass Foundation; a grant-in-aid from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); and a grant-in-aid from the Institution for Fermentation, Osaka.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Ashida H, 2005, MOL BIOL CELL, V16, P1439, DOI 10.1091/mbc.E04-09-0802; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Brand-Miller JC, 1998, J PEDIATR-US, V133, P95, DOI 10.1016/S0022-3476(98)70185-4; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garrido D, 2012, ANAEROBE, V18, P430, DOI 10.1016/j.anaerobe.2012.04.012; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Hirayama Y, 2012, APPL ENVIRON MICROB, V78, P4984, DOI 10.1128/AEM.00588-12; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Honda Y., 2013, J APPL GLYC IN PRESS; INABA T, 1984, CHEM PHARM BULL, V32, P1597; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kobata A, 2013, P JPN ACAD B-PHYS, V89, P97, DOI 10.2183/pjab.89.97; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Matsumura H, 1997, BIOSCI BIOTECH BIOCH, V61, P1211, DOI 10.1271/bbb.61.1211; Mitsuoka T., 1988, ASIAN MED J, V31, P400; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Newburg D, 1995, HDB MILK COMPOSITION, P273; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; SANO M, 1992, P NATL ACAD SCI USA, V89, P8512, DOI 10.1073/pnas.89.18.8512; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Urashima T., 2011, OLIGOSACCHARIDES SOU, P1; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Woodworth A, 2002, J BIOL CHEM, V277, P50941, DOI 10.1074/jbc.M209876200; Wuhrer M, 2006, FEBS J, V273, P347, DOI 10.1111/j.1742-4658.2005.05068.x; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	45	54	57	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25194	25206		10.1074/jbc.M113.484733	http://dx.doi.org/10.1074/jbc.M113.484733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23843461	Green Published, hybrid			2022-12-28	WOS:000330619000019
J	Ivankova, K; Turecek, R; Fritzius, T; Seddik, R; Prezeau, L; Comps-Agrar, L; Pin, JP; Fakler, B; Besseyrias, V; Gassmann, M; Bettler, B				Ivankova, Klara; Turecek, Rostislav; Fritzius, Thorsten; Seddik, Riad; Prezeau, Laurent; Comps-Agrar, Laetitia; Pin, Jean-Philippe; Fakler, Bernd; Besseyrias, Valerie; Gassmann, Martin; Bettler, Bernhard			Up-regulation of GABA(B) Receptor Signaling by Constitutive Assembly with the K+ Channel Tetramerization Domain-containing Protein 12 (KCTD12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; AUXILIARY SUBUNITS; GLUTAMATE RECEPTORS; TRANSGENIC MICE; SUSHI DOMAINS; B RECEPTORS; EXPRESSION; CELLS; PHOSPHORYLATION; TRAFFICKING	GABA(B) receptors are the G-protein coupled receptors (GPCRs) for GABA, the main inhibitory neurotransmitter in the central nervous system. Native GABA(B) receptors comprise principle and auxiliary subunits that regulate receptor properties in distinct ways. The principle subunits GABA(B1a), GABA(B1b), and GABA(B2) form fully functional heteromeric GABA(B(1a,2)) and GABA(B(1b,2)) receptors. Principal subunits regulate forward trafficking of the receptors from the endoplasmic reticulum to the plasma membrane and control receptor distribution to axons and dendrites. The auxiliary subunits KCTD8, -12, -12b, and -16 are cytosolic proteins that influence agonist potency and G-protein signaling of GABA(B(1a,2)) and GABA(B(1b,2)) receptors. Here, we used transfected cells to study assembly, surface trafficking, and internalization of GABA(B) receptors in the presence of the KCTD12 subunit. Using bimolecular fluorescence complementation and metabolic labeling, we show that GABA(B) receptors associate with KCTD12 while they reside in the endoplasmic reticulum. Glycosylation experiments support that association with KCTD12 does not influence maturation of the receptor complex. Immunoprecipitation and bioluminescence resonance energy transfer experiments demonstrate that KCTD12 remains associated with the receptor during receptor activity and receptor internalization from the cell surface. We further show that KCTD12 reduces constitutive receptor internalization and thereby increases the magnitude of receptor signaling at the cell surface. Accordingly, knock-out or knockdown of KCTD12 in cultured hippocampal neurons reduces the magnitude of the GABA(B) receptor-mediated K+ current response. In summary, our experiments support that the up-regulation of functional GABAB receptors at the neuronal plasma membrane is an additional physiological role of the auxiliary subunit KCTD12.	[Ivankova, Klara; Turecek, Rostislav; Fritzius, Thorsten; Seddik, Riad; Besseyrias, Valerie; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland; [Prezeau, Laurent; Comps-Agrar, Laetitia; Pin, Jean-Philippe] Univ Montpellier 1 & 2, CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France; [Prezeau, Laurent; Comps-Agrar, Laetitia; Pin, Jean-Philippe] INSERM, U661, F-34094 Montpellier, France; [Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79108 Freiburg, Germany	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Freiburg	Bettler, B (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch	bettler, bernhard/AAO-8018-2020; Turecek, Rostislav/H-2706-2014; Pin, Jean-Philippe/Y-6668-2019; Turecek, Rostislav/AAL-3523-2020	Pin, Jean-Philippe/0000-0002-1423-345X; Turecek, Rostislav/0000-0003-4978-7556; Comps-Agrar, Laetitia/0000-0002-5260-6536; Gassmann, Martin/0000-0001-6201-3032; Bettler, Bernhard/0000-0003-0842-8207	Swiss National Science Foundation [3100A0-117816]; National Center for Competences in Research (NCCR) 'Synapsy, Synaptic Bases of Mental Health Disease'; European Community [201714]; CNRS; INSERM; Agence Nationale pour la Recherche [ANR-09-BLAN-0272]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competences in Research (NCCR) 'Synapsy, Synaptic Bases of Mental Health Disease'; European Community(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Swiss National Science Foundation (3100A0-117816), the National Center for Competences in Research (NCCR) 'Synapsy, Synaptic Bases of Mental Health Disease,' and the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201714 (to B. B.) and by CNRS, INSERM, and the Agence Nationale pour la Recherche (ANR-09-BLAN-0272) (to J.-P . P.).	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Benke Dietmar, 2012, World J Biol Chem, V3, P61, DOI 10.4331/wjbc.v3.i4.61; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Craig MT, 2013, J PHYSIOL-LONDON, V591, P835, DOI 10.1113/jphysiol.2012.248088; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Engle MP, 2006, NEUROSCIENCE, V138, P1277, DOI 10.1016/j.neuroscience.2005.11.064; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Hannan S, 2011, J BIOL CHEM, V286, P24324, DOI 10.1074/jbc.M110.220814; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pagano A, 2001, J NEUROSCI, V21, P1189; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pooler AM, 2009, EUR J NEUROSCI, V29, P869, DOI 10.1111/j.1460-9568.2009.06636.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sexton PM, 2009, DRUG DISCOV TODAY, V14, P413, DOI 10.1016/j.drudis.2008.12.009; Sibille E, 2009, AM J PSYCHIAT, V166, P1011, DOI 10.1176/appi.ajp.2009.08121760; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Yan D, 2012, J PHYSIOL-LONDON, V590, P21, DOI 10.1113/jphysiol.2011.213868	40	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24848	24856		10.1074/jbc.M113.476770	http://dx.doi.org/10.1074/jbc.M113.476770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23843457	Green Published, hybrid			2022-12-28	WOS:000330612300049
J	Rawnsley, DR; Xiao, JP; Lee, JS; Liu, X; Mericko-Ishizuka, P; Kumar, V; He, J; Basu, A; Lu, MM; Lynn, FC; Pack, M; Gasa, R; Kahn, ML				Rawnsley, David R.; Xiao, Jiping; Lee, John S.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; He, Jie; Basu, Arindam; Lu, MinMin; Lynn, Francis C.; Pack, Michael; Gasa, Rosa; Kahn, Mark L.			The Transcription Factor Atonal homolog 8 Regulates Gata4 and Friend of Gata-2 during Vertebrate Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; HEART TUBE FORMATION; VASCULAR DEVELOPMENT; VENTRAL MORPHOGENESIS; CARDIAC MORPHOGENESIS; LUNG DEVELOPMENT; GENE-EXPRESSION; RIGHT VENTRICLE; FOG-2; ZEBRAFISH	GATA and Friend of GATA (FOG) form a transcriptional complex that plays a key role in cardiovascular development in both fish and mammals. In the present study we demonstrate that the basic helix-loop-helix transcription factor Atonal homolog 8 (Atoh8) is required for development of the heart in fish but not in mice. Genetic studies reveal that Atoh8 interacts specifically with Gata4 and Fog1 during development of the heart and swim bladder in the fish. Biochemical studies reveal that ATOH8, GATA4, and FOG2 associate in a single complex in vitro. In contrast to fish, ATOH8-deficient mice exhibit normal cardiac development and loss of ATOH8 does not alter cardiac development in Gata4(+/-) mice. This species difference in the role of ATOH8 is explained in part by LacZ and GFP reporter alleles that reveal restriction of Atoh8 expression to atrial but not ventricular myocardium in the mouse. Our findings identify ATOH8 as a novel regulator of GATA-FOG function that is required for cardiac development in the fish but not the mouse. Whether ATOH8 modulates GATA-FOG function at other sites or in more subtle ways in mammals is not yet known.	[Rawnsley, David R.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; He, Jie; Lu, MinMin; Pack, Michael; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Rawnsley, David R.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; Lu, MinMin; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Basu, Arindam] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Xiao, Jiping] NYU, Dept Psychiat, New York, NY 10016 USA; [Lee, John S.] Bristol Myers Squibb Co, Hopewell, NJ 08525 USA; [Liu, Xi] Fourth Mil Med Univ, Xian 710032, Peoples R China; [Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 4H4, Canada; [Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 4H4, Canada; [Gasa, Rosa] Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Gasa, Rosa] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona 08017, Spain	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; New York University; Bristol-Myers Squibb; Air Force Military Medical University; University of British Columbia; University of British Columbia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Kahn, ML (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	markkahn@mail.med.upenn.edu		Kumar, Vinayak/0000-0002-1899-0386; Lynn, Francis/0000-0001-9318-1063	National Institutes of Health [T32 HL007971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grant T32 HL007971.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Barnett P, 2012, CURR TOP DEV BIOL, V100, P171, DOI 10.1016/B978-0-12-387786-4.00004-X; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Brien GL, 2009, SEMIN CELL DEV BIOL, V20, P835, DOI 10.1016/j.semcdb.2009.07.010; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023005; Conway SJ, 2010, PEDIATR CARDIOL, V31, P318, DOI 10.1007/s00246-009-9608-x; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; De Luca A, 2011, CLIN GENET, V80, P184, DOI 10.1111/j.1399-0004.2010.01523.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Gore AV, 2011, DEVELOPMENT, V138, P4875, DOI 10.1242/dev.068460; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hashiguchi M, 2013, DEVELOPMENT, V140, P1970, DOI 10.1242/dev.088104; Her GM, 2004, GENESIS, V38, P26, DOI 10.1002/gene.10248; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Manuylov NL, 2009, THESCIENTIFICWORLDJO, V9, P575, DOI 10.1100/tsw.2009.75; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; PHILLIPS SEV, 1994, STRUCTURE, V2, P1, DOI 10.1016/S0969-2126(00)00002-2; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shu WG, 2002, DEVELOPMENT, V129, P4831; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Torday JS, 2007, INTEGR COMP BIOL, V47, P601, DOI 10.1093/icb/icm069; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945; Zaytouni T, 2011, ADV GENET, V76, P93, DOI 10.1016/B978-0-12-386481-9.00004-3; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	64	25	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24429	24440		10.1074/jbc.M113.463083	http://dx.doi.org/10.1074/jbc.M113.463083			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836893	hybrid, Green Published			2022-12-28	WOS:000330612300013
J	Farrand, L; Byun, S; Kim, JY; Im-Aram, A; Lee, J; Lim, S; Lee, KW; Suh, JY; Lee, HJ; Tsang, BK				Farrand, Lee; Byun, Sanguine; Kim, Ji Young; Im-Aram, Akechai; Lee, Jihoon; Lim, Semi; Lee, Ki Won; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.			Piceatannol Enhances Cisplatin Sensitivity in Ovarian Cancer via Modulation of p53, X-linked Inhibitor of Apoptosis Protein (XIAP), and Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; CYTOCHROME-C; TUMOR XENOGRAFTS; DOWN-REGULATION; RESVERATROL; RESISTANCE; DRP1; CHEMOTHERAPY; ACTIVATION; THERAPY	Resistance to cisplatin (CDDP) in ovarian cancer (OVCA) arises from the dysregulation of tumor suppressors and survival signals. During genotoxic challenge, these factors can be influenced by secondary agents that facilitate the induction of apoptosis. Piceatannol is a natural metabolite of the stilbene resveratrol found in grapes and is converted from its parent compound by the enzyme CYP1BA1 p450. It has been hypothesized to exert specific effects against various cellular targets; however, its ability to influence CDDP resistance in cancer cells has not been investigated to date. Here, we show that piceatannol is a potent enhancer of CDDP sensitivity in OVCA, and this effect is achieved through the modulation of several major determinants of chemoresistance. Piceatannol enhances p53-mediated expression of the pro-apoptotic protein NOXA, increases XIAP degradation via the ubiquitin-proteasome pathway, and enhances caspase-3 activation. This response is associated with an increase in Drp1-dependent mitochondrial fission, leading to more effective induction of apoptosis. In vivo studies using a mouse model of OVCA reveal that a number of these changes occur in association with a greater overall reduction in tumor weight when mice are treated with both piceatannol and CDDP, in comparison to treatment with either agent alone. Taken together, these findings demonstrate the potential application of piceatannol to enhance CDDP sensitivity in OVCA, and it acts on p53, XIAP, and mitochondrial fission.	[Farrand, Lee; Byun, Sanguine; Kim, Ji Young; Im-Aram, Akechai; Lee, Jihoon; Lim, Semi; Lee, Ki Won; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Major Biomodulat, Seoul, South Korea; [Byun, Sanguine; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1N 6N5, Canada; [Byun, Sanguine; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Ottawa Hosp Gen Campus,3rd Floor,Rm W3107,501 Smy, Ottawa, ON K1H 8L6, Canada.	btsang@ohri.ca	Byun, Sanguine/AAR-5451-2021; Lee, Ki Won/M-4114-2018	Byun, Sanguine/0000-0003-3903-5887; Tsang, Benjamin K./0000-0003-1213-3946	World Class University Program through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology; Canadian Institutes of Health Research [M0P-126144]	World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by World Class University Program Grant R31-10056 through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology and Canadian Institutes of Health Research Grant M0P-126144.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alas S, 2001, CANCER RES, V61, P5137; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; American Cancer Society, 2012, CANC FACTS FIG; Amiot MJ, 2013, BIOCHIMIE, V95, P1233, DOI 10.1016/j.biochi.2013.01.008; Asselin E, 2001, ENDOCRINOLOGY, V142, P2451, DOI 10.1210/en.142.6.2451; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Biggar RJ, 2012, CLIN CANCER RES, V18, P2133, DOI 10.1158/1078-0432.CCR-11-1389; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Brown JM, 1999, CANCER RES, V59, P1391; CANPOLAT C, 1994, CANCER, V74, P3059, DOI 10.1002/1097-0142(19941201)74:11<3059::AID-CNCR2820741125>3.0.CO;2-Z; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Covens A, 2002, GYNECOL ONCOL, V85, P71, DOI 10.1006/gyno.2001.6552; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Ghamande S, 2001, CANCER RES, V61, P7556; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Hesketh PJ, 2004, SUPPORT CARE CANCER, V12, P543, DOI 10.1007/s00520-003-0562-5; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Maggiolini M, 2005, J MOL ENDOCRINOL, V35, P269, DOI 10.1677/jme.1.01783; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Plumb JA, 2000, CANCER RES, V60, P6039; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rezk Youssef A, 2006, Am J Obstet Gynecol, V194, pe23, DOI 10.1016/j.ajog.2005.11.030; ROSE DP, 1986, CANCER-AM CANCER SOC, V58, P2363, DOI 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-#; Sasaki H, 2000, CANCER RES, V60, P5659; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Takahashi S, 2012, BRIT J NUTR, V107, P774, DOI 10.1017/S0007114511003588; Wolter F, 2002, J NUTR, V132, P298; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	60	75	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23740	23750		10.1074/jbc.M113.487686	http://dx.doi.org/10.1074/jbc.M113.487686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23833193	Green Published, hybrid			2022-12-28	WOS:000330611400014
J	Tanaka, K; Kondo, K; Kitajima, K; Muraoka, M; Nozawa, A; Hara, T				Tanaka, Kiyoko; Kondo, Keiichi; Kitajima, Kenji; Muraoka, Masatoshi; Nozawa, Akinori; Hara, Takahiko			Tumor-suppressive Function of Protein-tyrosine Phosphatase Non-receptor Type 23 in Testicular Germ Cell Tumors Is Lost upon Overexpression of miR142-3p microRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-CHROMOSOME 3P21.3; HD-PTP; ENDOTHELIAL MIGRATION; LUNG-CANCER; GENE; EXPRESSION; CARCINOMA; LEUKEMIA; SCREEN; DOMAIN	Protein-tyrosine phosphatase non-receptor type 23 (PTPN23) is a candidate tumor suppressor involved in the tumorigenesis of various organs. However, its physiological role(s) and detailed expression profile(s) have not yet been elucidated. We investigated the function and regulation of PTPN23 in the formation of testicular germ cell tumors (TGCTs). Expression of PTPN23 in human TGCT cell lines was significantly lower than that in spermatogonial stem cells in mice. Overexpression of PTPN23 in NEC8, a human TGCT cell line, suppressed soft agar colony formation in vitro and tumor formation in nude mice in vivo. These data indicate that PTPN23 functions as a tumor suppressor in TGCTs. Multiple computational algorithms predicted that the 3' UTR of human PTPN23 is a target for miR-142-3p. A luciferase reporter assay confirmed that miR-142-3p bound directly to the 3' UTR of PTPN23. Introduction of pre-miR-142 in the PTPN23 transfectant of NEC8 led to suppressed expression of PTPN23 and increased soft agar colony formation. Quantitative RT-PCR data revealed a significantly higher expression of miR-142-3p in human seminomas compared with normal testes. No difference in mRNA expression between seminoma and non-seminoma samples was detected by in situ hybridization. Both quantitative RT-PCR and immunohistochemical analyses revealed that PTPN23 expression was significantly lower in TGCTs than in normal testicular tissues. Finally, a lack of PTPN23 protein expression in human TGCTs correlated with a relatively higher miR-142-3p expression. These data suggest that PTPN23 is a tumor suppressor and that repression of PTPN23 expression by miR-142-3p plays an important role in the pathogenesis of TGCTs.	[Tanaka, Kiyoko; Kitajima, Kenji; Muraoka, Masatoshi; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Setagaya Ku, Tokyo 1568506, Japan; [Kondo, Keiichi] Yokohama City Univ, Med Ctr, Dept Urol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Nozawa, Akinori] Yokohama City Univ, Med Ctr, Dept Pathol, Minami Ku, Yokohama, Kanagawa 2320024, Japan	Tokyo Metropolitan Institute of Medical Science; Yokohama City University; Yokohama City University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	tanaka-ky@igakuken.or.jp			Japan Society for the Promotion of Science [23592356, 23390256]; Exploratory Research Grant [23659481]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exploratory Research Grant	This study was supported by Japan Society for the Promotion of Science Grants-in-Aid (C) 23592356 (to K. T.) and (B) 23390256 (to T. H.) and Exploratory Research Grant 23659481 (to T. H.).	Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Castiglioni S, 2012, BIOCHEM BIOPH RES CO, V421, P380, DOI 10.1016/j.bbrc.2012.04.024; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Cheng Y, 1998, P NATL ACAD SCI USA, V95, P3042, DOI 10.1073/pnas.95.6.3042; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eyzaguirre E, 2002, MODERN PATHOL, V15, P1068, DOI 10.1097/01.MP.0000028574.10294.7D; Foster K, 1995, EUR J CANCER, V31A, P2392, DOI 10.1016/0959-8049(95)00437-8; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gingras MC, 2009, INT J DEV BIOL, V53, P1069, DOI 10.1387/ijdb.082820mg; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Korff S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-329; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Lin RJ, 2012, J SURG ONCOL, V105, P175, DOI 10.1002/jso.22066; LOTHE RA, 1989, GENOMICS, V5, P134, DOI 10.1016/0888-7543(89)90097-9; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Mariotti M, 2009, CANCER LETT, V273, P155, DOI 10.1016/j.canlet.2008.08.017; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Scrima M, 2012, AM J PATHOL, V180, P1202, DOI 10.1016/j.ajpath.2011.11.038; Sekido Y, 1998, ONCOGENE, V16, P3151, DOI 10.1038/sj.onc.1201858; Sun YP, 2013, J IMMUNOL, V190, P4005, DOI 10.4049/jimmunol.1202911; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Tanaka K, 2002, DEV BIOL, V246, P466, DOI 10.1006/dbio.2002.0671; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wei MH, 1996, CANCER RES, V56, P1487; Wistuba II, 1997, CANCER RES, V57, P3154; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	42	25	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23990	23999		10.1074/jbc.M113.478891	http://dx.doi.org/10.1074/jbc.M113.478891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23843459	hybrid, Green Published			2022-12-28	WOS:000330611400037
J	Werner, S; Frey, S; Riethdorf, S; Schulze, C; Alawi, M; Kling, L; Vafaizadeh, V; Sauter, G; Terracciano, L; Schumacher, U; Pantel, K; Assmann, V				Werner, Stefan; Frey, Sabrina; Riethdorf, Sabine; Schulze, Christian; Alawi, Malik; Kling, Lea; Vafaizadeh, Vida; Sauter, Guido; Terracciano, Luigi; Schumacher, Udo; Pantel, Klaus; Assmann, Volker			Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; TAMOXIFEN RESISTANCE; BONE-MARROW; CELL-LINES; ERBB3; RECEPTOR; FAMILY; EXPRESSION; DROSOPHILA; HEAD	Using a retrovirus-mediated cDNA expression cloning approach, we identified the grainyhead-like 2 (GRHL2) transcription factor as novel protooncogene. Overexpression of GRHL2 in NIH3T3 cells induced striking morphological changes, an increase in cell proliferation, anchorage-independent growth, and tumor growth in vivo. By combining a microarray analysis and a phylogenetic footprinting analysis with various biochemical assays, we identified the epidermal growth factor receptor family member Erbb3 as a novel GRHL2 target gene. In breast cancer cell lines, shRNA-mediated knockdown of GRHL2 expression or functional inactivation of GRHL2 using dominant negative GRHL2 proteins induces down-regulation of ERBB3 gene expression, a striking reduction in cell proliferation, and morphological and phenotypical alterations characteristic of an epithelial-to-mesenchymal transition (EMT), thus implying contradictory roles of GRHL2 in breast carcinogenesis. Interestingly, we could further demonstrate that expression of GRHL2 is directly suppressed by the transcription factor zinc finger enhancer-binding protein 1 (ZEB1), which in turn is a direct target for repression by GRHL2, suggesting that the EMT transcription factors GRHL2 and ZEB1 form a double negative regulatory feedback loop in breast cancer cells. Finally, a comprehensive immunohistochemical analysis of GRHL2 expression in primary breast cancers showed loss ofGRHL2expression at the invasive front of primary tumors. A pathophysiological relevance of GRHL2 in breast cancer metastasis is further demonstrated by our finding of a statistically significant association between loss of GRHL2 expression in primary breast cancers and lymph node metastasis. We thus demonstrate a crucial role of GRHL2 in breast carcinogenesis.	[Werner, Stefan; Frey, Sabrina; Riethdorf, Sabine; Kling, Lea; Pantel, Klaus; Assmann, Volker] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, D-20246 Hamburg, Germany; [Schulze, Christian] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20246 Hamburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, D-20246 Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat 2, D-20246 Hamburg, Germany; [Vafaizadeh, Vida] Inst Biomed Res, D-60596 Frankfurt, Germany; [Terracciano, Luigi] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel	Assmann, V (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Tumor Biol, Martinistr 52, D-20246 Hamburg, Germany.	v.assmann@uke.de	, Malik/AAB-7437-2021; Schulze, Christian/AGJ-7744-2022; Terracciano, Luigi M./AAB-5335-2022	, Malik/0000-0002-5993-7709; Schulze, Christian/0000-0001-9442-7141; Terracciano, Luigi M./0000-0002-9393-9660; Vafaizadeh, Vida/0000-0002-0875-6246; Schulze, Christian/0000-0002-1442-1987	European Research Council [ERC-2010-AdG_20100317 DISSECT]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council Grant ERC-2010-AdG_20100317 DISSECT (to K. P.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Assmann V, 1999, J CELL SCI, V112, P3943; Assmann V, 1998, J CELL SCI, V111, P1685; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dompe N, 2011, P NATL ACAD SCI USA, V108, pE943, DOI 10.1073/pnas.1100132108; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Dworkin S, 2012, DEVELOPMENT, V139, P525, DOI 10.1242/dev.066522; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moussian B, 2005, BIOESSAYS, V27, P987, DOI 10.1002/bies.20308; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Rifat Y, 2010, DEV BIOL, V345, P237, DOI 10.1016/j.ydbio.2010.07.017; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Simon R, 2002, EXP HEMATOL, V30, P1365, DOI 10.1016/S0301-472X(02)00965-7; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Yang XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056195	56	87	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22993	23008		10.1074/jbc.M113.456293	http://dx.doi.org/10.1074/jbc.M113.456293			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814079	hybrid, Green Published			2022-12-28	WOS:000330598200010
J	Boslem, E; Weir, JM; MacIntosh, G; Sue, N; Cantley, J; Meikle, PJ; Biden, TJ				Boslem, Ebru; Weir, Jacquelyn M.; MacIntosh, Gemma; Sue, Nancy; Cantley, James; Meikle, Peter J.; Biden, Trevor J.			Alteration of Endoplasmic Reticulum Lipid Rafts Contributes to Lipotoxicity in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; FREE FATTY-ACIDS; ER-STRESS; NEUTRAL SPHINGOMYELINASE; CERAMIDE ACCUMULATION; INDUCED APOPTOSIS; GOLGI TRANSPORT; CHOLESTEROL; PALMITATE; DEATH	Chronic saturated fatty acid exposure causes beta-cell apoptosis and, thus, contributes to type 2 diabetes. Although endoplasmic reticulum (ER) stress and reduced ER-to-Golgi protein trafficking have been implicated, the exact mechanisms whereby saturated fatty acids trigger beta-cell death remain elusive. Using mass spectroscopic lipidomics and subcellular fractionation, we demonstrate that palmitate pretreatment of MIN6 beta-cells promoted ER remodeling of both phospholipids and sphingolipids, but only the latter was causally linked to lipotoxic ER stress. Thus, overexpression of glucosylceramide synthase, previously shown to protect against defective protein trafficking and ER stress, partially reversed lipotoxic reductions in ER sphingomyelin (SM) content and aggregation of ER lipid rafts, as visualized using Erlin1-GFP. Using both lipidomics and a sterol response element reporter assay, we confirmed that free cholesterol in the ER was also reciprocally modulated by chronic palmitate and glucosylceramide synthase overexpression. This is consistent with the known coregulation and association of SM and free cholesterol in lipid rafts. Inhibition of SM hydrolysis partially protected against ATF4/C/EBP homology protein induction because of palmitate. Our results suggest that loss of SM in the ER is a key event for initiating beta-cell lipotoxicity, which leads to disruption of ER lipid rafts, perturbation of protein trafficking, and initiation of ER stress.	[Boslem, Ebru; Sue, Nancy; Cantley, James; Biden, Trevor J.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Weir, Jacquelyn M.; MacIntosh, Gemma; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Baker Heart and Diabetes Institute	Biden, TJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.biden@garvan.org.au	Meikle, Peter J/B-4023-2009; Biden, Trevor/AAW-2829-2021	Boslem, Ebru/0000-0001-6123-4108; Biden, Trevor/0000-0001-5211-0234; Meikle, Peter/0000-0002-2593-4665; Cantley, James/0000-0003-2509-1271	National Health and Medical Research Council; Young Garvan Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Young Garvan Fellowship	This work was supported by a National Health and Medical Research Council project grant (to T. J. B.), by research fellowships (to T. J. B. and P. J. M.), and by the Young Garvan Fellowship (to E. B.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Bonifacino J. S., 2003, CURRENT PROTOCOLS CE; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Gonzalez-Pertusa JA, 2010, ENDOCRINOLOGY, V151, P1487, DOI 10.1210/en.2009-0975; Gouaze-Andersson V, 2007, BBA-MOL CELL BIOL L, V1771, P1407, DOI 10.1016/j.bbalip.2007.09.005; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maceyka M, 1997, J CELL BIOL, V139, P1411, DOI 10.1083/jcb.139.6.1411; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Veret J, 2011, BIOCHEM J, V438, P177, DOI 10.1042/BJ20101386; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Worgall TS, 2011, ADV EXP MED BIOL, V721, P139, DOI 10.1007/978-1-4614-0650-1_9; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433	66	88	89	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26569	26582		10.1074/jbc.M113.489310	http://dx.doi.org/10.1074/jbc.M113.489310			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897822	Green Published, hybrid			2022-12-28	WOS:000330594500023
J	Go, YM; Jones, DP				Go, Young-Mi; Jones, Dean P.			The Redox Proteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTEINE-SULFINIC ACID; NITRIC-OXIDE SYNTHASE; S-NITROSYLATION; OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATION; GLUTATHIONYLATED PROTEINS; THIOREDOXIN REDUCTASE; HYDROGEN-SULFIDE; ACTIVE-SITE; AMINO-ACIDS	The redox proteome consists of reversible and irreversible covalent modifications that link redox metabolism to biologic structure and function. These modifications, especially of Cys, function at the molecular level in protein folding and maturation, catalytic activity, signaling, and macromolecular interactions and at the macroscopic level in control of secretion and cell shape. Interaction of the redox proteome with redox-active chemicals is central to macromolecular structure, regulation, and signaling during the life cycle and has a central role in the tolerance and adaptability to diet and environmental challenges.	[Go, Young-Mi; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	Emory University	Jones, DP (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	dpjones@emory.edu			National Institutes of Health [ES009047, HL113451, AG038746]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants ES009047, HL113451, and AG038746. This is the seventh article in the Thematic Minireview Series on Redox-active Protein Modifications and Signaling.	Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Billiet L, 2012, FREE RADICAL BIO MED, V52, P1473, DOI 10.1016/j.freeradbiomed.2011.12.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; CAPRARI P, 1995, CHEM-BIOL INTERACT, V94, P243, DOI 10.1016/0009-2797(94)03339-A; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; EPSTEIN CJ, 1963, COLD SPRING HARB SYM, V28, P439, DOI 10.1101/SQB.1963.028.01.060; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Go Young-Mi, 2011, J Proteomics Bioinform, V4, P196; Go YM, 2013, CRIT REV BIOCHEM MOL, V48, P173, DOI 10.3109/10409238.2013.764840; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Go Young-Mi, 2008, V464, P303; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HAYAISHI O, 1955, J AM CHEM SOC, V77, P5450, DOI 10.1021/ja01625a095; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Higdon A, 2012, BIOCHEM J, V442, P453, DOI 10.1042/BJ20111752; Ishima Y, 2007, J PHARMACOL EXP THER, V320, P969, DOI 10.1124/jpet.106.114959; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Keilin D., 1966, HIST CELL RESP CYTOC; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kim JR, 2004, FEBS LETT, V567, P189, DOI 10.1016/j.febslet.2004.04.055; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; Knoefler D, 2012, MOL CELL, V47, P767, DOI 10.1016/j.molcel.2012.06.016; Kondo N, 2004, IMMUNOL LETT, V92, P143, DOI 10.1016/j.imlet.2003.11.030; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kuiper JWP, 2011, BLOOD, V118, P6164, DOI 10.1182/blood-2010-09-310383; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; MASON HS, 1955, J AM CHEM SOC, V77, P2914, DOI 10.1021/ja01615a088; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Morot-Gaudry-Talarmain Y, 2009, FREE RADICAL BIO MED, V47, P1715, DOI 10.1016/j.freeradbiomed.2009.09.014; Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagy P, 2010, ADV MOLEC TOXICOL, V4, P183, DOI 10.1016/S1872-0854(10)04006-3; Rappaport SM, 2012, TOXICOL LETT, V213, P83, DOI 10.1016/j.toxlet.2011.04.002; Reynaert NL, 2006, BBA-GEN SUBJECTS, V1760, P380, DOI 10.1016/j.bbagen.2006.01.006; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Roede JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033020; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Salzano AM, 2006, J CHROMATOGR B, V833, P41, DOI 10.1016/j.jchromb.2005.12.025; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Shartava A, 1997, AM J HEMATOL, V55, P97, DOI 10.1002/(SICI)1096-8652(199706)55:2<97::AID-AJH8>3.0.CO;2-Y; Sies H., 2007, ENCY STRESS OXIDATIV, V3; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Sies H, 1982, METABOLIC COMPARTMEN; Skalska J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008115; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Truong TH, 2011, BIOORG MED CHEM LETT, V21, P5015, DOI 10.1016/j.bmcl.2011.04.115; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang XG, 2010, ANTIOXID REDOX SIGN, V13, P565, DOI 10.1089/ars.2009.2833; Watarai H, 2000, P NATL ACAD SCI USA, V97, P13251, DOI 10.1073/pnas.230445397; Waterman MR, 2005, BIOCHEM BIOPH RES CO, V338, P7, DOI 10.1016/j.bbrc.2005.08.120; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291; Zangger K, 2002, J INORG BIOCHEM, V88, P135, DOI 10.1016/S0162-0134(01)00379-8; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	98	163	165	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26512	26520		10.1074/jbc.R113.464131	http://dx.doi.org/10.1074/jbc.R113.464131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23861437	hybrid, Green Published			2022-12-28	WOS:000330594500018
J	Hinkofer, LC; Seidel, SAI; Korkmaz, B; Silva, F; Hummel, AM; Braun, D; Jenne, DE; Specks, U				Hinkofer, Lisa C.; Seidel, Susanne A. I.; Korkmaz, Brice; Silva, Francisco; Hummel, Amber M.; Braun, Dieter; Jenne, Dieter E.; Specks, Ulrich			A Monoclonal Antibody (MCPR3-7) Interfering with the Activity of Proteinase 3 by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; WEGENERS-GRANULOMATOSIS; SERINE PROTEASES; NEUTROPHIL ELASTASE; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; CATHEPSIN-G; PR3; AUTOANTIGEN; DISTINCT	Proteinase 3 (PR3) is an abundant serine protease of neutrophil granules and a major target of autoantibodies (PR3 antineutrophil cytoplasmic antibodies) in granulomatosis with polyangiitis. Some of the PR3 synthesized by promyelocytes in the bone marrow escapes the targeting to granules and occurs on the plasma membrane of naive and primed neutrophils. This membrane-associated PR3 antigen may represent pro-PR3, mature PR3, or both forms. To discriminate between mature PR3 and its inactive zymogen, which have different conformations, we generated and identified a monoclonal antibody called MCPR3-7. It bound much better to pro-PR3 than to mature PR3. This monoclonal antibody greatly reduced the catalytic activity of mature PR3 toward extended peptide substrates. Using diverse techniques and multiple recombinant PR3 variants, we characterized its binding properties and found that MCPR3-7 preferentially bound to the so-called activation domain of the zymogen and changed the conformation of mature PR3, resulting in impaired catalysis and inactivation by alpha(1)-proteinase inhibitor (alpha(1)-antitrypsin). Noncovalent as well as covalent complexation between PR3 and alpha(1)-proteinase inhibitor was delayed in the presence of MCPR3-7, but cleavage of certain thioester and paranitroanilide substrates with small residues in the P1 position was not inhibited. We conclude that MCPR3-7 reduces PR3 activity by an allosteric mechanism affecting the S1' pocket and further prime side interactions with substrates. In addition, MCPR3-7 prevents binding of PR3 to cellular membranes. Inhibitory antibodies targeting the activation domain of PR3 could be exploited as highly selective inhibitors of PR3, scavengers, and clearers of the PR3 autoantigen in granulomatosis with polyangiitis.	[Hinkofer, Lisa C.; Korkmaz, Brice; Jenne, Dieter E.] Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Hinkofer, Lisa C.; Korkmaz, Brice; Jenne, Dieter E.] Ctr Lung Res DZL, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Seidel, Susanne A. I.; Braun, Dieter] Univ Munich, D-80799 Munich, Germany; [Korkmaz, Brice] INSERM, U1100, Ctr Etud Pathol Resp, EA 6305, F-37032 Tours, France; [Silva, Francisco; Hummel, Amber M.; Specks, Ulrich] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA; [Silva, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Inmunol Clin & Reumatol, Santiago 8330033, Chile; [Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Mayo Clinic; Pontificia Universidad Catolica de Chile; Max Planck Society	Jenne, DE (corresponding author), Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Max Lebsche Pl 31, D-81377 Munich, Germany.	dieter.jenne@helmholtz-muenchen.de	Jenne, Dieter Erich/AAP-1414-2020; Seidel, Susanne A. I./AAI-2811-2020	KORKMAZ, BRICE/0000-0002-5159-8706	National Institutes of Health [RO1-AR49806, RC1-AR58303]; Vasculitis Clinical Research Consortium [U54-RR019497]; European Union [261382]; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [JE194/4-1, BR2152/2-1]; NanoSystems Initiative Munich; Center for NanoScience; Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems; Mayo Clinic Monoclonal Antibody Core Facility; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049806, RC1AR058303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vasculitis Clinical Research Consortium; European Union(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NanoSystems Initiative Munich; Center for NanoScience; Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems; Mayo Clinic Monoclonal Antibody Core Facility; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AR49806 and RC1-AR58303 (to U. S.) and U54-RR019497 from the Vasculitis Clinical Research Consortium (to F. S.). This work was also supported by European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 261382 (INTRICATE), the Alexander von Humboldt Foundation, a joint grant from the Deutsche Forschungsgemeinschaft (JE194/4-1; BR2152/2-1), the NanoSystems Initiative Munich, the Center for NanoScience, the Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems, and the Mayo Clinic Monoclonal Antibody Core Facility.; Supported in part by funds from The Mayo Foundation.	CAMPANELLI D, 1990, J EXP MED, V172, P1709, DOI 10.1084/jem.172.6.1709; Capizzi SA, 2003, KIDNEY INT, V63, P756, DOI 10.1046/j.1523-1755.2003.00765.x; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; CSERNOK E, 1990, AM J PATHOL, V137, P1113; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Garwicz D, 1997, J LEUKOCYTE BIOL, V61, P113, DOI 10.1002/jlb.61.1.113; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jenne DE, 2006, CLIN NEPHROL, V66, P153; Kallenberg CGM, 2011, CLIN REV ALLERG IMMU, V41, P224, DOI 10.1007/s12016-011-8258-y; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Kuhl A, 2010, J IMMUNOL, V185, P387, DOI 10.4049/jimmunol.0903887; LINDLEY H, 1972, BIOCHEM J, V126, P683, DOI 10.1042/bj1260683; Lone AM, 2010, AAPS J, V12, P483, DOI 10.1208/s12248-010-9208-y; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Rao NV, 1996, J BIOL CHEM, V271, P2972, DOI 10.1074/jbc.271.6.2972; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Silva F, 2010, J AUTOIMMUN, V35, P299, DOI 10.1016/j.jaut.2010.06.021; Specks U, 1996, FEBS LETT, V390, P265, DOI 10.1016/0014-5793(96)00669-2; Sun J, 1998, CLIN EXP IMMUNOL, V114, P320; Sun JY, 1998, J IMMUNOL METHODS, V211, P111, DOI 10.1016/S0022-1759(97)00203-2; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	38	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26635	26648		10.1074/jbc.M113.495770	http://dx.doi.org/10.1074/jbc.M113.495770			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902773	hybrid, Green Published			2022-12-28	WOS:000330594500029
J	Amie, SM; Bambara, RA; Kim, B				Amie, Sarah M.; Bambara, Robert A.; Kim, Baek			GTP Is the Primary Activator of the Anti-HIV Restriction Factor SAMHD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; REVERSE-TRANSCRIPTASE; INFECTION; EXPRESSION; SUBSTRATE	SAMHD1 (SAM domain-and HD domain-containing protein 1) is a dGTP-dependent dNTP triphosphohydrolase that converts dNTPs into deoxyribonucleosides and triphosphates. Therefore, SAMHD1 expression, particularly in non-dividing cells, can restrict retroviral infections such as HIV and simian immunodeficiency virus by limiting cellular dNTPs, which are essential for reverse transcription. It has previously been established that dGTP acts as both an activator and a substrate of this enzyme, suggesting that phosphohydrolase activity of SAMHD1 is regulated by dGTP availability in the cell. However, we now demonstrate biochemically that the NTP GTP is equally capable of activating SAMHD1, but GTP is not hydrolyzed by the enzyme. Activation of SAMHD1 phosphohydrolase activity was tested under physiological concentrations of dGTP or GTP found in either dividing or non-dividing cells. Because GTP is 1000-fold more abundant than dGTP in cells, GTP was able to activate the enzyme to a greater extent than dGTP, suggesting that GTP is the primary activator of SAMHD1. Finally, we show that SAMHD1 has the ability to hydrolyze base-modified nucleotides, indicating that the active site of SAMHD1 is not restrictive to such modifications, and is capable of regulating the levels of non-canonical dNTPs such as dUTP. This study provides further insights into the regulation of SAMHD1 with regard to allosteric activation and active site specificity.	[Amie, Sarah M.; Bambara, Robert A.] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Kim, Baek] Emory Univ, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA	University of Rochester; Emory University	Kim, B (corresponding author), Emory Univ, Dept Pediat, Ctr Drug Discovery, 1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI077401, AI049781];  [GM068411];  [AI049815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781, R01AI077401, T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198, T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077401 and AI049781 (to B. K.) and by Training Grants GM068411 (Cellular, Biochemical, and Molecular Sciences) and AI049815 (HIV-1 Replication and Pathogenesis) (to S. M. A.).	Amie SM, 2013, J BIOL CHEM, V288, P20683, DOI 10.1074/jbc.M113.472159; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; FOX IH, 1981, METABOLISM, V30, P616, DOI 10.1016/0026-0495(81)90142-6; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; McKenna CE, 2010, BBA-PROTEINS PROTEOM, V1804, P1223, DOI 10.1016/j.bbapap.2010.01.005; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tchigvintsev A, 2011, BIOCHEM J, V437, P243, DOI 10.1042/BJ20110304; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029	23	60	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25001	25006		10.1074/jbc.C113.493619	http://dx.doi.org/10.1074/jbc.C113.493619			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23880768	Green Published, hybrid			2022-12-28	WOS:000330619000002
J	Fonseca-Maldonado, R; Vieira, DS; Alponti, JS; Bonneil, E; Thibault, P; Ward, RJ				Fonseca-Maldonado, Raquel; Vieira, Davi Serradella; Alponti, Juliana Sanchez; Bonneil, Eric; Thibault, Pierre; Ward, Richard John			Engineering the Pattern of Protein Glycosylation Modulates the Thermostability of a GH11 Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; ENDOPLASMIC-RETICULUM; PICHIA-PASTORIS; QUALITY-CONTROL; GLYCANS; SIMULATION; EXPRESSION; STABILITY; EFFICIENT; DYNAMICS	Protein glycosylation is a common post-translational modification, the effect of which on protein conformational and stability is incompletely understood. Here we have investigated the effects of glycosylation on the thermostability of Bacillus subtilis xylanase A(XynA) expressed in Pichia pastoris. Intact mass analysis of the heterologous wild-type XynA revealed two, three, or four Hex(8-16)GlcNAc(2) modifications involving asparagine residues at positions 20, 25, 141, and 181. Molecular dynamics (MD) simulations of the XynA modified with various combinations of branched Hex(9)GlcNAc(2) at these positions indicated a significant contribution from protein-glycan interactions to the overall energy of the glycoproteins. The effect of glycan content and glycosylation position on protein stability was evaluated by combinatorial mutagenesis of all six potential N-glycosylation sites. The majority of glycosylated enzymes expressed in P. pastoris presented increased thermostability in comparison with their unglycosylated counterparts expressed in Escherichia coli. Steric effects of multiple glycosylation events were apparent, and glycosylation position rather than the number of glycosylation events determined increases in thermostability. The MD simulations also indicated that clustered glycan chains tended to favor less stabilizing glycan-glycan interactions, whereas more dispersed glycosylation patterns favored stabilizing protein-glycan interactions.	[Fonseca-Maldonado, Raquel] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Sao Paulo, Brazil; [Vieira, Davi Serradella; Alponti, Juliana Sanchez; Ward, Richard John] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Sao Paulo, Brazil; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ward, Richard John] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universite de Montreal	Ward, RJ (corresponding author), Univ Sao Paulo, FFCLRP, Dept Quim, Ave Bandeirantes 3900, Ribeirao Preto, SP, Brazil.	rjward@ffclrp.usp.br	Maldonado, Raquel/C-2706-2013; Ward, Richard John/C-2460-2012; Vieira, Davi S/E-7424-2015; Fapesp, Biota/F-8655-2017	Ward, Richard John/0000-0003-1136-5737; Vieira, Davi S/0000-0001-8353-6262; Fapesp, Biota/0000-0002-9887-8449	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/18850-2, 2009/50838-5, 2008/57908-6, 2010/52322-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [574002/2008-1, 140124/2009-8, 307795/2009-8]; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Canadian Center of Excellence in Commercialization and Research (CECR); Canadian Foundation for Innovation; Fonds de Recherche du Quebec en Sante (FRQS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Canadian Center of Excellence in Commercialization and Research (CECR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec en Sante (FRQS)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/18850-2, 2009/50838-5, 2008/57908-6, and 2010/52322-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 574002/2008-1, 140124/2009-8, and 307795/2009-8; and Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES). The Institute for Research in Immunology and Cancer is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canadian Foundation for Innovation, and the Fonds de Recherche du Quebec en Sante (FRQS).	[Anonymous], [No title captured], DOI DOI 10.1016/B978-0-12-059820-5.50015-X; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cheng SM, 2010, CHEMPHYSCHEM, V11, P2367, DOI 10.1002/cphc.201000205; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Georis J, 2000, PROTEIN SCI, V9, P466; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hecht ML, 2009, CURR OPIN CHEM BIOL, V13, P354, DOI 10.1016/j.cbpa.2009.05.127; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kawasaki N, 2009, BIOL PHARM BULL, V32, P796, DOI 10.1248/bpb.32.796; KUKURUZINSKA MA, 1987, ANNU REV BIOCHEM, V56, P915, DOI 10.1146/annurev.biochem.56.1.915; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu DN, 2012, J PHYS CHEM B, V116, P390, DOI 10.1021/jp203926r; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miyamo S., 2002, J COMPUT CHEM, V13, P952; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mulloy B, 2010, BIOCHEM SOC T, V38, P1329, DOI 10.1042/BST0381329; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shental-Bechor D, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3650700; Sinha S, 2007, BIOPHYS J, V92, P208, DOI 10.1529/biophysj.106.092668; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Straumann N, 2006, BIOCHEM J, V393, P459, DOI 10.1042/BJ20050857; Taylor M. E., 2011, INTRO GLYCOBIOLOGY; Torrez M, 2003, BIOPHYS J, V85, P2845, DOI 10.1016/S0006-3495(03)74707-9; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Vieira DS, 2009, MOL PHYS, V107, P59, DOI 10.1080/00268970902717959; von der Lieth C., 2010, BIOINFORMATICS GLYCO; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WOODS RJ, 1994, NAT STRUCT BIOL, V1, P499, DOI 10.1038/nsb0894-499; Woods RJ, 1998, GLYCOCONJUGATE J, V15, P209, DOI 10.1023/A:1006984709892; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuried E., 2012, STRUCTURAL GLYCOBIOL	50	51	66	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25522	25534		10.1074/jbc.M113.485953	http://dx.doi.org/10.1074/jbc.M113.485953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846692	Green Published, hybrid			2022-12-28	WOS:000330619000047
J	Furger, E; Frei, DC; Schibli, R; Fischer, E; Prota, AE				Furger, Evelyne; Frei, Dominik C.; Schibli, Roger; Fischer, Eliane; Prota, Andrea E.			Structural Basis for Universal Corrinoid Recognition by the Cobalamin Transport Protein Haptocorrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-B-12 TRANSPORT; PLASMA TRANSPORT; INTRINSIC-FACTOR; BINDING; ANALOGS; TRANSCOBALAMIN; MECHANISMS; COMPLEX; MODEL	Cobalamin (Cbl; vitamin B-12) is an essential micronutrient synthesized only by bacteria. Mammals have developed a sophisticated uptake system to capture the vitamin from the diet. Cbl transport is mediated by three transport proteins: transcobalamin, intrinsic factor, and haptocorrin (HC). All three proteins have a similar overall structure but a different selectivity for corrinoids. Here, we present the crystal structures of human HC in complex with cyanocobalamin and cobinamide at 2.35 and 3.0 angstrom resolution, respectively. The structures reveal that many of the interactions with the corrin ring are conserved among the human Cbl transporters. However, the non-conserved residues Asn-120, Arg-357, and Asn-373 form distinct interactions allowing for stabilization of corrinoids other than Cbl. A central binding motif forms interactions with the e-and f-side chains of the corrin ring and is conserved in corrinoid-binding proteins of other species. In addition, the alpha- and beta-domains of HC form several unique interdomain contacts and have a higher shape complementarity than those of intrinsic factor and transcobalamin. The stabilization of ligands by all of these interactions is reflected in higher melting temperatures of the protein-ligand complexes. Our structural analysis offers fundamental insights into the unique binding behavior of HC and completes the picture of Cbl interaction with its three transport proteins.	[Furger, Evelyne; Schibli, Roger; Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, CH-5232 Villigen, Switzerland; [Frei, Dominik C.; Prota, Andrea E.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Schibli, Roger] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Paul Scherrer Institute; Paul Scherrer Institute; ETH Zurich	Fischer, E (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci, OIPA 10A, CH-5232 Villigen, Switzerland.	eliane.fischer@psi.ch; andrea.prota@psi.ch	Prota, Andrea Enrico/R-9526-2019; Fischer, Eliane/M-2590-2013	Prota, Andrea Enrico/0000-0003-0875-5339; Fischer, Eliane/0000-0002-3399-3737; Schibli, Roger/0000-0002-1537-3833	Swiss National Science Foundation [31003A-112455]; Novartis Foundation for Medical-Biological Research Grant [10C74]; Research Committee (FoKo) of the Paul Scherrer Institut	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical-Biological Research Grant; Research Committee (FoKo) of the Paul Scherrer Institut	This work was supported by Swiss National Science Foundation Grant 31003A-112455, Novartis Foundation for Medical-Biological Research Grant 10C74 (to A. E. P.), and the Research Committee (FoKo) of the Paul Scherrer Institut (to E. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen R H, 1975, Prog Hematol, V9, P57; Alpers D. H., 1999, Chemistry and biochemistry of B12., P411; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BURGER RL, 1975, J BIOL CHEM, V250, P7707; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2006, FEBS J, V273, P4742, DOI 10.1111/j.1742-4658.2006.05478.x; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Furger E, 2012, THESIS ETH ZURICH; Furger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037421; Greibe E, 2012, J BIOL CHEM, V287, P33917, DOI 10.1074/jbc.M112.398016; Greibe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035660; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; KOLHOUSE JF, 1977, J CLIN INVEST, V60, P1381, DOI 10.1172/JCI108899; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moestrup SK, 2006, CURR OPIN HEMATOL, V13, P119, DOI 10.1097/01.moh.0000219654.65538.5b; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1998, VITAMIN B12 B12 PROT, P461, DOI DOI 10.1002/9783527612192.CH30; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Randaccio L, 2010, MOLECULES, V15, P3228, DOI 10.3390/molecules15053228; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolters M, 2004, PREV MED, V39, P1256, DOI 10.1016/j.ypmed.2004.04.047; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394; YANG SY, 1982, BLOOD, V59, P747	37	28	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25466	25476		10.1074/jbc.M113.483271	http://dx.doi.org/10.1074/jbc.M113.483271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846701	hybrid, Green Published			2022-12-28	WOS:000330619000042
J	Hsu, KS; Kao, HY				Hsu, Kuo-Sheng; Kao, Hung-Ying			beta-Transducin Repeat-containing Protein 1 (beta-TrCP1)-mediated Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Protein Degradation Promotes Tumor Necrosis Factor alpha (TNF alpha)-induced Inflammatory Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; TRANSCRIPTIONAL REPRESSION; ADIPOSE-TISSUE; KINASE ALPHA; TNF-ALPHA; TRCP; COREPRESSOR; PHOSPHORYLATION; ACTIVATION; PATHWAY	Cytokine modulation of the endothelium is considered an important contributor to the inflammation response. TNF alpha is an early response gene during the initiation of inflammation. However, the detailed mechanism by which TNF alpha induces proinflammatory gene expression is not completely understood. In this report, we demonstrate that silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) represses the expression of a subset of TNF alpha target genes in human umbilical vein endothelial cells. Upon TNF alpha stimulation, we observed an increase in the E3 ubiquitin ligase beta-TrCP1 and a decrease in SMRT protein levels. We show that beta-TrCP1 interacts with SMRT in a phosphorylation-independent manner and cooperates with the E2 ubiquitin-conjugating enzyme E2D2 to promote ubiquitination-dependent SMRT degradation. Knockdown of beta-TrCP1 increases SMRT protein accumulation, increases SMRT association with its targeted promoters, and decreases SMRT target gene expression. Taken together, our results support a model in which TNF alpha-induced beta-TrCP1 accumulation promotes SMRT degradation and the subsequent induction of proinflammatory gene expression.	[Hsu, Kuo-Sheng; Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Hsu, Kuo-Sheng/0000-0002-5700-6943	National Institutes of Health [R01 DK078965, HL093269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H. Y. K.).	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ann EJ, 2012, J BIOL CHEM, V287, P36814, DOI 10.1074/jbc.M112.356048; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Speigelman VS, 2001, J BIOL CHEM, V276, P27152, DOI 10.1074/jbc.M100031200; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spiegelman VS, 2002, J BIOL CHEM, V277, P36624, DOI 10.1074/jbc.M204524200; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	48	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25375	25386		10.1074/jbc.M113.473124	http://dx.doi.org/10.1074/jbc.M113.473124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861398	Green Published, hybrid			2022-12-28	WOS:000330619000035
J	Huang, CH; Hsiao, HT; Chu, YR; Ye, YH; Chen, X				Huang, Chih-Hsiang; Hsiao, Hui-Ting; Chu, Yue-Ru; Ye, Yihong; Chen, Xin			Derlin2 Protein Facilitates HRD1-mediated Retro-translocation of Sonic Hedgehog at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; MISFOLDED PROTEINS; MUTANT ALPHA-1-ANTITRYPSIN; QUALITY-CONTROL; ERAD COMPLEX; DEGRADATION; DISLOCATION; MEMBRANE; RETROTRANSLOCATION; RECOGNITION	Endoplasmic reticulum-associated degradation (ERAD) is an important system that eliminates misfolded proteins from the ER. Three derlins have been implicated in this process, but their precise function remains unknown. In this study, we report that although both derlin1 and derlin2 are capable of binding the ERAD-specific ubiquitin ligase HRD1, they associate with the HRD1-containing complex with different affinities. Accordingly, these derlins have nonredundant functions in ERAD with derlin2 being an essential functional partner for HRD1-mediated ERAD of SHH and NHK. We show that derlin2, but not derlin1 or derlin3, is required for ERAD of both glycosylated and nonglycosylated SHH, as well as NHK. Derlin2 appears to act at a post-targeting step for HRD1-dependent retro-translocation. Without derlin2, the assembly of HRD1 into a functional retro-translocation homo-oligomer proceeds normally, and substrate targeting to the HRD1 complex also occurs. However, the ERAD substrate SHH-C is largely trapped inside the ER lumen. These observations raise the possibility that derlin2 may regulate the movement of substrates through the HRD1-containing retro-translocon. Our study is the first to report that derlin2 functions with HRD1 in ERAD of certain substrates independent of their glycosylation status. The mammalian ERAD system may require multiple derlins that each functions with a distinct E3 partner to eliminate a specific subset of substrates. This is different from the model in Saccharomyces cerevisiae, in which Hrd1p alone is sufficient for retro-translocation.	[Huang, Chih-Hsiang; Hsiao, Hui-Ting; Chu, Yue-Ru; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan; [Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); China Medical University Taiwan	Chen, X (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhu Nan Town 35053, Miaoli County, Taiwan.	xchen@nhri.org.tw			NRPGM (National Research Program for Genomic Medicine); National Science Council, Taiwan; National Health Research Institutes, Taiwan, Republic of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075044] Funding Source: NIH RePORTER	NRPGM (National Research Program for Genomic Medicine)(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan, Republic of China(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NRPGM (National Research Program for Genomic Medicine), National Science Council, Taiwan and National Health Research Institutes, Taiwan, Republic of China.	Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Plemper RK, 1999, J CELL SCI, V112, P4123; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Stanley AM, 2011, FEBS LETT, V585, P1281, DOI 10.1016/j.febslet.2011.04.009; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	33	33	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25330	25339		10.1074/jbc.M113.455212	http://dx.doi.org/10.1074/jbc.M113.455212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23867461	Green Published, hybrid			2022-12-28	WOS:000330619000031
J	Wu, X; Huang, LT; Wu, Z; Zhang, C; Jiang, DY; Bai, YT; Wang, Y; Chen, G				Wu, Xia; Huang, Lanting; Wu, Zheng; Zhang, Ce; Jiang, Dongyun; Bai, Yuting; Wang, Yun; Chen, Gong			Homeostatic Competition between Phasic and Tonic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC GABA(A) RECEPTORS; CEREBELLAR GRANULE CELLS; SUBUNIT MESSENGER-RNAS; GABAERGIC SYNAPSES; SYNAPTIC INHIBITION; PYRAMIDAL NEURONS; GAMMA-2 SUBUNIT; DELTA-SUBUNIT; RAT-BRAIN; TRAFFICKING	The GABA(A) receptors are the major inhibitory receptors in the brain and are localized at both synaptic and extrasynaptic membranes. Synaptic GABA(A) receptors mediate phasic inhibition, whereas extrasynaptic GABA(A) receptors mediate tonic inhibition. Both phasic and tonic inhibitions regulate neuronal activity, but whether they regulate each other is not very clear. Here, we investigated the functional interaction between synaptic and extrasynaptic GABA(A) receptors through various molecular manipulations. Overexpression of extrasynaptic alpha 6 beta 3 delta-GABA(A) receptors in mouse hippocampal pyramidal neurons significantly increased tonic currents. Surprisingly, the increase of tonic inhibition was accompanied by a dramatic reduction of the phasic inhibition, suggesting a possible homeostatic regulation of the total inhibition. Overexpressing the alpha 6 subunit alone induced an up-regulation of delta subunit expression and suppressed phasic inhibition similar to overexpressing the alpha 6 beta 3 delta subunits. Interestingly, blocking all GABA(A) receptors after overexpressing alpha 6 beta 3 delta receptors could not restore the synaptic GABAergic transmission, suggesting that receptor activation is not required for the homeostatic interplay. Furthermore, insertion of a gephyrin-binding-site (GBS) into the alpha 6 beta 3 delta subunits recruited alpha 6(GBS)beta 3 delta(GBS) receptors to postsynaptic sites but failed to rescue synaptic GABAergic transmission. Thus, it is not the positional effect of extrasynaptic alpha 6 beta 3 delta receptors that causes the down-regulation of phasic inhibition. Overexpressing alpha 5 beta 3 gamma 2 subunits similarly reduced synaptic GABAergic transmission. We propose a working model that both synaptic and extrasynaptic GABA(A) receptors may compete for limited receptor slots on the plasma membrane to maintain a homeostatic range of the total inhibition.	[Wu, Xia; Huang, Lanting; Wu, Zheng; Zhang, Ce; Jiang, Dongyun; Bai, Yuting; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Huang, Lanting; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Huang, Lanting; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fudan University; Fudan University	Chen, G (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gongchen@psu.edu	Wu, Zheng/H-3234-2019	Jiang, Dongyun/0000-0002-3496-6271; Chen JNU, Gong/0000-0002-1857-3670	National Institute of Health [MH083911, MH092740]; Natural Science Foundation of China [31129003]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092740, R01MH083911] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Health Grants MH083911 and MH092740 (to G. C.). This work was also supported by Natural Science Foundation of China Grant 31129003 (to G. C. and Y. W.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Gonzalez MI, 2011, NEUROSCI LETT, V497, P218, DOI 10.1016/j.neulet.2011.02.052; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hines RM, 2012, CURR OPIN NEUROBIOL, V22, P552, DOI 10.1016/j.conb.2011.10.007; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones A, 1997, J NEUROSCI, V17, P1350; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Krogsgaard-Larsen P, 2004, BIOCHEM PHARMACOL, V68, P1573, DOI 10.1016/j.bcp.2004.06.040; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Luscher B, 1997, MOL BRAIN RES, V51, P197, DOI 10.1016/S0169-328X(97)00242-8; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Schneider Gasser E. M., 2007, EUR J NEUROSCI, V25, P3287, DOI DOI 10.1111/J.1460-9568.2007.05558.X; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Sun CS, 2007, J NEUROSCI, V27, P12641, DOI 10.1523/JNEUROSCI.4141-07.2007; Sun YJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-21; Tia S, 1996, J NEUROSCI, V16, P3630; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Yu LMY, 2009, CURR OPIN NEUROBIOL, V19, P327, DOI 10.1016/j.conb.2009.07.002; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002; Zheng T, 1993, Brain Res Dev Brain Res, V75, P91	66	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25053	25065		10.1074/jbc.M113.491464	http://dx.doi.org/10.1074/jbc.M113.491464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839941	hybrid, Green Published			2022-12-28	WOS:000330619000006
J	Ye, CQ; Bandara, WMMS; Greenberg, ML				Ye, Cunqi; Bandara, W. M. M. S.; Greenberg, Miriam L.			Regulation of Inositol Metabolism Is Fine-tuned by Inositol Pyrophosphates in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHETIC GENES; PHOSPHATIDIC-ACID; TRANSCRIPTIONAL REGULATION; RESPONSIVE GENES; MEMBRANE-LIPIDS; TELOMERE LENGTH; LEUCINE-ZIPPER; YEAST; HEXAKISPHOSPHATE; COMPLEX	Although inositol pyrophosphates have diverse roles in phosphate signaling and other important cellular processes, little is known about their functions in the biosynthesis of inositol and phospholipids. Here, we show that KCS1, which encodes an inositol pyrophosphate kinase, is a regulator of inositol metabolism. Deletion of KCS1, which blocks synthesis of inositol pyrophosphates on the 5-hydroxyl of the inositol ring, causes inositol auxotrophy and decreased intracellular inositol and phosphatidylinositol. These defects are caused by a profound decrease in transcription of INO1, which encodes myo-inositol-3-phosphate synthase. Expression of genes that function in glycolysis, transcription, and protein processing is not affected in kcs1 Delta. Deletion of OPI1, the INO1 transcription repressor, does not fully rescue INO1 expression in kcs1 Delta. Both the inositol pyrophosphate kinase and the basic leucine zipper domains of KCS1 are required for INO1 expression. Kcs1 is regulated in response to inositol, as Kcs1 protein levels are increased in response to inositol depletion. The Kcs1-catalyzed production of inositol pyrophosphates from inositol pentakisphosphate but not inositol hexakisphosphate is indispensable for optimal INO1 transcription. We conclude that INO1 transcription is fine-tuned by the synthesis of inositol pyrophosphates, and we propose a model in which modulation of Kcs1 controls INO1 transcription by regulating synthesis of inositol pyrophosphates.	[Ye, Cunqi; Bandara, W. M. M. S.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu			National Institutes of Health [R01 DK081367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK081367 (to M. L. G.).	ALLISON JH, 1980, J NEUROCHEM, V34, P456, DOI 10.1111/j.1471-4159.1980.tb06619.x; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ASHBURNER BP, 1995, MOL CELL BIOL, V15, P1709; AUSUBEL F, 1994, CURR PROTOC MOL BIOL; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Fu Y., 2006, METHOD MOL BIOL, P257; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HUANG KN, 1995, GENETICS, V141, P1275; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Loewen Christopher J R, 2012, F1000 Biol Rep, V4, P4, DOI 10.3410/B4-4; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOEWUS FA, 1962, BIOCHEM BIOPH RES CO, V7, P204, DOI 10.1016/0006-291X(62)90175-4; Maslanski J. A., 1990, METHODS INOSITIDE RE, P113; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Rupwate SD, 2012, FEBS LETT, V586, P1555, DOI 10.1016/j.febslet.2012.04.022; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Strahl T., 2007, BIOCHIM BIOPHYS ACTA, V1771, P252; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Wykoff DD, 2001, GENETICS, V159, P1491; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	56	32	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24898	24908		10.1074/jbc.M113.493353	http://dx.doi.org/10.1074/jbc.M113.493353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824185	hybrid, Green Published			2022-12-28	WOS:000330612300054
J	Bersuker, K; Hipp, MS; Calamini, B; Morimoto, RI; Kopito, RR				Bersuker, Kirill; Hipp, Mark S.; Calamini, Barbara; Morimoto, Richard I.; Kopito, Ron R.			Heat Shock Response Activation Exacerbates Inclusion Body Formation in a Cellular Model of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; UNDERLIES; INDUCTION; STRESS; CELLS	The cellular heat shock response (HSR) protects cells from toxicity associated with defective protein folding, and this pathway is widely viewed as a potential pharmacological target to treat neurodegenerative diseases linked to protein aggregation. Here we show that the HSR is not activated by mutant huntingtin (HTT) even in cells selected for the highest expression levels and for the presence of inclusion bodies containing aggregated protein. Surprisingly, HSR activation by HSF1 overexpression or by administration of a small molecule activator lowers the concentration threshold at which HTT forms inclusion bodies in cells expressing aggregation-prone, polyglutamine-expanded fragments of HTT. These data suggest that the HSR does not mitigate inclusion body formation.	[Bersuker, Kirill; Hipp, Mark S.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Calamini, Barbara; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Stanford University; Northwestern University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	Kopito@stanford.edu	Hipp, Mark/AAA-4238-2022	Hipp, Mark/0000-0002-0497-3016	National Institutes of Health from the NINDS [5R01NS042842-10]; National Institutes of Health [2T32HG000044-16]; Deutsche Forschungsgemeinschaft; National Institutes of Health Training Grant in Signal Transduction and Cancer [T32 CA70085]; National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases [T32 AG000260]; NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health Training Grant in Signal Transduction and Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS042842-10 from the NINDS (to R. R. K.).; The recipient of National Institutes of Health Predoctoral Grant 2T32HG000044-16.; Supported in part by a fellowship from the Deutsche Forschungsgemeinschaft. Present address: Dept. of Cellular Biochemistry, MaxPlanck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.; Supported by the National Institutes of Health Training Grant in Signal Transduction and Cancer (T32 CA70085) and the National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases (T32 AG000260). Present address: Dept. of Neurobiology and Center for Drug Discovery, Duke University, Durham, NC 27704.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Calamini B, 2012, CURR TOP MED CHEM, V12, P2623; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Chafekar SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037929; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Riva L, 2012, J HUNTINGTONS DIS, V1, P33, DOI 10.3233/JHD-2012-120020; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298	22	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23633	23638		10.1074/jbc.C113.481945	http://dx.doi.org/10.1074/jbc.C113.481945			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839939	Green Published, hybrid			2022-12-28	WOS:000330611400002
J	Mishra, AK; Del Campo, CM; Collins, RE; Roy, CR; Lambright, DG				Mishra, Ashwini K.; Del Campo, Claudia M.; Collins, Robert E.; Roy, Craig R.; Lambright, David G.			The Legionella pneumophila GTPase Activating Protein LepB Accelerates Rab1 Deactivation by a Non-canonical Hydrolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE; STRUCTURAL BASIS; DRRA; RAS; BINDING; DISPLACEMENT; RECRUITMENT; COMPLEX; MODEL; STATE	GTPase activating proteins (GAPs) from pathogenic bacteria and eukaryotic host organisms deactivate Rab GTPases by supplying catalytic arginine and glutamine fingers in trans and utilizing the cis-glutamine in the DXXGQ motif of the GTPase for binding rather than catalysis. Here, we report the transition state mimetic structure of the Legionella pneumophila GAP LepB in complex with Rab1 and describe a comprehensive structure-based mutational analysis of potential catalytic and recognition determinants. The results demonstrate that LepB does not simply mimic other GAPs but instead deploys an expected arginine finger in conjunction with a novel glutamic acid finger, which forms a salt bridge with an indispensible switch II arginine that effectively locks the cis-glutamine in the DXXGQ motif of Rab1 in a catalytically competent though unprecedented transition state configuration. Surprisingly, a heretofore universal transition state interaction with the cis-glutamine is supplanted by an elaborate polar network involving critical P-loop and switch I serines. LepB further employs an unusual tandem domain architecture to clamp a switch I tyrosine in an open conformation that facilitates access of the arginine finger to the hydrolytic site. Intriguingly, the critical P-loop serine corresponds to an oncogenic substitution in Ras and replaces a conserved glycine essential for the canonical transition state stereo-chemistry. In addition to expanding GTP hydrolytic paradigms, these observations reveal the unconventional dual finger and non-canonical catalytic network mechanisms of Rab GAPs as necessary alternative solutions to a major impediment imposed by substitution of the conserved P-loop glycine.	[Mishra, Ashwini K.; Del Campo, Claudia M.; Collins, Robert E.; Lambright, David G.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Roy, Craig R.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Mishra, AK (corresponding author), Two Biotech, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	Ashwini.Mishra@umassmed.edu; David.Lambright@umassmed.edu		Roy, Craig/0000-0003-4490-440X; Collins, Robert/0000-0002-4580-5991	National Institutes of Health [GM056324, AI041699]; Jane Coffin Childs postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041699, R37AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056324 (to D. G. L.) and AI041699 (C. R. R.). This work was also supported by a Jane Coffin Childs postdoctoral fellowship (to R. E. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Arasaki K, 2012, CELL HOST MICROBE, V11, P46, DOI 10.1016/j.chom.2011.11.009; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cheng W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002528; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Gazdag EM, 2013, EMBO REP, V14, P199, DOI 10.1038/embor.2012.211; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MP, 2012, J BIOL CHEM, V287, P35036, DOI 10.1074/jbc.M112.396861; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Yu Q, 2013, CELL RES, V23, P775, DOI 10.1038/cr.2013.54; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	50	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24000	24011		10.1074/jbc.M113.470625	http://dx.doi.org/10.1074/jbc.M113.470625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821544	Green Published, hybrid			2022-12-28	WOS:000330611400038
J	Kanzaki, H; Shinohara, F; Kajiya, M; Kodama, T				Kanzaki, Hiroyuki; Shinohara, Fumiaki; Kajiya, Mikihito; Kodama, Tetsuya			The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; RECEPTOR ACTIVATOR; OXIDATIVE STRESS; BONE-MARROW; TRAF FAMILY; RANKL; LIGAND; IDENTIFICATION	Reactive oxygen species (ROS) act as intracellular signaling molecules in the regulation of receptor activator of nuclear factor-kappa B ligand (RANKL)-dependent osteoclast differentiation, but they also have cytotoxic effects that include peroxidation of lipids and oxidative damage to proteins and DNA. Cellular protective mechanisms against oxidative stress include transcriptional control of cytoprotective enzymes by the transcription factor, nuclear factor E2-related factor 2 (Nrf2). This study investigated the relationship between Nrf2 and osteoclastogenesis. Stimulation of osteoclast precursors (mouse primary peritoneal macrophages and RAW 264.7 cells) with RANKL resulted in the up-regulation of kelch-like ECH-associated protein 1 (Keap1), a negative regulator of Nrf2. It also decreased the Nrf2/Keap1 ratio, and it down-regulated cytoprotective enzymes (heme oxygenase-1, gamma-glutamylcysteine synthetase, and glucose-6-phosphate dehydrogenase). Nrf2 overexpression up-regulated the expression of cytoprotective enzymes, decreased ROS levels, decreased the number of tartrate-resistant acid phosphatase-positive multinucleated cells, reduced marker genes for osteoclast differentiation, and attenuated bone destruction in both in vitro and in vivo models. Overexpression of Keap or RNAi knockdown of Nrf2 exerted the opposite actions. In addition, in vivo local Nrf2 overexpression attenuated lipopolysaccharide-mediated RANKL-dependent cranial bone destruction in vivo. This is the first study to show that the Keap1/Nrf2 axis regulates RANKL-dependent osteoclastogenesis through modulation of intracellular ROS signaling via expression of cytoprotective enzymes. This raises the exciting possibility that the Keap1-Nrf2 axis may be a therapeutic target for the treatment of bone destructive disease.	[Kanzaki, Hiroyuki] Tohoku Univ Hosp, Sendai, Miyagi 9808575, Japan; [Kanzaki, Hiroyuki] Tohoku Univ Hosp, Dept Orthodont, Sendai, Miyagi 9808575, Japan; [Shinohara, Fumiaki] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi 9808575, Japan; [Shinohara, Fumiaki] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Kajiya, Mikihito] Hiroshima Univ, Div Appl Life Sci, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Kodama, Tetsuya] Tohoku Univ, Dept Biomed Engn, Grad Sch Biomed Engn, Mol Delivery Syst Lab, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Hiroshima University; Tohoku University	Kanzaki, H (corresponding author), Tohoku Univ Hosp, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanzaki@dent.tohoku.ac.jp	Kajiya, Mikihito/A-4288-2018; Kanzaki, Hiroyuki/C-7942-2018; Kanzaki, Hiroyuki/M-2764-2019; Kodama, Tetsuya/T-2246-2019	Kajiya, Mikihito/0000-0001-6652-0007; Kanzaki, Hiroyuki/0000-0003-3473-1218; Kanzaki, Hiroyuki/0000-0003-3473-1218; Kodama, Tetsuya/0000-0003-4727-9558	Ministry of Education, Culture, Sports, Science and Technology [23689081]; Nestle Nutrition Council, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nestle Nutrition Council, Japan	This work was supported by Grant-in-aid for Scientific Research 23689081 from the Ministry of Education, Culture, Sports, Science and Technology and the Nestle Nutrition Council, Japan.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Haro ERA, 2011, J PERIODONTAL RES, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; HATA K, 1992, BONE, V13, P139, DOI 10.1016/8756-3282(92)90003-F; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hayashi SI, 1998, BIOCHEM CELL BIOL, V76, P911; HELFRICH MH, 1987, CELL TISSUE RES, V249, P125, DOI 10.1007/BF00215426; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Sasaki H, 2009, FREE RADICAL BIO MED, V47, P189, DOI 10.1016/j.freeradbiomed.2009.04.025; Sriarj W, 2009, J BONE MINER METAB, V27, P315, DOI 10.1007/s00774-009-0063-9; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wei XC, 2005, J BONE MINER RES, V20, P1136, DOI 10.1359/JBMR.050206; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wild AC, 1998, BIOCHEM J, V332, P373, DOI 10.1042/bj3320373; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324	46	111	115	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23009	23020		10.1074/jbc.M113.478545	http://dx.doi.org/10.1074/jbc.M113.478545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801334	Green Published, hybrid			2022-12-28	WOS:000330598200011
J	Sung, KH; Lee, SY; Song, HK				Sung, Kwang Hoon; Lee, So Yeon; Song, Hyun Kyu			Structural and Biochemical Analyses of the Eukaryotic Heat Shock Locus V (HslV) from Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; CELL-DIVISION INHIBITOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 20S PROTEASOME; COMPLEX; SULA; DEGRADATION; ACTIVATION; SUBUNITS	In many bacteria, heat shock locus V (HslV) functions as a protease, which is activated by heat shock locus U (HslU). The primary sequence and structure of HslV are well conserved with those of the beta-subunit of the 20 S proteasome core particle in eukaryotes. To date, the HslVU complex has only been characterized in the prokaryotic system. Recently, however, the coexistence of a 20 S proteasome with HslV protease in the same living organism has been reported. In Trypanosoma brucei, a protozoan parasite that causes human sleeping sickness in Africa, HslV is localized in the mitochondria, where it has a novel function in regulating mitochondrial DNA replication. Although the prokaryotic HslVU system has been studied extensively, little is known regarding its eukaryotic counterpart. Here, we report the biochemical characteristics of an HslVU complex from T. brucei. In contrast to the prokaryotic system, T. brucei possesses two potential HslU molecules, and we found that only one of them activates HslV. A key activating residue, Tyr494, was identified in HslU2 by biochemical and mutational studies. Furthermore, to our knowledge, this study is the first to report the crystal structure of a eukaryotic HslV, determined at 2.4 angstrom resolution. Drawing on our comparison of the biochemical and structural data, we discuss herein the differences and similarities between eukaryotic and prokaryotic HslVs.	[Sung, Kwang Hoon; Lee, So Yeon; Song, Hyun Kyu] Korea Univ, Dept Life Sci, Seoul 136701, South Korea	Korea University	Song, HK (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	hksong@korea.ac.kr	Song, Hyun Kyu/D-6763-2016; Sood, Anoop Kumar/A-7344-2013	Song, Hyun Kyu/0000-0001-5684-4059; Sood, Anoop Kumar/0000-0001-5702-4108	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0028168]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A092006]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (Grant 2011-0028168) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (Grant A092006).	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barboza NR, 2012, EXP PARASITOL, V130, P171, DOI 10.1016/j.exppara.2011.10.011; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chrobak M, 2012, INT J PARASITOL, V42, P329, DOI 10.1016/j.ijpara.2012.01.008; Couvreur B, 2002, MOL BIOL EVOL, V19, P2110, DOI 10.1093/oxfordjournals.molbev.a004036; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forouzan D, 2012, J BIOL CHEM, V287, P39254, DOI 10.1074/jbc.M112.386458; Gille C, 2003, J MOL BIOL, V326, P1437, DOI 10.1016/S0022-2836(02)01470-5; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Halperin T, 2001, PLANT MOL BIOL, V45, P461, DOI 10.1023/A:1010677220323; Higashitani A, 1997, MOL GEN GENET, V254, P351, DOI 10.1007/s004380050426; KANAOKA Y, 1985, CHEM PHARM BULL, V33, P1721; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; Kang MS, 2001, EMBO J, V20, P734, DOI 10.1093/emboj/20.4.734; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000048; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Park E, 2008, J BIOL CHEM, V283, P33258, DOI 10.1074/jbc.M805411200; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Ruiz-Gonzalez MX, 2006, J MOL EVOL, V63, P504, DOI 10.1007/s00239-005-0282-1; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; SONEZAKI S, 1995, APPL MICROBIOL BIOT, V43, P304; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Song HK, 2003, BIOPHYS CHEM, V100, P437, DOI 10.1016/S0301-4622(02)00297-1; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Tschan S, 2010, INT J PARASITOL, V40, P1517, DOI 10.1016/j.ijpara.2010.05.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	57	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23234	23243		10.1074/jbc.M113.484832	http://dx.doi.org/10.1074/jbc.M113.484832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818520	Green Published, hybrid			2022-12-28	WOS:000330598200030
J	Vaidyanathan, VG; Liang, FT; Beard, WA; Shock, DD; Wilson, SH; Cho, BP				Vaidyanathan, Vaidyanathan G.; Liang, Fengting; Beard, William A.; Shock, David D.; Wilson, Samuel H.; Cho, Bongsup P.			Insights into the Conformation of Aminofluorene-Deoxyguanine Adduct in a DNA Polymerase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSLESION SYNTHESIS; AROMATIC-AMINES; STRUCTURAL INSIGHTS; MUTAGENIC RELEVANCE; KLENOW FRAGMENT; I KLENOW; BETA; FIDELITY; REPLICATION	The active site conformation of the mutagenic fluoroamino-fluorene-deoxyguanine adduct (dG-FAF, N-(2'-deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene) has been investigated in the presence of Klenow fragment of Escherichia coli DNA polymerase I (Kfexo(-)) and DNA polymerase beta (pol beta) using F-19 NMR, insertion assay, and surface plasmon resonance. In a single nucleotide gap, the dG-FAF adduct adopts both a major-groove-oriented and base-displaced stacked conformation, and this heterogeneity is retained upon binding pol beta. The addition of a non-hydrolysable 2'-deoxycytosine-5'-[(alpha,beta)-methyleno] triphosphate (dCMPcPP) nucleotide analog to the binary complex results in an increase of the major groove conformation of the adduct at the expense of the stacked conformation. Similar results were obtained with the addition of an incorrect dAMPcPP analog but with formation of the minor groove binding conformer. In contrast, dG-FAF adduct at the replication fork for the Kfexo(-) complex adopts a mix of the major and minor groove conformers with minimal effect upon the addition of non-hydrolysable nucleotides. For pol beta, the insertion of dCTP was preferred opposite the dG-FAF adduct in a single nucleotide gap assay consistent with 19F NMR data. Surface plasmon resonance binding kinetics revealed that pol beta binds tightly with DNA in the presence of correct dCTP, but the adduct weakens binding with no nucleotide specificity. These results provide molecular insights into the DNA binding characteristics of FAF in the active site of DNA polymerases and the role of DNA structure and sequence on its coding potential.	[Vaidyanathan, Vaidyanathan G.; Liang, Fengting; Cho, Bongsup P.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Beard, William A.; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Rhode Island; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, BP (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	bcho@uri.edu	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health (NIH) [CA098296, P20 RR016457]; NIEHS, NIH [Z01-ES050158, Z01-ES050161]; NIH [1U19CA105010]; NATIONAL CANCER INSTITUTE [R01CA098296, U19CA177547, U19CA105010, R56CA098296] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants CA098296 (NCI) and P20 RR016457 (Center for Research Resources) (to B. P. C.) and Research Projects Z01-ES050158 and Z01-ES050161 in the Intramural Research Program of NIEHS, NIH, and in association with NIH Grant 1U19CA105010 (to S. H. W.).	ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, P NATL ACAD SCI USA, V103, P17231, DOI 10.1073/pnas.0605069103; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Beland F. A., 1990, HDB EXPT PHARM, P281; Bergoglio V, 2002, CANCER RES, V62, P3511; Canitrot Y, 2004, NUCLEIC ACIDS RES, V32, P5104, DOI 10.1093/nar/gkh848; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Chary P, 2012, CHEM RES TOXICOL, V25, P2744, DOI 10.1021/tx300368f; Cho B., 2010, CHEM BIOL DNA DAMAGE, P217; Cho BSP, 2004, J ENVIRON SCI HEAL C, V22, P57, DOI 10.1081/LESC-200038217; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Efrati E, 1997, J BIOL CHEM, V272, P2559; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Harding MM, 2010, CRYSTALLOGR REV, V16, P247, DOI 10.1080/0889311X.2010.485616; Hoffmann JS, 1996, J BIOL CHEM, V271, P15386, DOI 10.1074/jbc.271.26.15831; Hsu GW, 2004, J BIOL CHEM, V279, P50280, DOI 10.1074/jbc.M409224200; Hubscher U, 2011, CURR OPIN CHEM BIOL, V15, P627, DOI 10.1016/j.cbpa.2011.08.009; Jain N, 2009, NUCLEIC ACIDS RES, V37, P1628, DOI 10.1093/nar/gkn1063; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Klarer AC, 2011, CRIT REV EUKAR GENE, V21, P323, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.30; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Liang FT, 2008, J MED CHEM, V51, P6460, DOI 10.1021/jm800692a; Liang FT, 2007, J AM CHEM SOC, V129, P12108, DOI 10.1021/ja075271p; Liang FT, 2011, CHEM RES TOXICOL, V24, P597, DOI 10.1021/tx2000587; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meneni SR, 2007, BIOCHEMISTRY-US, V46, P11263, DOI 10.1021/bi700858s; Meneni S, 2007, J MOL BIOL, V366, P1387, DOI 10.1016/j.jmb.2006.12.023; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Neumann HG, 2007, CRIT REV TOXICOL, V37, P211, DOI 10.1080/10408440601028603; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Patel DJ, 1998, CHEM RES TOXICOL, V11, P391, DOI 10.1021/tx9702143; Patnaik S, 2010, CHEM RES TOXICOL, V23, P1650, DOI 10.1021/tx100341u; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Scharer OD, 2011, DNA REPAIR, V10, P667, DOI 10.1016/j.dnarep.2011.04.017; See KY, 2000, MUTAT RES-REV MUTAT, V463, P215, DOI 10.1016/S1383-5742(00)00047-8; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SIROVER MA, 1977, J BIOL CHEM, V252, P3605; Skipper PL, 2010, CARCINOGENESIS, V31, P50, DOI 10.1093/carcin/bgp267; Stone MP, 2011, CHEM BIODIVERS, V8, P1571, DOI 10.1002/cbdv.201100033; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Upton TG, 2009, ORG LETT, V11, P1883, DOI 10.1021/ol701755k; Vaidyanathan VG, 2012, CHEM RES TOXICOL, V25, P1568, DOI 10.1021/tx300289d; Vaidyanathan VG, 2012, BIOCHEMISTRY-US, V51, P1983, DOI 10.1021/bi2017443; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Zhou L, 1997, J AM CHEM SOC, V119, P5384, DOI 10.1021/ja9632771	61	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23573	23585		10.1074/jbc.M113.476150	http://dx.doi.org/10.1074/jbc.M113.476150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798703	Green Published, hybrid			2022-12-28	WOS:000330598200061
